>PK3-2_00001 hypothetical protein
MMKNKVKELRARFGYSQEKLGETVGVTRQTVAAIEKGDYVPSLLLALKICKAFSMKMEDV
FWLEEEN
>PK3-2_00002 hypothetical protein
MSMKTKAAFQLVLFGLACWTLIAYFEASEGIASFFRTKSGEMVFELNLTPFILFVAATAV
YLYLQKKSRPARKQLLLPDEFEEQDEREKMMTAKACRASYIAVYFSLPAAAVLLIFYPLF
QSRIPFFPIVIVFIIMIIQHLSYVISFKKNEKNSGAL
>PK3-2_00003 Alternate 30S ribosomal protein S14
MAKKSKVAKELKRQQLVEQYAAMRRELKEKGDYEALSKLPRDSAPGRLHNRCMVTGRPRG
YMRKFKMSRIAFRELAHKGQIPGVKKASW
>PK3-2_00004 hypothetical protein
MRRLDQLVQITQRKKNEEGEGKNKHITNQFGIVDKQGNTAADSAVKRDDSATQEMTQNIS
SPEPISFDKPVLIGSSIKGTDEPMHTSEHKKELIKHQDALLYYVELHH
>PK3-2_00005 hypothetical protein
MEIQRRTYQILKKNRMDVAASQAFTAEAVDIGEGISSADMYIEHCQKGKLVETVGPVSAD
YSEEKE
>PK3-2_00006 Alkanesulfonate monooxygenase
MEILWFIPTHGDARYLGSESDGRTADHLYFKQVAQAADRLGYTGVLLPTGRSCEDPWLTA
SALAEETNDLKFLVAVRPGLMQPSLAARMTSTLDRISDGRLLINVVAGGDPYELAGDGLF
ISHDERYEATDEFLTVWRRLLQGETVTYEGKHIKVENSNLLFPPQQAPHPPIYFGGSSQA
GIETAAKHTDVYLTWGEPPEQVKEKIERVKKQAEKEGRSVRFGIRLHVIARETEHEAWEA
AERLISHLDDDTIAKAQAALSRYDSSGQQRMAVLHQGDRTKLEISPNLWAGIGLVRGGAG
TALVGDPQTIADRMAEYQALGIESFIFSGYPHLEEAYYFAELVFPLLPFENERTRKLQNK
RGEAVGNTYFVKEKNASV
>PK3-2_00007 Putative aliphatic sulfonates transport permease protein SsuC
MKAEAAGSLPKTNAEAVQKKPRKMKYGWMKGLLLPVVIIAIWQIIGGLEVVSATVLPTPV
TIILTFKELILSGELFGHLQISIYRAALGFLLGAGLGLIIGILAGFSKRTELYLDPSLQM
LRTVPHLAVTPLFILWFGFDEVSKILLIALGAFFPVYINTFNGIRGVDAKLFEVARVLEF
KWHQQISKVILPAALPNILLGIRLSLGIAWLGLVVAELMGSSSGVGYMIMDARQFSQTNK
VFAGIIIFAVVGKLTDSFVRLLERKLLKWRNSYEG
>PK3-2_00008 Putative aliphatic sulfonates-binding protein
MKKGLIVLVAVFFLLAGCGANGASGNKQLKEIRIGIQQSLSPLLIAKEKGWFEDAFEKEG
IKVKWVEFQSGPPQFEGLAADKLDFSQVGNSPVISGQAAGIDFKEIGLSQDGLKANGILV
NQNSGIQDVKDLKGKKIAVAKGSSGFDFLYKALDQVGLSAHDVTIIQLQPDEAASAFENG
SVDAWSIWEPYLSLETIKHGAKILVNGESTDLYSPGFTLVRTKFAKEHPDEVVRFLKVFN
KAVVWQKEHLDEAADLYANIKDIDKEVVENVLKNTEPLNEVIRDDIVKAQQETADFQYRT
KAIDKKIDVKEVVDNTFIKKALKESSTGGDQ
>PK3-2_00009 Aliphatic sulfonates import ATP-binding protein SsuB
MAVTISIKEKAFVQEGRKTTVLENIQLSIAPGEFLTVIGPSGCGKSTLLKIIAGLDSDYD
GSVDINGRSVTAPGIQQGFIFQEHRLFPWLTVEQNIAADLNLKDPKVRQKVDELIEIVRL
KGAEKAYPRELSGGMSQRVAIARALLREPEVLLLDEPFGALDAFTRKHLQDVLLEIWRRK
KTTMILVTHDIDESVYLGNELAILKAKPGNIHKLMPISLAYPRNRTTPDFQAIRQKVLSE
FEKTEELEYAEGSGI
>PK3-2_00010 Vegetative catalase
MSSNKLTTSWGAPVGDNQNSMTAGSRGPTLIQDVHLLEKLAHFNRERVPERVVHAKGAGA
HGYFEVTNDVTKYTKAAFLSEVGKRTPLFIRFSTVAGELGSADTVRDPRGFAVKFYTEEG
NYDIVGNNTPVFFIRDAIKFPDFIHTQKRDPKTHLKNPTAVWDFWSLSPESLHQVTILMS
DRGIPATLRHMHGFGSHTFKWTNAEGEGVWIKYHFKTEQGVKNLDVNTAAKIAGENPDYH
TEDLFNAIENGDFPAWKLYVQIMPLEDANTYRFDPFDVTKVWSQKDYPLIEVGRMVLDRN
PENYFAEVEQATFSPGTLVPGIDVSPDKMLQGRLFAYHDAHRYRVGANHQALPINRARNE
VNNYQRDGQMRFDNNGGGSVYYEPNSFGGPKESPEDKQAAYPVQGIADSVSYDHNHHYTQ
AGDLYRLMSEDERARLVENIVNAMKPVEKEDIKLRQIEHFYKADPEYGKRIAEGLGLPIK
KDA
>PK3-2_00011 hypothetical protein
MGIKKEKGRKRFRKRKTYGNQILPLELLIEKNKREIMNSAELMEEIYMRIDEKHTAVRH
>PK3-2_00012 Phosphomethylpyrimidine synthase
MKNNSVQQANISIMSSFSGSKKVYVEGSSSDILVPMREIALSPTTGSFGEEENAPVRVYD
TSGPYTDPDVTINIEEGLMPLRQKWITKRGDVEEYEGRAIKPEDNGYKKANPNVSYPGLK
RKPLRAKSGQNVTQMHYAKKGIITPEMEFIAIREHVSPEFVRDEVASGRAIIPSNINHPE
SEPMIIGRNFHVKINANIGNSAVTSSIEEEVEKMTWAIRWGADTMMDLSTGKDIHTTREW
IIRNCPVPVGTVPIYQALEKVNGIAEDLTWEIYRDTLIEQAEQGVDYFTIHAGVLLRYVP
LTAKRTTGIVSRGGAIMAQWCLAHHQESFLYTHFEEICEIMKAYDIAFSLGDGLRPGSIA
DANDEAQFAELETLGELTQIAWKHDVQVMIEGPGHVPMHKIKENVDKQMDICKEAPFYTL
GPLTTDIAPGYDHITSAIGAAMIGWYGTAMLCYVTPKEHLGLPNRDDVREGVITYKIAAH
AADLAKGHPGAQIRDDALSKARFEFRWRDQFNLSLDPERALEYHDETLPAEGAKTAHFCS
MCGPKFCSMRISQDIRDYAKDKELSEWDAIQEGMKEKAEEFVNQGSQLYK
>PK3-2_00014 hypothetical protein
MKQIIAMGGGGFSMEPENLSLDQYIINQLERKSPHICFLPTASGDSQSYVQRFYDAFQTL
DCVPSHLSLFKPPSTDLTSFLMAKDVIYVGGGNTRNMLVLWKEWGLDLILKEAWKNGVVL
AGLSAGAICWFEEGVTDSAGPLTSMKSLGFLQGSFCPHYDGEKDRRPIYHQLVSNKFLCD
GYAADDGAALHFVNDQLVQTVSSRPDAKAYRVMMGEHGISETPLPVKYLD
>PK3-2_00015 hypothetical protein
MKRRCLIYETSSFLYDFVTVLCKLKAKRAEIADEQLPLIDHATLF
>PK3-2_00016 hypothetical protein
MDKESMVADELHRMFLAGELQITVEEDINNISERLRNGDLSLDRLSGEDAFIKETVNEAL
RRVEQ
>PK3-2_00017 Sporulation-control protein spo0M
MSFFKKLAASAGIGAAKVDTILEKDAYFPGEEVRGTVHVKGGKIAQDIRYIDVQLNTQYV
IVKDDEELRKYATIHSFRVTGSFTIQPGEEHQFPFSFSLPLDTPITVGKVEVAVVTDLDI
QGGIDKSDHDRIFVEAHPWIENVLEAIENLGFRLNEADCEQAPYFQRRLPFVQEFEFIPT
SGYYRQMLDELELIFLIDEDGLDIIFEVDRRARGLRGWLEEMYNDGEQLVRVRFSQSELE
DAEGLEEVLEEIIDQYAE
>PK3-2_00037 hypothetical protein
MDNLLRPIYQERASHPNTLAVIMIERRNKTSSLTDNFDAALLVIVKEADEPVFIKHYEFD
QKTASLHVVTDSQIQEWILLGTNRRIIDWIVNGRVMFDRNEYIVELIDRLNTFPFAERKL
KIGLEYGKLIRRYVEGKAFFEADQFLDAYNAVVHALHHLARIEVIDRGFHPETTVWSQVR
QMEPQVYKLYSELIESHESLEKRLELLFLANDFLIHSKAEIGSSHLFEVMKEKDIWQFGE
LLQHPDLKHFTPDLGVMLDYLTDKGLINVCQIETKGQAVYHRGYSFKKDVDSNS
>PK3-2_00038 hypothetical protein
MAKYSSKINKIRTFALSLVFVGFIIMYIGIFFKESVLLSSLFMILGLLSIGLSTVVYFWI
GMLSTKAVRVICPGCKKETKVLGRVDMCMHCREPLTLDKGLEGKEFDESYNKKKISK
>PK3-2_00039 Peroxide operon regulator
MAAHELKEALETLKETGVRITPQRHAILEYLVNSMAHPTADDIYKALEGKFPNMSVATVY
NNLRVFRESGLVKELTYGDASSRFDFVTSDHYHAICENCGKIVDFHYPGLDEVEQLAAHV
TGFKVSHHRLEIYGVCQECSKKENH
>PK3-2_00040 Putative peroxiredoxin bcp
MTIEIGQKAPDLELKGDHGETVTLSDYKGKYIVLYFYPKDMTPGCTTEACDFRDSHESFA
ELDAVIIGVSPDSQEKHGKFKEKHNLPFLLLVDDEHKLAEAFDVWKLKKNFGKEYMGIER
STFLIDKEGRLVKEWRKVKVKDHVADALQTLKDMSEK
>PK3-2_00041 Glutamate-1-semialdehyde 2,1-aminomutase 1
MHTKSIELHNEALEHIVGGVNSPSRSYKAVGGGSPVAMEKANGAYFWDVDGNKYIDYLAA
YGPIITGHAHPHITEAIKKAAENGVLYGTPTKHEVTFAKMLKEAIPAMDKVRFVNSGTEA
VMTTIRVARAYTGRTKIIKFAGCYHGHSDLVLVAAGSGPSTLGTPDSAGVPKSIANEVIT
VPFNDIESYKAALDKWGSEIAAVLVEPIVGNFGIVEPKEGFLEKVNELTHDAGALVIYDE
VITAFRFMYGGAQDLLQVKPDLTALGKIIGGGLPIGAYGGKKEIMEQVAPLGPAYQAGTM
AGNPASILSGIACLEVLKEEGVYEKLDHLGAMLEEGILQHAETHGITITVNRLKGALTVY
FSDEKVENYEQAERSDGETFATFFKLMLERGINLAPSKYEAWFITTAHTEQDIKDTLAAV
EDAFKHLKN
>PK3-2_00042 hypothetical protein
MLCHTIYYRKECTHKPMKLGARIFKTGIAITLALYLASWIGLPAPIFAGIAAIFAIQPSI
YRSFLIIIDQVQANIIGAVIATVFGLIFGPSPIMIGLTAVIVITIMLKLKIEHTISIALV
TVIAILESAGDDFLMFALIRTSTVILGVLSSFIVNLVFLPPKYETKLIHNTVENTEEIMK
WIRLSMRQSTEHSILKEDIEKLKEKMIKLDQTYLLYKEERSYFKKTTYVKSRKLVLFRQA
IITANRALDTLKKLHRLENDIYHMPEEFQETLTEELDYLLYWHERILMRFVGKIKPHDDA
DEEGIQYKQLLTKSFLKNQQNTDDELIDYNMLNIMASAVEYREQLEHLETLITSFQTYHP
KDCEIETEE
>PK3-2_00043 Putative multidrug export ATP-binding/permease protein
MHPSLSICGMNGICIIQNNGYVKPVAGYNRFFTWAHTHHDKERGGISVGVMKRYMQFVKP
YKKQIFVTVLIGIVKFSIPLALPLLLKYVVDDIIQGGGTASDKTTSLLTIMAIMFALFLI
LRPPVEYYRQYFAQWTASKVLYDIRAKLFDHIQKLSLRFYANTRTGEVISRVINDVEQTK
DFVITGLMNIWLDMLTILIVISIMLTLDVKLTLISIVLFPLYGISVKYFYGRLRKLTRER
SQALAQVQGHLHERIQGMPVIRSFAIEDHEQAQFNEKNGHFLDKAIRHTNWNAKTFAVVN
TITDLAPLIVIACAGYFVINGPLTVGTMVAFVGYIDRMYNPVRRLINSSTTLTQSIASMD
RVFEFIDEPYELIDKPNAIKAEQIRGEVEFQNVSFQYEKEKENILHDVSLKVNRGETVAL
VGMSGGGKSTLVSLIPRFYDVSSGRLLIDGTDIRDYEARSLRNQVGMVLQDTFLFSETIR
ENIAIGKPDATLDDIIEAAKAANAHEFILSFPEGYETRVGERGVKLSGGQKQRISIARVF
LKNPPLLILDEATSALDLESEHYIQEAMDKLAKDRTTFVVAHRLSTITHADKIVVMENGT
IIEVGTHDELMDYESQYKHLFTIQNLN
>PK3-2_00044 hypothetical protein
MGYPKEGETIQIHSYKHNGLIHRIWNETTILKSTEMCVIGANDRTMVTESDGRTWITREP
AICYFHARQWFNVIGMLREDGVHYYCNISSPFAYDGEAIKYIDYDLDVKVFPDMTYNILD
EDEYDDHRKAMNYPKEIDSILRDYLNTLLHWIHQRQGPFAPEFVDMWYERYLHYTK
>PK3-2_00045 hypothetical protein
MTEFEKLVSEQMKTMDKLLDLQSELDRCKQIEAELRHLERDARLRGIQNEIAVKRKHLAD
IQDMFQKQTEQVIRSYRSSEKPSSFV
>PK3-2_00046 Small, acid-soluble spore protein gamma-type
MANSNNFSKTNAQQVRKQNQQSAAGQGQFGTEFASETNAQQVRKQNQQSAAGQQGQFGTE
FASETNVQQVRQQNQSAEQNKQQNS
>PK3-2_00047 Enoyl-[acyl-carrier-protein] reductase [NADPH] FabL
MEQNKCALVTGSSRGVGKAAAIRLAENGYNIVINYARSKKAALETAEEIEKLGVKVLVVK
ANVGQPAKIKEMFQQIDETFGRLDVFVNNAASGVLRPVMELEETHWDWTMNINAKALLFC
AQEAAKLMEKNGGGHIVSISSLGSIRYLENYTTVGVSKAALEALTRYLAVELSPKQIIVN
AVSGGAIDTDALKHFPNREDLLEDARQNTPAGRMVEIKDMVDTVEFLVSSKADMIRGQTI
IVDGGRSLLV
>PK3-2_00048 putative protein YfhS
MYVGRDMSELNMVSKEDWKNSELAYFHHAFQQIMPYLNEEGQSKYRELTQEIEARGGMKR
NEADYSHGTRVSYD
>PK3-2_00049 Adenine DNA glycosylase
MNELEHKLKQKDIQQFRDDLISWFEREQRVLPWREDQDPYKVWVSEVMLQQTRVETVIPY
FLRFVEQFPTVEALADADEEKVLKAWEGLGYYSRVRNLQSAVKEVKQEYGGIVPPDEKDF
GGLKGVGPYTKGAVLSIAYNKPIPAVDGNVMRVMSRILSIWDDIAKPKTRKIFEEAIRAF
ISKEKPSEFNQGLMELGALICTPKSPSCLLCPVQRHCSAFEEGTERELPVKSKKKKPGIK
TMAAIVLTDEDGQVYIHKRPSKGLLANLWEFPNLETQKGIKTEREQLTAFLENEYGIQAD
ISDLQGVVEHVFTHLVWNISVFFGKVKQVSDARELKKVTKDELEQFAFPVSHQKIWKMAV
EAAAYSAAP
>PK3-2_00050 putative protein YfhP
MDTGTHVVMGIALGGIATLDPVVGSDPAMAHAVMIAALAGSQAPDIDTVLKLKNNAVYIR
NHRGFTHSIPAVLFWSVTIPAILYLFYPQADFLHLWLWTLLAVVLHVFVDIFNAYGTQAI
RPFSKKWVALGLINTFDPFIFISHLAAIAIWYAGGNPGITFLSLYIILAGYYLVRLIMQL
RIKRKLHEMIHDEIESIIISPTMKFRQWRIAVTTAHAFYVGRSMEGHVVILDTFNRVPVP
ETEVMHAAKQDDNIAAFLSFSPVYRWEVDTFKDHYEVRFIDLRYRSKGHYPFVAIVHIGH
DLNIRSSYTGWIFSEEKLQKKLKLGSI
>PK3-2_00051 hypothetical protein
MKRKYVMIYAASLLVSVLAHAFFVKEWADGRYMTGPGDGLAQMIVFKKLLFDQYTNGNFF
YNYSFGLGGGTFSQLGYYFSASFLFLAISAAVWLLQAVQLIGESDTLFWAQAAVFISIFK
LSLIIFTAASVFQYLLKHRAASFTGAVLYGASIIYFRHEAYWDFFTDTMIWLPLLVLGAE
KIIRERRPAWFIIACSLTLINNFYFAYINLIFIGFYVLFRWLIRLEEHEEKRWIQCRMFL
VSGLISFGISAAAFVPVVYGYLNNLRPSYSQKIEWFNFDDNILFSSRIIIVPAAFLLFLF
IVSFYKNRVFRLFAGLSLLFILFHFSPYAASVFNGFSAPQNRFEYVLAFTIAGAAAAGLS
QLSELKWKELLPAIAVVLLLYLYHIQRYELDIWKPANESILLLLFLTIAALFAAAFAKKR
AKAAVYGMIILSSLFVANTYQKYALSEGGGLDSVTKAYLTGEEYKGQESSELIRRLQKKD
DDPLMRIDWMNGVFNNTPIIYGFNGFSAYSSILNQHLLTFYWNDLSIDMGRESVSRYASL
GDRANVYSLLYGKYYMTEKTNEANVPYGFKKHLQSEHYVVYKNQYMLPFVKTADAVYSEN
ELDKLPALAKEQAMLKGIVVADPSGKTEQAPKPANLIPTSDIAAKHAEYQNGLLTVTGEN
GGELIITPKQASSAPGDYYVSFYLRSKAKDKGFTLKVNDYVTTRKSNQSIYKTGVNDLTV
RVPKSGDISIKLPKGTYELKNIALYEENYKTLKSAALQNKTDKADNLTWDKNKLTFAYQL
SKDKYMMLPIPYEKGWELKINGKTQTIEKADYAFIGFKAQKGDNHIELVYYPPYFKISAL
ISLVSLLLAALYIRRKKARL
>PK3-2_00052 Putative glycosyltransferase CsbB
MKKGLISIIIPSYNEGYNVKLIHESLKKEFKSIHYDYEIFFINDGSVDDTLQQIKDLAAV
SSRVKYISFSRNFGKEAAILAGFEHVQGEAVIVMDADLQHPTYLLTEFIKGYEEGYDQVI
AQRNRKGDSPVRSLLSSLYYKFINKAVEVDLRDGVGDFRLLSRQAVDALLKLSEGNRFSK
GLFCWIGFDQKIVFYENVERKNGTSKWSFSSLFNYGMDGVVSFNHKPLRICFYTGIFILL
LSIIYIIATFVKILTNGISVPGYFTIISAVLFLGGVQLLSLGIIGEYIGRIYYETKKRPH
YLIKEANIPNKDLPETNELKSVRRLTKMH
>PK3-2_00053 Epoxide hydrolase A
MDGVKCQFVKTNGITLHVAAAGPEDGPLLVLLHGFPEFWYGWKNQIKPLADAGYRVIAPD
QRGYNLSDKPDGIDSYRIDTLRDDIIGLITQFTDGKAIVIGHDWGGAVAWHLASTRPDYV
EKLIAINIPHPHIMKTITPVYPPQWLKSSYIAFFQLPDIPEASLKENDYETLNKAIGLST
RPEIFSSDDVSRYKEAWNQPGALTAMLNWYRALRKGSLAEKPAYETAPYRMIWGMEDRFL
SRRLAKETERRCPNGHLIFVDEASHWINHEKPAIVNQLILEYLKNQ
>PK3-2_00054 hypothetical protein
MAGIVSGGLMIIAGILIKLFPPKSINSVYGYRTRRSMSDQSLWNEANRYSATLMILSGLV
IAALGLLLKSNLIILQLILLLAACVIIFMLTEKRLKTMTHSQGGDRSGRS
>PK3-2_00055 hypothetical protein
MKKKQVMLALTAAAGLGLSALYSAPAAQAAPLHDISASMPSSDTYIIKAGKLNVRTQPNH
KGDILGTLSSEQKVTVIGFANDDWAQIHFKGKKAYISTHFLMKTASQAKTAKQTAFYAPT
PENGKAKQLSSGTEVTILGWGFSKNGGFDFTWAFVDYGGVKGYIQTKDLQIR
>PK3-2_00056 hypothetical protein
MNTYIEKLTNLLLEKNDMISYIQAKTWVELLWSDFEATYAKAGHAYQGEKMTEKIVSQWI
ENYGGQLHLFQSSRDDVNDYLNQSKGLLH
>PK3-2_00057 Small, acid-soluble spore protein K
MVRNKEKGFPYENENKFQGEPRAKDDYASKRADGSINQHPQEKMRASGKR
>PK3-2_00058 Inner membrane transport protein YdhP
MSIKNPSVKFIIFVLMICTFSIGYTEYAVMGILTSIANDFHIQVSSAGLLVTAYAASVCL
TGPIVTIIAVKLPRKPVLLGLMAIFILSNLMSALAPNFAVLAVSRILSASIHGAFFAIAM
VFASEMVPPEKRAAAAASMNGGLTVALMLGVPFGSYLGDVLNWRAVFSIITALGVIGFLG
LMAAVPNRKPKVIPMLMNEWGVFKHKQVLYSFAITILGYSGVFIAYTFIEPILRHSAGFS
TVGITGALFAYGLGGVAGNFFAGKVPLPLLTRTMIGVMIGLIGVLAVFPYIAIYPAAAIV
GTFLFGACAFGTPPLLQTKVISSSEGGTTIAAAVSVSAFNLANALGAWIGGMILSGTGSY
SWLFAGGALMTACGLVLSTFAHVSEKKSVYEYQVNKG
>PK3-2_00059 putative protein YfhH
MEKRYSQMTSHELNTEIASLSEKARKAEQLGIINELAVLERKITMAKAYLLNPEDFSPGA
AYRVEGTEDEFTISYLNGVFAWGCRTSSPDQEEALPISVLQEKKQT
>PK3-2_00060 Regulatory protein RecX
MPFITKISAQKKNTERFNIFLDEKYAFSVDADVLVKFELKKGKELDDLDIIEIQYGDGVK
KGFNRALEFLSYRMRSTKEVEDHLKKKEISAPVIAEVIHKLNDYKYLNDQEFAAAYVSTH
KKTNGKGPDVLFRELRAKGIDDDTIKEALSSFSFEDQTREAVKHVEKLLKKDKKLSTKEL
KQRAQMQLQRKGFSFDVISAALEQIEYENDEDTEKEALRLHAEKAFRKYRYDGSYESAMK
VKQFLFRKGFSLDLIEQFLQEEE
>PK3-2_00061 Epimerase family protein
MNIAMTGGTGFLGRHLTGVLTRQGHHVYILSRNARETEQKNITYVQWLTEGAAPKQELPH
IDVWINLAGKSIFGRWTEKTKQHILSSRINATREVQRLIHKQKEKPKALIQASAVGIYGT
SLEKTFTEDSPTSDEDFLSHTAHMWEKEGQKIEAMGIRTVYARFGVMLGEKGALPLMVLP
YKLLAGGTIGTGRQWLSWIHVEDAAQMIRYAMEDTGISGPMNVTAPNPVEMKQFGKTIAR
VKHRPHWLPVPEFFLSKALGEMSLLIVKGQRALPKKAITSGFRFTYSDLEFALSQLITDG
KAV
>PK3-2_00062 hypothetical protein
MEKKREKHQQGANLKKMQEVLYSGEFKKAEKAAKRK
>PK3-2_00063 hypothetical protein
MGRNHIHKNRDKNKQKLPQVPDALKRETDGVYEEYSSELADADDRKAQERAKAADNRAKK
KNR
>PK3-2_00064 Putative NAD(P)H nitroreductase YdjA
MPQTEQIHQHSALRDIIRSRRSIRKFKPEPVPSAVILDMLETAKYAPNHRVTEPWRFIYV
SSEAGKANLINTFASFSQKAKPDMTEDKLQNFKNTLGRVPGFLLVVFQQDENERARDDDF
AATSSLIQNLQLLAWEKGIGMVWKSGKILYDKEVHQAFGLQDNERFAAIIQTGYPDEAPE
VKKRTPIRERFTDM
>PK3-2_00065 putative isomerase YddE
MKEIEVLKYEAFTSSPGKGNPAGVVLQGDDYTEEEMQTIAELAGYSETSFIKKSESADLE
LRYFTPGHEMNLCGHATVASLYALCEKGLLKSGKTYSIQTKAGILPVKIAEKEGRIHITL
EQASPQFKPFTGDREKLAGALGITEEDFHDDLPIVFGSTGIWTAIVPLRSLEASKKMVPD
NKQFPEVLVDLPKASVHPFTFETVHPANDLHGRHFSSPYSGTIEDPVTGTASGVMGAYMQ
QYGRADQREFVVEQGQEIGKDGKVEIEISEEGGHVKVHMTGTAVYSETRILKI
>PK3-2_00066 putative siderophore transport system permease protein YfhA
MKLRFGVTEAEKKAWIVFLVLLGLTAAVLIISAGLGQRFIPPWDVAKTFFGAGSKLDELM
IMSFRMPRILTALCAGVCLAAAGAILQGLVRNPLASPDIVGITGGAAVAVVLVMMFFSDR
SSSLTISLSWLPAAAFIGASAVGLIVYLLAYKNGASTFRLVLIGIGFSMSAQAMTTLLMI
KGPIYRASQANVYITGSVYGSNWQHVKIAIILSVILLFICFVALKNMNIQVLGEDIAAGA
GSAVQRNRFFLLLLSTALTGCAVSVAGTIGFVGLMAPHIARRLVGSSYGALLPASALIGA
LLVLTADIVGRTLFAPVEVPAGVFTAAIGAPYFIYLLYKTRNS
>PK3-2_00067 putative siderophore transport system permease protein YfiZ
MAAMFSSLTQGLLSVNELELAQVLFWLTGSVQGRSLDLLMTMLPYAAAALVISFFLGQKI
NLLVMGEDVAKGLGQKTGLLKFVMALCVVLLAGAAVAIAGPISFIGIIIPHFARFIVGND
YRWVLPFSAVLGAVLLVAADIGARYIIMPQEVPVGVMTAIIGMPVFVYIARRGAKL
>PK3-2_00068 Vitamin B12 import system permease protein BtuC
MICKKASSKWIVLLCLILILLAAVCASVVYGYTGTSWRQVYQAFTSFDGTNEHVIIKDVR
LPRALVATVVGASLAAAGVLMQALTKNPLASPGIFGINAGAGFFIVAGSFFSIFNHLRRW
YGARFSGLHSPLRLSMPQARLEEKG
>PK3-2_00069 putative siderophore-binding lipoprotein YfiY
MKKHISMLFVFLMAVMVLSACNSSESSSNSEGSSSKTRTVKHAMGTSDNIPAHPKRIVVL
TNEGTEALIALGIKPVGAVKSWKGDPWYDYLKDDMKGVKNVGLETEPNVEAIAELKPDLI
IGNKVRQEKIYDQLNAIAPTVFAESLAGNWKDNLTLYANAVNKADKGKEVIADFDKRVSD
LKNKLGDQTNKTVSVVRFLSGESRIYYTDSFSGIILDQLGFKRPEKQVELFKKQKDQFTF
STDSKESIPDMDADVLFYFTYKADNAKENEKWANQWTSSSLWKNLKAVKSGNAHEVDDVV
WTTAGGIKAANYLLDDIETYFLKTK
>PK3-2_00070 Phosphatidylglycerol lysyltransferase
MLIKKNALSILKIAFPIAVLLFVIYQSKKELTNLSFKRTLMVINGLERTDLFILVLIGLL
AVAAMSLYDYVLKYSLRLSITNGKVFRVSWIANSFNNVLGFGGLAGVGLRMMFYKEHTKD
HKALVKGIAWLTSSMLLGLSVFSIFVAARVLPVDEVIHEKPWLWAVVIGFALILPLSLAV
SKIKGRKAGEEENADKVKNPIFAYIGASVVEWLMAGTVIYFALFAMGIHADIRYVFGVFV
IAAIGGMISLVPGGFGSFDLLFLLGMEQLGYHQEAIVTSIVLYRLAYSFIPFGLGLFFAA
GDLTENTMKRLETNPRIAPAIETTNVLLVVQRAILVRILQGSLSLIVFVAGLIVLASVSL
PIDRLTVIPHIPRPALLLFNGLSLSSALILLILPIELYKRTKRSYTMAITALVGGFVFSF
LKGLNISAIFVLPMIIVLLVLLKKQFVREQASYTLGQLIFALALFTVALFNYNIIAGFIW
DRMKKVLRHEYFVHSDSHITHATIMAIIIVPLFFFIFTMVYHKKTKPIGEKADPERLASF
LNEKGGNALSHLGFLGDKRFYFSSDGNALLLFGKIARRLVVLGDPSGKRESFPLVLEEFL
NEAHQKGFSVLFYQIEREDMALYHDFGYNFFKLGEEAYVDLHTFTLTGKKKAGLRAINNR
FEREEYTFHVDHPPFSDAFLEDLKQISDEWLGSKKEKGFSLGFFDPSYLQKAPIAYMKNA
EGEIVAFANVMPMYQEGEISVDLMRYRDDAPNGIMDALFIRMFLWAKEEGCTSFNMGMAP
LSNVGTAFTSFWSERFAAVIFNNVRYMYSFSGLRAFKEKYKPEWRGKYLAYRKNRSLSVT
MFLVTRLIGKSKKDSV
>PK3-2_00071 hypothetical protein
MEYNLHDTTVLNENILSSEEREIWVLYMKVLTSAGLGDVSEWMKLDMSMPQMKVLMLLNN
HGTLKVSDIAEKMGASLSNTTGLLDRLEKSGFVKRSHSEEDRRSVVVQLTENAKNIFRGL
YEKGHLKLKRSLELLSPEEKQAVSEGLSILSKALEKAKKE
>PK3-2_00072 Multidrug resistance protein 3
MSEALTTQKSQKWAISLFTIGVFMAALDNGIISAALTTINESFAVSPSWGSWGITLYTLG
LSVSVPIVGKLSDRYGRKKLFLIEVCLFGLGSLLVALSQNFPLFLISRLIQALGGGGIFI
IGSSHILATLPKEKQGKALGLLGAMNGMAAVLGPNIGSFLLDWTGSWHWLFLINLPIAVL
LVIFGACFIAETKASEAKRLDTAGIFLLSLSILAVMYGMTNLDGANLLHSLGTPEVYGYI
VFGILCFAALISFEKRVEMRGGDPILAYSLLRNNMFQRTLIIGLLSGGLLAAVIFIPSYV
EQYLGVPAAKAGYWMTPLALASGIGAWLGGALTDKKGPVKTVVLSGIISCAGFALFPLWV
TEKWEFVIASVAAGIGFGFLLGAPLNVLVSEAAKTNKGTALGTLSLVRQIGLTLSPTLYA
GFITAGFDQIGDEIKSRLSESGHSEKAMQMMPEIDSSNVSSLQEQIERIPVPEVKSAISD
AIHASVASGYDHLYAAAAVISLLVIAAISLPAFRRQKR
>PK3-2_00073 Putative metal-dependent hydrolase YfiT
MTKANLSYPIGEYMPKESISKEQKEEWIQALEEVPAKLKQAVEGMTDSQLDTPYRDGGWT
VRQVVHHLADSHMNSYIRFKLCLTEETPAIRPYDEKAWSELKDSKTADPSGSLALLQALH
GRWTALLRTLTDQQFQRGFYHPATKEIMTLENALGLYVWHSHHHIAHITELSKRMGWS
>PK3-2_00074 hypothetical protein
MQKYLANVLLGNFIGYFILVIFQFYILHMIFHEYLKKASPKWVLSISFLVTAAYLSYFTA
VSPVPASEESGAFPFFWVPFAGWLFYFCLAYYCGKEYKRFLALLNQYRWVVYGAALASAV
LVVIVSYVGEIGMISSKRPDIMLYSTSMIFLCFHLFSKMKHVPKIIMFISNYSFSIYLLH
AYFMIIGYVLLTNMPGIPAIPAVILLFAVCTCGPILTSWALNKFKYGYLFVGKIYQPKQK
KATVEVRDHAG
>PK3-2_00075 hypothetical protein
MQIKEIFVIRCISCLSVVLLHIISMVLMLQAEALANISHTVDSFRTLLMFSTPAFIFISE
FLLARSYPDGVPNGFLKKRGKVIFIPFLFIAAIDAMLMTSAMGER
>PK3-2_00076 Extracellular esterase EstB
MKKIFIASVICLSMILSVLTAQPSSAKAETVHNPVVLVHGISGASYNFFAIKNYLISQGW
QSNKLYAIDFYDKTGNNFNNGPQLASYIDRVLKETGAKKVDIVAHSMGGANTLYYIKYLG
GGNKIQNVVTLGGANGLVSSVALPGTDPNQKILYTSIYSLNDQIVINSLSRLQGARNIQL
YGIGHIGLLSNSQVNGYIKEGLNGGGLNTN
>PK3-2_00077 hypothetical protein
MRVLKYAILGLLRKGELSGYDITSYFKEELGQFWSAKHSQIYPELKKLTDEGFITFRTTI
QGTKLEKKMYTLTDSGKRELHDWLIRHQPIPETVKDEFMLKAYFISSLSRQEASDLFTDQ
LLKRKAKLSDLQGSYEKLMASAEPMSFSSPDFGHYLVLTKALEREKNYVSWLESILAMID
EG
>PK3-2_00078 hypothetical protein
MNVTLRELTGELIRVVPMDKSHIQGLYEAAKDENIWAHLPKTITTLHDMEAFVEEALKTK
ESGTEFPFVIIHRETGKIVGTTRFLYMSFSSRSLEIGWTWFHPSVWGTSVNTECKYLLLQ
YCFEQLATIRVQFKTDERNIRSQKAIERLGAVKEGILRNQMIRKDGTFRNSVFYSIIDSD
WPSVKLHLEQRLKLTFTVCDEGGVQTGTNAQF
>PK3-2_00079 Linearmycin resistance permease protein LnrN
MKKILAICGIELSLIFKKRQNYLMMFAAPLLLTFVFGGMLGGNDDKLRLAVIDQDDTILS
QHYIRQLKTHDDMYTFETMSESKAAEKLKQKKIAGIIIISRSFQAQLEKGKNPELIFRHG
PDLSEAPMAKQYAESTLAKLNIQVTAAKTSAQAAGENWKAAYKTVFAKDSKDAEPAVKRK
TFSDNEESADASDTASTAAGFCILFVMLTMMGAAGTILEARKNGVWSRLLTASVSRAEIG
AGYVLSFFVIGWIQFGILLLASHWMFGINWGNPGAVIVLVSFFLLTVVGIGLVIAANVRT
PEQQLAFGNLFVIATCMVSGMYWPIDIEPEFMQSIAEFLPQKWAMSGLTEIIANGAHVTD
ILGICGILLAFAAITFAAGLKALRA
>PK3-2_00080 Linearmycin resistance permease protein LnrM
MKKSLWIAWKDVKIRITDRKGFIMLILMPLILTCILGAALGSVVDGGSRIDGIKVGYVQS
DQSNAANMFKTDVLKKMKSVKVTQASSEDEIKNLLDEKKIDVGILIPKQWEAGKTSAFVY
ADPDQTLKSSIIETAAASFIDQYKTVKEAASASMDYVSKTSAVKQGKLDPAHFANSLVKA
LEKETGDKLTIKEKSVGSKAATSFQYYSAAMLCMFMLFHMTVGAKSFLQEKETETLARML
MTPAQKSAILFGKWLGTYLFAIIQFFIFLVVTINIFGVDWGGNLLYVSVLGLSYAAAVSG
ISVLLASCISDMKSADAIGGFGIQLLAVLGGSMLPLYQFPDFLQSVSKAVPNRWALDGFL
SLMEGGGWADLQKPVLLFAVIGLCSLALGIRRLHTR
>PK3-2_00081 Linearmycin resistance ATP-binding protein LnrL
MLQAENIKKAYGKKTIVKGISFSLQKGESFGLLGPNGAGKSTTISMISGLVPHDSGNITV
GGYVIGKETAKAKQKIGVVPQEIALYPTLTAHENLMFWGKMYGLTHGEAKKRSAEVLEYV
GLTDRAKDKIATFSGGMKRRINIGAALMHKPELLIMDEPTVGIDPQSRNHILETVKQLNE
TGMTVIYTSHYMEEVEYLCDRIGIIDQGEMIAIGTKNDLCSRLGGDTIIQLTVSEIDEAF
LYAIRSLAHVNGVTVHESELKIDISAAHHEKVVTSLLAEATAHHINLLSLQVQEPNLERL
FLNLTGRTLRD
>PK3-2_00082 Transcriptional regulatory protein LnrK
MIKIIITDDQDIVREGLASLLQLREELNVIATARNGQEAFEKAKELEPDIVLMDIRMPVS
NGVEGTKLITNSLPGVKVLMLTTFKDSELIAEALEEGASGYLLKDMSADTIVKAVMTVQS
GGMVLPPELTAQMLNEWKREKQLKGINEKEKPKELLDLTERELEVLAQLGYGLNNKEIAE
KLFITEGTVKNHVSNIISKLSVRDRTQAAIYSVRYGVSDF
>PK3-2_00083 Sensor histidine kinase LnrJ
MYLSIVKEDNWFGYVFIAAGAAMYAANHVLMTKETNAIWFCLIDIAIGFSFGFIFPGAGL
FIIMLCPVAVAFFLRRFPKRTAWSVLCLCSILFLIVLIRTYAMFGTEFVIDHLTSMTFVV
FCGVVGKLIRKLLDAQETAKQQYRELTESHLALSAAHEELHLYAKQVEELTAIHERNRMA
REIHDTVGHKMTALLVQLQLLREWQKRGSQKAEETVGVCETLAREALDDVRLSVRTLQTE
NDPSLIETLKQLTKDFYKNAGVTTEFAVSGDPAMIPLSLHPTLVRTVQEALTNAKRHGGA
TACSIQLACTTDSISLVIKDDGKGNPDAALGFGLLNMKKRAAEHGGMIRFESERDQGFTV
IAEFSLANKKWSFGPAQQKENLS
>PK3-2_00084 hypothetical protein
MIRKELGNGSDEREGSVFYENVHLDGELFNVSVYCERG
>PK3-2_00085 Catechol-2,3-dioxygenase
MTSIHEDTTIGYVKLTIRSLERSLQFYCNAIGFKVLKKTDRQAELTADGKRALLVLEENP
SAVVLPERSVTGLYHFAILLPNRKELGITLARLIEHGIAIGHGDHAVSEALYLSDPDGNG
IEMYADRPRSTWQRDREGNYVMTTTAVDIEGLLEEAGDERKAALPNETIIGHIHLHVSDL
NEAKAFYTDVLGFDIVGNYAGMSALFVSAGGYHHHIGLNIWAGRNAPPKPTNASGLDYYT
VVLPHQEELDRVADRVKRAGYSIEETENSFRVKDPVSGAHILFVV
>PK3-2_00086 Putative oxidoreductase CatD
MNKTFEIGTLLLRVITGIIFFVHGLSKFQGMEGTIQFFGSIGLPSFMAYVIAAIELVGGV
LVFFGLATRIVGVLFALTLIGAIITVKLKAPFMGNAEFDYLLLLTSIHLALTGSRFLALD
PLVFKAKKSENVSA
>PK3-2_00087 putative ABC transporter ATP-binding protein
MLKDIRKPFQYPKLPIDKKEGAKKRAKAKDAKGTLRRIWSYLAERKGLLILVMLMVVISA
IFGLLGPFVIGKAIDHFIVGKTVSGLIPVLILLLVIYVIQALSLWFQNYWMITISQGTVF
RMRSELFTHLHELPIPFFDKQRHGELMSRVTNDIENVSSTLNTSVIQILSSVITFVGTIA
VMMYMSPLLTVITLTIIPVMAVSLKWITNRTGKLFKEQQKNLGELNGYIEESVSGAKVIK
AYSREKQITAEFLEKNAALKTSGFWAQTISGFIPKVMNSLNNLSFTMIAAIGGLFALKGW
ISIGSIVVFAEYSRQFTRPLNDLANQFNTMLSAIAGAERVFDVLDEKEEREDEKNAVHQP
IQTGGIEFRDVSFGYDEGQQTLKHLQFTVPAGQSIAFVGPTGAGKTTVTNLLARFYEPDE
GRILIDGTDIKTLTRASLRKNMGFVLQDSFLFQGTIRENIRYGRLDASDQEVEAAAKTAN
AHSFIERLPKGYDTVLTQNGSGISQGQKQLISIARAVLADPVLLILDEATSNIDTVTEVN
IQEALARLMEGRTSVIIAHRLNTIQRADQIVVLKDGEMIEKGSHDELIRQKGFYRDLYES
QFEK
>PK3-2_00088 putative ABC transporter ATP-binding protein
MQKALSFLKPYSWLAGIALILMLTELAVELMQPLLIAKIIDDGILKQDMRHVWTWGAVMV
GLTVLSFAAGMLNSFYAAHVSQSFSYDTRKGLFQKIQSFSYSTFGQFSSSSYITRLTNDV
TQVQNMIFMSLRFMLRAPLMIAGGIVLSLAVNVKLGFFLLVTIPILILFLLWVLKKGGAL
FRSVQKRLDQLNTVMQENLTAMKLIKALLRGSHEVKRFIKANTRLMEKTVSAFQLVEFTM
PVLMLLMNLCILLILWAGAYSITSGGTQVGDVVAIINYATRITGALSMFPFLIMIFTRAK
ASGDRIGEVLETEGDERAEGIISDQLSGRIEFQHVSFRYPEMDREALRNVSFSAKPRETI
AILGATGSGKSTLFQLIPRLYQPDAGSIYIDEKPIHDVPAEGLRKQIGYVPQEVLLFSGT
IKENIAWGKENASLNEIMEAAKHAQIHETIMKLSNGYDTVLGQRGVNLSGGQKQRISIAR
ALIRKPAILLLDDSTSALDLQTEAKLLEAISTYECTTLIITQKMTTAMKADKILLLEDGE
LIEKGTHSELLSESQLYKRIYESQFGREGSESC
>PK3-2_00089 PTS system maltose-specific EIICB component
MMQKIQRFGSAMFVPVLLFAFAGIIVGVSTLFKNETLMGPLADPDGFWYQCWYIIEQGGW
TVFNQMPLLFAIGIPVALAKKAQARACLEALTVYLTFNYFVSSILTVWGGAFGVDMNQEV
GGTSGLTLIAGIKTLDTNIIGAIFISSIVVFLHNRYFDKKLPDFLGIFQGSTYIVMISFF
IMIPIALAVSYIWPMVQSGIASLQSFLVASGAVGVWIYTLLERILIPTGLHHFIYTPFIY
GPAVAEGGIVTYWAQHLGEYSQSAKPLKELFPQGGFALHGNSKIFGIPGIALAFYATAKK
EKKKLVAGLLIPVTLTAIVAGITEPIEFTFLFISPFLFAVHAVLAATMSTVMYMAGVVGN
MGGGLIEAVTLNWIPLFGSHGMTYVYQILIGLSFTAIYFFVFRFLILKFNIATPGREKDD
QQETKLYSKKEYRERKIKDETASAAETETADDTAFLYIEALGGKDNITEVTNCATRLRVS
VKDDSKVEPDSVFRALGAHGVVRNGKAFQVIIGLSVPQMRERVEKILNQ
>PK3-2_00090 HTH-type transcriptional regulator GlvR
MQLEELINQHYSKLNDNDFHILKYILNHKHTCYHLGIDALAKACSVSRSSILRLAQKLGF
SGYSEFRVFLKWEDQPEEGESMSFQKLLDDIEANLKFLRTKDMTDMCQLIDDADRIFVYG
SGNAQKICARDLQRMFIPRHRYLILIEDRNEFNLMRDDFKVNDLFIIISLSGETPELIPQ
ARMLSAKGIPFISITNLKNNVLAQLTPHNLYATSKPVTLSDRTEIVAFAPFFLVGEALFR
AYVDYKEAEKNDIE
>PK3-2_00091 Maltose-6'-phosphate glucosidase
MKKKSFSIVIAGGGSTFTPGIVLMLLDHLEEFPIRKLKLYDNDGERQERIAGACDVFIRE
KAPEIEFTATTDPEEAFTDVDFVMAHIRVGKYAMRALDEQIPLKYGVVGQETCGPGGIAY
GMRSIGGVLEILDYMEKYSPDAWMLNYSNPAAIVAEATRRLRPDSKILNICDMPVGIEDR
MAQILGLSSRKEMKVRYYGLNHFGWWTSIQDQEGNDLMPKLKEHVSQYGYIPKTEAEAVE
ASWNDTFAKARDVQAADPATLPNTYLQYYLFADDMVKKSNPNHTRANEVMEGREAFIFSQ
CDMITREQSSENSEIKIDDHASYIVDLARAIAYNTGERMLLIVENNGAIANFDPTAMVEV
PCIVGSNGPEPITVGTIPQFQKGLMEQQVSVEKLTVEAWAEKSFQKLWQALILSKTVPNA
RVARLILEDLIEVNKDYWPELDQSPTRIS
>PK3-2_00092 hypothetical protein
MDSYKVIALANKYSAAAEEVRSSKLLLESRLSALGDAWQGKARDSFDQDFEETKAAYDQF
EQELLETSQELKAAAVKIEERKAEIARMEELERKAREERHKLGR
>PK3-2_00093 hypothetical protein
MSGNIAVDPNKLEQFANDVVTELTDMENKYKDLHVELGQMILQCDPRYSSCFSGVGDAWS
SGKALVTKLSDNEIFIRKTGDKFVEQDDILRKLYHAYDKYGTMTSLTALMLTQGKYYGLG
LTKFAKQPSGLHTARHSKLLLDISRAVDSSRYQKAARVLLNPKYLFKKTNRPFSDLVHKK
FTKYFPQDTVDFSNSVRSYTRGFLNEAGVRSTLKDVGKTGLKFAKGNAITATLITGATET
FGAGLKIAENYAKYQDKPEVLKRENAKAVGNAVNNTIFVAGGATAGAVIGGAIGSFAGPV
GTVLLGAAGSYVGGVVGEQIAKYTAGFAEKAALKLKEPIHAVVDTAKKGLESAGKVVKSV
NDGIDAANQTIHKGIDSAKKGMEKAKKTADSLIHGATHFLKGKLSFG
>PK3-2_00094 hypothetical protein
MKQFTISIEELLFCFYSEGFFEQGMALKQAYFPEIEDEQLGALFEAACRSLLAKDAAEYR
NHQYRLKDEYCPFIHVLNDADYTVKLSKFNGQGAEQNVSCHVSKFGTYSHELLFDEQVHR
ITKMESSEGLLAKTDEFLHIIDTEDKRESIVTLTSNEFEKLLEGASDNPSYLKEFLDKHD
HQEDVTRFVNDLALRKGKMDTLMRLAYDKDNTPEVADMAFVLPGARHTWLVTGITQNEFS
ILPAHKDVVNQIISKKE
>PK3-2_00095 hypothetical protein
MKNQEIVEVKSRMFLRIWAFVGSAGMGLACLWLFYMGITFQTKYYLLAIPAGFLFTLFCL
YLFIIFFPAFTPRGNTIFRIKTGKDGELFTDKVSVTFTDIKKIEMGRHKFSLKGIFQEDI
MIQTVDQKTIRIPTWNIITNPLFFEAVERYILPHLNEEAKSNWIGQFTEIQRSAYLKEFE
NHPKL
>PK3-2_00096 hypothetical protein
MIEVKSMMFLRAWLFLATGGAFIAGVWLVSEALTFESKYALLYLGVGLMAIVYGLITFFM
AFPAFTSRGNVIFSVKAGPDGEIFSRKRSARFPEIKRIYMGRHRFSLKGIFFEDIIIEKT
DGKVVRIPTWNIIANPLFFEAVERYILPHLDEETKRNWISQFTEVQRSAYLKEFENNPKL
>PK3-2_00097 hypothetical protein
MLITILLFLAAGLAEIGGGYLVWLWLREAKPVGYGIAGALILIVYGILPTFQSFPSFGRV
YAAYGGVFIVLAVLWGWLVDRKTPDLYDWIGALICLIGVCVILFAPRE
>PK3-2_00098 Small, acid-soluble spore protein H
MNIQRAKEIVESPDMKKVTYNGVPIYIQHVNEDNGTARIYPLDEPQQEHEVQLTNLKED
>PK3-2_00099 Acetoin dehydrogenase operon transcriptional activator AcoR
MNSIPNDLQTWKRFVKDGVLDEARLRKRIAESWHRCKKAEVNPYLEKGPKVLQQTELDQQ
SNKHSFFLTTAKPYLDKLLPALKEMEMMALLIDSDGVVHALDGHPRALYEAKRINFVEGA
CWTETAVGTNAIGTALHISEPVAIQGSEHYSVASHHWNCSAAPIHHEDGSLAGVIDISCP
ASGAHPHMLGIATAIAYAAERELAAKSREKELELISRFGERAASCVPMVLCNTKQHIISA
SVPIRTSMPEWQGRHLYELKERGFSIEKAVTMGNGGTCFYLSEQKKKTAFRFNGVIGQSG
RSQAMLKNLERAAVADATVCLSGETGTGKEVAARALHENSERRHGPFIAVNCGAIPSDLI
ESELFGYAEGAFTGAKRNGYKGAFQKADQGTLFLDEIGEISHSMQVALLRVLQERKITPV
GGTKEVPVDIRVIAATHCDLRELAESGKIREDLFYRLHVYPIELPPLRDRPEDIPDLFQY
YKQKHHWPGELPLDFLDMLKEWRWPGNIRELFNVFERLSIRFPDGRMRDEPLTALLEAAG
LPITPAEKKPAAAGALTLREQIQKDMMIKALESAKGNVSQAAKISGIPRSTFYKRLKKFN
LSAES
>PK3-2_00100 Dihydrolipoyl dehydrogenase
MTLAIIGGGPAGYAAAVSASQQGRSVLLIDKGPLGGTCLNEGCIPTKSLLESANVLDKIK
HADHFGIELPPGAISVDWSKMQNRKQQVVRQLVQGVQYLMKKNQIQVVKGTASFLSDRKL
LIEGENGKEIREADQILIASGSEPIELPFAPYDGEWIIDSKDALSLSEIPSSLVIVGGGV
IGCEYAGLFARLGSRVTIIETAGQLIPAEDEDIARLFQEKLEEDGVEVHTSSRLERVDQT
AKTAIWKSGQREFKTKADYVLVAIGRKPRLDGLQLEPAGVDFSPKGIQVNGHMQTNVPHI
YACGDAIGGIQLAHAAFHEGIIAASHASGRNVKINEKHVPRCIYTSPEIACIGMTEQQAR
SVYGDVKIGEFPFSANGKALIKQQAEGKVKIVAEPEFGEIVGVSMIGPDVTELIGQAAAI
MNGEMTADMAEHFIAAHPTLSETLHEALLSTIGLAVHA
>PK3-2_00101 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MAVKVVMPKLGMAMKQGEVSIWNKKVGDPVEKGESIASIQSEKIEMDIEAPENGTLIDIK
VKEGEEVPPGTAICYIGNANESVQEEAKEPAAEDSEPPAVQPAKQESQPAAAKKERIKIS
PVARKIAEKAGLDVKQLKGTGPGGRIVKDDVTKALAEQKKEQTEPVSEQKAKETPVTGMR
KVIAARMQESLANSAQLTITMKADITKLAALQKQLSPTAEERYGTKLTMTHLVSRAAVLA
LQAHPVLNSFYKNERIITHPHVNLGMAVALENGLVVPVIRHAEKKSLIELAQSISENAKK
AREGRAGSEELQGSTFSITNLGAFGVEHFTPILNPPETGILGIGASYDTPMYQGEEIVRS
TILPLSLTFDHRACDGAPAAAFLKTIKTYLEEPAALIL
>PK3-2_00102 Acetoin:2,6-dichlorophenolindophenol oxidoreductase subunit beta
MARVISMSDAINEAMKLAMRRDENVLLIGEDVAGGAAVDHLQDDEAWGGVLGVTKGLVQE
FGRSRVLDTPISEAGYMGAAMAAASTGLRPIAELMFNDFIGTCFDQVINQGAKFRYMFGG
KAQVPITVRTTYGAGFRAAAQHSQTLYGLFTSIPGLKTVVPSNPYDAKGLLLAAIEDNDP
VFFFEDKTSYNMKGEVPENYYTIPLGKADIKREGGDITLFAVGKQVNTALEAAAQLAEKG
IEAEVLDPRSLSPLDEEAIFTSLEKTNRLIIIDEANPRCSIATDIAAIVADKGFDLLDAP
IKRITAPHTPVPFSPVLEDQYLPTPDQIVRVTLELLGEPAMN
>PK3-2_00103 Acetoin:2,6-dichlorophenolindophenol oxidoreductase subunit alpha
MELLKREGLSLTEEKALWMYQKMLEIRGFEDKVHELFAQGVLPGFVHLYAGEEAVAVGVC
AHLHDGDSITSTHRGHGHCIAKGCDLDGMMAEIFGKATGLCKGKGGSMHIADLNKGMLGA
NGIVGGGFTLACGSALTAKYKQTKNVSVCFFGDGANNQGTFHEGMNLAAVWNLPVVFVAE
NNGYGEATPFEYASACDSIANRAAAYNMPGVTVDGKDILAVYQAAEEAIERARNGGGPSL
IECMTYRNYGHFEGDAQTYKTKDEKTEHLEEKDAIQGFKNYLLKETDANKLSDIEQRVSE
SIEKAVSFSEESPYPKESELLTDVYVSYEKGGM
>PK3-2_00104 hypothetical protein
MGDITLKPRNMSFKQTFNLITIPCVRWGFLHPKVTCDGIEEASKEIEAGLKKAVPQVIKA
DAALSIENGQFTLDTKWNKQLAEKAPMSMTIQLDASGLSKTDAVKMAETVRKTLNERDIH
TQTAR
>PK3-2_00105 hypothetical protein
MKRLCIIPCGKKKIWDIHPDKGPVRAEDAYLSPFHQACERYAKAFFDEWVILSAKHGFLR
PDDIVPENYDVTFGTAHPEIMAADELRRQFHEKGFFDIEELVMLGGKKYRSVLNAVIDEH
QHISWPLSSYKGIGYMLQALNRAVEEKHELQHLVQMKKSV
>PK3-2_00106 putative tRNA-dihydrouridine synthase
MKTRLGYTDVDEWRGWLTHILKQDIANLSIHLRTRAEMSKVDAHWELIPEIKKLRDEIAP
DTLLTINGDIPDRETGLKLAEQYGVDGIMIGRGIFTNPFAFEKEPKEHTSKELLDLLRLH
LDLHDKYSELEARPYKPLPRFFKIYLRGFRGASELRNQCMNTKSTDEVRALLDDFERKYL
DGAE
>PK3-2_00107 putative tRNA-dihydrouridine synthase
MTENFWRELPRPFFVLAPMEDVTDVVFRHVVSEAGRPDVFFTEFTNSESYCHPDGKDSVR
GRLTFTEDEQPMVAHIWGDKPENFRKMSIGMAGLGFKGLDINMGCPVPNVAGNGKGSGLI
CRPDVAAELIEAAKAGDCL
>PK3-2_00108 23S rRNA (uracil-C(5))-methyltransferase RlmCD
MNQQKKQAPVELKVGQTFPLTIKRLGINGEGVGYFKKKVVFVPGALPGEEVVVQATKVQP
KFSEGRIKKIRKASEHRVAPPCPVYEQCGGCQLQHLAYSQQLREKRDIVIQSLERHTKFK
VENMEIKETIGMDNPWNYRNKSQFQIGRSQSGSIIAGLYGLESHDIVPIKDCVVQHPATN
KTTGIVRRILEDFNVSVYNERKRKGDVRTIVTRVGFETGEVQVVLVTAKETLPHKEEIVK
AIQKRLPEVKSIIQNVNGAKTSVIFGEKSKPLAGNTVIQEVLGDVSFELSARAFFQLNPE
QTVKLYDEVKKAAQLTGKEKVVDAYCGVGTIGMWVADGAKEVRGMDVIKESIDDAKKNAK
KHDMTNATYVTGTAEHWLPKWTKEGFRPDVVIVDPPRTGCDSTFLDTIKKVKPKRFVYVS
CNPSTLAKDLQALSKDYRVEYIQPVDMFPQTAHVEAVAKLVLKSSN
>PK3-2_00109 hypothetical protein
MKKFLTAACTLGLLLSAAGCGNDSSATSAKTEKTAEDKSENLDLLKKDFNSITKEDWKKI
HISKKDMNGAFEKMTEANSKGEKVVKKVEIKNNTVVITFNNSDGKSMENSLSAIFFDQFL
RDLYKHSSYYDGSEPTIRFVDLDNQLIQESDQPLDTDNETDGSSQNSGRKILTTPGETSN
EDNGEIVTLDKIADIQKQAAMKPLTITVDQVKLLARTNISPLQLKLFKKLTDQKVSEPLR
YIQITYKAENTGDTQVDWQGIESVETNDGQKLKIADNNIFKDNDHVFAPHTENEGVIGAI
YSGKADDLHELKITFSPITNGTPGQSMTVKLD
>PK3-2_00110 hypothetical protein
MWEENVSVTPPYHFDRVLDRLSLDPLNAADREAREIRVPIRNQGGDVCIVKVQALGHADE
PEFLVSGETDQEEMMMEIKRIFQWENDLQHVLAHFSKTSLSAIFEEHAGTPLVLDYSVYN
CIMKCIIHQQLNLSFAYTLTERFVHAFGEQKDGVWCYPKPETIAELDYQDLRDLQFSMRK
AEYAIDTSRMIAEGTLDLSELPNMTDEDIMKKLIKIRGIGPWTVQNVLMFGLGRPNLFPL
ADIGLQNAIKRHFQLDDKPAKDVMLAMSKEWEPYLSYASLYLWRSIE
>PK3-2_00111 Cobalt/magnesium transport protein CorA
MINITAITTEHQLLKNIPIERVEQPDIAWYWVDFYGPEDTETALLRDFFHFHPLAIEDCF
QHMQRPKLDHYDGYRFYVIHALNHETLETEEVDIFQGERFVVTFHLHETPGIAKVRERLH
ASPDILKKGPGHISYMIMDQLVDEYFPLVYKIEDRLNEIEESRPHKTYGTLMDEVFELRT
DLLHLRRTVIPMRDLLYRILSLDHVKEQRETKAYFSDIYDHLLKLSEIVESNRDMTSDLR
DSYVTLNSNRMNAIMMTLTIVSTIFIPLTFIAGVYGMNFDHMPELHWKYGYFAVLGLMAA
LVIGMLIWFVHKGWFKIFK
>PK3-2_00112 3-hydroxyisobutyrate dehydrogenase
MKIAVIGLGNMGQPIARNVLQAGYELTVYNRTKQKTEELASEGAQAADTPRQAAESADIV
ITMLSDDDSVSSVTFGEDGLIEGLAKNGIHISMSTISVEFSEKLAAAHAEKGQSFLAAPV
LGRPDAAAKAALRIITAGPAEAKQTAKPLLDSLSQQVFDVGEESKTANAAKISINFLLVS
MLEALSESFLMMEKYGLEQKQFLEIASALFGSPVYQNYGTIMAEQKFEPAGFKMSLGLKD
TNLALAAAEQVSANLPLAELAKSHFESGIEQGFGDLDWAALIKCIK
>PK3-2_00113 Peptidoglycan-N-acetylmuramic acid deacetylase PdaA
MKWMCAICCAAVLLAGGAAQAEAVPNEPINWGFKRSVNHQPPDAGKQLNSLIDKYDAFYL
GNTKEKTIYLTFDNGYENGYTPKVLDVLKKHRVTGTFFVTGHFVKDQPELIKRMSDEGHI
IGNHSFHHPDMTTKTADQIQDELDSVNEEVYKITGKQDNLYLRPPRGVFSEYVLKETKRL
GYQTVFWSVAFVDWKINNQKGKKYAYDHMVKQAHPGAIYLLHTVSRDNAEALDDAITDLK
KQGYTFKSIDDLMFEKEMKLPSL
>PK3-2_00114 hypothetical protein
MGNAVNNKDQQIDYLKNRLDMFMNVIDSLDPEATDVEDIDRLISMLDDLEAKYERFKKDW
E
>PK3-2_00115 7-carboxy-7-deazaguanine synthase
MTQNTKLRPITPEFDPWEAYMDVDQYGDMQLTNVEFTTTTLCNMRCEHCAVGYTLQPKDP
NALPIDLLLKRLEEIPLLRSISITGGEPMLSLKSVKEYVVPLLKYARERGVRTQINSNLT
LDIERYEWIIPYLDVLHISHNWGTVEDFAEIGFAMMDRKPTFEQRARYFEKMIENSRALV
DAGVMVSAETMLNKRTLPHIEHIHRQITEDMKCQRHEVHPMYPSDFASALESLSLKEMRQ
AIHRLLDIRDEKTWMLFGTLPFYACSSDEEDQKLLRRLRAAKNVTVRNDPDGRSRLNVNI
FDGNIIVTDFGDTPPLGNIQTDSLPSAYEKWRETKLAKELNCHCPNVRCLGPNVLVKNSY
YQNTDFTKRQARS
>PK3-2_00116 putative MscS family protein YfkC
MEETFTEIFQNKIVDILLVAVILWVGVFIINRLVQLFFKRTDFIEERKEKTIESLVRSVT
QYTATIGFIFYVISLFVHDFGKILAGAGVAGIVIGFGAQSLIKDVLAGVFLIYERQLHKG
DYVTVNNLFNGTVEEIGLRSLQIREWSGKLLTISNGEVRQIENYNIDFMRITESFLISFK
EDPDRVYSVLEEACDMLNEELRDSLKRDEFGNPTEPFQIHGITALNKINRGVEFTVKGMV
KDDDYFKASLAVRRVLVRQLYQNNVQMLEEAVRIDRTQ
>PK3-2_00117 putative protein YfkD
MKKLFHSTLIVLLFFSFFGVQPIHAKKQFKVPNSVASISKENTYPNASQDQPMLQPSRLA
KELLDHSEVKIENPHLIKMLNESNISGTPLAVGYRATIFLGKWALGYESNETVANWEYKR
INTNRADNRGGKETAEMHYAQEQQYKVKGGLTAKVPNAEDVKSMMMLKAMEKTNLPLAFE
TVVGAGTKRDQIYKVAPKKLGYLNAYAPAVNEKGKVTYGEVYLVLKGNKRKLVVKNVTSQ
GIGAWIPVQDHVTFGFQLSSLPR
>PK3-2_00118 Ca(2+)/H(+) antiporter ChaA
MNRIFFILVAAGVPLSVIGSLMHWPSAVLFAVYCVTIIALASYMGRATEALSIIAGPRIG
GLLNATFGNAVELIISIFALKEGLTGIVLASLTGSVLGNLLLVAGLSFFVGGLKYKRQEF
NIHDARHNSGLLIFAVIVAFVIPEVFSIGMGDASKLNLSIGISIILILLYVAALYFKLVT
HRGVYQPNNAVQHEEEEQPEWSGKVATIVLFAATIVVAYISENLVHTFHSVAEQFGWSEL
FIGVIIVAIVGNAAEHASAIIMAYKNKMDIAVEIAVGSTLQIAMFVAPVLVICSIFFPVR
MPLVFTLPELVAMVSSVLLMIAISNDGDSNWFEGATLLAAYVIMAIGFFLL
>PK3-2_00119 putative MFS-type transporter YcaD
MSRFHFFILVLLVSISGFSQGMLLPVISIIFETNGESAAINGLHATGLYIGVLLASPFME
APLRKLGFKPLIVIGGSIVILSLFGFIWLQSVWVWFLLRLFIGIGDHMLHFSTQTWVTSM
SSKQNRGRNLSIYGLSFGLGFAAGPFMVPLVKLSPALPFIVSGCFSLFAWLFVFFLQNAY
PETSPHETKSDNSFRRFYQAMLFGWVAFMPTFGYGFLETALNGSFPVYALRLGISVDAVA
LILPAFAIGSIIFQFPLGILSDKYGRRNVLLVILLTGALCFFIAGVFPSPYVIGCCFFIA
GMAVGSTFTLGISYMTDLLPPHLLPAGNLLCGITFSLGSILGPIAGGWYMQTFESANLFY
FITLTLSVVWLALVLGKPKSWPQAETYSSSS
>PK3-2_00120 hypothetical protein
MTKHTKKGGSHNKQNSKSKSGNKTSGSANGQNGYH
>PK3-2_00121 hypothetical protein
MNFLKELFSRYTLHEGQSKSAELAYFFLLSLFPFLIFMLTLTAYLPISTDDVLGVVEQYA
PDSAMSLIESITQQTLNNRNGGLLSFGIIAALWSASNGMNAIVRSLNHAYDVEENRSFII
VRLTSIFLTIAMVFTILVALLLPVFGREIGRLASDFVGASDLFLSVWAAIRWGVSPLILL
IVFSALYVIAPNKKLSLRFVMPGAVFATIGWIVVSTLFSFYVSTFANYSATYGSIGGIIV
LMIWFYLSGILIILGGEINALLHKRKKLPDENPYH
>PK3-2_00122 hypothetical protein
MNNERLMLKGIFLGAAAGAALSLFHKPTRQACGMRWLTCKHKLSLYKSNPELLKNTVITK
VDEAKKLAQTLSDEVGFVNQQVKELKKTTPQVMELVQETKEHFSKK
>PK3-2_00123 Low molecular weight protein-tyrosine-phosphatase YfkJ
MISVLFVCLGNICRSPMAEAIFRDLAAKKGLEGKIKTDSAGIGGWHIGNPPHQGTQEILQ
REGISFEGMLARQVSEQDLTDFDYIIAMDAENIGSLRSMAGFKNTSHIKRLLDYVEDSDL
ADVPDPYYTGNFEEVCQLIKTGCEHLLASIQKEKQL
>PK3-2_00124 hypothetical protein
MSSPNTETLTQMIEEISQKLNMLNVGVIKAEDFSDEKIEDLTYLHSMVMKKQSFSPSEMQ
AIAQELASLRK
>PK3-2_00125 Inner membrane transport protein YdiN
MKTTPIKTASGMYINYFFLGMVNIILASNMSSLTKQWNTDPTGISYVIAAIGFGKLLTYG
ISGVLSDKIGRKPLVVASAGIMAVFLVGIPLSPSYELAFVFALLAGIANSAMDAGTYPAL
TELFPAASGSANVLVKAFMSVGAALLPLLITFLADNSLFYGFAFYLPAAVYALNIVYLST
LSFPKKQKKPISGGQQETSAFLSEPVFQKEGTALIIIGFTSTALFTVSQIWLPSYAQKAA
GLAESASVQLLSYYSIGSLTSVLLLALLLNRWVKPVLITLLYPIITLCTLAVMLTVHVPV
VLDITAFFLGFSTAGVFQITITLMTELFWKRKGTVTGIVATASSIASILLPIATGLIAKS
GGIAHIFMFDFGIAVIGTAAAAFLYYRYKKLTGAQA
>PK3-2_00126 General stress protein 18
MGKKIAVVLTDYFEDSEYTEPAKAFKEAGHELTVIENEKGKTVKGKQGNAEVTVDASIDG
VNPSDFDALLIPGGFSPDQLRADDRFVQFAKAFMTDKKPVFAICHGPQLLINAKALDGRK
ATGYTSIRVDMENAGADVVDQEVVVCQNQLVTSRTPDDIPAFNRESLALLEK
>PK3-2_00127 Trifunctional nucleotide phosphoesterase protein YfkN
MRIQKRRTHVGNILRILLPPIMILSLILPTPPIHAEESAAPQVHLSILATTDIHANMMDY
DYYSDKETTDFGLARTAQLIQKHREQNPNTLLVDNGDLIQGNPLGEYAVKYEKENIISGA
KTHPIISVMNALKYDAGTLGNHEFNYGLDFLDGTIKGADFPIVNANVKTASGENRYTPYV
MKEKTVTDENGNEQKVKVGYIGFVPPQIMTWDKKNLEGQVQVQDIVESANETIPKMKAGG
ADVIIALAHTGIEKQAQSSGAENAVFDLATKTKGIDAIISGHQHGLFPSAEYAGVSQFDV
EKGTINGIPVVMPSSWGKYLGVIDLKLKKTDGSWKVADSKGSIESIAGTVTSRNETVTNA
IRQTHQNTLEYVRKPVGKTEADINSFFAQVKDDPSIQIVTDAQKWYAEKEMKDTEYKDLP
ILSAGAPFKAGGRNGANYYTNIPAGDLAIKNVGDLYLYDNTVQIVKLTGSEVKDWLDMSA
GQFNQIDPSKGGDQALLNENFRSYNFDVIDGVTYQVDVTKPAKYDENGKVINAGSSRIIN
LSYDGKPINANQEFLVVTNNYRASGGGGFPHLTSDKIVHGSAVENRQVLMDYIIEQKTVN
PKADNNWSIAPVSGTNLTFESSLLAKPFADKADDVAYVSESANNGYGVYKLQFDDDSNPD
PPKDGLWDLTVMHTNDTHAHLDDAARRMTKINEVRSETDHNILLDAGDVFSGDLYFTKWN
GLADLKFMNMMGYDAMTFGNHEFDKGPTVLSDFLSGNSTTVDPANRYRFEAPEFPVVSAN
VDVSNEPKLSSYVKKPQTFTAGEKKEPGIHPYILLDVDGEKVAVFGLTTEDAATTSSPGK
SIVFHDAFETAQKTVKTIQEEEKANKIIALTHIGHNRDLELAKKVKGIDLIIGGHTHTLV
DKMEVVNNEEPTIVAQAKEYGQYLGRVDVAFDENGVVQADKSNLSVLPIDEHTEENAETK
QELDQFKGELEDVKNEKVGYTDVALDGQREHVRTKETNLGNFIADGMLAKAKEAAGARIA
ITNGGGIRAGIDKGDITLGEVLNVMPFGNTLYVADLTGKQIKEALEQGLSNVENGGGAFP
QVAGIEYTFTLNNEPGHRVLDVKFESPNGDKVDLNTDDTYRVATNNFVGAGGDGYSVFTE
ASHGEDLGYVDYEIFTEQLKKLGNKVSPKIEGRIKEVFLPTKQKDGSWTLDEDKFAIYAK
NANTPFVYYGTHEGSQEKPINLKVKKDQVKLLKERESDPSLTVFNYWYSMKMPMANLKTA
DTAIGVKSTGELNVSLADVYDFTVKQKGKEIKSFKEPVQLSLRMFDIEEAHNPAIYHVDW
KKKAFTKTENGSVDDDMVTGYTKHFSEYTILNSGENNKPPEFPTDQPTGGDDGSNGGGSD
KPGGKQPTDGKGGNDTPPGTEPTNGSGGNGSGGNGSGGSGTDGPAGGLLPDTATSMYSVL
LAGLLVSALGTALYLHQRRKQNKANQA
>PK3-2_00128 Putative NAD(P)H nitroreductase YfkO
MADVKKQILDAYNFRHATKEFDPNKKVSDSDFEFILETGRLSPSSLGLEPWKFVVVQNPE
FREKLREYTWGAQKQLPTASHFVLILARTAKDIKYDADYIKRHLKEVKQMPQDVYEGYLS
KTEEFQKHDLHLLESDRTLFDWASKQTYIALGNMMTAAAQIGVDSCPVEGFQYDHIHRIL
EEEGLLENGSFDISVMVAFGYRVRDPRPKTRSAVEDVVKWV
>PK3-2_00129 HTH-type transcriptional regulator TreR
MKVNKFIAIYKDIAQEIEGGRWKAEEILPSEHELTAQYDTSRETVRKALHMLAQNGYIQK
IRGKGSIVLNREKMQFPVSGLVSFKELAQTLGKETKTTVHKFGLEPPSELIQKQLRANPD
DDIWEVIRSRKIDGEHVILDKDYFFRKHVPHLTKEICENSIYEYIEGELGLSISYAQKEI
VAEPCTDEDRKLLDLRGYDHMVVVRNYVFLEDTSLFQYTESRHRLDKFRFVDFARRGK
>PK3-2_00130 Trehalose-6-phosphate hydrolase
MKTEQTPWWKKAVVYQIYPKSFNDTTGNGVGDLNGIIEKLDYLKTLQVDVLWLTPIYDSP
QHDNGYDIRDYYSIYPEYGTMEDFERLLSEAHKRGLKVVMDLVVNHTSTEHKWFQEAVSS
KDSPYRDFYIWKNPQGNGSVPTNWESKFGGSAWEFDEASGQYYLHLFDVTQADLNWENEE
VRKHVYDMMHFWFEKGIDGFRLDVINLISKDQRFPDAEDGDDGRSYYTDGPRVHEYLHEM
NEKVFSHYDSMTVGEMSSTKVDHCIRYTNPENKELDMTFSFHHLKVDYPNGEKWALAPFD
FLKLKEILSEWQTGMHAGGGWNALFWCNHDQPRVVSRYGDDGAYRVKSAKMLATAIHMMQ
GTPYIYQGEELGMTNPKFEDISSYRDVESLNMYRAFKKKGMADQEITAILQAKSRDNSRT
PVQWNDAKNGGFTTGTPWIPVAANYREINAEAALKDQNSVFYHYQKLIQIRKTYDIVTEG
TYELIAKDDPKVFAYLRHGGNEKLLVINNFYETEAAFTLPDSLAPDEWRAEVLLTNDEMR
EGLQNMTLRPYESIVYRLTKPC
>PK3-2_00131 PTS system trehalose-specific EIIBC component
MGELNKSARQIVEAVGGAENIAAATHCVTRLRFALIDESKVDQELLDQIDVVKGSFSTNG
QFQVVIGQGTVNKVYAELVKETGIGESTKDEVKKASEKHMNPLQRAVKTLADIFIPILPA
IVTAGLLMGINNILTAQGIFFSTKSIVQVYPQWADLANMINLIAGTAFTFLPALIGWSAV
KRFGGNPLLGIVLGVMLVHPDLLNAWGYGAAEQSGKIPVWNLFGLEVQKVGYQGQVLPIL
LASYMLAKIEMFLTKRTPEGIQLLVVAPITLLVTGFASFIIIGPVTFAIGNVLTSGLISV
FGSFAALGGLLYGGFYSALVITGMHHTFLAVDLQLIGSKLGGTFLWPMLALSNIAQGSSA
LAMMFIVKDEKQKGLSLTSGISAYLGITEPAIFGVNLRYRFPFIIAMISSGLAGMYISSQ
GVLASSVGVGGVPGIFSIMSQYWGAFAIGMAIVLIVPFAGTYAYARLKRK
>PK3-2_00132 Spore germination protein A1
MNKRDKALQLIKELEDNQDRPISSDLKENLENLTLLTEGCSDIVFRQFDFGNGLCGFIVY
IEGIVKSEHIQDHALRPFLKHLTDQIDEHEEVLQNTLSISSVASETSVSKVAESIIEGNA
VLFAEGHSKCLILKIKGGQRRSIEEPITESTIRGSREGFTENLRVNTALVRFRVKTLQLK
MISFKIGTRTKTDIVLAYIDGLADPKVIDKVKKRIKKIKIDAVLESGYIEEFIEDDTYSP
FPQLQYTERPDTVSAQLLEGRFAIFTDNTPFVLTGPITFWQLMQASEDYYERYLMSNLIR
WLRYMFLFVALYLPAIYVAVITYHQDLMPTNLMFSVASAREPIPFPAIVEALIMEISFEA
LREAGVRLPKTIGQTVSILGALVIGTAAVEAGIVSAPMVIIVSLTGIASFTIPRFNLAIS
IRMLRFPLMFLASIFGIFGIMLGTIILVLHLCKLQSFGIPYLSGISPFKRDEVKDILVRA
PWWTMTRRPGTYSRGNGQKGAKREDPQDEENNI
>PK3-2_00133 Spore germination protein B3
MKKTIYKCVAPLLFCMLLAGCWDRTEINDIAFVVSSAIDKKKEQYRVALQIPLVGQLGGQ
TGGGGGTAGSKTWYVDSASGTTIKEANNKLQTSLSRTINTSHRRTVVIGEEMARDGVAPI
FDILTRNPQNRLTALILVSQGEARDILNTDVQLEQFPAEMIRELAIMATNRPVFLSRFMS
DLLEKGSDAYAPVITASKTKPGGKGKSNLKIDGLAIFKKDKLVDIFKDEHMTAALILLNQ
ARQPEFILDLPNQMGKASIQLQKSNASFHTAEKNGKLSVTIEIRAKGIIMENQSTYETRE
NDQFYIIQKALNKAIKEDVISTVHRLQKRKADPAGFQDRMIRSMAIKKNMRSKKWDDVYK
DMEIHVIPIVTIEQGGVLYKTISH
>PK3-2_00134 hypothetical protein
MISYILQTVIVCIAIYAYEWKNFRSANTITKWAFSLLIAGSAFLWIYMRVNPLLPRLGHL
FKYIPF
>PK3-2_00135 hypothetical protein
MNKTSAYQGLFFGALYTLAVGLKHAPILMIESAKQNAWHSYILGVMVVIPVLWLMHRLMK
KHQDKNIYELLSDSSPIAGRFIIFLFSLYFLLINAHDIRFFINLINILFLPRTPMTVLGG
VIIFVAICIAREGNETLARMAQIFLFPFGTLVLFLPFTLATQIELQNLTPVFEGPIQYLQ
SGFYAFGTMGELIILPLLFSGRSLPLKHSIIAILLGALLLAIMLFSSISVFGPNLTSTFF
DPAYMVIRQIRITDFLDRSDLIIAALWIPVIMVKIAGSLYIVVYGFSFLHSKIDLKAMYT
PTGMFSLVCSFWFFLNTNQLIDFNRVKPIINVVISLLLPLFIYLIMKTKAMLGAKTKH
>PK3-2_00136 Amino-acid carrier protein AlsT
MEQLLEWVTRISDWLWGPPLIILLTGTGLYFTILLKCFQFRYPLYILKQTIGSIGKKPKG
EGTVTPLQALTSALSSTIGAANIVGVPAAIMFGGPGAVFWMWLIALFAMAIKFSESVLAV
HYREKNERGEFVGGPMYYITKGLRMKWLGVFFSVALIVELIPSIMVQGNSVSVSLAETFS
FNKIYAGIGIAFVIGLVVIGGVKRIGKVTEFVVPLMAGAYAGAGLLIVLMNLSSVPAFFS
LIFSNAFTSSSAVGGFAGAALAETVRWGFARGLYSNEAGMGTAPIAHAAAMTDHPVRQGF
WSVIGIVIDTLIICTTTAFVVLASGVWTGKNAINDPAALTTAAFQHYFGSGGGYFVSISL
VFFVVSTIMVVIFYGVKQAEFLFGRMAGHVLKFVYLAAIIIGAAGGAKAIWGFLDLALAF
ILVPNVIALLLLSRKVKALYTEFFTSEQYYLKDRRKTKQNTVYQTKEAKDS
>PK3-2_00137 hypothetical protein
MDFSHIVSEDKIKRAIKDGEFDNLPGMGKPLPKDDAAHLPESLRMGYRMLKNAGMAEDEG
ALKKELMTIDHLISKCYDEKEREQLIRKKNEKQMMLDKLVDKKGMFSKSGVRFL
>PK3-2_00138 Lipoteichoic acid synthase 2
MKTFIKERGLAFFLIAVVLLWVKTYVGYVLNFNLGIDNTIQKILLFVNPLSSSLFFLGFG
LLFKKKLQQTAIIVIHFLMSFLLYANIVYYRFFNDFITIPVIMQAKTNGGQLGDSAFSLM
RPTDAFYFIDTIILIILAIKVNKPAETSSKKSFRIVLASSILVFLINLAVAESDRPELLT
RSFDRNYLVKYLGTYNFTIYDAVQNIKSNSQRALADSSDVTDVENYMKANYDVPNNVYFG
KAEGKNVIYVSLESLQSFIIDYKIDGKEVTPFLNKLAHDNETFYFDNFFHQTGQGKTSDA
EFMMENSLYPLAQGSVFVNKAQNTLQSVPAILKSKNYTSATFHGNTQTFWNRNEMYKAEG
IDKFFDSAYYDMNEENTKNYGMKDKPFFKESMPLLESLPQPFYTKFITLSNHFPFGMDEG
DTDFPAGDFGDSVVNNYFQSAHYLDQSIEQFFNDLKKDGLYDKSIIVMYGDHYGISENHN
KAMAKVLGKDEITDYDNTQLQRVPLFIHAAGVKGEKVHKYAGDVDVAPTILHLLGVDTKD
YLMSGSDILSKEHREVIPFRNGDFISPKYTKVSGKYYDTKTGKELDESEVDKSEDSLVKK
ELEMSDKIINGDLLRFYEPKGFTKVNPSDYDYTKHGEDSSETSTDDEDK
>PK3-2_00139 PTS system N-acetylglucosamine-specific EIICB component
MLSFLQKLGKSFMLPIAVLPAVGIILALGREDVFNIPFVYQAGTAVFDHLPLIFAIGIAI
GISKDSNGAAGLSGAISYLMLDAATKTIDKTNNMAVFGGIVAGLIAGYTYNRFKDTKLPE
YLGFFSGRRLVPIITAIITIILAGIFGAVWPPIQSGINAFGEWMLGLGGIGAGIFGLFNR
LLIPLGLHHVLNNIFWFQFGEYNGVTGDLARFFAKDPTAGTYMTGFFPIMMFGLPAACLA
MVVTAKPSKRKATAGMMIGFALTAFITGITEPIEFAFMFLSPLLYAVHAVLTGLSLFIVN
WLGIRSGFSFSAGAIDYVLSYGIAEKPLLLLLVGICYAAVYFIVFYVLIKALNLKTPGRE
DDDIDEVLDENTVQDVNENIMLKGLGGKENLQTIDHCATRLRLTVKDTALVDEVLLKKAG
AKGVVKSGGQSVQVIIGPNVEFAAEELRAAMK
>PK3-2_00140 Methionine aminopeptidase 2
MIVTNDQELEGLKKIGRIVALAREEMKRKAEPGMSTKDLDLIGKAVLDEHGAVSAPEKEY
DFPGVTCISVNDEVAHGIPSTSKILKAGDLVNIDISAEFGGFYSDTGISFVLGDGEERLH
KLCQCAEDAFQKGLQQAKAGKRQNQIGRAVYHEARSQGFTVIKTLTGHGIGRSLHEAPNH
IMNYYDPFDNALFKNGTVIALEPFISTKAETIVEAGDGWTFKTPDKSMVAQVEHTIVITK
DEPIILTKL
>PK3-2_00141 putative protein YflH
MNRDQEKIQIENEMDAMHGTTKEEILKDFEEFKDYLSKQVNRGKKLGLDDGKLVKSAAIL
GDYLAKHEEPQNSEEMLLQELWSVADEDEKKHLAQLLVKLVDKQ
>PK3-2_00142 hypothetical protein
MLPGFLDIVTARLFQICYTTIMSVKGAFICMWFIIFGIIFFIEGIMITVYGVKKKNGMLT
YIGIVFSIMTFGVVMMKLTGH
>PK3-2_00143 hypothetical protein
MHYGSKGWYVAELKKQGITHHEGRKLQSYKTYFLANLLETKKKQS
>PK3-2_00144 Protein YiiM
MKPAHYSVLSLNLGKPQTLEYDGKKIETGIMKRPADSAVMLYRENFAGDGQADLVNHGGP
DKAVCVYPAAHYPFWEEFLSRPLSSAAFGENLTVAGLTEENVCIGDVFQLDEAVVQVSQP
RQPCVKLAKKFGVKEMVLKVQQTGYTGFYFRVLEEGRVAHGAALELLSRGEKDISVQFAN
RINYHDAKNLAAIERILSENALSESWRSSFMKKRDRLLPVE
>PK3-2_00145 Acylphosphatase
MLQYRIVADGRVQGVGFRYFVQMEADKRKLAGWVKNRGDGRVEILAEGPENALQSFLEAV
KNGSPFSKVSGISVTESRSLEGHHRFSIVYS
>PK3-2_00146 Nitric oxide synthase oxygenase
MTPVYAGVFIVFQDDTEKSFVFPLKNDTMKSMNAFEGESLLEEKEILWNEAKAFIAACYQ
ELGKEGEVKDRLDGIKSEIDRTGSYVHTKEELEHGAKMAWRNSNRCIGRLFWNSLNVIDR
RDVRTKEDVRDALFHHIETATNNGKIRPSITIFPPEEKGEKQVEIWNHQLIRYAGYESYG
ERIGDPASRSLTAACERLGWRGERTDFDLLPLIFRMKGDEQPVWYELPRSLVIEVPITHP
EIEAFSDLELKWYGVPIISDMKLEVGGIHYNAAPFNGWYMGTEIGARNLADEKRYDKLKK
VASIIGISTDYNTELWKDQALVELNKAVLHSYKKQGVSIVDHHTAASQFKRFEEQEEEAD
RKLTGDWTWLIPPISPAATHIFHRSYDNSIVKPNYFYQDKPYE
>PK3-2_00147 putative metallo-hydrolase YflN
MSDPYMPMTSIRSGTGFEAAKGVHGLTVQIANVYFIQLPSEPHSFVLIDAGMPQSAGMIV
HEAKQRFGDGFQLKAIILTHGHFDHIGAIEEILEHWDVPVYVHSREMPYVTGKEDYPPAR
PDSKSGLVAKLSPLFPRHSIDISSHVQALPEDGSVPFLDEWIWIATPGHTPGHISLFRED
GRVLVAGDAVITVEQEKMADVLIQKQELHGPPAYFTPDTETAAQSIQKLAGLEPEALLTG
HGIPMTGKNFRSDLTELANRLLSH
>PK3-2_00148 Mg(2+)/citrate complex secondary transporter
MLAILGFLMMLVFMALIMTKRLSVLTALVLTPIVFALIAGFGFTEVGDMMISGIQQVAPT
AVMIMFAILYFGIMIDTGLFDPVVGKILSMVKGDPLKIVVGTAVLTMLVALDGDGSTTYM
ITTSAMLPLYLLLGIRPIILAGIAGVGMGIMNTIPWGGATPRAASALGVDPAELTGPMIP
VIASGMLCMVAVAYVLGKAERKRLGVIELKQPANANEPAAAVEDEWKRPKLWWFNLLLTL
SLIGCLVSGKVSLTVLFVIAFCIALIVNYPNLEHQRQRISAHSANVLAIGSMIFAAGVFT
GILTGTKMVDEMAISLVSMIPEQMGGLIPAIVALTSGIFTFLMPNDAYFYGVLPILSETA
VAYGVDKVEIARASIIGQPIHMLSPLVPSTHLLVGLVGVSIDDHQKFALKWAVLAVIVMT
AVALLIGAISISV
>PK3-2_00149 hypothetical protein
MKKCMILLIALLLFMQGDIRQAAAPRLPDGPVEIVVPAEPSGGWDVTAQAIQSVLRQKQI
VKGEVHIVYKPGGGGDKGWKYVNKSSIQTISMTSSLILSNDLLGQSKLKTDDFTPLAILS
KEWQTVALPKGSALANGKDLLNEIKMNPGKVKIGFAPGFGNDDQLSFVRAADMYGINPFH
IQFLQYESSEQLIQALIKHEIEAASMTLSEAKPYERHGDITLAAVTSDKRLSGFPDVPTW
KEQGIPFVFSHWRGILGPKNMSEEEISYWDQALKKVTSSPEWKRKINEQDWESFYLNSRE
TKRFLEQQSAFYQSIMTGN
>PK3-2_00150 Transcriptional regulatory protein CitT
MIHIAIAEDDFRVAQIHERLIEQLDGFKVIGKAANAKETMALLEKQRADLLLLDIYMPDE
LGTTLIPEIRRRFPEVDIMVITAATETRHLQEALRAGIAHYLIKPVTADKFRQVLLQYKE
KRKLLLSQPEVSQSLIDHIFGNGVKTSLPAEDLPTGINSITLRKIKEALRNASEGLTAEE
LGEKMGASRTTARRYAEYLVSKEEARAELEYGIIGRPERKYYLAAD
>PK3-2_00151 Sensor protein CitS
MVKKRFHFSLQTKIMGLIAALLVFVIGVLTITLAVQHTQAERSQAEQLAVQTARTISYMP
PAKELIERKGGHAAEAQEVIEQMKEQTGAYAIYILDEKGGIRSASGKNGQKKLERSREIL
FGGSHVSETKADERRVIRGSAPIMKEQKGYSQVIGSVSVDFLQTETEQSIKKHLRNLSVI
AVLVLLLGFAGAAALAKSIRKDTLGLEPHEIASLYRERNAMLFAIREGVIATNREGVVTM
MNVSAAEMLKLPEPVIHLPIDDVMPGAGLKSVLEQGEMLPNQEVSVNDQVFIINTKVMTQ
GGQAYGIVVSFREKTELKKLIDKLTEVRKYSEDLRAQTHEFSNKLYAILGLLELGEYEEA
IELIKEEYAIQNEQHDILFQNIHSQQVQAILLGKMGKASEKKVKLSIDDNSSLAPLSAHI
GLSHLITIIGNLIDNAFEAVADQSEKEVFFFITDIGHDIVIEVSDTGPGVPPDKMEAVFQ
RGYSSKGMKRGYGLANVKDSVHELGGWIELANQKTGGAVFTVYIPKEKQRGNPFDSHRDC
GG
>PK3-2_00152 Putative malate transporter YflS
MASEKDAGKQSAVKLVPLLITVAVGLIIWFIPAPSGLEPKAWHLFAIFVATIIGFISKPL
PMGAIAIFALAVTALTGTLSIEDTLSGFGNKTIWLIVIAFFISRGFIKTGLGARISYVFV
QKFGKKTLGLSYSLLFSDLILSPAIPSNTARAGGIIFPIIRSLSETFGSSPANGTERKIG
AFLLKTGFQGNLITSAMFLTAMAANPLIAKLAHDVAGVDLTWTSWAIAAIVPGLVSLIIT
PLVIYKLYPPEIKETPDAAKIATEKLKEMGPFKKSELSMVIVFLLVLALWIFGGSFNIDA
TTTALIGLAVLLLSQVLTWDDIKKEQGAWDTLTWFAALVMLANFLNELGMVSWFSNAMKS
SVSGFSWIVAFLILIVVYFYSHYFFASATAHISAMYSAFLAVIVAAGAPPLLAALSLAFF
SNLFGSTTHYGAGAAPVFFGAGYVPQSKWWSIGFILSIVHIVVWLVVGGLWWKVLGIW
>PK3-2_00153 Pectate lyase
MKKVMLATALFLGLTPAGANAADAGHQTLGSNDGWGAYSTGTTGGSKASSSNVYTVSNRN
QLVSALGKDTNTTPKIIYIKGTIDMNVDDNLKPLGLNEYKDPEYDLDKYLKAYDPGTWGK
KEPSGTQEEARARSQKNQKARVMVDIPANTTIVGSGANAKVVGGNFQIKSDNVIIRNIEF
QDAYDYFPQWDPTDGSSGNWNSQYDNITINGGTHIWIDHCTFNDGSRLDSTSPKYFGRKY
QHHDGQTDASNGADYITMSYNYYHDHDKSSIFGSSDSKTSDDGKLKITLHHNRYKNIVQR
APRVRFGQVHVYNNYYEGSTSSSDYAFSYAWGIGKSSKIYAQNNVIDVPGLSAAKTISVF
SGGTALYDSGTLLNGTQINASAANGLSSSVGWKPSLHGTIDASANVKSNVIAQAGAGKLN
>PK3-2_00154 General stress protein 17M
MKPVVKEYTNDEQLMKDVDELQQMGVAKEDVYVLSHDDDRTERLADNTNANTIGAKETGV
KHAVGNMFNKKGDELRNKIHEIGFSEDEAAQFEKRLDEGKVLLFVTDNEKVKSWA
>PK3-2_00155 putative protein YfmB
MQYFSPEQQYNAWVVSDLVKQIFHQRSGCSPGIHELAVFAEEHFQIDIDFVFSIIMNIGD
IEFALAEEIEKKLSGYLSALLPYVNANMLETSKANANAYLSRRHGNAVYQLFVSDDAFMR
KQ
>PK3-2_00156 Fe(3+)-citrate-binding protein YfmC
MRTYSNKLIAIMSVLLIACFIISGCSSSQNNSGSSESKSKDSRVIQHEEGKTPVSGTPKR
VVVLELSFLDAVYNLGITPVGIADDNKKDMIKKLVGSSIDYTSVGTRSEPNLEVISSLKP
DLIIADAERHKNIYKQLKQIAPTIELKSREATYDETIDSFTTIAKALNKEDEGKEKLADH
NKVINGLKAELPKDENRNIVLGVARADSFQLHTSSSYDGEIFKMLGFTHAVKSNEAYQEV
SLEQLSKIDPDILFISANEGKTIVDEWKTNPLWKNLKAVKNGQVYDADRDTWTRFRGIKS
SETSAKDVLKKVYNK
>PK3-2_00157 putative siderophore transport system permease protein YfiZ
MYHSAKRRSSSRLMMFIIALIILIFGLGLNLSVGASDIGIIDSLKYLFVWDGSKEQLIIS
TLRLPRTLIGVFVGASLAVAGALMQAMTRNPLASPQIFGVNAGASLFVVASLVILPASPY
SSVVFAFAGAAAGGAIVYMIASSGGMTPVKLALSGMAVHLFLSSMTQAIIILNESGEDVL
YWMTGAIDGSNWHDVMTIAPFSVIGIGLALVFSGSVSVLGLGDETAKGLGQNMSGIRILI
SFIILLLSGASVAVAGPIGFVGLLVPHIVRKLIGEHYQYVLPFSALFGAILLVYADVLAR
WIAFPYESPVGIVTAIIGTPFFLYLARKGRNLK
>PK3-2_00158 Fe(3+) dicitrate transport system permease protein FecD
MKKTTSKQKRPLLAILILAVLLIVLSVISIGFGALYISPDAVVTNLLGVDHSFEFIIQQY
RLPRILLAILAGAGLAAAGAILQGVIRNPLASPDVVGISKGSGLAAMAVILIFPESPVYV
LPFSAFAGAAIIAVLLLLIARKKSIQSSSLALSGIALGAVCHAGMQYMMVKFPGDVNAAL
IWLTGSLWGRNWEEVKLLAPWLLILFPIVCILIPKLDLMSLGDELAQGLGENANRLRFIL
IFTAVALAGSCVAVVGSIGFIGLLAPHIARRLTGEKAKYLLPASALIGAIILLIADTLGR
GIMPPVEIPAGILTAVIGAPYFLYLLKFEARKQ
>PK3-2_00159 putative siderophore transport system ATP-binding protein YusV
MGKLAADQLTLSYDSTVIIDEVDLKIEEGKITALIGANGCGKSTILKSLARLMAPKSGTV
LLEGKDIHRQPSKEVAKKLAILPQSPQAPEGLTVEELCYFGRHPHKKLLSKHTQEDHDMV
EWALDATGMIELKERTLDALSGGQRQRAWISMALAQGTDLLLLDEPTTYLDISHQIEVLE
LLKKLNRDHGRTIVMVLHDLNQAAQYADYLISVLDGKIYNAGTPEDVFTQPFFREVFGLE
CCIMRSPIDQKPMCLPTGLCPKLRAT
>PK3-2_00160 Hercynine oxygenase
MTLLMQDHKSIYNKDIEILIEVEELITSVPENKKNDFKSLIDNRIMTLLNKIQHPVAAEN
VFGMCIAYPNTYIRYRLIDFVEKWVPYFSAVETIINLTQDPDDLVSFKAMDVCANHKIEE
SVAYLSSIIDDVRESISYPKKPVGLGAQKVLSTLLDIFGVEKYEELVMLKNYFDQNGILP
NNFDFEEKIPQSLIEEFEKTEEDGMILIPGGFFEFGLNENEIPDKTFNWKDAVPRQKVWL
PPFFIDKYPVTNKDYDIFTEFIEENGHIFCHPNEPQNKQHRRNTYWDDRYLDNHPVTGID
FYDAFAYARYKGKELPTEFQWEKAARGEKGNIWPWGDKFDPAKVQYAGSLYNEPITSLKS
WRENLLKAHADKELNHLTSDIFEQNGESPYGVCGMIGGTWEWTRSELKTKRAFHPIFENV
PFNSVNSFAVLKGGSFFSHPGLMFPSFRAKDIPFCRHNEMGIRCVKNIPVYKIRESINGP
ITNKAIY
>PK3-2_00161 hypothetical protein
MSKGYYSILFSQTTTNLGFSLYTMVVISFLFKMTNSTTIASMVTLISIIFRIFGSAILPL
ITIRLKLHLTIIISQLIQMLLLICLFYSLLRIHSNQTLILVFIIISCISFFNGWFSPLKS
AIIGEIISPDKRVKANGLLSTVDQTFQFVGWSLGGLIIAFLGEGYTIILTIFLLFTSLIS
LLFCLPHGHANSVIREKNSPNKSIVSGWRYLFSQKKLRTIIIMDLIESWAGMIWIGSVSL
AFVNEVLHKGESWWGFINGAYYLGSMIGGFIIYKLSARFQNKLINFMLIGAVSYGSLTLI
YGFISNSYLALILVLFMGPAYILRDLTQETFIQNITTEQTRINIMSARSSLVQFIFMFSI
LAIGAISDFLGVRLVYVSAGILLLVSAIYGFSQLQYKKKVNKHISF
>PK3-2_00162 Putative NADP-dependent oxidoreductase YfmJ
MTASQQQIQLARRPQGVPVHEDFRFETIPVPKPKQGEVLVKTLYVSVDPYMRGRMQDTKS
YVEPFTLNEALSGGVISEVMADGDHLKKGDIVIGNLSWQEFSAVTESALRKIDISLAPAS
AYLGMLGMTGLTAYFGLLDIGRPKKGETVVVSGAAGAVGSAVGQIAKIKGARVVGIAGSD
EKIAYLKQELQFDEAINYKTADDIQKALEDACPDGVDVYFDNVGGPISDAVMILLNEFAR
IPVCGAISSYNAESEADDMGPRVQSKLIKTKALMQGFIVSDYSDRFAEGAKQLAEWLRDG
KLHYEETITEGFENIPDAFLGLFKGENKGKQLIKVSDPS
>PK3-2_00163 hypothetical protein
MATIDRFQILKESELKILEHWFENEDTRRRMDGMLPLDAWYERVKEDENDSIIMAYDGQL
PAGMVVIEFVEERAYIGLIVNPLYRLQGYGKRILQKLLNDPDFNSVREWAASIEEDNRIS
LACFQAAGFTLEETEPDEDGFLTLILRS
>PK3-2_00164 putative ATP-dependent RNA helicase YfmL
MTQTWPFLHNAQSFIQENWNASGFQKPTPVQEQAAQLIMDGKDVIAESPTGTGKTLAYAL
PVLERINPDQKHLQAVILAPSRELVMQIFQVIQDWKAGSELRAASLIGGANVKKQVEKLK
KHPHIIVGTPGRVFELIKAKKLKMHEVKTIVLDETDQLVLPEHRETIKQIIKTTLRDRQL
LCFSATLKKETEDVIRELAQEPEVLKVQRSKTEAGKVKHQYLICDQRDKVKLLQKLSRLQ
GMQALVFVRDIGNLSVYAEKLAYHHVDLGVLHSEAKKMERAKIIAAFEDGEFPLLLATDI
AARGLDIENLPYVIHADIPDEDGYVHRSGRTGRAGKEGNVLSLVTKLEESKLKKMAKKLG
VELSEAVYAGGKLKTK
>PK3-2_00165 putative ABC transporter ATP-binding protein YbiT
MSILSVKDLSHGFGDRAIFNNVSFRLLKGEHVGLIGANGEGKSTFMNIITGKLEPDEGKV
EWSKNVRVGYLDQHTVLEKGKSIRDVLKDAFHYLFAMEEEMNEIYNKMGEADPDELEKLL
EDVGVIQDALTNNDFYVIDSKVEEIARGLGLSDIGLERDVTDLSGGQRTKVLLAKLLLEK
PEILLLDEPTNYLDEQHIEWLKRYLQEYENAFILISHDIPFLNSVINLIYHVENQELTRY
VGDYHQFMEVYEVKKQQLEAAYKKQQQEVAELKDFVARNKARVSTRNMAMSRQKKLDKMD
MIELAAEKPKPEFHFKPARTSGKLIFETKDLVIGYDSPLSRPLNLRMERGQKIALYGANG
IGKTTLLKSLLGEIQPLEGSVERGEHLFTGYFEQEVKETNNNTCIEEVWSEFPSYTQYEI
RAALAKCGLTTKHIESRVSVLSGGEKAKVRLCKLINSETNLLVLDEPTNHLDVDAKEELK
RALKEYKGSILLISHEPDFYMDIATETWNCESWTTKVL
>PK3-2_00166 hypothetical protein
MTQFYYLTAKMPLETGFFGHQVRRSRKGHPLRSGIDAAGIYLEEADDVSVHLRLPFQVMV
HAEEGTFAMDKAHPDEYDQKCLQALYQYIHSVMKNSFSVEWFTAWADEEDFELSAKRELT
LDEFTSPLQLILKDRELLRIVQKKWQ
>PK3-2_00167 Multidrug efflux protein YfmO
MDKTKQVNQKTGLLSQPKAVWAVAFACVISFMGIGLVDPILPAIAAQLHASPSEVSLLFT
SYLLVTGFMMFFSGAISSRIGAKWTLILGLIFIIVFAGLGGSSSSIAQLVGYRGGWGLGN
ALFISTALAVIVGVSVGGSAQAIILYEAALGLGISVGPLAGGELGSISWRAPFFGVSVLM
FIALIAISLMLPKLPKPAKRVGVFDAMKALKYKGLLTMAVSAFLYNFGFFILLAYSPFVL
DLDEHGLGYVFFGWGLLLAITSVFTAPLVHKALGTVRSLVVLFVAFAVILIIMGIWTEHQ
TLIITCIVVAGAVLGMVNTIMTTAVMGAAPVERSIASSAYSSVRFIGGALAPWIAGMLSE
HFTASTPYTVGGIVVFVGMLVLLMGRKHLAGIKAGH
>PK3-2_00168 HTH-type transcriptional regulator YfmP
MEWMKIDQVAKRSGLTKRTIRFYEEIGLIPAPKRTDGGVRLYSEDDMEELEKVISTKEVL
GFSLQELQHFMETSRQLELNKEGYLLSLDPKERKEKLEEIQETLNHQLDLIDEKIRTFQS
FKERLQGMKGKAERAIQSIE
>PK3-2_00169 hypothetical protein
MTWAIVMLILMSLVKIVLTCLPTGVMEWLLSKFEVHAKLSDEQAVLSLDGKRLEGEEKKK
VIDQFNKAVFLEKYYIYPGDEERYLHPENGGMPLVIDTKKGKHDVKLFVYRYDDHIDVVK
QYKKKVIAYQLLSESLQKQSLSVTGSLA
>PK3-2_00170 Energy-dependent translational throttle protein EttA
MSILKAENLYKTYGDKTLFDHISFHIEENERIGLIGPNGTGKSTLLKVIAGLESIEEGDI
TKSGSVNVEFLHQDPELPAGQTVLEHIYSGESAVMKTLREYEKALYELGEDPENEQRQKH
LLAAQAKMDANNAWDANTLAKTVLSKLGVNDVTKPVNELSGGQKKRVAIAKNLIQPADLL
ILDEPTNHLDNETIEWLEGYLSQYPGAVMLVTHDRYFLNRVTNRIYELEQGSLYTYKGNY
EVFLEKRAEREAQAEQKETKRQNLLRRELAWLRRGAKARSTKQKARIDRVEALKEQKGPQ
SSGSLDFAIGSHRLGKQVIEAENVMIAYDGRMLVDSFDELIIPGERIGIIGPNGIGKTTL
LNTLAGRHTPDGGHITIGQTVRIGYYTQDHSEMNGELKVIDYIKETAEIVKTADGDIITA
EQMLERFLFPRSMQQTYIRKLSGGEKRRLYLLQVLMQEPNVLFLDEPTNDLDTETLSILE
DYIDQFPGVVITVSHDRYFLDRVVDRLIVFEGNGVISRFQGSYSDYMEESKAKKTAAKPA
VEAKPAEAEPKKKRKKLSYKDQLEWDGIEDKIARLEEKHEQLEADIAAAGSDFGKIQELM
AEQAKTGAELEAAMDRWTELSLMIEELEG
>PK3-2_00171 Putative sensory transducer protein YfmS
MSIRTEKETVDLLDAFIKVAPYLNSLVQDDITIGIYDTEKLLVNIPAKTFSLNVKAGDPL
QKGDIITDAIRSNQKKTSMVPKELFGFPLIARAIPLHDENGKVIGGVGLGTSLEESSKLH
DVAESLSAVVEQTAAAISDISESINGFSSQMTGISSQAKKVSESAGEIADISVTVKGISD
QSNLLGLNAAIEAARAGESGKGFSVVADEIRKLATHSKENVGQIDQITKKIHSLLKGLEE
SIESINQHTDGQAAAVEQISATMQEISGSAQHLAKMAEKALEEE
>PK3-2_00172 Benzaldehyde dehydrogenase YfmT
MFQYEELNKQFIGGKWQEGSSPNALENKNPYTQKTFTTFQKATADDVDEAYRAAALAKKK
WDAVNPFEKRAILEKAVTYIEENEEAIIYLIMEELGGTRLKAAFEIGLVKNIIKEAATFP
VRMEGKILPSTIDGKENRLYRVPAGVVGVISPFNFPFFLSMKSVAPALGAGNGVVLKPHE
ETPICGGTLIAKIFENAGIPEGLLNVVVTDIAEIGDSFVEHPVPRIISFTGSTKVGSYIG
QLALKHFKKPLLELGGNSAFIVLEDADIEYAVNAAVFSRFTHQGQICMSANRVLVHSSIY
DKFLELYQEKVESLKVGDPMDPDTIIGPLINSRQTDGLMKSVEQAIEEGAVPVKLGGFNG
TIVEPTILKDVKPFMSIAKEELFGPVVSFMKFDSEDEAVDIANETPFGLSGAVHTSNLER
GVAFAKRIETGMIHVNDTTINDEPNVAFGGEKQSGLGRLNGEWSLEEFTTLKWISVQHEK
RSFPY
>PK3-2_00173 putative amino acid permease YhdG
MSSLFRKKTLETLSAQSKSKSLARTLSAFDLTLLGIGCVIGTGIFVITGTVAATGAGPAL
IISFILAGLACALAAFCYAEFSSSIPISGSVYSYSYVTLGELLAFLIGWDLMLEYVIALS
AVATGWSSYFQSLLAGFNLHLPAALTGAPGSTPGAVFNLPAAVIILLITAIVSRGVKEST
RFNNVIVLMKIGIILLFIIVGIGYVKPDNWSPFMPFGMKGVIVSAATVFFAYLGFDAVSN
ASEEVKNPQKNMPVGIISALAVCTVLYITVSLVLTGMMPYTKLNVGDPVSFALKFVGQDA
VAGIISVGAIIGITTVMLALLYAQVRLTFAMSRDGLLPGLFAKVHPQFKTPFRNTWLTGI
VAAGIAGFINLGTLAHLVNMGTLAAFTVISIAVIVLRKKHPEIKASFRVPFVPVVPIISA
GICLWFMYSLPDVTWLSFVIWIAVGTLVYFLYARKHSLLNK
>PK3-2_00174 Putative HAD-hydrolase YfnB
MKQYRTLLFDVDDTILDFKAAEALALRLLFEDQNIPLTDKMKTQYKTINQGLWRAFEEGK
ITRDEVVNTRFSALFKEYGYEADGALLEQKYRSFLEEGHQLIDGAFDLISNLQLQFDLYI
VTNGVSKTQYKRLRDSGLFPFFKDIFVSEDTGCQKPMKEYFDYVFERIPQFSAEHALIIG
DSLTADIKGGQLAGLDTCWFNPAMKQNELEIMPTYEIRKLEELYHILNIENTVSC
>PK3-2_00175 Fosmidomycin resistance protein
MAIAAPLKEKTVQKPGTTVYPILIIIGICHMLNDSLQAVIPAMFPILERSMSLSFTQLGI
IAFTLNMVSSVMQPVVGWYTDKRPRPYALPIGLTASMLGILGLAFAPSFVTILCCVFFIG
LGSAIFHPEGSRVAYMAAGTKRGLAQSIYQVGGNSGQAMAPLITALILVPLGQFGAVWFT
LVAALAVMFLLHIAKWYAARLGSLAQKSGKQKKTADNTAITKSVVSALIIIIFLIFARSW
YTSAIGNFYTFYAMDTYHVSIQQAQSYIFVFLLFGAVGTFLGGPLADRFGKRFVILGSLL
CSAPLAILLPFAGPVLAYGVLALIGLVLMSSFSVTVVYAQELVPGKIGTMSGLTVGLAFG
MGAIGAVALGALIDTAGLTPTMIAIAFLPVLGILAFLLPSDQKLREWHS
>PK3-2_00176 hypothetical protein
MVSTFHFSTIVSRTHIFKLMPMIHSLHEHCDDFHLYVLCVDQKAYELLQHVPWEHVTFVQ
LHEMEDPELLQAKSNRTFHEYCWTLKPAFLFHVMSKWDDAEYFAHMDTDLFFFSDPARIF
AENPTASLYLTDHRNSPRFISYYERTGRYNTGFVGAGNTKEAYEAVWQWRQDCIAFCTVE
MDTERKTYGDQRYVEKWPDQYKGVHVVKSIGANTALWNIENYKIGQKDGRVYIDETPLIF
YHFSGFTLVTEKEFNLCWYYRIEDEATIEMIYMPYILNLKRWIDEIQSAFPDFADGFIPK
HAVPDTHFIQLD
>PK3-2_00177 hypothetical protein
MKASVIIPAYNSKERLYNSLLSLNHQECDEEFEVIVADNGSEDGTLSMLESFQADFPLVF
TRIKENRGIAYGRNQALRNARGDILIFHDSDMLAAKDLVAKHIKAHENEENLVVCGLFWK
RIYSFYYERFEDEHKEQLAKLVDEMPKKDKQKLLKEADIKNGSFLDKSFDLDTDFIDVLK
RILDEYGDDLKGYHMPWRFFITNNSSVKRKHVVDLGLFDEGIVRYGFEDYDLGIRLHQAG
LTFRLHRDIVSVHQEHPSNCKSVDDIRANIAYMCDKYNNIRSLDVHLAFNGPFPPDMTNG
IMTDIHKLLESQKYDMLLNLFLELLHVVKERNIDPDWQKKAPRVTAKNFDLQSVRKLLPK
AKKKLGVNDFANALYALVNDLLHVDLR
>PK3-2_00178 hypothetical protein
MTVASAYCTVLSKGRLYQAVALFKSLEQVDQDSPIFTLCMDEDTHRVLQKLKMKQLNLVP
VAALENEMLLKLKETRDQSEYCWTMKPIFLQAVLNSNPELDRVTYIDGDLFFYADPAPIF
ENQPDCSVLLSRGDIVIPSFEREQIDMLQRLLGRYNSGFISFKHDDAGTDCLEWWKERCL
EECKNAPGEGKFGDQGYLDYMSELFPNVCDITTPGVNIGHWNYGQHTFSWENGRIVLEDG
SPLIFYHFSGYRIVSINEIKQIHETTRTDLPFMHELYQETLPHIIQHIKTLDPEFNGFAS
KDDNK
>PK3-2_00179 CDP-glucose 4,6-dehydratase
MKELIEQGANVTGLVRDHVPQSNLYQGEHIKKMNVVRGSLEDLPVIERALGEYEIDTVFH
LAAQAIVGVANRNPISTFEANILGTWNILEACRKHPLIKRVIVASSDKAYGDQENLPYDE
NMPLQGKHPYDVSKSCADLISHTYFHTYGLPVCITRCGNLYGGGDLNFNRIIPQTIQLVL
NGEAPEIRSDGTFVRDYFYIEDAVQAYLLLAEKMEENNLAGEAFNFSNEIQLTVLELVEK
ILKKMNSDLKPKVLNQGSNEIKHQYLSAEKARKLLNWTPAYTIDEGLEKTIEWYTEFFKK
>PK3-2_00180 Glucose-1-phosphate cytidylyltransferase
MKAVILCGGKGTRMSEVTNDIPKPLAMIGGKPILWHIMKIYQYYGVNEFILLLGYKGEKI
KEYFLDYEWKHNSLTLDSSTGEVHMLGQPETWKITFLETGEDTLTAGRILQAKDYIGDET
FLLTYGDGLANINLFHLISFHQAKGAAATVTGIDKVSQFGTLTVEDGMAKTFSEKTSSDG
IINGGFFVFSPKVFDYLPKNGNAMFEDEPLKNLAKDGELAVYRHYGFWTAIDTYKNLLEV
NKMWDQGQQVWKVW
>PK3-2_00181 Lipoteichoic acid synthase 1
MNEELKVFKKVEVAMKKLFSYKLSFFVLAVILFWAKTYLSYKTEFNLGVKGTTQEILLIF
NPFSSAVFFLGLALLAKGRKSAIIMLIIDFLMTFVLYANILFYRFFDDFLTFPNIKQSGN
VGNMGDGIFSIMAGHDIFYFLDIIILIAVLIWRPEFKEYKMKKRFASLVILSGVALFFIN
LHFAEKDRPQLLTRTFDRNYIVKYLGLYNYTIYDGVQTAQTESQRAYASSDDLTSVENYT
TSHYAKPNAEYFGSAKGKNIIKIHLESFQSFLIDYKLNGQEVTPFLNKLAHGGEDVTYFD
NFFHQTGQGKTSDAELTMDNSIFGLPEGSAFVTKGENTYQSLPAILDQKEGYTSAVLHGD
YKSFWNRDQIYKHIGYDKFFDASTYDMSGENVINMGLKDKPFFTESIPKLESLKKPFYAH
LITLTNHYPFNLDEKDASLKKATTGDNTVDSYFQTARYLDEALEQFFKELKEAGLYDNSV
IMIYGDHNGISENHNRAMKEILGKDITDYQNAQNQRVPLMIRVPGKKGGMNHTYGGEIDV
MPTLLHLQGIDSQKYINFGTDLFSKDHDDTVAFRNGDFVTPKYTSVDNIIYDTKTGEKLK
ANEETKNLKTRVSQQLSLSDSVLYKDLLRFHKLSDFKAVDPSDYHYGKEKEIK
>PK3-2_00182 Bifunctional cytochrome P450/NADPH--P450 reductase 1
MKETSPIPQPKTFGPLGNLPLIDKDKPTLSLIKLAEEQGPIFQIHTPAGTTIVVSGHELV
KEVCDEERFDKSIEGALEKVRAFSGDGLFTSWTHEPNWRKAHNILMPTFSQRAMKDYHEK
MVDIAVQLIQKWARLNPNEAVDVPGDMTRLTLDTIGLCGFNYRFNSYYRETPHPFINSMV
RALDEAMHQMQRLDVQDKLMVRTKRQFHHDIQTMFSLVDSIIAERRSNGDQDEKDLLARM
LNVEDPETGEKLDDENIRFQIITFLIAGHETTSGLLSFATYFLLKHPDKLKKAYEEVDRV
LTGAAPTYKQVLELKYIRMILNESLRLWPTAPAFSLYPKEDTVIGGKYPITTKDRISVLI
PQLHRDRDAWGEDAEEFRPERFEHQDQVPHHAYKPFGNGQRACIGMQFALHEAALVLGMI
LKYFTLIDHENYELDIKQTLTLKPGDFRIRVQTRHQEAILADVPAAEKAAGDEQKEKRET
KGASVIGLNNRPLLVMYGSDTGTAEGVARELADTASLHGVRTEVAPLNDQIGKLPKEGAV
VIVTSSYNGKPPSNAGQFVQWLQEIKPGELEGVHYAVFGCGDHNWASTYQYVPRFIDEQL
AKKGATRFSARGEGDVSGDFEGQLDEWKKNMWADAIKAFGLELNENADKERSTLSLQFVR
GLGESPLARSYEAAHASIAENRELQSANSDRSTRHIEIALPPDVEYQEGDHLGVLPRNSQ
TNVSRILHRFGLKGSDQVTLSASGRSAGHLPLGRPVSLHDLLSYSVEVQEAATRAQIREL
AAFTACPPHKRELEELAAEGVYQEQILKKRISMLDLLEQYEACDMPFERFLELLRPLKPR
YYSISSSPRVNSGQASITVGVVRGPAWSGRGEYRGVSSYYLAERQAGDDIVMFVRTPESR
FQLPEDPETPIIMVGPGTGVAPFRGFLQARSALKREGKTLGEAHLYFGCRNDRDFIYRDE
LEQFEKDGIVTVHTAFSRKEGLPKTYVQHLMADHAETLISILDRGGRLYVCGDGSKMAPD
VEAALQQAYQSVHGTGLQEAQNWLKHLQDTGMYAKDVWSGI
>PK3-2_00183 hypothetical protein
MDFEIRFLSFYVIQVEGKDEQANKQFKHFQTLDTGEFEESELKDFLDGELKKIVKRKADR
HPQSEQVPTKIGHFIVEPGHELDSNPNYNMFNRARLAETKEDFNELSEQFVRTYLDTSAV
RGGVFLVASAVPRKYFDESFVFIMKCDFEPKVARISDASSLIKKVEMAITTKNMKSIQYP
FMPEEGMIEEGELKIHQSSHARYFEDFLKFVEYGESMPEIMKNQVMNMVQEHVYETFEDN
SEELKQFEHDIEIWEASEKREIQERLDTHQVIEASAQIIEHTPEAQLKMKVGETEIKGLL
ADFGDSIHLAKVNGRYVALIEAETISFEKGSSPVEFYKPEGLHEVIERIQQRNTEQQ
>PK3-2_00184 hypothetical protein
MPCNTYYSDYVLKICTDADSYSERATSIDCVATYGGGSIATFDYSMRVEVWNGHDWVVNE
VKKGSFSHSTPAKVFKLKNQRSLKKGKNSARVRLIATNRASGAKFNIKTPAFIVKR
>PK3-2_00185 FAD-dependent urate hydroxylase
MKHIVIAGGGIGGLSAAISLSQAGFSVTLCEASSENRKTGAGILQPQNALAILKELGVFE
ECCKHGFQTEWFKTFDAQGNLLFKVSESFLDDTLPGRNNILRKTLNDILMKHAEAAGVNI
KWGKKVVAYEETAESVTAVCEDGEKMKADILAGFDGIHSAVRDKMLQKETEKEHLGMGAW
RFYIELPDYSFEDATLMYRSGDTQIGVAPLAEHAGYVFVLQPCTSDYWDEEDTRFDRIKE
ILSGFPGLDFVTKHMSKEHPVIFNKLEQVAVQEPWYKGRVVIGGDAAHAGAPTLALGAAM
AIEDAIVLAEELKNHDDTKTAFHAYYERRAPRALKVQNLSSEIVRRGLKGEPGAEELIGE
CYAVLREGY
>PK3-2_00186 hypothetical protein
MMELKHLPKYQHITEHAETYANIDAGSLELFLSLFDISKKMNHVMEHYFAGSGLSEGKFK
ILMLLFDAEDHTLSPTELAKQSNVTKATITGLLDGLVRDGFVSRRHHTEDKRKISIELTT
EGKARLEEFLPGHFSKISAVMENYSDEEKDMFVKMLGDLFERLSVFKD
>PK3-2_00187 hypothetical protein
MKKQMGAYVSLAAAMAIVGSSVVVGKLMVERIPVFLSSGLRFLIASVVLLTLLFCIEKGL
PALTKKDVLVLLVQSFTGVFLFSICLLYGVQYTTGTESGILTSTTPMVIGILSFFLLREK
IEKKTLIGILLAVCGVMAINLFGAGSQDGTPHALFGNMLIIAAVIGEALFTLMAKLLSPH
ISALAISTFVSLFGFLFFLPFALFEASSFDYSVPTVLDWSYVLYYALFVTVLAFYLWYSG
VTKVPAGVSGIFTSVLPVSAVILSGVILKEPFEFVHFIGIACVIGGIFVTVIKKKQPDAY
PAAEEKTL
>PK3-2_00188 putative protein YetJ
MQATVHESKQSIMQRILTVFVFTLLIATVGLFIGQFVPVALMLPLSILEVAMIILAFWMR
RRKAVGYAFVYTFAFVSGITLFPIVSHYASIAGAYVVLEAFGSTFVIFAVLGTIGAKMKK
DLSFLWSFLLVAVIALAVVGIFNIFSPLNSAAMMAYSVIGTIVFSLYILYDLNQIKHRHI
TEDLIPVMALSLYLDFINLFINLLRFFGILSSDD
>PK3-2_00189 hypothetical protein
MVSKSTIDPEVIEKIISSLETLDFGTVQITVHDSQVTQIEKIEKHRFSLKRKESK
>PK3-2_00190 hypothetical protein
MNIDQLLYQYIIDNTADITEKWFSLRCQLKGELYSADNLSEETKKLLTEQHTFTNITIAS
AFLEDQNEFQENMAKWALAIAKNRVEQDVQVHEVVEAISNSRISFWDAVVSFIKENREIV
TNEDADRWNRIVNQSFDKLIIEFSEQYQKIMLMRLTSQQELISELGCPVISIADGIGILP
LIGSIDTKRAQVILETVPVRCIERKITSLVVDLSGVPIVDTMVAQQLYNLSKTLFLLGVK
AVFSGIRPDVAQTSIQLGLDFSEYETYGTLKQALENMGVRCIVEELEENK
>PK3-2_00191 hypothetical protein
MYYVDPYMFAGHFYEPWPALEYEYRYPWPDIGSGAVPGFGGGSGPGIGGGAVPGFGGGSG
PGIGGGAVPGFGGGSGPGIGGGAVPGFGGGSGPGIGGGGVPGMGGAPQGPPPSQIPAKPQ
KPQGAQGAAFLVEPITIRPCLFRFTYVWLTNGRSFWFFPIILGRRSVGGFYWDTSRRRWV
YFALDTNLIDVVSCSY
>PK3-2_00192 hypothetical protein
MIKQIGTVAVYVEDQQKAKQFWAEKAGFDIAADHPMGPEASWLEVAPKGAGTRLVIYPKA
MMKGSEQMKASIVFECEDIFDTYEKMKANGVEFLGEPNQMEWGTFVQFKDEDGNVFLLKE
>PK3-2_00193 Heme-degrading monooxygenase HmoA
MFVQLRKMTVTEGHADKVIERFSAEGIIEKQEGLIDVTVLEKNVRRGDEEVVVMIRWESE
DYWKQWEKSDAHIAGHKANKGKSKPDYLINTEVSMYHVRAVKKGTHE
>PK3-2_00194 hypothetical protein
MGDYLNVAIELVCGLGILFVILKFLGKTQFSQLTPFDFISALILGELVGNAVYDHEIKIK
EIIYASLLWGLLIFLIELITQKLKGTRKFLEGEPNIVIHKGKLKYKMLKKNKLDINQLQS
LLRQKGCFSIQEVEYAILETNGMISILPKADFDKPTRKDMNLPPKDVSLPITLILDGEIV
FDNLVEAGVDEQWLKQSLQKHGVEKTEDVLYAEWHANQPLYLITYEEGSSS
>PK3-2_00195 Alpha-galacturonidase
MFHISMLDQIKIAYIGGGSQGWARSLMSDLSIDERMSGTVAFYDLDFEAAQKNEVIGNYS
GEGRWRYEAVSTLKKALSGADIVIISILPGSLDDMEIDVHLPERFGIYQSVGDTVGPGGI
IRGLRAVPMFAEIARAIRDYAPDSWVINYTNPMSVCTRVLYKVFPGIKAIGCCHEVFGTQ
KLLSEMVTERLGIEVPWREDIRVNVLGINHFTWITEASYRHIDLLPIFREFSAHYGESGY
ELEAESWRDSVFRSAHRVAFDLFETYGAIPAAGDRHLAEFLPGSYLKQPELWNFHLTSVS
FRKQDRDEKQKETEQLIVQKQGVARKASGEEGVNIIAALLGLGELVTNVNMPNQGQVSNL
PLQAIVETNALITRNRVQPICSGALPKGVEMLAARHVSNQEAVAEAGLTKDRGLAFQAFL
NDPLVTIDRSDAELLFHDMLAMHQMM
>PK3-2_00196 L-arabinose transport system permease protein AraQ
MAEIHTMHNTKAGRVFDVCNILFLGGVGAITILPFLYIIAGSFATEAELAQRSFFIFPKT
FTLEAYKYVFSTPTFIRSMGVSIFITVVGTAVQLFFTFTMAYPLAKRHVKGRNLLLNLVI
FSMLFSGGMIPTYLVVKSLGLLDTYWALILPMAINPFNLIIIKNFFQQLPRELEESAKMD
GCSEIGVFWRIALPLSKPVIATFALFYAVGIWNDFFHALLYINDSAKWPLQMVLRQVTIL
SDLTATNGDTMQNTVPPEQGIKLAVIVIATLPILAVYPFLQKHFAKGMLIGSVKG
>PK3-2_00197 putative multiple-sugar transport system permease YteP
METVPKKGDAPVLTAGKGISWMAALKRDKWLYLLLIPGLLYFLIFKYLPMWGVLIAFKDY
SPYLGFWKSEWVGFDYFKDFFMNPDFFRLLRNTLMLASLDLLFAFPAPLILALLLNELRK
AVYKRCIQTFIYVPHFVSWTIVVSITFVFFTVDTGVINKMVMSLTGEQISFLSDADWFRP
MIVMQSIWKETGWGTILFLAALATVDQEQYEAAIMDGAGRFRRMWHITLPAIRSTIIVLL
ILRIGSFLNLGFEQVYLMTNSLNRSVADIFDTYVYMMGITQGAYSYSTAVGLFKSVVGII
LIFGANYIAKKFDQEGLF
>PK3-2_00198 Lipoprotein LipO
MKNRMRKKWMALPLAVMMIAGCSNSETSNSASGSKDTIKIMAPLLSPESPSDKSPSLKAL
EKYTGKEIKVTWVPDSSYNDKFNIVMASGEMPHAIVIKDKSAGFIKSVKAGAFWELSPYL
KDYKNLSQADEKILKNSSVNGEVYGIYRTRDLIRACMIIRTDWLKNVGLDMPETLDDFYE
VLKAFKEKDPDGNGKDDTYGMVVPKWMGLGNGSPWDVLQIWFGAPNRYGVENGKLIPDFT
TKEYMEALTFFKKLYDEGLINKDFAVMDSAKWNDPVVKGKAGVIVDTGSRASQIQSAMEE
ADESNKDVIDIVGSLEGPNGKRTFPTSGYSGMIAIPKSSVKTEKELKEVLSFLDKMNDKE
AQILTNNGVEGRNYELKDGVFTSLEKNNKSLLYEHEGLAQFSMSIPKSEYYIEDQKTKLF
QHRKDIITEGEKIAVFNPAESLVSDVYTQKGAQLDNIILDARTQFIIGEIDEKGFEDAVE
LWKNSGGNDLMKDLNKLYQSSK
>PK3-2_00199 hypothetical protein
MKKIKWLSEQPKVTSGVAWGVPWKKGELQKGDCLALVNEKAESRYVQCEPSAYWPDGSIK
WTKHAAVFRGQEHHRYAIQKGEAPRPAETLSIKDSGRDIQVDTGTLICTINKTGSDFIQS
LQNNGKPIAAGGRLVAIRETRKETAAETVLFHEASVSLIKRVMIEKSGPIKAVVKIEGVH
VLKNEEWLPFVIRLTFYAGLSELSIVHTQLIDKNSKQEFIKGLGIEFDLVLEGEPYNRHF
RFAGEKGMYKEPAQLFGTRKFNERYPLYEKQINGELLSPSEEHKEWFAHGTQNAVWNDIK
IVQDSSDHYSLSKRTGKDYAWVGMLHGSRAKGLCYAGGENGGIALGLRYFFEKYPSALEI
TGLAGSHPKMTIWLWPPDGEAMDLRHYTGNTHVASAYEGFDEMRSDPTGIANTNEISLSC
FSRMPSDDVLNAHANKWQAPSLLVCEPDVYYESKALGVWSVIDTSHPLKKELEEQLDAAF
LFYKKEVEQRRWYGFWHYGDVMHTYDPIRHMWRYDLGGYAWQNNELVPTLWLWQAFFRSG
REDIFRMAEAMTRHTSETDSFHLGEYAGLGSRHNVVHWGCGCKEARISMAGLYKFYYYLT
GDERTGDLLTEVKDADCALVKTDPMRAFYEKGKHPTHARTGPDWAAFCSNWLAEWERTEN
PEYLKKIETGISCLKRLPLRLLSGPTFEYDPATSMLHHMGDGIAGGYHMIIAFGAPQVWM
ELTELLDDREWEEMLSEFGEFYTLSDEEKRKKSGGALHDRHFHWPMFAAAMTAYAARKKQ
DPHLAAKAWNLLLDDKLSHTPLPIKPERIETWTQLEELPWVTTNTVSQWCLNVIAALELI
GDALPAKKDTSGKKG
>PK3-2_00200 Beta-galactosidase YesZ
MKGKLYHGACYYPELWDEETIRQDIDMMREAGINVVRIGEFAWSVMEPEEGKIDVGFFKK
IITRLYDNGIETIMCTPTPTPPIWLSHGSPERMHVNEKREVMGHGSRQHACTNNPYFRKK
AAIITTSIAKELGQLQGLIGWQLDNEFKCHVAECMCETCLRLWHDWLKSRYGVIERLNEA
WGTDVWSETYQTFEQVPQPGPAPFLHHASLSTMYQLFSMEMIAQFADEQAKIIRCYSDAP
ITHNGSVMFSVDNERMFRNLDFASYDTYASQENASAFLLNCDLWRNLKRGRPFWILETSP
SYAASLESSAFPHADGYLQAEAVSSYALGSEGFCYWLWRQQRSGSEISHGSVLSAWGEPT
VGYQNVLAVERARKEIESVILSTEPVQAEAAMTYSDRAKAFIKTEPHRGLQHRSLVTHFY
ERILNTGIHRDLIPEGVPLDGYRLLFTPFVPYLSAEFINKASAFAEAGGIWIAGPLTGGR
TSEHTIHTDCGLGELEKTAGIKTLFTFPMNEDMNTGKAFGITAPLGLWSAVFDTGSGNIL
GTVESGPGAGHAFLTEQKHGKGKIVMLGALPSENEGDAMLEALVRHYAAEAAISVRSDVT
PGTIVAPRKGDNGLVWIIVNMDGKGGSVTLPEAGTDLLTNRSAKAGRLAVGPHEYLVIQF
EHHS
>PK3-2_00201 putative rhamnogalacturonan acetylesterase YesY
MANHIYLAGDSTVQTYGDSTNQGGWGQFLGSHLPEYIQVINRAIGGRSSKTFVEEGRLQA
ILDVIEPDDWLFVQMGHNDASKNKPERYTEPYTTYKQYLKQYIAGAREKGAHPLLITPVA
RFHYENGVFLNDFPDYCIAMKQTAEEENVQLIDLMEKSLAFFTEKGEEKVYTYFMVSEGI
NDYTHFTKKGANEMAKLVAKGIKELGLPLTESIIKEG
>PK3-2_00202 hypothetical protein
MVYKAKADCLERMAYHNAGRTGLKLPAVSLGLWHQFGDAYSAENVHQRSGHEGEKAERIR
ERTGAIATANGARVAFKG
>PK3-2_00203 Rhamnogalacturonan exolyase YesX
MTRGLIAVKTEQGVFVSWRFLGTDHETTTFHLYRNGKRITREPIEDSTNFLDRNGTADSV
YQVAAVNKGREEKLSKEAPAWRENVLEVPLNKPEGGVTPDGKPYTYSANDASVGDVDGDG
EYEIILKWDPSNSKDNAHDGYTGEVLIDAYKLDGTFLWRINLGKNIRAGAHYTQFMVYDL
DGDGKAEIAMKTADGTTDGKGRIIGDEHADFRNEQGRILSGPEYLTVFKGETGEALMTVE
YEPPRGKLEDWGDRYGNRMDRFLAGIAYLDGVRPSLVMARGYYTRAVLVAYDFRNGRLKK
RWIFDSNQPGHEAYAGQGNHSLSVADVDGDGKDEIIYGAMAVDHDGTGLYTTGLGHGDAM
HVGYLDPSRKGLEVFQVHEDASKPYGLSLRDAGTGEILWGVHAGTDVGRGMAAHIDPSYK
GSLVWGIDPPGNDGMSYGLFTSKGEKISDKAPASANFAIWWDGDLVRELLDHDLDGTIGR
PKIEKWDAENGCLKTIFQPDGVLSNNGTKGNPVLQANLFGDWREEVIWRTEDSSALRIYT
TTHFTRHRFYTLMHDPVYRLGIAWQNTAYNQPPHTGFYLGMGMKKPPKPALYIAGSKAEA
PL
>PK3-2_00204 Rhamnogalacturonan endolyase YesW
MIKRRKRMFTAVTLLVLLVMGVSVCPVKAEGAARQMEALNRGLVAVKTDGGIFVSWRFLG
TENTSVSFNVYRDGQKLNASPVKTTNYVDKNGSAGSAYTVRAVVNGTEQAASEKASVWAQ
PYHSVPLDKPAGGTTPKGEAYTYSANDASVGDVDGDGQYELILKWDPSNSKDNSQDGYTG
DVLIDAYKLDGTKLWRINLGKNIRAGAHYTQFMVYDLDGDGKAEVAMKTADGTKDGTGKV
IGNANADYRNEQGRVLSGPEYLTVFQGATGKELVTANFEPARGNVSDWGDSYGNRVDRFL
AGIAYLDGQRPSLIMTRGYYAKTMLVAYNFRDGKLSKLWSLDSAKSGNEAFAGQGNHNLS
IADVDGDGKDEIIFGSMAVDHDGKGMYSTGLGHGDALHTGDLDPSRPGLEVFQVHEDKNA
KYGLSFRDAATGKILWGVYAGKDVGRGMAADIDPRYPGQEVWANGSLYSAKGAKIGSSVP
SSTNFGIWWDGDLLREQLDSNRIDKWDYQNGVSKNVLTASGAAANNGTKATPALQADLLG
DWREEVVWRTEDSSALRIYTTTFPTEHRLYTLMHDPVYRLGIAWQNVAYNQPPHTSFFLG
DGMAEQPKPNMYTP
>PK3-2_00205 putative protein YesV
MKTTVTDALYAVCEAVVKIAWLNGLWLLFTLLGGILFGWAPSTAAMCAVIRKWLMGQKDV
PVFPLFFDTYKKEFLKVNAIGLAFAALFLILSANYHYFSASTDWLSFTVTSCTLLAGLLY
IIALLYVFPLYVHYRLPLRKYLPQALLFGAMRPLTTGCMLIGCGFVLYLLYTLPGLIPFY
GPCLFGLVSMFFALRGFQKTEAQHRQAG
>PK3-2_00206 putative protein YesU
MYKEGACLYRNPLRSASDVKNWRMEGGGQISFDDHRLHLSHVLDEAHFVYWCPETFPDGI
IVTWDFSPIEQPGLCMLFFAAAGIGGEDLFDPSLKKRTGQYPEYHSGDINALHLSYFRRK
YAEERAFRTCNLRKSRGFHLTAMGADPLPSPDDADSPYRMKLIKDKGYVHFSINDLPILE
WMDDGSAYGPVLTKGKIGFRQMAPMKAAYRDFAVHQAVRR
>PK3-2_00207 Rhamnogalacturonan acetylesterase RhgT
MEKPIQVFLAGDSTVSDCPPQEAPMAGWGQVFGQLFSEDVKVYNHAKGGASTNSFVDEGR
LQAIAERITQGDYLFIQFGHNDQKPRGTKPYSTFQQFLTMFADTAREKGAHPVFVTSVQR
RRFDENGRIEHTLGEYPDAMKALAKELDVPVIDLQTKTKVLYEAYGSEESKRLFVWFQPN
EHPNYPDGIEDNTHFSETGAMEVAKLVAEGVEELGLPLKDHLVSREGKEYV
>PK3-2_00208 HTH-type transcriptional regulator YesS
MKKQPQQKERVSRWKGTYFKRNFVFILLIACIPGLLTGGAIYFLSIDKVEKELQRSHETQ
VAREVSRMDEKLGVLELALTQMAYDSSLMNGLAERDLEKDFTFSYQLTKKLFLLRDQQPL
IEQASIFLNSPRPLVLSPEYSALTEQEAHRKYRPLLASDNSIYWNRSGNQAMLIQLIPGA
AEKPFGAIMLAVDPKEMESILQSLSPYPDGSALLLDQNQEVLFHEGEKDFEKTLLKEVKT
QPDGNGHFQMEWDGKVYSVSFGEMNRMHQQWTFVSAAPLSAITAPMVFLSKVIIVMLVIC
LILAVCMTWYASKKIYRPIQHLLGLFTGGEKKAWQASGQDEFKWIEKRWHDLSVESRKLQ
EQLLRQTPHMKKSFLQHLLQGDFYDDNEKSLRSRMEEAGWNIGENVFHVLDLQVTGLHCE
KSVFRPGDEQLAVFTLTNMAEELAAKHCLQTSILDIGRLSVTVLVMKTNSSDLRAFVTEL
ARQFGDAARLSLTGTMSRKSERVMEIPGLFQDVKSGKFRRQFANRHQVIDLQSDFPQDER
SAPYYPFELEKQIVQAIRLERKQEAEELIRVCVEELAEKAAIDRHVHSALIQLFSRIQED
VLQSGLNPSDLFQHRDLLLDISELREPNEAVSWLMDAVVTPYLSKLEGRKNRQQKQLADR
VIAMIQEQYMADISLESCADALGINSYTLSKAFKQVTGINFIDYVTNIRIEKAKELLVNT
NKKIHDVSEEVGYRHNYFNRIFKKQVGMPPGVFRQMYQETP
>PK3-2_00209 Unsaturated rhamnogalacturonyl hydrolase YesR
MAQLIFDEEKVTSVIDRIVKRTFQMDFAWDWPGGVAFYGVAEAYEATENEEYINLLKTWV
DEQLEDGLPPLSINGVSIGHTLLFLHKVTGDHVYLETAGEMAEYVLHKAPRFGEGILQHT
VNSAEYVFPEQAWADTLMMAGLFMLRIGRVMEREDYVEDGLRQFHGHEDVLQDPVTNLYY
HAWDNKVQNHLSGIYWGRANGWAALTMAKALPLIEVTHPSFMIIDGSLRDQLSALVRLQD
ESGLWHTILDDPDSYLEVSASAGIASALLSSGKLYTKYVQKSLAAILDAVEEDGRVSKVS
AGTAVMKNAEGYKQVPYKRIQGWGQGLALTFLADVLRTKKHVYQ
>PK3-2_00210 L-arabinose transport system permease protein AraQ
MEPVNQPVREAPVFERKKAVRVRPKRILFHVFTASLAVLLLYPVIWLFVSSFKESASIFT
TSHSLIPDPFILSNYAEGWKGIAGQPFLTFIKNSAVIVGLSTIGAVLSSAVIAYGFARIP
FKGKAFWFACMMGTLMLPHEVLMIPQYILFAKLDWLNSFKPIVVPQFFGHAFFIFLMIQF
IRTIPVELDEAARIDGCGRFACFWRIILPLIAPALATSAIFSFYWKWEELIQPLLYLNKP
ELYPVSLALKLFLDTESASNWGAMFAMSAVSLLPVILVFFLFQKYIVQGISTTGLK
>PK3-2_00211 Lactose transport system permease protein LacF
MTGNGADAMKKSRSIRKDNLAGYAFISPFIIGFLCFTVIPMGASLFLSFTSYDLFTAPKW
IGLDNYKEMFTGDEKYWQSLKVTFTYVLAGVPLRLGFALFIAVILNNASKGTAIYRTLFY
LPSIIGGSVAVAIMWRNIFGNDGVINALLFFVGIDQKILWYQDPTSALWTLILLSVWQFG
SSMLIFLAGLKNIPSSYLEAASVDGANRVQRFFKITLPILTPIIFFNLVMQTISAFMTFT
PAYIISKGEGGPLDGTLLYSLYLFQRAFNYFQMGYASAMAWVMLIIVGLITLILFKTSSY
WVHYESKEE
>PK3-2_00212 Putative ABC transporter substrate-binding protein YesO
MKKICYVLLSLVCVFFFSGCSAGEEASGKKEDITLRIAWWGGQPRHDYTTKVIELYEKKN
PHVHIEAEFANWDDYWKKLAPMSAAGQLPDVIQMDTAYLAQYGKKNQLEDLTPYTKDGTI
DVSSIDENMLSGGKIDNKLYGFTLGVNVLSVIANDDLLKKAGVSINQENWKWEDYEKLAY
DLQDKAGVYGSNGMHPPDIFFPYYLRTKGERFYKEDGTGLAYHDDKLFVDYFKRQLRLVK
AKTSPTPDESAQIKGMEDDFIVKGKSAITWNYSNQYLGFAQLTDSPLSLYLPPEQMKEKA
LTMKPSMLFSIPKSSEHKKEAAKFINFFVNNEEANMLIKGERGVPVSDKVADAIKPKLNE
EEANIVEYVETASKNISKADPPEPVGSAEVIKLLKDTSDQILYQKVPPEKAAKTFRKQAN
EILERNN
>PK3-2_00213 Protein-glutamate methylesterase/protein-glutamine glutaminase
MYKILLADDERIILDGMAGIIEWEALGASLIGKAQNGNEAYEKILHKQPHIVITDIKMPG
MDGLELIKKVSAVSPSVQFIVLSGFGEFEYAKEAMKYGVKHYLLKPCNEQQIVSSLEEII
AELKQLDVRKKKTAHLKHELNHIRSFAADQYLEGLIAGVAQLPPPPSLAGKKVRLMILKG
EQSIDDTDRKAFGSALTAVCSSGEWTVLAVEENAAEKAADVFADRRVSISQAGELRNAGQ
LFRDTAEASGDLHGSAVILKMIRLVADELGNPNLSLKWAAKDMLFMNPDYLGKLFKQETG
EKFSQYVTRVRLEHAMKQMRIRRDVSVSEIAEEIGFGDNPKYFSLVFKKYTGLTPSEFRK
KQGGASAG
>PK3-2_00214 hypothetical protein
MKKRVAGWYRRMKIKDKLFVFLSLIMAVSFLFVYSGVQYAFHVYDEQIYRKSSEVLRMSS
ERIEDELKKIEDVSYQIITDEQIQRILSMQNRDDTYDQYQMKQELWDQLAEYAGDEKYID
SIHLIDARGSEYSAGSSSSALLKQEREEVLKRAKAKNGRNLWMTLGGSDPVLISARQIRS
YHQLRLNGLGMVLIQANVKQMIRDLPKDWGDSVGDIMIADKGGNLVYSAHAPLLVPEAAK
ETIKHPGYDLIKKNGKRYFISFLQSSYQNWSYYNVIPFDQMFEKISFMKTVIGTCFLLFF
CVVLLFGRKIANSITEPIEQLVSAMKSVQDGGIEAGVSLSLPEYTQDEAGMLNRHFTAMM
KRINELMEENVEKQLIIKETELKALQAQINPHFLYNTLESINWLAKANQQKQISKMVESL
GFLLRNSIHMKKDTVTIQDEADIVLHYMTIQRFRFEERLNFTLDIDEEVNDCLIPKLTLQ
PLAENAIQYALEPFTRPCAIRIQAKKTKDGVCITVEDKGPGMDERMLETPGGRGIGLWNI
RERIRLTFGEPYGLRIQSKEGKGTRIVITIPCRNEVV
>PK3-2_00215 putative protein YesV
MIHSVANGLNRFCTWVMRLAYLNVLWILFSLAGLVVFGLMPATAAMFSVAREWAKGNTDA
PVFSVFFRAFKKEWRAAQILGLIVVTAGLFLFADMRIAAQMNQPVLVNVFLSISLIFALV
VLYVFPVFSHFDVKIREVLSISFLIAFSRPAVTLLMAAGAVGVLFLVLFHVTFLLFFSGS
LLSLILTKLSFKAFQSMDQRQEKEKAA
>PK3-2_00216 hypothetical protein
MWTILFVTGIVTACLFAGVSVFLRMKLPGKKWPEWILAGLVVLGVLAIWYSLVYVRGWEG
AALGMLGFNVMCGAAAGYLIGRAILRYMKK
>PK3-2_00217 hypothetical protein
MSAFKMKNETIADGFYACPGVYEDAEAITGLLVRTAEWLRDRGSTQWSGLLEGHDTHDIT
GSIADGHVFVFKKDEELAAVVMLLPEPSEWDRKLWGEDGHEASIYLHRLAVSRQFAGQGL
GARVLQWAETGIHFPEKTRIRLDCVADNDALHSFYRRMGYEFMGADPSGYHLFEKEILAE
>PK3-2_00218 Manganese catalase
MWVYEKKLQYPVKVSTCNPTLAKYLIEQYGGADGELAAALRYLNQRYTIPDKVIGLLTDI
GTEEFAHLEMIATMVYKLTKDATPEQLREAGLGDHYVNHDSALFYHNAAGAPFTATYIQA
KGDPIADLYEDIAAEEKARATYQWLIDISDDPDLNDSLRFLREREIVHSMRFREAVEILK
EERDKKKIF
>PK3-2_00219 hypothetical protein
MAKKVDAEYYRQLEQIQAADFVLVELSLYLNTHPHDEDALKQFNQYSGYSRHLKRQFESS
YGPLLQFGNSPAGEDWDWGKGPWPWQV
>PK3-2_00220 hypothetical protein
MKDMQPFTPVKSYTPFHSRFDPCPPIGKKYYRTPPNLYMTFQPEHMEQFSPMEALRKGTL
WKDLYDFYENPYRGGDAHGKKG
>PK3-2_00221 NAD(P)H azoreductase
MMKQRPILITGGTGTVGSRIASRLIELGYRVRIASRKKGDLTDAEYVYFDWKDASSFTPA
LEQIKQIYLVAPVGELDPAPYVLPFLKEAKRLGAKRVVMQSASVVPEDGPVFGALHQAVR
DFLEWTVLQPSYFMQNFINVQHRVSIQTEGRITTASGEGKLGFIDADDIAETAVRTLIDD
VPHQTHHILTGPEALSYAEAAEIIGASAGRRVEHVSISRSELQHRMEAAGLPADYAQFMA
ELDEAIRHGAEHRVTDTVKRVTGKEPRSLTEFAAAHSAYWKR
>PK3-2_00222 putative protein YesE
MLMNEFEKACETLRQFMAYMLEKDMKSWTELWDENAVFEFPYAPEGSPKRIEGKAAIYDY
IKDYPDQIHLSSFTAPTVYRAADTNTIIAEFQCDGHVIETRLPYRQSYISVIETRDGRIV
RYKDYWNPLVVKEAFGGSFLQTEASGK
>PK3-2_00223 HTH-type transcriptional repressor ComR
MGRNKEFDTALVLHRAIEVFGEYGYEGTSLQGLLSHLGIARQSLYDTYGTKRDLFLSAVR
TYLDGKNAAVIERLEAPGSVKDAIQDIFQEGVNVLKDPERAKACYIINSAIEQIPHDPEL
AQYFEGQSKQLEDAFYQAILRGKDQGELTGEDTDISALARYLNQSRLSLTFVAKVTADLD
RLQDHVDVSLSVLD
>PK3-2_00224 hypothetical protein
MTDTDTRQIYGGPGFGTYPGYGIGRPGFGMYGGMSGYPGYGMYGGYPGYGMYGGYPGSGM
DGGMSGYPGYGAPGGYGGYPSGGYAGSPGPGPVSYPSMPHENDGHHHYYHHHHDGEDNHH
HHHHHDGKDNHHHHHGGNYGHHHHHMGHWGPDGYK
>PK3-2_00225 putative transcriptional regulatory protein
MDKVNHNIQIDIYEREWNIMGRKWNNIKEKKASKDANTSRIYAKFGREIYVAAKQGEPDP
ESNQALKVVLERAKTYSVPKNIIERAIEKAKGGAEENFDELRYEGFGPNGSMIIVDALTN
NVNRTAPEVRAAFGKNGGNMGVSGSVAYMFDATAVIGVDGKTADEALEILMEADVDVRDI
LEEDDSVIVYAEPDQFHAVQEAFKNAGVEEFTVAELTMLAQSEVTLPDEAKEQFEKLIDT
LEDLEDVQQVYHNVDLGE
>PK3-2_00226 hypothetical protein
MLIKKKVMMFFAVTLIFGGISFPFLTNSGGFKESTDRNTTYTDHSPHNVIIDQEKKALS
>PK3-2_00227 Response regulator aspartate phosphatase H
MTQAIPSSRVGVKINEWYKMIRQFSVPDAEVLKAEVEQDIQQMEEDQDLLIYYSLMCFRH
QLMLDYLEPGQTYGNRPTVTELLEMIETPQKKLTGLLKYYSLFFRGMYEFEQKEYVEAIG
YYREAEKELPFLSDEIEKAEFHFKVAEAYYHMKQTHVSMHHILQALDIYHQHPLYSIRTI
QSLFVIAGNYDDFKHYDRALPHLEAALELAMDIQNDRFTAISLLNIANSYDRSGNYQMAI
QYFQKAAKLSRETVADLLPKVLFGLSWTLCKAGQTQKAFQFVEEGLEHITTYPNAGPLKL
YQKLYSFLQAVYKESVDETRILEMLAYFEKKNLHAYIEACARSAAAVLESRCHFEHAAVF
YRKVLKAQEDILKGECLYAY
>PK3-2_00228 hypothetical protein
MSYKLGALLLSILFLLSACSDSGASEDKDQEKPTVKKASVTKLTEQEVKSALKNDIDSIF
NAFNKAGKENGWSTANKADFSKLRPDVLPYATGTFADRTLKDLAGEYYCECDAPFQPGTD
FDVRFTYEYDKNKIKASSIDPATELNNMGTSWTFELVKEDGDWKINKWDSKSLQGDDIKL
TKEEAKTILSRNGETAEFVKSYDSKAAGGTAYLFNVKNSNGERQAAISSKDTSLVSDVDN
ETEAAEQETAQPTAETASSDTADTQSSEQTTGSTKADYVAKLSATEKKEKHNDYQSDYQM
IEDHGYNYQMWDGLLNEIYGALQKQLSASDMAALKIEQRQWIKDRDAAAQKRYDEEGGGS
LSRVVQTEELAKQTKERCYKLVNAYMK
>PK3-2_00229 hypothetical protein
MLGLRFVKSEFRISNFRIDTLAFDAETKSFVIIEYKNTKNFSVVDQGYAYLAAMLNHKAD
FILEYNENHDFSLKRDDVDWSQSKVIFISPVFTVYQKQSIHFKDLPIELWEIKRYENDLV
HMNQMKAEGVSESIKTISRQSETIQEVSKEIKVFSEEDHLADKPFDIIELYQQLKEFIFN
LDDHISIKPTKLYIAFTSNKRNFTDILILKSGLKVWVNMKKGELHDPEERMRDVSETGHW
GNGDYEIFIKDDEHIEYIMGVIKQSYEKNK
>PK3-2_00230 hypothetical protein
MGKDFLIIKIKDIQKGDTLTNRACGNWDMKLSRAKECKRAIVVRSGVILNVYKIVDAWES
DEPAKITKTNNRVRFQLAECRDYSYLIGGTLKTKTQNPVSSLSLETLMELVK
>PK3-2_00231 Putative ribonuclease YeeF
MKVFEAKTLLSEATDRAKEYKELRTQMVNLRKALKSVADLSDSEFSGKGASNIKAFYHDH
VGVTDQWIDYIDMKIAFFNSIAGAAEDKGLSDAYIEESFLEHELANAHKKSKSIMSEQKK
AMKDILNDIDNILPLDLFSTETFKDELADANDKRKKTLEKLDALDEDLKTEYALSEPNEQ
FIKSDFQKLQEATGKGKNATPIHYNAKAYRESDIHKKKGDIDKRTEAYLKIKKEEAKERE
IEKLKERLKNYDYADADEFYSMAKTIGYENLTAEQQRYFTQIENTRELEAGFKGVAVGLY
DSGKDAVTGLWDMVTDPGGTVEAITGAVAHPIKTYEAISAAIEESYQKDMVNGDTYSRAR
WVSYAVGTVVTSVVGTKGVGAVSKTGTAAKVTTKVKTAASKSATAQKAITVSKQTVDHIK
QKVNTGIEVSKKHVKTKLKQIGDLTLADILPYHPRHDLVPAGVPYNTVNGVTLKEGLQKF
AKVILPKPYGTSSSGRRTPAPVVPPVTVKYGEHFARWSRKKVLKPNIVYKTKEGYTYTTD
NYGRITSVKADLQLGEAKRNQYAQTNAGKPQDRKPDDDGGHLIATQFKGSGQFDNIVPMN
SQINRSGGKWYEMEQEWAKALSKKPPKKVAIQIEPVYSGDSLRPSYFDVTYKIGSRKEIS
VSIKNQPGG
>PK3-2_00232 putative antitoxin YezG
METRKMQDLYQLIGEKLNDIIPGEWTKIYLYAEVLDDSTMVLFHFRTPENNQIIYSQDIP
SHYNVSKDIFKTLLRELREIFEELRTEHRNNNDDVWTNLTLTLDSSGEFQLDYNYDDILA
SELDGYERIAIWEYKNLGILPEDEDDKEFVISYLGL
>PK3-2_00233 hypothetical protein
MNILIINTINKLYNEANFSQDNYLSICKQPITLPEEIKSFVKSM
>PK3-2_00234 hypothetical protein
MDKLTKEELIFLVKELMNPTLDDEKVSEYLDLLEKNVPHPASSDLIFWSNEDYTAEQVVK
IALNYKDE
>PK3-2_00235 hypothetical protein
MVKNILKRYEEAKVFIQHSSEEQFEEGFSKIRNKLDTLTRAYLESANDYMNPMLREMHKT
EKLLKKYDETGQS
>PK3-2_00236 Response regulator aspartate phosphatase A
MRSLGTISSPHVGMKINEWNRHIQKFNVTDAEMLKAEIERDIDIMEEDQDLLIYYQLIAF
RHQLMIDYVIPSEGNQMELSEYLKRIEGSNRKMEKLVEYYYYFFQGMYEFKEGNFLSAIT
FYQKAENTIPYISDEIERAEFYFKMAEVFYHMKQTHVSMHYSSQAYNIYKTHDLYSVRRI
QCHFVIAGNYDDLESHEKALPHLEQALKGERLLESKNKRIYGQALFNIGNCYLKMGELTK
AAKYMEQSILQFKKSNFNNLTQAYHDLALIYFLQHKQEQAMDCFRKDVRFACKFDDALFK
IMFEGLQALFIKKGEASILLNVFNKLETSQGYPYMEELALLAAKFYTEIGQMDDSVICFK
KMVHARKQIQRGDCLYEI
>PK3-2_00237 hypothetical protein
MKFKLTLCAVIALIGVSFISSSLGNEVNVASRNMTSKAANDSTNSLADKAIFGITENGTL
G
>PK3-2_00238 hypothetical protein
MNNQLREIVNLLEKINSHGQTNILSVEEFEEQQDNLNDLSEIINDMDKLLKKSKRIDLNN
VQDADQLLFEIHKTMTSLEWHISEISDLTIKLFKKNNKV
>PK3-2_00239 23S rRNA (uracil-C(5))-methyltransferase RlmCD
MKMKPPVEKNEYYDVTFEDLTHDGAGVAKVQGFPIFVPNALPEEKAQIKVTRVKKGFAFG
RLIELKEESPHRTDAPCPIYKQCGGCQLQHMTYEGQLLFKQKQVKDVLERIGKLDLSNVT
VHPTLGMEDPWNYRNKAQVPVGEREGGLVAGFYQQRSHDIIDMSACLIQQSKNDEAVQAV
KDICANYGVRAYNEERHKGWLRHIMVRYGVVTGEMMIVFITRTNDFPHKAKIIEDITAQF
PHVKSIVQNINPNKTNVIFGNETNVIWGEEYIYDLIGDVKFAISARSFYQVNPEQTKVLY
DKALEYAELKGEETVIDAYCGIGTISLFLAKQAKKVYGVEIVPEAIEDAKRNAELNGITN
AEFAVGEAETVIPKWYEEGITADTLVVDPPRKGCDEALLRTIVEMKPKRVVYVSCNPGTL
ARDLRVLEDGGYQTLEVQPVDMFPHTNHVECVAVLELREGN
>PK3-2_00240 Diacylglycerol kinase
MKRARIIYNPTSGREIFKKHLAQVLQKFEQAGYETSTHATTCAGDATHAAKEAALREFDL
IIAAGGDGTINEVVNGLAPLDNRPTLGVIPVGTTNDFARALGIPREDILKAADTAINGVA
RPIDIGQVNGQYFINIAGGGRLTELTYDVPSKLKTMLGQLAYYLKGMEMLPSLRPTEVEI
EYDGKLFQGEIMLFLVTLTNSVGGFEKLAPDSSLNDGMFDLMILKKANLAEFIRVATMAL
RGEHINDQHIIYTKANRVKVNVSEKMQLNLDGEYGGMLPGEFVNLYRHIHVVMPKEKAEQ
LDD
>PK3-2_00241 Swarming motility protein SwrC
MNHVINFVLKNKFAVWLMTIIVTAAGLYAGMNMKQESIPDVNMPYLTISTTYPGATPSQV
ADEVTKPVEQAVQNLDGVSVVTSTSYENASSVMIEYDYEKDMDKAKTEAAEALENVSLPD
DAKDPEISRYSLNSFPILTLSVSSDKDNLQKLTKQVEDSLVPKLEGIEGVASVQVSGQQV
EEVEFSFKDDKLKEYGLDKDTVKQVIQGSDVTTPLGLYTFGNEEKSVVVSGDIETIKDLK
NMRIPTASASSAGGSAASQAAAQSAQAAAAAQAQQSASTDVPTVKLSDIATIKDVKKAES
VSRTNGKDSIGINVVKANDANTVEVADDVKAELKQFKEDHKGFDYSATLDMAEPITQSVE
TMLSKAIFGAIFAIVIILLFLRDIKSTLISVVSIPLSLLIALLVLQQLDITLNIMTLGAM
TVAIGRVVDDSIVVIENIYRRMRLKDEPLRGKALVREATKEMFKPIMSSTIVTIAVFLPL
ALVGGQIGELFIPFALTIVFALAASLLISITLVPMLAHSLFKKSLTGAPIKAKEHKPGRL
ANIYKKVLNWALSHKWITSIIAVLMLLGSLFLVPLIGASYLPSQEEKTIQLTYSPEPGET
KKEAEAEAEKAEKILLDRKHVDTVQYSLGSGSPLAGGDSNGALFYIKYESDTPDFDKEKD
NVLKKIQKQSDRGEWKSQDFSSSGNNNELTYYVYGDSENDIKATVKDIEKVMKDEKDLKN
VNSGLSSTYDEYTFVADQEKLSKFGLTASQISQALMTQTSQEPLTTVKKDGKELDVNIKT
EKDEYKSVKDLENKKITSATGQEVKIGDVAKVKEGSTSDTVSKRDGKVYADVTGEVTSDN
VTAVSAAVQKKIDKIDLPDNVSIDTGGVSADIADSFTKLGLAMLAAIAIVYLVLVITFGG
ALAPFAILFSLPFTVIGALVGLYVSGETISLNAMIGMLMLIGIVVTNAIVLIDRVIHKEA
DGLSTREALLEAGSTRLRPILMTAIATIGALIPLALGFEGGSQVISKGLGVTVIGGLISS
TLLTLLIVPIVYEVLAKFRKKKPGTEEE
>PK3-2_00242 hypothetical protein
MNEKKEKIIKTSIHLFAKKGFASTTIQEIASECGISKGAFYLHFKSKEALLLSACEYYIG
MSMQKMKNIEEDLAGKPPKEVLKKQIGAQFKDFRDHKDFIVLLLTENIIPENQEIKQYFY
KVTMETDKLYRNALLASYGEGIERYVADLSIMARGIVHSYMNVMVFNGELNIDADEISAF
LMERLDDLVQGLNRSSLNPMVPKDIFSPMPAGKDQLLEDIQKVKENSTLPEDITVSLDVI
GEELSQEKPRKPIIKGMLSNLTGITDEEVEKLRASISIFISI
>PK3-2_00243 Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit B
MNFETVIGLEVHVELKTKSKIFSSSPTPFGAEANTQTSVIDLGYPGVLPVLNKEAVEFAM
KAAMALNCEIATDTKFDRKNYFYPDNPKAYQISQFDKPIGENGWIEIEVGGKTKRIGITR
LHLEEDAGKLTHTGDGYSLVDFNRQGTPLVEIVSEPDIRTPEEAYAYLEKLKSIIQYTGV
SDCKMEEGSLRCDANISLRPIGQEEFGTKTELKNLNSFAFVQKGLEHEEKRQEQVLLSGG
VIQQETRRYDEATKKTILMRVKEGSDDYRYFPEPDLVELYIDDEWKERVKASIPELPDER
RKRYIEELGLPAYDAMVLTLTKEMADFFEETVQKGAEAKQASNWLMGEVSAYLNAEQKEL
ADVALTPEGLAGMIKLIEKGTISSKIAKKVFKELIEKGGDAEKIVKEKGLVQISDESVLL
KLVTEALDNNPQSIEDFKNGKDRAIGFLVGQIMKASKGQANPPMVNKILLEEIKKR
>PK3-2_00244 Glutamyl-tRNA(Gln) amidotransferase subunit A
MSLFDHKITELKQLIHKKEIKISDLVDESYKRIQAVDDKVQAFLALDEEKARAYAKELDE
AVDSRSEHGLLFGMPIGVKDNIVTKGLRTTCSSKILENFDPIYDATVVQRLQDAEAITIG
KLNMDEFAMGSSTENSAYKLTKNPWNLDTVPGGSSGGSAAAVAAGEVPFSLGSDTGGSIR
QPASFCGVVGLKPTYGRVSRYGLVAFASSLDQIGPITRTVEDNAFLLQAISGVDKMDSTS
ANVDVPDFLSSLTGDIKGLKIAVPKEYLGEGVGKEARESVLAALKVLEGLGATWEEVSLP
HSKYALATYYLLSSSEASANLARFDGIRYGYRTDNAENLIDLYKQTRSEGFGDEVKRRIM
LGTFALSSGYYDAYYKKAQKVRTLIKKDFEDVFEKYDVIVGPTTPTPAFKIGENTKDPLT
MYANDILTIPVNLAGVPGISVPCGLADGLPLGLQIIGKHFDESTVYRVAHAFEQATDHHK
AKPEL
>PK3-2_00245 Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit C
MSRISIEEVKHVAHLARLAITDEEAKMFTEQLDSIISFAEELNEVNTDNVEPTTHVLKMK
NVMREDEAGKGLPVEDVMKNAPDHKDGYIRVPSILD
>PK3-2_00246 Osmoregulated proline transporter OpuE
MSIEIIISLGIYFIAMLLIGWYAFKKTTDINDYMLGGRGLGPFVTALSAGAADMSGWMLM
GVPGAMFATGLSTLWLALGLTIGAYSNYLLLAPRLRAYTEAADDAITIPDFFDKRFQHSS
SLLKIVSALVIMIFFTLYTSSGMVSGGRLFESAFGADYKLGLLLTTAVVVLYTLFGGFLA
VSLTDFVQGAIMFAALVLVPIVAFTHVGGVAPTFHEIGAVNPHLLDIFKGASVISIISYL
AWGLGYYGQPHIIVRFMAIKNIKDLKPARRIGMSWMIISVLGSVMTGLVGVAYAHKFGVA
VKDPEMIFIIFSKILFHPLITGFLLSAILAAIMSSISSQLLVTASAVTEDLYRTFFRRKA
SDKELVMIGRLSVLVIAVIAVLLSLNPSSTILDLVGYAWAGFGSAFGPAILLSLYWKRMN
EWGALAAMIVGAATVLIWITTGLAKSTGVYEIIPGFILSMIAGIIVSMITKRPAKASYRL
FGVMEKLLRRKK
>PK3-2_00247 Protein SapB
MSWYIDPDILLKLGIATLIGMVIGLERELKNKPLGLKTCIVIAVSSCMLTIVSINAAYHF
PKYYRIMMDPLRLPAQIISGVGFIGAGVILRKSNDVISGLTTSAMIWGAAGLGLATGAGF
YKEAFASLLFILISVEFLPWVVRKIGPDRLQEKDIRIRMSLSDKDKMTEILKEMKRRDIK
THSVRIDDLGEKEFPIMEVKVRVHKNRYTTDVYYDIKDIEGVVGVKCDTL
>PK3-2_00248 Stress response kinase A
MHKDIKKIFHEDQVLAEAVKKYGFPKSQVRFLADAENYVYECMKDNQCYILKITHTIRRS
SDYMMGEMEWIRHLAQGGLSVAKPLPSLSGKDVEEVPDGNGGSFLLRVYEKAPGQKVGKS
DWNETLFSELGRYTGSMHSLTKSYKLSNPAFKRQEWDEEEQLKLRKYVPEDQTKVFLQAD
LLMNELRRLPKSRDSYGLVHADLHHGNFHWDQGKITAFDFDDIGYNWFVNDISILLYNVL
WYPVVPYEDKAAFTEEFMTHFMKGYWEENDLDPAWLKRIPDFLRLRHMLIYGLLHQMFDL
NAIGEEEKEMLAGFRRDIENGTPITAFDFSVLA
>PK3-2_00249 hypothetical protein
MKKTLVMAATAAVLMLSACSSGFGGEKEEEITQKTAKSSEKAIVPKYNISDSYYKMVLPF
KAGKARGLTTEQLNTRLDIDEFETGLMRLAQDSFSTDDYLFQEGQYLDEDTVLSWLARKK
TGSDLKKAQKEDKNFKNEGLNPALPSSGSTEEKNESSPVYLASMLEHDYLVRKDKNSIQL
GGVMIGLALNSVYYYREKTGDPQKEVEIKDSTLRQQGEKIAQEVINRLRKKDNLKNVPIT
VALYKQASKTSIVPGNFIAKTEVKAGSADISNWDDINEKYVFYPADTTTAEKHPDDTEVF
KRFKNSIEEYFPNYTGVVGTALYENDEMKKMKIDIPMQFYGKSEVVAFTQFLTGEVMDYY
SKGSVDVEVNITSSDGQEAVIIRNAGDKEPNVHIYD
>PK3-2_00250 DNA ligase
MDKETAKQRADELRRTINKYSYEYYTLDEPSVPDAEYDRLMQELIAIEEEHPDLRTPDSP
TQRVGGAVLEAFQKVTHGTPMLSLGNAFNADDLRDFDRRVRQAVGDDVAYNVELKIDGLA
VSLRYEDGYFARGATRGDGTTGEDITENLKTIRNIPLKMKRDLSIEVRGEAYMPKRSFET
LNEERIKNEEEPFANPRNAAAGSLRQLDPKIAAKRNLDIFVYSIAELDEMGVETQSQGLD
FLDEIGFKTNQERKKCGSIEEVIALIDEFQAKRADLPYEIDGIVIKVDSLDQQEELGFTA
KSPRWAIAYKFPAEEVVTKLLDIELNVGRTGVITPTAVLEPVKVAGTTVSRASLHNEDLI
REKDIRIFDKVVVKKAGDIIPEVVNVLVEQRTGEEKEFSMPTECPECGSELVRIEGEVAL
RCINPECPAQIREGLIHFVSRNAMNIDGLGERVITQLFEENLVRNVADLYKLTKEEVIHL
ERMGEKSTENLISSIQKSKENSLERLLFGLGIRFIGSKAAKTLAMHFESLENLKKASKEE
LLAIDEIGEKMADAVITYFHKEEMLELLDELQELGVNTLYKGPKKVKAEDSNSYFAGKTI
VLTGKLEQLSRNDAKAQIEALGGKLTGSVSKNTDLVIAGEAAGSKLTKAQELNIEVWNEE
QLMGELKK
>PK3-2_00251 ATP-dependent DNA helicase PcrA
MNYISNQLLSGLNPVQQEAVKTTDGPLLLMAGAGSGKTRVLTHRIAYLMAEKHVAPWNIL
AITFTNKAAREMKERVESILGPGADDIWISTFHSMCVRILRRDIDRIGINRNFSILDTAD
QLSVIKGILKERNLDPKKFDPRSILGTISSAKNELTEPEEFSKVAGGYYDQVVSDVYTDY
QKKLQKNQSLDFDDLIMTTIKLFDRVPEVLEFYQRKFQYIHVDEYQDTNRAQYMLVKQLA
ERFQNLCVVGDSDQSIYRWRGADIANILSFEKDYPNASVILLEQNYRSTKRILRAANEVI
KNNSNRKPKNLWTENDEGIKLSYYRGDNEFGEGQFVAGKIHQLHSTGKRKLSDIAILYRT
NAQSRVIEETLLKAGLNYNIVGGTKFYDRKEIKDILAYLRLVSNPDDDISFTRIVNVPKR
GVGATSLEKIASYAAMNGLSFFQAIQQVDFIGVSAKAANALDSFRQMIENLTNMQDYLSI
TELTEEILDKTEYREMLKAEKSIEAQSRLENIDEFLSVTKNFEQKSEDKTLVAFLTDLAL
IADIDQLDQKEEESGGKDAITLMTLHAAKGLEFPVVFLMGLEEGVFPHSRSLMEEAEMEE
ERRLAYVGITRAEQELYLTNAKMRTLFGRTNMNPESRFIAEIPDDLLENLNEKKETKAPS
ARKMQPRRGPVSRPVSYASKTGGDTLNWAVGDKAGHKKWGTGTVVSVKGEGEGTELDIAF
PSPVGVKRLLAAFAPIEKQ
>PK3-2_00252 Heptaprenylglyceryl phosphate synthase
MYDVTEWKHVFKLDPNKDLPDEQLEILCESGTDAVIIGGSDGVTEDNVLRMMSKVRRFLV
PCVLEVSAIEAIVPGFDLYFIPSVLNSKNADWIVGMHQKAMKEYGELMSMEEIVAEGYCI
ANPDCKAASLTEAEADLSIGDIVAYARVSELLHLPIFYLEYSGVLGDIEAVKKTKAVLET
STLFYGGGIKDAETAKQYAEHADVIVVGNAVYEDFDRALKTVAAVKGE
>PK3-2_00253 hypothetical protein
MTCGSNCAVGLPKEFLYFLPIRLLLFGKYSTVEMVT
>PK3-2_00254 hypothetical protein
MGTIIIALIAFIIGIIAIPVVLFVWIYIQDEKQQEHSILRNYPVIGRFRYILEKIGPELR
QYLYSNDNEEQPFSRKEYEQTVISGKYKSRMMGFGSVRDFDKPGYYIRNALFPKQKEELR
VNQTPKIETQIYTLDADNLFKRKEHAEHIKADPYYLHPDDVQVIGEHTCEQPFYVKGLVG
QSAMSYGSLGERAITALSKGLHQAGGTWMNTGEGGLSEYHLKGGADIICQIGPGLFGVRK
RNGEFSWEEFKRKSRLDQIKAFELKLAQGAKTRGGHVDGAKVSEEVADIRNVEPGKSIDS
PNRFHEFSSVPDMLDFIEKLRDVGQKPVGIKLVAGHPDELHELFSYMKKSGKHPDFITID
GSEGGTGASFFELADTVGLPIMTALPIVDTLLRQYGLRSHLKIFASGKLLTPDKIAIALA
LGADFVNIARGMMFSVGCIRALVCHTNTCPAGVATTDPKLQKALSVEEKQHRVCNYVISL
REGLFNLAAASGINSPVCFSKEHVVYRKEDGSIVDIDKLIHQYVS
>PK3-2_00255 hypothetical protein
MQIDKLRGKELDQLFNSILSLKDLEECYRFFDDLCTINEIQSLAQRLEVARMLREGNTYH
KIETETGASTATISRVKRCLNYGNDAYEMALDRVKATETESSSK
>PK3-2_00256 Putative lipoprotein YerB
MKKWMTVCVLCFVFFLLVSCQQKDAVPDSAKKPKAPLTGLEIEQKVTERRPVAVVVNNHP
KARPQSGLSKADIVIEALAEGQITRFLAIFQSQMPETVGPVRSAREYFVTLSNGFDSIFV
HHGWSPGAKEQLESGAADYMNGLDFDGSLFWRADFSKPPHNSYTSYDYIKKAAEQKGYEL
KGKTDPLLFQTSEAKPANESYNVRVDYGTKNVTNLVEYNYDKKAEAYTRSSDGVITTDRE
TGKPVAMQNIFIVEASHHIIDQDGRRDIDLESGGKGLLFQHGNVIETDWKQVNGRIVPVK
DGKWLPFVPGKTWINIVPDLDAASISKGEGV
>PK3-2_00257 Putative adenine deaminase YerA
MSERTFNWKNKDIRAQVDVVDSKLLPTLLLRNALVLNPYVKQWLKKNIWIYQDRIVYVGH
ELPNRAEEIHTIDCEGKYIVPGYIEPHAHPFQIYNPQTLAEYVSQYGTTTFVNDNLFLLL
QSGKKKALTILNELKKQPVQYFWWSRYDLQTEVLNEDHVLPFDVRKQWIEHPDVIQGGEM
TGWPRLVDGDDLMLHCMQATKKQRKRIEGHFPGASDKTLTKMKLFGADCDHEAMTGEEVM
RRLELGYYVSLRNSSIRPDVRKILQELHEKGFRYYDHFFYTTDGATPNFYKGGMTNELIR
IALEEGVPAIDAYNMASFNIAKYYQMDDYLGVVGPGRLASLNILEDPLDPNPVTVLSKGI
ILREDGCDLKAFTKTAWNKGGLVPLELSYDMTMDDLQFSMPMGVKMRNAVIMEPYMIEID
NSMEQLSFDHDESYLTMLDKHGKWRVNTMIKGFASSVQGFVSSFTTTGDIVAIGKNKADM
LLAFARMKEIGGGIVLAENGNILHEIPLALCGCASSEAYEDVLEKEQKLRNLLTERGYEF
CDPVYTLLFLQSTHLPYIRITPRGIFDVMKKTVLFPSIMR
>PK3-2_00258 hypothetical protein
MKPNISLINAVFRIACGLTIMSAASAKFTKKPWCKMHLFYIFMGAMKAGSGILRFCPVTY
MFQNSDLGNNEQEHQNR
>PK3-2_00259 L-methionine/branched-chain amino acid exporter YjeH
MLPELQRSITWIQGTALTIGAVLGCGILILPSVTADAAGPASLFIWVFMSFLSFLLVGTL
ARLVKIAPSAGGITAYVQLAFRKKAGAILGWIMLGSVPIGVPIIALTGAHYVSYVTKASD
WQITLIAGCMLAVSILLHMRGIQLSANISTLVICVIVFLLVTSVAVSLPHVKAAEFKPFL
PHGWSAAGSVSVMIFFSFVGWEMITPLAEEFTHPEKDVPLSLFLAAACVAGLYIMLSFVT
VGTHSYGENGEIASLAMLISKGAGENGVYVTVCLALFITFATIHANIAGFSRMVYALARE
GHIPVYFGKLSETKHTPIRVLTALAAVFGLVLASHGLFQIDLTTLLKGPSAAFIASYICT
MAAALKLLTWRDSGWWMALGACAACAVIYSFSGWALLYPVVLAAAGYLYIKKKLTHIS
>PK3-2_00260 HTH-type transcriptional regulator LrpC
MDDTDLQILSHLQRNGRLTMVELGKLVGLSSPSAAERVRKLEDKGVITGYSANICYEKLN
KHVTAFILMEPKSCKHYATFATAHPDVAENHRITGMYSYVTKVVTESVHTLEDFIDASMT
HGKPTTLVVLSSSAHRPAFL
>PK3-2_00261 Phosphoribosylamine--glycine ligase
MNVLIIGKGGREHTLAWKAAQSSLVENVFAAPGNDGMAASAQLVNIEESDHAGLVSFAKE
NQVGLTIVGPEVPLIEGLVDKFEKAGLRVFGPSKAAAIIEGSKQFAKDLMKKYDIPTAEY
DTFTSFEEAKAYVQEKGAPIVIKADGLAAGKGVTVAMTEEEAIACLHDFLEDEKFGDASA
SVVIEEFLSGEEFSLMAFVKGEKVYPMVIAQDHKRAFDGDKGPNTGGMGAYSPVPQISEE
TVRHAVETIVQPAAKAMVQEGRSFTGVLYAGLMLTENGSKVIEFNARFGDPETQVVVPRM
ESDLVQVLLDLLDDKEVDLRWKDTAAVSVVLASEGYPESYAKGTPIGSLAAETEQVVVFH
AGTKAEGGEFVTNGGRVANVTAFDETFEAARDRVYKAVDEIIKPGLFFRKDIGARALKAA
AQK
>PK3-2_00262 Bifunctional purine biosynthesis protein PurH
MTIKRALISVSDKTNLVPFVKELTELGVEVISTGGTKKLLQENSVDVIGISEVTGFPEIM
DGRLKTLHPNIHGGLLAVRGNEEHMAQINEHGIQPIDLVVVNLYPFKETISKEDVTYEEA
IENIDIGGPGMLRAASKNHQDVTVIVDPADYSPVLKQIKEEGGVSLQKKRELAAKVFRHT
AAYDALIADYLTDVVGEKEPEQFTVTFEKKQSLRYGENPHQEATFYQTALPVKGSIAQAE
QLHGKELSYNNIKDADAAVQIVREFTEPAAVAVKHMNPCGVGTGKTIAEAFDRAFEADKT
SIFGGIIALNREVDKATAEVLHNIFLEIVIAPSFSQEALDILTAKKNLRLLTLDVAAAVQ
KEKQLTSVQGGLLIQDLDMHGFDDAEISIPTKREPNEQEWEDLKLAWKVVKHVKSNAIVL
AKDNMTVGVGAGQMNRVGSAKIAIEQAGEKAKGSALGSDAYFPMPDTVEEAAKAGVTAII
QPGGSIRDEDSIKKADEYGIAMVFTGIRHFKH
>PK3-2_00263 Phosphoribosylglycinamide formyltransferase
MKKFAVFASGNGSNFEAIVTRLKEENWEASVSLLVCDKPQAKVIERAEAFHIPSFAFEPK
SYENKAAFERAIIEQLALHEVELIVLAGYMRLIGDTLLQAYGGKIINIHPSLLPAFPGID
AVGQAYRAGVKVAGITVHYVDEGMDTGPIIAQKAIEIDESDTLETIEQRIHMLEHKWYPS
VIKQLLGLNNRGEKA
>PK3-2_00264 Phosphoribosylformylglycinamidine cyclo-ligase
MSEAYKNAGVDIEAGYEAVKRMKKHVERTKRLGVMGSLGGFGGMFDLSELSYQKPVLISG
TDGVGTKLKLAFSMDKHDTIGVDAVAMCVNDVLAQGAEPLFFLDYLAVGKADPVKIEQIV
QGVADGCEQSGSALVGGETAEMPGLYTADEYDIAGFSVGVAEKDEIVTGEKIEEGHLLIG
LSSSGLHSNGFSLVRKVLLDDAELDLDKTYEPFERPLGEELLEPTRIYVKPVLAAVKSGK
VDGMAHVTGGGFIENIPRMLPAGLSAEIDHGSWPIPPIFSFLQEYGKLKEEDMFNVFNMG
IGFVLAVKEEHLTDVIGTLESNGEKAYLIGRVKQGEGVTFGGAALS
>PK3-2_00265 Amidophosphoribosyltransferase
MLAEIKGLNEECGVFGIWGHEEAPQITYYGLHSLQHRGQEGAGIVATDGEKLTAHKGQGL
ITEVFQNGELSKVKGKGAIGHVRYATAGGGGYENVQPLLFRSQNNGSLALAHNGNLVNAT
QLKQQLENQGSIFQTSSDTEVLAHLIKRSGHFTLKDQIKNSLSMLKGAYAFLIMTETEMI
VALDPNGLRPLSIGMMGDAYVVASETCAFDVVGATYLREVEPGEMLIINDEGMKSERFSM
NINRSICSMEYIYFSRPDSNIDGINVHSARKNLGKMLAQESAVEADVVTGVPDSSISAAI
GYAEATGIPYELGLIKNRYVGRTFIQPSQALREQGVRMKLSAVRGVVEGKRVVMVDDSIV
RGTTSRRIVTMLREAGATEVHVKISSPPIAHPCFYGIDTSTHEELIASSHSVEEIRQEIG
ADTLSFLSVDGLLKGIGRKYDDSNCGQCLACFTGKYPTEIYQDTVLPHVKEAVLTK
>PK3-2_00266 Phosphoribosylformylglycinamidine synthase subunit PurL
MSLLLEPSKEQIKEEKLYQQMGVSDDEFALIESILGRLPNYTEIGIFSVMWSEHCSYKNS
KPILRKFPTSGERVLQGPGEGAGIVDIGDNQAVVFKIESHNHPSALEPYQGAATGVGGII
RDVFSMGARPIAVLNSLRFGELTSPRVKYLFEEVVAGIAGYGNCIGIPTVGGEVQFDSSY
EGNPLVNAMCVGLINHEDIKKGQAKGVGNTVMYVGAKTGRDGIHGATFASEEMSDSSEEK
RSAVQVGDPFMEKLLLEACLEVIQCDALVGIQDMGAAGLTSSSAEMASKAGSGIEMNLDL
IPQRETGMTAYEMMLSESQERMLLVIERGREQEIIDIFDKYDLEAVSVGHVTDDKMLRLT
HKGEVVCELPVDALAEEAPVYHKPSQEPAYYREFLETDVPAPQIEDANETLKALLQQPTI
ASKEWVYDQYDYMVRTNTVVAPGSDAGVLRIRGTKKALAMTTDCNARYLYLDPEVGGKIA
VAEAARNIICSGAEPLAVTDNLNFGNPEKPEIFWQIEKAADGISEACNVLSTPVIGGNVS
LYNESNGTAIYPTPVIGMVGLIEDTAHITTQHFKQAGDLVYVIGETKPEFAGSELQKMTE
GRIYGKAPQINLDVELSRQRALLEAIKKGFVQSAHDVSEGGLGVAIAESVMTTENLGANV
TVAGEAALLFSESQSRFVVSVKKEHQAAFEAAVKDSVHIGEVTADGLLAIQNQDGQQLIH
AQTKELERAWKGAIPCLLKSKA
>PK3-2_00267 Phosphoribosylformylglycinamidine synthase subunit PurQ
MKFAVIVLPGSNCDIDMYHAVKDELGHEVEYVWHEETSLDGFDGVLIPGGFSYGDYLRCG
AIARFANIMPAVKQAAAEGKPVLGVCNGFQILQELGLLPGAMRRNKDLKFICRPVELIVQ
NDETLFTASYEKGQSITIPVAHGEGNFYCDDETLASLKENNQIAFTYGSNINGSVSDIAG
VVNEKGNVLGMMPHPERAVDELLGSADGLKLFQSIVKNWRETHVTTA
>PK3-2_00268 Phosphoribosylformylglycinamidine synthase subunit PurS
MYKVKVYVSLKESVLDPQGSAVQHALHSMTYNEVQDVRIGKYMELTIEKSDRDLDVLVKE
MCEKLLANTVIEDYRYEVEEVVAQ
>PK3-2_00269 Phosphoribosylaminoimidazole-succinocarboxamide synthase
MNIVKNELLYEGKAKKIYKTDDENTLYVVYKDSATAFNGEKKAEISGKGRLNNEISSLIF
KHLHTKGINNHFIERISETEQLIQKVTIVPLEVVVRNVVAGSMSKRLGIPEGTELEQPII
EFYYKDDALGDPLITEDHIWLLKAATPEQVETIKSITKTVNEELQSIFDDCHVRLIDFKL
EFGLDAEGQVLLADEISPDTCRLWDKETNEKLDKDLFRRNLGSLTDAYEEIFKRLGGIHH
V
>PK3-2_00270 Adenylosuccinate lyase
MIERYSRPEMSAIWTDENRFQAWLEVEILACEAWAELGVIPKEDVKVMRENASFDINRIL
EIEKDTRHDVVAFTRAVSESLGEERKWVHYGLTSTDVVDTALSYLLKQANDILLKDLERF
VDIIEEKAKEHKYTVMMGRTHGVHAEPTTFGLKLALWHEEMKRNLERFKQAKAGIEVGKI
SGAVGTYANIDPFVEQYVCEKLGLKAAPISTQTLQRDRHADYMATLALIATSIEKFAVEI
RGLQKSETREVEEFFAKGQKGSSAMPHKRNPIGSENMTGMARVIRGYMMTAYENVPLWHE
RDISHSSAERIILPDATIALNYMLNRFSNIVKNLTVFPENMKRNMDRTLGLIYSQRVLLA
LIDTGLTREEAYDTVQPKAMEAWEKQVPFRELVEAEEKITSRLSPEKIADCFDYNYHLKN
VDLIFERLGLA
>PK3-2_00271 N5-carboxyaminoimidazole ribonucleotide synthase
MISLSNQITYPGAVIGIIGGGQLGKMMAVSAKQMGYKVAVVDPVKDSPCGQVADIEITAH
YNDREAIRKLAEISDIITYEFENIDYDSLHWLKDHAYLPQGSELLLITQNRETEKKAIQA
AGCEVAPYSIVNTKDELKQAVQDLGLPAVLKTCRGGYDGKGQFVIKEETQMEQAAALLEH
GTCILESWVSFKMEMSVIVVRSVNGEVSTFPAAENIHHNNILFQSIVPARVEEGIQKKAA
ELAVKLAAELNLVGPLAVEMFLTEDGELLVNELAPRPHNSGHYTLDLCETSQFEQHIRAV
CGLPLGNTDLLKPGMMVNLLGDEVKLVEEEPELLKEAKLYIYGKHEIKKGRKMGHITFMK
QPEDHWIQEITNKWMNRDGGQAE
>PK3-2_00272 N5-carboxyaminoimidazole ribonucleotide mutase
MQPLVGIIMGSTSDWETMKNACDILDELNVPYEKKVVSAHRTPDLMFEYAETARERGIKV
IIAGAGGSAHLPGMTAAKTTLPVIGVPVQSKALNGLDSLLSIVQMPGGVPVATTAIGKAG
AVNAGLLAAQILSAFDEDIARKLDERRENTKQTVLESSDQLV
>PK3-2_00274 hypothetical protein
MAKPKKKKFEVTDQQTIDAVLQQMKEEGYLPVRRMEEPIFMEKKENGSIQIVPCGKKIVF
EGKLI
>PK3-2_00275 hypothetical protein
MMQTILSNGIAMVLIILIINIVYVSFFTIRMILTLKGQRYLAAGISTIEILVYVTGLSLV
LDNLDQIQNVIAYALGYGLGVIVGMKIEEKLALGYIMVNVITKELDLDLPKQLREKGYGV
TNWVAGGLEGDRTALQILTPRRYELQLYDTIKTLDSKAFIIAYEPKTIHGGFWVKAVKKR
RIKE
>PK3-2_00276 hypothetical protein
MADLLRRAINQKKQFLKTKLLLSEFYQGRGEQLADYTLSELEKEYKSLLKMKKEI
>PK3-2_00277 hypothetical protein
MTEERKETFEEEINQSERIDADEEPLSRMSRNASRQSKQKQKQKQKPHKERGESTAKEKL
ASVWAAINRYCGFAFSILKSPAKTVVADGFSHYKYGLISMLIFSMIFSIGNWFQLKASWN
RPLGFGERHHAFYDGFLVVLVYLLLFFTVMVFAVWAVSRYMMKQKVTFREAAAGLGSLLV
PVIAVSILWLIFAIVNVPMLTVLFTVLILFSIFFMMALYVQRLYQAAQDAPIDYIYCVLA
AVAVALLFAAVTWPFISEYFTASLIPL
>PK3-2_00278 Guanine/hypoxanthine permease PbuG
MKKYFQFDELGTSYRNEIIGGLTTFLSMAYILFVNPITLALESVKDFPEALRIDQGAVFT
ATALASAAGCILMGLIARYPIAIAPGMGLNAFFAFSVVLGMGISWQAALSGVFISGLIFV
ALSLTGFREKIINAIPPELKLAVGAGIGLFITFVGLQGSGIISANPSTLVTIGNIHSGPV
LLTIFGVIVTVILMVLRVNAGVFIGMLLTAVAGMIFGLVPVPTQIIGSVPSLAPTFGQAW
LHLPDIFSVQMLIVILTFLFVGFFDTAGTLVAVATQAGLMKENKLPRAGRALLADSSSIV
IGAVLGTSTTTSYVESSSGVAAGARSGFAAIVTGVLFLLATFFSPLLSVVTSNVTAPALI
IVGALMVAPLGKIAWDKFEVAVPAFLTMIMMPLTYSIATGIAIGFIFYPITMVCKGKAKE
VHPIMYGLFVVFILYFIFLK
>PK3-2_00280 GMP synthase [glutamine-hydrolyzing]
MTTMTKLVNEMILVLDFGSQYNQLITRRIREFGVYSELHPHTLTAEEIKEMNPKGIILSG
GPNSVYDENSFRCDEKIFELDIPVLGICYGMQLMTHYLGGKVEAASQREYGKANIRIEGT
PDLFKDLPNEQVVWMSHGDLVVEVPEGFTVDATSHHCPNSAMSKADKKWYGVQFHPEVRH
SEYGNDLLKNFVFGVCDCEGKWSMENFIEIEMQKIRETVGDKQVLCALSGGVDSSVVAVL
IHKAIGDQLTCIFVDHGLLRKGEAEGVMKTFSEGFNMNVIKVDAQDRFLNKLKGVSDPEQ
KRKIIGNEFIYVFDDEADKLKGIDYLAQGTLYTDIIESGTATAQTIKSHHNVGGLPEDMQ
FELIEPLNTLFKDEVRALGTELGIPDDIVWRQPFPGPGLGIRVLGEVTEEKLEIVRESDA
ILREEVANHGLERDIWQYFTVLPDIRSVGVMGDARTYDYTIGIRAVTSIDGMTSDWARIP
WDVLEVISTRIVNEVKHINRVVYDITSKPPATIEWE
>PK3-2_00281 hypothetical protein
MPHDDQKGSRLSLLLFYFLAFLLLWEWLRPLDSFTNTKHTGFFIVFIGLTFLLTFFRMKW
FVTVPFCVIFTLISIHILFYQGSIFDLSWISSFLKDIYLNITLIQSGQWNDMIPSFRTLL
FFVLLWLLVYLLHYWVIYQRRILFFFMMTVAYITILDTFTPYDATFAVIRIVLIGFFMLG
LLYLERIKLMEKIALPKTSILKWFLPLSVFILAAVGFGLAAPKSDPAWPDPVPFLKKITN
QDRVPAGESKIGYGNHDESLGGPFQQDDTPVFTWQGKERTYFRVETKDTYTGKGWIETDT
GMSYQLSGGKVENLWFDHKVATERSTVRVKVDEHYGYNHVMYPIGTAAIQSKQAVSLEMN
GNTEQISPISEQAGEIRNMGSYTVTYKSPVYKLDELRKVKVRNSSEEYTFSDRYMQLPDS
LPERVRTLAIKLTQDHDNMFDKVKAVEDYLGSNAFTYETENVTIPKDDEDYVDQFLFETK
MGYCDNFSSAMVVLLRSAGIPARWVKGYTSGEYKEAGNKNGSIYEVTNNNAHSWVEVYFP
EQGWVTFEPTKGFTNPAEFTSSDTKDSGSENSSSSKKTKEEQKEEKKQPGKEEKQKEKQE
SAVSKKPSASHTNAGTGWYLAFAVLAVLMVAAVLLYVFRSLWIPVFVVRKLKRRSDQHVF
FEAYDALLKQLKRRGLPKRDSETLRDYAKRIDGKYYSKDMSKLTLRYERTLYRNEDSASL
WNDSRELWENLIKRRWS
>PK3-2_00282 hypothetical protein
MNKKWQWFVYGWKLIVLTLLTAAVFSYAMFQGGFVSWFLFYAFLPFVVYAGLLALYPLRS
FQASRQMVKTQLRAGDRLGVSITLKRKLPFPLMYMVIEDCLPEGIESLNRDEAAAKRLVF
PWFKRSMTMSYELARVPRGEHRFHAVRVRTGDVLGLIEKTAFYELEDTLFVYPFFERLPY
QVNERHQEDGVSGSSPIHQHHSSVAASVRNYQPGDRFAALDWKTSARRSQLMTKEFEPSR
SKNLFLLMDRFSSEAFEEVVSVTASILHSALKNGAGAGLASVGKEKTIFPIQEGEQHFQH
MLRHLAVAHCDAAAPVSRYVREELGKPSVRQADKVIVTGLITEDLLNIAETGSGRATVIL
AKEKDAELFQAENVLIERMMKRQIRVQVIRGGQVSRVV
>PK3-2_00283 hypothetical protein
MAYQEDLHPLLGKAVEHINRVMVGKRDIAILSLAAILAKGHVLLEDVPGVGKTMMVRALA
KTIGADFKRIQFTPDLLPSDVTGVSIYNAKTMEFEYRPGPIMGNIVLADEINRTSPKTQS
ALLEAMEEGSVTVDGHTMPLSAPFFVMATQNPVEYEGTYPLPEAQLDRFLFKLRMGYPSF
HEELDVLTLQEKNHPIETLEPVIAKEDFILLQREVQNVRADDSIKEYIVEIVQKTRQHAS
VQLGVSPRGSIALMKAAQAYALLHDRDYVIPDDIQYLAPFTLPHRMLLRPEARFEGIEAE
TIIREIMSAVKVPVQRSSVR
>PK3-2_00284 Manganese efflux system protein MneS
MERYDELKKGESGALVSIAAYLVLSAMKLIIGYMFHSEALTADGLNNTTDIIVSVAVLIG
LRISQKPPDEDHLYGHFRAETIASLIASFIMMVVGLQVLFSAGESIFSAKQETPDMIAAW
TAAGGAAVMLAVYQYNKRLAKKVKSQALLAAAADNKSDAFVSIGTFIGIVAAQFHLAWID
TVTAFVIGLLICKTAWDIFKESSHSLTDGFDVKDISAYKQTIERISGVSRLKDIKARYLG
STVYVDVVVEVSADLNITESHDIANEIERRMKEEHAIDYSHVHMEPLERK
>PK3-2_00285 GABA permease
MNQSQSGLKRELKTRHMTMISIAGVIGAGLFVGSGSVIHSTGPGAIVSYALAGLLVIFIM
RMLGEMSAVNPTSGSFSQYAHDAIGPWAGFTIGWLYWFFWVIVIAIEAIAGAGIIQYWFH
DIPLWLTSLILTIVLTLTNVYSVKSFGEFEYWFSLIKVVTIIAFLIVGFAFIFGFAPGSE
PVGLSNITGKGGFFPEGISSVLLGIVVVIFSFMGTEIVAIAAGETANPIESVTKATRSVV
WRIIVFYVGSIAVVVALLPWNSANILESPFVAVLEHVGVPAAAQIMNFIVLTAVLSCLNS
GLYTTSRMLYSLAERNEAPRRFMKLSKKGVPVQAIVAGTFFSYIAVVMNYFSPDTVFLFL
VNSSGAIALLVYLVIAVSQLRMRKKLEKTNPEALKIKMWLFPFLTYLTIIAICGILVSMA
FISSMRDELLLTGVITGIVLISYLVFRKRKESEKAAAKPVTQQQPDILP
>PK3-2_00286 Spore coat protein A
MTLEKFADALPIPDTLKPVQQSKEKTYYEVTMEECTHQLHRDLPPTRLWGYNGLFPGPTI
EVKRNENVYVKWMNNLPSTHFLPIDHTIHHSDSQHEEPEVKTVVHLHGGVTPDDSDGYPE
AWFSKDFEQTGPYFKREVYHYPNQQRGAILWYHDHAMALTRLNVYAGLVGAYIIHDPKEK
RLKLPSGEYDVPLLITDRTINEDGSLFYPSGPENPSPSLPNPSIVPAFCGETILVNGKVW
PYLEVEPRKYRFRIINASNTRTYNLSLDNGGEFIQIGSDGGLLPRSVKLTSFSLAPAERY
DIIIDFTAYEGQSIILANSAGCGGDVNPETDANIMQFRVTKPLAQKDESRKPKYLASYPS
VQNERIQNIRTLKLAGTQDEYGRPVLLLNNKRWHDPVTEAPKAGTTEIWSIINPTRGTHP
IHLHLVSFRVIDRRPFDIAHYQESGALSYTGPAVPPPPSEKGWKDTIQAHAGEVLRIAAT
FGPYSGRYVWHCHILEHEDYDMMRPMDITDPHK
>PK3-2_00287 hypothetical protein
MLTNDLNEKTRQYISIYAELKSKLKWKVAHDQILMLISSAYIVNKREFDFQRFYDLSSYI
KSNIGSFSTLNSHHRFTVASILDIHFQQEAKQAFLTFIDRYNEMVRLGYKRNIFTYLSAL
ILLTGKSETANHREQMNMALAVYQQMKKNHYFLTSTQNIPLAVLLAENGQGLQALNKAEA
CYHQLAAGGFRKGHHLHQTSHILALHTEKDAETLVLQCRKLFQTITESHKKPKDVHYPDL
ALLTFLEEPDIKTVLAITHELNQEKRFKWQKEMNFKIAVSLYLSEHMEKNLLMESGLYTA
IETAIQAQQAAATAVIVSSTAASHSHDGN
>PK3-2_00288 AB hydrolase superfamily protein YdjP
MPYITLEDQTRLYYETHGSGTPILFIHGVLMSGQFFHKQFSALSANYQCIRLDLRGHGES
DKVLHGHTISQYARDVSEFLKAMELDRAVLAGWSMGAFVVWDYLNQFGNDNIQAAVIIDQ
SASDYQWEGWEHGPFDFEGLKTAMHAIQTDPLPFYKNFIHNMFAEPPAETETEWMLAEIL
KQPAAISSTILFNQTAVDYRGTLQNINVPTLLCFGEDRKFFSTAAGEHLRSNIPSSTLVT
FSKSSHCPFLEEPDAFNSTLLTFLGMIGKP
>PK3-2_00289 hypothetical protein
MSYYNKRNQEPLPKEDVSTWECTKEDCNGWTRKNFASSDTPLCPLCGSKMVDGIRSLVNL
QNNSQTKTS
>PK3-2_00290 hypothetical protein
MITNQQQKDLKKRAQFKKLNLAINSYVELLFLSIPLIHFFKWLGSLALHLVH
>PK3-2_00291 IS3 family transposase ISBsu1
MKKRKKNGQPYAVVDNILDRNFQSDRPLEKLVTDITYLPYGQKQLYLSSILDLYNGEVIA
FTIGDKQDTDFVLDTLNQLPMLSENCVLHSDQGSVYTSYEYQKAVNTKGITMSMSRKGTP
ADNASIESFHSSLKSETFYLNSIDRTTTAIVERTVIEYIHYYNNIRIQTKLNNQSPINYR
QLAV
>PK3-2_00293 hypothetical protein
MGTRVSYPVEVKQKAVEMRLAGVPMKEIMQKLNIKNKTQVQTWVRWHKAGETHRFEQPVG
KQYTYGKGPEYSSELEKLQAEIRYLRQQNEVLKKYNELERKLIAKRQSNL
>PK3-2_00294 hypothetical protein
MKKRIVLLLIVVIAAAAAGFAFYAAKDKGQESAADVSVHTESGDKLLVSITNTDLLTKYY
ENDKVIHQEKLTSYPAFALDQKQQALYYTGNNDQNEMRLFKLDLKSNKKTMLYKGAESAD
SLFLSKDRSTIYFRLGKADESNFRIAAFDLKTKKYKNLYPAAKDQDDSVSSFFYNKKTDS
FALLHYSVEEDYKKTDEANEKGIDPEPTTIHFSAGHQSKFDELKSLDKFISDIAVSDDDK
RILFTSYTQKGTEQTASIQMLNADTKKYETIISNQKTFKLLMDAQPQFSKDGKNIYFLAE
AEGAKKLKDETGREAKVRTIYSYNLENKTFKKVWENPNGIINSFSVIN
>PK3-2_00295 putative protein YdjM
MLKKVILAAFILVGSTLGAFSFSSDASAKHVNGNITWYNGVGKKGSSGKKLGHWDCATKI
GFDVPKNGTKIRAYAKAKPKKVITVYKNDVGRMPHAVLDVSPKAFKALGYPLSRGKVAGH
YSY
>PK3-2_00296 Sorbitol dehydrogenase
MKAARWHNQKDIRIENIEEPKTEPGKVKIKVKWCGICGSDLHEYLGGPIFIPVDKPHPLT
NETAPVTMGHEFSGEVVEVGEGVKNYKAGDRVVVEPIFATHGHQGAYNLDEQMGFLGLAG
GGGGFSEYVSVDEELLFKLPDELSYEQGALVEPSAVALYAVRSSKLKAGDKAAVFGCGPI
GLLVIEALKAAGATDIYAVELSPERQQKAEELGAIIVDPSKTDDVVAEIAERTGGGVDVA
FEVTGVPVVLRQAIQSTTIAGETVIVSIWEKGAEIHPNDIVIKERTVKGIIGYRDIFPAV
LSLMKEGYFSADKLVTKKIVLDDLIEEGFGSLIKEKNQVKILVRPN
>PK3-2_00297 Major myo-inositol transporter IolT
MNKQGNQMSFLRTIILVSTFGGLLFGYDTGVLNGALPYMGEPDQLNLNAFTEGLVTSSLL
FGAALGAVFGGRMSDFNGRRKNILFLAVIFFISTIGCTFAPNVTIMIISRFVLGIAVGGA
SVTVPAYLAEMAPVESRGRMVTQNELMIVSGQLLAFVFNAILGTTMGDSSHVWRYMLVIA
SLPAVFLFFGMIRMPESPRWLVSKGRKEDALRVLKKIRDDKQAASELQEIEFAFKKEDKL
EKATFKDLSVPWVRRIVFIGLGIAIVQQITGVNSIMYYGTEILRDSGFQTEAALIGNIAN
GVISVLATFVGIWLLGKVGRRPMLMTGLIGTTTALLLIGIFSHVLEGSPALPYVVLSLTV
TFLAFQQGAISPVTWLMLSEIFPLRLRGLGMGVTVFCLWMVNFAVSFTFPILLAAIGLST
TFFIFVGLGICSVLFVKKFLPETKGLSLEQLEENFRAYDRGEAKKESGAEVIG
>PK3-2_00298 hypothetical protein
MNEIYIIAGLLLLTAGMVDFLWTTLWLESGAGPITRCLSAWLWKGCRKISGDHAKVLSTA
GPLLLCLTLVIWISLFWSGWVCIFSSDPHSLVETQTKEPASWSDRIYFSGYVMFTLGNGD
LSPNGDLWRLVTVIETAQGLLTITFSVTYLISVLSAVNQKRSFAQSVLSLGHDGTGIVQT
AWNGKDFHDIDFLLIAFSSELGKLTAQHNAFPILHFYHSTQREESSVIAVTVLDEALTIL
KYGIPVQYQPNQLHIKEARTSIKNYLDTVHTAYIHPAEQAPPEPDISKLQQSGIPAFSKQ
TFQTAINSIKERRQLLLGIVQAGARKWPVQDSAE
>PK3-2_00299 hypothetical protein
MSFFRNQLANVIEWEEFRDDMIFYKWNNREIKKGSRLIIRPGQDAVFLSNGRVEGIFQDD
GDYDIESEIIPFLSTLKGFKFGFNSGMRAEVLFVNTKEFTVRWGTKQAINIPAAGMPGGM
PIRANGTFNVKVQDYISLIDKIAGVKDQYFVEDIKIRITSILDQLLMKWITREGKDMFNL
QANAFDIAKGIQEDLDMQLIGDGLTVTGFQIMSFNYPQEVQDMITKNASYGMVGDVNRYQ
QISMTDGMASGKMSGGGAASDMAGMMMGMNMANQMMNQMNQNQQAQSSGSQSSGGGSKPN
FCPNCGTKTGEANFCPNCGQKLV
>PK3-2_00300 hypothetical protein
MRGFFGKAILVVLAVFIIMPVLGIESARASESQQHVYDHAHLLSKAEIEKLESLSAELGA
KRDTDFIIITTKSTNGEDIADYAGDFYDRYGKGSTAILTIDMANREVFIAGYKKAEKYLD
NSRLNSIRNTISSDLSNEDYFKAFKTYIQLSYKDMGIIPGINPDNIFFTWWFQLIAAIAA
GGIAVTIMLYQSGGKVTVNGNTYMDQRTSDVIDQYDTYIRTTVTRERKPSNDKDSGDGGV
TKGGTSYSGSRGNF
>PK3-2_00301 hypothetical protein
MIISYKCPNCGSDMAFDSESGSLSCGSCGRQDNIESLPKENIAARFSDDEAKEYQCENCG
AVLITEAETTATTCSFCGGAAILADRLSGHLAPAKVIPFTISKQEAEQAFRKWCKKGLLT
PRGFMSADRIKSITGMYIPFWMFDLNSEVQVRANCTRVHQYEEGDYICTETEHFEAFRDI
NLDYLKIPVDASEKMKDELMDKLEPYSYEELKDFQTAYLAGYIAEKYNYTDEELFPRAKE
KISSYIDSYIHSTFSGYTSVNVRDKHIHTKNVNSFYVLLPVWMVSYDYERAEHIFAMNGQ
TGKVVGKPPISRGKVAAWFSGIAGGTFLALKLVSLMMGGGF
>PK3-2_00302 Phage shock protein A 
MSIIARFKDIMSANINALLDKAENPEKMVDQYLRNMNSDLSKVKAETAAVMAEEQRTKRE
CHECQTDMEKMESYAMKALQAGNEGDARKFLERKTSLESKLSELQTANQIAAANAAQMRK
MHDKLVSDIGELEARKNMIKAKWAVAKTQERMNKLGASVSSTSQSMSAFGRMENKVNQAL
DQANAMAELNSAPQDDIADLTAKYDTAGSSQVDDELAALKAKMMLDK
>PK3-2_00303 Fructokinase
MRSHSVVCIGELLIDFFCTDVDVDLMEGRNFLKSAGGAPANVSAAIAKLGGHASFSGKVG
KDPFGYFLKQTLDAVHVDTSMLVMDEKAPTTLAFVSLKQNGERDFVFNRGADALFTLEDI
DQDKLNEAKILHFGSATALLSEPFCSTYLRLMSIAKDNGQFISFDPNYREDLWKGRVSEF
VSVAKKAIALSDFVKVSDEELEIISGVKDQEKGVAILHEMGAKIVAVTLGKSGTLLSNGK
EKEIIPSIPVTSIDSTGAGDAFVGAALYQLANMDQIQSVDADFAKLREMVSFANKVGALV
CTKIGAIDALPSMKEIEVSL
>PK3-2_00304 Isoprimeverose transporter
MIETEKATALKAKHHGLSWFERIGYGFGDMSYNIVFQFVNAYLLFYYTDVGGIQPAVIAT
LFLVVRVLDAIFDPIMGLILDKTDTRWGKARPYLLWVAFPFALFTFLCFTTPHFGETGNM
VYAYITYILLGMSFSMQTIPVNSLTGRMTNSVEERTVLTTTRMILVYIGILLSISCATPL
AAAIGGEDQAFGFQMTALIYAAVSIVLNLFSFFTVRERIQPKKRKKQGIKKTLSVLLRNK
PLLMLTSSFLSFAIGFNIKLSTMVYYFTYNVNHKEFVFLGTVLFFRAALISNLFIPFFSE
KWGRKQVMIITAALSLISYAGLHFTPYSSITLIFIWLFASGFFTTPLNTLAWGMVADCVD
YAEWKTGVRADGVVISSMSFINKLGVALAGSFSAIYLGIAGYVANADQTVTSLNAIKNMN
ALIPGLFILLSIILIAFYPLTEKRYKRIISELEQRSVR
>PK3-2_00305 L-threonine 3-dehydrogenase
MTHTVPQSMKAAVMHNTREIKIETLPVPDINHDEVLIKVMAVGICGSDLHYYTNGRIGNY
VVEKPFILGHECAGEIAAVGSSVDQFKLGDRVAVEPGVTCGRCEACKEGRYNLCPDVQFL
ATPPVDGAFVQYIKMRHDFVFLIPDSLSYEDAALIEPFSVGIHAAARTKLQPGSTIAIMG
MGPVGLMAVAAAKAFGAGTIIVTDLEPLRLEAAKKWERPMSSISMNRTRLKRLRRLRMKE
ALMLLGKQRGIQRHCNLHWLLCAGAGNWRLSVCLHRTRFRSMCRLLRIMRLIFTGSSVMP
IRIQRELNFSLPALWTQSIL
>PK3-2_00306 hypothetical protein
MAELENQKQFAQLLAPGVKSLKLHPDYKIIRKKNEKTGQSYIDKIALQLGVSSNTIKSWI
GQMGENYIPGRIDDGKLFGVIWIILNKTDFDIEWLTDLLETTTIPVIKPALPVWAASCLK
KAKTLRKDRSFGTPSEDEIEKAIKRLFHDRLSHETNALTEQPSTHNLPSRWSGHFIGRSF
DMEAIRQWMLSPSPVCLITGWAGMGKTTIALEAAYSCVDDTSDWPAFNSIIWVSADWKGL
SFSDFLNTIAYQLGRTEQIDKSINEKRFVVRNALANYTREKSILLIVDSIDTAERDIHEF
ITSLPQGVKVLLTARENVKQTYRESFGEMAAIQLSGLDQTDALEFFQRELHRCLQTCNLP
QKREKLEQLLHLSSDLKNEFILATAGNPKAMALSIAYMSDDDIPAQQLIHELGKAGYSLL
ELFEFLFGRTWDRCNEDTQKLWQVLCFFSKPPDDKSLAAAAGLDARRFHYAMEQMRSYAL
IQPERSEGRTQYLAHQTVVAYGEQHLSEQHEYEKEARIRWAHYYIDYAETHLKREQPNSI
YWSYLLGRNLDQMKREWPNILKVIIWASETGQKEILIELITRTSHFLSRINLPLRIEYGR
KAADAAHQLGQHTREAYFRIDTAGWALMEVNDLDGALQQIEAGSRILEQSDTHDALDLKV
WGHALKARLFLKAGQQEKAKTILNKIEDQPISPTIQHRVLLVRGDLSFARGHDEEAIQLY
ETANEISSTYGGEKTIEAYFNLGVAYVKRGQFEKAEEAFEQMLYDKHNANQVELIYYYYG
MAQLLYRKGEKTKAMEANQKAIRLIDSWEPAIGIRGEVERLARVTKENE
>PK3-2_00307 hypothetical protein
MHFSGIIDRLALYDLHRKRSKDKHFSSAFTANADDREEFYSANIADVSIDLNESKKNYRV
GTFSYESLIQSGNPVNDTLKGEVFLNENDIDPPNVIFVHGWRMDSFDRVKKIFFNRIMND
LGWNMYYYSLPYHFEREPENSLYSGELMISANIDRTIESTRQAIVDLRAFIHWIKANKKG
PVIIVGVSLGGWVTNLIATLESKIDVVVSIFYANRLSYSIWNTIPGKYIREELEQNGVTY
EDLIKYWNITDPCQALPKVNKDNILLISAKHDQFIDLKDADYLWESWGRPTRYVYNCGHS
GIVLCRKKLANDTLSFIREKLV
>PK3-2_00308 60 kDa chaperonin
MAKDIKFSEEARRAMLRGVDALADAVKVTLGPKGRNVVLEKKFGSPLITNDGVTIAKEIE
LEDAFENMGAKLVAEVASKTNDVAGDGTTTATVLAQAMIREGLKNVTAGANPVGVRKGME
QAVAVAIENLKEISKPIEGKESIAQVAAISAADEEVGSLIAEAMERVGNDGVITIEESKG
FTTELEVVEGMQFDRGYASPYMVTDSDKMEAVLDNPYILITDKKITNIQEILPVLEQVVQ
QGKPLLLIAEDVEGEALATLVVNKLRGTFNAVAVKAPGFGDRRKAMLEDIAVLTGGEVIT
EDLGLDLKSTQITQLGRASKVVVTKENTTIVEGAGETDKISARVTQIRAQVEETTSEFDR
EKLQERLAKLAGGVAVIKVGAATETELKERKLRIEDALNSTRAAVEEGIVSGGGTALVNV
YNKVAAVEAEGDAQTGINIVLRALEEPIRQIAHNAGLEGSVIVERLKNEEIGVGFNAATG
EWVNMIEKGIVDPTKVTRSALQNAASVAAMFLTTEAVVADKPEENAGGAGMPDMGGMGGM
GGMM
>PK3-2_00309 10 kDa chaperonin
MLKPLGDRVVIELVESEEKTASGIVLPDSAKEKPQEGKIVAAGSGRVLESGERVALEVKE
GDRIIFSKYAGTEVKYEGTEYLILRESDILAVIG
>PK3-2_00310 Membrane-embedded CAAX protease MroQ
MRKQYWFIILTYILMQFSSIIAIPLLFKFGYGGGQPTTENLLHAQGLWSVISFIACLVVI
LLILRTVPKETLRNGQKDSVGLSILWAIAGFFIALFSQGIAGSIEYYVFGIGRESENTQA
ILKVIQAVPFMIVVSSVIGPILEEIIFRKIIFGTLYEKTNFFFAGLISSIIFGIVHADLK
HLLLYTAMGFTFAFLYARTKRIWVPIFAHLMMNTFVVIMQLEPVQKYLEQQSAQMQLIIG
GLFL
>PK3-2_00311 hypothetical protein
MRNPVVWGMIYFAVGCIFTYLAASSPGSMWSFYSILLMVFAAYNISISFKMFAFSFKIKK
NQK
>PK3-2_00312 Sec-independent protein translocase protein TatCy
MKVNQMSLLEHIAELRKRLLIVALAFVVFFIAGFFLAKPIIVYLQETDEAKQLTLNAFNL
TDPLYVFMQFAFIIGIVLTSPVILYQLWAFVSPGLYEKERKVTLSYIPISILLFLAGLSF
SYYILFPFVVDFMKRISQDLNVNQVIGINEYFHFLLQLTIPFGLLFQMPVILMFLTRLGI
VTPMFLAKIRKYAYFTLLVIAALITPPELLSHMMVTVPLLILYEISILISKAAYRKARKS
SAADQDVSSGQ
>PK3-2_00313 Sec-independent protein translocase protein TatAy
MPIGPGSLAVIAIVALIIFGPKKLPELGKAAGDTLREFKNATKGLTSDEEEKKKEDQ
>PK3-2_00314 Redox-sensing transcriptional repressor Rex
MNKDQSKIPQATAKRLPLYYRFLKNLHASGKQRVSSAELSDAVKVDSATIRRDFSYFGAL
GKKGYGYNVDYLLSFFRKTLDQDEMTDVILIGVGNLGTAFLHYNFTKNNNTKISMAFDIN
ESKIGTEVGGVPVYNLDDLEQHVKDESVAILTVPAVAAQSITDRLVALGVKGILNFTPAR
LNVPEHIRIHHIDLAVELQSLVYFLKHYSVLEEIE
>PK3-2_00315 Cyclic pyranopterin monophosphate synthase
MNGFSHFNEQGRAQMVDISEKSSTVRTAAAVSSVHMKNEVYEKIQSHDIGKGDVLAVAQV
AGIMAAKQTSNIIPMCHPLSLSGVDISFGWKIKETEVILHIKAQVKTKGSTGVEMEALTS
ASVCALTVYDMCKALDKGMVIGPTFLLEKTGGKNGDFKRELSEYNLEDQK
>PK3-2_00316 putative ABC transporter ATP-binding protein YbiT
MMILQINQLSKSFGADTILNNIKLEVRNRDRVAIVGRNGAGKSTLLKIIAGQLSYEKGEI
IKPKDITMGYLAQHTGLDSKLTIKEELLTVFDHLKAMEKEMRTMEEKMAAADSSELESIM
KTYDRLQQEFRDQGGYQYEADVRSVLHGLGFSHFDDSTQVQSLSGGQKTRLALGKLLLTQ
PDLLILDEPTNHLDIDTLTWLEHYLQGYSGAILIVSHDRYFLDKVVNQVYEVSRAESKKY
HGNYSAYLDQKAAQYEKDIKMYEKQQDEIAKLQDFVDRNLARASTTKRAQSRRKQLERME
VMSKPLGDEKSANFHFDITKQSGNEVLRVQDLTISYENQPPLLTEVSFMLTRGESAALVG
PNGIGKSTLLKTLMDALKPDQGTISYGSNVSVGYYDQEQAELTSSKRVLDELWDEYPGLP
EKEIRTCLGNFLFSGDDVLKPVHSLSGGEKARLALAKLMLQKANFLILDEPTNHLDLDSK
EVLENALIDYPGTLLFVSHDRYFINRIATRVLELSPNHIEEYLGDYDYYTEKKTEQLELE
KMNQQEETEKTPAAVKSDSKRSYEEEKEWKKKERQRLRRIEEIEAAVQTIEENISHNDEL
LCDPEVYQDHEKVQAIHADNEKLNQELESLLSEWEELSTEEA
>PK3-2_00317 tRNA N6-adenosine threonylcarbamoyltransferase
MSEQKDIYVLGIETSCDETAAAIVKNGKEIISNVVASQIESHKRFGGVVPEIASRHHVEQ
ITLVIEEAFRKAGMTYSDIDAIAVTEGPGLVGALLIGVNAAKALSFAHNIPLVGVHHIAG
HIYANRLVEEIVFPALALVVSGGHTELVYMKEHGSFEVIGETLDDAAGEAYDKVARTMGL
PYPGGPQIDKLAEKGNDNIPLPRAWLEEGSYNFSFSGLKSAVINTLHNASQKGQEIAPED
LSASFQNSVIDVLVTKTARAAKEYGVKQVLLAGGVAANRGLRAALQKEFAQNEGVTLVIP
PLALCTDNAAMIAAAGTIAFEKGIRGAYDMNGQPGLELTSYQSLTT
>PK3-2_00318 [Ribosomal protein S18]-alanine N-acetyltransferase
MKTKAAVRNMRLDDIDHVYEIETSSFTSPWTKDSFYHELLENPYAHYLVIEKDGHVAGYC
GIWIVLDDAQITNIAIKPEYRGQSLGETLFRSAVELCKEKDARRLSLEVRVSNHPAQGLY
KKFGMQPGGIRKNYYTDNGEDALIMWVTINE
>PK3-2_00319 tRNA threonylcarbamoyladenosine biosynthesis protein TsaB
MTILAIDTSNYTLGIALLREETVIAEHITYLKKNHSVRAMPAVHSLLNACDMTPQDLSKI
VVAKGPGSYTGVRIGVTLAKTLAWSLHIPITAVSSLETLAANGRHFDGLISPIFDARRGQ
VYTGLYEYKNGHLEQVVSDQNVMLAEWLEMLKEKDRPVLFLGHDTSIHKQMIEDVLGTKG
IIGTAAQHNPRPSELAFLGAEKEAEDVHGLVPDYLRLAEAEAKWIESQK
>PK3-2_00320 tRNA threonylcarbamoyladenosine biosynthesis protein TsaE
MKQLKWRTVNPEETKAIAKLTASFAKPGDVLTLEGDLGAGKTTFTKGFAEGLGITRVVNS
PTFTIIKEYNDGALPLYHMDVYRMEDESEDLGLDEYFHGKGVCLVEWAHLIEEQLPQERL
QIVIKRAGDDEREMTFTAVGDRYEMLCEEISRHDNISN
>PK3-2_00321 Thiamine-monophosphate kinase
MDEFDLIHSITPRTIHHSSVDVGIGDDAALYTAKHGVQEIVCVDTMVEDVHFKLLYSSPE
DIGYKALAVNISDIAAMGGIPKFYLVSIAVPPKWTKSEIKAMYEGMNELAKLYHMDLIGG
DTVSISDKLVVTVTVIGEVEKGRACLRSLARPNDIVFVTGEIGSSAAGLSLLLEKTHSQT
SAIDTDYFIHRHKRPEPRVSVGRLCSSFKRTALNDISDGLASELNEIAEASYVSIEIDES
MLPVHSHLPKLNSTWKEWALFGGEDFELTGTISKSDWEVLKQECETRQLPITKIGHVREK
TESNVILKTLNGSRILEKKGYNHFK
>PK3-2_00329 putative manganese catalase
MYYYKEELINIIKPDKPDPAAAKVLQEILGGHYGEMRTMMQFFFQSSNFRGKQKQYRDLL
RGIFLEEIAHVELVQNTINALLDESGGEGVGSQGADQAPLDEAVKHANPHHYIIGAQSSL
PVDAGGNPWNGSWVYNHGNLITDLLDNLLLESTGVLQKTRIYEMSSNQTFRETLAFLIVR
DNAHQNAFAKALETLGVEWAKLLPVPNYDINKYPECRKYVEFGYHNAQFNFRLDETRIGE
IFQGTSPSRNGGELQVIEPPAGFPVPVLPEMPNEHSPGLGDMNA
>PK3-2_00330 Mannan endo-1,4-beta-mannosidase
MFKKHTICLLMIVLLVSAVLAKPIEAHTVSPVNPNAQQTTKAVMNWLAHLPNRAENRVLS
GAFGGYSHDTFSMAEADRIRSAAGQSPAIYGCDYARGWLETVKIEDSIDVSCNSELLSYW
KSGGIPQISLHLANPAFQSGHFKTPITNDQYKNILDSSTAEGKRLNAMLSKIADGLQELE
NQGVPVLFRPLHEMNGEWFWWGLTSYNQKDNERISLYKQLYKKIYHYMTDTRGLDHLLWV
YSPDANRDFKTDFYPGASYVDIVGLDAYFQDAYSISGYDQLTALNKPFAFTEVGPQTANG
SFDYSLLINAIKQKYPKTIYFLAWNDGWSPAANKGASALYNDSWTLNKGEIWNGGSLTPI
VE
>PK3-2_00331 putative mannose-6-phosphate isomerase GmuF
MKHPLFLEPVFKERIWGGTALRDTFGYAIPSEKTGECWAVSAHAHGSSAVKNGPLAGKTL
DQVWQDHPEVFGFPDGKVFPLLVKLLDANMDLSVQVHPDDDYAILHENGDLGKTECWYII
DCKEDAELILGHHARTKEEFKQQIESGDWNGLLRRIKIKPGDFFYVPSGTLHALCEGTLV
LEIQQNSDTTYRVYDYDRCNDKGQKRTLHIEKAMEVITIPHIDTVHTPAVNEVDNAVITV
YVQSDYFSVYKWKISGRAVFPSQQTYLLGSVLSGSGRIVNHGIQYECNEGSHFILPAHFG
EFSIEGTCELMISHP
>PK3-2_00332 Putative fructokinase
MLGGIEAGGTKFVCAVGKEDGTIIDRIEIPTTMPEETIEKVIQYFRQFSLQAIGIGSFGP
VDNDKTSKTYGTITATPKAGWRHFPFLQTIKNEMKIPVGFNTDVNAAALGEFLFGEAKGL
DSCMYITIGTGIGARAIVEGRLLQGLSHPEMGHIYIRRHPDDAYQGKCPYHKDCFEGLAS
GPAIEARWGKKAADLSDINQVWELEGYYIAQALTQYILILAPKKIILGGGVMNQKQVFSY
IYQYVPEIMNSYFNFSELSDSISVYIVPPRLGGNAGIIGTLVLANQALQAESASGEVKS
>PK3-2_00333 HTH-type transcriptional regulator GmuR
MNKYEIIANEMRSRIKNNVYPIDQPIPDEVSLAKEFNSSRMTMKRALDNLVAEGLLFRKR
GHGTFIIQSAIQDDHVHVVSNEILGLTNLLKDKEIKSKVIQFEVQFPTEEVAAHLSIDQK
TPVYYVVRLRIVEGEPYVLEKTYMPTHLIPGINDDVLHGSVYNHISNELQLKIAGSHRKI
RACKSDHIDQQHLGCKQDDPILEVEHVGFLDNGIPFEYSFSRHRHDKFVVTSVNIRR
>PK3-2_00334 6-phospho-beta-glucosidase GmuD
MTQTEQYHFPKDFWWGSSASATQTEGAADRDGKGQNIWDHWFEKEPHRFFDHVGPAATSQ
FYDNYKEDIRLMRELGHNSFRLSISWSRLIPNGTGEINAKAEAFYNSVINELIANGIEPF
VNLFHFDMPMELQKTGGWVNRETVNAYEHYAKTSFRLFGDRVKKWFTHNEPIVPVEGGYL
YDFHYPNKVDFKEAVQVGFHTMLSSARAIQAYREMKQDGKIGIILNLTPSYPRSSHPADV
KAGEIADAFFNRSFLDPSVKGEFPKELVEILKSEGFVPDYQKEDLEVIKHNTVDLLGVNY
YQPRRVKAKEHLPNPDAPFLPDRYFDPYVMPGRKMNPHRGWEIYEKGVYDILINLKENYG
NIECFISENGMGVEGEERFRDDQGIIQDDYRIEFIKEHLKWIHRAIQEGSNVKGYHLWTF
MDNWSWTNAYKNRYGFVSVNLEKDGERTVKKSGKWFKEVAELNGF
>PK3-2_00335 PTS system oligo-beta-mannoside-specific EIIC component
MFEKISQFLVPIAGRLNNNRYLQVLRDAFMLAFPLTIFGSIFVVLTNLPFLNKIMNASML
TSFQSQFGIASTATMGIMSVFVVFGIGYYLSKSYQVEAVFGGAIALVSFLLLTPFIVQPE
TGDAITGVIPVDRLGAKGMFLGMITAFLSGEIYRRIVQKNLTIKMPAGVPPAVAKSFAAL
IPAFITLTVFLLINVLVTQLFKTNMHDVIYHAIQAPLVGLGSGIIPTLIAVFFIQILWFF
GLHGQIIINSVMDPIWNTLQVENLSAYTAGKEIPHIISKPFMEIYTVGMGGTGMTLAIVF
TILIFMKSRQMKQVSKLGLAPGIFNVNEPIIFGLPIVMNPIILVPWVLAPMVVTLVTYLA
MSAGLVPPPTGVTVPWTVPLFLNGIMATNSIMGGVMQLVNLLIVFVIWFPFLKAMDKLNL
AKEKEQAVQETAAQQNDNNIKM
>PK3-2_00336 PTS system oligo-beta-mannoside-specific EIIA component
MEQMKITDLTDEQISFQLILHSGNARSCIIQSLRAYKEGNKEEADALMSKAEQDLSAAHD
IHFQMIQKESGGEAAAFSLLLMHAEDHLMSTLTMKELVKELLDLFKTKNL
>PK3-2_00337 PTS system oligo-beta-mannoside-specific EIIB component
MKKILLACSSGMSTSLLVTKMKEYAQSIGEEAEIWAVGQDKAKEDMKKADAVLIGPQMSF
LKSELQKEADQYSIRVEVIDMMAYGMADGKKAYEQALSLMENQ
>PK3-2_00339 Purine efflux pump PbuE
MNFKVFLLAASTIAVGLVELIVGGILPQIANDLDISIVSAGQLISVFALGYAVSGPLLLA
LTAKVERKRLYLIALFVFFLSNLVAYFSPNFAMLMVSRVLAAMSTGLIVVLSLTIAPKIV
APEYRARAIGIIFMGFSSAIALGVPLGILISDSFGWRILFLGIGLLALVSMLIISIFFEK
IPTEKMIPFRDQIKTIGNLKIASSHLVTMFTLAGHYTLYAYFAPFLEETLHLSSFWVSIC
YFLFGISAVCGGPFGGALSDRLGSFKSILLVTGSFAVIMFLLPLSTSSMIFFLPVMVIWG
LLSWSLAPAQQSYLIEIAPDSSDIQQSFNTSALQVGIALGSAIGGVVLDQTGTVVSTAWC
GGSIVIIAVLFALISLTRPVQTAKKSSL
>PK3-2_00340 putative protein YdhK
MKVSKKALGILMLSLVFILSACGNNNSTKESKHENHSGSSSHEEMEHSGSADVPEGLQES
KNPKYKVGSQAVINASHMKGMKGAEATVTGAYDTTAYVVSYTPTNGGQRVDHHKWVIQEE
IKDAGDKTLNSGDQVILEASHMKGMKGATAEIDSAEKTTVYMVDYTSTTSGEKVKNHKWV
TEDELSAKS
>PK3-2_00341 hypothetical protein
MEINDIIYGQHQIDGVLEELLKSAPVQRLKGIYQGGASFLVNRKWDVTRYEHSVGVMLLI
KKLGGTIEEQIAGLLHDVSHTAFSHVIDVVFENEAEDYHENIFQQVIVQSEIPGILEKHG
YDAEELLTDETRWTLLEQPAPELCADRTDYTLRDMYRYGHIGLHEAQTFLDHLIVRNGRM
FPDRIEAAEWFVGVYYKEVIDFFLNPVNVYGYEYLARTLKAALRHHVISADDLLKTDQEV
LDILHASKNEEVLSLLTHIHPRVQVKEDDTQYDFHLKKKMRLIDPSVFHHGKWVKSSAVS
ENIRKWGESAYQKAKKGVYIKVLHH
>PK3-2_00342 hypothetical protein
MVISSGIFHCDELDGYGALDDDGEIQGCITYVIDGQECEIISLDSIIEKRGIGTALLQQV
KVTAKQTHCQRIKLITTNDNVHAMEFYQKKGYQFTELFPNAVEKARRMKAEIPEKAENGI
LIRDEILFSKVID
>PK3-2_00343 hypothetical protein
MSSHYKYPLIFTASLLVAFCLIFFSYHLIHQVRLEYPNWQGKSKDQNWEAVFTKNEDAPN
EYSGNLYWIGNEDETDNTYVESLIVKKDDEVLLSSDTEIPMRAYSGGTSRDGSAKEKSIS
FLERLDEHELEGHDISIEVKWKQGKHDAASHFHLHEKNLFD
>PK3-2_00344 Intracellular iron chaperone frataxin
MKFFSAFLAGIDDPFHRERTEEVLTGVKNKYPNLNPEMKWNQPMFTDHGTFIIGFSVSKK
HLAAAPESVAITHAEDDIVKAGYDYTKELIRIPWKSPVDYPLLEKMIEFNIRDKANCSTF
WRK
>PK3-2_00345 Alkaline phosphatase 3
MKKFPKKLLPIAVLSSIAFSSLASGSVPEASAQEKKKGNQDDIKNVIVLIGDGMGVSYTS
AHRYLKDNKKTKFVEPTAFDQYLVGQQTTYPEDPEQNVTDSASAATAMSAGIKTYNNAIA
VDNDGSEAKTVLEAAKEEGKSTGLVATSEITHATPASFGSHDHSRKNMNSIADDYFDEMV
NGKHKIDVLLGGGKSNFDRKDRNLIKEFKKAGYSYVDNRKDMLKNKDSQVLGLFADGGLP
KKIDRTKDIPSLKDMTNTAIKKLSKDKDGFFLMVEGSQIDWAGHDNDIVGAMSEMEDFEQ
AYKAAIDFAKKDKHTLVVATADHSTGGYSIGADGIYNWFSEPIKAAKRTPDFMAEKIADG
ANVEKTLKTYIDQKKLALTAAEIQSVEKAAKTKEVLEIDNAIEEIFNKRSHTGWTTGGHT
GEDVPVYAYGPSSETFAGQIDNTEIAKNVFKALQYNIKIHDK
>PK3-2_00346 hypothetical protein
MKRILSLFAFAIMLAGCSSNASSEKPSTGGEQAVKATPQSTSSHKDSLDEYQPNSQVTDD
RSLLKVGQTFSDDKGKAVLKDIKQVNQTYKIGGVELTVKEMKLIHLRPDYSMIDYFHVLT
HDEEFDFVKVFVEIKNTSSKKVNVAPIALMKTNTGETFDWNKDIYLEELNGELEGGAEKS
GNLGFIVNASSSHDHDKEAEKKEAEIKWIEITTSDVFDHNHKKISDAQKIKIRF
>PK3-2_00347 Demethyllactenocin mycarosyltransferase
MKSVLILNFPAEGHVNPTLGITKAFSDKGYDVHYISTEKYKKRLEAAGATVHLHRDLLRT
TPIHVGSPNGILDFLKIHIKTSLDILRIVKDLSKNIQFDFVYYDKFGAGELVRDYLDIPG
VSSSASFLFGEEHLKILPLHPESGAPLELDQECEDLLEKMKETYGVAPKNLVQFMNNKGK
LNVVYTSRYFQPESDRFGDECLFIGPSFPKRAEKTDFPLEQLKGEKVIYISMGTVLDNTE
EFFNLCIDAFSGFNGKVVIAAGEKADLTKLKQAPEHFIIASYVPQLEVLEQADVFITHGG
MNSVNEGIHFSVPLVVMPHDKDQPMVAQRLSELHAGRVISKDEVNVQILKQAVDEVLHND
QYTAGIKKINQSFQECMDMDEVMERIDELIRAKNK
>PK3-2_00348 Putative sporulation-specific glycosylase YdhD
MFIHIVGPGDSLFSIGRRYGASVDQIRSVNGLDETNIVPGQALLIPLYVYTVQPGDTLTA
IAAKAFVPLERLRAANPGISPNALQAGAKITIPSISNYIAGTLSFYVLRNPDLDRELIND
YAPYSSSISIFEYHIAPNGDIANQLNDAAAIETTWQRRVTPLATITNLTSTGFSTELVHQ
VLNNPTARTNLVNNIYYLVSTRGYGGVTIDFEQVSAADRDLFTGFLRQLRDRLQAGGYVL
TIAVPAKTSDNIPWLRGYDYGGIGAVVNYMFIMAYDWHHAGSEPGPVAPITEIRRTIEFA
IAQVPSRKIIIGVPLYGYDWIIPYQPGTVASAISNQNAIKTAMRYQTPIQYSAEYQSPFF
RYSDQQGRTHEVWFEDVRSMSRKMQIVREYSLQAIGAWQLTLGFTPGPWLLRKFFTIRKV
>PK3-2_00349 HTH-type transcriptional repressor RspR
MDDFKLDKPTPYYLQFYNQLKKMIFNGTFMPGERINETQLAKSFGVSRSPIREAMRLLEK
DGLLKADDRNGFSITSLTAKDVDEIYKIRIPLEQLAVELVIDEADEEELAILEKQLEETE
KAIHDGMEDTEIISLNQKFHELLVDFSHNRHLKNLLEHVNDLIHFCRILNYTGDHRAETI
LSEHRKIFEEVKKKNKDAAKQHVMAHFNHDCEHLKRVLEEGKEN
>PK3-2_00350 hypothetical protein
MLIILVMFLLGIILGFIGAGGAGFVIALLTLLFHIPIHTALGTSLAGMAFTSLSGAYSHY
REGNIQMKIGLIVGCFAAVGSFFGAKLTSFIPADLLHYLTAGMLFLSAILILIRLFLLKE
KAQMNQSNLSTYTRAIILGIVSGILSGTFGIGSAPFIQIGLMIMLNLSIRHSVGTTMLVI
IPLAVGGGIGYITEGFVDYVLLIKVLVGTMCGAYVGAKFTNLMPKVVLKSAIFLTPAIAG
LLLLF
>PK3-2_00351 Bicyclomycin resistance protein
MLHNPIGKERLALAFLLGMLAILGPLNIDMYLPSFPEIADDLSASASLVQLSLTACLVGL
TIGQLIVGPVSDAQGRRKPLLICIFLFALSSLFCALSPNITTLVAARFLQGFTASAGLVL
SRAIVRDVFTGRELSKFFSLLMVITAVAPMVAPMTGGAILLLPFATWHTIFHVLMIIGFL
LVLLIALRLKETLPPEKRIPSSIGTSVKTMGSLLKDRSFMGYALTVGFIHGGSFAYVSGT
PFVYQDIYGVSPQVFSILFGINGLAIISGSFIIGRFGGIIHEKSLLRIAVITSMIATAVL
LTMTMIHGPLATLVISIFIYMITIGMVLTSTFTLAMEKQGHRAGSASALLGMLPLLLGSI
VSPLVGINETTAIPMGAIMFVTAVIGSLAFFGLTKERAEQSS
>PK3-2_00352 hypothetical protein
MIIGCALVTMIPRIIPFLVVRNITLPESVLKWLSYVPVCVLTALVVKDCMLQSQDFLGLN
WPVAVTLDPDSLDRDKNEKLIYYCDQRCPSYGGFAIMGIKQENRHLLDQGIRP
>PK3-2_00353 Transcriptional regulator SlyA
MASFCSEEAEILYQLQGVNKVIGLKFEACTGISQSRLELLTLLYHADEISQSDLQKKVNI
DSAAVTRHLKQLEAKGMVSRRRKPEDNRITLVRLTDQGRERIESSKKEKERFMKEMLANV
SADERRLLIDVLARMRNNINNIEA
>PK3-2_00354 Putative NAD(P)H nitroreductase YodC
MIKTNDFMEIMKGRRSIRNYDPTVKISKEEMTEILEEATTAPSSVNAQPWRFLVIDSPEG
KEKLAPLASFNQTQVTTSSAVIAVFADMNNADYLEEIYSKAVELGYMPQEVKDRQIAALT
AHFEKLPAQVNRETILIDGGLVSMQLMLTARAHGYDTNPIGGYDKENIAETFGLDKERYV
PVMLLSIGKAADEGYSSYRLPIDTIAEWK
>PK3-2_00355 Putative membrane protein YdgH
MRAIIKFKWAIAAVILALTVVLSLFSPNLTELANQKGQAQLPADAVSERANAILKQAGED
SNSISVVFTLDHALKKDTEDQLRTMIDKIKKIDGVEEVTSPLTADKEVKDQLISKDKKTV
LIPVTITGSDKKAEKIADDIYKIVPDDLTAYITGASLINQDFAHSSEEGLKKTEVITVCL
IIGLLLIVFRSVVTPFIPIVVVGFSYLISQSILGILVHNVDFPISTFTQTFLVAILFGIG
TDYCILLLTRFREELANGHDKKEAALIAYRTGGKTLFISGFAVLIGFSALGFAKFAIFQS
AVGVAVGVGILMIILYTLLPLFMVTLGEKLFCPSKKVLSHSDNKLWAFLGRHSVVRPFLF
IVITVIITLPFILTYDDQISFDSTAEISSDYKSVKALEAIKDGFGEGKAFPINVVVKGDK
DLTTADTIPYLGNISKAIKKVDHVDSVMTITQPTGEKIKDLYIDKQLGSVSDGLDKTAKG
IADVQSGLTDIENGLNQMAGQTGSASNSSSGGSLGDAAEGLGKINQQLQLVSKQMSQTGN
TAQTVQQLTAISGQLGQIQTGLEQANQQLTGQQAQAGTLTESLKKLADGVKSANDGLTKI
SDGISASSDMLEDMSKSSTVRDTGIFIPDQVMKDKDFKKSIDQYSFADGKGVELSVVLDS
NPYSEQAITTINQIKKAVANEVEGTPLEDSQIVYGGVTSMNADLKELSTTDFSRTMVIMI
IGLFIVLTILFRSMIMPVYMIASLLLTYYTSLSITELIFVNGLGNAGISWAVPFFSFVIL
IALGVDYSIFLLDRFKEEVHMGIEQGVVRSMSKMGSVIITAAIILAGTFAAMMPSGVNTL
MQVASVIIIGLLLYGLVILPLFIPAIIVTFGEGNWWPFGRKKIKE
>PK3-2_00356 hypothetical protein
MLNEQKLCQAINLFVEVLLEGTEFVHREINQDVFKHISREQADLLKILKVKGPTSPGSLA
MYQNVHKSAISNRLKKLLDKGLVEWDDCLANRDKRSKLINITASGEHILEELDSAIFNAL
KELIDDIDEEHLQSIIEIFTILKSKFKGGDSAE
>PK3-2_00357 hypothetical protein
MLDFSLKLYEYNVWANQQIFNRLKELPKEVYRQEIQSVFPSISHVLSHVYLSDLGWIEVF
SGKRMNDALALAEQLKEQTEAKELEEMEALFLKLSDRYTLFLQQKEQLNKLLQIQNPSGG
IMKTAVYELVPHVVNHGTYHRGNITAMLRQAGYASAPTDYGLYLYMTKTEMA
>PK3-2_00358 D-serine/D-alanine/glycine transporter
MTDDMRNDNINQQKLERGLKNRHIQLIAIGGAIGTGLFLGSGKSIHFAGPSILFAYMITG
IICFLIMRSLGELLLSNLNYHSFVDFVQDYLGDMAAFITGWTYWFCWISIAMADLTAVGL
YTQYWLPGVPQWVPGLIALIILLIMNLATVKLFGELEFWFALIKVIAILALIVIGLVMIF
KGFSTSSGVSSFTNLWSHGGMFPNGIHGFILSFQMVVFAFVGIELVGLTAGETENPEKVI
PKAINNIPVRVLLFYIGALLVIMSIYPWDVINPSESPFVQVFVAVGIVGAASIINFVVLT
SAASACNSAVFSTSRMVYSLAKDNNAPESMAKLTQRKVPSNALFFSAIVILIGVTLNYIM
PEGVFTLITSISTVCFIYIWGITVICHMKYRKTRPELAKTNKFKLPLYPFTNYLILAFLA
FILVVLALAEDTRVSLFVTPVWFILLIVIYKVRKAKHQ
>PK3-2_00360 ABC-F type ribosomal protection protein VmlR
MKEIITLTNVSYEVKDLTVLKNVNASVQQGDIIGIIGKNGAGKSTLLHLIHNDLTPAQGQ
ILRQDVKVAVVEQETASYSFADQTPAEKKLLEKWCVPVRDFQQLSGGEKLKARLAKGLSE
DADLLLLDEPTNHLDEESLQFLIQQLKSYRGTVILVSHDRYFLDEAATKIWSLEAQTLIE
FKGNYSGYMQFREKKRLAQQREYEKQQKMVERIEAQMNELSSWSEKAHAQSTKKEGFKEY
HRVKAKRTDAQIKSKRKRLEQELEKTKAEPVEPEYTVRFSIDTTQKTGKRFLEVQHVTKA
FGERTLFQNAHFTIQHGEKVAIIGPNGSGKTTLLKIILGQETAEGSVWVSPSANIGYLTQ
EVFDLPLEQTPKELFENETYKARGHVQNLMRHLGFTASQWTEPIKHMSMGERVKIKLMAY
ILEEKDVLILDEPTNHLDLPSREQLEETLSQYSGTLLAVSHDRYFLEKTTNSKLVISDNG
IEKQLNEVPSERNDREELRLKLETERQEVLGKLSFMTPNDKGYKELDQAFNELTKQMKEL
DQQDKKD
>PK3-2_00361 putative N-acetyltransferase YycN
MTLTLEDMTVAEFEAFREMSVRNYAKQNIMSGTWTEKEAFEKSEQAYEKLIPNGRNSSNH
FFWNITNEQGERMGWLWLYADPFHPQKEAFIYSFGLYEAFRGRGLAQLALQTLDERAREL
GAERLALHVFAHNEIAVHLYEKMGYTMTNIRMRKQLC
>PK3-2_00362 hypothetical protein
MIFVIMKIGLAAFMLAGGIIKVFRVPFQVEHWRHYQYPLWFLTVTGILEIAGALAMTVGI
WNRYAAFGAGALFVVLMAGAVHAHMFRARQSVFMTIPAMICLIVSIMIMIRELT
>PK3-2_00363 hypothetical protein
MKSKKGRKGEESRKRLLEAAANEFSNRGFYETKVSEIVKRAGLTQPSFYLYFQSKEAIFD
ELITNFHSRIKKLTESLLLENGLNTKDVSKRVLSAVETVFQCLDEDKDVTKIGFFLNPEA
KQMKKDLAMVLKENLEAEQRLGYFDSELDMETVAECLIGMIEHLTDSFLLTGIKDPASLA
AQVVNLLIYGMLPKGSDGR
>PK3-2_00364 hypothetical protein
MPSTVINLYYLKINSISGNGSITIGEAAHNSHTANNKSQGINSSFGDTSPAESIMENFLN
DPDINDQTELGNSDTTNMNAPPLPVPPILD
>PK3-2_00365 hypothetical protein
MPYQINIANIKVNGVTQNGNIDVGPTVHNSHTANSKYFGANFSLGDFSPSSSLLNTGNLD
TDISDQDQIGNPSAPISNQI
>PK3-2_00366 Spore coat protein P
MDLEKMRKWLEITNEYKQSDFWTNVLKYKAPEQFFDSKAYTLVYDFYQDEEYNFIIVEMP
GVYEEELTIRLLSKTKLLIKGTSTPVFPAEMEVQRERYYGEIERTIQLPEAAESHLLQFQ
MLNGLLHISYPRQAEHIAFTKGF
>PK3-2_00367 hypothetical protein
MDGEMSENNLKQNHLPEAWLLEELQKRDVKVKETVYAVLLGFDIFMWINIKTNISPYRYR
MREAY
>PK3-2_00368 hypothetical protein
MIEIEIVIRTVASFGLLLMAERVLGKQTISQMTIFDFIAAITLGAIAAGVAYNTSKKPHN
MAISFLSIKNRKLRKFFVGDPTVLIQNGKILESNMRKMRYTLDYLNQQLREKEIFNIEEV
LFAILEMNGKLTVLRKPQFRYVTKQDLMIEEKVRIDCR
>PK3-2_00369 hypothetical protein
MNFTWEAFVLIIAGVILLRISGRKSIAQMTSTQTVVMISIGTIIVQPIIENSLVKTLIGA
AIFTLTLILMEWLQIRFNLIEKMLTGKAKIVIENGHLRIENLKRMRLTADQLEMQLRLHG
VTAIQDVKKATLEANGQLGIELTDDAKPLTVRDLKQLIHPDFLRKDGQAQHSGNQNIFNE
IGKKNKKTTLKSCIKSVRDLCDFLSFIVYYCRFVYAIAAHTSYCINSNNGEER
>PK3-2_00370 hypothetical protein
MMRCPVYIRSISGNSVFNNGFAFSISPFSVSKATEGAGENNRGMVFERSLYSQTSSTNSQ
AVNQNITNAIQELINQILA
>PK3-2_00371 hypothetical protein
MDFPIIHTNVWDAVIAVPTIILITQILKILLKIPKTIVPSAALMIGLIISIFISHRHSLF
SGVFMGWFYGYAAIGSYSSLKTTIISFRQNQNDTPNS
>PK3-2_00372 hypothetical protein
MRSQINISNLTINGITQNANADIGQNLQNSHTANSKNYGVNFTLGDYSPSTSIIISAIFD
DDKSDQGQSDNPSSPSET
>PK3-2_00373 hypothetical protein
MGWSKWINLFCVIVLGAVMGYKLFTHQHISTLHLIISSALILWNIIGLFSKEATHQTRQT
>PK3-2_00374 Protease synthase and sporulation protein PAI 2
MFIPAPFKLNESEAYDVIRENGFATLFSMHEGMPFATHLPLLMSADKACLYGHFALQNPH
WKDIGGQSVLAVFHGPHCYISPSWYETNKAVPTWNYVAVHVYGEVELLEDEKELADSMKD
LVLKYETPDSSYKLDDVDPAFLAGLHKGVKGFKISINKIEGKAKLSQNHSLLRQTLVMNQ
LNQIPYTDEQRIASLMKEHINKNQGEGFDK
>PK3-2_00375 HTH-type transcriptional regulatory protein GabR
MKNMIFAFHHDRPKYIQIYERFKSLIEQGHIEANEQLPSIRELAHSLQVSRNTTLMAYDQ
LIAEGYIRGEKRKGYFANEIEPLLFQGKETLSQNKQTETPPQALIDFRPGAVDQTHFPLA
IWRRVSNQMLTLEKSYLYGEPFGEKRLREQIAAYLLESRGVQTDANSIMIGSSTQQMLIY
LGQILKDDFSGIIVEDPGFSGGREAFQLQGFTLETLPVYETGADFSVLHQMKERLIYVTP
SHHSPYGVSMSIQERQALIHWADKQDGYILEDDYDSEFRYTQQPFPALASIHSERVIYLG
NFSKSFLPGIRLSYMVLPEPVLQRYQRRFHQFESTASLLSQLTMAEFMKEGEWTRHIKRM
RVVYKRKMQHLTAAIKRHIGHHATIIGEQSGLYILVKVHQHCAEESLIQRALEYGVKVYP
TALYFVNNIPDEPLIKLGFGHLGFDDITHGVQLLKQAWGTA
>PK3-2_00376 hypothetical protein
MKEMTELHSLDSIENFIKQHQFSFIYISRPDCTVCHAVLPQLRILLNQFPNIKLGHINAD
DVEEVAGRFSVFTVPVLLLFIDGTEFLREARFVHFEQLEDRLQRVYRLYEDE
>PK3-2_00377 Putative oxidoreductase MhqP
MEDAGLLLIRIMIGVVFLFYGTQKLFGWFGGYGIKGTGQWFESIGVKPGKFAAALSGLGE
FASGILFILGIFLPLGAAIITIIMLGAIVKVHGAKGFANGAGGFEYNVVLIAVSIGVALI
GSGAYALHF
>PK3-2_00378 Putative ring-cleaving dioxygenase MhqO
MAKKTMGIHHITAIVGHPQENADFYAGVLGLRLVKQTVNFDDPGTYHLYFGNEGGKPGTI
ITFFPWAGARQGIIGDGQVGVTSYVVPKGAMAFWEKRLEKFNVPYTKIERFGEQYLEFDD
PHGLHLEIVEREEGKANTWTFGDITPDVAIKGFGGATLLSAQPEKTGELLENIMGLERVG
NEGDFVRYRSAGDIGNVIDLKLTPIGRGQMGVGTVHHIAWRANDDEDQLDWQKSIASYGY
GVTPVRDRNYFNAIYFREHGEILFEIATDPPGFAHDESQETMGGKLMLPEQYEPHRAQIE
QGLLPFEVRELD
>PK3-2_00379 Putative NAD(P)H nitroreductase MhqN
MAEFVQLVNERRSASNFLPGHPITKDELNEMFELVALAPSAFNLQHTKYVTVLDPDVKGK
LQQAANGQYKVFSSSAVLLVLGDKQAYQQAADIYEGLKMLGILNKQEYDHMVQDTVSFYE
NRGEPFKRDEAIRNASLSAMMFMLSAKEKGWDTCPMIGFDAEAVKQILNIDDQYEVVMMI
TVGKEKTESRRPRGYRKPVNEFVEYI
>PK3-2_00380 Manganese efflux system protein MneP
MASEREQISKKVALIALIANLILMAGKVFFGLIGDSEAVFADGIHSAADVVASIAVLAVI
GISNKPPDQDHPFGHGKAEVISEAIVGMILVLVSVYILIEAILSFVEGPGVPQYSALFAA
LISYVAKQILYRYSIKQGEKWNSKAIIAIAYDHKGDIVASLAAFIGVLLAIIGNTRGWSY
LLYADAIASAIVAYLIFKISMELIRPSVDVLMEKSVDPELIEEYKAVILHCPQVKRLDKI
RAREHGHYKLLDVRLSLDHDLTIKQGHDIAREIRNEIKRQFSDVEEVLIHVNPYFEE
>PK3-2_00381 hypothetical protein
MLQTLPLELTVLYNVNNHMNRKVVKMKEFFSIGEVSKLFNVKISALRYYDEIGLLKPEYK
DGKTNYRYYSTQQFERLDTIKYLRALGLPIHKLLDFYNSQNTNTLIDLLKNQQTEIDRKK
MELERIEKKISRRIIQIEDAVHTPLHHISKIKLPAIRVAYLQHEYILGHDIEHSLAQLRT
HLNVNEDIFIGKIGLSISAENVKANQFDKYSSIFMILEDDAEKTSSEITFPSREYLQTRF
KGSHPEAEPYYKQLLAYMKEHHYEIAGDSIEITLIDYGITNNPDHYVTEILLPIK
>PK3-2_00382 putative membrane protein YdfK
MQESLLEEKAYVRNHIQHRYDHCRKYYRGLFKKGIKDEYQDILMQAMGFAAVALGVNAIA
QHLPDSQYPILFIVSLALGGLLGQSINLELRFNKLVNKFSKSNLAEGLSTAILLFCIGSL
SILGPVEAALHGDYTYLLTNGILDGITSIVLASTFGFGIAAAAIVLFAWQGSIYLFAKLM
ESALNTDLINEITIVGGILILSSGISILGIKKCKTMNLLPSLLIPPVALFIIHVFGLRF
>PK3-2_00383 Maltose O-acetyltransferase
MNSKNKIYYERGTDELRKQNIRAHKLVREFNHAEPEEVEKKEEIIRNLFGTVGINPNVEY
NFHCDFGYNIHVGDHFYAGYNCTILDVAEVRIGDNCMIGPDVGIYTAGHTIEPKDRHKSG
YGIPIIIGDNVWIGGGCVILAGVTIGDNSVVAAGSVVTKDVPPNSVVAGNPGKVLKYIE
>PK3-2_00384 Phosphoglycolate phosphatase
MAQSLIFDMDGTLFQTDHILELSLEDAFDFLRSLGKWDTVTPIQKYREIMGVPLPEVWKI
LLPNHSNEIREKMDAYFLERLIANINQGKGALYPHVEEIFSYLRDNGYSIFIASNGLIEY
LKAIVSFYQLDRWVTETFSIQQIHTLNKGDLVNTILKKYGIQQAAVVGDRLSDINAAKDN
GLMAIGCHFDFAQEEELAQADFVIHDLLELKTLLPELKISKGF
>PK3-2_00385 Membrane protein YdfJ
MSRMLYKLGGWVARHRVKVICAWIVVLVASIGLAITLKPSFSKDMSIPDTPSEKAMDVIQ
KEFPHGPDQGSIRVIFGAEDGEKLTAKTAEKAIENTLKEINKDDSVDLIASPFVTGTIAK
DGTVAYADIKYKASADDIKDYSIKHVKDSLKIADNEGLQTELSGDIPGAEMEIGGVSEIV
GIILAFVVLAITFSSLLIAGLPIITALIGLGVSIGLVLIGTQVFDIASVSLSLAGMIGLA
VGIDYALFIFTKHRQFLSEGIQKNESIARAIGTAGSAVVFAGVTVIVALCGLTVVNIPFM
SAMGLTAGLSVLMAVLASITLVPAVLSIAGKRMIPKANKKKGKQSSDTNVWGRFVTKHPI
LLSVCSILILIVISIPSMHLELGLPDAGMKAKDNPDRRAYDLLADGFGEGFNGQLTIVAD
AASVTENKAEAFADAVKEIKGLDHVASVTPAMPNKEGNFAIITVVPTTGPNDAATKDLVK
EVRSLSDKNGVDLLVTGSTAVNIDISDRLNDAIPVFAVLIVGFAFVLLTIVFRSLLVPLV
AVAGFVLTMTATLGMCVFVLQDGNLIDFFKIPEKGPILAFLPILSIGILFGLAMDYQVFL
VSRMREEYVKTKNPVQAIQAGLKHSGPVVTAAGLIMIFVFAGFIFAGEATVKANGLALSF
GVLFDAFIVRMTLIPSVMKLMGNAAWYLPKWLDKIIPNVDIEGHQLTKEIQPEIDHEQKK
QISV
>PK3-2_00386 Response regulator protein VraR
MNKVLIVDDHLVVREGLKLLIETNDHYTIIGEAENGKTAVRLADELKPDIILMDLYMPEM
SGLEAIKRIKEKHDIPIIILTTYNEDHLMIEGIELGAKGYLLKDTSSETLFHTMDAAIRG
NVLLQPNILKRLQEIQLERMKKQSSDTQLTEKEVIVLKAIAKGFKSKAIAFDLGVSERTV
KSRLTSIYNKLGANSRTEAVTIAMQRGILTLDK
>PK3-2_00387 hypothetical protein
MRIRNPFKENYYSHDRRALNMLALRVPGLAFILMIYVASVVLQFITASWSILLLNVFTIL
MAVFSFLHWHSYRWVKKRVILYFALQGLITFTLANVMTGFLVLVIIGLYAFLIGQIAGMA
DRRRTFLILYLLLLLSINVPHQIHKGEYLHFIVIAAPIMIVIITYAATLFAQVDEKIKAQ
LTLERLELAHQQVEQLTLQNERQRMARDLHDTLAQGLVSLNMQLDAIHVHLTKGNTERAK
EIIQQSMKRVKGTLADARSAIDDLRSKSEEIGFLKERITSLMDHFQESTGMGGFLDYRLH
QVLDVRTAENCYYIIGECITNAAKHAEAESISVSIWDDDKGRLHLTVKDNGKGFDVEKSK
KKRGHYGLLGIQERVRAMNGQFNIKSTKLKGTQIEITVPIQGEMQDE
>PK3-2_00388 hypothetical protein
MYWFLGVLLYFLIGTCVFIGVIRDSHSGSRTLLALAAPLIILGYPYFYSKQLLAKR
>PK3-2_00389 hypothetical protein
MSQRVPYYDAAPEGMKIMMDMEKYTKQSSINRTTRELIKIRVSQINGCAFCLDMHTSEAR
KMGETEQRIYCLSAWNECDFYSSEEKAALELSEHITLIPTKRVPDDLYHRVREHYDEKQY
IDLVLIINQINSWNRISIAMGNQATSR
>PK3-2_00390 hypothetical protein
MNPNIAKISSLLSDPSRSSILLTLMDGRIHPAGELAYLANIKPQTASFHLKKLLEEKLIS
VEKHGRHRYYRLCNSEAANVIEQLLCIAPKAKVTSLKDSKEKSDLHFARTCYDHLAGYAG
VQITNSLVEQGMLKKVDLNFEVTPEGSLFFSNLGINEDQQRNKRRAFARCCLDWSERQHH
LAGAIGNALLVRMLEEEWIVRMPKTRAIRITQSGKNAFEKYFKVNM
>PK3-2_00391 hypothetical protein
MDIEKQDTLHFKEIKPKIMYYGASTFLLTTLNEDGTTNISPMSSSWALGNYLVLGVGLGG
KAIDNINRHKECVINLPGPDLWENVERISSYSGKKNIPPLKKQLGFTYKKEKYEAAGLTP
LQSKTVLPTRIKECPIQIEAEVKHIRIPEYDSSFAIVETQALHFHAEERIILNENHINPS
KWSPLIYNFRHYFGLGKERGKTFRSET
>PK3-2_00392 HTH-type transcriptional regulator NorG
MSFPEDIKMKNLPKYRQIVHFIKEKIGNGEWPIGSKIPSQRTLAKDFQVNRSTVITALEE
LMADGLIEGRMGKGTVVINNTWTLLAKNSAPNWDQYVTSGIQRPSQKIVQEINQSESNTD
FIQLSKGELSAEIFPLAAMKKMMGQVSQNMEAFGYEEPKGYFPLREALSSYLRTIGINAS
PSSILIVSGALQALQLISMGLLQRGSTVYLDQPSYLYSLHVFQSADMKLTGIPMDQDGLL
PENLHMTRGERGRSILYTNPCFHNPTGILMSKKRREEILAASENTQLPIIEDDIYRELWI
DEIPPLPMKTIDKNGHVLYIGSLSKTLSPGLRIGWIVGPEPVIERLSDIKMQTDYGSSSL
SQRVAAEWFTSGQYQLHLEKVRQQLKVRRELALSSLETHLKNVATWNIPKGGFFIWIKVL
PSISMKLLYAKALSKGILLNLGSIYAQEKGNYIRLSYAYASLEDLQKGIYELGLMIKELA
SK
>PK3-2_00393 putative inner membrane transporter YedA
MRKKTVQIIISHSLMIGLWASAFPGIRAGLEGYTPEHLALFRLLIGSMALLLFAVLTRMR
LPDMKDIPAIFLLGILGFALYHILLNIGEKTVSAGVASLLVTTTPIFSAMLSRLFFREHF
GFVKWLGSMISLSGVFLIAFGAGDYTYSLSGILFILLAAFSESIYFVFQARYIKKYGFIP
FVTFTIWGGTIPMLVFLPGLGGEMMNASISVTLSIVYLGLLPTVIPYFALAYVTAFVGAS
EATLSLYVTPALALVISWVWIGEIPAFLSLLGGMVTVSGVCFTYLRQNKMKGYGNALRHK
>PK3-2_00394 Transcriptional regulatory protein WalR
MDKTKILIIEDDEAIADLLSYGLMQEGFQTCTEANGALGLKQLDQFKPDLLLLDWMLPDY
SGLDICKKVTHRYNIPILMITAKSDITDKVLGLEFGADDYITKPFDLREVIARIRTILRR
LEQANHVNDRGTSNEEHIQFKNIMIIPDERIVKKDGNIVDLTPKEFDLLKTLIDHRGKIF
TRSELLEFIWGYDFAGDTRTVDTHIQRLRKKLNASDLIKTVFGIGYKFEKQEE
>PK3-2_00395 Adaptive-response sensory-kinase SasA
MLRTIKGKFIIGFFLIFSLSFLVLNQTVKSVIRSSNEKIVTSDLIELKKNSIVYINQAFL
INHYKNNELYFGDMADEIVESLTHSTGSHVSVYTLDGTMLSSSNRTVFSQGIDNDLKKAI
NGKNAYHITYDRNKAQVFFSYPVVIDGAKVGILRFSKNFNLLYKQSGEILNIIFYIALAI
FVAAFLFSYILSRHITIPIVKLTEATSEVKKGKLDVDIHFPRKDEIGQLTINFNDMITRI
RDQITTIEKDRDRLKELNEQEKRFFDNMTHELKTPLTSIQGYAEIIKEKGDSDQKFFDKG
MHHIVEESRRLHNLVIKLLEVSRETSEDRTFDRVDAGTILKDVCESMKLRAERYNKRIIC
EIEEDLYVYGQMNRLRQLFINLLDNAIKYSLSNSDIIIKANVIGDQVLFIFKNPSHPYDD
NQYTKVFQPFYSVNQKVTEEGSVGLGLSIVKTIVEEHGGTIKMFYKENHTNITIELAYMK
VEK
>PK3-2_00396 hypothetical protein
MKNKQFFILSGVLLIFLICVSSYNVGKRSETIIIPNDENHIDDDQKSGSFQVKKIYRLPK
ADELLGWSSSNAIVGFFKGDDTAEREVHHLQRLSFPFEKPETLKSVKSNTANLKMSPDGK
SIAGLAMLSDKTTLNLISLTNRDKKEIASFSSSKDAYVQDVSWSNNSKYICYLVINSAKN
GQTAVNVFNIDSGTLKTYPLKNLDEKESLTAVSISDDGHRVLLTALHGQQYRIMTGIVSD
DGINVQKKRQNSYDKPVWLNNDQFVFLDSGETLCEYDLRNNELSVLLENVAVFKISNDRK
KIAYSLYDKDNTYAGKLQGKNILLAEPVYHGTNPSEIYWSPDGSNLLIHDQSPYSMENPS
ARLFDDHSYIITFK
>PK3-2_00397 Peptidoglycan-N-acetylglucosamine deacetylase
MNKIGKIGFGILIILGVTLLCISWKALAGPKQESLKESAAASEPMHKEKHKHSAEKKEEQ
KTSPKIGKVVYLTFDDGPNPAASEKIMDLLHKFNAKGTFFMLKPNIERNPDLVRKMVESG
HSVGSHGVTHQVSEIYKSPESFAAEMNDTLDYIKDTTKVNTHLIRAPYGSKPYITGPFRE
VVKRDHFNLWDWTVDSEDWKYTHGEFVKNTIQQVNNLVGKEPLVVLMHEKPTTSAYLEEL
LKYFRESGYEMKAINDSIKPVQFRVN
>PK3-2_00398 Polyisoprenyl-teichoic acid--peptidoglycan teichoic acid transferase TagU
MQRIILFILALLLTIGGLTCYSIYRNVAKSVNHMYKPLDKDSKQQNAGIGQDPISILLMG
IDERPGDKGRPDSMIVLTVNPETKTSTMVSIPRDTRVFMRSKNTNIKMNAAYTYEGIEGT
VQTVEQFLNIPINYYIKVNMEGFKDIVDAIGGITVNNDFPFTLEGVHIPKGEQHLDGKVA
LKYARMRKEDPRGDFGRQQRQREIINEIIHEGAQLKSLKNYQGILAALEKNIQTNLTLDK
MIDIQRSYKEAVQHVKQIEIKGEDKK
>PK3-2_00399 hypothetical protein
MQELPKEKYKGLKPLFDKTFCPTFVYAILEQTIPGVVYADDQTSPGSFFIGTESGIYFIA
GDEENQVFNDFIAEYYEKQARAAKRFTLFSSNDAWDQVMKTILKDDLNQMKRMAFSFRQK
PSEPALELPKELVLKRIDEEIISNSTEFNSAYYEEYWSSASHFSSQGFGFAVLHGNHVVS
ECTSIFLGGNRAEMDIYTLEEYRGMGLAYCAGSKFIEFCLENGIIPNWDCDVCNKSSITL
AAKLGFKPVTEYSIFYSGKS
>PK3-2_00400 Arsenate reductase
MPKKTLYFLCTGNSCRSQMAEGWGKKYLGDKWNVYSAGIEAHGLNPHAVKAMKETGIDIS
NQTSDIIDPNILNNADLVVTLCGDAADKCPMTPQHVKREHWGFDDPAKAQGTDEEKWAFF
QRVRDEIGDRLKLFAETGE
>PK3-2_00401 Arsenical pump membrane protein
MSIGWSACGGAVLALIAGVVNFHDVLTVTGIVWNATLAFVAIIIISLILDNIGFFEWAAL
HMAKAAKGSGVRMFVYVSILGAIVAALFANDGAALILTPIVLAMVRALHFNEKLVFPFII
ASGFIADTTSLPLVVSNLVNIVSADYFHITFIDYASRMIVPNLFSLLASIIVLYLFFRKS
IPKRYDLTEVKKPAEAIKDQNMFKLSWYILGLLLVGYFASEFLSIPVSVVAVIIAICFLI
AAQKSPAVHTKKVLKEAPWAIVFFSIGMYVVVYGVRNAGLTDVLSDVIQAVADQGVFAGT
IGMGFIAAILSSVMNNLPTVMIDALAIAGTDTHGMMREALIYANVIGSDLGPKITPIGSL
ATLLWLHVLSQKDLKISWGTYFKTGIILTIPTLFITLVGLYFWLMMIH
>PK3-2_00402 HTH-type transcriptional repressor AseR
MAIDVAAMTRCLKTLSDQTRLMMMKLFLEKEYCVCQLVEMFEMSQPAISQHLRKLKNAGF
VNEDRRGQWRYYSINGSCPEFDTLQLILHQIDQEDELLHHIKQKETQACCQ
>PK3-2_00403 HTH-type transcriptional regulator AqdR
MQSKRGRPRDEGTHKAILSAAYDLLLEKGFDAVTVDKIAERAKVSKATIYKWWSNKAAVI
MDSFLSTATDRLPVPDTGSSVHDILTHATNLARFLTSREGTVIKELIGAGQLDAKLAEEY
RTRFFQPRRLQAKGLLEKGVQQGELRENLDIEVSIDLIYGPIFYRLLITGDEVNDSYVHD
LVMNAFKGVQAT
>PK3-2_00404 hypothetical protein
MNKLNKQTADQGVSPSLTLLLAAACGIIVANLYYAQPLAGLISEAIGLSPSSAGLIVTLT
QIGYVAGLLFLVPLGDIIENKKLVVVSLLLSAAALTATAFVKDGTLFLAAAFFIGLGSIA
AQVLVPFASYLASDAARGRVVGNVMSGLLLGIMLSRPISSLVADIWGWNAIFALSAAVSV
VLAIVLSKVLPARKPTADTNYTALLGSMWKLLRTTPVLRRRAIYHAFAFGAFSLFWTTVP
LLLSGPAFHFSQKAIALYALVGIAGAVAAPIGGRLADRGLTRIATGIALGVVIVSLLLPL
MIQSSSPVGIAVLVAAAILLDMGVSANLVLSQRAIFSLAPEIRSRLNGLFMSIFFLGGAA
GSSIGGWAYASGGWSAALWIGIAFPVIALLYFITEK
>PK3-2_00405 hypothetical protein
MNTTKKHKKFKAKMILQVIMVIIGGIIAAYGLETVLIPNSVSDGGVTGLSIVGSQLFNLP
LGILIAVINIPFVWLGYKQIGKGFALLSIIGIVSLAAGTSFFHHTPAIIEGDTLLITVVG
GIILGFGMGLALRNGGALDGIDMLAVLLSRKLPFGTSDLILFLNLFVFIFVSTVFGLQGA
LLSVIAYYIASKVIHVVEEGLSGSKTFQIITAEPELMVETIRDQLGRSATYKEAYGGFSH
EKFKEITCVINRLEETKLKEIINEIDKGAFVTVYDVAEVKGSNFRKPNTH
>PK3-2_00406 hypothetical protein
MKLDEFTIGQVFKTKSLTLTKDDIMRFAGEFDPQYMHVDEEKASKGRFNGIIASGIQTLS
ISFKLWIEEGFYGDDIIAGTEMNHITFIKPVYPDDELHTIVKVLDKQPKRNQLGILTVLL
STYNHKEEKVFEGELSVLIKQ
>PK3-2_00407 HTH-type transcriptional regulatory protein GabR
MDITPFLNRNLGIPLYQQLYRYFKENMHQGRIQKGMKLPSKRLLASQLSISQTTVERAYE
QLAAEGYIVSKPRSGWFADYHDSDFAYRKMKSASPMKEEAQETKQWIDFHYGNVDSSYFP
FSAWRKSMVNSLDQYGRELYRPGHVLGEFELRTLIAEYLYQSRGVHCDPDQVIIGAGNPI
LLQILCQVFEPNILIGYEDPGYPRARKIFEANRMNILPIPVDDEGICIQKIKEQQPNLVY
VTPSHQFTLGTIMTINRRIQLLKWAAEHQSFIIEDDYDGEFRYTGQPIPSLQGLDRHNRV
IYMGTFSKSLLPSLRISYMILPSPLLKKGHDIASLYKQTVSCHSQLTLADFIKNGEWQKH
INRMRKLYRKKRAILLEAVQRELGKHVRIRGENSGLRILLDVYMPFSEKELIEKAKEHGV
KIYPVSLSYQNNPPAKTVSLGFAGVSESNIREGIKKLKAAWDV
>PK3-2_00408 hypothetical protein
MNKTTNGWINGFIGVLIFSGSLPATRLAVADFNPLFLTVCRAAIAGVLAGSLLLIFRQQH
PAKRDIISLLVVAFGVVIGFPLLTALALQYVTSAHAIVFVGLLPLATAIFGVLRGDERPH
PVFWIFSATGSLLVAGFALIQGGGSSPLGDAYMLASIVVCGLGYAEGARLSRRLGNWQVI
SWALVLSLPLMLPLSFFFTPDSWSGIGTPALLSLAYVSLFSMLIGFVFWYRGLAQGGIAA
VGQLQLLQPFFGLLLASVILHEKVGWALVAVNIAVIMCVAAARRFAK
>PK3-2_00409 HTH-type transcriptional regulator LrpC
MFDHTDMQILEELSKNSRITMKELGEKVHLTGQAAASRVAKLEDNGVIEGYTIKVNQVKL
GCYIHALLNIFTKSTHHQPYLSFIKTQEKYVINNYKISGDGCYLLECRFPSNERLDQFLV
ELNKHVNYKLSIVINK
>PK3-2_00410 hypothetical protein
MNIQQIRNATLVVKYAGKTFLIDPMLGEKGVYPPFPNAPRQDQNNPLVELPTSVDNIIQN
VDAVIVTHLHLDHWDEAAKEVLPKDIKLFSQNEEDATEIRNAGFKNVEVLTENTVFEGIQ
LIKTKGEHGRGDILKLAGLVCGVVFKHESEKTLYVAGDTVWYNAVQEEIDTHQPDIIIVN
GGDNQFYEGGSLIMGKEDIYETHKAAPKAKIIVSHMEAVNHWGLSREELKSFIQEKGISS
HVLVPDDGESYSF
>PK3-2_00411 Fumarate hydratase class II
MLVTALNPYIGYENSAKIAKFAHKEGLTLKEAAVGLKLLTEEQFDEMVKPENMVKPNI
>PK3-2_00412 Fumarate hydratase class II
MPGKVNPTQCEALTMIAAQIMENDATIGFDSSQGNFELNVFKPVIIYNFLQSVQLLSDGI
KSFHDHCAVGIEPNKKTIKENIS
>PK3-2_00413 hypothetical protein
MKKRSKVFYSHVALLLLALLLAGCTGSKNEESKQSSNRAAAQSDQNDHETEDSTATGKDE
PESTTESEQSATKASTEHQSKESKTDESSETSSEDGKEDNGLAAYSSEKIEYARVWLQLG
PNQELDELNVRHISAGEPVNPNDDTSASYPEDVIQLAGSRLVDGSVTYSGNGDGTINVYN
VPLRWDSADHLDQGVMRETTENIIKNTKKVYVDTGDNEKIKQLIDIMVIH
>PK3-2_00414 Glucose 1-dehydrogenase 4
MGKFEGKIALVTGGTSGIGLATAQKFVNEGAYVYITGRRQNELDKAVNQIGKNVTGVQGD
ISKLEDLDKLYDIIKQEKGKLDILFANAGTGNFLPLGEITEEQVDRTFDINVKGTIFTVQ
KALSLFPDKVGSIIVTGSTAGSIGNPAFSVYGASKAALRALVRNWILDLKGTEIRVNVVS
PGGILTPAYDELFGDTLEEVMENSRNTVPAGKVGTPEEVANAVSFLASDESSYLTGIELF
VDGGLAQV
>PK3-2_00415 putative HTH-type transcriptional regulator YtcD
MKKFSCGFEVTKEVIGGKWKGLVLYFLMNGPKRTSELKRIIPNITQKMLIQTLRELEASG
LVSRKMYNQVPPKVEYSSTELGESLKPILQELCQWGSHYAEQEYAEGEFEIVPPEKVSY
>PK3-2_00416 hypothetical protein
MLKNLPVLLALLSVGGILNMISHTITLSVPFHWIVLLLGVALVFYSAVCLVAYNINQKRN
LSSK
>PK3-2_00417 hypothetical protein
MRKLRAIVLDCELTEECKWMHPCYTFNNKNIVLIHGFKEYCALLFHKGALLQDSHGILIQ
QTENVQAARQVRFPNVQEIVEVEAILKAYIQEAIEVERAGLQVKKNTEFTIPEELQNKFD
EIPALKTAFEALTPGRQRAYIFYFSQAKQSKTRESRVEKCVQKILDGKGLKD
>PK3-2_00418 hypothetical protein
MTNSKTNPKVDEFLSKATKWKDEYEKVESYRS
>PK3-2_00419 hypothetical protein
MLKRFCLVFLTLIMSIAVVLAAAKDSPGDNVISFDQPIILMISIGIIVFLFIPPLAMSFF
GNWVVRIISGVYQCFIVLTFLGLIPIGFLIPNGFLTILVSIAGTLVSIASVVVTLFIDRK
KEVTS
>PK3-2_00420 Riboflavin transporter RfnT
MLHKESEKALKVQTASSQPYINSPEKQKALYKRTLFVVSISQIFGGAGLAAGVTVGALIA
QEMLGTDAFAGLPSALFTLGSAGAALFVGRLSQRFSRRTGLSAGFIIGGLGAIGVIIAAI
INSVILLFASLLIYGAGTATNLQARYAGTDLANRKQRATAVSITMVFTTFGAVAGPSLVN
VMGDFALSIGVPSLAGPFILAAAAYILAGVVLFIMLRPDPLVIARAIESINQEPSDKEHL
TANGHAENKRGIVVGATMMVLTQIVMVAIMTMTPVHMRHHGHGLGAVGLVIGFHIGAMYL
PSLVTGVLVDKLGRTAMAIASGTTLLLAGLIAAFAPGDSMVLLVIALSLLGLGWNFGLIS
GTALIVDSTGTSTRAKTQGTVDVLIALSGAAGGALSGMIVAGSSFLTLSFAGGILSLLLI
PVVVWARGGKSSA
>PK3-2_00421 Vitamin B6 salvage pathway transcriptional repressor PtsJ
MPINSFENYPMSWKPSIDKTEKPIYKALAGQLEQDIINGGLLPGTKLPPQRELADYLDLN
VSTISKAFKVCELKGLLSASVGSGTFVSYDALSNAYLLEDTKPKHLIEMGATLPDHASYE
PLLHQLKNMLQDEDYEKWFGYGRAGESLWQKDAAVKLIRRGGFETAVDHILFANGGQNAI
AAALASLCKPGDRIGVDHHTYPGLKTVASMLSVQIMPIKSVNHEMSPQSLEYACKNENIK
GVYLIPDYHNPTASFMSVENRRMIAEIAKKYNLFVIEDASYHLLNKNPLPALASFAPEQV
IHIASLSKSLAPGLRLAYVAAPSQFKEPISKALYNLNITVSPLLAELSARTIVSNQFEVL
IESHREQTIRRNQIVNRYLADYTCLGVETGIFRWLLLPGKMTGAEFEELAAQHGVQVYAA
ERFVVGNSCPERAVRVSVCAPNTLEELEQGLMILKRLLTGLT
>PK3-2_00422 hypothetical protein
MDSLKRMNTALHYIEENLTNDIDFKEAARLAFCSEYHFKRMFSFLAGISLSEYIRRRRLT
LAAFELKDSSVKVIDMAIKYGYHSPDSFARAFQNLHGIRPSEARHNGHSLKAYPRMTFQL
SIKGGSEMNYRIEEKEAFRIVGIKKRVPILFKGVNPDIASMWESLDEAAINQLKKLSNAV
PLGLISASTNFSEGRAEENGELDHYIGAATTKQCPNHLSQLEVPASTWAVFEAIGPFPDA
LQEVWGRIYSEWFPSSNYEQIEGPEILWNEHKDVTSPAFKSEIWIPISKK
>PK3-2_00423 hypothetical protein
MADQREALRVRLEELVKHEILILREFRSEREKIYSRLRELERSYDILCRGKKSQSQSELI
EQTASAVKTSHITSKPIQQKRGDRAELNRTPPVKQH
>PK3-2_00424 Branched-chain amino acid transport system 2 carrier protein
MSKKVSSSYIIIIGLMLFALFFGAGNLIFPPMLGQMAGKNVWIANAGFLVTGVGLPLLAI
IAFVFSGKQNLQSLASRVHPMFGIVFTTLLYMAIGPFFAIPRSGNVSFEIGVKPFLSNDA
GPVSLIIFTILFFALACLLSLNPSKVIDVVGKFLTPIKLSFIGLLVVVAVVRPIGTIQAP
SKEYTSHVFFKGFQEGYLTLDALVAFVFGIIIVNALKEQGASTKKQLMAVCAKAAAIAAT
LLALIYTALSYMGASSVVKLGLLENGAEVLAKVSSYYFGSYGSILLGLMITVACLTTSVG
LITACSSFFHELFPSVSYKKFAVILTVFSTLVANIGLTQLIKVSMPVLMTMYPIAISLIL
LTFLHSVFKGKAEVYQGSLLFTFIISLFDGLNEAGIKIEAVNRVFTQILPMYSIGLGWLI
PAIAGGIGGYILSAFRTKKTDFSE
>PK3-2_00425 hypothetical protein
MTMTMTQQIITIAMVVLGTMLTRFLPFMIFPSGKPTPKYVQFLGKVLPSAVIGLLVIYCF
KDVSLFSGSHGIPELIGAAAVVLLHFWKKNMLLSIAGGTIVYMALVQLFF
>PK3-2_00426 hypothetical protein
MNKNKESLNSHYIYTHMNKRSQIWMAFRSAFPYTFPILAGFLFLGIAYGIFMHSLGFSAI
YPIIMSVMIFAGSMEFVAANFLLGAFNPMNALFLTLMVNARHLFYGISMLDKYRGTGKKK
LYLIYGMCDESFSINYTADIPANVDKGWFMFFVTLLNHLYWVAGAAIGGIFGSYVKFNTE
GLDFVMTALFIVIFIEQWMKEKKHHSALTGLGLSAASLMIFGGNQFIIPAMLAILGVLTV
LRKPLEKAEVSV
>PK3-2_00427 Leucine-responsive regulatory protein
MAIILDETDKAILRELQEDASISNLNLSKKIGLSPSACLARTKNLVETGVIKKFTTIVDE
KKLGIEVTAIALVNLSPLNRETIHSFLEDINKFPQVQECYTLTGSHDYMLKIVAKDMESY
RNFIIDSLMQNPAISGVDTSMVMSTEKRTVSVPIDEV
>PK3-2_00428 IS1595 family transposase ISBath1
MWKDVYEEFSELTKSEQMALFNAMKQDLFPDEPDKITKLLKSIREARFASGLGCVHCGRE
VHL
>PK3-2_00429 IS1595 family transposase ISBath1
MTNTPFSGSRYPEKWIKYIELIVEGYTLPKIAERLKIHISTAFYWRHKILNALGSLGFNQ
LQGIVESDETFFRESMKGREITHRKAKKHGEKEKKRGISNLKIAVVVAQDRNGNMIARKA
GTGRVKAEEIDTVIGEYIHPSSLLCTDTATNYKKFAKLKGLQHETVNERQKPRVKKGIYH
IQHVNNSHNRLKGWMERFQGVATKYLDNYLNWFRWLEIGKQIAFDERVKQMLVSACRKSN
HTTVEMLGCA
>PK3-2_00430 IS1595 family transposase ISBce21
MRPNLTKDINVDNFKDFYWLKEELQSFCRENGISASGSKIEISDRIETFLRTGEIKKPIR
KSKVDSKSEPQVDLSLDTIISENHRCSQNVRAFFKTVIPNFHFSTYIQNYFKNNIGKTYR
DVVDAWYKEEERKKDPSYKKKIAPQFEYNQFIRDFFADSNNQGKSREEAIEAWNNIKKLP
GSNKYTPNN
>PK3-2_00431 RNA polymerase-binding transcription factor CarD
MFQIGDNIVYPMHGAGIIEAIEEKEFLEEKQQYYVIKMSISNMTVMIPTRKVLSSKIRPV
TDILALKHIIHIFQHGESADRLLPWKQRYKVNTDKIKTGDIQEGAEVVRDLMRMKKEKAL
NASEKKMLDNAYEFLISELEVIKGITENQIKSFC
>PK3-2_00434 Cold shock protein CspC
MEQGTVKWFNAEKGFGFIERENGDDVFVHFSAIQGDGFKSLDEGQKVTFDVEQGARGAQA
ANVQKTA
>PK3-2_00435 Fatty acid desaturase
MVYNTGTSKAIKRFLDLEDHQGRGNFKKMNEQNLRTLRKLVSPYEKSDLQKSICQIINTL
APFLLLWYLAYKSLPISYFLTLAISVVAAGFLVRTFIIFHDCCHYSFFKNRKANRILGTI
TGILTLHPFDHWAHDHSVHHATSSNLDKRGTGDIWVLTVEEYKEASTKTKIMYRLYRNPF
VMFIIGPIYVFGITNRFNRKGAKRKERMNTYVTNLGIVALAALLCWAIGWKNFLLVQTPI
FMISGSLGIWMFYIQHTFEDSYFEEDKHWEYVKAAVEGSSFYKLPKIMQWLTGNIGFHHV
HHLSPRVPNYKLEMAHNNTEPLQNVPTITLATSIKSLKFRLWDEEGKKFVGFNHLKKTCK
RQVSDRLRTD
>PK3-2_00443 Protein SprT-like protein
MDNEELQKLTEDISETYFKKPFRHQALFNDRLKTTGGRYLLTSHNIELNRKYLIEHGREE
LIGIIKHELCHYHLHLEGKGYKHRDRDFRVLLQLVNAPRFCTPLKKKTESKKTYMYICTA
CGQQYIKKRAMNPDRYRCGKCRGKIKRIFS
>PK3-2_00444 Protein YhgF
METSALLKQQIAKEIGLSQKHVESVIRLLEDGNTVPFIARYRKEQTGSMDEVQIQTISER
WQYIQNLNQRKEEVIRLIAEQDKLTDDVKRKIEQSVKLQEVEDLYRPYKQKRKTKATVAK
SKGLEPLADYILTLPQDNRLAATADQYISEEKEVFTREEAIEGAKHIIAEQISDEPSFRK
WIRQETFKKGTIKSAAGKSADTDEKNVYEMYYEYEEPIAKVVPHRVLAMNRGEKEDILKV
SIEPPADHIKAYLEKQIIKNCSTSVKEILQETIEDSYKRLIQPAIEREIRKELSEKADEQ
AIHIFSENLRKLLLQPPMKGKTVLGVDPAFRTGCKLAVSDETGKVLEIDVIYPHAPVNKT
KEAHEKVKKILEQHQVEMVAIGNGTASRETEQFIVNVLKDMPRKIYYVIVNEAGASVYSA
SELAREEFPELQVEERSAVSIARRLQDPLAELVKIDPKSVGVGQYQHDVSQKRLNESLRF
VVETVVNQVGVNVNTASAALLQYVAGLSKSVAGNVVKKREEIGKFSNRKELKDIPRLGAK
TYEQCIGFLRVQEGTEPLDRTGIHPESYKETKALLKKLGLSTEQIGTAELKDKINQLALS
ETAKELGIGEITLKDICEQLTRPERDPRDEVPKPLLKTDVLQLEDLKEGMELQGTVRNVV
DFGAFVDIGVKQDGLVHISKLSNQFVKHPLDVVSVGDIVTVWVDGVDVQKGRVSLSMVK
>PK3-2_00445 hypothetical protein
MEWHSKFSGPSTSPGFLLWQATQSWQRKVGKALAEFDLTHVQFVLLTSCKYMIVHGETVT
QKKLASFSQTNIMMVSEVVRTLEKKGFIQRSKNPQDKREVLLSITETGEEKVTAALPIVE
EIDQAFFSAAMKEENFLNGLRELLKNE
>PK3-2_00446 hypothetical protein
MNTKYWIGVVSEQHVLKGADGGFAQLCHGKKAPLTKMKEGDWLIYYSPRDAYPDGKLLRS
FTAIGKVKSGNIYPYQMAPNFIPYRLDIDYYPCQKIGFYSIKSQLEFVQETKHLGFLFRR
GHFEISKNDFLTISQAMGVNISGMAL
>PK3-2_00447 hypothetical protein
MWNYEYTAIADADLEKIWNRYQETETWDQWDVGIASVSLKGPFQNGTEGTLLLQGHTVLF
WLEHVEKHRSFSVMANMPHNNVKMAFSHVLQKQKGGLHITHGVVLDGAEAQKWGEIIGPE
LSKDIPAAVNRLVHLCGGVIK
>PK3-2_00448 Phosphoserine phosphatase RsbX
MIQVEENEHIQTLVYQLNKEGKSVCGDSFFMKADDKELICAVADGLGSGSLANESSAAIK
DLVENYANEDVQSIIERCNQAMKNKRGATASILKINFEQRQFTYCSVGNVRFILHSPSGE
SFYPLPISGYLSGKPQKYKTHTATYEKGSKFIIHTDGLNVPDIRSHLKKGQSVEDISNSL
KMYTTSRKDDLTYILGQLA
>PK3-2_00449 RNA polymerase sigma-B factor
MTQPSKTTKLTKDEVDRLISDYQTNQDEQAQETLVRVYTNLVDMLAKKYSKGKSFHEDLR
QVGMIGLLGAIKRYDPVVGKSFEAFAIPTIIGEIKRFLRDKTWSVHVPRRIKELGPRIKM
AVDQLTTETQRSPKVEEIAEFLDVSEEEVLETMEMGKSYQALSVDHSIEADADGSTVTIL
DIVGSQEDGYERVNQQMMLQSVLHVLSDREKQIIDLTYIQNKSQKETGDILGISQMHVSR
LQRKAVKKLREALIEDPSMELM
>PK3-2_00450 Serine-protein kinase RsbW
MKNNADYIEMKVPAQPEYVGIIRLTLSGVASRMGYTYDEIEDLKIAVSEACTNAVQHAYK
EDKNGEVSIRFGVFEDRLEVIVADEGDSFDFDQKQQDLGPYTPSHTVDQLSEGGLGLYLM
ETLMDEVRVQNHSGVTVAMTKYLNGERVDHDTTIKNYETN
>PK3-2_00451 Anti-sigma-B factor antagonist
MNINVDVKQNENDIQVNIAGEIDVYSAPVLREKLVPLAEQGADLRICLKDVSYMDSTGLG
VFVGVFKTVKKQGGSLKLENLSDRLIRLFDITGLKDIIDISAKSEGGVQ
>PK3-2_00452 Phosphoserine phosphatase RsbU
MDFREVIEQRYHQLLSRYIAELTETSLYQAQKFSRKTIEHQIPPEEIISIHRKVLKELYP
SLPEDVFHSLDFLIEVMIGYGMAYQEHQTLRGIQQEIKSEIEIAANVQQTLLGTKIPQEE
ALDIGAISVPAKQMSGDYYHFVKDKESINIAIADVIGKGIPAALCMSMIKYAMDSLPEMG
IHPSQVLKNLNRVVEQNVDASMFITMFYANYNMVNHQFTYASAGHEPGFYYSQKDNTFYD
LEAKGLVLGISQDYDYKQFDQYLEKGDMIVLFSDGVTECRTENGFLERPDLQKLIEEHMC
SSAQEMVKNIYDSLLKLQDFQLHDDFTLIVLRRKV
>PK3-2_00453 Serine/threonine-protein kinase RsbT
MNDQSCVKIMTEWDIVAARQLGRNVAKELGFGTVDQARITTAISELARNIYLYAGKGQIG
IEQVSDRGKKGLKIIAEDQGPGIPDIRKVMEDGFSTSGGLGAGLPGVKRLMDEFSLNSVS
GEGTEIQAIKWLR
>PK3-2_00454 RsbT antagonist protein RsbS
MRHPKIPILKLYNCLLVSIQWELDDQTALTFQEDLLNKIYETGANGVVIDLTSVDMIDSF
IAKVLGDVITMSKLMGAKVVLTGIQPAVAVTLIELGIALEEIETALDLEQGLETLKRELG
E
>PK3-2_00455 RsbT co-antagonist protein RsbRA
MSNQTVYQFIAENQNELLQLWTDTLKELSQQESYQLTDQVYENISKEYIDILLSSVKDDT
AAEDQISELALKAVQIGLSLKFLATALAEFWKRLYTKMNDKRLPDQESTELIWQIDRFFS
PINTEIFNQYSISWEKTVSLQKIALQELSAPLIPVFENITVMPLVGTIDTERAKRIMENL
LNGVVKHRSQVVLIDITGVPVVDTMVAHHIIQASEAVRLVGAKCLLAGIRPEIAQTIVNL
GIDLSQVITKNTLQKGIQTALEMTDRKIVSLGE
>PK3-2_00456 Endoribonuclease EndoA
MIVKRGDVYFADLSPVVGSEQGGVRPVLVIQNDIGNRFSPTAIVAAITAQIQKAKLPTHV
EIDAKRYGFERDSVILLEQIRTIDKQRLTDKITHLDDEMMDKVDEALQISLALIDF
>PK3-2_00457 Antitoxin EndoAI
MSESSARTEMKISLPENLVAELDGVAMREKRSRNELISQAVRAYVSERTTRHNRDLMRRG
YMEMAKINLNISSEAHFAECEAETTVERLVSGG
>PK3-2_00458 Alanine racemase
MMSTKPFYRDTWAEIDLSAIKENVSNMKKHIGEHVHLMAVVKANAYGHGDAETAQAALDA
GASCLAVAILDEAISLRQKGLKAPILVLGAVPPQYAAIAAKYDVTLTGYSVEWLQEAARH
TKEGSLHFHLKVDSGMNRLGVKTEEEVQNVLAILDRNSRLKCKGVFTHFATADEKERGYF
FMQFERFKELIAPLPLKKMMVHCANSAAGLRLKKGFFNAVRFGIGMYGLHPSAEIADEIP
FQLRPAFTLHSTLSHVKLIKKGESVSYGAEYTAEKDTWIGTVPVGYADGWLRTLKGTEIL
VKGKRLKIAGRICMDQFMVELDQEYPPGTKVTLIGRQGDEYISMDEIAGRLGSINYEVSC
TISSRVPRMFLENGSIMEVRNPLLQENASK
>PK3-2_00459 Sporulation protein YdcC
MRKSFVLLLTGLLAVLILSACGQKTQQDIVTGLDEKAKEYTSYKAKAKMTIETGSEPQVY
NVEIWHKKPSLYRVYLENPKKDQNQVILRNENGVFVLTPSLNKSFRFQSDWPNNSSQVYL
FESLVKDVQNDSDAVFTAKEKKYVFETKTNYQHNKMLPTQEITFNKKDMSPLSVKVMDTD
RKVMVKVEFSSFEFNKQFDKESFDEKKNMTLSQMDVATSAKPSDTFAVKTPLELPLGVKL
LEEKDITTEDGKRIIMTYGGEKSFTLIQEKAQIAKASSSVTLNGEPVNLGYTIGALSDSS
LSWTYDGVDYLLSSKDLSKEEMVTVAKSMQGQSSK
>PK3-2_00460 Holo-[acyl-carrier-protein] synthase
MIYGIGLDITELKRIASMSGRQKRFAERILTQSELDQYHELSEKRKIEFLAGRFAAKEAF
SKAFGTGIGKQLSFQDIEIKKDQNGKPYIICVKLSQAAVHVSITHTKEYAAAQVVIERLS
S
>PK3-2_00461 Rhomboid protease GlpG
MFIRTENFQTIIRLYPVVTFILALQAVLWLFFSLPVHSVVLWRDAVTGYNLGVANGEWWR
LITPVLLHAGFTHLLFNSMSIFLFAPALERMLGKARFLLVYAGSGIIGNIGTYVTEPLDY
VHVGASGAIFGLFGVYLFMVLFRKELIGQEHSKMILTLLAFAVLMSFINSNINMMAHLFG
LCGGFLLSFLCVQKKERRY
>PK3-2_00462 hypothetical protein
MMSEPKRLHPAAVILNLCHTIIQTIKNIILPFFFVYIVNSNNTVRFYGAIALGVLFIWLV
AASIIKWRRFTYRIEDDEFRIEEGLFVTKKRYISIERIQTMNTSAGVIQQIFKLVKLQIE
TAGGGKEAEAVLSAISVEEAERIKEAVFKKKAQRRESERDGDCPEAEQELIPAVEPQEQY
RMNAKELLMAASTSGGIGVIISAVLALISQLDEILPMDWFFDKFSFLQHANVGIYAVLIF
IGLFIAWIFSIAGMMFKYANFQIIKKEQELVISRGIIEKHQVTIPLRKIQAIKIKENIIR
QLFGFVTVSIVSAGGGDREKEEGALTILFPMIHKKKLPHMLRTFTPEYTLEENVRRLPRR
ALKRYLFRSVIFSIFLIIPLCIFFQPWGYLSIILLPAELLFGYLAYKDAAWTINGDRLQL
TSRFISRTTGIVLKRRMQVCKFSQSYFQKKGRLYTISTSVKSSSLMEELSVRDVGEEDAG
FILNWYSYEKADG
>PK3-2_00463 hypothetical protein
MREQPKNQISPDGLKVWRLQEIIVSAVCLLIVIAVAVLSYYFHWPYWISGVLGAVWLLGS
IVTVFIIPKIRHKVWRYEVHEHEIDIQSGIFVVTRVIVPMVRVQHVDTSQGPLLKKYNLA
TVKISTAATVHSIPALEMGEADRLRDSISRLARVTDDDV
>PK3-2_00464 DEAD-box ATP-dependent RNA helicase CshA
MTITFQDFNLSSDLMKAINRMGFEEATPIQAQTIPLGLSNKDVIGQAQTGTGKTAAFGIP
LVEKINPESPNIQAIVIAPTRELAIQVSEELYKIGQDKRAKVLPIYGGQDIGRQIRALKK
NPHIIVGTPGRLLDHINRRTIRLNNVNTVVMDEADEMLNMGFIDDIESILSNVPSEHQTL
LFSATMPAPIKRIAERFMTEPEHVKVKAKEMTVSNIQQFYLEVQERKKFDTLTRLLDIQS
PELAIVFGRTKRRVDELAEALNLRGYAAEGIHGDLTQAKRMVALRKFKEGAIEVLVATDV
AARGLDISGVTHVYNFDVPQDPESYVHRIGRTGRAGKTGMAMTFITPREKSMLRAIEQTT
KRKMDRMKEPTLDEALEGQQQVTVERLRTAISENNLNFYMTAAAELLEDHDAVTVVAAAI
KMATKEPDNTPVRLTDEAPMVSKRYKNQRSSKRRDGQGGGYRGGKGKSNNRSSYDKKRSN
DRRSSGSGDRRQKKSY
>PK3-2_00465 UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase
MIKRTVKNIAEMVKGTLTNPQYEQTVIHGVATDTRKLEQHQLFIPLKGEHFNGHTFVPQA
FEAGVAAVLWDRSEPNAPESQAVILVDDTLSALQQLAKAYLQELGTRVIGVTGSNGKTTT
KDMIHAVLGTRYRVHKTGGNFNNHIGLPLTVLAMPEDTEIAVLEMGMSAKGEIDLLSRLA
NPDAAVITNIGESHMQDLGSREGIAEAKLEIINGLKEDGVLIYIGDEPLLQKAYSCETKT
YGTGEQNDYQLQDVSQSEAGTHFTIKGMENSFFIPILGKHNVMNAMAAIAAGAYFGIAPE
DAVKGLSGLKVTGMRLELIKTDSGISIINDAYNASPTSMKAAIQLTESLDGYGKKMLVLG
DMLELGDLEETFHKECGAVISPEKIDRVFTYGKLGAFIAEGALQHFEKDRVSHYDEKKDL
LQAVKENASKGDLILFKASRGMKLEEIVKDLIESPLS
>PK3-2_00466 D-alanine--D-alanine ligase
MKTSLGLVYGGKSAEHNVSLQTALAVIKALNTEKFDIHPIYITEKGEWVRGARLTEPVSN
VKMLQFEQGGSAFSPAALNQEMFPQEASQQNEAIDVVFPLLHGPNGEDGTIQGMLELLNI
PYVGNGVLASSAGMDKVVMKHLFAQAGLAQAKYAAFLKKDWTRSPEESCEQVEQELGYPC
FVKPANLGSSVGISKCRDREELQKAFELAFQYDRKVVVEEGINGREIEIGVLGNDDPKCS
VVGEIAPKTDFYDYKAKYEDGDTDLMIPANVTDEEYAKISDMAIKSFKAIDGSGLVRADF
FLTADGEVLINEVNTMPGFTPFSMFPLLWKEAGVEYADLIEQLVELAKERHAEKQLIKHT
F
>PK3-2_00467 Thioredoxin-like protein YdbP
MKKITTNEQFNELIQSDKEIIVKFYADWCPDCTRMNMFIGDILEEYNQNDWYELNKDELP
ELADKYQVMGIPSLLIFKNGEKTAHLHSANAKTPEEVTEFLSEHIS
>PK3-2_00468 Manganese efflux system protein MneS
MERTENLKKGEKGALLNILAYVILAVVKLVIGILYHSEALRADGLNNGTDIVASVAVLIG
LRISQRPADSDHPYGHYRAETISSLVASFIMMVVGIEVLIGGGRAIAGGTTETPSLIAAW
TALGSAVFMYGIYIYNKRLAASIKSSALMAAAKDSRSDAFVSAGAFIGVMSSQLQLPWID
PVTAFIIGIIICKTAWDIFKDASHSLTDGFHLKDLEPYKQTVGRIGNVHRLKDVKARYLG
STVHIEMVITVDPKLTVEEGHGVADEVEDKIKHEHDVTHVHVHVEPDDIK
>PK3-2_00469 hypothetical protein
MTPQSAETRKKQLIHLLIQNGIYKKSKRHLYELSLTELESEYKHVRRAPEHAEA
>PK3-2_00470 hypothetical protein
MPKRKVKTYQQLIQENKEAIMGNPKLMNVIYDRIDRKHQKNLQEQNNT
>PK3-2_00471 Putative acyl-CoA dehydrogenase YdbM
MSLFIQNDQQWQWMEKIGRLADEFQQTAAEDDEQGRFPVEKIQKLRNAGYTALTLPASHG
GGGISVYDMLLFQERLARGDAAAALSIGWHLSVIGELGEGNSWDKDVFAFIAKEVQNGAV
INRAATEAQTGSPTRGGRPGTNAVKKDGKWAVNGRKTFTTMSQALDYFLVTAWIEEKQTT
GVFLIHKDDPGLSIEETWDMMAMRATGSHDLVLNEVTLEEDKLVELLQGPRGAKPNGWLL
HIPAIYLGIAQAARDYAVQFASEYSPNSLKGPIKDVPAVQQRTGEMELELLNARHFLFHI
AQLYDDPKRRPHLRSELGAAKHIVTNAALSVVDKAMRIVGAKSLELTNPLQRYYRDVRAG
LHNPPMDDAVIQKLAAEAFES
>PK3-2_00472 hypothetical protein
MRNFITALPIVLLLGFSFVSFMFQFEHLVYFRLALGLFSLAGLYMIYKMKTGIRYFIIYL
YASWIVLAAVTAFEEPIFSSFFFGGLVMTMGYLTYMLIYLGMKQDRDANPV
>PK3-2_00473 hypothetical protein
MSKLIWNEHMKLFNRKVTFVSLILMAVFQFFMALIIKRIVISAGTDENFIGYLSYTPSLN
ILLQALTIVIAATIVSMEFDKKTIKFLLIRPVKRQKIFWSKLITVVMVSFYLYLAYYILA
LLFGLVFFGTSVSAESKTLLINTLELIGSNWLEAVMMGLFGLLCSSLFRNSAVAVVVSFV
VLYGASTLVQLMKLFENKWGSFLLFANTDFTQYSSGQTVLFSGMTPLFSVGIIIIHAIFF
IAVGWWCFCKRDVRV
>PK3-2_00474 Bacitracin transport ATP-binding protein BcrA
MAEPILHIEGLDKKIGSKQILKQISMDVMEGEIIGLLGPNGSGKTTLIRIIVGLLTQNSG
NVTISGFQHDTEFEKAMEAVGAIVENPEFYPYLTGWENLKHFANMHKKIADERLDEVVER
VGLTSAIHDKVKTYSLGMRQRLGIAQAILHRPKLLILDEPTNGLDPAGMKDFRDHIKELA
EQEGTAVLFATHLLREVEDLCDRVIIIQKGEIKAEVSLHGTDQKTEKAVIEVQPEEKALN
WLAGNQYQAERQDGAIVVEVAKENIPELNRSLVGQGLNVFSIMPYTQSLEDEFIKATAHQ
EEGEELV
>PK3-2_00475 Proton/glutamate-aspartate symporter
MKLATKIIIALVLGAVTGIILNVTSPELFENLNKFVFGPLGTIFLNLIKMLVVPIVFFSL
TLGVAGLGDPKKLGRIGVKAISYFLITTAVAITIAIILALVIKPGEFGTYDTSSAEFTAE
KAPSIADTLLNIIPTNPVQAMTEGNMLQIIAFAIFVGLGITMLGKKADMLLKVVEQGNEL
MMYLVNLVMKFAPYGTFGLIATAIGSQGFSAMKAMGLYMIVVTVALLIHAVVTYGSTVAL
LARRNPITFFKDFFEVMVVAFSTSSSNATLPVSMDVAQKKLKVPEPISSFVQPLGATINM
DGTAIMQGVATIFIAQVFGHDLTFTQLLMVILTAVLASVGTAGVPGVGLIMLAMVLQSVG
LPVEGIGLILGIDRLLDMLRTVVNTTGDAACAVIITETEKNKQPEQAPTLSV
>PK3-2_00477 hypothetical protein
MAALVKFFQHPGVRRFSVFVVLTGVLYLFKSMINLILLTFIFTFLMDRLELVVRQFLSQF
FRVSQRVVITFLYMLLAVLLTVGGFVFYPVVAAQIQQLVKQIKHIAYHPDTIPFFDEITS
VFGDINISSYVKEGFNVVYTYLADISTFGLQIVMALILSMFFLFEKKRLSEFMGKFKTSK
LAVFYEEIAFFGSKFARTFGKVLEAQFIIALVNCILTFIALWIMHFPQLFGLSIMVFFLG
LIPVAGVVISLIPLSIIAYSTGGGMYVLYIVLVIFAIHAIETYFLNPKLMSAKTELPIFF
TFTVLIFSEHFFGIWGLIIGIPIFVFLLDILDVTNKEEGPKRFQEKSNKK
>PK3-2_00478 C4-dicarboxylate transport protein
MKLFKNLTVQVITAVIIGVIVGLVWPDVGKEMKPLGDTFINAVKMVIAPIIFFTIVLGIA
KMGDMKKVGKVGGKAFIYFEVVTTLALIIGLFVVNIMKPGAGLDYSKLEKGDVSQYTQNG
GQGIDWIEFVTHIVPSNMVDAFAKGDILQVLFFSILFGVGLAALGEKGKSVIDFFDKVSH
VFFKIIGYIMRAAPIGAFGAMAYTIGHFGLDSIKPLASLMMSVYITMFLFVFVALNIICK
LYGFSLWNYLRFIKDELLIVLGTSSSESVLPRMMDKMERYGCSKSVVGLVIPTGYSFNLD
GTSIYLSMATVFLAQVFGVDLSIGQQITIILVLMLTSKGAAGVTGSGFIVLASTLSALQV
IPLEGLALLLGVDRFMSEGRAIVNLIGNGIATIIVAKSENEFDEAKSIEAVEGMKKMKTA
V
>PK3-2_00479 Transcriptional regulatory protein DcuR
MARKEWKVLLIEDDPMVQEVNKDFITTVKGFTVCATAGNGEEGIKLIKEKQPDLVILDVY
MPKKDGIKTLQEIRKQKLEVDVIVVSAAKDKETISLMLQNGAADYILKPFKLERMRQALE
KYKQYKQKIEANDTLSQEQLDAILHMPQQSVQELPKGLNHFTMNEVTAFLKQQTAPLSAE
EVAKALGIARVTARRYLDYLEKNGTIKLDVQYGGVGRPVNRYVFKG
>PK3-2_00480 Sensor histidine kinase DcuS
MNKKKLSIRWKITILSYILVIFSFLIGGIVLIGNIQHTEERELKKRLMNTARTVSEMTEV
KEALTRKKQTEAVRRAVEEIRMINEADYIVVMDMNHIRYTHPVSTSIGKKSEGADEEAAF
AEHIYFSEAKGEIGTAVRAFYPVKDHDLNQIGVVLVGKTLPGIADILLHLKRDIAFIVVL
TLGFGLAGSLLLARHIKKQMFQLEPHEIVRMYEERTATFHSMNEGVIAIDNRLIITIFNE
KAKQIFEVQGNLVGKVIWEVLKDSRLPEIVERNKAVYNEEIRVSGKVIMSSRIPIVMKKK
VIGAVAIFQDRTEAAKMAEELTGVKNFVEALRVQNHEHMNKLHTIAGLIQLGKSEKALQL
AFQASTEQENVTEFLHRSIQNDAAAGLLLSKIRRGRELGIAVHIDENSSLQQFPEHVDQH
DIVVLLGNLIENAFGSFETVQSDDKRIDISIEQTDDILAILIEDNGCGIETAHMPRLYDK
GFTVNKTGGTGYGLYLVKQITDKGSGAIEVDSHAGRGTSFSIVFPMKGEEAQHGS
>PK3-2_00481 C4-dicarboxylate-binding periplasmic protein DctP
MKSLLACLALMIAGIATALFIGFHDRSGSKEIVYDDDQEGLQDQIVFKFSHVVAENTPKG
LAANKFADLVNEKSGGKMKIEVFPNGSLYSDIEEIEALQNGDVQFIAPSTSKLGMLSPEW
GVLDLPYAFTDYDAVKKGLNGSIGTQLFDSLKKNQLKGLAYWTNGFKQITTNQGPVKTPD
DLKGQDLRIMQSDVIEDQFKLLGAAPHQESFNSTFQLLENNVVDGEENTISNIYSKKFYN
VQDYLTISSHGYLGYAVMTDEHFWNAQTPETRRILTEAMKETTEWNETYAEQMNKEQLDE
IKKNSSITIYELTEKEKKAWMKGTDPVYRKYEPIVGRKLIQALLELRENS
>PK3-2_00482 putative manganese catalase
MFKHTKMLQHPAKPDRPDPLFAKKMQEILGGQFGEISVAMQYLFQGWNTRGNEKYKDLLM
DTATEEIGHVEMIATMIARLLEDAPLDQQEKAAEDPVIGSILGGMNPHHAIVSGLGAMPE
SSTGVPWSGGYIVASGNLLADFRANLNAESQGRLQVARLFEMTDDKGVKDMLSFLLARDT
MHQNQWLAAIKELEAQEGPIVPGTFPKALEKQEFSHQLINFSEGEESAGQTWLNEKAPDG
EAFEYVKEAKAFGEKPELKPAPPFVHDTLPGRE
>PK3-2_00483 hypothetical protein
MLIKKIVCEIDAANAEAFAKAQSQWGALSHVNGFIKQAGGWRKTIDGPLIAEIISVWENR
AAYDHFMENEHDSIYDGNEQKAVIHSIEVTLYEEDELFDDLLHHPDIQYEPDWTVLKT
>PK3-2_00484 hypothetical protein
MSEMQNLLAIANEVKEKHANFSISEVNDHCVRLAVFTGEYDWHHHPDSDELFIVLEGELL
IDFKDKETAVLKANDSLLIPKGTVHRTRSYVRTVNLCVEHKHAETVITENSSC
>PK3-2_00485 Glucose starvation-inducible protein B
MADNNKMSREEAGRKGGETTSKNHDKEFYQEIGKKGGEATSENHDKEFYQEIGEKGGEAT
SRNHDKEFYQEIGEKGGEATSENHDKEFYQEIGRKGGEATSKNHDKEFYQEIGSKGGNAR
NND
>PK3-2_00486 hypothetical protein
MTTERKEDLHQQLKEIEKWEKDQQKVWFWEKLSRLPFQLLDKLTPEFIQKKIGTLLEEVG
SFVQTGGQYLTSEKQIIKMFQKKLPDEIFESLEDVRKAPLLVMDEIAEGMGKNRINAATV
QGATTGVGGVFTLAADIPAVLGLSLKTLQDIAVAYGYDPKEKKERVFIVKCLQLTSADVV
GKKSILQELKDYDQDRTYKNVASQIQGWREVVLGYRDTFGWKKLFQLVPVAGMVFGAATN
RSTINDITETGMMLYKKRRILERLKETQQEMV
>PK3-2_00487 hypothetical protein
MPWSMKDYPASLKNLEKPVKKKAIEIANAMIDEGYEDGRAIPIATSKAKEWAENASNEEI
DDFLKHDDETERDEDPSSGGDPELMDKAEHVIKHKNSWAVKAEGAKRVSEIKDTKKEAIE
RAKEIAAHKGTGVIVHLADGSVQRKIKTGS
>PK3-2_00488 hypothetical protein
MISFLVSLVVAIVIGLIGSAIVGNRMPGGIFGSMIAGLIGAWIGHGLLGTWGPSLAGFAI
FPAIIGAAIFVFLLSLVFRGLRKEA
>PK3-2_00489 Divalent metal cation transporter MntH
MMNKDITAQSPRSKAVQDALDGKIKGFRGLLPFLGPAFIAAIAYIDPGNFATNISAGSKY
GYMLLWVILFSNIMALLIQSLSAKLGIATGKNLPEVAREEFPKPVSIGLWIQGELVIIAT
DLAEFIGAALGLYLLFGIPMLEASIIAAIGSFAILELQRRGYRSLEAGIAGMLFVVVIAF
ALQTFFAKPDAASVMKGLFVPTFHGTDSVLLAAGILGATVMPHAIYLHSALTQRRVVGKT
DAERKKIFRFEFIDILIAMLIAGAINASMLIVAAALFFKNGLFVEDLDVAFQQFGHLVSP
VSAMLFGIGLLVAGLSSSSVGTLSGDVIMQGFINYRIPLYVRRFITIIPPILIIASGVNP
TSALVLSQVVLSFGIAFALIPLIMFTSNKRIMGSLINSKWVTVVSWLIAVLIVALNVFLI
IDTFR
>PK3-2_00490 hypothetical protein
MSVFILFYLWIVPIVIGILCSVAAYKSKGKMRIAPGIAMIVLSIISLITAFTAGHTNFHV
FIGGMFLFGTLLAGSAFPFFFGLKKKEK
>PK3-2_00491 hypothetical protein
MFEFIKLAVYLFGSAGMIYAACHDLRHAQNGQKDKCIFFQNKKISAFVLVCFICLFLSNL
TECMSL
>PK3-2_00492 Putative thiamine pyrophosphate-containing protein YdaP
MVHKTAGQAMAELLEQWGVDHVYGIPGDSINEFIEELRHERNRLNFVQTRHEEVAALAAA
AEAKLTGKIGVCLSIAGPGAVHLLNGLYDAKADGAPVLAIAGQVSSGEVGRDYFQEIKLE
QMFEDVAVFNREVHSAESLPDLLNQAIRTAYSKKGVAVLSVSDDLFAEKIKREPVYTSPV
YIEGNLEPKKEQLVTCAQYINNAKKPIILAGQGMKKAKRELLEFADKAAAPIVVTLPAKG
VVPDKHPHFLGNLGQIGTKPAYEAMEECDLLIMLGTSFPYRDYLPEDTPAIQLDSDPAKI
GKRYPVTAGLVCDSALGLRELTEYIERKEDRRFLNACTEHMQHWWNEIEKDETEAATPLK
PQQVVARLQEAAADDAVLSVDVGTVTVWMARHFKMNANQDFIVSSWLATMGCGLPGAIAS
SLAEPDRQAIAVCGDGGFSMVMQDLPTAVKYKLPITVVILNNENLGMIEYEQQVKGNIDY
VTKLQNVDYAAFAESCGAKGIKVTRAEELAPAFHEALHSDQPVVVDVMIGNEPPLPGKIT
YGQAKGFSKYMLKNFFENQKIEMPSLKKSLKRLF
>PK3-2_00493 RNA pyrophosphohydrolase
MYTKGAFVIVTNEKHQILLVKRKDVPLWDLPGGRVDPGETAEAAAVREVLEETGYSAVLS
AKIGVYLRPKFQDEQYVFAGNITSGRAIVTGMETADMKWFSPQRLPLLMVPNRKRQISDF
MNGARDVHVILKDTSMLAAIDLFKRRLGK
>PK3-2_00494 Potassium transporter KimA
MYHSIKRFLIGKPLKSQAAGEQKLTKLKALAMLSSDALSSVAYGTEQILIILATISAAAF
WYSIPIAVGVLILLLALILSYRQIIYAYPQGGGAYVVSKENLGEKPGLIAGGSLLVDYIL
TVAVSISAGTDAITSAFPALHDYHVPIAVFLVIVIMILNLRGLSESASILAYPVYLFVVA
LLVLIAVGLFKLMTGQIDQPVHHTPLGTPVAGITLFLLLKAFSSGCSALTGVEAISNAIP
AFKNPPARNAARTLAMMGILLAILFAGITVLAYGYGTAPKPNETVVSQIASETFGRNVFY
YVIQGVTSLILVLAANTGFSAFPQLAFNLAKDQYMPRMFTVRGDRLGFSNGIIFLGIASI
VLILLFGGQTEHLIPLYAVGVFIPFTLSQTGMCIKWNKQKPKGWIGKMLINACGALISFM
VLSILFVTKFNVVWPVLIFMPIVVLLFYVIKNHYTAVGEQLRIVDEQPEEIKGTVVIVPV
AGVTSVVQKSIQYAKSLSDQVIAVHVSFDREQEKKVEKRWEELHNGVRLVTLHSSYRSLV
HPFDKFLETVEAKAKKEQFSVMVLFPQFITKKRWHTILHNQSAFLLRVRLFWKKDIMVAT
LPYHFKK
>PK3-2_00496 hypothetical protein
MTFLKQIMIFLTSLMLMAMTGQAAFAKEVQVSGSLLGKSSQEQAKQQVLTSDLITLYGSK
DSAELTYQIPAGASSGNQQLVIEYEASNLLISPSSLTAVIDNEPVKTLKLDGDSKRKTLK
LNLNKSQSAQGYHNVSLKFYGVMKEGVCVRQDTSGNWIKIYPDSRLTLADSSEAKGTSLD
HYPYPFAQSGNTAEKTAIVIPDEPSSAEIEAAVKTEGYLKTVDSSVSISYVTESDLKKID
KPTIFIGVDKHWNGKVKNLMKQAGLQAKGEKLLLAERVLKSEGKQQPVLFAQAASDDVLT
EKISVITNQTYTGQLSGDTLSISKLQQTEKKESNKLALENFGADDITIGADKTSSAHYFY
PASAVLDQNQSAKLSLKLKKSETIQASTAENESSSQAAELKIMINGQPHSVRLDELGKED
KNGFYHVTVKVDPKLLQKNRYIDIQFVTTGLKENNPCNTTDEEKWVFIDKSSTLSYGIKG
TSPSADFQEWPLPYAGTQEQTTMIVLPDNVSQSKLKELSLVTESFGSEAQHAYTVKKSSE
VTANDAKERNLIFIGGINQFSLLKEKSSDLLVPQAKDGSFDVSGFEMLNETTKQVAFTQA
SPWDSRYTMAVFTSSKGNGAAVTKEIINYLNSTDDSATVVNETDSQQVFTNHQQLKSETN
SSSAEQPSQDNSQKWLYIGVLALIMVIAAVFIWIAVRRRKRKTDTE
>PK3-2_00497 hypothetical protein
MIMSNTIFVVNLFYDLDLSVGFLAMILWILAFFLFMTEVMITLSIEKTEMNKQNFFIVFL
MYFTYSQAWIVLVIYSLFVEIKHRLFKQEVKWYKTERYNQHKSG
>PK3-2_00498 Poly-beta-1,6-N-acetyl-D-glucosamine synthase
MGNTLFFISLSLIWVMLLYHMFLMQGGFRHYMTFERNIPKWRENMKELPKVTVLIPAHNE
EVVIRQTLKAMVNLYYPKDRLEIIVVNDNSSDRTGDIVNEFSEKYDFIKMVITKPPNAGK
GKSSALNSGFAESNGDVICVYDADNTPEKMAVYYLVLGLMNDEKAGAVVGKFRVINAAKT
LLTKFINIETICFQWMAQGGRWKWFKIATIPGTNFAIRRSIIEKLGGWDDKALAEDTELT
IRVYNLGYHIRFFPAAITWEQEPETWKVWWRQRTRWARGNQYVVLKFLAQFFKLKRKRII
FDLFYFSLRTSCFSLV
>PK3-2_00499 hypothetical protein
MNYKVITLLCVTMLLLSAIASFPVSAQAKEQDAGILIIYSTLDGKESSQVKMLDLLAGHF
TSHVAVKKDSDVVASDLKGKDHVIYYGQTKRKLSKKLVSFISSVKKPVVAIGYNAGQISQ
FSGLSLAGKENVYQVHSRSEKTDVSLESGLNVLSVSGLKGKALYTFKADDGKTHSFIWKT
KKANVYIGLTNLLNDNLIVAKQLRDAFGEKAETTLLYLRLEDISPMSDEKLLLQAGTYLY
KRHVPFILAVIPVYLNPETGDKVYLSDKPKMVKVLKKLQSMGGSIIVHGYTHAYRYSETG
EGFEFWDAKADQPITSGNAEDPPSILENEQDFSNEQAYNSYLKPFREKEESYTKQKLTRA
IEDLTSSGLYPLAFEAPHYTMSEYGYQIASQYFTSIFGQVQLSGTTWKTSGASPYVTAPS
MLHGMTLYPETIGFVDTSKQNPLGDMEEHISQMIDFEGGVAGGFYHPYLGMKYLPELVDQ
MERIPDSEWLDLKKTKQTVKTDKVEIHTSGDGTIQVKNGVSAIDEFFDHHRQTSLEKALW
ILSAVVLLFVVMFVSYTFYLRATLKKRIFKERRSLG
>PK3-2_00500 putative diguanylate cyclase DgcC
MKISFNESQKLFSYFSGLIAALSLFIYYVSAQQSEGALILCITFVVIAAGIWFGPIYALA
VTLIVLFVLGTLMMFFQTGQAALFPAEEGLRMLVVWGIALLLFSFISGRIHDIAAELRRS
VTRLQSEIKSFVAVDRVTGFDNKQRMKLELSEEIKRAERYGNSFVFLLLHMHYFKEFKSL
YGEKETDRLFQYVSQQIGSSVRETDKKFRPSDERIGIVLTHTPAEHMPAVLTKLKKQLDT
YQLENGKYVSLTFHVCYLPYRKDIKTADQFLEELENEMMMNEL
>PK3-2_00501 hypothetical protein
MRHVLIAVILFFLSIGLSAGCAEAGNKTQTQSASEVNTSPLQPAEYFIYHNLMNDQGLIK
TDFSDQPSYLSESLGLWMEFLVSKNDVPHFQEQYQHLTDSFLMGNHLVTWMIQNGQASGT
NALIDDMRIMLSLDQAAAKWGRSDYAQTARDIGTALKTYNMNNGLFTDFYESQAASKDVT
ISYVMPDALAVLKKYGIIDEETEQRNANVLYSAPLQNGFLPKTYSSETKKYTYDSEVNLI
DQLYAAWHLPEGNEKAAVFADWIKQEFQTNGKLYGRYSADTKEPAVQYESPSVYALAVLF
LTKQHEDTSVIKAIYDRMNDFEILDPVKSYYGGYMSGTQTHSFDNLLPLLVERKLFNENI
IQ
>PK3-2_00503 DNA topoisomerase 3
MSKTVVLAEKPSVGRDLARVLKCHKKGNGYLEGDQYIVTWALGHLVTLADPEGYGKEFQS
WRLEDLPIIPEPLKLVVIKKTGKQFNAVKSQLIRKDVNQIVIATDAGREGELVARWIIEK
ANVRKPIKRLWISSVTDKAIKEGFQKLRSGKEYENLYHSAVARAEADWIVGINATRALTT
KFNAQLSCGRVQTPTLAMIAKREADIQAFTPVPYYGIRAAVDGMTLTWQDKKSKQTRTFN
QDVTSRLLKDLEGKQAVIAELKKTAKKSFAPALYDLTELQRDAHKRFGFSAKETLSVLQK
LYEQHKLVTYPRTDSRFLSSDIVPTLKDRLEGMEVKPYAQYVSQIKKRGIKSHKGYVNDA
KVSDHHAIIPTEEPLVLSSLSDKERKLYDLIAKRFLAVLMPAFEYEETKVIAEIGGETFT
AKGKTVQSQGWKAVYDMADEDDEQEDDRDQTLPALQKGDTLAVRTLIETSGQTKPPARFN
EGTLLSAMENPSAFMQGEEKGLVKTLGETGGLGTVATRADIIEKLFNSFLIEKKDKDIFI
TSKGKQLLQLVPEDLKSPALTAEWEQKLSAIAAGTLKSAVFIKDMKAYANQTVKEIKNSS
QTFRHDNITGTACPECGKMMLKVNGKRGTMLVCQDRECGSRKTIARKTNARCPNCHKRME
LRGQGEGQTFACVCGHREKLSVFEKRKNKDKGRATKRDVSSYMKKQNKDEPINNALAEQL
KKLGLDK
>PK3-2_00504 HTH-type transcriptional regulator LrpC
MKLDQIDLNIIEELKKDSRLSMRELGRKIKLSPPSVTERVRQLESFGIIKQYTLEVDQKK
LGLPVSCIVEATVKNADYERFKSYIQTLPNIEFCYRIAGAACYMLKINAESLEAVEDFIN
KTSPYAQTVTHVIFSEIDTKNGRS
>PK3-2_00505 hypothetical protein
MTNRVKLARVEKGWTQAQLAQQVQVTRQTIGLIEKGKYNPTLQLCIAIAQALDKTLDQLF
WEGDGH
>PK3-2_00506 hypothetical protein
MKHLFFNFRDEYIERKMKQFYGEAGFLLAALMLADLIIRGFILHREPIEYMVSGIGFALF
AGYILIRYLLSGLEHPDIATKAAYRKKRKEIMAVSVTSGVIFFIITILFTDVPRTLNEWL
DALMLAVLFFFFYFMLNFLSLRSSFLKNKDLSDDK
>PK3-2_00507 hypothetical protein
MLQTPIGRLRTMGFIEGMSLLILLFIAMPLKYWAGLPLAVTIVGSVHGGLFILYLLVLAY
AAFSVKWPLKWSAAGFIAAFVPFGNFLYDRGLRKYK
>PK3-2_00508 Lipid II flippase Amj
MHVITTQVLFIFCFLLLIHSIETLAYATRLSGARVGFIASALSLFNVMVIVSRMSNMVQQ
PFTGHLIDDAGKNALAIVGEQFRFLIFGSTVGTILGIILLPSFVALFSRAIIHLASGGGS
VIQVFQKGFSKQGFKNALSYFRLPSLSYVKGFHIRLIPKRLFVINMLITSIYTIGVLSAL
YAGLLAPERSTTAVMASGLINGIATMLLAIFVDPKVSVLADDVAKGKRSYIYLKWTSVTM
VTSRVAGTLLAQLMFIPGAYYIAWLTKWF
>PK3-2_00510 General stress protein 26
MNQQDIKQKVLDVLDHHKVGSLATVQKGKPHSRYMTFFHDGLTIYTPTSKETHKAEEIEN
NPNVHILLGYDCEGFGDAYVEVAGKAKINNSSELKDKIWSSKLERWFDGKDDPNLVILEI
EPEDIRLMNAGEKTPVSLEL
>PK3-2_00511 Putative ribosomal N-acetyltransferase YdaF
MFTCKVSEHITIRLLEPKDADRLAELIIENQQRLGQWLFFAENPSGAETYRETIIPDWRR
QYADLNGIEAGLLYDGSLCGMIGLHNLDQVNRKAEIGYWIAKEYEGKGIMTAACRTLITY
AFEELELNRVAICAAVGNQKSRAVPERLGFQEEGKARDGLFVNGRYHDLVYYSLLKREWK
ETK
>PK3-2_00512 putative D-lyxose ketol-isomerase
MGITKEEVNSYYQKAGIVLKDEEVDEIQLMDYGLGKERKVGLQLFVYVNTDRYCSKELVL
FPGQTCPEHRHPPVDGQEGKQETFRCRYGKVYLYVEGEKTPLPKVLPPQEDREHYTVWHE
IELEPGGQYTIPPNTKHWFQAGEEGAVVTEMSSTSTDKHDIFTDPRI
>PK3-2_00513 General stress protein 39
MTNYPNELPAQTQNRQPGIESEMNPSPVYEYENYKGADKLKGKVALITGGDSGIGRAVSV
AYAKEGADIAIVYKDEHGDAEETKKRVEQEGVKCLLIAGDVGDEEFCNEAVEKTVNELGG
LDILVNNAGEQHPKESIKDITSEQLHRTFKTNFYSQFYLTKKAIDYLKPGSAIINTTSIN
PYVGNPTLIDYTATKGAINAFTRTMAQALVKDGIRVNAVAPGPIWTPLIPATFPEETVAQ
FGQDTPMGRPGQPVEHVGCYVLLASDESSYMTGQTLHVNGGNFVTT
>PK3-2_00514 2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial
MINMLSKKFSKPKGIIGMIAGYIMAAENQTLNQWTIDQLGITCGDSILEIGFGPGYCMRQ
MLKREKDVQLHGIDVSETMLKLATRRVNSKSVRLIQGSIETFPLPASFYDKVISVNNYTI
WNDQTKGVKQIYRALKPGGRAAITMQPREADASPEKTKSFGKQMIADLKAAGFEDIELQL
KHIKPELSVCATAKKPVT
>PK3-2_00515 Long-chain-fatty-acid--CoA ligase
METLQHLILHDMPDSEEIEAVKSGTHILTYAGYRKRINQLANALLQKGIQKGDRVALLCK
NGHPASTVMFAALEIGAVVVPVSWQLKPYEMTGILKASEPKAMFYGAEFKEILDEVLPEL
SSLRITMETGTAYETSAEFEALFAGPDHLPETEMVSPDDTALLMFTSGTTGNPKRCMITH
GGIYRYVTRSNSSTTRMKGLRFLACHPIYHTSALICIMLGTFEGTTFIFTKDQDPVHMLK
VIEEEKIQSVMALPVFYTYLLEAWETHQTDLSSLVILMTGGTKVPSSLIRRYLDIGIPLA
HGYGSTEAWGISTWMPNMGMDKAASAGKPVEGVKVKVEDPQTGEELPQGEIGEIVVHTPF
LFKGYEDNPEATAKVLQNGWFKTGDSGYVDEDGFIFITGRYKDVIIYGGDNVYPDQVEEV
IQQIPGILETAVVGIPDPLYGEKPRAFIVTNGGQRITEEDVIAFCQERLSAYKIPEVEFV
NELPKNNLGKVKKDVLRKQAVHS
>PK3-2_00516 Transcriptional regulator MtlR
MYMTAREQKLLKHLLLQNRYVTVTELAELMEVSTRTIHRELKSIKPLMETVGLTLDKQPG
KGLKAVGSPEDKQKLLTDLSYEQHEYSADERKLLILCSLLESQEPVKLYTLAHDLQVTNA
TVSYDLDELEKWIAPFGLTLIRKRGFGIQLIGPENAKRKIVGNLIVNRLDIQMFLEAVEL
NIKGKADSSEKMFGVVSKGELLKMERILFQLKEKIAFSLSDSSYIALVVHLTFAIERIQL
GETITMEQTELDELKNAKEYSSALEIAGELERAFGVTIPKAEVGYITIHLRSANRKYKTE
YKAQEIELETALQTKRLIAFISDKIRMDLTKNYSLYEGLIAHLEPAVSRIKENIEIYNPM
KEQIKRDYFLLYMAIEEGVEKYFPGMSFSDDEIAFIVLHFGSALEIKKEEAKVKALVVCS
SGIGSSKMLASRLKKELPEIQSFDMSSLIELKGKDVQAYDMIVSTVPIPYENIDYIMVSP
LLNEEDANQVKQYIKRKIPLILEKRRNPKEEAHQADVPDMLAAAESIGRYMAVMQDVLRH
FTLTHLKTNPDHSMLLLELFQQLEKEGLIRDPKKAAVCLAEREKQGGLGIPGTNMALYHL
KNDEIVLPFFKMYDLSTSYEVNGMDGNTLSMTRILVMMAPGSLSAEGSEILSAISSAIIE
SGESMAGFQEEGEQELYQRLNRIFFTWMKEKNIL
>PK3-2_00517 Oxidoreductase YdhF
MQRIQLAEDLQFSRVIHGLWRLNEWNYSDAELLSLIEWCIDHGITTFDHADIYGGYTCEK
LFGNALALSPGLRENIELVTKCGIVLESPERPAHRSHHYNTSKSHILASVEQSLMNLRTD
YIDVLLIHRPDPLMDPEGVADAFQALKCSGKVRYFGVSNFKDHQYRMLESYLPEKLVTNQ
IELSAYQLENVLDGTLNLCQEKRMSPMAWSPLAGGKVFTGDTDKDRRVRTAFESVQAEIG
AASMDEVMYAWLFTHPAGIMPIVGSGKRERISAAVHALAYKLDQDQWFRIFTASQGHDIP
>PK3-2_00518 Peptidoglycan D,D-transpeptidase MrdA
MLKKCILLVFLCVGLIGLIGCSKTDSPEDRMEAFVKQWNDQQFDEMYQSLTKDVKKEISK
KDFVNRYKTIYEQAGVKNLKVTAGNVDEDDKDNKTMKHIPYKVSMDTNAGKVSFKNTAVL
KKEKTDDEESWNIDWDPSFIFKQLADDKTVQIMSIEPKRGQIYDKNGKGLAINTDVPEIG
IVPGELGDKKDKVIKELAKKLDLTEDDIKKKLSQGWVKDDSFVPVKMVKPDRQKLVSEAT
SLQGVTRTNVSSRYYPYGEKTAHLTGYVRAITAEELKKKKDGTYSDTSNIGIAGLENVYE
DKLRGTTGWKIYVPQTGEVIAEKKAKDGEDLHLTIDIKTQTKLYDELKDDSGAAVALQPK
TGETLALVSAPSYDPNGFIFGWGDKEWKKLNEDKNNPFSAKFNKTYAPGSTIKPIAAAIG
IKNGTLKADEKKTIKGKEWQKDSSWGGYSVTRVSERLQQVDLENALITSDNIYFAQNALD
MGADTFTKGLKTFGFSEDIPYEFPIQQSSIANDKLDSDILLADTGYGQGQMQMSPLHLAA
AYTPFVDNGDLVKPTLIKKDSQTADVWHKQVVTKEGAADITKGLKGVVEDQRGSAYQPVV
KGITVAGKTGTAELKASKDDKDGAENGWFVGYDYKNKDLLVAMMIQNVQDRGGSHYVVEK
AKKQFQSN
>PK3-2_00519 hypothetical protein
MVREAAMLYIKEGLEQEFEEAFRQAAPIISGMKGYITHSLSKCMEETHKYLLLVEWETLE
DHTEGFRGSSEYQEWKALLHRFYTPFPTVEHFQDVQ
>PK3-2_00520 hypothetical protein
MFRIFKMSFAVIIIILALIAFKYTEHTSVIQSVMLVFLGAVMFMQGLEERKKENDGSGAF
NIYTAVFVWSVSLIGFTLHII
>PK3-2_00521 Spore germination lipase LipC
MVLRYTALGDSLTTGRGSGLFSPGFVHRFGDMMEADLKANTAIAIFAKSGLNTEEILGLL
SYPYVQKCIQNADMITITGCGNDLIDSVLAYQSSKDETIFTRVSAHCHENFEKMIAKIAE
IKGENPSPYAIRVFNLYNPFPGIEIAGKWITSYNSQLETLASAPHVKIADAYSIFKGKEE
EYLSFDGVHPNSKGYQAMAEAVHKLGYKELSVS
>PK3-2_00522 HTH-type transcriptional regulator KipR
MQNKNKTVVKSMALLHLFLHEPNLTLSELVSKSGMPKTSVHRMVSSLEEMGFLNRDACGA
YSLGLVFLEFGQLVADRLDIRKIAKPVMEELCREVDEAVQLIMRDGNEAIYVEKIEGTQT
VRLYTAIGRRSPLYAGACARSILSFLPREEIETYINQTELVSIGSGTITDPEKLLQEIDA
SVQNGYTISCSELENYTAAIGAPIFNHKRQVTAGISIAGFEARFTEDRLPYLTEKVKDAA
LQISRKIGYS
>PK3-2_00523 5-oxoprolinase subunit C
MRVLKPGLLTTVQDIGRKGYQKYGVLASGAMDTVSLRIANLLIGNSENEAGLEITLMGPG
PSFYFSKTALIAVTGADFTLRINDEEAPLWKPVLVKENSTVTFGPCKLGSRAYLAAAGGI
DVNAVMESKSTYVRAGIGGLHGRALQKEDELTIGEMSSLSKIILTRLSPQLGKQGFAAPK
WSVSCGRFLPLKKNPVIRVLEGKQFGFFTEESKTRFYEETFRVTPQSDRMGYRLKGEPLE
LKAPLEMVSEAVSFGTVQVPPDGNPIILLADRQTTGGYPRIAHIISADLPIVSQIMPGEH
VQFEPVTLQEAEALAIEREQHIKELKTRMKMEWLT
>PK3-2_00524 5-oxoprolinase subunit B
MTVRYQIEQLGDSAMMIRFGEEINEQVNGLVHAAAAYIEEQPFPGFIECIPAFTSLTVFY
DMYDVYKHLPRGISSPFEKVKRDVEERLKEIAADYENSRRIVEVPVCYGGEFGPDLEEVA
KINQLSPEEVIDIHTSGEYVVYMLGFAPGFPFLGGMSKRIAAPRKSSPRPSIPAGSVGIA
GLQTGVYPISTPGGWQLIGKTPLALFRPQEDPPTLLRAGDTVKFVRISEEDYHAYKEESN
>PK3-2_00525 Putative hydro-lyase
MDQLNKMAPRDVRALIREGKITGPTAGMSGGYAQANLVILKKDLAFDFLLFCQRNQKPCP
VLDVTETGSPVPSLAARDADIRTDFPKYRIYRRGVLTEEVSDITPYWEDDFVGFLIGCSF
SFEQALINNGIAVRHIDEGTNVPMYKTNIDCVPAGAFQGKMVVSMRPVPERLAVRAAQVT
SRFPAVHGGPIHIGNPGAIGIRDLDKPDFGDAVSIREGEVPVFWACGVTPQAVAMNVKPE
MVITHAPGHMLITDIRDESLAVL
>PK3-2_00526 hypothetical protein
MEQQKKTAGKKAGSWSLLMGAAFLMATSAIGPGFLTQTATFTNTLAASFGFVILISIILD
IFAQTNVWRIIAVSGKRGQEIANMVLPGLGYFIAILVVLGGLAFNIGNIGGAGLGLQVLF
GIKPETGALISAVIAILIFVIKEAGKAMDRFTQIAGFAMIILTLYVAITSAPPVGHAVAN
TFAPEHISIFAIVTLVGGTVGGYITFAGGHRLLDAGIKGKESIPQVTKSSVVGILITSVM
RIALFLAVLGVVSKGLHIDESNPAASVFKLAAGNVGYKIFGLIMWSAAITSVIGAAYTSV
SFFKTFSPKIEKNSRGIIIGFIVVSTLAFVTIGQPAKILVLVGSLNGLILPIALGTLLVA
AYKKNIVGDYKHPLWLTGTGALVVIVMAVMGIYTLFTQLPKLWS
>PK3-2_00527 5-oxoprolinase subunit A
MFQVDLNCDLGESFGAYTIGLDQDILEYVTSANIACGFHAGDPGVMRKTVALAAEKGVKI
GAHPGLPDLLGFGRRNMAISPEEAYDLVVYQIGALSGFLKAEGLRMQHVKPHGALYNMAA
VDQKLSDAIAKAVYKVDPGLVLFGLAESELVKAGERIGLQTANEVFADRTYQADGTLTPR
SQPDALIESDDAAVTQVIKMVKEGAVKSQQGHDVSLKADTVCIHGDGAHALTFAQKIRKE
LKASGIEVTAITSKK
>PK3-2_00528 5-amino-6-(5-phospho-D-ribitylamino)uracil phosphatase YcsE
MSVQREDVDIKLIAIDMDGTLLNDEQLISDENRKAIREAEDKGVYVVISTGRTLMTCREL
AESLKLSSFLITANGSEIWDSNFNLVERKLLHTDHIQMMWDLRNKHNTNFWASTVNKVWR
GEFPENITDHEWLKFGFDIEDDDIRNEVLEELRKNKELEITNSSPTNIEVNALGINKAAA
LAKVSEKLGFTMDNVMAMGDSLNDIAMIKEAGLGVAMGNAQDIVKETADWITDTNIEDGV
AKAIRHWVL
>PK3-2_00529 hypothetical protein
MTERKQQNKPNENPEHNDLTDPIPNEELKENMNDEKHKRQQRDHSQSERDYDTK
>PK3-2_00530 3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ
MNSLSLPHRYPFLFIDGVTESEPGKHAAAYKLISENEWFITDTQTEMPFSLVIEALAQTA
AFTGITDENSLGLLSSVKKAEKLGAAVPGDRLDLTFEVTRNRRGFVFGHAKASVGGQPVA
EAEIGIYIEK
>PK3-2_00531 hypothetical protein
MSQKPLVILAHEIYGINSHMKKMARLIKMAGYDVMTPNLLGDGEVYTLQEENTAYEQFTK
YERLKTGEILIQNLIRQNAGRPIFVIGFSAGATIAWKCSSMPEVSGAVCYYGSRIRDSLH
HVPVCPVLLFFPSYEPSFNVSLLIQKLREKQQPHLEIYQFDALHGFANPDSDTFDRALLF
KTLSIIKNEAEKLPRLV
>PK3-2_00532 Signal peptidase I U
MNAKTIALKKKIKTRWIVVLSIVFIAALIFTIRMAFYKPFLVEGSSMDPTLKDSERILVD
KAAKYTGGFHRGDILVIHDEKSGRSFVKRLIGLPGDSVKMKNDQLYINDKKVEEPYLKEH
KQEVKELGVTLTGDFEVEVPSGKYFVMGDNRLNSMDSRNGMGMPSEEDIIGTESLVFYPF
GEMRRAK
>PK3-2_00533 D-malate dehydrogenase [decarboxylating]
MKQFEIAAIPGDGVGKEVVAAAEKVLHTAAEVHGGLSFSFTSFPWSCDYYMEHGEMMPED
GIHTLTQFAAVFLGAVGNPELVPDHISLWGLLLKIRRELELSINMRPAKQMAGITSPLLH
PNDFDLMVIRENSEGEYSEVGGRIHRGDDEIAIQNAVFTRKATERVMRFAFELAKKRRGH
VTSATKSNGIYHAMPFWDEVFQQTAADYREIETSSQHIDALAAFFVTRPETFDVIVASNL
FGDILTDISSSLMGSIGIAPSANINPSGKYPSMFEPVHGSAPDIAGQGLANPIGQIWTAK
LMLDHFGEEELGAKILDVMERVTADGIKTRDIGGQSTTAEVTDEICARLRKL
>PK3-2_00534 Mannitol-1-phosphate 5-dehydrogenase
MIALHFGAGNIGRGFIGALLHHSGYHVVFADVNDTMVSLLNEKKEYTVELAEVGHSSEVI
GPVSAINSGSELEKLYQLIDEAALITTAVGPNVLKLIAPSIAEGLRRRNSANALNIIACE
NMIGGSSFLKKEIYSHLTEAERESINETVGFPNSAVDRIVPIQHHEDPLKVSVEPFFEWV
IDESGFKGETPAINGALFVNDLTPYIERKLFTVNTGHAVTAYVGYQRGLKTVKEAIDHPE
IRRVVHSALLETGDYLIKAYGFKQAEHDQYIKKIIGRFENPFITDDVTRVARSPLRKLGE
NDRLVSPAKKIKEPNALAEGIAAALRFDFTGDPEAVELQALIDEKGYSGVLQEVCGIQSH
EPLHAIVLKKLNQ
>PK3-2_00535 Mannitol-specific phosphotransferase enzyme IIA component
MQVLAKENIKLNQTASSKEEAIKLAGQTLIDNGYVTEDYICKMFEREETSSTFMGNFIAI
PHGTEEAKSEVLHSGISIIQIPDGVEYGEGNTAKVVFGIAGKNNEHLDILSNIAIICSEE
ENIERLISAKSEEDLIAIFNEVN
>PK3-2_00536 PTS system mannitol-specific EIICB component
MQQEQQGGMKVKVQRFGSYLSGMIMPNIGAFIAWGIITALFIPAGWFPNEQLNTLVSPMI
TYLLPLLIAYTGGKMIYDHRGGVVGATAAIGVIVGSDIPMFLGAMIMGPLGGYLIKQTDK
LFKDKVKQGFEMLINNFTAGIVGAALTILAFYAIGPVVLTLNKLLAAGVEVIVHANLLPV
ASVFVEPAKVLFLNNAINHGILSPIGIEQASQTGKSILFLVEANPGPGLGILLAYMFFGK
GSSKATAPGAAIIHFFGGIHEIYFPYILMKPVLILAAIAGGASGLLTFTIFNAGLVAAAS
PGSIIALMAMTPRGGYFGVLAGVLVAAAVSFIVSAVILKSSKASEEDLAAATEKMQSMKG
KKSQAAAALEAEQTKAEEASELSSESVNKIIFACDAGMGSSAMGASILRNKVKKAELDIS
VTNTAINNLPSDADIVITHKDLTDRAKAKLPNATHISVDNFLNSPKYDELLEKLKK
>PK3-2_00537 putative protein YcnL
MKETRCPNCGKPLTGDMVRSSNVPCQFRCGHCRERLYEYKVSAPIMLLSLAVIVLLIYLL
LLLRNAVGSMVPAVQHVPMAIFALVCAYPVFIVSERMIAKYVIQNGSIIYRGKRKGS
>PK3-2_00538 HTH-type transcriptional repressor YcnK
MLPINRQQHILKWLKEEGALRISDISAKFGVSEMTVYRDVNQLVQSNQVIKTAGGITLPA
QTPQADHMCSYCLKPVNQAYSVQLITVNQDIEQLCCAHCAFLRYADKTEEVSHLICRDFL
LHTTVSAGSAYFVVNAELNLHCCQPQAIPFATLDHAERFQKGFGGAVRTFDQALEDMLQD
RKKRCTCTKK
>PK3-2_00539 Copper transport protein YcnJ
MKRNRWWIILLLFLVFLPKTSFAHAYIVTSSPLENSELKSAPAQVEIEFNEPVEEGFHYI
KVYNSNGDRVDTDKTEIKKDNNHIMTVKLKKNLPHDVYRAEWNAVSADGHPVSGVIPFSI
GKADGGFSSQKAAGSALNPAAAADRAILYTALSLFIGTIFFHLFWYKGKTEQLAKRTRRI
LIVSITALGLALLLQLPIQTKANAGGGWDSAFQPGYIRETLFETAGGTIWIIQAVLYALL
AISVFPAIRKNRFASFGYWTAPLIFFFGLLLAKAFTGHAAVVEEKTVGILMDFLHLSSAS
IWVGGVAAIVLLLAKEWRQPDKTLAWETVSRFSPWALTAVGVILFSGLLNGFFIIRSMDS
LFHTAYGQALLVKSGLFVLMLVLGAIHFLLTRKQRRAGISRTLKAEWAIGIAVLITAAVF
TSLPSPPEPAPEPFYQTKAIENGQSVSLSISPNQPGKNEFELRVTDHNGDPVKNIQQITL
TIYKTGLSGSENKSTFQLKEKTKGVFQDENLSINEKGNWKIKVHGLTGDFNEINIMFTKT
N
>PK3-2_00540 putative protein YcnI
MLKKIAFMLCPVIVGSLLFFTAPASAHVSVKPAESAAGSWETYTMKVPSEKNQPTTKVVL
KMPKDVEFQQYEPIPGWKVSTQKHDDKSVSVTWEATDGGIQEGQFQQFTFVAKNPEKAEE
AAWDAYQYYKDGSIVEWTGDEDADTPHSITNITSAKQVTDAHGATKTEDDSEDTGSSALD
ITAIVLAAAAIILSVAALVKKKRD
>PK3-2_00541 Glucose 1-dehydrogenase
MYPDLKGKVVAITGSASGLGKAMAIRFGKEQAKVVINYYSDKQDPNEVKEAVVKAGGEAV
IVQGDVTKEEDVKNIVQTAIKEFGTLDIMINNAGLENPVPSHEMPLKDWDKVIGTNLTGA
FLGSREAIKYFVENDIKGNVINMSSVHEMIPWPLFVHYAASKGGIKLMSETLALEYAPKG
IRVNNIGPGAINTPINAEKFADPKQKADVESMIPMGYIGEPEEIAAVAVWLASKESSYVT
GITLFADGGMTKYPSFQAGRG
>PK3-2_00542 Glucose uptake protein GlcU
MDLLLALLPALFWGSIVLFNVKLGGGPYSQTLGTTIGALIVSFVIYLFVQPVLSLRIFIV
GIVSGLFWSLGQANQLKSIELMGVSKTMPISTGMQLVSTSLFGVIVFREWSTPIAITLGI
LALIFIIVGIILTSLEDKKGRKEGEPSNLKKGILILLVSTLGYLVYVVVARLFNVSGWSA
LLPQAIGMVVGGLVLTYRHKPFNKYAIRNILPGLIWAGGNMFLFISQPRVGVATSFSLSQ
MGIVISTLGGIFILREKKTKRQLIAIGIGIALIIAAAVFLGIAKTNS
>PK3-2_00543 Succinate-semialdehyde dehydrogenase [NADP(+)]
MPDQLTVYNPATGEEIKTIPQQSAKEVEEAIERSHQAFKTWSKTSANERASLLKKWYELI
VEHKEELADLITKENGKPYQEAVGEVLYGAGYIEWFAEEAKRVYGRTVPAPTTGKRIVVT
RQPVGPVAAITPWNFPNAMITRKAAPALAAGCTFIIKPAPDTPLSAYELARLAYEAGIPK
DVLQVVIGDGEEIGNVFTSSPKIRKITFTGSTPVGKILMKNSADTVKHVSMELGGHAPLI
VDEDANIDLAVEQAMVSKYRNAGQTCVCANRLIVHESIKDEFAAKLSEQVSKLKVGNGLE
EGVNVGPIINKRGFEKIVSQIDDAVDKGAKVLAGGTYDRNDDKGCYFVNPTVLADVDTSM
NIMHEETFGPVAPIVTFSDIDEAIQLANDTPYGLAAYFFTENYRRGIYISENLEYGIIGW
NDGGPSAVQAPFGGMKESGIGREGGSEGIEPYLETKYMSIGL
>PK3-2_00544 4-aminobutyrate aminotransferase PuuE
MSQTTASITTAQWQQKRDQFVSKGVSNGNRSLAVKGEGAELYDLDGRRFIDFAGAIGTLN
VGHSHPKVVEAVKRQAEELIHPGFNVMMYPSYIELAEKLCGIAPGSHEKKAIFLNSGAEA
VENAVKIARKYTKRQGVVSFTRGFHGRTNMTMSMTSKVKPYKFGFGPFASEVYQAPFPYY
YQKAEGMSDESYDDMIIQAFDDFFIASVAPETVACVVMEPVQGEGGFIIPSKRFVQHVAS
FCKEHGIVFVADEIQTGFARTGTYFAIDHFDVVPDLITVSKSLAAGLPLSGVIGRAAMLD
AAAPGELGGTYAGSPLGCAAALAVLDIIEEEGLNERSEEIGKIIEDKAYEWKQEFPFIGD
IRRLGAMAALEIVKDPETREPDKAKAAAIAAYANQNGLLLLTAGINGNIIRFLTPLVISD
GLLNEGLSILDAGLRA
>PK3-2_00545 HTH-type transcriptional regulatory protein GabR
MDITITLDRSEQADYIYQQIYQKLKKEILSRNLLPHSKVPSKRELAEKLKISVNSVNAAY
QQLLAEGYLYAIERKGFFVENLDMFSAEEHPPFALPDDLKEVHIDQSDWISFSHMSSDTD
HFPIKSWFRCEQKAISRSYRTLGDMSHPQGIYEVRAAISRLISLTRGVKCRPEQIVIGAG
TQVLMQLLTELLPKEAVYAMEEPGYRRMYQLLKNAGKQVKTIMLDEKGMSIAEISRQQPD
VLVTTPSHQFPAGTIMPVSRRIQLLNWAAEEPQRYIIEDDYDSEFTYDVDSIPALQSLDR
FQNVIYMGTFSKSLLPGLRISYMILPPELLRTYKKRGCDLQTCSSLTQLALQEFIESGEY
QKHIKK
>PK3-2_00546 HTH-type transcriptional regulatory protein GabR
MKQQYKEKRERLISALETKFSGKITVKGANAGLHFVTEFDTSRTEQDILAHAACQQLEIF
GMSRFALKKDKGQTGRPALIIGFARLKEKDIQEGVERLFHAVYGHKKIPGTGD
>PK3-2_00547 hypothetical protein
MNIPNHPETETLQLTKVLHALSDPLRLELVKQLAEAKEKTCGTCADVQVAKSTLSHHFKV
LRESGIAQVRIEGKRRYYSLRAEDLEKAFPGLLEAVLNVDQDRW
>PK3-2_00548 Putative monooxygenase YcnE
MIVLQAYIKVKPEKREEFLSEAQSLVQHSRAEEGNAQYDLFEKVGEENTFVMLEQWKDEA
AMKFHNETAHFQGFVAKGKELLSAPLDVVRTELSE
>PK3-2_00549 FMN reductase [NAD(P)H]
MNEVITSLTDHRSIRSYTDEPVAQEQLDQIIQAVQAAPSSINGQQVTVITVQDKERKKKI
SELAGGQPWIDQAPVFLLFCADFNRAKIALEDLNDIKMEITNGLESVLVGAVDAGIALGT
ATAAAESLGLGTVPIGAVRGNPQELIELLELPKYVFPLSGLVIGHPADRSAKKPRLPQEA
VNHQETYLNQDELTSHIQAYDKQMSEYMNKRTNGKETRNWSQSIATYYERLYYPHIREML
EKQGFKVEK
>PK3-2_00550 hypothetical protein
MLDKKTDILLAARKLFSEKDFTSVSMQAIAEECKMSKASIYKLFQSKEDLLLELLSFNQK
QMVAAASRLQENTALTPEERLTQKVKMELEGFRRNQQFFNMLTYGNPKLHNDRVKQHIHQ
TRSTIICWHRDSLIQAYGEAILPFVWDLVIILHGMMREFLMLIKIEEKPLELNPIAEFII
STLNQIVKNKETGQSLLPPEAIELYIHSASSYEPKDKSALLSESLKELHKGISSLPAADY
DVDELASAAAMLEEEAKKEEPRAFLLKSLIGYLEQTGVLTQPVSMLKTLLIT
>PK3-2_00551 putative multidrug resistance protein EmrY
MNTSIEPKPFNRSVIVGILLAGAFVAILNQTLLITALPHIMRDFNVDANQAQWLTTSFML
TNGILIPITAFLIEKFTSRALLITAMSIFTAGTIVGAFAPNFPVLLTARIIQAAGAGIMM
PLMQTVFLTIFPIEKRGQAMGMVGLVISFAPAIGPTLSGWAVEAFSWRSLFYIILPFAVI
DLILASILMKNVTTLRKTQIDILSVILSTFGFGGLLYGFSSVGSYGWTSSTVLISLLVGV
ISLLLFITRQMKLEKPMLEFRVFTFGVFSLTTLLGTLVFALLIGTETILPLYTQNVRNVT
AFDTGLMLLPGAVVMGFMSPFIGRIFDRVGGRGLAIAGFCIIFLTSLPFMQLTEHTSLAW
IVVLYTVRLLGTAMIMMPVTTAGINALPRHLIPHGTAMNNTIRQVGGSIGTALLVSVMSN
QAAHAGTTNIKHAALHGMNAAFIVAACIALVGFLLSFTLKKPQRPAEQQPAR
>PK3-2_00552 IS3 family transposase ISBsu1
MHLGISRASYYRWKKNLMKGHPKRHLDKQIGTLCREHKYRYGYRKITAILKKRMRINHKT
VQRIMQKNQWQCQVKVKKRKKNGQPYAVVDNILDRNFQSDRPLEKLVTDITYLPYGQKQL
YLSSILDLYNGEVIAFTIGDKQDTDFVLDTLNQLPTLPENCVLHSDQGSVYTSYEYQKAV
NTKGITMSMSRKGTPADNASIESFHSSLKSETFYLNSIDRTTTAIVERTVIEYIHFYNNI
RIQTKLNNQSPINYRQLAV
>PK3-2_00554 hypothetical protein
MGTRVSYPVEVKQKAVEMRLAGVPMKEIMQKLNIKNKTQIQTWLRWYKAGDTHRFEQPVG
KQYTYGKGPEYASELEKLQAENRYLRQQNEVLKKYNELERKLIAKRQSNL
>PK3-2_00555 Petrobactin-binding protein YclQ
MKKFALLFIALVTAVVISACGNQSTSSKGSDSKNEQITVKHQLDKNGTKVPKNPKKVVVF
DFGSLDTLDKLGLADKVAGLPKQALPSYLSKFKDDKYADVGSLKEPDFEKVADLDPDLII
ISGRQSESYKEFSKIAPTIYLGVDTTKYMESFKSDAETIGKIFGKEDEVKDELATIDNSI
ADVKKTAEKLNKNGLVIMANDGKISAFGSKSRYGLIHDVFGVTPADKNIKASTHGQSVSY
EYISKTNPDYLFVIDRGTAIGESSSTKQVVENDYVKNVNAVKNDHVVYLDSATWYLSGGG
LESMTQMIKEVKDGLEK
>PK3-2_00556 Petrobactin import ATP-binding protein YclP
MVEVRNVSKQYGGKVVLEETSVTIQKGKITSFIGPNGAGKSTLLSIMSRLIKKDSGEIFI
DGQEIGACDSKELAKKMSILKQANQINIRLTIKDLVSFGRFPYSQGRLTEEDWVHINQAL
GYMKLEDIQDKYLDQLSGGQCQRAFIAMVIAQDTDYIFLDEPLNNLDMKHSVEIMKLLKR
LVEELGKTIVIVIHDINFASVYSDHIVALKNGRIVKEGPPEEIIETSVLEEIYDMTIPIQ
TIDNQRIGVYFS
>PK3-2_00557 Petrobactin import system permease protein YclO
MRNQIKIALLVGLAIVCVGLFLFYDLGNWDYTLPRRIKKVAAIVLTGGAIAFSTMIFQTI
TNNRILTPGILGLDSLYMLIQTGIIFLFGSANIVIMNKNINFIISVLLMILFSLVLYQIM
FKGEGRNIFFLLLIGIVFGTLFSSLSSFMQMLIDPNEFQVVQDKMFASFNNINTDLLWLA
FIIFLLTGAYVWRFTKFFDVLSLGREHAVNLGIDYDKVVKQMLIVVAILVSVSTALVGPI
MFLGLLVVNLAREFLKTYKHSYLIAGSVFISIIALVGGQFVVEKVFTFSTTLSVIINFAG
GIYFIYLLLKENKSW
>PK3-2_00558 Petrobactin import system permease protein YclN
MKLRYLFILLIILAVTSVFIGVEDLSPLDLFDLSKQEASTLFASRLPRLISIVIAGLSMS
ICGLIMQQISRNKFVSPTTAGTMDWARLGILISLLLFTSASPLMKMLVAFVFALAGNFLF
MKILERIKFNDTIFIPLVGLMLGNIVSSIATFIAYKYDLIQNVSSWLQGDFSLVVKGRYE
LLYLSIPLVIIAYVYADKFTLAGMGESFSVNLGLKYKRVVNIGLIIVSLITSLVILTVGM
LPFLGLIIPNIVSIYRGDNLKNSLPHTALLGAVFVLFCDILGRVIIFPYEISIGLMVGII
GSGIFLFMLLRRKAYA
>PK3-2_00559 Aspartokinase 3
MKVVKFGGSSLASGAQLEKVFHIVTSDPARKAVVVSAPGKRYAEDTKVTDLLIACAEQYL
ASGNAPELAEAVVERYALIANELQLEQTIIGKIRDDLFTLLEGDKSNPEQYLDAIKASGE
DNNAKLIAAYFRHKGVKAEYVNPKDAGLFVTNEPGNAQVLPESYQNLYRLRERDGLIIFP
GFFGFSETGDVITFSRSGSDITGSILANGLQADLYENFTDVDAVYSVNPSFVENPKEISE
LTYREMRELSYAGFSVFHDEALIPAFRAGIPVQIKNTNNPSAEGTRVVSKRDNTNGPVVG
IASDTGFCSIYISKYLMNREIGFGRKALQILEEHGLTYEHVPSGIDDMTIILREGQMDAA
TERSVIKRIEENLHADEVIVEHHLALIMVVGEAMRHNVGTTARAAKALSEAKVNIEMINQ
GSSEVSMMFGVKEAEERKAVQALYHEFFAGVLIS
>PK3-2_00560 hypothetical protein
MSGYSNSGGYGGISSFALIVVLFILLIIVGTAFVGGY
>PK3-2_00561 hypothetical protein
MSGYGTSFALIVVLFILLIIVGTAFVGGY
>PK3-2_00562 Phosphatase RapC inhibitor
MKLKSKLFVICLAAAAIFTAAGVSANAEALDFHVTERGMT
>PK3-2_00563 Response regulator aspartate phosphatase F
MKSGVIPSSAVGQKINEWYKYIRTFSVPDAEVLKAEIQQELKHMQHDSNLLLYYSLMEFR
HQLMLDYLEPLEKLNIEDQPSLSELSRNIDSNQADLKGLLDYYVNFFRGMYEFDKREFIS
AITYYKQAEKKLSFVADHIERAEFYFKIAEAYYYMKQTYFSLINIKNAYEIYVEQETYNV
RIIQCHFVFGVNLMDERNFEQAARHFKLALDMAEGEQKAQLVGRAYYNLGLCYYNQDLLD
LAIDYFEKAVSTFESSRIINSLPQAYFLITLIYYKRGKHDNASEYHKRGYEYAKETDDAD
YAVKFEFLQSLYQDQPNEEGIERCFQYLKNKNMYADIEDLALEVAKYYYEQKWFKLSASY
FLKVEEARKQIQRSEGLYEIEI
>PK3-2_00564 Sensor histidine kinase RcsC
MKIKYLYQLLLSHISILILAFVIVISLFSHFVKDFAYQNKVEELTSYAVQIANEFQNGQV
DMHRLYPYQDLLSTRKTQFMLFDEKQRPYFMPEGFPPREKLKKSEWNKLKKGQTVMIRAD
GRFDDEVSLVAQPIFVQNEFKGAVLLISPISGVEQMVNQVNLYMFYAVISTLVITILVSW
LLSKFHVKRIEKLREATDKVASGDYDIHLENSYGDEIGVLASDFNIMAKKLKQSRDEIDR
LEKRRRQFIADVSHELRTPLTTINGLVEGLNSNTIPEDNKEKCFSLISEETKRMLRLVKE
NLDYEKIRSQQITLNKLDVPLIEVFEIVKEHLEQQAEEKQNKLTIQVEDHIIVHADYDRF
IQILVNITKNSIQFTQNGNIWLRGIEGYKETIIEIEDTGIGISKEDIEHIWERFYKADIS
RTNTAYGEYGLGLSIVKQLVEMHQGTVEIKSEEGKGTKFIIRLPLTAKQQ
>PK3-2_00565 Transcriptional regulatory protein SrrA
MKILMIEDNVSVCTMTEMFFFKEGFEAEFVHDGLEGYQRFTEENWDLIILDIMLPSMDGV
TICRKIRETSTVPIIMLTAKDTESDQVIGFEMGADDYVTKPFSPLTLVARIKAVIRRYQA
TGKAVIDEDMIESECFTINKKTREVFLNGEPVENLTPKEFDLLYYLVQNPRQVFSREQLL
EQVWGYQFYGDERTVDVHIKRLRKKLASEDKPFLYTVWGVGYKFDED
>PK3-2_00566 hypothetical protein
MNFIKRAFWNMKAKKGKTLLQLFVFTVICVFVLSGLTIQSAAQKSSELARQELGGSVTLQ
VDRQKQMEKQQDSGEKRSFESTPIKVSDANKLAALDHVKSYNYITSASANAGNFDAIESS
SSSDSSSSSSSANAKNSQGGGQGGPQMVQADLSIEGVISTALVDDFSDGDSKITDGRAIT
KSDVGKKVTVINETLAEENDLSVGDSITIESATDEDTTVKLKIVGIYKTTSSGDDQAQNF
SFLNPYNKLYTPYTATAALKGDDYKNTIDSAVYYMDDAKNMDAYVKAAKKTSIDFDTYTL
NTNDQLYQQMVGPIENVASFSKNVVYLVSVAGAVILGLIVMMSIRERKYEMGVLMAIGEK
RWKLIGQFLTEILIVAVIAIGLASVTGNLVANQLGNQLLSQQISSSTDSTQTASGQMPGG
GGGMGGGMFGHSSSNVDVIDSLNVAVSMNDMLVLGGIGILIAIIATLLPSISVLRLHPKT
ILTKQE
>PK3-2_00567 Lipoprotein-releasing system ATP-binding protein LolD
MSLLEFQQVGYWYKDKSQPLFQDINISFQKGKFYTIVGTSGTGKTTFLSLAGGLDAPKEG
TILYDGKAVSKIGLTNFRNQYVSIVFQAYNLLPYMTALQNVTTAMDITGSKEKNKEAYAL
EMLEKVGINEKQARQKVLTLSGGQQQRVSITRAFCCDTDLIVADEPTGNLDEDTSKEIVR
LFQDLAHKENKCVIMVTHDEQIAKVSDINIRLSRGSFTVKENVAVV
>PK3-2_00568 Spore germination protein YndE
MEKAKISIRQLFVMIIIFELGSSLLITPGTMAGRDAWIAVLLGCAAGLFLFYLYQGIYQC
YPESSPKEYMDDMLGTKLSWLFSFLYILYFAYIAARVLRDFGEMLLTFAYHDTPIIIVNA
MLMVVSIYAVRKGIEVLARSAELLFGAMYLLGALGLVLIIVSGSMDPHLLKPVLANGISP
VLHSVFTQTMYVPFGEVVLFVMIFPNLNDRKNVKKMGMIAIAISGLIVALTVAINISVLD
VDLTLRSQFPLLSTIQTIKVEEFLDRLDVFFMLALIIGGFFKVSLYLYAVVVGTSTLFKE
KNPSQLAYPMGLGILILSITIATNFSEHLNEGLKVVPLYIHLPFQVVFPLFLFILAVWKK
KRREKSNGAEAKKQ
>PK3-2_00569 Spore germination protein B3
MVRKRVLAVLMLLSVIVLPGCWDKRELTDLAIISAIGIDRTNEGNYVLHLQIINPGNVAG
GLQGGGAGDRPPVSVYSIEGDNMTEALRKASMKVSRRLYFAHTNLVVISEKLAKEEGLDY
VLDNLDRDTEFRTTATIVVAHKTKAENIVKILTPIDKIPSNKVNKTLDFTEAQYGRVVKT
NIQDVMKTLAASTKAPVIPGYMMIGDDKKGISMENTQATDPKAILQADGLAIFNKSGRLK
YWIEDDESVGAVWLMNKVQHTFVNADWDKTKDAVSLQVTHQATKLVPEMRNGRPRIHIHV
TVEGIIDAVKYPFQLSNPKVLAALEKALNKELEKEISDTVKKVKKNKIDFIGFGDTIYRK
YPKQWEKMKETWDKEYLPDLPVDVKAETYIRRTGLRNNPLKHQLEDK
>PK3-2_00570 Spore germination protein B1
MPLFSKQKNKTDSKDKQKTEEKNQAQQKEKERPVLVSPSLAKNIAEMKKEVGSSSDVIIR
EIKIGEQDRVHLAIIYIAGLVDNNTIQESLIEPLVQDESIQNSHAIQQILQKTLPLGGVK
AEKSWDKLFSELMLGNALVFADGFEETLICSTQGGEQRSIQEPSTQVSFRGPRQGFTESL
QTNISMIRRYIKNPNVWVEKMKIGSVTHTDVALMYIHGICDEKVLKEVRSRLKKIDIDSI
LESGYIEQLIEDETFTTFPTMYHTERPDVVAGNLLEGRFAIVVDGTPFVLIAPALFVQFF
QSVEDYYSRFDIATSIRILRILVFFISLVAPAVYVAATTFHQEMIPTQLLVVIAAQREIV
PFPAVVEALTMEVAFEILREAGVRLPRVVGSAVSIVGALVIGQAAVQAGIVSPAMVIIVA
LTAIASFATPAFAMAISARLIRFIFIIASSVMGFYGLILGIIIMFVHLCSLRSFGVPYMS
PLAPFSSQGIKDTLFRVPWWADEKRPESISKKDKVRQGKGQRPEPDGSRGMVNKDLKEGD
QNGS
>PK3-2_00571 hypothetical protein
MKILGVTGIILICLLTISVFMDMLQGFSLTKAVYNNMSSFKMTTFAEWVVLSFFGLVLVR
EMYVIYKSKKKNP
>PK3-2_00572 hypothetical protein
MAEFILNAADFGILGDGKTDSTELINQCLSTAVSKGYHTVWFPKGTYLIDGTLGGDPNQK
FRNAGIIVPGNLEILMDPECIIKVIPNSSWGYSAFYVGKQENITISGGQIIGERDGHTYA
SAGIRSTHEWGFGICIEGCSNVVIDDVKISDFTGDGMIVSPRGLKTTNDYRTSEHITIRR
CEVRRSRRNNISITGCDMVTVEECVIEDAGTGNGTAPRFGIDIEGYGEGDVDYEEPVNVS
IRNNHFIGNASSSVTNFNGYGILIEGNHSDNTISYGYGTQTVIKGNILRRAEDAAAAPRV
GITGLGVSQGKESSDAVIAGNLITGFSTGIDVRGKSVLVTNNKISNFENTGILVYQSSDV
KVDGNQIQNGLSETRRSTGLRAVLSDDTAFLNNCLIEVFDGVNISGGDMIIRDNVLRKFS
RGIWIAQGNAVVEGNTMIPDAFEGVLESYAVSVTNNAGAVIKNNTFKEFKNYPIYCSTSA
KTSIISNHIERSPLLVTIYISAGVHEIFDNTISVNRTAGNPIVIYVNGSAGSIISGNTIN
NLSAGTATAIQTNTSTNSKIIGNRIFKGTINKHSSDTADGNILA
>PK3-2_00573 Di-/tripeptide transporter
MASIDNESIIKSVPQKGFFGHPRGLFTLFFTEFWERFSYYGMRAILLYYLYTETVNGGLG
FDKGTAVAIMSIYGSLVYMSTIIGGWLADRVFGTANTVFYGGIFIMFGHIALAYPGSAVA
FYISMVLIIIGTGLLKPNVSSVVGDLYTKEDPRRDSGFSIFYMGINLGGLLAPLIVGTLG
QKYNYHLGFGVAAVGMLLGLIVFALTRKKNLGLAGSNVPNPLSKKSAIGTGIGVIIVAIA
VIISVQTGVLTIKRFIDLVSILGILIPVIYFIIMFTSKKADKTEKSRLAAYVPLFIGAVM
FWAIQEQGATILAVYADERIRLSLGGLELQSSWFQSLNPLFVVIFAPIFAWLWMKLGKRQ
PSTPVKFSIGIILAGLSFIIMVFPAMQGKEALVSPLWLVLSFLLVVLGELCLSPVGLSVT
TKLAPAAFSAQTMSMWFLTNAAAQAINAQVAGLFDKIPETTYFGTIGLISIVLGGILLLI
SPIIKRAMKGVL
>PK3-2_00574 Proline iminopeptidase
MKMTGICHSDGFDLSYRIEGEGAPILVIGSSVYYPRLFSSDIKQKYQWIFADHRGFAKPK
RELRAEDLRLDAVLDDIERMRTSLQLEDVVILGHSGHAFMALEYARTYPEHVRKVALFNT
APDNSEARQRKSESFFMETASLERKKRFEKDIAHLPQDIEKDPERRFVHMCIRAEAKSFY
QERSGAAALWDGVFTNMPIIDELWGHTFARLDLIQRLADVHVPVYIGLGRYDYLVAPVEL
WDAVEGGYPHVEKVIFEKSGHQPMLEEPQAFDQSFSKWMDK
>PK3-2_00575 hypothetical protein
MIDVNCLSDRLFELLDGNRLNEKQHEAFVLQTVSEDGWPHAAMISAGEIIALSRTDVRIA
LWKNTATSANILRTGKAQFTAWWKGAAHYVKLQCEPLPPLKDAEYERDRFACRIVSVKED
VAKYADLASGVHIQLHSPEEVLDRWEKTLEELKR
>PK3-2_00576 Protein BsdD
MHTCPRCDSKKGEVMSKSPVDGAWEVYQCQTCFFTWRSCEPESITNPAKYNPAFKIDPKE
TETAVEVPAVPERKA
>PK3-2_00577 Phenolic acid decarboxylase
MAYQDFREFLAALEKEGQLLTVNEEVKPEPDLGAAARAASNLGDKSPALLFNNIYGYNNA
QIAMNVIGSWPNHAMMLGMPKDTPVKEQFFEFAKRYEQFPMPVKREETAPFHENEITEDI
NLFDILPLFRINQGDGGYYLDKACVISRDLEDPDNFGKQNVGIYRMQVKGKDRLGIQPVP
QHDIAIHLRQAEERGVNLPVTIALGCEPVITTAASTPLLYDQSEYEMAGAIQGEPYRIVK
SKLSDLDVPWGAEVVLEGEIIAGEREYEGPFGEFTGHYSGGRSMPIIKIKRVYHRNNPIF
EHLYLGMPWTECDYMIGINTCVPLYQQLKEAYPNEIVAVNAMYTHGLIAIISTKTRYGGF
AKAVGMRALTTPHGLGYCKMVIVVDEDVDPFNLPQVMWALSTKMHPKHDAVIIPDLSVLP
LDPGSNPSGITHKMILDATTPVAPETRGHYSQPLDSPLTTKEWEQKLMDLMNK
>PK3-2_00578 putative UbiX-like flavin prenyltransferase
MKLVVGMTGATGAIFGVRLLEWLKAAEVETHLVVSPWANVTIKHETGYTLKEVEQLATYT
YSHKDQAAAISSGSFDTDGMIVAPCSMKSLASIRTGMADNLLTRAADVMLKERKKLVLLT
RETPLNQIHLENMLALTKMGTIILPPMPAFYNQPGSLEEMVDHIVFRTLDQFGIRLPEAK
RWNGIEKQKGGA
>PK3-2_00579 HTH-type transcriptional regulator BenM
MDIRQLRYFITIAQEQKITSAAKKLHMAQPPLSRQLKQLEDELGVVLFDRNKKKQMTLTY
EGTVFLKRAKEILHRFEDAVIEVQELKEEVAGTLAVGSTIYCAALMLEKVTQIKERYPHL
TFNIWENEPATLLELLESRQIDAAVTTTLIKSDTVHFKQLDDIPCVLVLSKEAGYPCGDT
IKMEDIPSFPLILLRPVNGKGVYNQVMNEFHRLNLEPRIVCECHDSATLLSLVSSGFGAS
ILPVTMIPVHMRNHVHTVHIENNPFIMTPAVMWRTDSYLPKPVQQFLNLF
>PK3-2_00580 L-cystine-binding protein TcyA
MKKALLALFMVVSIAVLAACGAGNDNQSKDNAKNGDLWASIKKKGVLTVGTEGTYEPFTF
HDKDTDKLTGYDVEVITEVAKRLDLKADFKETQWDSMFAGLNSKRFDVIANQVGKTDRED
KYDFSDKYTTSRAVVVTKKDNNDIKSEADVKGKTSAQSLTSNYNKLATKAGAKVEGVEGM
AQSLQLIQQGRVDMTYNDKLAVLNYLKTSGNKNVKIAFETGDPQSTYFTFRKGSGEVVDQ
VNKALKEMKEDGTLSKISKKWFGEDVSK
>PK3-2_00581 L-cystine transport system permease protein TcyB
MFLNNLPALTLGTAIPWDLVQQSFWPILSGGIYYTIPLTILSFIFGMIIALTTALARMSK
VRPLRWVFSVYVSAIRGTPLLVQLFIIFYLFPAFNVTLDPFPSAVIAFSLNVGAYASEII
RASILSVPKGQWEAGYTIGMTHQKTLFRVILPQAFRVSIPPLSNTFISLIKDTSLASQIL
VAELFRKAQEIGALNLDQILVIYIEAAFIYWIICFLLSLVQHVIERRLDRYVAK
>PK3-2_00582 L-cystine import ATP-binding protein TcyC
MLTVKGLNKSFGENEILKKIDMKIEKGKVIAILGPSGSGKTTLLRCLNALEIPNRGELAF
DDFSIDFSKKVKQADILKLRRKSGMVFQAYHLFPHRTALENVMEGPVQVQKRNKEEVRKE
AIQLLDKVGLKDKMDLYPFQLSGGQQQRVGIARALAIQPELMLFDEPTSALDPELVGEVL
KVIKDLANEGWTMVVVTHEIKFAQDVADEVVFIDGGVIVEQGPPEQIFSAPKEERTQRFL
NRILNPL
>PK3-2_00583 hypothetical protein
MKQELVLRWTFYFAGLIILAFGVSLTIEGKALGISPWDAFHYSLFQHFGFTVGQWSIIIG
AIIVGLTSLFTKAWPKIGAILNMVLIGVFIDFFNFLLPAPSTYMGSVIVFSLGGVLIGYG
VGVYVSAGLGAGPRDSLMMLITEKTGWNVQWVRNGMEITILFAAWGMGGPIGFGTILTAI
LTGLILRFSLPQSIQLLNYAVARRTAAVKASPPVH
>PK3-2_00584 4'-phosphopantetheinyl transferase Sfp
MKIYGMYMDRPLSQGETERLMSFISPEKREKCLRFYHKEDAHRTLLGDVLVRSVVSKQYQ
LDKADIRFSAQEYGKPCIPDLPDAHFNISHSGRWVICAFDSQPIGIDIEKMKPISLEIAK
RFFSKTEYTDLLAKNKDEQTDYFYHLWSMKESFIKQEGKGLSLPLDSFSVRLHQDGQVSI
ELPDNHAPCYIRTYEVDPGYKMAVCAARPDFPEDITMVSYEALL
>PK3-2_00585 HTH-type transcriptional regulatory protein GabR
MEKYMNLLTRIEEMMQSSAYQEGDRLPSIRQLSARYQISKSTVIRALQELEKRHLIYSVP
KSGYYIVKKTGKSKSGQPGLIDFATSAPDPDVFPYLDFQHCINKAIDTYKNDLFIYGTPK
GLPSLIRVLRKLLANQQVFADERHIFITSGVQQALSLLCAMPFPNGKEKIAIEQPGYHLM
IEQLETLGIPAIGVKRTEEGLDIAEVERLFQTESIKFFYTMPRFHNPLGCSLSERDKQEL
VRLAEAYDVYLVEDDYLGDLEENKKADPLFAYDLSSRVIYLKSFSKMMFPGLRVGAAVLP
DVLADTFHTYKKLNDIDCSMISQAALEIYLKSGMYGRHKEKIRASYKERSLMLHQAIQTY
GHLGSGRFAFSSGQAPCIHTHLVLPRDLPASRVIQRLKKQGVLLEAIDRHYLSDYPKENL
LKINISNVKTEDIEHGVKLLMSYL
>PK3-2_00586 hypothetical protein
MFKQQQASAYTAAILYSFIIGLSFLFVKIALQTAEPFDILAHRFTIAFAAATVPVLFGWV
KLSIRVKDVMAILPLALLYPALFFSFQAFGLVYSSSSEAGIIQAAIPIFTMVLASYILKE
RSTRAQKGFTVLSVAGVMFIFVMKGVDVESASLKGSLLILLSALSSAMYNTAARKMTQRF
KLTELTYIMSAIGFVVFNAIAIVRHSAAGTVGTYFQPFRETGFVLAIVYLGVLSSLVTSF
LSNYTLSRIEAFKMSAFNHVATLVTMIAGVMILNESLAWYHLAGAVCIMIGVVGSNTTRQ
KKTKPPGTPAKK
>PK3-2_00587 hypothetical protein
MVQYASESINLPGEITFKDVREIFFYQIGKISFFYFLLFCAVFAAVHSINGWPRLVFGSD
ALNLFVNGILILVMSVLITLLLLLLLYVKFSRAYKKNERMKSKRTYTLNQEGIRICSKKY
DLIFNWDEITAVFEYKNIFRVNTSSGQYIAIPKRFFHSKEEMNRFRGIILKNTETIKVKW
KKDQH
>PK3-2_00588 L-lactate transporter
MHASPKMKWFVLFTFVFAIGMNSFRNSFQFFMLPMADTFHADRSLISVSVSIFMITTGIV
QFFVGFFIDRFSVRKIMALGAVCISASFLMLPYSPNVHVFSALYGVLGGIGYSCAVGVTT
QYFISRWFDTHKGLALAILTNANSAGLLLLSPIWAAAPYHAGWQNTYMILGVVMAAVLLP
LLVFGMKHPPHAQAPSVKKSYDWRGFRNVIKQSRLIHVLYFGVFTCGFTMGIIDAHLVPM
LKDAHVSHVNGMMAAFGAFIIIGGLLAGWLSDLLGSRSVMLSILFFLRLLSLICLLIPIL
GIHQSDLWYFGFILLFGLSYTGVIPLTAASISESYHSGLIGSLLGINFFIHQIAGALSVY
AGGLFFDMAHDYLLIIVVCIVFVGVSAGIELMPVLNKQKAKETHQSI
>PK3-2_00589 Surfactin synthase thioesterase subunit
MSQLFKSFDASKKTRLICFPFAGGYSASFRPLHAFLQGECEMLAAEPPGHGTNQTSAIEN
LEELTDLYKKELNLRPDRPFVLFGHSMGGMITFRLAQKLEREGIFPQAVIISAIQPPHIQ
RKKVSHLPDDQFLDHIIKLGGMPAELVENKEVMSFFLPSFRSDYRALEQFELHDVAPIQS
PVHVFNGLDDEKCIRDAEGWKKWAKDITFHEFDGGHMFLLSHTEEVAERIFAILNQHPII
QT
>PK3-2_00590 Surfactin synthase subunit 3
MSQFSKDQVQDMYYLSPMQEGMLFHTILNPGQSFYLEQITMKVKGGLNIKCLEESMNVIM
DRYDVFRTVFIHEKVKRPVQVVLKKRQFHIEEIDLTHLTGSEQAAKINEYKEQDKIKGFD
LTRDIPMRAAIFKKAEESFEWVWSYHHMILDGWCFGIVVQDLFKVYNALREQKPYSLPPV
KPYKDYIKWLEKQDKQASLRYWREYLEDFEGQTTFAEQRKKQKDGYEPKELLFSLPEAET
KAFTELAKSQHTTLSTALQAVWSVLISRYQRSDDLAFGTVVSGRPAEIKGVEHMVGLFIN
VVPRRVKLSEDITFNGLLKQLQEQSLQSEPHQYVPLYDIQSQADQPKLIDHIIVFENYPL
QDAKNEENSENGFEMEDVHVFEKSNYDLNLMASPGDEMLIKLAYNENVFDEAFILRLKSQ
LLTAIQQLIQKPDQPVSTISLVDDKEREFLLTGLNPPAQTHEAKPLTDWFKEAVNVHPDA
PALTYSGQTLSYRELDEEANRLARRLQKQGVGKGSVVALYTKRSLELVIGILGVLKAGAA
YLPIDPKLPEDRISYMLTDSAAACLLTHQDMKEQAAQLPYTGTTLFIDDQTRFSEQTSDP
AISIEPDDPAYIMYTSGTTGKPKGNITTHANIQGLVKHVDYMAFSEKDTFLSVSNYAFDA
FTFDFYASILNASRLIIADEHTLLDTERLTNLIQHEKVNVMFTTTALFNLLTDAGEDWMK
GLRCVLFGGERASVPHVRKALRIMGPGKLINCYGPTEGTVFATAHVVRDLPDSISSLPIG
KPISNASVYILNEQKQLQPFGAVGELCISGMGVSKGYLNRHDLTKQKFIANPFKPGETLY
RTGDLARWLPDGTIEYAGRIDDQVKIRGHRIELEEIEKQLQEYPGVKDAIVVADRHESGD
ATINAYLVNRTQLSAEDVKAHLKKQLPAYMVPQTFTFLEELPLTTNGKVNKRLLPKPDQN
QLAEEWVGPRDETEETIAQIWSEILGRQQVGIHDDFFALGGHSLKAMTAASRIKKELAID
LPVKLLFEAPTIAGISAYLKNGGSDGLQDVTIMNPDQEQIIFVFPPVLGYGLMYQNLASR
LPSYKLCAFDFIEVENRLDRYADLIQKLQPEGPLTLFGYSAGCSLAFEAAKKLEEQGRAV
QRIIMVDSYKKQGVSDLDGRTVESDVEALMNVNRDNEALNSEAVKQGLKQKTHAFYSYYV
NLISTGQVKADIDLLTSDTDFDMPEWLASWEEATTGAYRVKRGFGTHAEMLQGETLDRNA
EILLELLNTQTVTVS
>PK3-2_00591 Surfactin synthase subunit 2
MSKKSIQKVYALTPMQEGMLYHAMLDPHSSSYFTQLELGIHGAFDLEIFEKSVNELIRSY
DILRTVFVHQQLQKPRQVVLAERKTKVHYEDISHADAERQKEHIERYKQDVQRQGFNLAK
DILFKVAVFRLDADQLYLVWSNHHIMMDGWSMGVLMKSLFQNYEALRAGRTPANGQGKPY
SDYIKWLGKQDNEEAESYWSERLADFEQPSVLPGRLPEKKDEYVNKEYSFTWDEKLVACI
QQAANRHQVTGPNLFQAVWGIVLSKYNFTDDVVFGTVVSGRPSEINGIETMAGLFINTIP
VRVKVDRDAAFADIFSAVQQHAVEAERYDYVPLYEIQKRSALDGNLLNHLVAFENYPLDQ
ELENGSMEERLGFSIKVESAFEQTSFDFNLIVYPGQTWTVKIKYNGAAFDSAFIERTAEH
LTRMMEAAVDQPAAFVREYGLVRDEEQRQIVEVFNSTKAELPEGMAVHQVFEEQAKRTPA
STAVVYEGIELTYRELNTAANRLARKLIEQGLQKGETAAIMNDRSIETVVGMLAVLKAGA
AYVPLDPALPEDRLRFMAEDSSIRMVLAGKTYAEQAHQLQVPVLTLDSGVEESEAADNLN
LPSAPSDLAYIMYTSGSTGKPKGVMIEHKSILRLVKNAGYVPVTEEDRMAQTGAVSFDAG
TFEVFGALLNGAALYPVKKETLLDAKQFAAYLREQRITTMWLTSPLFNQLAAKDAGMFGT
LRHLIIGGDALVPHIVSKVRQASPALSLWNGYGPTENTTFSTAFQIDREYSGSIPIGKPI
GNSTAYIMDEQQRLQPIGAPGELCVGGIGVARGYVNLPELTEEQFLEDPYRPGERIYRTG
DLARWLPDGNIEFLGRIDNQVKVRGFRIELGEIETKLNMAEHVTEAAVIIRKNKADENEI
CAYFTADREVSVSGLRKTLSQSLPDYMVPAHLIQLDSLPLTPNGKINKKELPAPQSEAVQ
QEYAAPETESEKKLAEIWEGILGIKAGVTDNFFMIGGHSLKAMMMTAKIQEHFHKEVPIK
VLFEKPTIQELALYLDENESKEEQTFEPIRQASYQQHYPVSPAQRRMYILNQLGQANTSY
NVPAVLLLEGEVDKDRLENAIQQLINRHEILRTSFDMIDGEVVQTVHKNISFGLEAAKGR
EEDAEEMIKAFIQPFELNRAPLVRSKLVQLEEKRHLLLIDMHHIITDGSSTGILIGDLAK
MYQGADLELPQIHYKDYAVWHKEHADHQKDEAYWLDTFKGELPVLDLPADFERPAERSFA
GERVMFGLDKQITAQIKSRLAETDTTMYMFLLAAFNVLLSKYASQEDIIVGSPTAGRIHP
DLQGVPGMFVNTVALRTAPAGDKTFAQFLEEVKTASLQAFEHQSYPLEELIEKLPLTRDT
SRSPLFSVMFNMQNMEIPSLRLGDLKISSYSMLHHVAKFDLSLEAVEREEDIGLSFDYAT
ALFKDETIRRWSSHFVNIIKAAAANPNVRLSDADLLSPAETAALLEERHMTQITEATFAA
LFEEQAQQTPDHPAVKAGGKLLTYRELDEQANQLAHHLRAQGAGSEDIVAIVMDRSAEVM
VSILGVMKAGAAFLPIDPDTPEERIRYSLEDSGAKIAVVNERNMTAIGRYDGTIINLDDK
EWRNESKERLSPISGSRNLAYVIYTSGTTGKPKGVQIEHRNLTNYVSWFSQEAGLTETDK
SVLLSSYAFDLGYTSVFPVLLAGGELHIVQKETYTAPDEIGRYIKEHGITYIKLTPSLFH
TMVNTASFTKEPNFASLRLIVLGGEKIIPADVLAFSNMYRHTGFINHYGPTEATIGAIAG
RVDLSEPDAFTKRPTIGQPIANAGALVLNEALKLVPPGASGQLYITGQGLARGYLNRPQL
TAERFVENPYSPGSLMYKTGDVVRRLSDGSLEFIGRADDQVKIRGYRIEPKEIETVMLSL
SGIQEAVVLTVSEGGLQELCAYYTADHAIEKAELRNLLSQTLPSHMIPAFFVQVDAIPLT
ANGKTDRNALPKPNAAQSGRKASAAPETALEKNLCSIWQKTLGIDAIGIDDNFFDLGGHS
LKGMMLIANIQAELEKTVPLKALFEQPTVRQLAAYMEASAVSGGRHVLKPADKQEMYPLS
SAQKRMYVLNQLDRQTISYNMPSVLLMEGELDLSRLRDSLNQLVNRHESLRTSFTEANGE
PVQRILEAAAVDLHVFEAKEDEAEQKIKEFIRPFDLNDAPLIRAVLLRIEAKKHLLLLDM
HHIIADGVSRGIFVKELALLYKGEQIPKPALHYKDFAVWQNEAEQKDRMKEHEAYWLSVL
SGELPELDLPLDYARPPVQSFKGDTVRFRTGSETAKAVEKLLAETGTTLHMVLHAVFHVF
LSKISGQRDIVIGSVTAGRTNADVQDMPGMFVNTLALRMEAEEQHTFAELLEQAKQTNLS
ALEHQEYPFEDLVNQLDLPRDMSRNPLFNVMVTTENPDKEQLTLQNLSISPYESHQGTSK
FDLTLGGFTDENGIGLQLEYATDLFSKETAEKWSEYVLRLLKAVAENPNQPLSSLSLVTE
TEKQTLLDAWKGKTFPVPTDKTVHQLFEETALRHKDRPAVTYNGQSWTYGELNAKANRLA
RILIDCGVCADERVGVLTKPSLEMSAAVLGVLKAGAAFVPIDPDYPDQRIDYILQDSGAK
LLLKQEGISVPDSFSGDVILLDGARTILSLPLDENDEENPLTAAKAENLAYMIYTSGTTG
QPKGVMVEHHALVNLCFWHHDAFNMTAEDRSAKYAGFGFDASIWEMFPTWTIGAELHVID
EAIRLDIVRLNDYFETNGVTITFLPTQLAEQFMELENTSLRVLLTGGDKLKRAVKQPYTL
VNNYGPTENTVVATSTVINPEEGSLSIGQAIANTRVYILGEGNQVQPEGVAGELCVAGRG
LARGYLNREDETAKRFVADPFVQGERMYRTGDLVKWVNGGIEYIGRIDQQVKVRGYRIEL
SEIEVQLAQLSDVQDAAVTAVKDKGGNTAIAAYVTPETADIEALKSALKETLPDYMIPSF
WVTLNELPVTANGKVDRKALPEPDIEAGSGEYKAPATDMEELLAGIWQDVLGIPEIGVSD
NFFSLGGDSIKGIQMASRLNQHGWKLEMKDLFQHPTIEELTQYVERAEGKQADQGPVEGE
VILTPIQRWFFEKNFTNKHHWNQSVMLHAAKGFDPERVEKTLQALIEHHDALRMVYREEN
GEILQAYKPISESKVSFEIVDLYGSDKDMLKSQIKILADRLQSSLDLQNGPLLKAEQYRT
EAGDHLLIAVHHLVVDGVSWRILLEDFASGYMQAEKEENIVFPQKTNSFKDWAEELAAYS
QSADLLQQVEYWSQIDDEQVSPVPKDYETEQRIVKHTSAVLSELTEEETKHLLTDVHQPY
GTEINDILLSALGLTMKEWTGGAKIGINLEGHGREDIIPNVNISRTVGWFTAQYPVVLDM
SEADASAVIKSVKENLRRIPDKGVGYGILRYVTETAETKGFTPEISFNYLGQFDSEVKTD
FFEPSAFDMGRQVSEESEALYALSFSGMIRNGRFVLSCSYNEKEFERATVEEQMERFKEN
LLMLIRHCTEKEDKEFTPSDFSAEDLGMDEMGDIFDMLEENLK
>PK3-2_00592 Surfactin synthase subunit 1
MEITFYPLTDAQKRIWYTEKFYPHTSISNLAGIGKLVSTDKVDWVLVEQAIQEFIRRNDA
MRLRLRLDKNGEPVQYISEYRPVDIKHTDTTGDPNAIESISQWSREETKKPLPLYDCDLF
RFSLFTIKENEVWFYANVHHVISDGISMNILGNAIMHIYLELAGGLETKAGISHSFIDHV
LSEQDYAQSKRFEKDKAFWNKQFESVPELVSLKRNASAGGSLDAERFSKDVPEALHQQIL
SFCEANKVSVLSVFQSVLAAYLYRVSGQNDVVTGTFMGNRTNAKEKQMLGMFVSTVPLRT
NIDGGQAFLDFVKDRMKDLMKTLRHQKYPYNLLINDLRETKSSLTKLFTVSLEYQVMQWQ
KEEDLAFLTEPIFSGSGLNDVSIHVKDRWDTGKLTIDFDYRTDLFSREEITIVCERMITM
LENALSHPDHAIDELTLISEAEKEKLLARAVGESVSYRKDMTIPELFQEQAELLSDHPAV
VFEGRTLSYRTLHEQSARIANVLKQKGVGPDSPVAVLLERSERMITSIMGILKAGGAYVP
IDPEFPAERIQYILEDCGADFILTESKVAAPAADAELIDFDRAIAEGAESLTADVNARNL
AYIIYTSGTTGRPKGVMIEHRQVHHLVESLQQTIYQSGSQTLRMALLAPFHFDASVKQIF
ASLLLGQTLYIVPKKTVTNGSALAAYYRKHNIEATDGTPAHLQMLIAAGDFEGLKLKHML
IGGEGLSSVVADKLLKLFKEAGTAPRLTNVYGPTETCVDASVHPVSTESAVHSAYVPIGK
ALGNNRLYILDQKGRLQPEGVSGELYIAGDGVGRGYLHLPDLTAEKFLQDPFVPGDRMYR
TGDVVRWLPDGTIEYLGREDDQVKVRGYRIELGEIEAVIQQAPDVAKAVVLARPDEQGNL
EVCAYVVQKPDSEFASASLREHAARQLPDYMVPAYFTEITEIPLTPSGKVDRRKLFALEV
KAVSGTAYTAPRNETEKAIAAIWQDVLNVEKAGIFDNFFETGGHSLKAMTLLTKIHKETG
VEIPLQFLFEHPTIASLAEEADHRESRAFAAIEPAEKQEHYPLSLAQQRTYIVSQFEDAG
VGYNMPAAAILEGPLDIQKLERAFQELIRRHESLRTSFVLDNSTPRQNIHDSVNFNIEMI
NRSGRSDETVMTSFVRKFDLAKAPLFRIGLMELGENRHMLLFDMHHLISDGVSIGIILEE
LARIYKGEQLPELRIQYKDYAVWQSGQAAEGYQKDRAYWKETFAGELPVLQLLSDYPRPP
VQSFEGDRVSIKLDAGLKDRLHRLAEQNGATLYMVMLSAYYTLLSKYTGQDDIIVGTPSA
GRNHSDTEGIVGMFVNTLAIRGEVKQDETFTRLIARVRKQVLDAFSHQDYPFEWLVEDLN
IPRDVSRHPLFDTMFSLQNATEGIPAVGDLSLSVHETNFKIAKFDLTMQARETDEGIEVD
LDYSTKLFKQSTADRLLNHFARLLEDAAAEPEKQISEYKLLSEEGAASQIQQFNPERTPY
PKDKTIVQLFEEQAAKTPDQPALQYEGESLTYRELNERANRLARGILSFGAGEGRTAAVL
CERSMDMIVSILAVLKTGSAYVPIDPEHPIQRMQHFFRDSGAKVLLTQKKLKALAEESEF
SGVIVLADEEESYHADVQNLALPLDSAAMANLTYTSGTTGTPKGNIVTHANILRTVKETN
YLSITEQDTILGLSNYVFDAFMFDMFGSLLNGAKLVLIPKETVLDMARLSRVIERENISI
LMITTALFHLLVDLNPACLSTLRKIMFGGERASVEHVRKALQIVGKGKLLHMYGPSESTV
FATYHPVDELEKHTLSVPIGKPVSNTEVYIMDRAGHVQPAGIAGELCVSGEGLVKGYYNR
PELTEEKFVPHPFASGERMYKTGDLARWLPNGDIEFIGRIDHQVKIRGQRIELGEIEHQL
QTHDRVQESVVLAVDQGAGDKLLCAYFVGEGEISSQELREHAAKDLPAYMVPAVFIQMDE
LPLTGNGKIDRRALPLPDANVSRGVSYVAPRNETEQKVADIWAHVLQAEQVGVYDQFFDI
GGHSLAGMKMLALVHQELGVELSLKDLFQSPTVEGLAQVIDSAEKGTVISISPAKKQDTY
PVSSPQKRMYVLQQLEGAETSYNMPAVLRLTGELDVERLNSVMKQLMKRHEAFRTTFEIK
DGETVQRIWEEAECEMAYFEAVEEETERIVSEFIKPFKLDRLPLFRMGLIKHSDTEHVLL
FDMHHIISDGASVGVLIEELSKLYDGETLEPLRIQYKDYAVWQQQFIQSELYKKQEEHWL
KELDGELPVLTLPTDYSRPAVQTFEGNRIAFSLEAGKAAALRRLANETDSTLYMVLLASY
SAFLSKLSGQHDIIVGSPVAGRSQADLSQVIGMFVNTLALRTYPKGEKTFADYLREVKET
ALSAFEAQDYPLEDLIGNLQVQRDTSRNPLFDAVFSMQNASIKDLTMKGIQLEPHPFERK
TAKFDITMTADETDGGLTFVLEYNTALFKPETIERWKQYWMQLLDAVTDNPNQPLSSLSL
VTETEKQTLLEAWKGKTLSVPTDKTVHQLFEETALCHKDRPAVTYNGQSWTYGELNAKAN
RLARILIDCGVCADERVGVLTKPSLEMSAAVLGVLKAGAAFVPIDPDYPDQRIDYILQDS
GAKLLLKQEGISVPDSFSGDVILLDGARTILSLPLDENDEENPLTAAKAENLAYMIYTSG
TTGQPKGVMVEHHALVNLCFWHHDAFNMTAEDRSAKYAGFGFDASIWEMFPTWTIGAELH
VIDEAIRLDIVRLNDYFETNGVTITFLPTQLAEQFMELENTSLRVLLTGGDKLKRAVKQP
YTLVNNYGPTENTVVATSTVINPEEGSLSIGQAIANTRVYILGEGNQVQPEGVAGELCVA
GRGLARGYLNREDETAKRFVADPFVQGERMYRTGDLVKWVNGGIEYIGRIDQQVKVRGYR
IELSEIEVQLAQLSDVQDAAVTAVKDKGGNTAIAAYVTPETADIEALKSALKETLPDYMI
PSFWVTLNELPVTANGKVDRKALPEPDIEAGSGEYKAPATDMEELLAGIWQDVLGIPEIG
VSDNFFSLGGDSIKGIQMASRLNQHGWKLEMKDLFQHPTIEELTQYVERAEGKQADQGPV
EGEVILTPIQRWFFEKNFTNKHHWNQSVMLHAAKGFDPERVEKTLQVLIEHHDALRMVYR
EEPKDVVQYNRGLEAASAQLEIIHIEGQAKDHEDRIEREAERLQSSIDLQEGGLLKAGLF
QAEDGDHLLLAIHHLVVDGVSWRILLEDFAAVYTQLEQDNEPVLPQKTHSFAEYAERLQD
FANSKAFLKEKEYWRQLEEQTVAPKLPKDRESGDQRMKHTKTIEFSLTAEETEQLTTKVH
EAYHTEMNDILLTAFGLAMKEWTGQDQVSVHLEGHGREEIIEDLTISRTVGWFTSMYPMV
LDMKHADDLGYQLKQMKEDIRHVPNKGVGYGILRYLTAPEHKEEMAFSIQPDVSFNYLGQ
FDDMSDAGLFTRSELPSGQSLSPETEKPNALDVVGYIENGKLTMSLAYHSLEFHEKTVQT
FSDSFKAHLLRIIEHCLSQDGTELTPSDLGDDDLTLDELDKLMEIF
>PK3-2_00593 HTH-type transcriptional activator HxlR
MSRMDDKRFNCEKELTLAVIGGKWKMLILWHLGKEGTKRFNELKTLIPDITQKILVNQLR
ELEQDLIVHREVYPVVPPKVEYSLTPQGESLMPILDAMYEWGKGYMELIDIDKNVMKESL
>PK3-2_00594 3-hexulose-6-phosphate synthase
MELQLALDLVNIPEAIELVKEVEQYIDVVEIGTPVVINEGLRAVKEVKEAFPQLKVLADL
KIMDAGGYEIMKASEAGADIITVLGATDDATIKGAVEEAKKQKKKILVDMINVKDIESRA
KEIDALGVDYICVHTGYDLQAEGKNSFEELTTIKNTVKNAKTAIAGGIKLDTLPEVIKQN
PDLVIVGGGITSAADKAETASKMKQLIAQG
>PK3-2_00595 3-hexulose-6-phosphate isomerase
MKTTEYVTEILNELHRSAAYISDEEADQLADRILSSNQIFTAGAGRSGLMAKSFAMRLMH
MGFNAHIVGEILTPALREGDLVIIGSGSGETKSLIHTAAKAKSLHGVVAALTINPDSSIG
KQADLIVKMPGSPKDQSNGSDKTIQPMGSLFEQTLLLFYDAVILKLMEKKGLDSETMFTH
HANLE
>PK3-2_00596 hypothetical protein
MLIKQLKLKLGTKILCLVFVIILLFSASVGTVMLKEITESMKQMATEKAKGDLALSSAYI
DDVISGDWQIKNNQLYKGQTQINGNEDIVDLLGKKTGDTVTIFQQDTRVSTNVMKNGERA
VGTQASSEVTDAVLKNGKRFYGQADVAGSSYQTAYMPLKDKNGDIIGMLYTGANQSILTS
LTQSLFTQFAIVLVIVIIVSVILVLLFTRRINKRLNALKCAFESAGNGDMTIEVSDKSGD
ELSELSVYYNKMRIKLNDTIQTVQQSALQLASASQQLSAGAEETNQASEKITEAVQQIAN
GAQHQMTRIENSESSLKQASADIRDISSNTAAIADKGQLAQSKADIGQKEISDVQAQMDA
IHDSIQKSGEIIQQLDGRSKQIEQILSVITQIADQTNLLALNAAIEAARAGEHGKGFAVV
ADEVRKLAEESQQSAGQISKLIAEIQNDMDQSARSIEHVKTEAAEGVSMIQRTRDAFKEI
AAATGEISVEISDLSASVSNISESAHQINNSFTANTADIKESTENTRQAAALTEEQFAAM
EEITAASETLSQLAEELTGIISQFKMIDQPENSR
>PK3-2_00597 Sporulation-specific extracellular nuclease
MDIIKTILLVIAVIAAAAVGLIKGDFFSADQKTSQTKEYDETIAFPSDRYPETAKHIKDA
LNEGHSDVCTIDRDGAEERREQSLKDVPSKTGYDRDEWPMAMCKEGGEGASVEYITPADN
RGAGSWVGHQLTDYPDGTKVLFTIQ
>PK3-2_00598 DNA-entry nuclease inhibitor
MIKSWKPQELSISYHQFTVFQKDSAPPVIDWTDEAIEKGYAAADGAISFEAQRNTKAFIL
LRLNSSETVNSYEKKVTVPFHVTENGIEIESIMSKRLSFDLPKGDYQLTCWTVPAEMSDL
HADTYIIDAVSV
>PK3-2_00599 Aryl-phospho-beta-D-glucosidase BglC
MIHQHPESFPKHFLWGSASAAYQIEGAWNEDGKGPSVWDVFTKIPGKTFKGTNGDIAIDH
YHRYKEDVALMAEMGLKAYRFSVSWPRIFPSGKGEINEAGLAFYDNLIDELLSHNIEPVL
TLYHWDLPQALMDEYGGFESRNIIEDFNNYCITLYKRFGDRVKYWVTLNEQNYNFNHGFI
TAMHPPGVKDRKRFYEANHIAFLANAKAIESFREYVPEGKIGPSFAYSPAYPLSSHPEDI
LAFENAEEFMNNWWLDMYCWGTYPQIPFRYLEKQGWAPTIEAGDTELLAKGKPDFVGVNY
YQTITYERNPLDGVSEGKMNTTGQKGTNQETGIPGVFKTKKNPHLTTSNWDWTIDPIGLR
IGLRRITSRYQLPVFITENGLGEFDKVEDGTVQDDYRIDYLRSHLEQCRQAISDGVDLIG
YCSWSFTDLLSWLNGYQKRYGFVYVNRDEENTHDLKRLKKKSFYWYQDVIKTNGESL
>PK3-2_00600 hypothetical protein
MFLKKVTLLRDKISDFDKFPFSIPAISQLNEILFTSQVTFFVGENGSGKSTLLEAIADKC
EFNTAGGSRNNVYELQESDSHLGDYIRLSWLPKVANGFFLRAESFYHLSLHLDEMELDAP
QPYRSYGGRPLHKQSHGESFMSLFRHRFKEKAIYLLDEPEAALSPARQLAFLRVIHDLVR
GGNVQMIIATHSPILLGYPNANILSFDGGRIHHTEYENTEHVQLTRYFLGQREKVLAELF
RD
>PK3-2_00601 hypothetical protein
MAVLSKIIISALIIGFVTEISKRNPAYGGIIAALPLVSLLSLFWMQIQGEKTAQLSQFTS
GVLTGIPATVCLLAILAFLLKIHVPFWLALCVGILGWVVFLWMQKFFLNILCN
>PK3-2_00602 hypothetical protein
MEMDFIAKLNQQWTDIYYLLHYKHKDNLSHQAIRLMQHIEKQGEATIGALAEYLSVSHNT
ASEHTKRLIQKGFVAKRRSQQDERKVLVFLTQEGRSILEQHTQLDKEKLKEIIERMSTSE
KEILEQAFELLSKEAKQWQF
>PK3-2_00603 hypothetical protein
MRWIKINIIILFIAAAVISLAGTAEAAEKQQQPLANVTLTDQQKKEIEQLEAEILKKRKD
VISKYVQYGVLPKERGEHIKNHIDKHFEMMKQNGFVPKPHPHAHKFEKRH
>PK3-2_00604 hypothetical protein
MNIYKPAGFWIRLGAALLDYIIVSVPLLLIYWLITGKDPNDSIFISLIVLLYSILLPVFW
RGYLIGKRICGIRIVKKDGSQVSLLTMVLRVIVAGLVYGITFGLGLIASLILIGVREDKR
TLHDLIAGTYVTYASPSEEELYTDE
>PK3-2_00605 putative zinc-binding alcohol dehydrogenase
MKALTYQGKEHVEVKDAADPGIQHEKDAIIRITATGICGSDLHLYKNGIPAAPDYIIGHE
PMGIVEEVGNEVKTLKKGDRVVIPFNIGCGECFYCKHQMESQCDESNPNPHTDAGGLFGF
SEFNGNFPGGQAEYLRVPYADFSSFKVPADSELEDEQVLLLSDVMPTAYWSVEHSGVKKG
DTVLILGAGPIGLMAQKFAWMKGAKRVISVDQVSHRLEHAKRTNGAETFNFSEHDEIGKL
LYNETNGGADVVIDCVGMDGTPLSKENTSEKPNQFGTISPILTASEAVKKFGTVQLTGAY
ISQADGFPLGDFFTRNVSVKMGQAPVIHLMPMLYEMVKQKEIDPTDIITHKFSLADAPKA
YDIFDKKEDGNIKVILKP
>PK3-2_00606 putative ABC transporter extracellular-binding protein YckB
MKSFKQSKAVIFSLTMAFFLILAACSGTNEAGSKDTGWEQIKDKGKIVVATSGTLYPTSY
HDTDSGSDKLTGYEVEVVREAAKRLGLKVEFKEMGIDGMLTAVNSGQVDAAANDIDVTKD
REKKFAFSTPYKYSYGTAIVRKDDLSGIKTLKDLKGKKAAGAATTVYMDVARKYGAKEVI
YDNATNEQYLKDVANGRTDVILNDYYLQTLALAAFPDLNITIHPDIKYMPNKQALVMKKS
NTALEKKMNETLKEMSKDGTLKKLSKQFFNKADVSKKLDVDVQDVDL
>PK3-2_00607 L-cystine transport system permease protein YecS
MINSIQWEYIFNTKLAIESFPYVIKGIGYTLLISFVSMFAGTVIGLFISLARISRLPLLR
WPAKLYISFMRGVPILVILFILYFGFPYIGIEFSAVTAALIGFSLNSAAYIAEINRSAIS
SVEKGQWEAASSLGLSYWQTMRGIILPQSIRIALPPLANVLLDLIKASSLAAMITVPELL
QHAKIIGGREFDYMTMYILTALIYWAICSIAAAFQNILEKKYAHYV
>PK3-2_00608 Putative metal chaperone YciC
MKKIPVTVLSGYLGAGKTTLLNSILQNREGLKIAVIVNDMSEVNIDAGLVKQEGGLSRTD
EKLVEMSNGCICCTLREDLLIEVEKLAKEGRFDYIVIESTGISEPIPVAQTFSYIDEEMG
IDLTKFCQLDTMVTVVDANRFWHDYQSGDSLLDRKEALGEEDERDIADLLIDQIEFCDVL
ILNKCDLVNEQELEQLEKVLRTLQPRAKFIRSVKGNVKPQEILHTGLFNFEEASGSAGWI
QELTTGHAEHTPETEEYGISSFVYKRRLPFHSSRFYQWMDQMPKNVVRAKGIVWCASHNS
LALLMSQAGPSVTIEPVSYWVAALPKLEQEQVKQQEPEILEEWDPEFGDRLTQLVFIGTD
LDEEAITKELDQCLLTEYEFDSDWSLFEDPFKWKLNE
>PK3-2_00609 hypothetical protein
MYKWLIIIVGSQSSTLAVHLVNRGKHRLRTLLSLISMNGLVKYLRSLRFFTGHRAFSGAS
>PK3-2_00610 Putative L,D-transpeptidase YciB
MNCSFLLAAVLVPACLLSACSYHAEEHASADTKKTAEHVTSDQKTEKTSIDWTKPSGGKY
PDIKQKHVWIDVDVKDQKAYIKEGSNTLYTMIVSSGLDQTKDDATPKGTFHIEPERGEWF
FSEGYQEGAEYWVSWKNHGEFLFHSVPMTKDKKVIEKEAKKLGVKASHGCIRLAIPDAKW
IYENIPEHTKVVIR
>PK3-2_00611 GTP cyclohydrolase FolE2
MNQRILLPGKPERLQYFGSVSPMKGEKPVEKEKMKDLQNIRKNYFFDIQHVGVANVSHPV
TINSAMTPAEQTTAANFTMTCDLRRNQKGINMSRLTELLQVYHQNGWILSFSSLQQFTKE
LAENMNQSSASVEVRFPWFFERKSPKLEKAGLMHADILMSVTYRKDQPFEQRAGISAKVT
TLCPCSKEISEYSAHNQRGTVSIWADIHPAVSLPSDFKADLLHAAESNASARLHPVLKRP
DEKAVTETAYENPRFVEDLARLIAADLYELEWVSAFEIECRNEESIHLHDAYAKLRFSKQ
EDRI
>PK3-2_00612 Nitrate transporter
MKLSELKTSGHPLTLFCSFLYFDVSFMIWVMLGALGVYISQDFGLSPLEKGLIVAVPILS
GSVFRIMLGILTDRIGPKKTAVIGMLVTMVPLLWGTFGGRSLPELYAIGILLGVAGASFA
VALPMASRWYPPHLQGLAMGIAGAGNSGTLFATLFGPRLAEQFGWHIVMGMALIPLLIVF
VLFVSMAKDSPAQPAPQPLKNYLHVFGQKETWFFCLLYSVTFGGFVGLSSFLSIFFVDQY
QLSKIHAGDFVTLCVAAGSFFRPVGGWISDRVGGTKVLSVLFVIVALCMAGVSSLPSFSM
VIVLLFVGMMGLGMGNGAVFQLVPQRFRKEIGMVTGIVGAAGGIGGFFLPNILGSLKQMT
GTYAIGFITFSCIALLAFAFVLAAGYYWRKSWSAESSPADV
>PK3-2_00613 Assimilatory nitrate reductase electron transfer subunit
MKKQRLVLAGNGMAGIRCIEEVLKLNRQMFEIIIFGSEPHPNYNRILLSSVLQGEASLDD
ITLNSKDWYAKHGITLYTGETVVQIDTDRQLVITDRKRSLSYDKFIAATGSSPYILPIPG
ADKEGVCGFRTIEDCRALMSMAKHNQKAAVIGAGLLGLEAAVGLQHLGMDVSVIHRSAGI
MQKQLDQTASRLLQTELERKGLTFLLEKDTVSISGTSRADGIRFKDGSSLKADLIVMAAG
VKPNIELAVSSGIEVNRGIIVNDCMQTSAPNVYAVGECAEHNGTVYGLVSPLYEQGKVLA
RHICGDLCEGYQGSAPSAALKIAGIDVWSAGKVHEDERTASINIYDEQAGIYKKALFEDD
KLAGVILYGDTRDKPRFLDSLLKQRDISIVKKQLFEPEKSGTSFESMPFSETICQCNSVT
KGAIQEAVHTKGLTTVEEVKHCTRASGSCGGCKPLVEDFLRYMTSGEYEEPAGTPSFCGC
TDFTEDDLIAELQLLPYTDPAEAMSRLGWKTGNGCRKCVPAIQYYLEKLHAGFVQPESSS
EDTCILIPQMYGGMTNAEQLRNLADIIETYSIPDVSITHGQRLKLSGIKPADLPNIKKDL
KMPARSNEHRHALQSVKACTCGPNRSIQQLAVQIERQLERLSMPASISVSLSCETDCTDA
AIQDIGAIRTQAGWDIYISGIRGTHARSGALFCVTDNAESTAGMIKGLIQYYRETAHYLE
AVHLWMDRLGIVHIREVLFEEDLRTQLLDNLQTDLSLIQNPPIEAGAHKKG
>PK3-2_00614 Assimilatory nitrate reductase catalytic subunit
MTERLLRYFRDKQQDIQSEKTYDTQCPFCSMQCKMQLVEQTIVTRKKYTAIGIDNPTTQG
RLCMKGMNAHQHALNSSRITQPLLKKNGEFMPVSWEEALNHIKDRVTMIQAEHGHDAMAV
YGSASITNEEAYLLGKFARVGLQTKYIDYNGRLCMSAAATAANQTFGADRGLTNPLSDIP
HTRVIILAGTNIAECQPTIMPYFEKAKENGAYIIAIDPRETATTKIADLHLKIKPGTDAA
LANGLVKIIIDEQLINEDFIRSRTNGFEELEQHTDALSLEDISEQTSVPLAHMRKAAVKF
AKETSGMLFTARGIEQQTDGTAAVKGFLNMVLITGKIGKPYSGYGAITGQGNGQGAREHG
QKADQLPGYRSIENEQHRAHIAKVWGIYQNELPRKGVSAYEMMEKINDGDIKGLFLMCSN
PAVSSPNANLVKKALRKLTFFVAIDLFISETATYADVILPASSYLEDEGTMTNVEGRVTL
REASKPCPGEAKHDWQIICEIASVLGKGRYFSYASAEEIFNELREASRGGIADYSGITYD
RLRREGGIHWPCPEPDHPGTGRLFADSFVHPDQKAALSVISNEPAVPKEKPTAEYPLYLT
TGRVMSHYLTGVQTRKSAALAARHFESFMEIHPQTAASFHIEDRVLVKIESPRGSIIVRS
KLSEQIRKDTVFVPIHWAEAQNVNDLIGEALDPACKMPGFKVCAVRIRPI
>PK3-2_00615 Nitrite reductase [NAD(P)H]
MGKKQLVLVGNGMAGVRAIEEILSVAKDEFQITIFGAEPHPNYNRILLSKVLQGDTDIKD
ITLNDWDWYEENNIQLYTNETVIKVDTENKTVITDADRIQPYDELILATGSVPFILPIPG
ADKQGVTAFRDIKDTDTMLAASKQYKKAAVIGGGLLGLEAARGLLNLGMDVSVIHLAPYL
MERQLDATAGRLLQNELEKQGMTFLLEKQTEEIVGAGRVEGVRFKDGSSIEADLVVMAVG
IRPNTQLGAESGIPVNRGIIVNDYMQTEIPHIYAVGECAEHRGIAYGLVAPLYEQAKVLA
KHICGIETKPYEGSVLSTQLKVSGVEVFSAGDFDESEDKKAIKVFDEQDGIYKKIVLRGN
QIVGAVLFGDSSEGNRLFSMIQKEADISETSKISILQPLNQEAGISITAAMSDDEIICGC
NGVSKGDIIQAIQEKGCSSTDEIKACTGASRSCGGCKPLVEEILQHTLGSDFDASAQKEA
ICGCTTLSRDEVVEQIKAKGLSHTREIMNVLGWKTPEGCSKCRPALNYYLGMINPTKYED
ERTSRFVNERMHANIQKDGTYSVVPRMYGGVTNSTDLRKIADVVDKYEIPLVKMTGGQRI
DLIGVKKEDLPKVWEDLDMPSGYAYGKTLRTVKTCVGEQFCRFGTQDSMALGIDLEKKFE
GLNTPHKVKMAVSACPRNCAESGIKDLGVVGIDGGWELYVGGNGGTHLRAGDLLMKVKTN
EEVLEYAGAYLQYYRETANYLERTSAWLERVGLSHVQSVLNDPEKRQELNGRMNETLSVH
KDPWKGFLEDKQTSKELFENVVTTS
>PK3-2_00616 Assimilatory nitrite reductase [NAD(P)H] small subunit
MVNKDVTKVWIGKIEELPEQLGKTVYIEDKELAVFKLSNGSIRAIENRCPHKGGVLAEGI
VSGEYVFCPMHDWKISLEDGIVQEPDHGCVKTYETLIEGEHVYLVY
>PK3-2_00617 Uroporphyrinogen-III C-methyltransferase
MKNGIVYFVGAGPGDPGLLTIKGKQALEEADVILYDRLANPKLLEFASPDCQFIYCGKLP
DRHFMKQRDINALLVEKASKGLTVVRLKGGDPSVFGRVGEEADALHEHGIRYEMVPGITS
GIAAPLYAGIPVTHRDFASSFAMITAHDKSLKGTPNLDWEGLARSVQTLVFYMGVKNLSY
ICQQLIAYGKSPSVPVIVIQWGTWGRQRSVKGSLENIQQKVQEHQITNPAIIVIGDIVNF
QTHSWFESKPLIGQHLMVVTHGEDKAPLADELRASGADVIEWPKWRTERTPVNEEILRKI
GTFEDIFFTSRRAVCEFFQALAFKKVDIRQLTARLSAASEHAETELEKRGFLVSAIQPDS
EKRLVVGSRHSVKNMQTHRPCSFYITHENVIDDRFTHMIQRTISEAPLHMIICPSKTSVQ
QLISTGEQIGILPEPSASRPPIVCIGDNTAAGAYGFTAVQEQDELFAFLQNQQAGKKLLH
S
>PK3-2_00618 Ferredoxin--NADP reductase 1
MAENQEVYDVTIIGGGPIGLFTAFYCGMRELKTKVIEFLPRLGGKVSLFFPEKIIRDIGG
IPGIAGKQLIEQLKEQAATFDPDIVLNQRVTEFERLEDGTIVLTGSEGEKHYTRTVILAV
GMGTLEVNEFDSEDATRYAGKNLHYGVEKLNAFKGKRVVISGGGDTAVDWANELEPIAAS
VTVVHRREEFGGMESSVTKMKQSSVRVLTPYRLEQLSGDEERIQSVTICHTESGQREDIE
VDELVINHGFKIDLGPMKEWGLEIEEGRVKADRHMRTNLPGVFVAGDAAFYESKLRLIAG
GFTEGPTAVNSAKAYLDPKAENMAMYSTHHKKLVHK
>PK3-2_00619 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase
MKRRVETITFEGHTLEYSVTGKGAPILVMHGGHSNCYEEFGYTALIEQGYSIITPSRPGY
GRTSKEIGKNLANASRFYVNVLDHLQIERVHVIAISAGGPSGICFASHYPERVNTLTLQS
AVTKEWITPKDKEYKAARILFRPPVEKWMWKLISSLNNAFPRLLFRAMSPQFSILSFQRI
KSMMVEKDIEAFRKMNSRQRSGEGFLLDLSQTAISAKELMAITCPVLIMQSVYDGFVNLS
HAHHAKEHIPDAALCLLHSWGHLIWLGKEAAEADRIIIGFLET
>PK3-2_00620 Putative two-component membrane permease complex subunit SMU_747c
MSGGFIVTAQSSFLQLNSIFISILIEAIPFILIGVILSGIIQMFVSEEMIARIMPKNRFL
AVLFGALAGILFPACECGIIPITRRLLLKGVPLHAGVAFMLTAPIINPIVLFSTFIAFGN
RWSVVFYRGGLALAVSVIIGIILSYQFKDSQLLKPDEPGHHHHHHHTLLQKLGGTLRHAI
DEFFSVGKYLIIGAFIAAAMQTYVKTSTLLAIGQNDVSSSLVMMGLAFVLSLCSEVDAFI
ASSFSSTFSLGSLIAFLVFGAMVDIKNLLMMLAAFKKRFVFLLITYIVVLVLAGSLLVKG
>PK3-2_00621 Putative two-component membrane permease complex subunit SMU_746c
MFRLLVLMGFTFFFYHLHASGNLTKYINMKYAYLSFIAIFLLAILTVVQAYVFIKSPEKG
GHHHDHDCGCGHDHEHDHEQNKPFYQRYLIYVVFLFPLVSGIFFPIATLDSSIVKTKGFS
FKAMESGDHYSQTQYLRPDASLYYAQDSYDKQMKQLFNKYSGKKEISLTDDDFLKGMETI
YNYPGEFLGRTIEFHGFAYKGNAINKNQLFVLRFGIIHCIADSGVYGMLVEFPKDMNIKD
DEWVQIKGTLASEYYQPFKSTLPVVKVTDWSTIKKPDDPYVYRGF
>PK3-2_00622 Proline-responsive transcriptional activator PutR
MEELLERVFSFSDVDKLIDFISYELQKPVILESADFFLLAYNSYYINHFDSANQQTIFSK
KCPVQIFERFLKDGIIEKLKTEPEPFRVNKIESIGLNQRVVVSAKHKGEVMGYIWIQELD
QNLTEEELDFLYETSFHVGKIIYKTNKLKQEKEEKAEDLIKRAIYQQFISEKELRREAER
INTVLPSMFSVVILHAANGDGEAVEDLKENIRSYLNLRDKVSHVLTIESNIVIVVASFSQ
KSSVSSAASEFINKLLTHFHFQKIPTPIYIGIGNEYDHLLKLGKSYTEALEVIKAAEITG
NQENIPYEYAKLGIYRYLESIEQKNELLEYKNKDLALLKAKDQESSTELLKTLEVYLLNN
CKTKPAAEQLFIHQNTLNYRIKQITEMTSIDLSDFRTRCQLYLDLMLMKKK
>PK3-2_00623 High-affinity proline transporter PutP
MAGMLLIGYFAYKRTSNLTDYMLGGRSLGPAVTALSAGAADMSGWLLMGLPGAMFSTGLS
GIWIVFGLCLGAWANWLYVAPRLRTYTEQAGNSITIPGFLENRFGDQTKLLRLFSGIVIL
VFFTFYVSSGMVSGGVLFNSILGMDYHTGLWVVTGVVVVYTLFGGFLAVSWTDFVQGIIM
FAALILVPIVTFFHTGGASDTVAEIRSVDPDMFNIFKGTSVLGIISLFAWGLGYFGQPHI
IVRFMAITSVKEIKRARRIGMGWMILSAVGAVLTGLGGIAYYHQNGMTLKDPETIFIQLG
NILFHPIITGFLISAILAAIMSTISSQLLVTSSSLVEDLYKSMFRRSASDKELVFLGRMA
VLAVSIIALLMAWEKNNTILGLVSYAWAGFGASFGPVVLLSLFWKRMTKWGALAGMIVGA
ATVIIWANAGLSDFLYEMIPGFAASLLSVFIVSVLTQAPSQAVADQFKDYQDTMSQ
>PK3-2_00624 1-pyrroline-5-carboxylate dehydrogenase 2
MTTPYKHEPFTNFQDQSNVEAFKKALATVSEYLGKDYPLVINGERVETEAKIVSINPADK
EEVVGRVSKASQEHAEQAIEAAAKAFEEWRYTSPEERAAVLFRAAAKVRRRKHEFSALLV
KEAGKPWNEADADTAEAIDFMEYYARQMIELAKGKPVNSREGEKNQYVYTPTGVTVVIPP
WNFLFAIMAGTTVAPIVTGNTVVLKPASATPVIAAKFVEVLEESGLPKGVVNFVPGSGAE
VGDYLVDHPKTSLITFTGSREVGTRIFERAAKVQPGQQHLKRVIAEMGGKDTVVVDEDAD
IELAAQSIFTSAFGFAGQKCSAGSRAVVHEKVYDQVLERVIEITESKVTAKPDSADVYMG
PVIDQGSYDKIMSYIEIGKQEGRLVSGGTGDDSKGYFIKPTIFADLDPKARLMQEEIFGP
VVAFSKVSNFDEALEVANNTEYGLTGAVITNNRKHIERAKQEFHVGNLYFNRNCTGAIVG
YHPFGGFKMSGTDSKAGGPDYLALHMQAKTISEMF
>PK3-2_00625 Proline dehydrogenase 2
MITRDFFLFLSKSGFLNKMAKNWGSRVAAGKIIGGNDFNSSIPTIRQLNSQGLSVTVDHL
GEFVNSAEVARERTEECIQTIATIADQQLNSHVSLKMTSLGLDIDMDLVYENMTKILQTA
EKHKIMVTIDMEDEVRCQKTLDIFKDFRKKYEHVSTVLQAYLYRTEKDIDDLDSLHPFLR
LVKGAYKESEKVAFPEKSDVDENYKKIIRKQLLNGHYTAIATHDDKMLDYTKQLAKENGI
AKDKFEFQMLYGMRSQTQLNLVKEGYNMRVYLPYGEDWYGYFMRRLAERPSNIAFAFKGM
TKK
>PK3-2_00626 hypothetical protein
MKQRIIDELKRIEQSYGVKIVYAVESGSRAWGFPSQDSDYDVRFIYVPKKEWYFSIEMER
DVIEEPIHDLLDISGWELRKTLRLFKKSNPPLLEWLSSDIVYYEAFTTAEQLRKLRTEAF
KPEASVYHYINMARRNVKDYLQGQEVKIKKYFYVLRPILACKWIEEHGTIPPMDFTVLMN
ELVTDPELKAEMETLLERKRRGEELDLEARIHVIHEFIETEIERIMEAAKTLKAEQKDMT
PELNRLLLNTVEEVWKDGGS
>PK3-2_00627 Cephalosporin-C deacetylase
MQLFDLPLNQLQTYKPEKTAPKDFSEFWKSSLDELAKVQAAPDLQPVDYPADGVKVYRLT
YKSFGNARIAGWYAVPDKEGPHPAIVKYHGYNASYDGEIHEMVNWALHGYAAFGMLVRGQ
QSSEDTSISPHGHALGWMTKGILDKDTYYYRGVYLDAVRALEVISSFDEVDETRIGVTGG
SQGGGLTIAAAALSDIPKAAAADYPYLSNFERAIDVALEQPYLEINSFFRRNGSPETEEQ
AMKTLSYFDIMNLADRVKVPVLMSIGLIDKVTPPSTVFAAYNHLETEKELKVYRYFGHEY
IPAFQTEKLAFFKQHLKG
>PK3-2_00628 Hydrogen peroxide-inducible genes activator
MDIKVMEYAAEIARRQSFTKAAEHLHIAQPSLSQQIKKLENELGLPLFHRSHGSVTLTPH
GRRFIEKAEDIIRSRDDLLREMQERSHGIGHKLSIGIPAVTGRYIFPPLLKQFLARYPHV
EVQLVEKDPVSLEEMTAKGEVDLSVLSLPIEDERLSITPLLTEPIVLAVPKEKQRWMPPE
MTVLIEKALEGEKGGQPSVPLDMVRHVPFILLKEGYGFRRTVLDLCAESGFKPNAAFKTS
HIETAQSLVANGLGVTMAPNMVRRDKDPGVIYLSIQSAPSRTLVFVFLKNRYISLTAQAF
IELSRESLKQTFDEDSLENKSENI
>PK3-2_00629 putative methyltransferase YcgJ
MTNETPFSQNAEMYRDEKVFAEGEDLGLMIKTADCRAEHRVLDIGAGAGHTALAFSPYVQ
ECAGVDATKEMVEVASSFAQEKGAGNVRFQQGTAESLPFPDESFDIITCRYAAHHFSDVR
KAVSEVARVLKKDGRFLLVDHYAPEDPALDEFVNHLNRLRDPSHVRENSLSEWRSMFSAN
QMDYHDIQMWNLPIQYESWIKRGGTPADREKQIISHLHQASEEARDMFCIKWNQNGQPDS
FCLKAILIQGIKR
>PK3-2_00630 Shikimate kinase
MNAKRAIPVRERNIVLIGFMGVGKTTIGQLVAKKLYRDFIDIDQEIEKDFSMTIPEMFEE
KGEDFFRKTEKEYILDICHHKRFKIVSLGGGSFKQEEIRKSCLENCLVLHLDLSWENWKQ
RADLLIESRPVLHNRSMDEMEQLFNERKVIYDKHNSKVATDNLSPEEVADYIVETLKIGW
DLYQPM
>PK3-2_00631 Tunicamycin resistance protein
MEMIIWINGAFGSGKTQTSFELHRRLKASYVYDPEKMGFALRSMIPPDIAEDDFQNYPLW
RTFNYSLLASLTDTYHGIIIVPMTIVHPEYFNEIIGRLRHDGQTVHHFTLMASKETLLKR
LSTRAEGKNSWAAKQIDRCIEGLSSPVFADHLQTDNMSIQDAAETIAARTQLTLEPDTRG
SLRRFADRLMVKLNHIRIK
>PK3-2_00632 NH(3)-dependent NAD(+) synthetase
MSMQEKIMRELHVKPSIDPKQEIEDRVNFLKQYLKNTGAKGFVLGISGGQDSTLAGRLAQ
LAVESIREEGGNAQFIAVRLPYGTQQDEDDAQLALKFIKPDKSWKFDIKSTVSAFSDQYQ
QETGDQLTDFNKGNVKARTRMIAQYAIGGQEGLLVLGTDHAAEAVTGFFTKYGDGGADLL
PLTGLTKRQGRTLLKELGAPERLYLKEPTADLLDEKPQQADETELGISYEEIDDYLEGKE
VSAKVSEALEKRYSITEHKRQVPASMFDDWWK
>PK3-2_00633 hypothetical protein
MTQQYIVEPKKGLGLKLKKGQILKVVDVEGQQVADFVAYHAKDFYEHLDQGATIDANHSI
NVKVNDHIYSNLYKPMLTLIEDTVGKHDLLLPACRPDMNRLLYGKQKDEFQDTCYDNMNR
ALEQFGVPKPHMHYPFAIFMNTVLDEKGNLSVETPLSNAGDYVRLRAEMDLIVAFSSCPI
EKGKCNGESVTSIRVEVS
>PK3-2_00634 Aromatic amino acid transport protein AroP
MIMSQTKKDQQKGNLAWWQLSLIGVGCTIGTGFFLGSSIAIVKSGFSVLLSFLIAGIGTY
FVFEQLAKLSAKQPEKGSFCAYARKAFGKWAGFSNGWVYWSSEMLITGSQLTAISLFTKH
WFPQVPLWVFASIYAVLGLLIIFTGLSVFEKTENVLAVIKTAAIFMFIVIAILALCGILS
GGKPDVQVPNKVSEFFPYGAMGLWTGLIYAFYAFGGIEVMGLMAVHLKKPEEASKSGKLM
LATLAIIYIISIGLALLLVPLQTFTEEDSPFITSLKGHNLEVILDIFNGIFIIAGFSTLV
ASLFAVTTLLCTMADDGDAPKCFTLKEGKKICWPALGLTFAGLVLSIILSLVLPKNIYEH
MTTAAGLMLLYTWLFILFSSKKLTDPEGMGKTQIYLAMILIAAAVSGTLFEKSSRPGFFV
SIGFLAIIAIVTMIYQKKQGHKDRPASS
>PK3-2_00635 hypothetical protein
MVNGIYTKSFLERNQAELPEWQRIAFELLAETLADDADTFPCIPGRQAFLTDQLRITFAG
DPRENRTAEELAPLLAAYGKISRDTGKYASLVVLFDTPEDLAEHYSIEAYEELFWRFLNR
LSEQDEKEWPEDIPADPEHYKWEFCFDGEPYFILCATPGHEARRSRSFPFFMITFQPRWV
FEELNGSTAFGRNMSRLIRSRLKAYDHTPIHPELGWYGGKDNREWKQYFLRDDEKQVSKC
PFSYLKSLFNKMK
>PK3-2_00636 hypothetical protein
MNIFLSYIVLGLSLSAPVGPVNAAQIDKGIKNGFWHAWIFGLGAMTADGLYMLFIYFGLS
QFLTAPFVKTFLWLFGFFVLTYTGIETLKNVREPMDVRSSRGKPSFRKTFASGFLISLSN
PLSILFWLGIYGSILAKTAEAYNMNQLLIYSSGIMIGILIWDFCMAITASMFRNLLHKKL
LRGLTGIAGVSLLVFGFYFGYQGIKQLLG
>PK3-2_00637 hypothetical protein
MSTRNSRSELEKTAVQIFRKLGTRTVLFHQAAAHALGLFPTDLKSADILNEAGPMTAGEL
GKKTGLSTGSVTALVDRLEKAGYVAREKDPNDRRRVMIVPLTASKKHIKDLFHSLSESTM
DLCREYTEEELELIFSFVDKASDIMEEELERLKQ
>PK3-2_00638 Multidrug resistance protein 3
MDTTSAKQASTKFVVLGLLLGILMSAMDNTIVATAMGSIVADLGSFDKFAWVTASYMVAV
MAGMPIYGKLSDMYGRKRFFLFGLIFFLIGSALCGIAQTMNQLIIYRAIQGIGGGALLPI
AFTIIFDLFPPEKRGKMSGMFGAVFGLSSVLGPLLGAIITDSINWHWVFYINVPIGALSL
FFIIRYYKESLEHRKQKIDWGGAITLVVSIVCLMFALELGGKTYDWNSIQIIGLFIVFAV
FFIAFFIVERKAEEPIISFWMFKNRLFATAQILAFLYGGTFIILAVFIPIFVQAVYGSSA
TSAGFILTPMMIGSVIGSMIGGIFQTKASFRNLMLISVTAFFIGMLLLSNMTPETARVWL
TVFMMISGFGVGFNFSLLPAASMNDLEPRFRGTANSTNSFLRSFGMTLGVTIFGTVQTNV
FTNKLSDAFSGVKGSAGSGAAQNIGDPQEIFQAGTRSQIPEAILNRIIDAMSSSITYVFL
LALVPIVLAAVTILFMGKARVKTTAEMAKKAN
>PK3-2_00639 L-lactate permease
MWEQLYDPFGNEYVSALAALTPILFFLLALTVFKMKGILAAFLTLAVSFFVSVLAFHMPV
EKAISSVLLGIGNGLWPIGYIVLMAVWLYKIAVKTGKFTIIRSSIAGISPDQRLQLLLIG
FCFNAFLEGAAGFGVPIAISAALLVELGFKPLKAAALCLIANAASGAFGAIGIPVITGAQ
IGDLSALELSRTLLWTLPMISFLIPFLLVFLLDRMKGIRQTWPALLVVSGVYTAIQALTM
AVLGPELANILAALFSMGGLALFLRKWQPKEIYREEGAGESGEKKAYSAADIAKAWSPFY
ILTAAITIWSLPAFKALFQEGGLLYQTTLLLKMPFLHQQIMKMPPIAPSAMPLDAVFKVD
LLSATGTAILAAVIVTGLFSKNFSSRDAFASLKETGKELWVPIITICFVMGFANLANFAG
LSSSIGLALAKTGDLFPFVSPVLGWIGVFITGSVVSNNALFGHLQVVTGAQIGAGSDLLL
AANTAGGVMAKLVSPQSIAIAAAAVGQTGKESKLFKRTVAYSLILLLIICIWTFILARLG
L
>PK3-2_00640 L-lactate dehydrogenase
MNKHVNKVALIGAGFVGSSYAFALINQAITDELVVIDLNIEKAMGDVMDLNHGKAFAPQP
VKTSYGTYEDCKDADIVCICAGANQKPGETRLELVEKNLKIFKGIVSEVMASGFDGIFLI
ATNPVDILTYATWKFSGLPKERVIGSGTTLDSARFRYMLSEYFGAAPQNVHAHIIGEHGD
TELPVWSHANVGGVPVSELVEKNDAYKQEELDQIVDDVKNAAYHIIEKKGATYYGVAMSL
ARITKAILHNENSILTVSTYLDGQYGADDVYIGVPAVVNRGGVAGITELNLNEKEKEQFL
HSAGVLKNILKPHFAEQKVN
>PK3-2_00641 Alpha-amylase
MFQKRFKTSLLPLFAGFLLLFHMVLAGPAAANAETQNTSNELTAPSIKSGTILHAWNWSF
NTLKHNMKDIHDAGYTAIQTSPINQVKEGNQGNKSMSNWYWLYQPTSYQIGNRYLGTEQE
FKEMCAAAEEYGVKVIVDAVINHTTSDYAAISNEIKSIPNWTHGNTQIKNWSDRWDVTQN
SLLGLYDWNTQNTQVQSYLKRFLETALNDGADGFRFDAAKHIELPDDGNYGSQFWPNITN
TSAEFQYGEILQDSASRDAAYANYMNVTASNYGHSIRSALKNRNLSVSNISHYASDVSAD
KLVTWVESHDTYANDDEESTWMSDDDIRLGWAVIASRSGSTPLFFSRPEGGGNGVRFPGK
TQIGDRGSALFEDQAIAAVNTFHNVMAGQPEELSNPNGNNQIFMNQRGSQGIVLANAGSS
SVSINVSTKLPDGSYDNKAGAGSFQVRDGKLTGTLNARSVAVLYPDDIANAPQVSLENYK
TGVTHFFNDQLTITLRANANTTKAVYQINNGQETAFKDGDQLTIGKGDPFGKTYNITLTG
TNSDGVTRTQKYSFVKRDPSSAKTIGYQNPNHWGQVNAYIYKHNGGRAIELTGSWPGKAM
TKNADGIYTLTLPADTDTTNAKVIFNNGSAQVPGQNQPGFDYVQNGLYNDSGLSGSLPQ
>PK3-2_00642 hypothetical protein
MNNLRNRLSGVNGKNKRVKEKEQKIWSEIGMIAGSFALLDVIIRGIMFEFPFKEWAASLV
FLFLIILYYCIRAGASGMLMPRIDTEEELQKRVKQQRIDSIAVAFAVVVLTMYDRGIPHT
FFAWLKMILLFIVCSGVLFFLRYVIVKLAYRRAVKEEAEKKSS
>PK3-2_00643 hypothetical protein
MSMPAAETQPKKKRTTFKMPDAYVLLFMIAFICAIASYIVPSGEFERVTKGDITTAVPGS
YHSIDQSPVSLISFFTSLQDGMVGSAPIIFLILFTGGTIAILEKTGAINGLIYNVISKFR
TKQLLFICIVGALFSILGTTGIVVNSVIGFIPIGLIVARSLKWDAVAGAAVIYIGCYAGF
NSTILSPSPLGLSQSIAELPLFSGIGLRVVIYICFLLSSIIYIYLYTRKLKKSKDASVLG
TNWFPAAGMGEAGTEEDQSVPFTARHKLILAVAGLSLIGFLYGALKLGWSDSQMAATFIF
ISVLAGLIGGLAANDIAKTFITGCQSLVYGALIVGMARSISVILENGKLLDTVVNALASL
LDGFSPIAGAIGMYIASALLHFLISSGSGEAVVFIPILAPLADLMGITRQVAVEAVMLGE
GVVNCVNPTSGVLMAVLAASGIPYVKWLRFMVPLALIWFLIGLVFIVIGVMINWGPF
>PK3-2_00644 N-acetylcysteine deacetylase
MRKLSEDMKQTIMDIFEHLHANPEVSWKEYETTAFLKQKLEDLGCRTRTFADCTGVVGEI
GSGSPVVAVRADIDALWQEVNGTFRANHSCGHDSHMTMALGTLMLLKKQSELPKGTIRFI
FQPAEEKGGGALKMIEEGVLDDVDYLYGVHVRPIQETQNGRCAPSILHGSSQHIEGTIIG
EEAHGARPHLGKNSIEIAAFLVHKLGLIHIDPQIPHTVKMTKLQAGGESSNIIPGKALFS
LDLRAQTNEAMETLIAETERACEAAAAAFGAKIELQKEHSLPAATQNKEAEAIMAEAIAD
IIGAEQLDEPLVTTGGEDFHFYAVKVPSLKTTMLGLGCGLQPGLHHPHMTFDRNAMFTGV
HILANAVLKTFQKAESPAAANAS
>PK3-2_00645 Glycine betaine-binding protein OpuAC
MLKKIIGIGVSAMLALSLAACGSESDEHATAAEQVNKTIIGIDPGSGIMSLTDKAMKDYD
LNDWTLISASSAAMTATLKKSYDRKKPIIITGWTPHWMFSRYKLKYLDDPKQSYGSAEEI
HTITRNGFSKEQPNAAKLLSQFKWTQDDMGEVMIKVEEGEKPSKVAADYVKKHKDQIAEW
TKGVQKVKGDKINLAYVAWDSEIASTNVVGKVFEDLGYDVTLTQVEAGPMWTAIATGSAD
ASLSAWLPNTHKAYAAKYKGKYDDVGTSITGVKMGLVVPEYMKNVNSIEDLKK
>PK3-2_00646 Glycine betaine transport system permease protein OpuAB
MDRLPRIPLADIIDRFVDWITITFGGFFDGIANGLAAFVNGIVSGLGFIPSILLTIIFAA
LAWWISTRGIALFTLIGFLVIDYLGYWDPMLQTLALVLTSVIISIVVGVPIGIWASQKEM
VRRIVTPILDLMQTMPAFVYLLPAIFFFNIGVVPGVVASVIFAMPPTIRMTVLGIKQVPA
DLIEATEAFGSTTAQRLFKVQLPLATKTILAGINQSIMLALSMVVIAAMVGAPGLGSEVY
SAVTQLKTGIGVEAGIAIVIVAITLDRITQNIKVKKKSRGNA
>PK3-2_00647 Glycine betaine transport ATP-binding protein OpuAA
MSVDEKPIKIKVEKVSKIFGKQTKKAVQMLANGKTKKEILKATGSTVGVNQADFDVYDGE
IFVIMGLSGSGKSTLVRMLNRLIEPTAGNIYIDGDMITNMSKDQLREVRRKKISMVFQKF
ALFPHRTILENTEYGLELQGVDKQERQQKALESLKLVGLEGFEHQYPDQLSGGMQQRVGL
ARALTNDPDILLMDEAFSALDPLIRKDMQDELLDLHDNVGKTIIFITHDLDEALRIGDRI
VLMKDGNIVQIGTPEEILMNPSNEYVEKFVEDVDLSKVLTAGHIMKRAETVRIDKGPRVA
LTLMKNLGISSIYAVDKQKKLLGVIYASDAKKAAESDLSLQDILNTEFTTVPEDTYLTEI
FNVVSDANIPIAVVDEKQRMKGIVVKGALIGALAGNNEYINAEGADEQTQDPSAQEVK
>PK3-2_00648 hypothetical protein
MTMKQSDDQIRAQIFKALSDESRLAIIRTLYYSGKELSCGEVGEKCNIVKTTASYHFKTL
REAGLTATRKDSRTKYVSLREDTFQTYLPGFLETL
>PK3-2_00649 Purine efflux pump PbuE
MNRIWLFFSVMFVIGTDTFLLSPLLPLLQDQFHVSTDMSGWMVSAYALGYALFALIAGPI
SDRLNRKTVMLWGFAGFIVSTFLCGIAPSFAAMCLFRFAAGVSAAFVTPQIWASIPVIVQ
PSQIIKSLGIATAGLAASQMLGLPIGAFFASFTWHTPFFVLSACSLILVLILAAVMPDIR
PAEQMARPSIFSPYRELFSLPKTSIILLAYFLFQTGNFASFSFLGTWLSADYHLTVSQIG
AAMLVLGLGNMLGSLIGSRISAKLGMFKTLIGGMLLMGALYFALPFFPNLFIVETSFFLT
FFTAGIIFPLMMGVFQSISPNARGTIASLSNAAMYAGTTVGTCIAGFLYQSAHHFGAVTG
LTAILFILSMALYQTINKTRKRQPAARAQM
>PK3-2_00650 Putative niacin/nicotinamide transporter NaiP
MGKQQPISQRKLLGVAGLGWLFDAMDVGILSFIIAALHVEWNLSPEEMKWIGSVNSIGMA
AGAFLFGLLADRIGRKKVFIITLLCFSIGSGISAFVTGLSAFLILRFVIGMGLGGELPVA
STLVSEAVVPEKRGRVIVLLESFWAVGWLVAALISYFVIPSFGWQAALLLTALTAFYALY
LRTSLPDSPKYESLSAKKKSVWENVKSVWARQYIRPTVMLSIVWFCVVFSYYGMFLWLPS
VMLLKGFSMIQSFEYVLLMTLAQLPGYFSAAWLIEKAGRKWILIIYLIGTAGSAFFFGTA
DSLGLLLTAGMLLSFFNLGAWGVLYAYTPEQYPTAIRATGSGTTAAFGRIGGIFGPLLVG
TLAARHISFSVIFSIFCIAILLAVVCILIMGKETKQTELE
>PK3-2_00651 TelA-like protein
MTTENQNPLVLDKNEEISQQKADDIRLQLRQEPEVKRLVQQIDVKNQMELLEYGKEPAVE
ISKFSDRILGMMKTTSVTDSGTMLTQLGKIMDRFDKNDFDEPKGLMAKIFKRGGSMIEKI
FKKYQTLGGEIEKIHVEISKYKDEMTKTNYTLDEMYENNIKYYMELEKYVVAGQMKLEEM
QSVLPSYEEKAASGNQLAQMQLDTMRNGIQALEERVYDLDMARMVALQTAPQIRLLQRGN
AKLIGKINSAFIITIPIFKNGIIQAVTVKRQKLVADSMSELDRRTNEMLRRNAENISSQS
VEIARMAGRPSIDIETIESSWNTIVSGMQETKQIEEENKRLREDGARRIAQLQDNIKKAA
LQQ
>PK3-2_00652 hypothetical protein
MRQEELTIHKALPADGDWKSLLLQPLPERDHYETEQGLSFSRLAGQILGTPIDETDYYNE
LYEMSINDRVAILSETLDKTIEPETFQKLQHIHSINQKEKGLSVSRFVAFLDGEKLIAKH
SNPLMHRHLRKALMTLLHTFADSHEKGLNHPDFRRVLLDVSKFSLNHLNPWLEKTDIERE
MPKVVWYGDATKSQLYFLYYLMLVGCDVLLFHPAGTDQLALVDPKQELSFTEKLPDVSEL
QPFPKEKPDRKSTVAYRSTKEIEHVLNHEESMLYKPWQFRDHTPVSVTLKTTYDELFLIT
KERAFIRPNFKADKHSIEIPNVFAKIMGVSKDNKEYWNRLHTLADYQETEMIKSFPFTEE
IKSNYQFHYSHALDHEGNIDPDKLMASNVWQYKQLPAGVQAAIAKTISRMCRHPRLKAMP
QEQVKDVQIYLFKQTTNLPANLLKLLQMFDYAQTVPKLLLYHTEMSGGLTRSDAAALLFL
NEIGIDIIIYNPPGHQDVEQFIEEDQYDIHWLDDMVFQQDYKEPSIVRRLFRTITQK
>PK3-2_00653 hypothetical protein
MDFLHHIMSTYASFFDWKMWGEVLSDPVSWGLIGSLVVLEGLLSADNALVLAVMVKHLPE
KQRKKALTYGLFGAYIFRFIFIGLGMLLIKFWWIKVLGALYLAWLVIKHFWIGEKEEEAD
GMKKNSWMVRTFGIFWATVVSVELMDLAFSVDSILAAFAVSEKVWVLLIGGMLGILMMRT
VAKVFLVLIDKIPELENTAFVLIGIIALKMAASAFHYEMPHSVFFIIIIAAFAVTLIIHY
INKQKQVREQTAASKEE
>PK3-2_00654 General stress protein 16U
MAIQLSKGQRIDLTKTNPGLTKAVIGLGWDTNKYSGGDDFDLDASAFLVDAHDNCVNDLD
FVFYNNLEHPSGGVIHTGDNRTGEGDGDDEQIIVDFSKVPAHIEKIGITVTIHDAEARSQ
NFGQVSNAFVRVVDEETQNELLRFDLGEDFSIETAVVVCELYRHGGEWKFNAIGSGFSGG
LAALCRNYGLQV
>PK3-2_00655 General stress protein 16U
MAISLAKGQKVDLTKTNPGLSKVVVGLGWDTNKYDGGHDFDLDSSVFLLDAAGKCASPND
FIFYNQLEGGNGSVVHSGDNLTGLGEGDDENVKVNLSAVPANIEKISFVITIHEAEARSQ
NFGQVSNAFVRIVNEETNEELIRYDLAEDFSIETAIIAGELYRHNGEWKFSAIGSGYQGG
LARIATDYGLQVG
>PK3-2_00656 Stress response protein SCP2
MAISLEKGQRIDLTKGKAGLSKLMVGLGWDPVSSGGGFFSKLLGGGGPNIDCDASVLMLE
NGKFTEKKNLIYFGNLKSSCGSVRHTGDNLTGDGAGDDEQIMIDLEKVPANIDKLVFVVN
IYDCVRRKQDFGMIQNAFIRVVDQSNHEEMLKYNLRDNYAGRTSLITAEIYRSGSEWKFA
AIGEGTNDTRLEDIISRYV
>PK3-2_00657 hypothetical protein
MIHLSILDQAPVSKGKSPVTTLQHSVELAHLSEQWGYKRYWFAEHHSTRGLASTAPEIMI
ARIAAHTSTIRVGSGGVLLPQYSPYKVAETFRQLEALYPNRIDLGVGRSPGGTAKTRLAL
TDGVTKSLTEFNRQLQDVSYFLTDSLPAGHPYAGIKAAPLIDTAPELWVLGLGENSARRA
AHQGIGYVFGHFINPERGENAFRVYRESFRPSAHFSSATALFTIFVICAKTDEEAEELAL
SQDLWLLRVGKGLDSRVPSIEEAKAHPYTASDKKLIEENRKRMVIGSPNTVKQQLLELTD
RYETNEIMVLCNVFDFEAKKESYERLAGLFL
>PK3-2_00658 High-affinity zinc uptake system membrane protein ZnuB
MEMFDLEFMRRAFLAGGMIAIMAPILGVYLVLRRQALMADTLSHISLSGVAIGFFLSTNI
TAASIVVVTVGAIGIEYMRRAYRTYSEVSIAILMAAGLSFAMFLISFSKGTANMSIDQYL
FGSLVTVNQQQVYIIGIITLLILLYFIVLKRPLYLLTFDEATAKTSGINTNFLSMSFSIV
TGLAISVIIPIIGVLLVSALLVLPAAFAIRIAKGFNMVFMTAILISLFSVFMGLTSSYQL
GTPPGPSITLLLIVLLLIGFMVQGVWMFIKKETQRKKARQ
>PK3-2_00659 High-affinity zinc uptake system ATP-binding protein ZnuC
MNLVSLKDIVFGYSHTPVLDKVSLDIESGEFVGITGPNGAAKSTLMKVMLGMLKPWEGTV
TISKRNTEGKRLTIGYVPQQISSFNAGFPSTVLELVQSGRYTKGKWFKRLNEEDHIEVEK
ALKMVEMWELRHRKIGDLSGGQKQKICIARMLASNPDLLMLDEPTTAVDYDSRKGFYEFM
HHLVKNHNRTVVMVTHEQNEVQQFLDKVIRLERGEKGGWKCLTWNSCDELF
>PK3-2_00660 High-affinity zinc uptake system binding-protein ZnuA
MTSVYYDIGLQNRYHFDLSHYEKEGIYDMFKKWSGLFVIAACFLLVAACGNSSTKGSADS
KSDKLHIVTTFYPMYEFTKQIVKDKGDVDLLIPSSVEPHDWEPTPKDIANIQDADLFVYN
SEYMETWVPSTEKSMGQGHAIFVNASKGIDLMEGSEEEHEDHEEHEEHDHSHAMDPHVWL
SPVLAQKEVKNITAQIVKQDPDNKEYYEKNSAEYIAKLQDLDKLYRTTVKKAEKKEFITQ
HTAFGYLAKEYGLKQVPIAGLSPDQEPSAADLAKLKTYAKEHNVKVIYFEEIASSKVAET
LASEIGAKTEVLDTLEGLSKEEQDKGLGYIDIMKQNLDALKDSLLVKS
>PK3-2_00661 putative oligo-1,6-glucosidase 2
MKTDWWKDAVVYQIYPRSFQDSNEDGIGDLRGIISRLDYIKELGADVIWICPIYPSPNVD
YGYDVTDHKTIMDSYGTMDDFHELLDQVHQRGLKLVMDFVLNHTSVEHPWFKEAELDKNS
KYRSYYFWRPGTKTGPPTDWLSDYGCPVWQYEEHTGEYYLHMNAVKQADLNWEHPEVRQA
VFDMMRFWLDKGVDGLRIDQLHLISKKEYLPSYEDYINQQAEPKPFQPNGERIHDYLKEM
TDEVFSRYDVMSVGEVGSVTPEEGLKYTGTDKHELNMIFHFQHMELDQQPGKEHWDIKPL
ELSDLKSVLTAWQKKLEHQGWNTLYWCNHDQPRIVSRFGDDGDYRKASAKMLATVLYLMK
GTPYMYQGEEIGMTNAPFTRIEDYKDIQTINMYHKRVFEKGYDPQDVMRSILAKSRDHAR
TPMQWSSGKNAGFTDGTPWLKVNPNFTSINVEEAQRDPDSILTYYKKLIRLRKQYAELIK
GSYDLLFPDDPQLFVYMRENGKQQLLSVNNFSKEQAIFRWPEHCGKAQASLLLSNYNNNG
DLADEMVFQPFESRVYLLDNTIK
>PK3-2_00662 Glucose 1-dehydrogenase 2
MYKDLTGKTAIVTGSSKGIGRAIAERFGQEKMNVVVNYHSDPSGADETVDIIKHNGGKAV
AIEADVSKEAGIQALLDTALAHFGTLDVMVNNSGFNGAEAMPHEMSLEDWQRVIDVNVTG
TFMGAKAALSHMMKNNIKGNVLNISSVHQQIPRPVNVQYSTSKGGIKMMTETLALNYAEK
GIRVNAIAPGTIATESNVDTKKEENRQKQLKKIPMKAFGKPEEVAAAAAWLVSEEASYVT
GATLFVDGGMTLYPSQLE
>PK3-2_00663 Response regulator aspartate phosphatase J
MRAMIPSEEVAVKLNEWYKLIRAFEADQAEALKQEIEYDLEDMEENQDLLLYFSLMEFRH
RIMLDKLMPVKDSDTKPPFSDMLNEIESNQQKLTGLLEYYFYYFRGMYEFKQKNFILAID
HYKHAEEKLEYVEDEIEKAEFLFKVAEVYYHIKQTYFSMNYASQALDIYTKYELYGRRRV
QCEFIIAGNLTDVYHHEKALTHLCSALDHARQLEEAYMIAAAHYNIGHCKYSLGDYSEAE
NYFKTAAAIFEERNFQQAVQAVFSLTHIYCKEGKYDRAAETYERGVKCAAEWEDDMYLTK
FRLIHELYFGSGDRNVLTECFDLLESRQLLADAEDLLHDTAERFNQQERYESAAFFYRRL
MNIKKKLAEQRLQ
>PK3-2_00664 Peptidoglycan L-alanyl-D-glutamate endopeptidase CwlK
MKLSAKTSVILCILFLLDLCFSYIRHEWHSQNALQDMPVPSDLHPVVKQNGDALKAAAAN
KGITVVITEGFRSFKEQDELYKQGRTKKGNIVTYARGGESYHNYGLAIDFALQKKDGSII
WDMEYDGNQNGKSDWLEVVEIAKTLGFEWGGDWKRFKDYPHLEMIPD
>PK3-2_00665 hypothetical protein
MVNKQLKKKAQEIGNVPPHYELEIEDYDQKQKKKGQAYFIWKDPEDPEKHIIVELGNDGA
LLTFSTTVRSEADKRLPDAELKLTALQFAAANHPNTFMNFHFQSKEERGQHIRFVYTKME
LGLPLPNSGFLIEMTRSGQIVHFLYYGEEHKAEVPKEFVAKEKVVSHYLNTMSLQLMYDV
IDGEQAPRLVYEPILPGYSYPADVDEIVPDQHIADERIENVEPLPPLQNKEKIDIYAMLG
LTSDMLKVSEKDFGDEIGSTWRKGTAPERKDLSIGSYFETRNKNTIKMKTDKRTGKLKAA
LSFIDQQNGRKCSTEECQRTALQFLYALYPRADEFFRVNPVRIDDRGRVRNHFSVWYKGV
PLRFGAARIIVNPETGMIDAFMAPDIDPEQLETINHRPDVSAEEARETFLAAFDVKLKWQ
PDFATGSGQHYKLVYYPVYPSYIDAHIRKKKRL
>PK3-2_00666 hypothetical protein
MKGAAFVKKEKLKQKALEIGSVPTHLKLEVEDYGDDEKRAYFCWIDPQNEHIGIIVELGP
DGQLESLSRDMEPESGESLPEKRLEEIMRVFVETHYPGEISAFVREENDRTYDDKVRFSY
VQMEEGLPLPMSGFMADVSLSGEVIYFRYYGKARSIIEPKRVADYDEALAFIKKDVEFDL
LFEILHRSVYKNGDDQPHLVYESKCRAITVPADLVQEEQEFDDDDGRERESFPLPLFEGI
HEKADPGSMIGLDKGFVKEREADLGDGRIGTVWRNPDDPVYQPEDKSLYSWFKRRSHQVL
KTVHNKETGKLESVMSSMEKEGPLTVTEAECEKIALRFLFALFPNADQYFKIRYDESDEE
ENAVAGFTFEAHCHGVPLRFGQIRICVSRQTGHITVYMGPDIDPKELEAVHPVPAISAEQ
AKSIFWRHFKVELGWVREYRDDDEHSYRLVYKPVYPRMIEAHTGELVSSSW
>PK3-2_00667 putative lipoprotein YcdA
MFQKKTYAVFLILLLMMFTAACSGSKTSAEKKESETEKSSDIAQVKIKDVSYTLPSKYDK
STSDDQLVLKVNVAVKNKGKDPLNVDSMDFTLYQGDTKMSDTDPEDYSEKLQGSTINADK
SVEGNLFFVVDKGKQYELNYTPESYGDKKPKSVTFKIDGKDKKILATADKLQDSAKALSA
YVDILLFGKDNADFEKITGANKNEIVNDFNESAKDGYLSASGLSSTYADSKALDNIVNGI
KEGLSKNSSIQAKTTSISKDEAIVEATVKPVDASSLSDRIEDKVKDYYSKNSNASYEEAV
KYALQVYPEEFKKLGPASSEKTVEVKMKKNDIDQWQLDTDDYRAAELVEAFIKE
>PK3-2_00668 Aldo-keto reductase IolS
MDQTRTLGKTNLQVKRIGFGANAVGGHNLFPNLNDETGKDLVRTALDGGVNFIDTAFIYG
LGRSEELIGEVVQERGVRNELIIATKGAHKEVNGSIELDNSRDFLRGEVEKSLKRLKTDY
IDLYYVHFPDGKTPLAEVAGTLKELKDEGKIKAIGVSNLDYQQLKEFNTDGYLEVFQAEY
SLIQRDAEKELLPYCEKHGISFIPYFPLASGLLTGKFTKDTVFEDFRKDKPQFQGETFIH
NLQKVDKLKAVAEEKQAETAHVALAWLLTRPAIDAIIPGAKRPEQLKDNLKTLNIELTED
EVNFISGIFI
>PK3-2_00669 ABC transporter permease protein NatB
MLSHIYKKEMIDALRDRKTILLTILVPMIMMLGLVFFYESMLSDKGEKYTLAIGHSLPPA
LESKLNAIDEISVKTFAKPKEAVDDGKADAYLNVPKEFDSYVNSMTPFTVDVYGNSVDQG
SSNAMQLVQSALDQYKNEIVQERLTNKHIDQSVIQPFTIQQKEAEEEKGVSAIMLSAILP
MLILTSIVSGAMPIALDIMAGEKDRKSIEALLLTPVSRNKMLAGKWLAVSTFGVASGVLA
LVFLILSTVLFTENLKTAFQLGDHMWSVIGASALIIVLSALLISAMELFISIISSSVKEA
QSYMSLVVFLPMFPMFFIFSKAPNQFDISYFVIPFLNLHALFKQLLFGMIDPAAILCTSG
TIAVLITIFYLLARACFLKDKWVLPK
>PK3-2_00670 ABC transporter ATP-binding protein NatA
MITLTDCSRRFHDKKKVVKAVRDVSLTIQKGEVVGILGENGAGKTTMLRMIAALLEPSQG
AITVAGFDTVKQPAEVKKRIGVLFGGETGLYDRMTAKENLQYFGRLYGLNRHEIKARIED
LSKRFGMRDYMNRRVGGFSKGMRQKVAIARALIHDPDIILFDEPTTGLDITSSNIFREFI
QQLKREQKTILFSSHIMEEVQALCDSVIMIHSGEVIYRGALESLYESERSEDLNYIFMSK
LVRGIS
>PK3-2_00671 Transcriptional regulatory protein NatR
MVKVGLVDDYRVDLEKLEAIMSRMQNVEIVFSTDSAEEAYSRVKNGDIDLLLADIEMPHM
SGYELADLIRSHSLDVDVIFVTGNGGYAVHAFDLNVHDYIMKPYHADRLNASFDRYLKKK
TETSLNGRILIKQKSEMHVLQKKDIIFAERTGRSTTIVTTAEEVQTYQTLNDIKGDLPEK
DFLRSHRSFIINIHYIKHFSAYTKHSFTVSFEGTPKKAMITKQQLDYFQNYYF
>PK3-2_00672 hypothetical protein
MVTFFQWLCLFLFSFIFYQGAAALSHSTALSLPVAALGAATAGFYLWKTKRVWGRSSFQI
CAWIAVIQVMSAAVVLIGTDIMPALFVIVIFAACEGLRVGQAASLARFSDQIDKLAQAEQ
HANRMLMDVRSRNHDTMKHLTAIRSAQSKADTQAYIQNWADQYSQYDRFLKGENAYVAGV
LYDFLEKARVSGVKVSLHMHTPLSSLPFSPADQVSLAGNILENALDSAAEAREKAEIKLE
TSLRSGLYVLICENSTPGMDPKVLDTLYQSFGRSTKSGAHEGMGTYIIQKLVKSASGRLD
FTYRHPVFRLEIKIPFQK
>PK3-2_00673 hypothetical protein
MGKVKRNAPCPCGSGKKYKKCCGSKVVDFPTELAAKEAKQIQEDLVEYAFTVHRESISGF
INQHDFLSAMDRQTKDISVFNLGIWGIFFHPLAGEKTIFDEYLQKKGDSITRPKTREIVE
TWKSMTPALLLLQDLKEGVIHFEDVITKKQFEVEMDANNQDLPPVGSLILGYPIHEAEKA
EFFMQFTIFPVKRTEALISKVKKYADAAVKNGKTPEDFMKQEFNNVLFALLAEKDEEPQA
ETAEESSVEWANDMEKETAAAIEKGMSGDEYPTELIPAVIDIWKTFCEKKSPVIRKPEAF
AAAVEYYVNAISLNGASVSQAKLAKKYGVSASTISSRYKEIESTLQDEADRFAQALSS
>PK3-2_00674 hypothetical protein
MELAGFMLRACALVLDVIIAAAVILAAGFMFGDGSAGVIVTAILMLLVYPLLMPLTKWKG
TLGKKIIGLQIVRDETHEKISLPQAIVRYMIAWVHVFSRLIYLTAAFTKKKQAVHDMAAK
TIVLKAE
>PK3-2_00675 Lipase EstA
MKFVKSKFIALVTILMLSVTSLFALQPSAKAAEHNPVVMVHGIGGASFNFAGIKSYLVSQ
GWSRDKLYAVDFWDKTGTNFNNGPVLSRFVKKVLDETGAKKVDIVAHSMGGANTLYYIKN
LDGGNKVENVVTLGGANRLTTGKALPGTDPNQKILYTSIYSSADMIVMNYLSRLDGARNV
QIHGVGHIGLLYSSQVNSLIKEGLNGGGQNTN
>PK3-2_00676 L-asparaginase 2
MKKQRLLILTLFTALLLAITGCSQSPETKESPKEKPQTQQVSSASASEKKELPNIKILAT
GGTIAGADKSKTSTTEYKAGVVGVESLIEAVPEMKDIANVSGEQIVNVGSTNIDNKILLK
LAKRINKLLASDDVDGIVVTHGTDTLEETAYFLNLTVKNDKPVVVVGSMRPSTAISADGP
SNLYNAVKVAGTPEAKGKGALVVLNDRIASARYVTKTNTTATDTFKSEEMGYVGTIADDI
YFNNEITRKHTKDTDFSVSNLDQLPQVDIIYGYQNDGSYLFDAAVKAGAKGIVYAGSGNG
SLSDAAEKGAVNAVKKGVTVVRSTRTGNGVVTPNQEYAEKVLLASNSLNPQKARILLMLA
LAKTDDPQKIQAYFNEY
>PK3-2_00677 putative HTH-type transcriptional regulator YxaF
MSYGDSREKILAAATRLFQLQGYYGTGLNQIIKESGAPKGSLYYHFPGGKEQLAIEAVNE
MKEYIRQKIADCMVAYTDPAEGIQAFLKELSCQFSCTEDIEGLPVGLLAAETSLKSEPLR
EACHEAYKEWASVYEEKLRQAGCSEIHAKEASTVINAMIEGGILLSLTAKNSTPLLHISS
CIPDLLKR
>PK3-2_00678 putative multidrug resistance protein EmrY
METAAKASQQYKVMPIMISLLLAGFIGMFSETALNIALTDLMKELNITAATVQWLTTGYL
LVLGILVPVSGLLLQWFTTRQLFTVSLIFSILGTLIAALAPSFPFLLAARIVQALGTGLL
LPLMFNTILVIFPPHKRGAAMGTIGLVIMFAPAIGPTFSGLVLEHLNWHWIFWISLPFLV
LALVFGMAYMQNVSEITKPKIDVLSIILSTIGFGGIVFGFSNAGEGSGGWSSPTVIVSMV
VGVVGLILFSIRQLTMKQPVMNLRAFRYPMFILGVIMVFICMMVILSSMLLLPMYLQGGL
VLTAFASGLILLPGGILNGFMSPVTGRLFDKYGPKWLVIPGFVIVTVVLWLFSNVTTAST
AVLIIILHTCLMIGISMIMMPAQTNGLNQLPREFYPDGTAIMNTLQQMAGAIGTAVAVSI
MAAGQHDYMSTVKNPADPAVIPQALTAGVQHAFIFAMIVAIIGLIGAFFLKRVKVDH
>PK3-2_00679 hercynylcysteine sulfoxide lyase
MEHLPQQYRQLFPTVQTHTMLASCSQSALAEPVSRAIKDYHDSLLLMGTNWNEAIEKTES
ARNEFAQLIGAEPDEIAIVPSVSDALVSVASSLTDFKKKHVVYTEMDFPTVSHVWQALSD
YNVSVIPSIDGGLPLEQYEAHITDETVLTCVPHVHYRDGFVQDVKAIAEISKRKGSLLFV
DAYQSAGHIPIDVREWGVDMLAAGTRKYLLGISGMAFLYVRKELADALKPKASAWFGRES
GFDAPYAKGARRFQTGTPAFISVYAASSALSLLNHIGVSRIRDHVKTICSDARQYAAEKG
LQLAAQAGRQPGMVAIRDERASETAILLRKKKVICAPRDTVIRLAPHFYNTKDELRHAID
EIAAVFAAR
>PK3-2_00680 Pyrrolidone-carboxylate peptidase
MRKKVLITGFDPFDKETVNPSWEAAKQLNGFETDEAIITAEQIPTVFKTALDTLRQAIQK
HQPDIVICVGQAGGRMQVTPERVAINLADARIPDNEGHQPIDEEISPGGPAAYWTGLPVK
RMTEKMKENGIPATVSYTAGTFVCNYLFYGLMDHISRTSPHIRGGFIHIPFIPEQTIDKT
APSLSLDTIVLALRIAAVTAAQYEEDVKSPGGTLH
>PK3-2_00681 Sec-independent protein translocase protein TatCd
MDKKETHLIGHLEELRRRIIKTLAAFLLFLITAFLFVQDIYDWLIRDLDGKLAVLGPSEI
LWVYMMLAGICAIAASIPVAAYQLWRFVAPALTKTERKVTLMYIPGLFALFLAGISFGYF
VLFPIVLSFLTHLSSGHFETMFTADRYFRFMVNLSLPFGFLFEMPLVVMFLTRLGVLNPY
RLAKARKLSYFLLIVVSILITPPDFISDFLVMIPLLVLFEVSVTLSAFVYKKRLTDETAA
A
>PK3-2_00682 Sec-independent protein translocase protein TatAd
MFSNIGIPGLILIFVIALIIFGPSKLPEIGRAAGRTLLEFKSATKSLVSGDEKEEKSAEL
TAVKQDKNAG
>PK3-2_00683 Alkaline phosphatase D
MAHDNRFDEWVQKLKEESFQNNTFDRRKFIQGAGKIAGLSLGLTIAQSVGAFEVNAAPKF
SSYPFTLGVASGDPLSDSVVLWTRLAPDPLNGGGMPKQAVPVKWEVAKDEHFRKIVRKGT
EMAKPSLAHSVHVEADGLEPNKVYYYRFKTGHELSPVGKTKTLPASGANVQKMTFAFASC
QQYEHGYYTAYKHMAKEKLDLVFHLGDYIYEYGPNEYVSKTGNVRTHSSAEIITLQDYRN
RHAQYRSDANLKAAHAAFPWVVTWDDHEVENNYANKIPEKGQSVEAFVLRRAAAYQAYYE
HMPLRISSLPNGPDMQLYRHFTYGNLASFNVLDTRQYRDDQANNDGNKPPSDESRNPNRT
LLGKEQEQWLFNNLSSSTAHWNVLAQQIFFAKWNFGTSASPIYSMDSWDGYPAQRERVVN
HIKSKNLNNVVVLTGDVHASWASNLHVDFEKTSSKIFGAEFVGTSITSGGNGADKRADTD
QILKENPHIKFFNDYRGYVRCTVTPHQWKADYRVMPFVTEPGAAISTRASFVYQKDQTGL
RKVSSTTIQGGVKQSNEVEEDRFFAHNKAHEKQMIKKRAKITN
>PK3-2_00684 hypothetical protein
MAAIDLQKKSVKIVLEKKQLTKVTARVGLVLDITGSMRTLYKNGTVQNVVERILAVADHF
DDDGLLDVWVYDNEFSRLKPVSEKDFSGYVEREILNNDRLHKFGRNNEPPVMKDVLRKYV
TEEPSSYPAFIVFINDGGCKKSIKPIIEASSDKPVFWQFVGIGNGNFDFLNQLDTLEGRV
VDNTKFLHIDEIDSISNDELYDALLTEFPFWLKKAREKGIVKEQEIVREQEPPAEKPKKK
GFFSRLFSK
>PK3-2_00685 Cell wall hydrolase CwlJ
MAVVRATSADVDLMARLLRAEAEGEGKQGMLLVGNVGVNRLRANCSDFKGLRTIRQMIFQ
PHAFEAVTHGYFYQRARDSERALARRSINGERRWPAKFSLWYFRPEGNCPAQWYNQPLVA
RFKSHCFYQPTAETCENVYNTF
>PK3-2_00686 hypothetical protein
MKGKMFTTLMLMFMLAGGGCKPTEESAVSVQSPAPPDSAKNKVYDIHEDFIEAERKFGTE
LFQNMSDKDGLTDNLLISPYSLQQVLLMTANGADRDTLKEIKAALYLSDIHDRAINESSS
ALMKRFESLSEGDLRTANAIWSKLEAKPDFKQTIKQFFLGSVFKMDDNIQAAKNSINQWT
AHQTKGHIDDIAGDLSPEAVSLLVNAVCFQEKWAMPFDRHVTAEKPFFLPDGSAKKLLMM
KQTARLDYLENELFRAVKLPYEDKHLSFTLFLPKKKPDSFMSLFTNQNIKAWDSAFQPKT
VKLSLPRFALKGKYNVKHVLHDMGVKSVFSEADFSRMFTEDRGVSIDDVNHHTFIKVDET
GTEAAAASSAEIVESALAPEVTLTANRPFFFVITDEQTTSLLFLGFVANPNE
>PK3-2_00687 hypothetical protein
MTHVKALAIKGIMTIIVLYLVLGLGFGFTFGDTLLMTIVLGVISYLLGDLYVLPRWNNMI
ATLADFGLAFLVIWLMGMPLSMGMTGGEVALAALFGAIAMAIGEYCFHFYMMSKEIGKKH
YLETRTDS
>PK3-2_00688 hypothetical protein
MNLIRIELRKMKLGWYVRGILIANLIIMGFLWLISYSEKADGGVSFQSMEEAFLIIGTFV
RAVFIVFGAVLIAKLVISEYKNKTILVMFTYPISRKKLLTAKLMIAAGLTFITILLSNIL
IAAGFFVLNSIYHFIPGELTSEIMSQQAIKMAVFAFGAAGTSLVPIFFGMRKHSVPATII
SSVVIVMLISSTSPGFSISSVVYIPLSLAAFGLFFSYMAIRNADKQDA
>PK3-2_00689 Bacitracin transport ATP-binding protein BcrA
MTYIVQTNGLTKTYQGKEVVSNVSMHIKKGEIYGFLGPNGAGKTTIMKMLTSLVKPTSGE
ISILGNQLTHTSYKVLGSIGSMIEYPIFYENLSATENLDLHCEYMGYHNKKAIQEVLDMV
NLKQIDKKPVKTFSLGMKQRLGIARAILTKPDLLILDEPVNGLDPIGIKKIRQLFQVLSK
EYGMTLLISSHLLGEIEQIADTIGVIRDGRLLEEVSMEAVRGQNTEYIELVTPDQTRACF
VLEKELRLSNFKILNEKTIRIYEAEASQAAISKALILNDVDIESMNKKYTSLEDYFISLI
NGNNIGA
>PK3-2_00690 Sensor histidine kinase RcsC
MAVLWMALVIVLACLNVIQFMMKKKRDGNLAYTAEQLDAMLNRHSAGRILLHTDDQALKD
LLVNINLLVENRQQISAQFAKTEQSMKRMLTNMSHDLKTPLTVILGYIEAIQSDPDMPDE
ERERLLGKLRQKTNELIQMINSFFDLAKLESEDKDIPITKIHMNDICKRNILHYYDAVQS
KGFQASIDIPDTPVYAQANEEALDRILQNLLSNAIQYGAAGKLIGMTLSYDETNIAITVW
DRGKGISETDQQRVFERLYTLEESRNKAFQGSGLGLTITKRLTEKMGGTISVQSKPYEQT
AFTVTLKRMTY
>PK3-2_00691 Transcriptional regulatory protein WalR
MQRILLVEDDHSISEMVGHYLTKEGFEIVNAFDGEEGILLFRQDSYDLILLDIMLPKLNG
MDFLKIIREKSNVPVLMISAKDGDVDKALGLGFGADDYIAKPFSMIELTARVKAAIRRAT
QYSAEEPAENNVIRIHQLAIDIDNVSVLKNGEPLQLTSTEWQLLCLFAANPKKVFTKEQI
YRSVWNEEYFGDQNIINVHMRRLREKIEDDPSAPQYIKTLWGIGYKLGEF
>PK3-2_00692 hypothetical protein
MREEEKRKFREAASGTIFLLIGTVCFASKSIWIKWAYQMGAEPDAVLLYRQLFAVPLFWL
IFLFYRPSMPDGNKKGDLVKACVAGVFVFFLSPLLDFIGLNHVSAMVERILLMSCPIFVI
LFTACGDRNMVTVQDLFTVLAVMFGLFFALGGWDTELFQANMIGSAFILLSSAVYAGYLV
LSGRLVHQIGGIRLNAYGMTAAGAAMMLYIGIKSTIGLNTPIAAYPPAVYGLFVLIAVAT
TVIPFVLMLEGIKRIGAQRAAVISMAGPVLTIFYGALFLGERLRLTQAIGCAAVFLIITG
MEYRKLKTGKK
>PK3-2_00693 Tryptophan RNA-binding attenuator protein inhibitory protein
MVIATDDLEVACPRCERAGEIEGKPCPACSGKGVILTAQGYTLLDFIQKHLNK
>PK3-2_00695 hypothetical protein
MTNLTEKQVITEIVRVAREQGLTVHSKNAQLNETGMDFQVVFAEDDTGMQWVLRKPRRSD
VVERAYAEGRTLAFLRANFTADVPDWRIHTPELIAYPMLKGTPAAGIDLEQKQYVWNMNH
QPPSDNFVHTLAGILAELHGTNQTAAGQSGIEVIMPEDFRRMTAESMVDVKNKLGVSKQL
WERWQTWINDDAYWPGFSTLIHGDLHPPHILIDQNERVAGLLDWTEAKVADPAKDFVLYQ
TIFGEKETARLLEYYNQAGGRIWAKMHEHISEMQAAYPLEIAKFALQTQQEEHINMALEA
LGVKLG
>PK3-2_00696 Galactarate dehydratase (L-threo-forming)
MAMNLRQNQAPFYIKVNETDNTAIIVNDGGLPKGTVFSCGLVLEEDVPQGHKVALTDLNQ
GDEIVRYGEVIGFADETVKRGSWIREALVRMPAPPELDDLPLANRVPKPLPPLEGYTFEG
YRNADGSAGTKNILGITTSVQCVVGVLDYAVKRIKEELLPKYPNVDDVVPLHHQYGCGVA
INAPDAIIPIRTIQNLAKHPNFGGEVMVIGLGCEKLLPARIASENPDDILSLQDHQGFAA
MIQSILEMAEERLIRLNSRTRVTCSVSDLVTGLQCGGSDAFSGVTANPAVGYAADLLVRA
GATVLFSEVTEVRDAIHLLTPRAVNEEVGQSLIKEMKWYDSYLRRGEADRSANPSPGNKK
GGLSNVVEKALGSVAKSGTSPISGVLGPGERAEQKGLLFAATPASDFVCGTLQLAAGMNL
QVFTTGRGTPYGLAAAPVLKVSTRHSLSEHWADLIDINAGRIATGEASIEDVGWEIFRTI
LDVASGRKQTWADRWGLHNDLCLFNPAPVT
>PK3-2_00697 HTH-type transcriptional regulator LutR
MYEGLEDLKVDTVNRKTLAKQVIERIVHLLSSGQLKAGDKLPTEMELMDILHVSRPVLRE
ALSSLETLGVITRKTRGGTYFNDKIGMQPFSVMLALATDNLPAIIEARMALELGLVTIAA
EKINEDELQRLQKTIDDIANSTDNLYGEADKEFHRIIALSANNPVVEGMIQSLLITHAKI
DSQIPYRERDVTVEYHKKIYDALAKRDPYKAHYHMYEHLKFVRDKILKGMDEK
>PK3-2_00698 Glucarate dehydratase
MSSSIQEQVQNEKRSNIPSITEMKVIPVAGHDSMLLNLSGAHSPFFTRNIVILTDSSGNQ
GVGEVPGGEQIRRTLELAEPLVVGKSIGAYQSILQTVRKQFADQDRGGRGIQTFDLRTTV
HAVTALEAALLDLLGKFLQEPVAALLGEGKQRDEVKMLGYLFYIGDRKRTALPYQSDEQS
DCAWFRLRHEEALTPEAIVRLAESAQERYGFQDFKLKGGVLRGEDEIEAVTALSKRFPEA
RITLDPNGAWSLEEAIALCKGKHDVLGYAEDPCGDENGYSAREVMAEFRRATGLPTATNM
IATDWREMGHAIQLHAVDIPLADPHFWTMQGSVRVAQMCHDWGLTWGSHSNNHFDISLAM
FTHVAAAAPGRITAIDTHWIWQDGQRLTKQPFEIADGCVKVPNKPGLGVDIDMEQVEKAH
ELYQKMNLGARNDAIPMQFLMSNWEFDRKRPCLVR
>PK3-2_00699 putative glucarate transporter
MKKDYANVSPAGKKTSVRWFIVFMLFLVTSINYADRATLSITGDSVQHDLGLDSVAMGYV
FSAFGWAYVIGQLPGGWLLDRFGSKTVIALSIFFWSFFTMLQGAIGFFTAGTAIILLFAL
RFLVGLSEAPSFPGNGRVVASWFPSSERGTASAFFNSAQYFAIVIFSPLMGWLTHSFGWH
SVFVVMGAAGILLAVIWLKTVYEPKKHPKVNEAELAYIEQGGGLISMDDGKSKQETESKW
PYIKQLLTNRMLIGVYIAQYCITTLTYFFLTWFPVYLVQARGMSILEAGFVASLPALCGF
AGGVLGGIVSDILLKKGRSLTFARKVPIIIGMLLSCSMIVCNYTDSAWLVVVIMSLAFFG
KGFGALGWAVVSDTSPKECAGLSGGLFNTFGNIASITTPIIIGYIVNATGSFNGALVFVG
ANAIAAILSYLLLVGPIKRVVLKKQEQDPDQSLPV
>PK3-2_00700 Alpha-ketoglutaric semialdehyde dehydrogenase
MSVITEQNTYLNFINGDWVKSQSGDMVKVENPADVNDIVGYVQNSAAEDVERAVAAANEA
KTAWRKLTGAERGQYLYKTADIMERRLEEIAACATREMGKTLPEAKGETARGIAILRYYA
GEGMRKTGDVIPSTDKDALMFTTRVPLGVVGVISPWNFPVAIPIWKMAPALVYGNTVVIK
PATETAVTCAKIIACFEEAGLPAGVINLVTGPGSVVGQGLAEHEGVNAVTFTGSNQVGKI
IGQAALARGAKYQLEMGGKNPVIVADDADLEAAAEAVITGAFRSTGQKCTATSRVIVQSG
IYDRFKEKLLQCTKDITIGDSLQEDVWMGPIASKNQLDNCLSYIEKGKQEGASLLIGGEK
LEDGKYQNGYYVQPAIFDNVTSEMTIAQEEIFGPVIALIKVDSMEEALDIANDVKFGLSA
SIFTQNIGRMLSFIDEIEAGLVRINAESAGVELQAPFGGMKQSSSHSREQGEAAKDFFTA
IKTVFVKP
>PK3-2_00701 putative 5-dehydro-4-deoxyglucarate dehydratase
MSRIRKAPAGILGFPVAPFNTQGKLEEEALFQNIEFLLEEGLEAIFIACGSGEFQSLSQK
EYEQMVEVAISAAGGKVPVYTGVGGNLSTALEWAKLSEKKGADGYLILPPYLVHGEQEGL
YQYAKTIIESTDLNAILYQRDNAVLSLEQIKRLTEFEQLVGVKDGVGNMDLNINLVYTLG
DRLGWLNGMPMAEVTMPAYLPIGFHSYSSAISNYIPHISRMFYDALKNGNDELVKELYQH
VILPINDIRKQRKGYAVSLIKAGMEIMGLNVRNTARPPVGPVEKEHYQQLEAILKQAADR
FPKKTATV
>PK3-2_00702 Protein-glutamate methylesterase/protein-glutamine glutaminase
MRFFIADDDRAVRSILRQIIEDEDLGEAAGEADDGSQVEGHMLQFKQIDILLIDLLMPER
DGIETIRQLQNTYSGKIVMISQVEAKEMVGEAYSLGIEYFIHKPINRVEIVTVLQKVKER
IELEQSIGAIQHSLSRLVNRPERKARLQQKSDSGLKEAGTFLLSELGMMGEGGAHDLMAV
LQYLSEHEQSEPYEKHIPSLKQIFTQVAERKLGAGASETEVNREMKASEQRIRRAIIHSL
HHFASLGTTDFSNPKFETYASKFFDFPVVSQKMKELQSKDAKPLAPAKVNMKKFIHVFFL
EAKLLYETMKERRM
>PK3-2_00703 Sensor histidine kinase GlnK
MLITVPLAGELKFYPLNEEFRISFGAPVFFFFLSLLRHVPAVLPGLLTGAAVFVFRVLLE
LWGGGHEGLAPILYDQASGFFFYMTYACLFSVLKANRFRERPVMLGFIGFMIEIVSDCVE
LAVQFLIFHTVVTPEKITDIAVIAISHTFIVMSFYTVLKLYETQSREKQTRQQHEHMLMI
VSNLYEETVHLKKTLKTTEKVTNDSYQLYREAKGMDEQLSRRILRLAGEIHEVKKDNQRI
FAGLSKMISNESLRDYMRASDLLQLVIRMNEKYAEALGKQIDFHCSIEGEHDDYHVFTVL
SIINNLTANAVEAMGEEGMISLRLRKQNESMIEFQVEDNGPGISEKIGDIVFDPGFTSKY
DEFGTPSTGIGLSYVKEIVTELEGDITFDNQQRGVVFAIRLPVRHLIQKG
>PK3-2_00704 Glutaminase 1
MKELIIEPKEEQDPVSQLRDWVEHYRPFSANGQSANYIPALGKVNDSQLGICILEPDGTM
IHAGDWNVPFTLQSISKVISFIAACMSRGIPYVLDRVDVEPTGDAFNSIIRLEINKPGKP
FNPMINAGALTIASILPGESAYEKLEFLYSVMETLIGKRPRIHEEVFQSEWETAHRNRAL
AYYLKETNFLEADVEETLEVYLKQCAMESTTEDIALIGLILSHDGYHPIHRKQVIPKDVA
KLAKALMLTCGMYNASGKYAAFVGVPAKSGVSGGIMALVPPSARRDQPFQFGCGIGIYGP
AIDEYGNSLTGGMLLKHMAQEWELSIF
>PK3-2_00705 Amino-acid carrier protein AlsT
MQQVLEHIIGIANDLLWSKLLIVLLLSLGIYFTFRLKFLQVRMLKEMVKVLREGAASRSK
NSISPFQAFCISMAARVGTGNITGIAIAIALGGPGAIFWMWIIAIIGSASSFVESTLAQV
YKVKDVNGFRGGPAYYMEKGLNKRWMGALFAVLITLSFGIVFNSVQSNTVSLAFENAFGT
NRLTLGLILIAVFGTIIFGGVKRIAKLAESIVVVLAVLYIGVAFFVIFTNITQLPDVLAL
IVKNAFGFDQAAGGALGAALMQGVRRGIFSNEAGMGSAPNAAATATTSHPVKQGLIQAFG
VLTDTLVICTSTAFIILFSDAYHTPGLSGIALTQASLSSHVGPWASGFLAILILLFGFCA
LIGNYYYGETNIGFLNKSKKLIFVYRIGVLAMIVFGCVAKVQLVWDLADLFMGLMVVVNL
IAIFLLSKVVFAALQDYTRQKKAGKDPVFYKDVLKNHNGIECWPLSDTKADSHNKQIS
>PK3-2_00706 Homocysteine S-methyltransferase
MNPIQHILDTYPLIVLDGAMATELERKGCDLNDSLWSAKILMEEPDLIKQVHTDYFAAGA
DCAITASYQSTFEGFAARGLSEAEARRLIEMSVTIAAEARDEFWAFEENRLNRPKPIIAA
SVGPYGAYLADGSEYRGNYGISEGELIEFHRPRIKALIEAGADVLACETIPCLTEAKAIV
RLLKEFPETYAWISFSAKDGLHISDGTPAADCASWLDEYRQIAALGINCTPLQHIPSLID
ELKKHTSKPIIVYPNSGEQYDPETKTWNGAACAEPYGETARTWLEKGAKLIGGCCRTKPE
DIREIAAWARSIKTT
>PK3-2_00707 Amino-acid permease RocC
MKSAHNKNETNFQRSMKSRHLFMLSLGGVIGTGLFLSSGYTIQQAGPAGTILAYLVGAGI
VYLVMLCLGELSVAMPVTGAFHTYAAKYIGPGTGFTVAWLYWLTWTVALGSEFTAAGLLM
QRWFPHTSVWMWSAVFALLIFLLNAFSVRFFAESEFWFSSIKVLAIILFILLGGAAMFGI
IPIKGGEAAPLLSNFTAEGGLFPNGFVPILMTMLSVNFAFSGTELIGIAAGESVDPDKTI
PKAIKTTVWRLSLFFVGTIFVLSGMIPIQDAGVIKSPFVAVFDRVGVPYAADIMNFVILT
AILSAANSGLYASSRMLWSLSKEKTLHPTFAKLTSKGTPFNALVFSMIGGILSLLSSVFA
PDTVYVVLVSISGFAVVVVWMGIAASQFMFRKRYIEAGNKAADLKYRTPLYPFVPIAAFL
LCLASVIGIAFDPNQRIALYCGIPFMAVCYAVYYAKNRKSQPTADITQSK
>PK3-2_00708 Branched-chain-amino-acid transaminase 1
MLIRLNKLIEREKIAFHKEKPDPSSLEFGKYFTDYMFVMDYEEGMGWQHPRIAPYAPLTL
DPSASVFHYGQAVFEGLKAYRTEDGRVLLFRPDQNIKRLNRSCERMSMPPLDEELVLEAL
TQLVELEKDWVPKEKGTSLYIRPFVIATEPSLGVKASKSYTFMIVLSPVGSYYGDQLKPV
RIYVEDEYVRAVNGGVGNAKTSGNYAASLQAQRKADGLGYDQVLWLDAIEKKYVEEVGSM
NIFFVMNGEAVTPALSGSILSGITRASAIELIRSWGIPVREERISIDEIYAASVRGELTE
VFGTGTAAVVTPVGELNIHGKTVIVGDGQIGDISKKLYESITDIQLGKVKGPFNWTVEV
>PK3-2_00709 putative membrane protein YbgB
MFLLTNGKVLWGAVIAAFLLSIVFYAFLPAQMPIHYDVGNSPDLTVNKLVGTVMLPVLMV
VFAWARKINWQFVIAVYILLICHIVVLCLAV
>PK3-2_00710 HTH-type transcriptional repressor GamR
MVLWSQLKGTVSIQNGENEMTALYSVIKFKIIELIKSGKYQANDQLPTESEFCEQYDVSR
TTVRLALQQLELEGYIKRIQGKGTFVSTAKIQTPIPHKITSFAEQMRGLRSESKVLELVV
IPADHSIAELLKMKENEPVNKLVRVRYAEGEPLQYHTSYIPWKAAPGLAQEECTGSLFEL
LRTKYNIEISRGTESIEPILTDETISGHLLTNVGAPAFLSESLTYDKNEEVVEYAQIITR
GDRTKFTVEQSYQS
>PK3-2_00711 putative glucosamine-6-phosphate deaminase 2
MKIIIADHYEELCKLSAAIIKEQIQAKKDAVLGLATGSTPVGLYKQLISDYQAGEIDFSK
VTTFNLDEYAGLSPSHPQSYNHFMYEHLFKHINMQPGHIHIPQGDNPQLEAECKVYEDLI
RQAGGIDVQILGIGANGHIGFNEPGSDFEERTRVVKLSESTIQANARFFGGDPVMVPRLA
ISMGIKTIMEFSKHIVLLASGEEKADAIQKMAEGPVTTDVPASILQKHNYVTVIADQKAA
QKLQNASHS
>PK3-2_00712 Putative PTS system glucosamine-specific EIICBA component
MFKKAFQILQQLGRALMTPVAVLPAAGLLLRFGDKDLLNIPIIKDAGGVVFDNLPLIFAV
GVAIGLAGGEGVAGLAAVIGYLILTVTLDNMGKLLGLQPPYEGAEHLIDMGVFGGIIIGL
LAAYLYKRFSSIELHPVLGFFSGKRFVPIITSVSSLAIGVIFSFVWPLIQNGINAASSLI
ADSTVGLFFYATIYRLLIPFGLHHIFYTPFYFMMGEYTDPSTGNTVTGDLTRFFAGDPTA
GRFMMGDFPYMIFCLPAVALAIIHTARPEKKKMISGVMISAALTSLLTGITEPVEFSFLF
VAPVLYLINSILAGVIFVVCDLFHVRHGYTFSGGGIDYVLNYGLSTNGWVVIPVGIVFAF
IYYYLFRFAILKWNLKTPGRETDEADQTEAKAPVAKDQLAFHVLQALGGQQNIANLDACI
TRLRVTVHQPSQVSKDELKRLGAVGVLEVNNNFQAIFGTKSDALKDDIKTIMAGGVPDTA
AALDTETDQQQKPVSGEAFIYPLKGETVSLADVPDQVFSEKMMGEGFAIDPSEGKVVAPA
DGEIVSIFPTKHAIGFKSAGGTEILIHVGIDTVKLNGEGFEALVASGQAVKQGETLLTFN
LDYIKQHAASAVTPVIFTNVSEEDMKHIQMK
>PK3-2_00713 Proton/glutamate-aspartate symporter
MKKLIAFQILIALAVGAVIGHFFPDFGMALRPVGDGFIRLIKMIVVPIVFSTIVIGAAGS
GSMKKMGSLGIKTIIWFEVITTLVLALGLLLANVLKPGVGLNLSHLAKKDIDELSGYTEK
VVDFKQMILDIIPTNIIDVMARNDLLAVIFFAILFGVAAAGIGKASEPVMNFFESAAQIM
FKLTQIVMVTAPIGVLALMAASVGQYGIELLLPMFKLVGTVFLGLFLILFVLFPLVGLIF
HIKYFEVLKMIWDLFLIAFSTTSTETILPQLMDRMEKYGCPKRVVSFVVPSGLSLNCDGS
SLYLSVSCIFLAQAFHVDMTLSQQLLMMLVLVMTSKGIAAVPSGSLVVLLATANAVGLPA
EGVAIIAGVDRVMDMARTGVNVPGHAMACIVVSKWEKAFRQKEWTSVNGQTESL
>PK3-2_00714 hypothetical protein
MEKQYRVLLYYKYVPIEDPETFREQHLAFCKELGLLGRILVSSEGINGTVSGTVEQTEKY
METMKADPRFADMVFKIDEEEGHTFKKIFVRHKKELVTLRLEDDVDPNETTGQHLKPAEF
YEKMQDPNTIVIDARNDYEYDLGHFRGAVRPDIEAFRELPEWIEENKDMLEGKQILTYCT
GGVRCEKFSGWLMKQGFEDVSQLDGGIVTYGKDPEVQGKLWDGQCYVFDERISVPVNRVE
HVIVGKDYFTGEPCERYVNCANPSCNKKIICTPENEYKYMRSCSHECRTNPRNLYVKEHN
MTEEEVNARLAAIENADHAAAE
>PK3-2_00715 hypothetical protein
MQRQLCFIQISALSILLYQFESQVAFTRTFKKLYHMPPGAYRTFMKKFVSKKEESYMEKK
MKGWVLSGSHPFQFEMGIDRENVHQGKASGYLKSTMVQDIGEFATMMQQFKADRYLGKRL
RLSSFIKTKGVQHFASLWMRVDSAADDVLQFDNMSNRPIAGTTNWNHYAIVLDVPENSAV
ISFGVQLSGPGQVWMDHVVFEEVDKSVPSTNLEMPGELLDEPVNLSFEEEL
>PK3-2_00716 Transposon Tn10 TetD protein
MYYEKAVQKTIDWIESHLHEQISNEDIVNVSGFSKFHFHRIFQKEVGMSVASYIRLRSLA
NAAAALLYTDLRIIDIALSV
>PK3-2_00717 hypothetical protein
MNRIVVKMILPLLIVCLAFSSFSVSARAASEEKHWERWIERHAQPLDASDASNKDLRFLK
KVLKGKRIVQLGETTHGAGEINATKVRMIKYLHEELGYDVLAFESDFANTNASYLNMDQS
TPKSTMKNSIYAVWHTEDVVELFAYMKEQKEKGDPLILTGFDIQSMKNSFNDAANQWVKA
VDPEKAELLSQSENDFSTLVTDSGTFDQFTQKKEKLVKNYQELIKFAETNASALKAHLPK
EPKAYQMFMHSLQLRIDVMEMYMLEEMKEKLKDYPENIEDFSFYMRDRMIAEQFQWVAET
LYPNKKIIVWGHNYHLRKQNTKMIQDWTYVNGPNMGDYLPERLKKQTYTIGIYAYSGASL
DSSDNKTVMPVTSPPPPGSLEALLKAADHPAVFVDFLHTKNKKGTSWMYTPRTALYWGYK
EEQMILKEQYDGVIWLEHITPSVIIK
>PK3-2_00718 hypothetical protein
MEKQIVSWITDYQNTGDEAVLRQLREACWPIVESVLQEKATDEGQVSDLREKGIERFPFI
ISKYQADVQLPVETFLRNTYRFYFHQVMRESR
>PK3-2_00719 Phosphatidylserine decarboxylase proenzyme
MFNTAVKILYRSLIELTNHRLSSYLIKGFCESKISKPVIPLFSKHFRLNWDDVDGKAADY
GSLSELFIRNINLERRPVSKETHAVVSPVDGVVQTIGTINPNQTFTVKGKDYSFAELTGC
KSADHQYNGGYFVVLYLSPRHYHRFHSPISCRYQKLAELGNRSYPVNQLGLKYGKDVLSK
NYRFVYELNGGSRNVLMIPVGAMNINSIVQTSTRDELEIGEELGYFSFGSTVILIFEKGA
FQPSANLTEGQEVQVGELIGYEEHKEELA
>PK3-2_00720 Protein DedA
MELVQQLIADYGYLAIFLMLVLGIVGLPIPDEVMMTVVGYFTQTHVLNYELSILISFVGA
LLGMLISYMIGRKAGRPFIDKYGKWVGLKEKRMMKVEKWMKKYGPYSLILGYFIPGVRHV
TCYFSGIGKMDLKTYIAFAAIGAFLWCFIFITIGRVIGIIHV
>PK3-2_00721 hypothetical protein
MNYIPCMITIGNFTCGLLAIHSLLYHNIHSAVLFIFTGMFLDFFDGMAARKLNAVTDMGK
ELDSFADLVTFGVAPSMLAYSVALYALPFIGILCALTYSICGMLRLSKFNIEQSKLPTFI
GMPIPFAGMCLVILSFVYNPILLAIGTCGLSYLMVSKIKFPHFKKHAAENLESERWN
>PK3-2_00722 Carboxylesterase YbfK
MTQDSMQFASAESGLRFYQAYDQSLSLWQMESEAFYVSTRFGKTHIMASGPKDAPSLILL
HGGLFSSAMWYPNIAAWSSQFRTYAVDIIGDKNKSIPTAALDTRADCAEWLKDVFDSLGL
QKAHLAGLSLGGSHIVNFLLQAPERVSRAVVMSPAEAFISFHPDVYKYAAGLTGGSGAEA
YIKWITDSRYDLHPLLRRQIVTGVEWQDEQRTLKPAENGFPYVFSDRELKSIAVPILLMF
GEREVMYHQQMALERAAVLVPGIQAEIVKNAGHLLSLEQPEYVNQRVLSFLSGE
>PK3-2_00723 hypothetical protein
MYSTIFNIGQINKYSKLAIFMSILFICGCSSQTHSAQKETAIPVTLHVEDGEGLPVEGVQ
VTIVKAPASDQEPSAEIGEILGKTDKNGDIKWDTGKKGDYSVALTKGEKSVTHHISLTED
KKDKVISLLFKE
>PK3-2_00724 Extracellular metalloprotease
MKLVSTFRKKWIAYLTILCLSLTAAVSFSAPAQAAENPQTSVSNTGKEADVPKNQTSKAE
QVSAPYEGTGKTSKSLYGGQTELEKNIQALQPSSIIGTDERTRISSTTSFPYRATVQLSI
KYPNTSSTYGCTGFLVNPNTVVTAGHCVYSQDHGWASTITAAPGRNDSSYPYGTYSGTMF
YSVKGWTESKNTNYDYGAVKLNGSPGNTVGWYGYRTTNSSSPAGLSSSVTGYPCDKTFGT
MWSDTKPIRSAETYKLTYTTDTYGCQSGSPVYRNYSDTGQTAIAIHTNGGSSYNLGTRVT
NDVFNNIQYWANQ
>PK3-2_00725 Formate-dependent phosphoribosylglycinamide formyltransferase
MYQSKKVLLLGSGELGKEVVIEAQRLGVQTVAVDSYEHAPAMQVAHNSYVVDMLDREQIR
TIIEKEKPDLIVPEVEAIATDELLKLEEEGFHVIPNARAAKLTMDREGIRRLAAETLGLA
TAGYEFANTYDEFVQAAAQIGFPCVVKPLMSSSGKGQSVCRSEADLESCWETAMEGGRVK
NGRVIVEEFVPFESEITLLTVRAVNGTTFCEPIGHVQKDGDYIESWQPHHMTKQQMEEAK
HIAKAITDELGGYGLFGVELFLAKDKVYFSEVSPRPHDTGLVTLVTQNLSEFALHVRAIL
GFPITEITQLSPGASRPLKAPEESAEYTVDGLENALAVPKTQVRVFGKPVTKAGRRMAVA
LSAADTVETARENAKKALDQLSIK
>PK3-2_00726 HTH-type transcriptional activator RhaS
MQNETRTLQLDPHLHIEAYRFKGIMQKFPNHFHDYYVIGFIEKGQRYLACQDQEYIINPG
DLLLFNPRDTHSCEQIDGRTLDYRCINVMPDVMEKAVEEITGTGHLPYFSQHVLFRHELT
ASLQELHILISDEKQALRKEELFLHLLEELIRHYSDVTFLNSLPEPSVEVKLVCEFLEEH
YAENVTLNDLSELTGWSKYHLLRSFTKQKGITPNSYLETIRINQAKKLLEQGVRPIDAAF
QTGFSDQSHMTKFFKRQVGLTPKQYMKIFEKELQG
>PK3-2_00727 hypothetical protein
MSIQRETTGHTAAIVTILIWGTTFISTKVLLADFTPMDILFYRFLIGFIALILVRPKMIP
FKNWQQELLFAGAGLFGVTLYFLLENIALTYTYASNVGMIVSIIPMITAVLAHFLLEGEK
LRLTFFIGFGAALTGLLLITFNGHVVLRLNPFGDILAAGAALVFGGYSIFMKKLSAYDYH
IIELTQRVFLYGLLFMVPALFSFDFHLDLSRFSSASNVLNMLFLGIGASALCFATWNYSV
GVLGAVKSSAYIYMVPVITIAASILILHEKMTWIALLGGALTLFGLYISELKPKVKRMEN
GSKMDA
>PK3-2_00728 hypothetical protein
MVDEMVLITQQWLNETYSGKHGYNPVEESGKTGWDTIYGLTRALQIELGISEPADNFGPT
TQRLFKPLKKQDPNSKPSNMNFILQGALWCKGFNPGGFTGVFYEKTENAVKEFQKAAGLT
TQDGIVTTLIMKALLDMSAFKLVSGGDSRIRQIQQNLNRDYNDYIGLMPCDGLYARDTNK
ALIYALQKEEGMSTSVANGFFGNGTTSLCPTLTPGDSRTGFVLIVQYALYCNGKAFDPGE
FDGKYGVGVVSAVKAFQEFMCLPQTGYADMPTIKALLSSSGDTTRAASACDTATILTAEK
AQTLRNNGYKTVGRYLTGNVRTSSGLTSKALTSKELAVILDAGLKVFPIYQDGGYESSYF
VKDQGTRDAYSAASAARRLGFPSGTTIYFAVDFDAYDYEVTDKIIPYFQEIKSAFAKMQT
FSTAPKYEIGVYGPRNICIRTAETGLTKYSFVANMSTGFSGNLGYPMPNNWSFDQFYEGT
IGSGSGSIGIDKDGYSGRDSGASIVNPPSDPVYDARLRTLTDILSTIPALENLSNLANAM
FEFDTTETIFTSPELDIILSTSLLATIPSEGSPNTITITNGKPGAYITGLLGDTQTSLTA
SQIDSYQNLLNSLSLSVRNGYLEIYVNPTAESLNIQIKIYTPDIPVGDNATTGLTTMITF
KIKQKHFTLPDTEEVYSPDWESTLTHITFGVAAVLGIAALLTAIPETLAVGGAVAFISAF
LALFPSANK
>PK3-2_00729 hypothetical protein
MTLNQQTFKETAKMAETITQYKENDKEILNFLTKQDSIMLNQLKVFFSEPQLTLIHSIKT
VIYGTLVTLFLYFTTNELPHVGSLLARLFFVVVGFIWLASCFKNAKAIQVSQNFKQKSEN
ARIVGMIDFVLEQKYKKSISE
>PK3-2_00730 L-lactate transporter
MKRLHYAWIIVSVTFLILLAVQGVRLSFGAFVEPWEQQFSMDRGTISLISTLSFIVYGIS
QPVIGRLVDKWGARAVLSWSSLLTGVSIFLTYFVTSPWQLFLLYGLGVSLGVGGASNVAA
SVLVVNWFSKKRGLAFGIMEAGFGAGQMLLVPGSLMLIHWFSWKLTVVVLGLLLMVIVFP
AALLMLRNNPSEMNAEPIGGLAEAEKETASKTTALSVTGMFRMKPFWFLMLPFLICGFTT
VGLMDTHLIPFSHDHGFSTTVTSAAVSLLAGFNIAGILLSGIIADRWSSRKILCFLYAVR
ALSIVILIYSHEPYLLLAFAILFGLVDFATVAPTQMLATQYFQNYSIGLMIGWLSLAHQI
GSALGAYVPGVIYTVTGEYTLAFYLSIGMLVLASVMNVMLREPAAVMRDNAAVAEKV
>PK3-2_00731 hypothetical protein
MKQFEKEDLIYKQKSKDDARHHYIYVTETGKTIYKKLEEKANEQVELMLKEIDQKDQHKL
AEAMAEIEAILSQSLSSRISDISIRDYFLSDDLQLLIEKQRQFYAEAHGWDDTFLAYLQE
TFDAEIENIWIAESGGKFAGSVGLVKHDEKTVQLRWFLVDAAFRGRGLGTQLLEHLLAYC
RDMKFERVFLWTVSTMAEARPLYEKFGFTISEVKKEAPLWGQRLTEERWDLELS
>PK3-2_00732 hypothetical protein
MDELDIAFGILPLGIMVLSIVGTCVCKNVYLMPLLSLLVSLVLTFTIFNKSFLGWAVVYS
LVSLALSYITLIVIRKRRASGR
>PK3-2_00733 Glycerol-3-phosphate transporter
MFHIFKPAPHIERLDDSKTDAAYKRLRLQVFIGIFIGYAGYYLLRKNFAFAIPYLQEQGF
SKTELGLVLAAVSIAYGFSKFIMGMVSDRCNPRYFLATGLFLSAIVNILFVSMPWVTSSV
TLMFIFMFINGWFQGMGWPPCGRTMAHWFSISERGTKMSIWNVAHNIGGGILAPLVTLGI
AMFVTWKSVFFFPAIIAIIISFLIVLLVRDTPQSCGLPPIEEYRNDYPKHSFKNQEKELT
TKEILFQYVLNNKFLWYIAFANVFVYFVRYGVVDWAPTYLTEAKGFSPEDSRWSYFLYEY
AGIPGTILCGWISDRFFKSRRAPAGVLFMAGVFIAVLVYWLNPAGHPLVDNIALISIGFL
IYGPVMLIGLQAIDLAPKKAAGTAAGLTGFFGYIGGSAFANAIMGFVVDRFDWNGGFIML
VSSCILAIVFLALTWNTGKRAEHV
>PK3-2_00734 Glycerophosphodiester phosphodiesterase
MRKNRILTLVLLSLGLLSFMVTPVSAASKGNLLSPDRILTVAHRGASGYVPEHTILSYET
AQKMKADYIELDLQMTKDGKLIVMHDEKLDRTTNGTGWVKDYTLADIKKLDAGSWFNEAY
PEKAKPQYAGLKVPTLDEVLDRFGKRANYYIETKSPDTYPGMEEKLIASLQKHKLLGKHA
KHGQVIIQSFSKESLVKVHQLQPNLPTVQLLESKQMASMTDAALEEIKTYAVGAGPDYKA
LNAENVSMIRSHGLLLHPYTVNTEADMRRLLDWGVTGVFTNYPDVFQHVKKDYKKSLES
>PK3-2_00735 hypothetical protein
MLAIDIQTLLFEFLGGLGIFLIGIKFMGDGLQKSAGDRLRNILDRFTSNPLMGVLAGMIV
TVLIQSSSGTTVITVGLVSAGFMTLRQAIGVIMGANIGTTVTAFIIGIDIGAYALPIIAV
GGFLLFFFKHKHVQNAGQIVFGFGALFYGLELMSGGMKPLRSLEAFHDLTVSMSSNPVLG
VVIGTLFTVLVQSSSATIGILQGLFSDGLIDINGALPVLFGDNIGTTITAVLASLGASVA
ARRAAATHVLFNLIGTAIFLILLKPFTALILSLQTSMGLDPKMTIAFAHGIFNTTNTIIQ
LPFVGLLALIVTKLIPGKDSMVEYKSHLDPIFIEQSPSIALGQAKEEVLQMGNFAVQGLE
VTKEFLVTKQTKHAANAYQIEDAVNNLDRKITDYLIELSSSSLSEHESEEHHMLMDTVRD
IERIGDHFENVIELIEYQQAHRVVITESAMADVTEMMDLTISTVKASMDALHHNDVKIAE
QVIEKEDEIDKMERKLRKKHIIRLNEGLCTGQAGIVFVDMISNLERIGDHAVNIAEAVIG
ENQ
>PK3-2_00736 Aspartate-proton symporter
MKYTQYSHGSFIGFIAGWANWIAIVSVIPVEAVASVQYMSSWPWEWAKWTSGLVKNGTLT
GEGLAFASVLLLIYFLLNYWTVNLFSKANSFITIFKIIIPGLTIGALLFVGFHGENFTSG
QSIAPNGWASVLTAVATSGIVFAFNGFQSPINMAGEAKNPGKSIPIAVVGSLFVATVIYV
LLQVAFIGAVNPSDLVHGWSHLNFNSPFADLAIALNINWLVIVLYADAFVSPSGTGITYT
ATTSRMIYGMEKNKYMPSIFGKLHPIYGVPRQAMFFNLIVSFIFLFLFRGWGVLAEIISV
ATLISYITGPITVMTLRRTGKDLYRPLRLKGLNVIAPLGFIFASLVLYWARWPLTGQVLF
IILIGLPIYFYYQAKAKWKGFGQNFKAGVWMVFYLLAMMVISYLGSDKFGGLNVIHYGWD
MVLIAIVSLVFYVWALKSGYQTEYLKDAKEINSQLFNGQSEAAAGKE
>PK3-2_00737 Aspartate-proton symporter
MNQLHRRMGTFSLMMVGLGSMIGSGWLFGAWRAAQIAGPAAIISWIIGMVVILFIALSYS
ELGSMFPEAGGW
>PK3-2_00738 hypothetical protein
MKQKLLLSGLAVSTVGITSYLLKDPSNRQKAREFIHSMKMKMTKQPSMESFPVDKAGHPH
PEDIEDNKMVSEGSMYPVQYYDEKKK
>PK3-2_00739 Fatty-acid peroxygenase
MNEQIPHDKSLDNSLTLMQEGYLFVKNRTERYHSDLFQARLLGKTFICMTGAEAAKLFYD
TERFQRQNALPKRLQKTLFGVNAIQTMDGDAHIHRKMLFLSLMTPPHQKRLAELMTEEWG
AAVTRWEKADQVVLFEEAKEILCRVACYWAGVPLKETEVKERADDFIDMVDAFGAVGPRH
WKGRRARPRAEEWIERMIEDVRAGLLKTPAGTALHEMAFHTQEDGSELDSRMAAIELINV
LRPIVAISYFLAFSALALHQHPKYKEWLRSGSSREREMFVQEVRRYYPFGPFLGALVKKD
FEWNNCEFKKGTSVLLDIYGTNHDPRLWDNPDEFRPERFEEREENPFDLIPQGGGHAEKG
HRCPGEGITIEVMKASLDFLVNQIEYGVPEQSLHYSLARMPSMPESGFVISGISRKR
>PK3-2_00740 putative beta-lactamase YbxI
MNVDDEFKDTDGTFILHDMQKDKTFVYNRERANKRQTPQSTFKAVNALIGLQVKAVRDEY
DVKRRDGVKREFESWNRGHTLGSAMRESAIWYYQAYREISARKE
>PK3-2_00741 putative beta-lactamase YbxI
MVSHSLIRQQGYQRGIDQFWLQSSLTISPLEQEAFLEKLLEEELPFDKSVMKTVKRMMIQ
EEGERYTLYGKT
>PK3-2_00742 hypothetical protein
MGAIERSGYTFQPEFSVVRQNGAIHVYRHGEFVEEIEFEFNGKYPDHDLIEELVNHYCFE
HEI
>PK3-2_00743 Sigma-G-dependent sporulation-specific SASP protein
MDVTLGYLRESLSNHLENEICQRICKKMLAKRYVNEEEFVKDLDDNEMSFLNHVLEKEIK
YAQNEQDQKRAKELNEVYELLL
>PK3-2_00744 putative transport protein YifK
MIFYIGAIFVIVTVYPWDELNSLGSPFVSTFAKIGVTAAAGIINFVVITAAMSGCNSGIF
SAGRMLYTLGVNGQAPKFFTKVSRNGVPLYGTLAVLIGLAVGVVLNYIAPPKIFVYVYSA
SVLPGMIPWFIILISHIGFRKAKGAALDNHPFKMPFAPITNYVTIAFLLMVLVGMWFNDD
TRVSLIVGVIFLALVVISYYVFGIGKRSQANLTKSGQAAE
>PK3-2_00745 putative transport protein YifK
MANKELKRGLGARHIQMIALGGTIGVGLFMGSASTISWTGPSVLLAYAICGIFIFFIMRA
MGEMLYVEPSTGSFATFGHQYIHPLAGYITAWSNWFQWIIVGMSEIIAVGSYMKYWFPDL
PAWIPGIVAMVILGAANLISVKSFGEFEFWFAMIKIVTIILMIIAGIGIIFFGFGNGGDA
IGLSNLWSHGASLQAVSLDSSLRCHLSSRPIKGLS
>PK3-2_00746 hypothetical protein
MRLNRQFIRTQMLAENILKKDAAVKREKTPGNTAAALDKAYSRLESRSANEGINQFNYSK
TSVAGNSGTFSKMYQTANVRTVTDTGAETVIKSTNPYESESDIRIKILDEKYSRINAINK
TKSDPLGYIKDKYQNSKSPYFRSDLSAAERQAAYDNETEWLFKGKAQNYNLQDAAFRNVT
FNGEAEAENAKVYQRSQVNQQLQVLLNRNHIHIPEGTELTFTITPIDYKVRVSGSDDEDL
IKQIEQVLQSGDNSKELFLHIMKSQSSDSTQFSDEAYKKYQAAREMYEVTGCHLKDLEVI
DGRYVTPDGRDLLDVYKEELEKNPVQKETALYAVSHYRSELNKIAEAGYDTIPDFILSID
YSNGSLRDVGQSKSYGTGDTEWLDILKRQTGVNY
>PK3-2_00747 hypothetical protein
MKKWLIPFAIMLSVLFTFTCSASAAGVTAITGNNSFDTAMPIGYWKYKNIDTTILEAGQD
EAYFTFTANKGEKVYVKSTYQSAYTGMKIEIYDKNRAPVSQGTEVISPTTFSSFIYANAD
AQNTTDTFYVKVSRGSYTGNMYFTISIENRIKSGSGTFQFSGVAENKGNTALSPSGSDSS
VIKADLTNQSGIPRDAIVTRVQTTSTQTPSQGNTRHFIMTNENNEWRRALVNSSTSGSYD
ISLSDQLSVAKVWSFKYNTLATARSTMSNVKAKIDYEYDVTKQF
>PK3-2_00748 putative serine/threonine-protein kinase YbdM
MALKQLKKLLFDRPLKDSVILNHQYKIEECLGMGGYGLVYSCTDVHTQTAYVLKQLRPTK
AKKEKERVRFHQEMKLLKSIHHPQIPAFIEDFVIDGQAYYVMQLIEGENIEELLFFRKQP
FTELMALQLLSQLLGIVEYLHDRFIFHSDIRTPNIIINDGRLCLIDFGLAKQLTPEETEE
IKVRKQDDFFDLGETLLFLLYSQYKGKKKKNSTWLEELTLTNEVTLLLKKLLGIDEEYQH
TASIREDVNRAIQSVT
>PK3-2_00749 hypothetical protein
MTDTADTGITAAAGADITEAIAAAQAKEDTTTVMAGVIVTNAGATAAVNPKKVLVPLLGQ
GFFLCDRLNGPIYIFANGSGVLILFINAQ
>PK3-2_00750 hypothetical protein
MKLKTKYQLLLCTAVISVPVLLLAVSILMSVIYENMFKSMNHGTPFHRSFAYPAMLVVFL
LSLLLLAFLFSKSIHSLLHKINLLHHTIRHLASDQKVPDKIEVKRADEIGELIKSVNLLI
ERTTYRELELKQQEEIKKELLQKLRHDINTPLTALRLQLFYLEGQCHEQAVFESLYQQIE
YISKLTNEFNLYSAETLESSYIVNEEVRLNELLETAVKKWDYLYSMNGIELHFKPGDQDV
IWMSNVLWMQRLFDNIFQNTLKHSKAEKMEVAIKDGTVSIRDDGIGFDQNKNSEGLGLQI
IEDICRLLAMTYELQTNESGTRFLFSKE
>PK3-2_00751 Transcriptional activator protein CopR
MKGYHILIVEDDVMIGGLLQKILQREGYHVMWKTDGADVLSVIQRMDLVIMDVMLPGEDG
YQMSAKIKKLGLRIPVIFLSARNDMDSKLQGLKIGEDYMVKPFDPRELLLRMQNMLEHHY
GTFTQIKHLYIDAETKKVFNESLHDEVLFTAIERKIFFYLYENRDSTLTKDHFFEYLWQL
EDRNPNIVNVHIKKIRAKINDQAGEIIENIYGEGYRLNTVVKK
>PK3-2_00752 hypothetical protein
MKTLWKVLKIVFGVLAALILLVSVSVFIYHHYQLNKEAALLKGKGTVVDVDGKKMTVYEE
GSGKDTFVFMSGSGIAAPAYEMKGLYSKFSKENKIAVVDRAGYGYSDVSNDDRDIDTILE
QTRKALMKSGNKPPYILMPHSISGIEAVYWAQKYPKEIKAIIAMDIGLPQQYVTYKLSGI
DRLKVRGFHLLTSIGFHRFMPSAVYNPEVIRQSFLTDKEKEIYKAINFKQFFNADMEHEL
LQSYQNGSKSVNLPAPKETPVLLLDAVSDQNRNSAYAIQNRKDYETFAAQFNTADIKELR
GTHSIYLYQPDQIYKLSMEFMRKVR
>PK3-2_00753 Thioredoxin-like protein SkfH
MKAEQIINEWPSHLPWLNQSQSDLIFPSDSYYLLYFWSMSCPNCHQLTDQVLQDKKGMNV
KVIGVHVPYIEEEKSVEVVSTYALDRGITIPIVLDQNYEIVTTCHVKGIPSFCLLSQYGQ
IVAKTMGDVGWGKMVKKIKGL
>PK3-2_00754 putative protein SkfG
MKSNGDELSLSVQNLANTNEITIVQAIGELKKSGKDAIPVLVEALKEEGSLRNIAAAVLG
EFGEDASEAAEELSCLLKSHSEDTRMAAAISLMRIGKPSLPYVIKIAQKSEGQSCFWASW
CIAWIDPSYIETKMYECLKREHEHPSGMVAPFAAEEALGKLIAFQLKDKED
>PK3-2_00755 Putative bacteriocin-SkfA transport system permease protein SkfF
MPFLIMLLFVGTIGFQVSFVSISAIWDMSFTGWVLTGVFILYTAFGLFSNRLPSQMADIM
WLYGTPTSFSKVVYSVLFFSVTWKALLWFISAILGDVLIVLLFGEHTNLIGRSIIFVGLF
FIAEVWLMSVSCARTVKKMKRVYTSIFLLMLGIYSICLFQLYFLQHSPVLWEGIGRFISG
AGIVFETLSPLYVAVFIGIIAVSFLTISFTSSQVEMKESLVKEAEFWEDFQERQFGSGQF
MQKPKTTWWGLQGLNGIWSFLWLELLLMKKHLFFHSIHTLMIGCVFYVVIFIYPEWFYLL
FFLVVSAVMLSSYYSGIVRHSQSGALHLFPGVLWGKIIILEIMNTVWLFILYCVSIAFMA
VENLVYWYIYGLGIYIWFMTIRLFAFTNTSRNDLKLSFPQYYKSFFMALGMSGICLYVIN
LLTSGWYTLVMVVFIGSLCWCVLYRFR
>PK3-2_00756 SkfA peptide export ATP-binding protein SkfE
MQLMQVQDLSKCYRNGDGIEHLSFSIQRGEIVALLGPNGAGKTTTIRCLTGLYKPDKGNI
LIDGSPPGHVSVQKKVALIPDQPYLYPTLTAAEHIQFRARGFHQGKKGLKERVYYALKEV
HLEEKANELCGQLSRGQKQRVVLAGAIVQDALLYILDEPTVGLDIPSKQWLSNWLKVKTD
QGCAAFVSTHSLEFVLETADRVLLIRDGELMKSLSVPRLKEEQSEWRKEVIRLLGEWSDE
>PK3-2_00757 Sporulation-killing factor biosynthesis protein SkfC
MNSLPIVFWVILAVVALMLFIKFKPPTIASLLLSKEEAKEISIQFIKEFVGIDVENWDFY
SVYWYDHDTVNKLHHLGILKKNRKVLYDVGLVESWRVRFVHQNQSFVVGINANREITFFY
ADVPKKSLSGKFEQVSPEAFKQRLMVSPDGLWSRADMTGTGKKEEDFQEVSTYWYIAEAG
DIRLKMTVELQGGRISYIGTEQEILTDQMSKVIRDEQVESTFGVSGMLGSAVAMVLAILI
LVFMNVQISIITSLVLGLLIIVCQSLTLKEDIQLTIVNAYDARMSVKTVSLLGVLSTLLT
GLLTGFVVFICSMAGNALAGELGWKTFEQPMIQIFYGIGAGIISLGATSLLFNLLEKKHY
LSISPELSNRTVFLSGFTFRQGINMSIQSSVGEEVIYRLLMISVIWWLSGNIIISIIISS
FLWAIMHQVNGYDPRWIRWLHLFVFGCLLGVLFIKFGFVCVLAAHFIHNLVLVCMPLWQY
KLQRHMHPDKPKYTSF
>PK3-2_00758 Sporulation killing factor maturation protein SkfB
MSNDRVKDFDLPELAVHLQPHGAVMIDRKSMFYFRLSGRGAQLAFLLSKNKNLHKTARIW
EIVKKEEMSAEQLKAELSSHPFTEAWTQGLLDQPLHVSGSLDSYLPISCTLQLTNACNLS
CSFCYASSGKPFPQELNSEQWILVMQKLAARGVADITLTGGEAKLIKGFKELVVAASSLF
TNVNIFSNGLNWRDDEVELLSHLGNVSVQISIDGMDDTHDQLRGRKGGFKESMNTIKKLS
EVNIPVIVAMTINESNAGEVSDVVEQCAVAGAFIFRAGKTLSVGRATEGFKALAVDFEEL
VQKQLREARDRWGDCLNIIDWEHEESSFTTDFCTPGYLAWYIRADGYVTPCQLEDLPLGH
ILEDSMADIGSPDRLLQLKCDAKNCKCIGKIELSEPDLPFQKEVKAGIRE
>PK3-2_00759 Sporulation killing factor
MKRNQKDWESVSKKGLIKPGGTSIVKAAGCMGCWASKSIAMTRVCALPHPAMRAI
>PK3-2_00760 Purine efflux pump PbuE
MNISGINGKLLSGVLLIFGIASLVGSKFGGYSTDKWGVPFTLVGGMTLHIVTLILLSFVT
HSYIGVLVILILWSFAAWSTGPTQQFHLATIEPEMSGVLLSMNQSMMQLAMAVGAGIGGV
FVENVSLASITWIGALGVMIAIIASLMIFHSQPKQMLKDINQ
>PK3-2_00761 Purine efflux pump PbuE
MSNTWKIYILAIVSFLVGTSEYIISGILDHIAHTLGVTLAAAGQLITIFSLVYALSTPVL
MALTASMDRRKLMMYALGLFVFGNILAFVLPGYGWFIAARIIMAMGAGVVVVTALTIAAK
IASEGKQGSAIATVVMGFTASLIIGVPLGRMIAVALGWKAVFGSIALLGLIAMAVIFFTL
PHTEGDKPVPLLQQLALFKKRKVAMGLSITFFWLGDILLLIPICHRIS
>PK3-2_00762 hypothetical protein
MICCLQFHFRELVRNKLKRSYAFSKKRIDISEYNDIMIHMEPIEVFKALSNESRLQILQW
LKEPDRHFAPHEGIDMNTIGVCVSQITDKLKMTQSTASQYLTILLRAGLIKAERIGKYTY
YKRDEEAIGKLADFLKTEI
>PK3-2_00763 hypothetical protein
MKKSKGSFESEISKSITQWEKDYLGRGSVSVKTDILRDMIIVNLKGILTPAEYAVCESKE
GMLSVKQTRSELVESGIEELKNIILTITGEEVTSFHTDLSSRTGERVMVFKLVNDLEKNL
>PK3-2_00764 hypothetical protein
MQSNLTDFVTKTIENMSSFDRENMECLQKVTRKAIDLYHLKSYEEVEETHLGSIRFLHIH
SIMEENMLSKLIVISRNGKTDLDIEDVYAGQVVREY
>PK3-2_00765 hypothetical protein
MNVNKKVLFLTDIENGLEPILQEATNTSAENMLTIQSYGASISHPYGEIMRSVIIAIYQE
NVEEVFVVGTKDKRTSKGSGLTQLETMKDKIKTLDYLFQNCRPEFLGGTVDEWLSENSSG
CIEKSVDIIRQHPLVPSYVKVRGLIINHQDGKSPIVEVPSIETASSLA
>PK3-2_00766 hypothetical protein
MGITSVLTKENVKKKDTDIDVQESDINVFIQSASRVIAPLWPISTFAARNPWMGLENQSF
DQVADWLKNTRDVDIYPSASMIRSAKNKGEIDEDFVEMGLQRWLDSHFFNIPRDVAERFC
HAGLKLDPLPSALLSSHKLEKLVNECSGLDPIESFYMQPISSYIENQDGERLVDILDQHV
IKWSKLYLDESQAGWTMPNREEGFYRAWQHLIQYDPALSKQERKRLKDWPQEAHMALQEA
LFALEIPESEIQTYLEGHLLSLPGWAGMMLWRSQQSSHEHALLTEYLAVRISMERALIKP
YLPLNIERSEKRISMTPLLAAWIHWGGLTLEEWSQMPANEQNEYLSFAYRFDEKLRRKLW
LEAWEQTHADQLSQKIISKQRENIGEKSALAQLAFCIDVRSEPFRRQLEKEGPFETIGVA
GFFGVPIATCELGSKHSHASLPIIQKPQHKIKEFADEDALEKYNQRKQAVHSVSYTFKTM
KQNVLASLLLPELSGPWLSLQMAARSFVPRKADRFIRNLRKTWLRKPDTKLSLHHDDDAQ
AEIPVGFTKEEKVSYARQALKMMGLTENFAPLVVICGHGSQSTNNPYSAALDCGACGGAA
GGFNARVLAALCNLSEVREVLLTEGITIPEDTVFAAAEHNTTVDELHWLYVPELSEAAQE
AFERIEAVMPKVRHHVNAERLAQLPNFQSKLKNPKAEAHRFAEDWSEIRPEWGLARNASF
IIGQRELTQDCDLEGRAFLHNYDWKQDESGDLLANIIAGPGTVAQWINLQYYASTVAPHY
YGSGNKATQTVTAGLGVMQGNASDMLAGLPWQSVMQSDHEAYHSPLRLLIVIQAPREYVE
RLLNHDSVFLQKVQNGWVRLASIGPDGCWESW
>PK3-2_00767 NAD(P)H-quinone oxidoreductase subunit 2, chloroplastic
MYQITERILPKGEFEMLFSLSLSSLLTLFFIMLIISGISGLLFLHPRVPLSYVRIHIGIL
ALPLLVSILLLANSNVNGEIGPWHLDSLACLMAFFVLAIGFVIQRFSVRYLMGDQSYRKY
FPLFTFTTGAASITWLSGDLRLMVICWGATLVGLTLLIRLNRAWHVASEAAKVSGRLFLL
SWFSLFFAMIWLFQVTGQWRLSLVLTNESLAQLGIWERTGIHLLIVLAVIIPAAQWPFQR
WLIESIVAPTPVSAIMHAGLVNAGGIILTRFSPLFHGGIASIILLLLAGISVLIGTGISL
VQVDYKRQLVGSTIAQMGFMLIQCALGAYIAAIIHLILHGLFKATLFLQAGSAVQRHEAS
TRVNEGSSYLWIVAGRTLALVIGVAFWLTAPGEGYQFISALILGWSLSVSWTQLVAFGEG
KIGRIVGLTFLGGAALVYFVIHHLFYKWLHTTVLQSVQPPMSAVIIVLCLLLFGGALGTW
VARQRSSVFSAVLYLWLVRLGEAKPKTVESHPDYLKQYLS
>PK3-2_00768 Undecaprenyl-diphosphatase BcrC
MDISEVNISLFRLVNDLGKEHPFLNPLFSFIAEYMVFLLALSVLFIWFTRDTDNRIMILC
ASIAFICAFTIGKVAGAFHSNYQPFVELGEVNKLIHKEKDNSFPSDHTILFFSYCISFWL
FKRGWSILWVLLAVLVGVSRIWVGVHYPFDVLAGVLISLAVSTFIYLTFPKLKVIQTTIK
IYGKCENMLLYRFKRKENKSKNF
>PK3-2_00769 Glutamine--fructose-6-phosphate aminotransferase [isomerizing]
MCGIVGYIGQLDAKEILLKGLEKLEYRGYDSAGIAVANEQGIHVFKEKGRIADLREVVDA
NVEAKAGIGHTRWATHGEPSYLNAHPHQSALGRFTLVHNGVIENYVQLKQEYLQDVELKS
DTDTEVVVQVIEQFVNGGLDTEEAFRKTLTLLKGSYAIALFDNDNRETIFVAKNKSPLLV
GLGDTFNVVASDAMAMLQVTNEYVELMDKEMVIVTDDQVVIKNLDGDVISRASYIAELDA
SDIEKGTYPHYMLKETDEQPVVMRKIIQTYQDENGKLSVPGDIAAAVAEADRIYIIGCGT
SYHAGLVGKQYIEMWANVPVEVHVASEFSYNMPLLSKKPLFIFLSQSGETADSRAVLVQV
KALGHKALTITNVPGSTLSREADYTLLLHAGPEIAVASTKAYTAQIAVLAVLASVAADKN
GIDIGFDLVKELGIAANAMEALCDQKDEMEMIAREYLTVSRNAFFIGRGLDYFVCVEGAL
KLKEISYIQAEGFAGGELKHGTIALIEQGTPVFALATQEHVNLSIRGNVKEVAARGANTC
IISLKGLDDADDRFVLPEVNPALAPLVSVVPLQLIAYYAALHRGCDVDKPRNLAKSVTVE
>PK3-2_00771 Phosphoglucosamine mutase
MGKYFGTDGVRGVANSELTPELAFKVGRFGGYVLTKDKQRPKVLIGRDTRISGHMLEGAL
VAGLLSIGAEVMRLGVISTPGVSYLTKAMDAEAGVMISASHNPVQDNGIKFFGGDGFKLS
DEQEAEIERLMDESEDKLPRPVGADLGLVNDYFEGGQKYLQFLKQTADEDFTGIHVALDC
AHGATSSLATHLFADLDADVSTMGTSPNGLNINDGVGSTHPEALSAFVKEKNADLGLAFD
GDGDRLIAVDEKGNIVDGDQIMYICSKHLKTEGRLKDDTVVSTVMSNLGFYKALEKEGIK
SVQTAVGDRYVVEAMKKDGYNVGGEQSGHLIFLDYNTTGDGLLSAIMLMNTLKATGKPLS
ELAAEMQKFPQLLVNVRVTDKYKVEENEKVKAVISEVEKEMNGDGRILVRPSGTEPLVRV
MAEAKTKELCDEYVNRIVEVVRSEMGLE
>PK3-2_00772 CdaA regulatory protein CdaR
MDKFLNNRWAVKIIALLFALLLYVAVNSNQAPTPKKPGESFFPTSTTDEATLTDIPVKAY
YDDENYVVTGVPQTVNVTIKGSTSAVKKARQTKNFEIYADMENLKTGTHKVELKAKNVSD
GLTISINPSVTTVTIQERTTKSFPVEVEYYNKSKMKKGYSPEQPIVSPKNVQITGSKNVI
DNISLVKASVNLENADETIEKEAKVTVYDKDGNALPVDVEPSVIKITVPVTSPSKKVPFK
IERTGSLPDGVSIANIESSPSEVTVYGSQDVLDSLEFIDGVSLDLSKINKDSDIEAEIPL
PDGVKKISPSKVTLHIEVDSEADQKFENVTIKTVGLSSSQNIEFLDPESQAIDVTAKGSP
ANIKKLKKSDVELYVNVSDLEDGEHSVKLEVNGPQNVTWSLGQKNAKIKLTSKKSNTSTN
DNSSNTSGNQDDTDKQTNDQDNKQQEDTTNTDKNSNDQKQDENKDQNQDQEEDESTADSQ
SSSE
>PK3-2_00773 Cyclic di-AMP synthase CdaA
MAFEDIPFLQYLGNAVDILLVWYVIYKLIMVIRGTKAVQLLKGIVVIVLVRMASQYLGLS
TLQWLMDQAITWGFLAIIIIFQPELRRALEQLGRGRFFSRSGTPVEEAQQKTIEAITKAI
NYMAKRRIGALLTIERDTGMGDYIETGIPLNAKVSSELLINIFIPNTPLHDGAVIMKNNE
IAAAACYLPLSESPFISKELGTRHRAAVGISEVTDSLTIIVSEETGGVSVAKNGDLHREL
TEEALKEMLEAEFKKNTRDTSSNRWYWRGKKNG
>PK3-2_00774 Anti-sigma-W factor RsiW
MSCPEQIVQLMHMHLDGDILPKDEHVLKEHLETCEKCRKHFYEMEKSIALVRSTSHVEAP
ANFTANVMAKLPKEKKRASVKRWFRSHPVIAAAAVFIILMGGGFFNSWHNDHNFSVSKQP
NLVVHNNTVIVPEGETVKGDVTVKNGKLIIKGKIDGDVTVVNGEKYMASAGQVTGQIEEI
NQLFDWTWYKMKSAGKSVLNALDPNEKE
>PK3-2_00775 ECF RNA polymerase sigma factor SigW
MEMMIKKRIKQVKKGDQDAFADIVDIYKDKIYQLCYRMLGNVHEAEDIAQEAFIRAYVNI
DSFDINRKFSTWLYRIATNLTIDRIRKKKPDYYLDAEVAGTEGLTMYSQIAADGVLPEDA
VVSLELSNTIQQKILKLPDKYRTVIVLKYIDELSLIEIGEILNIPVGTVKTRIHRGREAL
RKQLRDL
>PK3-2_00781 hypothetical protein
MILVSSCLGGIECRYNGSHAASEKIRKLVDENKAVMVCPELLGGFSTPREPAEIIGGTGE
DVLNGTAKIVTASGEDVTALYMEGAAKTLAYAKEINASAVILKENSPSCGSGFIYNGTFS
GKKITGSGVTAALLKQAGYRVISENQLDDIL
>PK3-2_00782 hypothetical protein
MTLDISLSFYKPEHLPELQSFTLNNDDKRFTSLPNEVLTQALGMQDRYPVVILKDDLPVG
FFILHTSKETLSPYSNNPFALLLSSLSLNALHQGKGYAKKAMLKLPAFVSGYFPWCDEII
LAVNHLNTRAKHLYMKSGFLDKGRRRIGPLGEQLILHYFLSS
>PK3-2_00783 N-acetylmuramic acid 6-phosphate etherase
MSEPLNLHRLTTESRNSQTAGIHKATTLGILQMINNEDMKVAAAIQQVLPDIKTAVDCAY
DSFQNGGRLIYTGAGTSGRLGVMDAVECPPTYSVSTDQVIGIMAGGPKAFLQAAEGIEDS
EEAGAEDLKNIQLTSNDTVIAIAASGRTPYAAGALTYARKVGAHTIALTSNENSAISKDA
DHSIEVVVGPEAITGSTRMKAATAHKMILNMISTAVMVKIGKVYENLMVDVNVSNIKLKE
RAISIIQSLTNASYETARNTLEQANHHVKTAIVMLKTSTDQEQAKTLLDKANGFIDKAIE
NYQP
>PK3-2_00784 putative HTH-type transcriptional regulator YbbH
MAAGGLAIIQSMKHKLPPSERKLADYILTHPHKAIESTVSEISALANSSDAAVIRLCKSL
GLKGFQDLKMRVAGDLAKPVFQGYRDIAPREPLPSISEKAAGNAIQAIQDTSDLMDYKEL
ERAVSLLLKAHTVHFIGVGASGIVAKDAQQKWLRIHKQATAFTDTHLVASLIANADKDDI
VFAISFSGETQEIIELLTMAKEKGITIISLTQFSQTSVSALADVPLYTAHSNEALIRSAA
TSSRLAQLFMIDVLFLGMAAEQYEETTGYIDKTRAAIQSMRKK
>PK3-2_00785 PTS system EIIBC component
MSKENNYQHLAKKILELCGGKSNISSYTHCMTRLRITPYDESKTDAQALRALDGVLGVVE
AETLQIILGTGVVNHVTAAFSKLVSEEGVDVKEAAAKKKADINRKNATPFKLFLRKIASI
FIPLIPALVASGLITGITKAIIQAGWLSAESQIAIILTVIGSGLFTYLGILVGINASKEF
GGTPALGALAGILIINPEIAKISLFGEQLLPGRGGLIGVLFAAIFIAYTEQFIRRFIPQS
LDIIVTPTVSLLITGIVTYVVFMPLGGFISDAITSGLLSILDIGGIAAGFILGATFLPLV
VTGLHQGLTPVHMELINSIGNDPLLPILAMGGAGQVGAAFAIFAKTKKTTLRKAIAGGLP
SGLLGIGEPLIFGVTLPLGRPFITACLGAGIGGAFQAYFLVATSAIGVSGLPLSFLVLPS
QIILYIVGLFISYAAGFLLTYAFGYKDEMASQFD
>PK3-2_00786 N-acetylmuramyl-L-alanine amidase
MKTKTLFLFSAILTLSILTPNETFAQTADNQIKPKNINAETAQFSPEKLRKVDQMIERDI
AAGFPGAVLVVVKDGRLIKKEAYGYRKKYEGSELLRRPAKMKSRTMFDLASNTKMYATNF
ALQRLVSQGKLDVYEKVSAYLPDFKDQPGELMKGKDKIRVIDVLQHQSGLPSSFYFYTPE
KAGMYYSQERDKTIEYLTKIPLDYQTGTKHVYSDIGYMLLGCIVENLTGKPLDVYAEQEL
YKPLGLKHTLYNPVQKGFKPKQFAATERMGNTRDGVIHFPNIRTDTLQGEVHDEKAFYSM
DGVSGHAGLFSNADDMAILLQVMLNKGSYRSVSLFDKKTADLFTAPSATDPTFALGWRRN
GSKSMEWMFGPYASDNAYGHTGWTGTVTVIDPTYNLGIALLTNKKHSPVADPEENPNVFE
GDQFPTGSYGSVITAIYEAME
>PK3-2_00787 Beta-hexosaminidase
MKPVFPLILSAVLFLSCFLGTSQIKAASSSNSIDTKQLVNRMTLDEKLGQMLMPDFRNWQ
KKSESSPQAFTEMNEEVAGLIKKYQFGGVILFAENVKTTKQTVQLTDAYQKASPKIPLIL
SIDQEGGIVTRLGEGTNFPGNMALGAARNRINAYQTGTIIGKELSALGINTDFSPVVDIN
NNPDNPVIGVRSFSSNRELTARLGLYTMKGLQRQDIASALKHFPGHGDTDVDSHYGLPLV
SHSQERLREVELYPFQRAIDAGADMVMTAHVQFPAFDDTTYKSKLDGSDILVPATLSKKV
MTGLLRQEMGFNGVIVTDALNMKAIADHFGQEEAVVMAIKAGVDIALMPASVTSLKEEQK
FARVIQALKEAVKNGDIPEHQINKSVERIISLKIKRGIYPARSGDSIKEKIAKAQKIAGS
KRHLKAEKKIAEKAVTVLKNEQHTLPFKPKKDSRILIVAPYEEQTASIEQTIRDLIKRKK
IKSVSLSKVNFANQVFNAEHEKLVKEADYIITGSYVVKNDPAVNDGVIDDTISDSSKWAT
VFPRAVMKAALQHNKPFVLMSLRNPYDAANFEEAKALIAVYGFKGYANGRYLQPNIPAGV
RAIFGQAKPKGTLPVDIPSVTKPGDILYPYGYGLNIKTGKPL
>PK3-2_00788 hypothetical protein
MRKTIYAFLTGLMMFGTITAASASPDSRNQTAKKPKVQTGIDTLYPDFKKRLKGKRIGLI
TNPTGVNASLKSSVDILYENPDIKLTALFGPEHGVRGDAQAGDEVGSYIDEKTGIPVYSL
YGKTKKPTPEMLKNVDVLMFDIQDVGTRYYTYIYTMAYAMEAAKENGIPFMVLDRPNPQG
GKHFEGPVLEPEYASFVGLYPIPLKHGMTIGELALLFNKEFDINVDLIVVKMKHWKRKMD
FDDTKLPFVLPSPNMPTLESTFVYPATGLIEGTNISEGRGTTKPFELIGAPFIKSTELEE
ALNGLNLPGVTFRAASFTPTFSKHQGTLCHGVQLYVTDREKFEAVKTGLSIIKTIHDLYP
EDFEFLSTGSFDKLAGNGWLKTKIQNGASIEDIIDNYEKPLQQFSKTRKNISSIKT
>PK3-2_00789 HTH-type transcriptional activator Btr
MQHTVIYHPIQIEYLKKTSDLFSEQQLASSFVLIFHLKGHGHISIGTRVSPLQKKTLYVC
PPHETFGFTPAAEGHIDTCLIRLQSYIKENGHDVLTPCTETELARLKLVNVSHIENLAVR
LQELAALWNESSQLTQLKCAIEVQSLIYDLFTASFSEQTGTHSAIEKTKQYIETHADTKM
TLTQLSQMAGISAKHYSESFKKWTGQSVTEFITKTRITRAKRLMARSNCKLKEIAHQTGY
QDEFYFSRIFKKHTGCSPTSYMKKRRKKIAAYGRGTMGHLIPLHHIPYAAALHPKWTSYY
YQHYSTDIPVQLSAYRFNEKWEENLHTLSQAEPDVIFSMDSISPEEQNQLNRIAEVMYLP
SKESWRTHFLQTASFLKEEAEAEKWLAAYDQQTEAAKKTLQYAQGLRFLFLRLHKQNFYL
AHNRSVREVFFGDLGFCSANTADMPSEHAISLENIANYQADCIMLFLFKEPETIAYYQQL
QQTEEWQSLSAVRNHRVYLLSFDPWNEYSACGHERIIQQTVSLLSGDCP
>PK3-2_00790 Iron-uptake system-binding protein
MKKISLTLLILLLALTAAACGSKNESSASKASGTASEKKKIEYLDKTYEVTVPTDKIAIT
GSVESMEDAKLLDVHPQGAISFSGKFPDMFKDITDKAQSTGEKMEPNIEKILEMKPDVIL
ASTKFPEKTLQKISTAGTTIPVSHISSNWKENMMLLAQLTGKEKKAKKIIADYEQDLKET
KTKINEKAKDSKALVIRIRQGNIYIYPEQVYFNSTLYGDLGLKAPDEVKAAKAQELISLE
KLSEMNPDHIFVQFSDDENADKPDALKDLEKNPIWKSLKAVKEDHVYVNSVDPLAQGGTA
WSKVRFLKAAAEKLTQN
>PK3-2_00791 Iron-uptake system permease protein FeuB
MYSKQWTRIILITSPFAIALSLLLSILYGAKHLSADVVFTSLIHFDPGNTDHQIIWHSRI
PRAAGALLIGAALAVSGALMQGITRNYLASPSIMGVSDGSAFIITLCMVLLPQSSSIEMI
IYSFIGSALGAVLVFTLAAMMPNGFTPVQLAIIGTVTSMLLSSLSAAMSIYFQISQDLSF
WYSARLHQMSPDFLKLAAPFFLIGIVMAISLSKKVTAVSLGDDISKSLGQKKKTIKIMAM
LSVIILTGSAVALAGKIAFVGLVVPHITRFLVGSDYSRLIPCSCILGGIFLTLCDLASRF
INYPFETPIEVVTSIIGVPFFLYLIKRKGGEQNG
>PK3-2_00792 Iron-uptake system permease protein FeuC
MAKKYAVCIALILVVSYLSLTSGSFSVRPAELLSTLFQIDPNPQYEILLFDLRLPRVVMA
AIIGLGLGIAGAVIQAITRNGLADPGILGINAGAGAGIVAFMLLFQGQKEVTSIVAAMGM
PFFGLIGGLIAAILIYIFAWHRGNLDSGRIILVGIAINSGFSALSLFLSLKMDPQDYQMA
MVWKNGSIWSANWTYITAVLPWMLLFIPILIAKSRLLDTIRFDEDTVRSLGISSNKEKTI
LLVACVAIISACVSVAGSMAFVGLIAPHIARRLAGVEHRFILPLSGLIGMLLVISADFAG
KLFFQPAEVPAGIILAILGVPYFLYLLFKQKKGENA
>PK3-2_00793 putative protein YbbA
MIGSLSEHKAGKRRFTLYLPPSYSQNTGRFPAVYVQDGSSLFHDQIELLESKFQQQILPE
LVLIGIKPDNRLDEYTPWPAASLSDRFPDFGGLGYHYLSDITNRFIPFIEVNWNVTREPQ
TRAMIGASLGGLISMFALLKYPSVFGKIGSISGSYWYDNAVETIHLSSLKPGTARIFMSV
GSEEGREKQSIQRDMLRNTKQVHQSLKEKGFTEDYLCLSIEKGAVHQRKHFCKQFITALE
WLYGKNRSIQ
>PK3-2_00794 Pantothenate precursors transporter PanS
MMLQKLNRVLGRVMPLLTPTSVVLGVLLSQFLNGYESAVPWIFAFITFAGSLSANFQSLR
HALSHPLPMILALFVLHIFMPLFAWGSGHLIFKGDPLTITGLTLAVVIPTGITSLIWAAM
YKGNVGLTLSIILVDTVLSPLIVPLSLSLLAGAQVHMDVWGMMKGLIVMVVIPSFLGMLF
NQMSSPERTAAVSSALSPFSKLCLMAVIAINSSAIAPYFKAVDLRFIGIAVTVFFIALTG
YAAAWLIGKMMKRRQEEIVSLIFTGGMRNISAGAVLAVTFFPSQVAVPVVIGMLFQQILA
ALFGYMLNRFELKPVLQKA
>PK3-2_00795 Bicarbonate transporter BicA
MNNSFTLKQQWFGNIRKDILAGILVALALIPEAIGFSIIAGVDPMVGLYASFCIAIIISI
FGGRPGMISAATGSMAVVMVSLVADYGLQYLFAATILTGIIQVILGISKIARLMKFIPRS
VMIGFVNALAILIFSAQLPQFEGASWGMYAMLAGSLVIIYVLPRFTTAVPSPLVAIIVMT
IIAVTFHVDVRTVGDMGNISSSLPHFLIPDVPFTFETLQIIFPYSIALAFVGLLESLLTA
QIIDEMTDTDSDKNKESRGQGIANIVTGFFGGMAGCAMIGQSVINTKAGGRGRLSAFVAG
AFLMFLIAVLSHVVVKIPMAALVAVMVMVSVGTFDWSSLKGLKKAPITDSIVMVVTVITV
VVTDDLSKGVFVGFLLSAVFFVAKISKLKIVSHAEDQKLRTYQVKGQIFFASVTDLTNAF
IYQEDIERVVIDLTEAHVWDDSGAAALDKIVAKFKEQGIEAELKGLNNASKNLMKQMA
>PK3-2_00796 putative zinc-type alcohol dehydrogenase-like protein YjmD
MKALVWTPNNRLEMQEVEEPQIKKMNDVKVRIYGTGICGTDLNVLKGKMHATHNMILGHE
SVGVVTETGPEVTNVKPGDRVVIDPTQFCGKCYYCRKGLTCYCETFEDWQLGLGAHGTFA
DYYVGEDRFMYKIPDDMEWERATLIEPLSCVLNVIERAAIKPEDSVLILGSGPIGLLVQM
MVKKLSRLTVATEVGEYRSEAARRISDYVYHPQDLTADEVRRINQGRTFDVIFDAIGNQL
DWAYPLINKGGRLVPMGFDDTYEMKIRPFQLLSNGVTIVGTGEARQIMEDAVSCAADMPQ
LSELITEKTPLENYEAAIQELMGIDPLSDDRKDITAVKTILISHPEMM
>PK3-2_00797 hypothetical protein
MLEYVKSKKESVAFYTEDGGLKVFGENPQYILIVDPIDGTRPAAAGLEMSCISIALAAYK
PDAKIKDIEFAFLLELKTGAYMYGDVYSEGIYYEGYRGTLPNLSKVTDIKHMFWSLEFNG
HPANLMTDAYGHLIDQSANNGGVFVFNSASYSISRIITGQMDAYVDIGNRLLKDDPALLK
DFQDVGNGQVLHLFPYDIAASVFLAKKAGVVITDAYGKSLDDTLLTDLSYNNQQSCIAAS
TKELHQKLLDQIRWDRKEETYESVGLDS
>PK3-2_00798 hypothetical protein
MKEYIIELGKFVYEEVKGQKGTLKNRLVNGYSPGEMHSLTLMPLLRTQCWNM
>PK3-2_00799 Isoleucine 2-epimerase
MGTKEITNPDSLYYKVDDVVMERGEGIYLYDSEGNEYIDCASATFNLNLGYTNKEVIDTV
KEQADQLIHVTSSYQTNAVNKLAEKLVEISPDNLTKVHPKVSSGSAANEGAIKMAQNYSG
KTDVISLFRSHLGQTYMMSALSGNSFRREPFPPQFSFGLQVPDPYCNRCFYNQKPDSCGM
LCVERINDFIEYASNGKIAAMIIEPISGNGGNIVPPKEYFKQLRKLCDEHDIALIFDEIQ
TGFGRTGKMFAADYFDVKPNLMTVAKGLGGTGFQVAATLTEEKYTGLAGHNHSFTYGSNV
MASAAACKTIEIMQRPGFLENVTIVGNYIMDSLEHMKKEFTFIADVRGVGLMIGVEIVKE
NNEPDVELTNYIAKRAMDYGLILRTSRYGFGNVFKIRPPLTITLSEAEVLCFKLRKLLED
IK
>PK3-2_00800 Glucose/mannose transporter GlcP
MKTRLLWIGCFSYGSIAFTLVILGAVLPELLSHYAQSYSNGGVLVFSQFMGFLIGVLGMP
YAVKKLGRRKVVVIGLAMISCELFIYFLPPWPLLFVLVSMAGLGAGLVESCVGTIILTAI
KERQAIAMSKMEVAYGLGALFMPLLSGFLISNNVWALAFLVLGLSSFLLMLVWSRMSFGR
LDDLLIRQTGTLGHGKQQAPISFRKHGLLFISLAAAYFFFYGGSEVSIVHFIPSIFAEKW
EISNSLATITVTIYWIGMIIGRLLTGPVSEKLTYHRYLRLINIGGLISLCILAISKTAIA
GFVLCFFLGLFMAGMFAIALIITNQFYPGKTEQTTSMLLAANGLGGSILPIAVGWSLDEF
PIQTAFWLFTTLMLIMLGIVLVLKVLENLKSRKLDNMDTEESKSAQI
>PK3-2_00816 hypothetical protein
MNHFYVWHIKRVKQFIIILIAAFAAASFFYIQRAVPLPVFSTDTGPKAIYKGETDSKDIA
LTFDISWGDEKAEPILDTLKANGIKNATFFLSASWAERHPDTVARIVKDGHQIGSMGYAY
KNYANLESSEIKKDINRAQTAFEKLGIKDIQLLRPPTGQFNKNVLTVAKQYNYTVVHYSV
NSQDWTNPGVEKIIDNATKQVSGGDIILLHASDSAKQTEEALPDIIHQLKEKGLKNVTVG
DLIANSDAKSSEVK
>PK3-2_00817 hypothetical protein
MKSRGLVRFFFSILAVGAIITSIVGFALKWGEYKGLFLAFEAGQIFSVLFWFIGVGMIFS
VISQMGFFVFLTVHRFALEILRSSSLWNLLQLFFILFVAFDLMYVRFLFFGESGESMAGY
AWLPVFLLIFGVITAYIKQKQSSKKTFMSSLFLMVVITALEWFPALRVNNEDWLYLMLFP
LMACNAFQLLMLPKFAAK
>PK3-2_00818 Spore germination protein GerD
MSKAKTLLMSCFLLLSVTACAPKDQAADMDYDQTKKMVVDILKTDDGKKAIKELLNDDAM
NEALVIDQDAIKGTIEKTLTSKKGEEFWKNIFEDTDFAEGFAKTLQTEHEKVIKKLMKDP
DYQKMLMGVMQDPGMNKKYSELAKSQEFRSYLEEVINETLSSPLYKKQFEDELKKAAKDT
AKESE
>PK3-2_00819 Iron-sulfur cluster carrier protein
MIREDEVRKLVGEMREPFLQRPLGELDAVKEIKIKPEKRHVSVKVALAKTGTAEQMQIQQ
EIVNVLKGAGAETVGLRFEELPEETVAKFRAPSAEKKTLLNMDNPPVFLAVASGKGGVGK
STVSVNLAISLARLGKKVGLIDADIYGFSVPDMMGITVRPTIEGEKLLPVERFGVKVMSM
GFFVEENAPVVWRGPMLGKMLNNFFHEVEWGEVDYIVLDLPPGTGDVALDVHTMLPSCKE
IIVSTPHPTAAFVAARAGSMAIKTAHEVVGVIENMAYYESAKTGEREYVFGKGGGDKLAE
ELNVPLLGRIPLKQPDWDKDQFAPSVYDENHPIGEIYQDIAKELVAKMSVQV
>PK3-2_00820 Germination-specific N-acetylmuramoyl-L-alanine amidase
MRKKLKWLSFLLGFIVLLFLFKYQFSNNDSWKPWSLPLSGKIIYLDPGHGGPDGGAVGGK
MLEKDVTLEVAFRVRDYLQEQGALVIMTRESDTDLAPEGTKGYSRRKAEDLRQRVKLINH
SEAELYISIHLNAIPSQKWSGAQSFYYGKYAENEKVAKYIQDELRRNLENTTRKAKRIHG
IYLMQNVTKPGALVEVGFLSNPSEAKLLGKPKYQDKVASSIYKGILRYFTEKGDPPE
>PK3-2_00821 hypothetical protein
MAEVLSFMDVKRQKDFELEKNLLKELSLRQIIQSVKDCLEPLFPFLHDERDIISEGCIDF
AIEAYLLGGRFGIFGYYGESMQSISARSAREEEELRMEFFDYLYNWIHEQYATFDKNTVY
EAARKFIKDWWTAGFVQREKQCKLRMR
>PK3-2_00822 hypothetical protein
MNALKHNSKAWDQKVETGNEWTVAVEQHVIEQAKKGNWDIRVTPMKDVPKDWFPPVKGLK
VLCLASGGGQQGPVLAAAGADVTVLDNSEKQLNQDKMVAERDGLTIHTVKGSMDDLSQFK
DESFDVIVHPVANVFVENVLPVWKEAHRVLKRNGALISGFVNPVVFLFDVELEQQGVLKV
KHSIPYADSEDLPKHKVKKLIENNEALEFGHSLEDQIKGQIDAGFIVTGFYEDKGGFVLD
QYIHTYSATRSVKL
>PK3-2_00823 30S ribosomal protein S9
MAQVQYYGTGRRKSSVARVRLVPGEGRIVVNNREISEHIPSAALIEDIKQPLTLTETAGT
YDVLVNVHGGGLSGQSGAIRHGIARALLEADPEYRTTLKRAGLLTRDARMKERKKYGLKG
ARRAPQFSKR
>PK3-2_00824 50S ribosomal protein L13
MRTTPMANASTIERKWLVVDAAGKTLGRLSTEVASILRGKHKPTYTPHVDTGDHVIIINA
EKIELTGKKLTDKIYYRHTQHPGGLKSRTALEMRTNYPEKMLELAIKGMLPKGSLGRQMF
KKLNVYRGSEHPHEAQKPEVYELRG
>PK3-2_00826 tRNA pseudouridine synthase A
MRLKCTISYDGHLFNGYQVQPGKRTVQDELEKALAVLHKSKDRIPVVSSGRTDSGVHAAG
QVIHFDSPLSIPAERWPYALNALLPDDIAVKQAEIADDGFHARFSAVKKEYRYFVYTEKH
PDVFKRHYAYHFSYHLNVQNMREAAKHLIGTHDFTSFCAAKTEVQDKVRTIYELDWTETD
DGLQMRITGSGFLYNMVRIIAGTLLDAGIGKIFPDDVKSMLEAKDREAAGRTAPGHGLYL
WNVYYDN
>PK3-2_00827 Energy-coupling factor transporter transmembrane protein EcfT
MMDSMIIGKYVPSSSLVHRLDPRTKLITIFLFVCIVFLANNVQTYALLGLFTVGVVSLTR
VPFSFLMKGLKPIIWIVLFTFILHILMTHEGPVIFQLGVFKVYEGGLVQGIFISLRFVYL
ILITTLLTLTTTPIEITDGMEQLLNPFKKLKLPVHELALMMSISLRFIPTLMEETDKIMK
AQMARGVDFTSGPVKDRVKAIVPLLVPLFVSAFKRAEELAVAMEARGYQGGEGRTKYRKL
VWTGKDSSVIVSLMILAALLFFLRT
>PK3-2_00828 Energy-coupling factor transporter ATP-binding protein EcfA2
MDITIKDVEHRYQMKTPFERLALYDINASIKEGSYVAVIGHTGSGKSTLLQHLNGLLKPT
KGQISLGSTVIQAGKKNKELKALRKKVGIVFQFPEHQLFEESVLKDISFGPMNFGVKKED
AEQKAREMLQLVGLSEELLDRSPFELSGGQMRRVAIAGVLAMDPEVLVLDEPTAGLDPRG
RKEIMDMFYKLHQRGNLTTILVTHSMEDAAAYADEMIVMHKGTIQASGSPRDLFLQGEDM
AGWGLDLPETIKFQRQLEAALGVRFKGPMLTIEDAAAEIRALFQGEKTL
>PK3-2_00829 Energy-coupling factor transporter ATP-binding protein EcfA1
MNQNQLISVEDIVFRYRKDAEGRALDGVSLQVYEGEWLAIVGHNGSGKSTLARALNGLIL
PESGDIKVAGIQLTEESVWEVRKKIGMVFQNPDNQFVGTTVRDDVAFGLENNGVPREEMI
ERVDWAVKQVNMQDFLDQEPHHLSGGQKQRVAIAGVIAARPDIIILDEATSMLDPIGREE
VLETVRHLKEQGMATVISITHDLNEAAKADRIIVMNGGKKYAEGPPEEIFKLNKELVQIG
LDLPFSFQLSQLLRKNGLALEENHLTQEGLVKELWTLQSKM
>PK3-2_00830 50S ribosomal protein L17
MSYRKLGRTSAQRKAMLRDLTTDLIINERIETTETRAKELRSVVEKMITLGKRGDLHARR
QAAAYIRNEVANEENNQDALQKLFSDIATRYEERQGGYTRIMKLGPRRGDGAPMAIIELV
>PK3-2_00831 DNA-directed RNA polymerase subunit alpha
MIEIEKPKIETVEISDDAKFGKFVVEPLERGYGTTLGNSLRRILLSSLPGAAVTSIQIDG
VLHEFSTIEGVVEDVTTIILHIKKLALKIYSDEEKTLEIDVQGEGTVTAADITHDSDVEI
LNPDLHIATLGENASFRVRLTAQRGRGYTPADTNKRDDQPIGVIPIDSIYTPVSRVSYQV
ENTRVGQVANYDKLTLDVWTDGSTGPKEAIALGSKILTEHLNIFVGLTDEAQHAEIMVEK
EEDQKEKVLEMTIEELDLSVRSYNCLKRAGINTVQELANKTEEDMMKVRNLGRKSLEEVK
AKLEELGLGLRKDD
>PK3-2_00832 30S ribosomal protein S11
MAAARKSNTRKRRVKKNIESGIAHIRSTFNNTIVTITDTHGNAISWSSAGALGFRGSRKS
TPFAAQMAAETAAKGSIEHGLKTLEVTVKGPGSGREAAIRALQAAGLEVTAIRDVTPVPH
NGCRPPKRRRV
>PK3-2_00833 30S ribosomal protein S13
MARIAGVDIPRDKRVVISLTYIFGIGRTTAQQVLKEAGVSEDTRVRDLTEEELGKIRDII
DKLKVEGDLRREVSLNIKRLIEIGSYRGIRHRRGLPVRGQNSKNNARTRKGPRRTVANKK
K
>PK3-2_00834 50S ribosomal protein L36
MKVRPSVKPICEKCKVIRRKGKVMVICENPKHKQKQG
>PK3-2_00835 Translation initiation factor IF-1
MAKDDVIEVEGTIVETLPNAMFKVELENGHTVLAHVSGKIRMHFIRILPGDKVTVELSPY
DLTRGRITYRYK
>PK3-2_00836 Methionine aminopeptidase 1
MIICKTPRELGIMREAGRIVALTHEELKKHIKPGISTKELDQIAERFIKKQGAIPSFKGY
NGFRGSICVSVNEELVHGIPGSRVLTDGDIISIDIGAKLNGYHGDSAWTYPVGNISDDDK
KLLEVTEESLYKGLQEAKPGERLSNISHAIQTYVENEQFSVVREYVGHGVGQDLHEDPQI
PHYGPPNKGPRLKPGMVLAIEPMVNAGSRYVKTLADNWTVVTVDGKKCAHFEHTIAITET
GFDILTRV
>PK3-2_00837 Adenylate kinase
MNLVLMGLPGAGKGTQGERIVEDYGIPHISTGDMFRAAMKEETPLGLEAKSYIDKGELVP
DEVTIGIVKERLGKDDCERGFLLDGFPRTVAQAEALEEILEEYGKPIDYVINIEVDKDAL
MERLTGRRICSVCGTTYHLVFNPPKTPGVCDKDGGELYQRADDNEETVSKRLEVNMKQTQ
PLLDFYSEKGYLANVNGQQDIQDVYADVKDLLGGLKK
>PK3-2_00838 Protein translocase subunit SecY
MFKTISNFMRVSDIRNKIIFTLLMLIVFRIGAFIPVPYVNAEALQAQSQMGVFDLLNTFG
GGALYQFSIFAMGITPYITASIIIQLLQMDVVPKFTEWSKQGEVGRRKLAQFTRYFTIVL
GFIQALGMSYGFNNLANGMLIEKSGVSTYLIIALVLTGGTAFLMWLGEQITSHGVGNGIS
IIIFAGIVASIPKTIGQIFETQFVGSNDQLFIHIVKVALLVIAILAVIVGVIFIQQAVRK
IAIQYAKGTGRSPAGGGQSTHLPLKVNPAGVIPVIFAVAFLITPRTIASFFGTNDVTKWI
QNYFDNTHPVGMAIYVALIIAFTYFYAFVQVNPEQMADNLKKQGGYIPGVRPGKMTQDRI
TSILYRLTFVGSIFLAVISILPIFFIQFAGLPQSAQIGGTSLLIVVGVALETMKQLESQL
VKRNYRGFMKN
>PK3-2_00839 50S ribosomal protein L15
MKLHELKPSEGSRKTRNRVGRGIGSGNGKTAGKGHKGQNARSGGGVRPGFEGGQMPLFQR
LPKRGFTNINRKEYTVVNLDKLNGFAEGTEVTPELLLETGVISKLNAGVKILGNGKLEKK
LTVKANKFSASAKEAVEAAGGTAEVI
>PK3-2_00840 50S ribosomal protein L30
MAKLEITLKRSVIGRPEDQRVTVRTLGLKKTNQTVVHEDNAAIRGMINKVSHLVSVKEQ
>PK3-2_00841 30S ribosomal protein S5
MIMRRIDPSKLELEERLVTVNRVAKVVKGGRRFRFAALVVVGDKNGHVGFGTGKAQEVPE
AIRKAVEDAKKNLIEVPMVGTTIPHEIIGRFGAGNILLKPASEGTGVIAGGPVRAVLELA
GVADILSKSLGSNTPINMIRATLQGLSELKRAEDVAKLRGKSVEELLG
>PK3-2_00842 50S ribosomal protein L18
MITKTSKNAARLKRHARVRAKLSGTAERPRLNVFRSNKHIYAQIIDDVNGVTLASASTLD
KDLNVESTGDASAATKVGELVAKRAAEKGVSDVVFDRGGYLYHGRVKALADAAREAGLKF
>PK3-2_00843 50S ribosomal protein L6
MSRVGKKLLEIPSDVTVTLNDNNTVAVKGPKGELTRTFHPDMEIKVEDNVLTVARPSDQK
EHRALHGTTRSLLGNMVEGVSKGFERGLELVGVGYRASKSGNKLVLNVGYSHPVEIVPEE
GIEIEVPSQTKVVVKGTDKERVGAIAANIRAVRSPEPYKGKGIRYEGEVVRRKEGKSAK
>PK3-2_00844 30S ribosomal protein S8
MVMTDPIADMLTRIRNANMVRHEKLEIPASKLKREIAEILKREGFIRDVEFVEDSKQGII
RVFLKYGQNNERVITGLKRISKPGLRVYAKSNEVPRVLNGLGIAIISTSQGVLTDKEARA
KQAGGEVLAYVW
>PK3-2_00845 30S ribosomal protein S14
MAKKSMIAKQQRTPKFKVQEYTRCERCGRPHSVIRKFKLCRICFRELAYKGQIPGVKKAS
W
>PK3-2_00846 50S ribosomal protein L5
MNRLKEKYNKEIAPALMTKFNYDSVMQVPKIEKIVINMGVGDAVQNAKAIDSAVEELTFI
AGQKPVVTRAKKSIAGFRLREGMPIGAKVTLRGERMYDFLDKLISVSLPRVRDFRGVSKK
SFDGRGNYTLGIKEQLIFPEIDYDKVTKVRGMDIVIVTTANTDEEARELLTQVGMPFQK
>PK3-2_00847 50S ribosomal protein L24
MHVKKGDKVMVISGKDKGKQGTILAAFPKKDRVLVEGVNMVKKHSKPTQANPQGGISNQE
APIHVSNVMPLDPKTGEVTRVGYKVEDGKKVRVAKKSGQVLDK
>PK3-2_00848 50S ribosomal protein L14
MIQQETRLKVADNSGAREVLTIKVLGGSGRKTANIGDVIVCTVKQATPGGVVKKGEVVKA
VIVRTKSGARRSDGSYISFDENACVIIRDDKSPRGTRIFGPVARELRENNFMKIVSLAPE
VI
>PK3-2_00849 30S ribosomal protein S17
MSERNQRKVYQGRVVSDKMDKTITVVVETYKKHSLYGKRVKYSKKFKAHDENNQAKIGDI
VKIMETRPLSATKRFRLVEVVEEAVII
>PK3-2_00850 50S ribosomal protein L29
MKANEIRDLTTAEIEQKVKSLKEELFNLRFQLATGQLENTARIREVRKAIARMKTVIRER
EIAANK
>PK3-2_00851 50S ribosomal protein L16
MLLPKRVKYRREHRGKMRGRAKGGTEVHFGEFGIQALEASWITNRQIEAARIAMTRYMKR
GGKVWIKIFPSKPYTAKPLEVRMGSGKGAPEGWVAVVKPGKVLFEISGVSEEVAREALRL
ASHKLPIKTKFVKREEIGGESNES
>PK3-2_00852 30S ribosomal protein S3
MGQKVNPVGLRIGVIRDWESKWYAGKDYADFLHEDLKIREYISKRLSDASVSKVEIERAA
NRVNITIHTAKPGMVIGKGGSEVEALRKALNSLTGKRVHINILEIKRADLDAQLVADNIA
RQLENRVSFRRAQKQQIQRTMRAGAQGVKTMVSGRLGGADIARSEYYSEGTVPLHTLRAD
IDYATSEADTTYGKLGVKVWIYRGEVLPTKKKTEEGGK
>PK3-2_00853 50S ribosomal protein L22
MQAKAVARTVRIAPRKARLVMDLIRGKQVGEAVSILNLTPRAASPIIEKVLKSAIANAEH
NYEMDANNLVISQAFVDEGPTLKRFRPRAMGRASQINKRTSHITIVVSEKKEG
>PK3-2_00854 30S ribosomal protein S19
MARSLKKGPFVDGHLMTKIEKLNETDKKQVVKTWSRRSTIFPQFIGHTIAVYDGRKHVPV
FISEDMVGHKLGEFAPTRTYKGHASDDKKTRR
>PK3-2_00855 50S ribosomal protein L2
MAIKKYKPTSNGRRGMTTSDFAEITTDKPEKSLLAPLHKKGGRNNQGKLTVRHQGGGHKR
QYRVIDFKRDKDGIPGRVATVEYDPNRSANIALINYADGEKRYILAPKGIQVGTEIMSGP
EADIKVGNALPLINIPVGTVVHNIELKPGKGGQLVRSAGTSAQVLGKEGKYVLVRLNSGE
VRMILSACRASIGQVGNEQHELINIGKAGRSRWKGIRPTVRGSVMNPNDHPHGGGEGRAP
IGRKSPMSPWGKPTLGFKTRKKKNKSDKFIVRRRKNK
>PK3-2_00856 50S ribosomal protein L23
MKDPRDVLKRPVITERSADLMAEKKYTFEVDVRANKTEVKDAVESIFGVKVDKVNIMNYK
GKSKRVGRYTGMTSRRRKAIVKLTADSKEIEIFEA
>PK3-2_00857 50S ribosomal protein L4
MPKVALYNQNGSTAGDIELNASVFGIEPNESVVFDAILMQRASLRQGSHKVKNRSEVRGG
GRKPWRQKGTGRARQGSIRSPQWRGGGVVFGPTPRSYSYKLPKKVRRLAIKSVLSSKVND
NNVIVLEDLTLDTAKTKEMAAILKGLSVEKKALIVTADANEAVALSARNIPGVTVVEANG
INVLDVVNHEKLLITKAAVEKVEEVLA
>PK3-2_00858 50S ribosomal protein L3
MTKGILGRKIGMTQVFAENGDLIPVTVIEAAPNVVLQKKSTENDGYEAIQLGFDDKREKL
SNKPEKGHVAKAETAPKRFVKELRGVEMDAYEVGQEVKVEIFSAGEIVDVTGVSKGKGFQ
GAIKRHGQSRGPMSHGSRYHRRPGSMGPVDPNRVFKGKLLPGRMGGEQITVQNLEIVKVD
AERNLLLIKGNVPGPKKTLITVKSAVKSK
>PK3-2_00859 30S ribosomal protein S10
MAKQKIRIRLKAYDHRILDQSAEKIVETAKRSGASVSGPIPLPTEKSVYTILRAVHKYKD
SREQFEMRTHKRLIDIVNPTPQTVDALMRLDLPSGVDIEIKL
>PK3-2_00860 Putative aminoacrylate hydrolase RutD
MIPEKKRSIAIMKELSIDNTKQMLMINGTNTKNPLLLFLHGGPGTPQIGYVRHYQKELEE
HFTVVHWDQRGSGLSYSKRISHHSMTISHFVNDAIQVTQWLLDHFSKTKLYLAGHSWGSL
LALHVLRQRPGLFYAYYGISQVVNPHLEESAAYQYIREISDRKRASIRSSLIRFIGAPPW
KKGIQHLIYRFCVEMGRGGLTHHHHQFLAVLFQMLTGHEYGIRNMHKFLNGLRFSKKHLT
KELYQFNAFASVPSIKVPCFFISGKHDLIVPSEISKQYYQALEAPEKFWFQFENSAHNPH
IEEPSLFASTLSNHALYHL
>PK3-2_00861 Elongation factor Tu
MAKEKFDRSKSHANIGTIGHVDHGKTTLTAAITTVLHKKSGKGTAMAYDQIDGAPEERER
GITISTAHVEYETETRHYAHVDCPGHADYVKNMITGAAQMDGAILVVSAADGPMPQTREH
ILLSKNVGVPYIVVFLNKCDMVDDEELLELVEMEVRDLLSEYDFPGDDVPVIKGSALKAL
EGDAEYEAKIFELMDAVDEYIPTPERDTEKPFMMPVEDVFSITGRGTVATGRVERGQVKV
GDEVEIIGLQEENKKTTVTGVEMFRKLLDYAEAGDNIGALLRGVAREDIQRGQVLAKPGT
ITPHSKFKAEVYVLSKEEGGRHTPFFSNYRPQFYFRTTDVTGIIHLPEGVEMVMPGDNTE
MNVELISTIAIEEGTRFSIREGGRTVGSGVVSTITE
>PK3-2_00862 Elongation factor G
MAREFSLDKTRNIGIMAHIDAGKTTTTERILFYTGRIHKIGETHEGASQMDWMEQEQERG
ITITSAATTAQWKGYRVNIIDTPGHVDFTVEVERSLRVLDGAVAVLDAQSGVEPQTETVW
RQATTYGVPRIVFVNKMDKIGADFLYSVGTLRDRLQANAHAIQLPIGAEDNFEGIIDLVE
NVAYFYEDDLGTRSDAKEIPEEYKEQAEELRNSLIEAVCELDEELMDKYLEGEEITIDEL
KAGIRKGTLNVEFYPVLVGSAFKNKGVQLVLDAVLDYLPGPTDVAAIKGTRPDTNEEIER
HSSDDEPFSALAFKVMTDPYVGKLTFFRVYSGTLDSGSYVKNSTKGKRERVGRILQMHAN
SREEIATVYAGDIAAAVGLKDTTTGDTLCDEKDLVILESMEFPEPVIDVAIEPKSKADQD
KMGIALAKLAEEDPTFRTQTNPETGQTIISGMGELHLDIIVDRMKREFKVEANVGAPQVA
YRETFRSGAKVEGKFVRQSGGRGQFGHVWIEFEPNEEGAGFEFENAIVGGVVPREYIPAV
QAGLEDSLENGVLAGFPLIDIKAKLFDGSYHDVDSNEMAFKIAASMALKNAVSKCNPVLL
EPIMKVEVVIPEEYMGDIMGDVTSRRGRVEGMEARGNAQVVRAMVPLAEMFGYATALRSN
TQGRGTFTMHMDHYEEVPKSIAEEIIKKNKGE
>PK3-2_00863 30S ribosomal protein S7
MPRKGPVAKRDVLPDPIYNSKLVSRLINKMMIDGKKGKSQTILYKSFDIIKERTGNDAME
VFEQALKNIMPVLEVKARRVGGANYQVPVEVRPERRTTLGLRWLVNYARLRGEKTMEERL
ANEILDAANNTGAAVKKREDTHKMAEANKAFAHYRW
>PK3-2_00864 30S ribosomal protein S12
MPTINQLIRKGRVSKVENSKSPALNKGYNSFKKEHTNVSSPQKRGVCTRVGTMTPKKPNS
ALRKYARVRLTNGIEVTAYIPGIGHNLQEHSVVLIRGGRVKDLPGVRYHIVRGALDTAGV
ENRAQGRSKYGTKKPKAK
>PK3-2_00865 Ribosome-associated protein L7Ae-like protein
MSYDKVSQAKSIIIGTKQTVKALKRGSVKEVVVAKDADPILTSSVVSLAEDQGISVSMVE
SMKKLGKACGIEVGAAAVAIIL
>PK3-2_00866 DNA-directed RNA polymerase subunit beta'
MLDVNNFEYMNIGLASPDKIRSWSFGEVKKPETINYRTLKPEKDGLFCERIFGPTKDWEC
HCGKYKRVRYKGVVCDRCGVEVTRAKVRRERMGHIELAAPVSHIWYFKGIPSRMGLVLDM
SPRALEEVIYFASYVVTDPANTPLEKKQLLSEKEYRAYLDKYGNKFQASMGAEAIHKLLQ
DIDLVKEVDMLKEELKTSQGQRRTRAIKRLEVLEAFRNSGNKPSWMILDVLPVIPPELRP
MVQLDGGRFATSDLNDLYRRVINRNNRLKRLLDLGAPSIIVQNEKRMLQEAVDALIDNGR
RGRPVTGPGNRPLKSLSHMLKGKQGRFRQNLLGKRVDYSGRSVIVVGPHLKMYQCGLPKE
MALELFKPFVMKELVEKGLAHNIKSAKRKIERVQPEVWDVLESVIKEHPVLLNRAPTLHR
LGIQAFEPTLVEGRAIRLHPLVCTAYNADFDGDQMAVHVPLSAEAQAEARILMLAAQNIL
NPKDGKPVVTPSQDMVLGNYYLTLERAGAVGEGMVFKNTDEALLAYQNGYVHLHTRVAVA
ANSLKNVTFTEEQRSKLLITTVGKLVFNEILPESFPYMNEPTKSNIEEKTPDRFFLEKGA
DVKAVIEKQPINAPFKKGILGKIIAEIFKRFHITETSKMLDRMKNLGFRYSTKAGITVGV
SDIVVLDDKQEILEEAQSKVDNVMKQFRRGLITEEERYERVISIWSSAKDVIQGKLMKSL
DELNPIYMMSDSGARGNASNFTQLAGMRGLMANPAGRIIELPIKSSFREGLTVLEYFIST
HGARKGLADTALKTADSGYLTRRLVDVAQDVIIRETDCGTDRGILAKPLKEGTETIERLE
ERLIGRFARKQVKHPETGEVLVNENELIDEDKALEIVEAGIEEVWIRSAFTCNTPHGVCK
RCYGRNLATGSDVEVGEAVGIIAAQSIGEPGTQLTMRTFHTGGVAGDDITQGLPRIQELF
EARNPKGQATITEIDGTVVEINEVRDKQQEVVVQGAVETRSYTAPYNSRLKVAEGDKITR
GQVLTEGSIDPKELLKVTDLTTVQEYLLHEVQKVYRMQGVEIGDKHVEVMVRQMLRKVRV
IDAGDTDVLPGTLLDIHQFTEANKKVLLEGNRPATGRPVLLGITKASLETDSFLSAASFQ
ETTRVLTDAAIKGKRDELLGLKENVIIGKLVPAGTGMMKYRKVKPVSNVQPTEDMVPVE
>PK3-2_00867 DNA-directed RNA polymerase subunit beta
MTGQLVQYGRHRQRRSYARISEVLELPNLIEIQTSSYQWFLDEGLREMFQDISPIEDFTG
NLSLEFIDYSLGEPKYPVEESKERDVTYSAPLRVKVRLINKETGEVKDQDVFMGDFPIMT
DTGTFIINGAERVIVSQLVRSPSVYFSGKVDKNGKKGFTATVIPNRGAWLEYETDAKDVV
YVRIDRTRKLPVTVLLRALGFGSDQEILDLVGENEYLRNTLDKDNTENSDKALLEIYERL
RPGEPPTVENAKSLLDSRFFDPKRYDLANVGRYKINKKLHIKNRLFNQRLAETLVDPETG
EILAEKGQILDRRTLDKVLPYLENGIGFRKLYPNGGVVEDEVTLQSIKIYAPTDQEGEQV
INVIGNAYIEEEIKNITPADIISSISYFFNLLHGVGDTDDIDHLGNRRLRSVGELLQNQF
RIGLSRMERVVRERMSIQDTNTITPQQLINIRPVIASIKEFFGSSQLSQFMDQTNPLAEL
THKRRLSALGPGGLTRERAGMEVRDVHYSHYGRMCPIETPEGPNIGLINSLSSYAKVNRF
GFIETPYRRVDPETGKVTGRIDYLTADEEDNYVVAQANARLDDEGAFIDDSIVARFRGEN
TVVSRNRVDYMDVSPKQVVSAATACIPFLENDDSNRALMGANMQRQAVPLMQPEAPFVGT
GMEYVSGKDSGAAVICKHPGIVERVEAKNVWVRRYEEVDGQKVKGNLDKYSMLKFVRSNQ
GTCYNQRPIVSVGDEVVKGEILADGPSMELGELALGRNVMVGFMTWDGYNYEDAIIMSER
LVKDDVYTSIHIEEYESEARDTKLGPEEITRDIPNVGEDALRNLDDRGIIRIGAEVKDGD
LLVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRVPHGGGGIIHDVKVFNREDGDE
LPPGVNQLVRVYIVQKRKISEGDKMAGRHGNKGVISKILPEEDMPYLPDGTPIDIMLNPL
GVPSRMNIGQVLELHMGMAARYLGIHIASPVFDGAREEDVWETLEEAGMSRDAKTVLYDG
RTGEPFDNRVSVGIMYMIKLAHMVDDKLHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEV
WALEAYGAAYTLQEILTVKSDDVVGRVKTYEAIVKGDNVPEPGVPESFKVLIKELQSLGM
DVKILSGDEEEIEMRDLEDEEDAKQADGLALSGDEEPEETASADVERDVVTKE
>PK3-2_00868 Ribosomal RNA large subunit methyltransferase G
MSEHYYSEKPSVKSNKQTWSFRLRNKDFTFTSDSGVFSKKEVDFGSRLLIDSFEEPEVEG
SFLDVGCGYGPIGLSLASDFKDRTIHMIDVNERAVELSNENAEHNGITNVKIYQSDLFSN
VNSAQTFASILTNPPIRAGKKVVHAIFEKSAEHLKASGELWIVIQKKQGAPSAIEKLEEL
FDEVSVVQKKKGYYIIKAKKV
>PK3-2_00869 50S ribosomal protein L7/L12
MALNIEEIIASVKEATVLELNDLVKAIEEEFGVTAAAPVAVAGGAAAGGAAEEQSEFDLI
LAGAGSQKIKVIKVVREITGLGLKEAKELVDNTPKPLKEGIAKEEAEELKAKLEEVGASV
EVK
>PK3-2_00870 50S ribosomal protein L10
MSSAIETKKVVVEEIASKLKESKSTIIVDYRGLNVSEVTELRKQLREANVEFKVYKNTMT
RRAVEQAELNGLNDFLTGPNAIAFSTEDVVAPAKVLNDFAKNHEALEIKAGVIEGKVSTV
EEVKALAELPSREGLLSMLLSVLQAPVRNFALATKAVAEQKEEQGA
>PK3-2_00872 50S ribosomal protein L1
MAKKGKKYVEAAKLVDRSKAYDVSEAVALVKKTNTAKFDATVEVAFRLGVDPRKNDQQIR
GAVVLPNGTGKTQRVLVFAKGEKAKEAEAAGADFVGDTDYINKIQQGWFDFDVIVATPDM
MGEVGKIGRVLGPKGLMPNPKTGTVTFEVEKAIGEIKAGKVEYRVDKAGNIHVPIGKVSF
EDEKLVENFTTMYDTILKAKPAAAKGVYVKNVAVTSTMGPGVKVDSSTFNVK
>PK3-2_00873 50S ribosomal protein L11
MAKKVVKVVKLQIPAGKANPAPPVGPALGQAGVNIMGFCKEFNARTADQAGLIIPVEISV
YEDRSFTFITKTPPAAVLLKKAAGIESGSGEPNRNKVATVKRDKVREIAETKMPDLNAAD
VEAAMRMVEGTARSMGIVIED
>PK3-2_00874 Transcription termination/antitermination protein NusG
MEKNWYVVHTYSGYENKVKANLEKRVESMGMQDKIFRVVVPEEEETDIKNGKKKVVKKKV
FPGYVLVEIVMTDDSWYVVRNTPGVTGFVGSAGSGSKPTALLPGEAETILKRMGMDERKT
DIDFELKETVKVIDGPFANFTGSIEEIDYDKSKVKVFVNMFGRETPVELEFTQIDKL
>PK3-2_00875 Protein translocase subunit SecE
MRIMRFFKDVGKEMKKVSWPKGKELTRYTITVIATVIFFVIFFALLDTGISQLIRLIVE
>PK3-2_00876 RNA polymerase sigma-H factor
MNLQNNKGKFNKEQFCQLEDEQVIEKVHVGDSDALDYLITKYRNFVRAKARSYFLIGADR
EDIVQEGMIGLYKSIRDFKEDKLTSFKAFAELCITRQIITAIKTATRQKHIPLNSYVSLD
KPIFDEESDRTLLDVISGAKTLNPEEMIINQEEFDDIEMKMGELLSDLERKVLVLYLDGR
SYQEISDELNRHVKSIDNALQRVKRKLEKYLEIREISL
>PK3-2_00877 putative protein YacP
MDILLVDGYNMIGAWPQLKDLKANSFEEARDVLIQKMAEYQSYTGNRVIVVFDAHLVKGL
EKKQTNHRVEVIFTKENETADERIEKLAQALNNIATQIHVATSDYTEQWAIFGQGALRKS
ARELLREVEAIERRIERRVRKITSEKPAGKIALSEEVLKTFEKWRRGDLD
>PK3-2_00878 Putative TrmH family tRNA/rRNA methyltransferase
MSQQHDYVIGKNAVIETLKSDRKLYKLWMAENTVKGQAQQVIELAKKQGITIQYVPRKKL
DQMVTGQHQGVVAQVAAYEYAELDDLYKAAEERNEQPFFLILDELEDPHNLGSIMRTADA
VGAHGIVIPKRRAVGLTTTVAKASTGAIEHIPVVKVTNLARTLEEMKERGIWVVGTDASA
REDYRNMDGNMPLALVIGSEGKGMGRLVKEKCDFLIKLPMAGKVTSLNASVAAGLLMYEV
YRKRNPLGE
>PK3-2_00879 Mini-ribonuclease 3
MLDFETIKDSKQLNGLALAYIGDAIFEVYVRHHLLKQGFTKPNDLHKKSSRIVSAKSQAE
ILFFLQDQSFFTEEEEAVLKRGRNAKSGTTPKNTDVQTYRYSTAFEALLGYLFLEKKEER
LSQLVAEAIQFGTSGRKTNESAT
>PK3-2_00880 Cysteine--tRNA ligase
MTITLYNTLTRQKETFVPLEEGKVKMYVCGPTVYNYIHIGNARPAIVYDTVRNYLEYKGY
DVQYVSNFTDVDDKLIKAANEIGEDVPTISERFIKAYFEDVGALGCRKADLHPRVMENMD
AIIEFVDQLVKKGYAYESEGDVYFKTRAFEGYGKLSQQSIDELRSGTRIRVGEKKEDALD
FALWKAAKEGEISWDSPWGKGRPGWHIECSAMVKKYLGDQIDIHAGGQDLTFPHHENEIA
QSEALTGKTFAKYWLHNGYINIDNEKMSKSLGNFVLVHDIIKQHDPQLLRFFMLSVHYRH
PINYSEELLENTKSAFNRLKTAYSNLQHRLNSSTNLTEDDDQWLEKVEEHRKAFEEAMDD
DFNTANAISVLFDLAKHANYYLQKDHTADHVITAFIEMFDRIVSVLGFSLGEQELLDQEI
EDLIEKRNEARRNRDFALSDQIRDQLKSMNIILEDTAQGTRWKRGE
>PK3-2_00881 Serine acetyltransferase
MFFRMLKEDIDTVFDQDPAARSYFEVILTYSGLHAIWAHRIAHALYKRKFYFLARLISQV
SRFFTGIEIHPGATIGRRFFIDHGMGVVIGETCEIGNNVTVFQGVTLGGTGKEKGKRHPT
IKDDALIATGAKVLGSITVGEGSKIGAGSVVLHDVPDFSTVVGIPGRVVVQNGKKVRRDL
NHQDLPDPVADRFKSLEHQILELKAELEDRKERINQK
>PK3-2_00883 Glutamate--tRNA ligase
MGNEVRVRYAPSPTGHLHIGNARTALFNYLFARNQGGKFIIRVEDTDKKRNIEGGEQSQL
NYLKWLGIDWDESVDVGGEYGPYRQSERNDIYKVYYEELLEKGLAYKCYCTEEELEKERE
EQIARGEMPRYSGKHRDLTQEEQEKFIAEGRKPSIRFRVPEGKVIAFNDIVKGEISFESD
GIGDFVIVKKDGTPTYNFAVAIDDYLMKMTHVLRGEDHISNTPKQIMIYQAFGWDIPQFG
HMTLIVNESRKKLSKRDESIIQFIEQYKELGYLPEALFNFIGLLGWSPVGEEELFTKEQF
IEIFDVNRLSKSPALFDMHKLKWVNNQYVKKLDLDQVVELTLPHLQKAGKVSTELSAEKQ
EWVRKLISLYHEQLSYGAEIVELTDLFFTDEIEYNQEAKAVLAEEQVPEVLSTFAAKLEE
LEEFTPDNIKASIKAVQKETGHKGKKLFMPIRVAVTGQTHGPELPQSIELIGKETAIQRL
KNI
>PK3-2_00884 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase
MFRIGQGFDVHQLVEGRPLIIGGIEIPYEKGLLGHSDADVLLHTVADACLGAVGEGDIGK
HFPDTDPEFKDADSFKLLQHVWGIVKQKGYVLGNIDCTIIAQKPKMLPYIEDMRKRIAEG
LEADVSQVNVKATTTEKLGFTGRAEGIAAQATVLIQKG
>PK3-2_00885 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase
MSYDVVIPAAGQGKRMKAGRNKLFIELKGDPVIIHTLRVFDSHRPCEKIILVINEREREH
FQQLLSDYPLHTAIELVAGGDERQHSVYKGLKAVKQEKIVLVHDGARPFIKHEQIDELIA
EAEQAGAAILAVPVKDTIKRVNHLQVSETIERSSLWAVQTPQAFRLSLLMKAHAEAEHKG
FLGTDDASLVEQMEGGSVRVVEGSYTNIKLTTPDDLTSAEAIMESESGNKHV
>PK3-2_00886 putative PIN and TRAM-domain containing protein YacL
MLKRIVQAFFIIFGGVVGIFLIPELFVLLNIQDIPLITNAYTSAAIGAIIFFLISIWGTE
YVVNWVKWIEDSLLKAPVPDLLFGSLGLVFGLIIAYLIVNVIPLDNIPYRIFSTIIPVFL
AFFLGYLGFQVGFKKKDELISLFSISAKMQKKKGTADEELEVQDKKLKILDTSVIIDGRI
ADICQTGFLEGVIVIPQFVLEELQHIADSSDVLKRNRGRRGLDILNRIQKELDIEVEIYE
GDFEDIQEVDSKLVKLAKLTSGVVVTNDFNLNKVCELQKVAVLNINDLANAVKPVVLPGE
EMNVQVIKDGKEHNQGVAYLDDGTMIVVEEGRNYIGKHIDVLVTSVLQTAAGRMIFAKPK
LLEKAL
>PK3-2_00887 DNA integrity scanning protein DisA
MEKEKKGAKHELDLSSILQFVAPGTPLRAGIENVLRANTGGLIVVGYNDKVKEVVDGGFH
INTSFSPAHLYELAKMDGAIILSDSGQKILYANTQLMPEATISSSETGMRHRTAERVAKQ
TGCLVIAISERRNVITLYQESMKYTLKDIGFILTKANQAIQTLEKYKTILDKTINALNAL
EFEELVTFSDVLSVMHRYEMVLRIKNEINMYIRELGTEGHLIKLQVIELITDMEEEAALF
IKDYVKEKIKDPFVLLKELQDMSSYDLLDDSIVYKLLGYPASTNLDDYVLPRGYRLLNKI
PRLPMPIVENVVEAFGVLPRIIEASAEELDEVEGIGEVRAQKIKKGLKRLQEKHYLDRQL
>PK3-2_00888 DNA repair protein RadA
MYASLSYQEIEQGRGLTLYMAKTKSKFICQSCGYESPKWMGKCPGCGAWNTMVEEMIKKA
PANRRAAFSHSVQTVQKPSPITSIETSEEPRVKTQLGEFNRVLGGGVVKGSLVLIGGDPG
IGKSTLLLQVSAQLSGSSNSVLYISGEESVKQTKLRADRLGINNPSLHVLSETDMEYISS
AIEEMNPAFVVVDSIQTVYQSDITSAPGSVSQVRECTAELMKIAKTKGIPIFIVGHVTKE
GSIAGPRLLEHMVDTVLYFEGERHHTFRILRAVKNRFGSTNEMGIFEMREEGLTEVLNPS
EIFLEERSAGSAGSSITASMEGTRPILVEIQALISPTSFGNPRRMATGIDHNRVSLLMAV
LEKRVGLLLQNQDAYLKVAGGVKLDEPAIDLAIAISIASSFRDTPPNPADCFIGEVGLTG
EVRRVSRIEQRVKEAAKLGFKRMIIPGANLDGWTKPKGIEVIGVANVAEALRTSLGG
>PK3-2_00889 Negative regulator of genetic competence ClpC/MecB
MMFGRFTERAQKVLALAQEEALRLGHNNIGTEHILLGLVREGEGIAAKALQALGLGSDKI
QKEVESLIGRGQEMSQTIHYTPRAKKVIELSMDEARKLGHSYVGTEHILLGLIREGEGVA
ARVLNNLGVSLNKARQQVLQLLGSNETGSSAAGTNSNANTPTLDSLARDLTAIAKEDSLD
PVIGRSKEIQRVIEVLSRRTKNNPVLIGEPGVGKTAIAEGLAQQIINNEVPEILRDKRVM
TLDMGTVVAGTKYRGEFEDRLKKVMDEIRQAGNIILFIDELHTLIGAGGAEGAIDASNIL
KPSLARGELQCIGATTLDEYRKYIEKDAALERRFQPIQVDQPSADESIQILKGLRDRYEA
HHRVSITDDAIEAAVKLSDRYISDRFLPDKAIDLIDEAGSKVRLRSFTTPPNLKELEQKL
DEVRKEKDAAVQSQEFEKAASLRDTEQRLREQVEDTKKSWKEKQGQENSEVTVDDIAMVV
SSWTGVPVSKIAQTETDKLLNMESILHSRVIGQDEAVVAVAKAVRRARAGLKDPKRPIGS
FIFLGPTGVGKTELARALAESIFGDEEAMIRIDMSEYMEKHSTSRLVGSPPGYVGYDEGG
QLTEKVRRKPYSVVLLDEIEKAHPDVFNILLQVLEDGRLTDSKGRTVDFRNTILIMTSNV
GASELKRNKYVGFNVQDETQNHKDMKDKVMGELKRAFRPEFINRIDEIIVFHSLEKKHLT
EIVSLMSDQLTKRLKEQDLSIELTDAAKAKVAEEGVDLEYGARPLRRAIQKHVEDRLSEE
LLRGNIHKGQHIVLDVEDGKFVVKTTAKTN
>PK3-2_00890 Protein-arginine kinase
MSLKHFIQDALSSWMKQKGPESDIVLSSRIRLARNFEHIRFPTRYSNEEASSIIQQFEDQ
FSDQEIPGIGKFVLIRMNDAQPLEKRVLVEKHLISPNLTESPFGGCLLSENEEVSVMLNE
EDHIRIQCLFPGFQLLEAMKAANQVDDWIEEKVDYAFHEQRGYLTSCPTNVGTGLRASVM
MHLPALVLTRQINRIIPAINQLGLVVRGIYGEGSEAVGNIFQISNQITLGKSEQDIVDDL
NSVAAQLIEQERSAREALYQTSKIELEDKVYRSYGVLSNCRMIESKETAKCLSDVRLGID
LGIIKGLSSNILNELMILTQPGFLQQYSGGALRPNERDIRRAALIRERLHLEMNGKRQED
ESI
>PK3-2_00891 Protein-arginine kinase activator protein
MFSHSEQISACPKCGMTFQQFRKIGRFGCSECYKTFHSNITPILRKVHSGNTVHAGKIPK
RIGGNLHVRRQIDMLKKELESLIHQEEFENAAHVRDQIRSLEQSLKSTDSEEEQG
>PK3-2_00892 Transcriptional regulator CtsR
MGHNISDIIEQYLKRVLDQNGKEILEIKRSEIADKFQCVPSQINYVINTRFTSERGYIVE
SKRGGGGYIRIIKIKMNNEVVLINNIISQINTYLSQAASDDIILRLLEDKVISEREAKMM
ISVMDRSVLHIDLPERDELRARMMKAMLTSLKLK
>PK3-2_00908 Lysine--tRNA ligase
MSQEEHNHEELNDQLQVRRDKMNQLRDNGIDPFGARFERTHQSQEVISAYQDLTKEELEE
KAIEVTIAGRMMTKRGKGKAGFAHLQDLEGQIQIYVRKDSVGDDQYEIFKSSDLGDLIGV
TGKVFKTNVGELSVKATSFELLTKALRPLPDKYHGLKDVEQRYRQRYLDLIVNPDSKHTF
ITRSKIIQAMRRYLDDHGYLEVETPTMHSIPGGASARPFITHHNALDIPLYMRIAIELHL
KRLIVGGLEKVYEIGRVFRNEGVSTRHNPEFTMIELYEAYADYKDIMSLTENLVAHIAQE
VLGTTTIQYGEEQIDLKPEWKRIHMVDAVKEATGVNFWEEVTVEQAREYAKEHGVEIKDS
MTVGHIINEFFEQKIEETLIQPTFIYGHPVEISPLAKKNPEDPRFTDRFELFIVGREHAN
AFTELNDPIDQRERFEDQLKEREAGNDEAHLMDEDFVEALEYGMPPTGGLGIGIDRLVML
LTNAPSIRDVLLFPQMRQR
>PK3-2_00909 tRNA-dihydrouridine synthase B
MFKIGDIQLKNRVVLAPMAGVCNSAFRLTVKEFGAGLVCAEMVSDKAILYNNAKTMGMLY
IDEREKPLSLQIFGGKKENLVEAAKFVDQNTTADIIDINMGCPVPKITKCDAGAKWLLDP
DKIYEMVSAVVEAVDKPVTVKMRMGWDEDHIFAVRNAQAVERAGGKAVALHGRTRVQMYE
GTANWDIIKEVKQSVSIPVIGNGDVKTPQDAKRMLEETGVDGVMIGRAALGNPWMIYRTV
QYLETGELKEEPQVREKMAVCKLHLDRLINLKGENVAVREMRKHAAWYLKGVKGNAKVRN
EINHCETREEFVQLLDAFTVEVEAKELQDAKVG
>PK3-2_00910 hypothetical protein
MEAEIWGRRIRAFRKLKGYTQEGFAKALGISVSILGEIERGNRLPSAAIIQNAADVLNIS
ADELAPPEK
>PK3-2_00911 hypothetical protein
MNNIAYIALGSNIGDKEAYLRQAVALLHQHDAVTVTKVSSIYETDPVGYENQDEFLNMAV
EIKTSLNPFELLELTQHIENELGRTREVRWGPRTADLDILLFNRENIETEQLIVPHPRMY
ERLFVLVPLAEICPQVEKEAKNAETDQEGVRVWKQKSGVDEFVHSES
>PK3-2_00912 Dihydroneopterin aldolase
MDKVYVEGMEFYGYHGVFKEENKLGQRFKVDLTAELDLSKAGQTDDLEQTINYAELYHVC
KDIVEGEPVKLVETLAERIADTVLKKFQPVQQCTVKVIKPDPPIPGHYKSVAIEVTRKKS
>PK3-2_00913 Dihydropteroate synthase
MAQQTIDQTQVIHTKPSALSYKEKTLVMGILNVTPDSFSDGGKYDSLDKALLHAKEMIDD
GAHIIDIGGESTRPGAEYVSEDEEMSRVIPVIERITKELGVPISVDTYKASVADEAVKAG
ASIINDIWGAKHDPKMASVAAEHNVPIVLMHNRPERNYNDLLPDMLSDLMESVKIAVEAG
VEEKNIILDPGIGFAKTYHDNLAVMNKLEILSGLGYPVLLATSRKRFIGRVLDLPPEERA
EGTGATVCLGIQKGCAIVRVHDVKQISRMAKMMDAMLNKGGVHHG
>PK3-2_00914 D-alanine aminotransferase
MIYVNGRYIEEKDAVLSPFDHGFLYGIGVFETFRLYEGCPFLLDWHIERLKRALEDLQIE
YTVSKHEILEMLDKLLWLNDIKDGNARVRLDISAGISDKGFVAQTYDKPTVLCFVNQLKS
ESLPSQKEGKVLSLRRNTPEGPFRLKSHHYLNNMYAKREIGNDPRVEGIFLTEDGAVAEG
IVSNVFWRKGSCIYTPSLDTGILDGVTRRFVMENAKNIGLELKTGRYGLEALLAADEAWM
TNSVLEIIPFTKIEEVNYAGRRGEAASALQALYKKEIKNMIHEKGGREWRSKR
>PK3-2_00915 Aminodeoxychorismate/anthranilate synthase component 2
MIDNYDSFTYNLVQYLGELGEELIVKRNDDITIEEIEELSPDFLMISPGPCSPDEAGISL
EAIKHFAGKIPIFGVCLGHQSIAQVFGGDVVRAERLMHGKTSDIKHDGKTIFEGLKNPLV
ATRYHSLIVKPETLPSCFTVTAQTKEGEIMAIRHNDLPIEGVQFHPESIMTSFGKEMLRN
FIETYRKEVIA
>PK3-2_00916 Aminodeoxychorismate synthase component 1
MAQRRPAGKKVPFQKDSFLQQFEKLAQSRKQHVLLESARGGRYSIAGLDPIATVKGKDGI
TTIKHGDEMLFKEGDPLRAFHSWFTTLETETDHELPDFQGGAIGFLSYDYARYIENFKML
SLDDLETPDIYFLVFDDIAVYDHHEESLWLITHVNGSDHETADVKLSELERMWLTELPAV
SSREMKHETDRSFAAPFTEDGFSQAVEKIKQYIASGDVFQVNLSIRQSQSLSGRPYQIYK
TLREVNPSPYMAYLETPDFQIICGSPELLVSKKGKLLETRPIAGTRSRGKTDEEDEALAN
ELIHNEKERAEHVMLVDLERNDLGRVSRYGSVSVNEFMAIEKYSHVMHIVSNVQGELQDG
YDAVDIIHAVFPGGTITGAPKVRTMEIIEELEPTRRGLYTGSIGWFGYNHDLQFNIVIRT
IYATGGQAFMQSGAGVVIDSVPKHEYRESFKKAFAMQKALELSKEETDKN
>PK3-2_00917 Cysteine synthase
MVRVANSITELIGNTPIVKLNRLADENSADVYLKLEYMNPGSSVKDRIGLAMIEAAEKEG
KLKAGDTIIEPTSGNTGIGLAMVAAAKGLKAILVMPDTMSMERRNLLRAYGAELVLTPGA
EGMKGAIQKAEELAEKHGYFVPQQFNNPSNPEIHRQTTGKEIVEQFGDDQLDAFVAGIGT
GGTITGAGEVLKEAYPSIKIYAVEPSDSPVLAGGKPGPHKIQGIGAGFVPDILNTEVYDE
IFPVKNEEAFEYARRAAREEGILGGISSGAAIYAALQVAKKLGKGKKVLAIIPSNGERYL
STPLYQFD
>PK3-2_00918 Foldase protein PrsA 2
MTREEWLKEMEDQYGKSTLEDMINVRVVEELAKKNNLKVSKSEIEREFLLIKAVNNSFYE
DGRTTEKEWKDQIRYNILLEELLTRDIDISNKELKSFYNKNKELYQFDDSYRLRHIVVKD
EEEAREVLKELKGGSSFEAVAAERSTDRYTSPYGGDLGFVTEASDNIPSAYIEEAKTLKE
DEWSDEPIKVSNGYAVIQLKEKLKARTFSYDEVKDQIRRQIAMDQLGDKATVKTLWKEAD
VSWFYGEKSTK
>PK3-2_00919 33 kDa chaperonin
MDYLVKALAFDGKVRAYAARTTDMVNEGQRRHGTWPTASAALGRTMTASLMLGAMLKGDD
KLTVKVEGGGPIGAIVADANAKGEVRAYVSNPQVHFDLNEQGKLDVRRAVGTSGTLSVVK
DLGLREFFTGQVEIVSGELGDDFTYYLVSSEQVPSSVGVGVLVNPDNTILAAGGFIIQLM
PGTDDETITKIEQRLSQVEPISKLIQKGLTPEEILEEVLGEKPEILETMPVRFHCPCSKE
RFETAILGLGKKEIQDMIEEDGQAEAVCHFCNEKYLFTKEELEGLRDQTTR
>PK3-2_00920 Type III pantothenate kinase
MLLVIDVGNTNTVLGVYHDGKLEYHWRIETSRHKTEDEFGMILRSLFEHSGLMFEQIDGI
IISSVVPPIMFALERMCTKYFHIEPQIVGPGMKTGLNIKYDNPKEVGADRIVNAVAAIHL
YGNPLIVVDFGTATTYCYIDENKQYMGGAIAPGITISTEALYSRAAKLPRIEITRPDNII
GKNTVSAMQSGILFGYVGQVEGIVKRMKWQAKQEPKVIATGGLAPLIANESDCIDIVDPF
LTLKGLELIYERNRVGSV
>PK3-2_00921 ATP-dependent zinc metalloprotease FtsH
MNRVFRNTIFYLLILLVVIGVVSYFQTSNPKTENMSYSTFIKNLDDGKVDSVSVQPVRGV
YEVKGQLKNYDKDQYFLTHVPEGMGADQIFNALKKTDVKVEPAQETSGWVTFLTTIIPFV
IIFILFFFLLNQAQGGGSRVMNFGKSKAKLYTEEKKRVKFKDVAGADEEKQELVEVVDFL
KDPRKFAELGARIPKGVLLVGPPGTGKTLLAKACAGEAGVPFFSISGSDFVEMFVGVGAS
RVRDLFENAKKNAPCLIFIDEIDAVGRQRGAGLGGGHDEREQTLNQLLVEMDGFSANEGI
IIIAATNRADILDPALLRPGRFDRQITVDRPDVIGREAVLKVHARNKPLDETVNLKSIAM
RTPGFSGADLENLLNEAALVAARQNKKKIDARDIDEATDRVIAGPAKKSRVISKKERNIV
AYHEGGHTVIGLVLDEADMVHKVTIVPRGQAGGYAVMLPREDRYFQTKPELLDKIVGLLG
GRVAEEIIFGEVSTGAHNDFQRATNIARRMVTEFGMSEKLGPLQFGQSQGGQVFLGRDFN
NEQNYSDQIAYEIDQEIQRIIKECYERAKQILTENRDKLELIAQTLLKVETLDAEQIKHL
VDHGALPERNFSDDEKNDDVKVNILTKTEEKKDDTKE
>PK3-2_00922 Hypoxanthine-guanine phosphoribosyltransferase
MMKHDIEKVLISEEEIQKKVKELGEELTNEYQDTFPLAIGVLKGALPFMADLIKHIDTYL
EMDFMDVSSYGNSTVSSGEVKIIKDLDTSVEGRDILIIEDIIDSGLTLSYLVELFRYRKA
KSIKIVTLLDKPSGRKADIKADFVGFEVPDAFVVGYGLDYAERYRNLPYIGVLKPAVYES
>PK3-2_00923 tRNA(Ile)-lysidine synthase
MKSVEDFLKKHNLTLKGATIIVGVSGGPDSMALLHALHTLCGRSANIIAAHVDHRFRGAE
SEEDMRFVQAYCKAEQLACETAQINVTAYAHEKGLNKQAAARDCRYQFFEEVMLKHQADY
LALAHHGDDQVETMLMRLAKGTLGAGLAGMQPVRPFGTGRIIRPFLTITKEEILHYCREN
GLSYRTDESNAKDDYTRNRFRKTVLPFLKQESPDVHKRFQKVSEALTEDEQFLRSLTKDE
MNKVITSQSNTSVEINTSLLLALPMPLQRRGVQLILNYLYENVPSSFSAHHIQQFLDWAE
KGGPSGVLDFPKGLKVVKSYQTCLFTFEQWQCRNVPFEYQISGAADETAVLPNGFLIEAK
HCADSPEEHGNAVFITSEKKVRFPLTIRTRKAGDRIKLKGMNGSKKVKDIFIDKKLPLRE
RDNWPIVTDASGEIIWIPGLKKSIFEDLVIPNSDRIVLQYRQHEKCRGQAKS
>PK3-2_00924 putative serine/threonine-protein kinase YabT
MMNDALTSLACSLKPGVTIKGKWNGNTYTLRKQLGKGANGIVYLAEASDGHVALKVSDDS
LSITSEVNVLKSFSKAQSVTMGPSFFDTDDAYIPGTNTKVSFYAMEYIKGPLLLKYVSDK
GAEWIPVLMIQLLSSLSVLHQQGWIFGDLKPDNLIVTGPPARIRCIDVGGTTKEGRAIKE
YTEFYDRGYWGYGTRKADPSYDLFAVAMIMINSVHKKEFKKTNQPKEQIRSLIEGQPLLQ
KYKKVLFSALNGEYQSADEMKKEMLDAGQKAVQRKQAVKATPQPAARQRQQKTRQGKVTK
TRYTPKQKAAKSGGLFETTLIVISVLALYFAYIIFFLI
>PK3-2_00925 hypothetical protein
MNNGHLNQILLITDGCSNHGEDPLAMAAFAKEQGITVNVIGIMEENQIDPEAMKEVEGIA
LAGGGVHQVVYASQLSQTVQMVTKKAMTQTLQGVVNQELKQILGKNVEMEELSPEKRGEV
MEVVDELGETVHLQVLVLVDTSASMAPKLPTVKEALIDLSVSLNSRIGNNEFAMCIFPGK
KQEVELVLNWTPKLQSLSTLFAKLSTGGITPTGPAIREATLQFEKIRSRRSMLADDERRF
DEFGM
>PK3-2_00926 Stage II sporulation protein E
MEKVERRVNGPMAGQALEKLQSFFNRGAKLVTHHLHSLFFYKGFIYVVIGFLLGRAFILS
EVLPFALPFFGAMLLIRRDKALYAVLAVLAGALTISPKHSLLILGALLAFFVVSKVAAFI
TDDRVKALPIVVFFSMAAARAGFVYAQNGTFTTYDYVMAVVEAGLSFILTLIFLQSLPIF
TVKKVKQSLKIEEIICFMILIASVLTGLAGLSYQGMQAEHILARYVVLSFSFIGGASIGC
TVGVVTGLILGLANIGNLYQMSLLAFSGLLGGLLKEGKKAGAAIGLIVGSLLISLYGEGS
AGLLTTLYESLIAVGLFLLTPQSITKKVARYIPGTVEHLQEQQQYARKIRDVTAQKVDQF
SNVFHALSESFATFYQASDEKTDDSEVDLFLSKITEHSCQTCYKKNKCWVQNFDKTYDLM
KQVMLETEEKEYASNRRLKKEFHQHCSKSKQVEELIEDELAHHHAHLTLKKKVQDSRRLV
AEQLLGVSEVMSDFSREIKREREQHFLQEEQIIEALQHFGIEIQHVEIYSLEQGNIDIEM
TIPFSGHGESEKIIAPMLSDILEEQILVKAEQHSPHPNGYSHVAFGSTKSYRVSTGVAHA
AKGGGLVSGDSYSMMELGARKYAAAISDGMGNGARAHFESNETIKLLEKILESGIDEKIA
IKTINSILSLRTTDEIYSTLDLSIIDLQDASCKFLKVGSTPSFIKRGDQVMKVQASNLPI
GIINEFDVEVVSEQLKAGDLLIMMSDGIFEGPKHVENHDLWMKRKMKGLKTNDPQEIADL
LMEEVIRTRSGQIEDDMTVVVVRIDHNTPKWASIPVPAIFQNKQEIS
>PK3-2_00929 Polyribonucleotide nucleotidyltransferase
MSIEVGSKLQGKITGITNFGAFVELPGGSTGLVHISEVADNYVKDINDHLKVGDQVEVKV
INVEKDGKIGLSIKKAKDRPQARPRNDFRPKESFEQKMNKFLKDSEDRLSSLKRNTESKR
GGRGARRG
>PK3-2_00930 Cell division protein DivIC
MNFSRERTITEIQNDYKEQVERQNQLKKRRRKGLYRRLTVFGALVFLTAIVLASSVWSQT
SSLSAKEEKKEQLEKELKSLKTKQTDLKEEISKLKDEDYVTELARRDLFMSGDGEIIFNV
EKKSK
>PK3-2_00931 Spore protein YabQ
MTLTTQFYTMLAMSGMGLWLGASLDTYRLFVIRAKTARWLLFIHDILFWILQGLLFFYVL
LHVNEGEFRLYIFLAVLLGIATYQSLCKRIYIKILKFVIYLVVSVYQFFKKLIQHVLFRP
IVWTCGAILWLAAFLLKKTYRLIVFLLLCLYKIAMVLCFPIRFIAKQCLKLLPVKLRLTF
RRYFEKGAGFLRKKKKLLVTIRTTITRFLKR
>PK3-2_00932 Spore protein YabP
MNSYYDQKGSSSVPEQHDVTMKGRKHLDISGVKHVESFDNEEFLLETVMGMLSVRGQNLQ
MKNLDVEKGIVSIKGRVFDLVYLDEQQGDKAKGFFSKLFK
>PK3-2_00933 putative protein
MRLDKFLKVSRLIKRRTLAKEVADQGRISINGNQAKASSDVKPGDELTVRFGQKLVTVQV
NELKDTTKKEEAANMYTILKEEKLGE
>PK3-2_00934 hypothetical protein
MAGNITVVGLGAGDMDQLTIGIHKLLTKADTLYVRTKDHPLIQELEKETKNIRFFDDIYE
KHDQFDAVYEEIANILFEEAQREDVVYAVPGHPFVAEKTVQLLTERQKEKNVQVRVAGGQ
SFLDATFNALQIDPIEGFQFVDAGTLSADELELRHHLIICQVYDQMTASEVKLTLMEKLP
DDYEVVIVTAAGSRDEVIQTVPLFELDRNVALNNLTSVYIPPIKEEKLLYHEFSAFRSII
RELRGPNGCPWDKKQTHQSLKQYMIEECYELLEAIDEEDTDHMIEELGDVLLQVLLHAQI
GEDEGYFTIDDVIKGISEKMVRRHPHVFKDVKVQDENDVLANWEDIKKAEKNTAEASLLE
SVPKTLPALSKAAKLQKKAAKVGFDWEDVSDIWEKVSEEMKEFSSEISEDPHEHNLKAEF
GDILFALVNVARFYKIEPEEALAMTNDKFRRRFSYIEETAKEKGIELADMSLEDMDKLWN
EAKETERRS
>PK3-2_00935 lipid II flippase MurJ
MDDSIGVKRHWIWQGAFVLILAGVISKILSAVYRVPFQNIVGDVGFYIYQQVYPFLGIAV
MLSTSGFPVIISKLMNDYSEKSHHTILKISAVFLSLIGVLLFLCLYMGAAPIALFMGDSH
LTVLIQVTAYAFLLFPFVALLRGGFQGRHDMLPSALSQITEQFLRVAVLLSLSFWLVKKG
ASLYTAGAAAASGSLAGSFMALIILGFFWFKAIRDNRMDRLNEHVITTKELVKKLFLYSV
TICVSSLLLLFIQLVDALNLYALLSGGEASEEAKRLKGIYDRGQPLLQLGSVFAVSIATS
LVPYISKAVKNKELKIMKEKAASSLKLCLVLGTGASAGLICILEPVNIMLFQNGEGTAAL
QIFSCSILFASLAVTAAAVLQGAGYTVFPAIAVGAGVAVKWVLNALLVPRYGIEGASLAT
AASFASVAGLNLYQLRKKRWLDKLRGIMIPVIGSALFMSVVLLAYMRLWTFLFPAAGRGA
AAIESITAVAIGGAVFIYCMMKLGVFTDEELNSVPFGSKLSKIMRRREQHGG
>PK3-2_00936 Stage V sporulation protein T
MKATGIVRRIDDLGRVVIPKEIRRTLRIREGDPLEIFVDRDGEVILKKYSPISELGDFAK
EYADALYDSLGHSVLICDRDVYIAVSGSSKKDYLNKSISEMLERTMDQRSSVLESDAKSV
QLVNGIDEDMNSYTVGPIVANGDPIGAVVIFSKDQTMGEVEHKAVETAAGFLARQMEQ
>PK3-2_00937 Transcription-repair-coupling factor
MDNIQTFIKESDDFKSIINGLHEGLKEQLLAGLSGSARSVFTSALANETNKPIFLITHNL
YQAQKVTDDLTSLLEDRSVLLYPVNELISSEIAVASPELRAQRLDVINRLTNGEAPIVVA
PVAAMRRMLPPVEVWKNSQMLIQVGHDIEPDQLASRLVEVGYERSDMVSAPGEFSIRGGI
IDIYPLTSEHPVRIELFDTEVDSIRSFNSDDQRSIETLTSINIGPAKELIIRPEEKARAM
EKIDKGLAASLKKLKADKQKEILHANISHDKERLSEGQTDQELVKYLSYFYEKPASLLDY
TPENTLLILDEVSRIHEMEEQLQKEEAEFITNLLEEGKILHDISLSFSFQKIVAEQKRQL
LYYSLFLRHVHHTSPQNIVNVSSRQMQSFHGQMNVLAGEMERFKKSNFTVVFLGANKERT
QRLSSVLADYEIEAAMTDSKKALVQGQVYIMEGELQSGFELPLMKLAVITEEELFKNRVK
KKPRKQKLTNAERIKSYSELQIGDYVVHINHGIGKYLGIETLEINGIHKDYLNIHYQGSD
KLYVPVEQIDQVQKYVGSEGKEPKLYKLGGSEWKRVKKKVETSVQDIADDLIKLYAEREA
SKGYAFSPDHEMQREFESAFPYQETEDQLRSIHEIKKDMERERPMDRLLCGDVGYGKTEV
AIRAAFKAIGDGKQVALLVPTTILAQQHYETITERFQDYPINIGLLSRFRTRKEANETIK
GLKNGTVDIVIGTHRLLSKDVVYKDLGLLIIDEEQRFGVTHKEKIKQIKANVDVLTLTAT
PIPRTLHMSMLGVRDLSVIETPPENRFPVQTYVVEYNGALVREAIERELARGGQVYFLYN
RVEDIERKADEISMLVPDAKVAYAHGKMTENELETVMLNFLEGESDVLVSTTIIETGVDI
PNVNTLIVFDADKMGLSQLYQLRGRVGRSNRVAYAYFTYRRDKVLTEVAEKRLQAIKEFT
ELGSGFKIAMRDLTIRGAGNLLGAQQHGFIDSVGFDLYSQMLKEAIEERKGDTAKTEQFE
TEIDVELDAYIPETYIQDGKQKIDMYKRFRSVATIEEKNELQDEMIDRFGNYPKEVEYLF
TVAEMKVYAKQERVELIKQDKDAVRLTISEEASAEIDGQKLFELGNKYGRQIGLGMEGKK
LKISIQTKGRSADDWLETVLGMLKGLKGVKKQTISST
>PK3-2_00938 Anti-sigma-F factor Fin
MALHYYCRHCGVKVGSLESSMVSTDSLGFQHLTNEERNDMISYKENGDVQVLTICEDCQE
ALDRNPNYHEYHTFIQ
>PK3-2_00939 Peptidyl-tRNA hydrolase
MLVIAGLGNPGKNYENTRHNVGFMVIDQLAKEWNIELNQNKFNGLYGTGFVSGKKVLLVK
PLTYMNLSGECLRPLMDYYDVDNEDLTVIYDDLDLPAGKIRLRTKGSAGGHNGIKSLIQH
LGTSEFDRIRIGIGRPVNGMKVVDYVLGSFTKEEAPEIDGAIDKSVKACEASLSKPFLEV
MNEFNVKV
>PK3-2_00940 General stress protein CTC
MATLTAKERTDFTRSSLRNIRTSGHVPGIIYGKDTENKPVSLDSVELIKTLRDEGKNTVL
TLDVGGKQHSVMVTDLQTDPLKNEITHADFQVVNMSEDIEVEVPIHLTGEAIGVKNGGVL
QQPLYELTVKAKPKAIPQSIEADISKLDVNEVLTIADLPAGGDYSFNHESDEVVASILPP
QQQEAAEIDEEESADAQPEGENKEQ
>PK3-2_00941 Ribose-phosphate pyrophosphokinase
MSNQYGDKNLKIFSLNSNPELAKEIADIVGVQLGKCSVTRFSDGEVQINIEESIRGCDCY
IIQSTSAPVNEHIMELLIMVDALKRASAKTINIVIPYYGYARQDRKARSREPITAKLFAN
LLETAGATRVIALDLHAPQIQGFFDIPIDHLMGVPILGEYFEGKNLEDIVIVSPDHGGVT
RARKLADRLKAPIAIIDKRRPRPNVAEVMNIVGNIEGKTAILIDDIIDTAGTITLAANAL
VENGAKEVYACCTHPVLSGPAVERINNSTIKELVVTNSIKLPEEKKIERFKQLSVGPLLA
EAIIRVHEQQSVSYLFS
>PK3-2_00942 Bifunctional protein GlmU
MDKRFAVVLAAGQGTRMKSKLYKVLHPVCGKPMVEHVVDEALKLSLSKLVTIVGHGAEDV
KKQLGDKSEYALQAEQLGTAHAVKQAQPFLAAEKGVTIVICGDTPLLTAETMEQMLKEHT
QREAKVTILTAVAEDPTGYGRIIRGENGAVQKIVEHKDASEEERLVTEINTGTYCFDNEA
LFRAIDQVSNDNAQGEYYLPDVIEILKNEGETVAAYQTGNFQETLGVNDRVALSQAEQFM
KERINKRHMQNGVTLIDPMNTYISPDAVIGSDTVIYPGTVIKGEVQIGEDTIIGPHTEIM
NSSIGSRTVIKQSVVNHSKVGNDVNIGPFAHIRPDSVIGNEVKIGNFVEIKKTQFGDRSK
ASHLSYVGDAEVGTDVNLGCGSITVNYDGKNKYLTKIEDGAFIGCNSNLVAPVTVGEGAY
VAAGSTVTEDVPGKALAIARARQVNKDDYVKNIHKN
>PK3-2_00943 hypothetical protein
MKCKNFLLSTIKFEKSELKKDCRKKAFVSPFSSPCFWLFFKKLQLLRILMLQCHPNDDTH
LTRHLESFLACLN
>PK3-2_00944 Putative septation protein SpoVG
MEVTDVRLRRVNTDGRMRAIASITLDHEFVVHDIRVIDGNNGLFVAMPSKRTPDGEFRDI
AHPINSSTRGKIQDAVLNEYHRLGDTEALEFEEAGAS
>PK3-2_00945 2-iminobutanoate/2-iminopropanoate deaminase
MTKAVHTKHAPAAIGPYSQGIIVNNMFYSSGQIPLTPSGEMVNGDIKEQTHQVFSNLKAV
LEEAGASFETVVKATVFIADMEQFAEVNEVYGQYFDTHKPARSCVEVARLPKDALVEIEV
IALVK
>PK3-2_00946 Pur operon repressor
MKFRRSGRLVDLTNYLLTHPHELIPLTFFSERYESAKSSISEDLTIIKQTFEQQGIGTLL
TVPGAAGGVKYIPKMKQAEAEEFVQTLGQSLANPERILPGGYVYLTDILGKPSVLSKVGK
LFASVFADREIDVVMTVATKGIPLAYAAASYLNVPVVIVRKDNKVTEGSTVSINYVSGSS
NRIQTMSLAKRSMKTGSNVLIIDDFMKAGGTINGMINLLDEFNANVAGIGVLVEAEGVDE
RLVDEYMSLLTLSTINMKEKSIEIQNGNFLRFFKDNLLKNGETEL
>PK3-2_00947 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase
MRILEKAPAKINLSLDVTRKRPDGYHEVEMIMTTIDLADRIELMELAEDEVRVSSHNRFV
PDDQRNLAYQAAKLIKDRYNVKKGVSIMITKAIPVAAGLAGGSSDAAATLRGLNRLWNLN
LSAETLAELGAEIGSDVSFCVYGGTALATGRGEKIKHIGTPPHCWVILAKPTIGVSTAEV
YRQLKLDDVEHPDVHGMIEAIEEKSFQKMCSRLGNVLESVTLDMHPEVAMIKNQMKRFGA
DAVLMSGSGPTVFGLVQYESKVQRIYNGLRGFCDQVYAVRMIGEQNALD
>PK3-2_00948 hypothetical protein
MNLLFTAFCFALFWFPVILTKVPSDLTKDKTVTHYRDVHEWLSLLKKGLFRLGRRRGVMS
DEFKYELAKDLGFYDTVKNGGWGEIKARDAGNMVKRAIEIAEQQMAQNQNNR
>PK3-2_00949 Protein Veg
MAKTLSDIKRSLDGNLGKRLTLKANGGRRKTIERSGILAETYPSVFVIQLDQDENSFERV
SYSYADILTETVELTFNDDAASSVAF
>PK3-2_00950 Sporulation-specific protease YabG
MCGVRNVQFQIGDMVARKSYQMDVLFRIIGIEQTSKGNSIAILHGDEVRLIADSDFSDLV
AVKKDEQMMRKKKDESRMNESLELLRQDYKLLREKQEYYATSQYQHQEHYFHMPGKVLHL
DGDEAYLKKCLNVYKKIGVPVYGIHCHEKKMSASIEELLDKYRPDILVITGHDAYSKQKG
SVDDLNAYRHSKHFVETVQNARKKIPHLDQLVIFAGACQSHFESLIRAGANFASSPSRVN
IHALDPVYIVAKISFTPFMERINVWEVLRNTLTREKGLGGIETRGVLRIGMPYKSN
>PK3-2_00951 Ribosomal RNA small subunit methyltransferase A
MNKDIATPNRTKEILKKYGFSFKKSLGQNFLIDTNILDRIVDHAEVTEKTGVIEIGPGIG
ALTEQLAKRAKKVVAFEIDQRLLPILKDTLSPYDNVTVIHQDVLKADVKSVIEEQFQGCD
EIMVVANLPYYVTTPIIMKLLEEHLPLKGIVVMLQKEVAERMAADPSSKEYGSLSIAVQF
YTEAKTVMTVPKTVFVPQPNVDSAVIRLILRDGPAVDVENEAFFFQLIKASFAQRRKTLL
NNLVNNLPEGKAQKSTIEQVLEETNIDGKRRGESLSIEEFAALSNGLYKALF
>PK3-2_00952 Ribonuclease M5
MKIKEIIVVEGRDDTARIKLAVDADTIETNGSAIDDQVIDQIRLAQKTRGVIILTDPDFP
GEKIRKSISEAVPGCKHAFLPKHLAKPKNKRGIGVEHASIESIRACLENVHEEMEAQPSD
ISAEDLIHAGLIGGSAAKRRRERLGDLLKIGYTNGKQLQKRLQMFQIKKSDFMSALDTVM
REEQNE
>PK3-2_00953 hypothetical protein
MGEREGRVDSLLDTLYNLSEEKEAFFIIQKMKKLFSVKLSKSKVILVAACLLLAGSGTAY
AAHELTKQSVSVSINGKKKHIRTHAKTVGDLLETLDIKTRGEDKVTPAKQTEITADLDVV
YEAAKPVKLTINGEEKTLWSTAKTVGALLDEQDVDVKEHDQIDPAIDTDISKDMKINIEP
AFQVTVNDAGKQKKIWTTSTTVADFLKQQKMNIKDEDKIKPALDAKLTKGKADITITRIE
KVTDVVEEKIAFDVKKQEDASLEKGKEKVVQKGKEGKLKKHFEVVKENGKEVSRELVKEE
TAEQSKDKVVAVGTKQSSPKIEKVSASGDSKTVVSRSNESTGKVMNVSSTAYTASCSGCS
GHTATGVNLKNNPNAKVIAVDPNVIPLGSKVHVEGYGYAIAADTGSAIKGNKIDVFFPEK
SSAYRWGNKTVKIKILN
>PK3-2_00954 putative metal-dependent hydrolase YcfH
MLFDTHAHLNAEQYDTDLEEVIERAKAEKVERIVVVGFDRPTITRAMEMIEEYDFIYAAI
GWHPVDAIDMTDEDLAWIKELSAHEKVVAIGEMGLDYHWDKSPKDVQKEVFKKQIALAKE
VNLPIIIHNRDATEDVVTILKEEGAEAVGGIMHCFTGSAEVARECMKMNFYLSFGGPVTF
KNAKKPKEVVKEIPNDRLLIETDCPFLTPHPFRGKRNEPSYVKYVAEQIAQLKGMTFEEV
ASITTENAKRLFRIN
>PK3-2_00955 Methionine--tRNA ligase
MPQENNTFYITTPIYYPSGKLHIGHAYTTVAGDAMARYKRLKGFDVRYLTGTDEHGQKIQ
QKAEQENITPQEYVDRAAADIQKLWKQLEISNDDFIRTTEKRHKVVIEKVFQKLLDNGDI
YLDEYEGWYSIPDETFYTETQLVDIERNEKGEVIGGKSPDSGHPVELIKEESYFFRMGKY
ADRLLKYYEENPTFIQPESRKNEMINNFIKPGLEDLAVSRTTFDWGVKVPENPKHVVYVW
IDALFNYLTALGYDTENDELYQKYWPADVHLVGKEIVRFHTIYWPIMLMALDLPLPKQVF
AHGWLLMKDGKMSKSKGNVVDPVTLIERYGLDELRYYLLREVPFGSDGVFTPEGFVERIN
YDLANDLGNLLNRTVAMINKYFDGQIGSYKGAVTEFDQTLTSVAEETVKAYEKAMENMEF
SVALSTLWQLISRTNKYIDETAPWVLAKDPAKEEELQSVMYHLAESLRISAVLLQPFLTK
TPEKMFEQLGITDESLKAWDSITAFGQLKDTKVQKGEPLFPRLEAEEEIAYIKGKMQGSA
PAKEETKEEEPVQEVDRLPEITIDQFMDVELRVAEVIKAEPVKKADRLLKLQLDLGFEKR
QVVSGIAKHYTPEELVGKKLVCVTNLKPVKLRGELSQGMILAGEADGVLKVVSIDQSLPK
GTRIK
>PK3-2_00956 Transition state regulatory protein AbrB
MKSTGIVRKVDELGRVVIPIELRRTLGIAEKDALEIYVDDEKIILKKYKPNMTCQVTGEV
SDDNLKLAGGKLVLSKEGAEQIISEIQNQLQNLK
>PK3-2_00957 Ribosomal RNA small subunit methyltransferase I
MLKRQMSFNGKSDMGILYLVPTPIGNLEDMTFRAIDTLKSVDAIAAEDTRQTKKLCHVYE
IETPLVSYHEHNKESSGHKIIEWLKSGKNIALVSDAGLPTISDPGAEIVKDFTEIGGYVV
PLPGANAALTALIASGIVPQPFFFYGFLNRQKKEKKKELEILKKRRETIIFYEAPHRLKE
TLSAMAEILGDREIAVTRELTKKYEEFIRGTLSEVIEWANEDQIRGEFCLVVEGSKNEES
DEEAQWWGTLTVKEHVEHYISKGATSKEAIKKAAVDRNVPKREVYDAYHIQQ
>PK3-2_00958 hypothetical protein
METNNHFFYVVKCKDNSWYAGYTNDLQKRVKTHNDGKGAKYTKVRRPVELIFAEAFTTKR
EAMQAEYYFKKLTRKKKELYIEEKRNSEEAVYVKAPNEL
>PK3-2_00959 tRNA1(Val) (adenine(37)-N6)-methyltransferase
MVSLRDDERLDYLLAEDMKIIQSPTVFAFSLDAVLLSKFAYVPIQKGKIVDLCTGNGIVP
LLLSTRSKADILGVEIQERLQDMAIRSVEYNKLQDQIQIIHDDLKNMPEKLGHNRYDVVT
CNPPYFKTPKQTEQNMNEHLRIARHEIHCTLEDVISVSSKLLKQGGKAALVHRPGRLLEI
FELMKAYQIEPKRVQFVYPKQGKQANTILVEGMKGGRPDLKILPPLFVYDEQNEYTKEIR
TILYGDK
>PK3-2_00960 Initiation-control protein YabA
MDKKELFDTVINLEEQIGSLYRQLGDLKQHIGEMIEENHHLQLENKHLRKRLDDTTQQIE
KFKADKKESKTQKTEQTDIGEGYDNLARLYQEGFHICNVHYGSVRKEDCLFCLSFLNKK
>PK3-2_00961 hypothetical protein
MYNVIGVRFKKAGKIYYFDPNGFHIEHDSCVIVETVRGVEYGQVVIANKQVDEHDVVLPL
RKVIRVADERDLLIVEENKQEALSAFDICQKKVAEHGLDMKLVDVEFTFDRNKVIFYFTA
DGRVDFRELVKDLASIFKTRIELRQIGVRDEAKMLGGIGPCGRMLCCSTFLGDFEPVSIK
MAKDQNLSLNPTKISGLCGRLMCCLKYENDEYETAKEQLPDLGEMITTASGPAKVVGLNI
LERVLQVELKNREKVIEYTWEELLEEGVVSAQTTD
>PK3-2_00962 hypothetical protein
MTELQPRVMKLLYNSIEKDRLSHAYLFEGKKGTGKLDAALLLAKSFFCLEDGAEPCESCR
NCKRIESGNHPDLHLVQPDGLSIKKAQIQALQEEFSKTGLESHKKLYIISHADQMTANAA
NSLLKFLEEPNKDTMAILITEQPQRLLDTIISRCQTLPFQPLQPKAIEDRLIEQEVSPHM
ARLLANMTNNVAEAVELSRNDEFAESRAKVIKLYEVLHQRKGHAFFFIQDQWMPFFKEKT
HQEMGLDMLLLIYRDVLSIQIGNEDKLIYQDLFQSIKQHALQSTQQSVTNQILAVLEAKK
RLHSNVNVQGLMEHLVLMLQEG
>PK3-2_00963 hypothetical protein
MKINKDIRTFIDNKQLPSVKTSEITASFKTSMENQSSKLKFDQLTRLLSDIEAFGKRLTK
SRNFKDLARFKGLVKRFVQEAVDSGLSHETSKSFDLYGNSRTLGLVKEIDEKLIQLTEEM
MDQEKPAIDLLDRIGEIKGLLINLYT
>PK3-2_00964 Cyclic di-AMP receptor A
MKLIVAVVQDQDSNRLLKTLTDHNFRVTKLATTGGFLKSGNTTFMIGVEDIRVDKALSLI
KENGQKRDQMIAPVSPMGGNADSYVPYPVEVEVGGATVFVLPVDEFHQF
>PK3-2_00965 Thymidylate kinase
MSGLFITFEGPEGAGKTTVLQEIKNILTAEGLQVTATREPGGIDIAEQIREVILNENNTL
MDPKTEALLYAAARRQHLVEKVKPALEQGHVVLCDRFIDSSLAYQGYARGLGIDEVLSIN
EFAIGDMMPHVTVYFSIDPEEGLKRIHANGSREKNRLDLEKLSFHTKVQEGYQELMKRFP
KRFHSIDASQSKDHVVQDVLKVINEALKKIQL
>PK3-2_00966 Arginine decarboxylase
MNTPLYTALIQHARRNSHSFHVPGHHNGDVFFDDAKSIFDPLLSIDVTELAGLDDLHHPS
GVIKEAQELVSQLYGSAESFFLVNGTTVGNLAMILSVCEPGDTILVQRNCHKSVFHAVDL
SGAEPVYLAPDIDAALHVPTHVPLDTIKEALAAYPDAKGLVLTNPTYYGHSADMTEIISE
AHEYGIPVLVDEAHGAHFVLGEPFPVSALKMGADIVVQSAHKTLPAMTMGSYLHLSHSGG
VDRDIVAEYLNRLQSSSPSYPIMASLDIARAYVQRIIEEQKLPDILQRIQSLKQTFDSLA
NAEAVRPADPRMITDPLKLTIRSKRGHSGYTLQNILERANIFTELADENQVLLVLPLGGK
RRINAETIKSIDEEIEKTPPDQMFVSAEWGAQPVTVLPYQKKVLHTFKKEYVDFDAAAGR
LNAEDVIPYPPGIPMIMAGERITEESVQKLSRLISMKTHVQGNMKIKEKQLLVYIEEEKS
>PK3-2_00967 TelA-like protein
MSRDQSDLHIDELLTDPFGDIEIPEAESVKAEQQQVRLVDVLPEENKEKAIQLAEQIDHK
NMQSIVLYGSQAQSKLLNFSHTMIDHVQKKDVGEIGEILGELMKKLEQVNPDDLQSKKKG
FLARVFGRVSNSLQEVLSKYQKTSVQIDRISLKLEHSKNALISDNKLLEQLYEKNKEYFA
ALNVYIAAGEIKLEELKTKTIPELRQQAESSEHNQMAVQEVNDLIQFADRLDKRVHDLLL
SRQITIQSAPQIRLIQNTNQALAEKIQSSIVTAIPLWKNQVAIALTLLRQRNAVDAQQKV
SDTTNELLLKNAELLKTNTIETVRANERGLVDIDTLKKVQESLISTLEETLTIQEEGRIK
RRQAEEELMMMEGDLKQKLLTLKER
>PK3-2_00968 hypothetical protein
MQRFLHFLIWSLTSSATFVFVGILSFFGLNQSLFFSFVYGLASGTVVYTAGIWNTRRLFL
KRHELTGREYAYIKKNLEESRQKIIRLRKALFQAKSIQMFKQNAEMLRLVRRIYILTKKE
PKRFYQAERFYYQTLDSVVELTEKYAFLSSHPKKSKELWMSLSEARITLAELTKRLEEDL
TQLMGDEIDELQFELDAAKHSLKK
>PK3-2_00969 Anti-sigma-G factor Gin
MDETVKPNHTCVICDQEKNRGIHLYTKFICLDCERKVISTSTSDPDYAYYVRKLKSIHTP
PLYS
>PK3-2_00975 Sigma-K factor-processing regulatory protein BofA
MEPIFIIGIILGLVILLFLSGSASKPLKWVGITAVKFVAGALLLVCVNMFGGSLGIHVPI
NLVTTAISGILGVPGIAALVIIKQFII
>PK3-2_00976 hypothetical protein
MGFLRKKTLRREFDEKLTEQLFKQKEEWNRQKKLVEKSLEPSAEVLYELKVAEAKYFFYL
REAKQRDLKISRWK
>PK3-2_00977 Recombination protein RecR
MQYPEPISKLIDSFMKLPGIGPKTAVRLAFFVLGMKEDVVLDFAKALVNAKRNLTYCSVC
GHITDQDPCYICEDTRRDKSVICVVQDPKDVIAMEKMKEYNGQYHVLHGAISPMDGIGPE
DIKIPELLKRLQDDQVTEVILATNPNIEGEATAMYISRLLKPSGIKLSRIAHGLPVGGDL
EYADEVTLSKALEGRREL
>PK3-2_00978 Nucleoid-associated protein
MRGGMGNMQKMMKQMQKMQKDMAKAQEELAEKVVEGTAGGGMVTVKANGQKEILDVIIKE
EVVDPEDIDMLQDLVLAATNEALKKVDEITNETMGQFTKGMNMPGLF
>PK3-2_00979 hypothetical protein
MSYQALYRVFRPQRFEDVVGQEHITKTLQNALLQKKFSHAYLFSGPRGTGKTSAAKIFAK
AVNCEHAPVDEPCNECAACKGITNGSISDVIEIDAASNNGVDEIRDIRDKVKFAPSAVTY
KVYIIDEVHMLSIGAFNALLKTLEEPPEHCIFILATTEPHKIPLTIISRCQRFDFKRITS
QAIVGRMNKIVDAEQLHVEEGSLDIIASAADGGMRDALSLLDQAVSFSGDILKVEDALLI
TGAVSQLYIGKLAQSLHDKNVSDALETLNELLQQGKDPAKLIEDMIFYFRDMLLYKTAPG
LEGVLEKVKVDETFRGLSEQIPAQAIYEMIDILNKSHQEMKWTNHPRIFFEVAVVKICQT
SHQSAADLPEVDMLMEKIQQLEQEVERLKTTGIKAAAESPKKETPRAPKGGKSNYKAPVG
RIHEILKEATRPELDKLRNSWGKLLAHLKQQNKVSHAALLNDSEPVAAASAAFVLKFKYE
IHCKMVAEDNNGVRTNLEQILESMLGKRMDLIGVPEAQWGKIREEFLVDHQQENEGSNEP
AEEDPLIAEAKKLVGADLIEIKD
>PK3-2_00981 tRNA-specific adenosine deaminase
MTQDELYMIEAMKEARKAEEKGEVPIGAVLVMNDEIVARAHNLRETEQRSIAHAEMLVID
EACKALGTWRLEGATLYVTLEPCPMCAGAVVLSRVEKVVFGAFDPKGGCSGTLMNLLQEE
RFNHQAEVVSGVLEEECGEMLSSFFRELRKKKKALRKNLSE
>PK3-2_00982 Enterobactin synthase component B
MSKADTTLLIVDMINNFEFDMGESLAKKTEKIVPHILSLKEYARQNDWPIIYINDHYGLW
QADIKNIQQECTNERSKDIIRQIAPDDADYFLIKPKHSAFYETALHTLLTELQIKHIILT
GIAGNICVLFTANDAYMREYSITIPKDCIASNRDEDNEFALTMMENVLFAEITTEKQITE
K
>PK3-2_00983 Cortical fragment-lytic enzyme
MVKQGDTLSAIASQYRTTVSQIIETNEIPNADSLVVGQTIVIPIAGQFYDVKQGDTLTSI
ARQFNTTAAELARVNRIQLNTVLQIGFRLYIPPVPKRDIESNAYLEPRGNQVSENLQQAA
REASPYLTYLGAFSFQAQRDGTLVAPPLTNLRSIAENQNTTLMMIITNLENQAFSDELGR
ILLNDNTVKRRLLNEIVENAKEYGFRDIHFDFEYLRPQDREAYNQFLREARDLFHREGLE
ISTALAPKTSATQQGRWYEAHDYRAHGQIVDFVVLMTYEWGYSGGPPQAVSPIGPVRDVI
EYALTEMPANKIVMGQNLYGYDWTLPYTAGGTPARAISPQQAIVIADQNNASIQYDQTAQ
APFFRYTDAENRRHEVWFEDARSIQAKFNLIKELNLRGISYWKLGLSFPQNWLLLSDQFN
VVKKTFR
>PK3-2_00984 Deoxyguanosine kinase
MNTAPFIAIEGPIGAGKTTLATMLSQEFGFPMINEIVEDNPYLDKFYDNIEEWSFQLEMF
FLCHRYKQLEDTSDHFLKKGQPVIADYHIYKNVIFAERTLSQHQLEKYKKIFHLLTDDLP
KPNFIIYIKASLPTLLHRIEKRGRPFEKKIETSYLEQLIADYEVAIKQLQEADPELTVLT
IDGDSKDFVLNKSDFERIAAHVKELIV
>PK3-2_00985 Deoxyadenosine/deoxycytidine kinase
MKELHIPKNSIITVAGTVGVGKSTLTKALAKRLGFKTSLEEVDHNPYLEKFYHDFERWSF
HLQIYFLAERFKEQKTIFEAGGGFVQDRSIYEDTGIFAKMHADKGTMSKIDYKTYTSLFE
AMVMTPYFPHPDVLIYLEGDLENILNRIEERGREMELQTNRSYWEEMHTRYENWISGFNA
CPVLKLRIEDYDLLNDESSIENIVDQIASVIHENQKK
>PK3-2_00987 Serine--tRNA ligase
MLDTKMLRANFQEIKAKLVHKGEDLTDFDKFEALDDRRRELIGKVEELKGKRNEVSQQVA
VLKREKKDADHIIKEMREVGEEIKKLDDELRTVESELDTILLSIPNIPHESVPVGETEDD
NIEVRKWGEMPSFAYEPKPHWDIADELGILDFERAAKVTGSRFVFYKGLGARLERALYNF
MLDLHVDEYNYTEVIPPYMVNRASMTGTGQLPKFEEDAFKIREEDYFLIPTAEVPITNMH
RDEILSGDNLPINYAAFSACFRSEAGSAGRDTRGLIRQHQFNKVELVKFVKPEDSYEELE
KLTNQAERVLQLLELPYRVMSMCTGDLGFTAAKKYDIEVWIPSQDTYREISSCSNFEAFQ
ARRANIRFRREAKGKPEHVHTLNGSGLAVGRTVAAILENYQQEDGSVVIPKVLRPYMGNR
EVIKP
>PK3-2_00989 Pyridoxal 5'-phosphate synthase subunit PdxT
MLTIGVLGLQGAVREHIHAIEACGAAGLVVKRPEQLNEIDGLILPGGESTTMRRLIDTYQ
FMDPLREFAAQGKPMFGTCAGLIILAKEIAGSDNPHLGLLNVVVERNSFGRQVDSFEADL
TIKGLDEPFTGVFIRAPHILEAGENVEVLSEHNGRIVAAKQDHFLGCSFHPELTEDHRVT
QLFVQMVEEYKQKALV
>PK3-2_00990 Pyridoxal 5'-phosphate synthase subunit PdxS
MAQTGTERVKRGMAEMQKGGVIMDVINAEQAKIAEEAGAVAVMALERVPADIRAAGGVAR
MADPTIVEEVMNAVSIPVMAKARIGHIVEARVLEAMGVDYIDESEVLTPADEEFHLNKNE
YTVPFVCGCRDLGEATRRIAEGASMLRTKGEPGTGNIVEAVRHMRKVNAQVRKVVAMSND
ELMTEAKNLGAPYELLLQIKEEGKLPVVNFAAGGVATPADAALMMQLGADGVFVGSGIFK
SDNPAKFAKAIVEATTHFTDYKLIADLSKELGTAMKGIEISNLLPEQRMQERGW
>PK3-2_00991 D-alanyl-D-alanine carboxypeptidase DacA
MNIKKCKQLLMSLVVLTLAVTCLAPMSKAKAASDPIDINASAAIMIEASSGKILYSKNAD
KRLPIASMTKMMTEYLLLEAIDQGKVKWDQTYTPDDYVYEISQDNSLSNVPLRKDGKYTV
KELYQATAIYSANAAAIAISEIVAGSETKFVEKMNEKAKELGLTDYKFVNATGLENKDLH
GHQPEGTSVSEESEVSAKDMAILADHLITDYPEILETSSIAKTKFREGTDDEMDMPNWNF
MLKGLVSEYKKATVDGLKTGSTDSAGSCFTGTAELNGMRVITVVLNAKGNLHTGRFDETK
KMFDYAFDNFSMKEIYAEGDQVKGHKTISVDKGKEKEVGVVTNKAFSLPVKNGEEKNYKA
KVTLNKDTLTAPVKKGTKVGKLTAEYKGDEKDYGFLNSNLAGVDLVTKENVEKANWFVLT
MRSIGGFFAGIWGSIVDTVTGWF
>PK3-2_00992 Inosine-5'-monophosphate dehydrogenase
MWESKFSKEGLTFDDVLLVPAKSEVLPRDVDLSVELTKTLKLNIPVISAGMDTVTESAMA
IAMARQGGLGIIHKNMSIEQQAEQVDKVKRSERGVITNPFFLTPDHQVFDAEHLMGKYRI
SGVPIVNNEEDQKLVGIITNRDLRFISDYSMKISDVMTKEELVTASVGTTLDEAEKILQK
HKIEKLPLVDDQNKLKGLITIKDIEKVIEFPNSSKDIHGRLIVGAAVGVTGDTMTRVKKL
VEANVDVIVIDTAHGHSQGVLNTVTKIRETYPELNIIAGNVATAEATRALIEAGADVVKV
GIGPGSICTTRVVAGVGVPQITAIYDCATEARKHGKTIIADGGIKFSGDITKALASGGHA
VMLGSLLAGTSESPGETEIYQGRRFKVYRGMGSVAAMEKGSKDRYFQEENKKFVPEGIEG
RTPYKGPVEETVYQLVGGLRSGMGYCGSKDLHALREEAQFIRMTGAGLRESHPHDVQITK
ESPNYTIS
>PK3-2_00993 hypothetical protein
MTYHEWKDLALFYSVESTQKFLEKVYTKNGIDDAKKNSFKNSERFIYFLKHAESFYKQAS
KSPLEIKPILLFYGMAQLIKACLITRDPHYPSHTSVLAHGVTTRKRKKQNYCFSDDEVKI
QRNGLCMHFMQHLFAQSDIVDERYTMKKLLMTIPELGDTFYFQEKERFLTIVEKEKDKIF
VPEDVVINYKMSDSRFADYMSHHFQWSFAKKNEHGLLFELSPQDTNPWTSISLLYDMGKN
QYFIPSQRERFLRLPEMAVHYLILYNIGMIARYETEWWYELLTQHISDDYVLIQQFLLVT
ENKFPKYALQFLLQF
>PK3-2_00999 DNA gyrase subunit A
MSEQNTPQVREINISQEMRTSFLDYAMSVIVSRALPDVRDGLKPVHRRILYAMNDLGMTS
DKPYKKSARIVGEVIGKYHPHGDSAVYESMVRMAQDFNYRYMLVDGHGNFGSVDGDSAAA
MRYTEARMSKISMEILRDITKDTIDYQDNYDGSEREPVVMPSRFPNLLVNGAAGIAVGMA
TNIPPHQLGEIIDGVLAVSENPDITIQELMEVIPGPDFPTAGQILGRSGIRKAYESGRGS
ITIRAKAEIEQTSSGKERIIVTELPYQVNKAKLIEKIADLVRDKKIEGITDLRDESDRTG
MRIVIEIRRDANANVILNNLYKQTALQTSFGINLLALVEGQPKVLNLKQCLEHYLDHQKV
VIRRRTAYELRKAEARAHILEGLRIALDHLDAVISLIRNSQTAEIARTGLIEQFSLTEKQ
AQAILDMRLQRLTGLEREKIEEEYQSLVKLIAELKDILANEYKVLEIIREELTEIKERFN
DVRRTEIVTSGLETIEDEDLIERENIVVTLTHNGYIKRLPASTYRSQKRGGKGVQGMGTN
EDDFVEHLISTSTHDTILFFSNKGKVYRAKGYEIPEYGRTAKGIPIINLLEVEKGEWINA
IIPVTEFNEDLYLFFTTKHGISKRTSLSQFANIRNNGLIALGLREDDELMGVRLTDGTKQ
MIIGTKNGLLIRFPETDVREMGRTAAGVKGITLTDDDVVVGMEILEEESHVLIVTEKGYG
KRTPAEEYRTQSRGGKGLKTAKITENNGQLVTVKATKGEEDLMIITASGVLIRMDINDIS
ITGRVTQGVRLIRMADEEHVATVALVEKNEEDEQEETQEETQEETQEEV
>PK3-2_01000 DNA gyrase subunit B
MAMEQQQNSYDENQIQVLEGLEAVRKRPGMYIGSTNSKGLHHLVWEIVDNSIDEALAGYC
TDINIQIEKDNSITVVDNGRGIPVGIQEKMGRPAVEVIMTVLHAGGKFDGSGYKVSGGLH
GVGASVVNALSTELDVTVHRDGKIHRQTYKRGVPVADLEVIGETDHTGTTTHFVPDPEIF
TETTVYDYDLLANRVRELAFLTKGVNITIEDKREGQERKNEYHYEGGIKSYVEYLNRAKE
VVHEEPIYIEGEKDGITVEVALQYNDSYTSNIYSFTNNINTYEGGTHEAGFKTGLTRVIN
DYARKKGLIKENDPNLSGDDVREGLTAIISIKHPDPQFEGQTKTKLGNSEARTITDTLFS
AAMETFMLENPDAAKKIVDKGLMAARARMAAKKARELTRRKSALEISNLPGKLADCSSKD
PSISELYIVEGDSAGGSAKQGRDRHFQAILPLRGKILNVEKARLDKILSNNEVRSMITAL
GTGIGEDFNLEKARYHKVVIMTDADVDGAHIRTLLLTFFYRYMRQIIENGYVYIAQPPLY
KVQQGKRVEYAYNDKELEALLSTLPQTPKPGLQRYKGLGEMNATQLWETTMDPSSRTLLQ
VTLEDAMDADETFEMLMGDKVEPRRNFIEANARYVKNLDI
>PK3-2_01001 hypothetical protein
MYIHLGDDFVVSTRDIVGIFDFKANMSPIVEEFLKKQKHKVVPSVNGTPKSIVVTVQNIY
YSPLSSSTLKKRAQFMFEIDS
>PK3-2_01002 DNA replication and repair protein RecF
MYIHNLELTSYRNYDHAELQFENKVNVIIGENAQGKTNLMEAIYVLSMAKSHRTSNDKEL
IRWDKDYAKIEGRVMKQNGAIPMQLVISKKGKKGKVNHIEQQKLSQYVGALNTIMFAPED
LNLVKGSPQVRRRFLDMEIGQVSPVYLYDLSLYQKILSQRNHFLKQLQTRKQTDRTMLDV
LTDQLVEVAAKVVVKRLQFTAQLEKWAQPIHAGISRGLEELTLKYHTALEVSDPEDLSKI
GDSYQEAFSKLREKEIDRGVTLSGPHRDDVLFYVNGRDVQTYGSQGQQRTTALSLKLAEI
DLIHEEIGEYPILLLDDVLSELDDYRQSHLLHTIQGRVQTFVTTTSVDGIDHETLRQAGM
FRVQNGALVK
>PK3-2_01003 hypothetical protein
MANPISIDTEMITLGQFLKLADVIQSGGMAKWFLSEHEVFVNNEPDNRRGRKLYVGDVVE
IEGFGSFQVVN
>PK3-2_01004 Beta sliding clamp
MKFTIQKDRLVESVQDVLKAVSSRTTIPILTGIKIVASDDGVSFTGSDSDISIESFIPKE
EGDKEIVTIEQPGSIVLQARFFSEIVKKLPMATVEIEVQNQYLTIIRSGKAEFNLNGLDA
DEYPHLPQIEEHHAIQIPTDLLKNLIRQTVFAVSTSETRPILTGVNWKVEKSELLCTATD
SHRLALRKAKLDIPEDRSYNVVIPGKSLTELSKILDDNQELVDIVITETQVLFKAKNVLF
FSRLLDGNYPDTTSLIPQDSKTEIIVNTKEFLQAIDRASLLAREGRNNVVKLSAKPAESI
EISSNSPEIGKVVEAILADQIEGEELNISFSPKYMLDALKVLEGAEIRVSFTGAMRPFLI
RTPNDETIVQLILPVRTY
>PK3-2_01005 Chromosomal replication initiator protein DnaA
MENILDLWNQALAQIEKKLSKPSFETWMKSTKAHSLQGDTLTITAPNEFARDWLESRYLH
LIADTIYELTGEELGIKFVIPQNQDVEDFMPKPQVKKAVKEDTSEFPQNMLNPKYTFDTF
VIGSGNRFAHAASLAVAEAPAKAYNPLFIYGGVGLGKTHLMHAIGHYVIDHNPSAKVVYL
SSEKFTNEFINSIRDNKAVDFRNRYRNVDVLLIDDIQFLAGKEQTQEEFFHTFNTLHEES
KQIVISSDRPPKEIPTLEDRLRSRFEWGLITDITPPDLETRIAILRKKAKAEGLDIPNEV
MLYIANQIDSNIRELEGALIRVVAYSSLINKDINADLAAEALKDIIPSSKPKVITIKEIQ
RVVGQQFNIKLEDFKAKKRTKSVAFPRQIAMYLSREMTDSSLPKIGEEFGGRDHTTVIHA
HEKISKLLADDEQLQQHVKEIKEQLK
>PK3-2_01006 Ribonuclease P protein component
MKKRNRLKKNEDFQKVFKHGTSVANRQFVLYTLDQPENDELRVGLSVSKKIGNAVMRNRI
KRLIRQAFLEEKERLKEKDYIIIARKPASQLTFEETKKSLQHLFRKSSLYKKSSSK
>PK3-2_01007 Membrane protein insertase MisCA
MKRRIGLLLSMVGVFMLLAGCSSVKEPITADSPHFWDKYVVYPLSELITYVAKLTGDNYG
LSIILVTILIRLLILPLMIKQLRSSKAMQALQPEMQKLKEKYSSKDQKTQQKLQQETMAL
FQKHGVNPLAGCFPILIQMPILIGFYHAIMRTQAISEHSFLWFDLGEKDPFYILPIVAGV
ATFVQQKLMMAGNAQQNPQMAMMLWIMPIMIIVFAINFPAALSLYWVVGNLFMIAQTFLI
KGPDIKKNPEPQKAGGKKK
>PK3-2_01008 hypothetical protein
MRDVTAAGRNVDEAVQSGLQELGLTRDKVEITVIEKGNKGFLGIFGKKPAVVKLVEKIDP
IQQAKSYLQTIAEAIAGKSHVTVQESKKTVSFHITGEKAALLIGKRGQTLNALETLTQLV
LNRYPGQYKNVMVDAENYRLKRKDTLSQLAIRLADQALKTKKAVHLEPMPSSERKIIHDT
LSGYANHQIKTYSMGEGENRHLVISHKR
>PK3-2_01009 tRNA modification GTPase MnmE
MDTIAAISTPMGEGAIAIVRLSGPEAIQIADKIYKGPKGKTLSSVDSHTIHYGHIVDRPS
DRVVEEVMVSVLKAPRTFTREDVIEINCHGGIVTVNQVLQLALREGARLAEPGEFTKRAF
LNGRIDLSQAEAVMDLIRAKTDRAMNVAMNQMEGRLSALVRRLRSEILETLAHVEVNIDY
PEYDDVEEMTHQLLVEKATAVKKEIEALLRTSEQGKILREGLSTVIIGRPNVGKSSLLNS
LVHEAKAIVTDIPGTTRDVIEEYVNVRGVPLRLVDTAGIRETEDIVERIGVERSRQVLKE
ADLILLVLNYSEELSEEDVKLFEAVEGMDVIVIMNKTDLEAKIDSERVRELANGRPVVTT
SLLKEEGINDLEEAIQSLFYTGAIESGDLTYVSNTRHISILQQAKRAIEDALSGIEQDVP
IDMVQIDLTRCWELLGEIIGDSVHESLIDQLFSQFCLGK
>PK3-2_01010 tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG
MGYEAGQYDVIVIGAGHAGVEAALASARQGAKTLVLTINLDMVAFMPCNPSVGGPAKGIV
VREIDALGGEMGRNIDKTHIQMRMLNTGKGPAVRALRAQADKFQYQHEMKNTLEKEPNLT
LLQGIVERLIVEDGECRGVITQTGAHYRAKAVVMTTGTYLRGRIILGDLSYSSGPNNQQP
SIKLSEHLEELGFDLVRFKTGTPPRVKSDTIDYSKTEIQPGDEVPRAFSYETVEYITDQL
PCWLTYTSPETHEIIDSNLHRSPMYSGMIKGTGPRYCPSIEDKVVRFNDKPRHQIFLEPE
GRNTQEVYVQGLSTSLPEDVQQRMLATIPGLENVQMMRAGYAIEYDAIVPTQLWPTLETK
KITNLYTAGQINGTSGYEEAAGQGIMAGINAGRKALGKEEVILSRSDAYIGVLIDDLVTK
GTNEPYRLLTSRAEYRLLLRHDNADLRLTEIGHRIGLISDERYAAFEKKKAAIEAEKKRL
HSVIIKPSPENQEYIRSLGGSELKDGVRGTDLMKRPEMNYETVTKLAPPEVPVPQDVSEQ
VEIQVKYEGYIEKSLQQVEKLKKMENKKIPDRIDYDAIKGIATEARQKLKNVRPLSVAQA
SRISGVNPADISILLVYLEQGRIAKIAE
>PK3-2_01011 Ribosomal RNA small subunit methyltransferase G
MNIEEFTSGLAEKGISLSPRQLEQFELYYDMLVEWNEKINLTSITEKKEVYLKHFYDSIT
AAFYVDFNQVNTICDVGAGAGFPSLPIKICFPHLHVTIVDSLNKRITFLEKLSEALQLEN
TTFCHDRAETFGQRKDVRESYDIVTARAVARLSVLSELCLPLVKKNGLFVALKAASAEEE
LNAGKKAITTLGGELENIHSFKLPIEESDRNIMVIRKIKNTPKKYPRKPGTPNKSPIEG
>PK3-2_01012 Nucleoid occlusion protein
MKHSFSRFFGLGEKEQEPEIAEHETNKEEILEIPVNAIVPNRFQPRTIFSDEKIKELAMT
IHTHGIIQPIVVRHTEEEGQYELIAGERRWRAVQSLEWEKIPAIIKDFSDTETASVALIE
NLQREELSSIEEAHAYARLLELHDLTQEALAQRLGKGQSTIANKLRLLKLPQPVQDAIME
KKITERHARALIPLKQPELQVTLLTEIIEKSLNVKQTEDRVVKMLEQGQRKPKPRRKAFS
RDTRIAMNTIRQSLSMVEDSGVKLNTEEEEFEEYIQLTIRIPK
>PK3-2_01013 hypothetical protein
MVYKTKRDVPVTLMVVFLILLIQADAIVPFVLGNVRISGWIIFTLLTLLNVLIIWSFIDL
KYVLKDHQLIIKAGLIKHHIPYEKIDKVVQKKKLWSGFRLIGSRHAITIYYQGGWGHAVI
SPQNHEEFIHKLEEKNTNITKFTKSN
>PK3-2_01014 Sporulation initiation inhibitor protein Soj
MGKIIAITNQKGGVGKTTTSVNLGACLAYIGKRVLLVDIDPQGNATSGLGIEKADVEQCV
YDILVDDADVIDIIKATTVENLDVIPATIQLAGAEIELVPTISREVRLKRALEAVKQNYD
YIIIDCPPSLGLLTINALTASDSVVIPVQCEYYALEGLSQLLNTVRLVQKHLNTDLMIEG
VLLTMLDARTNLGIQVIEEVKKYFRDKVYKTVIPRNVRLSEAPSHGKPIILYDPRSRGAE
VYLDLAKEVAANG
>PK3-2_01015 Stage 0 sporulation protein J
MAKGLGKGINALFNQVDSSEETVEEIKVADLRPNPYQPRKHFDDEALAELKESVLQHGIL
QPLIVRKSLKGYDIVAGERRFRAAKLAGLETVPAIVRELSEALMREIALLENLQREDLSP
LEEAQAYDSLLKHLDLTQEQLAKRLGKSRPHIANHLRLLTLPENIQQLIAEGTLSMGHGR
TLLGLKNKNKLEPLVQKVIAEQLNVRQLEQLIQQLNQNVSRETKKKEPVKDAVLKERESY
LQNYFGTTVSIKRQKKKGKIEIEFFSNEDLDRILELLSERES
>PK3-2_01016 hypothetical protein
MNRKGGLFSSQERVKQYVSHTDAAAAKQIQTILSSSLRKAAGKPIVVVCIGTDRSTGDSL
GPLVGMKLKQMPLTRFHIYGTLSDPVHAVNMKDKINDIQKIHKNPFIIAVDACLGRVKSV
GSFQIGEGPLKPGAGVQKDLPEVGDLHINGIVNVSGFMEYFVLQNTRLHLVMNMANVLAE
GLSLTDRTEWRQERLNPLQKLTGRI
>PK3-2_01017 hypothetical protein
MLWRAGMKWMLLILGSLIGAGYASGQEIWQFFGAESGLAIVLFTIMFMFSSYIVMKISFK
VQSTHFLPVLEHLMGPWLAKIYDVLIIFYLFSTTMVMIAGGGVTLQMYKLPFWWGIALIC
IVTVCLFFWDVKGILSVNGILIPVLVAGLLYALISFQSTHHHTWTIDLTRQYNWPASITF
TSLNILSVVAILSSVGKEMKGLGEAKIASVASGLIFGVISFVYNETLVDLAGSLSQFEIP
LFAVLEGAPYLLFLCMTAVLCLAIYTTTVAGLLGLSSRLMAFVHMPRWMIVLILLALMVP
FTSFGFSDLIAFLYPIYGMLNLYLLVCLLLYPILSKWK
>PK3-2_01018 hypothetical protein
MADKDFGLNDIVEMKKTHPCGANSWKIIRMGMDIRIKCEGCSHSVMIPRKEFERKIKKVL
VKHEEPTS
>PK3-2_01019 putative dimethyl sulfoxide reductase chain YnfF
MSKVHQSACPLNCWDSCGFLVTVEDGKVTKVDGDPNHPITEGKICGRGRMLETKTNSPDR
LRYPMKKQNGEFVRISWEQALDEIADKLREIKETSETTAVLHSHDYANNGLLKALDQRFF
NGYGGVTEIVGSICWGSGIEAQSWDFGRSYGHGPLDIYNSKHVVVWGRNVSRTNMHLYHH
LQQVKKKGATITVIDPIFNPTAKLADRYISVKPGMDGWLAAAVLKVLIETGRTDGTFISE
HSVGFDHVKELLNTVSLEEFIVKTETSMEELEYLAGLYADGPVSTFMGLGMQRYKNGGGT
IRWIDALVAASGNVGIKGGGANFGNVQIGESFAKTKLTLPELKTASRSFSMMTQAEEVLT
AADPAIEMIIVTCGNPLTQVPNTNKVRQAFENVPMTVAIDSIMTDTAKLCDYVLPTATVF
EEEDIYYSSMYHHYVQYGKKLVEPQDEAKPDSWIWSELAKRLGFGELFEHSTEEFLEMGL
SSLEAEDVTLERLKEKGHLPLPVKQVPWDDYEFLTPSGKFEFTSSLAEEKGFSGLLQLNV
PEESVFHNEELAGKYPYTLLSIHPQRSNHSQHVPFIEKLQHIQVDISPDIAAEQNLQDGD
AVAIFNDRGRLKGKAKVMKQAHPKTINIDEGMWAAFGGSVNALTNDTNSDNGMGSTLYDC
LVGLKKA
>PK3-2_01020 Ribosome-binding ATPase YchF
MALTAGIVGLPNVGKSTLFNAITQAGAESANYPFCTIDPNVGIVEVPDDRLQKLTELVKP
KKTVPTAFEFTDIAGIVKGASKGEGLGNKFLSHIRQVDAICHVVRAFSDDNITHVSGKVD
PIDDIETINLELILADMETVEKRITRVSKLAKQKDKDAVFEFEILSKLKEAFESEKPARS
VDFTEEQQKLVKQLHLLTSKPILYVANVSEDEVADPSGNENVAKIREYAAGENAEVIVVC
AKIESEIAELEGDEKQMFLEELGIEESGLDQLIKASYSLLGLATYFTAGEQEVRAWTFKK
GMKAPECAGIIHSDFERGFIRAETVAYEDLLAGGGMAGAKEAGKVRLEGKEYVVQDGDVI
HFRFNV
>PK3-2_01021 30S ribosomal protein S6
MRKYEVMYIIRPNIDDESKKAVIERFNNVLTSNGAEITGTKDWGKRRLAYEINDFRDGFY
QILNVQADAAAVQEFDRLAKISDDIIRHIVVKEEE
>PK3-2_01022 Single-stranded DNA-binding protein A
MLNRVVLVGRLTKDPELRYTPNGAAVATFTLAVNRTFTNQSGEREADFINCVTWRRQAEN
VANFLKKGSLAGVDGRLQTRNYENQQGQRVFVTEVQAESVQFLEPKNGGGSGSGGYNEGN
SGGGQYFGGGQNDNPFGGNQNNQRRNQGNSFNDDPFANDGKPIDISDDDLPF
>PK3-2_01023 30S ribosomal protein S18
MAGGRRGGRAKRRKVCYFTSNGITHIDYKDVDLLKKFVSERGKILPRRVTGTNAKYQRKL
TAAIKRARQMALLPYVSGE
>PK3-2_01024 Exodeoxyribonuclease
MKLISWNVNGLRAVMRKMDFLAYLKEEDADIICLQETKIQDGQVDLQPEGYHVYWNYAVK
KGYSGTAVFSKQEPLRVMYGIGIEEHDQEGRVITLEFENMFVMTVYTPNSKRGLERIDYR
MLWEEALLDYILELDKKKPVVLCGDLNVAHQEIDLKNPKANRKNAGFSDQERGAFIRFLE
AGFVDSFRHVYPDLEGAYSWWSYRAGARDRNIGWRIDYFIVSERLKEQIEDAGISADVMG
SDHCPVELMINI
>PK3-2_01025 Catabolite control protein B
MANIKEIARLANVSVSTVSRVLNHHPYVSEEKRKLVHQVMKELDYTPNRTAIDLIRGKTH
TVGVILPYSDHPCFDKIVNGITKAAFQHEYATTLLPTNYNPAIEVKYLELLRTKKIDGLI
ITSRANDWDSIIAYQEYGPIIACEHTGDIDVPCAYNDRKAAYAESFRYLKSRGHENIAFT
CVREADRSPSTADKAAAYQSVCGRLEDRHMLSGCNDMNDGERAAEHFYTSERIPTAIYAN
SDEVAAGIHVFAQKNNWDVEIIGEGNSSISRVLGFPSLDLNLEQLGIAAFSLFLQDEPDD
IKIQHQFEKKA
>PK3-2_01026 hypothetical protein
MRIEHTAIWVKDLERTKAFYETYFNGKANDLYHNEKKDFKSYFITFDSGARLEIMKKGNV
IDTPSQTMTGWAHIAFSVGSREKVDELTARLKKDGFAVVNGPRTTGDGYYESVIEDDEGN
LIEITI
>PK3-2_01027 Maltose O-acetyltransferase
MLRTEKEKMAAGELYNPEDPQLLLERKHARQLIRQYNETPEDDAVRTELLKELLGSIGDQ
VTILPTFRCDYGYHIHIGDHTFVNFDCVVLDVCEVRIGRHCLIAPGVHIYTAGHPLDPIE
RKSGQEFGKPVSIGDHVWIGGRAVINPGVTIGDNAVIASGSVVTKDVPANTVVGGNPARM
LKEL
>PK3-2_01028 Inner membrane metabolite transport protein YdjE
MNTIFRQKNTHPFSNAANRLDRLPISRVHFQVLTALGIVYFFDLADLFTLSNVAPALIEH
WGIPLSTIANVTAASFLGMFLGASLGGRLSDRIGRKKALNLFVFVFSIASLCNAAAWDIP
SLMTFRFLTGFGVAAAMVITNSYLAEFFPSSVRGKYISFCAMIGLIGVPITNIVSAFVIP
LGSWGWRLVFVWGAVGLIYFFFIRRLEESPRWHENRGDYAKADAILNRIEAQVEQEKGPL
PAPAQPKANSSVQQHAGYAGLLKGRNLKITIILSAVWIFETFGFYGFASWVPSLLKSNGF
TMENTLWYNVLHSIGAPLGALLGSMISERFQRKWILAASAFLTAIAGLLYGMTFIPIMII
VFGFIVNITERVFTSNLYAYTSEPYPTEYRSSGSGLAYGLGRFSNIFGSLLVGFIAVQLG
YVSVFLFIGGCWLACSLLLICFGPNTNAKQI
>PK3-2_01029 hypothetical protein
MNPFIRPLEGNNTLWRYFFAFLVMVGLYVFGNIAYLFAILFTVIVNPDITFDLDKAVLSD
PLVDLYLSHVIYLFAIPGVWLAVRFILKRPFRTVITPNAQINWRRILFGFIAYFLLMIAA
QLLDFAIHPDSYSMQDVDASRFIWLLAAAVILVPIQTSAEELFFRGFLLQAFGRVTKNPI
ILTLIVGGLFGVLHFANPEMNNGAVWAGIEYLTFGFVWTYYTIKTGSIEISLGAHAANNM
FLCMFITEKNSVYGGIPSLFMVTRGNPMWEALFTIAVNLVFAGIALWYHKKSQSKQQGS
>PK3-2_01030 Cellobiose 2-epimerase
MPNKSKPNRLINEKSPYLLQHAHNPVDWFPWGEEAFEKAKRENKPVLVSIGYSTCHWCHV
MAHESFEDEEIARLLNERFVAIKVDREERPDVDSVYMRICQLMTGQGGWPLNVFITPDQK
PFYAGTYFPKTSKFNRPGFVDVLEHLSETFANDREHVEDIAENAAKHLQSKTAAKSGEGL
SESAIHRTFQQLASGFDTIYGGFGQAPKFPMPHMLMYLLRYYHNTGQENALYNVTKTLDS
MANGGIYDHIGYGFARYSTDDEWLVPHFEKMLYDNALLLTAYTEAYQVTQNSRYREICEQ
IITFIQREMTHEDGSFFSALDADTEGEEGKYYVWSKEEILNTLGDDLGTLYGQVYDITEK
GNFEGKNIPNLIHTKREQIKADAGLTEEELILKLEDARQRLLKTREERTYPHVDDKVLTS
WNALMIVGLAKAAKVYEEPKYLRLAKDAITFIENQLIIDGCVMVRYRDGEVKNKGFIDDY
AFLLWAYLDLYEASFDLSYLQKAKKLTDDMISLFWDEEHGGFYFTGHDAEALIVREKEVY
DGAVPSGNSVAAVQLLRLGQVTGDLSLIEKAETMFSVFKPEIDAYPSGHAFFMQSVLRHV
MPKKEIVIFGSADDPARKQIIAALQKAFKPNDSILVAEHPDQCKDIAPFAADYRIVDGKT
TVYICENFACQQPTTNIEEAIQTLISSRD
>PK3-2_01031 DNA gyrase inhibitor
MNITIEELPESRIAYFRNVGEYGEKQNKELMETFKKWAKLNDVFDNSTILGIPQDNPEIT
PKEECRYDVCVVINKDFNVKKPAHVGEFSGGKYAVFLLDHTKEAVRDFWGNISSEIERNN
LSIREQPIIERYTPQMIDSHFCEILIPIQ
>PK3-2_01032 hypothetical protein
MPTNNKPNRLIAEKSPYLLQHAHNPVNWFPWEEEAFEKAKRENKPVLVSIGYSTCHWCHV
S
>PK3-2_01033 hypothetical protein
MLNKPSDYIEAGLKLELEEDLKYLFNLTADIKMVPKGTIVLSQGQRVSSLYYIHKGIMRG
YYIDASGNDVTKCFAAETEFACAEGLLRVEEARFSVESLQDSICVVIPYNSIYQGMKKTN
QMKVIFTNYIQKILVDTLNREQALLMKDALERYMEFKREYSSLESRINQSYIASYVGIRA
SSLSRIKRSMKIE
>PK3-2_01034 Aurachin B dehydrogenase
MKKISLVTGANGHLGNNLVRELLKRGETVRAGVRDLNDKEPFIGLDCEIVYADLRDKDSL
HKALDGVNTLYQVAAVFKHWAQDPEKEIIIPNVEATQNIMEAAKDANVRKIVYVSSVAAL
SLDKTNLKGKIDETTWLENSYGNAYFDSKARAERTAWDLAEKYDLDMVSVLPGAMIGGEF
LKKTPTILAFDSILLGKMKVNYISEMTPIDVTDVVKGMIAAAEKGVRGTRYILANEEPVT
SDDIIKIAKNLFLILRYHKNILKNSC
>PK3-2_01035 hypothetical protein
MPNKSKPNRLIAEKSPYLLQHAHNPVHWFPWGEEAFEKAKRENKPVLVSIGYSTCHWWQV
RIANTYNYDILEVYYIQETIKGDELLELKNKIKRAAI
>PK3-2_01036 hypothetical protein
MKHLNIYLMLLGFSIFTGATFNLAKYTVGYFSPSSSAAWRFGLAAAVMLIILIFTEGINK
SQLRKNAVSYIVLGIIGIFGFNALFFVGLKYTSPVNGALIMGLNPLLTAILARIILKDKM
TKKQGLGIFFAFIGVLLVITQGSIETIKTLSISGGDLIILTGNVCWALYGVLGRRFVKDG
TPLSTTTYTMVIGAVSLIVVSLFTSNPVSLPNIPIGVWGAIAFMAFFTSVLGYLWWNQGI
KEIGASKTSLFFNLVPVVTMIISFAVGTPIKVFQVIGAGLVILGVLTASGVIRIPKYNTK
EQSAV
>PK3-2_01037 hypothetical protein
MYSISKAAEKTSISSYTLRYYEKIGLLPPPKRKNSGRRFYTETDIQFMLFLKSLKETGMS
LEDINEFVKDGCILEKISSDVKSAQLSPSINKRIEILTKHLEKMEIKKRELEEVISTTKG
KLDTYHSILKEEVENK
>PK3-2_01038 hypothetical protein
MIANKMKYMYYGLGILVLSLGISLTIQSGLGTSPFDALLVGLSEEVGLTVGSWEVLISVI
LLLCNSILTRKKPILLGLITAFITGIGIDLWLFVVKNTLDPNALLSKLICFGIGLVLIGL
GTAIYLQTKFASTPIDHLTLIIRDLSKERSYFREHWYMLFS
>PK3-2_01039 putative N-acetyltransferase YjcF
MNIKRITTETDLHVAKDIRKTVFIEEQQVPESDEFDQFDTINEQCQHVLVYHKNLPVGTG
RVRIIDQTGKLERICILKPYRKFGLGKGIISGLENIMKEKGISAFKLHGQTQAAGFYKKL
GYQITSQEFMEDGIPHVLMTKE
>PK3-2_01040 hypothetical protein
MNDILREIGMIARALDSISNIEFKDLDLTRGQYLYLVRIYENPGIIQEKLAEMIKVDRTT
AARAIKKLEMQGFIQKRPDEQNKK
>PK3-2_01041 hypothetical protein
MEVALSGFTPEEKETIFKLVHRVRKNVERDWEYVKKGNKRDY
>PK3-2_01042 Hydroxyacylglutathione hydrolase
MNLRQLSEHVFQCEFELDEPIHIPVHTWFIKDGDDVYIVDTGIERFVDVQIRAALAIGNP
KAILLTHGHSDHIGGASKWLERFDIPIYAHQKELIYINGEAPYPNKNEVENTGVAHIVQP
LTEQTLAHLPLQYYLTPGHSPGHVVYHHQTDRTLLTGDLFITNEEDLHPPIRRFSVDINE
NIDSGAIIDKIKPTLICSSHGEEILYNEELYKNYVLRYRD
>PK3-2_01043 Beta-lactamase 3
MKSLSNIFRTSVFRKMIPVLFLSCATLVGCSNNNVDAESTKPPKKETSSNHNFAKLEEEY
DVKLGVFALDTGTNQTVTYHPDERFAYASTHKALAVGALLQQKSIEELNQRITYTREDLV
NYNPITEKHVDTGMTLKELADASLRYSDNTAGNLILKQLGGPTGFKKALEEMGDDITNPE
RFEPDLNEVHPGETHDTSTPKALATSLQAFTLGDALPIEKRELLIDWMKRNTTGDALIRA
GVPKGWEVADKTGAGSYGTRNDIAIIWPPKGDPIVLAVLSSRDKKDADYNDKLIAEATKE
VIKALKVKNK
>PK3-2_01044 hypothetical protein
MFDVFPIMQQLLEMLWYLHEAISLEAAKPIHRELRTCFKKTDKLTRLSKESLLTLLVHVH
RTEVNEWLLKTSELVRAQARNPKLPKKISRGSVLIGAKLKGLDLRGANLRGALLIAADLR
NADLGMTDFIGADLRDADLRGADLTESIFLTQAQVNAANGDSNTKLPQSLQIPAHWK
>PK3-2_01045 putative protein YybH
MEQQIKDIISACDVAIKNEDFDTLMNYYTEDAILVVKPGMTARGKEEIKKAFIAIANYFD
HDIVPTQGEMAILEAGDTALVLSQTLLDSDKTDSEYAMERRATYVFKKNAQDEWLCAIDN
SYGTDLIGV
>PK3-2_01046 hypothetical protein
MTSLNLYDIRMAPYWFYAGGNGGLVQHPYVFRQPVSSRAIIASARGDVTGDGVIDEVFLT
GIQMPGSPLWREITLVIRDGRTHQEQRIQLQNNMGYNPSLFLGDMTGDKIDDVAVVIDTG
GSGGTIYAYIFAYLNRQFRQIFNSDVFNDEFKYSVSYLNQYKASVISHHQNETYILDLTY
KGREYLNEIYTSQGVLKMPIEGWVNPLSGLYPVDFDRDGTYELVAYQRIAGRYNADSLGY
VQTVLKWNGRRFMFDRQTVSIFGSDLS
>PK3-2_01047 putative galactarate transporter
MTEEVFIMSQERVKRPGHTRWYISSLLSGIIILNYFDRVAISVAAPAIQDSFHLTATELG
IVFSIYTYSYTLMQLPVGSLLDRFGVAWVTRIGMTIWSFLTILLAFLQGKLLLYLFRFLI
GLTSASAFPAASKATALWFPPSERGLANSLFDSAAKFSNVLGAPLVAFLVTTFDWRVAFL
TIGCINVLFTIFFWQYYEQPERHKRISKSELNYIQKHNTITTEQIPYKTGPLLKALFTNR
KVWGLMIGFTGYGYTFNLLLTWLPTFFKHTYGMDLMSSGLFTAVPWLISTISGIAVGGWL
VDYFIKKGYSNTKVYRTVIIVGMSFGFFFLGSILTDNITVAIICISIGLAGISATAPVGW
SISAELAPIGSVSMLSSMVNLANNLFGGIIAASLTGYLFDVTGSFTLSFLVAGFVLLLGL
FFYVFVLGDVKRIKLE
>PK3-2_01048 hypothetical protein
MSKLKKWLKRELVRKGLPLAKEKLIPILKEKMRKKR
>PK3-2_01049 hypothetical protein
MKIMLTVVAGVGLLSAGGCGMLNQVNDGLNYTSEATGYVEKVKTFAEDAPELAEQAVHDS
EAKEKLEAQLESIKQAAADFNELTPPAAAEEIHQTIQEHNETLQKSADDVLKQVEEGKVS
LEEWEQSDLIQNTKQIADVMGQIEKLGE
>PK3-2_01050 Manganese-dependent inorganic pyrophosphatase
MEKILIFGHQNPDTDTICSAIAYADLKNKLGFNAEPVRLGQVNGETQYALDYFKQESPRL
VETAANEVNGVILVDHNERQQSIKDIEDVQVLEVIDHHRIANFETAEPLYYRAEPVGCTA
TILNKMYKENNVKIEKEIAGLMLSAIISDSLLFKSPTCTDQDVAAAKELAEIAGVDAEEY
GLNMLKAGADLSKKTVEELISLDAKEFTLGSKKVEIAQVNTVDIEDVKKRQAELEAAISK
VVAEKSLDLFLLVITDILENDSLALAIGNEAAKVEKAFNVTLENNTALLKGVVSRKKQVV
PVLTDAMAE
>PK3-2_01051 putative HTH-type transcriptional regulator YybR
MSEKNNIYPNKEGCPVEFTLDVIGGKWKGILFYHMIDGKKRFNEFRRICPSITQRMLTLQ
LRELEADGIVHREVYHQVPPKVEYSLTEFGRTLEPIVLQMKAWGESNRDVLESYRSNGLL
KDQQK
>PK3-2_01052 Spore coat protein F
MDERRTLAWHETLEMHELVAFQSNGLIKLKKMIREVKDPQLRQLYSVSIQAVEQNLRELL
PFFPQAPHREDEEEERADNPFYSGDLLGFAKTSVRSYAIAITETATPQLRNVLVKQLNAA
IQLHAQIFQYMYQHGYYPAYNLSELLRNDVRNANRALSMK
>PK3-2_01053 hypothetical protein
MWDMIKNFFLFSSGVLQATTLLLVILIFMYVRKTKKKNKESSGFMDDKH
>PK3-2_01054 hypothetical protein
MKQTRALMEGAILISLFAIITLLVVYVPLVGTILLFVLPLPMILYTIRHGLKLGIWMGVV
SLPVVFIVGSFNGLIVAFMSACAGIAMGHYFKKKEPGHAVISGALIYMLCIVFYIVISIQ
FLGTNIIDEAMTNSRQSLDIVETVGKQTGNAEQFEKQLKLMEEQLGTAQYLFPTAIVVLG
AIFSFLSYLVAKPLLRRFSPDIPSLKPFRELKFPQSVVVLYLMIVMLSFLPLEKGQMLYS
IALNGEFILGFLIFIQGVSFIFFYCHKKQYPKAAAVIAVILGFVHPIFMAAIRILGVLDM
GFQIRNKVN
>PK3-2_01055 Cyclic-di-AMP phosphodiesterase GdpP
MPSFYEKPLFRYPIYALIALSIITILISFYFNWILGTVEVLLIAVILFFIKRADSLIRQE
IDAYISTLSYRLKKVGEEALMEMPIGIMLFNDQYYIEWANPFLSSCFNESTLVGRSLYDT
CESVVPLIKQEVESETVSLNDRKFKVVIKRDERLLYFFDVTEQTQIEKLYENERTVLAYI
FLDNYDDVTQGLDDQTRSTMNSQVTSLLNAWAQEYGIFLKRTSSERFIAVLNEHILTELE
NSKFSILDEVREKTSFDGVALTLSVGVGASVSSLKELGDLAQSSLDLALGRGGDQVAIKL
PNGKVKFYGGKTNPMEKRTRVRARVISHALKEIVSESSNVIIMGHKFPDMDSIGAAIGIL
KVAQANNKDGFIVIDPNQIGSSVQRLIEEIKKYEELWSRFITPEEAMEISNDDTLLVIVD
THKPSLVMEERLVNKIEHIVVIDHHRRGEEFIRDPLLVYMEPYASSTAELVTELLEYQPK
RLKINMIEATALLAGIIVDTKSFSLRTGSRTFDAASYLRAKGADTVLVQKFLKETVDSYI
KRAKLIQHTVLYKDNIAIASLPENEEEYFDQVLIAQAADSLLSMSEVEASFAVARRDEQT
VCISARSLGEVNVQIIMEALEGGGHLTNAATQLSGISVTEALERLKHAIDEYFEGGVQR
>PK3-2_01056 50S ribosomal protein L9
MKVIFLQDVKGKGKKGEVKNVADGYAHNFLIKKGLAVEANASNISALNGQKQKEKKEAIA
ELEQAKSLKETLEKLTVELSAKSGEGGRLFGSVTSKQITEQLQKDHKIKVDKRKLDLPDG
IRALGYTNVPVKLHPEVQAVLKVHVKEEA
>PK3-2_01057 hypothetical protein
MKTKRFDAVLILILLTAAFLNMYNIWQDDTANLYYLAAVKSMTQSFHNFFYASFDPSGFV
TVDKPPVVLWIQTIFALIFGVHTWSVILPQAFAGVGSVFLLYRMIKPTFGIGAARIAALV
MALTPIAAAVSRTNNIDTMLVFTLLLGSACLLRAVKHGKLVWLLTAFALIGLAFNMKMMQ
AFMVLPAFVLFYLIASRISLKKKIGSLILSLVLLTGISLSWAVVVDSTSSSSRPYVGSSQ
TNSVLELSFGYNGTERLLGQTTGLARSDTNAADGGNMQNNSNMQAPNGSGSASSQNGKSD
GNTANQNGNPSFGNNSQAPPSGQSGTPNGGGGTPPTGGSGPGNGGPGGGGGKSMNMFGTG
DAGPLRLFQSALSGQISWMLPFALIGLLGGIVSWYRDRRGQAAEMKETLFWTAWLVPVAG
FFSVAGFFHQYYLIMLAPPIAALSGIGWYMMCRLYKNNKDWASYLLPAAVLITAAFQVYI
LSAYTSQIGSVWMYVLGLLGLGITFALLMLKRSHPFSKHLAIIGLCVLLLAPVYWSATPL
LYGGNSVLPESGPQLKSSANGGSMFSSEVDTGLLSYLRKHNTGEEYLFATLTTVTAAPYI
INENESVMAMGGFNGTDPILTVSELKKLVKAGKVKYFLLSRNNSGNSELVSWIKKNGKEI
SSDQYSSSSNSTNSTQQGMMRGGPGGESQQSLYLVE
>PK3-2_01058 putative transporter YycB
MPKHKNIQSFWLITGIIFIAFNLRPAITSVGPVISSIRADLHMSNGTAGFLTALPLLSFA
VLSPLAPKLGQRLGNERTLWLGLLMLLIGILLRSAGVTWALFAGTALIGIGIAIGNVLLP
SLIKHKYPEKSGIMISLYTTSMCIFAALASGVSVPLAAQMGGGWKQAFLLWGVMALLALL
IWIPQLRHRDTANKAVKLQTSSIWFSKMAWHVTIFMGLQSFLFYSSIAWFPEILRSHGMD
TSTAGWMVSLMQFASLPFTFLTPVLADRMKHQRGIAAGLTAVYLIGLCGLLAGGSHILLA
IWMIIIGIGQGSSISLALTLIGLRSENAQQAAALSGMSQSFGYLLAAIGPIFVGYLFDQT
HSWTMPIVLLIAALILMGAAGLGAGRDQYILQTQKQRNSA
>PK3-2_01059 putative protein YycC
MRPLQISAETAQKLAESLNLPLEQIMHMPQHILLAKLAELQKEEEQS
>PK3-2_01060 hypothetical protein
MHAPLSLLKQMLNEHQKDTEKAVTYEEYLAVRLRLQELMGKFASFEEWDLYQKAADLMMH
TGFQWMK
>PK3-2_01061 hypothetical protein
MMKKYAVTPNVDADGWFIKVENVAPTALYTSKDAAIEKAKQVAKENSPSKLVIYDQFKNV
EEEHSF
>PK3-2_01062 Replicative DNA helicase
MTDVLNDRLPPQNIEAEQAVLGAIFLQPSALTLASEVLIPDDFYRMSHQKIYNAMLVLGD
RGEPVDLVTVTSELANTDLLEEVGGISYLTDIANSVPTAANIEYYAKIVEEKSILRRLIR
TATTIAQDGYTREDEVEDLLSEAEKTIMEVAQRKNTSAFQNIKDVLVQTYDNIEQLHNRK
GDITGIPTGFTELDRMTAGFQRNDLIIVAARPSVGKTAFALNIAQNVATKTDESVAIFSL
EMGAEQLVMRMLCAEGNINAQNLRTGNLTEEDWGKLTMAMGSLSNSGIYIDDTPGIRVSE
IRAKCRRLKQESGLGMILIDYLQLIQGSGRSKDNRQQEVSEISRELKSIARELQVPVIAL
SQLSRGVEQRQDKRPMMSDIRESGSIEQDADIVAFLYRDDYYDKETENKNIIEIIIAKQR
NGPVGTVSLAFVKEYNKFVNLERRFDDAGVPPGA
>PK3-2_01063 putative protein YycE
MGKRFSYFHAAQIRIARPTGQLHEIIRFYEEGLGLKRIGEFSQHNGYDGVMFGLPHADYH
LEFTQFDGESGAPVPHPDSLLVFYVPDAGELKAITSKLKHMGYQEVESENPYWSHGGVTI
EDPDGWRIVFMNTKGLSGK
>PK3-2_01064 Adenylosuccinate synthetase
MSSVVVVGTQWGDEGKGKITDFLSENAEVIARYQGGNNAGHTIKFDGVTYKLHLIPSGIF
YKDKTCVIGNGMVVDPKALVTELAYLHERNVSTDNLRISNRAHVILPYHLKLDEVEEERK
GANKIGTTKKGIGPAYMDKAARIGIRIADLLDRDAFAEKLERNLEEKNRLLEKMYETEGF
KIEDILDEYYEYGQQIKKYVCDTSVVLNDALDEGRRVLFEGAQGVMLDIDQGTYPFVTSS
NPVAGGVTIGSGVGPTKIQHVVGVSKAYTTRVGDGPFPTELKDEIGDQIREVGREYGTTT
GRPRRVGWFDSVVVRHARRVSGITDLSLNSIDVLTGIETLKICVAYRYKGEIIEEFPASL
KALAECEPVYEEMPGWTEDITGAKSLSELPENARHYLERVSQLTGIPLSIFSVGPDRSQT
NVLRSVYRAN
>PK3-2_01069 Transcriptional regulatory protein WalR
MMDKKILVVDDEKPIADILEFNLRKEGFEVHCAHDGNEAVEMVEELQPDLILLDIMLPNK
DGVEVCREVRKKYDMPIIMLTAKDSEIDKVIGLEIGADDYVTKPFSTRELLARVKANLRR
QLTTAPAEEEPSSNEIHIGSLVIFPDAYVVSKRDETIELTHREFELLHYLAKHIGQVMTR
EHLLQTVWGYDYFGDVRTVDVTVRRLREKIEDNPSHPNWIVTRRGVGYYLRNPEQD
>PK3-2_01070 Sensor histidine kinase WalK
MNKVGFFRSIQFKITLIYVLLIIIAMQIIGVYFVNQVEKSLINSYEQSLNQRIDNLSYYI
EQEYKSDNDSTVIKDDVSRILNDFTKSDEVREISFVDKSYEVVGSSKPYGEEVAGKQTTD
LIFKRIFSTKQSYLRKYYDPKSKIRVLISAKPVMTENQEVVGAIYVVASMEDVFNQMKTI
NTILASGTGLALVLTALLGIFLARTITHPLSDMRKQAMELAKGNFSRKVKKYGHDEIGQL
ATTFNHLTRELEDAQAMTEGERRKLASVIAYMTDGVIATNRNGAIILLNSPALELLNVSR
ETALEMPITSLLGIQENYTFEDLVEQQDSMLLEIERDDQLTVLRVNFSVIQREHGKIDGL
IAVIYDVTEQEKMDQERREFVANVSHELRTPLTTMRSYLEALAEGAWENKDIAPRFLMVT
QNETERMIRLVNDLLQLSKFDSKDYQFNREWIQIVRFMSLIIDRFEMTKEQHVEFIRNLP
DRNLYVEIDQDKITQVLDNIISNALKYSPEGGHVTFSIDVNEEEELLYISVKDEGIGIPK
KDVEKVFDRFYRVDKARTRKLGGTGLGLAIAREMVQAHGGDIWADSIEGKGTTITFTLPY
KEEQEDDWDEA
>PK3-2_01071 Two-component system WalR/WalK regulatory protein YycH
MIGMKRENIKTILLTVLVIISLVFTWGIWTFQPNFSEGSSSTESTVREKHKIEKNTQKLS
ETVRPREMFIHDDGAHYKVDETLYEEVWSDLPHWDVKGIKDISDQYDKTGFKSWFYGIGS
SEAKLDLHFSDTIPIDIFQTLFKWSNQSFEYSSFDHILIPFNETKANKKIYLVSYSKQLI
LEVTVESANYRNIMNDLENRQSNMPAYSLFSIGSKKEFLLPNKPLTMDKKEFVTESIKTS
TFKQALFSDPSIVREDSNYNNRNVLTDGISRLDVNLSQRQVQFQQRNLVQSTSYQTGELI
KKSQKYLEDTGSWTDHYQFFNINDSQQLSFYIFMDQMPVINSTAKPFGATSAITVQWAND
DILSYKRPNFSLGTNPIKTSETELMSGSEVRLLLSKQNKYDTDKIDQIFLAYQLVSTSTN
DDPLVELEPVWAMKINGKIVAITKDLLSKEGANSGVE
>PK3-2_01072 Two-component system WalR/WalK regulatory protein YycI
MEWNKTKSIFIVAFLILDIFLGYQFFQKWQATSKEYEVIKNDVEHDMKADHITYEGLNKE
ATEGYRITANQKTFTKEEIEALKDQKPLMDMPSDDHKVTSLKMKFTNPIALSKKNIEDDA
QALVSSKIQDGEKYKFWKVDKSKKEVIFFQTYEGHYIYQKTDNSSNMIGQVVLHLNDKYE
VVSYDQTTLETFKQIQKESLITEMDAVELLYYQNQLKEYSTVKSCKFGYVAQYPLTSTQV
LAPVWRITVEYEKKVNGEKKTVQEYFTVNALESTILDTDQ
>PK3-2_01073 Putative metallo-hydrolase YycJ
MSLQFSVLASGSTGNAFYLETEDHAFLVDAGLSGKAMDGLMAQIGRKLDDVDGIFVTHEH
SDHIKGLGVVARKYKLPIYANEKTWKAMENQIGKIDTDQKFVFPMETVKSFGGLDVESFG
VSHDAAEPMFYVFHYNGRKLALMTDTGYVSDRMKGIIRSSNVFVFESNHDVGMLQMGRYP
WSIKRRILSDVGHVSNEDAALAMTDVIGDETSRIYLAHLSQDNNMKELARMSVQQTLASK
GFVTGETFELYDTDPKKATPLCAV
>PK3-2_01074 Serine protease Do-like HtrB
MVDYDREEEQTAPEQPKRSKKGYFLSSLIGVIVGAVLMAFIMPYLSNEGLDTGALDQQQN
NGRESIRTVNVSVNNTVTKIVSNVSPAVVGVVNIQKSDIWGESGEAGSGSGVIYKKNDNS
AYVVTNHHVIEGASQIEISLKDGSRVAAELVGSDQLMDLAVLRVKSDKIKAVADFGDSDK
VKSGEPVIAIGNPLGLEFAGSVTQGVISGTERAIPVDSNDDGQPDWNAEVLQTDAAINPG
NSGGALLNMDGKVIGINSMKIAESAVEGIGLSIPSKLVIPVIEDLEKYGKVKRPFLGIEM
KSLSDIASYHWDETLKLPKDVTNGAVVMGVDAFSPAGKAGLKELDVITEFDGHKVNDIVD
LRKRLYQKKVGDRVKVKFYRGGKEKSVTIKLSSADQLGS
>PK3-2_01075 Arginine utilization regulatory protein RocR
MVKDSEFLTLVFQSILDEIDVGLHVVDEHGNTIVYNNKMMQIEDMEKHDVLNKNLMDVFM
FSKQQDSTLVQALQEGKTIKNVKQSYFNNKGQEITTINHTYPIVKDGKIRGAVEIAKDVT
KLERLIRENMNKKGSTTYTFDSILGTSPAIQDVIENAKRATRTSSSVLLAGETGTGKELF
AQSIHNGSDRSGGPFISQNCAALPDSLVESILFGTKKGAFTGAVDQPGLFEQAHGGTLLL
DEINSLNLSLQAKLLRALQERKIRRIGSTKNTPIDVRIIATMNEDPIDAIAGERMRKDLY
YRLSVVTLIIPPLRERKEDILLLASEFIQKNNHLFQMNVEHISEDVKQFFLSYDWPGNIR
ELEHMIEGAMNFMTDEQTITASHLPYQYHLKIKPAEIPEPETPRHQPAADLKEKMESFEK
YVIENVLRKHGHNISQAAQELGISRQSLQYRLKKFSHPPAE
>PK3-2_01076 Ornithine aminotransferase
MPALSKSKEIIDQTSHYGANNYHPLPIVISEALGAWVKDPEGNEYMDMLSAYSAVNQGHR
HPKIIQALKDQADKITLTSRAFHNDQLGPFYEKTAKLTGKEMILPMNTGAEAVESAVKAA
RRWAYEVKGVADNQAEIIACVGNFHGRTMLAVSLSSEEEYKRGFGPMLPGIKLIPYGDAD
ALRQAITPNTAAFLFEPIQGEAGIVIPPEGFLQEAAAICKEENVLFIADEIQTGLGRTGK
TFACDWDGIVPDMYILGKALGGGVFPISCIAADREILGVFNPGSHGSTFGGNPLACAVSI
ASLEVLEDEKLADRSLELGEYFKSELESIDNPVIKEVRGRGLFIGVELTEAARPYCERLK
EEGLLCKETHDTVIRFAPPLIISKKDLDWAIEKIKHVLQNA
>PK3-2_01077 Amino-acid permease RocE
MDSKLGYAPCRCSSLDPIQVAEGVQNVNTNQDNGNQLQRTMKSRHLFMISLGGVIGTGFF
LGTGFTINQAGPLGAVLSYLVGGFIMFLTMLCLGELAVAFPVSGSFQTYATKFISPAFGF
AFGWLYWLGWAVTCAIEFLSAGQLMQRWFPHVDVWIWCLVFAALMFVLNAITTKAFAESE
FWFSGIKILIILLFIILGGAAMFGLIDLKGGEQAPFLSHFYEDGLFPNGIKAMLITMITV
NFAFQGTELIGVAAGESEDPEKTIPRSIKQTVWRTLVFFVLSIIVIAGMIPWKQAGVVES
PFVAVFEQIGIPYAADIMNFVILIALLSVANSGLYASTRILYAMANEGQAFKALGKTNQR
GVPMYALIVTMAVACLSLLTKFAQAETVYMVLLSLAGMSAQVGWITISLSQIMFRRKYIR
EGGKTEDLKFKTPLYPVLPILGLTLNTVVLISLAFDPEQRIALYCGIPFMVICYIIYHVV
IKKRQQANRQLEL
>PK3-2_01078 Arginase
MDKTISVIGMPMDLGQARRGVDMGPSAIRYAHLIERLSDMGYTVEDLGDIPINREKINND
EELKNLNSVLAGNEKLAQKVNKVIEEKKFPLVLGGDHSIAIGTLAGTAKHYDNLGVIWYD
AHGDLNTLETSPSGNIHGMPLAVSLGIGHESLVNLEGYAPKIKPENVVIIGARSLDEGER
KYIKESGMKVYTMHEIDRLGMTKVIEETLDYLSACDGVHLSLDLDGLDPNDAPGVGTPVV
GGISYRESHLAMEMLYDAGIITSAEFVEVNPILDHENKTGQTAVELVESLLGKKLL
>PK3-2_01079 hypothetical protein
MKKFLIGAGVAAVILSGWFIADHQTHSQEMKVAEKMIG
>PK3-2_01080 Response regulator aspartate phosphatase G
MNKIAPAEIANMLNDWYLAIKKHEVEESARCFEEVKPLLDDMEEDQEVLAYFSLLELRHK
VLLHEARGQGFQHEEPSHMNATSDMLKYYFFLFEGMYEAYKNNYDIAIGLYKEAEQYLGN
IPDPIEKAEFHLKVGKLYYKLGQNIVSLNHTRQAVKTFREETDYKKKLASALVTMSGNFT
EMSQFEEAETYLDEAIRITRELEDHFFEAQLLHNFGLLHAQSGKSEEAVFKLEAALQHEE
YARSAYYYHSVYLLIRELFKIKKKNQALSYYQEAKEKLTAEPNRICEAKIDILYAIYAEG
GHAETFHLCKQQMDDLLSEKEYDSVRELSILAGERYREHGLYKEAAHFFYEALQIEELIK
RTEVI
>PK3-2_01081 putative N-acetyltransferase YycN
MTMMLIPMQTAEFRSYLTYTVKHYAGEKVKAGTWLPEDAQLLSKQTFSDLLPKGLETPHH
HLWSLTLHEKEIVGWLWIHAEPEHPQQEAFIYDFGLYEPYRGKGYAKQALAALDQTARSM
GVRKLSLHVFAHNQTARKLYERTGFQETDVVMSKKL
>PK3-2_01082 hypothetical protein
MRMKKRVSIFMIALTVCGGLFVSPAKAEKTTDYAEEIAELQPGTTAEDIMKSASQVAKQQ
HVKQDVILKQFYKEITADKAEGDRLAKESGMSIMGGSSGTKKLPTSAKGNIYYTNSYTAY
YNHGHVGMYSAADKIVESVPSDGVRQIAYNARDVEDNSIVQTVNVTSSQKTSAADWAVSK
VGDPYSFNFVNNRNTGHDGAKNCSKLLWSAFLLKAGIDIDSNGGLGVYPRDITSSSYTAT
IMTIR
>PK3-2_01083 hypothetical protein
MKKLMITIAMLILAGIALFVFVSPLKSHKAVSQQDLRDPDFLDDKEVLLYLSTSADQDAL
GGGKSYALFISQDGSLSSFKMKGLELGSAKVHGDSVMLEDKNTIYTIKDGLSSHKRAYQH
TGDSAGFLQNTDGFYTLYNSGYDKKGDGYRSELYRQMDGEWKKDVIPNYIRASGFHDGAI
YALVPTADEKGYQLLQIQADQKKLTCHNITEWQYREGASVESQLAVDDQAVYVMIRGQKA
RNLYQMVKINKKSGKVELHDIAEYKNDEQTIYSSMPFSFKNSFFSYDGHLYFIDGFGKVY
KIDAKTGKTSIAFTLSSEKMKADFKEITQKGSSLYFFTYTYNKPAYIEQYSLKTGKKVKE
KEIGKVKDVVVPKSHLKLYDFEVMKGF
>PK3-2_01084 hypothetical protein
MFKKIVIGTLALGITLGVGSTFASPASAAELSTQEVKAQDIKYVTGYKVTYWGLSDYNDI
PDYYNYSIDGYKGTLELYNFEPRYDGGWTAFYQGYVSN
>PK3-2_01085 hypothetical protein
MLTKRVILLAVIISLTSAAVMFLLNGGKGDWLDILGTIIGCFLGIFVVVRIQKKQS
>PK3-2_01086 Glutathione-independent formaldehyde dehydrogenase
MTGNKAVVYKGKGTVAVEDIGYPELILKDGPGVPKANVNRKCEHGVILKVITTNICGSDQ
HMVRGRTTAPEGLVLGHEITGEVIETGRDVEFIKKGDIVSVPFNIACGRCVMCRTQKTHV
CLNVNPDRPGSAYGYVDMGGWVGGQSEYVMVPYADFQLLVFPDKEHALEKILDLTMLSDI
FPTGFHGAYTAGVQTGSTVYIAGAGPVGLAAAHSAQLLGASTVIVGDLNEDRLAQARSFG
CETVNVQKHDRLGEQIEQILGEPTVDAAVDCVGFEASGHVNQGEAPAAVLNSIMDVTQVG
GSLGIPGLYVTEDPGAKDADAKTGSLKIRFGLGWAKAHTFVTGQTPAMTYNRNLMKAILS
GRAQIAKAVNATVISLDDAPKGYSDFDKGAAKKFVIDPHGTLK
>PK3-2_01087 hypothetical protein
MKQTYYSCEEHIETVLDMYIDDHELPPEIRKIEHTNSLSTACELCGDPAVYIVGNE
>PK3-2_01088 Ribosomal RNA large subunit methyltransferase H
MNINIVTIGKLKEKYLKQGIEEYTKRLSAYAKIDIIELPDEKAPENLSDQDMKIIKDKEG
DRILSKISPDAHVIALAIEGKMKTSEELADTIDKLATYGKSKVTFVIGGSLGLSDAVMKR
ADDKLSFSKMTFPHQLMRLILVEQIYRAFRINRGEPYHK
>PK3-2_01089 hypothetical protein
MKLVKLTLENYRSFGPEPTSINISDLTALIGTNSVGKTTVLSAIIKLFGESTNIKRSDFH
LLNNQTPEEVESNYFKLEAKFEFFKENSDPDEYGIPIYFENFIVSEKGGNPYIRIQLHAT
WQKSYDPEGSVDYRYYYIQCSEGENSEEHLKPINAHDKSKIKVIYVPAVRNPSDQLKNAS
GTILWRILKQINWKESDKEAIKEKIDLLDTQVANQQGISTVKSIIADQWKNYHNDQRYSN
ANIKFGSNDLESILKKLDVEFTPSHTEKAFKVSDLGDGLKSLFYLTLIDSLLELENKAIE
EITSEVTEEGRILNIDPPAITVVLVEEPENHVSPHLLGKVIKNLKSLGDKPNAQIIITSH
SPSIIKRIDPNQIRHLRIEKNNSKTVVKEVLLPPKDDEAFKFVKEAVKAYPELYFSSLVI
LGEGDSEEILLPKFLTLYNNNLDSIGISVVPLGGRHVNHFWRLLTQLAIPFITLLDLDRE
RDGGGWGRIKYALKQLIENGVDGSKLLLLKNGQILETQHLEKMHEWSLDEKRLEYLDNWI
SLLEGYNIYFSNPIDIDFMMIENFLDEYLMILKHNEGPLLAIDDKTNKRIHKLSTDDKNT
AAYLDRINDSVRKTLKENGGNGDTYTKEQKELMIWYNYFFLTRGKPVTHLQALSLIEEQH
LKDSTPDVIQRMAKKAKQILNL
>PK3-2_01090 ATP-dependent DNA helicase PcrA
MDTLNGLVNSWVPSGGLSLEQNALSAAKNLKNSLVVAGPGAGKTELLAQKACFLLETNSC
PKPKRILAISFKKDAAVNLKERVNLRVSPELAIRFNSKTFDSFAKNILDSFISTLPLKYR
PNLNYSLFDKSNNDIVKAYAKFGIFQRKGMKRNEFVNVLLKHLNSQPLPIKNDELLENVW
NYLLKGNEESTARINFPMICQLAIYILNTNPLILKSLQKTYSHVFLDEFQDTTTLQYDLV
KTCFISSSISLTAVGDNRQRIMVWAGAKKDIFECYKKDFFATPYNLIMNHRSAPRLLEIQ
KVVNNYLQDQPFTPIPNSRWSTEDGISEIWYFKNSKKEAQIVASRINELIYSLEIPYNEI
CIIVKQTVDKYSQDIISELEKYNIAARNETLFQDLLKEELIILLINTLKSAIDVKNSDAW
IKIWDIKMELAGVKGSIINQTISHLLFEFKMFLNKVKDELDKLNELEGFRKILLDIMDYY
GVDKIRKFYPQYSQGEYINQVRDNLVDYLFAFYQKTGSWQEAIDSFEGRFSIPIMTIHKS
KGLEYEAVFFVGFDDNAFWTYSNQEEEDTCTFFVGLSRAKKYLYFTFSKLRDNGFCQNTN
ISPLYDMLRDSKTVDELTF
>PK3-2_01091 hypothetical protein
MNGRKDILDAWITIEQLSEGSINKKDKPLKPLYTVEEDWNKFFSDFLTKQKEQQNVSDKF
FKKSGLVLYFDIFNFQEIVDILREKYKIAKTYEEVSNSDKFTFSVYFDNQLNFIADKLFY
TMSGYIRRHGDLPKDILKVENSFREDLNRKFDEDFNTTISELLQNYNVTAENFRYAFVKN
LDNGDVNLHSFFIGDLNKAKTITNKNLDRYFNGFSGYRKNLDGKKESTHFNSHMFEMILQ
PKFYPLGRFPSNPDFALSFMQQVAVNLALNDENDIRSVNGPPGTGKTTLLKDIFADLVVQ
QATEISQLSDKNIQGSLVYWQSAKLGVLPHSISDKNIIVASSNNGAVQNIVKELPKKEKI
ADDFQKQLEEANYFKDVSNSKLTGEGFGKNRKIKSELLNEDNWGTFSLEGGASTNINKLL
LTIEVIEKDLEENYQANTDVSVYQEFLRLYDELKTEREKNQEYSEKMYSLQKLKTKHKDQ
AIALEQEEKKKRTNLILQEEEAKRELERLRQESIKLQKDLSNSSIEIKNLNNLQAQYERN
YDVVTSQKPSFFWFQKIFNKSKVEQYFKNLNNTNAHLNHLSQQKTKLLNDHMKLESELEE
NVSKGEYTRKQIQDTKADFEQWMNTKQNDFKKLEQEIALLEKLKLQSGIKELDFSLSYDE
LQKSNPWFTKHFRILQSELFISALKVRKQFLYENRKNLRAARIIWNKQSEYIGKENGHQL
ISESWQWLNFAIPVVSTTFASFGRMFKNLNENSIGNLFIDEAGQALPQASVGAILRSKKV
MVVGDPSQIKPVMTLDSNVLTLIGRNYKVDEKFVSADASTQTIVDATSQYGFQKNEDEWI
GIPLWVHRRSNYPMFTIYNEISYDGLMVQGKSEDESQGKSQWYDSTGKANDKFVKEQADL
LKSLIDKRLQEDPDLAEEIYVISPFRNVAYKFTQVLDEINFTKRENGKTTNIGTVHTFQG
KEAKIVYFVLGADTNNSGAARWAVSDPNMMNVAATRAKEEFYVIGDKKLYASLGSEVANK
TISIIDDYNR
>PK3-2_01092 Fructose-1,6-bisphosphatase class 3
MESKYLDLLAQKYDCEEKVVTEIINLKAILNLPKGTEHFVSDLHGEYQAFQHVLRNGSGR
VKEKIRDIFSGVIYDREIDELAALVYYPEDKLKLIKHDFDAKEALNEWYKETINRMIKLV
SYCSSKYTRSKLRKALPAQFAYITEELLYKTEQAGNKEQYYSEIIDQIIELGQADKLITG
LAYSVQRLVVDHLHVVGDIYDRGPQPDRIMEELINYHSVDIQWGNHDVLWIGAYAGSKVC
LANIIRICARYDNLDIIEDVYGINLRPLLNLAEKYYDDNPAFRPKADENRPEAEIKQITK
IHQAIAMIQFKLESPIIKRRPNFNMEERLLLEKIYYDKNEITLHGKTYQLENTCFATVNP
EQPDELLEEEAEVMDKLLFSVQHSEKLGRHMNFMMKKGSLYLKYNGNLLIHGCIPVDENG
NMEMMMIEDKAYAGRELLDVFERFLREAFAHPEETDDLATDMAWYLWTGEHSSLFGKRAM
TTFERYFIKEKETHKEKKNPYYYLREDEATCRNILAEFGLNPDHGHIINGHTPVKEIEGE
DPIKANGKMIVIDGGFSKAYQSTTGIAGYTLLYNSYGMQLVAHKHFNSKAEVLSTGTDVL
TVKRLVDKELERKKVKETNVGEELLQEVAILESLREYRYMK
>PK3-2_01093 Putative exported peptide YydF
MKKENTNNETVKNLEFKGLLDESQKLAKVNDLWYFVKSQDSRWILGSGH
>PK3-2_01094 hypothetical protein
MYNKTVSINLDSRCNASCDHCCFSSSPTSTTRMEKEYIRELVTEFAKNKTIQVISFTGGE
VFLDYKFLKELMEIIKPYEKQITLISNGFWGISKKKVQEYFHDMNSLNVIALTISYDEYH
APFVKPSSVKRIFEHSRKYRGSIDISLNMAVTKDKMSNHILEELGDSILGVKITKFPMIS
VGAAKNRIKQENIHKFYSLEDEDSLHCPGYDIVYHHDGEIYPCCSPAIFETKITLREEYN
QSFERTVEKLNSNLLLFILRKEGFKWFLDILKENNKIEEFDIPYEFSSICGVCGSLFNSA
EKINYFYPYMEKYYNENFKV
>PK3-2_01095 Putative peptide zinc metalloprotease protein YydH
MKILKYEDKKYEVIVQNNVFIKDKKSGEYYKNSLNSLTDEQLLRFKMYKEKVSPKFFYLF
LFFTAFMFILNYIHLIKLQNGLSSVFHGWKMWIIIVIYFIMNIVLHELGHIYSLKFFGKN
FDKVGFKLNFYVFPAFYVQLNETYMLSRNEKIIVHLFGLFINYLLINTLELINQFTFSSE
TLTMAFMLFSSTLLWNLVPILNSDGYKILLAFLSLDEYSRFKTNHWLVLTIQIIGIGLAI
NSVVHWILYIVN
>PK3-2_01096 putative peptide export ATP-binding protein YydI
MNIANYTLKVKGKTLLQDTDLQFSNGKINHVVGKNGVGKSQLAKDFLLNNSKRIGRDIRQ
NVSLISSSSNIPNDVSKDFLLHFLSKKFDVEMIDKIAHLLNLDNIDGKVLIKNLSDGQKQ
KLKLLSFLLEDKNIIVLDEITNSLDKKTVIEIHGFLNKYIQENPDKIIINITHDLSDLKA
IEGDYYIFNHQEIQQYHSVDKLIEVYINE
>PK3-2_01097 putative peptide export permease protein YydJ
MKLEFKKSISNKVIIILGAMFVFLFLLGYFLLVGIDKVSNVTPEMFFFSSYTVATQFGLM
LFSFVIAFFINREYSNKNILFYKLIGENIYTFFYKKIAVLFLECFIFITLGLLIISLMYH
DFSHFALLLFLFSAVILQYILIIGTISMLCPNILISIGVSIVYWMTSVILVAISNKTFGF
IAPFEAGNTMYARIERVLQSDNMTLGGNDVLFIILYLVSIIIINAIILRFSKTRWIKMGI
>PK3-2_01098 hypothetical protein
MYKIIIPAILAIFLLWILLQISLEMSIVKNPMNYFIVFIIFFLFIKMVKEKQ
>PK3-2_01099 hypothetical protein
MQSIVKLSTVRLAALVFLIGALALPVLPNAADAAESQATYKVENLNDRELKMTFEHADVQ
TLILMEMPP
>PK3-2_01100 hypothetical protein
MKNILIRAGISPFDTFDAAEMIVRNSIGGNVGNLVYAYSVFRTLMTEGTTMTPDYYRIQP
ADAEQINKKYDMYIIPLADAFREDFVPSLRKYTQLIKKLTIPVVVIGVGLRAPFEPKLNE
GFPFDQDVKAFVSAVLERSNMIGVRGEITAKYLSRLGFREGIDHTVIGCPSMYAFGRELK
IRETNITPESMVTVNSSRLSPKHVLDFITRSMKEFPNHYFIPQWRKEMILTYAGAPAIAK
PADNYPVSMEDPAYQNDRVRFFLNVPTWLDFLRQADLSFGARLHGNIAATIAGTPSLLLP
KDARMRELAEYHQLTHVMANEITEQTKLSELIETLDFHQPEKRQAQNFDHFISFLNQNEL
DHIYKEKAIPDTVPFDEKLSNTKLLPPVTTVSGCSSTETAKRWEALMALEVAKKEKTIKD
LKKKVKKYQGTLNRKSVRIALKTANMLSVK
>PK3-2_01101 NADH dehydrogenase
MGLDANIKAQLNQYMQLIENDIVLKVSAGEDDISKDMLALVDELASMSSKISVEKAELNR
TPSFSVNRVGEDTGVTFAGIPLGHEFTSLVLALLQVSGRPPKVDQKVIDQVKKISGEYHF
ESYISLTCHNCPDVVQALNMMSVLNPNITHTMIDGAAFKSEVESKNIMAVPTVYLNGESF
GSGRMTLEEILAKMGSGADASEFADKEPFDVLVVGGGPAGASAAIYTARKGIRTGVVAER
FGGQVLDTMSIENFISVKATEGPKLAASLEEHVKEYDIDIMNLQRAKRLEKKDLFELELE
NGAVLKSKTVILSTGARWRNVNVPGEQEFKNKGVAYCPHCDGPLFEGKDVAVIGGGNSGI
EAAIDLAGIVNHVTVLEFAPELKADEVLQKRLYSLPNVTVHKNAQTKEITGDQSVNGITY
VDRETGEEKHVELQGVFVQIGLVPNTEWLDETVERNRIGEIIVDKHGATSVPGLFAAGDC
TDSAYNQIIISMGSGATAALGAFDYLIRN
>PK3-2_01102 Alkyl hydroperoxide reductase C
MSLIGKEVLPFEAKAFKNGEFIDVTNESLKGQWSVFCFYPADFSFVCPTELEDLQNQYAA
LQELGVEVYSISTDTHFVHKGWHDSSEKIGKITYAMIGDPSQTISRNFDVLDEESGLADR
GTFIIDPDGVIQTVEINAGGIGRDASNLISKVKAAQYVRQNPGEVCPAKWEEGGETLTPS
LDLVGKI
>PK3-2_01103 hypothetical protein
MPIFTLFSWGLFLAIIVSLFMIFKTLLMSPIVWIIVIVLVLFFRKRRNH
>PK3-2_01104 6-phosphogluconate dehydrogenase, NAD(+)-dependent, decarboxylating
MFNTIGVIGLGVMGSNIALNMANKGENVAVYNYTRDLTDQLIQKLDGQSLSPYYELQDFV
QSLEKPRKIFLMVTAGKPVDSVIQSLKPLLEEGDVIMDGGNSHYEDTERRYDELKEKGIG
YLGVGISGGEVGALTGPSIMPGGDRDVYDKAAPILTKIAAQVGEDPCCVYIGPKGAGHFT
KMVHNGIEYADMQLIAEAYTFLRETLRLPLDEIASIFETWNQGELKSYLIEITAEILRKK
DEKTGQPLIDVILDKTGQKGTGKWTSMQAIDNGIPSTIITESLFARYLSSLKEERVAAQD
VLAGPEAEEKHFDKDTWIEYVRQALYMGKVCAYAQGFAQYKMSSDLYGWNLPLKDIALIF
RGGCIIRADFLNVISEAFSEQPNLSNLMIAPYFSDKLQAYQTGMRKVVCEGISTGSSFPC
LTTALSYYDGYRAGRSNANLLQAQRDYFGAHTYERTDMEGVFHTNWSE
>PK3-2_01105 High-affinity gluconate transporter
MPLIIVALGILALLFLIMGLKLNTFISLLVVSFGVALALGMPFDKVVSSIEEGIGGTLGH
IALIFGLGAMLGKLIADSGGAQRIAMTLVNKFGQKNIQWAVVIASFIIGIALFFEVGLVL
LIPIVFAISRELKISILYLGIPMVAALSVTHGYLPPHPGPTAIAGEYGANIGEVLLYGFI
VAVPTVLIAGPLFTKFAKKIVPASFAKNGNITSLGTQKTFKLEETPGFGISVFTAMLPII
IMSVATIIDLLQETIGFADNGVLAFIRLIGNASTAMIISLLVAVYTMGIKRSIPVKTVMD
SCSTAISQIGMMLLIIGGGGAFKQVLINGGVGDYVADLFKGTALSPIILAWLIAAILRIS
LGSATVAALSTTGLVIPLLGHSDVNLALVVLATGAGSVIASHVNDAGFWMFKEYFGLSMK
ETFATWTLLETIISVAGLGFILLLSLVV
>PK3-2_01106 Xylulose kinase
MTSYMLGIDIGTTSTKAVLFSENGDVIQKESIGYPLYTPDISTAEQDPEEIFQAVIHTTA
RITKQHPEKQISFISFSSAMHSVIAIDENDKPLTPCITWADNRSEGWAHKIKEELNGHEV
YKRTGTPIHPMSPLSKMAWITNERKDIASKAKKYISIKEYIFKQLFNEYVIDYSLASATG
MMNLKRLDWDEEALRIAGITPDHLSKLVPTTEIFQHCTPELAIQMGIDPETPFVIGASDG
VLSNLGVNAIKKGEIAVTIGTSGAIRTIIDHPQTDEKGRIFCYALTDKHWVIGGPVNNGG
IVLRWIRDEFASSEIETATRLGIDPYDVLTKIAQRVRPGSDGLLFHPYLAGERAPLWNPD
VRGSFFGLTMSHKKEHMIRAALEGVIYNLYTVFLALTECMDGPVTRIQATGGFARSEVWR
QMMSDIFESEVVVPESYESSCLGACILGLYATGKIDSFDAVSDMVGSTHRHTPIEDSAKE
YRKLMPIFINLSRLLESQYTQIADYQRGLISHN
>PK3-2_01107 hypothetical protein
MLDSNDLLYPAKWLSKASTGVRVACELRMRIISGMIESGTILSENTIAAEFSVSRSPVRE
ALKILASEKIIRLERMGAVVIGLTEKEIAEIYDVRLLLETFVFERLVKIDIEPLVKDLSK
ILEIMKVSIKYEDADEFSFQDVLFHETIIRAIDHSYIHMIWNNLKPVMESFILLSMRVRL
KEKYEDFTRILDNHELYIQAIKAKDRALMIQSLHQNFDDVQEKVEDLWLSQQMLAKGAEY
NND
>PK3-2_01108 Glycerate 2-kinase
MKIIIAPDSFKESLSALEAADAIERGFKSVFPGADYRKLPMADGGEGTVQSLVDATNGWI
KEQIVKGPLGEPVEAFFGMLGDGKTAVIEMAAASGLHLVPVEKRNPLVTTTKGTGELITA
ALDAGAERLIIGIGGSATNDGGAGMIQALGGRLLDESGREIGSGCGALSQLASIDVSGLD
PRIHHVKLEVACDVDNSLTGPRGASAVFGPQKGATDDMVRVLDQHLTHFADVAEKALGTT
FRETEGAGAAGGLGWSLLAFLHADLKRGIDIVLEAVDFENEVQDADLVITGEGRIDSQTI
YGKTPIGVAKAAKAYDVPVIGIAGSISRDSDAVYQHGIDALFSIVPGAVPLEDAFEHAAE
YMERTARDIAASIKLAKTMFLI
>PK3-2_01109 General stress protein 30
MTVQEIKGKKLVKGIAPNVEPEALLNDKRKVFLFGSPSYTNIGDQAIAYAEEKFIKNHFP
YYEYIEIMDYATDEGIELVKEIIRKDDIVCFTGGGNLGNLYLDIEEDRRKVFSSFKDYKS
ISLPQSVYFEDTEEGNKEKKKTQDAYHQNPNLTIAARETQTLDVVKQTFNSNVIFTPDMV
LSLDIVPKELERDGVLFILRADKEKVTDEEFISQMMKWAEKTTYTERTDTVLDTVDTIDY
ADRKKHFMEMLDRIGSSKLVITDRLHAMIFSIITKTPCLVFGNSYGKAKHSYRDWLESLN
FIEYTDKNDVEELERMIDRLLQAEPNDVDVSKDFQPLVDFFRS
>PK3-2_01110 Na(+)/H(+) antiporter NhaG
MDHLDLHHIFELGFLLVMIAAGITAIAKKCRQPYPIALVIVGAIIGLVHIPLLEPLKDFI
TEGEVFNFVIITLFLPALLGEAALKLPFSHLRENKRSVLALAFGGTLISFLIVGFSSMWL
MHLAIPAAFVFAALMSATDPVSVLSIFKSVGAPKKLSIVVEGESLFNDGLAVVLFNISAF
YLMTYLDLGIQGAGLGLWEFIKVISLGLIIGGVLGYVFSQLTKYFDDYPLEIIFSIILFY
SSFLLAEIAGASGVIAVVVAALIFGNYGARIGMSPTTKLNINNFWDVAALLANSLVFLMV
GLEITRIDLTDKWGLAIMAIVIVLIARSASVYISLALIKNFPASWQHTINWGGLKGSLSI
ALVLSLSRDFPGREDILVFAFSVVLFSLVVQGLTIKPLLERLGVNQKEEGNQEYEELLAK
GHRLETAIQEVQQAKHNLLIHEAVSSELTDQYKEEIRQLHQQTNELFETYPELKNKQQTI
LKKHSLYAQYQAIENLSKEDIISNEVAEQEQARIIDEIVRLENDH
>PK3-2_01111 Holin-like protein CidB
MQQACIAIIIILLTAAAYAAMVKLYKRFPLPFLIPVLTTTILIVTVLVLFHVSYEGYMIG
GKWINSLLGPAVVALAYPLYKQWHIIVKHCVPIIGGVLVGLCMGMISGLIFAEAFGIDHD
LLLSILPKSITTPVAIQIAAGLGGVPSMTVVFVMIAGFSGVILGPLVLKWLRIRSSLGQG
IALGSASHALGTSKAFEYGELAVSMSSVSMTLCAVLGSFFGPIVVWLFHI
>PK3-2_01112 Holin-like protein CidA
MRAIRIILQVLILYVFFMIGDAIQHLLHLPVSGSIVGLVLLLICLGLRIVPVSIIEDGAG
FLLSFLPLLFIPAMTGVMKYPSLISINGLMLLITVVLSTIVTISAAGFASQLLEKKAKKR
EEKEKCSKHVSQSL
>PK3-2_01113 hypothetical protein
MYYTSIHGVVNVGDWNGERERVEKQNSIKRIEYELTTFIRRAVYLDQSEKRTGNLERSSY
LLLRQLDEFGPARVKELADSFKLDISTLSRQAAALEAKELIYRFSDPSDGRVSLFTITKL
GKQTLKADKQKRLERYEQMLKEWSAKEKEMFGELLQRMNKAFID
>PK3-2_01114 hypothetical protein
MIYPPEAVAEAILFAAEHPKRDMYIGSQAKAIALLGAFFPRLTDRLMEKIMYRSQHAERP
SNPREESALYEAGYGMHDRGTNKGWIRSRSYYMKATKRPMVSAAVVAGLLAWAAVKRSR
>PK3-2_01115 3-phenylpropionate-dihydrodiol/cinnamic acid-dihydrodiol dehydrogenase
MTNDDAVTNIEKLEQHNPGKNTKLKLKKLKDQVIVITGASSGIGLVTARMAAEKGAKVVA
AARNEDALKELTEELKEKGHEAIWVKADVGSEEDVNRIAETAISTFGRFDTWVNNSAVSI
YGHAMDVTVDDMKRMFDTNFWDLFTEQERPSNTTQAEACRARSLMSEACSATGAPSYNPH
THQPNSRFTAGRKASEWSSKRNRRPSQLRSSIRAELTRLTTNTRAAISTNSRLITAP
>PK3-2_01116 putative HTH-type transcriptional regulator YxaF
MTSRGDSREKILHTASRLFQLQGYHATGLNQIVKESGAPKGSLYHFFPNGKEELAIEAVT
YTGKLIGHLIQQSMDEFSDPIEAIQQFIKKTASQFDNTESIKGIPVGLLASETALISEPL
RTVCMKVFKSWEAVFARKLIEDGFAEEEANQLGMLINSMIEGGIMLSLTNKDKTPLLLIA
EQIPVLVRKKG
>PK3-2_01117 Quercetin 2,3-dioxygenase
MKTLCEHSLPKEKMPYLLRSGEGDRYLFGRQVATMMANGKSTGDLFEIVLLSGGKGDAFP
LHVHKKTHEGILVLNGKLELTLDGERYLLVSGDYANIPAGTPHSYRMQSHRTRLVSYTMK
GNVASMYSVIGNPYDHAEHPPHAIEEVPNERFAKAAAVVDIAFLDEEKPAGAATLAELAE
LPDGAVPYVLESGEGDRLLTGDQLHRIVAAQKNTDGQFIVVSSEGPKGGRIVDHYHEHHT
ETFYCLEGQMTMWADGQEIQLNPGDFLHVPAHTVHSYRLDSHYTKMVGVLVPGLFEPFFR
TLGEPYEGHIFPSEPQALRFDRVLQNIKALDLKVMKP
>PK3-2_01118 hypothetical protein
MSSLQPTLANERIVVLDVLRGMAIFGILFVNLAHFSYPDMYLFMLGDENFFTEKWSEADV
LVTEILTFFIQTKCILLFSFLFGFGMVVMMERAASKGKRFVPPYARRLAALLLLGTVHAF
LIWDGDILTEYALLGFVLLLFRKAKPKTLLIWAISLYLLFSLPFMLTGFDQSTGQEWAQA
VTQQAKQALHVYGSGSLKDIAEQRIHDRLVYMSSNGMLTYNPINFFFASIPYFSMFLLGA
AAAKSRYLHEPGKHRKGLKRVWMAGLVIGISAQVLYSVTDKDVFLLIGAPFLMFFYVTTV
VYLYHKTRVRTVLQSFSAVGKMAFTNYLMQSIVCTWIFYHYGLGLYGKVYPAAGVLITIA
VCAVQMVFSHLWLRVFRMGPFEWLWRSATYLSWQPIVKKTKV
>PK3-2_01119 hypothetical protein
MEKPAGFWIRFLAYFIDGIIVSVPSYIILFMINTVFVAGSVAANPYMTEEEYLVKYMTMA
FLPTMLIMIVISVLYYGLLTASKMQGTLGKKILGLKVVNEQGERVSVGQGIGRYFAYILS
GIIFYIGFIMIAFGEKKGLHDIICKTRVVYK
>PK3-2_01120 hypothetical protein
MSRKNSVAIMTAISAFLFCVMIAAASLSPLAGTGGAANQFHSVGMWSAIGMILVLYFIPF
IIYMLGVDAMRYVMAVLCGFGLLIHLSSAGFILMFSFFSDHLLSEVIFVIGVSLAAAAVN
VIWFVAAFRSVAEKTSANSLT
>PK3-2_01121 putative protein YxaL
MVKSFRMKALIAGAAVAAAVSAGAVSDVPAAKLLQPTAAYAAETVFSQNNGASGFLTGRY
DVQAMAPAMFNWSRESRFAGNTDGTLKWQNDIRTTPQNGAGAVVDGDGTVYLHSRDGEMK
AFNPDGSVKWVTGNLGKTFTQSPVLGTNGVIYLASYDKKIYFIDKETGEILTTVPLSGGP
SSETVIGSDGTLYFSTLDNYVHAIKPTSKSTWTERWKLKTNGVVSSVPVLAKNGTVYVGT
YNNVFYAINSGTGQVKWSRTTSNAFKGYPVIDKDGNVYAGNQDGQLYAYTSTGSLKWKFP
LNGFSSSSPAIDHNGNIYIGSGSGELFSISKNGDMNWSFYTEGPVRTAPLIDANGTVYFG
SDDMKVYAADANGNELWSYQTDSNVVSSPQLAEDGTLYIGSYTKLMAFGK
>PK3-2_01122 hypothetical protein
MIQINTLIVLPLIDAGSSYMTEGQYKFYILIFGTIPVIAIIYIFGILYYSLLTSSKMQAT
LGKKLLGIIVVNQYGERISFWHSFGRFFAYIPSGILYIGYIMAAFPSKLALHDYICGTKV
VYKNKNLD
>PK3-2_01123 Aldehyde dehydrogenase
MEQQIKDDIQRVFQLQKKQQKALRASTAEQRREKLQRFLDSVIAHEEEIIEAIRKDVRKP
YHEVKKAEIEGTKKAIRDNMNNLEKWMAPKEVGSSLSPEANGILMYEPKGVTLILGPWNY
PFMLTMAPLAASLAAGNSAIVKLSDFTMNTSNIAAKVIRDAFDEKEVAIFEGEVEVATEL
LDQPFDHIFFTGSTNVGKIVMTAAAKHLASVTLELGGKSPTIIDSEYDLMDAAKKIAVGK
FVNAGQTCIAPDYLFIKKDVQDKFAGILQTIVNAGFMEDDRNPDRSKFTQIVNDRNFNRV
KDLFDDAIEKGAEVVFGGVFDASDRTISPTVLKNVTPDMKIMQEEIFAPILPMMNYEDID
EVIDYVNDRDKPLALYVFSHNQDLIDNVLQHTTSGNAAINDVVVHFSDVNLPFGGVNTSG
IGSYHGVYGFKEFSHEKGVFIQAAK
>PK3-2_01124 Nucleoid occlusion factor SlmA
MAESAEAQVKQALLALLEERDIQHITMKEIAEKAKVSRGTLYLYYEDKFSIIEDVVEDMK
EGLGEALYDAFKHMDTLHLNKKRHTVHPTLSFVHEHRSFFGTMMNRGQFHRFFKEVFQQD
VLLAPVNVNLTPIEQEIYGHYRALYTYAIILYWLNEDADASPEAISQKVWELVSQKRFYW
LFGQAPSRKRQKDKQIDRRVVRTREALQKALLDVLAEKKDYRAITISDMTRKSNIRRATF
YDHYASKEELLQTMIQQSCAEMIDHLTIASSPNELSFEKAEEALARLLSALDRMPIVHLL
NRDWVVPHVIPELLKALESFYLHQQTNIPAEKKLYAYYVSAMIIGLILYRLDEGKAHAPE
VLAREFLQFLDVKKYKVVLL
>PK3-2_01125 hypothetical protein
MSQNKLLFLLFLFSSIVRLFFNTVLSPTVSWKSWTVNIVFILLSLLFLNLTLKERKSKDQ
VS
>PK3-2_01126 Lactococcin A secretion protein LcnD
MKRKLQRISDLQDSIKNNKSFAKQDDKYSSYYSSYQTNKQNLEQQLDDLRKMKDELDKHS
FSQQKENLNGQLESLKQDMLVKLSEEKDELNQSLDEINSSMKSDDSDSDSDNSEETNYKL
SIEQLKTNLLNQTSQKQTDLQTTLKSKEDDLKMIDLQLEKYKIKATSDGYVNVLTNISPG
DNLQAGTAILAIIPDKEKLKANIYIPSHEITNINEKDEVRFHIENTNQTIKGVITKISPD
SISDQNGQKFYIAESTIESKEIEKNNGTKIHLKNGMQTDVSIIVDSKRYIDYFLDVLHLR
>PK3-2_01127 hypothetical protein
MKRNFFNLHDLKDSREFYESKPKPIGVFFTYILIALLIACIVFSFYGKKEVILKTTADIQ
YTKPNSNVTNEVAGKVKTVDIKQVDKVKKGDTLLTLDNTEIQAQKKAVKADIKDLKEQVG
LNKTLKKSIENDKNLFSEDDHWGYQDQYLSYEKQSNLLESSKENAKTQQKNLKKQKKA
>PK3-2_01128 Lactococcin-G-processing and transport ATP-binding protein LagD
MFFNRYHCVRQLDQKDCGAACLSTIAKHYGSKLSLAYIRDIAGTDTQGTSALGMVKAAEQ
LGFSAKAVRAEHTAFDQSFTLPAIAHIIIDQQLLHYVVIHKISKDKIIIADPGKGIVTYQ
KDDFFKIWTGILILLAPTETYKKQTETSNISADIFRLILQQKSLIIHTFLASFIITIFGI
LGTFYFQTIIDQILPNGLSNTLHILSIGLLIMYLFKVFLIGFRQYLMILLGQKLSISIMF
GYFQHVLTLPMKFFSNRKVGEIISRFTDANKVIDAVVSASLSAILDTIMLIMVGIFLYLQ
NTTLFLITLAFIPFYILTVWIFIKPYENINNSEMENNAQLTSKIVETLNGIETVKAYNAE
YMMSFETEKRFVKYLRSAFKHGVIDNLQSSIKMFLDLASGALILWIGSTQVMKGTLTIGQ
LITYNALLTYFLNPLQNIIGLQSKLQSASVASKRLGEILKLEPELKENKERITSTSSITG
PLSFNKINFRYGTRRLILKDITLHIQKGEKVAFVGESGSGKSTLTKLLMKFYTAESGEVL
INGYHINDIHTNALRESISYIPQESHFIQGSILENLLLGNSGSFTFEEIIEVCKQTNVHD
FVNDLPMRYDTLVEENGSNLSGGQKQRLAIARALLRKPNILIMDESTSNLDTTTEQGISK
MIYAQTVDVTTIIIAHRLSTIMHCDKIFVMENGEIIEYGNHNDLLKKKGKYYELWENQMP
SREMVTI
>PK3-2_01129 hypothetical protein
MKLFYSYIIAGGLFCISLSYFFHLGVFNLALYLIYINYAFILYKRDKSSK
>PK3-2_01130 hypothetical protein
MNNNLKLERTRANLTQEQLAEKIGVTRQTIGLIEKGKYNPSLQLCLKICIELKVTLNDVF
WTHNREEETDEG
>PK3-2_01131 hypothetical protein
MKDERISHIENKIGHESFLLVIALVFVSFILSIMFKMPSTLMTIIILFVGSGYYGLRAMS
KGILRVNLKKKKKSSYFLLIVFTFILYMATSVLFKIITFPFTTKEFLFQILMYILWLIPF
SLIMYTTYKFSNRQQKKELEN
>PK3-2_01132 hypothetical protein
MNAKSIKDVELQALTLEEAEQIDGGSYAKYLGSAVVTGAGAGVVGGVPGVILGAHAGAIA
GSVGYLGGSLIAGKWL
>PK3-2_01133 hypothetical protein
MENNNHLSELNVKEMEQIDGGGWRSALGGAFSGALVGASTVGVGGAAVGGPVGGAGGAIT
GGIVGGIVGGINAW
>PK3-2_01134 Dihydroanticapsin 7-dehydrogenase
MGRLENKTAVITGAATGIGQATAEVFANEGARVMIGDINTDQMKETVEAIRQNGGQADAF
HLDVSDENSVKAFADQMKEACDTIDILFNNAGVDQEGGKVHEYPVELFDRIMAVDLRGTF
LCSKYLIPLMLENGGSIINTSSMSGRAADLDRSGYNAAKGGITNLTRAMAIDYARDGIRV
NSISPGTIETPLIDKLAGTKEQEMGEQFREANKWITPLGRLGQPKEMATVALFLASDDSS
YVTGEDITADGGIMAYTWPGKMLFDEKWKEETK
>PK3-2_01135 hypothetical protein
MKVQHKKELKFYCFITIPSAFVVLTVISFILQEITFPVTASAFLNASWHNLLFLIPFGLF
FYPVHIWMKREFGRWNGAAKKRGG
>PK3-2_01136 Chaperone protein HtpG
MAKKEFKAESKRLLDMMINSIYTQKEIFLRELISNSSDAIDKIYYKALTDDALTFDKDSY
YIKVAADKGARTLTISDTGIGMTKDELEQHLGTIAKSGSLAFKKENELKDGHDIIGQFGV
GFYAAFMVADVVTVISKALGSEEAYKWESAGADGYTIEPYEKDSVGTDVILKIKENTEDD
SYDEFLEEYRLKAIIKKYSDFIRYPIKMDTTINKPKEGSENEFEEVQEEQTVNSMVPIWR
KNKSELTDEDYEKFYAEKHYGFDKPLTHVHISVDGAVRYNAILFIPENMPFDYYSKEYEK
GLELYSNGVLIMNKCADLLPDHFSFVKGMVDSEDLSLNISREMLQHDRQLKLIAKNISKK
IKSELQSLLKKDREKYETFYNSFGRQLKFGVYNDFGANKDQLKDLLLFYSSKEKKLVSLD
EYVSRMPEEQKYIYYATGDSYDRIEKLPQTEMVADKGYEILYFTEDIDEFAIKMLASYQE
KEFKSVSSGDLGIDTDEDQKQSEEEESKYKDLFEEMKNILSDKVKNVRVSKRLKSHPVCL
AADGEVTIEMEKILNAMPDSQNVQAEKVLEINPNHEVFQTLQDAFEQDKEKLSLYTNLLY
NQALLIEGLPIQDPVEFTNNICKVMV
>PK3-2_01137 putative metabolite transport protein CsbC
MIYFFGALGGLLYGYDTGVISGALLFINNDIPLTTLTEGLVVSMLLLGAIFGSALSGTCS
DRWGRRKVVFVLSIIFIIGALACAFSQTIGMLIASRVILGLAVGGSTALVPVYLSEMAPT
KIRGTLGTMNNLMIVTGILLAYIVNYLFTPFEAWRWMVGLAAVPAVLLLIGIAFMPESPR
WLVKRGREDEARRIMNITHDPKDIEIELAEMKQGEAEKKETTLGVLKAKWIRPMLLIGVG
LAIFQQAVGINTVIYYAPTIFTKAGLGTSASALGTMGIGVLNVIMCITAMILIDRVGRKK
LLIWGSIGITLSLAALSGVLLTLGLSSSTAWMTVVFLGVYIVFYQATWGPVVWVLMPELF
PSKARGAATGFTTLVLSAANLIVSLVFPLMLSAMGIAWVFMIFSVICLLSFFFAFYMVPE
TKGKSLEEIEASLKNRFKKKKSSQSQVLNERTL
>PK3-2_01138 hypothetical protein
MENNFFLKMKGTGKTPLQVNGKDAVTGLIGGFITILTLASLTAYTSSLWLMAPFGASCVL
VFSAWNAPLSQPRNVIGGHFISALTGIVVLHLFGAHPWTFALGTGLAICLMMLTKTTHPP
AGADPIVVIQGAYAWSYLVFPVLIGSIIIVIIALVVNNLRKNRQYPAFWL
>PK3-2_01139 hypothetical protein
MANAQFPLITQNLSLDLVNTEIISYDKRHDLIQSEKDLMAWLEIMGETAPFLSSLTLQQV
QEQLQRIHQFRAELRKHFERIADGSEPSPAFISFLQDQIAAAPFSYQIIDDKLARIPNGE
SDDSILSLIAYDALWLIHTKEIQHLKRCANEKCILLFLDKTGRRKWCSMKICGNRHKVSR
HQKKMNHE
>PK3-2_01140 hypothetical protein
MRLVLNEQEIVDGICVYVSNDEDIYPEDVEVKELSYNKRTGFFAEAKYGLHHKQLMSDEI
SEGIIQFLEEYHNFNPDVTVVELQFDKKKGFSALVFVNEGE
>PK3-2_01141 hypothetical protein
MKLKYVKALVAVTVALGVLLPSTISHAKSFSGRSSSSYSSRSSSSSYSGSYKSSPKSSYS
SGSSSSSKKSKTSDDSSSSISMKKKSSSTSSSSSSKKSSGTFSGATSKVSGKTYSGKTSK
AYVGGRYVSVNHYYNAGFSPSGWFGYYSGFTTGMFMISMMHPWGYTYHPVGGPGYVSYGA
SPIAWIVDIIALIVILIIVIALIRAFKAPQTYRRRF
>PK3-2_01142 Aldo-keto reductase IolS
MKKATLGKSDLQVFPIGLGTNAVGGHNLYPNLNEETGKELVREAIRNGVTMLDTAYIYGI
GRSEELIGEVLREFNREDVVIATKAAHRKQGNDFVFDNSPEFLKKSVDESLKRLNTDYID
LFYIHFPDEHTPKDEAVNALNEMKQAGKIRSIGVSNFSLEQLKEANRDGLVDVLQGEYNL
LNREAENTFFPYTKEHNISFIPYFPLVSGLLAGKYTEDTTFPEGDLRNEMENFKGERFKE
NIRKVNKLAPIAEKHNVDIPHIVLAWYLARPEIDILIPGAKRADQLVDNIKTADVTLSQE
DISFIDQLFS
>PK3-2_01143 Glucitol operon repressor
MKLMRIQEMEEYILSHGTVSLDELCQVFNVSKNTVRRDINKLTEKGAIEKVYGGVTSIEK
TALVPFENRTIQHQDEKTKIAHYASRFIEDHDLIFIDSGTTTKSILDTLDPAKNVTILTN
SLDIINAASALKNINLIIIGNNYKRKTRSFVGMDDPAMLDKYNINKAFMSATGTTLSHGL
TNSDLLEYEIKKRISEKAKEVYLLADHSKFGKSTLLTYAPFDRLHCIVTSQPLDDEYTQY
CNEHQIGIHLA
>PK3-2_01144 Malonate-semialdehyde dehydrogenase
MAEIRKLKNYINGEWVESKTDKYEDVVNPATKEVLCQVPISTKEDIDYAAQTAAEAFKTW
SKVAVPRRARILFNFQQLLSQHREELAHLITIENGKNTKEALGEVGRGIENVEFAAGAPS
LMMGDSLASIATDVEAANYRYPIGVVGGIAPFNFPMMVPCWMFPMAIALGNTFILKPSER
TPLLTEKLVELFEKAGLPKGVFNVVYGAHDVVNGILEHPEIKAISFVGSKPVGEYVYKKG
SENLKRVQSLTGAKNHTIVLNDANLEDTITNIIGAAFGSAGERCMACAVVTVEEGIADEF
MAKLQEKAADIKIGNGLDDGVFLGPVIREDNKNRTLSYIEKGLEEGARLVFDGRENVSDD
GYFVGPTIFDNVTTEMTIWKDEIFAPVLSVIRVKNLKEAIEIANQSEFANGACLFTSNSN
AIRYFRENIDAGMLGINLGVPAPMAFFPFSGWKSSFFGTLHANGKDSVDFYTRKKVVTAR
YPAPDFN
>PK3-2_01145 5-deoxy-glucuronate isomerase
MSYLLRKPQSNEGSNGVTLVHEITKSNSDLTFVEFKVLDLASGSSYAEELKKQEICIVAV
TGKITVTDHESTFENIGTRESVFERKPTDSVYISNDRAFEITAVSDARVALCYSPSEKQL
PTKLIKAEDNGIEHRGKFSNKRTVHNILPDSDPSANSLLVVEVYTDSGNWSSYPPHKHDQ
DNLPEESFLEETYYHELDPGQGFVFQRVYTDDRSIDETMTAENENVVIVPAGYHPVGVPD
GYTSYYLNVMAGPTRKWKFHNDPAHEWILER
>PK3-2_01146 5-dehydro-2-deoxygluconokinase
MKYTFNEEKAFDIVAIGRACIDLNAVEYNRPMEETMTFSKYVGGSPANIAIGSAKLGLNA
GFIGKIPDDQHGRFIESYMRNTGVDTTQMIVDQDGHKAGLAFTEILSPEECSILMYRDDV
ADLYLEPSEVSEDYIANAKMLLVSGTALAKSPSREAVLKAVQYAKKHQVKVVFELDYRPY
TWQSADETAVYYSLVAEQSDIVIGTRDEFDVMENRTGGSNEESVNHLFGHSADLVVIKHG
VEGSYAYSKSGEVFRAQAYKTKVLKTFGAGDSYASAFIYGLVSGKDIETALKYGSASASI
VVSKHSSSEAMPTADEIVQLIEAQS
>PK3-2_01147 3D-(3,5/4)-trihydroxycyclohexane-1,2-dione hydrolase
MGKKIRLTTAQALIKFLNQQYIHVDGKEEPFVEGIFTIFGHGNVLGIGQALEQDAGHLKV
YQGKNEQGMAHAAMAYSKQMLRRKIYAVSTSVGPGAANLVAAAGTALANNIPVLLIPADT
FATRQPDPVLQQMEQEYSAAITTNDALKPVSRYWDRITRPEQLMSSLLRAFEVMTDPAKA
GPATICISQDVEGEAYDFDESFFVKRVHYIDRMQPSERELQGAAELIKSSKNPVILVGGG
AKYSGARDELVAISEAYNIPLVETQAGKSTVEADFANNLGGMGITGTLAANKAARQADLI
IGIGTRYTDFATSSKTAFDFDKAKFLNINVSRMQAYKLDAFQVVADAKVTLGKLHGLLAG
YESVFGTTIRELKDEWLAERERLSKVTFKREAFDPEIKHHFSQEVLNEYADALNTELPQT
TALLTINETIPEDSVIICSAGSLPGDLQRLWHSNVPNTYHLEYGYSCMGYEVSGTLGLKL
AHPDREVYSIVGDGSFLMLHSELITAIQYNKKINVLLFDNSGFGCINNLQMDHGSGSYYC
EFRTDDNQILNVDYAKVAEGYGAKTYRANTVEELKAALEDAKKQDVSTLIEMKVLPKTMT
DGYDSWWHVGVAEVSEQESVQKAYEAKEKMLESAKQY
>PK3-2_01148 Inosose dehydratase
MGKNEILWGIAPIGWRNDDMPEIGAGNTLQHLLSDIVVARFQGTEVGGFFPEPAILNKEL
KLRNLRIAGKWFSSFILRDGLGEAAKAFTLHCEYLQQVNADVAVVSEQTNSVQSLEKNVF
TEKPNFTDEEWERLCEGLNHLGKIADQHDLKLVYHHHLGTGVQTAEEVDRLMAGTDPARV
HLLYDTGHAYISDGDYLGMLEKHISRIKHVHFKDARLNVMEQCRLEGQSFRQSFLKGMFT
VPGDGCIDFREVFELLLKHSYSGWIVIEAEQDPDVANPLEYALIARNYIDEQLLDLA
>PK3-2_01149 Major myo-inositol transporter IolT
MGTEHMCNTNGDSAFNKRTITAALANYIDAGSIVAGSAGLSLWVSYLKLSDTQIGLLGAL
SANAISAAVGALLGGFLADKVGRKAVYTNSMLVYAIGICLVLFGVNFPMLLSGYMIIGLS
VGADITASWTIIAENAPKKNRARHCGVAQVAWAAGAVVVLLLSVLVGDLGLLGNKIVFAH
LLVIALITYILRIRLPESDAWQSKNQPRDAQAEKPAVLNKTSYFDLLKPMYLKSILFLMG
VYLVWNLAAGVMGFFMPYIYQQVGGVSASTANLLQMGLFIFTGLGVALIFMPFADKYRKT
VFGIAAFMAVIGWTLFLLPVEGLPVLLLFIVVIGINNGAGQQANYQLWASEIFPTQYRAS
AQGLMFFLVRISIGIWSLFVPMIITNFGIGTMAAILLGCVTASMIIGLLFAPNTSGKSLE
QIQEELYGSPQSQVKQGTESKIM
>PK3-2_01150 Inositol 2-dehydrogenase/D-chiro-inositol 3-dehydrogenase
MSLRIGVIGTGAIGKEHINRITNKLSGAEIVAVTDVNQEAAQKVVEQYQLNATVYPNDDS
LLADENVDAVLVTSWGPAHESSVLKAIKAQKYVFCEKPLATTAKGCMRIVEEEIKVGKRL
VQVGFMRRYDSGYVQLKEALDNHVIGEPLMIHCAHRNPTVGDNYTTDMAVVDTLVHEIDV
LHWLVNDDYESVQVIYPKKSKNALPHLKDPQIVLIETKGGIVINAEIYVNCKYGYDIQCE
IVGEDGVIKLPEPSSISMRKEGKFSTDILMDWQRRFVAAYDVEIQDFIDSIQKKGEVSGP
TAWDGYIAAVTTDACVKAQESGQKEKVELKEKPGFYQSFTTVEN
>PK3-2_01151 hypothetical protein
MKLALDPSMYRDDLTLEEMVYKTAELGYEYIELSPREDFCPFYKYPKVDSAKIKQLKRLL
RDTGVKLSSLLPLYHWAGPEEDRRQAAVRNWKRAIEIAVELEVDLMNSEFSGSKYDPLTS
EEKFIKSMDELLPVFEKEGIKLNLQAHPYDFIETHKGAMDMIRALDKDWINLVYSTAHTF
FYDDGKGDIATMFDEAGDRLTHVLFADTFNHKAAHGLRYIVNPPDAKVTVHQHLDIGQGE
VDFETIFRKLREMKFDGIATNAVFAWVDERADESSRFMLKKMKEELGLA
>PK3-2_01152 Inosose isomerase
MKLCFNEATTLENSNLKQDLELCEKHGYDYIEIRTMDKLPEYLKDHSLKDLAEYFQTHHI
KPLALNALVFFNNRDEKGHNEIIAECKDMMETCKTLGVKYVVAVPLVTEQKIVKEEIKKS
SAEVLTELSDIAEPYGVKIALEFVGHPQCTVNTFEQAYDIVNTVNRDNVGLVLDSFHFHA
MGSNIESLKQADGKKIFIYHIDDTEDFPIGFLTDEDRVWPGQGAIDLDAHLSALKEIGFS
DVVSVELFRPEYYELSAEEAIQTAKKTTVDVVSKYFNM
>PK3-2_01153 6-phospho-5-dehydro-2-deoxy-D-gluconate aldolase
MAFVSMKELLEDAKRGQYAVGQFNINGLQWTKAILQAAEEEQSPVIAAASDRLVDYLGGF
KTIAAMVGALMEEMSITIPVVLHLDHGSSAERCRQAIDAGFSSVMIDGSHQPIEENIVMT
KEVTGYAAKHGVSVEAEVGTVGGMEDGLVGGVRYADITECERIVKETNIDALAAALGSVH
GKYQGEPNLGFKEMEAISRITDIPLVLHGASGIPQDQIKKAITLGHAKININTECMLAWT
DETRRMFQENSDLYEPRGYITPGIEAVEETVRSKMREFGSAGKAAKQQVG
>PK3-2_01154 Response regulator protein GraR
MNKIMIVEDSEDIRGLLKNYLEKYGYQTVIAADFTAVLDVFLREKPDVVLLDINLPSYDG
YYWCRQIRQHSTSPIIFISARSGEMDQVMAIENGGDDYIEKPFSYDIVLAKIKSQIRRAY
GEYAAKQGEKVIEYAGVQLFVERFELRFQDEKSELSKKESKLLEVLLERGEKVTGRDRLM
EKTWDTDIFVDDNTLNVYITRLRKKLRELNAPVSIESVRGEGYQLRAQS
>PK3-2_01155 Sensor histidine kinase GraS
MKLFLRSHTVLILLFLLQGLFVFFYYWFAGLHSFSHLFYILGVQLLILAGYLAYRWYKDR
GVYHWLSSGQEGTDIPYLGSSVFCSELYEKQMELIRLQHKKLHETEAKLDARVTYMNQWV
HQVKTPLSVINLIIQEEDEPVFEQIKKEVRQIEFGLETLLYSSRLDLFERDFKVEAVSLS
ELLQSVIQSYKRFFIQYRVYPKMDIRDDHLIYTDAKWLKFAIGQVVTNAVKYSAGKSDRL
ELNVFRDEDRTVLEVKDYGVGIPSQDIKRVFDPYYTGENGRLFQESTGIGLHLVKEIMGK
LNHTVDISSSPGEGTSVRFSFLTKM
>PK3-2_01156 ABC transporter ATP-binding protein YxdL
MANMLEVKHINKTYKGQVSYQALKQISFSIEEGGFTAVMGPSGSGKTTLLNIISTIDRPD
SGDILIHGENPHRLKRTKLAHFRRKQLGFVFQDFNLLDTLTIGENIMLPLTLEKEAPSVM
EEKLRGIAAKLGIEDLLNKRTFEVSGGQRQRAAIARAVIHKPSLILADEPTGNLDSKASK
DVMETMQSLNQDDHVTALMVTHDPVAASYCRRVIFIKDGELFNEIYRGENRQVFYEQILD
VLSMLGGNANDLSSVRL
>PK3-2_01157 ABC transporter permease protein YxdM
MTFLQFAYKNVTRNKRAYLAFFLSSAFSVLIFFTFAMFLFHPALKEGYLNNIAKKGLTAA
EWMIFVFSFLFVLYSVNAFLKSRNKEFGILLMQGITPGQLRKLITAENMFIGVMSIAAGV
IGGFVFSKTFFTVGAYILEMDALPLYMPWKALGITAGGFLLLFFLLSQFTILFVRSNTVI
KLIKGTDKIKPEPKPSVLLSLFGIACLCGGYGMVLKGNVHGTEPFIILLLTVIGTYFFFS
QSSIWILRALKKWKTFYLRGKNVIWVSDLVYRLKDNARLFFIVSIISAVAFTATGVLAMY
KSTVGAEESAYEMEYISFSNNPKEQTHLKDIDHELKTHGFTYKKDKIEVSYVRYQEGESV
PPVYMIRESDVSKYFHVKLNGLKHDEAVYFPGTYDRNFKNEAPDQLKLLNRKGKPSDQKL
SVKEVEKPLISLNAIIAVNDQTFDQLKSLGDKASLYGYSYDHWKDSLGISQSLKNEIYGN
YIDVHSDFMAKAGTYYDTVQLPSLSLFIGLFIAIVFFVAAASFLYFRLFTDSDEDRERYR
SLAKIGLSEREMSQSVTIQLAILFFFPFVIAVMHTLFALRTLAVEGYSDVAGPLSLTIGG
FFIFQLLFFLAVRSSYLKKMNK
>PK3-2_01158 putative protein YxeA
MKKAMAILAVLAAAAAICGLLFFHNDVTDSFNPFIHQQDVYVQIDRDGRHLSPGGTEYTL
DGYNASGKKEEVTFFAGKELRKNAYLKVKAKGKYVETWEEVKFEDMPDSVQSTLK
>PK3-2_01159 Iron(3+)-hydroxamate-binding protein YxeB
MKKNTLLVGMLVLLIMFASACSGTASKGSSDDSASEKTEMRTYKSTKGNVKIPAHPKRIV
TDFYAGELLSVGANVVGSGSWSFDNPFLKSKLKDVKDVGDPISVEKVMELQPDLIVVMNE
ENVDKLKKIAPTVVIPYNTAKNVQDTVSMFGDIAGAKDEAKSFMADFNKKAEAAKKKIAG
VINKDATFGIYENTDKGEFWVFNDNGGRGGQAVYNALGLKAPEKIEQDVIKKGEMKQLSQ
EVIPEYAADYMFITDYNPKGESKTLDKLEDSSIWKNLDAVKHNRLFINDFDTFYPYDPIS
VSKQVDIITDMLIKRAKENKK
>PK3-2_01160 hypothetical protein
MGITKRGAAWEWLHSWWMLFIFMPFAITSFFAFLFIGIKVRNRKWIMYGIIYFFVFAFGF
VLPDPPGVFVVLPLWAVTIIHGFKVRPLYLIQLDVYKDNVEARAFDEARSEAESRFHAPK
QSIQDIHIRKER
>PK3-2_01161 hypothetical protein
MHTTQHSLQQLNQCRQTAQQLIQQTQQSSQQYRQMLHQEQQNIQMLQQILNHEQQAAHTI
QQALHGHDMAIQKCQQVVNMCNQMQQELTGQSSVMNSNVSTLPFGQNTPFQQQSYQQ
>PK3-2_01162 putative protein YxeE
MNPYQYYSPQLPQQEPYYSQYDYTSYPQQEYYEPYQTDRQPPALERRVAALERQNQQQTR
ELTRLTNEDRRQNREIARLAEQVNQLSQTVERHTRRLNRLNQRLRTVENRLNIPFTAGEG
GF
>PK3-2_01163 putative protein YxeF
MLGSKRLIALLLAAVCIMVSGCQQQKEETPFYYGTWDEGLAPGPTDGVKSATVTFTKDEV
VEKEVIEGRGEVQLPFMAYKVISQSTDGSIEIQYLGPYYPLKSKLKRGENGTLIWEQNGQ
TKTMTRIKSSMIGKEETDEK
>PK3-2_01164 hypothetical protein
MRNKKAERLVLTGLILHIIQWAFLLWAFLKIKHLFSDYTIYNPNVIGGSMQSLSFIQMLR
AMMYSGALVNYVLFFALVLLMYCVAIHAILIVLELTAYVMIRRNPASSWVFFLTAAGVKL
AILNITGIPFLAAGFLLMKQEKAETGGMETERKRKPRTRVRRQGRRLNRNRRKSSLPVEY
QKKKRYDGTIA
>PK3-2_01165 Sugar phosphatase YidA
MYKLIAIDMDGTLLNDRHEVTVEVRNALHAAKAEGVKIVLCTGRPIGGVRRYLDELNLIE
EGDYVIAYNGALVQNTHTNEVVTELSLGYDDLTSLYDLSLELKTPMHFFDSSNLYTPNRD
ISEFTVYESYVTQVPLHYRKIDEVPKDILIPKVMFIDKPENLSRVITSIPNDVRGKYTMV
RSAPFFYEILHPEASKGNAVRQLSQLLGIEQAEVMCIGDNGNDLTMIEWAGCGVAMANAI
PEVLEAANFQTRSNNEHGVAHAIHELVLEK
>PK3-2_01166 Nitrilotriacetate monooxygenase component A
MTSKKKQIKLGVFLAGTGHHVASWRHPDAPADASMNLDYFKELAKTAERGKLDMLFLADS
LSIDSKSHPNVLTRFEPFTLLSALAQVTSRIGLTATASTTYSEPFHVARQFASLDHLSNG
RAGWNVVTSSIESTALNFSGEKHLEHHLRYQRAEEFVEVVKGLWDSWEEDAFIRNKETGE
FFEKEKMHELNHKGEYFSVRGPLNVSRTPQGQPVIIQAGSSGDGKALAARTAEVIFTAQN
HLESAQEFYQSIKEQAAEFGRDPEKIAIMPGIFPIIADTEEAAQAKYKELQDLIIPSVGL
QILQNYLGGINLSAYPLDGPLPKLDADASNAVKSRFKLVQEMAERDNMTIRELYKYVAGS
RGHHIFVGTPEQLADKMQEWVDHKACDGFNIMPPLLPEGIEVFVEKVVPILQERGVFRKE
YEGATLREHFGLEKPVNRYAK
>PK3-2_01167 S-(2-succino)cysteine N-acetyltransferase
MKAQYRLAVERDAEQILELTLRAYEPIRKLGIRFAAAHADLDLVLRNIRKNACYVMEEDG
RIIATISLRMPWGQQPGPFGVPHIWWFAVDPDTGQKGIGTKLLQWLEETILRDTLKVPFV
SLGTAEKHPWLIEMYERKGYVRAGEQDLGKGHMTVYMKKQLRNDL
>PK3-2_01168 putative amino-acid-binding protein YxeM
MKMKKWTVLLVAALLVVLSACGNGNSSSKEDDNVLHVGATGQSYPFAYKENGKLTGFDVE
VMEAVAKKIDMKLDWKLLEFSGLMGELQTGKLDTISNQVAVTDERKETYHFTEPYAYAGT
QIVVKKDNTDIKSVDDLKGKTVAAVLGSNHAKNLESKDPDKKINIKTYETQEGTLKDVAY
GRVDAYVNSRTVLIAQIKKTGLPLKLAGDPIVYEQVAFPFAKDDAHDKLRKKVNKALDEL
RKDGTLKKLSEKYFNEDITVEQKH
>PK3-2_01169 putative amino-acid permease protein YxeN
MNTIDWEFMISAFPALIQALPITLFMAVAAMIFAIIGGLILALITKNKIPVLHQLSKLYI
SFFRGVPTLVQLFLIYYGLPQLFPEMSKMTALTAAIIGLSLKNAAYLAEIFRAALNSVDD
GQLEACLSVGMTKFQAYRRIILPQAIRNAIPATGNTFIGLLKETSLAFTLGVMEMFAQGK
MYASGNLKYFETYLAVAIVYWVLTIIYSILQDLFERAMSKPYRT
>PK3-2_01170 putative amino-acid import ATP-binding protein YxeO
MITVKNIRKAFKDLVVLDGIDLEVKRGEVVAIIGPSGSGKSTLLRCLNLLERPDQGLIEI
GEAKLNAEKFTRKEAHRLRQQTAMVFQNYNLFKNKTALQNITEALIVAQHKSRDEAKRIG
MDILKQVGLEHKADSYPITMSGGQQQRIGIARALAVNPHAILLDEPTSALDPELVAGVLQ
VIKSIAEKQTTMIIVTHEMAFAKEVADKVIFMADGHIIEQGTPEELFDHPKNERTKRFIK
QVGEPAELI
>PK3-2_01171 hypothetical protein
MADKTFHNRLINMRRDLHEHPELSFQEVETTKKSAAGLRKSVSKFLTFLNWKQA
>PK3-2_01172 N-acetylcysteine deacetylase
MIAEIKGQEDGPVIAIRADIDALPIQEQTNLPFASKVDGTMHACGHDFHTASIIGTAILL
NQRRAELKGTVRFIFQPAEEIAAGARKVIEAGVLDGVSAIFGMHNKPDLPVGTIGVKEGP
LMASVDRFEIVVKGKGGHAGIPNNSIDPIAAAGQIISGLQSVVSRNISSLQNAVVSITRV
QSGTSWNVIPDQAEMEGTVRTFQNEARQAVPEHMKRVAEGIAAGYGAQAEFKWFPYLPSV
QNDGAFLNAASEAAARLGYQTVHAEQSPGGEDFALYQEKIPGFFVWMGTNGTEEWHHPAF
TLDEDALTVASQYFAELAFLVLETMK
>PK3-2_01173 hypothetical protein
MSRQGLTAGLAEAVRTSQPEHSIDAMREAKKGLLDFTAASFAGREDKGIQKLLRLIKGEG
GTPLVPIIGQGTKAAPLQSAMLNGFIAHALDFDDVHSDVRGHPSAVIVPALMASAARGHD
ERLLGAYIVGVEVIARLGESIGSRHYEKGWHNTGTLGAIAAACAAGYADELTQEELEKAI
GFAATQSAGMRVQFGTEMKPLHAGLAAQAGLLAVKLAQSEFGGSRTALDGETGFFGLYGD
LEKAQNTLLNRWGAPWRIVKPGLWFKIYPFCSAAHHAADAIRKLVSEQAISAANTERIEV
IFPPGGDAALTESSPKTGEEGRFSVEYVIALALHGHELTAEHFNSQPIPSGIQTTIGHIQ
RVYDNAIQPAPHAVPKGRFTIVRAYLKDGRMCEARVDCPKGAPGNELSEEDIKEKLKGTV
PHEKARDIITAIEQADIKGFLAHIE
>PK3-2_01174 hypothetical protein
MTVNDAVLFILSAFLLWGAADYCLGNRWGLGERFADGFKAMGPLALSMIGIVSLAPVLAA
ILIPIVSPIYTAIGADPSSFANTILAIDMGGYALAGEMAKDPEAGLFSWVFLGTMMGPAI
VFTIPVALGIIEKEDHPYFAKGMLIGLCTVPIGCLIGGLCAGFDIVMIGKNLLIPSLLSI
VIAFGLWRYTDSVIRLFHLFGKAVSMVAIIGLAAVSVETMTGIVLIPGMEKVETGIQTTG
TIAIALAGAFPMTAFITKAFKKPLQALGRCFHLDETATAGLVTSLAHHIPMLASLKHMTP
RGKVINVAFAVSGAFVLGSHLGFVAGMKKELAAAMMIGKLAGGVTAAAAAAWMTPAQSAN
QSKHVSAGH
>PK3-2_01175 hypothetical protein
MAVKDQCMSKIKQETKPWIKRFGRLGYFAFGGVFILLGILAFMTAAGAGGAKDSSGALQT
LSRMPYGSFLLFFIGVGLIGYVIWMVLSALKDTEGHGTSRRGLSRRTGNFFSAAVYASIA
WNALRFVFGKGDGSTSEQTWSAYVLAQPFGQWLTGLTGAVFILFAIVQFVKGVRAAFMKE
FDTSKMNKQMICIAKNTGRAGNIARAIIFSAIGYFLIKTAMTSDPDDTRGFDGALAELAQ
QPHGKMILSLLACGLILYGMYAMMKGIYQHMTWEK
>PK3-2_01176 hypothetical protein
MKDYFLLIKRDLQTGFQHAKNNFIILLILTLFFLLYPVLLLKTYDQNSYYSYLDTLLIGI
GGVPIELVIQHSFKFPFLWLFIQLSLILIMNTWARTDIINFSSFTRIRIRKVYLLIISKY
TCTFIITFIYCSLTFLLTFCLCSLFGIHSTNYTEYTLHTLNFSDFKMPYLQLTWFVILLN
FSSVLCAVFLFTTLSIMMKPVYAFLILTAWYVLSIFRDSFVFIGNLSMVLRQPLFHQNVF
ASIMITLLVQVIIILICIITSIIYLNKKDIIGDSID
>PK3-2_01177 hypothetical protein
MKKKLYLALILICLILVTSYSIYQYRATNKNYAGYKLTVVNSNLDTRIKALGLTQSFGKA
KTEVVEDDMLNKITNFLIPFNFKNDTDKAVTFHPEFYRLMRGEDMTQSIDFIDNRTKKRV
NSIPPHTTIKGEAKFTYNDMNKTASLQLNINSRHGMTINLFKIPVYK
>PK3-2_01178 Bacitracin transport ATP-binding protein BcrA
MSKVIIEAKDIVKTFKRNTVLDSISFKLDKGKIYGFQGRNGSGKTMLLRVLSGLMRPTKG
QILINGINMTKQGNFPNNIGVLIEYPGFVPDYTGFKNLKLLSKIQSKISDNDIKKAIESV
GLNPDDKKKYKKYSLGMKQRLGIAQAIMEDQQIIMLDEPTNALDRDTVKVVENLLFKLKA
EGKTILIASHDSETLHAVSDKIFDIDCGRIVGESERNVN
>PK3-2_01179 hypothetical protein
MFVIREWKNLITDLYADKWKISSWLCLFILTILFLIKNARLEDLKGTISIADAMDQFFSI
YTFTFPLSPLFLLFMSIGVLPFFSLFRIIRYRSRSELFLALIARLFGISLCFTLLLLFFG
YIISGIWCGNFVHYWDTTAGTPYIRYGEQIDLSSFSGIWMITRYFITSTLVFFFFSAAVS
AIYLFLSNYIYSFIAVMSLIIMDRMMSNFYEFSILHDHLSLNLDQWLVPESFETTVFLFT
GGTILLFSIIYVQMVKKDYSNGKIDENNVKKN
>PK3-2_01180 hypothetical protein
MGALILHRLLHRKSFYIAILIGLFCSVAYFYTDELFLEESIEKDGGIAFTPYTKWMGIGG
ISDYPTLFLFLLPVIVSLPLADLFASDQRTGYTPFLFIRKKASLYFKALFGLNFAAAFIT
GTLPLIVNLYLSFMKLPNIPPDRVINNEMPLVTGYTFFPDFYYSHPLLHILFYILLTGLF
SGVWASFALSISMLFHNMFIVVLSPFVLQFILNTVFTTLGQDQMQASSFLQQQAPNGASW
SAMCFQLIGVMLLSLIIFLLGVRKYVRD
>PK3-2_01181 hypothetical protein
MKKKFFIFTLIIGLSFTLIGINKAFAYTPKGMTASYHFGFLKGNPYDETRKLDKYNTSPV
YQKVTDINISYLSWVKANGHDASHGHNYTVRKKGVILMTNYAVEDYKGSRKTVNASIAAK
KDGNGHSNGTWSPDYR
>PK3-2_01182 hypothetical protein
MKKKILVFMLILGVSFTSLGTAKLLAKHPPDGNFVDTKFHFGFLKGNPYDETTGRQKYRT
TYVYQNVKDVNIAYTSWVKASGHDASHGHNYTVRNKGVVLMTNYAVEDYRSWWAESVSTS
IAAKKNGNGHSNGVWSPDYDKYS
>PK3-2_01183 hypothetical protein
MKKLIFSLFFTASLLMVSACAKNNEVKMVTDSVSEPIIVITDTSKDPKSENNDFWLDSES
KNIYFKKIFWSSDFKNGPFYNKQVETNNADIKKSLEDKKTDIVPLPKHNKIEMVKELKHP
TPNYILGKIRDEKGKEVTWKQTYKDPGPDADFQIKLPSFKGKSAVVSLRFIWLNENHDCY
GVADKIFNIKKI
>PK3-2_01184 Deoxyribonucleoside regulator
MDREKQQLSIEAARLYYQSDYSQQQIAEQLNISRPTVSRLLQYAKEKGFVQIRVMDPFED
LDALGSMLEEKYGLLEAHVVFSPTSDYAGITHDLSRYGAEYMHETVKDGDVVGVSWGTTM
YQIAQNMQPKQVKGVEVVQLKGGISHSRVNTYSAETIQLFAEAFQTMPRYLPLPVVFDNA
DVKRMVEKDRHIERIIEMGKQANIALFTVGTVRDEALLFRLGYFNEEEKALLKKQAVGDI
CSRFFDAKGNICSSAINDRTIGVELEDLRLKERSILVAGGSRKVSSIHGALTGKYANVLI
IDQHTARVLVNDL
>PK3-2_01185 Deoxyribose-phosphate aldolase
MSLANIIDHTALKPHTQKAEILTLIEEAKTYKFASVCVNPTWVELAAKELEGTGVDVCTV
IGFPLGANTTETKAFETKDAISKGATEVDMVINIAALKDKEDDVVEADIRGVVEAAAGKA
LVKVIIETCLLTDEEKERACRLAVSAGADFVKTSTGFSTGGATKEDIALMRKTVGPDIGV
KASGGVRTKEDVDTMVEEGASRIGASAGVSIVKGENASDGDNY
>PK3-2_01186 Nucleoside permease NupC
MKYLIGIIGLIVFLGLAWIASSGKKRIKIRPIVVMLILQFILGYILLNTGIGNFLVGGFA
KGFNYLLGYAAEGINFVFGGLVNADQTTFFMNVLLPIVFISALIGILQKWKVLPFIIRYI
GLALSKVNGMGRLESYNAVASAILGQSEVFISLKKELGLLNQQRLYTLCASAMSTVSMSI
VGAYMTMLKPEYVVTALVLNLFGGFIIASIINPYEVAKEEDMLRVEEEEKQSFFEVLGEY
ILDGFKVAVVVAAMLIGFVAIIALINGIFNAVFGISFQGLLGYVFAPFAFLVGIPWNEAI
NAGSIMATKMVSNEFVAMTSLTQNGFHFSGRTTAIVSVFLVSFANFSSIGIIAGAVKGLN
EKQGNVVARFGLKLLYGATLVSFLSAAIVGLIY
>PK3-2_01187 Pyrimidine-nucleoside phosphorylase
MRMVDIIIKKQNGKELTTEEIQFFVNGYTDGSIPDYQASALAMAIFFQDMSDRERADLTM
AMVNSGETIDLSAIEGIKVDKHSTGGVGDTTTLVLAPLVAALDVPVAKMSGRGLGHTGGT
IDKLEAIDGFHVELTKDEFIKLVNRDKVAVIGQSGNLTPADKKLYALRDVTGTVNSIPLI
ASSIMSKKIAAGADAIVLDVKTGAGAFMKTEEDAAELAKAMVRIGNNVGRQTMAVISDMS
QPLGFAIGNALEVKEAIDTLKGEGPEDLHELVLTLGSQMVVLAKKAAALDEARAKLEEVM
KNGKALEKFKDFLKNQGGDSSIVDDPSKLPQAAYQIDVPAKEAGVVSEIVADEIGVAAML
LGAGRATKEDEIDLAVGIMLRKKVGDKVENGEPLVTLYANRENVEEVIAKVYDNIRIAAE
AKAPKLIHTLITE
>PK3-2_01188 Amino-acid permease RocC
MNLQENSGQQLKRTMKSRHLFMISLGGVIGTGLFLSTGYTLNQAGPGGTILAYLIGGLMM
YLVMQCLGELSVAMPVTGSFQKYATTFIGPSTGFMVGIMYWVNWVVTVGSEFTASGILMQ
RWFPDSSVWMWSAVFAALLFVCNAFSVKLFAETEFWFSSVKIVTIILFIILGGAAMFGLI
SLNGAADAPMLSNFTDHGGLFPNGFLAVFIAMISVSFAFSGTELIGVTAGESANPQKDIP
RSIRNVAWRTVIFFIGAVFVLSGLISWKEAGVIESPFVAVFAEIGIPYAADIMNFVILTA
LLSVANSGLYASTRMMWSLANENMISPRFKKVTSKGIPLNALMISMAVSCLSLVSSIAAP
GTVYVVMVAIAGFAGVVVWMSIALSQLLFRKRFLKKGGNIKDLTFRTPLYPLMPIAALLL
CSASCIGLAFDPNQRIALFCGIPCIILCYLIFYFKRKMMKSKKIGQEEYQIDHIL
>PK3-2_01189 Formimidoylglutamase
MDKYPFLREAGSSFKDRDVTKMSDLIAKWEGQSIKGPALIGAPLSKSSISHSGASFAPGT
IRQALKQSSAYSAELGEHVVSDLLYDLGDIDIHVTDIVKSHHQICHTMHALLSDHPDWVP
LILGGDNSISYSTIKAIAQTKGTIAVIQFDAHHDVRNTEDGGPTNGTPFRRLLDEEIIEG
RHLIQLGIREFSNSQAYEAYAKKHHVNIHTMDMIREKGLLPTIKEILPAVQTKTDSIFIS
VDMDVLDQSHAPGCPAIGPGGLYTDELLEVVKYIAQQPNVAGIEIVEVDPTLDFRDMTSR
AAAHVLLHALKGMKRSPFL
>PK3-2_01190 Imidazolonepropionase
MPKQIDTILINIGQLLTMESSGPRAGKSMQDLHVIEDAVVGIHEQKIVFAGKKGAEADYE
ADDIIDCSGRLVTPGLVDPHTHLVFGGSREKEMNLKLQGISYLDILAQGGGILSTVKDTR
AASEEELLQKGHFHLQRMLSYGTTTAEVKSGYGLEKETELKQLRAAKKLHESQPVDLVST
FMGAHAIPPEYQHNPDDFLDQMLTLLPEIKEQELASFADIFTETGVFTVSQSRRYLQKAA
EAGFGLKIHADEIDPLGGAELAGELKAVSADHLVGASDEGIKKLAESGTIAVLLPGTTFY
LGKSTYARARAMIDEGVCVSLATDFNPGSSPTENIQLIMSIAALHLKMTAEEIWHAVTVN
AAHAIGKGEEAGQLKAGRSADLVIWQASNYMYIPYHYGVNHVHQVMKNGTFVVNREGAIY
G
>PK3-2_01191 Urocanate hydratase
MTDVKKSIRANRGTELECLGWEQEAVLRMLRNNLDPEVAEKPEDLIVYGGIGKAARDWDA
FHAIEHSLKTLQNDETLLVQSGKPVGLFRTHPQAPRVLLANSVLVPKWADWEHFHELEKK
GLMMYGQMTAGSWIYIGSQGILQGTYETFAELARQHFGGSLKGTLTLTAGLGGMGGAQPL
SVTMNEGVVIAVEADEKRIDKRIETNYCDRKTASIEEALAWAEEAKLAGKPLSIALLGNA
AEVHHTLLKRGVKIDIVTDQTSAHDPLIGYVPEGYSLDEADRLRQDNPDLYVRLAKQSMK
KHVEAMLAFQQKGSVVFDYGNNIRQVAKDEGLENAFDFPGFVPAYIRPLFCEGKGPFRWA
ALSGDPADIYRTDALLKELFPENKALHRWIDMAQDKVMFQGLPSRICWLGYGERKKMGLA
INELVRNGELKAPVVIGRDHLDCGSVASPNRETEAMKDGSDAVGDWAVLNALVNTAAGAS
WVSFHHGGGVGMGYSLHAGMVAVADGSELADERLARVLTSDPGMGIIRHADAGYERAVEV
AKKQDIIVPMQKERE
>PK3-2_01192 Histidine ammonia-lyase
MVTLDGSSLTTADVARVLFDFEEAAASEESMALVKKSRSAVERIVREEKTIYGINTGFGK
FSDILIQKEDSAALQLNLILSHACGVGDPFPECVSRAMLLLRANALLKGFSGVRAELIEQ
LLAFLNKRVHPVIPQQGSLGASGDLAPLSHLALALIGQGEVFFEGERMPAMMGLKKAGIQ
PVSLTSKEGLALINGTQAMTAMGVVAYIEAEKLAYQTERIASLTIEGLRGIIDAFDEDIH
SARGYREQIDVAERIRFYLSDSGLTTSQGELRVQDAYSLRCIPQVHGATWQTLGYVKEKL
EIEMNAATDNPLIFDDGDKVISGGNFHGQPIAFAMDFLKIAMSELANIAERRIERLVNPQ
LNDLPPFLSPHPGLQSGAMIMQYAAASLVSENKTLAHPASVDSIPSSANQEDHVSMGTIA
ARHAYQVIANTRRVIAIEAICALQAVEYRGIEHAASYTKQLFQEMRKVVPSIQQDRVFSY
DIERLTDWLKKESLLPDYQNEELRGMNI
>PK3-2_01193 Hut operon positive regulatory protein
MIHMTLHKERRIGRLSVLLLLNEAEESTQVGELERDGWKVCLGKVGSMDAHKVVAAIETA
SKKSGVIQSEGYRESHALYHATMEALHGVTRGEMLLGSLLRTVGLRFAVLRGNPYESEAE
GDWIAVSLYGTIGAPIKGLEHETFGVGINHI
>PK3-2_01194 Extracellular endo-alpha-(1->5)-L-arabinanase 2
MFNRLFRVCFLAALIMAFTLPNSAYAQKPVFKEVSVHDPSIIETNGIFYVFGSHLASAKT
NDLMQWQQLTTSVSNNNPLIPNVYEELKDTFEWAQSDTLWAADVTQLADGKYYMYYNACR
GDSPRSAMGVAVADNIEGPYKNKGIFLKSGMEGTSDDGTPYDATKHPNVVDPHTFFDQNG
KLWMVYGSYSGGIFILEMNPKTGFPLPGQGYGKKLLGGNHSRIEGPYVLYNPDTKYYYLY
LSYGGLDATGGYNIRVARSKTPDGPYYDGEGNSMLDVRGKEGTFFDDRSIEPYGVKLMGS
YSFETENEKGTGYVSPGHNSVYYDEKTGRSYLIFHTRFPGRGEEHEVRVHQLFMNKDGWP
IAAPYRYAGETLKEVKQKDITGTYKLIQHGKDISADIKKTINIQLNKNHTISGEMTGEWQ
KTGKNTADITLAGKKYNGVFLRQWDSVREKNVMTFSVLNSSGEAVWGSK
>PK3-2_01195 hypothetical protein
MHSEMLLHSVKADLHEKQEQIHQLKRVLHEIRQIKHEFSEAQHLIHRPHLNREAWRGTHA
ERFEDIREGMNKAYQQIKSDQVSGIIESIEGKIHSLEGDIYSIRRQITRIEHEIEKEKHK
K
>PK3-2_01196 hypothetical protein
MAQEIKMVYGTVKQGLSQLKNSAELKSSLPGHLSGRNHLSAVKSIEQLNEDIKKLTEAYA
SVLAKHIAQTESAVNAMKETDENISSSMK
>PK3-2_01197 Ribonuclease YxiD
MKTLDVHALHEGIQHTIEKLDKQKQQLEKLEKSVEHLAGMKDALKGKGGDAIRTFYEECH
KPFLLFFGMFIDEYKKVLKQTQHAISSVESDSHGMIAEAFLSHDARHGVKHAREVTEQLT
DAVNRQTSAIGHIVSLPTVNDSFFRMETEQAERLITDTLHKLLQFDGQQTQALETAKSDF
QTMKKYIDQLETMYTGPKIEITGYKSGSILKSKEEENINQTFGAINPQMKQADDSPMEMM
LKKLEKHKQSNVDTVMKDGKQQKIEREIHADDSNVTVLQKEAAAHPKVYGDIRVINDKLY
NHKGLKKIDTIQVIDELESDTASIDYVGGKYFVYENGQIVREFYTGGKKRLEEVSYIPED
KVGGAKPLDSFLAGTQYEFVEWVSPQGAVKKLAVRGGKRVVTNVAKHVAEKESKDVNKAV
SKNTVKNISHPVLDNTRSGSALKKPDGQHGFNDIIDNYTPQAKEFEIVGGDDVKRKLYQI
EGGMKYYDYKDVYNKGLRINERITTIKDQNGVFEWIVDPTKGVTHRRFIPNGQITGSPNQ
RP
>PK3-2_01198 hypothetical protein
MSVYVDVLKQYRIKYDWKTLYVGLKLDLIKYCDVTNYAVDFLTRHPETNDQNIIQLAWGD
QDFDYESLLLSILKESNFDGLNLDANSLQVEKRKWRFVILVFLKKKHQKDFEELLNQIAE
VYADFNYPEDMDSFINYLPSKDNFKQSKYSKEENIARLINLFNEFLNKEHKYLQN
>PK3-2_01199 PTS system beta-glucoside-specific EIIBCA component
MDYDKLSKEILQLVGGEDNVQRVIHCMTRLRFNLHDNSKADRSQLEQLPGVMGTNISGEQ
FQIIIGNDVPKVYQAIVRHSNLSDEKSAGSSSQKKNVLSAVFDVISGVFTPILPAIAGAG
MIKGLVALAVTFGWMAEKSQVHVILTAVGDGAFYFLPLLLAMSAARKFGSNPYVAAAIAA
AILHPDLTALLGAGKPISFIGLPVTAATYSSTVIPILLAIWIASYVEKWIDRFTHSSLKL
IVVPTFTLLIIVPLTLITVGPLGAILGEYLSAGVNYLFDHAGLVAMILLAGTFSLIIMTG
MHYAFVPIMINNIAQNGHDYLLPAMFLANMGQAGASFAVFLRSRNKKFKSLALTTSITAL
MGITEPAMYGVNMRLKKPFAAALIGGAAGGAFYGMTGVASYIVGGNAGLPSIPVFIGPTF
IYAMIGLVIAFAAGTAAAYLIGFEDVPSDGGEQPAAGKSDEGSGEIIHSPIKGEVKALSE
VNDGVFSAGIMGKGFAIEPEEGEVVSPVRGSVTTIFKTKHAIGITSDQGAEILIHIGLDT
VKLEGQWFTAHVKEGDKVTPGDPLVSFDLEQIKAAGYDVITPVIVTNTDQYAFSPVKEIG
KVQTKEALLALS
>PK3-2_01200 Aryl-phospho-beta-D-glucosidase BglH
MSSNAKRFPEGFLWGGAVAANQVEGAYNEGGKGLSTADVSPNGIMSPFDESMTSLNLYHT
GIDFYHRYKEDIALFAEMGFKAFRTSIAWTRIFPNGDEEEPNEEGLTFYDNLFDELSKHR
IEPVVTISHYEMPLGLVKHYGGWKNRKVIEFYERYAKTVFQRYQHKVKYWMTFNEINVVL
HAPFTGGGLVFEEGENKRNAMYQAAHHQFVASALAVKAGHEIIPDSKIGCMIAATTTYPM
TSKPEDVFAAMENERKTLFFSDVQARGAYPGYMKRYLAENNISIEMAEGDEEILKEHTVD
YIGFSYYMSMAASTDPEDLAKSGGNLLGGVKNPYLKSSEWGWQIDPKGLRITLNTLYDRY
QKPLFIVENGLGAVDKVEKDGAIEDDYRINYLRDHLIEAREAIADGVELIGYTSWGPIDL
VSASTAEMKKRYGFIYVDRDNEGNGTLNRTKKKSFSWYQQVIATNGESL
>PK3-2_01201 TRAP-T-associated universal stress protein TeaD
MFNKMLVAIDGSEMSAKALDAAVHLAKEQQAELSILHVGREAVVTTSSLTGIVYVPEHFI
DEIRNEVKKEGLKILENAKEKAAENGVQAEIIYANGEPAHEILNNAKEKGVSLIVVGSRG
ISGLKEMMLGSVSHKVSQLSPCPVLIVR
>PK3-2_01202 L-isoleucine-4-hydroxylase
MVQVSKVQKELTSDISNYASFLKENGYSYIPSDFYQQKNTDAAVRELQLTYEDLKADPKG
GGRYRAHSRYILAPQSDTLELDPDNGYFQSKEYNYDDGGIVREFDKISNEFLQHPVTQQM
IHSNVEMARQTDFVDWEKEVIVGLHQIRYHVTPDAPSYSSPIWLHRDDEPLVFVHLFQLS
EDAIGGDNLIAPSVKQIDKVLRLTDPLETLALGQKVFHAVTPVGTANIDGAHRDILLVTF
SNR
>PK3-2_01203 Dihydroanticapsin 7-dehydrogenase
MAKKKNIIITGANSGIGFAAVKQFLADGFRVVGVDIQTNKMSEFIVNSDFHMAEADLSDV
QQAESLMPKLEQSQLIPDILINAAGIREITPVLELSAESFKKVIDINLTAAFILSRDAAR
LWSKLEKKGCVINIASVSGLMAEPARAAYVSSKHAVIGLTKQLAMEFGSKGIRVNSISPG
VIQTELTEEYFLDDEMVQLIKDNHALHTWGQPNDIVSCMKYLASDDAHFITGSNFVIDGG
WTAGKKL
>PK3-2_01204 hypothetical protein
MMQQDLSITPKQKSTAVLKMVISMVIFGSIGFFSEHTNLQSFELVFVRCLCATLFLSFCW
LASGQYKTEKWSKRDVLQTLACGFFLVFNWVFLFKSFEETSVTIAISVYHLAPVLVLLLG
SIIYRERLNVISVSSIIICFLGTALISGINGSTSITQLMGSGIIWAVLAALFYAFTTLLG
KGIQNLSPYTTTFLQTGLGVIILIPFIHFGAFADLSQGNWIMVISTGIIHTGIVYLLFFD
SLRFLSTKFISIIVFLDPAVAIVLDTAFTGFRPDLYQTLGIVMIFAGMALTLVRRRGKAD
VVAEDNNIEQA
>PK3-2_01205 hypothetical protein
MGLKGEKLMYYFYEISTLNDYDRVEKEYRTIEDIIFDIFKKIESKQYAMYSYSVSNKDSH
DRIYSARLKGNTLFNPKKISFTKTSAEEYKNTIVAHENIILVRKDDELKNILSTVHITEK
TIIKDLLNIVFYHIEITDSETIRIGSRHRENILNII
>PK3-2_01206 hypothetical protein
MTSSKLAEKLKENKRYLLIKEVKERLNNCTKKGFIYQFTEAELSRKLLDTVLSNSIVGIV
REVGVISKKEAKQLLKETIITVGSERINDIVYLFHPQSDEVGAIKSTLKDCIEHLDCLLD
FIEFEDQLLSNSFILMEPSFTFVICLFHTEYGCELFYAKNL
>PK3-2_01207 hypothetical protein
MVINLIEPNLLECTNKIKSVLTGQTTREEVSDWAGTYVYAYDPEVEDDRVWNMLILLSGI
DLKDSPETYLHSTDDLNDWIKQYTE
>PK3-2_01208 hypothetical protein
MFKKELSLNIKVFESEAEYTHKILFQNVASTYYSADVGDMRLKKIDPEEYNWQVFEMSYH
PEGIGNLSNSVIPEYQSNANFLIDMNRMLIAIEAETVRFDDQSFYAYQLNN
>PK3-2_01209 hypothetical protein
MKKLKMNKIINTDTQDCFFHADPLGRVYIGKGVKGDVTISIYDPSGDIRDFRVKEQIAYS
DIQLFQQCADGYVFVYYESYEPKVKVFSEEGRVKSAFHLPSGVSCCLLDEKQNLWVGLND
EGIYDDENPDGHSVWCFTLDGQQKEIHIDRKLEEMDAPAVDDCYGLAEKNGLIYMLYYGD
AVIAAFDDTVVRRVWILSDKEPDSEAFYQLAISEEGFLVGTFNCYSEELESSLYLISADV
SQEMEEITCCDSNGEALDVQQLKLTSNAVYAVASSGVYKQDIQ
>PK3-2_01210 hypothetical protein
MMNWRALSQTKQDRIWSEVNKLIKWKPGSRCHHIIPPDPYRVFDISSGMSSKAGHNDVSG
VLSDLETSILKAFQLCTGKNDVMYALDWQHDGYTFSPHQAIPQDEFGEWPVPVFPNGDYY
FFFHQNFSWGLLGDPWKYTITVFGEELLEAIDNDPPILFQDK
>PK3-2_01211 hypothetical protein
MLQKLKKRQRELEEMPYPDELYGFETDIYEFFMLVDGSLDYVLANKRMPRHQRRSLEKSF
FELYPEISTAMIKNNTDLYCHILLYEQVRQEICVALSN
>PK3-2_01212 hypothetical protein
MEITSISSIGNLDMIALKPHQVVMSCELEDAESFYRFWEGLAYDRIMIQVITTGSFIEHL
SEYFEGHAYKVTKLAKREFRFQSVLQNADRDIAGYLFLLASINDDVFLITDPQPDKSYFS
EGKLQCLTDSGERIMWFEYDAVDIYMVGGN
>PK3-2_01213 hypothetical protein
MNITQYEKMKKHLSDADTGPFTLNEFSFYMKEDDRYIHIPVFELKLSAQTCDIHLRFEDI
SASRLDDLESIDAVELEILPTDDQWERLRYYVYDEEDQISFYCGGWDVIKFDKKSH
>PK3-2_01214 hypothetical protein
MVISTGIIHTGIVYLLFFDSLRFLSTKFISIIVFLDPAVAIVLDTVFTGFRPDLYQTLGI
VMIFAGMALTLVRRRGKADVVAENSQM
>PK3-2_01215 hypothetical protein
MKQKKLIMTFVAFVIALTSFTAIDLAGNKAQAKDWVKKGSIWTTHYHSGSFKNYTYSPTF
QIWYSGQGTNASITAKGSGSGKIKAEMQQKTSKGWKTIKTFYAKKKGYTNLNYSKASKSY
KTKYRFKFSNTGTKKTINYTFASLY
>PK3-2_01216 hypothetical protein
MKQRKYMMSEGLAFSEEKDMKRLSDMASKGWVLDSFAFMGYKLRKAEPQNLIYSLDYRAV
EDHNIDEYLDIFENAGWEHICSVYDTHIFAADPGTKPIYSDRSTMIDKYKQSEFTLRYIT
LFMLCLTAAVTVIRNTFIPGEASILHNTIHVLFVFLIAITIPATLTYAASVFRIWRVKRR
NPNLE
>PK3-2_01217 hypothetical protein
MPKQRPQEMDQLTDPAYYIVLTLLEPKHGYSIMQEIQEMTDDSFTIGPATLYTLLKKLLQ
EEIIELVNNDNPRRKVYQTTRGGQELLKKEIQRRKWMAEHGERAFQQLKGDWS
>PK3-2_01218 putative esterase YxiM
MKKGMAAVFVMMLMLCCGGIKSVTASEQKVYQFDFGSGSVEPGYIGVRASDRYDPSKGYG
FQTPENMKDVAASGVGVKSDAVQFLTYGTKSNNTFHVDLPNGLYEVKVTLGNTARASVAA
EGVFQVINMTGDGAEDTFQIPVTDGQLNLLVTEGKAGTAFTLSALKIKKLSDQPVTNRTI
YVGGDSTVCNYYPLNSSKQAGWGQMLPHYIDKHTFQVRNMASGGQIARGFRNDGQLEAIL
KYIKPGDYFILQLGINDTNPKHNESEEEFKEMMRDMIRQVKAKGADVILSTPQGRATDFT
SEGIHTSVNRWYRASILALAEEEKTRLIDLNVLSSAYFTSIGPEKTLALYMDGDTLHPNR
SGAGALARLAVQELKRQGIDGF
>PK3-2_01219 ATP-dependent RNA helicase DbpA
MSHFKNYQISHDILRALEGLGYTEPTKVQRSVIPAALERKDLVVKSQTGSGKTASFGIPL
CELADWDENKPQALILTPTRELAVQVKEDITNIGRFKRIKATAVFGKSSFDKQKAELKQK
SHIVVGTPGRVLDHIEKGTLPLDRLSYLVIDEADEMLNMGFIEQVEAIIKHLPTERTTML
FSATLPEDIEKLSRQYMRNPEHIEIKAAGLTTRNIEHAVIQVREEHKFSLLKDVLMTENP
DSCIIFCRTKEHVNQLTDELDDLGYPCDKIHGGMIQEDRFDVMNEFKRGEYRYLVATDVA
ARGIDIENISLVINYDLPVEKESYVHRTGRTGRAGNKGKAISFVTAFEKRFLADIEEYIG
FEIQKIEAPSQEEVAKKKPDFLSKMNDRPEIKKDKSEELNKDIMKLYFNGGKKKKIRAVD
FVGTIAKIEGVTADDIGIITIMDNASYVEILNGKGPQVLKVMKNTTVKGKKLKVNKANK
>PK3-2_01220 hypothetical protein
MKRFTKQENSWILYDWANSAYSIVVTTAVFPLFYKSAAAESGVSAAQSTAYLGYTIAIST
FILAMLGPILGTIADYEGCKKRLFGFFVSAGVASTAMLAFIPSEHWLLLLLFYTISAIGF
SGANVFYDAFLVDVTPEKRMNLVSARGFGLGYIGSTIPFIVSIAVILLAQAETIPVSVSA
ASQLSFFITAAWWGLFTIPMLKHVHQRYFIKREPHIVINSFKRLGQTMKRIRQYRALFLF
LLAYFFYIDGVGTIITMSTSYGSDLGISPSSLLIILFVTQVVAAPFSIAYGRLAERFTGK
TMLYVGIVIYMIVCVYAYFLETTLDFWILAMLVATSQGGIQALSRSYFARLVPKRHANEF
FGFYNIFGKFASIMGPLLIAVTAQMTGKSSTAVFSLIILFVIGIVILAFVPEENHAGVSQ
HQNDLPL
>PK3-2_01221 hypothetical protein
MRRIGLCVSLLITVLAMGACESEAQTFADRDHKSVKQTAAKPMTNKKKQDFQTLASDMQL
AIVFSSMIHLSEAFDYGIGNPEYFVRSSMTEEKADIAKENLESIQLENKPLRKQNSEAFA
LLQKTRNHEMSREETQLLKENRDAFFEVTDSMIKLISQVTPKNAKKTRLQLDKLKKQYTQ
YSAESIKIMNSIVKKQGADKASFERHLEALLQKQPGQPVLSELN
>PK3-2_01222 Transcription antiterminator LicT
MKIAKVINNNVISVVNEQGKELVIMGRGLAFQKKSGDDVDEARIEKVFTLDNKDVSEKFK
TLLYEIPIECMEVSEEIISYAKLQLGKKLNDSIYVSLTDHINFAIQRNQKGLDIKNALLW
ETKRLYKDEFAIGKEALEMVKNKTGVSLPEDEAGFIALHIVNAELNEEMPNIINITKVMQ
EILSIVKYHFKIEFNEESLHYYRFVTHLKFFAQRLFNGTYMESQDDFLLETVKEKYHRAY
ECTKKIQTYIEREYEHKLTSDELLYLTIHIERVVKQT
>PK3-2_01223 PTS system beta-glucoside-specific EIIBCA component
MGYQAAAKNILQLVGGEENVRSLVHCATRLRFTLNDRSKADKDQIEALDDVVTVVESGGQ
FQVVIGNHVSEVYQEIGRMSNLLHDGRSEGSAQKGNLFGRLVDIVSSIFTPLLGVMAGAG
ILKGLLMICTNAGWLKTEETTYTILYAAADSLFYFLPLLLAITAARKFGANLFVSVTVAG
ALIYPTIIELKNGNAEADFFGIPVVLMNYTSTVIPIILAIFVMSYVEKYLNRVIHDSVKT
FITPLICLVTIVPLTLIVFGPIGVNAGNAIASAILAIFSFNPMLAGAVIAALWQILVIFG
IHWGIVPVILNNIAVNGQDSIKPATAAAVFTQTGAAVGVMLKTKNKKLKALAGSAAVTGI
FGITEPAVYGVTLRLKKPFVCGVISAAVGGAIIGQAHSVAIASGAPGLLTIPIFYGQGFA
GFILGISVSFMLSIILTYIVGFEDPAEQTEIKAEPSASSVRRQEIGSPLEGKVVPLTEVK
DKVFASETLGKGIAILPEKGRLVAPADGVISTVFPTGHAFGMVTDQETEILIHLGFDTVK
LGGKHFYPKVVQGQTVKQGDLLAEFDLDDLLKAGFDMNTPIIITNADQYTDVIQTDQKQV
KIEERIFSLI
>PK3-2_01224 Aryl-phospho-beta-D-glucosidase BglC
MNYKTLAAFPENFLWGASTSAYQVEGAWNEDGKGPSVIDARDSYPEGTTDFKVASDHYHR
YKEDVALFAEMGFKAYRFSIAWTRIIPDGDGDINQKGIEFYSNLIDELLTYKIEPIVTMY
HFDLPNALQKKGGWSQRATIDAFERYSKVLFEHFGDRVKYWLTINEQNMMILHGSALGTL
DPNLQNPKKELYQQNHHMLVAQAKAMNLCHDMLPDAKIGPAPNIALIYPASSKPEDIVAA
FNYNAIRNWLYLDMAVHGRYNTTAWAYMKEKGYTPVIEEGDMEILQAAKPDFIAFNYYTS
QTAAASKGDGSDEAARGGDQHLKTGEDGVYRGSSNPHLKKNDFGWEIDPVGFRSTLREIY
DRYQLPLIITENGLGAFDQLEENDKVNDDYRIDYLKQHIEQIQWAITDGVDVFGYSPWSA
IDLISTHQGCSKRYGFIYVNRDEFDLKDLRRIRKKSFYWYKELIASNGEILKR
>PK3-2_01225 hypothetical protein
MKNKKIFSLPFLCAVLIVAFSFCLNSNAAAAQNVPKEKAILKQQETLKNHEEIEEVSLKQ
ADAGSLKKDKKAETIKVKKPANENVFKTTSMYNSEDQVFDTSSVLNENNPDDMYFFSTSS
DRTLITRILSGNSQYYLKLYVVNWDTGEAQPTNIAMDAGNLVLLKELPAGDYMIRVYSEG
TMGDSYNIQLNAKNPSNYTSVKSITSNLQSFVAEYADGSVYANGTLLYNTSTKTSSLSWE
RVFYFSYGDGYNQRTHSISSVKVKSVSDPVTYRSSYASSNSAVMVYLDTGTLFMHHVSAY
RTGVGYEDSFLDTLGKKTPRRLDADDQNYGDHILIVDLKTGKAIDFFSVLNYYYASGVES
LPVISYIQ
>PK3-2_01226 Citrate transporter
MLAILGFVMMIVFMYLIMSNRLSALIALIVVPVVFALISGFGQDLGEMMIQGVTDLAPTG
IMLLFAILYFGIMIDSGLFDPLIAKILSLVQGDPLKIAIGTAVLTMTISLDGDGTTTYMI
TIAAMLPLYKRLGMNRLVLAGIAMLGSGVMNIIPWGGPTARVLASLKLDTSEVFTPLIPA
MIAGVLWVIAVAYILGKKERKRLGVISIEHAPSADTDAAPLKRPALQWFNLLLTVALMAA
LITSLLPIPVLFMIAFAIALMVNYPNVKEQQKRISAHAGNALNVVSMVFAAGIFTGILSG
TKMVDAMAHSLVSLIPDAMGPHLPLITAIVSMPFTFFMSNDAFYFGVLPIIAEAASAYGI
DAAEIGRASLLGQPVHLLSPLVPSTYLLVGMAGVSFGDHQKFTIKWAVGTTIVMTIAALL
IGIISF
>PK3-2_01227 Catalase HPII
MSDDQNKRVNEHSKDEQLEQYRVDNSGKKMTTNQGLRVSEDEHSLKAGVRGPTLMEDFHF
REKMTHFDHERIPERVVHARGYGVHGFFQVYEPMTEYTRAKFLQDPSVKTPVFVRFSTVA
GSKGSADTVRDARGFATKFYTEEGNYDLVGNNIPVFFIQDAIKFPDLVHAFKPEPHNEMP
QAATAHDTFWDFVANNPESAHMVMWTMSDRGIPRSYRMMEGFGVHTFRFVNEQGKARFVK
FHWKPVLGVHSLVWDEAQKIAGKDPDFHRRDLWETIENGGTVEYELGVQMIDEEDEFKFD
FDILDPTKLWPEELVPVKIIGKMTLNRNQDNVFAETEQVAFHPGNVVPGIDFTNDPLLQG
RLFSYTDTQLIRLGGPNFHELPINRPVCPFHNNQYDGYHRMTINKGPVAYHKNSLQNNDP
SPATAEEGGYVHYQEKVEGKKIRQRSDSFNNYYSQAKLFWNSMSPVEKQHIISAFCFEVG
KVKSKDVQRQVVDVFSNVDAGLAEEIAKGVGVAPPAKRKASKEILTSPALSQARTVKTAA
TRKVAVLAGNGFDGKELQTMLDALKQEGITADMISQTLGHITSGAGQQLEVGATFLTADS
VLYDAVYAAGGPALKGNKQAMAFISEAYNHYKTIGAANEGMDLLQSAVGTTEGPGIVTAK
DEADYTAFSKAFIDAVAAHRHWDRRI
>PK3-2_01228 hypothetical protein
MNEKQLAEAYERDENMMILVFAQWCVNHDLDPLELYAKAYPQQKLNESLKKTIDELAVPK
QESEHIPDQTVVAVLEMFGNTDLAQAVHEAISERKQEKRH
>PK3-2_01229 hypothetical protein
MKWNKMLKTAGIAVLLFSVLAYAAPSLKAVQAKTPTVSSHTHKKIKELKYPQVHHIGNAA
FEKKINQELKAYIEQSYQEYLKNKKAGEQQGFKAEYQTSFSVKYNAAGKLSIQTLNYIYS
GGAHGLTSVQSFNYDLKAQKRVTLNQILNTKTKVSKTKDYLYSYMKKHDELFFPDVKKED
IALNKDTMFYFTKNGIAIVFGQYDLGPYAAGIRDVQVPASIYQS
>PK3-2_01230 Purine nucleoside transport protein NupG
MYFLLNLVGLIVIMAVVFLCSPQKKKIKWRPIITLIVLELLITWFMLGTKVGSWAIGKIG
DFFTWLIACASDGIAFAFPSVMANETVDFFFSALLPIIFIVTFFDILTYFGILPWLIDKI
GWVISKASRLPKLESFFSIQMMFLGNTEALAVIRQQLTVLNNNRLLTFGLMSMSSISGSI
IGSYLSMVPATYVFTAIPLNCLNALIIANLLNPVHVPEDEDIIYTPPKEEKKDFFSTISN
SMLVGMNMVIVILAMVIGYVALTSAVNGILGVFVHGLTIQTIFAYLFSPFAFLLGLPVHD
AMYVAQLMGMKLATNEFVAMLDLKDNLKSLPPHTVAVATTFLTSFANFSTVGMIYGTYNS
ILDGEKSTVIGKNVWKLLVSGIAVSLLSAAIVGLFVW
>PK3-2_01232 23S rRNA (guanine(745)-N(1))-methyltransferase
MKRTADVSMFRCPLCGSSMDAASGKSLICTERGHTFDLSRHGYVNFLTKPIKTGYDAGLF
EARSRLIGECGFFGPLHQAIADLISHPKSGEEAFTILDSGCGEGTHLNALCGFDYAGKTA
VGAGIDLSKDGIVKASKAFKDHMWAVADVARAPFHDHQFDVVLSIFSPSNYAEFHRLLKD
DGMLIKVVPRSDYLIELRQFLYTDSPRRTYSNAAAVERFTANVEQSRHSRVRYVKTLDQQ
AIHWLLKMTPLAWSAPKDRVSLLKEMKSAEMTVDVDILIGMN
>PK3-2_01233 hypothetical protein
MELIIILLALGLLMFTAYRGFSVILFAPICALFAVLLTDPSHVLPFFSSIFMEKMAGFIK
LYFPVFLLGAIFGKVVEMSGLAASIAKTIVRLVGAKRAILAIVLMGAILTYSGVSLFVVV
FAVYPFAKNLFREANIPKRLIPGTIALGAFTFTMDALPGTPQIQNVIPTTFFKTDIYAAP
WLGLTGAVIVLAAGMLYLESRRKKAQSSGEGYGGFDSENSAARETSEFAAEPDKSPLQHA
LAFVPLILVGAMNKCFTIYLPKWYPNGFDFSSIGLKEFGKLDLSAAAAIWSVELALVIGI
ITTILFDWRRVFAQMKVGLNEGIGGALLASMNTGAEYGFGGIIAALPGFHKLSSGISHTF
TDPLVNGAVTTTALAGITGSASGGMGIALSAMSDQYLQAIQAYNIPPEVMHRVISMASGG
MDTLPHNGAVITLLAVTGLTHRQSYRDIFAITLIKTAAVFAVIAIYSLTGLV
>PK3-2_01234 putative succinyl-CoA:3-ketoacid coenzyme A transferase subunit A
MEKVLSSSKEAAELIHDGDTLIAGGFGLCGIPEQLILAIRDQGAKDLTVVSNNCGVDDWG
LGLLLANRQIKKMIASYVGENKIFERQFLSGELEVELVPQGTLAERIRAGGAGIPGFYTA
TGVGTSIAEGKEHKTFDGRPYVLERGITGDVAIVKAWKADTMGNLVFRKTARNFNPVAAM
AGKITIVEAEEIVEAGELDPDHIHTPGIYVQHVVLGASHEKRIEKRTVRQASGKGEAK
>PK3-2_01235 putative succinyl-CoA:3-ketoacid coenzyme A transferase subunit B
MKEARKRMVKRAVQEIKDGMNVNLGIGMPTLVANEIPDGVHVMLQSENGLLGIGPYPVEG
TEDADLINAGKETITEVTGASYFDSVESFAMIRGGHIDLAILGGMEVSEKGDLANWMIPG
KMVKGMGGAMDLVNGAKRIVVIMEHVNKHGEPKVKKTCGLPLTGQKVVHRLITDLAVFDF
DNGHMTLTELQEGVTIEEVYEKTEADFAVSQSVLKQNS
>PK3-2_01236 D-beta-hydroxybutyrate dehydrogenase
MKKHVALVTGAAGGIGFEIAREFAREGASVIVSDLHQEACEKAATKLAEEGFDTAAIPCD
VTKESQVAGMVDAIQKQYGRLDILVNNAGIQHVAPIEEFPTETFEQLIKVMLTAPFIAMK
HVFPIMKKQQFGRIINIASVNGLVGFAGKSAYNSAKHGVIGLTKVGALEGAPHGITVNAL
CPGYVDTQLVRNQLSDLSKTRNVPYDSVLEEVIFPLVPQKRLLAVKEIADYAVFLASEKA
KGVTGQAVVLDGGYTAQ
>PK3-2_01237 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase
MPQQTTPAEQKSLQRKKPPFRADQVGSLLRSEPVKKARLQRAAGELTAEQLRQIENDEII
RIVEKQKETGLNVVTDGEFRRAWWHFDFLENLDGVEAFTPEQGIQFHNVQTKARGIKVTG
DIDFSTHPMLEDYSFLHSIAGDATPKMTIPSPNMLFFRGKLEKGAYKNDYHLFQHDVSKA
YKKAIQAFYDRGCRYLQLDDTAWAVFLSETGLKQIEAFGTTPDELRQLFAKSINDAIADR
PDDLTVTMHICRGNFQSTWTAEGGYDAAAETIFDGLNLDGLFLEYDDSRSGGFEPLRYVK
RSDLQLVLGLVTSKFGELEHPDDVKRRIEEASRYVSLDQLCLSPQCGFASTEEGNKLTEE
QQWAKLRHVVEIANDVWK
>PK3-2_01239 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase
MAQQTSLTGQKTEKKRKAPFRADHVGSLLRSAPVKEARQKKAAGEITAEQLRDIENQEII
RIVEKQKEIGLEVVTDGEFRRSWWHYDFLEGLDGVEPFIPAEGIQFHNAKTKARSIKVTG
KLDFTNHPALADYQFLHKIAGDATPKLTIPSPNMLFFGEKADKGIYDDQEEYFHDLAQAY
KKAIKAFYDAGCRYLQLDDTSWSLFFEEKGREVVRALGGDPETLPALFAKTINDAVADRP
DDLAITMHICRGNFRSTWAASGGYDAVAETILDGLNLDGLFLEYDDDRSGNFDPLRFVKR
KDLQIVLGLITSKYGELENPEDVKRRINEAARFVSLDQLCLSPQCGFASTEEGNLLTEEQ
QWAKLRHVIDIANDVWR
>PK3-2_01241 hypothetical protein
MIDLFMKQKMFSFKDAFHIYDRDKQERFKVEGRFFSLGDSLQLTDSSGKTLVSIEQKVMS
FLPRYEISIGGKMVCEVTKKLTFFKPKFEISKLNWEVDGDLWKDEFQLMDGENVRMSVSK
KWLSWGDSYHLQIANEEDVLICTAIAIVLDMVLYDDEDESIF
>PK3-2_01242 hypothetical protein
MSIVTIEPIINKNNHQNVRLFSGHQVRLFLRGSYLFFIDLEFFEYFLTIYPYNREYQNFF
WEVCKMILFIIIALCGYLLFSFSKDNRRKPQKTSPLPAAAPHHNNLIDLDAIRQKRRMHL
S
>PK3-2_01243 Peptidase T
MKEEIIERFTTYVKVDTQSDESVDTCPSTPGQLTLGNMLVDELKSIGMQDAAIDENGYVM
ATLPSNTEKDVPTIGFLAHVDTATDFTGKNVNPQIVESYDGKDIVLNEQLQVILSPDQFP
ELPGYKGHTLITTDGTTLLGADNKAGIAEIMTAMDYLIKHPEIKHGAIRVAFTPDEEIGR
GPHKFDVKRFNASFAYTVDGGPLGELEYESFNAAAAKITIKGNNVHPGTAKGKMINSAKI
AMKLNSLLPADEAPEYTEGYEGFYHLLSIQGDVEETKLHYIIRDFDKDHFQSRKETMKRV
VEELQNEYGQDRIQLDMNDQYYNMREKIEPVIEIVNIAKQAMENLGIEAKISPIRGGTDG
SQLSYMGLPTPNIFTGGENFHGKFEYISADNMVKAVNVIVEIAKLFEEQA
>PK3-2_01244 Transcriptional regulatory protein LiaR
MNKDKIRVALADDQPLVREGFRYVINAQQDMAVSGEAGDGHGIISLAKQTKPDVILMDVQ
MPHCSGIEAAKDIMTAIPDTKIVILTTFDTEEYVFEGIRAGAVGYLLKDTLPEELIDAIR
AAARGEAIFRTVTAAKIISETFRAKQQPHAEELAEPFTKRELEVLQQMAYGLRNEEIAEK
LFVSESTVKTHVHRILQKCNAQDRTQAVVFAIRNGIVQ
>PK3-2_01245 hypothetical protein
MNRQSPARHYKKLVPSLILILNCIQFLSHPSGADPILIAFVFAVYLAFIWIIPYAASAAV
HLSIFIGLWLLTVYLWAVSGQEQGAAFFLIVFLMVYAAIKLPARQSLICTVCLIGGNVFI
LYTVFDSSWDDIVSNISIMIGLYVLFSSMRFRREARREAERNHAELAKMHVQLEQAHEEL
QKAHAELQEASVLSLRYAVLEERTRIARDIHDSIGHELTSVIVQLQSLPYILKSSKEDSE
KVIQNVLSVARECLQEVRSVVHQMGRSESMVGLTALRGLIHQVEERSGLHVSLDTAGLSE
EAWPQNISETIYRILQEALTNIIRHAHASHAAAVISNDETHLYLTITDNGQFTGHLTCGF
GLTGMKERAEKAGGSLSLSAVQPSGLQIELSLPLTITNKEQKDEQR
>PK3-2_01246 hypothetical protein
MAMSPYIFIVFILIFLSMYRERTVRPGKLLIIPLLLLWGVSASFQPAYFHSALHVAISGI
LLLIGLACGFGIGKMVNVRIHPETGKVTSRGSLGSVILILVILSLRTAARVWLPESNEIF
IGIIHSMFFIPLGTITARNIMLYKAYRRLTAGKVSIQ
>PK3-2_01247 HTH-type transcriptional regulator CysL
MDLKWLQTFIAAAESENFRETAERLYLTQPAVSQHMRKLEDELGMRLFLHSGRRVVLTDE
GRLFLPYAKEMIHVYQAGKQKVSQWKQGYSRSLTLAVHPYIASYILPRFLPAYIQKHPHV
ELSTHVAGSDDIKQAVEHNEADIGLSRKDPNTATLYYQHICEGTLCLAAPFQENKPADAA
TVFRRYRLLTHDHPSYGDAFLDNIRSHYPFLQMMAVGQTDTAVHMMKAGMGASFLPAYII
KQEEAEKKLMAVRTPPHLELPPSQTFMMWKRNSEDIQHFHAMLHDFMQREQV
>PK3-2_01248 hypothetical protein
MNIYVEANPYLHDKYSKYADENDKREGNPFVSFPIRFEDIPPGAKTLALTFIDHDAIPIC
GFSWIHWTAANIPARIGELPEHASEKRQDLMIQGQNSFASPLAGSTNPKIIHQYCGPTPP
DKDHTYTLTVYALDAELNLQPGFYMNQLYREMKERILAEASIELLARV
>PK3-2_01249 UDP-glucose 4-epimerase
MAILVTGGAGYIGSHTCVELLNSGYEIVVLDNLSNSSAEALNRVKEITGKDVTFYEADLL
DREAVDSVFAENEIEAVIHFAGLKAVGESVAIPLKYYHNNLTGTFILCEVMEKYGVKKIV
FSSSATVYGVPETSPITEDFPLGATNPYGQTKLMLEQILRDLHTADNEWSVALLRYFNPF
GAHQSGRIGEDPNGIPNNLMPYVAQVAVGKLEQLSVFGNDYPTKDGTGVRDYIHVVDLAE
GHVKALEKVLNTTGADAYNLGTGTGYSVLEMVKAFEKVSEKEVPYRFADRRPGDIATCFA
DPAKAKRELGWEAKRGLEEMCADSWRWQSSNVNGYKSVKS
>PK3-2_01250 hypothetical protein
MSGKLTHCKACGQEIAKGVKKCPNCGKDQRNFFMRHKIITIILAIVVIIIIANMGNSGDS
QASTTTTSSNSKKSTKTVQKSDMEKLYTNANQFKNYKVDLYVKVFDVEQDDDGTYLQGYN
NPEKLSKNTLIMSDDSDLDIKDDDIIHVVGTVKDKYDGENALGGSVSAPRIIADSIEKSD
YATAFAPAQKTINVNKTQNQHGFALTLQKVELAEKETRLYVKIENKSQDEISFYDFNAKI
TADNKQIEPKSDLSEYPEIQSEILPGVKTEGIIVFPKIESKTANIILEGSSENYDITINP
FTFEVNLDQ
>PK3-2_01252 hypothetical protein
MKKKMLDVLMLVIGAFFFALAVNMFAIPNDLGEGGVTGITLILYYVFQWSPGVTNFILNA
FLLLVGYKFLDGKTTVYTIIAVAANSLFLHLTHGWSTPSDELIINTIFAGVFAGVGIGMI
IRVGGTTAGSAILARIANKYLDWNVSYALLFFDLIVVFSSYFIIGAEKMMFTIVMLYIGT
KVMDFIIEGLNTKKAITVISENKSEIAKQVNTLMDRGVTILSGKGNYTGQSKEILYIVIN
KQELSMLKKIIRSCDKKAFVIVHDVRDVFGEGFVDISK
>PK3-2_01253 Putative aldehyde dehydrogenase AldY
MGLEALNKSFINGKWTEGESGRTEDILNPYDQSVITTASLAANKQLEGAFDIAQQAQKEW
AKSTAEDRKAVLQKARGYLQENRDDIIMMMSRETGGTIIKSTIELDQTIAILDEAMTYTG
ELGGVKEVPSDIEGKINKIYRLPLGVISSISPFNFPMNLSMRTIAPAIALGNSVVHKPDI
QTALSGGTIIAKAFEHAGLPEGVLNVMLTDLKEIGDAMLTNPIPRLISFTGSTAVGRRIG
EIAGRDFKRMALELGGNNPFAVLSDADVDRAVDAAIFGKFIHQGQICMIINRIIVHQDVY
DEFVEKFTARVKQLPYGDQTDPKTVVGPLINERQIEKALEIIEQAKADGIELAVEGKRVG
NVLTPYVFVGADNNSTIAQTELFAPIATIIKASSDQEAIDMANDTEYGLSSAVFTSDLEK
GETFALQIDSGMTHVNDQSVNDSPNIAFGGNKASGVGRFGNPWVVEEFTVTKWISIQKQY
RKYPF
>PK3-2_01254 Leucine-rich protein
MKSLSSIYPGSIVSEELCVKEGCLCFFDENSQRYICIPKTEISEKETLLLQSFLTPADEV
NQMSLKPPEENKWFAFLFSSGEVPANVKKRTRFVHFHLLGKIERASFAEAVRHFWPVPFV
IVWMHEDRGVVVEQESEAAAGKDELESLAKVLESDFYFSVRFYAGRFYEPDESLRNHYAR
EQTYFLFAEKRLPQMQSVTFEMIFPFLLLETEKEKLETLLSEEAEILFGNEAELRKTIKL
FIENNSNVTLTAKKLHLHRNSLQYRIDKFIERSGIDIKTYKGALLAYFISLQSKDSE
>PK3-2_01255 Oligosaccharides import ATP-binding protein MsmX
MAELRMEHIYKYYDQKEAAVDDFNLHIDDKEFIVFVGPSGCGKSTTLRMVAGLEEISKGD
FYIEGKRVNDVAPKDRDIAMVFQNYALYPHMTVYDNIAFGLKLRKMPKPEIKKRVEEAAK
ILGLEEYLHRKPKALSGGQRQRVALGRAIVRDAKVFLMDEPLSNLDAKLRVQMRAEIIKL
HQRLQTTTIYVTHDQTEALTMATRIVVMKDGKIQQIGTPKDVYEFPENVFVGGFIGSPAM
NFFKGKLTDGVIKIGSAALTVPEGKMKVLREKGYIGKEVIFGIRPEDIHDELIVVESYKN
SSIKAKINVAELLGSEIMVYSQIDNQDFIARIDARLDIQSGDELTVAFDMNKGHFFDSET
EVRIR
>PK3-2_01256 hypothetical protein
MWHAAMWGGISGSAVLLGALASMFLPIRKQMIGYIMAFGTGVLIGAAAYELLGDAVAEGG
IVSTGAGFIAGAVVFTVFDYAVSNRGASQRKRSGQAAASGGGIAIFIGTIMDAVPESIMI
GASLLEEQSVSFLLVIAIFISNIPEGLSSTAGMKNSGYSRTKIMLLWAAVLVISILASWS
GFFFLDGASEEAMSAIAAFAGGGIIAMIASTMMPEAYEDSGPMTGLIAALGLLTSLILNQ
FS
>PK3-2_01257 Poly-beta-1,6-N-acetyl-D-glucosamine N-deacetylase
MKRFILSIFLLGSCLALAACADKEANAEQQMPKAEQKKPEQKTVHVQKKEDDTSAWIKTE
KPAKLPILMYHSISSGNSLRVPKEEFEAHMKWLHDKGYQTLTPKEAYLMLTQDKKPSEKC
VLITFDDGYTDNYQDAYPVLKKYGMKATIFMIGKSIGRKHHLTEDQMKEMAQHDISIESH
TIDHLELNGLTPEQQHSEMADSKKLFDGMLHQQTSIISYPVGRYNEETLKTAKETGYQMG
VTTEPGAASRDQGMYALHRVRVSPGMSGASFGTYIESMK
>PK3-2_01258 hypothetical protein
MVIQTMALTMMAAAVTEVSAIPAVAAEAIERLLFYFIDSMYVPKDAPDMPGDTRTR
>PK3-2_01259 Protease HtpX
MPMGTDLLLFVIFGLGLYFISALAAKLIPAVDFWIDIALWVGAAVYIFSHQSFMDGIVSI
ATMFYCYWTAMDLTVSERAEKPSGHWQEVELARNKTRLLSDITLTAVVFAGAIIFFIYGP
DPSALKYVILFGMISGGGALVKRILNVFSVTVLYSASLEKLHISSRYETRTYPLSDLKDI
QLESTADLLKLHSLLTMYSSRLDLTTSFQQVIKLSLPGETLFLTLKEPQRWKAILREYTD
AEINVDNVVSVLPFYHRKNVKRLLGKLYFAASVKGVSAYALLVLALYALHATPWIMGGAV
MLYWVFNMYLSDRVLRAAMDAKPCHHPHVQAAADKIFCKAGISHVRIYETESDDYNGMAV
GMNVGRSMVILTSATLTLPLRVIEGILAHEAIHIKKRDVLSSQLLRFLYLGAVVGIILLI
EQQIARPEAHKIALWAFIMATILLFQLYQSFCSQWMEVRADNLGASLLEGGYKQMAEALK
VLAVRQDEDIQKQSAYSSETDADEIQIDSLTRDKSWLFRLIDFQFAPHPPMYWRVSTLLS
NKGHGVLKRWLRDRLKETISLK
>PK3-2_01260 Citrate/malate transporter
MGELQTQLQLQTDTIHEGVRKENWFARAMNIKVGIIPLPVYALLFILITVFVMHHDVKSD
ILTSIAVMAFFGFTFAQIGKSIPIIRSIGGPAILATFIPSAVVYYHLLPNDIVKSTTEFT
ENSNFLYLFIAGIVVGSILGMKRETLVKAFMKIFIPLIVGSAAAAIVGLAVGTLLGIGFQ
HTLLYIVIPIMAGGVGEGAIPLSIGYSDIMPISQGEAFALVLPSIMLGSLCAIILAGLLN
RIGKKKPEWTGNGKVDRSEQESPALEKSQSGQQMFNLSLFASGGILAVSLYLVGMLAHDF
FGFPAPVAMLLLAVLIKLFRLAPSSIENGAFGVSRFFSTAVTYPLLFAIGVSMTPWDKLI
AAFNLSNIITILSVVVTMMAVGFFTGKWLNMYPIETAIINACHSGQGGTGDVAILSAAER
LELMPFAQVSTRIGGAITVSLTLLLLHQFY
>PK3-2_01261 Cytochrome bd ubiquinol oxidase subunit 1
MSELVLARIQFASTTLFHFLFVPMSIGLVFMVALMETLYLVKKNELYLKMAKFWGHLFLI
NFAVGVVTGILQEFQFGLNWSDYSRFVGDVFGAPLAIEALLAFFMESIFIGLWIFGWDRL
PKKIHALCIWLVSFGTIMSSFWILTANSFMQEPVGFTIKNGRAEMNDFAALITNPQLWVE
FPHVIFGALATGAFFIAGVSSFKLLKKKEVPFFKQSFKLAMIVGLCAGLGVGLSGHMQAE
HLMESQPMKMAASEGLWEDSGDPAAWTAFATIDTKNEKSSNEIKVPYALSYLAYQKFSGS
VKGMKTLQAEYEKIYGKGDYIPPVKTTFWSFRIMVGAGVVMILAALGGLWLNRRKKLENS
KWYLRIMIALISFPFIANSAGWIMTEIGRQPWTVMGLMTTAQSVSPNVTAGSLLFSIIAF
GVMYLILGALLVFLFIREIKKGAEHSDHHDVPVSTDPFSQEVYHGISS
>PK3-2_01262 Cytochrome bd-I ubiquinol oxidase subunit 2
MASLHDLWFILVAVLFVGFFFLEGFDFGVGMATRFLGHNELERRVLINTIGPFWDANEVW
LLTGAGAIFAAFPNWYATMLSGYYIPFVIVLLALMGRGVAFEFRGKVEHLKWVKVWDWVV
FFGSLIPPFVLGVLFTTLFRGMPIDADMNIHAHLADYINVYSVLGGVTVTLLCFQHGLMF
ITLRTIGDLQNRARKMAQNIMGVVFVAVLAFAALSAYQTDMFTRRGEITIPLVVLIVICF
MLAALFIRKKKDGWTFGMTGAGLALTVGMIFISLFPRVMVSSLQSAYDLTVANASSGDYS
LKVMSIAALTLLPFVIGSQIWSYYVFRKRVSHKEPMTY
>PK3-2_01263 ATP-binding/permease protein CydD
MGKDLFRYKGMKRILTVITCLTLIQTAAIIMQAEWLSEAVTGLFNGEGIVSLFPVIGFFL
IAFVARHVVTVARQKIVYQYAARTGADLRKSFLDQLFRLGPRFAKKEGTGQMVTLAMEGI
SQFRRYLELFLPKMVSMAIVPAAVVIYVFFQDRTSAIILVAAMPILIIFMILLGLVAQRK
ADRQWKSYQRLSNHFVDSLRGLETLRFLGLSKLHSKNIFYVSERYRKATMSTLRVAFLSS
FALDFFTMLSVATVAVFLGLRLIDGDILLGPALTALILAPEYFLPVREVGNDYHATLNGQ
EAGKTIQEILSQPGFKEEAPLQLGTWSNQDELKLSGVSVGRSVSDIDLSFKGKKKIGIIG
ASGAGKSTLIDILGGFLEPDGGMIEVNGSGRSHLQDGSWQNNLLYIPQHPYIFDDTLANN
IRFYHPSASAEDTARAAAAAGLTEMVDNLPDGLEGRRIGEGGRALSGGQAQRVALARAFL
GNRPILLLDEPTAHLDIETEYEIKETMLDLFKDKLVFLATHRLHWMLDMDEIIVLDGGKV
AEIGTHEELLAKNGVYTKLVEAQLGERA
>PK3-2_01264 putative ABC transporter ATP-binding/permease protein
MKKEEWILPYIKQNARLFVLVIFLGAVTIFSAAFLMFTSGFLISKAATRPENILLIYVPI
VAVRTFGIARSVSRYVERLVGHHIILKIVSDMRVRLYNMLEPGALMLRSRFRTGDMLGIL
SEDIERLQDAFLKTVFPAVSALLLYAVSVIALGFFSWPFAILLALYLFVLVVLFPVVSLL
VTRAKNAKLKSGRNVLYSRLTDAVMGVSDWMFSGRRHAFIDSYEKEERDWFELERKKVRF
TRWRDFAAQCLVAGLILLMLFWTAGQNADGELTRTMIAAFVLVVFPLTEAFLPLSDALGE
VPGYQDSISRMNKVAPQPEASQTESAAEPLDLQDVTLSFRDVAFSYDNNSQVLNRFSFTL
RQGEKMALLGRSGSGKSTSLALIEGALKPDSGSVTLNGVETALLKDQIADAVAVLNQKPH
LFDTSILNNIRLGNGDASDEDVRRAAKQVKLHDYIESLPDGYHTSVQETGIRFSGGERQR
IALARILLQDTPIIILDEPTVGLDPITERELMNTVFEVLKGKTILWITHHLAGVEAADKI
VFLENGKTEMEGTHEELLAANERYRRLYHLDVPVK
>PK3-2_01265 ADP-dependent (S)-NAD(P)H-hydrate dehydratase
MNVPFWTEEHVRASLPERDAKSHKGTYGTALLLAGSDDMPGAALLAGLGAMRSGLGKLVI
GTSESVMPLVVPVLPEATYWRDGWKKAADAQLETVCRAIAIGSGLPQTENVQQAVDHVLA
ADCPVILDAGALTKRTYPKRESPVILTPHPGEFSRMTGVSVKELQNKRAEYAKEWAAQLQ
TVIVLKGNQTVIAFPDGDCWRNPTGNGALAKGGTGDTLTGMILGMLCCHEEPKHAILNAV
YLHGACAELWTDEHSAHTLLAHELSDMLPRVWKRFE
>PK3-2_01266 hypothetical protein
MKVERRTIEYIPNEERHGKAKDLFPVWFGANMHITTLVTGTIPVAMGLNLFWSVAAIICG
TLIGAIFMASHSAQGPQLGIPQMIQSRAQFGVIGAILPLFLVMFIYLGFFASSTILAAGT
LSSFVPIPGSWSIIGLSAVCFLLTIFGHDLIHKMQKILSWTSFAVFFAATILIFQLPVPA
GSWIPGAVDLPIFLVAVSAVATWQLAYAPYVADYSRYLPVQTPASKTFWYSYAGTSFSSI
WMMLLGALLTTALPDFTANSGSQIVQLFGPFSFIMLIIVLFGQMAINVFNLYGAFMSTTT
TLEPFLKLKVTPKVRIIMILGVTLVGTVLSLLGQSNFMELFLNFIFFISYFLIPWTAINL
VDYYFVRHGKYQVKAMFDVNGPYGKVNWITTIAFVLSILLEIPFINTSFYIGPLAKMFGG
GDIAWIVGLAVPSVLYYVLMKPRLKKRAGYQEKLSSL
>PK3-2_01267 RNA polymerase sigma factor SigY
MDTHEEQQLIQQAKEGDDEAFTALFHYHYSFLYKYLLKLSLHPDLSEELVQETFLKGYIH
LRSFQGRSKFSTWLISIASRLYLDHQKKRKREWKRNQAVTEEAIRKIKWDVSVKGEEWSE
TLDLFSKLDPKLRTPVLLRHYYGYTYAEIGLMLQIKEGTVKSRVHKGLQQIRKEWDDE
>PK3-2_01268 putative protein YxlC
MNKEKRSLHLKSELQKIDETANPSIPDQKELLYQLSQMKAERRRKLLKEIILFVFCALMV
VSAAILAFTQAPAVFIVLQVCVLAALPILIVTEKKRQLGECEVERR
>PK3-2_01269 Negative regulatory protein YxlD
MTQTEMIITAAAYLIVLAQGIFLFIDAKKRNRMAWVWGIVGLIQAPMPLICYYFFVIKPD
REKRGIKQ
>PK3-2_01270 Negative regulatory protein YxlE
MNISWEMILPLIVLQLVLAVFALISCIKEERTNGSKWMWAAIIVCINIIGPILFFTVGRK
QR
>PK3-2_01271 putative ABC transporter ATP-binding protein YxlF
MLSIESLCKSYRHHEAVKNVSFHVNENECVALLGPNGAGKTTTLQMLAGLLSPTSGTIKL
LGEKKPDRRLIGYLPQYPAFYSWMTANEFLTFAGRLSGLSKKKCQEETGEMLEFVGLQES
AHKRIGGYSGGMKQRLGLAQALLHKPKLLILDEPVSALDPSGRFEVLDMMRELKKHMAVL
FSTHVLHDAEQVCDQVVIMKNGEISWKGALQRLKKQHQTNVFTLTVKEKLKGWLEEKPYV
SAIVYFNPSQAVFELQDLHAGKTLLSDCIRTGLTVTHFEQKKESLEDVYLKVVHA
>PK3-2_01272 putative transmembrane protein YxlG
MKVMLTLLKKEWLEGWKSGKLIWLPLAMMIVGLTQPLTIYYMPEIIEHGGNLPDGMKISF
TVPSGSEVMVSTLSQFNTLGMALIIFSVMGCVANERNQGVTSLIMSRPVTAAHYIVSKWL
TQSVIGIGAFAAGYGLAYYYVRLLFEHTSFSHFAASLGLYALWIMFIVTAGLAGSTMFRS
LGAAAAFGIGLTAAVSFAVSLFPDGAKWLPAELCKQAEHILLHGERADFFAWSLIFSILC
IMLLAVFSVWRFQRYESY
>PK3-2_01273 hypothetical protein
MLFVPFSAALFTICITHACIGLALGFVFPLLLSRVVDISSARLKMSVMGFYQSFYALGIF
LGPLLAGKTAQLFGLAEVFYGAGLLAFAAFLVMLAQKRNMIH
>PK3-2_01274 Inner membrane transport protein YajR
MELQQDMIPQKKTIGALDHAVFLCMVFCFWFSGYIYVPVFSLYLEDLHFSYGAIGIILGS
YGVTQILLRFPLGLLSDILFSLRKQLLIAGFGFSVLSSLLFLMFDSFFFVLAARLFAGIT
ASMWVMATILYAHYFNNINASKAMGIMQFFTVMPQFVSIVFCGLAAARLGRQVPFWMALA
ASAAGLVICCFIKDPSASPANRDTIRVKQYIQDTLRLPKLKLFTILSMTAHAVLFMTVFG
FTPLFIHQLGMGDAELLWVMSAFFLPHAAANL
>PK3-2_01275 Catalase
MKDDHQKKHHGTNAQSSEDALSHKTSGKNESEDTLTNRQGHPVTDNQNVRTVGNRGPTTL
ENYDFLEKISHFDRERIPERVVHARGAGAHGYFEAYGSFGDEPISKYTRAKLFQEKGKKT
PAFVRFSTVNHGKHSPETLRDPRGFAVKLYTEDGNWDLVGNNLKIFFIRDPLKFPDLVHA
FQPDPVTNIQDGERIFDFISQSPEATHMITFLFSPWGIPANYRQMQGSGVHAYKWVNEEG
KAVLVKYHFEPKQGIRNLTQKEAEEIQGKNFNHATQDLYDAIENGDYPEWEVYAQIMSDD
EHPELDFDPLDPTKLWYKDDFPWKPIGKLVLNKNPENYHAEVEQASFGTGVLVDGLDFSD
DKLLQGRTFAYSDTQRYRVGANYLQLPINSPKKHVATNQEGGQMQYRVDRAEGQNPHVNY
EPSIMGGLKEAKQDGKDHTPHVEGEVKREAIDRTNNFGQAGETYRRFTEFERNELITNLV
NTLSTCRKEIQDQMIENFTKADPDYGKRVAEGLKKASGNNSNGPIGTTDTEQAAKQAEQE
SHPSDPY
>PK3-2_01276 Putative 3-methyladenine DNA glycosylase
MTREKNPLPITFYQKTALELAPSLLGCLLVKETDQGTASGYIVETEAYMGAEDRAAHSFN
NRRTKRTEIMFAEAGRVYTYVMHTHTLLNVVAAEEGIPQAVLIRAIEPHEGQLLMEERRP
GRRPREWTNGPGKLTKALGVTMNDYGRWITEQPLYIESGYTPEEISTGPRIGIDNSGEAR
DYPWRFWVTGNRYVSR
>PK3-2_01277 putative licABCH operon regulator
MLHGRLRDILRLLMAAEAPVTSSFFAAQLNVTTRTVRNDIKELQGVLSGHGAFVQSVRGS
GYKLRIHDEQTFRMLLQDVFQQKKGLPVLPEERMAYLMKRLLLAEHYLKLDELAEELFIS
KSTLQTDLKEVKKRLLPYRIVMETRPNYGFKLRGDEVQMRYCMAEYIVDERETEIDVLND
KADILPNEEIEIIRSAILTKMKNDRIPLSNLGLNNLIIHIAIACKRIRTENHVSLFREDM
EHILHQKEYQAAEAIVKELESALAVTFPKDETAYIAMHLLGTKRMTQPQCGEDTFSIDEE
TDQLTCAMIKAVDRELKLGIVHDNELKIGLALHVKPAISRNRYGMNLRNPMLAAIKEHYP
LAFEAGIIAGMVIKEQTGIDIHENEIGYLALHFGAAIERKKTESPPKRCIIVCASGAGSA
QLLREKLRSHFGKRLDILGTAEYYSLDQISYESIDCVISTIPIKKELPVPVLKVNTLLGG
TDFAKIESILSDEKEKAARYLKKELVFFQKDLRSKEEVIQFLGQKAVDCGYADEGIIDSI
FEREDMSPTCFGNLVAIPHPLVPQTKTTFWAVCTLKKPIDWENQRVQFVCLLCVEKENKA
DLQSMYKLLGSILDDPAAVNQLIKSRSYQELSDVFDQKMTS
>PK3-2_01278 Lichenan-specific phosphotransferase enzyme IIB component
MNILLVCAAGMSTSLLVSKMEKSAQEQGKDYTIWAVSGDSVQNHIDKADVLLLGPQVRYL
LPQLKKLGESKGVPVDVINTVHYGTCNGAEVLKSAEQLGHVS
>PK3-2_01279 Lichenan permease IIC component
MNKVNQILEEKVMPIAGRIAGQRHLQALRDGIILTMPLIIIGSFFLIIGNLPIPGYAEFM
AKTFGSSWSEKLAYPVDATFEIMGLVAAFGIAYRLAEKYGVDALSAGAISLAAFLLATPY
QVPFTPDGSTKEIMVGGGIPLSLMGSKGLFVAMIIAMVSTEIYRLIIQRNLVFKMPDGVP
PAVSKSFVALIPGFVVIFLIWGARLIVEATPFESLHNIVSVLLGTPLSILGGSLGGSLVA
EAVKMLLWACGLHGANIVGGVMAPIWYGAMDANRIAFQAGEELPKIFTQQFFDIWVNIGG
SGATLALVVTMFLRARSKQMKQLGKLAIGPAIFNINEPIIFGMPIVMNPMLLLPFIITPL
VTVTLTYIGMSTGLVAKPAGIAVPWTMPPIFSGYLATGGKVSGAVMQAINIAVSFVVYYP
FFRMWDKQKLKEENDLELVQTPAASDDKEAAL
>PK3-2_01280 Lichenan-specific phosphotransferase enzyme IIA component
MEAIAAAKSGNAEEARKKIQDAAEELSKAHHYQTELIQNEAGGEKTEMTLLMVHAQDHLM
NAMTVKDLAAEIIELYEKITEQRGASI
>PK3-2_01281 putative 6-phospho-beta-glucosidase
MTKGLKLVTIGGGSSYTPELVEGLIKRYEELPVRELWLVDIPEGEEKLNIVGTLAKRMVE
KAGVPIDIHLTLDRRKALKDADFVTTQFRVGLLQARAKDERIPLKYGVIGQETNGPGGLF
KGLRTIPIILEIAKDIEELCPNAWLVNFTNPAGMVTEALLRYSNLKKVVGLCNVPIGIKM
GVAKALDVDVDRVEVQFAGLNHMVFGLDVFLDGVSVKDQVIEAMGDPKNAMTMKNISGAE
WEPEFLKALDIIPCGYHRYYFKTKEMLEHELEASQTEGTRAEVVQKVEKELFELYKDPNL
AIKPPQLEKRGGAYYSDAACNLISSIYNDKHDIQPVNTMNNGAIASIPDDSAVEVNCVMT
KNGPKPIAVGDLPVSVRGLVQQIKSFERVAAEAAVTGDYQTALLAMTINPLVPSDTVAKQ
ILDEMLEAHKAYLPQFFNKIEA
>PK3-2_01282 Branched-chain-amino-acid aminotransferase 2
MTKQTIRVELTSTKKPKPDPNQLSFGRVFTDHMFVMDYAADKGWYDPRIIPYQPFSMDPA
AMVYHYGQTVFEGLKAYVSEDGHVLLFRPDKNMERLNLSNDRLCIPQIDEEQVLEGLKQL
VAIDKDWIPNAEGTSLYIRPFIIATEPFLGVAASHTYKLFIILSPVGSYYKEGIKPVKIA
VESEFVRAVKGGTGNAKTAGNYASSLKAQQVAEEKGFSQVLWLDGIEKKYIEEVGSMNIF
FKLNGEIVTPMLNGSILEGITRNSVIALLKHWGLPVSERKITIDEVIQAHKDGILEEAFG
TGTAAVISPVGELIWQDETLSINNGETGEIAKKLYDTITGIQKGAVADEFGWTTEVAALT
ESK
>PK3-2_01283 hypothetical protein
MKMTGNTVLITGGSAGIGLELAKRLLELGNEVIICGRSEARLAEAKQQLPSIHTKQCDVA
DRSQREALYEWALKAFPNLNVLVNNAGIQKEIDFKKGTEELFVDGDEIELNFQAPVHLSA
LFTPHLMKQSEAAIVQVTSGLAFNPLAVYPVYCATKAALHSFSLTLRHQLRDTSVEVIEM
APPMVDTGLNQKSRDKQGLTYRGISTEEYVQYFLDGLKEGKQEITNERVEGLQNATRADY
DRVFEQMNTQEN
>PK3-2_01284 Protein DltD
MKKRFFGPIILAFILFAGAIAIPSSWLTGFISDKRVKESATALNPSMFQGLYLQDQMLKD
PTYLPIYGSSELSRLDEFHPSNYFQVNNEGFTPYLVGKGGSQSLIHSLNFAAHMDQLKGK
KIVFIVSPQWFIKRGSDEQHFAPNYSALQGLDLAFNDQIDPEIKKKMMKRMLRFKAVQND
AILCELYKAIVNGQTWKVNALKPAAKVYYSMLEKKDMYYSATESSGPKRHISQSVKDKSW
SELNKLADQSGKRHSASNDFHIDNPVYKKLKPKVPKLKGKNKGKSYAVSPEYGDFEMMLD
ILKDAGAEPMFVTIPVNGKWYDYTGFPKKGRTDYYKKVNKQIIAKGFQVADFSGHEYDPY
FMKDTIHIGWKGWVYVDKAIDEFYKTGKVTSS
>PK3-2_01285 D-alanyl carrier protein
MDFKQEVLDVLAEVCQDDIVKENPDIEIFEEGLLDSFGTVELLLAIENRFDILVPITEFD
RDVWNTPNNIVNQLSELK
>PK3-2_01286 hypothetical protein
MTPYSSFLFFILLGILLLPTIILGLNGKRFQAYNMFISIIILALIFSHDLHGVIALCLFT
IWQVLLISGYLAYRQKANSGFVFCGAVIASILPLFLSKIWPFLSHPQPHHPTHNLISFLG
ISYLTFKGVQLIMEARDGLLKEQLPLHRLLYFILFFPTISSGPIDRYRRFVKDEQKAWTK
EEYADLLYTGIHKIFIGFLYKFIIGYAINTYFIMNLPAITHNKILGNLLYMYGYSMYLFF
DFAGYTMFAVGVSYIMGIKSPENFNKPFISKNIKDFWNRWHMSLSFWFRDYVFMRFVFWM
TKKKWIKNRMAVSNIGYFLLFMLMGVWHGLAPQYIIYGLYHAVLMTCYNFFEKWNKKYKW
LPSNRWTTVLAIVITFHFVCFGFYIFSGKLFHHHH
>PK3-2_01287 D-alanine--D-alanyl carrier protein ligase
MKLLHAIQTHAESYPQTDAFRSQGQSLTYQELWEQSDRAAAAIQQRISGEKKAPILVYGH
MEPHMIVSFLGSVKAGYPYIPVDLSIPSERIAKIIESSGAELLIHADGLPIDELGQQIQT
VSAEELLENKNASVSQDQWVKEHETFYIIYTSGSTGNPKGVQISAANLQSFTDWICADFP
VNGGKTFLNQAPFSFDLSVMDLYPCLQSGGTLHCVTKDAVNKPKILFEELKKSGLNVWTS
TPSFVQMCLMDPGFSQDLLPDADTFMFCGEVLPVSVAQALLERFPKAKIFNTYGPTEATV
AVTSVEITDHIISRNESLPVGFAKPDMNIFIMDEQGQPLPDGEKGEIVIAGPSVSRGYLG
EPELTDKAFFSYEGEWAYRTGDAGYIQDGQIFCQGRLDFQIKLHGYRMELEEIEVHVRQS
QYVRSAVVIPYQPNGTVEYLIAAIVPEEHEFQKEFQLTSAIKKELAASLPAYMIPRKFIY
QDHIQMTANGKIDRKRIGEEVLV
>PK3-2_01288 hypothetical protein
MKLFEHLIVKYSCDCRKNGKGIFDMLQLMKQLYEKPAVKWTCHTGFYLMILLVLFFMYGF
HTANTGSYIYNDF
>PK3-2_01289 1,4-dihydroxy-2-naphthoate octaprenyltransferase
MNQTNKGEGQTAPQKESMGQILWQLTRPHTLTASFVPVLLGTVLAMFYVKVDLLLFLAML
FSCLWIQIATNLFNEYYDFKRGLDTAESVGIGGAIVRHGMKPKTILQLALASYGIAILLG
VYICASSSWWLAVIGLVGMAIGYLYTGGPLPIAYTPFGELFSGICMGSVFVLISFFIQTD
MINTQSILISIPIAILVGAINLSNNIRDIEEDKKGGRKTLAILMGHKGAVTLLAASFAVA
YIWVVGLVITGAASPWLFVVFLSVPKPVQAVKGFVQKELPMNMIVAMKSTAQTNTFFGFL
LSIGLLISYFR
>PK3-2_01290 GTP pyrophosphokinase YwaC
MDLSVTHMDDLKTVMEDWKNELLVYKFALDALDTKFSIISQEYNLIHGHNPIEHTKSRVK
SFESIVNKLMRKGCEITTKEMKEHIHDIAGVRIICSFISDIYNVVNVLKQHEDLRIVKVK
DYIQTPKPNGYRSLHLIIEMPVNLTNRVEYVKAEIQIRTIAMDFWASLEHKIYYKLNNDV
PKQLTDELKEAAEIAHYLDEKMLGIKKEVD
>PK3-2_01291 sugar efflux transporter
MKHSISLSRGLAFLMAVTSGFSVANVYINQTLLVSMADTFHVTAAQAGMIATLAQVGYAA
GNLLLVPLGDLFERRRLIVSLLFLVGVCSAASALAVSFSWLIITNLLLGFFTIIPQILVP
FAAGLANDKNRGKVLGNVAIGLVCGILGARVVSGAIDAQYGWRVMYWIACAAAVIIMLII
RFCFPKSKGTQAVHYGKLISSLFPLLIKEKALRKACVNQGFMFGAFSLFWTTLVFVVSEP
PFSFGSQTAGTIGLVGIGGAFATPLIGRIIDQRGAAFANKLCMSFTLLSFVLLMAGRTSL
IVIVLGALFITMGVQANQVACQAEIFQLSAEMRSRLNGIFMVSTFLGGALGSYAGGAVWM
LFHWNGVCILGIIMIGIAFSSRITINRATKQSDIGREIEAGANK
>PK3-2_01292 hypothetical protein
MQTSEHYKKGLDILKQIDEENYEAIVDSFKQSIAPDLGVLAVEFNYGQIFSRPGLDLKSR
LLATVAGLTALGNTQQLKFYINGALNVGWTQEELIEVMMQMIIYSGFPNALNTILPVAAE
VFAERNK
>PK3-2_01293 hypothetical protein
MDGMAEKRKELGEFLKLKRAQLSPQEFGLPLGTRRKTTGLRREEMAQLSGIGVTWYTWLE
QGRDIRVSTQVLESISRVLKLNYEEKRHVFLLAGHHVLLDDQDEENKSLPLAVRHFIDHL
TNCPVYVTDEKWDVIAWNTAACAVFGDFGQMGRKERNAIWRCFTSKEYRDLLDDWESHAK
KLIAQFRSTASRFLGEAWIKELIDELTEVSPEFKKWWNHHEVLGTHAGEKVLHHPAAGTM
VMEHMTLQIYDSPDLKLTIYRPLEKENTADKLKALLIDG
>PK3-2_01294 Aminopeptidase YwaD
MKKLLTVMTMAVLTAGTVLLPAQSVTPAAHAIQISDSERELPFKAKRAYSTISQLSEAIG
PRIAGTAAEKKSALLTASSLRKLKLDVKVQRFGIPDRLEGTLASEGRDILLRAASGSAPT
DEQGLTAPLYNAGLGYPKDFTADAKGKIALISRGDLTYYEKAKNAEDAGAKAVIIYNNKE
SLVPVTPNLSGNKAGIPVVGIKKEDGEALAQQKEATLKLKAFSNQTSQNIIGIKKPKNIK
HPDIVYVTAHYDSVPFSPGANDNGSGTSVMLEMARVLKSVPSDKEIRFIAFGAEELGLLG
SSHYVDHLSEKELKRSEVNFNLDMVGTSWENASELYVNTLDGQSNDVWESSHTAAEKIGF
DSLSLTQGGSSDHVPFHEAGIDSANFIWGDPETEEVEPWYHTPEDSIEHISKERLQQAGD
LVTAAVYQAVKKEKKPKTIKKQMKAKASDIYEDIK
>PK3-2_01295 Tyrosine--tRNA ligase
MKTFEQLTAAQQKEIERQLQLYMTGAHEVIPPEELKAKLVKSISAGTPLKIKLGLDPSAP
DVHLGHTVVLNKLRQFQENGHIVQLLIGDFTGKIGDPTGKSAARKQLTDEEVQHNAKTYF
QQFGKVLDIEKVELHYNSNWLKTLNLEDVIELAGKITVARLMERDDFEERIAMQKPISLH
EFFYPLMQGYDSVVLESDIELGGTDQHFNVLMGRHFQERYNKEKQVVILMPLLEGLDGVE
KMSKSKNNYIGIDEHPNDMYGKTMSLPDSLMKKYIQLATDLELEEKKQLVKDLETGAVHP
RDAKMLLAKTIVRMYHGTEAAEAAEHTFKTVFQDNSMPEDIPDVKWEGEKTIAVVDLLVT
LGLLSSKSEARRMIQNGGVRINGEKIADIYSNAEIKENTIIQVGKRKFLKLQ
>PK3-2_01297 hypothetical protein
MERSHQHQQLRKEEHDTLSKLKQMPVESLNLEAISIATNLYRSAQNLRVKMETKVLSSYN
LSWTAFSILYDLWVRGTLETRKIAELSGISTATASNVIKTLEKKSFCSKSIDTRDRRLVL
VSITDSGKQAIEELYPEFHKGETELIAGMTKGEQKTLIELLRKVADNLHTP
>PK3-2_01298 hypothetical protein
MQKYVQSVYKHDPFHLYSAEHVVTLAIIALLAILLFLFRREVKRPKVSRFLRYLFVFLLL
GSQIGYQIWMIAAGRWSVRTSLPLQLSDLSVYLSAIMLVTKSRKLFVFLYFVGIGSSFQA
LATPDLGMFSFPHIRYILFFISHGSVFLSCLLMAVIGTYRLRQRALWGTVLIVNVYGVCI
YLLNRWLGANYMYLTKKPGGSSLLDVLGPWPWYIASAEAITIASFYILYWLYHMFKK
>PK3-2_01299 General stress protein A
MKKDEIMHIVSCADDNYARHLGGMFVSLLTNMDQNREVKLYVIDGGIEPDNKKRLEETTL
KFGVPIEFLEVDTNMYEHAVESSHITKAAYYRISIPDLIKDESIKRMMYIDCDALILDDI
SKLWDLDIAPYTVAAVEDAGQHERLKEMNVSDTGKYFNSGIMIIDFESWRKQNITEKVIN
FINEHPDEDFLVLHDQDALNAILYDQWYELHPRWNAQTYIILKMKTPATLSGQKLYRETR
ENPAIVHFCGGEKPWNSNTKHPYRDQYFHYMSYTKWNTISNPAMNQ
>PK3-2_01300 Levansucrase and sucrase synthesis operon antiterminator
MKIKRILNHNAIVVKDQNEEKILLGAGIAFDKKKNDIVDQSKIEKTFVRKDTDDYKQFEE
ILETLPEDHIQISEQIISYAEKELNIKINERIHVAFSDHLSFAIERLSNGMVIKNPLLNE
IKVLYPKEFQIGLWARALIKDKLGIHIPDDEIGNIAMHIHTARNNAGDMTQTLDITTMIR
DIIEIIEIQLSINIVEDTISYERLVTHLRFAIQHIKAGESIYELDAEMIDIIKEKFKDAF
LCALSIGTFVKKEYGFEFPEKELCYIAMHIQRFYQRSVAR
>PK3-2_01301 Negative regulator of SacY activity
MQKEIAKELFLLAGGKSNIISISHCTTRLRFEVKDEAKIDIHAIENLQGVQGTFFRYGLF
QIIFGAGVVNKIYKEVVHVLEAAPSEEPVKEKKASRKLNPVAAFAKTLSDIFVPIIPAIT
ASGLLMGLIGMIKVFHWFAAGSPWIKMLDLVSSTAFILLPILVGFSAARQFGSNPYLGAV
IAGLLTHPDLLDPSMLGSKTPASLDIWGLHIPMMGYQGAIIPILLSVYVMSKIEKLLKSI
VPKSLDVVIIPFISVMMTGCLALIVMNPAASIIGQIMTQSIVYIYDHAGIAAGALFGGIY
STIVLSGLHHSFYAIEATLLADPRVGVNFLVPIWSMANVAQGGAGLAVFFKTKQSSLKKI
ALPASLTAFLGIVEPIVFGVNVKLIRPFIGAAIGGAIGGAYVVAAHVVSNSYGLTGIPMI
SIVLPFGAANFVHYMIGFLIAAVSAFLATLFLGFKEETE
>PK3-2_01302 Minor extracellular protease Epr
MKNMSCKLVISVTLFFSFLAIGPLAHAQNSSEKEVIVVYKNKSGKETVLDSDAEVEQQYK
HLPAVAVTADQETVKELKQDPDILYVENNVSFTAAGGTDFKVLSDDTDTSDNFEQWNLEP
IQVKQAWKAGLTGKDVKIAVIDSGISPHDDLSIAGGYSAVSYTSSYKDDNGHGTHVAGII
GAKHNGYGIDGIAPEAQIYAVKALDQNGSGDLQSLLQGIDWSIANGMDIVNMSLGTTSDS
QILHDAVDKAYEQGVLLIAASGNDGNGNPVNYPAAYSSVVAVSATNENNQLASFSTTGDE
VEFSAPGTNITSTYLNQYYATGSGTSQATPHAAAMFALLKQRDPAETNVQLRADMQKNIL
DLGTAGPDQQFGYGFIQYKAQETDSAYAAAEQAVKKAEQTKTQTDIDKARELVSQLPDSE
AKTALQKRLDKVQSYRNVKDAKDKVVKAEKYKTQQTVDTAQAAIDKLPNGTDKKNLQKRL
DQVKRYIASKQAKEKVAKAEKSKKKTDVDSAQSAVSKLPAGSEKTALQKRLNKVQSTNLK
TAQQTVTAAEKKSTDANATKAQSAVNQLQSGKDKTSLQKRLDKVKKKVAAAEAKKVEAAK
TKVKKAEKDKTKKSKTTAQSAVNQLKASADKTKLQKRLNAVKPKK
>PK3-2_01303 Lichenan permease IIC component
MSAFTRVMEEKIMPVAGKIAGQRHLSALRDGIILTMPLIIIGSVFLILTSLPIPGYADFM
ASVFGKEWADKLGYPVNASFDIMAMIAAFGIAYRLAESYGVDALSAGAISIAAFLLATPF
EVPFTPDGSTESVMVGGGIPITLLGSKGLFVAMLIALFSTEMYRYIIQKNIVFKMPDGVP
PAVSKSFVALIPGFIIVFLVWLARLLIEMTPFQSLHNVVGDLLGTPLSILGGSLGGSLVA
EFVQMLLWSCGIHGASIIGGIMAPIWYGAMDANRLAFQAGEALPSIFTTQFFQIWINVGG
SGATLALVLTMLVRSRSKQMKQLGRLGIGPALFNINEPIIFGMPIVMNPLLIVPFIIAPL
LTITATYIGMSTGLVAKPAGIAVPWTMPPLISGYLATGGKVSGAVMQLVNLVITCAIYYP
FFRIWDHQKWKEESAVESGDKNGL
>PK3-2_01304 Lactoylglutathione lyase
MAKRIDHTGIMVRDINASITFYEEVLGMKLKDRITHSNGVIELAFLGFEDGPETEIELIQ
GYSSELPVEGKVHHIALLTDDIAAEYTKAERMNAKFIDEEITTLPNGYRYFYIEGPDGEW
IEFFQR
>PK3-2_01305 Ribosomal RNA large subunit methyltransferase I
MKLLTLKQAAAAKIKKGYPLIDKEALAGSAGHVKEGDLIDIVSESGEFLARGYYGLQNKG
VGWTLTRNKQEQIDQAFFLSKLTKAVKARAELFGAQDTTAFRMFNGEGDGIGGVTIDYYD
GYLLVQWYSKGIYTFKAMLVSALDELDLDYKAIYEKKRFDTAGQYVEDDDFVKGKRGEFP
IIIQENGIQYAVDLNEGAMTGIFLDQRHVRKAIRDRYAKGRTVLNTFSYTGAFSVAAALG
GAEKTTSVDVANRSLAKTIEQFSVNKLDYEAHDIKVMDVFNYFSYAAKKDLRFDLIILDP
PSFARTKKRTFSAAKDYKNLLKETIAITADKGIIVASTNSSAFSMKKFKGFIDAAFKETN
ERYTIIEEFTLPEDFKTISAFPEGNYLKVVFLQKK
>PK3-2_01306 hypothetical protein
MNGQKRNSISKGLQVDIVLKADQKTGKLTRGTVKDILTKSSFHPHGIKVRLEDGRIGRVQ
QIIST
>PK3-2_01307 hypothetical protein
MHNLQVRRHYAALKGFYLFAFLGTGSIIPLLSMYLTKEQHVSGSQVGLIMSLGPIVMIFF
QPFWGMLSDYTQKTKSLLAVCTSITGFIGLGYIAFDGFPLFILIAACFAAFQSTIIPLSD
SISLRYTQETNGNYGGIRLFGSLGFGVAVFVMGQVTNQLYPIHVIFIFGCAFLCIAAILA
TQMPGQQKTKTKVNIRKGFRELISNKTFLIFMIITFTTFAPNLANNTYFSLFLDKSGASL
SAIGILFFIGVISEIPFMRFAQTFIDKMGLLNVIMLSGGVSLFRWALYFTAPSLWIIYAT
VFLQGVAIGLFIPAALQYVKKITPSHVEATALTMYAAIGNGFGNWFCTFTGGYIFDYVSI
FAVYLLFGMLSIAGFGLTLYLMKAEKNKHTLHQPAVTFKP
>PK3-2_01308 Inner membrane protein YohK
MFIGIVSLFLTVLVYLGAKKVYQRFPRVYTSPLLVTPAVLVCLLLLVNVPYKSYNLGGGF
LTDMLQPATVAFAIPLYKYFPVLKKYAVEIILNVAVGSCIAIISTALIAKWLHLGTGLID
SLVPRSVTTPIAMNVSEMIGGMPAVTAVFVILTALFGTVIGPMVIRYFRIDNEIARGVLL
GTSAHGAGTSKAFELSSVSGTISSVSMILAAIMTLCAAPFLLSFM
>PK3-2_01309 Holin-like protein CidA
MLHPFYRQKEYLLFFIYILPIARPYVQYEYKGGINMKKLLLTVIQIALLFIFARLINWVT
ALLHINIPGSIIGIVILFTLLHFKIIKLEWIELGAAWLLGELLLFFIPSAVGVIEYGDIM
SKFGVSILLVVIISTFVVMVSTGTLTQIIAKRKEKKHTCSSEL
>PK3-2_01310 HTH-type transcriptional regulator CynR
MDIRHLTYFLEVARLKSFTKASQSLYVSQPTISKMIKNLEEELGIELFSRNGRQVELTDA
GQSMYVQAQEIIKSFQNLTSELNDIMEVKKGHVRIGLPPMIGSGFFPRVLGDFRENYPNV
TFQLVEDGSIKVQEGVGDGSLDIGVVVLPANEDIFHSFTIVKETLMLVVHPSHRLADEKE
CRLRELKDEPFIFFREDFVLHNRIMTECIKAGFRPHIIYETSQWDFISEMVSANLGIGLL
PERICRGLDPEKVKVIPLIDPVIPWHLAIIWRKDRYLSFAARAWLEHTKSYLWDPKKDSK
G
>PK3-2_01311 Hydroxyethylthiazole kinase
MDAQSAAKCLTAVRQHSPLVHSITNNVVTNFTANGLLALGASPVMAYAKEEVADMAKIAG
ALVLNIGTLSKESVEAMIIAGKSANEHGVPVILDPVGAGATPFRTESAGDIIREVRLSAI
RGNAAEIAHTVGVTDWLIKGVDAGEGGGDIIRLAQQAAQKLNTVIAITGEVDVIADTSNV
YTLHNGHKLLTKVTGAGCLLTSVVGAFCAVQDNPLFAAIAAISSYGVAAQLAARQTADKG
PGSFQIELLNKLSSVTEQDVQELATIERMTVS
>PK3-2_01312 Thiamine-phosphate synthase
MTRISREMMKELLSVYFIMGSNNTKADPVTVVQKALKGGATLYQFREKGRDALTGEARLE
FAKSVQEACREAGVPFIVNDDVELALKLKADGIHIGQEDANAKEVRDAIGDMILGVSAHT
MSEVKQAEEDGADYVGLGPIYPTETKKDTRAVQGVSLIEAVRRQGISIPIVGIGGITIEN
AAPVIQAGADGVSMISAISQAEDPEGAARKFHEEVHTYKTGR
>PK3-2_01313 Ferrous iron permease EfeU
MTRGLALILFSLLMVFGSAAHAEEDSIAALIQLNKQMIKSVEEGDIDSAQQTFETFKAKW
KKEEPSIKKENLTSHSKMDSNIAMISLSFINQDADKLKTQLEELSSHLETYQQAVVLKKT
SSGQSRASLTAYIQSLKDTKQLIEKNQFDEASSAIDNLITSWLAVEGDVVSRSKEAYTTS
EENLALMKAEIGSHPEKVSKQIDEMIQLLEPIASSSYSWWDAALIPIREGMEALLVIGAL
LTMTKKARVTRSSAWIWGGASVGMVVSLAAGIGVTLLFSSSVFGENNFLLGGLTGVLSAV
MLLYVGVWLHRNASMDKWREKINIQKSQALKKRSLLSFALIAFLAVVREGLETVIFFIGL
VGKLPLTELIGGTAGGLIVLVIVGVLMIKLGMRIPLKPFFLLSMAVVLYMCVKFLGTGVH
SLQLAGILPSDAENWLPSVSVLGIYPSMYSTIPQLLILLFLLIALVSEAAKHFTTNGKEL
TK
>PK3-2_01314 putative iron uptake system component EfeM
MNFTKIAISAGCILALCAGCGANDTSSTKEKASSEKSGVSKEIAASVDKMETIISKLNDS
AEKGDQKEIEKKGKELNSYWLSFENDIRGDYPFEYTEIEKHLQPIYTEAQKNKPDTDKIK
TESESLKASLEDLADAKKSSKKASDQLAKAADEYKDYVKEQSDQLVKATEAFTKAVKSGD
IEKSKTLYGKARVYYERIEPIAESLGDLDPKIDARENDVEEGGKWTGFHKLEKAIWKGQD
ISGEKATADQLLKDVKELDGSIGSLKLTPEQIVAGAMELLNEAGISKITGEEERYSRIDL
VDLMANVEGSEAVYQTVKSALVQDHSDLTEKLDTEFSEFEVLMAKYKTNDQSYTSYDKLS
EDQIRELSTKLTTLSETMSKIANVL
>PK3-2_01315 putative deferrochelatase/peroxidase EfeN
MSNEQKKPEQIHRRDILKWGAMAGAAVAIGASGLGGLAPLVQTAAKSSKKDEKEDEQIVS
FYGKHQAGITTAHQTYVYFAALDVTAKEKSDIITLFRNWTSLTQMLTSGKKMSAEQKNQY
LPPQDTGESVDLSPSNLTVTFGLGPDFFEKDGKDRFGLKNKKPKHLAALPAMPNDNLDEK
QGGGDICIQVCADDEQVAFHALRNLLNQAVGTCEVRFVNKGFLSGGKNGETPRNLFGFKD
GTGNQSTKDDTLMNSIVWVQSGEPDWMTGGTYMAFRKIKMFLEIWDRSSLKDQEDTFGRR
KSSGAPIGQKKETDPVKLNQIPPNSHVSVAKSTGKQILRRAFSYTEGLDPKTGYMDAGLL
FISFQKNPDNQFIPMLKALSAKDALNEYTQTIGSALYACPGGCKKGEYIAQRLLES
>PK3-2_01316 hypothetical protein
MTVHIKVYSDYVCPFCFIGKAAFEEAIEGKDVEVEWMPFELRPSPSPQLDPVNDPSKQYM
WKTSIEPMAEKLGVEINFPNVSPHPYTDLAFEGFHFAKEFNKGHDYNTRVFQAFFQEGQN
IGDIDILTKLAEEVGLNGITFKSALESRTYQDVQRQALKHAYEEADITAVPTFIIGDTVI
PGAAGKDVFEKAISEEQQKK
>PK3-2_01317 Cation/acetate symporter ActP
MNMTAFLLFLAIVGLTLIITYFAAKKTKTTSEFYTAGGGLTGVQNGLAIAGDYMSAASFL
GIAGMIALYGFDGFFYSIGFLVAYLVVLYIVAEPLRNLGKYTMADMIAARFKEKKIRGVA
ALNTIAISTFYMIAQLVGAGALIKLLLGLDYTAAVLIVGVLMTIYVVFGGMIATSWVQII
KAILLMAGTLVISIIVFSKFGFNLNTMFEQMKTATPLGADFLNPGNKYKVPLETLSLNLA
LVLGTAGLPHILIRFYTVKDAKTARTSVVSATWIIGVFYIMTVFLGFGAAAFVGFDAITA
ADQAGNMAAPLLAKALGGDFLFAFVSAIAFATILAVVTGLVLSAASAFAHDIYSQIIRKG
EATEKEQMKAARWASVAVSVLSILLAIFAQSLNVAFLVALAFAVAASANLPLIVFTVFWK
RFNASGALWGSLTGLISALVLVSMSPSVWDPSGGAIFTGDPLISLSNPGIISIPLGFLGA
WLGTMLSSDKTVDEDTFAEIQVKAHTGIHMDQK
>PK3-2_01318 hypothetical protein
MYKADYKQIAATPAFQAFLKQKRAFIVPSSIFFFVFYFSLPVLTSYFTFLNKPAIGAVSW
AWLFAIAQFAMTWILCTVYSRKAAQFDRYVSALKSDLKGEQT
>PK3-2_01319 Transcriptional regulator SlrA
MKTHVKKDLDKDWHMLMQEARSIGLGIRDVRQFLESETALRKNNRKKTVRQD
>PK3-2_01320 hypothetical protein
MKKNKFQIKREATFESFIDAGLHLLIDRAYDPFSVEDISRAAGYSKGAFYVHFVSKDDFL
LLLLEKRQMKKKIIIEYLDQKEQMSVKPLTLDEAAKHAAELLYSYYINKPSWDITSFAMN
MPTYKVLQKCKAYVRLYELWVEENALYIKWLKERKLIDACIDPEYTAKIICAVLDGIIKQ
SHVLGQPATFRAFLDALSVFITPERARVRPRISKSFSESEEHQ
>PK3-2_01321 hypothetical protein
MKYREMIMYIIMGVFTTIVNIASFYILVEIMNMDYKAATVAAWILSVLFAYITNKLYVFQ
QKTHDLQSLLKELTAFFSVRVLSLGIDLGMMIILVGQFNTNETLAKILDNAVIVVVNYAA
SKWLVFKKTKEEGV
>PK3-2_01322 Galactokinase
MREELKGIFASVFGEKEGLRFFFAPGRVNLIGEHTDYNGGHVFPCALTMGTYAAVAERND
GLVRMYSDNFKDTGIKECRLDDIRYQKEDDWANYPKGVIYEFQQRGYSVPHGFDIVFSGN
IPNGAGLSSSASIELLMGVVLQSYFHPEVDALELVKMAQRAENDFIGVNCGIMDQFAIGM
GKKHHAMLLNCDTLDYEYSKLDVSGLALVIANTNKKRTLADSSYNTRRQECNDALLDLQK
ALDIVSLGDIKPSDFDTHSSLIQNETNRRRAKHAVYENHRAIKTARMFKENNIDEIGRLM
KESHLSLKDDYEVTCPELDELVFAAWDHEGVIGSRMTGAGFGGCTISIVKDAFVDDFIQK
VGDRYQEKTGLKADFYAANIGEGARELKGE
>PK3-2_01323 Galactose-1-phosphate uridylyltransferase
MSIVEHLEQLLEYGLERKLISIWDREYTRNRLYEALDIKHPEPVSRTSVKQAQSLPDLLA
PIYKWAAETGCMEADTDTYRDLLSAKLMGCFVPAPSEVIRKFEETKALYGPKQATKEFYQ
YSEDVYYIRSDRIAKNVHWTVPTDYGELEMTINLSKPEKDPKAIAAAKEQAETNYPMCLL
CKENVGFEGSVNHPARQNHRIIPVILNDEEWYLQFSPYVYYPEHCIVLKGEHEPMEISRK
TFERLLSFLGQYPHYFIGSNADLPIVGGSILSHDHFQGGAHDFPMARADAEDVYELNDHP
GVSLGLVKWPMSVLRLQGCKPDDVAEAADHIFRTWQTYSDEKAGIAAYTGDTPHNTVTPI
ARRRGDLYELDIVLRNNRTDEEHPLGIFHPHQEVHHIKKENIGLIEVMGLAILPGRLQEE
MKETAAALCSDDPKTALEQNPLTAKHKEWALRLMEKRTITKEDADLVIKEELGHVFARIL
EHAGVFKQTPEGKQAFKRFIGHLGVKPVKSLNR
>PK3-2_01324 hypothetical protein
MMSFIISLIVAIIIGWLGSLFVKGDMPGGIIGSMIAGLIGAWIGHGLLGTWGPHLAGFAI
IPAIIGAAIVVFLVSLLTRKRG
>PK3-2_01325 Quinol oxidase subunit 2
MHFRFITSIGRMVIFLFRALKPLLVLALLTVVFVLGGCSNASVLDPKGPVAEQQSDLILL
SIGFMLFIVGVVFVLFTIILVKYRDRKGKDNGSYNPEIHGNTFLEVVWTVIPILIVIALS
VPTVQTIYSLEKAPEATKDKEPLVVYATSVDWKWVFSYPEQDIETVNYLNIPVDRPILFK
ISSADSMASLWIPQLGGQKYAMAGMLMDQYLQADKVGTYEGRNANFTGEHFADQEFDVNA
VTEKDFNSWVKKTQKESPKLTKEKYDELMLPENVDELTFSSTHLKYVDHGQDAEYAMEAR
KRLGYQAVSPHSKTDPFENVKKNEFKKSDDTEE
>PK3-2_01326 Quinol oxidase subunit 1
MKLKWDEFFVTGDPLILGAQVSIALSTIAIIVVLTYFKKWKWLWSEWITTVDHKKLGIMY
IISAVIMLFRGGVDGLMMRAQLALPNNSFLDSNHYNEIFTTHGTIMIIFMAMPFLIGLIN
VVVPLQIGARDVAFPYLNNLSFWTFFVGAMLFNISFVIGGSPNAGWTSYMPLASNDMSPG
PGENYYLLGLQIAGIGTLMTGINFMVTILKMRTKGMTLMRMPMFTWTTLITMVIIVFAFP
VLTVALALLSFDRLFGAHFFTLEAGGMPMLWANLFWIWGHPEVYIVILPAFGIFSEIISS
FARKQLFGYKAMVGSIIAISVLSFLVWTHHFFTMGNSASVNSFFSITTMAISIPTGVKIF
NWLFTMYKGRISFTTPMLWALAFIPNFVIGGVTGVMLAMAAADYQYHNTYFLVSHFHYVL
IAGTVFACFAGFIFWYPKMFGHKLNERIGKWFFWIFMIGFNVCFFPQYFLGLQGMPRRIY
TYGPNDGWTTLNFISTVGAFMMGVGFLILCYNIYYSFRYSTREISGDSWGVGRTLDWATS
SAIPPHYNFAVLPEVKSQDAFLHMKEEKTELYPESKFKKIHMPSNSGRPFFMSVAFGLAG
FGLVFEWYWMGVVGLIGVLLCMVLRSFEYDNGYYVSVDEIKETERKISE
>PK3-2_01327 Quinol oxidase subunit 3
MEHAEHGNSNAPMEYQSETGRLNILGFWIFLGAEIVLFSTLFATFFVLKNRTAGGVLPDE
LFEVNLVMIMTFLLLISSFTCGIAVHEMRRGSLKGVVIWTIITLLLGAGFVGCEINEFVH
YVHEGAALSTSAFWSGFFVLLGTHGTHVTIGIFWIAGILIQLKKRGLTPQTSSKIFISSL
YWHFLDVVWIFIFTGVYLMGLGGL
>PK3-2_01328 Quinol oxidase subunit 4
MANKSAEHSHFPWKHIVGFALSIVLTLLALWVAVYTDLSSSAKLWIIFGFAFIQAALQLL
MFMHMTESENGGIQVGNTLFGFFGAIVIVLGSIWIFAAHYHHGDHMDGNPPGGAEHSEHS
GHNE
>PK3-2_01329 Spore morphogenesis and germination protein YwcE
MDMFFAYLLVASATPLFIWLDNKKVALSAIPPIILMWVFFFFYATESLSPLGHTLMIILF
AVNVIVAHIAAFIIYGLPYLRRKRSS
>PK3-2_01330 Peptidoglycan glycosyltransferase RodA
MGRYKKQQSPFYQGDLIFIFGVFFIISVVSIYAAGQFGQYGNTDWIQQLVFYLLGAIAIT
VLLYFDLEQLEKLSLYIFILGILSLIILKISPESIAPVIKGAKSWFRFGRITIQPSEFMK
VGLIMMLASVIGKANPKGVRTLRDDIHLLLKIAGVAAIPVGLILMQDAGTAGICMFIVLV
MVFMSGINWKLITIIAGSGILLISLILLVMINFPDAAKSVGIQEYQIKRVTSWVSDSNET
QNDDSGWQVDQAIMAIGSGGILGNGISHLKVYVPESTTDFIFSIIGESFGFIGCAFVVIM
FFFLIYRLVVLIDKIHPFNRFASFFCVGYTALIVIHTFQNIGMNIGIMPVTGIPLLFVSY
GGSSTLSTLIGFGIVYNASVQLTKYRSYLFNS
>PK3-2_01331 FMN reductase (NADPH)
MNNTIETILNHRSIRSFTDQFLTADEIDTLVKSAQAASTSSYVQAYSIIGVSDPEKKREL
SVLAGNQPYVENNGHFFVFCADLHRHQKLAEEKGENISELLENTEMFMVGLIDAALAAQN
MSIAAESMGLGICYIGGIRNELDKVTEVLQTPDHVLPLFGLAVGHPENLSGKKPRLPKQA
VYHENTYNTNADDFRETMNAYDKTISDYYRERTNGKREETWSDQILNFMKQKPRTYLNDY
VKDKGFNKN
>PK3-2_01332 hypothetical protein
MISLSILDQSPVSEESSAETALQQTVALAQAAEDLGYKRFWVSEHHFSKRLAGSSPEVLI
SHIAAKTKRIRVGSGGVMLPHYSAYKVAENFRVLEGLTPGRIDLGLGRAPGGMPIASWAL
NDGGKRNADQYPQQIKELTMYLHDLADDKHRFPNLTAAPHISTAPDVWLLGSSGESALLA
ADSGAGYMFAHFINGEGGEDTVRQYKRRFKPSVLGDTPRAAVAVFVLCADTEEKAEELAA
VLDFTLLAGEQGIPLKGVPSFEAVRDNAYSPYEQRRIADNRSRMIVGTKEQVKEQLLALS
KAYGTEEIMAVTITHHFEDKLQSYRLLQEAFAN
>PK3-2_01333 Minor extracellular protease vpr
MKHGIIRFLLVSFVLFFTLSTGMTGVQAAPISSKSSADLEKAEVFGDIDMTTSKKTTVIV
ELKEKSLAEAKEAGESQTKSKLKNARTKAKNSAVKAVKNGKVNREYEQVFSGFSMKLPAN
EIPKLLAVKDVKAVYPNVTYKTDNIKDKDVTISEDAVSPQMDDSAPYIGANDAWDLGYTG
KGVKVAIIDTGVEYNHPDLKKNFGQYKGYDFVDNDYDPKETPTGDPRGEATDHGTHVAGT
VAANGTIKGVAPDATLLAYRVLGPGGSGTTENVIAGVERAVQDGADVMNLSLGNSLNNPD
WATSTALDWAMSEGVVAVTSNGNSGPNGWTVGSPGTSREAISVGATQLPLNEYAVTFSSY
SSAKVMGYNKEDDVKALNNKEVELVEAGLGEAKDFEGKDLTGKVAVVKRGSIAFVDKADN
AKKAGAIGMVVYNSLSGEIEANVPGMSVPTIKLSLEDGEKLVSAMKAGETKTTFGLTVSK
ALGEQVADFSSRGPVMDTWMIKPDISAPGVNIVSTIPTHDPQNPYGYGSKQGTSMASPHI
AGAVAVIKQAKPKWSVEQIKAAIMNTAVTLKDGDGEVFPHNAQGAGSARIMNAIKADSLV
SPGSYSYGTFLKENSNETKKETFTIENQSSIRKSYTLEYSFNGSGTSTSGTSRVVIPAHK
TGKATAKVKVNTKKTKAGTYEGTVIVREGGKTVAKVPTLLIVKEPDYPRVTSVSVSEGSV
QGTYQIETYLPAGAEELAFLVYDSNLDFAGQAGIYKHQDKGYQYFDWDGTINGGTKLPAG
EYYLLAYAANKGKSSQVLTQEPFTVE
>PK3-2_01334 hypothetical protein
MKRLLVSLRVWMVFLMNWMTPDRKTAAAAVYSAQRTYQRKAAVQAAGLVSFYEWRMAVNE
EEKQNAKAAALYKRRCLQAFKESPKQERAGPHLYMAVKRR
>PK3-2_01335 Levansucrase and sucrase synthesis operon antiterminator
MKIYKVLNNNAALIKEDDQEKIVMGPGIAFQKKKNDLIPMNKVEKIFVVRDENEKFKQIL
QTLPEGHIEIAEDIISYAEGELAAPLSDHIHIALSDHLSFAIERIQNGLLVQNKLLQEIK
ALYKKEYEIGLWAIGHVKETLGVSLPEDEAGYIALHIHTAKMDAESMYSALKHTTMIKEM
IEKIEQYFNRKVDENSISYQRLVTHLRYAVSRLESNEALHRMDDEMLYFIQKKYSFAYQC
ALALAEFLKSEYQLHLPESEAGYITLHVQRLQDLSE
>PK3-2_01336 Nitrite transporter NirC
METQALQKVEQYALKKQNIFASSKIRYVLRSILASMFIGFGITAASKTGSYFSMADSPFA
FPAAAVTFGAAILLIAYGGGDLFTGNTFYFTYTALRKKIRWRDTLYLWLSSYAGNLIGAI
LFAILISATGLFEEASVHSFLIHLAEHKIEPSASELFFRGMLCNWLVCLAFFIPMSLKGE
GAKLFAMMLFVFCFFISGFEHSIANMCTFAISLLIEHPDTVTLMGAVRNLIPVTLGNLTA
GIVMMGWMYYTLNPDK
>PK3-2_01337 Negative regulator of SacY activity
MDYKETAKRLIELLGGKENIISAAHCATRLRLVMKDESKIDQEQVEELDGVKGAFSSSGQ
YQIIFGTGLVNKVYDAFSKEADIEREEHVNHQDAAKEKLNPAARFAKTLSNIFVPIIPAI
VASGLLMGLLGMVNAFHWMSKDSALLQLLDMFSSAAFIFLPILIGVSASKEFGSNPYLGA
VIGGIMIHPNLLNPWGLAEATPDYMHLFGFDIALLGYQGTVIPVLLAVYVMSKVEKWTRK
VVPHAVDLLVTPFVTVIVTGFVAFIAIGPLGRALGSGITVALTYVYDHAGFVAGLIFGGT
YSLIVLTGVHHSFHAIEAGLIADIGKNYLLPIWSMANVAQGGAGLAVFFMAKKAKTKEIA
LPAAFSAFLGITEPVIFGVNLRYRKPFIAAMIGGALGGAYVVFTHVAANAYGLTGIPMIA
IAAPFGMGNLINYLIGMAIAGVSAFIAAFIMKINEDEGRKK
>PK3-2_01338 hypothetical protein
MTAHDQELRRRAYEEVEKKSLSLTAIRTASIFTLCRRLGC
>PK3-2_01339 Sucrose-6-phosphate hydrolase
MPPVGLLNDPNGVIYWKGSYHLFFQWQPFQTGHGAKFWGHYTTQDVVNWKREGIALAPSD
WFDKNGCYSGSAVTKDERLYLFYTGNVRDQDGNRETYQCLAVSDDGLSFEKKGVVARLPE
GYTPHFRDPKVWEHEGTWYMVIGAQTENMQGHAVLFASDNLTEWRFLGPITGAGFNGLDD
FGYMWECPDLFSLQGSDVLIVSPQGLEADGFRYQNVYQSGYFVGCLDYNKPELRHGDFTE
LDQGFDFYAPQTLEDDQGRRILFAWMAVPDQDEGFHPTIDYHWIHCMTLPRQLTLSGQKL
IQQPLPEMKAMRRNEKNIQINMHGSSGTIPVENPERAEILIKDIDTESGFSISIRGTAAF
SFHKDEGVVTLERTSFDGKRTEARHCRIKDLRTVHMFIDASSVEIFINDGEEVFSARYFP
FPGNHEVKASSPGKSAMNVGIWTLM
>PK3-2_01340 hypothetical protein
MNIHEQKITPECLEKAADQVEDKREEYKDVLLQLKKMLGGTAPHSETAEILSRAYEQMKE
YALFVQSIEAFLRKSANNLKVK
>PK3-2_01341 Pyridoxine kinase
MSMHKALTIAGSDSSGGAGIQADLKTFQEKNVYGMTALTVIVAMDPNNSWDHQVFPIDTD
TIRAQLATITEGIGVDAMKTGMLPTVEIIELAAKTIKEKQLKNVVIDPVMVCKGANEVLY
PEHAQALREQLAPLATVITPNLFEASQLSGMNELKTVDDMIEAAKKIHALGAQYVVITGG
GKLKHEKAVDVLYDGETAEVLESEMIDTPYTHGAGCTFSAAVTAELAKGAEVKEAIYAAK
EFITAAIKESFPLNQYVGPTKHSALRLNKQS
>PK3-2_01342 hypothetical protein
MKISIVIVTYNRIPALCELLESISEQTLKPYEIIIVNDAGESVVPVKALYPELPIAVINL
EKNSGHVAARNAGVKEASGDCIMLCDDDDFFTPGHLERMAKEIETADFVHSDAEIVSFEE
KNGTRYPVSRKLFAYTADYEDMRVFSTYVPSGSMYRRFLHDEIGYFDADVHNYWDWDFYL
RAAKDYRVKRVPCASVIYAFSDAGDNQSADLGAKRKQYLDRLSEKHGLGELPTKNFAVLL
EEPEMKRREAQSEIVWDGKPVYSRLHRS
>PK3-2_01343 Uracil-DNA glycosylase
MKQLLQDSWWDQLKEEFEKPYYLELREMLKREYAEQTIYPDSRDIFNALHYTSYDDVKVV
ILGQDPYHGPGQAQGLSFSVKPGVKQPPSLRNIFLELQQDIGCSIPNHGSLVSWAKQGVL
LLNTVLTVRRGQANSHKGKGWERLTDRVIDVLNERERPMVFILWGRHAQMKKERIDTSKH
FIIESTHPSPFSARNGFFGSRPFSRANAYLERMGEAPIDWCIKDL
>PK3-2_01344 4,4'-diaponeurosporen-aldehyde dehydrogenase
MNSIPSIVSKHKAYFAAGHTRSLESRLNMLQKLKQAIKTHEADITAALYQDLHKSEQESY
TTEIGIVLEEISFVIKRLGKWIKPKRVKTPLTHLGSKSMIIPEPYGTVLVIAPWNYPLQL
ALSPLIGAIAAGNTVVLKPSEYTPTVSAVLSKLISSVFPSDYVAMEEGGPEVSTALLQQP
FDYIFFTGSVAVGKIVMEAAAKQLIPVTLELGGKSPCIVHKDADIQLAAKRIVFGKFTNA
GQTCIAPDYLFVHEDIKTKLTEEMKRAISEFYGPQPEQNPQYGKIVSERHYQRLLSFLND
GVPLTGGQSNPDHHKIAPTILDQVKDDSPVMQEEIFGPILPLFTYGDIDEVIKKVQSRPK
PLALYIFTTNKEIERAVLENLSFGGGCVNDTLMHVATPYLPFGGVGESGIGSYHGFDSFN
TFTHKKSVVKQTNRFDFAFRYPSSKNGLRMIRKILK
>PK3-2_01345 putative protein YwdI
MNIHISALIQKMEEELKKAKTAERDEELKRYVAVVRSLCDVVLDQPEAASAPRIQPSSTP
SHAAPPSTDQLMMEKMMGSAGLTKYRKQEKEKQEEDGNGESLFDF
>PK3-2_01346 Putative purine permease YwdJ
MKLVLGALQWTAFIIAAAIVVPVAVSQSFHLDHSDSARLIQSTFFVLGIAAVIQCLKGHR
LPINESPAGLWWGVYTIYAGLTGTVFATYGDTLRGLQGALLVSAVCFFLLSVFKVIDRLA
ALFTPVVTGVYLLLLVMQLSQPIIKGILGIGYRKDGVDGLVFGLALVVIAAAFLMTNSNI
MFFKQYSILLALFGGWVLFAAAGAAKPMEMPERLFQLPSLFPFGTPLFNSGLIITSVFIT
ILLIVNMLASMKVVDIAVKKFGKQPDGQHHERHAGFAASFSHLLSGLTGAIAPVPISGAA
GFIETTKMPSKKPFMIGSILVVVISVIPFFMNAFASLPSPVGFAVNFVVFSAMGGLAFAE
FDSYEKAELKRVRSVIGISLLTGVGIMFVPETALKGLHPVFISLLSNGLVLGTLAAIAAD
QFQLWRRRKSDNLVSSENKD
>PK3-2_01347 hypothetical protein
MKVFIILGAINALIAVGLGAFGAHGLEGKIPDKYLQVWHTGVQYHMYHALGLFVVAFLAD
KLSGIGSVTTAGWLMFAGIVLFSGSLYILSVTQVSILGAITPLGGVAFIISWIMIVVAAV
KYL
>PK3-2_01348 Spore coat protein GerQ
MKPKKNQYQQMQAFDNMQGYQPQYGANPYPQQGQGGQMQMMGMQPMMPMQQGQQGQQGFG
FPGQQQGGGFQIPSGPTPSAPGQSVPGMLPVEESYIENILRLNRGKTATIYMTFENSKEW
GSKIFRGVIEAAGRDHIILSDPKSGTRYLLLTIYLDYITFDEEIAYTYPYSMSSYSPR
>PK3-2_01349 Spore coat polysaccharide biosynthesis protein SpsA
MPKVSVIMTSYNKSDYVAKSISSILSQTFSDFELFIMDDNSNEETLNVIRPFLNDNRVRF
YQSDVSGVKERTEKTRYAALINQAIEMAEGEYITYATDDNIYMPDRLLKMVQELDAHPEK
AVIYSASKTYHLNEHRAIVKETVRPAAQVTWNAPCAIDHCSVMHRYSVLEKVKEKFGSYW
DESPAFYRIGDARFFWRVNHFYPFYPLAEELDLNYITDQSIHFQLFESEKNEFVRNLPPQ
SNCRELRESLKKLGMG
>PK3-2_01350 hypothetical protein
MSAYLSNYWVLYRKYVELLDRLRYKGIPLGLISNFYQYISPELRVMMEEEPELFGPVDQH
IDEGQIQPFFEEKIQNIVKANVEPVKGKVILHFDYLRFTNENYYQFDPEKTAVLARWSLP
HYCDLPVMSKREIADSCQKGDPKPYLETACSILAPFDDHPAFGDQAFRDRLYKDIPLFME
AIDTVDALFEQEKISAVVVGTAEDIYSRVLALMCHRRGVVSICLQHGALMGDEAFIPVFT
TYQAVFGAYEAEWFKRKGCKPEQILVTGHPRFDQIFDRTLMDMSAFYRKLSFHPSKKIVL
IATQPFSEDFYSGVLEGLSDQKQLQIIIKPHPWEIGKNKLDLYHAAAKKHKACRVIKKEL
ELYDVLPYADAAVTQTSTVGLEAMLFEKPVLIGKSTGNRTYPYYESLGDFMFDQPDELAR
TLIEVLRSPAVHQKAEEARLAFTAANYPVAESTNALFSELKAKTGVDYKREDTE
>PK3-2_01351 UDP-4-amino-4-deoxy-L-arabinose--oxoglutarate aminotransferase
MVQKRNHFLPYSLPLIGKEEIQEVTDTLESGWLSKGPKVQQFEKEFAAFVGAKHAVALNS
CTAALFLALKAKGIGPGDEVITSPLTFSSTANTIIHTGATPVFADIDENTLNIDPEKLEA
AVTPRTKAVVPVHFGGQSCDMDAILAIAQKHGLFVLEDAAHAVYTTYKQRMIGSIGDATA
FSFYATKNLATGEGGMLTTDDEELADNIRVLSLHGMSKGAWNRYSSNGSWYYEVDSPGYK
MNMFDLQAALGLHQLKRLDEMQKRREEIAGRYQAAFQRIPGLITPFVHDDGRHAWHLYVL
QVDEKQAGVTRGEMITALKDEYNIGTSVHFIPVHIHPYYQKQFGFKEADFPIALNYYKRT
LSLPLYPSMSDEDVNDVIEAVRDIVKGAG
>PK3-2_01352 dTDP-fucosamine acetyltransferase
MYTVKENVSKEAIESFLHSRQLTLDVPYQFSLGLFENSGLQGVLLYEDSLWESKILQKKV
MNVKLLAANSTGQLKRLFQAFYSVRQMDETDFIFVRVPAEDIGAAHVIQQQPSSYFVGSL
LKLAKPPSFYDKTPPFFELGPPEPGDTEAICELARDSFTKSRYFQDPHLSREAANNVFHE
WTRNNLNGRAALNIVAKYNGEVIGYLQGLSRDDECILDLMAVKPGFEGKRIAFHLLANLI
EHPSTQKHKTVTAGTQLHNVRAIRLYERMGFTAEQSYYYYHIWPGKEAK
>PK3-2_01353 Spore coat polysaccharide biosynthesis protein SpsE
MAEFQIANKTVGKDAPVFIIAEAGINHDGKLDQAFALIDAAAEAGADAVKFQMFQADKMY
QKDPGLYKTAAGKDVSIFSLVQSMEMPAEWISPLLDYCREKQVIFLSTVCDEGSADLLQS
TSPSAFKIASYEINHLPLLKYVARMNRPMIFSTAGAEISDVHEAWSTIRAEGNDQIAIMH
CVAKYPAPPEYSNLSIIPMLADAFPDAVIGFSDHSEHPTEAPCAAVRLGAKLIEKHFTID
KNLPGADHSFALNPDELKEMVEGIRKTEAELKQGIRKPVSEKLLGSSYKTTTAIEGEIRN
FAYRGIFTTAPIQKGEAFSEDNIAVLRPGQKPQGLHPRFFELLAGGVRAVRDIPADTGIV
WDDILMKDSPFYE
>PK3-2_01354 8-amino-3,8-dideoxy-manno-octulosonate cytidylyltransferase
MNDILFIIQARMGSTRLPGKVLRPLGSNRLLDILVHRVRKSVFYQKDQDNLVIATSDRET
DDKLEAHCIKHGFRVFRGSEERVLDRFVEVIKTVKPTVVIRLTGDNPFVDPELLDVMIKA
HLDQGADYTYILNTPLGICGEAVNAKLLIDISRIQALEDQYQEHVTLYVRNHPALYHVQF
LEAPERFRAPQYRLTIDTKEDYESIKALYQKAGERPDVSASELISLLNRNPDAAIEREAE
>PK3-2_01355 UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MRIGIFADGGYEKGMGHVVRMKRLAEELKRRCLITFFTNQESELFLLEEHWHVIVKPELR
QHEFILREIKSKKLDLLLFDILGAPAELLTKIKAETDAKIVLFEERNPKAIDQSDVIING
IYGHIRSRVYDQGNTRIYEGPNYLILHPAFQAARNDYTLKKECRNILVALGGSDPKQLIF
RVLAAADQVPAMKDKNTMFVMGSASPHQEAARRQIQKKPQYTVIGQTNDMAGLMKQADAA
IVAGGISLYEAVCIGVPCLVLSQVEHQTATAKTFAEQGAALDLGLGEFVSDETLIYQMSR
LISSYPLRLSLHNGGRPLVDGKGIKRVSAILQDLYDQ
>PK3-2_01356 Glucose-1-phosphate thymidylyltransferase
MKGVILAGGNGSRLMPLTKAVNKHLLPVGPYPMIYWSIMKLEEAGIKDILLISQKEHMPQ
FYKLLGNGEELGVTITYQVQPAASGISDGLSYAKRFTKKEPFILLLGDNIFEDSLKPYTE
RFEQQGKGAKVLLKEVDDPERFGIAEIDEKNKRIRSIIEKPAQPPTNLCVTGIYMYDAEV
FSYIEQISPSKRGELEITDVNNLYIENSQLTYDVLKGWWVDAGTHESLHLASQLVHKALQ
KGQGEK
>PK3-2_01357 dTDP-glucose 4,6-dehydratase
MAKSYLITGGAGFIGLTFTKLMLKETDARITVLDKLTYASHPEEMETLKENSRFRFVKGD
ISVQEDIDRAFDQTYDGVIHFAAESHVDRSISQAEPFITTNVMGTYRLAEAVLQGKAKKL
IHISTDEVYGDLEADDPAFTETTPLSPNNPYSASKASSDLLVLSYVKTHKLPAIITRCSN
NYGPYQHSEKMIPTIIRHAKQGLPVPIYGDGLQIRDWLFAEDHCRAIKLILEKGTDGEVY
NIGGGNERTNKELASTIMKHLGCEELFAHVEDRKGHDRRYAINASKLKNELGWRQEVPFE
EGIARTIRWYTDNDR
>PK3-2_01358 dTDP-4-dehydrorhamnose reductase
MTKVLVTGAGGQLGLELCRQLKQAGYEVIALTKKMMDIADQRSVWHSFGHYQPDIVVNAA
AFTSVDKCETELDKAYLINGIGAYYTAIEATRIGAQYVHISTDYVFDGKGTQPYKEDDPL
DPNTIYGKSKKLGEELIRLATKDCTIIRTSWVYGHGGSNFVHTMLKLAETKQELRVVNDQ
IGSPTYTKDLAEAVIKLFSHPPGIYHVTNSGICSWYEFAKAIMEESGLTTIILPVTTEEY
GNKTPRPAYSVLSHRAIEEAGIRPRHWREALREYLQERSSARD
>PK3-2_01359 dTDP-4-dehydrorhamnose 3,5-epimerase
MIEGVKVKKLTKHSDDRGFFAELVRDDENLLERFGQASWSKSYPGVIKAFHYHEKQDDLW
FFPTGHAQVVLYDLREDSKTKGETDVYYMGEDNPMLLLIPKGVAHGYRVLGETPLTIIYF
TTMSYNPDQPDEKRIPWDDETIGFNWNTEFR
>PK3-2_01360 putative biofilm-surface layer protein B
MFKKTSFVSSLFISSAVLLSILLPSGQAHAQSATIEAKTINSTTEWTTSDIEVTYKPNAV
LSLGAVEFRFPDGFHATTRDSVNGRTLKETQILNDGKTVRLPLTLDLLGASEFDLVMVRK
TLPRAGTYTIKGDVVNGLGIGSFYAETQLVINPR
>PK3-2_01361 Catabolic NAD-specific glutamate dehydrogenase RocG
MSAKQVAKDKEKEALNLFLSTQTIIKEALRKLGYPGDMYELMKEPQRMLTVRIPVKMDNG
SVKVFTGYRSQHNDAVGPTKGGVRFHPEVNEEEVKALSIWMTLKCGIANLPYGGGKGGII
CDPRTMSFGELERLSRGYVRAISQIVGPTKDIPAPDVYTNSQIMAWMMDEYSRLREFDSP
GFITGKPLVLGGSQGRETATAQGVTICIEEAVKKKGIKLQNARIIIQGFGNAGSFLAKFM
HDAGAKVIGISDAHGGLYNPDGLDIPYLLDKRDSFGMVTNLFTDVITNEELLEKDCDILV
PAAIANQITAKNAHNIQASIVVEAANGPTTIDATKILNERGVLLVPDILASAGGVTVSYF
EWVQNNQGYYWPEEEVAEKLRNVMVNSFETIYQTAATHKVDMRLAAYMTGIRKSAEASRF
RGWV
>PK3-2_01362 1-pyrroline-5-carboxylate dehydrogenase
MTVSYAHEPFTDFTGAKNKAAFGESLAFVNTQLGKHYPLVINGEKIETDRKIVSINPANK
EEVIGYASTADQELAEKAMQAALQAFESWKKQRPEHRANILFKAAAILRRRKHEFSSYLV
KEAGKPWKEADADTAEAIDFLEFYARQMLSLKEGAPVKSRAGEFNQYHYEALGVGIVISP
FNFPLAIMAGTAAAAIVTGNTILLKPADAAPVVAAKFVEVMEEAGLPNGVLNYIPGDGAE
IGDFLVEHPKTRFVSFTGSRAVGCRIYERAAKVQPGQKWLKRVIAEMGGKDTVLVDKDAD
LDLAASSIVYSAFGYSGQKCSAGSRAVIHQDVYDEVVEKAVALAKTLAVGNPEDPDTYMG
PVIHEASYNKVLSYIEIGKSEGKLLTGGEGDDSKGYFIQPTIFADVDENACLMQEEIFGP
VVAICKARDFDHMLEIANNTEYGLTGALLTKNRAHIERAREDFHVGNLYFNRGCTGAIVG
YQPFGGFNMSGTDSKAGGPDYLILHMQAKTTSEAF
>PK3-2_01363 Purine efflux pump PbuE
MNSKQNNDIETKHHFPLFLALALTMGVFAAGSEELVISPLLPDLAKAFHSDVSVLALSIS
IYGIMIFIGAPLLVPLGDKYSRELSLMAGLVIFIIGTVICALAQNIFFFFLGRALSGLAA
GAFVPTAYAVVGDRVPYTYRGKVMGLIVSSWSLALIFGVPLGSFIGGVLHWRWTFWIFAL
MGVLVVLLILLEMRRHAKHKNSGKEEKEEPAGTFRDALKVPRVPVFITITFCNMIGFYGM
YSFLGSYLQDVFTGGNTAAGLFIMIYGIGFSMSVITGKVADRIGKMRSLLIALGVISVLL
ACLAYAPASMILLIVSLFIWGLMQSLTVTLLSTILSDCSERHRGKIMAFYSLASNLAVTL
GSALMGPVYVGYGYAAVGFICAAITVLGFVLSVLAYKKYGKHEQKADQSLSQ
>PK3-2_01364 Prephenate decarboxylase
MIILDNSIQTKNRTDSISKLITVNTLGPEGTSSEYAAKHFISNFTLQQGLNSKLSLHDTF
ESCIERTLQSPLEYTIVPHAYDGIKHFYMRPDLQLLQIFRCDTPMYGLAVRPDFDFSDDM
LDTFVVVSHPSPINLIKYFTRKDVRFKLVNSTSQAARKVKEGVYDIALTNELARQKYGLT
FVKTFKSIPMSWSLFGKGDVNYEN
>PK3-2_01365 H2HPP isomerase
MKTKEDMQELYFPTPKLIEWENGVRQYSSVRGDTEVLMSYVPPHTNVEPHQHKEVQIGMV
ISGELMMTVGDVTRKMTALESAYIAPPHVPHGARNDTDQEVIAIDIKRLKADETYTSPED
YFLNIFKTRDLLPGMEVTFFVEDWVEIMLAKIPGNGGEMPFHKHKNEQIGICIGGGYDMT
VEGCTVDMKFGTAYFCEPREDHGAINRSEKESKSINIFFPPRYNRAKAKKIKADE
>PK3-2_01366 Dihydroanticapsin 7-dehydrogenase
MNLTDKTVLITGGASGIGYAAVQAFLNQQANVVVADIDEAQGEAMVRKENNDRLHFVQTD
ITDEAACQHAVQSAVDTFGGLDVLINNAGIEIVAPIHEMELSDWNKVLQVNLTGMFLMSK
HALKHMLAAGKGNIINTCSVGGLVAWPDIPAYNASKGGVLQLTKSMAVDYAKHQIRVNCV
CPGIIDTPLNEKSFLENNEGTLEEIKKEKAKVNPLLRLGKPEEIANVMLFLASDLSSYMT
GSAITADGGYTAQ
>PK3-2_01367 Alanine--anticapsin ligase
MERKTVLVIADLGGCPPHMFYKSAAEKYNLVSFIPRPFAITASHAALIEKYSVAVIKDKD
YFQSLADFEHPDSIYWAHEDHDKPEEEVVEQIVKVANMFEADAITTNNELFIAPMAKACE
RLGLRGAGVQAAENARDKNKMRDAFNKAGVKSIKNKRVTTLEDFRAALAEIGTPLILKPT
YLASSIGVTLITDTETAEDEFNRVNDYLKSINVPKAVTFEAPFIAEEFLQGEYGDWYHTE
GYSDYISIEGIMADGEYFPIAIHDKTPQIGFTETSHITPSILDEEAKKKIVEAAKKANEG
LGLQNCATHTEIKLMKNREPGLIESAARFAGWNMIPNIKKVFGLDMAQLLLDVLCFGKDA
DLPDGLLDQEPCYVADCHLYPEHFKQNGQIPETAADLVIEAIDLPDGLLKGDTELVSFEA
AAPGTSVDLTLFEAFNSIAAFELKGSNSQDVAESIRQIQQHAKLTAKYVLPV
>PK3-2_01368 Putative bacilysin exporter BacE
MKQLKPNSKYLLYGQALSFMGDYCVLPALLILSTYYHDYWVTSGVIVVRSIPMVFQPFLG
VLVDRLDRIKIMLWTDIIRGMIFLGLTFLPKGEYPLIFLVLLFISYGSGVFFNPARLAVM
SSLESDIKSINTLFAKATTISIIVGAAAGGLFLLGGSVELAVAFNGVTYLVSAFFISRIK
LKFVPIQSENIKEAFQSFKEGLKEIKTNAFILNAMFTMITMALLWGIVYSYFPIVSRFLG
DGEIGNFILTFCIGFGGFIGAALVSKWGFNNNRGLTYFAVLSIVSLALFLFTPIFAVSVI
AAILFFIAMEYGEVLAKVKVQENAANQIQGRIFSVAEASIGLCISVGSMLINVLNAPVIM
GLIVVIVSGLFLHTKLVNKSFLERDNKTEQKGVF
>PK3-2_01369 Transaminase BacF
MEITPSDVIKTLPRQEFSLVFQKVKELEKTGAHIINLGQGNPDLPTPPHIVEALREASLN
PSFHGYGPFRGYPFLKEAIAAFYKREYGVSINPETEVALFGGGKAGLYVLTQCLLNPGDI
ALVPNPGYPEYLSGITMARAELYEMPLYEENGYLPDFEKIDPAVLEKAKLMFLNYPNNPT
GAVADAAFYAKAAAFAKKHNIHLIHDFAYGAFEFDKKPASFLEAADAKAVGAELYSFSKT
FNMAGWRMAFAVGNEKIIQAVNEFQDHVFVGMFGGLQHAASAALSGDPEQTESLKRIYEE
RIAFFTELCEKELGWKMEKPKGTFYVWAEIPKTFETSHQFSDYLLEHAHIVVTPGEIFGS
NGKRHVRISMVSKQEDLREFVMRIQKLNLPFASLQKVSR
>PK3-2_01370 NADPH-dependent reductase BacG
MSKRTAFIMGASQGIGKAIALKLADQHFSVVINSRNLDNIESVKKDILAKRPEATVIVLA
GDMSDQDTRAEIFQEIEAQCGRLDVLINNIPGGAPDTFDNCNIEDMTATFTQKTVAYIDA
IKRAASLMKQNEFGRIINIVGNLWKEPGANMFTNSMMNAALINASKNISIQLAPHNITVN
CLNPGFIATDRYHQFVENVMKKNSISKREAEEQIASAIPMKRVGSAEETAALAAFLASEE
ASYITGQQISADGGSMRSI
>PK3-2_01371 Putative heme-dependent peroxidase
MSEQQMTNEAAKTLDGWYALHDFRTMDWTSWKLLSSDERQSIIHEFTGLLEKWGVAQKEG
KGSQTLYSIVGQKADFMLMILRPTMEELNQIELEFNKSRLAEFTIPAYSYVSVVELSNYL
ASGDGDPYENPHVRARLYPELPESKYVCFYPMDKRRSGNDNWYMLSMEERRNLMRSHGLI
GRSYAGKVKQIITGSVGFDDYEWGVTLFSDDVLQFKKLVYEMRFDEVSARYGEFGSFFVG
NRLSLDTLPQFLYV
>PK3-2_01372 Phosphate acetyltransferase
MADLFSTVQEKVAGKDVKIVFPEGLDERILEAVSKLAGNKVLNPIVVGNENEIQAKAKEL
NLTLDGVKIYDPHTYEGMEDLVQAFVERRKGKATEEQARKALLDENYFGTMLVYKGLADG
LVSGAAHSTADTVRPALQIIKTKEGVKKTSGVFIMARGEEQYVFADCAINIAPDSQDLAE
IAIESANTAKMFDIEPRVAMLSFSTKGSAKSDETEKVADAVKIAKEKAPELTLDGEFQFD
AAFVPSVAEKKAPDSEIKGDANVFVFPSLEAGNIGYKIAQRLGNFEAVGPILQGLNMPVN
DLSRGCNAEDVYNLALITAVQAL
>PK3-2_01373 HTH-type transcriptional regulator CysL
MYYDVLKTFIAVVEEKNFTKAAEKLMISQPSVSLHIKNLEKEFQTALLNRSPKHFTTTPT
GDILYQRAKQMVFLYEQAKAEIYAHHHYVKGELKIAASFTIGEYILPPLLAQLQKLYPEL
NLDVMIGNTEEVSERVRMLQADIGLIEGHTNENELEIEPFMEDEMCIAAPNQHPLAGRRD
ISISDLQNEAWVTREKGSGTREYLDHVLSSNGLRPKSMFTISSNQGVKEAVISGMGLSVL
SRSVLHKDLIHREISILHIKDFSLKRKLSYIHSPLMENTKNKEIFITMLKSNYQSQRLK
>PK3-2_01374 Octanoyl-[GcvH]:protein N-octanoyltransferase
MANQPIDLLMQPTWRVIDQSSLGPLFDAKQSFAMDDTLCMSVGKGVSPATARSWVHHDTI
VLGIQDSRLPFLQDGISLLENEGYRVIVRNSGGLAVVLDEGVLNISLIFEDEKKGIDIDK
GYEAMVELMRRMLKPYNAKIEAYEIAGSYCPGSYDLSIDGKKFAGISQRRVRGGVAVQIY
LCADKSGSERADLIRRFYQAALKDKRNDKKGVYPEIRPETMASLSELLQTDISVQDLMFA
LLTELKALSTHLYSAGLSTDEEMEFEKNLVRMAERNAKVFG
>PK3-2_01375 hypothetical protein
MKGNVYSLFVLIAAIFWGTTGTVQTMAPESSTPLAFGAFRLLIGGSAMLLAVWISRELHM
KNWSWPLVLSAAVCMACYQPLFFSAVKETGIAVGTVIAIGSAPIIAGSMEWAVLKKRPRN
AWWIATVLALAGCWLLFSDGSNIRINLAGVLMALGAGASFAGYTLIIKSMMKTQPPRATS
AVVFMISAILLTPLLWQSDISWILTPRGLGTSLYIGLIATCAAYFLFAKGLSGIPASAAV
TLSLAEPLTASLLGVFFIGEMLSLSSWLGIALMMLGLLVISAAPRKQKNAEAAHLS
>PK3-2_01376 Prespore-specific transcriptional regulator RsfA
MTKQRQDAWSEENDLLLAETVLRHVREGSTQLNAFEEVGDKLNRTSAACGFRWNAVVRHQ
YEKALQLAKKQRKQRMRALGKGQPAKKRLLYQPPAVDPEIIQETAAEEPVTTDAPSAEHE
QQPFMSGEHMPFVDESFKEELASLSHLLSPQTPAAAPEMTMNDVIRFLQNYEGNNEQSSA
LKMENERLRKENQEFQSKIEQLEAEVQKLEKDQKTIQEDYETLVKIMNRARKLVLFEEDE
HASPSFKMDRNGNLEKLAE
>PK3-2_01377 hypothetical protein
MANEFRVCDDCQATNIKTLLPRLKEVDPDAKVEVGCQSYCGPGRKKSFAFVNNRPLSAPT
EDELIDKVKKKIKK
>PK3-2_01378 hypothetical protein
MAYPNGKLSEEKVFKDPVHRYVHVRDKLIWDLIGTREFQRLRRIKQLGTTYLTFHGAEHS
RFNHSLGVYEIVRRMVDDVFKGRSEWDDSERELCLAAALLHDLGHGPFSHSFEKVFHLDH
EDFTRDIILGDTEVNQVLRKVSPSFPQDVAEVIAKTYKNKQVVSLISSQIDADRMDYLQR
DAYYTGVSYGHFDMERILRVMRPREDQIVIKESGMHAVEDYIMSRYQMYWQVYFHPVTRS
AEVILTKILHRAKQLHDEGYVFTHAPVHFYSIFEGKLTLEDYLKLDESIILYYFQAWEDE
EDAILSDLCRRFINRQLFQYVEFNPNEEMSAYFELTSLFKEAGIDPSYYLVVDSSSDLPY
DFYRPGEEEERLPIHLLTQNGQIKELSRQSAIVESISGKRRTDHKLYYPMDLICDGSEHP
EAKMKIRQLLGLT
>PK3-2_01379 hypothetical protein
MLKEHAKLMKVFSDSGEIIGRKKLQKMIYIAKKMQFPFYEKYDFHFYGPYSEELTLQIEE
LCNLGFLHEVKEKKGGYFQYRYSLTETGSAFLDHADLDMPDIKGYIDSVNSRSSRFLELV
STILYFDGLEAEEKKEKVFTIKSKQKYTNDEYDEALQYIEELKQIC
>PK3-2_01380 hypothetical protein
MKMKSGMEQAVSVLLLLSRLPVQSSLTSEAISQRLRVSPSYLKKLMRTLVQAGLAESIPG
TKGGFTLTKPLADITLYDVYQAVEGRGSMYQGKGLLQSVFEGESSCVLETVMGEIEDKWA
NLMREESLQQVMDRVGELYDLEKIDDWVNEQMKGQLQ
>PK3-2_01381 Multidrug resistance protein Stp
MKNSGSIHKTDSSTGISVLIVLALGFLMATLDVTVVNVAMADMKSALSMSLSGVTWVVDG
YILTFASLLLAGGALADRFGSKTIYILGLAVFVIASCLCAVSINGEMLIAGRLMQGIGAA
LFMPSSLSLLAASYPDERVRARMFGLWAALVSAASGLGPFIGGVLVQAAGWQSIFLINVP
LGAAALISAYRILGRVPGKSSRVNITGHLLGMAALGFLSFALIQGPSAGWRSLVILGAFA
AAVLAFVLFLLREISAETSILPASLYKNDRFSAAQFVGFLLNFALFGGMFMLSLFLQEAR
GASSFMAGVELLPMMAVFVIGNLLFARLANRFEAGQLMFVSMAVSCIIALLLFVLVSPDF
PYWQLAVLMSVMNLGTGITVPAMTTVIMQAAGQKHANIAGAALNANRQIGALVGVAVSGV
IIHLSATWYAGAGFTFLMMGAAYSLAALLVWLFLAAHNGTAAPEKNINH
>PK3-2_01384 Threonine--tRNA ligase 2
MSKHVHIQLPDGQINEYPKGITIKEAAGTISSSLQKKAAAGRVNGRLVDLSFKLEEDAEL
SIITLDSQEGLQVLRHTSAHILAQAVKRLYGEVSLGVGPVIEDGFYYDMKLEQSLTSGDL
EAIEKEMKNIINENLEIKRIEVSYEEAKALFAEKGEPFKLEILNDIPRGEAITLYQQGEF
VDLCRGPHLPSTGMIKAFKLTRVSGAYWRGNSENEVLQRVYGVAFQKKKDLDAHLHMLQE
AAKRDHRKLGKQLELFMFSEEAPGMPFYLPKGQVVRNELERFSRELQTKAGYDEVRTPFM
MNQRLWEQSGHWDHYRDNMYFSEVDDTRFAMKPMNCPGHMLIFKNSLYSYRDLPIRMAEF
GQVHRHEYSGALNGMLRVRTFCQDDAHIFVREDQIESEIKEAIRLIDEVYRTFGFDYSVE
LSTRPEDSLGDDSLWEASERALAHVLEELGLPYEVNEGDGAFYGPKIDFHIKDALKRSHQ
CATIQLDFQMPEKFDLTYINEHNEKVRPVVIHRAVFGSIDRFFGILIEHFGGAFPVWLAP
VQVQIIPVSHVHLAYCRKVQAELKQLGIRAGIDERNEKLGYKIRESQVQKIPYVLVLGDH
EEQEGTVNVRQFGDQQSEHVPFQTFKDKLVKQVKNRSI
>PK3-2_01385 putative HTH-type transcriptional regulator YusO
MDHDKLEANLLDHALTKYLKSTKQLDETTVPKHVNNVRGFILRIIYRHGNCTIKDILKEV
TLSPSATTTALNHLEQEGFIERSRNNNDRRTVWITLSDSGRGVAEQMIENRQQLIDGMFE
RLTAEEKKTLLAIIAKLTQ
>PK3-2_01386 2-hydroxymuconate tautomerase
MPYVTVKMLEGRTEEQKRNLVEKVTEAVKETTGASEEKIVVFIEEMRKDHYAFAGKRLSD
ME
>PK3-2_01387 hypothetical protein
MDSFLYYPLSLMPYLVITLIVSFTIHELAHAYVAYKFGDDTAKKQGRLTLNPIKHLDPFG
TILILVAGFGWARPIPVNRRFFKKPRLAGVLVSIAGPVSNLILAFIGFFLLVLMHAYGME
MLAAFSTGLDQFFSIWIQLNLVLFLFNLLPLPPLDGYRIIEDLVPPGVRAKMTQAENYGF
IVFLVLFVTPLGSYVLWPMLNAGRDQILKLFSAIFQPLL
>PK3-2_01388 hypothetical protein
MEEKKKKSIGFNIIKSDPTDGHGGFGVGALSLDNISPVFVDVEEKEAFVDIGAMHARSTV
EKGIKFLPNKEEVPNGKPYWLVWVTIDRREEGPYYAGVTACEMTVDRSIRRGYKSLPEHV
NLMDKSMKRKIIVDKMDDSSKRVLGEFLKKHDQGFWDRSSDELKTSLFPENN
>PK3-2_01389 hypothetical protein
MMYETIRVGDWVIKADVEETRKQYEKEIDMCECLLCQNYREVMKALPPDKVRIFEDLGLQ
PSVCPDINEFGPEGDRHLYVASYFIVGRIIEGKKEWDPDRNWTISFELPRDGHFIPDGFP
KPIVQLDCITLLPWIMNEPYE
>PK3-2_01390 Penicillin-binding protein 2D
MDAMTNKRLRLTLKTVRAFIFLGALAALAAAAVFMTVILIAKYQGAPSVQVPQSTILYAN
DGSKLGETNYGEKRYWVPLKDMNPTIVKATVAVEDQNFYDHHGFDYKRMAGAALADLKAF
AKVQGASTITQQYARNLYLEHDKTWKRKWNEAFYTIRLEQNYSKDEILEGYLNTIYYGHG
AYGIEAASRLYFGKHAKNLTDAEAALLAGIPKGPSGYSPYVNETKAKERQKTIVRMMEKQ
RMISQKKAGELIKEPLSYQPLNKQVSKRKAPYFYDNAMRELEKKLGMTREQIETSGLNVY
TTVDKRMQRIAEETITETVNAGSDIQVGFSAIDPRTGNVLALVGGRDYQKSPFDRTTQAK
RQPASTIKPLLYYKAIQSGFTPVTLMKSEETEFQIDAKGETYSPSNYNGYYANKPITLLQ
ALALSDNIYAVKTHLFLGPNKLVQAAKEFGITAHLQALPSLALGTEPVRPIEMVNAYAML
ANGGEKIEPTFISRVTDAAGHVLYEKPNQHKQVLDEKAAFVTASMMSGMFDTDLNGYTSV
TGRTIANRLTRTYAGKSGTTSADSWMIGFNPKLAAGVWTGYDKNSTIDSVEEKSYAKTIW
ADFMEDALKGEPETAFKPPKGVTGVYIDPETGYTSGPGCAAKHYTYFVKGTEPANVCYGR
EPAKQTKDRLPAKEKPASPKKWWDKWLGRNH
>PK3-2_01391 Polyamine aminopropyltransferase
MSELWYTEKQTKNFGITLKVNKTLHTEQTEFQHLEMVETEEFGNMLFLDGMVMTSEKDEF
VYHEMVAHVPLFTHPNPEHVLVVGGGDGGVIREILKHPSVKKATLVDIDGKVIEYSKKFL
PSIAGKLDDPRVDVQVDDGFMHIAKSENQYDVIMVDSTEPVGPAVNLFTKGFYAGIAKAL
KEDGIFVAQTDNPWFTPELITNVQRDVKEIFPITKLYTANIPTYPSGLWTFTIGSKKYDP
LAVEDSRFFDIDTKYYTKDIHKAAFVLPKFVSDLIK
>PK3-2_01392 Agmatinase
MRFDEAYSGKVFIASRPEWEGADAILYGMPMDWTVSYRPGSRFGPNRIREVSIGLEEYSP
YLDRDLADLNFFDAGDIPLPFGNPQRSLDMIEEYVDSILEKGKFPMGMGGEHLVSWPVIK
AMYKKYPDLAIIHFDAHTDLRVDYEGEPLSHSTPIRKAAELIGPQNVYSFGIRSGMKEEF
EWAKENGMHISKFEVLEPLKEVLPKLAGRPVYVTIDIDVLDPAHAPGTGTVDAGGITSKE
LLASVHEIARSEVNVKGADLVEVAPVYDHSEQTANTASKIIREMLLGFVK
>PK3-2_01393 hypothetical protein
MKWKYKLLLACLAVSAVFITVEVSNSSTEHFDVAQRAMI
>PK3-2_01394 Response regulator aspartate phosphatase F
MTGVISSSSVGEKINEWYMYIRRFSIPDAEYLRREIKQELDKMEEDQDLHLYYSLMEFRH
NLMLEYLEPLEKMRIEEQPRLSDLLFEIDKKQARLTGLLEYYFNFFRGMYELDRREYVLA
IQFFKKAESKLIFVKDKIDKAEFFFKMSEVYYYMKQTYVSMDYARQAFEIYSEQTTYDIR
MIQCQSLFGANFLDLKQYEKAIAHFQKAFTLAEAEQQPQLMGRTLYNIALCKQNQNSFES
AIEYVKKSIRVFERSKMLPSLPQAFFLITQIYFKLGKMDNACEYHKKGKEYSAAAGDTVY
LTEFEFLESLYLSGPDEERIEKCFVFLESKMMYADIEDFALDVAKYYHQQESYKKASHYF
LKVEEARQHIQGGVNLYEMEV
>PK3-2_01395 putative protein YwhK
MRKNKLSFKEKAEAAQEECLCFCEEEASREAMFQAPIELPEGFVVDPAEAVANVTWNADS
LSCVIERCLIETGPEPDAIGVQFAVRLQGTVTLLVSVSPVRNQYGQGNGAVSVIHSAEID
QVVYYSDEPDDCPDFSDITIENLVVVPPFYGSPLSVTGTIVLVPEPEPVYAFTANPNDQS
VSVIDTNTHTVMTTIALPYRPTDIEITPDGSAVFVLHFNNNMISVIDYDTLTVTATILLD
QPPQSIKFIPNHEFAYVLGDTVIYVIGIDTLVVDRSIPVEGFDFAIDPNGLFAYVLNFGL
VQKVDLFTGEVTGTIERELIVSSIETDSPERYAYVLEQEFLFNYLTVIDLNTFTISDTQE
LEPDGQYRMFTSGTGVYLHDSFTGNLYSVSPNGAGVIGNVPQSARDFAFTPNGEFLYATH
FLEQNITVYNTDDYSVETVISLGVSPGAITI
>PK3-2_01396 putative protein YwhK
MKKNDLSVLHENCFCFCDEEISREAPFQVPINIPEGFTVDSAEAAAAVTWSTDNLTCISE
PCLIQTGPDIEDIGVRYAVRVQGTVTLLVSVSPVRNQYGQGNGSVSVIYDEEIDQVVYYA
AQSDRCPDFSQITVEDLLIVPPFYGSPLTVTGTLVLPPSPDPQSYVFTANSGDSTVSVID
AAANLVVAAIPFASVPTDLGVTPDKAYTYVLHGNTNLVSVIDNQTLTVTNTITVGNGPRK
IQFDSEGEFAYVMAGGSIYIIDLALQAVSSVFAIPNAADFALDPNGQFVFTANTAFWSID
QYDVNTGQLVDSLVNEFEYPSLVETPYAGEFAYVMNGELWPKSVTEISLSPLSRGDNLNR
SFEVLRAIVFSFDSTRAYLLEPYIDPFLTDNLTVVNTAANTIIANVSVPGAFDIAVTPDN
QYMYAAQPGDNTVTVYRTSDYTAVTVIPVGAGPSAIAM
>PK3-2_01397 Antilisterial bacteriocin subtilosin biosynthesis protein AlbG
MRKSTMFTLLLLLAGMAAYSFGWVQAVAKAAAQYVQMVDNEAVRLGLLACIASVLMLPAF
LYLHYVTQSVKNMTAAFQKLTQSHQSCCDFQQHRLCSRYAEDVKSLRDSYKNVRQTYVMA
AVLCQVVIFGCMFEIVKAVPFRLHTPPAVSMGLAVLLILYLLFYMRTYLLQLFQHGTLFR
KVLVGALAGAGIWWMLSFTISELLFLIIVAAIQQIGSSIYKHISDRRPASFEL
>PK3-2_01398 Putative zinc protease AlbF
MEKKAFFQHLDERTDIKYTESGLKIFRLKFPRAHLRLCNVKIDFGSRDVCLQAESGDTLL
PYGTAHFLEHLLFWHNGRNLYSDFFAHGALLNAFTTYTDTNFMFTSLPDRLRQTIPILLD
ALWNHSFDKKMITQEKAVITSEIQTAHLNHQLSYHYQLINMLSPASPAAVFPAGRTEDIE
ALDIHDLQKAYKAAYKPQQMTLFLIGGSEDTETLLPSHLRLEKHPVHKTERKIMSARPSI
SSSKKVLGDEERMEDTWTGLQIGALPGQNDLLTAKLYWDIASRILFQLDSPFFQEIQQTY
RLEIDRLSAEAHIYEDGGFLILHSQGAHSSAYIDVASYYVTQQKKKIADWLQYGKDSLTD
AIIYDSDYVRKCFEWAAECDRCNCSFLDIYGIIHEMNSQDFLSLIDALGSSNKAVIHVSQ
KEAIVQ
>PK3-2_01399 Antilisterial bacteriocin subtilosin biosynthesis protein AlbE
MIQAKENGLEVNLLKTHQFSTISIAASYLKPIESAAEPEEETIYFYGAAAHLKQQIIDAF
GYAAGSRFMYSANLFFDRQLKTCGTRLIHPSCNKNLHVDALMKTFADMSFPPSLSADAVE
KAKDELLLKIEKKFTDPFSYSAARLAEEAFGNPMYGTAMFGRKERIQAIHPKRFLDAADF
IVDLLSQHKQLNILGQVQACDIPGQASQASVVTAGRTLVNRHVFVTETRSAAGPSVLTLG
FDCGEMKDASDYIKIQLIDGLLGKYGHSALFKHFREKDLAVYHVITRYDVMNNLLLVSIC
TDQLHEKEIPSRVLEAVTHFQTNERELEQAKQFLRNEMLLQFDSPEGLLAYMGILRRFSC
TKEDLLDGISAVACRDVLEFIATISYIGAHVVRG
>PK3-2_01400 Antilisterial bacteriocin subtilosin biosynthesis protein AlbD
MNNLFPILSLLFKQLYSRQGKKDAIRIAAGLVILAVFEIGLIRQAGIDESVLGKTYIILA
LLLMNTYMVFLSVTSQWKESYMKLSCLLPISSRSFWLAQSVVLFVDTCLRRTLFFFILPL
FLFGNGTLSGAQTLFWLGRFSFFTIYSIIFGIVLSNHFVKKKNWMFLLHAAVFACVCLSA
AFAPAITIPLCAVHMIWAMIIDFPVFLQAPPQQSKMHSFLRRSAFSFYKREWNRFISSKA
MLLNYAVMAAFSGFFSFQMMNTGIFNQQVIYIVISALLLICSPIALLYSIEKNDRMLLIT
LPIKRRTMFWAKYRFYSGLLAGGFLLVAVIVGFISGRPISALTFVQCMELLLAGAFIRLT
ADEKRPSFSWQTEQQLWSGFSKYRSYLFCLPLFLATLAGAAVSLAVIPIAGLIIVYYLQK
QDGGFFDTSKRERLGS
>PK3-2_01401 Putative ABC transporter ATP-binding protein AlbC
MSILDIHDVSVWYERDNVILEHVDLQLEKGAVYGLLGVNGAGKTTLINTLTGVNRNFSGR
FTLCGIEAEAGMTQKTSDQLKIQRYFAADYPLLFTEITAKDYVSFVHSLYQKDFSEQQFA
SLAEAFHFSKYINRRISELSLGNRQKVVLMTGLLLRAPLFILDEPLVGLDVESIEVFYEK
MREYCEAGGTILFSSHLLDVVQRFCDYAAILHDKQIQKVIPIGEETDLRREFFEVIGHE
>PK3-2_01402 Antilisterial bacteriocin subtilosin biosynthesis protein AlbB
MSPAQRRILLYILSFIFVIGAVVYFVKSDYLFTLIFIAIAILFGMRARKADSR
>PK3-2_01403 Antilisterial bacteriocin subtilosin biosynthesis protein AlbA
MFIEQMFPFINESVRVHQLPEGGVLEIDYLRDNVSISDFEYLDLNKTAYELCMRMDGQKT
AEQILAEQCAVYDESPEDHKDWYYDMLNMLLNKQVIQLGNQAGRHTITTSGSNEFPMPLH
ATFELTHRCNLKCAHCYLESSPEALGTVSIEQFKKTADMLFDNGVLTCEITGGEIFVHPN
ANEILDYVCKRFKKVAVLTNGTLMRKESLELLKAYKQKIIVGISLDSVNSEVHDSFRGRK
GSFAQTCKTIKLLSDHGIFVRVAMSVFEKNMWEIHDMAQKVRDLGAKAFSYNWVDDFGRG
RDIVHPTKNAEQHRKFMEYEQNVIDEFSDLIPIIPYERKRAANCGAGWKSIVISPFGEVR
PCALFPKEFSLGNIFHDSYESIFNSPLVHKLWQAQAPRFSEHCMKDKCPFSGYCGGCYLK
GLNSNKYHRKNICSWAKNEQLEDVVQLI
>PK3-2_01404 Subtilosin-A
MKKAVIVENKGCATCSIGAACLVDGPIPDFEIAGATGLFGLWG
>PK3-2_01405 putative beta-barrel protein YwiB
MKQETPITLHVKSVIEDDGNQEVIEFRTTGFYYVKQNKVYLSYYEEHDLGKVKTIVKVSE
GEVLVMRSGAIKMNQRFVTGASTIAKYIMSFGELELKTSTKSIQSDLNEEKGRISIAYDM
HVGDEQQHLHNMTITYEGGTHA
>PK3-2_01406 Arginine--tRNA ligase
MNIAEQMKDVLKEEIKAAVLKAGLAEESQIPNVILETPKDKTHGDYSTNMAMQLARIAKK
APRQIAEEIVAHFDKGKASIEKLDIAGPGFINFYMNNQYLTKLIPSVLEAGEAYGETNIG
NGERVQVEFVSANPTGDLHLGHARGAAVGDSLCNVLSKAGYDVSREYYINDAGNQINNLA
LSVEVRYFEALGLEKPMPEDGYRGEDIIAIGKRLAEEYGDRFVNEEESERLAFFREYGLK
YELEKLRKDLENFRVPFDVWYSETSLYQNGKIDTALEALRETGHVYEEDGATWFRSTTFG
DDKDRVLIKKDGTYTYLLPDIAYHKDKLDRGFDKLVNVWGADHHGYIPRMKAAIEALGYE
KGTLEVEIIQLVHLYKNGEKMKMSKRTGKAVTMRDLIEEVGLDAVRYFFAMRSADTHMDF
DLDLAVSTSNENPVYYAQYAHARICSMLRQGEEQGLKPAADLDFSHIQSEKEYDLLKTIG
GFPEAVAEAAEKRIPHRVTNYIYDLASALHSFYNAEKVIDPENKEKSRARLALMQATQIT
LNNALQLIGVSAPEKM
>PK3-2_01407 putative nitrate transporter NarT
MINRQHIQLSLQSLSLVAGFMVWVLISSLISQITLDIHLSKGEISLVTAIPVILGSLLRI
PLGYLTNRFGARLMFMISFILLLFPVFWISIADSLFDLIAGGFFLGIGGAVFSIGVTSLP
KYYPKEKHGVVNGIYGAGNIGTAITTFAAPVIAQAAGWKATVQMYLVLLAVFALLHVLFG
DRHEKKVNVSVKTQIKAVYRNHVLWFLSLFYFITFGAFVAFTIYLPNFLAEHFGLNPADA
GLRTAGFIAVSTLLRPAGGFLADKMSPLRILMFVFAGLTLSGIILSFSPTIGLYTFGTLT
VAVCSGIGNGTVFKLVPFYFSKQAGIANGIVSAMGGLGGFFPPLILASVFQATGQYAIGF
MALSEVALASFVLVIWMYWQERMKTHTERNSQSVN
>PK3-2_01408 Anaerobic regulatory protein
MNFLSVRPSDSDFLSSGLYELLESISTKRKMEKHTYLFREGMDAEELYLIQSGLIEIGKL
TSDGKDLTLRICQKNDIVGELTLFTEEPRYMLSAKVLEDGEVLVINKNKLEKELIQNGAL
TFEFMKWMSTHLRKIQSKIRDLLLHGKKGALYSTLIRLSNSYGVERSDGILINIVLTNQD
LAKFCAAARESVNRMLGDLRKQGIISIDESGKIILHKRDYLRCEIECENCPLEICNID
>PK3-2_01409 hypothetical protein
MKALIPKQHGAWAMLLIPFLLGMVKGGPVLWHIPLFLGWLFLYLAVYPVTLALKKKQFKS
YQKWICYYGFPACCFLIISVFHKPPLIWAGVSLLPLFLIHMYFARRKNERALVNDIAGVL
FFCSGGLASCWLGTGTLDGWAWFIFFQSALFFIGSSFYVKSVIRERKNRGFAYWSWGYHL
LLPFLSALLGAGWAFLAFIPSSLRAWFFHGRDWPAKTIGILEIVNASFFFAVMCMFITR
>PK3-2_01410 putative transcription regulator ArfM
MKQCDYLLFLKQLPMFNEVPLDIVETLLKNGTFIRGSSDQSPSFLHSQSVYIVLKGSVRF
MDSRLPEGSKTVALWEKGDVFPIDEKGGMYLSPFISVNATSDILILNIPYYIFKKMMSYN
PQLQMNFLAMLQQNVFCSYQLFLRYLHTSQDENAESGS
>PK3-2_01411 Respiratory nitrate reductase 1 alpha chain
MKKKKMSPLFRRLNYFSPIEHHSNKHSQTTREDRDWENVYRNRWQYDKVVRSTHGVNCTG
SCSWNIYVKNGIVTWEGQNLNYPSTGPDMPDFEPRGCPRGASFSWYIYSPLRVKYPYVRG
VLINLWREALQTHQNPLDAWKSIVENPEKAKSYKQARGKGGFVRAEWPEVLKLISASLLY
TVMKYGPDRNVGFSPIPAMSMISHASGSRFMSLIGGPMLSFYDWYADLPPASPQIWGDQT
DVPESSDWYNSGYIITWGSNVPLTRTPDAHFLAEARYKGAKVISISPDFAESSKFADDWL
SIRQGTDGALAMAMGHVILQEFYVNQETERFIEYAKQYTDFPFLVTLSKENEVYTAGRFL
HAKDIGRQTKNDQWKPAVWNEQTGAFAIPQGTMGSRWDGQQKWNLHMIDEETGEPIESRL
SVLGIEDEIGTVRIPYFSNDGNKVLERDLPIKKLDLNGEEVCVTTVFDLILANYGVNRGI
GEQSAVSYDDPEPFTPGWQEQMTGIKKEAVIQIAREFAQNAIDTDGRSMIIVGAGINHWF
NSDTIYRAVLNLVLLVGAQGVNGGGWAHYVGQEKLRPAEGWQTIANAKDWEGVPKLQNGT
SFFYFATDQWRYEDQPISDLASPVAASSRYKHHADYNVLAARLGWLPSYPTFNKNGIDLY
KEAERAGAATPKDVGAYVASQLQEKKLSFAIEDPDNEANFPRNLFVWRANLISSSGKGHE
YFLKHLLGTTNGLMNDDSDSIRPEEIKWREQAPEGKLDLLINLDFRMAGTALYSDIVLPA
ATWYEKHDLSSTDMHPFIHPFAPAISAPWESKSDWDIFKALSKAVSDLAEEVDMEPVKEV
VATPLLHDTMQELAQPFGKINDWSKGECEAIPGKTMPNIQVVERDYKHIFHKMTALGPYA
GLKPSGTKGMSWSIADEYDSLKKRLGEITTDSVAKGCPNISEAKQVAEAILTLSSTSNGK
VAVKAWESLENITNLKLKDLAEEREEECFTFEQITAQPKTVITSPAFTGSEKGGRRYSPF
TTNVEKLIPWRTLTGRQSYYVDHELMMEFGETMATFKPILQHRPFLSKRPDQEGKEIVLN
YLTPHNKWSVHSMYFDSLPMLTLFRGGPTVWMNKDDAEDTDIKDNDWIECFNRNGVVVAR
AVLSHRIPKGMAFMHHAQDRHINVPGTKLTNNRGGTHNSPTRIHVKPTQMIGGYAQLSYG
FNYYGPTGNQRDLNVVIRKLKEVDWLED
>PK3-2_01412 Respiratory nitrate reductase 1 beta chain
MKIKAQIGMVMNLDKCIGCHTCSVTCKNTWTNRSGAEYMYFNNVETKPGIGYPKQWEDQD
KYKGGWTLKKGKLELKSGPKTNRLAGLFYNPNQPTIDDYYEPWNYDYETLTNSPQKKHQP
VARPKSSLTGDFMNIEWGPNWEDDLAGGHITGLEDPNVQKMEESIKTEFDEVFMMYLPRI
CEHCINPACVSSCPSGAMYKREEDGIVLVDQNACRSWRYCVSSCPYKKVYFNWQTNKAEK
CTLCFPRLEAGLPTICSETCVGRIRYLGVMLYDADKVEEAASVENEKDLYHSQLDVFLDP
NDPEVAKLAKEQGIPAEWIEAAQQSPIYKMIIDWKIALPLHPEYRTLPMVWYIPPLSPIM
NLFEGKGSQQTAEDIFPAIDQMRIPIDYLAQLLTAGDTDHIRSTLKKMSVMRQYMRAVQT
NKSIDPELISSVGLTEQQIEDMYRLLAIAKYDDRFVIPSSHREEVSDLYAEQGSCGLSFS
GGPGSCF
>PK3-2_01413 hypothetical protein
MNTTDRQITFSALSCLLSYPAEEWRAELPDWKALIHEIGNQQIREKLLRFFEASACFTPE
ALIEHYVYTFDFGKKTNMYVTYFNSGEQRERGIELLHLKNTYQQSGFLPTEKELPDYLPL
MLEFAAVAEAEAARSVFGKYLSNVRELASRLEKNDSIYAELLHVLLAALEDIGVRESSEE
GAVQA
>PK3-2_01414 Nitrate reductase-like protein NarX
MSGQILWGIMPYIVLTIFIGGHIYRYQHDQFGWTAKSSELLEKKKLAAGSTLFHWGLLCV
VGGHVMGILIPEGVYASLGISEHMYHKMAIGAGLPAGIAACTGLVILTYRRLFDKRIRKT
SSLSDILTLLLLLFMMLSGVAATFLNIDSKGFDYRTTVGPWFREIVLFRPDASLMESVPL
WFKFHIFIGYVVFILWPFTRLVHVFSLPLKYLTRSYVVYRKRS
>PK3-2_01415 hypothetical protein
MKRILLILTACLMTSAGLLTLRHSHVLTGGTAGLSLSLTYLFHSSFAIIFFLINIPFYVF
SFIRMGIKFTLSTVFAVTVLTLFTSADHWLPSVSISPLAGSICGGALIGFGLSLMFYHQA
SLGGANILALFLQKRCGWNPGTVNFLFDFGVVLAGIFSVGLLKGIFSLVSIAVTGLIVGF
FKNKIKGSYSLKPALLQNITPGQSQEASS
>PK3-2_01416 putative cardiolipin synthase YwiE
MLKRRLEFFFLYIMLIGAYVIWFFPVSRLEFYGGLLCYVSIIFFSIYSLILENRTSQHTL
LWIHILVFFPIAGYMFYLFSGQLYVKGKLFKTKRMYNREKLRKLFHMEETPEVTGLKDNQ
ERFFTYSTRAAHMNINTKSNIKVLKNGEETFPDIFKAMRKAESYIHIEYYMFKSDMLGRG
MMDIMMEKARQGVEVRFLYDAAGSIKLAGRDIMKMKQAGVDIVPFSPLKYGFFNQKLNFR
NHRKIVVIDGKIGFVGGLNVGKEYISRDPYIGFWRDTHLRLEGEIVQTLHAIFMLDWEYV
SNEVLIDQEEYNTPVPVEGEGIYQIVATGPDMKESMSDLYYEMISSAQKSVWIATPYFVP
NEPIRTALKAAATKGVEVRVMVPEKNDSFLTQYASRSYFPELLLEGIEVYSYQKGFMHQK
VLIVDGDLASVGTANMDMRSFQLNFEVNVFFTDAEAIRTLEAHFEEDMMDSEKLSPVGFY
KRGMADRTKESFARLFSGVL
>PK3-2_01417 Putative multidrug export ATP-binding/permease protein
MLRQFFSYYKPYKTLFFLDFFSAIAGGLMELSFPLIVNYFIDTLLPGRDWGLIIATSIGL
FAVYALSSALQYIVTYWGHMLGINIETDMRKSLFDHLQKLSFKFYDNNKTGTLMSKLTND
LMYIGEVAHHGPEDLFIAIMTILGAFGVMLFINWQLALLTFIIMPVVIWLALYFNKKMTK
AFTTLNKDIGDFSARVENNIGGIRLVQAFGNEAFEKERFAVNNQRFRVTKLSSYKIMAKN
GSISYMLTRFVTLFVLLCGTWFVIRGSLSYGEFVAFVLLTNVLFRPIDKINAIIEMYPRG
IAGFKSYMELMETEPDIQDSPDARDVSGLKGNIRYEHVSFGYDEHNNVLKNINLSIQAGE
TVAFVGPSGAGKSTLCSLLPRFYEATEGDITIDGISIKDMTLSSLRGQIGVVQQDVFLFS
GTLRENIAYGRLNASEEDIWQAVKQAHLEELVHNMPDGLDTIIGERGVKLSGGQKQRLSI
ARMFLKNPSILILDEATSALDTETEAAIQKALQELSEGRTTLVIAHRLATIKDADRIVVV
TKNGIEEQGRHHDLIEAGGLYSRLHQAQFGQMVRQ
>PK3-2_01418 IS1595 family transposase ISCac2
MDRKNVLFIAVSLDGMIAREDGSIDWLDEFEGEGDNGYSDFYQTVDTVVLGRSTYEHVKV
LTQVFPYQDKTCYVFTGTPGSYQDEHVTFINEGAKAFTDRLKQDKGLNIWIAGGAELVNA
FMKENAIDEFIITVIPVVLGSGIPLFHELTNDTKLRLKGMKQFRQAVQLHYVKS
>PK3-2_01419 hypothetical protein
MKNIKSLKVAAQAFTLRNLIHLYKMCHSGSHEVYIYSKKTMCKIKSLIELETFRMAHNEK
EYLIVVEGTKAPQLIEKFQNFIEPAEREAL
>PK3-2_01420 UV DNA damage endonuclease
MNFRFGFVSNAMSLWDASPAKTLTFARYSKLSKDERKEALLTVTKANLRNTMRTLHYIIG
HGIPLYRFSSSIVPLATHPDVMWDFVTPFQKEFREIGELVKTHHLRTSFHPNQFTLFTSP
KENVTNNAVTDMAYHYRMLEAMGIADRSVINIHIGGAYGDKDTATAQFHQNMKKLPQEIK
QRMTLENDDKTYTTEETLQVCEREDVPFVFDFHHFYANPDDNADLNEALPRMIKTWERIG
LQPKVHLSSPKSDQAIRSHADYVDANFLLPLLERFRQWGTNIDFMIEAKQKDKALLRLME
ELSSIRGVKRTGGGTLQWKS
>PK3-2_01421 Minor cardiolipin synthase ClsB
MKVLFVIIIIVVILFALILLDIFMGRASYRKNAYEPVFSKKKSDIELIHCGADLVERMMK
DIRQAASSVHVMFFIMKNDEVSHNMYTLLKTKAKAGVSVYLLLDWAGCRAIKKTALKTMK
NAGVHVHVMNRPRFPYFFFHMQKRNHRKISVIDGKIGYIGGFNIGEEYLGKKAKFGNWED
YHLRMKGEGVRDLQTLFTADLQRNTGSAELSPDVWPKLPQGNISHKIYATDGYSLEKTYV
ANIAQAKERITICTPYYIPTKSLQQALVKARKNGVAVTIIVPMKSDHPLVREAAFTYYSE
LLDAGCLIYRFYQGFYHVKALIIDDHFSIIGTANFDQRSFFLNEEVNVEIDDKAFTKEVY
ATIEEDIKRSELLTKDNFKKRTFRQRPAEWLGRALSYFL
>PK3-2_01422 putative iron-sulfur-binding oxidoreductase FadF
MSGFLIANALLFLIVTAYAVYLFFYLVKTRLAYIRLGQKEQFDQRIKERLRAIWVNVFGQ
KKLLKDKKSGIIHVMFFYGFILVQFGAIDFIIKGLAPDRHLPLGPVYPAFTFFQEIVTFL
ILIAVVWAFYRRYIEKLVRLKRGFKAGLVLIFIGGLMLTVLLGNGMNLIWHEHGLSWSEP
IASGLAFLLGGVGKTGAAVIFYIAWWAHLLFLLSFLVYVPQSKHAHLIAGPANVFFNRME
SAGKLEKIDFTDETKESYGAGKIEDFRQSQLLDLYACVECGRCTNMCPATGTGKMLSPMD
LILRLRDHLTEKGAAVTSRSPWVPAAAFRHTRGNQLAAASAGSGSREAAAALDYNPSLIG
DVITEEEIWACTTCRNCEDQCPVMNEHVDKIIDLRRYLVLTEGKMDSDAQRAMTSIERQG
NPWGLNRKERENWRDAAPDAEIPTVKEMKKEGKEFEYLFWVGSMGSYDNRSQKIAVSFAK
LLNHAGVSFAILGNKEKNSGDTPRRLGNEFLFQELAEKNISEFEKNDIKKIVTIDPHAYN
LFKNEYPDFGFEGEVYHHTEVLAELVKNGKLKPQHPLYETITFHDSCYLGRYNEVYDPPR
EILKAIPGVELVEMERNRETGMCCGAGGGLMWMEEETGNRINVARTEQALAVDPSVIGSG
CPYCLTMLGDGTKAKEAEDRVKTYDVAELLAQSVLGADMKMGEKP
>PK3-2_01423 Acyl-CoA dehydrogenase
MNFSLSEEHEMIRKLVRDFAKHEVAPTAAERDEQERFDRELFREMAQLGLTGIPWPEEYG
GIGSDYLAYVIAVEELSKVCASTGVTLSAHISLCSWPLFAYGTEEQKTEHLTQLALGEKI
GAFALTEAGSGSDAGGMKTTAERIGDHYVLNGSKVFITNGGIADIYIVFAVTDPEKKKKG
ISAFIVEKDAEGFVTGKKEKKLGIRSSPTTEITFEDCVVPAANRLGEEGEGFKIAMKTLD
GGRNGIAAQAVGIAQGALDAALQYAKERKQFGKSIADQQGIAFKLADMATMIEASRLLTY
QAAWLESSGLPYGKASAMSKLLAGDTAMKVTTEAVQIFGGYGYTKDYPVERYMRDAKITQ
IYEGTQEIQRLVISRMLAD
>PK3-2_01424 DNA-directed RNA polymerase subunit delta
MGIKQYSQEELKEMALVEIAHELFEEHKKPVPFQELLNEIASLLGVTKEELGDRVVQFYT
DLNIDGRFLALSDQTWGLRSWYPYDQLDEETQPTVKAKKKKAKKAVEEDLDLDEFEVVDE
DDLDLDEVEEELDLDTDDFDDEDLDEDDDDLEIEEDIIDEDDEDYDEDEEEVK
>PK3-2_01426 CTP synthase
MTKYIFVTGGVVSSLGKGIVAASLGRLLKNRGLNVTIQKFDPYINVDPGTMSPYQHGEVF
VTDDGAETDLDLGHYERFIDINLNKFSNVTTGKIYSTVLKKERRGDYLGGTVQVIPHITN
ELKDRVYRAGKETNADVVITEIGGTVGDIESLPFLEAIRQMKSDIGRENVMYIHCTLVPY
IKAAGELKTKPTQHSVKELRSLGIQPNIIVVRTEMPISQDMKDKIALFCDIDTKAVIECE
DADNLYSIPLELQKQGLDKLVCEHMQLSCEEAEMSEWKELVNKVSNLSQTITIGLVGKYV
ELPDAYISVVESLRHAGYAFDTDVKVKWINAEEVTESNIEELTSGTDGIIVPGGFGDRGV
EGKIVATKYARENNIPFLGICLGMQVASIEYARNVLGLKGAHSAEIDPSTQYPIIDLLPE
QKDVEDLGGTLRLGLYPCKLEEGTKAFEVYQDEVVYERHRHRYEFNNEFRQQMEDQGFIF
SGTSPDGRLVEIIELKDHPWFVASQFHPEFKSRPTRPQPLFKGFIGASVEAANQK
>PK3-2_01427 hypothetical protein
MLKIFTTQLTGIFSRIQDKESDAIEDGARLLAQAVISGHSIYLYGANELQGVFYEATESR
EPFPSVKAFPESAEEVTESDRVLMFCSGTGTPEEQALAKELYEKGAGVVCVSPAAKESAG
IEQYCDVHIDSKLKMPLVPDEDGTRYGFPSLMTALYVYHALSFTLKEILQEYA
>PK3-2_01428 Sporulation initiation phosphotransferase F
MMNEKILIVDDQYGIRILLNEVFNKEGYQTFQAANGLQALDIVTKERPDLVLLDMKIPGM
DGIEILKRMKVIDENIRVIIMTAYGELDMIQESKELGALTHFAKPFDIDEIRDAVKKYLP
LKSN
>PK3-2_01429 putative fructose-bisphosphate aldolase
MPLVSMTEMLNTAKEKGYAVGQFNLNNLEFTQAILQAAEEEKSPVILGVSEGAGRYMGGF
KTVVAMVKALMEEYKVTVPVAIHLDHGSSFESCAKAIHAGFTSVMIDASHHPFEENVATT
AKVVELAHFHGVSVEAELGTVGGQEDDVIAEGVIYADPKECQELVERTGIDCLAPALGSV
HGPYKGEPNLGFKEMEEIGKTTGLPLVLHGGTGIPTDDIKKSISLGTAKINVNTENQISS
AKAVRDTLAAKPDEYDPRKYLGPAREAIKETVIGKMREFGSSNQA
>PK3-2_01430 Transaldolase
MLFFVDTANIDEIREANELGILAGVTTNPSLVAKEANVSFHDRLREITDVVKGSVSAEVI
SLKAEEMIEEGKELAKIASNITVKIPMTSDGLKAVRALTDLGIKTNVTLIFNANQALLAA
RAGATYVSPFLGRLDDIGHNGLDLISDVKQIFDIHGLDTQIIAASIRHPQHVTEAALRGA
HIGTMPLKVIHALTKHPLTDKGIEQFLADWNK
>PK3-2_01431 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 2
MEKLNIAGGDSLNGTVHISGAKNSAVALIPATILANSEVTIEGLPEISDIETLRDLLKEI
GGNVHFENGEMVVDPTSMISMPLPNGKVKKLRASYYLMGAMLGRFKQAVIGLPGGCHLGP
RPIDQHIKGFEALGAEVTNEQGAIYLRAERLRGARIYLDVVSVGATINIMLAAVLAEGKT
IIENAAKEPEIIDVATLLTSMGAKIKGAGTNVIRIDGVKELHGCKHTIIPDRIEAGTFMI
AGAAMGKEVIIDNVIPTHLESLTAKLREMGYHIETSDDQLLIVGGQKHLKPVDVKTLVYP
GFPTDLQQPMTALLTRAKGTSVVTDTIYSARFKHIDELRRMGANMKVEGRSAIITGPVEL
QGAKVKASDLRAGACLVVAGLMADGVTEITGLEHIDRGYSSLEKKLEGLGATIWRERMTD
EEIEQLQNS
>PK3-2_01432 Fructose-1,6-bisphosphatase class 2
MERSLSMELVRVTEAAALASARWMGRGKKDEADEAATSAMRDVFDTVPMKGTVVIGEGEM
DEAPMLYIGEKLGNGYGPRVDVAVDPLEGTNILASGGWNALTVIAVADHGTLLNAPDMYM
EKIAVGPEAVGCIDIEAPVIDNLKAVAKAKNKDVEDVVATILNRERHAKIISELREAGAR
IKLINDGDVAGAINTAFDHTGVDILFGSGGAPEGVLSAVALKALGGEIIGKLLPQSEEEI
IRCNNMGLDLSKVLRMEDLVKGDDAIFAATGVTDGELLKGVQFKGSVGTTESLVIRAKSG
TVRFVDGRHSLKKKPNLVIRP
>PK3-2_01433 Transcription termination factor Rho
MKDVSISSLENMKLKELYELARHYKISYYSKLTKKELIFAILKANAEQEDLLFMEGVLEI
IQSEGFGFLRPINYSPSSEDIYISASQIRRFDLRNGDKVSGKVRPPKENERYYGLLHVEA
VNGDDPESAKERVHFPALTPLYPDRQMVLETKPNFLSTRIMDMMAPVGFGQRGLIVAPPK
AGKTMLLKEIANSITANQPEAELIVLLIDERPEEVTDIERSVAGDVVSSTFDEVPENHIK
VAELVLERAMRLVEHKKDVIILMDSITRLARAYNLVIPPSGRTLSGGIDPAAFHRPKRFF
GAARNIEEGGSLTILATALVDTGSRMDDVIYEEFKGTGNMELHLDRSLAERRIFPAIDIR
RSGTRKEELLVPKEHLDRLWSIRKTMSDSPDFAEKFMRKMKKTKTNQEFFDILNQEWKQA
NLSSARR
>PK3-2_01434 50S ribosomal protein L31
MKAGIHPNFKKATVKCACGNEFETGSVKEEVRVEICSECHPFYTGRQKFASADGRVDRFN
KKYGLK
>PK3-2_01435 Thymidine kinase
MYIMKQSGWLELICGSMFSGKSEELIRRVKRATYAKQEVRVFKPVIDNRYSEDAVVSHNG
TSMTSYAISSAADIWDHISESTDVIAVDEVQFFDKDIVGVLSSLADKGYRVIAAGLDMDF
RGEPFGVVPDIMAIAESVTKLQAVCSVCGSPASRTQRLIDGKPASYDDPVIMVGASESYE
ARCRHHHEVPGKSKK
>PK3-2_01436 putative NAD-dependent malic enzyme 2
MNNIKKTKEGHLETTLRGKEVLSIPTLNKGVAFSVEERQELGLEGLLPPTVLSLDQQAQR
AYEQFQAQPDRLRQNVYLSDLANRNEVLFYKLLQNHLREMLPVVYTPTVGEAIQEYSHEY
RRPQGIYLSIDNIDGIEKAFENLHATAGDIDLIVATDSESILGIGDWGVGGINIAIGKLA
VYTAAAGIDPSRVIPVVLDVGTNNEKLLNDPLYIGNKHERVQGERYEAFIDAYVKAALKF
FPKALLHWEDLGNKNARNIMKKYNHEILTFNDDIQGTGAITLAGVLAAMKKTGASIKDQR
VVVFGAGSAGIGIADQIRDTMVLAGLSEEEANKRFYTIDYRGLLTEEIEGILDFQKPYLR
GADEVKDWKRDEKGQIPFDEVVRQAKPTILIGTSGVSGAFTEEIVKEMASHVDRPVIMPM
SNPTHLAEAVPEDLFKWTDGKVLIATGSPFDNVEYNGVSYEIGQSNNAFAFPGLGLGSIV
AEARIITPAMFAATADAIAEMVDFETPGAGLLPSIDKLQEVSIQVAIAVAEAAIKEGVAN
RQPEDVKQAVLDAMWTPEYKKVIAK
>PK3-2_01437 hypothetical protein
MSILDILILLAPIFFVIVLGWFAGHFGSYDAKSAKGVSTLVTKYALPAHFIAGILTTSRS
EFLSQVPLMVSLIIGIVGFYIIILLVCRFILKYDLTNSSVFSLNSAQPTFAFMGIPVLGS
LFGANEVAIPIAVTGIVVNAILDPLAIIIATVGESSKKNEEGGDSFWKMTGKSILHGLCE
PLAAAPLISMILVLVFNFTLPELGVKMLDQLGSTTSGVALFAVGVTVGIRKIKLSMPAIG
IALLKVAVQPALMFLIALAVGLPADQMTKAILLVAFPGSAVAAMIATRFEKQEEETATAF
VVSAILSLISLPIIIALTA
>PK3-2_01438 Chromosome-anchoring protein RacA
MNTNMVASELGVSAKTVQRWVKQLNLPAERNELGHYSFTAEDVKILKSVQKQISEGTAIQ
DIHVPQSAQKRTGFLVQKTSGDTERRIEQLEQKLDTLLQQKQDENELLARIGELERQLKQ
KADEGVSYQLLQHRRELDDILADLQSLTSQMKEFTAQPIPETAAASEKTKARKKPLMSLF
KFQT
>PK3-2_01439 hypothetical protein
MLKSIHHIAIICSDYEKSKAFYVHKLGLQVIQETYRAERGSYKLDLSLNGLYVIELFSFP
DPPARQTRPEAAGLRHLAFTVSSLDKAVQELHEKGIETEPIRTDPLTGKRFTFFFDPDQL
PLELYEQ
>PK3-2_01440 Peptide chain release factor 1
MLDRLKSIEERYEKLNELLSDPEVVNDPKKLREYSKEQSDIQETVDVYRQYRDASEQLAD
AKAMLEEKLDAEMRDMVKEEISELQKETETLSERLKVLLIPKDPNDDKNVIMEIRGAAGG
EEAALFAGNLYRMYSRYAELQGWKTEVMEANVTGTGGYKEIIFMITGSGAYSKLKYENGA
HRVQRVPETESGGRIHTSTATVACLPEAEEVEVDIHEKDIRVDTFASSGPGGQSVNTTMS
AVRLTHLPTGVVVSCQDEKSQIKNKEKAMKVLRARIYDKFQQEAQAEYDQTRKSAVGSGD
RSERIRTYNFPQNRVTDHRIGLTIQKLDQILEGKLDEVVEALIVEDQASRLQQSEG
>PK3-2_01441 Release factor glutamine methyltransferase
MKTIFEALKWASSYLTEAGREENAAELLLLYDTGMDRSKLLASLQKPIGEDELYRFKRHV
EMHKEGVPVQYIIGKEFFYGREFMVNDDVLIPRPETEEVVYHLLEKYRRVFSEDGKLEVV
DVGTGSGAIAVTLALENQNFSVSAVDISKEALQVASANAEKLGADVRFYQGDLLEPFIKA
GKKADIIVSNPPYISEEEMADLSEIVRFHEPLHALTDGGDGLKFYKRFMEDIPLAMEDKV
FVVFEIGWKQGAAVKELILKAFKDAEVEVLKDINGKDRTICAVIHKNK
>PK3-2_01442 hypothetical protein
MKKALTAGILLIAIESMVGTIFPEALSYETMFGVASLVLIGLAIITSGLVVSGSDQRANY
HSETKESRTARMKMAAAFFVAAIPSILCYLLTVLF
>PK3-2_01443 hypothetical protein
MKYNYTVLLSAFTMSVLYSIIYIHSFIIAALITMAFYFLFPYLIFALPLQFMMNKKPKRF
SPLYLLYYLVSAFIANAIIFGVLQPSGQSLLQNTAFYLFAVLTAFVYWIWDSVLLQKKEA
>PK3-2_01444 hypothetical protein
MKKTAIICIYIFLLLSGALVGLAKEETAQQSENQPVVIPDQAIRLRILANSDSDEDQQLK
RHIRDAVNKEITIWVKDITSIEEARRVIRSKLPEIKEIAKETMKEEGANQSISVDFDKIS
FPTKLYGNMVYPAGEYEAILITLGNGEGANWWCVLFPPLCFLDFSNGEAVKEQEDKEASK
KQTEKVLEDVTAKAEKAKKEEKEEKEDGTEVKFFLVEWISDLFS
>PK3-2_01445 hypothetical protein
MQKRGERMFYQLRMAREKDGDVLEEFLKQAKTNHEGVKEGFTQFLMLEDSEKNIAGCLGI
EKISCDQGLLRSLVISDKLHQGHIVTLFQSMELLCEKHQIKTVYLIANQHSSADFLAAMG
FEPAESVPEELFSSDHFCESRQTEGAVLMKKSSG
>PK3-2_01446 Threonylcarbamoyl-AMP synthase
MKTKRWFVDVTDELSTNDPQIAQAAALLRENEVVAFPTETVYGLGANAKNTDAVKKIYEA
KGRPSDNPLIVHIADISQLDGLTGSAPEKAKTLMKRFWPGALTLILPCKPGALSPRVTAG
LETVAIRMPDHPLALALIRESGLPIAAPSANLSGKPSPTKAEHVAYDLDGRIAGIMDGGP
TGIGVESTVLSCAGDIPVLLRPGGITKEQIEAEIGPILVDKGLSDQNEKPISPGMKYTHY
APTAPLAICEGSPERIQHLIQEYQQGGRRVGVLTTEENAGVYSADYVKSCGRRAQLETVA
AGLYDALRSFDEQKVDFIIAESFPDTGVGLAIMNRLMKAAGGRVIR
>PK3-2_01447 putative manganese efflux pump MntP
MSDLFIGELMTLSIMAFALGMDAFSVGLGMGMIKLRKKQIFYIGFIIGLFHVIMPLGGMA
AGNMLSGLLGVLAVYIGGSLLFVLGIQMLMASFKQSEERFMSPTGPGLLLFAVGVSLDSF
SVGLSLGIYGSHPLLTITLFGLFSMMLTWLGLLIGKQVQSWLGTYSEALGGIILIVFGLK
LLLPI
>PK3-2_01448 Protein-arginine-phosphatase
MNIIFVCTGNTCRSPMAEALFKSIAETEGLNVSVRSAGVFASPNGKATPHAVEALFEKHI
ALNHVSSPLTEEHMKSADLVLAMTHQHKQIIASQFGRYRDKVFTLKEYVTGSHGDVIDPF
GGSIDIYKQTRDELEELLRQLAKQLKKDGR
>PK3-2_01449 Putative sugar phosphate isomerase YwlF
MKVAIASDHGGVHIRNEIKELMDELQVEYIDMGCDCGSGSVDYPDYAFPVAEKVVSGEVD
RGILICGTGIGMSISANKVKGIRCALAHDTFSAKATREHNDTNILAMGERVIGPGLAREI
AKIWLTTEFTGGRHQTRIGKISDYEEKNL
>PK3-2_01450 hypothetical protein
MNEIKQTWSTMLSEFQEQAGLKQDQLFVLGCSTSEVAGSRIGTSGSVDIAKSIYSGLAEL
QEKTGIHLAFQCCEHLNRALVVEEETAKLFRLPTVSALPVPTAGGAMASYAFKQMKSPVL
GETIQADAGIDIGDTFIGMHLKPVAVPVRVSQNSLGAAHVTLARTRPKLIGGVRAVYGCE
>PK3-2_01451 Serine hydroxymethyltransferase
MKHLPAQDEQVFNAIKNERERQQTKIELIASENFVSEAVMEAQGSVLTNKYAEGYPGKRY
YGGCEHVDVVEDIARDRAKEIFGAEYVNVQPHSGAQANMAVYFTILEQGDTVLGMNLSHG
GHLTHGSPVNFSGVQYNFVEYGVDKETQYIDYDDVREKALAHKPKLIVAGASAYPRTIDF
KKFREIADEVGAYFMVDMAHIAGLVAAGLHPNPVPYADFVTTTTHKTLRGPRGGMILCRE
EFGKKIDKSIFPGIQGGPLMHVIAAKAVSFGEVLQDDFKTYAQNVISNAKRLAEALTKEG
VQLVSGGTDNHLILVDLRSLGLTGKVAEHVLDEIGITSNKNAIPYDPEKPFVTSGIRLGT
AAVTSRGFDGDALDEVGAIIALALKNHEDEGKLEEARQRVAALTDKFPLYKELDY
>PK3-2_01452 Uracil phosphoribosyltransferase
MGKVYVFDHPLIQHKLTYIRNENTGTKDFRELVDEVATLMAFEITRDLPLEEVDIKTPVQ
AAKSKVISGKKLGVVPILRAGLGMVDGILKLIPAAKVGHVGLYRDPETLKPVEYYVKLPS
DVEEREFIVVDPMLATGGSAVEAIHSLKKRGAKNIRFMCLVAAPEGVEELQKHHSDVDIY
IAALDEKLNEKGYIVPGLGDAGDRMFGTK
>PK3-2_01453 hypothetical protein
MDDPKLTFSRQRKYLLFILAVYVLGYGLTAYKTVFLGLILGTVFSLFNFLLLVRRMNAFD
RAVEKGKSIRSLGSAARWCNAILAAAIAYKNPEHFHMASTIIGLMTIYPVIMIDSFIQLK
RSSMEER
>PK3-2_01454 ATP synthase subunit a
MNHEYRTIEFLGLTFNLTNILMITVASVIVLLIAILTTRTLSIRPGKAQNFMEWVVDFVR
NIIGSTMDLKTGANFLALGVTLLMYIFVSNMLGLPFSITIGHELWWKSPTADPAITLTLA
VMVVALTHYYGVKMKGLKEYSKDYLRPVPFMLPMKIIEEFANTLTLGLRLYGNIFAGEIL
LGLLAGLATSHYSQSVALGLVGTIGAILPMLAWQAFSLFIGAIQAFIFTMLTMVYMSHKI
SHDH
>PK3-2_01455 ATP synthase subunit c
MNLIAAAIAIGLGALGAGIGNGLIVSRTVEGIARQPEAGKELRTLMFMGIALVEALPIIA
VVIAFLAFFG
>PK3-2_01456 ATP synthase subunit b
MSQLPLELGLSFNGGDILFQLLAMLILLALLKKYALGPLLNIMKQREDHIAGEITSAEEK
NKEAQQLIEEQRVLLKEARQESQTLIENAKKLGEKQKEEIIQAARAESERLKEAARTEIV
KEKEQAVSALREQVASLSVMIASKVIEKELDEQAQEKLIQDYLKEVGESR
>PK3-2_01457 ATP synthase subunit delta
MSGSAVSKRYASALFDIANESAQLNQVEEELTVVKQVFQNEKALNDVLNHPKVPAVKKKE
LIQNAFGSLSQSVLNTIFLLIDRHRAAIVPELADEFIKLANEARQIEDATVYSVKPLTEA
EILSLSQVFATKAGVASLRIRNEVQTDLIGGIKVRIGNRIFDGSVSGKLQRIERQLAGEN
R
>PK3-2_01458 ATP synthase subunit alpha
MSIKAEEISTLIKQQIQNYQSDIEVQDVGTVIQVGDGIARVHGLDNCMAGELVEFSNGVL
GMAQNLEESNVGIVILGPFSEIREGDEVKRTGRIMEVPVGEELIGRIVNPLGQPVDGLGP
ILTSKTRPIESNAPGVMDRKSVHEPLQTGIKAIDALIPIGRGQRELIIGDRQTGKTSVAI
DAILNQKDQDMICVYVAIGQKESTVRGVVETLRKHGALDYTIVVTASASQPAPLLYLAPY
AGVTMAEEFMYNGKHVLVVYDDLSKQAAAYRELSLLLRRPPGREAFPGDVFYLHSRLLER
AAKLSDAKGAGSITALPFVETQAGDISAYIPTNVISITDGQIFLQSDLFFSGVRPAINAG
LSVSRVGGSAQIKAMKKVSGTLRLDLASYRELEAFAQFGSDLDQATQAKLNRGARTVEVL
KQDLNKPLPVEKQVAILYALTKGHLDDIPVADIRRFEEEYYMYLDQNHKELLDGIAKTGN
LPADEDFKAAIEGFKRTFAPSN
>PK3-2_01459 ATP synthase gamma chain
MASLRDIKSRITSTKKTSQITKAMQMVSAAKLNRAENNAKSFVPYMDKIQEVVSNVGRVS
GNVKHPMLLSREVKKTAYLVITSDRGLAGAFNSSVLRSAYQAMQERHQSKDEYAVIVIGR
VGRDFFKKREIPIISELTGLGDEVTFTEIKDLARQTIQMFIDGAFDELHLVYNHFVSAIS
QDVTEKKLLPLSDLGSGGGKRTASYEFEPSEEEVLEVLLPQYAESLIFGALLDSKASEHA
ARMTAMKNATDNAKELIDSLSLSYNRARQAAITQEITEIVGGAAALE
>PK3-2_01460 ATP synthase subunit beta
MKKGRVSQVLGPVVDVRFEDGHLPEIYNAIKISQPASENEVGIELTLEVALHLGDDTVRT
IAMASTDGVQRGMEAVDTGAPISVPVGNVTLGRVFNVLGENIDLNEPLPADAKKDPIHRQ
APSFDQLSTEVEILETGIKVVDLLAPYIKGGKIGLFGGAGVGKTVLIQELINNIAQEHGG
ISVFAGVGERTREGNDLFYEMSDSGVINKTAMVFGQMNEPPGARMRVALTGLTMAEHFRD
EQGQDVLFFIDNIFRFTQAGSEVSALLGRMPSAVGYQPTLATEMGQLQERITSTNVGSVT
SIQAIYVPADDYTDPAPATTFAHLDATTNLERKLTEMGIYPAVDPLASTSRALAPEIVGE
EHYAVAREVQSTLQRYKELQDIIAILGMDELSDEDKLVVQRARRIQFFLSQNFHVAEQFT
GQKGSYVPVKETVQGFKEILAGKYDHLPEDAFRLVGRIEEVIEKAKEMGVEV
>PK3-2_01461 ATP synthase epsilon chain
MKTVKVNIVTPDGPVYDADIEMVSVRAESGDLGILPGHIPTVAPLKIGAVRLKKDGQTEL
VAVSGGFVEVRPDQVTILAQAAEAAEGIDKERAEAARQRAQERLNSQSDDTDIRRAELAL
QRALNRLDVAGK
>PK3-2_01462 hypothetical protein
MNHSFFQPEKQYGEDLPIFEQEWEAIAFYYDYRQSQIEELNELCQFYNISLTYTRESLEE
LENLYFQSIQELLLADWNLPIEEFEKMISVYLIDCVIAHHEDAEWVVKPYPYTDGAYTMG
FRRHRKSWHTMNTCDGLYLRQKEDQPLLSLFDSLVRS
>PK3-2_01463 hypothetical protein
MSVLGQQAAIGIVVHLIFIAVTWWALQAVNIDPLIKKGKVVQARLLMILLTIAIGTAVAN
FFLDYLNYSQQLPYLF
>PK3-2_01464 putative protein YwmB
MKKKQVRHAIIISVMLSFVIAVFHTIHASELTPLAQIAEGMERQDVSIDKWTLHAKQNMS
LTKKEFYQKVQRLKSEYRQYDWVIAQEDKIVKAIGTYTDKKNRTSFRLQLVTTLKKHNPT
SYLLYEQMSLETPNSWNDTYEQFERETLGIFQEKVVIFTCLNGHLDDNMNIVLQKKANQL
SNEFQARSVEHVVEPNFVSISAFTDEWEEYIITSRHKMNLQIALRSAGMGGKHTVTVGTP
IVTTEY
>PK3-2_01465 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1
MEKIIVRGGQKLNGTVKVEGAKNAVLPVIAASLLASEEKSVICDVPTLSDVYTINEVLRH
LGADVHFENNEVTVNASYALQTEAPFEYVRKMRASVLVMGPLLARTGHARVALPGGCAIG
SRPIDQHLKGFEAMGAEIKVGNGFIEAEVKGRLQGAKIYLDFPSVGATENLIMAAALAEG
TTTLENVAKEPEIVDLANYINGMGGKIRGAGTGTIKIEGVEKLHGVKHHIIPDRIEAGTF
MVAAAITEGNVLVKGAVPEHLTSLIAKMEEMGVTIKDEGEGLRVIGPKELKPIDIKTMPH
PGFPTDMQSQMMALLLRASGTSMITETVFENRFMHAEEFRRMNGDIKIEGRSVIINGPVQ
LQGAEVAATDLRAGAALILAGLVAEGHTRVTELKHLDRGYVDFHKKLAAIGADIERVNDE
SASEQENKEAVSDLNA
>PK3-2_01466 hypothetical protein
MKQFVITLSVLCALILLIPTLLVIPFQHNKQAGISAESGKTAVSTKPASKGAETLKASPV
SIPVYRTANQSVENIPLEEYVIGVVASEMPATFKPEALKAQALAARTFIVRLMVSNSAVE
APKGSLVDDTQMFQVYKSKAELKKQWGASYEAKLKKITDAVASTQGKILTYNNQPIEASF
FSTSNGYTENAEAYWTSAIPYLKSVKSAWDKKSPKYLATKTFTAAEFEQKLGVNLDGSAT
VGKITGETPGHQVATAVINGKTLKGRDIREKLGLNSADFEWKRTGDTITVTTKGFGHGVG
MSQYGANFMAEEGKTVDDIVKHYYQGTQISDADSFLNKYMAKK
>PK3-2_01467 hypothetical protein
MKKRFSLIMMTGLLFGLTSPAFAAEKKESEAEAPANVAVLLDASGSMAKRIDGVSKFNSA
KKEISKFAGSLPEGTQVKMSVFGSEGNNKNSGKVQSCEAIRNVYGFQSFNEQSFLNSLNT
IGPTGWTPIAKALNEAKSSFDQLDTKGEKVVYLLTDGEETCGGNPIQTAKELRKDNITVN
VIGFDYKEGYKGQLNAIAKVGGGEYFPAYTQKDVEKIFTQQSLMLSK
>PK3-2_01468 hypothetical protein
MKKLLAAGIIGLLTASFASPSFAAEKQADTNVAVLFDGSGSMVQKTGGERKIDIAKKSVK
SFAELLPEDTNLMLRVFGHTGNNKLSGKALSCSTTETIYALHPYEGSLFDNSLSEIKPTG
WTPIAKALSDTRKEFEAFDADGKNVVYLITDGEETCGGDPAAEIEKLRESNVDTIVNIIG
FNFDVKGNEEMKQAAVAGGGEYISANSADEFEQAWEKEAQKFTE
>PK3-2_01469 hypothetical protein
MKLLGMIFLIAAVAFILLGVFLKLAAFFFVSMLTLIAAIVLFTILKKNQHNQT
>PK3-2_01471 Sulfur carrier protein FdhD
MNDKVTAVRDVWRYEQGEISKIEDRMVTEYPLTVILNGSEFVTLVCTPEHIKELVIGFLA
SEGVIRFQKEIKRFTIDESLGFVYVDLVHPETLDQKEYTKRVIGSCCGKGRHFYFQQDVK
TAKTAVSQIKISPEACMALMKDMQQRSETFQDTGGVHNAALCDTEKLLLMRTDIGRHNAL
DKLYGHCLLNGMSVRDKLIVFSGRISSEVLLKAAKIGVSIVISKSAPTELAVQMAEELNI
TAIGFVRNGSFNVYTHPERIGE
>PK3-2_01472 GTP 3',8-cyclase
MITESRQMLDKRNRPLRDLRISVTDRCNFRCTYCMPAELFGPDYPFLKKEELLSFEELER
LATLFVTRFGVEKIRLTGGEPLMRKDMPELIKKLVRIPGVRDIAMTTNGSLLPVYAERLK
EAGLKRVTISLDSLEDERFKKINGRGVSVSKVLEGVEAAKRAGLGVKINMVVQKGLNEKD
ILPMARYFKEKGHILRFIEFMDVGNTNQWEKKDVMTKAEIIDLINEHMPVEPVAPNYKGE
VASRFRYLDGSGEIGVISSVSDAFCGSCNRARLSARGELFTCLFASSGFDLRGPVRQELS
DDELSEMIGTVWKNRIDQYSVDRTLSKATDKKKVEMSYIGG
>PK3-2_01473 hypothetical protein
MGTRVSYPVEVKQKAVEMRLAGVPMKEIMQKLNIKNKTQVQTWVRWHKAGETHRFEQPVG
KQYTYGKGPEYSSELEKLQAEIRYLRQQNEVLKKYNELERKLIAKRQSNL
>PK3-2_01474 IS3 family transposase ISBsu1
MKDHPKRHLEKQIGTLCREHKYRYGYRKITAILKKRMCINHKTVQRIMQKNQWQCQVKVK
KRKKNGQPYAVVDNILDRNFQSDRPLEKLVTDITYLPYGQKQLYLSSILDLYNGEVIAFT
IGDKQDTDFVLDTLNQLPMLSENCVLHSDQGSVYTSYEYQKAVNTKGITMSMSRKGTPAD
NASIESFHSSLKSETFYLNSIDRTTTAIVERTVIEYIHYYNNIRIQTKLNNQSPINYRQL
AV
>PK3-2_01476 Response regulator aspartate phosphatase A
MAAYEIPSSQVGVKINKWYKHILAFQVADAVKLKEEIDQDIDRMEEDQLLLLYYQLISYR
HQIMLDYVKPDLYEESQLQYRELIQTLESNQDSISGLSEYYFHLFRGMYEFEQNNYISAI
SFYRKAEKMLAFVEDEIERAEFHFKVAEVFYIMKQTHFSMNHAVQALETYKAHDFYRVRR
IQTHFVISGNYIDYRNYEKALEHLDDAYRLALLEGQPRLIGSALYNMGNCYDDKGELDQA
AEYFEKALPVFEGHQLEQLPKALFSLTRVLFKKEDVQAALRYYEKGVAIAQKRNDIFSLE
KYKFLQALYVESVHLDMIQEVFDYMEEKALYVYIEEFALDAAAYFSHREQYKEAVYFYEK
AVSMREMIQRNDCLYQV
>PK3-2_01477 hypothetical protein
MFGFNDMVKFLWSFLIVLPLVQIIHVSGHSFMAFIFGGKGSLDIGMGKTLLKIGPIRFRT
IYFIDSFCRYGELKIDNRFSNALVYAGGCLFNLITIFAINLLIIHSVLKPNVFFYQFVYF
STYYVFFALLPVRYSEKKSSDGLAIYKVLRYGERYEIDK
>PK3-2_01478 Stress response protein CsbD
MGNDSLKDKMKGGLNKAKGEAKDKVGDMTDKADMQAEGKKDKAKGEIQKDIGEAKDKFTD
KD
>PK3-2_01479 hypothetical protein
MFLAFFDVTKYNKKSIGLVKVSKFLKYSLN
>PK3-2_01480 Aliphatic amidase expression-regulating protein
MKNKGVGIQAVFLLFLIMVLTTGCTAPKKVSEASGGAKKTVDVDTSGDSVKVGILHSLSG
TMAISEMSVHDAELMAIQEINQKGGVLGKKLEPIVEDGASDWPTYAEKMRKLLQQDKAAA
VFGGWTSASRKAMLPVVEQNNGLLFYPVQYEGMESSPHIFYTGATTNQQIVPAVDWLLKN
KGKKFFLIGSDYVFPRTANKIIKAQVKAAGGEIAGEEYTPLGHTNYSTLVSKIKEKQPDV
IFNTLNGDSNVAFFKQLKDAGISADDIPVMSASVAEEEIRGIGPDVLKGHYAVWNYFQTT
NTNENQTFVKNYKKMNGDSRVTSDPIEAGYNAVYLWAAAVEKAKSFDADKVKKAADGIVF
KAPGGTVKIDGDTQHLYKTVRIGQIAGDGQFKEVWNSGDPVKPDPYLKTYGWAKGLSK
>PK3-2_01481 High-affinity branched-chain amino acid transport system permease protein LivH
MSAVVTQLFNGISLGSILILIAIGLAVTFGLMNIINMAHGELIMSGAYTTYVVQQLFLSY
LPASLFSYYFLIAIIMAFAVAALIGIVIEKVIVRRLYDRPLDSLLATWGVSLILQQAARS
IFGAQNVAVKSPEWLTGGVTLFSVTFPYKRLFILALVLFALALLGFYLFKTSAGRRMQAV
TLNRSMAACLGVSVRKTDTLAFALGSGLAGIAGSSLTLLGSIGPTLGSSYLVDAFMIVIL
GGIGKLKGTIIGAVTVGLLSTFVEYSTSATIAKVVVFAFIILFLQWRPSGLASVRTRLLD
>PK3-2_01482 hypothetical protein
MKRFSQFSPYLVMFALFIAAPFFLQEFRLGLLAKFLCFAIVAVGICLIWGYTGILSLGHG
VFFGLGAYCMAMYLKIEASPTGIPDFMEWNGASELPWIWAIFRNPFAAIAAAVIVPVFLA
FLLGYFTFRNNIKGVYFSLISQAVVVVVVTLFIGSQDITSGTNGLTNFYTIFQYALADPA
MKQILYFTTVFFLGVSVVSGLFLTRSRFGRLLQAVRDGENRVRFFGYHSTVFKVFIYCVS
AAMAGIAGMLFVLQDGMISPEMMGIIPSVEMVLWVAIGGRHSIFGAVLGVLLTNGMKSYL
SEYYPDIWLYFLGVLFIIVVLYMPKGIVGLFEKLKTQLSSSKKKGAAAYETDTYLP
>PK3-2_01483 Autoinducer 2 import ATP-binding protein LsrA
MKPILTCRDVKVEFDGFWALQGADITVQERDIHFLIGPNGAGKTTLLDIICGKTKPHSGE
VLFQTNELTKAREYQIAKLGIARKFQAPSVFTQLTVFENLELAMKQKKTILSLLTARMTK
QQSDRIMGILRLVGLDEKRDLTAGGLSHGQKQWLEIGMQLAMEPKLLLLDEPIAGMTGKE
REKTGALLEEIAKTCSVLIVEHDMDFVRSFSRKVTVMHEGKVLCEGSMNDITSNEEVAAV
YLGRSGVS
>PK3-2_01484 High-affinity branched-chain amino acid transport ATP-binding protein LivF
MIAVSNVTSGYDQSMVLHSLSMEVRPGQIVAVLGRNGVGKSTLLKTIMGLLPAKQGDICF
NQTFVQNEKAETRARAGIAYVPQGRDIFSTLTVRDNLLLGEEPLPKKSRTGQIKKEIFQW
FPVLKEMLDRKGGDLSGGQQQQLAIARALMGDPKIILLDEPMEGIQPSIIELIRQVIAEI
SRKKEISVILVEHSLENALTCADYLYVIDRGTVVDHGKADEETARRFERHLTV
>PK3-2_01485 Urease subunit gamma
MKLTPVEQEKLLIFSAGELAKQRKARGVLLNYPEAAAYLTCFIMEGARDGKGVAELMEAG
RHVLTEKDVMEGVSEMLDSIQVEATFPDGVKLVTVHQPISAEVKS
>PK3-2_01486 Urease subunit beta
MKPGAFQIAEGTITINEGRDIREIAVKNTGSRSIQVGSHFHFAEANGALTFDREQAIGMR
LDVPSGTSVRFEPGEQKTVTLVEIGGRKTIRGLNGMADTFIDERGKEKTLANLHQAGWME
GVIR
>PK3-2_01487 Urease subunit alpha
MKMSREQYAELFGPTTGDKIRLGDTNLWIEVEKDFTVYGEEMIFGGGKTIRDGMGQNGRI
TGKDGALDLVITNVVLLDYTGIVKADVGVKDGRIVGVGKSGNPDIMDGVDPHMVIGAGTE
VISGEGKILTAGGVDTHIHFICPQQMEVALSSGVTTLLGGGTGPATGSKATTCTSGAWYM
ARMLEAAEEFPINVGFLGKGNASDKAPLIEQVEAGAIGLKLHEDWGTTPSAIKTCMEVVD
DADIQVAIHTDTINEAGFLENTLDAIGDRVIHTYHIEGAGGGHAPDIMKLASYANILPSS
TTPTIPYTVNTMDEHLDMMMVCHHLDAKVPEDVAFSHSRIRAATIAAEDILHDIGAISMT
SSDSQAMGRVGEVIIRTWQVADKMKKQRGALAGENGNDNVRAKRYVAKYTINPAITHGLS
HEVGSVEKGKLADLVLWDPVFFGVKPELVLKGGMIARAQMGDPNASIPTPEPVFMRRMYA
SYGKANRSTSITFMSQASIERGVTESLGLEKRISPVKNIRKLSKLDMKLNSALPKIEVDP
KTYQVFADGEELSCQPVDYVPLGQRYFLF
>PK3-2_01489 Putative HTH-type transcriptional regulator YwnA
MINSRLAVAIHILSLISMDEKASSEIIADSVNTNPVVVRRMISLLKKADILTSRAGVPGA
SLKKDPADISLLEVYRAVQKQEELFAVHENPNPKCPVGKKIQNALDDAFESVQKAMENEL
ASKSLKDVMNHLF
>PK3-2_01490 hypothetical protein
MKIGIIGASGKAGKEILKEAKTRGHEVTAIVRNASKVQEQDMAILEKDVFELTAEDIKAF
DAVVNAFGAAPGQEHLHVEAGRALISILKDAKNTRLLVVGGAGSLFVDEAKTIRLMDTPE
FPKEYLPTASNQGENLKDLQQTDSISWTFLSPAAFFDPAGKRTGSYQTGKDNVIVNAKGA
SYISYADYAIAVLDELEQPAHKNERFTVVSEAE
>PK3-2_01491 hypothetical protein
MNPETMNKTLISISKWGKATGILFIIMGAFAALSGAFFFLIGAVPGVLQIIAGIFLMRSA
KEAGQMAEHNSGQSEDLMLENYAKFVKMQGIYLIVSIAVSILAIIAFFIFLMLGIADGLF
SDYNTYSTY
>PK3-2_01492 HTH-type transcriptional activator mta
MKYQVKQVSEMAGVSIRTLHHYDDIQLLKPSAITDAGYRLYSDADLERLQQILFFKEIGF
RLDEVKEMLDHPNFDRKAALQSQKDMLMKKKQRMEEMIQTIDRTLQSIEGGELMNKRDLF
AGLSMKDIEEHQKAYADEVRKLYGREIAEQTEKRASAYSSDDWRAIMAEFDSIYRRIAAR
IEHGPGDVEVQAAVGAFRDHICQYHYDCTLDIFRGLGEVYITDERFTDSINQYGEGLAAF
LREAIIIYCDHQKKPLP
>PK3-2_01493 Major cardiolipin synthase ClsA
MAIFLINMNERGYKVSISSILLSLFFILNILLAIIVIFKERRDASASWAWLLVLFFIPVL
GFILYLLFGHNLRRKHLFQWEDRKKIGIERLLKHQLEDLETKQFQFNNRATFDNKDLIYM
LIMNNHAVFTEDNSVDVITDGRDKFQRLLNDISKAKDHIHLQYYIYKGDELGKKLRDALI
QKAKEGVQVRVLYDELGSRTLRKKFFKELREAGGHVEVFFPSKLRPINLRLNYRNHRKLV
IIDGMTGYVGGFNVGDEYLGLNPKFGYWRDTHIRLQGTAVHAIQTRFILDWNQASHHHTL
TYIPNHFPDYGPKGNVGMQIVTSGPDSEWEQIKNGYIKMISNAKRSILIQTPYFIPDASL
LDALRIACLSGVDVNIMIPNKPDHAFVYWATLSYIGDLLKAGATVYIYDNGFIHAKTIVV
DDEIASVGTANIDVRSFRLNFEVNAFIYDITIAKKLVSTFKEDLLVSRKYTYEEYLQRPL
WIRIKESVSRLLSPIL
>PK3-2_01494 hypothetical protein
MNFYRVEQMPGFIKKEMQKIQKAVQPFMKKTVIYRFLAIPLAAFSLFNLAAFLFHASADR
ESLISAGIFALLAALGLAFFKEAGYQHKQVQKTVHIYMLNRIKKSEILSEERKDSYTRQI
KEEPFAMRSFVEFLTEEDRRKKMY
>PK3-2_01495 hypothetical protein
MISLDKDENEIENLNEENSPAEEEIAPAENESHQLSASAVKSLSDIAKWGKISGILLIIT
GSLVTLSVLMTVIGAIPGVLLIISGVFLMRSAKAAAEAEGNLSGSAGESMLENYGKFIKM
QLFYAASSIVTGLIGIIIAVFMLVIIGIAAFENTDSYDDPDSYYYEDDPVFE
>PK3-2_01496 Putative phosphinothricin acetyltransferase YwnH
MNMTLRLAENKDLEAVVAIYNSTIASRMVTADTEPVTTEDRMEWFLGHTEARPLYVAEDE
SGNVAAWISFETFYGRPAYNKTAEVSIYIDEACRGKGVGSYLLQEALRIAPELGIRSLMA
FIFGHNKPSLKLFEKHGFAEWGLFPGIAEMDGERYDLKILGRELS
>PK3-2_01497 Stage II sporulation protein Q
MREEEKKTSQVKKLQQFFRKRWVFPAIYLVSAAVILTAVLWYQSVSNDDVKDQLADNGGN
SAYDNNDDAVEVGKSMENVAMPVVDSENVSVVKKFYETDAAKEEKEAALVTYNNTYSLSK
GIDLAEKDGKDFDVSASLSGTVVKAEKDPVLGYVVEVEHADGLSTVYQSLSEVSVEQGDK
VKQNQVIGKSGKNLYSEDSGNHVHFEIRKDGVAMNPLNFMDKPVSSIEKAAAAEQKAATE
ETEESIQQSSEKKDGSTEKGTEEKSGEKKDDSTDKSGSKESSTTEDTEQS
>PK3-2_01498 putative membrane protein YwnJ
MNRLLLAGWTLFILLSVCTESFSGMVVSQTVAFHFQPHPDLSRFLDMDFTELAIPEALIQ
KIGHAFSFFVLTYLLWKQRGSVKSAAAGSFAFAFFTEVLQLFFSRNGCIRDVLIDTVGIV
LFCGLFVLAKRRKHEMYEKY
>PK3-2_01499 Undecaprenyl-diphosphatase BcrC
MNYEIFKAINGLSHHNSVLDSIMVFITEYAIIAYALILLALWVFGNTQSRKTVLYAGITG
IAGLVINFLITQVYFEPRPFVTHTVHTLIPHDADASFPSDHTTGALAISIAMLFRNRKIG
WPLVIFGLLTGFSRIWVGHHYPVDVLGSLVVAIIIGFLFFRFSDLLRPFVDLIVRIYEAI
INKLTKKPTDQNF
>PK3-2_01500 Nitrogen regulatory PII-like protein
MSGQMFKVEIVTRPANFEKLKQELGKIGVTSLTFSNVHGCGLQKAHTELYRGVKIESNVY
ERLKIEIVVSKVPVDQVTETAKRVLKTGSPGDGKIFVYEISNTINIRTGEEGPEAL
>PK3-2_01501 Ammonium transporter
MQMGDTVFMFFCALLVWLMTPGLALFYGGMVKSKNVLSTAMHSFSSIAIVSIVWVLFGYT
LAFAPGNSIIGGLEWAGLKGVGFEPGAYSDTIPHSLFMMFQMTFAVLTTAIISGAFAERM
RFGAFLLFSVLWASLVYTPVAHWVWGGGWIGQLGALDFAGGNVVHISSGVAGLVLAIVLG
KRKDGTVSSPHNLIYTFLGGALIWFGWFGFNVGSALTLDGVAMYAFINTNTAAAAGIAGW
ILVEWIISKKPTMLGAVSGAIAGLVAITPAAGFVTPFASIIIGIIGGAICFWGVFSLKKK
FGYDDALDAFGLHGIGGTWGGIATGLFATTSVNSAGADGLFYGDASLIWKQIVAIAATYV
FVFIVTFVIIKIVSLFLPLRATEEEESLGLDLTMHGEKAYQDSM
>PK3-2_01502 hypothetical protein
MENAVFIDIRLYIYKRSYPYEQKRELTITRMFYTVLGVLTQIIH
>PK3-2_01503 hypothetical protein
MNKGGRLRRAVSKSIPATFRLFLAFNFFVYGLAKVVVGQFGEVTPEIEAAAGKGFTIAWA
FFGYSHVYELFIGFGEILAAVLLLIPRTSALGAVVFMPIIVNIVLINYCFHIGVQDLSTI
LMVMCLILIWVDRRKFMGIFRQEPLNGGQVMKR
>PK3-2_01504 Isochorismatase family protein YecD
MNTLNIDFQKTALVIIDLQKGIVPIDQSGQVVPNAKKLINEFRKHNGFISFVNVAFHDGA
DALKPQTDEPEQGGSGEMPADWAEFVPEIGVQDGDYTVTKRQWGAFFGTDLDLQLRRRGI
DTIVLCGIATNIGVESTAREAFQLGYQQIFITDAMSTFSEEEHEATLSFIFPRIGKSRTT
EEFLSQVK
>PK3-2_01505 Riboflavin transporter RibZ
MMISKKSRAVFLTAVGSGTMLNPLNSSMISLALHSIQHEFHLSFTTVSWLISSFYLASAV
AQPVTGKLGDLIGRKRLFLFGLILVAVSAIGAPFAPTFMTLLAMRLFQSVGSSAIYPSGV
GLIRNHIHERQASALAVLSIFASAMTALGPTVGGFLIVWGGWPAIFIVNLPFIILSFLLG
MYMFPKDQKKGTGIKTIIRQLDILGIVLFAGGIIFVLSFLLSFSTSPHTVEGVLGVLLLG
AFVWHELKTDKPFIDVRLFKTQRNLSAVYVQFILLNVFFYCLFFGLPSYFQDEMHLSVQT
SGLFMLFMSGMSIVVSPVTGKWIDRSGVVKPIFAGALLMTAGAVLLTIFFINVQTVGKGL
ILSLLGIGYGLGNVALQAAMLKTSPSNMVGTTSGLFQTCRYLGSILSSVILGILFGKEIT
AAHFDMMGIIMIITGGASLLMALRFAALMKTAS
>PK3-2_01506 putative allantoin permease
MKLKESQHQSNRLSNEDLLPLGQEKRTWKAMNFASIWMGCIHNIPTYATVGGLIAIGLSP
WQVLAIIITASLILFGALALNGHAGTKYGLPFPVIIRASYGIYGANVPALLRAFTAIMWL
GIQTFAGSTALNILLLNMWPGWGEIGGGWNILGIHLSGLLSFVFFWAIHLLVLHHGMESI
KRFEVWAGPLVYVVFGGMVWWAVDIAGGLGPIYSQPGKFHTFSETFWPFAAGVTGIIGIW
ATLILNIPDFTRFAKTQKEQIKGQFYGLPGTFALFAFASITVTSGSQVAFGEPIWDVVDI
LARFDNPYVIALSVITLCIATISVNVAANIVSPAYDIANALPKYINFKRGSFITALLALF
TVPWKLMESATSVYAFLGLIGGMLGPVAGVMMADYFIIRKRKLSVDDLYSETGRYVYFKG
YNYRAFAATMLGALISLIGMYVPALKSLYDISWFVGVLISFLFYIVLMRVHPPASSAIGT
FESGQVRQAE
>PK3-2_01507 hypothetical protein
MSKWYFILLAGVLTSVILAFVYDKTKANEEGSGDYLYVSPNGSDQNEGTKEKPFRTLAHA
SEEAGAGTTVMIREGTYHETLAVKHSGTDGKPVTFRNYENEKVVISGESVANAKYEIPLI
HIHDKHDIAISGLTIQDLSVSSEEATAMGIYVSGSSSHIAIKNNHVRNIETTADEGNAHG
IAVYGTGSMKDIQIEDNTIENLTLGASEAVVLNGNIDGFTIAGNVVRDNNNIGIDLIGYE
GTADKNDYVRNGVVENNTVYQNSTYGNPAYGDDYSAGGIYVDGGHSIEITKNTVHDNDIG
IEATSEHKGKYANAIQITDNKVYNNAYTGISIGGYDKKRGGTSNSLISGNIMYRNDTKGL
YGGQLLLQYDTKNNTIEKNILTAGDSRLFIGNDFTEIEGNTVNHNVYHKEPDQDGVWMWK
KNEYDSFASYRKATNNDSQSIYADPMYRDEDSYDFTLDPDSPARPVIE
>PK3-2_01508 putative MFS-type transporter YhhS
MVLLVNLFVFVFFYTFLTVLPIYTLQELGGTESQGGLLISLFLLSAIITRPFSGAIVERF
GKKRMAIVSMALFALSSFLYMPIHNFYLLLGLRFFQGIWFSILTTVTGAIAADIIPSKRR
GEGLGYFAMSMNLAMAIGPFLGLNLMKVVSFSVFFTAFALFMVAGLLVSFLIKVPQNQDS
GTTVFRFSFSDMFEKGALKIATVGLFISFCYSTVTAYLSVFAKSVDLSDISGYFFVCFAV
TMMIARPFTGKLFDKVGPGIVIYPSILIFSVGLCMLSFTHSGLMLLLSGAVIGLGYGSIV
PCMQTLAIQKSPAHRSGFATATFFTFFDSGIAVGSYVFGLFVASAGFSVIYLSAGLFVLI
ALLLYAWSQKKPAEAEGKVSIAE
>PK3-2_01509 putative HTH-type transcriptional regulator/GBAA_1941/BAS1801
MTYVNRHLIHQINQSARLIAKKANEQLEPFGLYSSQWSVLYCLRTIGPMTQKEIWSYLNV
EAPTVTRTIKRLEENGWVQRRQGEDKREKLVVLTKEAEKKYEEINVKMLKFEEELLADFR
DEDKKAFSHLFRMFLHQ
>PK3-2_01510 Stage III sporulation protein D
MHDYIKERTIKIGKYIVETKKTVRVIAKEFGVSKSTVHKDLTERLPEINPDLANEVKEIL
DYHKSIRHLRGGEATKLKYKKDEILEGEPVQQS
>PK3-2_01511 Cell shape-determining protein Mbl
MFARDIGIDLGTANVLIHVKGKGIVLNEPSVVALDKNSGKVLAVGEEARRMVGRTPGNIV
AIRPLKDGVIADFEVTEAMLKHFINKLNVKGLFSKPRMLICCPTNITSVEQKAIKEAAEK
SGGKHVYLEEEPKVAAIGAGMEIFQPSGNMVVDIGGGTTDIAVISMGDIVTSSSIKMAGD
KFDMEILNYIKREYKLLIGERTAEDIKIKVATVFPDARHEEISIRGRDMVSGLPRTITVN
SKEVEEALRESVAVIVQAAKQVLERTPPELSADIIDRGVIITGGGALLNGLDQLLAEELK
VPVLVAENPMDCVAIGTGVMLDNMDKLPKRKLS
>PK3-2_01512 Flagellar basal-body rod protein FlgF
MTTGKNAILEVGNLLKGLYTATSAMIAQQRRTEMLSNNIANANTSGYKADQGSMRAFPEM
LLSRIESKSPAGTSRTEIGSVNTGVYMQELKPLFTQGSLKSTDQPTDITLVENQVPVNTE
TNENAALFYPVQTADGIRYSKSSTFSLNENNQLTINGRPILSTDGQPITVDNENFTVSEN
GTVTTNGRPAGQIDVRMAEDVRNLKRDGNDLYSTADGNDLPSAAGNNQVSYSLKQGVSEL
SNVDVTSAYTEMTEAYRSFEANQKVIQAYDKSMDKAANEIGKI
>PK3-2_01513 Flagellar basal-body rod protein FlgG
MLRSMLTASTTLNQLQQQIDTISSNLSNSNTTGYKAKDTNFSELVRQQFDQVDEKNEEVA
KARKTPPGLRLGVGAMMNSRLVSDQGSVQKTDRDLDIAFTSPYQYLQVNINGNRQYTRDG
ALYLTPSANNANQLQLVTGNGYPVLDENGNTVNIDSSMKNITINKNGTLTASDGNAVQRF
NLGVVEVNNPQELKSEGNNLFSIDNAAAFEELNGANRQNIGMQQGSLEMSNVDISEQMTD
LITSQRSYQLNSRTITMGDQMLGLINSVR
>PK3-2_01514 Response regulator aspartate phosphatase F
MISKFIEKRMQNMLDEWYSAMSKRKMNHVCTLKEKIDQHHPKIKKNTKLWMRYQLFQARH
QLLFENQNGLDAMFNDLYVLEDKMDDELKYYLYFFSGLYEMVKTAPKHAVNHFKKAEQYL
AAIQNTFEAADLYYQTAGAYYLMKSPPLSIQYVKKALDIYLHQFGYIKKVITCKLLLAVN
YIDQERYEKAEQLFKEIIRKTQQLNDENLLCHAYYNLGFLKATEKKDQEALLYFKKVLKN
QEFETNSPVSYLHCVYESVRALFKTGKITEAKTVLQKGKELSEKVDIQTIYLKLKTLEAL
YTSVKDPYDQLLEYVLELEKIEAWVDLEVLLEDITEYYKKKDDFEKAAFFIMRG
>PK3-2_01515 3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ
MLDTQQIKEIIPHRYPFLLVDRITEVEEGKRAKGYKNVTANEEFFNGHFPQYPVMPGVLI
VEALAQVGAVAMLIKEENRGRLAFFAGIDNCRFKKQVKPGDQLHLEVEITRARGTIGRGK
GVATVDGEVVCEVELTFALGE
>PK3-2_01516 Large-conductance mechanosensitive channel
MKKGRWAGAHLPFFLSKHEKAGDCMWKEFKAFAMRGNIVDLAIGVVIGGAFGKIVTSLVN
DIIMPLVGLLLGGLDFSGLSFTFGDAVVKYGSFIQTIVNFLIVSFSIFIVIRTLNGLRRK
KEAEEEAAEEAPDAQEELLKEIRDLLKQQTKSPE
>PK3-2_01517 Sensor histidine kinase RcsC
MKEKFIFISIIFGYAAFFMIFIGIDHYSGSTLPAARHGAVNLENWDFQKDGNVPLNGKWT
LYPNQMLSPEEIHSSKGRNPIFVDVPSNVKVTKQGINVDYGTYKLMIRSKQDNQVFGIST
SFIYSANRIYFNGQNIGQSGIPSDKPDFTAQNRPYTSFFTLHKGENELVVQFSNFGKTPG
WGIAKPITFGTQEQILRENKISFLNDSIMITAFFITGLYFLGFFLQRKKDKHLLFFSVMC
LLFSFIILMIGKERIIFLLYPSISFSLLNSLSAISTVLVSIAVFLYLYFAYREIVSKRFI
RIATVSSALVLITDFLTVGFIGHSSYILHSVLAVSTLVYITYIFTIAAIRKLEGSVYLTI
ASISMSAFVILTTISAYSGKTAFSFNSIYSLPTVIALLAIVLLMAKQFAGAFRENEVLSW
KLLRIDRLKDEFIAKTSHEFKTPLNSIINICQTLLAGKGKRTIEEEKENMQLVIRMGYRL
SNLVNDILDLEKIKQGMLQIQPVPVDIYTIICSEMNFYNLLSRHKNLNMINHIPDDLPLV
LADENRFRQILTNLVDNAIKYTTEGQITLSASKLNDNMIKVTVTDTGSGISEADRQTIFE
SFQQTETNKDDGAGLGLSIVKQMVELQDGEIWVESEVGKGSAFHFTLPIAQNKSVSETKK
EFPKLQSVPNMLDISLVTPYYSEKIDAPTILIVDDNIDSLKILSEMLEGVPYNVIAAKNG
KEALEIVSCTKLDLIILDLMMPDMTGFEVCMKIRERFSMVDLPVLMVTAAIIGHDKYKAF
HAGANDILQKPYHYSEFMARIKNLIMMKHTANQATSMEMAFLQSQIKPHFLYNVLNTIIS
LTHLDIEKAREVTEEFTNYLRMSFDFQNTSAISSFRHELSIISSYLSIEKTRFGDRIEIL
FDIDKDIDFLLPPLMIQPLVENAVLHGVSKKRGGGWIKLTAKKQSGNEYYIKVEDNGAGM
SPEKRKDLLSSDFDHSVGLKNINQRLKHFCGSELMISSSPDVGTSVSMLIHLDETMESPP
ALSKRN
>PK3-2_01518 Protein-glutamate methylesterase/protein-glutamine glutaminase
MKALIVDDEHLALLHFKNMLERTNAFQSIMAYQDPIEVLEHPELPAADAVFLDIEMPGVN
GIELAEAIQSLNENIQVVFITAYNEFAIKAFELNAIDYLLKPVNYKRLETTVERIRTNNM
LRASAEHTEAHFSIQCFGNLQFHQTLKGVKTNIPVKWRTSKAREIYSFFLHNIGRAVSKD
RLIDLFWPDHDVTKASTQLYSTIYQIRKLFSQIPFSQTIEKTDAGYILRLSGAKVDVVEW
EKSLKEAPPLNTASLHLHMDLFMSYQNHYLMEHGYLWAEPEKTRLAQLWLGKAYELIDFL
IREVNDHQAMDICLQAEKIEPCDHKIMQYKLQLFNKNGKVEEAIKEYQRYKQIKDQMN
>PK3-2_01519 hypothetical protein
MRARSFPLGLKKSGRIIMIISLAIFFFFSQIASYTLTAQAVGVTPSDSQFFDSVTVKDAK
SQIVDGSKGNEPALKPGDDVTLTYEWSLKKDKKADSEQDINVEIPKNFTFDKGAEGEIKS
ADQVIGSYQVPAGSSTMKVKLTAASADSPDAKGTITLPAKFTADVKENEHTAAALFQLGG
GKTQQVIIPVKKDETTDGEAEEPKNDSSDTAGNQEGTDDKPAPSVSKEQKEEKQQPSDDT
KSGKSSNSDDSKKVSSSSQSAFKSLQTEEKQITQNILTGVTLTDENGEPYDKSNRASTDS
PVKISIDWAIPDGLGETINAGDKYEFDLPKEFIMHNDIVNLPLSAGDTTYGTFSIDTNGH
VVMTFNGEVKESSNVKGTLVIKTQFNEKKITGSTTQKIPFPVNSDTPETTVYFKPNVSKT
IDKSGALDKGINPGKVTWTVDVNKKLDQVKNAKLTESLPDGLIYRSVKVYELNVNIDGSV
SKGNEVSSGYNVDSKGNVTFDGTIDSAYRLVYETDIDNSAKPSEGGNVKLTNKAAFSGDN
LEPISAEATVAAKFGKMIAKSSTGYDGESQTFSWALSYNYGEKQIDQSKASITDSFGTGD
LHLVKDSLKVIPITFGQNGREQAGTPLKEGADYTLIDTGSGFEIKFNKTITSAYKITYQT
KVNSGVIIDKSTTYTNSVVTGTGDSKEASGIAIQQNLIKGYSNVDYEKKTVDWTITVNKN
KYSMNNWTLDDQFESGGLVLLDESFKLQDITNNKTLQKDKDYTLTKKPDHKGFTLALIGD
YAKTDSQFKITYTTTFNADYSNESVKNTAQSTWTDQNGNERTNKVSSGFTPNHQTSNNGF
KTGSYNAVSKEITWKIGVNYNGEPTKNPYIKDAITAPQQFVPDSVVVKSYTINKNGSITE
GDALDPSKYDVEEPSADNERTLTVHLKTGDSVPYLIAFKTSLKGQVIDQNQYTNKATYYN
DGYADRTLTGSVSVTNGGSLVFKGGKQNGSYIDWNINVNAGQSTLDDVKVTDTPDENQIL
DADSFKVYQAKYDENGVVKDSNGNLTAGDVELQKDKDYTLDIKTDNTTGEQSFVLTFIGS
YKQIDRAYVIKYRSLINIAGTSGHVKNKVSISGTNVKEQTQENSSSIFVAISSGDGSGSG
DKGSLTIFKTGADDKALEGADFQLWSEDAKQLLRTGTTDADGKLTFGNIRYGSYVLKEVK
APDGYTISDAYAKGVSVKIDSNSSKTGALYKVVNQQNKVTLIKQDEKNNPLASAVFKLEK
KSNDGTYTLIRTDIKSDQNGKVEMNGLPAGYYRLTETKAPAGFIVNTKAIHFSIAKNEKN
QVSDVNLGKMTNYQGKVSLTKENAEGQKLEGAVFNIVDQDGKIIQEKLTSDKDGKIEASG
LAPGRYAFVEIKAPAGYVLNTKKKEFTISELAAGKPEAADAGIAVNDKGSVELTKEDADG
KKLEGAVFKIIDREGNTVQEGLTSDKNGKVAASGLAPGRYAFVETKAPAGYVLNTEKIEF
EISDSSEGKLKATDAGIAVNHKGSVELTKENAEGQKLEGAVFNIVDEKGNTVQEELTSDK
DGKVKASGLAPGRYAFVETKAPNGYVLNTEKKEFTISESAAGKPESVDAGIIVNYQGSVQ
LTKENQDGKGLAGAVFKITDGNGKTVRDDLVSKEGGKIEVDGLAPGIYQFIEKKAPDGYL
LSEKPVSFAIKAEYGGKPEQVKVTAINTKNLVVLTKVDQHDQHKVLQGAEFNLTDANGKV
LKSGLVTDDKGQITVHGLKAGEYQFVETKAPKDYKLDQTPISFKITNTDTKTVEITAENI
LATGDVNVTKVDQDDKNTVLEGAEFKLLDESGKPVKTDGYGKELSELWKTDQNGQFAVKG
LAPGSYQLIETKAPEGYQLDETPIEFTIEKGQSKAVEIVVSNQKVKIPTPDKHDHSDKPT
PGGNGKDDGDHSKTNGTDGSSDGQSNTDKTLPKTGDTDSMLTAMIGILLLMAGGGLAVAS
RKKQRKG
>PK3-2_01520 hypothetical protein
MYKKMIITVFILCGLLLISSPYIKGGIIAYLSKSQSESALTVEQLKKNNGREAEFEFDSI
EPPELMDAVKAGFDHDQKAVIGRITIKSVDLELPIVKGTTNENLLIGAATMRPDQKMGEG
NYPLAGHHLKQKSLLFGPLENIKTGAQIVITDFKKDYIYSVTSKKVMSEMDADVIEETKE
KEITLITCDKAVETEGRLVVKGELVDSFGHTN
>PK3-2_01521 hypothetical protein
MRKEMKTFKLVDLNVERVDKEEKSIEQFPLIDGLIINKEDGENHWLIEALVAKEHLSFFE
QLQNSQTEAKVFVTITKKSNRPAQLTAAVKNIVKLEESIQVLLYGQMVTRKQQGTETILE
SLVKEGYTGTKLIEAFKQNI
>PK3-2_01522 putative protein YwpG
MNQFRLKEIYIDGTPSENCLIQKEVTYMLSRKEVFEVHLNKKGRISFLYETQDGMEQYKI
ELSMPEKKLSFQWFAWDGSSYVQMNTQNWLTKQIFFRFLKSTYIFKGKKQKMFLAEGKMK
TKDKNRG
>PK3-2_01523 Single-stranded DNA-binding protein B
MFNQVMLVGRLTKDPELRYTSAGAAVAHVTLAVNRSFKNASGEIEADYVNCTLWRKTAEN
TALYCQKGSLVGVSGRIQTRSYENTEGVNVYVTEVLADTVRFMDPKPREKAAD
>PK3-2_01524 HTH-type transcriptional repressor GlcR
MYQEERLVAILDFLKQHNRITTEQICTLLQVSRDTARRDLVKLEEQNAIIRTRGGAILPT
VHQKIQSYSGRLKTVSEEKNKIGKLAASLIHDGDRVILDASTTVQACAKHLTADDCTVIT
NSINLAEVLSDKEGIEIYLLGGKLEKEHRFLYGASVIEKLSSYHVDKALIGVVGISEHGI
TIAHEEDGMVKRKMIQQAKQVIALADHSKLGSTSFYQYAELSEIDLLITDRLPNQAFCDL
LDRNGVELLVTEQDEGKG
>PK3-2_01525 Phosphatase YwpJ
MKLIAIDLDGTLLNSKHQVSLENENALRQAQRDGIEVVVSTGRAYFDVESIFEPLGMKTW
VISANGAVIHDPDGRLYHQETIEKQRAYDILSWLESENYYYEVFTDSAIYTPQNGRELLE
IELDRFRSANPEADLSVLKQAAEVQYSQSGFAYIDSYQELFESDRPIDFYNILGFSFFKE
KLEAGWNRYEHDEDLTLVSSAEHNFELSARKASKGQALERLAARLNIPLEETAAVGDSLN
DKSMLESAGKGVAMGNAREDIKAMADAVTLTNDEHGVAHMIKNLL
>PK3-2_01526 RNA polymerase-associated protein RapA
MASLKEILIHVEQMEDGSFTLSAFDENEKPLPYSHMKKHLFQWHESSFYGTFLEDVSFIG
TTAVLLSPWMTVELLGKNSFNSFSSVQLTEETEPLIEAASTIYEFIADGDFLPDYEAWTN
GVFRWKDRDNLLEGFTADWFSAAVQDYIQYDDDLREKWELIKEKSPAVTTFRGHFLDEED
FLEGIGWIDDQSPFTVGLRLNEPDFDGDDWKIEMFLRDKKSGAVEFFDGLKSLKKSWQAH
SDKIAREQDRFHRTVPWLSFDSGTTLISEEEAWIFLSEASETLVDMGVEILLPSWWQIVR
ESNMMLKAKVSSSPRGESFVGMNALLDFNWRFATNGIELTEAEFNELVASNRRLVNIRGQ
WVKIDPQFIKQMKRLMEKAESEGLHMSDILARELMDQGEGGFEDADLIDTSAFAGIQFDL
SKQLRSLIRKLTAAENLPEHEVSPSFQGTLRPYQKYGMNWLLFLRESGFGACLADDMGLG
KTIQMIAYFLHVKECGRQKTPNLIIAPTSVLGNWQRELQTFAPELSVALHYGPRRPKGDD
FTAHYENADVVLTSYGLSHADSEELSSVTWSTICLDEAQNIKNAHTKQSRAIRKLKGHHH
IALSGTPMENRLTELWSIFDFMNKGYLGSLTGFHKRYVLPIEKDRDEKRIGQLQQLIRPF
LLRRTKRDKEVALNLPEKLEEKEFIPLSAEQASLYEQLVKDTFDHMTSLTGMQRKALILS
MLGRLKQICDHPALYLKEEQTELLAGRSVKLEKLLELMTAIRAQNESCLIFTQYIQMGNM
MKRLLEKTFGEPVQFLNGSLSKQERDSLVEKFQKKEYPTLILSLKAGGTGLNLTAANHVI
HYDRWWNPAVENQATDRAYRIGQERFVHVHKMITTGTIEEKIDVMLESKQTLNDQIIQSE
NWITELSTQELEELFTLSASAR
>PK3-2_01527 hypothetical protein
MLQNMISKDDVLASAEQLKELLPYNEENVQLIKKALILYRQDSVYRLQAVSPTEVTAYVQ
DVVPVRVTLNLFVIVKSGCSCPSGRICRHMLAVFLYVYAMFERVGTFTEYWLEREKLEES
KELVRRQFQEKVLPNEESLSSWLAFFDSEFSLWQARTPEGSQNMQGLYYGYLSALKKHTP
NKPELKSLYQIHSAIAVWLRMFTLIEAGKLNPEQDFYSLNPYVEQLMDTIYSSIDKLKTY
ALSFALDPFLEKTPDVIRHLLLKEDIFQYERIRIFGEIWSALLSRPKWVAREQEMLKKEA
GRRFSPELQFGRLHLEFLQKNDDVIFAEADQFPPEALPYTFQWLSEITAKKDWKRLKTWY
QRIEPIAMGYTKLDKPFKEIRDVIGELFLLLNAYVKQTNDQALFERYAAGCLPYTFTEYS
HHLYEKKRYAEWIEIHSLVGFSTSEMDKMMVKEIAASDPEALIPAYHREVAFFIDQKNRS
SYKEAARYLKKLRTLYRKAKKLKVWERYIQQLSSHYKRLRALQEELQKGKLIDGES
>PK3-2_01528 hypothetical protein
MSEKKLNQEEFLKILMHAHEIGERSSEMTTKEMLENLISHIKNGYAT
>PK3-2_01529 putative capsular polysaccharide biosynthesis protein YwqC
MGESTSLKEILSTLTKRMLLIMIVTAAATAAGGLISFFALTPIYENSTQILVNQSKNDQK
EVQFNDVQTNLQLINTYNVIIKSPAILDEVIKEMGLSMTSQELNDKISVSSEQDSQVVNI
SVKDENAETAAHIANTIASVFQDKITSIMNVDNVSILSKAEVSEHPSPVSPKPLLNIAIA
FAAGLAGSIGLAFLLEHLDNTIKSEEQLESLLDIPVLGTVSTIANEPKTAKSLHGMQSEK
AGSGHFGV
>PK3-2_01530 Tyrosine-protein kinase YwqD
MRRNVIAMTEPKSLNSEQYRTIRTNIEFASVDRKMQSVMITSACPGEGKSTTAANLAVVF
AQQGKKVLLIDADLRKPTVHTAFHLENMIGLTSVLLKKSSLKQAVQATNEKQLDVLTSGP
IPPNPAELLSSKWMKELTDEACAAYDMVIFDTPPILAVADAQILGSVADGSVLVISSGKT
EKEQAAKAKEALESCNSKLLGAIMNGKKLSKHSEYGYYGNKDNFIQNK
>PK3-2_01531 Tyrosine-protein phosphatase YwqE
MIDIHCHILPAMDDGASDFANSIEMARAAVRQGIRTIIATPHHKNGVYENEPGPVREAAD
QLNKRLIKENIPLTVLPGQEIRIYGDLERDLSEQQLLSLNDTKYILIEFPFDQVPRYAEQ
LFYDLQLKGYIPVIAHPERNREIRENPSLLYHLVEKGVASQITAGSLAGTFGKQLKAFSL
RLAEANLIHFVASDAHNLKTRNFHTQEALYVLEKEFGTDVPYMLTENAELLLQNQTIFRQ
PPQPVKRRKLFGLF
>PK3-2_01532 UDP-glucose 6-dehydrogenase YwqF
MNITVIGTGYVGLVTGVSLSEIGHHVTCIDIDAHKIDEMRKGISPIFEPGLEELMRKNTA
DGRLNFETSYEKGLAQADIIFIAVGTPQKSDGHANLAHITDAAKRIARHVKRDAIVVTKS
TVPVGTNDLIAGLITEHLAEPVSISVASNPEFLREGSAIYDTFHGDRIVIGTADQKTAKT
LEELFSPLQIPIYQTDIRSAEMIKYASNAFLATKISFINEISNICEKVGADIEAVAYGMG
QDKRIGSQFLKAGIGYGGSCFPKDTNALVQIAGNVEHDFELLKSVIKVNNNQQAMLVDKA
LNRLGGVTGKTVALLGLSFKPNTDDMREAPSIVIADRLAALDAHIRAYDPIAAGHAKHVL
PEAVEYKETIEEAVKGSDAVMILTDWPDIKQFSLAAYQNLMETPLIFDGRNCYTLDEASA
AGVEYYSVGRKAVVPPGSIQ
>PK3-2_01533 putative protein YwqG
MNHLPEKMRPYRDLLEKSAKEYVKLNVRKGKTGRYDSKIAGDPYFPKHETYPTDENGQPM
KLLAQINFSRIPQLDGYPSSGILQFYISVHDDVYGLNFDDRCVQKDFKVIYFENIIENED
ELVSDFSFIGTGECDFPILSEAAVEPVKSSEWVLPTDFQFEQYTGMETMEFFSQFGEDEE
DIYNELAEKGFGHKIGGYASFTQHDPREYAYKEHTIMLLQIDSDDDIDSMWGDVGIANFF
ITPDDLRKKDFSNVLYNWDCS
>PK3-2_01534 hypothetical protein
MGYESMLADIKSSLDGKISDVEDKIEKLKKAKKDIDTLQEEAITEIKEIVKPELGKHWTG
TKADDFDKGREEAKSEASKIVNDKYNDYMASIQFKIFTLEAEKFELNLTKSAANAAGDLL
AKGEEFVEEAGKQISKLKWW
>PK3-2_01535 hypothetical protein
MSEIKLKYDTVIKTLDSVKDALADVSIGVAGSNGKNKLDYTKKYHEREENIKTMLGDYKK
AVQKNIEDTKDNVDSLKEQDEAIAVK
>PK3-2_01536 Putative ribonuclease YwqJ
MSKVFESISLIEEAKSRKKQYETLEEQLNTLKKAFQEVADLGDNFKGKGADNIKDFFQGQ
AEIVESWLTLVSAQIAFLNGISGDIKDQELSDSYVETSFLDHELPNGDLKASEIVSAHKE
EIDSILSGISDIIDLDMYTLDDYADKMGDAQKIRRDTITAVDKLDESLTTEYQNLESLDN
AVLSKYSVLMQATSNGKNASPMYYDKKAFHSNEVYKSAIEVEKQGTTYIDAKTEQAEARR
LQEKAEEEANKPWYEKTWDGVCNFTGEVTGYYDYKRATEGVDPVTGEKLSAAERVTAGAM
AAAGFIPVVGWAGRAFKGGKAIYKTGKTVIAAEHALDAYKTGKSLDILKMSEMGAYGLVA
SNGFSEAVTGQDMFGNKVSEEKRKQGALEAITMIGGAGFAHYFDRLYQKNAPYVNKVGNE
SLSSNIAKTSEEKQTRLQYLRNKHGVLSKEDLHHRINLRAEVLNELSKIKSSGLTKKQRG
PAVAGVLDKKTGKYYFGINNIDGEPPKVLHPLIHDRIVNMPVELKEGYIKTSGAGSHAEV
NALNEALLQRPDAELKDLMVYVVSARKINKKMPEGVPMPRCPHCEYITQNTNYIPEALKY
GK
>PK3-2_01537 Putative antitoxin YwqK
MENEYDMKNIKEIGVDFEDLWFSSVSDEILDNPEDENGQPFTGLAYELYPNGQIIYFTKY
KNGLAHGLTCEFYKNGNKKSEKEYRYGQLHGKSIIWFENGRKKSEQQYEHSILICEKSWD
EEGNLLNQYELDTDSPHFEILESRRETHINLGRE
>PK3-2_01538 Endonuclease V
MKLFDVHNFDMKKEQDFLQLQFNLKNRINLSPTITLNSINTCAGVDLAYWEQNGEPYGVC
SIIVIDADTKEVIEKVQSMGKISVPYVSGFLAFRELPLIIEAAKKLETEPDVFLFDGNGY
LHYNHMGVATHAAFFLGKPTIGIAKTYLKIKGCDFEMPENEVGAYTDIIIGGEVYGRALR
TRRDVKPIFLSCGNHIDLESSYQITMSLINQESRLPIPVRLADLETHVLRTFYQKNHV
>PK3-2_01539 Chromate transport protein
MISIYLFMAFFIANVLGYGGGPASIPLMFEEVVNRYNWLSNDQFSNMLALANALPGPIAT
KIAAYVGYSAGGWPGFLIALIATVVPSALALIVLLRIIQRFRQSPVIKGMTLSVQPVIAV
MMLILTWQIGADGIKAIGWIQSIVIAGISLLAMTKFKMHPAFLIIAAFLYGGLVIPHL
>PK3-2_01540 hypothetical protein
MKNHPYRDMTAAMVRTGILGFGGGPSVIPLIRHEAVNKYKWIDDEEFGEILAIANALPGP
IATKMAAYLGFKLKGTLGAIVATLAHILPTCLAMVGLFAAVNVLSHSAIVAGMIGAVTPV
IAVMLGIMAYEFGQKALKGFGWVTGILFFIIAFIGLQTLQINPGLVIIIFLAYGAFHFKL
KDKITNKHSKDKGMSAS
>PK3-2_01541 hypothetical protein
MSHEYQIPNLVLDEIDKQILTILHEEGRISYTDLGKRVDLSRVAVQARINQLIEAGVIEK
FTAVINPAKIGIHVSVFFNVEVEPQFLEEVALKLEEEPAVTSLYHMTGPSKLHMHGIFAN
DQEMEEFLTKRLYPLRGVVSVDCQMLIKRYKSRMGMKL
>PK3-2_01542 Glutathione hydrolase-like YwrD proenzyme
MNKSVIGTKQMVVSPHYLASQAGNRILDKGGNAFDAAVAVSACLAVVYPHMTGLGGDSFW
LTFHQESNTVRVYNGSGRSGKNVTRDVYKGKSAIPLRGIGSAITVPGMVDSWDAVLKEYG
RMSLADVLEPARDYAQSGFPVSADQCRHTEKNLELLALTPYTADIFTRSGKAPVPGERFV
QKELAESLNMIAEKGRSAFYEGDIAQRIVSFLQHNGSCMTLDDFKAHRGEWTEPVSSDYR
GYSVYQAPPNSQGFTGLLTLNILENYDFTQIDHGSFEYYHVLVEALKKSFLDRNAVLTDP
EFADIPLERLLDKKYAKQLAEEIGYLAEPAESRPVGSDTAYAAVIDADGNAVSFIQSLYF
EFGSAVTAGDTGILLQNRGSFFSLDQDHVNTLEPRKRSFHTLMPAMACKDGKPKILYGTQ
GGEGQPQTQTAIITRMLDYGMHPQEAISEPRWVWGRTWGEEYEGLRVEGRFSEETIEKLK
DSGHLVEVVGDYDPLMGHAAAIKVDEEGFLQGGADPRGDGAAVGV
>PK3-2_01543 hypothetical protein
MTGTHFLIVILVILFINTAFYLYARKKLGIPKPPWWYKPVNSTQGLLEIVLLILLGFSLF
RFPPENMLILFLFLTNCLRTFMEWKYRREEKQYVHYLFGAALLLVIYVYICIFF
>PK3-2_01544 Flavoredoxin
MYIFQADQLSAKDTYKLLSGAVIPRPIAFVTTLSSNGAVNAAPFSFYNVVSSDPPLLSVS
VNRAEGRQKDTARNVVENGEFVVHVSDETIIEDINETAANLGPGESELTRTSLHPVESKS
VSVPGIKEARIRFECTLERHITFDNDQGVTTADLLIGRVVSFHIDEKVYDAEKGYVLTDE
LKPVSRLAGNHYAKLGEEFTLIRPS
>PK3-2_01545 Spore coat protein G
MGHYSHSDIKEAVKSAKNEGLKDYLYQEPHGKKRSHKKSHRSHKKSRSHKKSYCSHKKSR
SHKKSYCSHKKSRSHKKSRSHKKSYCSHKKSRSHKKSYRSHKKSRSYKKSYRSYKKSRSY
KKSYCSHKKKSRSYKKSYRTQKKSYCSHKKKSHKKHYKKPHHHCDDHKKHDDYHSKKEFW
KDGNCWVVKKKYK
>PK3-2_01546 Inner spore coat protein H
MKNQSNLPLYQLFVHPKDLRELKKDIWDDDPVPAVMKVNQKRLDIDIAYRGSHIRDFKKK
SYHLSFYQPKTFRGAREIHLNAEYKDPSMMRNKLSLDFFSELGTLSPKAEFVFLKVNGKN
EGVYLELESVDEFYLAKRKLADGAVFYAVDDDANFSLMSDLERETKTSLELGYEKKTGTE
EDDFYLQDMIFKINTVPKAQFKSEVTKHVDVDKYLRWLAGIVFTSNYDGFVHNYALYRSS
ETGLFEVIPWDYDATWGRDIHGERMAADYVRIQGFNTLTARILDEPDFRKSYKRLLEKTL
QSLFTIEYMKPKIMAMYERIRPFVLMDPYKKNDIERFDHEPDVICEYIIKRADYLKSELD
LLS
>PK3-2_01547 Hca operon transcriptional activator HcaR
MELRHLQYFIAVAEELHFGKAARRLNMTQPPLSQQIKQLEEEVGVTLLKRTKRLVELTAA
GEIFLNHCRSALMQIGQGIELAQRTARGEHGQLVIGFVGSATYEFLPPIIREYRKKFPSV
KIELKEIASYRQQEELLKGNIDIGILHPPLEHPELQIETTQSSPCILALPKQHPLALKES
INITDLENEPIITLSKEAWPTLYTDFIQLCEDAGFVPNIVQEATEYQMVIGLVTAGIGIT
IVPSSARRLFNLDVTYRSVDHFQLKAEWIIAYRKDSQNPVLRQFVDICKSLNEQK
>PK3-2_01548 Acetolactate synthase
MLTKATKEQKSLVKSRGAELVVDCLVEQGVTHVFGIPGAKIDAVFDALQDKGPEIIVARH
EQNAAFMAQAVGRLTGKPGVVLVTSGPGASNLATGLLTANTEGDPVVALAGNVIRADRLK
RTHQSLDNAALFQPITKYSVEVQDVKNIPEAVTNAFRIASAGQAGAAFVSFPQDVVNEVT
NTKNVRAVAAPKLGPAADDAISAAIAKIQTAKLPVVLVGMKGGRPEAIKAVRKLLKKVQL
PFVETYQAAGTLSRDLEDQYFGRIGLFRNQPGDLLLEQADVVLTIGYDPIEYDPKFWNVN
GDRTIIHLDEILADIDHAYQPELELIGDIPSTINHIEHDAVKVDFAEREQKILSDLKQYM
HEGEQVPADWKSDRVHPLEIVKELRNAVDDHVTVTCDIGSHAIWMSRYFRSYEPLTLMIS
NGMQTLGVALPWAIGASLVKPGEKVVSVSGDGGFLFSAMELETAVRLKAPIVHIVWNDST
YDMVAFQQLKKYNRTSAVDFGNIDIVKYAESFGATGLRVESPDQLADVLRQGMNAEGPVI
IDVPVDYSDNMNLASDKLPKEFGELMKTKAL
>PK3-2_01549 Alpha-acetolactate decarboxylase
MKRESNMQVLSRGQKDQPVSQIYQVSTMTSLLDGVYDGDFELSEIPKYGDFGIGTFNKLD
GELIGFDGEFYRLRSDGTATPVQNGDRSPFCSFTFFTPDITHKIDAKMTREEFENEINSI
LPSKNLFYAIRIDGLFKKVQTRTVELQEKPYVPMVEAVKTQPIFNFDNVRGTIVGFLTPA
YANGIAVSGYHLHFIDEGRNSGGHVFDYVLEDCTVTISRKMNMNLRLPNTADFFNANLDN
PDFAKDIETTEGSPE
>PK3-2_01550 General stress protein 14
MKILVLAVHPHMETSVVNKAWAEELSTYDNITVRELYKEYPDEAIDVAKEQQLCEQYDRI
VFQFPLYWYSSPPLLKKWQDLVLTYGWAFGSEGNALHGKELMLAVSTGSEAEKYQAGGGN
HYSISELLKPFQATSNLIGMKYLPPYVFYGVNGATEEDISLSAKRLAEYIQKPFA
>PK3-2_01551 hypothetical protein
MDQFEAAYESYKSRQTTDDQQTVPADKEEIIAVRRNEEDNIIAVKTSTGRELDYPTALSE
AKSGKLAHVDVFHKYGRDILRSEPDGIKENNLSELPDF
>PK3-2_01552 Cell wall-binding protein YwsB
MKKTTKVLSTLALAAGITAASAGGASTIHAQQPKTTVSIDDLYSYPIDSYLVSAEALNVR
TKASAASQKADTLHLGDSLKLISFTNADWAKVHYKNGKTGFVSTHYIVKAATTVKTKTKT
KVYRSAEGKSIKALPADTSVSFLGWSKTKKGGFDFDWVFVDYGGATGYMKTKDLYMTK
>PK3-2_01553 Ribose import binding protein RbsB
MKKAVSVILTLSLFLLTACSLEPPQWAKPSNSGHKKDFTIGLSVSTLNNPFFVSLKKGIE
KEAEKRGMKVIIVDAQNDSSKQTSDVEDLIQQGVDALLINPTDSSAISTAVESANAVGVP
VVTIDRSAEQGKVETLVASDNVKGGEMAAAFIADKLGKGAKVAELEGVPGASATRERGSG
FHNIADQKLNVVTKQSADFDRTKGLTVMENLLQGHPDIQAVFAHNDEMALGALEAINSSG
KDILVIGFDGNKDALASIKDGKLSATVAQQPELIGKLATEAADNILHGKKVKKSISAPLK
LETQK
>PK3-2_01554 Ribose import permease protein RbsC
MKTEHQPEQKRIHFDGVMQKLGPFLGLFILVIIVSILNPSFLEPLNILNLLRQVAINGLI
AFGMTFVILTGGIDLSVGAILALSSALVAGMIVSGVDPILAIILGCIIGAVLGMINGLLI
TKGKMAPFIATLATMTVFRGLTLVYTDGNPITGLGTNYAFQLFGRGYFLGIPVPAITMVL
AFAVLWVLLHKTPFGRRTYAIGGNEKAALISGIKVTRVKVMIYSLAGLLSALAGAILTSR
LHSAQPTAGESYELDAIAAVVLGGTSLSGGRGRIIGTLIGVLIIGTLNNGLNLLGVSSFY
QLVVKGIVILIAVLLDRKKSA
>PK3-2_01555 Ribose import ATP-binding protein RbsA
MQIEMKDIHKAFGKNQVLSGVSFQLVPGEVHALMGENGAGKSTLMNILTGLHKSDKGQII
INGNETYFSNPKEAEQHGIAFIHQELNIWPEMTVLENLFIGKEISSKLGVLQTRKMKALA
KEQLDKLSVSLSLDQEAGECSVGQQQMIEIAKALMTNAEVIIMDEPTAALTEREISKLFE
VITALKKNGVSIVYISHRMEEIFAICDRITIMRDGKTVDTTNIPDTDFDEVVKKMVGREL
TERYPKRTPSLGEKMFEVKNASVKGRFEDVSFYVRSGEIVGVSGLMGAGRTEIMRALFGV
DRLDSGEIWIAGKKTVIKNPQDAVKKGLGFITENRKDEGLLLDTSIRENIALPNLSSFSP
KGLIDHKREAEFVDLLIKRLTIKTASSETHARQLSGGNQQKVVIAKWIGIGPKVLILDEP
TRGVDVGAKREIYSLMNELTERGVAIIMVSSELPEILGMSDRVIVVHEGRISGEIQAQEA
TQERIMTLATGGR
>PK3-2_01556 D-ribose pyranase
MKKHGILNSHLAKLLADLGHTDKIVIADAGLPVPDGVLKIDLSLKPGLPAFQDTAAVLAD
EMVVEKVIAAAEIKTSNQENARFLETLFSKQKIEYLSHEKFKLLTKEAKAIIRTGEFTPY
ANCILQAGVLF
>PK3-2_01557 Bifunctional ribokinase/ribose-5-phosphate isomerase A
MRNICVIGSCSMDLVVTSDKRPKAGETVLGTSFQTVPGGKGANQAVAAARLGARVFMVGK
VGDDHYGTAILENLKANGVRTDYMEPVTHKESGTAHIVLAEGDNSIVFVKGANDDITPSY
AIDALEQIEKIDMALIQQEIPEETVDEVCRYCHSHDIPVMLNPAPARPLKQETIDHATYL
TPNEHEASILFPGLTVSEALALYPAKLFITEGEQGVRYSAGSKERLIPSFPVEPVDTTGA
GDTFNAAFAVALAEGKDIEAALRFANRAASLSVCSFGAQGGMPTRKEVEELLS
>PK3-2_01558 Catabolite control protein A
MATIKDVAGAAGVSVATVSRVLNDNGYVHEETRTRVIAAMEKLNYYPNEVARSLYKRESR
LIGLLLPDITNPFFPQLARGAEDELNREGYRLIFGNSDEELTKEREYLQTFKQNHVAGII
AATNYPDLEEYSGLHHPVVFLDRTHEGAPSVTSDGYTGGKLAAEAIIHGKSRRITLLRGP
VHLPTAQDRFHGALEVLKHAEVDFQVIETASFSFKDAQSMAKKLFATYPETDGVIASNDI
QAAAVLHEALRRGKNVPDDIQMIGYDDIPQSELLFPPLSIIKQPAYDMGKEAAKLLLRII
KKQPLTETAIQMPVTYIRRKTTRKEDHDA
>PK3-2_01559 Capsule biosynthesis protein CapB
MWLLIIACAVILVIGILEKRRHQKNIDALPVRVNINGIRGKSTVTRLTTGILIEAGYKTV
GKTTGTDARMIYWDTPEEKPIKRKPQGPNIGEQKEVMKETVERGANAIVSECMAVNPDYQ
IIFQEELLQANIGVIVNVLEDHMDVMGPTLDEIAEAFTATIPYNGHLVITDSEYTEFFKQ
KAKERNTKVIIADNSKITDEYLRKFEYMVFPDNASLALGVAQALGIDEETAFKGMLNAPP
DPGAMRILPLISPSEPGHFVNGFAANDASSTLNIWKRVKEIGYPTDDPIIIMNCRADRVD
RTQQFANDVLPYIEASELILIGETTEPIVKAYEEGKIPADKLHDLEYKSTEEIMELLKKR
MHNRVIYGVGNIHGAAEPLIEKIHEYKVKQLVS
>PK3-2_01560 Capsule biosynthesis protein CapC
MFGSDLYIALILGVLLSLIFAEKTGIVPAGLVVPGYLGLVFNQPVFILLVLLVSLLTYVI
VKYGLSKFMILYGRRKFAAMLITGIVLKIAFDFLYPIVPFEIAEFRGIGIIVPGLIANTI
QKQGLTITFGSTLLLSGATFAIMFVYYLI
>PK3-2_01561 Capsule biosynthesis protein CapA
MKKELSFHEKLLKLTKQQKKKTNKHVFIAIPIVFVLMFAFMWAGKAETPKVKTYSDDVLS
ASFVGDIMMGRYVEKVTDQKGTDSIFQYVEPIFRASDYVAGNFENPVTYQKNYKQADKKI
HLQTNKESVKVLKDMNFTVLNSANNHAMDYGVQGMKDTLGEFAKQNLDIVGAGYSLSDAK
KNISYQKVNGVTIATLGFTDVSGKGFAAKKNTPGVLPADPEIFIPMISEAKKHADIIVVQ
SHWGQEYDNDPNDRQRQLARAMSDAGADIIVGHHPHVLEPIEVYNGTVIFYSLGNFVFDQ
GWTRTRDSALVQYHLKKNGTGRFEVTPIDIHEATPAPVKKGSIKQKTIIRELTKDSNFAW
KVEDGKLTFDVDHSDKLKSK
>PK3-2_01562 hypothetical protein
MKFVKAIWPFVAVAIVFMFMSAFKFNDQLTDQEKQKIDTEMHKIQQQEEPANANK
>PK3-2_01563 Gamma-DL-glutamyl hydrolase
MNTLANWKKFLLVAVIISFWGSIITKAEIAEADMSSELIITEAKKLLGYQYKYGGETPKE
GFDPSGLIQYVFSKADIHLPRSVNDQYKVGTAVKPENLKPGDILFFKKEGSSGTTPTHDA
LYIGDGQMLHSTQSKGVIITNYKKSSYWNASYIGARRIAADPATADVPVVQEAEKYIGIP
YVFGGSTPSEGFDCSGLVQYVFQQALGIYLPRSAEQQWAVGEKVAPQNIKPGDVVYFSNT
YKTGISHAGIYAGGGRFIQASRSEKVTISYLSEDYWKSKMTGIRRFDNLTIPKENPIVSE
ATLYIGEVPYKKGGVSPETGFDTAGFVQYVYKKAAGISLPRYATSQYKAGTKVEKADLKP
GDIVFFQSTSLNPAIYIGNGQVVHVTLSNGVTITNMNTSTYWKDKYAGSIRVQ
>PK3-2_01564 5-amino-6-(5-phospho-D-ribitylamino)uracil phosphatase YwtE
MKCIAIDLDGTLLNKESVISAENRAAIKRAVDAGILVTICTGRATFDVKALLDDLDIPII
AANGGTIHDTGYRLISRTLMDQEAGKAIADYLLSKNIYFEVYTDDHLLSPFDGEAKLHAE
LDILKSANPNEKTDELWQGAMTQFKQFGIKPIPHIESVFDGSENIYKLLCFSFDMDKLKQ
AKEELKHHKKLAQTSSGKHIIEILPANSGKGHALTKLADIYGIDTQDIYAIGDSPNDLSM
FEVAGHRIAMENAIDELKEKSTFVTKSNDENGVAYFIDQLLSGQYA
>PK3-2_01565 Polyisoprenyl-teichoic acid--peptidoglycan teichoic acid transferase TagT
MEERTHRRKNKRRLRKWVKIVAGLMAFLVIAAGSVGAYAYVKLNNASKEAHVSLARGEQS
VKRIKEFDPGKDSFSVLLLGIDARQENGETVDQARSDANVLVTFNRKEKTAKLLSIPRDA
YVNIPGHGYDKFTHAHAYGGVDLTVKTVEEMLDIPVDYVVESNFTAFEDVVNELNGVKVT
VKSDKVIQQIKKDTKGKVVLQKGTHTLDGEEALAYVRTRKADSDLLRGQRQMEVLSAIID
KSKSLSSIPAYDDIVDTMGQNLKMNLSLKDAIGLFPFITSLKSVESIQLTGYDYEPAGVY
YFKLDQQKLQEVKEELQNDLGV
>PK3-2_01566 putative metabolite transport protein CsbC
MKKQSNLWLYFFGALGGALYGYDTGVISGAILFMKKDLGLNAFTEGLVVSSLLVGAIAGS
GAAGKLTDRFGRKKAIMAAALLFCIGGLGVAFAPNTGVMVLFRIILGLAVGTSTTIVPLY
LSELAPKHKRGALSSLNQLMITVGILLSYIVNYIFADAEAWRWMLGLAAVPSLLLLIGIL
FMPESPRWLFTNGEEGKAKKILEKLRGTKDIDQEIHDIQEAEKQNEGGLKELFDPWVRPA
LIAGLGLAFLQQFIGTNTIIYYAPKTFTNVGFGNSASILGTVGIGTVNVLMTLIAIKIID
KIGRKPLLLFGNAGMVISLIVLALVNLFFDNTPAASWTTVICLGVFIVVFAVSWGPVVWV
MLPELFPLHVRGIGTGVSTLMLHVGTLIVSLTYPILMEAIGISFLFLIYAAIGIMAFLFV
RFKVTETKGKSLEEIEQDLRDKNGQGGSAGKQQTVGT
>PK3-2_01567 Spore germination protein B3
MKIITKLAVMFLMLQVLCGCWDVRNIEKLSFARGLAIDETDDHQYKLTYQNLLPQSENSQ
TSGKPEFVNVTSHGKTILEAVSDVSIKDPPIYSDHLKVILLGEKLMRNQNIDQVFNHFIR
DDELRRSSYLMVARGKAADILTKGSPDQQQPMPSEKLIDLTTHSGYNGKIMMPLRIGRAS
VYSQNGYSYLIQAVKNQKGKAKYDGAGIVKRGSNKLVGFLSANETQTLTWVMGTIKGGVM
STTDKGHPITFEIKKSKTKIKPVIKNGKPVFHISVKTKGILTEDQNPKENSFSKTYLSRL
ENIFEKKLERDVKKVMDKLQHEYKTDPVFLSDHVRIQYPDYWNKVQGHWDELFSEADFTY
DISFKIINFGTVGK
>PK3-2_01568 Spore germination protein B2
MKKSEHKLTFMQTMIMISSTLIGAGVLTLPRSAAETDSPSGWLMILLQGVIFMIIALLFL
PFLQRNSGKTIFKLNSIVAGKFIGLLLNLFISLYFIGIVCYQARVLGEVVGFFQLKNTPM
SVVVFLFLAVAIYHVGGGVYPIAKVYAYIFPITLIIFMMLLMFSFRLFQLDFIRPVFEGG
YQSFFSLFPKTLLYFSGFEIIFYLVPFMRDPKQAKKAVALGIATSTVFYSITLFIVIGCM
TVAEAKTVTWPTISLIHALEVPGIFIERFDLFLQLTWTAQQFACMLGSFKGAHIGLTEIF
QLKNKNNAWLLTAMLAVTFFITLYPKDLNDVFYYGTLLGYAFLIVIAIPFFIWFLSWILK
KLGRDQLQ
>PK3-2_01569 Spore germination protein B1
MQIDSDLQNNLETLKKTLGQNDDMMFYTFAFGDSRQKACLLYIDGLTENKVLAQYVISPL
QREALAHKESTIEDLSAFFFGFHHSVVSTMKEIEQLIFTGHAVLLAEGYCGGLAFDTKSV
ETRSLEEPSSEIVERGPKIGFIEKLRTNTALLRERTGDPNLVIKEMILGKRTKKKIAVAY
IQDIAPDYVVKEVFKRLKSVEIDDLPESGTLEQLIEDEPFSIFPTILSTERPDRVESALL
EGRVSILVDGTPFALIVPVTVDEFIHSPDDYSQRWIAMSLIRMIRYSSILITIYLPGLYV
SLVSFHTGLLPTRMAISIAGSRLNVPFPPFVEAFFMIFTIELIREAGLRLPKPIGQTIGL
IGGVVIGQAAVQAQIVSALMVIVVSVTALASFTVPSYAYNFPLRVIRIAAMISAAALGMY
GVIMVYLFVIGHLMRLKSFGQDYIIPIMAQPGQDLKDTVIRIPTMFLKRRPTRNDPEDNI
RQR
>PK3-2_01570 Putative mannose-6-phosphate isomerase YvyI
MTQSPIFLTPVFKEKIWGGTALRDRFGYGIPSETTGECWAISAHPKGPSTAANGPFKGKT
LIELWEEHREVFGGVEGDQFPLLTKLLDVKENMSIKVHPDDYYAGENEEGELGKTECWYI
IDCKENAEIIYGHTARSKPNLSQ
>PK3-2_01571 Putative mannose-6-phosphate isomerase YvyI
MINSGDWEGLLRRIKIKPGDFYYVPSGTLHALCKGALVLETQQNSDATYRVYDYDRLDND
GSPRELHFAKAVNAATVPHVDGYIDESTESRKGITIKTFVQGEYFSVYKWDINGEAELSQ
DEFFLLCSVIEGSGLLMYEDETCQLKKGDHFILPAQMPDFTIKGTCTLIVSHI
>PK3-2_01572 Beta-N-acetylglucosaminidase
MKKRLIAPMLLSAASLAFFAITGSAQAAAYTDYSIYEVEPSKTFSSESQASQAVAKLEKD
TGWDASYQASGTTMAYQISAAGIQSEAEAKAILSGLTKQTAITGTSSPVGSKQPYVTITS
GAISGDKQANTILAKLKQETGVGGAVKASGTAQSYVNVTTPEIADETKVKALIQSLVKQT
GIKSTYQPITHTMSVTTIQSGTIVGDSKAEQIKNAFQKETGLKASLKETVKGQAFYTFTT
AAISGEVNAKNLVNQLKQSTGIAGSYKSINQKNTVESYNVQSAYFKGLNTVKDAISQIKK
NTGVSGSYQKVGKSNSYTVNMKGLTKQQLQKVDTFFKKKKWHYTPSSVKKRQRLQPIK
>PK3-2_01573 Beta-N-acetylglucosaminidase
MTTAKILGEQQANKAAAFFTQKKVKATKTAAGTSAENQYQLISEETSDQAKVTKGLNVLK
KNQLSASAKSVKKQIANTFKITTESLLDTVKVNQALTFFQSHHISAASQKTGQTAASSYK
IVTEAIISQEDIDRVLAFFKQNNAAGTTAKTGETAYTQYKIVTAQLSSKTTLNNGLTYLK
AQSLSPSYTTKSNTLYQISLNEQFTGNDAASAASAKLKQLYGWTSSIVKIKNGPQIMKTN
YNLSLRDMVQKQMTVSPQTDGAAYVSLTYINTATSTVTADVLNIRSTPAVSPTNVIDQFK
KGDKVKIIGQTNGWAKINLGWRNASSDEVVQYVNPNNFSRDSKYYFQFLKLSQTAGLNAA
EVNQKVLTGKGILTGKAKAFIDAANKYGINELYLISHALLETGNGTSDLANGLTYNGKTV
YNMYGIGAYDSNPNYYGAKYAYEQGWFTPEAAIIGGAKFIGSSYIHNTAYNQDTLYKMRW
SSTATHQYATDIGWAYKQVNRMYSLYSLLDGYTLYFDVPEYQ
>PK3-2_01574 Teichoic acid poly(ribitol-phosphate) polymerase
MKLARKIKNRLFRSKKKPKKENAAVIVHPADNRVFSLFDKTKRIEENQQVPVRKISEFSW
NGSILKIAGYMYIKGLPLQKEDQVRKRLLLVNNGVLFTAVSLRDVPVDQLSIDTSNVPGN
YKWAGFSQQINFSKLMNDKPLPQGEYKLFLEIEAVDDQNVKHQEVHTVGNVSKFLSNDVY
ATKMEFHSAKKLMKFNLIVNYDEGEKTINLSCNKLQEIDPSLLELDTGKEANRFLRKLNT
SVFHFAYDVFRLLPIKSNKIVFASDSRLDMTGNFEFVYEELLKREENFDFKFFLKSSIRD
RKSLSELLSMAYHFATSKIIFIDDFYPIIYPLKIRKNADLVQLWHAVGAFKTFGYSRIGL
PGGPSPHSKNHRNYTKVIVSSENIRKHYAEGFGVDIENVIATGVPRTDFFFDEAKKAFVK
ERLYTEYPFLKDKKVILFAPTFRGNGQQSAHYPFEVLDFDRLYRELKDEYIFLFKIHPFV
RNDANIPYQYSDFFYDFSSFREINELLLVTDILITDYSSVCFEYALLNKPMIFFSYDVDD
YIRKRDFYYDYFDFIPGPLAKTSDQMISIIKEEKYNFEQIDSFVHYFFDDLDGKASERVV
DQIVFPQEEEPLEDKVLNR
>PK3-2_01575 Teichoic acid ribitol-phosphate primase
MKTFLTRIVKGVFGTAYKLLSALLPVQHNKVVIASYREDHLSDNFKGVYEKLKQDPSLRI
TLLFRKMDKGLIGRAAYLLHLFSSLYHIATCRVLLLDDYYFPLYVVPKRKETIAIQLWHA
CGAFKKFGYSIVNKPFGPSSDYLKIVPVHSNYDYAVVSAPAAVPHFAEAFQMEQKQILPL
GIPRTDYFYQKEHIRSVLDEFHRAYPELKHKKKLLYAPTFRGSGHHQEGDATPLDLLQLK
SALNQKDYVVMLHLHPYMRKHAHTEEDDFVLDLTDSYSLYDLMAISDGLITDYSSVIFEY
SLLKRPMYFYCPDLEDYLEERDFYYPFESFVPGPISKDVASLAHDIKSDPEADAKRIEAF
SQTFITHQDGKSSERVADFISSFLTSGAD
>PK3-2_01576 Ribulose-5-phosphate reductase 1
MINQTYRLVSARQFEVTYKDKVVHSDKVVVRPTHLSICAADQRYYTGSRGKEAMDKKLPM
ALIHEGIGKVMFDPTGTFKVGTRVVMVPNTPVEEHEVIAENYLRSSRFRSSGYDGFMQDY
MFMAPDRLVELPDSINPYVAAFTELITIAVHALSRFERMAHNKRDTFGVWGDGNLGFIMT
LLLKKKYPDSKVFIFGKTPYKLDHFSFVDTAYQINDIPEDVRIDHAFECVGGRGSESAID
QIIAHVHPEACVALLGVSEYPVEIETRMVLEKGITLIGSSRSGREDFARTVDFLAQYPEV
VDYLETLVGGRFPVRSIEEITNAFEADLTSSWGKTVIEWEI
>PK3-2_01577 Ribitol-5-phosphate cytidylyltransferase
MIYAEILAGGKGSRMGNVNMPKQFLPLNKRPIIIHTVEKFLLNDRFDKILIVSPKEWINH
TKDILKKFIGHDDRLVVVEGGTDRNESIMSGIRYIEKEFGIQDDDVIITHDSVRPFLTHR
IIDENIDAVLQYGAVDTVISAIDTIIASEDQEFISDIPVRDNMYQGQTPQSFRISKLVEL
YNKLSDEQKAVLTDACKICSLAGEKVKLVRGEVFNIKVTTPYDLKVANAILQERISQ
>PK3-2_01578 Teichoic acid glycerol-phosphate primase
MKSWFAFFYYLFIKVIGTLLFWVKPGNQVALLVSFPDNARAILKEYQKGHYSFPIHVLLT
QHAKSLEKEFPELTVSVINEKHPLHICKAVFSMLSSKTVIVDNYFVLTTVLTGRPDIECI
QVWHANGAFKRFGLKDINTQNRSRSDVRRFRKVYASFDRIVVGSEHMAEIFKEFFDIKGD
KFLRFGVPLTDAYYEARENSNDLKNKYHLPAEKKIILYAPTFRDHQFESFSLPFLQKHLQ
HDLKGEYVLAVKLHPVMKQSAELPEESAWIKDVSDLPLADLLKMSDLLISDYSSVPFEFA
LLDKPILFYTYDMEAYDRTRGLIRDYTEVIPGVPCCDSGMLLNQLKDMNKLQSEVERFSR
EWNQYSRGNASRQLLSYINEKSS
>PK3-2_01579 N-acetylglucosaminyldiphosphoundecaprenol N-acetyl-beta-D-mannosaminyltransferase
MQTKPINQLDFVDSELTSFVSHLETSYLDQNKGAFIVTANPEIGFEAMQNPRYETVLSSA
DFILPDGIGVVMVSKLIGKPLQSRIAGYDLFTSLLDKADQKRKRVFFYGAAKHVIAQTIE
RVERDYPGIEIAGYSDGYVKDQREVADKIAASNPDMVFVALGYPNQEFFIHKYRHLFPQA
VAVGLGGSFDVFSGNVKRAPSFFIRFHLEWMYRLITNPARWRRMLSIPKYVAAVLKHERA
AAKPQYTGQVKDQSRHL
>PK3-2_01580 Glycerol-3-phosphate cytidylyltransferase
MKKVITYGTFDLFHYGHMKLLERAKNLGDYLIVGLSTDEFNLQKQKKSHHSYEHRKFILE
TIDFVNEVIPEKNWEQKISDIQKYDIDTFVIGDDWKGKFDFLKEYCEVIYLPRTEGISTT
QIKKDMASL
>PK3-2_01581 Teichoic acid poly(glycerol phosphate) polymerase
MKSFIFKKCRSLLVRAYSVLFKVFALLPRNNKLILFESYSGKQFSCNPRAIYEYLQENRD
QYDYKMIWSIDKRYISALDGVDAAYIKRFSLKWIWYMATAKYWITNSRLPLWIPKPKNTL
YVQTWHGTPLKKLANDMDEVHMPGTTTEKYKQNFLQEASKWDYLISPNAYSTEIFKRAFQ
FKKQILETGYPRNDILYSSNKESLIKKVKQELGIGEDKKIILYAPTWRDNEFKKVGQYKF
KLQFDLEKMKKELGDSVVILLRMHYLVSEKFNLGKYKEFVKDVSLYKDIRDLYLISDLLI
TDYSSVFFDYMNLKKPIVFFVYDLPAYRDSIRGFYFNFQQKTPGNLVQTSEELINTVKEL
LNNPHIDDNYEHFYNEFCQLEDGKASKRVIETIL
>PK3-2_01582 hypothetical protein
MFSIIMPIYNSENYLRDSIESVINQSIGFKDNIELILIDDGSVDSSPQICESFKNSYPNN
IKFLKIENSGPSAARNCGLLNVSERSKFIGFLDSDDTFSDNALRSVYDFFCDYEDVNIAV
LPVYYTGEKEGEHKLNSRFEKGTRVINILKDYKAIHFYIGGTFYRKHTINYTTLFDESIK
FWEDAIFFNQLLLREKSYGAVAEGKYFYRKRKEQNSLVDCSWFDKKGTHIC
>PK3-2_01583 hypothetical protein
MNVCYMTLLMDSIKKYDIVLPYFQFLIVYHIKLFLYPSYRDIYKSVLNYKEQKDFIDDFV
KILNFIEPQYIEEQDMPMYYKEFMFHLIEANAETLETIKKKKYYKVHVLLLRQK
>PK3-2_01584 hypothetical protein
MQENDGVYIKYFNRLKKCERKKMRKTIEVWGYKLRDFRYAGFVVEIPIWALAFDFVLKTS
NNTLELNHVNIFKSLLTKVLKN
>PK3-2_01585 hypothetical protein
MNEKSFNYDFSVIMPIYNVELYLTDAIESVINQTIGFENIQLILVNDDSPDKSEIICKEY
AQKYPNNIVYVKKQNGGVSSARNYGLNYAEGRYIQFLDPDDLVSEETFENVLNFFNQYKN
EIDIVAIPIFFEEGRTGEHNLNNKFSSTRILDVEKEPHHILTHCCSTFINKEALKNIRFD
ENCKIGEDAKLVNLIISQKKKYGLVKEAKYHYRVREDGSSAMQTAKANKNWFNHSLITFS
KNLIDITKNYEQKIPLFLQYMVMHDLKWKLLIKDISETPLDENEYREFLTLIREVLSYID
DDVIIETKSVSHFYLYHALKIKHGENYSRYVYERETEQDYYLYREGKIVSRLSDQTLTIE
ILEENEDSIHIEGFWSSLFNSKGFNFYAKIGDTKVKAKNIKRRHNDYISLGEVIKKYPGF
SIDIPKSYLADNHHIEFFITKGKKRKMAKLRFFKYSGLSNDLFNSYAAKKDYIFYYNYKK
LMFEQNNVKNRFIKEFRFLKSLNKIGGKSKKRKSAIKKAMLARVAHHVFTIFNRKPVWLF
IDRQDKADDNAEHLYRYAISKNDGVKKYFIIKKDSKDYNRIKKYGKVIPYRSLRHKILTL
SSSKVISTHADIWVVNPFFNMEIYFRDLFNFQFVFLQHGITMADHSEWLNKYSKNIKLLV
TSAKPEYRSIVKGNYNYKKENIFLGGFPRYDNLKKSEGEKQLLIMPTWRKDIVLPKDQAK
GVRPYNPKFKDSEYFARYNALINDERLIEFAKNNNYKITFFPHPDIQQQMVDFEKHEYVE
FANYNSSYQMLFNSSNIMITDFSSVAFDFAYEKKPVIYYQYEKSYHFKLDYYDYKKMGFG
DVIEDHNSLVDKVIYYMKNNSRMEDKYRKRVDNFFAYTDKNNRNRIYNAILQLDNSKVAK
>PK3-2_01586 hypothetical protein
MSLDLIFTDTLKLWEKFCGTSLYFLKVKKNSTSVTIFTGAFKFL
>PK3-2_01587 Teichoic acid translocation permease protein TagG
MNALVRIVKEQVTSFPLILRLASYETKSQYQMNYLGVLWQFLNPLIQMLAYWFVFGMGIR
NSKPVITGIGEVPFIVWMLAGLIPWFFISPTILDGSNSVFKRINMVAKMNFPISSLPSVV
IASNLFSYFVMMGVYVIVLLASGVYPSLHWIQYIYYLICMIVFMFSFSLFNSTISVLVRD
YQFLLQAVTRLLFFLLPIFWNISEQLGKNHPNLLPVLKLNPIFYLIEGFRNSFLDGKWFF
QDMKYTLYFWLFTFLLLLVGSILHMKFRDKFVDFL
>PK3-2_01588 Teichoic acids export ATP-binding protein TagH
MKLKVSFRNVSKQYHLYKKQSDKIKGLFFPAKDNGFFAVRNVSFDVYEGETIGFVGINGS
GKSTMSNLLAKIIPPTSGEIEMNGQPSLIAIAAGLNNQLTGRDNVRLKCLMMGLTNKEID
DMYDSIVEFAEIGDFINQPVKNYSSGMKSRLGFAISVHIDPDILIIDEALSVGDQTFYQK
CVDRINEFKKQGKTIFFVSHSIGQIEKMCDRVAWMHYGELRMFDETKTVVKEYKAFIDWF
NKLSKKEKETYKKEQTEERKKEDPEAFARFRKKKKKPKSLANAIQIAILSILTVFMAGTM
FFNAPLRTIASFGAIPQNEVKNHHGDAKGKAEERLTAVNKQGFIAAEKASAYKDQDLKQK
AGVTLPFGTKVTVAAKGKQAAKIKFDGHSYYVKQSAVATNVKHAELRASAFTPYVPQAAA
ASYEYFLKFLGDSSASIQSKLNGYTEGHTADGRKTLDFDYEKISYVLENDKASELIFHNI
SSVTPASLSLSDSDVLYDSSKDRFLVKTADQVFAVDNEEHTLTLMSK
>PK3-2_01589 UTP--glucose-1-phosphate uridylyltransferase
MKLKKVRKAIIPAAGLGTRFLPATKAMPKEMLPIVDKPTIQYIIEEAVEAGIEDIIIVTG
KSKRAIEDHFDYSPELERNLEEKGKTELLEKVKKASNLADIHYIRQKEPKGLGHAVWCAR
NFIGDEPFAVLLGDDIVQAETPGLRQLMDEYEKTLSSIIGVQQVPEEETHRYGIIDPLTS
EGRRYQVKNFVEKPPKGTAPSNLAILGRYVFTPEIFMYLEEQQVGAGGEIQLTDAIQKLN
EIQRVFAYDFEGKRYDVGEKLGFITTTLEFAMQDKELREQLVPFMEGLLNKEEI
>PK3-2_01590 hypothetical protein
MMTIKVSTPKLAYVCSGIHAAKKFNINTIDWNYPMDIVTFNHDPNGPSSFKDAAVINMYS
YFKGPEPQKVKIEHPIDQEGFTYIKEPNKPIYRYYDNGRYIKYQRFTASGELAVIDYFNE
NRQRFKREEYDSSGYVHSLMYMDLETNKPKQHLYLRADGTCYMTKWYKNDGTTEKIVIFD
EKENIVSVLYSENELSHYFLDRLINETEYLCLTSEVEIYTTLKSLSVADSSMYLGFIETN
EMLDNLEKEIGHLDAFVVPSLKRYHDTVEKTGPRTNICYVPEEPFTRKRFVDKIIGQVPF
NNKLKDMDVELLTAEWQSKSDLYLSAKVEFKGGVPAHSVGRHKMYWKLKNKKSGTESTFN
ANVSSEKDLMFTVSGTLGVQPVLDRLSTIELHLCSEWDNSFFASSVRVTDLKEVSLSEQS
ISGWQLTLTEENNHLCIHTAEGFRRKLMKRLFAKK
>PK3-2_01591 Poly(ribitol-phosphate) alpha-N-acetylglucosaminyltransferase
MRRIFSLIYEIDIEKGGITSSMMSRSFTFAERGHKIDLVTLDDKDNYNQIEKKLKNAGRL
HADVNILNIYDDYQNQHKHIKVGNAQESYYEQNRNRFEEPYAVYHNEEKLETEYFKNGLY
MKKKKWDESNNLLYVDHFNANMQLTKREFFTDGYVNKTVVFDTRSGKINQIHYTAPDGFC
YLTEWHHFNTGASQGVMLFERDEKEAVFFKNKHKFHTHWLEKLCEKEKDPIIICDGVGSA
SKVNEMREGLAKRYYCVHSNHLDYPYTLGSKVRKNHQYAMEHIKDYDGLIVLTNEQKEDI
MKDFESNNNIFVIPHAPRRLEKLQTFEKKKNEFVMVARYHEEKGIDKVIKAMEIVKKSRP
EIVLNIYGSGPGYEEYQQLIDDLQLDNVHLKGYIANPAPFYQQALATLLTSKFEGFSLAI
CESFSCATPVISFDVKYSPRELIKEHETGMLVEPDHIEMLADSIIYLYDNPEKAIQYGKN
AKNLMDTEYSEDRLFERWEEVFEMTR
>PK3-2_01592 Poly(ribitol-phosphate) beta-glucosyltransferase
MHFYTIFVHYMSFCEEIEADKDRGVMLKITAAVPTYNSEHFISRCLDSLVQQTMPNNEYE
IICVDDCSQDGTVSILKKYSEQYSNITVIERKKNSGGPGEPRNQAIRAANGEYIFFIDSD
DYLGIEAFERMYQFAQQHDSDIVLGKMVGVNGRAVPQAIFKETKPEADLVKSPLVYSIGP
TKLFKVSLLRRHDIYFPSNIQATEDQVFVMKAYLEADKISVLADYDYYYAVQHDGEHMTF
AYVAPKSYYGAMKVIIDMIRESRLSHTGKMKFMAKFLNRHFDFSRTTDFTVTIEDEQEQQ
TWMTELHYFVEQHIPREIDKLVHSHTRLKLYFVRQNDLKGLKQFEADKENMTQFTSVKDG
HIIANYPSLMSYHLTENERIIDDRNKLSHYVSKFQMKNNTFSLKGSVTHTALQPEHQAMQ
TLSGIWVHRERKTEKIISPVYSEGGKFEFLTKFTDLAVHEEDMGVWDFFIESEIDGYKKR
ARIGNSRDQYPYSKHAKYIGNNGTYAFSARPYFTKTYDNLSVDIRKQEDLKVEFRNNESD
LTFVFPGSQLFFPKQSLLLLECNNQEFLIPIKNQISSADGTVIQVDRNLVEQKFAPAHLQ
NTNIVLSINSYKTTLVPKKDVSVYFCSKNIEKKLWCFKIKKKVDLFIQSDQSKFYLTAR
>PK3-2_01593 UDP-N-acetylglucosamine 2-epimerase
MKKLKVMTVFGTRPEAIKMAPLVLELKKYPEIESYVTVTAQHRQMLDQVLEAFHIKPDFD
LNIMKERQTLAEITSNALVKLDELFKDIKPDIVLVHGDTTTTFAGSLAAFYHQIAVGHVE
AGLRTGNKYSPFPEELNRQMTGAIADLHFAPTCQAKENLLKENKKADSIYVTGNTAIDAL
RTTVRDGYSHPVLDQVGDDKMILLTAHRRENLGEPMENMFKAIRRIVEEFNDVQVVYPVH
LNPVVREAAQKHFGDSDRVHLIEPLEVIDFHNFAAKSHFILTDSGGVQEEAPSLGKPVLV
LRDTTERPEGVEAGTLKLAGTDEETIYQLAKQLLTDGEEYKKMSYASNPYGDGEASRRIV
EELLFHYGYRKEHPDSFTGK
>PK3-2_01594 Polyisoprenyl-teichoic acid--peptidoglycan teichoic acid transferase TagU
MRAEKRKKKRKVLLVILAIVAVFVLGTGGYAYYLWHKAASTVASIHESIDKSKKRDTEVN
INKKDPFSVLIMGVDERDGDKGRADTLIYMTVNPKTNTTDMVSIPRDTYTKIIGKGTMDK
INHSYAFGGTQMAVDTVENFLDVPVDYFVKVNMESFRDVVDTLGGVTVNSTFAFSYDGYS
FGKGEITLNGKEALAYTRMRKEDPRGDFGRQDRQRQVIEGIINKGANISSITKFGDMFKV
VENNVKTNLTFDDMWDIQSDYKGARKKIKQHELKGTGTKINGIYYYQADESALSNITKEL
KESLEN
>PK3-2_01595 Membrane-bound protein LytA
MKKLAILMFSMLLLLSACGTAENSSGSETNSDSQDAAAEETVTKEGTFAGLADSHTIAVT
IDGKETSIQVGSDLQDKMNSISEGQKVVVKYTKDSNGALMLKDLETK
>PK3-2_01596 Amidase enhancer
MKKMKLLLLSSVTIAALACPAFMQSAKAADKTISVKLSNYVGSKSSLDVDITGGYEIPGS
RIADTERYGGATRFDVANNVASAGWTNPTTVVIVNRDAFADALSATPLAKKYDAPILLTD
ADSLTPKTESEIAKLNPDNILIIGGTISVSKNVENTLKKYGSIDRIGGATRYEVSKNIAA
RMGNYSQAVVATGMVFTDALSIAPYAAMNGYPILLAGDNNIRSDYKIPSKVTIVGGPLSV
STGVEATLKKQATVKRIGGVSRYEVSANIVKELNMKATKVFMSNGQTFADALTGSVLAAK
QGSPLLLVESGSLPSPVANVVASKGTQAFALLGGSISISDTLKNKLADTFAGTGYTVKLS
GGNLVLYKNSTAIKTLGTSFTANPKKYATTNSISLNGTPYLGNMKFAIESGKYVRPTNVD
IPFEDYLKGVVPHEMPASWQKEALKAQAVAARTYSINSAGKVVQDTTAFQVYGGYDWNSK
TSEVVEATKGKVLKYNGNLISATYSSSNGGYTEASGEVWSSQLPYLIAKKDTYDPQRSWS
LSLNKTQLDKSSLNLKTPGSWWSTKNETNSAYLSGLKSWFIKNKYSSAESIKITKISSVK
FSTEKTAGQRPETASVTFSYFVKEKSNGYILSNGSLSEKTATISVPATELRTMLGASNMK
STYASVSSNTSAFIISGKGYGHGIGMSQYGANARAAVGQSYTTILRFYYPGTTLSSY
>PK3-2_01597 N-acetylmuramoyl-L-alanine amidase LytC
MRIFLKSIPMLVLGVVLFVPNVFAANSVTRLDGASRYEVAVNVSKQGWSSASTVVVANGT
AYADVLTAAPLAYKYNAPILLTESSKLTTPTKDRISQLKPSKVIVIGGTISVSDNVVSDI
KKLGISNVERIGGRSRYEVAQNISKKLSSNSKAVIANGTAYADSLAIGSYAARNGIPILL
TTASSIPAPTKSAMNSKGTSSTIVVGGEISVSKSVYSQLPSPTRIGGNSRFEVAANIAKK
YYSSSKAAFVSNGYQYADALAGSVLAAKQNRPMLFTDAGSLPTATRAVIGSNSKNTFTVL
GGTISVTANVVNQLKNVIVGKKVFVDAGHGGYDSGAIGNGLKEKDINLAVAKLVNSKLSK
GGAIPIMARSTDVFLELSERVAKAKSNNANLFVSIHANSATPAATGTETYYYTKYESANS
ERLATEIQNRLYKALNTQNRGVRLGNFHVIRESTMPSSLAELAFISNANDASKLKSALYQ
EKAAQAIYEGIIGYY
>PK3-2_01598 Poly(ribitol-phosphate) beta-glucosyltransferase
MKISIVIPVYNSEDLISECLDSLVNQTMPKEDYEIICVDDKSTDSSLDILNQYKKKYDNI
VVVERTINSGGPGAPRNDAIKIAKGEYILFVDSDDYVGNEALLRWYNFSKENQSDITLGK
LKGINGRGVPKSMFKETNPDVDLVDSKIVFTLGPQKLFKASLLKENQITFPTHIKAAEDQ
VFTMNAYLKAKKISVSADYDYYYLVKRDGEHMSVAYVPQRTFMERWKILSPPSRQVTWKK
PEKLS
>PK3-2_01599 Poly(ribitol-phosphate) beta-glucosyltransferase
MAVFLNRHFDFSRTKNVTIKMKTDEERAEWFKYLSSFIQAVPEEADQFLLPHIKLRLLFI
RNNDLQGLTQYEREEQNIKKFCTVNNGELIARYPSLEGYPISEELLKVNYKNKLEHYLQN
IEFNDRSLSIQGTIKHKLMDDEMNKNQSLTGVFVHRDTKAEKYISPASYENSTFTFECKF
DELASAEEDLGVWDFFIESSIDGYKLRARIGNKRAAYKYSTKTMYLGHNALFVYSARPYF
TMNYDNLSIDIKKHAYTEAELSYEIESKDLSFNFKDKQICLPNHSKIIVNTGQSEIALPV
KRIDLEPNCTKLTVNVQSLLEQLAHVKKEQRLIEFAINTSQNKISAKEDNQAIILDTKSV
ERKSMLFFSKMVEVQYKLLTSKSKFYFQY
>PK3-2_01600 hypothetical protein
MSAEKSMNVSREFSVQQIHSFTLSEKTARYLAVKRVMDIWFALIGLAIALPMIAVFSILI
CLETPGPAIYTQERVGKGGKPFKLYKLRSMKIDAEKSGAVWAQKQDPRVTRIGAFIRRTR
IDELPQLFNVLKGDMSMIGPRPERPVFTEKFQNEIPGFTQRLAVKPGLSGWAQVNGGYDM
TPKEKLIFDLYYIRNLTFTLELKIMLKTCKVVWTGDGAR
>PK3-2_01601 Teichuronic acid biosynthesis protein TuaB
MPSITKQIMSGAKWTSISTMCITIIQIVQFALLGNMMTLTEFGLVGMMTTVTVFAQIVLD
MGFGAALIQRDDATERQLSTLYWLNIMTGVLLFVLLYVSSPVIAGFYQREELVFLIRVLA
IMFLIAPIGQQYQYMLQKQLHFNTLSKIEIFSNVLSFGYLVIAVFMMDAILAYVISQVLL
QSSKGILYWAVYRKKWHPVFVFDLRGMKEFFSFGAFQLSSRLVNRLGANIDMILIGRFIG
AEALGIYNLAYQIVTIPVLKINPIVTRVAFPVFAKNKYENSVIREGFLNMTKMLALVSFP
LLIGLVSVSDAFIAAVFGEKWLAAVPVLNVLAIVGILRVLMNPNGSVLLAKGRADLAFYW
DTGVLLLYGLSLFAAVQTGSLLTVAWVYAIISVFNFLIGRWLLAYVIKLHLSAYFQSIMK
PFLITAAMAVIAFGVSLGTEHFSLQAEMRLAISVAAGALCYLFLLVKAYPQMKSKLLRKG
RLS
>PK3-2_01602 Putative teichuronic acid biosynthesis glycosyltransferase TuaC
MKILWITSVYPSSLKPGEGVFHETQVQELQKLGLDITVICPRPFHAAPIRMLKKAYRKKD
ARPEYEMRKGIPVYRPFYQAVPGQLKWAQPHRRIASAVLKTMKQRDLHPDLIHAHFAMPS
GGAAAVVAESERIPYVLTLHGSDVNVYPHYSKGAFKAFNRAVGSASAVLAVSRKLQEETK
KLSGFDSSVLPIGIQLSRFQENEQTKEEIRKKLGLPLDQRLAVYVGRLVREKGIFELSEA
IESLKEPPKAVFVGDGPAKAMLTQKGHIVTGQVPNHKVRDYLLAADMFVLPSYSEGMPTV
VIEALALKVPVICTDVGGVASLFGKHRHLLIKPKSAEALAEAITLYEHEQLWKPEVADDL
YEIVQAQFDAGRNAKALHHQYQTVMKTSV
>PK3-2_01603 UDP-glucose 6-dehydrogenase TuaD
MSAVKKIAVIGTGYVGLVSGTCFAEIGNKVVCCDIDESKIRSLKNGVIPIYEPGLADLVE
KNVLDQRLSFSNDIPSAIRASDIIYIAVGTPMSKTGEADLTYVKAAAKTIGEHLNGYKVI
VNKSTVPVGTGKLVQSIVQKASKGRYSFDVVSNPEFLREGSAIHDTMNMERAVIGSTSHK
AAAIIEELHQPFHAPVIKTNLESAEMIKYAANAFLATKISFINDIANICERVGADVSKVA
DGVGLDSRIGRKFLKAGIGFGGSCFPKDTTALLQIAKSAGYPFKLIEAVIETNEKQRVHI
VDKLLTVMGSIKGRTISVLGLAFKPNTNDVRSAPALDIIPMLQQLGAHVKAYDPIAVPEA
SAILGGQVEYYTDVYDAIDETDACLILTDWPEVKEMELVKVKTLLKQPIIIDGRNLFSLE
EMQAAGYIYHSIGRPAVRGMEPSDKYFPGLPLEELAKDLGSVNL
>PK3-2_01604 Teichuronic acid biosynthesis protein TuaE
MSIKRSAVHTLALLAAAIFGAVLLLGAIRKDIGFMQMAALLAVLAIGLFALTLVTAFTTK
DRLFMAIIYILIACTFLNNAFFAIHLGFFSLFLYRLLLIAAGCLHVIGMIRNRTHIERWN
GLQVKGILLFFGFWFIYGLVSLLWAKSVTAGIKYLALLAMGIFFVYLIVMYVQKMERLMI
VYTIWLVMTVFLMLIGFYNHITHHHLPSSTLYSGPEYKQHYPTSVFFNQNDFATFLSISF
FFYITMVKNIKNGYLKAIGLVLSLCALYLIFATGSRASLLGIFAGVAVYIFIVLPPVLKK
IAIWLSAAGITIFAVLFASRMYSKFWELFLAPQTLHSFHDRLPSNVARANLLKNAWHFFL
DSYGFGVGAGNVSYYLEHHALYDTDNVAEVHNWLVEILANFGLFIMLGYLAVYAYLIWVL
YKFYERNLENQSKLITEGLITALISFLVSSISPSSVSNLFFHWVFLALVIAAVNVLRRSR
QMPEPMYR
>PK3-2_01605 Teichuronic acid biosynthesis protein TuaF
MNDILIRIARRIKKNIIWIIALPIILGAAGYILPSQIADQKSYTAENTLAVGSYDYPVYN
STEEIPLLLKSDSFLKEALPDEKDEDLAEIKEKLTVKTESKSLLTLSYSDEDKDKTESVL
NAISSAFLKNDQKLYAEREAVIRRSIDALEGETVSEDSKVDKERFLYELKNTQLNLKSAS
VTDSETVSEASGGGMSPKKKAVLGVMIGLTIAFMFVVIPEFFRESF
>PK3-2_01606 Putative teichuronic acid biosynthesis glycosyltransferase TuaG
MTNWKPLVSVITPSYNARDYIEDTIHSVLEQSHSQWEMIIVDDCSTDGTRDILQQYEKID
ERIHVICLEENSGAAVARNKALERAQGRYVAFLDSDDKWKKDKLEKQLDFMMERSCAFSF
TGYSLMEQDGTPLDKFIGAPESLTYDDALKNTIIGCLTVMIDREQTGQIQMPNIRTRQDL
ATWLSLLKKGFTAYGMNECLAEYRLVDNSISSNKWKAAKKTWFVYREIERLHFIKATWCF
VQYAKNAVKKRL
>PK3-2_01607 Putative teichuronic acid biosynthesis glycosyltransferase TuaH
MKVETKEAIIHVIVATAEWGKDQLRYRRHRLAEFLAAQEETKEVIWVCPAPRTQGNEFQD
VYSRIRQFAVKDLLQKKMFRFGRYTDVFYRHKLSPLLDELASASANGEHCCLWYTFPGFP
LLSSLYPWDQVIYDCSDLWAAPISGRSNLLSEFRRKVIKSAELRIIHRADSITCSSDYLH
KEVDKKLSAGREKVHTVENGVEYELFSANKAVPDRSILQGREGTVLGFIGGIKPKLDFKM
IEEAALQKPDWTFLWVGPDATNGDVSFQELLRLPNVIWTGPADPKEVPHYMELIDIGIMP
YKQSSYNQAVFPLKLFEFLAAGKPVVGSNLPSTSKMKKPYVYEYVEGDHPLDFIAACEKV
LGHNGDESYKEMRRNIARAQDWNYLFKQIMKYTGIQKHA
>PK3-2_01608 putative undecaprenyl-phosphate N-acetylglucosaminyl 1-phosphate transferase
MLDERMIRIVVAFIVSLLTVLIITPIVKRIAIKIGAVDQPSNRKVHDKIMPRMGGLAIFI
GVVAGVLASGIYTETRMTAITAGAFIIIVLGILDDKFQLSAKVKFLVQLGVAIMIVSTGL
KMDFFSVPFLAERFELGWMAYPLTVLWIVGITNAINLIDGLDGLAAGLSVIGLSTIAVMA
LSGGKVLILSLSLVVIASTLGFLFYNFHPAKIFMGDTGSLFLGYCISILSLLGLYKSVTL
FSIVIPIIILGVPIFDTTFAIIRRILNKQPISAPDKSHIHHRLMAFGLSHRMSVLVIYLI
GFIFSISAIVLKSATIWLSLFIIFILIIFMQIIAEVTGLVNEKFKPFTKFYKRLVKRN
>PK3-2_01609 Polyisoprenyl-teichoic acid--peptidoglycan teichoic acid transferase TagV
MAERVRVRVRKKKKSKRRKILKRIMLLFVLALLVVVGLGGYKLYKTINAADDSYDALSRG
NKSNLRSQVVDMKKKPFSILFMGIEDYATKGQKGRSDSLIVVTLDPKNKTMKMLSIPRDT
RVQLASDTTGSKTKINAAYSKGGKDETVETVEKFLQIPIDKYVTVDFDGFKDVINEVGGI
DVDVPFDFDEKSDVDESKRIYFKKGEMHLNGEEALAYARMRKQDKRGDFGRNDRQKQILN
ALIDQMSSASNIAKIDKIAEKASENVETNIRITEGLALQQIYSGFTSKKIDTLSITGSDL
YLGPNNTYYFEPDATNLEKVRKTLQEHLDYTSDTSSTGTDESTTTDDTTGGSSSYSNDSS
TSSNSTTNSTTDSSY
>PK3-2_01610 IMPACT family member YigZ
MLHSYFTVKEAGEHEIVIEKSRFICHLSRVSTEQEAQEFIQKIKKQHWNATHNCSAYVIG
ENDHIQKANDDGEPSGTAGVPMLEVLKKRGLKDTCAVVTRYFGGIKLGAGGLIRAYGKSV
SEGLNHIGVVERRLMRVMHTSADYTWLGKIENELRESQFLLKEIHYAENVEFETYVEEKE
TNAFSEWMTELTNGKSDIKEGELTYLEKAVNHIKETE
>PK3-2_01611 Signal transduction histidine-protein kinase/phosphatase DegS
MNKTKMDSKVLDSILMKMLKTVDGSKDEVFQIGEQSRQQYEQLVEELKQIKQQVYEVIEL
GDKLEVQTRHARNRLSEVSRNFHRFSEEEIRNAYEKAHKLQVELTMIQQREKQLRERRDD
LERRLLGLQEIIERSESLVSQITVVLNYLNQDLREVGLLLADAQAKQDFGLRIIEAQEEE
RKRVSREIHDGPAQMLANVMMRSELIERIFRDRGAEDGFQEIKNLRQNVRNALYEVRRII
YDLRPMALDDLGLIPTLRKYLYTTEEYNGKVKIHFQCIGETEDKRLAPQFEVALFRLAQE
AVSNALKHSESEEITVKVEITKDFVILMIKDNGKGFDLKEAKEKKNKSFGLLGMKERVDL
LEGTMTIDSKIGLGTFIMIKVPLSL
>PK3-2_01612 Transcriptional regulatory protein DegU
MTKVNIVIIDDHQLFREGVKRILDFEPTFEVVAEGDDGDEAARIVEHYHPDVVIMDINMP
NVNGVEATKQLVELYPESKVIILSIHDDENYVTHALKTGARGYLLKEMDADTLIEAVKVV
AEGGSYLHPKVTHNLVNEFRRLATSGVSAHPQHEVYPEIRRPLHILTRRECEVLQMLADG
KSNRGIGESLFISEKTVKNHVSNILQKMNVNDRTQAVVVAIKNGWVEMR
>PK3-2_01613 Protein DegV
MNIAVVTDSTAYIPKEMREQHQIHMIPLQVVFGEETYREEIELDWKSFYDEVKKHAELPT
TSQPPIGELVALYEELGKSYDAVISIHLSSGISGTFSSAAAADTMVDNINVYPFDSEISC
LAQGFYALKAAELIKNGASSPEDIMKELEEMKKTVRAYFMVDDLAHLQRGGRLSSAQAFI
GSLLKVKPILHFDNKVIVPFEKIRTRKKAISRIYELLDEDASKGLPMRAAVIHANREEEA
VKIIEELSAKYPHVEFYNSYFGAVIGTHLGEGALGICWCYK
>PK3-2_01614 ComF operon protein 1
MPTEKSISFSKELRQTLQSRHLLRTELPFSDELIEWHLENGYIAVQNSISINKRGYRCNR
CGQNDQRYFSFYHSSGKKQLYCRSCVMMGRVSEDVPLYSWKEEDEPNWQPIKLTWDGELS
SGQQKAAKVLIEAISKKEELLIWAVCGAGKTELLFPGIESALNQGLRVCIATPRTDVVLE
LAPRLKAAFQGADISALYGGSDDKGRLSPLMISTTHQLLRYKNAFDVTIVDEVDAFPYSA
DQTLQFAVQKARKKNSTLVYLSATPPQELKRKTLNGKLHSVRIPARHHRKPLPDPRFLWC
GNWKKKLNRNKIPPVIMRWIQCHVKEGRPVFLFVPSVSVLEKAAVCLKDMNCRTASVHAE
DKNRKEKVQQFRDGQLDLLLTTTILERGVTVPKVQTGVLGAESPIFTESALVQIAGRTGR
HKEHADGDVIFFHYGKTKSMLDAKKHIKEMNDLAAKND
>PK3-2_01615 ComF operon protein 2
MLVNSKEIVMKELLDRYMDQLHMTCTCQVCKNDVLALSLNKVRPSYVTDLKKIAYTKAEM
VDKQKNTAMLVILAESAAVVSESPSDLCQTKQEEAFIN
>PK3-2_01616 hypothetical protein
MPNKAGGGIHKLICLLCDSQFSQAVTWRALFLLKPDEKVCHSCRSKLKKITGHICTICGR
PQSVDAVCRDCEAWKSRVSHSLLLRQNRSVYTYNDMMKETLSRFKFRGDAEIINAFKSDF
SSAFSEVYPDKHFVLVPIPLSKEREEERGFNQAQLLAECLSRPIRHPLIRLNNEKQSKKK
KTERLLSARIFDTKNNSAIGMNIILIDDLYTTGATLHFAARCLLEKGKAASVASFTLIRS
>PK3-2_01617 hypothetical protein
MGNLANCPKCNALFLKTKLQTVCQACIKEEEKSFEIVYKFLRKQENRQSTLSRITEETGV
EEELILKFIRQKRIQITHLPNLAYPCERCGASIREGKFCKACESDIKAQMDHLDHEDALK
TERENSKKDTYYAYNTKNN
>PK3-2_01618 hypothetical protein
MKINQFGTQSVNPYQKNYEKQAVQKTAAQPQDKIEISSQAKEMQSASDAVTGSRQEKIAK
LKAQIENGSYKVDANHIAKNMINFYKKQ
>PK3-2_01619 putative protein YvyG
MSAKPIIEQLKRLCVLHEHLLTLSEEKTEALKAGKTNELSNILTKEQKYIQAIGQTEDDR
IKATSAFLGYSENNTISACIAKTTGSEKEELEQLYEALSNVLGHLKKVNEMNRQLTRDAL
QFISISYDMLVPKENNFNYSKSIKAELPKSSRMKLFDSKA
>PK3-2_01620 hypothetical protein
MTSTFMGLETARRALSAQQAALSTTANNVANANTDGYTRQRVSLEATDYFPAVSKNAEKT
AGQMGTGVQGKSVERIRDIFLDYQYRLQNNSAGYYDTKAKALSQMEGILHETDGSGLNSV
LNSFWNSLQELSNNTNEDSARSVVAEKGKALAETFNYLSESLTNVQSNLKAELDTTVLDV
NSVLSQLNSLNKQIAQVEPVGLLPNGLYDQRDLLIDKLSSMVDIKVSYNKSGGNALASAE
GTVSIEILDKNKQSLGTVLDGKNYEVSELAANYDNETGLVSSISIGNTAVQAESFSSKGS
LLGFIESYGYVTAAGEEKGVYPDMLSDLDNMALEFAKAFNEVHRNGLTKSGEQGGDFFDF
TGGETEPAKGAADKIKVADSISDSSGANIAFSLTGAANDNSNATKLANVLTGDITINGKK
TSVLDYYSSLIGELGIKAQEANRLSSNTETQLNDADINRQQMSAVSLDEEMTNMIQFQHA
YNAAARMVTLQDEILDKVINGMGVGGR
>PK3-2_01621 Flagellin FlaB3
MRVTQGMIQQNSLRYIGSSYSKLDKLQSQISSGKKISKASDDPVVAMKSLKYNTQLSQVQ
QYQSNASQAFTWLENTETNITEGIDILSKVRELAVEAQNDTNGEEERQAIGVEVKQLKDQ
LLKIANTQVNGRYIFNGTNSDKPPVTDNGDGTYTISDTADVVVNISNNMTLKVNSDPKSA
FGGTSESGQNVFEMLDSFEKALSSGSLDGMDSVLDDIDQFSDGMSAERSDLGARYNRLEL
VNTRLSAQQETATKVLSDNEDVELEEVITEFIAQQSVHRATLAVNAQIVQPTLIDFLK
>PK3-2_01622 putative protein YviE
MQIPRLIMHSVQGKIGLTTTPASLKMEQPQADLEIQQPNAEMEISVTPGKLTIDQTQAWE
ELDRKHIFKRIEEEAQQGHEDVMAGIARTAEEGAELMRIENKGNPIASQAKRNSELHQIQ
LGEHYAPSLSRVKIQYTPSQLDIQITPRKPVIQAEPNKPIVEYMPGNVKVDMLQYPDLNI
DVEYPKES
>PK3-2_01623 Flagellar assembly factor FliW
MIIHTKYHGQMNVKEEQILLFENGIPGFLEEKQFVILPLSEDSPFVALQSVISENLAFIV
VSPFIFFKDYEFDLDESTAEFLDIDHIEDVEVMTIMTMAEPFEKSTANLLAPIIVNRKNM
MAKQVVLHDSLYTTKHPIGGESC
>PK3-2_01624 Translational regulator CsrA
MLVLSRKINEAIQIGADIEVKVIAVEGDQVKLGIEAPKHIDIHRKEIYLSIQEENNRAAA
LSSDVISALSSQKK
>PK3-2_01625 Flagellin
MRINHNIAALNTLNRLSSNNGAAQKNMEKLSSGLRINRAGDDAAGLAISEKMRGQIRGLD
MASKNSQDGISLIQTAEGALTETHAILQRMRELTVQAGNTGTQQPEDLTAIKDEMDALTE
EIDGISQRTEFNGKKLLDGSVTAGFTFQIGANATQNINVTIGNMDATTLGVKGIDVSSAT
FSFDTEIAKIDTAITSVSSQRSKLGAVQNRLEHTINNLSASSENLTAAESRIRDVDMAKE
MSEFTKNNILSQASQAMLAQANQQPQNVLQLLR
>PK3-2_01626 putative protein YvyC
MNIERLTTLQPVWDRYDTQIQNQKDHESEVPVHQVSYTNLAEMVGEMNKLLEPSQVHLKF
ELHEKLNEYFVKVIEDSTNEVIREIPPKRWLDFYAAMTEFLGLFVDEKK
>PK3-2_01627 Flagellar hook-associated protein 2
MVTRITGLASGMDIDDIVSKLMQTERAPLDKLTQKKQTLEWQRDSYREVNSKIKELQDYM
SNNKLTYPSTFQSKAVTSSNESVLTATGTASAANSSSTVEVASLATSAAYKANNYTGYTQ
GDYNLAFNVVAPGETTAKTVNISVTSADTIDNVISKINSSDLGVSAIKDKIWNGTEYVET
IAFSSKTTGAGGSIQAADSATADFMSGQLGFSLDADNKLTAYKEGTNAKVTINGFEMEKL
SNNFTVNGVTYSIKNTTAATGPVTTSVSTDVDGIYNQIKEFVDKYNELVDSLNEKLQEEK
YRDYAPLTSEQKEAMSDKEVELWEEKAKSGLLRNDTSISTGTNQMRTDFYSQVNANGKTY
QLTEFGITTSGTYQLRGHLEINEDKLKAKIQEDPQSVAALFTSGSNTSAYSDKGIMKRIG
DTLKSTVKSIEAKAGNSTMGTRDYSIGKNLNTISTDITKMKDRLNTIENRYYTKFSAMDS
AIQKMNEQSSYLSQLLAQ
>PK3-2_01628 Flagellar secretion chaperone FliS
MAIQNPYTAYQQNSVNTATPGELTLMLYNGCLKFIRLASQAIENDDMERKNENLIKAQNI
IQELNFTLNRNIELSSSLGAMYDYMYRRLVQANIKSDTSMLAEVEGYVTDFRDAWKQAIQ
SERKDRHGSGGIA
>PK3-2_01629 Flagellar protein FliT
MKNIDQLYTETQSMLSHIQDTPESDELLKQIEDFVVKRSELIQEVSLPLSEEEKKQVKLL
LEWDQVIVKEMERLKRLIAAELQQVKRKRAMHTTYLNPYNNFTIDGRYYDKRK
>PK3-2_01630 hypothetical protein
MKSIEDYTLLSAYYHLLFTIEEGLCYLIEAEQNLSKTEGDRIYQDLIQAFFYLDSTHSTL
LFIMDTRCAEICVKAFDQIFAEFDQLVSFSFPSHEFCEYLKEHFLSHYRKWMLSIHQCME
PFVIN
>PK3-2_01631 hypothetical protein
MDAVYPSMYGTLCNQLGECEVFVSFNQHIHIPPNRQNISKSKHNSTKFTEFSQKVYVSAG
IVKGKREIDTYP
>PK3-2_01632 Ribosome hibernation promotion factor
MNYNIRGENIEVTPALKDHVEKKIGKLERYFDHSVNADVNVNLKFYNDKESKVEVTIPMT
DLALRTEVHNEDMYNAIDLATNKLERQIRKHKTKVNRKFREQGSPKHLLANGLGSDTDIA
VQDEIEEEESLDIVRQKRFNLKPMDSEEAILQMNMLGHNFFVFTNAETNLTNVVYRRNDG
KYGLIEPTE
>PK3-2_01633 Protein translocase subunit SecA
MLGILNKMFDPTKRTLNRYEKIANDIDAIRGDYENLSDEALKHKTIEFKERLEKGATTDD
LLVEAFAVVREASRRVTGMFPFKVQLMGGVALHDGNIAEMKTGEGKTLTSTLPVYLNALT
GKGVHVVTVNEYLASRDAEQMGKIFEFLGLTVGLNLNSMSKDEKREAYAADITYSTNNEL
GFDYLRDNMVLYKEQMVQRPLHFAVIDEVDSILIDEARTPLIISGQAAKSTKLYVQANAF
VRTLKAEKDYTYDIKTKAVQLTEEGMTKAEKAFGIDNLFDVKHVALNHHINQSLKAHVAM
QKDVDYVVEDGQVVIVDSFTGRLMKGRRYSEGLHQAIEAKEGLEIQNESMTLATITFQNY
FRMYEKLAGMTGTAKTEEEEFRNIYNMQVVTIPTNQPVVRDDRPDLIYRTMEGKFKAVAE
DVAQRYMTGQPVLVGTVAVETSELISKLLKNKGIPHQVLNAKNHEREAQIIEEAGQKGAV
TIATNMAGRGTDIKLGEGVKELGGLAVVGTERHESRRIDNQLRGRSGRQGDPGITQFYLS
MEDELMRRFGAERTMAMLDRFGMDDSTPIQSKMVSRAVESSQKRVEGNNFDSRKQLLQYD
DVLRQQREVIYKQRFEVIDSENLREIVENMIKSSLERAIAAYTPREELPEEWKLDGLVEL
VNTTYLDEGALEKSDIFGKEPDEMHELIMDRIMTKYDEKEEKFGEEQMREFEKVIVLRAV
DSKWMDHIDAMDQLRQGIHLRAYAQTNPLREYQMEGFAMFEHMIESIEDEVAKFVMKAEI
ENNLEREEVVQGQTTAHQPQEGDDNKKAKKAPVRKVVDIGRNAPCHCGSGKKYKNCCGRT
E
>PK3-2_01634 Peptide chain release factor 2
MADPEFWNDQQKAQTVINEANGLKDYVNSYKKLNESHEELQMTHDLLKEEPDSDLQLELE
KELKSLTKEFNQFELQLLLSEPYDKNNAILELHPGAGGTESQDWGSMLLRMYTRWGERRG
FKVETLDYLPGDEAGIKSVTLLIKGHNAYGYLKAEKGVHRLVRISPFDSSGRRHTSFVSC
EVMPEFNDEIDIDIRTEDIKVDTYRASGAGGQHVNTTDSAVRITHLPTNVVVTCQTERSQ
IKNRERAMKMLKAKLYQRRIEEQQAELDEIRGEQKEIGWGSQIRSYVFHPYSMVKDHRTN
TEMGNVQAVMDGDIDTFIDAYLRSKLS
>PK3-2_01635 hypothetical protein
MDVRNKTYRTLQDYVYILIGAAITAVSFNVFLLPNKIAAGGVSGISTILQSYGFEAAYVQ
WIINIPLFIAGVILLGGKFGLKTLAGSVFLPLVVFLTRDIQPATHHELLAAIFGGVGIGL
GIGIVYLGKGSTGGTALAAQIIHKYTGLSLGTCLAIIDGLIVITAMIVFNIEQGLYAMLG
VFVSSKTIDVVQVGFNRSKMALIITKQEQAVKEAVLQKIDRGVTKISAVGGYTDDDRPIL
MCVVGQTEFTKLKQIVKQIDESAFVIVADASEVLGEGFKRA
>PK3-2_01636 Cytochrome c-551
MKSKLSILMLGFALSVLLAACGSNDAKEEKTDTGSKTEASASEGEELYQQSCVGCHGKDL
EGVSGPNLQEVGGKYDEHKIESIIKNGRGNMPKGLVEDKEAAVIAKWLSEKK
>PK3-2_01637 Cell division ATP-binding protein FtsE
MIEMKEVYKAYPNGVKALNGISVAIHPGEFVYVVGPSGAGKSTFIKMIYREEKPTKGQIL
INHKDLAAVKEKEIPFVRRKIGVVFQDFKLLPKLTVFENVAFALEVIGEQPSVIKKRVLE
VLDLVQLKHKARQFPDTLSGGEQQRVSIARSIVNNPDVVIADEPTGNLDPDTSWEVMKTL
EEINNRGTTVVMATHNKEIVNTIKKRVIAIEDGIIVRDESRGEYGSYD
>PK3-2_01638 Cell division protein FtsX
MVHMIKILGRHLRESFKSLGRNTWMTFASISAVTVTLILVGVFLVIMLNLNNMATNAEKQ
VEIKVLIDLTADQKAQDKLQSDIKELKGIQTVTFSSKEKELDQLVDSFGDSGKSLTMKDQ
ENPLNNAFVVKTTDPHDTPNVAKKIEKMDHVYKVTYGKEEVSRLFKVVGVSRNIGIALII
GLVFTAMFLISNTIKITIFARRKEIEIMKLVGATNWFIRWPFFLEGLLLGVFGSVIPIAL
VLSTYQYVIGWVVPKVQGSFVSLLPYNPFVFQVSLVLIAIGAVIGVWGSLTSIRKFLRV
>PK3-2_01639 Carboxy-terminal processing protease CtpB
MNQKIMAVIAAGSMLFGGAGVYAGMNLLEMDKPQAAAVPATAQADSERDKAMDKIEKAYE
LISNEYVEKVDRGKLLEGAIQGMLSTLNDPYSVYMDKQTAKQFSDSLDSSFEGIGAEVGM
EDGKIIIVSPFKKSPAEKAGLKPNDEIISINGESMAGKDLNHAVLKIRGKKGSSVSMKIQ
RPGTKKQLSFRIKRAEIPLETVFASEKKVQGHSVGYIAISTFSEHTAQDFTKALGELEKK
GIEGLVIDVRGNPGGYLQSVEEILKHFVTKDQPYIQIAERNGDKKRYFSTLTHKKEYPVN
VITDKGSASASEILAGALKEAGHYNVVGDTSFGKGTVQQAVPMGDGSNIKLTLYKWLTPN
GNWIHKKGIEPTIAIKQPDYFSAGPLQLKEPLKVDMNNEDVKHAQVLLKGLSFDPGREDG
YFSKDMQKAVMAFQNQNKLDKTGVIDTRTAEALNQLIEKKKSNEKNDLQLQTALKSLFVK
>PK3-2_01640 hypothetical protein
MLVSTPVLLLILARAYLYKENGGSQLKRASIVREKKYYELVEQLKDRTQDVTFSATKALS
LLMLFSRYLVNYTNVESVNDIDEECAKHYFNYLMKNHKRLGINLTDIKRSMHLISGLLDV
DVNHYLKDFSLSNVTLWMTQEG
>PK3-2_01641 Cell division topological determinant MinJ
MSVQWGFELLKSVGLFFLHPLFWFFIIVSLVFGYVRIKRERKTFHTRIADIYDELKFTYI
KGLIPGLLLSVVLGVLGISIPLGLLAIIAVITAAAALTLRANWMSAAYIVSASMLIGFGL
QINQAEPFLERFPQGFAVVWPAMAVFLGLLIIIEGAVAYRSAHVRTSPALVVSSRGLPIG
QQLANRIWLLPLFLLIPGNGLESHVSWWPVFTIPGGSFHFLWIPYFVGFGQRVQGSLPET
SIRITAKRVCVLGLIVTALGAVSLLWTPLAGAAVCAAVLGRIFLSIKQRVNDNAAPFYFS
KRDQGLMVLGIIPNTPAEDLELKIGEIITKVNGIPVKNVSDFYEALQHNRAYVKLEIIGL
NGEIRFDQRASYEGEHHELGILFVKDEREDEAAVLSGS
>PK3-2_01642 Riboflavin transporter RibZ
MSSRKEWALIVSLLLGAILVPINSTMIAVALSSISHTYNESIASITWVVTVYLIVMAVTQ
PIAGKLGDMYGNKTMYLWGVGLFLIASLGCALSPSLLLLIVFRALQAVGGALLTPNSIAI
IRHVVSEKRLPKVFGFFGLGAGLGAALGPFIGSMLIDSFSWHSIFWVNIPFLAIALFTAL
TMFPQYKENKSGAPLDIIGSLLLAGSIVSIILLTKNEASWGYAVYSVLILLFVPLFFRRE
KRTQHPIIDFALFKSSTFTNANLSVLLSNLMMYAVLLIMPLFMTSQFGLTTSNSGMALSV
FSIFMSASNWAGAQLHHKWGAKKIIFLSFAMMAGANLLFLLLSSSHSVLFLMLSLILGGL
ASGVGLTSMQVSSLATVDPSMSGVASGIFSTFRYFGSIISSALIGLISGYHTLFIILFAV
SIIGVFVSLGINSDETARLEKNSA
>PK3-2_01643 HTH-type transcriptional repressor Bm3R1
MKPTNKRILDAAMQLLVRKGYRATTTKEIAEKANVSEATIFRNFKNKQGLVEALLSQHSS
NRSSILEQTEGDLHKDLLHIGTCLLEELERKKDIIKISFREPAMFQDVINHVTEYPQSMK
QLLVDYLKTMSEKGVIQSGDEAEHADVFMSIIFGYFIHRLHLGDRVISMPQEKMLEHSTT
LFVKGISAD
>PK3-2_01644 hypothetical protein
MYSVLFRQAEESSQLAGAKGMNLIKLTKHGLPVPDGFIIQTNALARFMEDNQLHETSESI
ESGIIAGAFSEELKHELTSSFYQLRESYRSVAVRSSSASEDLEGASFAGQYETYLNIKTE
EEFLAKVKECWASFFSGRVSSYKKKMNNQIAEPLMGIVVQGLIDSEVSGVIFSRNPVTHD
DRELLISASYGLGEAVVSGSVTPDTYIVHKSSFEIQKEIGTKEIYMESAAEGITEKETSA
DMRSRFCLTDEQVIDLTEITKKTEDLYGYPVDVEFGIADHQVYLLQARPITTIEQDKKAA
EEERSFMITDADMNDFWLNMESNIEGPVSPLFSSFIVPALEYGLKKSMQKFPIGVVVEEV
KLYRGHIYSKNQGGQQQPAEDCGKELFPILSERMYDIINDTYLPFYETLDQLAQTEHTAE
SALDAFRKLKAFYLTAYEEHFNIVFPQILLTNKLQAMYQHIQGQSESAHFYEMLTGKMNK
SLETDRRLWLYSVEVRESPNMLEIFENTKPEQLQERLEQTDDGRHFLKNLHEFLQEYGWR
SVKSHDLIEQTWAENPHFALANIQNYVRNGYHFDNEFQKTKEKREKLYNDFLENIEDPDL
RKEFDRLYQWTLNSANIKDDHHFYIDAMLDAKARVFLLKVGELLAANGVIQNREDLWFLY
DDEVENALLHPVSLQGKAEKRKQIFHEYELAQAPAYLGTPTKEQLKAAEEIVGAVIEDEK
NTENHIFGIAASSGIATGPVKIIRDASEFSQFAPGEVLVCKMTTPLWTSLFQDAKAIITD
TGGILSHAAIIAREYGIPAVLGTRTATERLRDGDIITVDGSSGKITVVSRA
>PK3-2_01645 Protein CsbA
MITKAVFALFFPFMLVVLFTRVTFNHYVAIALTAALLFASYLKGYTETYFIVGLDVVSLV
AGGLYMAKKAAEKKEE
>PK3-2_01646 UvrABC system protein B
MKDRFELVSKYQPQGDQPKAIEKLVKGIQEGKKHQTLLGATGTGKTFTVSNLIKEVNKPT
LVIAHNKTLAGQLYSEFKEFFPNNAVEYFVSYYDYYQPEAYVPQTDTFIEKDASINDEID
KLRHSATSSLFERRDVIIIASVSCIYGLGSPEEYREMVVSLRPEMEIERNELLRKLVDIQ
YARNDIDFQRGTFRVRGDVVEIFPASRDEHCIRVEFFGDEIERIREVDALTGEILGDRDH
VAIFPASHFVTRAEKMEKAIQNIEKELEEQLKVMHENGKLLEAQRLEQRTRYDLEMMREM
GFCSGIENYSRHLTLRPPGSTPYTLLDYFPDDFMIVVDESHVTIPQVRGMFNGDQARKQV
LVDHGFRLPSALDNRPLRFEEFEKHMHNIVYVSATPGPYEIEHTDEMVEQIIRPTGLLDP
LIDVRPIEGQIDDLIGEIHARVERNERVLVTTLTKKMSEDLTDYLKEIGIKVNYLHSEIK
TLERIEIIRDLRLGKHDVLIGINLLREGLDIPEVSLVAILDADKEGFLRSERSLIQTIGR
AARNAEGRVIMYADKMTKSMEIAINETKRRREQQERFNEEHGITPKTINKEIRDVIRATA
AAEDKAEYKTKAAPKLSKMTKKERQKVVEQMEHEMKEAAKALDFERAAELRDLLLELKAE
G
>PK3-2_01647 UvrABC system protein A
MAMDRIEVKGARAHNLKNIDVTIPRDQLVVVTGLSGSGKSSLAFDTIYAEGQRRYVESLS
AYARQFLGQMDKPDVDAIEGLSPAISIDQKTTSRNPRSTVGTVTEIYDYLRLLYARVGKP
HCPEHGIEITSQTIEQMVDRILEYPERTKLQVLAPIVSGRKGAHVKVLDQIRKQGYVRVR
IDGEMAELSDDIELEKNKKHSIEVVIDRIVVKEGVSARLSDSLETALRLGEGRVMIDVIG
EEELMFSEHHACPHCGFSIGELEPRLFSFNSPFGACPTCDGLGMKLEVDADLVIPNQDLS
LKENAVAPWTPISSQYYPQLLHAVCTHYGIDMDVPVKDLPKHQLDKVLYGSGDDLIYFRY
ENDFGQIREGEIQFEGVLRNIVRRYKETSSDFIREQMEQYMSQKSCPTCKGYRLKKEALA
VLIDGRHIGKITELSVADALAFFKGLTLSEKDMKIANLILREIVERLSFLDKVGLDYLTL
SRAAGTLSGGEAQRIRLATQIGSRLSGVLYILDEPSIGLHQRDNDRLISALKNMRDLGNT
LIVVEHDEDTMMAADYLIDIGPGAGIHGGQVTSAGTPEEVMEDPNSLTGSYLSGKKFIPL
PPERRKPDGRYIEIKGAAENNLKKVNAKFPLGTFTAVTGVSGSGKSTLVNEILHKALAQK
LHKAKAKPGSHKEIKGLDHLDKVIDIDQAPIGRTPRSNPATYTGVFDDIRDVFAQTNEAK
VRGYKKAVSALT
>PK3-2_01648 UvrABC system protein A
MKGGRCEACRGDGIIKIEMHFLPDVYVPCEVCHGKRYNRETLEVTYKGKSISDVLDMTVE
FALSFFENIPKIKRKLQTLYDVGLGYITLGQPATTLSGGEAQRVKLASELHKRSTGRTLY
ILDEPTTGLHVDDIARLLVVLQRLVDNGDTVLVIEHNLDIIKTADYIVDLGPEGGAGGGT
IVASGMPEEITEVEESYTGRYLKPVMERDKKRMASLLKAKETATS
>PK3-2_01649 Flagellin
MRINHNIAALNTLNRLSSNNGAAQKNMEKLSSGLRINRAGDDAAGLAISEKMRGQIRGLD
MASKNSQDGISLIQTAEGALTETHAILQRMRELTVQAGNTGTQQPEDLTAIKDEMDALTE
EIDGISQRTEFNGKKLLDGSVTAGFTFQIGANANQNINVTIGNMDATTLGVKGIDVTADD
FSFDTEIVKIDTAITNVSSQRSKLGAVQNRLEHTINNLGASSENLTAAESRIRDVDMAKE
MSEFTKNNILSQASQAMLAQANQQPQNVLQLLR
>PK3-2_01650 hypothetical protein
MEKDPSDYTVTQESVLKLIHEQKRMNREMIAELEQIHGPLPISHDIQYIKVLLDSSNTHI
VQDLMSVSKQLYKKTL
>PK3-2_01651 hypothetical protein
MNRNQAIIASLCYFSVFIAPIIVPIVAYFVVDEKETKRHAIRSLISHIIPFVGWLVLFIA
LLGGAIATDGDSLLPVFVIIGGAVIYFLVVIGIIIWNVIQGIKVLRAA
>PK3-2_01652 hypothetical protein
MKQEKERILKLVEEGKLTAQEALTLIEKLDSDYKEKEEKITALSVHVHDEEEPFTAAKKE
SGKPSLGAKLFDWIDSAVKKVKEVDLDLNFGHAYDVQHIFQFKDTDFSSVELQIANGSVN
IVPWEDEDIRAECQAKVYRVDTQDAARHAFLQHIECEIKGNKFFIRTEKKTMKTNVTLYI
PQKEYDKIRVKLFNGPVRGEHLHVKEFSAKTTNGVLSFSHLTAEKATAETANGQIKLASH
SCGTIEAETINGLIDLRGRSESIDVQSFNGNIAINVTESDCSSIYAKTTTGSVELAIPDD
LAVKAELKSNLGSLSHELMDVEMLKEKNDTIQKEMMFTSNQAHDQNITVFSESLTGAIKL
KYSQR
>PK3-2_01653 hypothetical protein
MNRLYRSEKNKKIAGVVGGLAEYFNWDASLLRVITVILAVMTSVFPVLLIYIIWIFIVPS
ERDMK
>PK3-2_01654 hypothetical protein
MVKWAVSILVNALLLIVIDGYIDSIHISSIGAAIIASLILSILNVLIKPLLIIFTLPVTM
VTLGLFLFVINAITLMMTASIMGDSFQIDGFGTAIWASVILSVFHLLIQKGILEPLRKK
>PK3-2_01655 hypothetical protein
MGTRVSYPVEVKQKAVEMRLAGVPMKEIMQKLNIKNKTQVQTWVRWHKAGETHRFEQPVG
KQYTYGKGPEYSSELEKLQAEIRYLRQQNEVLKKYNELERKLIAKRQSNL
>PK3-2_01656 IS3 family transposase ISBsu1
MKDHPKRHLEKQIGTLCREHKYRYGYRKITAILKKRMCINHKTVQRIMQKNQWQCQVKVK
KRKKNGQPYAVVDNILDRNFQSDRPLEKLVTDITYLPYGQKQLYLSSILDLYNGEVIAFT
IGDKQDTDFVLDTLNQLPMLSENCVLHSDQGSVYTSYEYQKAVNTKGITMSMSRKGTPAD
NASIESFHSSLKSETFYLNSIDRTTTAIVERTVIEYIHYYNNIRIQTKLNNQSPINYRQL
AV
>PK3-2_01658 Bacillibactin exporter
MVNLSVSVFMIVTAIMQMILGTIIDFKGARFVLIAGILATAAASIGCAVTTDFTLFLIFR
MIQAAGSAALPLIAATTIGQLFTGNERGSAMGTYQMLLSAAPAIAPVLGGFIGEAAGYEG
IFWMLTAISVVILVINSMYFPMDSPAPSRQQSKGNVFTHYKSIFTNRTGNVILTLSFFLF
FIYFAVIVYLPLLLTEHYHIDVSIAGLLYLPLALSTIAGTFLFKKIQAKIALNTLFIGSN
AVAACSIVLFACTHSVSLILMAITLALFGISMGVIPPLYSTMITNEFEHNRGSAIGMFNF
IRYTGMAAGPMISAYLLTLMPSAMSFGLLGLVFAALSFFLLPQMYPPQKRMQQKKHHM
>PK3-2_01659 HTH-type transcriptional regulator PchR
MSDLTKQMIYDIYVRLLHLNEQKANTSLQQFFKEAAEEDMIDVPKNMTSIHVIDCIGQHE
PINNAGIARKMNLSKANVTKISTKLIKEEFINSYQLTDNKKEVYFKLTRKGRRIFDLHEK
LHKKRSWLFTNSSIHFHKMSKMLY
>PK3-2_01660 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MRKYTVIASLLLSLLSVLSGGHHEPKAFPVIKQEPFQTPHYIPLLENPPQIDVKAEMKSN
LVIEAQVRDNEYQAFSAFLFYKQSNELGYKMVPMDPTPGAVRKFLAQIPKRLIWNSELEY
YIVISNGKQRVESETQKLKLEGYQADLAHIPELLITELAVDTKNKGRADGYEFIEIYNTT
DRSIDFKDYHIRYRYPKEGPDSDLIWRPEKKITIPSGETFVVWLKPAGHPEMTAEDFNRY
YQTQLTEGKNLAVLEETEGMANTKPRAVVISTNTGKDISVAHYRKHTLRRLSSVLYKYPL
DGTAELLNISIGEKNPSPGTVLQAQVPEQKRKIKPDKEKPVIEDLTDRKPVRPAESIELR
ADIRDRSLVKTAAFYYRTDENKPFKRILAEKDRNDNLYHYIVYSPELIGKDQLEYYVAAG
DGINEAKTPVKMIDIKQTSKSHGLRMNIENRDTLSGIQFLKATTDRRTDSIKLWIDGKKQ
VTEPAMEKEVFFAFDTRKTNLYFKNAVTMEGKVLKVFDDTTNKYRTYSVPLPETLLRKGK
QLQRITIRSGSKVSPFDTAENRDDFLVKNARLVLSDGTVIRDERVSPEKELFIGDNQRSN
KSWQYQFNLPDGLFTSQLLEWDTSKLSEGAHHIQASDGKENVSLVVRVDNSGPHIEPNIT
EGQTYKGNLILQADMYDTWSKIEEAEASLDGESITLPYHTSSSELLPGKHSLKVTATDLA
GNKTVIERMFKTEREHPDQPEVIGSEADTHSARLSVRVKDPTNDNMDVAFYRGFQYTARN
HVKIFKHASLTEPPKSFMPESETPFTNKELERVSAADGKTVSTEKKELFPYHRFEVTVDP
SVDENDLAEAVWKGSSLPGRKVTMYVWNYRTNEWQPVDSFVAKDDKPFTLKASVIASDFV
RKSKMNVIVQDEVPPAKDMYTFVWMSDTQYYAESYPHIFDKQTAWIKDNQKLLNIKYVFH
TGDIVDDSADIRQWKNADRSMSVLDKNGIPYGVLAGNHDVGHKDGSYRAFGKYFGSNRFD
KKLHYGGSYKNNRGHYDLISSNGNDYIMLYMGWGITDEDIAWMNQVLKKHPDRMAVLAFH
EYLLVSGNRSPIGEKIFKEIVKPNPNVVMVLSGHYHSAMRKTDELDDDGDGKPDRLVHQM
LADYQGGPEGGQGYLRLLQFDQANDMVHVSTYSPYVNDKNYYDTDTYGNKDEFSLSLDLK
PRIKKVETDYFECNVYTNEELGKREQVKSGDTAEFRWDHLEPHSVYYWYTIVEDSFNGKT
KSPIWKFKTKKETYRPVPDQFDFRHVSNP
>PK3-2_01661 HTH-type transcriptional repressor NagR
MNIDKQSPIPIYYQIMEQLKAQIKSGELQPDMPLPSEREYAEQFGISRMTVRQALSNLVN
EGFLYRLKGRGTFVSKPKMEQALQGLTSFTEDMKSRGMTPGSRLIDYQLIDSTEELAAIL
GSGHPSPIHKITRVRLANDIPMAIESSHIPFELAGELNESHFQSSIYKHIERYNSIPISR
AKQELEPSAATSEEARILGIQKGAPVLLIKRTTYLQNGTAFEHAKSVYRGDRYTFVHYMD
RLS
>PK3-2_01662 Glucosamine-6-phosphate deaminase 1
MKVMECQTYEELSQKAARIVADTIKKKPDAVLGLATGGTPEGTYRELIRLHQTENLSFKN
VTTVNLDEYARLSSDDPNSYHYYMNNQFFQHIDSRPSRHFIPDGNADDLEAECRRYEQAV
ESLGGADIQLLGIGRNGHIGFNEPRTPFKSRTHVVTLNEQTRQANARYFPSIDSVPKKAL
TMGIQTILSSKRILLLISGKSKAEAVKKLLEGDISEDFPASALHLHSDVTVLIDREAAAL
RP
>PK3-2_01663 N-acetylglucosamine-6-phosphate deacetylase
MAESLLITGIAIVTENEVIKNGYVGVNGGKISTVSTERPKESYSKEIQAPADSVLLPGMI
DIHIHGGYGADTMDASFSALDTMSSRLPEEGTTSFLATTITQEHGHISQALVNARDWKAA
EESSLLGAELLGIHLEGPFVSPKRAGAQPKEWIRPSDVALFKQWQREAGGLIKIVTLAPE
EDKHFELIRYLKDESIIASLGHTDADFALLSEAAKAGASHMTHLYNAMSPFHHREPGVIG
TALAHDGFVAELIADGIHSHPLAAKLAFLAKGSSKIILITDSMRAKGLKDGVYEFGGQSV
TVRGKTALLSDGTLAGSILKMNEGARHMREFTNCSWMDIANITSANAAKQLGIFDRKGSV
TVGKDADLVIVNSDCEVMLTICRGNIAFISKEADQI
>PK3-2_01664 HPr kinase/phosphorylase
MAKVRTKDVMEQFNLELISGEEGVNRPITMSDLSRPGIEIAGYFTYYPRERVQLLGKTEL
SFFEQLPEEDKKQRMDSLCTDVTPAIILSRDMPIPQELIDASEKNGVPVLRSPLKTTRLS
SRLTNFLESRLAPTTAIHGVLVDIYGVGVLITGKSGVGKSETALELVKRGHRLVADDCVE
IRQEDQDTLVGNAPELIEHLLEIRGLGIINVMTLFGAGAVRSNKRITIVMNLELWEQGKQ
YDRLGLEEETMKIIDTEITKLTIPVRPGRNLAVIIEVAAMNFRLKRMGLNAAEQFTNKLS
DVIEDGEQEE
>PK3-2_01665 Phosphatidylglycerol--prolipoprotein diacylglyceryl transferase
MNEAIEPLNPIAFQLGPLAVHWYGIIIGLGALLGLWIAMRESEKRGLQKDTFIDLVLFAI
PIAIICARIYYVAFEWDYYAAHPGEIIKIWKGGIAIHGGLIGAILTGYVFSRVKNLSFWK
LADIAAPSILLGQAIGRWGNFMNQEAHGEAVSRAFLESLHLPEFIINQMYINGQYYHPTF
LYESLWSFVGVIILLLLRRANLRRGEMFLIYIIWYSIGRYFIEGMRTDSLMLTDALRIAQ
VISIVLIVLAVATIIFRRVKGYSKERYAE
>PK3-2_01666 hypothetical protein
MKKIFMAGLSAGLQTTWTLGKVIFPVTLLVTLLQHTPVMDWLVRLITPVMGLFGLSGEAA
IPLVLGNMLNLYAGIAGILTLDLSVKEVFILAVMLSFCHNLIIESTVAAKVGIRIGIILA
VRIGLAAVSAIVINLIWQGGQETAQYGFIAAKGAAPDGWLGMLAEALMKAGLGVLQLAAI
VIPLMIIIQFLRDLGWLHRFSRWLSPFTQLLGMNKNTSMTMVAGLTIGLAYGAGVMIKAV
EDDGVSRRDMTLAFIFLVACHAVVEDTLVFIPLGIPVWPLLLIRVTTAVLLTMAIAHTWK
KWKPTAVGKEAI
>PK3-2_01667 Pyrophosphatase PpaX
MSDKQVTTVLFDLDGTLINTNELIIASFLHTLEHYYPSKYKREDVLAFIGPSLFDTFSSM
DADKCDDMIAMYRAYNHDMHDTLVTEYETVYETLDALKKAGFKLGIVTTKLRDTVNMGLK
LTGIGEFFETVVTLDDVTNAKPDPEPVLLALKQLESEPEEAIMVGDNYHDVLAGKNAGTK
TAGVAWTIKGPETLAKHDPDYMLEKMSDLLQIVGVK
>PK3-2_01668 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase
MRKTDRHPVSGANSLWHVYQTVPFLKVVKNFIVIQIARYTPFIGMKNWLYRTFLRMKVGK
QTSFALMVMPDTMFPEKISVGTNTIIGYNTTILAHEYLIQEYRIGKVLIGDEVMIGANTT
ILPGVEIGDGAVVSAGTLVHKDVPAGAFVGGNPMRIIYTKEEMQERLKKPAE
>PK3-2_01669 Pectate lyase C
MKKIVSILFMFGLVMGFSQFQSSTAFAADKVVHETIIVPKNTTYDGKGQRFVAGKELGDG
SQSENQKPVFRVEDGATLKNVVLGAPAADGVHTYGNVNIQNVKWEDVGEDALTVKKEGKV
TIDGGSAQKASDKIFQINKASTFTVKNFTADNGGKFIRQLGGSTFHVDVIIDKCTITNMK
EAIFRTDSKTSTVRMTNTRYSNVGQKWIGVQHVYENNNTQF
>PK3-2_01670 hypothetical protein
MKTLRTLCVLIILSGVIFFGLKIDAKDIDIPFLNSLKKVVSDSNTDKAANSTKELKGSAE
PLDVVLYNQMDAPRLYNGCEVTSLAMVLNYAGYNVTKNTLANKIATVPLTYSSGLKGDPN
DGFVGDMANGPGLGVYHGPIYQLAKTYAGDKVSDLTGKRISAVYQQLEKGNPVWVITTAN
FTPVDNMQTWKTPNGTIDITYSEHSVAVTGYDEQYVYLNDPYGYKNRKTDRTSFEKAWKQ
MGSQAIVIQK
>PK3-2_01671 ATP phosphoribosyltransferase regulatory subunit
MFMFEKPHGMRDTLPGLYETKKKVRQSLTDLIDKWGYQFMETPTLEFYDTVGVQSAIEEQ
QLFKLLDQDGKTLVLRPDMTGPIARVAASKLLKQDHPLRVGYAANVFRAQEREGGRPAEF
EQVGVELIGDGTTSADAEVIALVIGALKSAGLASFKIAIGHAGIADALFVEVLGNVERAD
VLRRFLYEKNYVGYREHVKSLLLSSIDKSRLLELLELRGGIEVCGRAEEIVDSAQGKSVV
DELKVLWDILEDYGCTENVRLDLNMVSHMSYYTGILFEVYAENVGFVIGSGGRYNKLLGH
FDSPAPATGFGLRIDRLIEALYMKEEPCEIDAVIFSKEQRVQAIAYANEERMRGNKVVLQ
DLSGIENIDQMTKSFANVTYFIGARKEEQNG
>PK3-2_01672 ATP phosphoribosyltransferase
MGKLLTMAMPKGRIFEEAAGLLRQAGYKLPQEFEDSRKLIIDVPEENLRFILAKPMDVTT
YVEHGVADVGIAGKDVMLEEERDVYEVLDLKISKCHLAVAGLPNTDWSGVAPRIATKYPN
VASSYFREQGEQVEIIKLNGSIELAPLIGLADRIVDIVSTGQTLKENGLVETEHICDITS
RFIVNPVSYRMKDDVIDEMASRLSLVVEGETAK
>PK3-2_01673 Histidinol dehydrogenase
MKIKTISGAERLSLKRSIDAGTEEQRKTVRSIIDDVKANGDQAVRSYTARFDGIKVDSPL
VTKEEIEEAYTLLDSQLLQVIRQAIENIREYHERQLQSSWFYHRKDGTMLGQKVTALDSA
GVYVPGGTAAYPSSVLMNVIPALTAGVERIVLVTPPGKDGKLSPGVLAAAAELGIKDIYK
MGGAQAIAALAYGTETIEPVDKITGPGNIYVALAKREVFGDVDIDMIAGPSEIVVLADET
AIPSEIAADLLSQAEHDKLSSCVFVTDSMTLAEAVSAEVNEQLKTLPRREIAEASVNDFG
CIYVADTMDEAIDTVNTLAPEHLEIITQSPEALLGRIKHAGAIFLGRYSPEPVGDYFAGP
NHVLPTNGTARFSSPLNVTDFQKKSSIISYSQSAFEEHAESIAAFARLEGLEAHARSIEA
RERGNSK
>PK3-2_01674 Imidazoleglycerol-phosphate dehydratase
MRKAERARKTNETDIELAFTIDGEGQADIKTDVPFMTHMLDLFTKHGQFDLSIHAKGDVD
IDDHHTTEDIGICLGQALLEALGDKKGIKRYGSAFVPMDEALAQVVIDLSNRPHLEMRAD
FPAAKVGTFDTELVHEFLWKLALEARMNLHVIVHYGTNTHHMIEAVFKALGRALDEATTI
DPRVKGIPSTKGML
>PK3-2_01675 Imidazole glycerol phosphate synthase subunit HisH
MIGVIDYGMGNLYSVSKALERVGVPYFVSENPEELKEADAFILPGVGSFGDAMDNLRNAK
LDQLIHDMVSEGRLLLGICLGMQLLFDQSEENGTSPGLGLLKGKAVKLQAEDEQGNKLKV
PHMGWNRLSFHNQSPLLAETEEGYAYFVHSYYIDGMEEAALLASADYGVRVPAVVGKENV
FGAQFHPEKSSTAGMSILTQFTKMAAEQ
>PK3-2_01676 Phosphoribosyl isomerase A
MSAFTLYPAIDMRNGKCVRLVQGDYNKETIYGDSPYDMAALFANEGAEWIHLVDLDGAKE
GKRVNDRHVIEIAQKLDLKVEIGGGIRSESDVYEYLSAGVDRVILGSSAVSNPPFVKKML
KQYGGKIAIGLDARNGFVSTEGWLETSTLKAAELGKELANEGAEVFIFTDIATDGMLSGP
NIESTVELAKETGKSVIASGGVSSVEDLEALARYQADGVSGAIIGKALYTNQFTLSEALE
RVKGK
>PK3-2_01677 Imidazole glycerol phosphate synthase subunit HisF
MITKRIIPCLDVKEGRVVKGIQFLELKDAGDPVELAGVYDQEGADELVFLDISASHEGRK
TMVDVVEQVAAKLAIPFTVGGGINQLSDMKTILRAGADKVSVNTAAVLRPELITEGAEFF
GSQCIVLAIDAKYDQESGTYKVYTHGGRKKTDWEVTAWAKEGVKRGAGEILLTSMDSDGE
KKGFDHRLTKLVSEAVPVPVIASGGAGNAQHMLEAFTKGEADAALAASIFHYKETSIKEV
KSYLKEHGVNVR
>PK3-2_01678 Histidine biosynthesis bifunctional protein HisIE
MKQADELRFNEDGLIPAIVQDAASKEVLTLAYMNKESYEKTLETKETWFYSRSRQELWHK
GETSGNTQAVKGIRYDCDQDALIVLVEPSGPACHTGSYSCFTKEQTEEQAAGRFDIINEL
ERVIAERQAEMPEGAYTTYLFREGVDKILKKVGEEASEVIIAAKNRDHEELKWEAADLLY
HLLVLLREQALPLDDVLDVLKKRHSEK
>PK3-2_01679 hypothetical protein
MNKKIDELNKRVERLEQELESVKKEIAYLTADKKEQTIVKTEEYLKISKETEVPKEKHTL
ENMAGNWLPKIFIFVFLLGMIWAFAAAAEKGWVNTYMRVAAGLIVSIVLYVLGSRQYKKN
ASVLSISLLAGSNIVYIVSLFAGNMLYKIVPTSLTMILLAAGVAGGVYISRKYRSQTLIA
VIGAGVYLYPFLFGREQGNEYIFYVYEALVFAGLMYETVKQRYSVAWNIANYAFILAIFA
FLLFTDAEVSVWTLAVFIMQQAIMLYSALTSQSRFKKAVYLTAISIGAFVVFFTGFGLYI
KNDTALYAFYIAAFGFYILLSLWKTKGFSEIKHTLFVISMIYLNVLAADALDGNEILLYI
IFTLQGIIMCYVSYSKKSRLIGIAGVIVLLQSSCGLMQYPARSLHIFSIFAWLLLISSLF
AAYLFSKKIHYKQAAIVVTYAVSFLMLVFFSKLSIWITDKIDGVSSNAGVSLSWFMFVIV
MYAIYYAAKDKTWNRIGLIFLFITLAKMILIDSASIDIVWRAVLFILLGIIGLFISRIFY
SKKEKQ
>PK3-2_01680 Putative lipoprotein YvcA
MKKIILISISLLLTLTGGCSMNNNDQNSTNDNKTKAVNPKNIDPKDLPQVPAFQDEKTRE
YMVSTKEEEPGYYVLESKLKGFRMSFPADAKYLARRSSLTGKNKESIGFNSYDKDTNVMF
DGHVTFYKEESFVNEPETMLDIVSGKNDYKGEYKKSSKKNTDIYFAKKKDIFEDIERKYN
YSYSYFGYVKSTEEDNLGIEFAFTFGCKNENQPCSLDEEKAKNKVEKLINSITFFIR
>PK3-2_01681 Putative lipoprotein YvcA
MKKFIFICFSLLLALTGGCSMNDNDKNTTNDNKTEAVNPKNIDPKDLPQVPAFQDEKTRE
YMVSTKEEEPGYYLLESKLKGFRMLFPEDGEYVPDLSSTGENEETIVFDSFNKKLTFNMI
GNWIIIKKKVLRMTRIQCWTL
>PK3-2_01682 Putative lipoprotein YvcA
MLDIVSGRNSYEGKYEERKLSDKIVYSAQKKSVFDDVEGKNNLSYRFFGYVKSTKEDYLG
IEYSFRFACYKDEETCSLKKEEAKKVQKIIESGK
>PK3-2_01683 Putative lipoprotein YvcA
MKKIIFIFFSLLLALTGGCSMNDNDKNSTNDNKTEAVKPKDKDPKDLPQVPAFQDEKTRE
YMVATKEEEPGYYLLESKLKGFRMLFPEDGEYVPDLSSTGENEETIVFDSFNKKTNIQYD
GQLDYHQDKSFANDKDTMLDIVSGRNSYKGKYEERELSDKIVYSAQKKSVYDGIDGENNL
SYRFFGYVKSTKEDYLGIEYSFRFACYKDKESCSLKEEDARKKVQKIIDSITFLKVKKEK
>PK3-2_01684 hypothetical protein
MKNKNILENENVKLRLINLEYDYKERFASDKESEIKKAKTDFEADVRRIYKEETHRDLPK
NVEIYTSNELIKKNSKVNTSIRESGYDGTAIYIKDDKQHINQLHIISEGSVDNEDWSYNF
FGLFLGMDNSQYQATKEFTRNAKKETNDSNDLKTFAMGHSLANNNQVMVQLIDGEFDEVY
GVNGAQISVDHLLATDLNLRDTLMHKFHIRRLRDINDIPPEKLKKEIQKYYKDKGVTANI
TQRISKDDPLYGASGKADFITFGDVKMADTNTSVKGIRNIMDGIPDEDVRSIQKFLQKYK
DDYEKDGLNGFIKAASGIDIDLIEKVKYTDGALKKVSVLYENFDDVKQMYGRIKEELPAF
LGFLHTLLRNSGPVVDQLAENGYIDGTQKKVIKKELTNLNASMRGIESRYEHFIDHLKHG
QFTQALKDVGEIVEYVKSILSSIETLDKETKDALKLIVDGHSIVQMLNALSKEKGFSYKG
SDIYFTGKSGSGETIKVNISSAVRIYQNGMKIVEDMEDAISKYQKVYSQEIDEDFIDKKQ
AITTAIHHMEENPSHYAFDLQFRLAAGFSHTFDKLEKISVHESFHTGALPANDGIVAELK
KQTTDKRDFIKNIRESIEKLFEKEEMISQLFDFQT
>PK3-2_01685 hypothetical protein
MTSLFSESETEIVSTTYMFLTHDEMKGKAGSLNKPINDFLSLTKKFESSLKEEIKGQKGL
IVKKIKKELESKSEKQKAALQTIKEEHTAKVDRYKMIIEDLRQQDVTLTYRKKKPVKDA
>PK3-2_01686 Multidrug resistance ABC transporter ATP-binding/permease protein BmrA
MPTQQQKSKSKLKPFFALVKQTNPSYGKLAFALVLSIVTTLVSLLIPLLTKQLVDGFSMS
NLSSTQIGLIALVFFVQAGLSAYATYALNYNGQKIISGLRDLLWKKLIKLPVSYFDTNAS
GETISRVTNDTMVVKELITTHISGFITGIISVFGSLTILFIMNWKLTLLVLVVVPLAALI
LMPIGRKMFSISRETQDETARFTGLLNQILPEIRLVKASNAEDVEYGRGKTGISSLFKLG
VREAKVQSLVGPLISLVLMAALVAVIGYGGMQVSSGELTAGALVAFILYLFQIIMPMGQI
TTFFTQLQKSIGATERMIEILAEEEEDTVTGKQIENAHLPIQLDRVSFGYKPDQLILKEI
SAVIEAGKVTAIVGPSGGGKTTLFKLLERFYSPTAGIIWLGDKPVDTYSLESWREHIGYV
SQESPLMSGTIRENICYGLERDVTDAEVEKAAEMAYALNFIKELPNQLDTEVGERGIMLS
GGQRQRIAIARALLRDPSILMLDEATSSLDSQSEKSVQQALDVLMEGRTTIVIAHRLSTV
VDADQLLFVEKGEITGRGTHHELMASHDLYRDFAEQQLKMNADLENKAG
>PK3-2_01687 hypothetical protein
MGKHTSEHKNHAQIVQLLQDGQYFFHKGLKAYKERNLKRASKLIQRAVHLEPEDSEMLSQ
LAVIYSEMGQYQESNDLLDYIMANLEAELPECHYFKANNFAHLGLFQEAYKEAAAYSDAD
PDGEFAEENDNLLDLLDLGDGGTEDSLYDQDELLLRQDRAKSLLESGQLAEAVAALEEIT
ADYPELWSAYNNLALAYFYSGNIVKAKQTAYQVLSHNEGNLHALCNLLVFYYYEREDEKV
AELSDQLSNVYPMLLEQRYKLGATLALVGRYEIGYKWLKSLYKNGFEGDDTFFYWLSCSA
YFTGHTEFAETIWRKVESQYPGEDRPAPWVERREALPSSVEQRLAAYYISSTKGETEHLE
AVIRSKRITAPFENHFVKLLLNGDSAAPDVSEDALFAYQTVKLLEQAEKEEMKTEVMSCW
VFHVIQQIRAAASLKNERGWAAAICYIWKEAHGKHDTKKDTAARFGISPATLTKYMKYID
DILE
>PK3-2_01688 Peptidoglycan DL-endopeptidase CwlO
MRKSLITLGLASVIGTSSFLIPFTSKTASAETLDEKKHKIESKQSEVASSIEAKEKELTE
LQENQSKIEKELKDINAKALDTSNKIEDKKEENDKTKEEIKKLKKEIKETEARIEKRNEI
LKKRVRSLQESGGSQGYIDVLLGSTSFGDFISRATAVSSIVDADKDLIKQQEQDKAKLED
SEADLNDKLKEVQAALAKLETMQKDLDKQLDEKDKLFDQAKDSQKKTAKAISELKSEASE
LANQKANTEAEQARIKKEQEAAAALIKKQEEAQKASDETQTDDSQTATTETAKASSSSDD
SSDKSSNGSSNSSSNGSSSKKSSSSNSNSGGTVISNSGGIEGAISVGSSIVGQSPYKFGG
GRSQSDINNRIFDCSSFVRWAYASAGVNLGPVGGTTTDTLVGRGQAVSASDMKRGDLVFF
DTYKTNGHVGIYLGNGTFLNDNTSHGVSVDSMSNVYWKKAFKGVVRRVVQ
>PK3-2_01689 Thioredoxin reductase
MSEEKIYDVIIIGAGPAGMTAAVYTSRANLTTLMIERGIPGGQMANTEDVENYPGFESIL
GPELSNKMFEHAKKFGAEYAYGDIKEVIDGKEYKVVKAGSKEYKARAVIIAAGAEYKKIG
VPGEKELGGRGVSYCAVCDGAFFKGKELVVVGGGDSAVEEGVYLTRFASKVTIVHRRDKL
RAQSILQARAFDNEKVDFLWNKTVKEIHEENGKVGNVTLVDTVTGEESEFKTDGVFIYIG
MLPLSKPFENLGITNEEGYIETNDRMETKVEGIFAAGDIREKSLRQIVTATGDGSIAAQS
VQHYVEELQETLKTLK
>PK3-2_01690 8-oxo-dGTP diphosphatase
MTYLQRVTNCVLQTDDKVLLLQKPRRGWWVAPGGKMESGESVRDSVIREYREETGIYIIN
PQLKGVFTFIIKDGDHIVSEWMMFTFVADSYTGQNVSESEEGKLQWHGVNDIQNLPMAPG
DGHILDFMMKGQGLLHGTFTYTPDFELLSYRLDPQHIK
>PK3-2_01691 Nucleotide-binding protein YvcJ
MSVNESHDIQLVIITGMSGAGKTVAIQSFEDLGYFCVDNLPPSLLPKFLELMKESNSKMS
KVALVMDLRGREFFDRLIEALDEMAENPWITPRILFLDAKDSILVTRYKETRRSHPLAAT
GLPLEGIALERELLEELKGRSQIIYDTSDMKPRDLREKIVKHFASNQGETFTVNVMSFGF
KYGIPIDADLVFDVRFLPNPYYIESMRPLTGKDEEVSSYVMKWNETQKFNEKLIDLLSFM
LPSYKREGKSQVVIAIGCTGGQHRSVTLAENLADYFKKDYYTHVTHRDIEKRSRK
>PK3-2_01692 Gluconeogenesis factor
MGQKPKIAIFGGGTGLSVLLRGLKHKPVDITAIVTVADDGGSSGRLRNELKIPPPGDIRN
VLAALSDVEPLVEDLFQHRFNKGNDLTGHSLGNLILAAMTNITGDFFHAVTEMSKVLNVR
GKVLPAANASVVLHAEMEDGRVVSGESTIPAYGQRIKRVFLTPEQIDPLPETIDVIREAD
LIIIGPGSLYTSILPNLLVPKIGEEVIKAPAKKVYICNVMTQPGETLHYTAADHVKALNQ
HMGCGFIDTILVNSEDIPDEIKRKYEMESARPVDFDIEELKAMGLEVIRDQIVTYKNDVI
RHDTHKVASLLVDLLKE
>PK3-2_01693 putative cell division protein WhiA
MSFASETKKELTNLEVKDCCIKAELSALIRMNGALSFTNRHLVLDVQTENAAIARRIYTL
LKKQYDVSVELLVRKKMRLKKNNVYIVRFSENAKAILEDLKILGENFVFERSISEELVKK
RCCKRSYMRGAFLAGGSVNNPETSSYHLEIFSLYKEHNDSLCELLNEFQLNSKTLERKKG
YITYLKEAEKITEFLNVIGAHNSLLRFEDVRIVRDMRNSVNRLVNCETANLNKTIGASLR
QVENIKYIDERIGLDALPEKLREIAQLRIDYQEVTLKELGEMVASGKISKSGINHRLRKL
DEIAEQLRTGQTVTLK
>PK3-2_01694 HPr-like protein Crh
MVQQKVEVRLKTGLQARPAALFVQEANRFTSDVFLEKDGKKVNAKSIMGLMSLAVSTGTE
VTLIAQGEDEQEALEKLAAYVQEEV
>PK3-2_01695 Arylamine N-acetyltransferase
MSDFLKDCFQKIGWEKDHVSFGDLPLFLEAMAYRFPFENRAVLANEDYKVTKEELWRRLV
KEQHGGLCYDLNGFLYFVLREAGFHVKLIRGTVYAGHQEEWALEGTHAAVWLSAEKGEYI
VDIGFGINLALQPIPLSGKTVQSPVGSFRIKEEETEKGSHVLLMDKGEGWQIGYAFTLEE
SDLDDLDDMKDMIHLHEKSPFNKSPLASKLTLNGRMVMSDRHLTIHENGGEGQKSDIAPS
EFEKKLNTYFL
>PK3-2_01696 hypothetical protein
MKKIMLLVTITSILSACQPNYTGEYIEIGDSLTEYTKECFKENQIPYQYEKGKLYIPEDA
FDVVINTCS
>PK3-2_01697 Response regulator protein GraR
MYRILLVEDDDRIASLLGGHLHKYGYEVKIAEQLNDIKLEFAEMKPDLVLLDINLPFFDG
FYWCRQIRTISNAPIIFISARTDELNQVMAIENGGDDYITKPFHLEVVMAKIKSVLRRTY
GEYSPSLPQESRIIELGGLTVYPDQNEAEWNGTRILFSQKEFQLLSIFVRGHKKIVSRDE
LLEALWDDIDFVDDNTLTVNVNRLRRKLENAGLKDCISTIRGQGYQFQVNRKDEPEC
>PK3-2_01698 Sensor histidine kinase GraS
MLKTYLIDRFAIILFSLLGIGVSMLIAYLSIIESGAEPSAENIIYIWILPGALLAAGFAA
DYIRQFSFLTYVKKLAEQANSSNDIGQSLKARKPRTREQALWTKMVNALGQQYEGRLLQY
MNQQKQHYTFTNQWVHHMKTPVSVISLMIQEGKNGTASSFPTFLEELEDENERFRHGLDM
MLQTARLEEFAFDVRPQTFDLTELVRSLINQEKRQFIKRRLFPKLHVPANAVQISSDQKW
LSFVVEQLLFNALKYSKQGAGDQITIRIETEGHETRLSVADEGIGIPPQDLPRIFDAFFT
GENGRTMTEATGMGLYLAKQVCSRLGHQLYAESKEGIGTVMTIVFSSDTLVNVTAL
>PK3-2_01699 ABC transporter ATP-binding protein YxdL
MNVLQTTNLSKTYYSNKGTISYQALNDFDLSVAKGEFVGIMGPSGSGKTTLLNLLATIDK
PTQGEMMINGIQPKTLKDQDLALFRRRELGFVFQDFNLLDTLTIRENILLPLALDKVKLR
EMEARLEELADTLQIKHILDHRTYEVSGGQQQRAACARAIIHNPALILADEPTGNLDSKS
AKQVMNTLAQLNDEKEATILLVTHDATAASFCKRIVFIKDGRFFSEIRRGTNRQVFYQSI
LDTLSVLGGDFYEFENHRQ
>PK3-2_01700 ABC transporter permease protein YxdM
MNLRTIASKNILGNLQRYVAYFLSCVFAVSVFFVFTSFIFHPDVNEDNIYGGSLVKTCLS
AALIVIVVFCIFFISYSNSAFLQARKKEFGLLTLFGTSKQQLRKMIYYEQSLISLAAIAA
GIGAGLLFSKLFFMIMTWMLSVKVPISFAIVPKAFVMTAAGFLILFQTLLILSLGRIRKL
EIIELIKSAQKPKSLPAYSKWLTVLSVLCLGGGYYLAATANAIDMVFRVFPILILVLIGT
YFFFTQSSVAFFRTLYRKKHSFYKGTNIIVRSNMIFRLKDHARMLFLTSIITAVILTATG
VIYMFYADLQRQEEQSIPQSVSWVEKDASRFQVMEPKTAENTLKQADAEIKYKVNTTGIP
VTFKTALPFGNRKAEAGALLISEQTYNQIAKEKGYPVIHLQDQEAFINVAFQMMTKDTFG
EGENATFHTKSGKALSYVMKKQRNQGILMPVGEISRLLVVSEKSFVSLTQEVSLKEQTRV
IGYELENWKETVDVSKKLEGMVPKEHQSDFQTRAPGYQVIKQAVALTLFIGMFVSVLFFI
VQGSMLYLRMFTEIEDTRVQVLALKRIGITDKEIHSILGKQIGFLFFIPFIAGAIHAGFA
YVALSNMLNSNLFFEAVLVIFIYFVFQAVYYLVTRRIYKRAVLQHISF
>PK3-2_01701 Glyoxylate/hydroxypyruvate reductase B
MKPFVFITKPIPEEIEAFIGEHCRYEIWKEDTLPNNVLFEKLKDAEGLLTSGTSGPSINR
ELLEHAPKLKVVSNQSVGYDNFDIEAMKERGVVGTHTPYTLDDTVADLAFSLILSSARRV
AELDRFVRAGKWGTVEEEALFGIDVHHQTLGIIGMGRIGEQAARRAKFGFDMEVLYHNRH
RKQEMEDSIGVKYAELDTLLEQSDFILLITPLTEETYHMIGEREFKMMKDSAIFVNISRG
KTVDEKALIRALQEGWIRGAGLDVYEKEPVTQDNPLLQLDNVTLLPHIGSATAKVRFNMC
NQAAENMIAAIQGQTPKNLTREFQQ
>PK3-2_01702 Carbon disulfide hydrolase
MVSLTSILEHNQRFVREKKYEPYKTTKFPSKKLVIVTCMDTRLTELLPQAMGLKNGDAKI
VKNAGAIVSHPFGSVMRSILVAIYELQAEEVCIVGHHECGMSGLNATSILEKAKERGVEE
NCLNLLASAGLDLKTWLTGFHSVEESVSHSVNLIMNHPLLPKKVPVHGLVIHPETGKLDV
VINGYETELINTQL
>PK3-2_01703 C4-dicarboxylic acid transporter DauA
MRFSGRFKGYNLQKFQKDLIAGIVVGVVAIPLGMAFAIASGVEPEYGLYTVVIAGICISL
FGGSKYQIGGPTGAFVPILFGIVMQYGLENLLIAGFMAGVMLVLFGLFKLGKIMKFVPKP
VIVGFTAGIAVLIFTEQIANFLGLRNVEKHENFHHNMFEIAQKLGTFNGYAILTAVIGLV
ILLVSAKVMPKVPGALLALLISTLVAVVFFPDRMATIGSTFGEIPRHLPEFQFPELTLDK
MVMLFPAALVIALLGGLESILSAMVADNMKGSKHDSNKELVGQGIANMAAPLFGGIPATG
AIARTATNIKNGAVSPVSGVVHGVVVLLVLLVFAPYASHVPLASMAPILMVVAWNMSERK
EVANMLRLKNADSIILAATFVLTVLFDLIIGVATGLLLAFVFFIRRMSEATRVHNQESHP
VLAKREDPSVSMYAIEGPLFFGSIDSLESSLLEHVQKKPKTLILLMNKVHYMDTSAEAVL
GNIMNRIKRHNGKLMIVGLQSQPKELLHKTGLFHKIGKQHFFDHHDEITG
>PK3-2_01704 hypothetical protein
MQLADAEKWMKEFYEKRGWTEYGPFIRVGFLMEEAGELARAVRAYEIGRDRPDEKESTRA
EQKQELIEEMGDVIGNIAILADMYGVSLEDVMKAHQEKLTKRFEHA
>PK3-2_01705 LOG family protein YvdD
MKTICVFAGSNPGGNEAYKRKAAELGTYMAEQGIGLVYGGSRVGLMGAIADAIMENGGTA
IGVMPSGLFSGEVVHQNLTELIEVNGMHERKAKMSELADGFIAMPGGFGTYEELFEVLCW
AQIGIHQKPIGLYNVNGYFEPMMKMVKYSIQEGFSNESHLKLIHSSSRPDELIEQMQNYS
YPILEKKWTEI
>PK3-2_01706 HTH-type transcriptional repressor PurR
MATLSDVAKKANVSKMTVSRVINHPETVTDELKKLVYSAMKELNYIPNYAARALVQNRTQ
VVKLLILEEMDTTEPYYMNLLTGISRELDRNHYALQLVTRNSLNIGQCDGIIATGLRKTD
FEGVIKAFEKPLVVFGQNEMGYDFIDVNNEKGTFMATRHVMGLGEREVVFFGIDLDEPFE
RSREQGYIRAMNESFRKTNLFRIDNSSKKSECLAREVLKSLDKQAAFVCASDRIALGVIR
AAQSLGKRIPEDVAVTGNDGVFLDRISSPRLTTVRQPVVEMGEACARMLLKKMNEDGAAQ
GNLFFEPELIVRESTL
>PK3-2_01707 Intracellular maltogenic amylase
MEYAAIHHQPFSSDAYSYDGRTVHIKIRTKKGDADRISFIWGDPYEYNAGRWSANEQPMR
KIAATDMHDYWFAEVVPPFRRLQYAFVVTDRHEDIFFGSLGVCPYNEKTLETIHYYFKLP
FVHETDTFQAAEWVKSTVWYQIFPERFANGREDLSPENALPWGSKDPGVNDFFGGDLQGI
IDKLDYLEELGVNGIYVTPIFSAPSNHKYDTLDYYSIDPHFGDPELFRTLVSQLHQRGMR
IMLDAVFNHIGSASPQWQDVVKNGAQSRYKDWFHIHSFPVKEDNYDRFAFTPDMPKLNTA
NPEVQRYLLDIALYWIREFDIDGWRLDVANEVDHVFWKTFRQAVSAEKPDVYILGEIWHS
AEPWLRGDEFHAVMNYPFTEPMMEYFADRTIPASRMAHRINAHLMNGMKQANEVMFNLLD
SHDTKRLLTRCRNDEKKARALLAFMFAQTGSPCIYYGTEIGLDGENDPLCRKCMVWEKEK
QNQDMLRFMKRLIALRKQEHTLLTEGNLEWILLDDQNDLISFSRTLNEKTMIYFFNQGEG
TRHISLRDLNIERNKKICDVWTEQPLHQNDVIAVQPGEFFILGASAPV
>PK3-2_01708 Maltodextrin-binding protein MdxE
MILFKKGFALLAASVLTFGLAACSNSKDPASSDGKKVLTVSVEETYKDYIESIKAKFEKE
NDVTIKIVEKQMFEQLEALPLDGPAGNAPDVMLAAYDRIGGLGQQGHLLDIKPSHTKSFG
DKEMQQVTVDGMVYGMPLVIETLVLYYNKDLLQTAPKTFKDIEKLTEDSRFAFASEKGKS
TGFLAKWTDFYMSYGLLAGYGGYVFGKNGTDSGDIGLNNKGAVEAVKYAEKWFKTYWPKG
MQDNSSADDFIQQMFLDGKAAAIIGGPWSAANYKEAKLNYGAAPIPTLPNGEEYAPFAGG
KGWVASKYTKEPELAEKWLEYAANDANAYVFYEDTNEVPANTAARKKADEQKNELTSAVI
KQYETATPTPNIPEMAEVWTGAESLIFDAASGKKAAQTSANDAVNVIKENIKEKYVK
>PK3-2_01709 hypothetical protein
MNTHHTLAKQKRKAGFLSIIPGLGQIANQQFSKGLLFLAITCLFVVELSVFGIQALIGLV
TLGSVPGEDHSLFMLIEGTLQLIVTVIFLMFYIFNIYDSRKAAAMRAAGLKVNTTAKEMI
CHAGDKGFPYLFTLPAYIMMVFVIMFPVLVTLFVACTNYDFYHIPPNSLIDWVGFKNFMN
IFFLGSYRETFMNVLGWTIIWTICATTLQIILGIVTALFVNQDFIKGKRIFRMIFLLPWA
VPAFITIMSFSNMFNDSIGAINAQVIPLLNHLPFVELPAIAWKTDPFWTKTALIMIQTWL
GFPYIYVMVTGVLQAIPGELYEAAKIDGATFIQRFQHITFPMILFATAPVMITQYTFNFN
NFSIIYLFNEGGPGSAGAGAGSTDILISWIYKLTTGTSPQYSVAAAVTLLISFIVIGISL
IAFKKSNAFGNEEVM
>PK3-2_01710 Maltose/maltodextrin transport system permease protein MalG
MNAKTAKMLNRICNYLFLALLSIVIIYPLLITASSAFRVGNAASFQLDFSGSWTLDHFKR
LFDETLYLHWYSNTLVIALSVMVLQVTIVTLAGYTYSRYRFAGRKKSLVFFLIIQMVPTM
AALTAFYVLAMLIGALDQYWFLTAIYIGGGIPMNTWLMKGYFDTVPREIDEAARIDGAGH
LRIFASIVLPLVKPMLAVQALWAFMAPFGDYLLAKFLLRSPERLTIAVGLQSFISNPQQQ
KVALFAAGAILAALPICVLFFFSKRTLCPG
>PK3-2_01711 hypothetical protein
MKNLQNESFMIRCLKAAASPSRICRYAHTFSWLQLSFLFLFLTASLMAPLTVSFIKMDRF
DVASFMPAAIQQVNDQFADQLQGFQIRNGKLTGGKSSNQIEEGQNLLAIDTKHEYETSGE
NGRLKVTGYDNAIIFQSDQLVITDQNGTGFSVGYAKLDTELKEQNVHDVEVLIDTLWLAQ
YKPMIMMLAYTVIFLIQLFLTVVLAGGIWITKISNMISIVSFKEAATMAICASALPAFTA
AAVGMVHFDLITVLMIHSCGVILMISFAFRSLTKPRRYNGNLHSGGNDDKSAVI
>PK3-2_01712 Maltose phosphorylase
MINQRLFEIDEWKIKTHTFQKAHTRLQESLTSLANGYMGIRGNFEEGYSGDSHRGTYIAG
VWFPDKTRVGWWKNGYPDYFGKVINAMNFIGIGLYVDGEKIDLYQNQIESFKLELNMKEG
ILRRSVVVRIQDKIVRIRSERFLSLAVKELCAIHYEAECLTGDAVITLIPYLDGNVANED
SNYQEQFWQEEAKGADSHRGHLVTKTIENPFGTPRFTVSAAMANVTEGFVSESSQIAEMY
VENRYSYQTKASLKKFIIVTTSRDVRETELLSKAKELLAGVLESGYEEAKRRHTEQWKER
WAKADIEIKGDEELQQGIRYNIFQLFSTYYGGDARLNIGPKGFTGEKYGGAAYWDTEAYA
VPMYLATSEPGVTKNLLLYRYHHLEAAKRNAAKLGLKGALYPMVTFTGDECHNEWEITFE
EIHRNGAICYAIYHYVQYTGDDNYMKEYGIDVLVEVSRFWADRVHFSKRINKYMIHGVTG
PNEYENNVNNNWYTNVMAAWTLEYTLENLERISVEKRRLLDVQEEELEAWRNITEHMYYP
YSEELRIFIQHDTFLDKDLQSADELDPAERPLYQNWSWDKILRSNFIKQADVLQGIYLFH
DRFTIEEKRRHFEFYEPMTVHESSLSPSIHAVLAAELKMEKKALELCKRTARLDLDNYNH
DTEEGLHITSMTGSWLAIVQGFAGMRITNETLSFAPFLPKEWDGYSFNINYRNRLINVAV
GKMSAVFQLVKGEPLRMKVYEEPIVLNGRYERRTPDE
>PK3-2_01713 Oligo-1,6-glucosidase 1
MSEWWKEAVVYQIYPRSFYDANGDGFGDLQGVIQKLDYIKNLGADVIWLSPVFDSPQDDN
GYDISDYRNMYEKFGTNEDMFQLIDEVHQRGMKIIMDLVVNHTSDEHAWFAESRKSKDNP
YRNYYFWKDPKPDGSEPNNWGSIFSGPAWTFDEGTGQYYLHYFSKKQPDLNWENEAVRRE
VYDLMRFWMDKGVDGWRMDVIGSISKYTDFPDYETDNSRSYIVGRYHSNGPRLHEFIQEM
NREVLSHYDCMTVGEANGSDIEEAKKYTDASRQELNMIFTFEHMDIDTEQNSPNGKWQIK
PFDVVALKKTMTMWQSALMNVGWNTLYFENHDQPRIISRWGNDGKLRKQCAKAFATVLHG
MKGTPFIYQGEEIGMVNSDMPLEMYDDLEIKNAYRELVVENKTMSEKEFLKAVAKKGRDH
ARTPMQWNAGKHAGFTAGDPWIAVNSRYQDINVEESLEDKDSIFYYYQKLIQLRKQYKIM
VYGDFQLLQENDPQIFSYLREYQGEKLLVVVNMSEDKALFEVPPELIHEHWKVLITNYSH
ERADLKSIFLEPYEAVMGISI
>PK3-2_01714 Beta-phosphoglucomutase
MKAVIFDLDGVITDTAEYHFLAWKHIAEQIDIPFDRSVNEGLKGISREESLESILIVDGA
ETKYTNAEKQKLMHLKNQYYQMLISKLTPEDLLPGIGRLLCELKGENIKIGLASSSRNAP
EILKRLEIIDDFHAIVDPTALANGKPDPEIFLTAAALLGVSPADCAAIEDAEAGISAIKS
AGMFAVGVGHEQSMFGADLVVRNTCDLTLELLNEEWEQYKIKSF
>PK3-2_01715 ATP-dependent Clp protease proteolytic subunit
MNLIPTVIEQTNRGERAYDIYSRLLKDRIIMLGSAIDDNVANSIVSQLLFLEAEDPEKDI
SIYINSPGGSITAGMAIYDTMQFIKPKVSTICIGMAASMGAFLLAAGEKGKRYALPNSEV
MIHQPLGGAQGQATEIEIAAKRILLLRDKLNKVLAERTGQPLEVIERDTDRDNFKSAEEA
LEYGLIDKILTRNTEEQK
>PK3-2_01717 hypothetical protein
MGILSGNPQDEPMHYGEVFSLWTYVMAGNKMVGNYQMLLNHVGDDDLKKLLRESIEKCQD
EIKQVSTILKENGVALPPASPEPPAADLNDIPPGARFLDPDVAASAAAQNAAGLVTCSKI
MGQSIREDIAMMFGQFHLSKAATGAKYLRLLKNKGWLIPPPLHLQKHQDS
>PK3-2_01718 Guanidinium exporter
MAWFLLVIAGIEEIIAAIAMKYIDGTRKKWPIIVMTAGFGLSFYCLSQAMLVLPAGVAYA
VWTGIGSIGVSAVGFIWFKERFQLPQVISLFLILAGVIGLRLTSSS
>PK3-2_01719 Guanidinium exporter
MNWVLVFIAGLLEIVWASSLKHADSLLDWVVIFILIAISFMLLIRSYQKIPMAAAYTVFV
GIGTVGTYMTGMMLGESFSAAQMFFLALLLAGILGMKLFTKESKSNPEGEK
>PK3-2_01720 putative HTH-type transcriptional regulator YvdT
MPKQTSGKYEKILQAAIEVISEKGLDKASISDIVKKAGTAQGTFYLYFSSKNALIPAIAE
NLLTHTLDQIKGRLQGDEDFWAVLDILIDETFLITERHKDIIVLCYSGLAIDHSMEKWET
IYQPYYSWLEKIINRAIVNQEVAEGINAKWTARTIINLVENTAERFYIGFEQDENIDVSK
KEIFTFLRRSLGRA
>PK3-2_01721 Aspartate-proton symporter
MSKQGNFQKSMSLFDLILIGMGAIFGSAWLFAVSNVASKAGPSGAFSWIIGGAIILLIGL
VYAELGAALPRTGGIIRYPVYSHGHLVGYLISFVTIVAYTSLISIEVTAVRQYVAYWFPG
LTIKGSDSPTIAGWILQFALLCLFFLLNYWSVKTFAKANFIISIFKYIVPVTIIIVLIFH
FQPENLSVEGFAPFGFTGIQAAISTGGVMFAYLGLHPIVAVAGEVQNPKRNIPIALIICI
IVSTIIYTILQITFIGAIPSETLKHGWPAIGREFSLPFKDIAVMLGLGWLATLVILDAIL
SPGGNGNIFMNTTSRLVYAWARNGTLFGIFSKVNKETGTPRASLWLSFAMSIFWTLPFPS
WNALVNVCSVALILSYAIAPICSAALRVNAKDLNRPFYLKGMSIIGPLSFIFTAFIVYWS
GWKTVSWLLGSQLVMFVVYLCFSKYAPKEDVSLAQQLKSAWWLVGFYIMMLIFSYIGSFG
HGLGIISNPVDLILVAIGSLAIYYWAKYTGLPKAAIDYDK
>PK3-2_01722 Levanbiose-producing levanase
MNYKKAGKWLTVFLSFLGILLFIDLLPNEEPVKKTKSTQKPDYRAAYHFTTPDKWKNDPQ
KPIYFDGKYHYFYLYNRDYPKGNGTEWRHAVSEDLVHWTDEGVAIPKYTNPDGDIWTGSV
VIDKDNTAGFGKNALIAIVTQPSAKDKKQEQHLWYSTDKGKSFKPYSDNPVMPNPDTDDF
RDPKVIWDDQDNKWVMVMAEGTKIGFYESENLKDWRYTSGFFPEQAGIVECPDLYMMRAS
DGTNKWVLGASANGKPWGKPNTYAYWTGSFDGREFTADQTEAQWLDYGFDWYGGVTFEDG
KSTDPLEKRYALAWMNNWDYANNTPTMKNGFNGTDSVIRELRLQEQDGTYSLISQPTEAL
EQLTTSTDKIEDQDVNGSKTLSITGDTYQLDMDLSWSELKNAGVRLRESEDQKRHIDVGI
FAEGGYAYVNRAAANQPDKSNTYVESQAPYDVSKHKAHLKILVDKTTIEVFVGDGKTVFS
NEVFPKPEDKGITLYSDGGTASFKNITVKHLDTVHE
>PK3-2_01723 Levansucrase
MNIKKFAKQATVLTFTTALLAGGATQAFAKETTQKPYKETYGVSHITRHDMLQIPEQQKS
EKYQVPEFDQSTIKNISSAKGLDVWDSWPLQNADGTVANYHGYHIVFALAGDPKNADDTS
IYMFYQKVGETSIDSWKNAGRVFKDSDKFDANDSILKDQTQEWSGSATFTSDGHIRLFYT
DFSGKHYGKQTLTTAQVNVSASDSSLNINGVEDYKSIFDGDGKTYQNVQQFIDEGNYSSG
DNHTLRDPHYVEDKGHKYLVFEANTGTEDGYQGEESLFNKAYYGKSTSFFRQESKKLLQS
DKKRTAELANGALGMIELNDDYTLKKVMKPLIASNTVTDEIERANVFKMNGKWYLFTDSR
GSKMTIDGITSNDIYMLGYVSDSLTGPYKPLNKTGLVLKMDLDPNDVTFTYSHFAVPQAE
GNNVVITSYMTNRGFYADKQATFAPSFLLNIKGKKTSVVKNSILEQGQLTVNK
>PK3-2_01724 Penicillin-binding protein 4*
MKQEKSKQLGKLFSVLVEEYQFNGTILAAEDGDILYHHSFGYAELTEKRPLQTNSLFELA
SLSKPFTALGVILLEEKGILGYEEKVERWLPGFPYKGVTIRHLLNHTSGLPDYMGWFFAN
WDQQKIAVNQDIVDMLMNEGLPGYFEPNEGWLYSNTGYVLLAVIIEKASGMSYADFMKTH
IFSPAGMKKTRVYNRRLRPERIDHYAYGYVYDVHSETYVLPDDLEETNYVVYLDGIQGDG
MVNSVASDLFRLDQVLYEDDFISNASKETAFSSVRLSNGETFDYGFGWVLQNSPEKGKIV
SHSGGWPGYSTMMIRYIDYRKTLIYLSNKEEDAEYEQAILKAAENILFDQTYEIPERPAD
KKKKKIDPSIYSRYVGSYVFQDGMAAAVTAENERLYLHITGQLRMELFPSSEIRFFLRSL
SVEIEFVLGDEVAKSFIIYEDGTEEEAVRTN
>PK3-2_01725 Broad specificity amino-acid racemase RacX
MIGILAGMGPKSTSPFIDKVIDYCQKLYGAENDIDYPHMMIYSCPTPFYADRPVNHDEMK
RAIIDGAIKLEKTGVDFIALPCNTAHVYYEEIQRELSVPLLHIIEETIKEIPHTAKKAAV
LGTDSTMQSAIYQKGLKANGQEAVHNDHWQLAVNQLIAAIKQPNHMEYTQALWQTLYEEI
NQHADIIISACTDLNAVLDHIQSEIPIIDSADCLAKSTVSTYLSYQS
>PK3-2_01726 hypothetical protein
MNKPVLKRFASLEIKVDPPITIGETGLGLRRWIPIRSGTITGEVRGRILPGGADSQIIRA
DGRTDLSARYVIETADHEFIYIENNGIRQVSEPFRKQAAAGEIIDPEHVYFRTVPTFETG
SKAYQWLHDRLFIGSAERTPDYVRLDIYEVQ
>PK3-2_01727 Phenolic acid decarboxylase PadC
MENFIGSHMIYTYENGWEYEIYIKNDHTIDYRIHSGMVAGRWVRDQEVNIVKLTEGVYKV
SWTEPTGTDVSLNFMPNEKRMHGIIFFPKWVHEHPEITVCYQNDHIDLMKESREKYETYP
KYVVPEFAEITFLKNEGADNEEVISKAPYEGMTEDIRAGKL
>PK3-2_01728 hypothetical protein
MGKTGYIGAVIVVAACIIIFSAVMFLRDTTYYQPIRWTGIILFFAGIVMVPAYSAKRKPG
KEK
>PK3-2_01729 Para-nitrobenzyl esterase
MSHKTVTTQYGKVKGTTENGVHIWKGIPYAKPPIGQSRFKAPEPPEAWENELDATSYGPI
CPQPSDLLSLSYAELPRQSEDCLYLNVFAPDTPSQNLPVMVWIHGGAFYLGAGSEPLYDG
SRLAAQGEVIIVTLNYRLGPFGFLHLSSFDEAYSNNLGLLDQAAALKWVRDNISAFGGDP
ENVTIFGESAGGMSIAALLAMPAAKGLFQKAIMESGASRTMTKEKAASTAAAFLQVLGIS
ESQLDRLHTVSAEDLLNAADQLRKAENENLFQLLFQPALDPKTLPAEPEKAIAEGAAAGI
PLLIGTNRDEGYLFFTPDSDVHSQETLDAALEYLLGKPLAKKVADLYPRSLESQIHMMTD
LLFWRPAVACASAQSDYAPVWMYRFDWHPDKPPYNKAFHALELPFVFGNLDGLKRMANAE
VTDEVKQLSHTIQSAWITFAKTGNPSTEDVKWPAYDAEARKTLILDSEVTIENDPESEKR
QKLFPSQGE
>PK3-2_01730 hypothetical protein
MIGRIIRLYRKRKGYSINQLAVESGVSKSYLSKIERGVHTNPSVQFLKKISATLEVELTE
LFDAETMMYEKISGGEEEWRVHLVQAVQAGMEKEELFTFTNILKKEQQPETASYRNRKLT
ESNIEEWKALMAEAREIGLTVQEVKSFFKTMGR
>PK3-2_01731 putative capsular polysaccharide biosynthesis protein YwqC
MNENMSFKELYAIVRHRFVLILLITIGVTLIAGFVQFKVIPPTYQASTQVLIHESDGEEN
SNLSDIQRNLQYSSTFQSIMKSTALMEEVKADLHLSESASSLKGKVITSSENESEIITVA
VQDHDPAKAAEIANTLVNKFEKEVDERMNVQGVHILSEAKASESPMIKPARLRNMVMAFG
AAVMGGITLAFFLHFLDDTCKSARQLSERTGLPCLGSVPDVQKGRNRGIKHFGE
>PK3-2_01732 Putative tyrosine-protein kinase YveL
MVFRKKKARRGLAQISVLHNKSIVAEQYRTIRTNIEFSSVQTNLRSILVTSSVPGEGKSF
SAANLAAVFAQQQEKKVLLVDADLRKPTINQTFQVENVTGLTNVLVGNASLSETVQKTPI
DNLYVLTSGPTPPNPAELLSSKAMGDLISDIYEQFSLVIFDSPPLLAVADAQILANQTDG
SVLVVLSGKTKTDTVLKAKDALEQSNAKLLGALLNKKKMKKSEHYSY
>PK3-2_01734 UDP-N-acetyl-alpha-D-glucosamine C6 dehydratase
MIIALDTYLVLNSVIAGYQFLKDSYQFYDSGALLLTAVSLLLSYHVCAFLFRQYKQVWTY
TGLGELIVLLKGITLSAVVTGVIQYAVYHTMFFRLLTACWVLQLLSIGGTRVLSRVLKES
IRKKRSASSRALIIGAGSGGTLMVRQLLSKDDPDIIPVAFIDDDQTKHKLEIMGLPVIGG
KESIMPAVQKLKINYIIIAIPSLRTHELQVLYKECVRTGVNIKIMPHFDEMLLGTRTAGQ
IRDVKAEDLLGRKPITLDTSEISNRIKGKTVLVTGAGGSIGSEICRQISAFQPKEIILLG
HGENSIHSIYTELNGRFGKHIVFHTEIADVQDRDKMFTLMKKYEPHVVYHAAAHKHVPLM
EHNPEEAVKNNIIGTKNVAEAADMSGTETFVLISSDKAVNPANIMGATKRFAEMIIMNLG
KVSRTKFVAVRFGNVLGSRGSVIPVFKKQIEKGGPVTVTHPAMTRYFMTIPEASRLVIQA
GALAKGRQIFVLDMGEPVKIVDLAKNLIHLSGYTTEQIPIEFTGIRPGEKMYEELLNKNE
VHAEQIFPKIHIGKAVDGDWPVLMRFIEDYNELPEADLRARLFEAIDTDKMTAASVH
>PK3-2_01735 Putative glycosyltransferase EpsD
MMKKILFCATVDYHFKAFHLPYFKWFKRMGWEVHVAASGQTKLPHVDEKFSIPIRRSPFH
PQNLAVYRQLKEVIDTNQYDIVHCHTPVGGVLARLAARQARRQGTKVLYTAHGFHFCGGA
PIKNWLLYYPVEKWLSAYTDCLITINEEDYTLAKGLQRQGGNTQKIHGIGVNTERFRPVS
LEERQRLREKHGFREDDFILVYPAELNLNKNQKLLIEAAALLKDKIPSLRLVFAGKGAME
QTYRTLAEKLGASENVRFYGFCRDIHELIQLADVSVASSIREGLGMNVLEGMAAEKPAIA
TDNRGHREIIRDGENGFLIKIGDSAAFAGRIEQLYHKPELCRKLGQEGRKTALRFSEART
VEEMADIYSVYMDMDTKEKSV
>PK3-2_01736 Putative glycosyltransferase EpsE
MNSGPKVSVIMGIYNCERTLAESIESILSQSYKNWELIMCDDASTDGTLRIAKQYAAHYS
DRIKLIQNKTNKRLAASLNHCLSHATGEYIARQDGDDLSFPRRLEKQVAFLEKHRHYQVV
GTGMLAFDEFGVRGTRILPSVPEPGIMAKGTPFCHGTIMMRMSAYRTLKGYRSVRRTRRM
EDIDLWLRFFEEGFRGYNLQEALYKVREDSDAFKRRSFTYSIDNAILVYQACRRLKLPLS
DYIYIAKPLIRAFMPAAVMNRYHKKRVMNQKEGLVKHE
>PK3-2_01737 Putative glycosyltransferase EpsF
MNSSQQRVLHVLSGMNRGGAETMVMNLYRKMDRSKVQFDFLTYRNDPCAYDEEILSLGGR
LFYVPSIGQSNPLTFVRNVRNTIKENGPFNAVHAHTDFQTGFIALAARLAGVPIRVCHSH
NTSWKTSFNWKDRLQLVVFRRLILANATALCACGEDAGRFLFGRSNMERERVHLLPNGID
LDLFAPNGQRDEEKTARGIAADRLIIGHVARFHEVKNHAFLLKLAAHLKERGVRFQLVLA
GDGPLREKMEEEARRQDLLSEVLFLGTEDRIHELMRTFDVFVMPSLYEGLPVVLVEAQAS
GLPCIISDNITEKVDAGLGLVTRLSLSEPIGIWAETIARAAAAGRPKRELIKETLAGLGY
DAQQNVGALLNVYNITSGKGQ
>PK3-2_01738 Transmembrane protein EpsG
MIVYAVNMGIVFIWSWFAKMCGGRDDSLATGYRPNKLLIWIPLASLVLVSGLRYRVGTDF
QTYTLLYELAGDYQNVWQIFGFGTAKTATDPGFTALLWLMNFITEDPQIMYITVAAVTYS
FIMKTLADYGRPFELSVFLFLGTFHYYASFNGIRQYMVAAVLFWAIRYIISGNWKRYFLI
VLISSLFHSSALIMIPVYFIVRRKAWSPAIFGLSALFLGMTFLYQKFISVFVVVLENSSY
SHYEKWLMSNTNGMNVIKIAVLILPLFLAFCYRARLRKLWPQIDIVVNLCLLGFLFGLLA
TKDVIFARFNIYFGLYQMILVPYFVRIFDEKSNALIYIAIIVCYFLYSYLLMPVDSSVLP
YRTIFSR
>PK3-2_01739 Putative glycosyltransferase EpsH
METPAVSLLVAVYNTETYIRTCLESLRNQTVDNIEIIIVNDGSADASPDIAEEYAKKDHR
FRVIHQENQGLGAVRNKGIEAARGEFIAFIDSDDWIEPDYCERMLQAADDETDLIICNYA
AEFEDTGKTMISDIAETYRDQPKEHYIKALFEGKVRGFSWNKLYRRSMVEAHRLSFPLRG
ELEHVEDQFFSFRAHFFARSVSYVKTPLYHYRIHLSSIVQRYQKKLFESGLALYKANAAF
LQENNKLEEYDKELDTFIVLHSSICMLNEWKTSGSGRMFEKLRNVGVICADPVFQESLSK
TGTAPFDAKRSCLLLMAKYRMIPFVAMASAMYQRVIEYKMRNRG
>PK3-2_01740 Putative pyruvyl transferase EpsI
MLLQSLKINVAEWLLLKVKYPSQYWLGAADQPVKAAAHQKKIILTLLPSHDNLGDHAIAY
ASKAFLEREYPDFNIVEIDMKDIYKSAKALLRSRHPEDMVFIIGGGNMGDLYRYEEWTRR
FIIKTFFDYRVVQLPATAHFSDTKKGRKELKRAQKIYNAHPGLLLMARDETTYQFMKRHF
QEKTILKQPDMVLYLDRSKTPAEREGVYMCLREDQESVLQEDERNRVKAALFEEFGDIQS
FTTTIGRRVSRDSREQELEALWSKLQSAEAVVTDRLHGMIFCALTGTPCVVIRSFDHKVM
EGYQWLKDIPSMKLIEHPEPERVTAAVKELLTKGTPGAGFARDVYFKGLRDKISGEAQ
>PK3-2_01741 putative glycosyltransferase EpsJ
MTPLVSIIVPMYNVEPFIEDCIGSLLHQTLSDLEIILVNDGSPDRSGEIAEDYAKRDERI
RVIHQKNGGLSSARNAGIRAARGTYIGFVDGDDYVSSAMFQRLIEEAEQNQLDIAGCGFY
KQSADGRTYVPPQLDKNRVLAKPEIAERLKQAHETRFIWYVWRYVYRRELLERANLTFDE
DIRFAEDSPFNLSAFCEAERVKMLDEGLYIYRENPNSLTEVPYKPAMDEQIQKQYQAKIA
FYNHYGLAGACKEDLNVYICKHQLPMLLANACASPDPPKDIKKQIKHILSYDMVRQAVRN
TSVQHEKLLRGERLVLGLCKLRLIFLIKLFFEQRGTMKGSAKQA
>PK3-2_01742 putative membrane protein EpsK
MKFTINFSANLTAFLLSVFLSVWMTPFIVKTLGVEAFGFVHLTQNVINYFSIITVALSSV
VVRFFSVAAHRGEREKANAYISNYLAASVLISLLLLLPLAGSAFFIDRVMNVPQALLADV
RLSILIGSLLFILTFLMAGFGAAPFYANRLYITSSIQAVQMLVRVLSVLLLFACFAPKIW
QIQLAALAGAVMASVLSFYFFKKLIPWFSFRMKDLSFRISKELFQAGAWSSVNQIGVLLF
LQIDLLTANLVLGASAAGKYAAIIQFPLLLRSLAGTVASLFAPLMTSYYSKGDMDGLVNY
ANKAVRLNGLLLALPAALLGGLAGPFLAIWLGPSFSSIAPLLYIHAGYLVISLAFMPLFY
IWTAFNKQKTPAIVTLLLGAVNVVLAVTLSGPVHLGLYGITLAGAISLILKNAIFTPLYV
SRITGYKKHVFFKGIIGPLSAAVFAWAVCEAIRFVVKIDGWASLIATGMTVSCCYAVFAF
MFVCTKVERQLVLKRFRKTKGAVNL
>PK3-2_01743 putative sugar transferase EpsL
MILKRLFDLTAAIFLLCCTSAIILFAIAVVRLKIGSPVFFKQVRPGLHGKPFTLYKFRTM
TDERDSGGNLLPDEVRLTKTGRLIRKLSIDELPQLLNVVKGDLSLVGPRPLLMDYLPLYT
KKQARRHEVKPGITGWAQINGRNAISWEKKFELDVWYVDNRSFFLDLKILCLTVRKVLVS
EGIQQTNHVTAERFTGSGDVSS
>PK3-2_01744 Putative acetyltransferase EpsM
MRKVAIVGDGGHGKVIRELINARPDTCLAAVLDDKFRTLESGKEWYTGPPEAVSELRRLI
PDVLFLIAIGNNSVRKQLAERLGLKQENFITLIHPSAIVSKSAVIGKGTVIMAGAIIQAD
ACIGAHCIINTGAVAEHDNQISDYVHLSPRVTLSGAVAVQEGAHVGTGAAVIPQLTIGAW
STVGAGSAVIRSIPDGVTAAGAPARIISSIQT
>PK3-2_01745 Putative pyridoxal phosphate-dependent aminotransferase EpsN
MHKRIYLSPPHMSGREQHYISEAFRSNWIAPLGPLVNSFEEQLAERVGVKGAAAVSSGTA
AIHLALRLLEVKEGDSVFCQSFTFVATANPILYEKAVPVFIDSEPDTWNMSPKALERALE
DAKRNGKLPKAVIAVNLYGQSAKMDEIVNLCDTYGVPVIEDAAESLGTVYKGKQSGTFGR
FGIFSFNGNKIITTSGGGMLVSDDEAAIEKARFLASQARDPAVHYQHSETGHNYRLSNIL
AGVGIAQLEVLDKRVEKRRAIFSRYKHALGHINGVRFMPEYAAGVSNRWLTTLTLDNGLS
PYDAVQRLAEENIEARPLWKPLHTQPLFEPSVFYSHEGTGSICEDLFKRGICLPSGSNLT
EEEQDRVIDVLVHLFQTGEVKKWTASIR
>PK3-2_01746 Putative pyruvyl transferase EpsO
MDSKHSMISLKQKLSGLLDVIPKQSEIIYADYPLYGNVGDLFIMKGTEAFFKEHGIRVRK
RWNPDNFPVGRKLDPNLIIVCQGGGNFGDLYPYYQGFREKIVQTYPNHKIVILPQSIYFQ
NEDNLKRTAEIFSKHANLHIITREKASYATAQAYFTSNHIKLLPDMAHQLFPVVPTQQPL
NQKLRFIRTDHEANKELQEHAKAESYDWRTVLSASDRRTIAFLQTLNVLNKKAGNPLPIA
YIWEKYSDYIVNKAIRFFSCYESVETSRLHGHILSSLLQKENTVIDNSYGKNANYFHTWM
EGVPSTRLIQHASKKENLPAHM
>PK3-2_01747 putative protein YvfG
MSELFSVPYFIENLKQHIEMNQSEDKIHAMNSYYRSVVSTLVQDQLTKNAVVLKRIQHLD
EAYNKVKRGESN
>PK3-2_01748 hypothetical protein
MDMKLQQVQVLKPQLTQELRQAITLLGYHSAELAEYIDELSLENPLIERKETDTPPLSYH
KTNKNRMNAQEAGLQLSDPQRTLQDVLKQQSLDMNLTNTEKKIFNYLIHSLDSNGYLEEE
MEEAAQRLSVSTKETEAVLAKLQSLEPAGIGARSLQECILLQLKRLPNRNEQAEMLVSAH
FDAFAQKNWKALSNETGIPLHDIQDISDDIAALHPRPGLLFARPEQDVYIEPDIFITVKN
GHIAAELNPRSFPEIDLHPQYSTLLSSGSCQDTASYLSAKYQEWRWLSRALRQRKQTITR
IVNELITRQKDFFLKGRSAMKPLTLREIADCLSLHESTVSRAIKGKTIQTPYGLFEMKLF
FSAKAEASGDGEASNYAVKTHLQDLINQEDKTKPLSDQKLADLLYEQRGIQISRRTVAKY
RDQMNIPSSAARKRYK
>PK3-2_01749 L-lactate permease
MQWTQAYTPIGGNLLLSALAALVPIIFFFWALAIKRMKGYRAGLATLGIALIIAVLVYRM
PAEKALMSATQGAVYGILPIGWIIVTSVFLYKITVKTGQFDIIRSSVLSITDDRRLQALL
IAFSFGAFLEGAAGFGAPVAISAALLVGLGFNPLYAAGICLIANTAPVAFGAIGIPITAV
EGPTGIPAMEISQMVGRQLPFLSVFIPLYLIIIMSGFRKALEVWPAILVSGVSFAVVQYL
SSNFLGPELPDVLSALVSMAALAVFLKWWKPKITFRFAGEQESAAAIETAKTSPAAPAYS
GGQIFKAWSPFLLLTVMISIWGIPSVKSALIGHYEGSVVFLKWLNAVGEKLTFAPGVPFL
NNQIVNADGAPIEAVYKLEVLGSAGTAILIAAVLSKFITAISWKDWGAVFKETIQELKFP
ILTIASVVGFAYVTNSSGMSTTLGMTLALTGSMFTFFSPVLGWLGVFITGSDTSANLLFG
NLQKVTALSVGMDPVLSVAANSSGGVTGKMISPQSIAVACAAVGLAGKESDLFRFTIKHS
LFLLLLVCIITFLQHHVFSWMIP
>PK3-2_01750 HTH-type transcriptional regulator LutR
MKYKQIKTKKIYEEVADALLDMIKNGDLKPGDKLDSVQALAESFQVSRSAVREALSALKA
MGLVEMKQGEGTYLKEFELNQISQPLSAALLMKKEDVKQLLEVRKLLEIGVASLAAEKRT
EADLERIHAALKEMGSIETDGELGEKADFAFHLALADASQNELLKHLMNHVSSLLLETMR
ETRKIWLFSKKTSVQRLYEEHERIYKAVASQDGAQAEAAMLAHLTNVEDVLSGYFEENVQ
>PK3-2_01751 HTH-type transcriptional regulator LacR
MATIKDIAQEAGFSISTVSRVLNNDESLSVPDETREKIYEAAEKLNYRKKTVRPLVKHIA
FLYWLTDKEELEDVYFKTMRLEVEKLAKAFNVDMTTYKISDGIESIPKHTEGFIAVGTFS
DQELAFLRNVTGNGVFIDSTPDPDHFDSVRPDLAQMTRKTVNILSEKGHKSIGFIGGTYK
NPNTNQDEMDIREQTFRSYMSEKGMLDERYIFCHRGFSVENGYRLMTAAIDTLGDQLPTA
FLIAADPIAVGCLQALNEKGIAIPNRVSVVSINNISFAKYVSPPLTTFHIDIYELCKNAV
EMLLEQVQDKRKTVKTLYVGAELIVRKSMN
>PK3-2_01752 Cyclodextrin-binding protein
MKMVKKYSALMLCAAVGFSLAACGPKESTSAKSSSKGSELVVWEDKEKSIGIKDAVAAFE
KEHDVKVKVVEKPYAKQIEDLRMDGPAGTGPDVLTMPGDQIGTAVTEGLLKELHVEKDVQ
SLYTDASLQSQMVDQKLYGLPKAVETTVLFYNKDLISEKELPQTLEEWYDYSKKTADGSK
FGFLALFDQIYYAESVMSGYGGYIFGKDKDGSYNPSDIGLNNEGAVKGAALIQKFYKDGL
FPAGIIGEQGINVLESLFTEGKAAAIISGPWNVEAFSKAGINYGITKLPKLENGKSMSSF
IGVKSYNVSAFSKNEELAQELAVFLANEKNSKTRYEKTKEVPAVKSLANDPAIMKSEAAR
AVTEQSRFSEPTPNIPEMNEIWTPADSALQTVATGKADPKQALDQAAETAKGQIKAKHSG
K
>PK3-2_01753 hypothetical protein
MQHRQIALLLSIIPGLGQFYNKQWIKGFVFLFLGASFFAAFGDLLNMGFWGIFTLGTEVP
RDNSVFLLAEGIIAVIVTCFGLAVYYVNLRDAFQSGKQRDENKPLSSLKEQYQHIISHGY
PYVVSGPSLFILIFAVVFPILFSFALAFTNYDLYHSPPAKLIDWVGFQTFANIFTVDIWR
STFFDVLAWTVVWTLAASTLQVGLGIFLAIVVNQKDIRFKRFFRTILILPWAVPGFVTIL
IFAGLFNDSFGAMNHDILAFFGIEPLPWMTDANWSRLALILMQGWLGFPYIFLVSTGVLQ
SIPDDLYEAATIDGASVFAKLRYITLPMVFIAMAPIIITQFTFNFNNFNIIYLFNGGGPA
VTGSTAGGTDILVSWIYKLTMQSSQYSLAAALTILLSVFVISIALWQFRQTKSFKEEA
>PK3-2_01754 Maltose/maltodextrin transport system permease protein MalG
MLADMKVRKYIRLLLSYLLLACMAVIIVYPLLWTAGASFNPGNSLISTSIIPKHPTFDHY
KELFAGKESLQYVQWYINSMKISLFTMAGALICVTFTAYAFSRFRFKGRKYALTLFLLLQ
MIPQFSALIALFVLAQILGMINSHWLLILLYIGGLIPMNTYLMKGYMDSIPMDLDESAKI
DGASSTRIFLQIILPLSKPMAAVVAMNGFTGPLGDFVLSSTILRTPESYTLPVGLFNLVN
DVMGASYTTFAAGALLISIPVAVIFIMLQKNFVSGLTAGGTKG
>PK3-2_01755 Beta-galactosidase GanA
MMSKLEKTHVTEAKFMLHGGDYNPDQWLDRPDILADDIKLMKLSHTNTFSVGIFAWSALE
PEEGVYQFDWLDNIFERIHSIGGRVILATPSGARPAWLSQTYPEVLRVNAARVKQLHGGR
HNHCITSKAYREKTQNINRLLAERYGNHPALLMWHISNEYGGDCHCDQCQRAFREWLKSK
YDNSLKTLNRAWWTPFWSHTFNDWSQIESPSPIGESGLHGMNLDWRRFVTDQTISFYENE
IVPLKELTPHIPITTNFMADTPDLIPYQGLDYSKFAKHVDVISWDAYPVWHNDWESTADL
AMKVGFINDLYRSLKQQPFLLMECTPSAVNWHNVNKAKRPGMNLLSSMQMIAHGSDSVLY
FQYRKSRGSSEKLHGAIVGHDNSPKNRVFQEVAKVGETLEQLSEVVGTKRPAETAILYDW
ENHWALEDAQGFAKATKRYPQTLQQHYRTFWEHDIPVDVITKEQDFSPYKLLIVPMLYLI
SEDTISRLKSFTANGGTLVMTYISGIVNEHDLTYTGGWHADLQAIFGIEPLETDTLYPKD
RNAVSYRSQTYEMKDYATVIDVKTASAEAVYQEDFYARTPAVTSHQYKQGKAYFIGARLD
DPFHRDFYKGLIADLSLSPIFPIRHGKGVSVQARQDQDNDYIFIMNFTEERQLVTFHQSV
KDMVTGDILSGGLTMEQYEVRIVVNTH
>PK3-2_01756 Arabinogalactan endo-beta-1,4-galactanase
MRNGVNMFFAAAIVWSAFSSPGFAAAVEKEKHVPEVRTEDLFIKKVEGMNKDFIKGADVS
SVIALENSGVTFYNTSGKPQDIFTTLKQAGVNYVRVRIWNNPYDSNGLGYGGGNNDIQKA
IEIGKRATANGIKVLADFHYSDFWADPAKQKVPKAWANLSFEAKKAKLYEFTKQSLQKMI
KEGVNIGMVQVGNETTGAFAGESDWAKMSQLFNEGSRAVRETDPGILVALHFTNPETAGR
YSYIAETLRKNKVDYDVFASSYYPFWHGTLQNLTSVLKAVADTYGKKVMVAETSYTYTAE
DGDGHENTAPKSGQTLPYPISVQGQADAIRDVMQAVANTGTAGLGVFYWEPAWIPVGPKT
QAEKNKVLWETYGSGWASSYAAEYDPEDAGKWYGGSAVDNQALFDFNGHPLPSLQVFQYA
KSGHIPKKR
>PK3-2_01757 Phosphoserine phosphatase RsbP
MDKQLNDAPCGFLTLSEEGLIITVNRTLLKILNEEPEQVIGQHINTILTVPAQLFYQLYF
VPLLKLEHHIEEMYISLKTRDREEIPVLVNAVVKADRGATVTECVLIPMRKRNEYENELL
KARNAAQEALLAKQKANAELEIALGTLKAKQEELLEINKQNQQFKLNTKRELELARKIQE
NSLTEQIVNDQIQIDAYYKASSELSGDLYGFYQIDKHRYGIIILDVMGHGISSALITMSL
HPLFQRQITQGLSPVKVMKELDRHLHSLFQNDEEARHYCTAVYLEIDTATKKIDYVNAGH
PPALWQGADGTQHPLHATAPPIGMFEDTEFQSRSLPYTEGGRLLLYTDGVMDPTASCYLF
DILKDNPDLPIAGLKEKILTSLHHHKETHHKSDDECFILIDLK
>PK3-2_01758 Sigma factor SigB regulation protein RsbQ
MDDAILSRNHVKVKGSGKTSIIFAPGFGCDQSVWNAVAPAFEEDHRVILFDYVGSGHSDL
RAYDLNRYRTLDGYAQDVLDVCEALDLEETVFVGHSVGAVIGMLASIRRPALFSHLVMVG
PSPCYLNDPPEYYGGFEKEQLLGLLEMMEKNYIGWAAVFAGTVLNQPDRPEIKEELESRF
CSTDPVIARQFAKAAFFSDHREDLSKVTAPSLILQCADDIIAPAAVGEYMHKHLLHSSLK
QMEARGHCPHMSHPEETIQLIGDYLKVHV
>PK3-2_01759 Vitamin B12 import ATP-binding protein BtuD
MNEAVSVNNVTKHFQKKTAVNNISFSIKKGEIAAILGPNGAGKTTVISMLLGLLKPSQGE
IKLLNRIPHDQQIREKIGVMLQEVSVMPGLKVNEILELFRSYYPNPLSMKELVSLTALTK
EDLKTRAEKLSGGQKRRLSFALALAGNPELLIFDEPTVGMDTSSRHRFWQTIHGLADQEK
TIIFTTHYLQEADDAAQRILFFADGRLVADDSPMQLRSRIQKQSVSFTLHSDESLEKLSR
HPEVERVFHKHQRTIIQTSNTDKVLALIFQENIQARDIRIEHGTLDEAFRRLADGNREAM
>PK3-2_01760 hypothetical protein
MNMLQKQSIAEMKRVLRNKYFVLWSLMMPIAFYYLFTNVVNTNVPHQRAWDAHYLMSMTV
FSVMGSSIMTLGIRMVQERSQGWTAFIRITPLPDHIYLSAQMIGQSVIHVLSITVIFLFG
AIINDIALSPFEWIMSGLWILLGALPFLALGTLIGLMRKVETAAGISNVLYMLLALGGGM
WMPFEVMPDMMQNIGRWLPSYHFGSGAWELVRGGNPDWKNILVLIAYLILFMLLSKYIRR
KQEAV
>PK3-2_01761 Sensor histidine kinase DesK
MKKAITIFPKQFGFFPYIFLVYIIMPFLSLLKESGVKQLIGYGMLVLFVAAYRQLFCSLG
RGSFTYWLIVQMAIILIYSLFYDISYMYLGFFPANFVGYYREKTKFNRAFCGLIFMLLLP
CLYRLFANSVSIRELFSILPFQVIMLISPFGIRSMFRRIELETKLDQANEQIKELSKREE
RVRIARDLHDTLGHTLSLLTLKSQLIQRLATSDPERTRLEAKEMETSSRAALKQVRELVS
DMRTVTMAEELANIQHILRTGNITFEYEGDDDFSAVSPVTQNIISMCMREAVTNIIKHSK
ATHCAISITQFTDKMRIVIRDDGKGAAKEKTFGNGLRGMEERLMLIEGGLTLSAHNGTVV
TLTIPLIKKAE
>PK3-2_01762 Transcriptional regulatory protein DesR
MIRLLIAEDQRMLLGALGSLLDLEEDMTVIGQALNGEEALKAILKLEPDVCIMDIEMPVR
NGLDVAEELMQKGCGSKVIILTTFARPGYFERAVKAGVHGYLLKDGEIDDLAAAIRKCVK
GKRVFSPELTFNMMRDENPLTVREQEILRLAALGKTTKDITLELYLSQGTVRNYISEIIQ
KLNAKNRTEAASIAEEKGWI
>PK3-2_01763 Lactate utilization protein A
MKVSLFVTCLVDMFQTNVGKATVELLERLGCEVDFPEGQICCGQPAYNSGYVNDAKKAMK
RMIETFQDSEYVVSPSGSCTTMFREYPHLFADDPKWADKAQKLADKTYELTDFIVNVLGV
EDVGATLHTKATLHTSCHMTRLLGVREEPMKLLSHVKGLEFTTLPGKHNCCGFGGTFSVK
MAQISEQMVDEKVACVEETGAEVLIGADCGCLMNIGGRLDRKDKNVKVMHIAEVLNSR
>PK3-2_01764 Lactate utilization protein B
MAMKIGTDAFKERVSQGIDNEFMRGAVSGAQERLRTRRLEAAEELGNWEEWRSLSEEIRQ
HVLENLDFYLGQLAENVAKRGGHVYFAETSEEASSYIRDVIQKKNGKKIVKSKSMVTEEI
NLNEVLEKEGCEVVETDLGEYILQIDDHDPPSHIVAPALHKNKEQIRDVFKERLDYQHTE
KPEELVMHARAILREKFLEADIGITGCNFAIADTGSVSLVTNEGNGRLVSTLPKTQITVM
GMERIVPSFSEFEVLVSMLTRSAVGQRLTSYITALTGPKLEGEVDGPEEFHLVIVDNGRS
NILGTEFQSVLQCIRCAACINVCPVYRHVGGHSYGSIYSGPIGAVLSPLLGGYDDFKELP
YASTLCAACSEACPVKIPLHELLLKHRQNIVEKEGRAPISEKLAMKAFGLGASSLPLYKM
GSKWAPAAMTPFTEDEKISKGPGPLKSWTQIRDFPAPHKSRFRDWFTDRETSERTKEEQ
>PK3-2_01765 Lactate utilization protein C
MSKGTVQNQESFLNRIASRLGRERRTGGVAVPEWAHQPQYQTLQGYSADDLVTVLKNHCV
KIHTELIETDSTGLYNALREQVSRFSGGPVIIPKDPRFEAYGLKSLLTQEWPNDGTPVWE
WDAAKGKENIKKAEQANVGITFSEITLAESGTVVLFSSKDIGRSVSLLPTTYIAIVPKSS
IVPRMTQASDIIRQKIADGVTVPSCINYITGPSNSADIEMDLVVGVHGPVKAAYILVSDR
>PK3-2_01766 Putative sporulation-specific glycosylase YdhD
MKKWLIIAVSLAIAIVLFMYTKTEAKAAGMTLGYTTGDTASYNSLSKYHTYMNSIATDTF
AFEKNGHVIGDAPTKQLTYAKKKKIKTWAVISNYNDAIYDFDGDLASRVMSNKTAKKRFT
DQLIALAQKHSYYGINIDFEAVNPEDRSKYSRFIQDVSQALKKKHIKTMVSVPAKSADDQ
NDDWSWPYDYAKIGKYADYVQVMTYDEHGIWGEPGSVASTSWIKSSLQFSVKKIKANKVI
MGIPAYGYDWDVKDGSGSAAREWNELKSLIKKQKAKPAFNKKSGSMTFSYVDKKKHKHVV
WYENEKTVQTKSHLAKQYKIAGVSVYALGNESESFWKAIQKGTK
>PK3-2_01768 putative amino acid permease YvbW
MKKDNQTLKRTMTSRHIMMMALGGAIGAGLFKGSSSAIDVAGPSVIIAYLLGGIILLFIM
QGLAEMAVRNRNARTFRDLVQQVLGNYAAYFLDWIYWKMWVLNIAAEAVVAAIFIQYWLP
GCPIWVLALGISLVVTIVNLLSVKIFAETEYWLAMIKITVIIVFIILGLLLLFVSFGDHT
AAGFSNLTDHGGFFPHGGTGLITAMLVVIYSYGGTEIIGVTLAETKNPEKVVPKAVRSTL
TRIVAFYLLPFFIIVSLIPWNQVNSVPESPFVMVFKMVGIPGADHIMNAVILLAIISSMN
SGLYGSSRILYTQATDGRLPKIFSKLSSKNVPMFAILMCTSSLYIGVLISLFAGSQTFNY
LMGSLGYTVLFIWLIIGFAHLKSRKEQTETPAYYVKWFPYTTWFAVLALLAILIGVIITT
SIVITLITAAIYLLITVAYLIKGRKYQ
>PK3-2_01769 putative amino-acid metabolite efflux pump
MKQLSKTRTALLLAFLVIMWGINWPLSKAALAYSPPLLFAGIRTLIGGLLLVIVALPRIH
KLRLKKTWPIYLVSALLNITLFYGLQTIGLNYLPAGLFSAIVFFQPVLMGVFSWVWLGES
MFAMKVIGLILGFAGVAVISAAGFGGHISVIGVLLALGSALSWAFGTVYMKKTGSRVDSI
WMVALQLTIGSVFLLISGFGTESFSAIQWTAPFITSLLFISVFVIALGWLVFFTLVGSGE
ASKVASYTFLIPLISIVASSIFLHEPLTLSLLAGLLLIVTSICLVNSKSKAQKAASIAVK
EKAAQ
>PK3-2_01770 HTH-type transcriptional activator CmpR
MTITQLRVFVKIAETGSFTKAGQALNMTQPAVSHAISAIEAELDVKLIIRDRRNGLMLTD
TGKKILVHIREVLKGVEKVEQVAAAEKGLELGTIHIGTFSTASAYFMPKMISEFKQKYPK
LELVLHEGTVNEVKEWLHTRMIDVGILLYPTEEMEYIHLKKDKMTVVLRDDHPLCSRSAI
TLKDLDHEPMIVCDGGYESPFNDMFRQAGATLNAAFTVYNMNTSINMIREGLGIAILSEM
SMSGMPLPEHVVTRDLDPQVYRDVQLAVPSLKEASLAAKLFIEMAQELFGAE
>PK3-2_01771 hypothetical protein
MSNNQRKDTLLSVLNLSPVVQGGTIAESFRNSMDLARRAEEWGYHRYWLAEHHNIDGVAS
SATAVLIGHIAGGTKKIRVGSGGIMLPNHSSLVIAEQFGTLETLYPGRIDLGLGRAPGTD
QLTARALRRNINSGEDFPEQLEELRNYFKPKGNVRNQVRAIPGEGIDVPIWLLGSSGFSA
RLAGELGLPFAFAAHFSPANTVPALELYRNSFTPSEVLDEPYAMVGVTIIAADTNEKAQH
LATSHYQRFLDLVRGTPNQLKPPVEDMDQIWSPYEKAMVNEQLSSTIVGGPEEVKAKLED
FVKTTQADEIMVNSETFEHADRMRSFEIIADVWKNR
>PK3-2_01772 Arabinose metabolism transcriptional repressor
MLPKYAQVKEEISSWINQGKILPDQKIPTENELMQQFGVSRHTIRKAIGDLVSQGLLYSV
QGGGTFVASRSAKSALHSNKTIGVLTTYISDYIFPSIIRGIESYLSEQGYSMLLTSTNNN
PDNERRGLENLLSQNIDGLIVEPTKSALQTPNIGYYLNLEKNGIPFAMINASYAELAAPS
FTLDDVKGGMMAAEHLLSLGHTHMMGIFKADDTQGVKRMNGFIQAHRERELFPSPDMIVT
FTTEEKESKLLEKVKATLEKNSKAMPTAILCYNDEIALKVIDMLREMDIKVPEDMSIVGY
DDSHFAQISEVKLTSVKHPKSVLGKAAAKYVIDSLEHKKPKQEDVVFEPELIIRQSARKL
HE
>PK3-2_01773 Arabinose-proton symporter
MKNTPTQLEPNAPVTRSHSMGFVILISCAAGLGGLLYGYDTAVISGAIGFLKDLYSLSPF
MEGLVISSIMIGGVAGVGISGFLSDRFGRRKVLMTAALLFAISAIVSALSQDVSTLIIAR
IIGGLGIGMGSSLSVTYITEAAPPAIRGSLSSLYQLFTILGISATYFINLAVQRSGTYEW
GVHTGWRWMLAYGMVPSVIFFLVLLVVPESPRWLAKAGKTNEALKILTRINGETVAKEEL
KNIENSLKIEQMGSLSQLFKPGLRKALVIGILLALFNQVIGMNAITYYGPEIFKMMGFGQ
NAGFVTTCIVGVVEVIFTVIAVLLIDKVGRKKLMSIGSAFMAIFMILIGTSFYFQLTSGL
MLIFFILGFVAAFCVSVGPITWIMISEIFPNHLRARAAGIATIFLWGANWAIGQFVPMMI
DSFGLAYTFWIFAVINILCFLFVVTICPETKNKSLEEIEKLWIK
>PK3-2_01774 Central glycolytic genes regulator
MNQLIQAQKKLLPDLLLVMQKRFEILQYIRLTEPIGRRSLSASLEISERVLRGEVQFLKE
QNLVDIKTNGMTLTEEGYELLSVLEDTMKDVLGLTLLEKTLKERLNLKDAIIVSGDSDQS
PWVKKEMGRAAVACMKKRFSGKNIVAVTGGTTIEAVAEMMTPDSKNRGLLFVPARGGLGE
DVKNQANTICAHMAEKASGTYRLLFVPGQLSQGAYSSIIEEPSVKEVLNTIKSASMLVHG
IGEAKTMAERRNTPLEDLKKIDDNDAVTEAFGYYFNADGEVVHKVHSVGMQLDDIDAIPD
IIAVAGGSSKAEAIEAYFKKPRNTVLVTDEGAAKKLLRDE
>PK3-2_01775 Glyceraldehyde-3-phosphate dehydrogenase 1
MAVKVGINGFGRIGRNVFRAALNNPEVEVVAVNDLTDANMLAHLLQYDSVHGKLDAEVSV
DGNNLVVNGKTIEVSAERDPAKLSWGKQGVEIVVESTGFFTKRADAAKHLEAGAKKVIIS
APANEEDITIVMGVNEDKYDAANHDVISNASCTTNCLAPFAKVLNDKFGIKRGMMTTVHS
YTNDQQILDLPHKDYRRARAAAENIIPTSTGAAKAVSLVLPELKGKLNGGAMRVPTPNVS
LVDLVAELNQEVTAEEVNAALKEAAEGDLKGILGYSEEPLVSGDYNGNKNSSTIDALSTM
VMEGSMVKVISWYDNESGYSNRVVDLAAYIAKKGL
>PK3-2_01776 Phosphoglycerate kinase
MNKKTLKDIDVKGKVVFCRVDFNVPMKDGEVTDDTRIRAALPTIKHLADQGAKVLLASHL
GRPKGEVVEELRLTPVAARLGELLGKEVKKADEAYGDAVKAQISDMKDGDVLVLENVRFY
PGEEKNDPELAKAFAELADVYVNDAFGAAHRAHASTAGIAKHLPAVAGFLMEKELDVLGK
AVSNPDRPFTAIIGGAKVKDKIGVIESLLDKVDNLIIGGGLAYTFVKALGYEVGKSLLEE
DKIELAKSFMDRAKEKGVNFYMPADVLVADDFSNDANVKMVPISEIPSDLEAIDIGTKTR
ETYADVIKNSKLVVWNGPMGVFEIDLFAQGTKAVAEALAEAKDTYSVIGGGDSAAAVEKF
GLADKMSHISTGGGASLEFMEGKELPGVAALNDK
>PK3-2_01777 Triosephosphate isomerase
MRKPIIAGNWKMNKTLGEAVSFVEEVKSSIPAADKAEAVVCAPALFLEKLTSAVKGTDLK
VGAQNMHFEESGAFTGEISPVALKDLGVDYCVIGHSERREMFAETDETVNKKAHAAFKHG
IVPIICVGETLEEREAGKTNDLVADQVKKGLAGLSEEQVAASVIAYEPIWAIGTGKSSTA
KDANDVCAHIRKTVAESFSQETADKLRIQYGGSVKPANIKEYMAESDIDGALVGGASLEP
QSFVQLLEEGQYE
>PK3-2_01778 2,3-bisphosphoglycerate-independent phosphoglycerate mutase
MSKKPAALIILDGFGLRNETVGNAVALAKKPNFDRYWNQYPHQTLTASGEAVGLPDGQMG
NSEVGHLNIGAGRIVYQSLTRVNVAIREGEFERNQTFLDAMNNAKENNKALHLFGLLSDG
GVHSHINHLFALLKLAKNEGLTKVYIHGFLDGRDVGPQTAKTYINQLNEQIKEIGVGEIA
SISGRYYSMDRDKRWDRVEKAYRAMAYGEGPTYRSALDVVDDSYANGIYDEFVIPSVITK
ENGEPVAKIHDGDSVIFYNFRPDRAIQISNTFTNKDFRDFDRGENYPKNLHFVCLTHFSE
SVDGYVAFKPINLDNTVGEVLSQHGLKQLRIAETEKYPHVTFFMSGGREAEFPGEERILI
NSPKVATYDLKPEMSAYEVKDALVKEIEADKHDAIILNFANPDMVGHSGMVEPTIKAIEA
VDECLGEVVDAILAKGGHAIITADHGNADILITESGEPHTAHTTNPVPVIVTKEGITLRE
GGILGDLSPTLLDLLGVEKPKEMTGTSLIQK
>PK3-2_01779 Enolase
MPYIVDVYAREVLDSRGNPTVEVEVYTETGAFGRALVPSGASTGEYEAVELRDGDKDRYL
GKGVLTAVNNVNEIIAPELLGFDVTEQNAIDQLLIELDGTENKGKLGANAILGVSMACAR
AAADFLQIPLYQYLGGFNSKTLPVPMMNIVNGGEHADNNVDIQEFMIMPVGAPNFREALR
MGAQIFHSLKSVLSAKGMNTAVGDEGGFAPNLGSNEEALQTIVEAIEKAGFKPGEEVKLA
MDAASSEFYNKEDGKYHLSGEGVVKTSAEMVDWYEEMVSKYPIISIEDGLDENDWEGHKL
LTERLGKKVQLVGDDLFVTNTKKLAEGIKNGVGNSILIKVNQIGTLTETFDAIEMAKRAG
YTAVISHRSGETEDSTIADIAVATNAGQIKTGAPSRTDRVAKYNQLLRIEDQLAETAQYH
GINSFYNLNK
>PK3-2_01780 Aminopeptidase YwaD
MKMILMSAVLAGSVIWGASAEQLKETQSHSVSEMTPLFDEEHAYETIHELSEVIGPRETG
TEKEKEAASYISKRLQDEGLSVRIQPFQVKTYFSGSIMAGDHEYPMRSADKTAVEKEEKL
EAAVFDGGYGLSLEVKEAKGKIAVIREGKIPVSQKLINAQAAGAKAVIIYNRKTKPLAIR
PLKPKQITIPTAGMKKEDGEALLKEKQAVIQFKNYQNRTSQNIIGTRRAQHTKHPDILYV
TAHYDTVKGAPGADDNASGTSAVLELIEQSKHLPKNKEIRFILFGAEELWSAGSSYYVST
LTSDEIRHSRANFNADMIATDWKEASQMYITTPDGKENASINYAVNAARKAKLEAPRLTQ
LGYSDHVSFYEAGIPSANWIWLSPDTKEPGSWYHTENDNITHVSKKRLKEAGQLLLSAVK
EANID
>PK3-2_01781 UDP-N-acetyl-D-glucosamine 6-dehydrogenase
MNPVTKEARNLGHKRLLELIEAKQAVVGVLGMGYVGFPLALECVNKGYSVIGFDRNSEKV
SLLKDGQSHIRDIDDNQLKEALHTERFQVSENMSLIEQCDIIVICVPTPLNKKDKIPDLS
YIDSAVDTMLAYGRPNQLLILESTTYPGTTKQKIADRMASGRQVNIGSDFFIAYSPERID
PGNSQYEVADIPKVVGGMTRNCTKLASAFYNTIVTSIHPVTSPEVAETAKLLENTYRYVN
IALINEMALNCRELDIDIWEVINAADTKPFGFQKFSPGPGVGGHCIPIDPFYFKWIANQK
GLQTKLIDLADEINSEMPFSVSDYARKLVDKEQCSILLIGAAYKKNTNDSRESSAFAIIG
DLMKKGCTIDYYDPFISEIRLEDGSIKRSVPFTKEQVDQYDVVIIHTDHDDINYSILRDA
APIIFDTRNICREKMADNANLVTL
>PK3-2_01782 UDP-4-amino-4-deoxy-L-arabinose--oxoglutarate aminotransferase
MHMALLALGVGEGDEVIVPSFTFCSSVNVILHVGATPVFADICEDDLCIDPEDVRQKLSP
RTKAVIAVHFAGYPANLDELSSICKKNGLYLIEDAAHALGTRYKGKMIGTHGDAVCFSFY
ATKNITTGEGGALILKDEEAAERARLYGWHGITKNAWNRYGEKGSWRYDVLLPGFKYNMT
DIQAALGLVQLKRAAEIQEKRTRIANYYASELTNQSERAELPLTDIPSHITHSWHLFILR
VKKRGEMERDQFIENMKAKHIGLSVHFIPVHMHPYYKEHFPAKLPVTERIFPEIVSLPLY
SQLSKEDCQYIVQSIKEVLSLSQEVGQ
>PK3-2_01783 dTDP-glucose 4,6-dehydratase
MKNIAILGGAGFIGSELAGLLQNKGYHTIIADQKKPDFQAEFRKTNILDRQSLRESLKGA
DAVVHLAAMVGVDSCRSNEEDVIKVNFEGTKNVTEVCKELGIKTLLFSSSSEVFGDSPDY
PYTESSKKLPKSAYGKAKLKSEEYLREQASDSLHVRVVRYFNVYGPKQREDFVINKFFSL
AESGAELPLYGDGGQIRCFSYISDIVNGTYLALLHKGSAFEDFNIGNDLPISIKGLAEKI
NVMTGRKKENYTFKKLGEDGVRGKDIEIFKRAPSIEKAKRLLGYAPKVHLEEGLRMIKVE
RQKQKLPLS
>PK3-2_01784 GDP-perosamine synthase
MKDKNKNFHYPENPKRIKFPIYAGQLSGKSLFPHLISARRTSLAEKLEKRYGKGIELTSS
GSAALVLALTFSGAGPGKEVIFSSFSCPNVIDAVLQSGASPVFANLDDDLSLSFEDVKNK
VTDKTCAIILTHVYGRRENMKLIEWAKEKGIRIIDDAAQAMFTKQAGTFAGGLGDFGILS
FGPSKPLGSIGGGALIALKDVLDKNGRLPMEQRKQVNADYYAYMRQQRIQALMRSRTLSF
LFRKTGAQPSMKTSKLEVLPKTPAAVPLLRMHPVRQAIIEQQLTKMERLVKDSSENLETA
SCILARAEALYGIKMIQPQEGESLNYLTIVFPHEGERYDCSVYLASKGIQTCWNYLPLHL
IPLYQPYSRQGDEHSLWKRVLSLPFKPPLGTEKVKYIAETVLAYAEQKNKK
>PK3-2_01785 hypothetical protein
MEELPNTSFHPVKLTSDGGQVIYVPVFEQNGLLSGNMIGYGGVISDRPISFKWLQGEIKA
LFGQKLSRILLPHGQTSFIEETGEQWAEKATHILPLPDTFEELWTNCSGKARTAVRYAEK
KNVSVRLIGQESLSEFYELYKAHTAAIGAAYMLGQDFFQKLLESLGKQVFWIGAFLESEM
ISSSIFLYDHSHFYYWQNVNSPAGKETQASYLLMRNALSFAIGKKLQWVDFGYSHSKEIA
RPKRYWGAEEKRCRHFTEAE
>PK3-2_01786 putative protein
MSTFHRSGVKVVSGHQSSYLPWYGFFEKIHKSDIFAIHDTAQFEKKGFLNRNRIKTSQGP
MWLTVPLQMKNYKDIELRDMKIDQEQDWRKKHWMAIKMNYAKAPYFEEYQMFFKDVYQRE
WEYLHDLNMFIIDFFLRELRISTPICYASELECRKEKKSDFVLALCKELGADHYYSGSQG
SDYLIESDFDRSGITIEYQQIRTIHYPQLFGEHIPHLSMLDMLMNCGADISETLIKGGQY
DESNGICGAPGR
>PK3-2_01787 N-acetyl-alpha-D-glucosaminyl L-malate deacetylase 1
MKVMVFAAHPDDEIIGVGGALAKHVRQGDSVSAVIMAEGKSSRKEDYEKPCDSTMQHSYS
ETEQALSTLGISDFVRLNLPDNRLDSMDLLDVVKEAEKQIERFQPDIVYTQYGGDINIDH
AVVFRAVMTATRPLPGHTVKQVLAYETLSSTEWNYLKKDQFHANFFINIEEELELKLKAM
ACYGSELRDFPHPRSLQAIENNAYVWGAKSGFSAAEAFMLVRGTW
>PK3-2_01788 hypothetical protein
MIAQIPFFGLDPKQIDKKWVEAGYGLEANIFDGKSFEATDYVKTFKRTLDYTKQLEPSLL
TLHFPTDNADYVHEAHIKDRLLHFAELADVYGAKGITVHANQFMSVEEFQGYDLEGNRRK
IIEFFAAFDDELKGTDIWIGVENLPIIGNLGEDFDPIFIYPEDFEELTQLGLKHIGITWD
LCHWAITYQTHLSSSLMFRDEKLRYPDFFQFLSLKDSIKHYHFSSFRQLAFPHGDVRCFE
GRHPAEGTIDEPLLRQAAEMLKEIHRGDGTGIVFEVMEEDYTQRKESWRTLEWFGGASDE
DQKRT
>PK3-2_01789 hypothetical protein
MKIKNGRDSSYRTPNYAKLWSAQVFSSAADGVWLIALPLLVLDLTGSKILVGVISFIELV
PLTFGMFTGPFIDSSRKKSILYLCNIGRAVIMILLAVLSANGLLTVWIIGVCAFCLSLQS
MLFSPAKVALIPLLVPQKHLDQATSLMNTSELIGLIVGKLISGILIAAIPFGLLFFINGT
AFFVSAVLIALIHISESAGLKSKGAEALKTGYRMLKGNSSWMTSVCYFFIVNLVIAGFIS
VMGPILAVERFHENYSVWFAIMYSMFQAGMLLGNLAVFFKWNTKRLERLYPRTLTAVGLL
MMVLFFSLNGLECAIFLMLGVIISYIDVQTVLYFQKTVPTEYFGRIFALIFSIVKMGEPL
SAAVYTVLLVFMDADYIFLAVGLTLAVTFFILSVRQGMQRDAGKKANQFF
>PK3-2_01790 putative N-acetyltransferase YvbK
MQKLRIQIREKTNDELYDLLLLADPSKDIVDEYLERGECYTAWAGDELAGVYVLLKTRPQ
TVEIVNIAVKESHQKKGFGKQLVRDAIEKAKELGADTIEIGTGNSSIHQLSLYQKCGFRL
QAIDHDFFVRHYDEDIFENGIQCRDMVRLYLDL
>PK3-2_01791 hypothetical protein
MFCKECGQKNNEGAKFCKECGAAIGGSSRQAHKETASTAETRQAPRKPIPKKTIILWSSI
AAACVILFAAYKTGAYFTSKDRLVNKFEEAVNNEDKEQIASLLTPVNDKLKLTKNNVKPF
LAYLKDHPDKKDELFASLRAETTQKNIVYAEKDGKSLLVFDHYDLKVAPVYFEVTSNYKN
TDLYVNKEDAGSVKKTDQAQTLGPYIPGEYTVSAKLKNDVVDLVKKEDIQAVGDNSFRVD
LSLEADDVTFSLADDIKSGKGDLLINGKSIHKDPFKSVTYGPLLTDGSMTASVESEFPWG
KTKTAGVPIDHKEMELTLIPDQDTQDTIMNTIVKTTKQYSKALSDGNTAQMTEAGAKWKA
ETKDTVDSMKNTDSYLKDKYLETDFDLDTFALSQKNDGTWQVSVTGKELHQSASYSDYSK
PEMTDDSPSYEYILSYDKKQKKWIFENAESTFESAGTNIKKIKNDKPETYTSAWEGSKNK
DSESSASGDVTDEQVTLFMGSYLQGQADAVNQNNFSLMEDSLEKGSSLYSDQQHLVAKLN
KEGTTEDFNNYKVKSWSQNGSAITIKTYEEFYITKSGGSPKLRTYNWTYTGTVKNGRIYL
TSIQ
>PK3-2_01792 hypothetical protein
MYCPQCGHQTDGGKFCEKCGSPLPGQAGQQQAAQTGAAAKQAAKQFGSFVLAVLKRPYQE
CKTTGGEQLISAIITLVLFSLLTPLMFYILFSDGPGSVSFTAVFLEPTIYFILFLFGLHA
LIFFALKIAGNQVSFKDSFSRFGAFLIPFTAILILALFFFLLHTDICFTILAVGLIGALF
AIPPAMLSSYQHSYKGKIDIIYSTIVIYLIICVTFQLIVEHYIKEIFRYMLF
>PK3-2_01793 hypothetical protein
MFKKIAADALGLSDIGKIIEPHDYDKTDADDYVMHEDNEKIYFLIKTKADEYCFTNVALI
HVDGERATSSKRTLKRYPYSQYKISDVFLETAGKVDLDVEIKFKLGAEQFDIDVHKDQIE
KLKDLYKALLRIAETIYENDILINQAEQSLDKAVTILQHTRPEHVNIETQYKELTEFGFT
WLTSVRSQYHLKDFGDVFEKYINN
>PK3-2_01794 hypothetical protein
MFSFVVHVFISLFAVSNPIGNVPIFLTLTEGYTAAERKAIARKASILSFFILAAFLVFGQ
LIFKLFDINIHALRVAGGIFIFGIAYNLLNAKESHVQSLHHDEHKESKEKADISVTPLSI
PIIAGPGTIATVMSLSAGHGGIGHYVAVMIGIAAVIALTFLFFHYSSFISSKLGKTEMNV
ITRLMGLILAVVAVGMIGAGLKGMFPILAS
>PK3-2_01795 HTH-type transcriptional repressor OpcR
MEKTALDIIDHAEEHLIEKIAENMHTFGMPSTVGRVLGIIYMNRKPMTLSELSEATGMSK
TRMSQVVREMIDANIAEKVFEKGVRKDLYDVEQDYYQTFISLFAANWTKVVSKNKVFYKK
LNRELTDLLQRDGLTREAEEKVNQLLIELREWLHYYDWLSRLIEFFESEEVFQYVPKTKE
SSSLT
>PK3-2_01796 Glycine betaine/carnitine/choline transport ATP-binding protein OpuCA
MLKLEQVSKVYKGGKKAVNSINLDIAKGEFICFIGPSGCGKTTTMKMINRLIEPSSGKIL
IDGENIMEQDPVELRRKIGYVIQQIGLFPHMTIQQNISLVPKLLKWPEEKRKERAKELLK
LVDMGPEYLDRYPHELSGGQQQRIGVLRALAAEPPLILMDEPFGALDPITRDSLQEEFKK
LQRTLNKTIVFVTHDMDEAIKLADRIVILKAGEIVQVGTPDEILRNPANEFVEEFIGKER
LIQSRPDIERVEQMMNRTPVTVSADKTLSQAIQLMREKRVDSLLVVDRQNVLMGYVDVEM
IDQNRKKASVVGDVYRSDIYTVQKGALLRDTVRKILKQGIKYVPVVDEENHLAGIVTRAS
LVDIVYDSIWGEEDQLMTI
>PK3-2_01797 Glycine betaine/carnitine/choline transport system permease protein OpuCB
MNQMMTFLQTNGGELLYKTGEHLYISLIAVVLGIIVAVPLGVALTRMKKGAGAIIGVANI
VQTLPSLAILAFFIPLLGVGKVPAIVALFFYSVLPILRNTYTGIKGVNKNLLESGKGIGM
TGWEQIRLVEIPLAIPIIMAGIRTSTIYLIGWATLASFIGGGGLGDYIFIGLNLYQPEYI
IGGAVPVTILAIIIDYVLAVTERKVTPKGLQGMKEVS
>PK3-2_01798 Glycine betaine/carnitine/choline-binding protein OpuCC
MKTKKIKWLGAFTLVFVLLMSGCSLPGLGGASDDTIKIGAQSMTESEILANMIAQLIEHE
TDLNTALVKNLGSNYVQHQAMIGGDIDISATRYSGTDLTSTLGKEAEKDPKKALNIVQNE
FEKRFDYKWFDSYGFDNTYAFTVTKKFAEKEHIDTVSDLKKNASQYKLGVDNAWLKRKGD
GYKGFVSTYGFEFGTTYPMQIGLVYDAVKNGKMDAVLAYSTDGRIKAYDLKILKDDKRFF
PPYDCSPVIPEKVLKEHPELEGVINKLIGQIDTETMQELNYEVDGKLKEPSVVAKEFLEK
HHYFD
>PK3-2_01799 Glycine betaine/carnitine/choline transport system permease protein OpuCD
MLQEFYRHFLMSVYGVLFAAIVGIPLGILIARYRTLSGWIFAVTNVIQTIPALAMLAVLM
LVMGLGANTVILSLFLYSLLPIIRNTYTGIISIEHAYLESGKAMGMTKFQVLRMVELPLA
LSVIMAGLRTALVIAIGITAIGTFVGAGGLGDIIVRGSNATNGTAIILAGAIPTALMAVI
ADLVMGWLERALSPIKKKKNLAGAA
>PK3-2_01800 IS3 family transposase ISBsu1
MKDHPKRHLEKQIGTLCREHKYRYGYRKITAILKKRMCINHKTVQRIMQKNQWQCQVKVK
KRKKNGQPYAVVDNILDRNFQSDRPLEKLVTDITYLPYGQKQLYLSSILDLYNGEVIAFT
IGDKQDTDFVLDTLNQLPMLSENCVLHSDQGSVYTSYEYQKAVNTKGITMSMSRKGTPAD
NASIESFHSSLKSETFYLNSIDRTTTAIVERTVIEYIHYYNNIRIQTKLNNQSPINYRQL
AV
>PK3-2_01802 hypothetical protein
MGTRVSYPVEVKQKAVEMRLAGVPMKEIMQKLNIKNKTQVQTWVRWHKAGETHRFEQPVG
KQYTYGKGPEYSSELEKLQAEIRYLRQQNEVLKKYNELERKLIAKRQSNL
>PK3-2_01803 HTH-type transcriptional repressor OpcR
MEKDPLTIIEQAEDHLIERIAENMHAFGMPSTVGRVLGNIYMNRKPMTLAELSEATGMSK
TRLSQVVREMLDANIAEKVFEKGVRKDLYEVEQDYYQTFITLFTATWSKVVSKNKMMHKK
LNRELLSVLDEELTPEAEEKVNELLKELKEWLDYYHWLGRLIEFFESEEIFKYVPKP
>PK3-2_01804 Choline transport ATP-binding protein OpuBA
MLTLENVSKTYKGGKKAVNNVNLKIAKGEFICFIGPSGCGKTTTMKMINRLIEPSAGKIF
IEGENIMEQDPVELRRKIGYVIQQIGLFPHMTIQQNISLVPKLLRWPEHKRKERARELLK
LVDMGPEYLDRYPHELSGGSSSELVYYGHLPQSRRLS
>PK3-2_01805 Choline transport ATP-binding protein OpuBA
MDEPFGALDPITRDSLQEEFKKLQKTLHKTIVFVTHDMDEAIKLADRIVILKAGEIVQVG
TPDDILRNPADEFVEEFIGKERLIQSSSPDVERVDQIMNTQPVTITADKTLSEAIQLMRQ
ERVDSLLVVDDGHMLQGYVDVEIIDQCRKKANLVGEVLHEDIYTVLGGTLLCDTVRKILK
RGVKYVPVVDENRRLIGIVTRASLVDIVYDSLWGEEKQLAVLS
>PK3-2_01806 Choline transport system permease protein OpuBB
MNHIVQFLQTNGGELLYKTYEHITISLIAVILGVLVAVPLGVVLTRMKKGAGTIIGIVNI
IQTLPSLAILAFFIPLLGVGKVPAIAALFFYSVLPILRNTYTGIRGVNKNLLESGKGIGM
TPAEQVRLVELPLAAPVIMAGIRTSTIYLIGWATLAAFIGGGGLGDYIFIGLNLYQPEYI
IGGAVPVTILAIVIDYVLAVTERKLTPAGMQRLKEVS
>PK3-2_01807 Choline-binding protein
MKRTYLKWMTGLTLAVMLTLSGCSLPGLSAASDQTIKIGAQSMSESEIIASMLGQLIEHH
TDLKTTTIKNLGSNAVQQQALINGEIDIAATRYTGDALTGTLRMEPEKDPDKALALTQRE
FKKRYDLKWYDSYGFDNTYVFTVSKELADQYHLQTVSDIKKWAPQLKLGVDNYWMKLKGN
GYQDFTKTYGMAFDGTYPMQIGLVYDAVKSGKMDIVLAYSTDGRIKSYGLKMLKDDKQFF
PPYDCSPVVPEQVLKEHPELESIIHKMIGKIDTATMQELNYEVDGNLKEPSVVAKEYLEK
HHYFES
>PK3-2_01808 Choline transport system permease protein OpuBD
MNVLEQLMAYYAQNGGYVMDEFGRHFLMSAYGVLFAAVVGVPAGILIAHYRRLSAWVFAV
TNVIQTIPALAMLAVLMLVMGLGANTVIVSLFLYSLLPIIRNTYTGIISIEHAYLESGKA
MGMTKFQVLRMVELPLALSVMMAGLRTALVIAIGITAIGTFVGAGGLGDMIVRGSNATNG
TAIILAGAIPTAVMAVAADLLMAWLERALSPVKKKRNRTKRVQTAA
>PK3-2_01809 hypothetical protein
MRLTISRKFSLVFLTLILINLLIGGIGAFNMQHIIQKTDEINTKWIDGIKDITSINYLTE
HLSSKEKDFLIFTDKSKMDTLDQEMNQILKDINQKLDSYEKTISNDKEQKLFEELQTEVN
TYGDIHKQIIESGRTNDMDKARGLLVQTEASFEDMKKSVTQLVDFNKEGANTAVKETKNV
YHKGLIYTALLLAASIIISIFIWLYITRNIVKPIIRMKDSANHIAEGNLSNDIEPVNSKD
ELGDLNEALQKMVGNLRDIVGYSKEISSRVLSSSQVLATATNETRSGSKHITETMNEMAE
GSEQQAQDAVTIAESMNDFTESIDKAYNHGITISDTSQNVLELAVNGNENMDTSLQQMKT
IHHIVQEAVHKVKSLEQHSQDINKLVQVINGIAQQTNLLSLNAAIEAARAGESGKGFAVV
AEEVRKLADGVSDSVQDITRIVNGTQQEIHTVINYLESSFTEVEKGTENLTDTGQAMQQI
KQSVTHVAGSIKEVTDGLKQLTNQSITINQSIENIASVSEESAAGIEETFSITEQSAHSM
DQVLQNVEELEQLAKELNEKMDQFTI
>PK3-2_01810 HTH-type transcriptional regulator YodB
MNQSEMCPRFEKAVDILSKRWVALIVFQLLNGSQRFSEIEAALPNLSGRVLSERLKELEL
EGVVKRDVIPETPVRIEYSLTDKGKALAPILGEISKWATDWIDPSFLD
>PK3-2_01811 HTH-type transcriptional repressor RghR
MSPFGQQLRELRRARKLTVNQLAVYSGISSATISKIENGKRGTPKPVTIKKLAAVLKVPY
ENLMAAAGHIRSFPEEIHEASESYQSIYDIYQTAVTRGAGHLPIFNSQKWEHLSKQDIEN
LSKYFDFLASEAKKRVSSS
>PK3-2_01812 HTH-type transcriptional repressor RghR
MRYMESFGEQLRALREERKLTVNQLATYSGVSAAGISRIENGKRGVPKPATIKKLAEALK
IPYEGLMYKAGYIEEVHEARAPYETKCKLLEKAEAYDLKNLALLENEKWQYLNKEDLLML
DHYFSFISDEAKKRSADD
>PK3-2_01813 hypothetical protein
MRKVPVEKIQIRRDYVLQYMVNNDYSLNQLALEIGVSPATLSRVLNGERRPGQLVIGKML
HYFNLKFEDLFYYDFIDKSQ
>PK3-2_01814 AB hydrolase superfamily protein YvaM
MPLISIASKKHLYYEEYGQGIPIIFIHPPGMGRKVFYYQRLLSEHFRVIFPDLSSHGDSD
HADQPATISYYADEIVKFMDALHIDKAVLFGYSAGGLIAQHIGFTRPDKVSHLVLSGAYP
AVHNIIGEKIHKSGMYLLEKNAWLLIKILAVSHTNNKELRNLLTDHMKKADLAHWHQYYQ
DSLSYNCIEQLPHLNMPMLFMYGGLRDWTFPASSYYRKACSHAEFFRLEYQGHQLPTKQW
KTCNELVTGFVLTHHSQG
>PK3-2_01815 putative protein-export membrane protein SecG
MHAVLITLLVIVSIALIIVVLLQSSKSAGLSGAISGGAEQLFGKQKARGLDLILHRITVV
LAVLFFVLTIALAYIL
>PK3-2_01816 Carboxylesterase
MKVVTPKPFTFKGGDKAVLLLHGFTGNTADVRMLGRYLNERGYTCHAPQYEGHGVPPEEL
VHTGPEDWWKNVMDGYEYLKSEGYESIAACGLSLGGVFSLKLGYTVPIKGIVPMCAPMHI
KSEEVMYQGVLSYARNYKKFEGKSPEQIEEEMKEFEKTPMNTLKTLQDLIADVRNNVDMI
YSPTFVVQARHDHMINTESANIIYNEVETDDKHLKWYEESGHVITLDKERDLVHQDVYEF
LEKLDW
>PK3-2_01817 Ribonuclease R
MEKEAFMDKLLSFMKEEAYKPLTVQELEEMLNITEAEEFKELVKALVTLEDKGLIVRTRS
DRYGIPEKMNLIKGKISAHAKGFAFLLPEDTSLSDVFIPPNELNTAMNGDIVMVRLNSQS
SGSRQEGTVIRILERAIQRVVGTYTETRNFGFVIPDDKKITSDIFIPKNGKNGAAEGHKV
VVKLTSYPEGRMNAEGEVETILGHKNDPGIDILSVIHKHGLPGEFPADAMEQASSTPDTI
DEKDLKDRRDLRDQVIVTIDGADAKDLDDAVTVTKLEDGSYKLGVHIADVSHYVTENSPI
DKEALERGTSVYLVDRVIPMIPHRLSNGICSLNPKVDRLTLSCEMTINSQGQVTEHQIFQ
SVIKTTERMTYSDVNKILVDDDEELKQKYEPLVPMFKDMERLAEILRDKRMNRGAVDFDF
KEAKVLVNDEGAVKDVVIRERSVAEKLIEEFMLVANETVAEHFHWMNVPFIYRIHEEPNA
EKLQKFLEFVTTFGYVVKGTAGNIHPRALQSILDAVRDRPEETVISTVMLRSMKQAKYDP
QSLGHFGLSTEFYTHFTSPIRRYPDLIVHRLIRTYLINGKVDEATQGKWAERLPDIAEHT
STMERRAVDAERETDDLKKAEYMLDKIGEEFDGMISSVTNFGMFVELPNTIEGLVHVSFM
TDDYYRFDEQHFAMIGERTGNVFRIGDEITVKVVDVNKDERNIDFEIVGMKGSPRRPREL
DSSRSRKRGKPARKRVQSTNTPVSPAPSEEKGEWFTKPKKKKKKRGFQNAPKQKRKKKK
>PK3-2_01818 SsrA-binding protein
MPKGSGKVLSQNKKANHDYFIEETYETGIVLQGTEIKSIRAGRVNLKDSFAKIERGEVFL
HNMHVSPYEQGNRYNHDPLRTRKLLMHRKEINKLIGLTKEKGYSLVPLKLYLKNGFAKVL
LGLGKGKKNYDKREDLKRKDAKREIERAFRDSQKGF
>PK3-2_01820 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MKLNLQGKTALVTGSTSGIGKAIASSLAEEGAAVIINGRREEKVNQTIDELKTQHAEAVL
YPASFDLGTEEGCNELFQAYPEVDILVNNLGIFEPAEYFDIPDDEWFRFFEVNIMSGVRL
TRKYLHNMIEKKEGRVIFIASEAAIMPSQEMAHYSATKTMQLSISRSLAELTTGTNVTVN
TVMPGSTLTEGVETMLNSLYPGENLTVQEAEKRFMKENRPTSIIQRLIRPEEIAHFVTFL
SSPLSSAINGAALRADGGLVRSVF
>PK3-2_01821 hypothetical protein
MEKRILAETIRLIRQKGFSFTMNDLAAALGTSKRTLYAHYSSKDKLAEAVVEQFIAEMKQ
MERDIYENESLDVLEKVKQMLIGLPQGMELLNMGLLSELKKYHYDAWLTLDTFMKEEWTV
VLELLNECKRRKRIRNINPDLFVHMYIGSINQVYDPEYPLKHQFTTGEVLESIVDVLFNG
ITADEEADAT
>PK3-2_01822 Multidrug transporter EmrE
MNWGFLCLAILFEVAGTVSMKLSSGFTKLIPSVLLVIFYGGSLFFLTLTLKSIDVSVAYA
VWSGMGIVLITVFGFLFFQENVSVMKLISIGLIIAGVVSLNLIEQGTQSEPIHKSGHYK
>PK3-2_01823 hypothetical protein
MRYMKLFFLVTDIGFILYWLSAGFSLIPESWAFKHHEHPFMIAWNWSFFPLDILISITGL
YSLYLNRVNRADWKLMALISLVLTCCSGLQAISFWTFSRDFDLVWWLFNGYLLIYPLFFI
HVLLKESHVTKQC
>PK3-2_01824 Beta-glucanase
MSYMKRVLLLLVTGLFISLSAVTSTASAQTGGSFFDPLNSYNSGFWQKANGYSNGDMFNC
TWRANNVSMTSLGEMRLALTSPSYNKFDCGENRSVQTYGYGLYEVRMKPAKNVGIVSSFF
TYTGPTDGTPWDEIDIEFLGKDTTKVQFNYYTNGAGNHEKMVDLGFDAANSYHTYAFDWQ
PNSIKWYVDGQLKHTATSQIPTTPGKIMMNLWNGTGVDEWLGSYNGVTPLYAHYDWVRYT
KK
>PK3-2_01825 FMN-dependent NADH-azoreductase 2
MAKVLYITAHPHDEATSYSMATGKAFIESYKEANPNDEVVHIDLYNENIPHIDADVFSGW
GKLQSGTGFDELSESEKAKVGRLGELSDQFASADKYVFVTPLWNFSFPPVMKAYLDSVAV
AGKSFKYTEQGPVGLLTDKKAIHIQARGGYYSEGPAAEMEMGHRYIGIIMNFFGVPSFDG
IFVEGHNAEPDKAQQIKEDAIARAKEAGKTF
>PK3-2_01826 scyllo-inositol 2-dehydrogenase (NADP(+)) IolW
MDTIKVGILGYGLSGSVFHAPLLAVLNEYHISKVMTSRTQEVKRDFPDAEVVHELEDITN
DPEIELVIVTTPSALHYEHAMACIQAGKHVVLEKPMTATAEEGEKLKKAADEKGVLLSVY
HNRRWDNDFLTIKKLIADGSLENINTYQVSYDRYRPEIQARWREKEGAATGTLYDLGSHI
IDQALHLFGMPKAVTANVMAQRENAETVDYFHLLMDYGKLQAILYGGSIVPANGPRYQIH
GQHSSFIKYGIDGQEDALRAGKKPENDSWGADDPEFYGQLTTVHGTDKKTETIPSVNGCY
LTYYRKLAESIREGAALPVTADEGMNVIRVIEAAMKSSKEKRTIMLEQ
>PK3-2_01827 Copper-sensing transcriptional repressor CsoR
MEKHNEHKALNHKSSKEKDQITNRLKRIEGQVRGIQNMVENDRYCVDILVQISAVQAAMQ
KVALHLLEDHTHHCVADAIKSGDGEQAISELLDVFKKFTKS
>PK3-2_01828 Copper chaperone CopZ
MEQKTLQVEGMSCQHCVKAVETSVGELDGVSAVHVNLEAGKVDVSFDADKVSLKDIADAI
EDQGYDVAD
>PK3-2_01829 Copper-exporting P-type ATPase
MLSEQKEIAMQVSGMTCAACASRIEKGLKRMPGVTDANVNLATETSNVIYDPAETEAAAI
QQKIEKLGYHVVTEKVEFEIEGMTCAACANRIEKRLNKIEGVANAPVNFALETVTVEYNP
KEAAVGDLKEAVDKLGYKLKLKGDEDNEAAASKKKEERKQTARLIFSAVLSFPLLWAMVS
HFTFTSFIWVPGIFLNPWMQFALATPVQFLIGWSFYAGAYKALRNKSANMDVLVALGTTA
AYAYSLYLTIQSLGSHGHTDGLYYETSAILLTLILLGKLFETKAKGRSSDAIKKLMKLQA
KTATVVRDGQEQIIPIDEVLADDVVYVKPGERIPVDGEVIEGRSAVDESMITGESLPVDK
NPGDSVTGATVNANGFLKIKAVNVGKDTALSHIIKIVEEAQGSKAPIQRLADQISGIFVP
IVLGIAVLTFLIWYLWAAPGDFAEAISKFIAVLVIACPCALGLATPTSIMAGSGRAAEFG
ILFKGGEHLEKTHRLDTIVLDKTGTVTNGKPRLTDAISFGRFEETDLLQFAAAAETGSEH
PLGEAIVAGVKEKGLEIPKLTRFEAKIGAGILAEAGGKTILVGTRKLMESEQVEHGPLLN
QMEALEAEGKTVMLVSLDGEAAGLIAVADTIKDTSQAAVARLKELGLDVIMMTGDNRRTA
EAIAKEAGITSVIAEVLPEQKAAEIARLQKEGRQTAMVGDGINDAPALATADIGMAIGTG
TDIAMETADITLIRGDLNSIADAIRMSRLTMKNIKQNLFWALGYNSLGIPIAALGFLAPW
IAGAAMAFSSVSVVLNALRLQKVK
>PK3-2_01830 Cadmium, zinc and cobalt-transporting ATPase
MKQEYVLDGLDCSNCAQKIENGVKGIKGIDGCAVNFAASTLTVSADGKEEQWVTNKVEKK
VKSIDPHVTVRQKHKKKSADDGYRNRMINMLIRMAAAVILGAAAYFVHSGTIEFLLFLAA
YLVIGGDIVIRAGKNISRGQVFDEHFLMALATIGAFLIQQYPEGVAVMLFYQIGELFQGA
AVSRSRKSISALMDIRPDYANVKTENGIKLVSPEDVQIGDIIVVNPGESIPLDGKVIQGS
AMVDTSALTGESVPRKAAEGQEVMSGFINQNGVLHIEVTKGYQESAVSKILDLVQNASSR
KARTENFITKFAKYYTPAVVIIAALLAFVPPLMIPGAALSDWVYRALIFLVISCPCALVV
SIPLGFFGGIGAASKAGVLVKGSNYLEALNQVKYAVFDKTGTLTKGSFEVTEIKPAEGFT
KDRLLEAAAYAELHSQHPIAESVRKAYGKMLSSDTIESYEEIPGHGIFAKVNGTEILAGN
KKLMEREQINGVPDENAGTIVHVAVDQRYAGAIIIADQVKEDAAQAVADLKSLGIKQTVM
LTGDSKQTGEAVGKQLGIDEVYAELLPQDKVARVEALEAKLSQNEKLIFVGDGINDTPVL
ARADIGAAMGGLGSDAAVEAADVVLMTDQPSKIAEAIRIAKRTRRIVWQNIGFALGVKAI
FLILGAFGIATMWEAVFSDVGVTLLAVANAMRVMRLKNR
>PK3-2_01831 Disulfide bond formation protein D
MKKKQQSSAKFAVILTVVVVVLLAAIVIINNKTEQGNEAVSGQPSIKGQPVLGKDDAPVT
VVEFGDYKCPSCKMFNSDIFPKIQKDFIDKGDVKFSFVNVMFHGKGSRLAALASEEVWKE
DPDSFWVFHEKLFEKQPDTEQEWVTPALLGDLAKSTTKVKPETLKDNLDKETFASQVEKD
SDLNNKMNIQATPTIYVNDKVIKKFSDYDEIKETIEKELKGK
>PK3-2_01832 Disulfide bond formation protein C
MKNRIGFLYASWVVALVAMLGSLYFSEIRKFIPCELCWYQRILMYPLVLILGIATFQGDT
RVKKYVLPMAIIGACISIMHYLEQKVPGFTGIKPCVSGVPCSGQYINWFGFMTIPFLALI
AFILIIVFMCLLKGEKSE
>PK3-2_01833 hypothetical protein
MAWELLSVIGIIAFAVSGAIVAMEEEYDILGVYILGIVTAFGGGAIRNLLIGVPVSALWE
QGAYFQIALVSITIVFLFPKPLLKHWNKWGNLSDAIGLAAFAIQGALYAVKMGHPLSAVI
VAAVLTGSGGGIIRDLLAGRKPLVLKAEIYAVWAAFGGLIVGLGWLGNSFGLYVLFFVLV
VCRVCSYMFKWKLPNRSFRLDN
>PK3-2_01834 DNA helicase IV
MNQQDKEWKEEQSRIDEVLQELGKKERFLETSAGGLKQDIIGLRKSFWEDVTVNVDDAHE
AVETMASIKQQAELLSDRERNHRRMDQQLKRIHQLKATPYFGRIDFIENGEGQAERIYIG
LASCMDEKEEHFLIYDWRAPISSMYYNYSPGKVAYEVPGETIEGEMMLKRQFIIKNGALK
AMFNTDMTIGDEMLQEVLSHHSNTQMKNIVSTIQKEQNQIIRNEKSKFLIVQGAAGSGKT
SAALQRVAYLLYRHRGVIDAGQIVLFSPNFLFNSYVSSVLPELGEENMEQATFQEYIELR
LGRKFQCESPFDQLEYCLTETKDGGFPTRLAGITWKAGLSFQQFIDEYVTRLSSEGMIFK
NIVFRGQKLITKEQIQSYFYSMDQRQSIPNRMEQTAKWLLSELNKLEKKERRKDWVVQEA
ELLDKEDYLDVYKKLQDRKRFSESTFNDYQREQQLLASIIVKKAFTPLKKAVRLLAFLDM
KQLYLQLFSGWGGKFQHEKTAEIGELTGSAFAENKLLYEDAAPFLYMQDLIEGRKKNTKI
KHLFIDEAQDYSPFQMAYMRSIFPAASMTVLGDINQSIYAHAIHGAKRMDACFEGEPAEY
VRLRRTYRSTRQIVELTKAMLQDGADIEPFNRNGEIPRVFKTEGREDLCQKLTKEIERLQ
KQGHETIAVICKTAQQCIQAHSRISEYIDVRLIHKENQTFQKGVCVIPVYLAKGIEFDAV
LVYDASEEYYQTEHDRRLLYTACTRAMHTLTVFYTGKASPFGAAVPPHLYQNAE
>PK3-2_01835 Sulfite reductase [NADPH] flavoprotein alpha-component
MQLQVMNSPFNQEQAELLNRLLPTLTESQKIWLSGYLSAQSVSAQENAGAPAASVSAEAA
APAVSKEVTVLYGSQTGNAQGLAENAGKQLEQRGFQVTVSSMSDFKPNQLKKVNNLLIVV
STHGEGDPPDNALSFHEFLHGRRAPKLEDLRFSVLALGDSSYEFFCQTGKEFDQRLEELG
GKRISPRVDCDLDYDEPAAEWLESVLEGLSEAGGDSAAPAPAAAPQAGESPYSRTNPFRA
EVLENLNLNGRGSNKETRHVELSLEGSGLTYEPGDSLGVYPENDPELVDQLLKEMNWDPE
EIVTLNKQGDVRPLKEALVSYYEITVLTKPLLEQAAQLTGSNELRELLAPGNEENVKAYI
AGRDLLDLIRDYGPFSVSAQEFVSILRKMPARLYSIASSLSANPDEVHLTIGAVRYDAHG
RERKGVCSILCAERLQPGDTLPVYVQHNQNFNLPKDPETPIIMVGPGTGVAPFRSFMQER
EEAGAEGKAWMFFGDQHFVTDFLYQTEWQNWLKDGVLTKMDVAFSRDTEEKVYVQHRMLE
QSADLFEWLQEGAAVYICGDEKHMAHDVHNTLLEIIEKEGNMSREEAEAYLADMQQQKRY
QRDVY
>PK3-2_01836 Sulfite reductase [NADPH] hemoprotein beta-component
MVTKILKAPDGSPSDVERIKRESDYLRGTLKEVMLDRISAGIPDDDNRLMKHHGSYLQDD
RDLRNERQKQKLEPAYQFMLRVRMPGGVSTPEQWLVMDDLSQKYGNGTLKLTTRETFQMH
GILKWNMKKTIQTIHSALLDTIAACGDVNRNVMCASNPYQSEIHSEVYEWSKKLSDDLLP
RTRAYHEIWLDEERVAGTPDAEEVEPMYGPLYLPRKFKIGIAVPPSNDIDVFSQDLGFIA
IVEDGKLIGFNVAIGGGMGMTHGDTATYPQLAKVIGFCRPEQMYDIAEKTITIQRDYGNR
SVRKNARFKYTVDRLGLDTVKEELENRLGWSLEEAKPYHFDHNGDRYGWVEGIEDKWHFT
LFVEGGRITDYDDYKLMTGLREIAKVHTGEFRLTANQNLIIANVSSEKKAEISALIEQYG
LTDGKHHSALRRSSMACVALPTCGLAMAEAERYLPTLLDKIEEIIDENGLREEEITIRMT
GCPNGCARHALGEIGFIGKAPGKYNMYLGAAFDGSRLSKMYRENIGEEDILSELRVLLTR
YAKEREEGEHFGDFVIRAGVIKATTDGTNFHA
>PK3-2_01837 Sodium, potassium, lithium and rubidium/H(+) antiporter
MDIFLVVLVLLTIIAISNIVNRFIPFIPVPLIQVALGIVAASFPQGLHFELNTELFFVLF
IAPLLFNDGKRTPRAELWNLRAPILLLALGLVFATVIVGGYTIHWMIPDIPLAAAFGLAA
ILSPTDVVAVSALSGRVKMPKGILRLLEGEGLMNDASGLVAFKFAIAAAVTGAFSLAQAA
VSFVFISLGGLLCGVVISFLIIRFRLFLRRLGMQDVTMHMLIQILTPFVIYLAAEEIGVS
GILAVVAGGITHAVEQDRLESTMVKLQIVSSSTWNIILFILNGLVFVILGTQIPDVISVI
FNDTAISNMKVIGYILVITFTLMLLRFLWVLFFWNGKWFFNKDQNIYKPGLRSTLLISIS
GVRGAVTLAGSFSIPYFLEDGTPFPERNLILFLAAGVILCTLVIATVVLPILTEKEEEDE
KRNEKLLTARRKLIKTALQTIKEDMNDTNKTASLAVIAEYNEKMKNLRFQQYTSSNRIKK
QERKVRAQGVNAEQEALMKMLERGDIPEETANVLQERFNELEILYANPFKVGLSKTRLKR
LMYWIFFGEHKKPEMSILNEAGLIRATRVKTAKAAIEYLEKHKTEEHKEVFLSVISFYKQ
LIFRLEHSHHELKSSAHFENQKLEVKLKAVQAIRNEIQTLFEEREISRDISHELRQYIND
VEAAMLEGGE
>PK3-2_01838 Stress response protein YvgO
MKRIRIPMTLALGAALTIAPLSFASAEENPAPKISQTTTAGTSAAEVGLNVNLDVLGIAN
QIADAIKSAQNRDGFVKNLMESSFYASGQKYNVMVFNLSQEYEDHLNGVQFYGSAVYDGI
TYGIWVFEDGTFTNKGDGGWINWAFRGWFDRDGSTVEFHRP
>PK3-2_01839 Glyoxal reductase
MPKSLKDTVKLHNGVEMPWFGLGVFKVENGSEATESVKAAIKNGYRSIDTAAVYKNEEGV
GIGIKESGAAREELFITSKVWNEDQGYETTLAAFENSLERLQLDYLDLYLIHWPGKDKYK
DTWRALEKLYKDGKIRAIGVSNFQVHHLEELLKDAEIKPMINQVEFHPRLTQKELRDYCK
AQGIQLEAWSPLMQGQLLDNEVLAEIAEKHNKSVAQVILRWDLQHEVVTIPKSIKEHRII
ENADIFDFELSQEDMDKIDALNKDERVGPNPDELLF
>PK3-2_01840 Molybdenum transport system permease protein ModB
MALLPSSISASEFFTPVMLSFQVAAVAGIVVIILGTLAGAWMSRASFFGKTALETFFMLP
LVLPPTVVGFILIVIFGKHSFIGHAIERVFQQPVIFTWWAAVIASAVVAFPLMYQSAKTG
FADIDPDIQGAAMVDGASRWKVFIHISVPLAYPSLLTGSILSLARALGEFGATLMFAGNI
PGVTQTLPTAIYVALDSGNNTLAWAWVVCIVAISFLMLFFIQRRKTH
>PK3-2_01841 Molybdate-binding protein ModA
MFKKYSIITAALTVFLLAAGCSANQSSTDSEKQVTLTISAAASAQDALEEIQKNYKKEHQ
NITIQDNYGSSGALQKQISQGAGADLFFSAAEDKFQKLVDDGDIAKKDSTDLVGNEIVLV
VPKNGDSPVTSFSNLADSEKIALGTPESVPAGAYGKESLTKLSLWDKVKDKIVYGKDVRQ
VLSYVETGNVDAGVVYKTDALISKKVKIIDEAKADTHSPIVYPLGIVKETKHRKEAKEFY
DYLQSDEAMKVFEKYGFTAE
>PK3-2_01842 hypothetical protein
MMNETSSYTIEEVAGLLKVSKLTVYDLIKKGVLPAYRVGRQMRVDEEDLKQYKTNMRMSQ
PIAAAEEPRKIQVAEPEGRPNVMISGQDISMDLLSRHLENAIQETPLRKYKGSLNSLIDM
YQGRCDIVSLHLYDAETGRYNAPYVKRILSGEPFCLINAVLRKAGLYVQKGNPKNIQGWE
DLKRADIRIINREKGSGARVLLDEQLGLLGVNPADVKGYGDIVTDHYAVASQVSSGQADA
GIGAQHASHMGSVDFIPLIDEQYDIVVLKKHEQLLKAVKEILNSEEYKANLSHLNGYQTK
LTGKIMLET
>PK3-2_01843 Lipoteichoic acid synthase 2
MKGTFFHNQRFLCFSIVFMWVKTYAIYKLGFDFQIDSLLEELMLLINPFSFILPLFGIGL
LLKENKQRAFLLIANLVLTVILISNTIFYGFYIDFITIPVLFQASNMSDMGSSVKELFNP
LFIALFADLVFLLLLARKEKHPQTKAAPRTIKRYYAASCGMILCTLALAEVQQPKLLAHS
FDREMLVKSIGLFQFHIYDTISQTVNISAKAFADEDSMTAVKNYAEADYSKPDQSKFGLA
KGRNVIFVTLESTQSFVLNEKVNGKEITPFMNDFIKKSYYFDHFYQQTEQGKTSDSEFIV
ANSLYPSLSGAVFFTKSDHQFHTMYKSLKQHDYYSAVFHANHKTFWNRDVMYDSFGIDRF
FDVDDFHVTPGTSTSWGLKDKEFLEQSAGKLKSLPQPFYSSFITLTNHFPFEIDEKDQLI
DEFDSSSSLLNRYVTTVRYEDEALKHFIKKLKDEGLYENSMIVFMGDHYGISEAHNEAMA
EFLGKNEITPYDNVQLQRVPFIIHIPGITDQKPEIISDAGGQVDVKPTLMHLLGVDTKGD
IQFGNDLLSGGRTPFAVLRNGSFITNDFVYTKNTCYSQKTGKVLEDQDACLPYKEKANEE
LSLSDKVLNGDLLRFSE
>PK3-2_01844 Inner membrane protein YdjM
MTGKTHIMGGIASCTAAAYYYGFDPVLMAASGAVGALIPDICHTQSKIGRRFPILSKVVS
SVFGHRTFTHSLLFLLIMFFITATYIPDKNISAGLLIGMASHLILDAWTVNGIKLLFPST
IRVRLPLYMKTGSFSEQLVLAGLTIASCYYFYMLFHGRMF
>PK3-2_01845 Small, acid-soluble spore protein J
MGFFNKDKGKRSDKEKNVIQGALEDAGSALKDDPLQEAVQKKKNNR
>PK3-2_01847 Arginine/ornithine antiporter
MEQTKKWGFWLLTAFVVGNMVGSGIFSLPSSLASIASPFGATSAWLLTGAGVLMIALVFG
HLSIRKPELTAGPQSYARALFSDPKKGNAAGFTMVWGYWVASWISNVAIITSLAGYLTSF
FPVLVDKREMFSIGGQEVTLGQLLTFAVCTILLWGTHTILVASINGASKLNFVTTLSKVL
GFVFFIVAGLFVFQTALFGHFYFPIQGENGTSIGIGGQVHNAAISTLWAFVGIESAVILS
GRARSQRDVKRATITGLLIALSIYIIVTLITMGVLPHDKLVGSDKPFVDVLYAIVGNAGS
VIMALLAILCLFGTMLGWILLGSEVPYQAAKAGDFPAFFAKTNKKGSPVNALVITNVMSQ
VFIFSVISRTISDAFTFLTTAATLAYLIPYLVSAIYSLKLVIKGETYDQLKGSRLKDGLI
AILACAYSLFVIVTGTADLTTFILGIGLFFVGLIVYPFVIKKFRKEKQA
>PK3-2_01848 hypothetical protein
MLNHIGYFFTQFILSCIIIAISFFNMLYIGKPFSDVLLVFIFVLVLFGLLERLKKRFLQI
RLSVKVFLSISAFLSAVLTIGLLTREIVFQ
>PK3-2_01849 Iron(3+)-hydroxamate-binding protein FhuD
MTHIYKKLGAAFFALLLIAALAACGNNSESKGSSSSSKDEETFTYKAENGNVKIPKHPKR
VVVMADGYYGYFKTLGINVVGAPENVFKNPYYKGKTDGVTNIGDGTSVEKVIDLNPDLII
VWTTQGADIKKLEKIAPTVAVKYDKLDNIEQLKEFAKMTGTEDKAEKWLAEWDKKIAAAK
TKIKKAVGDKTISIMQSNGKDIYVFGKDFGRGGSIIYKDLGLQATKLTKEKAIDQGPGYT
SISLEKLPDFAGIIFSRVHGNQAVMMAAYLTAPFGIT
>PK3-2_01850 Iron-uptake system permease protein FeuB
MSQHKNIQAASEEIEWTSRTYGAVIILIAGLCLLCLGAFLSISLGAADIHLRTVWDAIFH
YQPTETSHQIIHDLRLPRTAAAALVGALLAVSGAIMQGMTRNPLAEPSIMGVTSGSAFAI
SIAFAFFPGLSAMGLVLWSFAGAGLGASTVMGIGMFSRGGLTPVKLALAGTAVTYFFTGI
STAIAIRFDVAQDISFWYAGGVAGVKWSGVQLLLIAGAVGLTLAFVIARSVTVLSLGDEL
AKGLGQYTSAVKVAGMLVVVILTGAAVSIAGTIAFIGLIIPHITRFLVGVDYRWIIPCSA
VLGAVLLVFADIAARLVNAPFETPLGALTSLIGVPFFFYLARRERRGL
>PK3-2_01851 Iron-uptake system permease protein FeuC
MKTKTKKPFVVMAVTFLFIVLVFFISLNLGVIKIAPLKTLQVFFGQGTARDELVLFEFRL
PRIILSLLVGAGIAVAGAILQSVSQNDLAEPGILGINAGGSLAVVLFIYFFQGSASDLSF
FGTFMLPFSALAGAILAAFLIYLLAWKKGVTPIRLILVGIGVNAGFNALLLIFQLKMDPH
DFMQAAVWISGSIWGANWNMIWAILPWIVILLPFTLYKARYLNILQLGDQLATGLGTAVE
RERRILLLAAVTLAASCVAAAGGIAFLGLIAPHVARRLTGPRHQTLIPVSAFIGAFLFLL
ADTLARNVLAPSEIPVGLVISVLGAPYFIYLLMKAN
>PK3-2_01852 putative siderophore transport system ATP-binding protein YusV
MDSLSTNQLGIGYGDRVIVEDLNISIPKGKITTLIGPNGCGKSTILKTMSRIMRSHAGAV
YLNGKAIHKMSTKDIAKDMAILPQTPEAPSGLTVYELVSYGRFPHQSGFGRLHDEDRRII
KWALEETGMAEFAERPIEALSGGQRQRVWIAMALAQGTELLLLDEPTTYLDLAHQLEILQ
LLDRLNKEQGRTILMVIHDLNHAARFSHYMIALKKGTVIKEGTVLEVMTPDILKQVFQID
AEIVTDPRTNKPVCLTYDLIKNEKTLVSV
>PK3-2_01853 Putative efflux system component YknX
MSKKKKWLIGGAICAGVLVLAGIGAGGFYFFTHMNQIAVSSSEPYAESVAVYMGGESESG
QTFSGKVEPEKQQKVYIDSEKGSIKKTYVKEGDQVKKGDKLFEYEGEDHSDEVEQANLQI
EMTNLQISRLQKSITETDKKLKAAGKEEKSQLQDELDQANFDLKTSQLELKQHQKELAAL
TKNKGSNVITSKHDGIVQSVNQDIADGAKGDQATGPYIQIVSTGKYLVKSQINELLMDTI
KKGSKVRVTLKTGGEGEWKGKVTSIGKLPAGAGEGEDTESFSEEEMNPQSSNYPFTILLD
SHKGLEVGYHVNIEVMSDEADADTIKLPSDMVIQDDGEPYVWKADENQKAVKQPVEIGDT
DENDMIEIKSGLTPEDYVIYPDPAVKEGKQVTVNADTE
>PK3-2_01854 putative ABC transporter ATP-binding protein YknY
MLTLNNISKSYKLGKEEVPILKHINLTVQSGEFLAIMGPSGSGKSTLMNIIGCLDRPTSG
TYTLDQINILKGKDGALAEIRNESIGFVFQTFHLLPRLTALQNVELPMIYNKVKKKERRQ
RAYEALEKVGLKDRVSYKPPKLSGGQKQRVAIARALVNQPRFILADEPTGALDTKSSEQI
LSLFSELHQEGKTIIIITHDPDVAKKADRTVFIRDGELLSDERGDISHA
>PK3-2_01855 putative ABC transporter permease YknZ
MLEHIRISFQSIFSHKLRSILTMLGVIIGIAAIIAIVSMLKGQSEQLKQSMIGMGNNAIN
VVYQPSGGEEEGGGSQVSYTSAPPVAEETVKAIKSDPMVKGLSLYYLSEGASVFHLTNVS
YPQVYGVDGDYFDMFPIRITEGRKLTENELNSTRQVVMINEAARDELFPDGDSLHKNIEI
NGVPFKVASVFTEKNQQESMFEGDYANPVLYAPKKVWPLIEGFDAPTQIAVQADSSEHIQ
EAGVMAADLLNQGLSDTELEKAEYTVMDLQEIAQEVESFNQSFALLLGGIASISLLVGGI
GVMNIMLVSVTERTREIGIKKALGAKRRVILFQFLTEAVVLTSIGGILGVLAGFGIAKLL
TVVFPMPFIVSVPAVVGALIFSMAVGIIFGLLPSIKASKLQPVDALRYE
>PK3-2_01856 Membrane-bound negative regulator YvrL
MKLQTSTKRLLRLSTQYVLAAAAVVLTYYAVILALFFLAGTSYRSAAHVLLFAVLFLILG
LFFEPFERLIIHSFTFFRTGKRLFIFLAGIVQLLFLWMTAHTTDQLMSDIWLSTTEEMIV
AGVFLILDKCNSALPS
>PK3-2_01857 Oxalate decarboxylase OxdC
MKKQNDIPQPIRGDKGATVKIPRTIERDRQNPDMLVPPETDHGTVSNMKFSFSDTHNRLE
KGGYAREVTVRELPISENLASVNMRLKPGAIRELHWHKEAEWAYMIYGSARVTIVDEKGR
SFIDDVGEGDLWYFPSGLPHSIQALDEGAEFLLVFDDGSFSENSTFQLTDWLAHTPKEVV
AANFGVTKEEIANLPGKEKYIFENQIPGSLKDDIVEGPNGEVPYPFTYRLLEQEPIESEG
GKVYIADSTNFTVSKTIASALVTVEPGAMRELHWHPNTHEWQYYISGKARMTVFASDGHA
RTFNYQAGDVGYVPFAMGHYVENIGDEPLVFLEIFKDDHYADVSLNQWLAMLPETFVQAH
LDLGKDFTDILSKEKHPVVKKKCSK
>PK3-2_01858 putative protein YvrJ
MDQVFIEEVVKQIGNLGFPALIAMYLLTRFEKKFDQLIELMTELKDQKAKN
>PK3-2_01859 RNA polymerase sigma factor SigO
MDYQGLLRSKCKEIMKHPIVKHFLSNPQHYRLFKNVMESPNEKDAKSLDEQFKQFYKEIR
IVKYMNSMIRIFSIDFDKRVRKNQKRYPLTVDHPEAGERLPSETGSDAFEAFLDLQDDLS
QHVQDYQLYQAIQNLTDKQKSVLTKVYLHGATMQEIADSLGESRQNISNIHKKGLENIRK
QLAAQKKGEK
>PK3-2_01860 Sigma-O factor regulatory protein RsoA
MNGQFEQKKQKDDMYDIEHLIACFSPMIRKKLSNTSYQEREDLEQELKIKMYEKADMLLC
QDVPGFWEFILYMVDENS
>PK3-2_01861 Transcriptional regulatory protein WalR
MENASILIVDDEKAIVDMIKRVLEKEGYRNILDAASAEEAIPVVKANKVDLIVLDVMMGG
MSGFEACTLIREYSEAPIFFLTARSSDADKLSGFAVGADDYITKPFNPLELAARIRAHLK
RTYQAKETNSNKTYTYDYFTFSPQNAELIVGGEAVACSAQLLQLLQYFCEHPNVVLSKDQ
IYEKVWGYPSYGDNNTVMVHIRKLREKIERDPSNPEYIVTVRGLGYRFIPNPEGKRS
>PK3-2_01862 Adaptive-response sensory-kinase SasA
MRLRWKFLFHFFGQMLIVILLLTVMLVASFFYLDSRFSDAESNSGLTKATTDTLEAYLDV
NEDGTWEVDDFLKKSVDKQHGWMQIIDSNGKTAYSYSVPKDVPGDFTKKELLSIYKTKKF
NHYRVNYWAINIEDKSYLLLSGWKLKSEQMLTSIEKREQKIDSLAHYKPSTIDYIKREKG
AIYLLDSNGNILDSINGTKSERKTLNQLELLKYSSKPWNYKREISVKILSKDRWMVATVP
NPVYVTDQEFNKSFLKVVLKAMFLVMAVLFMYIIWMTIWYMFRFGLPIFHTIKWLVNLSK
GKLEEPKNREGRPISKNKKGKIKQPYRFFGEIFESMDQLTETLRRDKRNREKIQATREEW
IAGLSHDLKTPLSSIYGYSMMLESKQYDWSPEEVKEMGQVVREKSEYMSKLIEDLNLTYR
LKNDALPIERKLTNLIPFFKNVIEDFKKNPFSEGYDISFVSKEEHIEFALDEAWFRRILE
NLLGNAVKHNDKGTEIQVILEQTKNHISLKVKDNGKGMDEETITNLFNRYYRGTNTKDSA
AGTGLGLAIAKELVHLHNGTIHVNSRINIGSVITILFKKQ
>PK3-2_01863 6-deoxy-6-sulfogluconolactonase
MDAVLEADTRAVIGEGPLWDEENGCLYWVDILGSELHIFEPEEKVNRSVKFKSFVTALAK
YSKDELIMTMKDGFYLYHLQGDSLEKIKQPKDMHESLRFNDAKCDPYGRLWAGTTSMEGE
QNQASLYRLDPDGRLIKMKDQVSTSNGLDWDRERNLMYYIDTPTQEIVCYSYDPESGDVS
NPESVYRFDQTDGLPDGMTIDQNGMLWVALFGGGRVVQIDPFQKKEIDSISVPAKYVTCC
AFGGKDLKTLYITTATEQMTETERYEQPHAGGLFSAKLETGGYQPVPFAGDV
>PK3-2_01864 D-beta-hydroxybutyrate dehydrogenase
MDLQLKDKLVLITGSTSGIGKAAAKSFLQEGAAVIVNGRKQETVDRTVEELSAFGTVHGA
AADLSKTDEAAAFIEKVNKIGDIDILVNNLGFFEVKDFADVTDEEWNQYFEVNVMSAVRT
SRHFLPKMLAKNSGRILNIASEAGIKPLPTMIPYSMTKTALISLSRGMAEMTKGTNVTVN
SVLPGPTWTEGVASYMEGAAQAAGQDTDTFIKDYFKVNEPTSLIQRYATAEEVANTIVFL
ASDAASAINGTAQRVEGGIIRSL
>PK3-2_01866 Vitamin B12-binding protein
MKKLAGIWTALLLAAVMLAGCGNTADQKDPKAKQKTEASEAFPVTIDDASNQDVTIKKEP
KKIVSLMPSNTEITYALGLGDKVVGVTTNDTYPKEVKKVEKVGDMNVNVEKVISLKPDLV
LAHESSMSASADAIKQLKDAGIAVLTVNDAQSFSEVYKSIEMIGEAAGAEKKADQLVKSM
KSDVRDIEEKAKTITKDEEKSVFIEVSPDPDIYTTGKDTFMNEMLNVIHAKNAAADQTGW
VQMTDEAIVKLNPDAIVTTDGVKAKAVEKRDGWSEINAVKRHRVYDVDPDLVTRSGPRLI
EGVEELAESIYPDTFKE
>PK3-2_01867 Hemin transport system permease protein HmuU
MRKAFTRIRLRNNRFAAYIIGFSFLAVSMILGISCGSLQIPIPAIFRVFWHEGFGGSIGS
DDPMYTNIMMNIRLPRVVLAALVGAALSIAGAAFQGLLKNPLADPYTLGVSSGASVGAVV
TLFFSLQLPIIGGFTLPVVSVAAALVTIAAVLSFSRLVHASMSVSTLILTGVIINSFLGA
FISLIIALTGDNLLPIVHWLLGSVSMRGWSYIVLFLPFFLLGTILLIINGRELNVMTYGE
DKAKLLGVSVQQRKMLILIAGSLLTGSAVAVSGTIGFVGLVIPHITRLLWGTDHRHLLPL
SALLGAGFLVLADLLSRTIIEPIELPIGIITSLAGAPVFALILIRQHRGGRSL
>PK3-2_01868 Vitamin B12 import ATP-binding protein BtuD
MMKAEGLSGGYGDSELINNVSLTVEKGEFLGILGPNGSGKTTLLHLLTGTLPAKEGGVYL
AGKPLTDYKPKELAQIMAVLPQKTDQAFTFTVKETVAFGRYPFQTGLFRQQTEKDEAIIQ
EAMEQTGVAAFAQKSIRELSGGEQQRVYMAQALAQQPQIIFLDEPTNFLDLAYQKELLDL
IKRLTRENGLAAVSVFHDLNTASLYCDELLFMKNGTAGPKQKPEYAVTEHHIKAVYDTDV
TALVHHSSPKPMVVIQPEKASVKQQPIPFEALLQTGHDDILLQTEIPLRTLSSAPVGGGF
SWSRALIHKRLPVQADPIEGLVAYLSENGFHLPETCAMASQGRLDRFVYRTYEDGELSVF
ICVMSGFSIWILINGYAADQFFVKALMIAEAERMKVLGDGRAEGDILIAATQTQSSQNTE
QRLNQLIQKGTAECVKEAAELFE
>PK3-2_01869 Corrinoid adenosyltransferase
MKLYTKTGDKGQTSLVGGRTDKDSLRVESYGTIDELNSFVGLALAELSGQSGFEDLTAEL
LNIQHELFDCGGDLAIVTERKGYKLTEESVSFLEKRIDAYTAEAPELKKFILPGGSKGAS
LLHAARTITRRAERRVVSLMKSEQIHETVLCYLNRLSDYFFAAARVVNVRSGIDDVEYER
SAIVFRDRSSSES
>PK3-2_01870 hypothetical protein
MFAFNSILWFLIYDGKGAVGTALLIAVTFLPEAVLAPVTGPFMKQTTLKFWMYFSDLTRA
AIVLIIPLCHFAGFSPLWFVMTLMIVHSATGAAYNPASIALIPQIVNEQGIQKANAVLQS
SAQIVRLGAVTLCGAFLTFISPSYTMLIALVLYLVSGFLVLFIKYTAVESQSESAVVTQR
GTYIGRLKRGFTLVRRHQILYPLAIYCIFMNFAAAPWEALSAVYVAEDLNGQPIVYSLLK
ATTAAGAFLLGFVLAKVKVNRYGLLFVTAGIVEGFAFFITGMNTFLPLVFLAAFTFGAAV
SAVNVPEYTIIQTSVDSEDQPQVYAVIHMISNISIPAGAVICGYAANAFGSGTVIAVGGV
VEIIAGIGILLFTKLAKAERSDLIKEREASVHL
>PK3-2_01871 Protein LiaI
MKINKKTIGGFLLIVFGISVFFGGGSFGFIIPLAIGSLMTYAGIKRFAAGKTITGIIVGG
IGAIMLICSLPFVVGIALAAAMVYYGWKLMKNGSADNGVSSFEPEPVSAAYQSHFDDEWE
EFLKKK
>PK3-2_01872 Protein LiaH
MVLKRMRDMFVASVHEGLDKLENPKVMLNQYVRDMESDIAKAKQTIVKQHTIAYQFKKKY
EEAAEVAGKRNNQAQLAFDAGEEDLAKKALTEMKYLEGKAAEHKASYEQANSQLAELKEQ
LAALETKLQDVKDKKQALIARANAAKAKEHMNTTFDKIDSESAYREFLRIENRIEEMEIR
ANYSKSAEAGTELTRKEFADDVEAELEKMRALSLQKSDQTSQAANE
>PK3-2_01873 Protein LiaG
MNKMLGKLLITAGILIFFAVIVKDVFAAGLGFVNGTETDSASALPRNIDSVVIESDNKDV
RIIAEERNDISAGISGDSGKLFVNENRKKLELTAKEKEFQFLNGFNRSSLVVRIPYDYKG
DLTVRTSSGDVSVDGNHHLVLSGLNAVSASGNMRVTNVRLQELKVKGSSGDVTISNTNYK
TAGIDLASGDANLADVSGSLDVKMTSGNLDAALKKVTGPVSVTLTSGDANLSLPQNGSFT
VSAKASSGDVSSPYSFADTAHKEEHQITGSQGSGGHPIDIKTDSGDVTIR
>PK3-2_01874 Protein LiaF
MTKKQLLGFIIALFGISMFLQIIGIGDLLFWPLFFLIAGYFLKKYSRDWLGSVMYIFAAF
LFLKNLFSITFNLFGYAFAAFLIYAGYRLVKGKPIFEPNEKRIDLNKKERNEPPKDVKQP
DMRSFFIGELQMMKQPFDLNDLNISGFIGDIKIDLSKAMIPEGESTIVISGVIGNVDIYV
PSDLEVAVSSAVFIGDINLIGSKKSGLSTKVYAESSDFSESKRRVKVSVSLFIGDVDVKY
V
>PK3-2_01875 Sensor histidine kinase LiaS
MRKKLLASLQWRAIRMTTGISLLLFACLISFMMFYYRLDPLVLLSSSWFGIPFILILLLI
SVTVGFASGYMYGNRLKTRIDTLVESILTFENGNFAYRVPPLGDDEIGLAADQLNEMAKR
VELQVASLQKLSNERAEWQAQMKKSVISEERQRLARDLHDAVSQQLFAISMMTSAVLEHV
KDADDKTVKRIKLVEHMAGEAQNEMRALLLHLRPVTLEGKGLKEGLTELLDEFRKKQPLD
IEWDIQDTPISKGVEDHLFRIVQEALSNVFRHSKASKVSVILGIKNNQLRLKVIDNGKGF
KMDQVKASSYGLNSMKERASEIGGVAEVISVEGKGTQIEVKVPIFPEEKGENERDSSIID
>PK3-2_01876 Transcriptional regulatory protein LiaR
MIRVLLIDDHEMVRMGLAAFLEAQPDIEVVGEASDGSEGVRLAGELSPDVILMDLVMEGM
DGIEATKQICRELPDPKIIVLTSFIDDDKVYPVIEAGALSYLLKTSKAAEIADAIRAASK
GEPKLESKVAGKVLSRLRHSGENALPHESLTKRELEILCLIAEGKTNKEIGEELFITIKT
VKTHITNILSKLDVSDRTQAAVYAHRNHLVK
>PK3-2_01877 Spore germination protein A3
MKVRILSMFICTLLLSGCWDSRNIEELSLIIGVGLDKPNDKNLELTQQILVPKKISSKEG
SSSDPTQLSITQGETVHQMIRTSALKHNPTFSQHLRVILLSKSVIADQIGMDAIINQFVR
DNGTRRSSYVFVTDSRTKDIFKMNDQGEPASNVIYDLTENNKVTIRMMEPVTLGEISEHL
TSDDSFIIPHVGEENGKLAINGASIIKNKLWLRDLTPGEVQNINLFTGTVEGGVVDMRHN
GNLFSYEVYSSSRKIKTDYKDGKFKFTVIRNIEGRLSEDWDPNEDSFKDSYIKGLEKAVE
KRLHKTVTAFVGKLQKDIKADVTGLGNEVRIHYPQKWEKIARKWDDDYFGTAEIDYRINV
VIRDFGTKGASK
>PK3-2_01878 Spore germination protein A2
MSQKQTQIKLNTFQGTSIIANTMLGAGLLTLPRALTSKANTPDGWIALILEGVIFIFFIY
LNTLIQKKHQYPSLFEYLQEGLGKWIGSIIGLLVCCYFIGVASFETRAMAEMVKFFLLER
TPIQVIILAFIGCGIYLIVGGLNDVSRLFPFYLVITLIILLILFCISFMIFDLDNLRPVL
GEGLGPVANSLTVVSISFLGVEIMLFLPEHMKKKKKTFRYASFGFLIPILLYILTYIIVV
GALTAPEVKTLIWPTISLFQSFELKGIFIERFESFLLIVWIIQFFTTFVIYGYFAANGLK
KTFGLSSKKSLILIGAATYFFSLWPDDANKVMMYSDYLGYIFVFLFLLPFILFFIVALKR
RITSK
>PK3-2_01879 Spore germination protein A1
MEHTFKEYIHDNLALVLPKLKENDDLVKNKKMLANGLVFYYLYFSELNDEKKVSESIKTL
IKDEETLTLDQVKKRLDQLDARPVETAEKTVESILSGNCAVFVNGLDKAYILTTGQKKTR
SLAEPTTEKVVRGPKVAFVEDLNTNLALIRQRTSHPKLITKKIMIGKNKLKPAAIMYIDG
KAKNSVIKDVKARLKNIQLEDIQDSGTLEELIEDNKYSPFPQIQNTERPDKVSSALFNGR
VAILVDSSPFVLLVPVSLGVLMQSPDDYYERWISASLIRSLRFASIFITLFLSSIYIALV
SFHQGLLPTALAVTISANRENVPFPPIFEALLMEVTIELLREAGLRLPNPLGQTIGLVGG
VVIGQAAVEANLVSSIMVIVVSVIALSSFTVPQYGMGLSFRVLRFISMFSAAILGLYGII
LFMLVIYTHLTRQTSFGSPYFSPNGFFSLKNTDDSIIRLPIKNKPKEANNPNEPKTDSNQ
T
>PK3-2_01880 hypothetical protein
MAQVRLAGKQEEIEQLIRSFEKHYDVSYTSKEYGRTNPKYKYSKDSRVYLELKLKSAKIE
K
>PK3-2_01881 Fumarate hydratase class II
MEYRIERDTMGEVKVPADKFWGAQTQRSKENFKIGSEKMPMRVVKAFAILKRSTALANKR
LGNLDAEKAEAIAAVCDEVLKGKYDDNFPLVVWQTGSGTQSNMNMNEVVANRATALLKEK
NSDQTIHPNDDVNRSQSSNDTFPTAMHVAAVLAVYEQLVPALDQLRNTLDEKAKAYNDIV
KIGRTHLQDATPLTLGQEISGWVYMLDRSKEMILEATDKMRALAIGGTAVGTGINAHPEF
GELVSEEITKLTGQTFSSSPNKFHALTSHDEITYAHGALKALAADLMKIANDVRWLASGP
RCGIGEIVIPENEPGSSIMPGKVNPTQSEALTMIAAQIMGNDATIGFAASQGNFELNVFK
PVIIYNFLQSVQLLSDGMNSFHDKCAVGIEPDKETIQENLSNSLMLVTALNPHIGYENAA
KIAKLAHKEGLTLKEAALKLELLTEEQFNEMVKPEDMVKPKA
>PK3-2_01882 hypothetical protein
MKEKEKLIIETALKLFAQKGYNATSVQEIAKECKISKGAFYIYFPSKEALLLSMLNYYYD
KTFTRILNIKTKGDSPRTAYRKQLTVLYENILEHKDFISMQMKEGSLPYTEEVEQCAKKI
RQSSLQFHIDSLLNIYGKSAEPYTAELCFLIEGISQIYLECMILLGYSVKPDQLADIIIN
RIDDMVKGMSERHDKPFITLEEASSLFGPLTHGRPDPLTESIVKSLRDKINSLNTNSSLE
LSESLDILEAEMKKKTPKLVIIKGMIHNLTESEALAKDAEQLKYLLKQQYI
>PK3-2_01883 putative protein YuzO
MRELDEMISRLRNRGIKVEKVKYPKQTLSEKKWVHQCKQPLKTNYRDFNGYSFT
>PK3-2_01884 Sensor histidine kinase CssS
MKNKPLSFQIWVVISGILLAISLLLLVLFSNTLRDFFTNETYTTIENEQHVLTEYRLPGS
IERRYYSEEATAPTTVRSVQHVLLPENEDASSDKDVSILSSSFIHKVYKLADKQEAKKKR
YSADVNGEKVFFVIKKGLSVNGQSAMMLSYALDSYRDDLAYTLFKQLLFIIAVVILLSWI
PAIWLAKYLSRPLVSFEKHVKRISEQDWDDPVKVDRKDEIGKLGHTIEEMRQKLVQKDET
ERTLLQNISHDLKTPVMVIRGYTQSIKDGIFPKGDLENTVDVIEGEALKLEKKIKDLLYL
TKLDYLAKQKVQYDMFSIAEVTEEVIERLKWARKELLWEIDVEEDILMPGDPEQWNKLLE
NILENQIRYADTKIEISMKQDDWNIVITIKNDGPHIEDEMLSSLYEPFNKGKKGEFGIGL
SIVKRILTLHKASISIENDKTGVTYRIAVPK
>PK3-2_01885 Transcriptional regulatory protein CssR
MSYTIYLVEDEDNLNELLTKYLENEGWNITSFTKGEDARKKMTPSPHLWILDIMLPDTDG
YTLIKEIKAKDPDVPVIFISARDADIDRVLGLELGSNDYISKPFLPRELIIRVQKLLQLV
YKEAPPVQKNEIAVSSYRVAEDAREVYDENGNIINLTSKEFDLLLLFIHHKGHPYSREDI
LVKVWGHDYFGTDRVVDDLVRRLRKKMPELKVETIYGFGYRMMTS
>PK3-2_01886 Serine protease Do-like HtrB
MDYRRDDQNDQHQTESSHTEHQNTENQQLIEHPEQQLLDAPVSYEAGRQETASALEMEKK
ETAVKKEKKRRAAWLSPILGGIIGGGLMLGIAPYLPSDQDQTTETVSANKQVQSDNFTTT
PITNASNVADMVEDLEPTIVGISNIQTSQNNTFGTGGGSSSESESGTGSGVIFKKDSNKA
YVITNNHVVEGANKLTVTLYNGETETAKLVGSDAITDLAVLEISSKNIKKVASFGDSSQL
RTGEKVIAIGNPLGQQFSGTVTQGIISGLNRTIDVDTTQGSVEMNVLQTDAAINPGNSGG
PLINANGQVIGINSLKVSESGVESLGFAIPSNDVEPIVDQLLQNGKVDRPFLGVQMIDMS
QVPETYQENTLGLFGDQLGKGVYVKEVQANSPAAKAGIKSEDVIVKLNGKDVKSSADIRQ
ILYKDLKVGDKTTIQVLRNGKTKTLNVTLTKQTESSSS
>PK3-2_01887 Metalloregulation DNA-binding stress protein
MKTENAKTNQTLVENSMNTQLSNWFLLYSKLHRFHWYVKGPHFFTLHEKFEELYDHAAET
VDTIAERLLAIGGQPVATVKEYTEHASITDGGNETSASEMVQALVNDYKQISSESKFVIG
LAEENQDSATADLFVGLIDEVEKQVWMLSAYLG
>PK3-2_01888 hypothetical protein
MNKKIAIVTGASKGFGQLAAVKLAKSFFVIATTRQPEKAEQLRELAAAHNVSDSIHIAAL
DVTDEQSIALFGKAISAYAPIDLLVNNAGTAYGGFVEDVPMEHFRQQFETNVFGLIHVTK
TVLPYIRKHGGAKIINVSSISGLTGFPALSPYAASKHALEGFSESLRIELLPFGIETALI
EPGSYKTSIWSTSLSNFMSVPADDSAYHQYYKKILAYVEKNADESGDPQEVADLIYQLAT
KQHVKKLRYPIGKGIKLTLLFRSLFPWSAWESILKKKLFS
>PK3-2_01889 Oligoendopeptidase F, plasmid
MALQGVNQRWDLDSFFKGGSQSEEFKGYIEKLSQSLHAFQDMTDAFQVPESPEEAEGLTA
LLDLFEQASVKLQQAGAFVSCLQAQNISDQKAVEHQSLMNRLNADFQSSLVTLDHKLVAI
KQDVWNGLLTKPGLRDVSYILNERRQRVAEKLSPGKEKLIGNLAVDGYHAWSDLYNMVVG
KMTIPYEENGVNKQLSVGQAENVMDHQDRAVRKTIYERLHQAWESKQDMFSSTLNHLAGF
RLETYKARGWENVLKEPLQINRMKKETLDTMWQVITENKQPFVQFLNRKASMLGLEKLSW
YDVEAPIGSDGKVYSYDEAANVIVSQFSTFGKKLSSFTEKAFRDRWIEAEDRSGKRVGGF
CTSFPDSGESRIFMTFSGSASNVSTLAHELGHAFHQEAMLNVRPLNRSYAMNVAETASTF
AEMIVADATVQQAETKEEKLVLLEDKVQRSVAFFMNIHARYLFETRFYEERKRGVVPADR
LNELMEEAQKEAYCNALGEYHPLFWASKLHFHITRVPFYNFPYTFGYLFSLGIYALALEE
KNAFEEKYIALLRDTASMTVEDLAMKHLGADITKRDFWENAIKLAVRDAEAFLQMTESSQ
RD
>PK3-2_01890 hypothetical protein
MHLIRAAGAVCLAVVLIAGCRLNEEQQQAEGENTAVTQLKSVPYSNFSLRVSYGDGEHNR
YEGIYTKNGTQETAEIQDKLSGVNQAGEEALDEMKMILSELSVTDQMAETEVIHSVLAAF
NLDSHYDHIDLKLKLKNGSVREIKK
>PK3-2_01891 putative siderophore transport system ATP-binding protein YusV
MGMSAISTETLSLGYGDAVIIDELNLTIPKGEITVFIGSNGCGKSTLLRSLARLMKPRGG
SVLLEGRAIAKLPTKEVAKELAILPQGPSAPEGLTVHQLVKQGRYPYQNWLKQWSKEDEA
AVERALKATKLEDMADRAVDSLSGGQRQRAWIAMTLAQETDIILLDEPTTYLDMTHQIEI
LDLLFELNEKEERTIVMVLHDLNLACRYAHHLVAIKDKRIYAEGRPEEVITCDLVQNVFS
MNCQVTQDPLFGTPLCIPHGKGRCIVREAAFTSHG
>PK3-2_01892 hypothetical protein
MEQKLQEQLDGLLEKYTELLLGETSNELKEEVKQWILYTHIAKSMPPLAKHWNATYPDAK
QGIKDIIQHIKELNEAHRNKQ
>PK3-2_01893 HTH-type transcriptional regulator YofA
MESGDLRVFQMVAREGSITKAAQKLGYVQSNVTARIQQLEAELGTMLFMRHNRGMTLSAS
GKLLLDYANKIIGLLDEASKALSSSVEPSGPLMIGSTQTTAAVRLPKLLASYYEEHPNVQ
LSLTTGHTQFLLDKVLRYELDGAFIGCECNHPELESYPAFEEEPVVVSAASVSGAEEAIT
KPILVYSTGCSYRETLEKWLRSVGVTQPVIMEFGTLEAIIGGVTAGLGISLLPKTVVQKH
EAEGSIRLYPLPEALRQMKTEFIVRKDSFISSALRTFMDSFAPNKKAASQKSSLL
>PK3-2_01894 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MNVVNKIALVTGGGTGIGRAASMELAKRGAIVAVNYSRSQSEAEETVEMIKKDGGQAFAI
QADVSKNREVRDMVQSIVKTYGTIDVLVNNASITRHIPMDDLEAATEDIWDELYAVNVKG
MFFCARAVVPFMKKSKAGAIVNVGSIAGITGAGSSMPYAVSKSAVHGLTKSLAHALAPEI
RVSGVAPGAVATRWWAGREEKMKSMIGTLLLQRIAEPEDVAQLICSLVEQESLTGQIITI
DSGQTL
>PK3-2_01895 hypothetical protein
MPFVQIHLRAGRSEAWLQKLSRTIHQSMTEEINVPEDDYFQVIRQYENSEFFYDPSYLQV
ERTDELIYIHFTLKHSRTTEQKKALYRSIASGIHSELGVRKEDVFIMLAGNKDEDWSFGN
GKAQMIE
>PK3-2_01896 Multidrug resistance protein 3
MSNEDKQQSKRTLLITGLIIAMFFSALDGTIVGTAMPKIVGDLGGLSMMTWLTTAYLLTS
TTIVPIAGKLADLLGRRIVYVSGLIIFMAASALCGMANNMTELIIFRGLQGIGGGIMMPM
AMIVIGDLFTGKQRAKFQGVFGAIYGLASVIGPQIGGWIVDSLNWKWVFYINLPVGIIAV
IFIARGLQGRQQTGPINFDIAGIFTMIVGVVSLLLALSFGGKDYAWGSWQILGLFALALI
GIVSFIIVESKAKEPILPMYLFKNRTFTFLNLIGFFMSIGMFGAITFVPFFMQGIVGVSA
SESGTIMTPMMISMIITSIIGGQLVYKIGIKPQIISGMIVMAGGFLLLTTLDLDTSKLVA
TSYMAIIGLGMGLVMPILTLALQESFSKEELGVVTSSSQFFRSIGGTFGITMLGAVMNAR
SGSLLTDKLVPYLDSLPAQASSFAAQLKGMIDTNPQGLLQSLFSPEAMKQIPEAFSTHVL
PILKTSLMDSLHSVFYTGLIFIAVGAVFTLFLKPIKLSNKNTGEQVKEKAAQAIESPSH
>PK3-2_01897 putative HTH-type transcriptional regulator YusO
MKSADRLMSDIQLSLQALFQKIQPEMLESMEKQGITPAQLFVLASLKKHGSLKISEIAER
MEVKPSAVTLMADRLEQKNLIARTHNTKDRRVIDISLTDEGDKKFEEVLAGRKAIMARYL
SFLTEEEMLQAAHITEKLAQAAAETDEKQNRKRGNE
>PK3-2_01898 hypothetical protein
MNQQNQKISNPQTPVPTTSEMNDRDFVNELLTTEKYMTTAYCTALHEFSHESLYQDIQSI
FDESQKAQRKLYDLMFQYGWYSVEAEDAQKLQKSYQKFQQTIQQQSPYQQ
>PK3-2_01899 hypothetical protein
MDNQQQSQMPPSVISTKDHLYLNDMLNWNLLAMKKAHFMAQQCQDQTLKQELDRVGHMHH
DHYQRILKHLQPSQQQSGYIQ
>PK3-2_01900 Proline dehydrogenase 1
MLRHVFLFLSQNKTLTKFAKAYGTRLGARRFVAGDTIESAVKTVKRLNRSGLCATIDYLG
EYAASEKEANQVAEECKKAIRAIAEHQLDSELSLKLTSIGLDLSEELCLSHLRAILSAAK
QYGVAVTIDMEDYSHYEQTLAIYRQCKQEFEMLGTVIQAYLYRAAEDIRNMCDIKPNLRL
VKGAYKESAAVAFPDKKGTDLHFQSLIKLQLLSGNYTAVATHDDDIIAFTKQLVAEHHIP
ASQFEFQMLYGIRPERQKELAKEGYRMRVYVPYGTDWFSYFMRRIAERPANAAFVLKGIL
KK
>PK3-2_01901 hypothetical protein
MVREKKNPSSAAVSAASVKGDAGPTQHYGGGKRTSQNQQYKKHNMEQS
>PK3-2_01902 putative 3-hydroxyacyl-CoA dehydrogenase
MHKHIRKAAVLGSGVMGSGIAAHLANIGIPVLLLDIVPNDLTKEEEKRGLTKDSPEVRSR
LSRQAVKKLLKQKPAPLTSVKNTSYITPGNLKDDAAKLNEADWIIEVVVENLEVKKQIFA
LVDEHRKPGSIVSSNTSGISVQEMAEGRSDNFKAHFLGTHFFNPARYLKLLEIIPIKETD
PDILKFMTAFGENVLGKGVVTAKDTPNFIANRIGTYGLLITVQEMLKGGYQVGEVDSITG
PLIGRPKSATFRTLDVVGLDTFAHVARNVYDKADGDEKEAFRLPGFMNDMLEKGWIGSKA
GQGFYKKEGKTIYELDPVTLTYGERKKIKSPALEAAKQAKGTKAKMKALIYSDDRAGRLL
WNITSQTLLYSAELLGEIADDIHAIDQAMKWGFGWELGPFEMWDAIGLRQSAEKLEQLGA
GIPDWVKDMLEKGNETFYIRENGTVFYYDRGEYRAVKENKKQIHLQALKETNGVIAKNSG
ASLIDLGDDVALLEFHSKSNAIGLDIIQMINKALEETERNYKGLVIGNQGKNFCVGANLA
MILMEVQDDNFLEVDFVIRRFQETMMKIKYSAKPVVAAPFGMTLGGGTEVCLPAARIQAA
SEAYMGLVESGVGLIPGGGGNKELYINHLRRGLDPMNAAMKTFETIAMAKVSASAQEARE
MNILKETDHISMNQDHLLYDAKQHAASLYDTGWRTPVKEKIKVPGETGYASLLLGAEQMK
LSGYISEHDFKIAKKLAYVIAGGKVPFGTEVDEEYLLEIEREAFLSLAGEAKSQARMQHM
LVKGKPLRN
>PK3-2_01903 3-ketoacyl-CoA thiolase
MKEAVIVSGARTPVGKAKKGSLATVRPDDLGAICVKETLKRAGGYEGNIDDLIIGCATPE
AEQGLNMARNIGALAGLPYTVPAITVNRYCSSGLQSIAYAAEKIMLGAYDTAIAGGAESM
SQVPMMGHVTRPNLALAEQAPEYYMSMGHTAEQVARKYGVSREDQDAFAVRSHQNAAKAL
AEGKFKDEIVPVEVTVTEIGENHKPQEKQFVFSQDEGVRPQTTADILATLRPAFSVDGTV
TAGNSSQTSDGAAAVMLMDREKADTLGLAPLVKFRSFAVGGVPPEVMGIGPVEAIPRALK
LAGLQLQDIGLFELNEAFASQAIQVIRELGIDEEKVNVNGGAIALGHPLGCTGTKLTLSL
IHEMKRRNEQFGVVTMCIGGGMGAAGVFELC
>PK3-2_01904 putative acyl-CoA dehydrogenase
MAKKTADVLKGGGFLIEDVTYDQMYTPEDFTDEHKMIAKTTEDYIEQDVLPHIDDIENHQ
FEHSVRLLKKAGELGLLGADVPEEYGGLGLDKISSALITEKFSRAGSFSLSYGAHVGIGS
LPIVFFGSEEQKKTYLPGLASGEKIAAYALTEPGSGSDALGAKTTAVLNEAGTHYVLTGE
KQWITNSAFADVFVVYAKVDGDKFSAFIVEKDFPGVSTGPEEKKMGIKGSSTRTLILDQA
EVPKENLLGEIGKGHVIAFNILNIGRYKLAVGTIGASKRVIELSAAYANQRRQFKTPIAG
FSLTQEKIATMASRLYAMESSVYRTVGLFEDNMSQFTAEDLKDGRQIAKSIAEYAIECSL
NKVFGSETLDYIVDEGVQIHGGYGFMQEYEVERAYRDSRINRIFEGTNEINRLIVPSTFL
KKAFKGELPLFEKAQTLQEELMMLMPEEPGSGVLEQEKYIVKQAKKIALFAAGLAAQKYG
KAIDREQEILVNVADIVSNVYAMESAVLRTEKAIAAQGEGKAAQKVLYTEIFVQEAFNEI
EAHAKESLIAMEEGDSLRMMLSALRKLTRVTPKNVIQKKREAAAGVFEAEKYIV
>PK3-2_01905 Regulatory protein MgsR
MSLTFYWYPKCGTCRKAKKWLEEHGKEINEIHIAEQPPSKEELKALYEKSGLELKKFFNT
SGMKYRELNLKEKLYHMSEDQQLELLASDGMLIKRPLTTDGEKVTVGFKEDQFEENWA
>PK3-2_01906 Glycine cleavage system H protein
MSIPKDLRYSGEHEWVKVEGEKARIGITHFAQSELGDIVFVELPEVGAEIKADEPFGSVE
SVKTVSELYAPINGTVVEINEDLDDSPEFVNESPYEKAWMIVVEPSDASEIEKLMTAEQY
EEMTQED
>PK3-2_01907 hypothetical protein
MAFSKQKLDVTNDVTGRFQNGRLSLYHENEMIGQMTSMNEYELKSGYSFENEKFYKTADV
VSGNDEKYVDCDYENGWC
>PK3-2_01908 Ribonuclease M5
MLAVNFTAFFYNLNVSNLTRQVKKMKMDELEKVMIVEGKSDKEKIESVLNEPVRIICTNG
TISQLKLEELADELYGKDVYILVDADESGEKLRKQLKREFNEACHLHIDRAYKEVAAAPK
HHVASVLLRANLNVHTIFLERKSRGV
>PK3-2_01909 hypothetical protein
MKELQEHELEHIADDVYLLYLYTPFCGTCQLASKMLTVVKEMLPDVAFYKNNVNYSPTFA
KAYQIESVPCFLLFKGGKVVERGYAFHSVSYLYELIKQKSSSASHL
>PK3-2_01910 hypothetical protein
MEKAEVLEDEYPHLFLKPLLNASTLLITFQGETEALTVSINEQGEMKKISPPQTSNLTFY
GNQAEIIHLLHGDISLQHLIQSGSLKVKGSFRALLKLEAILWLTNGFFQRILKN
>PK3-2_01912 Methionine import ATP-binding protein MetN
MINLQDVSKVYKSKHGDVNAVQNVSLSIQKGEIFGIIGYSGAGKSSLIRLLNGLEKPTSG
TVEVAGTKINEVNGRGLRKARHEISMIFQHFNLLWSRTVRDNIMFPLEIAGIKKSERIKR
ANELIKLVGLEGKEKSYPSQLSGGQKQRVGIARALANNPKVLLCDEATSALDPQTTDSIL
DLLSDINERLGLTIVLITHEMHVIRKICNRVAVMENGRVVEEGEVLDVFKNPKEDMTKRF
VQQVTEPEETKETLQHLLDETASGKTVQLTFVGDSAEQPLITEMIRNFNVSVNILQGKIS
QTKDGAYGSLFIHIDGDEEEVQNVIRFINDKQVKAEVITNV
>PK3-2_01913 Methionine import system permease protein MetP
MFEKYFPNVDLTELWNATYETLYMTLISLLFAFVIGVILGLLLFLTSKGSLWQNKAVNSV
IAAVVNIFRSIPFLILIILLLGFTKFLVGTILGPNAALPALVIGSAPFYARLAEIALREV
DKGVIEAAKSMGAKTSTIIFKVLLPESMPALISGITVTAIALIGSTAIAGAIGSGGLGNL
AYVEGYQSNNADVTFVATVFILIIVFIIQIIGDLITNIIDKR
>PK3-2_01914 Methionine-binding lipoprotein MetQ
MKKLFLGALLLVFAGVLAACGSNKGAESGKKEIVVAATKTPHAEILKEAEPLLKEKGYTL
KVKVLSDYKMYNKALADKEVDANYFQHIPYLEQEMKENTDYKLVNAGAVHLEPFGIYSKK
YKSLKDLPNGATIILTNNVAEQGRMLAMLENAGLITLDSKVETVDATLKDIKKNPKNLEF
KKVAPELTAKAYENKEGDAAFINVNYAIQNKLNPKKDAIEVESTKNNPYANIVAVRKGED
DSAKIKALMEVLHSKKIKDFIEKKYDGAVLPVSE
>PK3-2_01915 hypothetical protein
MNQDRGSMQDALKQYKLGLGTFEQKMPLMGRKFNEFTEQCFAGNSLTEREKQLIALGIAI
NAQDEYCMIYHTKGCLDEGATEENILEAVSVAAAFGGGAALSQGVTVVQQCIEEFGNTTH
>PK3-2_01916 Vegetative protein 296
MAASTLTIKDLHVEIEGKEILKGVNLEIKGGEFHAVMGPNGTGKSTLSAAIMGHPKYEVT
KGSITLDGKDVLEMEVDERAQAGLFLAMQYPSEISGVTNADFLRSAINARREEGDEISLM
KFIRKMDENMEFLEMDPEMAQRYLNEGFSGGEKKRNEILQLMMIEPKIAILDEIDSGLDI
DALKVVSKGINKMRSENFGCLMITHYQRLLNYITPDVVHVMMQGRVVKSGGAELAQRLEA
EGYDWIKQELGIEDETVGQEA
>PK3-2_01917 hypothetical protein
MTLDTKLSVDQEYLKSFSEKHQEPAWLKNLRLQALEQAEDLPMPKPDKTKITNWNFTNFA
KHTVDNEPLSSLEDLTDEAKALIDIENEDKTLYVQRDQTPAYLSLSQELKDKGVIFTDIL
TAAREHSDLVEKYFMKDGVKVDEHKLTALHAALVNGGAFLYVPKNVQVETPVQAVYVHES
NDTALFNHVLIVAEDHSSVTYVENYISTVNPKDAVFNIISEVITGDNASVTYGAVDNLSS
GVTTYVNRRGAARGRDSKIEWALGLMNDGDTISENTTNLYGDGTYGDTKTVVVGRGEQTE
NFTTQIIHFGKASEGYILKHGVMKDSASSIFNGIGKIEHGASKANAEQESRVLMLSEKAR
GDANPILLIDEDDVTAGHAASVGRVDPIQLYYLMSRGIAKEEAERLVIYGFLAPVVNELP
IEGVKKQLVSVIERKVK
>PK3-2_01918 Cysteine desulfurase SufS
MNITDIREQFPILHQQVNGHDLVYLDSAATSQKPRAVIETLDKYYNQYNSNVHRGVHTLG
TRATDGYEGAREKVRKFINAKSMAEIIFTKGTTTSLNMVALSYARANLKPGDEVVITYME
HHANIIPWQQAVKATGATLKYIPLQKDGTISLDDVRETVTSNTKIVAVSHVSNVLGTINP
IKEMAKIAHDNGAVIVVDGAQSTPHMKIDVQDLDCDFFALSSHKMCGPTGIGVLYGKKAL
LENMEPAEFGGEMIDFVGLYESTWKELPWKFEAGTPIIAGAIGLGAAIDFLEEIGLDEIS
RHEHKLAAYALERFRQLDGVTVYGPEERAGLVTFNLDDVHPHDVATVLDAEGIAVRAGHH
CAQPLMKWLDVSATARASFYLYNTEEEIDKLVEALQKTKEYFTNVF
>PK3-2_01919 Zinc-dependent sulfurtransferase SufU
MSFNANLDTLYRQVIMDHYKNPRNKGVLNDSIVVDMNNPTCGDRIRLTMKLDGDIVEDAK
FEGEGCSISMASASMMTQAIKGKDIETALSMSKIFSDMMQGKDYDDSIDLGDIEALQGVS
KFPARIKCATLSWKALEKGVAKEEGGN
>PK3-2_01920 hypothetical protein
MAKKMPDIGEYKYGFHDKDVSIFRSERGLTKEIVEEISRMKEEPQWMLDFRLKSLEHFYN
MPMPQWGGDLNSLNFDEITYYVKPSERSERSWDEVPEEIKQTFDKLGIPEAEQKYLAGVS
AQYESEVVYHNMKEDLEAQGIVFKDTDSALKENEDIFREHWAKVIPPTDNKFAALNSAVW
SGGSFIYVPKGVKVETPLQAYFRINSENMGQFERTLIIVDEEASVHYVEGCTAPVYTTNS
LHSAVVEIIVKKGGYCRYTTIQNWANNVYNLVTKRTICEENATMEWIDGNIGSKLTMKYP
ACILKGEGARGMTLSIALAGKGQHQDAGAKMIHLAPNTSSTIVSKSISKQGGKVTYRGIV
HFGRKAEGARSNIECDTLIMDNKSTSDTIPYNEILNDNISLEHEAKVSKVSEEQLFYLMS
RGISEEEATEMIVMGFIEPFTKELPMEYAVEMNRLIKFEMEGSIG
>PK3-2_01921 IS3 family transposase ISBsu1
MKDHPKRHLEKQIGTLCREHKYRYGYRKITAILKKRMCINHKTVQRIMQKNQWQCQVKVK
KRKKNGQPYAVVDNILDRNFQSDRPLEKLVTDITYLPYGQKQLYLSSILDLYNGEVIAFT
IGDKQDTDFVLDTLNQLPMLSENCVLHSDQGSVYTSYEYQKAVNTKGITMSMSRKGTPAD
NASIESFHSSLKSETFYLNSIDRTTTAIVERTVIEYIHYYNNIRIQTKLNNQSPINYRQL
AV
>PK3-2_01923 hypothetical protein
MGTRVSYPVEVKQKAVEMRLAGVPMKEIMQKLNIKNKTQVQTWVRWHKAGETHRFEQPVG
KQYTYGKGPEYSSELEKLQAEIRYLRQQNEVLKKYNELERKLIAKRQSNL
>PK3-2_01924 hypothetical protein
MNENIIPINRHTQEIPATESVIKNSGNSEVHIDIHIDTMPIAFAILCSALAAKQMTKEEF
DTAYTQLREMNNGYYNGSSVKQVINQETEE
>PK3-2_01925 Small, acid-soluble spore protein G
MSENRHENEENTDRNVAVARVQNSGNSNVVVNVNTDQDQAQAQTQDGEE
>PK3-2_01926 Glycine oxidase
MKSYIIVGAGILGASTAYHLAKSGAQVTVIDRKEPGQATDAAAGIVCPWLSQRRNQDWYQ
LAKGGARYYTDLIHQLEEDGETDTGYKRVGAISIHTDAAKLDKMEERAYKRREDAPEIGE
ITRLSVSETKKLFPILADGYESVHISGAARVNGRALCRSLLSAAKKRGAEIIKGNASLLF
ENGTVTGVRTDTKQFAADAVILTAGAWANEIMKPLGIHFQVSFQKAQIMHFEMTDANTGS
WPVVMPPNDQYILSFDNGRIVAGATHENDADLDDLRVTAGGQHEVLSKALTAAPGLADSA
VIEARVGFRPFTPGFLPVVGAVPGVGGLFAANGLGASGLTMGPFLGSELAKLALGKQTEI
DLSPYDPAGALA
>PK3-2_01927 UvrABC system protein C
MIKIDIPAPNVTITERQQSANENEPKIKAIYGFIDFHQIPRDKGGIFMFYNIHDELLFVG
KARKLRQRIKKHFEDNVSPIKHHRDEVYKIEVCVVDDPMERDIYETYIINTQQSKYNVDK
VFFK
>PK3-2_01928 Fructosamine deglycase FrlB
MSQATAKVNREVQAFLQDLKGKTIDHVFFVACGGSSAIMYPSKYVFDRESKSMNSDLYSS
NEFIQRNPVQLGEKSLVILCSHSGNTPETVKAAAFARGKGALTIAMTYKPESPLAQEAQY
VAQYDWGDEALAINTNYGVLYQIVFGTLQVLENNTKFEQAIEGLDQLQAVYEEALKQEAD
NAQKFAKAHEKESIIYTMASGANYGVAYSYSICILMEMQWIHSHAIHAGEYFHGPFEIID
ESVPFIILLGLDETRPLEERALTFSKKYGKKLTVLDAASYDFTAIDDTVKGYLAPLVLNR
VLRSYADELAEARNHPLSHRRYMWKVEY
>PK3-2_01929 Multiple sugar-binding protein
MKKMLLFLIIAAVSMFTIAGCSSQSSSADGKVTLKFFHRWPKEPEKSYFEEVVKEFEKDH
PDIDIQIEAVLNDSYKDKIKVMLGTTSPPDIYFSWSDEFAFKFIRGNKALDLSSYYKNDT
DWSSQIVQSQITPFTYESKQYGVPWQMDAKSFFYNKDIFQKLNLDPPKTWDELIDVSKKM
EENGYTPISFGTKATWTISHYIGTLNQRMVDEKTREKDYNAKTGEFTDEGYVKALEKLQE
LMPYFNKHVNSVDHEYVRQQFKSGKSAMIYAETAEIKLVEPVNLGMFPFPEISGQKGSSE
ALTGAPEGFMISSKTKHPKEAMEFLQFLTSKKMGEKLVKDVGKYSAVQGAATEENSTATQ
REAVQQIVDAKSMVPWFDMDVDVEIVDAYLTSVQQMLGGDMTPDQVMKAVQKAAKQVRAS
AE
>PK3-2_01930 Diacetylchitobiose uptake system permease protein NgcF
MVNQNKIIPYLFLVPALVFLLFVYIPIFENVFLSLFQWSSFSPEKTFIGLKNYVELFHDP
VFYQALTNNVLYAVISIICQVFGGLILAAVLEDKLVRKWSPFFRTVFFLPVVISMTVIAL
LFDFIYNPETGLLNQLLQAVGLDQLTRAWLGEDSTAMLSVIFVSQWQSVGYIAMLYIVSI
QKIPDELYEAARLDGAGKIQQFFHITIPQTKEMSFVAVVMTLTGAFTVFNEPYILTGGGP
GNASEVLSTFLYKSAFTKDMMGYASAIATVVLIITLALSLMQMKFFKTGKED
>PK3-2_01931 Diacetylchitobiose uptake system permease protein NgcG
MLPQKKTDSFRLEPVPDRHIEMKRKPGRKWYIGETSVWVFLFLYLIVIAYPLLWMVMSAF
KNSDDIFEHSWSLPSTWHPENFVSAWNQGISSYFMNSVIVTALTCVITVFISAWAAYGLS
RFEFKGKGFFLVLCLGGLMLTPQVSLVPLYSIIQSLGLYNTYWALILPYAAYRIPFTIIL
IRSYFLSISKELEEAAYLDGCTSFGVFFRIFLPMSVPILVTSGILTAYHTWNEFMFAIIF
IDDENLRTIPAGLMQFRDALQTDWGVLLAGLTISAAPIIILFLFMQKYFVRGIASGSVKG
>PK3-2_01932 Fructosamine kinase FrlD
MKMIAIGDNVVDYYQDQETFYPGGNALNVAVLAKRLGHAASYIGIVGNDEAAAHLLNVLK
LEQVNAEYIRQAHGENGMAIVTLDEQGDRIFVRSNKGGIQSRLRLMFQEKDFTFISGHDL
LHTSVYSRLENDLPQLCGLVPVSFDFSTNREDDYLRRVCPYVTYAFFSGSDLSESECGEL
AKTAHGYGAKMVCMTRGGQGAILSAGDRIYHQPIVETDIIDTLGAGDSFIAGFLTAFCVK
QDITYALRQAAETAAKTCGVYGAFGYGYPYRLEDGGSSEKTRIL
>PK3-2_01933 putative HTH-type transcriptional regulator YurK
MLNNGSSTPLYIQLKQIITDDIKKGVYSPTAKLPTENELCSKYNVSRITVRKAILDLVEE
GYLIRQQGKGTFVKSPKLKRELIAVNGYSEFMESTGKKPKHHVLSHEVIPAAKPIAEKLQ
INPESPVVELKRILYNDDQPLTFEVTHYPLDLFPGIDTFIADGVSMHDILRQQYQVVPTH
NTKLLNVVYAQQEESKYLDCDIGDALFEIDKTAFTSNDQPIYCSLFLMHTNRVTFTINSP
YT
>PK3-2_01934 Oligosaccharides import ATP-binding protein MsmX
MASLTFEHVKKSYHSQLTVKDFDLNVKDKELLVLVGPSGCGKSTTLRMVAGLESISEGNL
LIDGERVNDLPPKERDIAMVFQNYALYPHMTVFDNMAFGLKLRKMPKQEIAERVHTAARI
LEIEHLLKRKPKALSGGQRQRVALGRSIVREPKVFLMDEPLSNLDAKLRVTMRTEISKLH
QRLEATIIYVTHDQTEAMTMGDRIVVMNEGEIQQVAKPHDIYHYPANLFVAGFIGSPGMN
LLKGAIEEQHGELFFTNPSVRLHIPEEKAKRLREKGYAGEQMIAGIRPEHVTQMTGHDQL
FDSVCKAKVEVNENLGSELIVHVTAGDERLIVRLDGNSRIAAGDSIQLAVKMDHVVFFDA
ETEEAVY
>PK3-2_01935 Extracellular ribonuclease
MTKKARFLPLVCVLLISGWFAPAASASAQTAFSLNDRLASSPSGTGGLLSLAAPAAPYAD
TDTYYEGADGKTGESLKSALHRIISGHTMLSYSEVWNALKETDEDPANPNNVILLYTNES
RSKNLNGGNVGDWNREHVWAKSHGDFGTSKGPGTDIHHLRPADVQVNSTRGNMDFDSGGT
EYAKAPGNYYDGDSWEPRDDVKGDVARMLFYMAVRYEGDDGYPDLELNDKTGNGSAPYHG
KQSVLLEWNRQDPVDERERQRNEIIYEKYQHNRNPFIDHPEWADDIWP
>PK3-2_01936 Allantoate amidohydrolase
MEKQKLSVKNSIADYIEWLAQYGASADGGVTRLLYTKEWMDAQLAVKTEMSSCGLETRFD
DVGNVFGRLSGTHSPDEVIVTGSHIDTVINGGKYDGAYGVLAAMLAIKQLKETYGSPKKT
LEAVSLCEEEGSRFPMTYWGSGNMTGVFSLQDGAEPRDESGASLQSAMYECGFGKGEYQA
AYRADITTFVELHIEQGQTLEMSGRDLGIVTSIAGQRRYLVTLEGECNHAGTTSMKWRKD
PLAASSRIIHELLLRSEEQPDELRLTCGKITAEPNVANVIPGRVQFSIDIRHQHQRVLEQ
FHEDMAALINRICHQKGIRADIDEYMRIEPVPMDERLKAAALETAAENGISCEEMVSGAG
HDAQMIGRRHPACMLFVPSRGGISHSPKEYTSARQLETGVRALTDLLYKLAY
>PK3-2_01937 (S)-ureidoglycine--glyoxylate transaminase
MSGRKELCTPLRTIMTPGPVEVDPRVLRVMSTPVVGQFDPAFTDIMNETMDMLRELFQTK
NRWAYPIDGTSRAGIEAVLASVIEPGDDVFIPIYGRFGYLLTEIAERYGANVHTLECEWG
TVFDTEDIIQEMKKVKPKIVAMVHGETSTGRIHPLKAIGEACRAQNALFIVDAVATIGGC
EVKVDDWKIDAAIGGTQKCLSVPSGMAPITYNERVAGVIAARKKVERGIATQADRATLSG
NRPITSNYFDLSQLEDYWSERRLNHHTEATTMLYALREGVRLVLEEGLEDRIERHRHHET
ALTAGIKAMGLKLFGDDSCKMPVVTCVEIPGGIDGESVRHMLLAQFGIEIASSFGPLAGK
IWRIGTMGYSCRKENVLFVLAGLEAVLLRHGAGIEAGKALQAALDVYENAGRQAAV
>PK3-2_01938 hypothetical protein
MGTRVSYPVEVKQKAVEMRLAGVPMKEIMQELNIKNKTQIQTWVRWYKAGDTHRFEQPVG
KQYTYGKGPEYASELEKLQAENRYLRQQNEVLKKYNELERKLIAKRQSNL
>PK3-2_01939 IS3 family transposase ISBsu1
MHLGISRASYYRWKKNLMKGHPKRHLEKQIGTLCREHKYRYGYRKITAILKKRMRINHKT
VQRIMQKNQWQCQVKVKKRKKNGQPYAVVDNILDRNFQADRPLEKLVTDVTYLPYGQKQL
YLSSILDLYNGEVIAFTIGDKQDTDFVLDTLNQLPTLPENCVLHSDQGSVYTSYEYQKAV
KTKGITMSMSRKGTPADNASIESFHSSLKSETFYLNSIDRTTTAIVERTVIEYIHYYNNI
RIQTKLNNQSPINYRQLAV
>PK3-2_01941 hypothetical protein
MLRQKMEHGERGFVKRVKRRKNVWRKSEIILLKKACGVGTDPRF
>PK3-2_01942 putative xanthine dehydrogenase subunit A
MGNLHMMLDSLLEDREEAVLATIVQVEGSAYRKAGASMLFKKNGERIGLLSGGCVEEDLS
QRISELGDQLTSALISYDMRAEDDLSWGMGAGCNGMIHIHAEGITQEKRRHYERVRDCLH
SGKAVTAVTQIDSSRSLFLTENGHFGNWPDAPLQDIQRTVSTLHLPHFVPSANMFIQRIE
PKPRLILFGAGPDIVPLANLAADTGFSVIVTDWRPAFCTSSLFPKADRLITAFPAQMLSE
FQFLPQDAAVVATHHFQHDQAIIDFLFSQNLHYIGLLGSANRTKRLLNGKQPPAHFYSPV
GLKIGAEGPEEIAVSVVAEIIQTRKRLAVV
>PK3-2_01943 Purine catabolism protein PucB
MRGPYIIGVFLAAGKSKRMGQNKLALPLKGETIGSLSLKTALLSRLDHVLIVERTERASL
EWVGAPYHAPLFRKRWSLHVCRDAEKGQGHSVSSGMRKAESMGADGVVILLADQPQLSVD
HLNALVAMAPESFAVSSFLGVLTPPIYFSSACFPYVKVLKGDEGARRLLKSGQLGTGAVL
EAKEGAELNDIDTPEEYEMVRRAMV
>PK3-2_01944 putative xanthine dehydrogenase subunit C
MNGQVTKARMNIQLWRPAALDEAYSLLEQLVPDVCSASGGTLLQLQWDKGIFPKQHLVSL
EGIDEMRGISASDTHASIGALTTLNECRKNP
>PK3-2_01945 putative xanthine dehydrogenase subunit C
MQKEPLIKSALGCFSDAASAVAAPGIRSRATIGGNIASKIGDLIPLLLVLDAELIVYRKE
LIRLPIGDWLVDEDFETAIVTRVIIPRAEGERVFYRKLGRRQAFTGAVAVVAGRFLKDGC
IRLAAGHADITPDRLLESEAKWMASGWKPHGLYETLVRELPFSADAFMTAAYRKKAAANV
IMAELLAEGGE
>PK3-2_01946 putative xanthine dehydrogenase subunit D
MTINKPSRVRPDGRGKVTGELKYMTDLSFPGMLYGKVLRSAYPHAEIVSICTMKAEAMEG
VRAVVTHKDVPGLNRFGIVIPDQPVLCEDRVRYVGDAIAAVAAETEEIAEAALELIHVEY
KELEVIDLPEKALRPDAHRLHENGNILHRAFFTHGDIEKGFQVCDTVLEETYELPRQMHT
YMETEGGVAVPEDDGGFTMYAGTQHGYKDRFQLARIFGIPEEKIRVVSSPMGGSFGGKDE
LNIQPYAALLALKCGLPVKIHQTRKESVRSGIKRHPMKIAIKTGADQTGKILAHDVKIVA
DTGAYATLGPAVLDFSVEHAAGPYRIPNIRTEGLSVFTNNGVAGEFRGFGGNQITFALET
HLDRLSDMLGIDPLELRRKNIRKSDDLGPLEHRIAPTDGAAQVLDAISESPILARKRRNS
GYMRRGTGAAITMHGGGLGYGRMDAAGGRLSLLSDGKITASFGFEECGQGILAVIEHIVI
EELGCAAEDISIVIGDTAKVPKSGSSTASRGTSMVWHSIQRLKKPFLSQLKKRAAEWSGC
SAENLILGAAGLCDQNTTELVVTYKELAEKGPLAEETAFDFPTTPDPVDGGHFLYSFGAA
AVEVEVDLLTGDVKVIDCEHAIAAGPVVSAQGYRGQIEGGAAMALGYTLMEEAKMTDGRY
AAENLDQYIIPGVKDVPDIKLTAIEELMEGDSHGPRGVGEIGTIAITPAIVKAVHDAVGC
WINKLPISREELLEAIDRKGLKQWT
>PK3-2_01947 putative xanthine dehydrogenase subunit E
MDVKEAGSFPIKKGQFRMTVNGQEREVSAVPMARLSDLLRKEFQLTGTKVSCGIGRCGAC
SILIDGRLANACMTMAYQADGCFITTIEGLQKEELDICQTAFLEEGGFQCGYCTPGMTIA
LKALFEENPHPADEDIEEGLAGNLCRCTGYGGIMRSACRIREELSGGKRKPGF
>PK3-2_01948 hypothetical protein
MINKRAFSALLFMNIKELIRNPLTFFMVLAFPFLFLIMFGVLSSSTGVGTDLFEFIIPGI
IVMAFFTLAINGTSTPIIQMRDQGTLRLIGLTEASKLTFVLSQICARFVLAAFQLVALLS
IAYFNGMLQAQNIPQIMLVSLIGLLMLFALGYTVGSMRLSIEAVNGLSGGMLAPLLIVCG
LIMPMNLLPSWLETASKFIPLTYFGELLRYYLNGDNPALGVLFSYLILIASTALLAFAAV
RLFRWDNIRG
>PK3-2_01949 Linearmycin resistance ATP-binding protein LnrL
MKSSMPITVQNLNKSYEDHQVIKGISFDLRKGEVFGLLGPNGAGKTTILESIIGLRKPSS
GEVSVMGYNPLKQPEKIRPFIGVQPQETTLFPYLKVGETLKLFSSLYNKSRSPEEILKLV
GLEDMMNKPTRKLSGGQRKRLLISIALISDPDILFLDEPTASLDPHSRRQIWDIIQSLKE
NGKSVFLTTHSMEEAYTQCDRTAILNNGKFAALGTPVDLIQTHCPQQRLFLKYSDQKKVA
QLKNIPEIKKSSIKTLPIGYELEIVAEPITKNVISSIIKQIDADWSSIRIEQGTLEDVFL
KLTGKKIREGVLV
>PK3-2_01950 hypothetical protein
MSYLKEEIQINYPKKEMLLIGDWLLDSEREMLVNEDSTIPLSRIQFRLLHCLAVNNGRPV
SKAKLIKYAWGEEGFATKNALYVYINRLRQLIEKDVKRPRHILCLRREGYILYPKH
>PK3-2_01951 hypothetical protein
MAHSLEKLVQPLGGFINRVSSLPTYPGEPDFPIQVASTGDISQSLSHLSSLNPGKSLTGD
MDGAGGSLHEKDSRIKAIAEALERYSSCVYSEEQFIWATAAELGSKALDLKKVPTCSETE
LSHPRCPVNKPLLDSPLRWVKGMSLHTQEETWIPAIMTYLHLPAMSQGERFWLPISTGCA
AHTSYEQALVNAICEVIERDAISLTWYQELPLPHIIFDKKPDQEMTEFLNKTFENGNIKQ
YLFDGTTDLGIPTIYSLQLTPDNKKLAALIMCATDLNPQKAINKVMREAASSRIAMMAER
PAPQDIDDFYNVFHGATYMGKAERLHAYDFLVRSPNQSNLSELPNLERENAGENLKFLLN
RLEEKGLEAFAVDLTTDEAIHADMRVVRVIIPGLQPLSFSYRCRFLGHPRLYEATKAMGY
PVKAESEINAWPQPFA
>PK3-2_01952 hypothetical protein
MKPIHIMTTGDFGREVAQQLSKKIDHIVITPLNEPLYLLPSDRFPSARLHIFASWKSSSF
ISKQLDQLCFKWNEPWLPITMDHPYIRIGPLVIPGEGPCYHCFESRYLQHSPVPQYVKKI
DTYYHSHPDAGPKGFLRSFAGWSAIFASTVIKSIDENELSQSGRVWQLNMLTRESFSSQT
ISVHGCPRCGLKRPEENRSVAHLSENLQSLLSQRRGEVLMK
>PK3-2_01953 hypothetical protein
MKAASVMSAEQVGHAAYFDPNFRLPKKPRLIASLQMIPDQDSLLFHGTENLQVLKGNAVT
RFLPQLIPFLNGSYSIKDIMAEFDQYSTRDISNILSLLFMRGLLDDAEGDEGIDTSCFEP
DVYQFFQRSTDSTRVNRSAAEGLHKLKTAQILLLTDSEHGKILHEELVFMGAENVITARL
SDEVQIEHADLVIVFCTNPLNHKQLRSLDHICREKNIPWLLTRAAENVGVLGPYFEKNET
AAYQDYQITVESEDSQGKPSLEHIEMWEYYSAVEIVYFISRLAPSATGTEYVTFQFDDWT
CTSEKVHPRPDGNCCTGDSENELHPVFKFENAIAFPSKHLINPKSHQVHYNPKNLLLTNE
AKNYPSASLSELPKEEFLPQPKGGFLKNRIQPISEREELNLEALTRLFLTCGGLRESDSR
QISGKVQRWAPTGGNLGSCQIYILALSINGLSPNCYHYQYLDHSLAKVGPSLTVGEIKKK
ITDITGLKGDDLPKALVLLTGAYERVASKYNGFAYKVIHLDAGVALSQMHAVSAGLGIKV
NTIDQWNEQELLSCFGIDPKKEPVTALAGLDDGW
>PK3-2_01954 hypothetical protein
MTMASFEPFQLIDKLIEETKSFHLDCGIDRVIEGQQQENTNIRQSCLLPEKRYEGKELFH
ILKERTATRFYDQQPIDLSDLGTILAAVKEEDNRNWARQIGQGVDITVSVIAWRVQNLRC
PFFYDYCAETHSLKPMGEIPEQEKADDWFLQKEFVYAPAIIIINGTMNQSVKQYGGHGYR
HLMVRGGAAAQNAWLSALTLGLQGTIFAGALPRPLRECTPIDGRHRTQLCAFSFGKPLSF
SEK
>PK3-2_01955 hypothetical protein
MEEKKVELELFAEELETQMDFTMGPLSTWASATTVGSASCPGSTAGTASTASSLSG
>PK3-2_01956 hypothetical protein
MKEKKEYELELYAEEMTEIQSLSGFTTSATFGTVGCAGSSASTAGTISSYGG
>PK3-2_01957 hypothetical protein
MEKDKIFELELFAEELPEQVDLATIAASFSSTSSVSTASCPGTTAASAGTISCYG
>PK3-2_01958 hypothetical protein
MLKVNCEQTEKLELFAEELPEQVDMSSIVSTMSTGASYASWTTFVSTIATISTVK
>PK3-2_01959 hypothetical protein
MSEKDTTIKTLELYAEELPAQVDLATVAGTASTASSFTTASCPATTASTAGTASSYG
>PK3-2_01960 hypothetical protein
MLMNNAQVQYQYDEELLVNPLYLGEGVELLIGANEEPMLFDKHNGKYIRLSKVGLEIFNL
MDGTNTGQDIVNQLEKDYANYGNFPEIVYMFFSSLRKANVLNIKPLPEHQVKRAIRRAAD
KPMLRLPLAKSLNKSTEALLHLYYSIPKMLQKITFYILFFCAISSFMMLNMTGGWQIDWP
SIHWILLVCAIAFHLIIHEMAHALVTKAYGITIREAGVALLYYFIPVAYVDRTDTYRLKS
KKSRIHIALAGPYSDLLACGLWAAVSMLAPQGTISETAHLISFLQIMFVLSNLNLLLPTD
GYHAVEAAAGELSLRKRALTYLLHVSTFRKPPAYLQHVAKNRKIIYVTYSLVSLTYLFCL
LSAFFFLLRNAFGYMG
>PK3-2_01961 hypothetical protein
MKGHVAPFVMLRAAGGSIDSLACVDVQQTSENIEKILNLETEIEGMKEPLSGIFFHLISC
LNDDETNFLRFLLKVKRDIFNSRPFQIDDQNRSELQKRLTVSDYKLFNRWYMAVHDRQRY
MEDTKLLFEKEVEEAGQRLANAMDNKDWQKGLALANPKYLSAYNKHKAKLWRPHKQYART
SMSYLGRITMKTSPFSTFTKIGLTSFSADNTPPETNIQKTNFCSISKSICTELIFEMAQH
NELSQYLYYEKNQTLHTDKKNNMRLMKSNYTILNGFAWREDKMVSEVISSEEQLKVIKSL
RSGSYAEIEELLKHTSFTIPDLSAEQWIKPVLPFTRKTEKPLLSLYHFLQPIQTQKARRI
ARIVKWMNHCVEELAKSEPKQRLRYHQFIYRLAKRAFSELTDKIPKSVATEKLVYENVKC
TEDHPPLGQQVKRDLEQLSEQLRKHQFRTHLYDLLCEHFIEMYGQGGVCHDIQEFLYQFE
MRKDRPRLIKNALRKDKKTAVNLEESRVFAPYGVSSAPPSAIVFYQFAANNGSKGISNGD
YQLVVNQISSGLGLVLRFQSMFHEEQRNLGGLTKRWIHAMHPDSDIVHFPMISDFSNLQT
DPGITSQSLRWLAENPTADKNDILLKDLLLVHDPCGTLAFVNKEGRPVSPMYFGAVPQHM
MHGPVSYLLTIMNPWINAYQTNWVTSPLFSKSPPPEKVEFHPRIEEGRIVQRRARWRIPV
FLFPLKENRESDYAYFIRMKAFQKKYSLPDEGFLSGERTSVMLNPKQRKPMYLNFNSYHS
IAAAVSTIVEEDLLSVTFTEGLPNRHQHWLRNEEGHVVASEYMSLFQWPAEKKQESAIAN
EKGVFI
>PK3-2_01962 hypothetical protein
MKEWVFYSIYVPRAEYLENIIINIVTPIVKQVKDSVQVHKWFFIRYIDMQGPHIRLRFLV
NEDDIDIVEEITEEHLHRNLSKVLAEPLSEMSRLLPVKTDTRSFESGFQQEEYEPEYEKY
GGVQGVHIAEDIFQSSSELVLSLLNDPGFKDNDRFDFALFLMNKTAEHASLSADQARDLW
ESMLHHWSGADYTEGITYKTKLEEAAEKRIDVINVVIEKMHSNPFVIKLTEGYQKILQKA
FSQIQESEKIRTSHSHLSFHYIHMMNNRLGVWPIEEAYLGALLAQLSKHTTDIK
>PK3-2_01963 hypothetical protein
MTSGTVIGLISGTAALTVGTLGGVLGSAFNRQILNSIGVNSLPQNPKRKYTLIAKHCRFL
GEWNRFDSYNVFVFLLGILFLIGAGVLLIVRFETGGTPFQDTLQLAFLVNSLTWIAVSSI
LLLGRLVQLIHIYKYGIQNISKEEIAITQTKEHQNQNKFSLYWIIISAATILFIGGGLLL
LQYPVVFLSLAGAYFLFMFTFNSVYHKNKRK
>PK3-2_01964 hypothetical protein
MKEHDEVKNMIEGLHEHMPELNKMLHMNRVPLPEHISKSPPPPITWFDRLSHWLAYPSWQ
LPDLFSFRSVSQAFMILPILSGSIAAQILFFLFSGR
>PK3-2_01965 ECF RNA polymerase sigma factor SigM
MDILSDEELMEKVKQKDIEAYNSLYTRHAPKTYQFIFLYIRQKQAAEDLLQETFIRVYVK
CRSYKSEKASFRTWLHQIAHRLCIDYYRKHSKFKWQQMELDDYSEKHQGTIEQNIQNKIL
IQQYLGQLPDKERSILILAYYQGFTGKEISHILNIPEGTVKSKLHYSLKKLNKSIEKELN
DS
>PK3-2_01966 5-hydroxyisourate hydrolase
MGKLTTHILDLTCGKPATNVKIELKRLGEEAILVKEASTNADGRVDAPLLADEELVSGEY
VMEFHAGDYFASQKANTADQPFLTIVTVRFQLADPDAHYHIPLLLSPFGYQVYRGS
>PK3-2_01967 Uric acid degradation bifunctional protein PucL
MFTVDDLNQMDRHTLTDTLGSIFEHSSWIAEEAAALRPFSSLSDLHHKMAGIVKAADRQT
QLDLISKHPRLGTKKAMSDTSVREQQNAGLSKLEQPEYAEFLKLNEHYYARFGFPFILAV
KGKTKQDIRRALLARLENDPETEFQQALEEIYRIARFRLADIITEKGETQMKRTMSYGKG
NVFAYRTFLKPLTGVKQIPESAFSGRDNTVVGVDVTCEIEGDAFLPSFTDGDNSPVVATD
SMKNFIQRHLASYEGTTTEGFLHYTAHRFLDTYSHMDAITLTGEDIPFEAMPAYEEQGLG
TSQLVFRRSRNERARSVLKAARTGDTITITEQYSEITDLQLVKVSGNSFVGFIRDEYTTL
PEDGNRPLFVYLNIGWHYENTNDAYTSDPARYVAAEQVRDLASTVFHELETPSIQNLIYH
IGCRILTRFPQLTDISFQSQNHTWDTVVEEIPGSKGKVYTEPRPPFGFQRFTVTREDAEK
EKQKATEALGSLKS
>PK3-2_01968 Uric acid permease PucK
MKKQHNAFQLMMLGLQHMLAMYAGAILVPLIVGAAIGMNTGQLTYLIAIDLFMCGAATLL
QLWKNRYFGIGLPVVLGCTFTAVGPMISIGGTYGVSAIYGAIIAAGLIIILAAGFFGKLV
RFFPPVVTGSVVMIIGISLIPTAMNNLAGGEGSKDFGSLDNVLLGFGVTAFILLLFYFFK
GFIRSIAILLGLIAGTAAAFFMGEVDFSDVIEASWLHVPSLFYFGMPTFELPAVVTMLLV
AIVSLVESTGVYFALADITNRRLSEKDLEKGYRAEGLAIMLGGLFNAFPYTAFSQNVGIV
QLSKMKSVNVIAITGMMLMAIGLVPKAAALTTVIPNPVLGGAMIVMFGMVISYGIKMLSS
VDFDSQGNLLIIASSVSLGLGATTVPALFSSLSGAASVLAGSGIVIGSLTAIALNAFFQT
KQPDRAEIKT
>PK3-2_01969 Uric acid permease PucJ
MVKQKPFAVFSLGLQHVLAMYAGAILVPLLVGRALNVTSEQLSYLLAIDLLTCGVATLLQ
TLRGAYIGIGLPVMLGSSFVAVTPMIAIGANYGIHAIYGSIIATGVFIFLFARFFGKLTV
LFPPVVTGTVVTLIGLSLVPTGVKNMAGVEKINGSANPEYGSLENLLLSVGVLVLILVLN
RFLKGFARTLSVLIGIAAGTAAAAIMGKVSFSAAAEASLFQIPKPFYFGAPSFEIGPILT
MLIVGIVIIVESTGVFYAIGKICDRPLTKKDLVKGYRAEGLAIVIGGLFNAFPYNTFAQN
AGLLQLTKVKTRNIVVTAGCILACLGLIPKIAALASAVPSAVLGGATVVMFGMVIASGVK
MLSTVNLTNQYHLLTIACSLALGIGSSTAPAIFAEFPAPVRILVSDGIITGSLTAIFLNL
FFSMRGKKEKTAQKTELPVLDHTLALEKEV
>PK3-2_01970 Purine catabolism regulatory protein
MNIFDVMKIPAYENANLIAGKAGGEREVQHVNMMDAPDIADFLHKNELLVTTAYHLKDHP
HQLSELIQQMAKRGCAGLGIKTKRYLEDIPKEIIELADSYAFPIIELPAHIRLGDIVNAT
LSHILDMRSNELQQAIYAHKKFTNHIMSGKGLQSLLKKVSDLLQLPVLLLDQHAKMLSAS
HQISFETEKLKSTLNTVSGPFFTCFSTSPDQKTYSVLPIYNHEKNCGYLLIPDMVQAGDK
GLILTIEQAANVISFELLKENALKQFSRRARNEFFSNFIERSFSSDDEIKNRAKEFKLRW
DQKYMCIAGKLDRNDESISFTENQLASDGVFEFLEGELSAFPFPPHLFIKGNVGIILIEA
TDSWSEMHASVISFLEQFQLQVKAQFKRTVSFGISNICQKLIDVPDAFTEASDALQSGHL
SRSTEFIQVYHAKDVPELLRLLPVEDLKKFYNSTLQSLAEKQQEDQSLLHTLSVYLETHC
QISETAKRLYVHRNTVIYRLEKCEELLGKSLKDPETTMRLRLALRMQRLIS
>PK3-2_01971 Allantoinase
MAYDIVIKGAKAVTPDGVKEADIAVQNGMIAEIGSDIEASGSAIIQADGKFVFPGAIDCH
VHFNEPGREDWEGMETGSQMMAAGGCTTYFDMPLNCIPSTVTAEHLLAKAELGRRKSAVD
FALWGGLVPGHIDDIRPMAEAGVIGFKAFLSRSGTDEFRSVDERTLLKGMTEIAAAGKIL
ALHAESDAITSYLQMVLANQGKVDADAYAASRPEEAEAEAVYRTIQYARVTGCPVHFVHI
STAKAVQLIREAKQEGLDVSVETCPHYVLFSHDDLLEKGSVAKCAPPLRSPQSKEALIEA
LIAGHIDMVSSDHSPCRPSLKREDNLFLSWGGISGGQFTLLGMLELALEHQIPFETIAEW
TAAAPAKRFGLQKKGRLEAGCDADFVLVSMEPYTVTRESMFAKHKLSLYEGHTFPCRISA
TYSKGRCVYSNGEKVSGIDGALVVPL
>PK3-2_01972 O-mycaminosyltylonolide 6-deoxyallosyltransferase
MKINLLTIGTRGDVQPIIALGKELSRRGHHVTICTEGSFKDLAEKNKLSFSPIRTDYTHL
TQSEEGKSMLKGNPLSIVSQMKTVIYPMMEQMLDDIWTASIDADAIIYHPKVFGGYDIAE
ALHIPAFIAHPVPIIAPTRHFTNPVFPFAMQSGTLNRASFKINRLLTAAFFPLINKWRHE
TLSLPDKRSVFKDDSVLNGKHIPVLYGCSPSIIPFDQQWKGHVSMQGFWFLAEDDWTPPP
ELLHFLEAGPPPFTVSFSSMPLRNPDHTLNMLQQAFKETGQRAILLTGWSGIKQTTDSPH
IYTAGSIPHGWIFPRSRAVIHHGGAGTTAAALKAGKPMVICPFSGDQPFWARKMRDIGVA
AAPLKERDMTVAAFVSRINELISNNTYFQRASEAASLIDKEDGVRHTADFIEEKLEEKNP
AK
>PK3-2_01973 hypothetical protein
MEHVKYILKQSWSRHTSSKWTKECPASGQCGVTALVIQDQLGGAIFKTKVGESWHFYNSI
NGVVYDFTSEQFHAPIEYQHIPSSREEAFLDTNEEQYQHLRSAFSLHMNSISEET
>PK3-2_01974 hypothetical protein
MGDHDSIYPPKTASQKKLQAYSSHFPIVELDASFYAIQPARNNEKWVKETPETFQFIVKA
YQGMTGHQRGEIPFDSKEEMFDAFKVSLTPYLHSNKLAMVLFQFPPWFDCKKENVAYLRW
CKHQMGDIPCALEFRNRSWFSPPFYEQTLSFMKAEGWIHSVCDEPQIGEGSVPTVLRATD
ENKTLVRFHGRNKQGWMKPDGGKNWREVRYLYRYNQQELEDWKKHLNELQQQCKDVFVLF
NNNSGGDAADNGKQMLELLDIEYSGLAPRQLDLF
>PK3-2_01975 hypothetical protein
MSFVILAVLGLIAGTVGSLIGLGGGIVIVPSLMFLSTVTPLFQDVTPQVAIGTSLLVIIF
TGLSSTLAYIKYKTVDYKSGLIFFIGSGPGSIIGAYVSKLFNSSSFSVWFGIFMILISLS
LMLKAKARPVNKAHKGIIRTFQDDAGEPYTYSYQAPVGIAIAFVVGFLGGLFGIGGGSLM
VPAMMLLFLFPPKVAVATSMFIIFLSSMTGSVSHVISGHVNWLYALALVPGAWFGGKLGA
AVNRKMQTKTIVMIMRIVLILIGCQLIYEGIFS
>PK3-2_01976 hypothetical protein
MKEKLRLYHTNDLHSHFENWPKIVDYIEQKRIEHQSVSEETLVFDIGDHLDRFQFVTEAT
FGKTNVDLLNRLHIDGAAIGNNEGITLPHEELAALYDHAEFPVIVSNLYDKNGNRPSWAV
PYHIRTLKNGMTIAFLGVTVPYYPVYDKLGWTVTDALESVKETIQEVKGQADIIVLLSHL
GILDDQAVAEAVPEIDVILESHTHHLLEDGQVVNGVLLASAEKYGHYVGCVEITVDSVQR
SIISKTASVQNMAEWTGESEETKAFLKEKEREAEEKLSDAVAELAQDAEVKWFEESELPL
LLAYALKEWCGTDISMVNSGVILGPLKAGPVTKLDLHRICPHPINPVAVRLTGEELKETI
VHAASEQMEQLRIKGLGFRGEVMGKMVYAGVEVGTKRLDDGITHVTRITLNGEEIEKHKQ
YSVAVLDMFTLGRMFPIIRDAAEKEYFMPEFLRDLLAWKLAQ
>PK3-2_01977 hypothetical protein
MVNLTPIMIEGQPFTAVTVKLPKTNFMAVANDHGYIMCGALDVALLNEKLKERGIVAGRA
VGVRTIDQLLDAPLESVTYAAEDLGIHAGMSGREALLKMVK
>PK3-2_01978 Sporulation protein YunB
MPRYRGPFRKRGPLPFRYVMLLSVVFFILSTMVSLWMINGSIKPVLMDIGEMETKRIATE
VIQDSIEDYMSDSENMKDMFQMNSDENGNLTTIDFNTQVVNSVKTKVTKQLQAHLKEMET
HTGHSGASENIMINIPLGQVTGNSLLGNLGPKIPVRFNLIGDAFTDVKTKIKPYGINNAL
IDISIFVEIKVKVIIPFASKTAVVTNNVPVSIKAVQGEVPQFYNGSGGSGVTPSVQLPSG
KEEDSADSKNDKSSK
>PK3-2_01979 L-Ala--D-Glu endopeptidase
MKVLLTALLLLLFAFEPYASGKELSDPVLSKRMELYHKIEAVTQIPWYALAAVDQYEENV
RSNRKDLPDKAGIVSIYIPDEIWSGPENPNPKDDAPLSIKVFDGIGLDGDGDGKAEVSND
EDILYTFSQYLLSYGTDEDNIRIGLWNYYRRDQTVGIISEFMKLFKAYGHIDLGEHAFPL
PIRTDYSYRSTWGDARGFGGRRIHEGTDIFAHYGLPVRSTCYGVVEMKGWNRFGGWRIGI
RDINNTYHYFAHLNGFAKGIKTGQIVEPGQVIGSVGSSGYGPPGTAGKFPPHLHYGMYKD
NGKTEWSFDPYPHLRAWERYEYKKKK
>PK3-2_01980 Lipoyl synthase
MAKKDEHLRKPEWLKIKLNTNENYTGLKKLMRENNLHTVCEEAKCPNIHECWAVRRTATF
MILGSVCTRACRFCAVKTGLPTELDLQEPERVADSVALMNLKHAVITAVARDDQKDGGAG
IFAETVRAIRRKSPFTTIEVLPSDMGGNYDNLKTLMDTRPDILNHNIETVRRLTPRVRAR
ATYDRSLEFLRRAKEMQPDIPTKSSIMIGLGETKEEIIEVMDDLLANNVDIMAIGQYLQP
TKKHLKVQKYYHPDEFAELKEIAMQKGFSHCEAGPLVRSSYHADEQVNEASKKRQAQA
>PK3-2_01981 hypothetical protein
MKRIAVGLFLLTGLLSGCGGTGLDHAQNVRNQTQNQTRPIHVSDRNEAFNRHDENEQFGY
VRYQKEQFDGEQRKTPVMNREETAHIISSVTVQLPHIQDAATLVTDQEALVVYKTDSKNR
RLTADQVKKTAASVIPRYYHVYISDNPNHMQSIENYSNLGSGSRDIREIMSGTIQEMKAS
PQGSPVSENENANGETRQDMKIDRNDKNAR
>PK3-2_01982 putative protein YutD
MILIQNAEFELVHNFKDGFNEEAFKARYSDILNKYDYIVGDWGYGQLRLKGFFDDQNQKA
TFETKISTLDEYIYEYCNFGCAYFVLKRIRK
>PK3-2_01983 hypothetical protein
MYFVDRNKIEQTLGFFEHQLALFNSQTDWQSEIGGPALQRIGHLLIECILDTGNDMIDGF
IMRDPGSYDDIMDILVDEKVVTEKEGTELKQLIAYRKTLVQQYMLADSAELYRLITAHQT
ALQNFPQRIRSYLETELGPVSAFK
>PK3-2_01984 Acid sugar phosphatase
MKTYKGYLIDLDGTMYNGTEKIEEACEFVRTLKDRGVPYLFVTNNSSRTPKQVADKLVSF
DIPATEEQVFTTSMATAQHIAQQKKDASVYVIGEEGIRQAIEENGLTFGEENADFVVVGI
DRSITYEKFAVGCLAIRNGARFISTNGDIAIPTERGLLPGNGSLTSVLTVSTGVQPVFIG
KPESIIMEQAMRVLGTDLSETLMVGDNYATDIMAGINAGMDTLLVHTGVTKREHMTDDME
KPTHAIDSLTEWIPYI
>PK3-2_01985 putative protein YpjQ
MSENEQISQMEAKARARMKERGVEVSDIAELVFFLQKKYHPDLTIDECTLNVNRVLAKRE
VQNAILTGIELDVLAEQKKLSEPLQTMLETDESLYGVDEILAFSIVNIYGSIGFTNYGYI
DKEKPGILNHLNDKSTGECHTFLDDIVGAISAAASSRLAHRARHTE
>PK3-2_01986 hypothetical protein
MKGTIKEQYGIHVRQLSMYQHTYQCFQTPNSFFLIVPVSQFSDTELAELYYMSQYLQEQS
DPYVSVFIFTKEGELTFEHEGKTYALLKAAPPYSNRAFSIGQELAEFHRKGRGYPYEVKA
AGRIGQWKDLWGKRVDQLEVFWQRKVHTPPHEPFDKKMIESFPYYVGLSENAIQYLVDTE
LDDKPQAADSGTICHQRMERHTWSKESLIRIPADWVFDHASRDLAEYMRHTFLHHRQDFH
QQGFHFLQEYEQVTPLSSFSKRLLYSRLLFPLHYFEIVESYYMSSESEKHYCEEQLDFIL
NDCARYEQFLNTAQEFMNMRAQKLFVPRVNWLGKGSPG
>PK3-2_01987 Homoserine dehydrogenase
MKAIRVGLLGLGTVGSGVVKIIQDHQDKLMHQVGCPVTIKKVLVKDVEKKREVDLPKEVL
TTEVYDVIDDPDVDVVIEVIGGVEQTKQYLVDALRSKKHVVTANKDLMAVYGSELLAEAK
ENGCDIYFEASVAGGIPILRTLEEGLSSDRITKMMGIVNGTTNFILTKMIKEKSPYEEVL
KEAQDLGFAEADPTSDVEGLDAARKMAILARLGFSMNVDLEDVKVKGISQITDEDISFSK
RLGYTMKLIGIAQRDGSKIEVSVQPTLLPDHHPLSAVHNEFNAVYVYGEAVGETMFYGPG
AGSMPTATSVVSDLVAVMKNMRLGVTGNSFVAPQYEKNMKAPSDIYAQQFLRIHVKDQVG
SFSKITSVFSERGVSFEKILQLPIKGHDELAEIVIVTHHTSEADFSDILQNLNDLEVVQE
VKSTYRVEGNGWS
>PK3-2_01988 Threonine synthase
MELMWKGLIHQYKEFLPVTDQTPVLTLHEGNTPLIHLPKLSEQLGIELHVKTEGVNPTGS
FKDRGMVMAVAKAKEEGNDTIMCASTGNTSAAAAAYAARANMKCIVIIPNGKIAFGKLAQ
AVMYGAEIIAIDGNFDDALKIVRSICEKSPIALVNSVNPYRIEGQKTAAFEVCEQLGEAP
DVLAIPVGNAGNIAAYWKGFKEYHEKNGTGLPKMRGFEAEGAAAIVRNEVIKNPETIATA
IRIGNPASWDKAVKAAEESNGKIDEVTDDEILHAYQLIAREEGVFAEPGSCASIAGVLKQ
VKSGEIPKGSKVVAVLTGNGLKDPNTAVDISEIKPVTLPTDEDSILEYLKGAARV
>PK3-2_01989 Homoserine kinase
MNEADMLFTVTVPGSTANLGPGFDSVGMALSRYLKLTVFESDKWSFEAETETVAGIPAGT
DNLIYQVAKRTADLYGKEMPPVHVKVWSDIPLARGLGSSAAAIVAAIELADELCGLKLSE
ADKLHLASLEEGHPDNAGASLVGGLVIGLHEENETQLIRVPDADIDVVVVIPFYEVLTRD
ARDVLPKEFPYADAVKASAVSNILIAAIMSKDWPLVGKIMKKDMFHQPYRAMLVPELSKV
EHVAEMKGAYGTALSGAGPTILVMTEKGKGEELKEQLALHFPHCEVDALTVPKEGSIIER
NPLYQVKSV
>PK3-2_01990 Dipeptidyl-peptidase 5
MKKLMAAEDITAIVSVTDPQYAPDGSRAAYVQSQVNREQDSYTSNIWIYETKSGDSVPWT
HGEKRSTDPRWSPDGRTLAFISDREGDASQLYMMSTEGGEARKLTDIPYGVSKPIWSPDG
ESVLVMVSLEEGESIHDREKTEPDSFEPVEVQGLAYKRDGKGLTRGAYAQLVLVSVKSGE
VRQLTNHKADHGDAAFSPDGKWLVFSANLTETDDASKPHDICMMSMETGDLKQITSHRGS
FGPSSFSPDGRYLALLGHEQEYQNATLDKAWLYDIEQDRLTCLTEMLDVHLADALIGDSL
IGGGEQRPVWTKDSQGFYVIGTDQGSTGIYYISIEGLVYPIRLEKEYINSFSVSPDEQHF
IASVTKPDRPSELYSIPLGQEEKRLTGANDKFVGEHAISVPEDIQYVTEDGVTVNGWLMK
PAHAESETTYPLILNIHGGPHMMYGHTYFHEFQVLAAKGYAVVFVNPRGSHGYGQEFVNA
VRGDYGGKDYEDVMQAVDEAIKRDPQIDPKRLGVTGGSYGGFMTNWIVGQTDRFKAAVTQ
RSISNWISFHGVSDIGYFFTDWQLEHDMFADTEKLWDRSPLKYAANVETPLLILHGERDD
RCPIEQAEQLFIALKKMGKETKLVRFPKASHNLSRSGHPGQRIKRLNYISSWFDQYL
>PK3-2_01991 Fe/S biogenesis protein NfuA
MTEVEMKEQVQEVLDKLRPFLLRDGGDCELVDIDEGIVKLRLLGACGSCPSSTITLKAGI
ERALLEEVPGVVEVEQVF
>PK3-2_01992 hypothetical protein
MTKPVKLSVYGAETVCASCVNMPTAKDTYEWLEAALKRKYPNQPFAMQYIDIYEPPDNEH
VKELAEKIRNDEYFYPLVLVEDKIVGEGSPKLKDVYEEMEKHGYTENR
>PK3-2_01993 NADH dehydrogenase
MRVLHRLLPNQLPDDVSITLIDRNPYHCLKTEYYALAAGTISDHHIRVTFPEHPRLDVQY
GDISSIDIAQKQVLFQDREPISYDDAVIGLGCEDKYHNVPGAPEFTYSIQTIDQSRETYQ
KLNNLSANATVAIVGAGLSGVELASELRESRDDLNIILFDRGNLILSSFPERLSKYVQKW
FEEHGVRIINRANITKVEEGIVYNHDDPVSADAIVWTAGIQPNKVVRDLDVEKDAQGRVV
LTPHHNLPGDEHLYVVGDCASLPHAPSAQLAEAQAEQIVQILQKRWNGEALPESMPQFKL
KGVLGSLGKKAGFGLVADRPLIGRVPRLLKSGLLWMYKHHNG
>PK3-2_01994 hypothetical protein
MNPMIEFCVSNLAHGSQEARAILEKDPNLDVLEYGCLSYCGTCMESLFALVNGEVVMGET
PAELVENIYTFIEENPMF
>PK3-2_01995 Putative nucleoside permease NupX
MSVLWGLLGAVAIIAIAFLFSEKKSNIKIRTVIVGLCTQVAFGYIVLKWEAGRAVFLWFS
SRVQLLIEYANEGISFIFGPLLKVGDSPAFALSVLPVIIFFSALIAVLYHLKIMQLIFRV
IGGGLSKLLGTSKTESLAAAANIFVGQSESPLVIRPLIAGLTRSELFTIMTSGLSAVAGS
TLFGYALLGIPVEYLLAASFMAAPAGLVFGKLIIPETEKPQTVKSDFKMDEGEGAANVID
AAAKGASTGLQIALNVGAMLLAFVALIAVVNGVLGGIFGLFGLKDVTLESILGYVFSPIA
FLIGVPWHEALQAGSYIGQKLVLNEFVAYSNFGPHIGEFSKKTATIISFALCGFANFSSI
AIMLGTLGGLAPSRRSDIARLGLKAVLAGTLANLLSAAIAGMFI
>PK3-2_01996 Diaminopimelate epimerase
MNSFRFTKMHGLGNSYIYVNQFEEQLPEEKLAEIAIQVSSVYTGIGSDGMILICPSDQAP
VKMRIFNNDGSEGKNCGNGLRCVAKYAYEHKLVEETSFLIETLSGLVKAEVQTENGKVNV
VTVDMGEPRLTKAELPMLGGGEEHTINETMTFGEAELAGTAVSMGNPHIVFPIADIEQAP
LTTLGPVIEKDPRFPEGVNVEFVETVNEHELHFRVWERGSGITQACGTGACAAAVASVLN
GVSKRNQDITVHLAGGDLVINWKDNGHVMMTGPAETVCEGVYFL
>PK3-2_01997 Protein
MSNPVTITEAAALHIKDMMKEHEEENAFLRVGVKGGGCSGLSYGMGFEHEKGENDSMFDQ
HGITVLVDKESLDIMNGTVIDYKQSMLGGGFTIDNPNAIASCGCGSSFRTATNAGKPEEC
>PK3-2_01998 Spermidine/spermine N(1)-acetyltransferase
MTINIKKCSREDLKILQEISVETFNDTFKDQNSSENMKAYLDSAFNTEQLEKELSNISSQ
FFFVYCHHEVAGYLKVNTDDAQSEEMGDESLEIERIYIKKEFQKHGLGKHLLHKALDIAL
ECNKKKIWLGVWEKNENAVAFYKKMGFVQTGTHSFYMGDEEQTDFIMTKTLM
>PK3-2_01999 GMP reductase
MMENVFDYEDIQLIPAKCIVNSRSECDTSVRLGGRTFKLPVVPANMQTIIDEELAIQLAD
NGYFYVMHRFEPQTRIDFIKDMNARGLFSSISVGVKAEEYEFVRQLAEENLTPEYVTIDI
AHGHSNAVIEMIQHLKKHLPDTFVIAGNVGTPEAVRELENAGADATKVGIGPGKVCITKI
KTGFGTGGWQLAALRWCAKAASKPIIADGGIRTHGDIAKSIRFGATMVMIGSLFAGHEES
PGQTIEKEGKLYKEYFGSASEFQKGEKKNVEGKKMHVAHKGSIKDTLVEMEQDLQSSISY
AGGTKLDAIRNVDYVIVKNSIFNGDKY
>PK3-2_02000 hypothetical protein
MTQNEEKTPKFQKVQDRIIMVMIWIVAALVIALVLGTALNYMNIFK
>PK3-2_02001 Ferredoxin--NADP reductase 2
MREDTKVYDITIIGGGPVGLFTAFYGGMRQASVKIIESLPQLGGQLSALYPEKYIYDVAG
FPKIRAQELINNLKEQMAKFDQTICLEQAVESVEKQADGVFKLVTNEETHYSKTVIITAG
NGAFKPRKLELENAGQYEGKNLHYFVDDLQKFAGRRVAILGGGDSAVDWALMLEPIAKEV
SIIHRRDKFRAHEHSVENLHASKVNVLTPFVPAELIGEDKIEQLVLEEVKGDRKEILEID
DLIVNYGFVSSLGPIKNWGLDIEKNSIVVKSTMETNIEGFFAAGDICTYEGKVNLIASGF
GEAPTAVNNAKAYMDPKARVQPLHSTSLFENK
>PK3-2_02002 NADH dehydrogenase-like protein
MALNKPKIVILGAGYGGLMTVTRLTKFVGPNDADITLVNKHNYHYETTWMHEASAGTLHH
DRCRYQIKDVINQSRVNFVQDTVKAINVDEKKVVLANGELQYDYLVIGLGAVPETFGIKG
LKEYAFPIANINTSRLLREHIELQFATYNTEAEKRPDRLTIVVGGAGFTGIEFLGELAAR
VPELCKEYDIDRSLVRIVCVEAAPTVLPGFDPELVDYAVHYLEENGVEFKIGTAVQECTP
EGVRVGKKDEEPEQIKSQTVVWAAGVRGHPIVEEAGFENMRGRVKVNPDLRAPGHDNVFI
LGDSSLFMNEDTERPYPPTAQIAMQQGITVAKNLGRLIKGGELEQFKPDIKGTVASLGEH
NAVGVVYGRKLKGTPASFMKKVIDNRSLFLIGGLGLTLKKGKFKFF
>PK3-2_02003 hypothetical protein
MISLPVVIISIVLFFVLFFGIGFLLNMLLRMSWIMAVIYPVVCFFIISKEKLISYVQSPG
ESFAGLFHRIVSLAAADVLILASGLAGAIVSGIAINMLRKRGYQMF
>PK3-2_02004 putative protein YuiC
MLNMIRRLLMTCLFLLAFGTTFLSVSGIEAKDLSKWVQEHQEKHLKHAGLTLKALQQKKT
QTMSAAKDKTKPLEEAFDWDEYPVQKVTATGYTAGAESTGKKPGDPLYGLTYSGVKVKRD
LYSTVAADPAVFPIGTILFIPNYGLGVVADTGSAIKGNRLDLYFETVKDVYNEWGKKTLD
VYVIKKGTGKVTEDELEKLNETKSLQVFRNQYKTVKE
>PK3-2_02005 hypothetical protein
MELLTNFPLLSSLAAIIFAQVIKVPIQFIVSRKLDWSLVTSTGGMPSSHSAAVTALSTGV
ALEHGLGSSLFAVSAIFAVITMFDATGVRRHAGEQATVLNKLVIDFNRFVNEAKDFPKAE
DKEKQKKLKELLGHQPIEVFFGGLTGILLTLILAYFFM
>PK3-2_02006 Cytosol aminopeptidase
MFYAVQQLERTDTLVVGLFQKSRLTGKALEIDEMLEGHLTQLLKDGDVSSKPNQVSKVFP
PSSAGMKRIYFVGLGREANYSFEQAKECFAHVFQAIHKDRKQEAAVLLDTFISEDVPAAD
AAHALAESCLLASYEVQDYKHKSNEPDKQIEAVYAVTDEDTQEVQAGLRVGQAYGQGTNS
ARTLVNMPGNMLTATDLASYAEELAAKYDFECEILEKSEMEELGMGGILAVNQGSDEPPK
MIVLKYQGKKDWEDVVGLVGKGITFDTGGYSIKTKSGIVGMKSDMGGAAAVLGAMETIGE
LRPEQNVLAVIPSTDNMISGGAMKPDDVIVSLSGKTIEILNTDAEGRLVLADGITYAKQH
GASVLVDVATLTGGVVVALGTETTGAMTNDQRFYEQVVDAAGECGEAIWQLPITEKDKKR
VKNSQMADLSNSPGREGHAIMAGTFLGEFAESTPWVHLDIAGTATSNKATCFGPSGATGV
MARTLATLAERFALEEDKSES
>PK3-2_02007 hypothetical protein
MNAVVIAVLLMLVLSLLRVNIVIALILGALAGGLTGGLGLGETVKAFTEGLGGNATVAVS
YAMLGAFAAALTKTGLPDAMVEASVKLIGNKEDSRKKALSKVLIVLIILIVSCFSQNVVP
VHIAFIPVLIPPLLKIFNELEMDRRLIACVITFGLTAPYILLPVGFGQIFQGMLKDNMAD
AGLNVSLGDIPYALMIPVAGMVVGLILSIIVFRKPKTYETKEISGTNASPYTKKSLAIAV
LAIVVSLGVQLYLSQTLGVEGMIMGALAGLIILFVSGVMKRDEADSLITDGMVLMAFIGF
VMLVAAGFSNVLTKTGDVEALVKTAAGIMGHSQSLGALLMLIVGLLITMGIGSSFATIPV
ITTIFVPLCMQLGFSPMATVAIIGAAAALGDAGSPASDSTLGPTSGLSADGQHHHIWDTC
VPTFIFYNIPLIIFGWIAALVL
>PK3-2_02008 hypothetical protein
MKQHKLRAGDMALIGMFAALMAVGANITSVAPFLQVAGIPLSMQPFFCLLAALLIGSRRA
AIAMIVYALVGLAGAPVFAKFSAGFAPFAGQSGGFILSYIPAAFAAGWFLERKLQPSKVR
FLIASLIGTAIMYIIGTTYMYLALKLWIHTPVSYGTTWGYMTWFMVKDTALAVVLAFIAP
AIYRSIHKATGFNRNHISST
>PK3-2_02009 Putative protein-methionine-sulfoxide reductase subunit YedZ1
MYFGKTKQSDRSGRVPPNQNVTTSFPVLHTGNVPYYEDMAKWNLQVYGLVDQPMLLSFED
VKTFPQYESKNDIHCVTGWSRLDNVWQGVRACDIAEKAGVKEEAGYVILHAEEGWTTNLP
LDDFLAETSLLAYAHNGEPLTPDHGFPLRGVFPHLYFWKSAKWLRGIQFTKENHPGFWEQ
NGYHMRGDPWQNQRFTWD
>PK3-2_02010 Ferri-bacillibactin esterase BesA
MNENTTDRVKGGTQNAFTIPGTEMRMMTSRNENRTYQIFISKPNTPPPPAGYPVIYLLDA
NSVFGTMTEAVRVQGRRPEKTGVIPAVIVGIGYETAEPFSSVRHRDFTMPTAQSKLPERP
DGREWPEHGGAEDFFRFIEKDLKAEIERDYQIDRNRQTIFGHSLGGLFVLQVLLSNPDAF
QTYVAGSPSIHWNKPFILEKADHFASRVKKNNLSINILLAAGEFEQHHKSRMNDNARELY
ERLAVLSDQGIRAEFCEFSGEGHISVLPVLVSRALRFALHPDGPHISMG
>PK3-2_02011 2,3-dihydro-2,3-dihydroxybenzoate dehydrogenase
MNAMGIKGKVAFITGAAQGIGEAVARALASQGAHIAAVDYNPEKLEKVVRSLKAEGCHAE
AFAADVRDSAAVDEITARIERELGPIEILVNVAGVLRPGLIHSLSDEEWEATFSVNSTGV
FNASRSVSKYMMDRRSGSIVTVGSNAAGVPRTSMAAYASSKAAAVMFTKCLGLELAEYNI
RCNIVSPGSTETDMQWSLWADENGAEQVIKGSLETFKTGIPLKKLAQPSDIADAVLFMVS
DLAGHITMHNLCVDGGATLGV
>PK3-2_02012 Isochorismate synthase DhbC
MLEQNVLSETKAEHLLHEYQAGAFFLASPHRVLLAKGIREIVPEAEGQNQIETLSGRIAD
TLRQAKQSGQSRPLVVGAVPFDHVKAARLVVPEEVRWSGPLQFDHAEKEHQPANTYHIEP
VPAPEDYKNGVEQGLARIDDGTLSKIVLSRSLYLTSSEPIQTDELLHHLARHNTHGYTFA
ADVSGQAETSSHRTLLGASPELLVSRMGTQVVSNPLAGSRPRSDDPAEDQRRAAELLSSA
KDLHEHAVVADAVAAALRPFCRTLDVPEKPSLIKTETMWHLSSVIKGELSDPSVTALELA
AALHPTPAVCGTPTDLAREAILSIEPFDRGFFTGMVGWCDDAGDGEWIVTIRCAEAEERS
LRLYAGAGVVAGSKPEDELQETSAKFRTMLRAMGVNHL
>PK3-2_02013 2,3-dihydroxybenzoate-AMP ligase
MLNGFTPWPEELAETYRKNGCWAGETFGDLLRDRAAKHGDRIAITCGNTHWSYQELDTRV
DRLAAGFQKLGIQQMDRVVVQLPNIAEFFEVIFALFRLGALPVFALPSHRSSEITYFCEF
AEAAAYIIPDSYSGFDYRSLARQVQSKLPSLKHVIVAGEAEEFLELEALHTEPVKLPEVK
SSDVAFLQLSGGSTGLSKLIPRTHDDYIYSLKRSVEVCWLDHSTVYLAALPMAHNYPLSS
PGVLGVLYAGGRVVLSPSPSPDDAFPLIEREQVTITALVPPLAMVWMDAASSRHDDLSSL
QVLQVGGAKFSAEAARKVKAVFGCTLQQVFGMAEGLVNYTRLDDPEEVIVNTQGKPMSPY
DEVRVWDDQNRDVKSGETGHLLTRGPYTIRGYYKADEHNAASFTEDGFYRTGDIVRLTSE
GYIVVEGRAKDQINRGGEKVAAEEVENHLLAHPAVHDAAMVSMPDQFLGERSCVFIIPRD
EAPKAAELKAFLRERGLAAYKIPDRIEFVDSFPQTGVGKVSKKALREAIAEKLLTGSKK
>PK3-2_02014 Isochorismatase
MAIPAIQPYQMPTSSDMPQNKVSWVPDPNRAVLLIHDMQNYFVDAFTAGASPVTELSANI
RRLKDQCAQLGIPVVYTAQPGSQNPADRALLTDFWGPGLNSGPYEEKIITELAPDDNDLV
LTKWRYSAFKRTNLLEIMRKEGRDQLIISGIYAHIGCLVTACEAFMEDIEAFFVGDAVAD
FSLEKHQMALDYVAGRCAFTVMTDSLLDQLKNAPADTQKTSVNTGKEMFTCENIRKQIAE
LLQETPEDITDQEDLLDRGLDSVRIMTLVEQWRREGAEVTFVELAERPTIEEWQKLLTTR
SQQVLPNADYL
>PK3-2_02015 Dimodular nonribosomal peptide synthase
MPDTKDLQYSLTGAQTGIWFAQQLDPDNPIYNTAEYIEINGPINIALFEEALRHVIKEAE
SLHVRFGENMDGPWQMINPSPDVQLHVIDVSSEPDPEKTALNWMKADLAKPVDLGNDPLF
NEALFIAGPDRFFWYQRIHHIAIDGFGFSLIAQRVASTYASLMKGQSAAARSFGSLQAIL
EEDTDYRASEQYEKDRQFWLDRFADGPEVVSLADRAPRTSNSFLRQTAYLPLSDVSALKE
SARYFSGSWHEVVIAVSAVYVHRMTGSEDVVLGLPMMGRIGSASLNVPAMVMNLLPLRLS
VSTSMSFSELIQQISREIRSIRRHHKYRHEELRRDLKLIGENHRLFGPQINLMPFDYGLD
FAGARGTTHNLSAGPVDDLSINVYDRTDGSGLRIDVDANPEVYSESDIKLHQQRILQLLQ
MASAGEDMLIGQMELLLPQEKEQVIREWNETAKPEELLSIQNLFEKQAILTPERIALICD
DDRVNYQKLNEKANRLAHLLIEKGLGPEQFVALSLPRSPEMVVSMLAILKTGAAYLPLDP
EFPADRISYMLEDAKPSCIITTEEIAARLPDNLAVPQLVLDQSVTQEVVKRYSPDNPNVS
VSLAHPAYIIYTSGSTGRPKGVVVTLKSLSNFLLSMQETFSLGEEDRLLAVTTVAFDISA
LELYLPLISGAQIVIAKKETIREPQALAQMIEYFDIDIMQATPTLWHALVTNEPEKLRGL
RVLVGGEALPSGLLQALHELHCPVTNLYGPTETTIWSAAAFLEGGLKGVPPIGKPIWNTQ
VYVLDNGLQPVPPGVVGELYIAGTGLARGYFRRPDLTAERFVADPYGPPGTRMYRTGDQA
RWRADGSLDYIGRADHQIKIRGFRIELGEIDAVLAKHPDIEQAAVVVREDQPGDKRLVAY
IVTASVDIAELRRYVGADLPDYMVPAAFVEMDELPLTPNGKLDRKALPAPDFSTSVSERG
PRTPQEEILCDLFAEVLGLARVGIDDSFFELGGHSLLAARLMSRIREVMGAELGIAKLFD
EPTVAGLAAHLDQAQSARPALQRAERPERIPLSFAQRRLWFLHCLEGPSPTYNIPVAIRL
SGELDLGVLQTALYDLVCRHESLRTIFPETQGTSYQHILDADQARPDLHVTEIAEKALSE
RLAEAVRYSFDLAAEPAFRAELFIIGPDEYVLLLLVHHIVGDGWSLTPLTRDLGAAYAAR
CHGRAPEWAPLAVQYADYALWQQELLGSGDDPNSLIAGQLAFWKETLKNLPDQLELPTDY
SRPAEPSHDGDTIHFRIEPELHKRLQELARANRVSLFMVLQSGLAALLTRLGAGNDIPIG
SPIAGRNDDALGDLVGLFINTLVLRTDTSGDPSFRELLDRVREVNLAAYENQDLPFERLV
EVLNPARSRATHPLFQIMLAFQNTPDAELHLPDMESSLRIHSVGSAKFDLTLEISENRLA
DGTPNGLEGLLEYSTDLFKRETAQALADRLMRLLEAAESDPDQQIGNLDILAPEERRSMA
TDWQSVSDQIPHASLPEQFEKQAALSPDAIAVVYEDQSLSYAELNERANRLARMLISEGV
GPEQFVALALPRSLEMAVGLLAVLKAGAAYLPLDPDYPADRIAFMLKDAQPAFIMTNTKA
AGSIPPAENVPKIVLDDLDLEKKLNTYPADNPNNTDRIQPLSPLNTAYVIYTSGSTGVPK
GVMIPHQNVTRLFAATDHWFHFSSDDTWTMFHSYAFDFSVWEIWGPLLHGGRLVIVPHHV
SRSPEAFLRLLVKEGVTVLNQTPSAFYQLMQAEREQPDLGQALSLRYVIFGGEALELSRL
EDWYNRHPENRPQLINMYGITETTVHVSYIELDRSIAALRANSLIGRGIPDLGVYVLDER
LQPVPPGVAGELYVSGAGLARGYLGRAGLTAERFIADPFGPPGTRMYRTGDVARLRADGS
LDYVGRADHQVKIRGFRIELGEIEAALVQHPQLEDAAVIVREDQPGDKRLAAYVIPSSSD
TFDTAELRKYAAERLPDYMVPSAFVMMRELTLTPNGKLDRKALPAPDFAAAVTGRGPRTP
QEEILCDLFMEVLHLPRVGIDDRFFDLGGHSLLAVQLMSRIREALGVELSIGILFEAPTV
AGLAERLEMGSSQSALDVLLPLRTSGDKPPLFCVHPAGGLSWCYAGLMTNIGTDYPIYGL
QARGIGQRDELPKTLDDMAEDYIEQIRTIQPKGPYHLLGWSLGGNVVQAMATQLQNQGEE
VSLVVMLDAYPNHFLPIKEAPDDEEALIALLALGGYDPDSLGDKPLDFETAIEILRRDGS
ALASLDESVILNLKNTYVNSVGILGSYKPKTFRGNVLFFRSTIIPEWFDPIEPNSWKPYI
HGQIEQIDIDCRHKDLCQPEPLALIGKVLAVKLEEMNK
>PK3-2_02016 Protein MbtH
MANPFENADGTYLVLINEEGQYSLWPGFIDVPSGWTVVHEQKGREACLDYIQSHWSDMRP
NSLKPVENV
>PK3-2_02017 hypothetical protein
MAVQQYGVLKGIVLDMKRETDDDSPHFQVKVLGEENTYYRCAINVMSSSEESEVLYLADD
QFDSSSITILPNMPYGYTKINEANREVALDYVRGNLFDPGEMKPLPHEITGPDNDLNDFI
ETYIKKAKEEKAPVYIFGSKFGPEQAADKIFGFTPTNGMHNIHMNQGNAMDTRWKKDNGS
WHDGGILIQFGDQWAAVFLAFLSQSWCTDENGNPVRDCDHTQTSA
>PK3-2_02018 Alanine dehydrogenase
MIIGVPKEIKNNENRVALTPGGVSQLISNGHRVLVETGAGLGSGFENEAYVSAGAEIIAD
PKQVWDAEMVMKVKEPLPEEYVYFRKGLVLFTYLHLAAEPQLAQALKDKGVTAIAYETVS
DGRTLPLLTPMSEVAGRMAAQIGAQFLEKPKGGKGILLAGVPGVSRGKVTIIGGGVVGTN
AAKMAVGLGADVTIIDLNADRLRQLDDIFGHQIKTLISNPVNIADAVAEADLLICAVLIP
GAKAPTLVTEEMVKQMKPGSVIVDVAIDQGGIVETVDHITTHDQPTYEKHGVVHYAVANM
PGAVPRTSTIALTNVTVPYALQIANKGAAKALTDNAALRAGLNTANGHVTYEAVAKDLGY
EYVPAEKALQDESSVAGA
>PK3-2_02019 Proline-responsive transcriptional activator PutR
MTMPNDPFKYSFDRLEDVADHISDVLRCPITIEDVNHKLLAYSTHSDCTDPARTSTIIGR
RVPEKVINKLWKDGTIPALLKTDQPIRVKQIDEVGLSNRVAISIWKNNQVLGFIWALEIQ
KTLSDDDMITLQMAAKAVRNKLLKLQIRKTKNEERSQEFFWKMLTGHIHQEHDMADGFHK
LGMVAPSEFSVMIIRINGELTEKIEQQLQYLQETTQQVHVLLTTVDSNELIILTAPKTDH
PFQDLKQFALSTQKQLKERYKIEDVSIAFGGIYNSISFVSRSYQEALSVLKAKERFAEET
KHLFSFSELGIYQYLDVLDEKRKQTKYFNYSLSKLEQYDRDHQSNMVETLECFIEADSNV
NTASKVLNIHVNTLNYRLKRISQIAEIDLKNINQKFTIYLDIKLRHMDL
>PK3-2_02020 Protein YukE
MAGLIRVTPEELRAMAKQYGVESQEVLNQVDRLNRMISDLKSMWEGASSEAFADQYEQLK
PSFIKMSDLLQDVNQQLDQTANTLESTDQDIANQIRG
>PK3-2_02021 hypothetical protein
MKGKERLIHKKTALFLCKGDPNMYIDITIDLKHYNGNVFDLRLSDYHPVKKVIDIAWQAQ
SVAIPPREGHWIRVVNKDTVFSGECKLSDCGITNGDRLEIL
>PK3-2_02022 Type VII secretion system protein EssB
MSDKQKSYLENQLEAVAEKTDAGYTFTFQREKIKLLDGLEANVIKDVNPFIHKEIDVTDD
EVIITIQPPPSFKAFRFMKAKDKKSKWQFAYQLVQAVQQHNLSRLNLIVAPENIVFDKGL
TPYFLHYGVKESIPPYEHDEERVWRELKATAALAVDGSFAFEDYLKFNETLTFSAEAKAI
LDAASYDDLLELIQTHIDELEAKAKTYIHIPRKKWNIQRYIGLGLIVLLVPSLIYSMYVL
FFAQPKHQAIVDSNRAFLNKQYSEVISTLSKYDAESLPESVQYQLATSYVEVESIDSNEK
KKVENNLVTLQSDPQHFLYWIDIGRGSNKEAISIGRKLEYNPYIGLGLIRYKAEILADES
MKDDEKQKELDSVQSEIEQIRKQIKEQKEEELSDVSETDAASQTAEKQTDEEKQQAEEKA
AEEKAAAEEKAKKEEQEKKKQKRKMRKKMTNNVRHEAQVIACCHLAVRGFAI
>PK3-2_02023 ESX secretion system protein EccC
MSLLWVFYQNNVQKLKLSDLPSSHPVTIGPDVKDSVTIGTIPFASGVISLQRKESGGRYE
VFLGNDCLGTIEPDTSFSLQTDQQDIRFILTCSEPEKSVYFTGNRDEIICSSEKTNAAIY
LNPQDFAFAEQSTFSLLHVGESWSVRPESGTVFLNGEKIIDNTRLQPGDEIFWNFTQMRV
TEQDLLEIVHFAPFKTALTETVKPTTEMQKKYPQYRRTPRMVYDLPEDRVSFSFPSQESD
QTNRGLWLVILPPLVMLIVMGVVAIIQPRGIFILVSLAMFMMTLITSTVQYFRDKNQRKK
REEKRERVYKLYLDNKRKELQELAEKQKQVIEFHFPSFEQMKYLTSEISDRIWEKSLESK
DYLQLRLGTGTVPSSYEINMSGGDLANRDIDDLMEKSQHMQRVYKDIRNAPVTVDLAEGP
MGLVGKSQIVKNEIHQLIGQLSFFNSYHDLRFVFIFHEEEYKDWEWMKWLPQFQMPHIYA
KGFIYNEQTRDQLLSSLYELIRERDLEDDKEKLQFKPHFVFVITNQQLISEHVILEYLEG
QHEHLGISTIVAAETKESLSENITTLVRYINEHEGDILIQKKKAVRIPFRLDYHQRGDNE
RFSRTLRTLNHQVGITNSIPETVSFLELFHAKEVKEIGIQQRWLTSESSKSLSVPIGYKG
KDDIVYLNLHEKAHGPHGLLAGTTGSGKSEFLQTYILSLAVHFHPHEAAFLLIDYKGGGM
AQPFRNIPHLLGTITNIEGSKNFSMRALASIKSELKKRQRLFDQYQVNHINDYTKLYKQG
KAEVAMPHLFLISDEFAELKSEEPDFIRELVSAARIGRSLGVHLILATQKPGGIIDDQIW
SNSRFKVALKVQDATDSKEILKNSDAANITVTGRGYLQVGNNEVYELFQSAWSGAPYLEE
VYGTEDEIAIVTDTGLIPLSEVDTEDIAKKDVQTEIEAVVDEIERIQDDMGIEKLPSPWL
APLAERIPRTLFPSEEKDHFHFAYVDEPDLQRQEPIAYKMMEDGNIGIFGSSGYGKSIAA
ATYLMSFADVYTPEELHIYIFDFGNGTLLPLAKLPHTADYFLMDQSRKIEKFMIRIKEEI
DRRKRLFREKEISHIKMYNALSEEELPFIFITIDNFDIVKDEMHELESEFVQLSRDGQSL
GIYFMLTATRVNAVRQSLLNNLKTKVVHYLMDQSEGYSIYGRPKFNLEPIPGRVIIQKEE
LYFAQMFLPVDADDDISMFNGLKSDVQKLQERFASMEQPAPIPMLPESLSTREFSLRFKL
ERKPLSIPIGLHEETVSPVYFDLGKHKHCLILGQTQRGKTNVLKVMLEHLIDDETEMIGL
FDSIDRGLSQYAKESDVSYLETKEDIEQWIETAEDIFKTREAMYVEAVRQGDAHNLRFSQ
VVLMIDGITRFQQTIDTRIQDRLANFMKSYAHLGFSFIPGGNHSEFSKGYDSLTTEMKQI
RHAILLMKKSEQNVIPLPYQRQEPEIQPGFGYVVENGKEQKVQIPLCSAERESAR
>PK3-2_02024 ESX secretion system protein YueB
MTEQRKNLIKLISAVVIILLLPVLFFRFIGDDPTKKAVNSTRQIAVVNEDTGVLSDEVKS
DEEDKSAQFGKEVAAVLGERPDYSWTVVNRSAAETGLASKKYDAIVYIPSDFSRNILSYD
KDHPQKATLEFSIQDNLNAVNKEKVQRELEDAQKTMNKKMSALYWNFVSQKVDNIRGEFD
KIVNKESEFQNVMYNFYKPSSNDLAGEIKQQKDLIDELKKSMNEAQGTTKEKASTAEEAK
NTLKEFVDTVERYKEYQENQKKLLLTAQDSTQQQIHTGLDAIQAQQKANQFSERMSGLAT
GISQVKTQLGQTSTVLAAAQQIREGQVPQQELGMAKIQSDLIDQYQAASRQAALNQVYEL
LVPARQALTVAKGDDPIEDDGSDNDDQDKDPKEEDPEELKIDLEKQREELKNIAADIQDI
SDNLKEPEKEEPAPEDPGTEPDEPSTDIPEKPDDGGSTSPDDTQGDTGNDDNSSDTGNDG
QTDGNTQDQDQQPGTDGQEQNGDASNGESDSGQTETGTSAEQTASSDSALQLIQLANEDG
TGDSGDTEGDGGTTQPGDEDQTGNDEISDIAKAKEQLSKASERIKQIEEELKEKETAHNE
ELKKKLEELKEQMDGLNDEIDDLKDQVKKLEGKLENLEAKRKQEFEGMYSAIRELENKDQ
LQFSGEINTESISALMRYYKYLSVYDSVLSGTVDSSAKNNVIEGQQGNVKSVLALSPEES
ASWEALKNNTMQTDEDINSFIDGMTKFADEYSGFIRDSQAGVLDELTKISDSAAKASEQL
VTGATQESATFSNDGLSGTMALSVQDTVGQEVLQMSDMMGSLSDRQSGIIDYTTNMQQSV
NDVQTKADTLNNNWGKNVASTKLIRSDVYGILGNTLVDGQNNGYVYDYLANPLKISGEVP
EEKTQTVPPVVILVIILISSLLIGYFSSYYQNAPLLVKGALFGILNILVGLMISLFGLNI
YSLPDDQTIKWSVFTILLLVASSAFIRAAFRFGSIPGWVASAAMILFYVAPLIDLIMPNF
TFEDPVSKVYIDIQYGTGHLFTMGISVLLIITVIAAALPLIIRLMAEKTAESDETYEA
>PK3-2_02025 hypothetical protein
MLSFSLFIPSAAAAETEENTDVAPNQYEKKDIEIDTNYLHEDTYYEEKTELPEEQKDITF
DKPVDKDAELIKDLFTSADSEESNTIKAQSKQLGITFAEKPITKASSTETEEEQETPSLL
LPIIYVVLILLGIAGIVFLIPKVTAQENKKA
>PK3-2_02026 Benzil reductase ((S)-benzoin forming)
MELYIITGASKGLGEAIALQALEKGHEVHALSRTKSDVFHEKLTQHQIDLINLEEAEQQF
ETLLSSINPDRYSGITLINNAGMVTPIKRAGEASLDELQRHYQLNLTAPVLLSQLFTKRF
ALYSGKKTVVNITSGAAKNPYKGWSAYCSSKAGLDMFTRTFGFEQEDEELPVNMISFSPG
VMDTEMQAVIRSSSKKDFHDIERFRKLNETGSLRSPAFIAGTLLSLLETGAENGRIYDIK
EFL
>PK3-2_02027 hypothetical protein
MRKVTLMDVFTHPIAQKYLQRSGVAHAIACAYHAFRLSVRTDINPDLAAKAALLHDIGHY
EWYTDGKWDYEKYKRNDIHAIKGAERAHKLLIRLGEEPKAAKEIALAILLHTDSYLPEGE
LDKNTLQQIVKKADELDEEPGGHHHYRQIDPSTARKKIEKLDQLIDQAQSSMIKPV
>PK3-2_02028 hypothetical protein
MVNQGSPQLVSLVDPYVYQTIKKLIGSRFVIQTVRDTVRGRLIDVKPDHITIEGARNSVC
LIRIQHMISVTPDYSERV
>PK3-2_02029 Putative transport protein
MLKSKVHFWTLQILFVLLIIFVATKVSFVFQPFIVFISTLFFPMLIAGILYFIFNPVVRL
LEKKIPRTLSILLIYLLFIGLLAFVSASVGPVITSQVTGLFNNLPDYIKQIQSLTKDLSH
SQWFTWMMTQDYVSISKIEQSATSFLQNLPQNITSSLSAVFGVVTNITLVIITVPFILFY
MLKDGHRFPNLAVKILPASYRTEGLKIFKDLSDTLAAYFQGQLLICLFVGTACFIGYLIA
GLPYALILGIVMAITNIIPYVGPFLGAAPAVIVGFMDSPAKALFAIIVVVVVQQLDGNLL
SPLVIGKRLNTHPLTIILLLIGAGSFGGILGMILAVPVYAVVKAFFLNIVRLIKLRQRSR
LEENAKSAE
>PK3-2_02030 putative spore germination protein GerPF
MPAIVGPIYIMSVTGNAAASFGDVFAISPKSVAHSGAGSGAFQLGDFVKINNQTSKTFFK
DADIIDETVSFNG
>PK3-2_02031 hypothetical protein
MKIRKANITTETGMITDVYLHENRKELRTLVAVPQLEWSTIISYEEDKASLPERLGASLR
RHTEEAVADELAKKIIHWVTEM
>PK3-2_02032 putative protein YueI
MSEEKMDLYLQQGMYGALETKPDERHLFLGSLRERVLLALTKGQVLRSRPYEEAEHALKS
SKNITLLINGELQYQSYSSYIQMANRHGAHFKIVSDLQFHTPLGLVIASDIAVNRELIYV
QDDIFNRSVLKP
>PK3-2_02033 hypothetical protein
MKKALICIDYTNDFVASDGKLTCGEPGRMIEEAIVNLTEEFITNGDYVVLAVDSHDEGDQ
YHPETRLFPPHNIKGTEGKDLYGKLLPLYQKHEHEPNVYYMEKTRYSAFAGTDLELKLRE
RQIGELHLAGVCTDICVLHTAVDAYNKGFRIVVHKQAVASFNQEGHTWALSHFANSIGAQ
VAE
>PK3-2_02034 Nicotinate phosphoribosyltransferase
MLEYGFKDDSLSLHTDLYQINMAETYWRDGIHEKKAIFELFFRRLPFENGYAVFAGLEKA
IEYLENFKFTDSDLNYLQDELGYHEDFIEYLRGLTFTGSLYSMKEGELVFNNEPIMRVEA
PLVEAQLIETALLNIVNYQTLIATKAARIKGVIGDEVALEFGTRRAHEMDAAMWGARAAL
IGGFSATSNVRAGKRFNIPVSGTHAHALVQAYRDEYTAFKKYAETHKDCVFLVDTYDTLR
SGMPNAIRVAKEFGDRINFIGIRLDSGDLAYLSKKARKMLDEAGFTDAKVIASSDLDEHT
IMNLKAQGARIDVWGVGTKLITAYDQPALGAVYKLVAIEEDGKLVDTIKISSNPEKVTTP
GRKKVYRIINQLNHHSEGDYIALYDEQVNDQKRLRMFHPVHTFISKFVTNFYAKDLHELI
FEKGILCYQNPEISDIQQYVQDNLSLLWEEYKRISKPEEYPVDLSEDCWSNKMQRIHEVK
SRLEEELDEE
>PK3-2_02035 Cyclic di-GMP phosphodiesterase CdgJ
MRVFVARQPIFNRKEQVVAYELLYRESEENVYSAKDGDQATTDLVINSFLNIGIEKLTEG
KRCFVNFTESLMFSNLPTSFNPKQLVIEILEDIPITPALISRCKELKKMGYMLALDDFYA
INPQNEDLLEKLMSYIDILKIDFLKTTRMERRKILQTYGCSGLIFLAEKVETRKEYKQAV
QDGFQLFQGYFFSEPRIISGHDLSTHFYSYYELLNELSKEQPNIKRVTEYIERDLSLSYQ
ILKFLNSSHSRLSQKIESIQQAIMLLGFNEIKRWIYILSFKDLSRKGNSSKHEIIKISLM
RAKLCELLARKTARPQPASYMLIGMFSLIDTLLHREIEDIIQELPLIDEVGQALLGHQND
YYQMLELVKLIESNNWDTCTELGKELDKEEAYECYLEALEWCHKLMDAK
>PK3-2_02036 hypothetical protein
MRYRYPWFYAYPYEIRRPPASPANTDIFIRSAKQAAGLFADAQLVLSRIAGSRELSRRIL
TAAEQSDKQSVKRLIKQIGVRHEVDTVFNPDGIYISLIGTQSRMILALRWSEDRNHFASM
SL
>PK3-2_02037 Degradation enzyme regulation protein DegQ
MEKKLEEVKQLLFRLELDIKETTDSLRNINKSIDQLDKYNYAMKIS
>PK3-2_02038 hypothetical protein
MFHLVKWNGRGEVVIEQICLDSVRIKEKMKEIVDENILNEDLKTKLISFIEEKKQFSFAE
LAYHHYIAFDGKDVTAIELLASGIELLILSADIFDDIEDKDNLQASWMKIDPSIVINAAT
ALYTLSLQVISLVSNNPQHLSLTLQYSLQSLQGQHVDLNLTVSSESEFIEMIKLKSGSLV
TLPSVLGVYLATGEFNETVDEYSHYLGIVEQIANDHHGLYYPDNNDIKTRHNLAFYYLKN
KYNQSSIDLLNFYAQEDNQINNMDELKKKLRESGVIQYLNVIKNIALENFKESFKKLKLD
EQRKNKLFVQLLRGNLN
>PK3-2_02039 hypothetical protein
MKHIDKIISHLANNPEAFDQFKNGNLTLLNINEKEKKAILYAFEEGEAPRTSNWPPIEAI
SNFFEDDKRKSFI
>PK3-2_02040 Sensor histidine kinase ComP
MHRNNNVYKYLSLAFIILSFVYVIYLSYISVFNIFVGADVKINEQGKLEVTKVVDYEYYS
GVKKGDIILEVNGEKGSEVQLERGRLVNVESLTVERDNKSFHLENVSLISEENLFMYLIP
LISYSICLFCIFFVYRINKVRKSPSAFVLILFLLFVSVAYVSACGARKGEEVSTYLLVLT
LVSCPILYIHFIYKYFAELGTKLFKKKLLIIMYILPLINLLLEAVLSNRLNSSTFLSNLN
LISFFALVLTVSILIHQGIRKIKQNEQKSILKILAYINILSFSPFIIFFVIPYVLFDKYL
SPFSLAAFTLVIPFSLVYQFMTNRLYNIDFVVGRLKYYGFLAITPTVIVVTIFNYIQKPE
DNFYSVKLTVVIYLLMFAVFYFKEIIDFRFKLKRFTEKFNYQDGIFKFTQLIKQASSVDQ
VLDHFKNTILEVLNIDNACVYDNSKGRITLLSKNNFKDLTYKNYEQYVKSFSGDIGKIKE
FKQGFIIKIGERGDRSFLVLCFSSYNTFKLTRDEIAWLQTLAFYTNVSLENVMKIEELMV
HLEDLKQQESNPVWLKKLMYTIEEKQRSDLARDLHDSVLQDLISLKRQCELFLAEFKKDD
NPCREDVQDKLVQMNEQMSDVISMTRETCHELRPQLLYDLGLVKALSKLVAQQQERVPFH
IRLNTGRFTASLDLDSQLNLYRIIQEFLSNAVKHSQATDVLIMLISIQNKIVLHYEDNGV
GFDQEKHNEHTMSMGLSGIKERVRALDGRLRIETSEGKGFKADIEIEL
>PK3-2_02041 Transcriptional regulatory protein ComA
MKKILVIDDHPAVMEGTKTILETDSNLSVDCLSPEPSEQFIKQHDFSSYDLILMDLNLGG
DVNGMELSKQILQENPHCKIIVYTGYEVEDYFEEAIRAGLHGAISKTESKEKITQYIYHV
LNGEILVDFAYFKQLMTQQKTKPAPSSQKEQDVLTPRECLILQEVEKGFTNQEIADALHL
SKRSIEYSLTSIFNKLNVGSRTEAVLIAKSDGVL
>PK3-2_02042 Putative esterase
MMDMKHTLLEALGIEIVDNTAERCVAVMPVDHRTVQPFGYLHGGASVALAETAASVGAQN
LIDHATQACVGLEINANHLKSVKDGTVKAVAEPVHIGRTTIVYQIHIYDEQERLICISRC
TLAVIKK
>PK3-2_02043 Na(+)/H(+) antiporter subunit G
MIEIAKIIVAVFILLGSLVCLAASFGTLRLPDMYTRSHAASKGSTLGVNMVLLGVFFFLW
FINGEISAKILLGIFFIFITSPVGGHLICRAAYNSGVKLDERSVQDDYNGIRNFVIKRKE
DSYL
>PK3-2_02044 Na(+)/H(+) antiporter subunit F
MFTLILQIALGIMAVSTLLYVIRVIKGPTVPDRVVALDAIGINLIAITALVSILLKTSAF
LDIILLLGILSFIGTIAFSKFLEKGEIIENDRNC
>PK3-2_02045 Na(+)/H(+) antiporter subunit E
MAFQILLNVFLAFCWMFLSNDPSAAGFITGYILGMLSLFFFRRFFTRQFYLWKMFSIIKL
FFIFLKELYLANVSVLKTVLSPKLNIRPGIFAFKTELTKDWEITLLSLLITLTPGTLVMD
ISDDRTILYIHAMDIEDAEKAIFDIRESFEKAIQEVSR
>PK3-2_02046 Na(+)/H(+) antiporter subunit D
MINMNNFVILPILIPLLSAILLIFMTKNLMLMRIFSTAASAIGIVISGILVQTVFSKGIQ
TLSLGGWKAPYGIVLAADQFASLLVLTTSVIGLLVVLYSFRSVGEKRERSFYYSGVQFLL
AGVSGAFLTGDLFNMYVFFELLLIASYMLIVLGGTKIQLRESIKYIVFNIVSSAMFVIGV
GFLYAVTGTLNMADLSAKISESGQTGLITVIGVLLLIVFGMKGGIFPLYFWLPGSYYAPP
AAISALFGALLTKVGLYAITRVFTLIFIHDTAFTHQLMIWLAALTVIFGVIGSLAYSDVM
KIVIYNIITAVGVILFGVAVHTPASIQGAIYYLIHDMLIKGALFMLAGTLIALTGTASLH
KMGGLIKRYPVLGWMFFISAISLAGIPPLSGFVGKFKIAEGGFAEGEFTISMLILLSSLL
VLYSVLRIFIHAFWGEEKETPKPNQRTAKGLLYPTAIFLLLSLLFGLGTEWVSPYVDQAA
ETLLNPEKYIEAVLKE
>PK3-2_02047 Na(+)/H(+) antiporter subunit C
MEILMAVLAGIIFMAATYLLLSKSLLRVIIGTALLSHGVHLMLLTMGGLKKGAAPILSEH
AKSFVDPLPQALILTAIVISFGVTSFILVMAFRAYQELKSDDMDQMRGNDQHE
>PK3-2_02048 Na(+)/H(+) antiporter subunit B
MNEQKTNDIILQTVTKLVSFIILLFSFYLFLSGHNAPGGGFVGGLITSSSIVLLLLAYDL
KTVRSILPVNFIYVAGAGLLLAVLTGVGSFVFGAPFLTHTFGYFQLPILGKTELATATIF
DLGVYLVVVGITMTIIQTIGEEE
>PK3-2_02049 Na(+)/H(+) antiporter subunit A
MQLLHFAILSPFLFAFIIPFLAKYAKRVHTGWFVLILPVLLFIYFLPMIRMTQSGETLRS
VLEWIPSLGINFTVYIDGLGLLFALLITGIGSLVTLYSIFYLSKEKEQLGPFYVYLLMFM
GAMLGVVLVDNVMVLYMFWELTSLSSFLLIGYWYKREKSRYGAAKSLLITVSGGLCMLGG
FILLYLITDSFSIREMIHQVQLIAGHDLFIPAMILILLGAFTKSAQFPFYIWLPDAMEAP
TPVSAYLHSATMVKAGIYVIARFSPIFAFSAQWFWIVSLVGLFTMVWGSFHAVKQTDLKS
ILAFSTVSQLGMVISMLGVSAAALHYGHQEYYTVAAMAAIFHLINHATFKGSLFMAVGII
DHETGTRDIRKLGGLMAIMPITFTISLIGTFSMAGLPPFNGFLSKEMFFTSMLRVTHFDL
FNVQTWGALFPVLAWVGSVFTFIYSMKLLFKTFRGSYKPEQLEKKAHEAPIGMLVSPVIL
VAFAVSLFFFPNILSYSLIEPAMNSIYPTLLDSHEKFHVHISQWHGLNTEVLMTAGIIVI
GTIGYLTMNKWKGIYKLFPSKLTLNRLYDKLVTLMEKGSYRVTKQYMTGFLRDYLLYIFA
GFIILMGGAFVIKGGFSFTTEGMAKIGVYEIILTLVMISATAATVFARSRLTAIISLGVV
GYTLALFFVIFRAPDLALTQLVIETISVALFLLCFYHLPKLRLKKKTRTFRMTNFIISLG
VGIIVTLLGIASSSQRTKDSIASFFTKHSHDLGGGDNVVNVILVDFRGFDTMFEITVLTI
AALGIYSMIKTKVKEEGKSGE
>PK3-2_02050 hypothetical protein
MKRKVLMCSGLFCSVFAGAFILNQYDGREGAAANEEWELYLLEHHLSARMSELESKDLPF
GPREYIRIVNR
>PK3-2_02051 Citrate/malate transporter
MGAIPKTGAISPEQKVTQEKNLFQKIWSWEIGVIPLPLYTVLAIIIILSAYYNELPANML
GGFAIIMILGVFLGDIGQRIPILKDIGGPAILSLFVPSFLVFYNVLNSTSLDAVTNLMKT
SNFLYFYIACLVVGSILGMNRTVLIQGFIRMFVPLVAGTIAAVAAGILVGFIFGYSAYDS
FFFVVVPIIAGGIGEGILPLSIAYSQILGSSADVFVSQLVPAAIIGNVFAIICAALMKKL
GDKRPDLNGNGRLVKSKKANEIFNQKEAEAKIDFKLMGAGVLLACTFFIFGGLLEKFIFI
PGAILMIISAAAVKYANILPKKMEDGAYQLYKFISSSFTWPLMVGLGILFIPLDDVASVI
SIPFVIICISVVVAMIASGYFVGKLMNMYPVESAIVTCCHSGLGGTGDVAILSASGRMGL
MPFAQISTRLGGAGTVICATVLLRFFTS
>PK3-2_02052 hypothetical protein
MDFVQILSIIVPATLVYAAPLILTALGGVFSERSGVVNIGLEGLMIIGAFTSVLFNLFLG
PELGSAAPWLSLLAAMAAGALFSLIHAAAAISFRADQTVSGVAINMLALGAALFIVKLIY
GKAQTDKIPEPFYKTNIPGLSDIPILGKIFFSDVYYTSILAIALAFISWFILFKTPFGLR
IRSVGEHPMAADTMGINVYKMRYIGVMISGLFGGLGGGVYASTIALDFTHSTISGQGFIA
LAALVFGKWHPIGALGAALFFGFAQSLSIIGSLLPLFKDIPNVYMLMAPYVLTILALTGF
IGRADAPKANGVPYIKGKR
>PK3-2_02053 hypothetical protein
MVKRLSHLLVPLIAIILGLAAGALIMLASGYSVISGYSALWNGIFGEIYYVGETIRQITP
YILSGLAVAFAFRTGLFNIGVEGQLLVGWTAAVWVGTAFDGPAYIHMPLALITAAAAGGL
WGFIPGVLKARFYVHEVIVTIMMNYIALHMTNYIISNVLTDRQDKTEKIHASASLRSPFL
EQITDYSRLHWGIIVALLAAVIMWFIINKTTKGFELRAVGFNQHASQYAGMSVRKNIMTS
MLISGAFAGLAGAMEGLGTFEYAAVKGAFTGVGFDGIAVALLGGNTAVGVVLAASLLGGL
KIGALNMPIESGVPSEVVDIVIAIIILFVASSYAIRFVMGKLKKKGAN
>PK3-2_02054 Galactose/methyl galactoside import ATP-binding protein MglA
MEYVIEMLNIRKEFPGIVANDNINLQVKKGEIHALLGENGAGKSTLMNVLFGLYQPERGE
IRVRGEKVHINSPNKANDLGIGMVHQHFMLVDTFTVAENIILGKEPKKFGRIDRKRAVQE
VQDISDRYGLQIHPGAKVADISVGMQQRAEILKTLYRGADILIFDEPTAVLTPHEIKELI
QIMKNLVHEGKSIILITHKLKEIMEVCDRVTIIRKGKGIKTLEVRDTNQDELASLMVGRE
VSFKTEKKTAQPGAEVLAIDGMTVKDTRGVEAVRNLSLSVKAGEIVGIAGVDGNGQSELI
EAITGLRKTDSGTIILNGKQIQNLSPRKVTESGIGHIPQDRHKHGLVLDFPIGENIVLQS
YYKKPYSAFGVLHKGEMYKKARSLIREYDVRTPDEYTHACALSGGNQQKAIIGREIDRNP
DLLIAAQPTRGLDVGAIEFVHKKLIEQRDAGKAVLLLSFELDEIMKLSDRIAVIFEGHII
ASIDPQDTTEQKLGLLMAGSTRKEAGEANG
>PK3-2_02055 Membrane lipoprotein TmpC
MTGRINFEPNFSGGYILNKRKIGLAMSLVIAAGTILGACGTSDKSSVSSEGKNKFSVAMV
TDVGGVDDKSFNQSAWEGIQAFGKENGLEKGKNGYDYLQSKSDADYTTNLNKLARENFDL
IYGVGYLMEDSISEIADQRKKTNFAIIDAVVDKDNVASITFKEQEGSFLVGVAAALTSKS
GKIGFVGGMESELIKKFEVGFRAGVQAVNPKAVVEVKYAGGFDKADVGKATAESMYKSGV
DVIYHSAGATGTGVFTEAKNLKKEDPKRAVWVIGVDKDQYAEGQVEGTDDNVTLTSMVKK
VDTAVEDLTKKASEGKFSGGETLTYGLDQDGVGISSSQQNLSDDVIKAVDKWKKKIIDGL
EVPATEKELKTFKAE
>PK3-2_02056 Transcriptional regulatory protein DcuR
MINVLIVEDDPMVGELNKRYLSQIDGFQLKGIASSFQSALHILGEHHIDLILLDIYMPGK
NGLELLTELRAQNEAVDVIVISAASELDVIKKTLRYGAVDYLIKPFEFERFQTALSDYRR
KQKVYSTHRNMSQTELDAELFQKKEATEKVQLPKGLTKSTLKLIWSSIQSFENESFTTED
LAKHTEISQVSIRKYLKFLEDIQVLNVEMAYGTIGRPVFQYNVNTGNLNGIKQYL
>PK3-2_02057 Sensor histidine kinase DcuS
MKKTLKLQTRLTIFVCIVVLIALLITFFTVGAQTTKRIRDQEKATALQTAEMVAEAPMTA
SALESGKNQKELQNYTKRVQKITGTEFVVVIDMNGIRKTHPDPSKIGKKFRGGDESEVLN
GHVHISTASGTLGKSQRAFVPVYAENGKQVGAVAVGITVNEIDEVISHSLRPLYFIICVS
IFVGVIGAVIVARTVKNIMYGLEPYEIATLLEERSAMLESTKEGILAVDEHGKIKLANAE
AKRLFVKMGISTNPVDQDVNDILPKSRLKKVIETKKPLQDRDVRINGLELVFNEVPIQLK
GQTVGAIATFRDKTEVKHLAEQLSGVKMYANALRAQSHEFMNKLHVILGLVQLKEYDDLG
DYIKDIAIQQKSETNEIINDVKSSVLAGFLLGKQSFIREQGANLDIECSGVIPNAADPSV
IHELITIIGNLINNALDAVANMPKKQITMSMRFHNSILDIEITDTGAGMSEEDQAKVFEQ
GYSTKGKNRGFGLYFTQQSIENLKGQMILTSEENEGTTFSLRVPYEPKEENHD
>PK3-2_02058 hypothetical protein
MKNTYLTGYFPLIAILLFSSSLSISTSLYALNMLSSFGMYDGMLDYFSEKGIRLALFAAF
ALLYFMVLSALKLIANTVTELSLLFFANDPEGNNLKKIRMGSMVYLGGGILSFVLLHNVI
WIVIWFAVVTLAYFVFTVYRIYSTLSLMSLVGFILLELLFWFTFVIGILFIFIKLYNSIM
ASLPV
>PK3-2_02059 hypothetical protein
MTSKKIPNRVLLFDGVCNLCNGAVQFIIKRDPEGLISFTSLQSETGQSLLKKSGLPTDRF
DSFVFIEDGKVYTKSTAAIKVFRHLRGPWRLFVLFFAVPKPIRDMVYSFIAKNRYKWFGK
KNECMLPSPSIKKRFLP
>PK3-2_02060 Penicillin-binding protein 4
MTMLRKIIGWILLLCIIPLFAFTVIASGKEVKQMKSLDQVLDKNINLKDISLVQNSYMYD
RDGSLVSEIVSDHENRVLVPFDKIPEEVKQIFLTSEDRHFYEHKGFDFMGMVRATASNVK
DKKIDQGASTITQQLSRNLYLSHERSFSRKLTELAYSYQLEKKYTKNEILEAYLNTIYFN
NGVYGVGSAAEFYFSKPLKSLTVGEMAFICAIPNNPTLYDPLKHFDYTKGRQERLLKGLK
SAGVITDKELKKAVKQKIKLDVEKREDKYPDYVSYVNDEFTQLVSESEGYDKRLQKASGK
QKEKIENELSARVSTITKDGVKIYTALDPYMQNQVVAQMNSKLPYADVQGGAAVINHQTH
QVIALSGGKNYQKYDFNRAYQAYRQPGSSIKPLLDYGPYIEQTGATASSTIDASKFCSKD
YCPQNYNNRTYGTVTVDTAFKNSYNTPAIRMLDRVGIQKAFSYIEPYHFAKLVDSDYLLP
AALGGFTNGMTPLEMTKAYTTFGNSGSYTPSHAITKVTDLKGKTLYKWNDKSTQIFSVRT
NMQLKKLMSSVVKSGTGKKAYFKAPYIGGKTGTSNDYHDMWFVGLTDTYTMGVWVGKDTP
SSVEYLHSISPQLSIWKGTLQAAY
>PK3-2_02061 Staphyloferrin B transporter
MFGITFLMAFLVSPFWGRFGDKRGYKKILMATGTGIALSILLMGFVTSVYQLFFLRMAMG
LVTGFIPTSLAMISAQTPKSSAGKTLGTLQMGQVSGSLFGPLLGGMLADRFGFTYTFFIT
SFVIFSSVLLVLFGVKEQPLAEKAAKRASYTRKDVLSYIFHQPALWVMMLLTMLIQTGNF
SIQPLLALYVNELHGPVNLAFFSGMAFSATGLGSLLLARKWGDLGDRYGHRRILIGLLLA
ASFFFIPQALASSLSVLLVFRFLFGMAMGGLLPCITAAIRVQAPGSIQGEVLGYNVSFRF
LGNVLGPLLGGIISSHFTISAAFYVTAFLFFAGACMLWFMQKFRKDSYAKAS
>PK3-2_02062 hypothetical protein
MYKERKGTIIVVLAETKKFASHTMTKFFLRIEITSPSYYFGFLINYKETILNLKETKRLG
KFIIFRK
>PK3-2_02063 hypothetical protein
MTTNSLLIIDFEFTMPEGKYSPQNFFPEIIEAGIVKSVDGEVVETFSSYVRPKKFPKLTK
RCKSFLKITQKQVDEGMRFEDFIRKLNELDPEKNSTIITWGNMDMKVLKQNCMFNHIPFP
FKGEMRDLSLEYKNFFGDRTLTGLWKAAEEYGDSGTGTHHKALDDALTAHKLFKLVEQDK
QYLEKPKPPTIGERIDLSELFKRAT
>PK3-2_02064 Kinase-associated lipoprotein B
MSTFETGSIVKGFYKTGVYIGEITACRPQHYLVKIKAVLTHPAQGDLHHPKQADVPFFHE
RKALAYGEQTNIPHHMVKPYDGEVPDYAESLREAAAQLRAKLNADGSEWAKRSLKNLDVL
ENEYFNRP
>PK3-2_02065 Adaptive-response sensory-kinase SasA
MEILKDYLLHICFILFPILLYQVFWLGKPAILVPKINSGLVTLFACGASVLCIIFPIHEM
DYIQYGLQMIPVIICLFYISTASGLAVAAVVLCFELLFYEPSAIFVITLLPFLTIIPILF
QKKWPIMSKAKKLLLSLLIGCLEIFLFFASSWIFSALNILNFQKSGIFLYEAAVSGLFRS
SVLLLSIYIIESIAENIALRSQLIHSEKMTIVSELAASVAHEVRNPLTVVRGFVQLLFNE
ETLQNKSSADYKKLVLSELDRAQGIITNYLDMAKQQLYEKEVFDLSTLIKETSSLMVSYA
NYKSVTVESEAEPGLLVYGDATKLKQAVINLIKNSIEAVPHGKGIIHISAKRSGHTITID
ISDNGVGMTDHQMQKLGEPYYSLKTNGTGLGLTVTFSIIEHHHGTISFNSSFQRGTTVTI
KLPADLPH
>PK3-2_02066 Cystathionine beta-lyase PatB
MNFDKREKRLGTQSVKWDKTGELFGVTDALPMWVADMDFRAPEAITDALKERLDHGIFGY
TAPDQKTKDAVCGWMQNRHGWKVNAESIIFSPGVVTALSMAVQAFTEPGDQVVVQPPVYT
PFYHMVEKNGRRILHNPLQEKDGAYAMDFDDLGSKLSDPSVKLFILCNPHNPSGRSWSRE
VLLKLGELCLQHGVTVVSDEIHSDLMLYGHKHTPFASLSDDFAEISVTCAAPSKTFNIAG
LQASALIIPDRLKRAKFSASLQRNGLGGLNAFAVTAIEAAYSKGGPWLDELISYLERNMN
EAEAFLSTELPKVKMMKPDASYLIWLDFSAYGLSDAELQQRMLKKGKIILEPGTKYGPGG
EGFMRLNAGCSLATLQDGLSRIKAALA
>PK3-2_02067 hypothetical protein
MEESQAVREMIKIISKWDPFKYGEDFYETEAVDVVQAVYDEDDPDMLAKSIQHIFEASFE
QTLPIDSCREVAGQLLFIKDSSSCTP
>PK3-2_02068 2-hydroxy-6-oxononadienedioate/2-hydroxy-6-oxononatrienedioate hydrolase
MEAVSPIRRLTVDGVNVYYEHYQNPGRQTLVCVHGFLSSAFSFRKVIPLLRDKYDIIALD
LPPFGQSEKSRTFIYTYQNLAKLVIGMLDHLQVKQAALVGHSMGGQIALSAALQKPELFS
KVVLLCSSGYLKRSHPTIIFGTHLPYFHLYIKRWLSKEGVMKNLLNVVHDKALIDEEMID
GYGRPFQDEEIFKAMTRFIRHREGDLEPEQLKKMNKPALLIWGEEDRIVPVEIGKRLHGD
LPDSVLYSLGQTGHLVPEERPEFVSEHIAEFIK
>PK3-2_02069 hypothetical protein
MKLTEKETEILEILDENSRADLETIAKMAGIPVNEVQTIIDKLEKEKVIIDYSAMIDWRK
VDGHEGVTAMIDVKVTPKRGVGFDEVAERIYRFQEVESVYLMSGVYDLSVVIRGNSMSDV
ARFVSDKLSTLDSVVSTTTHFILKKYKHDGKVFETGDDDKRIVVSP
>PK3-2_02070 putative N-acetyl-LL-diaminopimelate aminotransferase
MEGVISLGVGEPDFVTAWNVREASILSLEQGYTSYTANAGLYSLREEISRYLSSRFDLSY
SPDNELIVTVGASQALDIAIRAIVNPGEEVIIPEPCFVAYDALVSLAGGIPVHVHTTAEK
GFKATAADFEAAVTEKTKAILICSPSNPTGSVYSKEELNEIAEFAKKHDVIVLADEIYAE
LTYDEEFTSIAALPEMKERTVVISGFSKAFAMTGWRLGFAAAPSVLRDAMLKIHQYAMMC
APAMAQFAALEGLKNGMEDVEKMKKSYRRRRNLFVETLNEIGLSCHHPGGAFYAFPSIKS
TGMSSEQFAEELLTQEKVAVVPGSVFGPSGEGYIRCSYATSIEQLQEALVRMKRFLHKTT
>PK3-2_02072 General stress protein 13
MAAKFEVGSVYTGKVTGLQAYGAFVALDEETQGLVHISEVTHGFVKDINEHLSVGDEVQV
KVLAVDEEKGKISLSIRATQAAPEKKESKPRKPKAAQVSEEASAPQGFNTLKDKLEEWIE
MSNRKDLIKK
>PK3-2_02073 hypothetical protein
MSTIQRICLVLTIIGAINWGLIGFFQFDLVAAIFGGQGSALSRIIYGLVGIAGLINLGLL
FKPNEERSREEAANPEMR
>PK3-2_02074 Long-chain-alcohol dehydrogenase 2
MQNFTYWNPTKLIFGRGEVERLPEELKPYGKNVLLVYGGGSIKRSGLYDQVIEQLNKAGA
TVHELAGVEPNPRVSTVNKGVAICKEHNIDFLLAVGGGSVIDCTKAIAAGAKYDGDAWDI
VTKKHQPKDALPFGTVLTLAATGSEMNSGSVITNWETKEKYGWGSPLVFPKFSILDPVNT
FTVPKNHTIYGMVDMMSHVFEQYFHHVSNTPYQDRMCESLLRTVIETAPKLINDLENYEL
RETILYTGTIALNGMLSMGARGDWATHNIEHAVSAVYDIPHAGGLAILFPNWMRHTLSEN
PARMKQLAVRVFDVEEAGKTDEEIALEGIDKLSAFWSSLGAPNRLADYDINDEQLDTIAD
KAMANGTFGQFKSLNKEDVLAILKASL
>PK3-2_02075 Long-chain-alcohol dehydrogenase 2
MENFTYYNPTKLIFGKGQVEQLRKELKQYGKNVLLVYGGGSIKRNGLYDQVTDLLKEEGA
VVHELSGVEPNPRLATVEKGIALCREHDIDFLLAVGGGSVIDCTKAIAAGVKYDGDAWDI
FSKKVTAKDALPFGTVLTLAATGSEMNPDSVITNWETNEKYVWGSNVTHPRFSILDPKNT
FTVPENQTVYGMVDMMSHVFEQYFHNVENTPLQDRMCFAVLQTVIETAPKLLEDLENYEL
RETILYAGTIALNGTLQMGYFGDWASHTMEHAVSAVYDIPHAGGLAILFPNWMRYTLDTN
VGRFKNLMLNMFDIDTEGKTDKEIALEGIDKLSAFWTSLGAPSRLADYDIGEDKLELIAD
IAAKEMEHGGFGNFQKLNKDDVLAILRASL
>PK3-2_02076 Glucose-6-phosphate isomerase
MTHVRFDYTKALTFFNEHELTYLRDFVKTAHHNIHEKTGAGSDFLGWVDLPEHYDKEEFA
RIKKSAEKIKSDSDVLLVVGIGGSYLGARAAIEALNHAFYNTLPKAKRGNPQVIFIGNNI
SSSYMRDVMDLLEDVDFSINVISKSGTTTEPAIAFRIFRKLLEEKYGKEEAKARIYATTD
KERGALKTLSNEEGFESFVIPDDVGGRYSVLTAVGLLPIAVSGVNIDDMMKGALDASKDF
ATSELEENPAYQYAVVRNALYNKGKTIEMLINYEPALQYFAEWWKQLFGESEGKDEKGIY
PSSANYSTDLHSLGQYVQEGRRDLFETVLNVEKPKHELTIEEADNDLDGLNYLAGKTIDF
VNKKAFQGTMLAHTDGNVPNLIVNIPELNAYTFGYLVYFFEKACAMSGYLLGVNPFDQPG
VEAYKVNMFALLGKPGFEEKKAELEKRLED
>PK3-2_02077 hypothetical protein
MKQLVKHLIIAGFSAVVLSILISFDAVDTEFSSSFGGTLSHFFIHAFLLIGLPLALFTDA
VHRIMHLKRSHTFFTKLGLYAAVVYLSWESAAGLAAAMAVYFLIECAFFSAGRTRETMIS
M
>PK3-2_02078 hypothetical protein
MISIPSAIDGQSFLFQELEQVMKPLGYVINGGWEYDHGYFDYKIDDRDGYLFLRIPVNAV
QGSLDERGAAVRIGTPFMLRQVFQADLDDHAEGGPFQSLFNQFSEPERRDAEIDPAYLDI
GASLVKELEDVLLH
>PK3-2_02079 hypothetical protein
MKSNRIFISWLRWPLFIRIGVIILFLILLFGQIIYILEPKQFTSVFEGIWWAVVTVSTVG
YGDYVPHTPLGQAAGILLILSGASFVTAYFATLSAAAFSRQHRYIEGKVAYKGRGHIIII
GWNEKTNRLLKELQLAAPSKTVVLIDESLKEGPLIENVHFIRGHAADDETLRRANITEAE
SVMITADQYKSEAEADMLSVLILLSVKGLNPLAYCIAEILTDRFVTNAERAGANHIIGTS
EFISRAMLQHYQVKLRPSKQQNGINLTLDEHVKLLAVPDELKGAAYKSCVLYFLEQNTTI
IGVQKEEGPIISPPHTYKVLETDQFLAI
>PK3-2_02080 Protein mistic
MGHTVKKSTGVMEAMKVTSEEKEQLSTAIDRMNEGLDAFIQLYNESEIDEPLIQLDDDTA
DLMKQARDMYGQEKLNEKLNTIIKQILSISLSEEGEKE
>PK3-2_02081 hypothetical protein
MTIIQRTVVVLIGTQLAASAVILFIFDLNSYNHFSGSFSWLHFLKELAGSFAFYLFSAGL
FFLLIGMCAPSRKKKRISVHGKENSLK
>PK3-2_02082 hypothetical protein
MLFIFLTIAALGLSFWAQFKVKSNFEKYSKVEASSGRTGAETARRILDINGLYDVPVEPV
RGTLTDHYDPTRRVVRLSEPVYYGRSISAISVASHEVGHALQHQESYGALVLRHKIFPVV
NFASGVAPLLFLGGMLLGSLNLIGLGIILFSAAVFFQLITLPVEFNASSRAKQIIVSEGF
IRNNEENGVNKVLSAAALTYVAAALVSLFELLRFVMIFLNGRNEN
>PK3-2_02083 hypothetical protein
MLILQLMAIFVLIGITAVFVAAEFAIVKIRGSKINQLIESGDSRALAAHKIISNLDEYLS
ACQLGITITALGLGWLGEPTFERILHPLFTMAGIPQPFNHIVTFVVAFIIVTFLHVVMGE
LAPKTVSIQKAEAVSLWIAKPLIWFYKITYPFIKALNGSASFLVKLFGFHSVKEHEVVIS
EEELRLILSESYEKGEINQSEFRYVNKIFEFDNRVAREIMIPRTEIAVISLEQSLEEAIH
HIINERYTRYPVIKEDKDHILGIINSKDMFKAYFLGQPIKLKQIMRPVIRVIESIPVQQL
LIRMQKERIHMAILVDEYGGTAGLVTVEDIIEEIVGEIRDEYDQDETPHILKKGEHHYVM
DGKALIDEVNDLLDIAIENEEIDTIAGWLLTQKMELEAGDVIHAEGCEFKILDAEDHHIR
FIEIKKTDFL
>PK3-2_02084 Oligo-1,6-glucosidase
MKKAWWKKAVVYQIYPRSFKDSNGDGIGDIQGIRSKLHYIKELGADVIWICPLYDSPNAD
NGYDIRDYENILSDFGTMADFDQLLDDIHKLDMKLIMDLVVNHTSDEHPWFIESRSSIHS
EKRDWYIWKDGKNGKAPNNWESIFGGPAWQYDQKTRQYYLHLFDQKQPDLNWENEKVRNA
VYDMINWWLDKGIDGFRVDAITHIKKKEGFPDMPNPKGMDCVPSFPYHMNVEGIMGLLRE
LKENTFSRYPIMTVGEANGVAAKEAADWAGEKTGIFNMIFQFEHLGLWDVEINESIDIVS
FKRILTDWQDSLEGIGWNALFMENHDQPRSVSVWGDDGVHLKESAKALASVYFLMKGTPF
IYQGQELGMTNVAFPSIKDYDDVAMKRMYETETAKGASHEDVMKIVWKKGRDNSRTPMQW
NADPHAGFSKAKPWIGINENYKWLNAEAQKNDQTSVFHFYKSLIKLRQTYDVFINGTYEL
ILPEDQQIFAYLRKNESHTALVAANLTGTPALFKHSGLPLSSDGLVLANVETEQHRHMTS
VLLKPYEARIYVWLR
>PK3-2_02085 hypothetical protein
MLKTLQIKTAKRDEMIEITREVEAFLQETGVTSGAAMIYCPHTTAGITINENADPDVKKD
MLRRFDEVYPWEHNLDRHMEGNTAAHMKSSTIGASQHVIIANGRLILGTWQGIYFCEFDG
PRTRTCYIKIMGE
>PK3-2_02086 hypothetical protein
MMNILQYSYKKRGKIEFVFEGWPHSKVTMAPIKGYYFVRFIKWSSQDPIVTRNDLEKMEW
AANQYFGTAPFYRKRKAFETPSSRK
>PK3-2_02087 Protein-glutamine gamma-glutamyltransferase
MIIVSGQWLRPQDIENWQIEENLNPLLKEMIETPVQFDYHSIAELMFELKLRMNIVATAK
KLYKSGAKFATFLKTYGNTAYWRVSPEGALELKYRMPPSKAIRDIAENGPFYAFECATAI
VVIYYLALIDTIGEEKFDASFENIILYDWHYEKLPIFTETGHHYFLGDCLYFKNPEFDPQ
KAQWRGENVILLGEDKYFAHGLGILSGQQIIDKLNSFRRKGAVQQAYLLPQATRLDVPSL
YRIVR
>PK3-2_02088 Methyl-accepting chemotaxis protein McpB
MKTFINWLKKPSISRKLIVSFIAILIIPILILEFSSYLSASGKLDQEIMGNAKNSVDTFN
TTVTNDLGAKAKAVTFFSESLKSSAFKGKSNQEELKAKFSQYVSINQGVARIYGGSENGT
YVQAPKEQLPDGYDPRQRPWYQDAVKAGGEIVVTDPYVAASDGSMVITIAQELKDGSGVV
AMDITIDKLLEQMKQIKVGKEGYVFIATKNKTYVAHQDHKAGEKLSGDWVAKMYANNSGE
LQYTLDNEDKKMTYTTNELTGWKIAGTMYMSEIKDASKSVLITGMIVLIASIVAGGVLIL
FIVRSITKPLKRLVQSSKTISSGDLTETIEIRSKDELGELGESFNEMGQSLRSLISAIQD
SVNNVAASSEQLTASAGQTSKATEHITMAIEQFSNGNEEQSEKVESSSHQLNLMNEGLQQ
VSQTSSDITKASIQSTEIAGTGEKFVQQTVGQMNSINQSVQQAEAVVKGLEGKSKDITSI
LRVINGIADQTNLLALNAAIEAARAGESGRGFSVVAEEVRKLAVQSANSAKEIETLIQEI
VAEIETSLHMFKEVNQEVQSGLVVTDNTKESFQSIFSMTNEIAGKLQTMNSTVEQLSARS
QHVSAAVSGIADVSKESSASIQDIAASAEEQLASMEEISSSSTTLAQMAEELRDLTKQFK
IE
>PK3-2_02089 Methyl-accepting chemotaxis protein McpA
MKKTLTTIRRSSIARRLIISFLLILIVPITVLSVIAYQSAVASLDIQMTQSAKENVQILD
HIIDDKISTTEKSLAFFSDWATADKFKDKKKTELKQEFKQFIQMNDNVAAIFSSSKDGDF
TRYPYADMPSDFNALDRDWYKEAMANKGKTIVTEPYESISSGKMVVTIARQAEDGSGVVA
IDMKIDDLVTTAKGINIGKDGYAFILSQNKKVIAYSGEKAGSELKGDWVDKLYKDKNGDF
EYTYEGKEKKMVFATSETTGWKISGTMYSDEIRDAASKVLTMASIVLAIAIAAGITAIYF
VIRSITKPLRRIVTSAEKISEGDLTETIEINSKDELGVLSQSFNHMAHSLRSLIHGIKDS
VEHVASSSEELTASADQTSRATEHITMAIEQFSNGSESQSDKIETTTEQINEMNDGLAEL
ARAAVVITETSADSTELSSKGETLVQKTADQMNTIDHSVKKAEQVVKGLEIKSKDITNIL
RVINGIADQTNLLALNAAIEAARAGEYGRGFSVVAEEVRKLAVQSADSAKEIESLISEIV
KEIHTSLNVLQSVNNEVETGLVMTDETKQSFKHISNMTKEIASTLQNMNATVEELSAGAQ
EISAASNDITAISKESSDGIQDIAASAEEQLASMEEISSSAQTLEKMSEELRDLTKRFKV
DE
>PK3-2_02090 Methyl-accepting chemotaxis protein McpA
MKKILQLIKQRSITRKLLVSFLSILIIPVVILAVFAYQSASSSLDRQMMGSALENVQQLN
EIINTSIGEKENSAAYFSEWLTKERYNAKSNASIEEKFSQFISLNKDVESIYTSDENGRF
TRYPDLPMPSGYNPVERDWYKKAVANKGKVVITDPYKTASTNTMVVTIAQQTKDGSGVIA
INMTIENLLKTTKKVNIGKQGYAFIMTKDKKVVAHPDETSGTELKGDYLEKMLNADKGDF
QYTMDGDKKKLAFDTNKLTGWKIGGTMYLDEIHEAAQPVLHLALIVLAAAIILGIIVMTF
VIRSITTPLKQLVGSSKRISEGDLTETIDIRSKDELGELGKSFNNMASSLRSLIHAIQDS
VDNVAASSEELTASAAQTSKATEHITLAIEQFSNGNEKQNENIETAAEHIYQMNDGLTNM
AQASEVITDSSVQSTEIASEGGKLVHQTVGQMNVIDKSVKEAEQVVRGLETKSKDITNIL
RVINGIADQTNLLALNAAIEAARAGEYGRGFSVVAEEVRKLAVQSADSAKEIEGLIIEIV
KEINTSLGMFQSVNQEVQTGLDITDKTEISFKRISEMTNQIAGELQNMSATVQQLSASSE
EVSGASEHIASISKESSAHIQDIAASAEEQLASMEEISSSAETLSSMAEELRDMTKRFKI
E
>PK3-2_02091 Methyl-accepting chemotaxis protein McpA
MGKFIQWIKQPSISKPLIAAFLAVLILPVGVLAYFSYQSAWNALDRELTNSAMGNVEELN
STLQNKLNNKVKALDYYSETLDKNILQAKNKTLLNEKLKQYTTLNADVGAIYAASENKKL
YKYPNSGIPKGFDPTERDWYKQAVAKKGQAVFSEPYTDEATGDMVVTISEQLKDGSGVVA
IDLNLDEVLAASQRIKIGKEGFAFITTGSQKYIAHPTIKPGTVGSGDWTNEVYSKEKGSF
EYTFEGKDKKMAFTTNKLTGWKIGGTYFVSELQDASSPVLNTALIILCVSIVIGGILILL
IIRAITKPLRTLVTTSAKISSGDLTEVIDIHSKNELGQLGESFNEMSASLRSVIGVIQTS
VENVASSSEELTASAAQTSKATEHITLAIEQFSDGNEAQSEKLETSSNHLSQMNDGISKV
AQASSTITKSSIQSSEAAGSGEKLVEHTVGQMKTIDQSVQKAEAVVKGLETKSQDITSIL
NVINGIADQTNLLALNAAIEAARAGEFGRGFSVVAEEVRKLAVQSADSAKEIEGLIQEIV
REISTSLSMFQSVNHEVKEGLQITDKTADSFKQIYEMTTQISGELQSLNATVEQLSAGSQ
EVSSAVEDISAVSKESSAGIQDIAASAEEQLASMEEISSSAETLANMAEELQDITKKFKI
ES
>PK3-2_02092 3-phenylpropionate-dihydrodiol/cinnamic acid-dihydrodiol dehydrogenase
MVKHVWDSQHAAQLQKGVEELVYRSNLIGSDRTVCNWGGGNTSMKTTEKDFRGREIEVMW
VKGSGSDLAAMKAHNFTGLKLDDIRPLIERGHMSDEEMVDYLSHCMIDSKHPRPSIETLL
HAFLPYNHVDHTHPDAIISICCADNGKQIAEDIYGNRFVWVPYVRPGFTLSKMIAEGVAN
NPNAELVLMEKHGLVTWGETSETCYEKTVSIIQEAEQYINERINQHELFGGKRYQPLPEE
QRKQILAAIMPVIRGAVSEEKKMILSYDDHDDVLEFVNSVQASALSQIGAACPDHLVHTK
RAPLYIEWNPETQDVRKLADLIKSGVERFTSEYQAYFTRNQQEGDQIFESAPRVILIPGI
GMVNTGKSYAMAKVSGALYRRAIAVMKGSTALGHFVSLNENESYHVEYWPLELYKLTLAP
PEAEFSRKVALVTGGAGGIGSAACRRFAAEGGHVIAADLNIEGAQKIAGEINDAYGEGRA
MAVKMDVTKEEDVQSAFEQAALAYGGIDIVVNNAGLATSSPFDETSLKEWNLNMNVLGTG
YFLVAREAFKQMKQQNRGGSMVFVGSKNSVYAGKNASAYSSVKALETHLARCIAAEGGEY
GIRVNSVLPDAVLQGSAIWGSSWREERAAAYGIEPDQLEEHYRKRTALVVNIYPQDIAEA
IAFFASSKAGKTTGCMITVDGGVPAAFTR
>PK3-2_02093 Glucitol operon repressor
MLVAERQQKIVEIVNMRSSIRVSELSDIFSVTEETIRRDLEKLEKEHKLSRSHGGAVSIQ
QQESEVHFSEREITNVTEKKAIAHEAAKYVKSGDRIILDASTTAWHMAKILPNIKLTVIT
NSMKVAIELSNKENISVISTGGILLAKSLSFAGPLAERSLETYHVNKSFLSCKGFDINNG
MSDSNEWQALLKKRMIERSDQTILMADSSKWGNRELSHIVSLQDISRLITDSGIDRASVK
ALEDKEVKVTAVPLPKRG
>PK3-2_02094 Rhamnulokinase
MIYTAIDIGASSGRVMVGELKEGKLDIQEIHRFANGFIQRDGHCFWDIDHLLKHILQGLE
KVKALGYERCTVGIDTWAVDYVLLDETGNRLREVMSYRDRRTEHTIGKLKQNLSKETIYQ
KTGIQFQPFNTIYQLYEEDCELLKKTDKVMMVPDYLGYCLTGKAVTELTNASTTQLLNVS
TGKLDSELLEAVSVQGQQFAPLTEPGCELGTLRNDWFPDYDLPACKVITVATHDTASAVI
AAPGVNDGWAYISSGTWSLIGVENKTPILTELALKNNYTNERGANNTIRFLKNIIGMWVI
QEVRQQLQTDYSFQQLAEEARKTEPFQQFINLNDKRFLNPDSMIEEIQHYCKETRQKIPR
TAGELACCIYSNLAIIYAIAIKELETITAKQIQQLHIIGGGAQNDFLNQLTADMSGKAVY
AGPTEATAIGNLLMQMIAAKEIKDIKEARQTVRNSFPIKVFTPKDIDRSTTIQSFRQTVL
KALSKRLKR
>PK3-2_02095 L-rhamnose mutarotase
MKRKASIMFVHHDKYEEYKKRHDDIWPEMAEALKAHGAHHYSIFLDEETGRLFAYLEIED
EEKWRKMADTDVCWRWWKSMSPLMKTNPDFSPVSIDLKEVFYLD
>PK3-2_02096 L-rhamnose isomerase
MTIKANYDSAKQAYEKWGINVEDALRQLEQVPISIHCWQGDDIEGFEVNKGELSGGIDVT
GNYPGKAQTPEELRRDLEKALSLIPGKHRVNLHAIYAETNGEAAERDELKPHHFENWVKW
AKGLGLGLDFNPTLFSHEKAADGLTLSHPDSTIREFWIRHCIACRRIGEYFGKELGTPCL
TNIWIPDGYKDIPSDRLTPRKRLKESLDRIFAEEINEQHNLDSVESKLFGLGSESYVVGS
HEFYLAYALTNHKLCLLDTGHFHPTETVSNKISSMLLYTDKLALHVSRPVRWDSDHVVVL
DDELREIALEIVRNQALGKVAIGLDFFDASINRVAAWIIGTRNMIKALLYALLLPNGYFK
QLQEEGRFTERLALMEEFKTYPFGAIWDYYCEQMGVPVKEAWLHDIKEYEQQVLLKRETS
SPIV
>PK3-2_02097 scyllo-inositol 2-dehydrogenase (NADP(+)) IolU
MIRFAIIGTNWITDRFLDSAAEIEDFQLTAVYSRSAERAAEFAVKHGAERTFSDLQEMAA
SDCFDAVYIASPNALHKEQAVLFMNHGKHVLCEKPFASNAKETEEMISAAKENGVVLMEA
MKTTFLPNFKELKNHLHKIGTIRRFTASYCQYSSRYDAFRSGTVLNAFQPELSNGSLMDI
GVYCIYPAVVLFGEPQDVKANGYALSTGVDGEGTVILSYDGFEAVLMHSKISTSYAPAEI
QGEDGTIVIDTIHRPERVEIRYRDGRLENISIHDPKPAMFYEADEFVTLIKEKKLESEEN
TFERSLITAKIMEEARKQMGISYPADQA
>PK3-2_02098 hypothetical protein
METLQTWSGRFKRFFLDNKFVLFLLVLLLIGLNILVFTKTSYIFTPIIVLLKTISLPIIL
TGIVFYLLNPIVDFLERRRIRRIYSILLLYLLIIGLITITIVSIIPFLKEQIMSLIDNIP
RYVDIVENQTKQLIGSNFVNQAQQTMNINISDLATKVSDQAATIVNSTFTGVGNFIGALT
EIIISIVTVPFILFYLLKDGKKLPVYILKFVPTRLKEQTYTVLSEMNHRLSSYIRGQIIV
SFCIGFLLFIGYLIIGLDYASLLAIIAACTSIVPYLGPTIAITPAIIIAIVTSPLMLLKL
VIVWTIVQLIEGKLISPQIMGKNLHIHPITIIFLLLTAGKLFGVVGIILAIPGYAVAKVI
TTHLFDWFKMRSHLYDEEKMKIRRVIKCDFRL
>PK3-2_02099 Undecaprenyl-diphosphatase
MTLWELFVAAVLGIVEGLTEYAPVSSTGHMIIVDDLWLKSSDLMSEEAANSFKVVIQLGS
ILAVVIVFKDRILNLLGLKKNITNDQKQGHKLSIAQIAVGLVPAAVLGFLFEDYIDEYLF
SVKTVAFGLIAGAVLMLFADWVNKRKTATDTLDRISYKQAIGVGLFQCLALWPGFSRSGS
TISGGVILGLNHRAAADFTFIMAMPIMMGASFLSLVKHWDSLSSDLMPFFIVGFICAFVV
ALFVVRFFLKLINKIKLVPFAIYRIILGVILLLIMM
>PK3-2_02101 Cysteine dioxygenase
MELYECIQDLFSGLKNPSVKDLAAALKQIPNASKLSQPYIKEPDQYAYGRNAIFRNNELE
VIVIHIPPHKETAVHDHGQSIGCAMVLEGKLLNSIYRSTGEHAELSNSYFVHEGECLIST
KGLIHKMSNPASERMVSLHVYSPPLEDMTVFEEQRGVLENS
>PK3-2_02102 hypothetical protein
MKTKHYWVISLLAVLAVGPGLMSNTALSSVQGLVQKTVGTSDFTLVNPILIGNMAFALLV
PAGPLLRKKFGARPIYLASLPVFILGSLLFAFSSDIVWMAAGRFLQGAATGVMLMIMIPM
LVLSFPIDRRNYALLVLIGGFYGSVIIGTILGTIATSWGHWRWLFYIFGALSLIGVAVSY
FFLHDEHHGAAEQERPLDSAGIILSVCLAAVSAVTFIFLQKWGISSGYVWTGFGVAICLL
LVLLIVEYKAKNPFISIKLMLLPKPVLGLFIIAAGTITVAVSLSAFQGLLRQMYGISQEH
LILLNLTLLIGVAIAAISSALLYDRVGPGMLGIIGALILVFVNFQWLHMQDRSSLYMFAV
LFIMLAAGTGLTVAAGLMGAAMGGPLPDLVKRMTAVQFLRLFVYMGVPILIGFFTKKDAA
RQDSMIMAYHDLFFISFILSVLLVCLSFCMNATGMGHKLAHKPHDKAKPAPAKPAVKSHK
VIRDTEYRNALRNLQK
>PK3-2_02103 Exo-glucosaminidase LytG
MARKKLKKRRLFISLFFIVSIPLALFVLATTLSKPIETSKEPEEIDEQQVFIDSLSGHAQ
ILYEKYHVLPSITIAQAILESDWGNSELAAQANNLFGVKGNYKGHHVTMETDEVEKGKRK
TIRAKFRKYSTFFESMDDHAQLFVRGTSWNKKKYKPVLEAEDYKAAATALQTAGYATDPE
YADKISAIVEKYDLDEYDEVNPSLKSVDLNASIKDSAVQDVWSKPSTDDRSIKLTSAQSY
IGKDIKVVSKKQKGQSVWYQFQINDKLIGWIDDSAVEIKEAT
>PK3-2_02104 hypothetical protein
MQKYRRRNTVAFTVLAYFTFFAGVFLFSVGLYNADNLELNEKGYYIAVMILVAVGAILTQ
KVTRDNAEDNEIIAEQEKRQNQSHIES
>PK3-2_02105 Ktr system potassium uptake protein B
MTLQKDKVIKWVRFTPPQVLAIGFFLTIIIGSALLMLPISTTKPLSWIDALFTAASATTV
TGLAVVDTGTQFTLFGQMVIMGLIQVGGLGFMTFAVLVVMILGKKIGLKERMLVQEALNQ
PTIGGVIGLVKVLFLFSISIELIAALILSIRLVPQYGWASGLFASLFHAISAFNNAGFSL
WPDNLMSYVGDPTVNLVITFLFITGGIGFTVLFDIMKNRRFKAFSLHTKIMLTGTLILNA
VAMLVIFVLEYSNPGTLGHLHIGDKLWASYFQAVTPRTAGFNSLDIGSMREGTIVFTLLL
MFIGAGSASTASGIKLTTFIVILTSVIAYLRGKKETVIFRRSIKYPIIIKALAVSVTSLF
IVFLGIFALTITEQAPFIQIVFETFSAFGTVGLTMGLTPELTAAGKCIIIVIMFIGRIGP
LTFVFSFAKTEKSNIRYPDGEVFTG
>PK3-2_02106 Ktr system potassium uptake protein A
MGRIKNKQFAVIGLGRFGGSICKELHRMGHEVLAIDINEEKVNAYASYATHAVIANATEE
NELLSLGIRNFEYVVVAIGANIQASTLTTLLLKEFDIPNIWVKAQNYYHHKVLEKIGADR
IIHPEKDMGVKIAQSLSDENVLNYIDLSDDYSIVELLATRKLDSKSIIDLDVRAKYGCTI
LAIKHHGDIRLSPAPEDIIHEQDCLVIMGHKKDIKRFENEGM
>PK3-2_02108 Biofilm-surface layer protein A
MKRKLLSSLAISALSLGLLVSAPAASFAAESTSTKAHTESTMRTQSTASLFATITGASKT
EWSFSDIELTYRPNTLLSLGVMEFTLPSGFTANTKDTMNGNALRTTQILNNGKTVRIPLA
LDLLGAGEFKLKLNNKTLPAAGTYTFRAENKSLSIGNKFYAEASIDVAKRSTPPTQPCGC
N
>PK3-2_02109 HTH-type transcriptional repressor OpcR
MDENPEFAAIEQARDLVIDSIAETMDLYGITRSVGILYGTMYMRDEMTLDEMREELQMSK
PSMSTGVKKLQDLNVVKKTFHRGIRKHTFVAEKDFFKFFTNFFPPKWEREVQVNVAAIEE
AQADLQDVLNKEGLKEDIKNEALQLFEQLESSKAYYDWLKRLAESVQSGEIFKFIPIETK
>PK3-2_02110 Betaine aldehyde dehydrogenase
MSQTLYIDGEWICAEKEQIRTIINPFNQEEIATVSEGGREDAIKAIAAARKAFDKGEWSA
LSGLERGKIVLKIAELIRRDLDELAELESLDTGKTLEESKADMDDIANVFQYYAGLADKD
GGEIISSPIPDSESKIIREPIGVCGQITPWNYPLLQASWKIAPALAAGNTIVMKPSEITP
LTTIKVFKLMEEAGVPKGVANLVLGPGATVGDELAVNKDVDLISFTGGIETGKKIMRAAS
GNVKKIALELGGKNPNIVFKDADLEVAVDQALNAVFFHAGQVCSAGSRLLVEDAIHDQFL
TELVKRAKRIKLGNGFHAETESGPLISAEHRAKVEKYVEIGIEEGAKLETGGKRPEDPEL
QNGFFYEPTIFSNCKSDMRIVQEEVFGPVLTVETFSSEEEVIALANGTIYGLAGAVWSKD
IEKCERVAARLRMGTVWINDFHPYFAQAPWGGYKQSGFGRELGKIGLEEYTEVKHVYRNT
KPAAVNWFNS
>PK3-2_02111 Choline dehydrogenase
MTLNMKIESMQKFHTFEIPTVIKHGIGAVKHTGEEVAALGVSKALLVTDPGIYKAGVADP
VIESLKEAGIEVVLFHKVEPNPPVRLVNEGSELYKKENCNGLVAVGGGSSMDTAKAIGVE
ATHEGSVLDYEAADGKKPLENRIPPLTTIPTTAGTGSEVTQWAVITDEEREFKFNTGGPL
IAAHLTIIDPELHISMPPHVTAMTGIDALAHAIECYTMKFAQPITDAVALMAIEYAAHYI
KRAFADGEDLEARYGMAQAAMLAGLSYGSESAGAAHAMSQTLGGIIPVAHGQCVAAMMGP
VMEYNWKGYPEKFARIAKAFGIDTSKMTTEEAAKASVNWMYDLVEDLEVPALEEQGVSPD
MIERLSKEAMKDPQTFGNPRDLNEKAYNWIYKRCFNLTPKTV
>PK3-2_02112 Putative metal-sulfur cluster biosynthesis proteins YuaD
MWKRMTAKTKSVYIADTDSFVTKQMDKLDFDYGGIPGDLHFGLTKKAGAREPMFSRGTEI
FNRRQISIVSIEECDEIAFKMGVPSILPEWLGANVAVSGLPDLKRRKQAHFS
>PK3-2_02113 Putative metal-sulfur cluster biosynthesis proteins YuaD
MWQLAAYLILKEGSRLIFPSGAALLCEGENDPCIQPGEVIQSYYPDKPKLTPAFVRCALG
IRGIVCIVERPGAVYAGDEIEVHSYQRKVKPRKAERV
>PK3-2_02114 hypothetical protein
MSIFNEARLETWNEVKGLSDEELNQKPSAEEWSIREVLDHLKKIDMAAQKMLKERVKEAP
VKEIQEKPLEAAQDRNNKRKAPSQLEPEHDFISGTQMKRELDVVREQLTAVIASLKEEDF
ERVLPHPVFQELTVRQWIDFIGHHEKRHLSQIKEIKEKTERA
>PK3-2_02115 putative membrane protein YuaF
MELFGVPIQTVYLYTLITAGSLTLLFLFFGDVFAGLSEGIPFLNPTLVLAFFTFFSAGGY
IGELALPLSSMFIALFSCILSIMLVVLLHIFVLVPLSSAEESLAYKEDDLRGRVGKVVTA
VPVDGFGEVVIEGIGGTISKSAISFDNQQISYGTRVLVVDVNNGVLSVTPHEPM
>PK3-2_02116 Inner membrane protein YqiK
MTMPIIIIIGVVFFLLIALIAVFITKYRTAGPDEALIVTGSYLGNKNVHVDEGGNRIKIV
RGGGTFVLPVFQQAEPLSLLSSKLDVSTPEVYTEQGVPVMADGTAIIKIGGSIGEIATAA
EQFLGKSKDDREQEAREVLEGHLRSILGSMTVEEIYKNREKFSQEVQRVASQDLAKMGLM
IVSFTIKDVRDKNGYLESLGKPRIAQVKRDADIATAEADKETRIKRAEADKDAKKSELER
ATEIAEAEKINQLKMAEYRRDQDTAKANADQAYDLETARARQQVTEQEMQVKIIERQKQI
ELEEKEILRRERQYDSEVKKKADADRYSVEQSAAAEKTKQLAEADAKKYSIEAMAKAEAE
KVRIDGLAKAEAEKAKGETEAEVIRLKGLAEAEAKEKIAAAFEQYGQAAIFDMIVKMLPE
YAKQAAAPLSNIDKITVVDTGGSGESSGANKVTSYATNLMSSLQESLKASSGIDVKEMIE
NFSGKGNVKQSINELTNEIKEAKTIKKSE
>PK3-2_02117 hypothetical protein
MANVREAKLEDLKDIAKVHVDSWRTTYHGIVPAEYLNSLNYKEFEDKWKSRSLKGVFVAH
DEKGSIFGFASFGPIRSKQDGYDGELYAIYLLEERQRQGAGRALLVKGTEFLLQHGFSSM
FVWVIEENPSITFYQAYSPERVAEDSFEIAGQRLKEVGLGWPDLSALKTVLNE
>PK3-2_02118 Thiamine transporter ThiT
MNQSKQLVRLIEIAIMTAAAVILDIVSGMFLSMPQGGSISIMMIPIFLISFRWGVKAGLT
TGLLTGLVQIAIGNLFAQHPIQLLFDYIIAFAAIGISGCFASSVRKAAVTKTKGKLIVSV
VSAVFIGSFLRYAAHVISGAVFFGSYAPEGTPVWIYSLTYNATYMVPSFIICAIVLCLLF
MTAPRLLKTDKA
>PK3-2_02146 1,4-alpha-glucan branching enzyme GlgB
MAAASPTAHDVYLFHEGSLFKSYQLFGSHYRELNGQSGYEFCVWAPHASEVRVAGDFNSW
SGEQHVMHKVNDNGIWTLFIPGLGDEERYKYEIVTRSGEIKLKADPYAIYSEVRPNTASL
TYDLAGYNWQDQTWQKKQKAKTLYEKPVFIYELHLGSWKKHSDGRHYSYKELSRSLIPYI
KEQGFTHIELLPVYEHPYDRSWGYQGTGYYSPTSRFGTPHDLMKFVDECHQENIGVILDW
VPGHFCKDGHGLYMFDGEPLYEYQEERDRENWLWGTANFDLGKPEVHSFLISNALYWTEL
YHIDGFRVDAVANILYWPNQDERHTNPYAVAFLKKLNQTMREAYPHVMMIAEDSTDWPQV
TGAVEEGGLGFHFKWNMGWMNDVLTYMETPPEERRYCHQLISFSLLYAFSEHFVLPFSHD
EVVYGKKSLLNKMPGDYWQKFAQYRLLLGYMTVHPGKKLIFMGSEFAQFDEWKDTEQLDW
FLDSFPMHQKASVFTQDLLRFYRKSKILYEHDHRAQSFEWIDVHNDKQSIFSFIRYGKRH
GEALVIICNFTPEVYHQYDVGVPFLTQYIEVLNSDSEAYGGSGQINKKPLAAKEGALHHK
PCYITMTIPLTAFRFYGRLKNEER
>PK3-2_02147 Glucose-1-phosphate adenylyltransferase
MKKQCVAMLLAGGKGSRLSGLTKNMAKPAVSFGGKYRIIDFTLSNCSNSGIDTVGILTQY
QPLELNSYIGIGSAWDLDRYNGGVTVLPPYAESSEVKWYKGTASAIYENLNYLNQYDPEY
VLILSGDHIYKMDYGKMLDFHIEKKADVTISVIEVDWKEASRFGIMKTNADGTITHFDEK
PKFPKSNLASMGIYIFNWPLLKQYLEMDDRNPYSSHDFGKDIIPLLLEEKRSFLLIRLKD
IGRMLEQCRACGKPIWIC
>PK3-2_02148 Glucose-1-phosphate adenylyltransferase
MQSLWEANMDLLKEDSELKLFERNWKIYSVNPNQPPQFISSDAQVHDSLVNEGCAVYGNV
SQSVLFQGVTVGKHATVTSSVIMPDVTIGEHVVIENAIVPKGLVLPDSAVIRSEKDIQEV
LLVSEEFVEKELI
>PK3-2_02149 Glycogen biosynthesis protein GlgD
MFNNQMLGVIDETTYKHSLQALTAQRSLGAIPFAGRYRLIDFMLSNMVNADIRSVAIFPK
YRYRSLMDHLGAGKEWDLHRKKDGLFFFPSPHLHQEYDEFGSFRQFSDHLDYFHRSTQQY
AVISNSHTVCNIQFQYVLKRHQEVGCDVTEVCQDGQSLQIYIMSTALLKDLIYGHSEKGY
KTIQEAVEKESSSLTICPYEYSGYTAIIDSVEKYYTHSMALIQPRFWQQVFLPQQPIYTK
VKDEPPTKYGKHSSVKNSLVANGCVLEGEVENCILFRAVHVGKGTKLKNCIIMQKTQIGE
DCLLEQVISDKDVKIGNATEAAGTAEQPLVLRKGLVQGELMNS
>PK3-2_02150 Glycogen synthase
MKILLAVSECTPFVKSGGLADVAGALPKALSQLGNEVAVMLPKYSQIPERWKKRMKKAAE
CTVAVGWRQQYCGIEHLAEDGVNYYFIDNEYYFNRDSLYGHYDDGERFAFFSRAVLEAAE
AVNVQADIVHTHDWHTAMVNYLLKEEYKKHPFFERMKCVLTIHNLQFQGIFPPDVTHDLL
GLEMDHFHYERLECNGFVNFMKAGIIAADHVTTVSPTYRNEILTPYYGEQLEQVLRYREN
DVTGILNGIDDTFYHPKSDPYIEAHYDSEHLACKEENKTRLQRRMGLPERNDIPLISMVT
RLTKQKGLDLVRRIMHELLEEQDIQLIVLGTGEREFEDYFRYAEFAFYEKCRAYIGFDEP
LAHQIYAGSDMFLMPSKFEPCGLGQLIALQYGAIPIVRETGGLYDTVRSYQEEEGTGNGF
TFSAFNAHDLKFTIERALSFYRQKDVWKSITKTAMTADYSWEQSAKEYQRIFEHVTRSGR
DVLE
>PK3-2_02151 Glycogen phosphorylase
MFSSKERFAALFLKRLEMTCGKSFKDSAKLDQYKTLGNMVREYISADWIQTNEKSRSNSG
KQTYYLSIEFLLGQLLEQNLMNLGVRDVVEAGLKEVGINLEEILQIESDAGLGNGGLGRL
AACFLDSLASLNLPGHGMGIRYKHGLFEQKIVDGHQVELPEQWLKNGNVWEVRNADQAVD
VPFWGEVHMTEKNGRLHFRHEQATIVTAVPYDIPIIGYETGTVNTLRLWNAEPYAHYHGG
NILSYKRETEAVSEFLYPDDTHDEGKILRLKQQYFLVCASLKSIVNNYRKTNKSLSGLHK
RVSIHINDTHPALAVPELMRILIDEENMSWEEAWHITVHTISYTNHTTLSEALEKWPIHL
FKPLLPRMYMIIEEINERFCRAVWEKYPGDWKRIEDMAITAHGVVKMAHLAIVGSYSVNG
VAKIHSDILKEREMRDFHLLFPNRFNNKTNGIAHRRWLLKANPGLSAIITEAIGNEWVKQ
PESLIRLEPYASDPAFIEQFQTNKSRKKQELADLIFCTAGVVVNPDSIFDVQVKRLHAYK
RQLLNVLHIMYLYNRLKEDSGFSIYPQTFIFGAKASPSYHYAKKIIKLIHSVAEKVNYDP
AVKQLIKIVFLENYRVSMAERIFPASDVSEQISTASKEASGTGNMKFMMNGALTIGTHDG
ANIEILERVGSDCIYTFGLKADDVLSYQENGGYRSREYYQHDRRIRQVADQLINGFFEGE
ADEFESIYDSLLPHNDEYFVLKDFSSYADAQERIQADYRDRRKWSERSILNIAHSGYFSS
DRTIREYAKDIWGIQPMM
>PK3-2_02152 Tryptophan-rich protein TspO
MKKIVGAIAVFVITYALFSAAGYLFPIDQEWYNSLKKPDWTPSGSAIGIIWAILFALISL
SAAIVYAAFSFKNAKSFWLTLLMNYVLNQAFSYFQFTQKNLLAASIDCLLVAITALVLMI
ITKKYSRAASYLLLPYVLWSAFATFLSFTIYSMNL
>PK3-2_02153 Spore coat protein I
MAENQEVIEEGNSSELPLSAEDERKLTELAENVLQGWDIQAEKIDVIQGNQMALVWKVHT
GSGAVCLKRIHRPEKKALFSIFAQDYLAKKGMNVPGILPNKKDSLYSKHGSFLFVVYDWI
EGRPFELTVKPDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWK
LMAQMEKEDPFSQLYLQEIDSFIEDGLRIKDRLLQSSYVPWTEQLKKSPNLCHQDYGTGN
TLLGENEQIWVIDLDTVSFDLPIRDLRKMIIPLLDTTGVWDEETFHVMLNAYESRAPLTD
EQKQVMFIDMLFPYELYDVIREKYVRKSALPKEELESAFEYERIKANALQQLI
>PK3-2_02154 Spore coat protein SA
MKIALIATEKLPVPSVRGGAIQIYLEAVAPLIAKKHEVTVFSIKDPNLADRETADGVHYV
HLAEDRYEEAVGEELKNGRFDLVHVCNRPSWVPKLKKQAPDAVFILSVHNEMFAYDKISQ
AEGEVCIDSVAQIVTVSDYIGRTITSRFPSARSKTKTVYSGVDLKTYHPRWTKEGQRARD
DMRSELDLHGKKIVLFVGRLSKVKGPHILLQALPDIIEEHPDVMMVFIGSKWFGDNELNN
YVKHLHTLGAMQKEHVTFIQFVKPKDIPRLYTMSDVFVCSSQWQEPLARVHYEAMAAGLP
IITSNRGGNPEVIEEGKNGYIIHDFEDPKRYAEHINDLLSSSEKRERLGKYSRREAESQF
GWQRVADNLLSVYEKNR
>PK3-2_02155 Spore coat protein S
MYQKEHEEQIVSDILSYYPFQIEHVALKSNKSGRKIWEIQTDQGAKLLKEAQMKPERMLF
ITQAHAHLQEKGLPVAPIHQTKNGGSCLGTDQVSYSLYDEVTGKEMIYYDAEQMKKVMSF
AGHFHHASKGYVCTDESKKRSRLGKWHKLYRWKLQELEGNMQIAASYPDDLFSQTFLKHA
DKMLARGKEALQALDESEYENWTKETHEHGGFCFQDFTLARLTEIDGEPFLKELHSITYD
LPSRDLRILLNKVMVKLSVWDIDFMVALLAAYDAVYPLTEKQYEVLWIDLAFPHLFCAIG
HKYYLKQKKTWSDEKYNWALQNMISVEESKDAFLDKLPELYKKIKAYREAN
>PK3-2_02156 hypothetical protein
MRSSRQKASISKLDLDQFVFTPPGSMGWQAHDTNSAEKEEEEKHLAAGSIRELPNINAPN
KYQEEKKDKETDRKVIDDEEKKFETIRELEEEHDSKRSAPPIEEEEDLELDEELDEEPEQ
AEDDRVEIIILPSESAPAPWFSHTVKRKA
>PK3-2_02157 Spore coat protein SA
MKLAFICTEKLPAPAVRGGAIQMMIDGITPYFSTRYDLTIFSIEDPSLPKRETKNGVQYI
HLPKEHYREAVAEELRASSFDLIHVFNRPLNVSLYKKAAPNSKIVLSLHNEMFSEKKMTF
AQGKEVLANVSMITTVSEFIKQTVIERFPEAEDITKVVYSGVDIRSYPPVWTIKGSAVRE
AYRKKYGIEDKKVILFAGRLSPTKGPHLLIHSMKRILQQHPDAVLVIAGGKWFSDDGENQ
YVTYLRKLALPYREHVIFTKFIPADDIPNLFLMADVFVCSSQWNEPLARVNYEAMAAGTP
LITTNRGGNGEVVKHEINGLVIDSYNKPSSFAKAIDRAFTDQQLMNKITKNGRHRVESSF
TFAHAAKRLNAVYESILAPENKQLPPPFLTQNLDLSFINQLFVKAKS
>PK3-2_02158 UDP-N-acetylglucosamine 4-epimerase
MKILVTGAAGFIGSHLCEELLKDETHHVIGIDDFIGPTPFSLKLKNLEVLLPEKRFTFIK
ENLLTADLSPLLEGVDVIFHLAAIPGVRSSWGNHFHPYAAHNIQALQRLLEACREHPIQT
FIFASTSSVYGEKQGKVSEDASLSPLSPYGVTKLTGEKLCHVYQQSFGIPIVILRFFTVY
GPRQRPDMAFHRLIKQHLLQKPLTIFGDGQQSRDFTYIGDCIKGITAVLGKPRLIGETVN
IGGAERASVLKIASLIEDISGKKATLHFSDKIAGEPSKTWADISKAKQLLHYNPDTSLKD
GLANEIAYLSSLYQGESK
>PK3-2_02159 UDP-glucose 6-dehydrogenase TuaD
MKICVVGAGYVGLTLSAALASIGHDMICTDKDVKKIEQLKNGDIPFYEPGLSDAVNHCGN
LSFSSEVKSSMEECPVIFIAVGTPPRSDGSANTKALQSVISDLSDAITSYKTIITKSTVP
PGTNENIAKQLIASGVSESLFNIVSNPEFLREGNALHDMLHPDKTVIGIQEGDHVSAAIV
KSIYKHIDTPYIITSLAGAELIKYANNFFLAAKISFINEMARICEAYQSDISDISRAIGL
DPRIGGHFLQAGIGYGGSCFPKDLQALQFAAQEQNTETYLLQAVQNINDTQLGLYIKKIK
SFFDTLHGKKAAVLGISFKPHTDDIRNSQAVRLMERLTELGCHVHAYDPEAVLPEHLQQH
VTQHSQAFDAIEESDFLFLATEWPEFLAIDWKKAANTMKGRLVIDGRNVLKKELLEACGL
ICTGVGRP
>PK3-2_02160 UTP--glucose-1-phosphate uridylyltransferase
MIKKAIIPAGGYGTRNLPVTKVIPKEMFPVGSKPVIHYIVEELKESGIEDILMVVSSHKN
LIVDYFDSSLALEAFLASRHKLHLLSEHPIPDIRIHYVRQPYARGLGDAISFGKQFAGGE
PFAVVLPDDLIFSAHQPALGQMIEAYTQYQCSVIGLKETKTEDLHHYGVIKGESVGKGLY
RIQDIVEKPKQNPPSHFAAAGRYIFTPDIFDELKTLKADAGGEVQVTDAIKASLGACDVY
GKLLEGKRYDIGLQRDYLKLITDMMTT
>PK3-2_02161 RNA polymerase-binding transcription factor DksA
MLTKDQLQHLKHELEETKKDILNRFKDNDHFQLNSAFPYDSWGELSAYDNHPGDQATELY
EREKDIALDLHEREHLRDIEYSLKAIENGTYGICEVSGKEIPYERLEALPTATTLAEYSS
QDVVSKDRPIEEETPFGQFEFDDDEEIRAPYDSEDSYQDVEKYGNSSTPQDMENPPLSYD
DMTMNAEENIGNTESYENFIATDITGKEITVYQSRAHERYEEELDEEGIMTTFGDLHAD
>PK3-2_02162 Salicylate biosynthesis isochorismate synthase
MVSGYNLCYQWRKKFKVCFFFISEIRFIIGKAGHLDCMICVFDTKKTQVYGIKSILRIME
ECLMVTTVQRSFRKEVLHALHKAKEVNHAVLISYSRQIESLDPLSFFNYGAKKYTGNRFF
WSDPESELTIVGLGKEAVFQTNQKNSERYREVFEQWERFKKTAFHIYEEEKLQHSAVGPV
LFGGFSFDPCEERGKQWDHFSEGDFFVPALMLTVTAEGPFLTVNRWVSGEEEAEAVLEGL
KAFAADFMVPGFDQGNQTLITAFEEMDKDDWLKAIETATSQIKEKQYDKVVLARELLLTF
DGPVQIEPVLKTLLKDQQTSYVFAIEQEGKIFVGASPERLIKRDGSTVMSSCLAGSIKRG
RDEEEDRRIGLELLNDEKNLLEHDIVVGMIQNAFESSCSEIEKPDGPVLYKTKSVQHLFT
PIVGQLRESASLFDLIEKLHPTPALGGAPQKKAVEVIREIEPLSRGWYAAPIGWIDSQDN
GEFAVAIRSGLIEGSTARLFAGCGIVEDSDPQSEYEETQIKLKPMISALGGERR
>PK3-2_02163 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase
MTVNPITHYIGSFIDEFALSGITDAVVCPGSRSTPLAILAAAHPDISVHVQIDERSAGFF
ALGLAKAKRRPVLLICTSGTAAANFYPAVIEAHYSRVPIIVLTADRPHELREVGAPQAIN
QHFLFGNFVKFFTDSALPEESPHMLRYIRTLAGRAAGEAQKRPMGPVHVNVPLREPLMPD
LSAEPFGRMRTGRHVSVKTGTQSVDRESLSDVGAMLAEAEKGMIVCGELHSDADKENIIA
LSKALQYPILADPLSNLRNGAHDKSTVIDAYDSFLKDDELKSNLRPDVVIRFGPMPVSKP
VFLWLKDDPDIQQIVIDEDGGWRDPTQASAHMIHSNASVFAEAIMAELADVTRSSEWLEK
WQFVNRRFREHLQTISSEEVSFEGNLYRILQHLVPENSSLFVGNSMPIRDVDTFFEKQER
NFRIYSNRGANGIDGVVSSAMGVCEGTKAPVTLVIGDLSFYHDLNGLLAAKKLGIPLTVI
LVNNDGGGIFSFLPQASEKAHFEDLFGTPTGLDFKHAAALYGGTYSCPASWDEFKTAYAP
QADKPGLHLIEIKTDRQSRVQLHRDMLNEAVREVKKQWEL
>PK3-2_02164 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase
MGTVSITVPDGVRYAVTDERPNASEAVVCLHGFTGSKQSWSFLDAMLPDTRLIKIDCLGH
GETDAPLNQKRYSTSRQVSDLAEIFDQLKLHKVKLIGYSMGGRLAYSFAVAYPERVSALV
LESTTPGLKTLEERRDRIMRDRKLADFILRDGIKAFVQYWENIPLFSSQQRLAEDIRQRI
RSGRLRNNKIGLANSLTGMGTGSQPSLWSHVEKIAVPVLLLCGEWDKKFCAINQEVHKKL
PSSRIEVVPKAGHTVHVEQPRFFGKIVSGFLTSI
>PK3-2_02165 1,4-dihydroxy-2-naphthoyl-CoA synthase
MAAEWKTKRTYDEILYETYNGIAKITINRPEVHNAFTPKTVAEMIDAFADARDDQNVGVI
VLAGAGDKAFCSGGDQKVRGHGGYVGDDQIPRLNVLDLQRLIRVIPKPVVAMVSGYAIGG
GHVLHIVCDLTIAADNAIFGQTGPKVGSFDAGYGSGYLARIVGHKKAREIWYLCRQYNAQ
EAMDMGLVNTVVPLEQLEEETIKWCEEMLEKSPTALRFLKAAFNADTDGLAGIQQFAGDA
TLLYYTTDEAKEGRDSFKEKRKPDFGQFPRFP
>PK3-2_02166 2-succinylbenzoate--CoA ligase
MLTEQPNWLMQRAQLTPERIALIYGDQTVTFAELFAASKRMAEQLAAHSVQKGDTAAILL
QNRLEMVYAVHACFLLGVKAVLLNTKLSTHERLFQLEDSGASFLMTDSGFDKEDYEHTVQ
TIDVDQLMKGAAKEVEIQAYMQLDQTATLMYTSGTTGKPKGVQQTFGNHYFSAVSSALNL
GITEQDRWLIALPLFHISGLSALFKSVIYGMTVVLHQRFSVSDVLDSINRHQVTMISVVQ
TMLASLLEETSRCPETLRCILLGGGPAPLPLLEKCREKGFPVFQSYGMTETCSQIVTLSP
EFSMEKLGSAGKPLFSCEIKIERDGQACKPFEHGEILVKGPNVMKSYFNRESANEASFQN
GWLKTGDLGYLDSEGFLYVLDRRSDLIISGGENIYPAEVESVLLSHPAVAEAGVSGAEDK
KWGKVPHAYLVLHKPVSAEELAAYCKERLAKYKIPAKFFVLDSLPRNASNKLLRNQLKDA
RKGELL
>PK3-2_02167 o-succinylbenzoate synthase
MIEIEKITLYHLSMNLKKPFKNSIETLQERKFLIVEAIDTSGVTGWGEVSAFSSPWYTEE
TIDTCLHMLKDFFIPNVVGREFNHPSDIPDSLARYKGNRMAKAGLESAVWDIYAKKKGMS
LAEALGGTRDKVPAGVVVGLAPLENMLKEIESYQKEGYQRIKIKIQPGQDVELVKAIRSR
FPNIPLMADANSSYELKDISRLKELDEYHLMMIEQPLQADDIVDHRHLQKHLKTPICLDE
SICSADDARRAIELGSCKIINIKPSRVGGLTEALKIHDLCKEHHMQVWCGGMLETGISRA
QNVALASLPQFTIPGDISSSSRYWDEDIVTPDIRIENGFISVSKQPGLGVEVNQDIMRKY
VTKMDVFTQHG
>PK3-2_02168 Manganese-binding lipoprotein MntA
MKQGLMAAALLACFALTGCGTDSAGKSADQRLQVTATTSQIADAAENIGGKHVKVTSLMG
PGVDPHLYKASQGDTKKLVSANVVLYSGLHLEGKMEDVLQKIGEQKQTAAVAEAIPKSKL
ISAGEGKTFDPHVWFSIPLWIYAADEIEAQFSKAMPEHADDFQKNAKEYKKDLQYLDKWA
RREIANIPEKSRVLVTAHDAFAYFGKEYGFQVKGLQGLSTDSDYGLKDVQELVDLLTEKH
IKAVFVESSVSEKSINAVVEGAKEKGHTVTIGGQLYSDAMGEKGTKEGTYEGMFRHNINT
ITKALK
>PK3-2_02169 Manganese transport system ATP-binding protein MntB
MFPVELDNVTVAYHKKPVLQDISLQVPEGKLIGIIGPNGAGKSTLIKTILGLVPRASGDI
SIYGKDYKHQRTRIGYVPQRGSVDWDFPTNALDVVLMGRYGRIGLLKRPKKADVELAKAA
LAKVGMLDYAKRQISQLSGGQQQRVFLARALCQDADIYFMDEPFAGVDAATERAIMTLLA
ELKEKGKTVLVVHHDLQTAEDYFDWILLLHLRKIAFGPAENVFTIENLQKTYGGRLTFLK
DKVLAEGQKG
>PK3-2_02170 Manganese transport system membrane protein MntC
MSALFESLWLQLQHPNTQWVLAGTLLLGAASGVLGSFVLLRKQSLIGDAMAHSALPGVCL
AFLFTGQKSLPIFLLGAALAGLLGTWCIQLIPRLSKTKEDSAIGIVLSVFFGVGIILLTY
IQQQGAGSQSGLDSFLFGQAASLVRQDIMLIAGISAVLLLLCIVFFKEFTLITFDLAFAK
GLGMPVRFLNGLLACLIVCAVVIGLQTVGVILMAAMLITPAIAARYWTERLTGMMVIAAA
AGGVSGVAGTLLSTTMKGMATGPLMILSATSIFLFSMICAPKRGLAAKAIRLIRLRRKTS
REQVLLTIYEQYEKNELYVTAESIREKRRLSLSLCRKVLNDLEKERCIVRIENGVWQMTP
TGIEKGYHTALKHRMYEVYLMHEMELANIEIDQDHFVPDRLPEETRERLFSLLKLYGRMP
ELRNAPADAEKGQIANEF
>PK3-2_02171 Manganese transport system membrane protein MntD
MSFEAWIIATGVLVGVSCALIGTFLVLRRMAMLADAISHTVLLGIVSAFLVTGSLDGIPM
FIGAAVSGLLTAFLVQLLHSKGVQSDAAIGVVFTSLFAVGVILLSVYGANVHLDIEHSLM
GEIAFVPWNTITAFGVDIGPKAFWMLASVLVLNVLLIGVCYKEFKIASFDPQMALALGIP
VLLIHYVQMGMLSLTTVASFDSVGAVLVVAMLIVPPAAAHLLTDRLLSMLILSALIGGLS
AVAGYFFATWLNVSISGAMAAMTGVCYAGAFLFSPLNGVVTRKLRTLNMQKERAG
>PK3-2_02172 hypothetical protein
MEQKILCEVNNCSYWGKGNKCTADAIYVVSHTGETAENSKETDCKTFKPHDL
>PK3-2_02173 Putative cytochrome bd menaquinol oxidase subunit II
MDISTDALIAISIIWGFVFIYAVMATMDFGAGFWSMIYLNKEHMKATDIANRFLSPTWEV
TNVFIVAIVVALFSFFPGATFVLGTVLLIPGSMILLLLAIRSGFLVFSNTAKERKTLRYI
SGISGFIIPAVLILVLPVTHGGFIEKTDGIYNLNMSKIFSSPNAYSFIGFAILSTLFLSS
LLLADFSNVAEEQDAYRAYRKSAMITGPISLLFAVCIMLTMRNEANWLYNGMLNDFSWII
ASFITFVIAGIALFLPNKSFGHNIGKPRLALIAIAIQYFLASYAYGRAHLPYMIYPDVTV
MSGFTEPATFRALFATYIVAFIILFPGFYFFWKMFMRDKRYIRQEE
>PK3-2_02174 Putative cytochrome bd menaquinol oxidase subunit I
MDDLVLARSLFGTTMGFHIIFATLGVGLPLMILVAELIYQKTKDDHYAIMAKRWTKAQAV
LLGVAIPTGTIAGTQLALLWPGFMEVIGRVMSLPFQIEIYAFFVEALFMSIYVYAADRLS
PAMRIVAVFFVLVGAAASAVLITNVHAFEGTPAGFKILNGKITDVDPWAAFFNPSFFITA
GHVVLSAFMTGAFIVASVAAYKMIRTRKKEKVYRFHRKALLLALTIGGIFSLLTALNGHE
SAQMLYEYQPEKLAGAEGLFETRSHAPLAIGGFTDPNEEKVKWAIEIPWALSFLAANRFD
TVVKGLNAFPRDEWPPLFIHTLFNAMVGVGMLLILYSIIGVVWRKVLKKDRFPTWLLVIF
MTAGPFSLIGIEFGWIFACTGRQPWVIYHLLKTSDVVTTTGSIGVLFLFFTFVYAVLGAA
VVYVLLYYFRKHPVDEDLNTAES
>PK3-2_02175 50S ribosomal protein L31 type B
MKEGIHPKNHKVIFQDVNSGYRFLSTSTKTSNETAEWEDGNTYPVIKVEVSSDTHPFYTG
RQKFNEKGGRVEQFKKRYNMGK
>PK3-2_02176 Carbon disulfide hydrolase
MSLLSDILEFNKTFTEQKEYEKYQTSKFPDKKVAILSCMDTRLVELLPHSMNMRNGDVKI
IKSAGALVTHPFGSIMRSLLVAVYELNADEVCVIGHHDCGMSKISSESMLNRIKERGIPD
ERIETLKYSGVDFDQWFKSFDSVEASVKDSVEVIKHHPLFPENVPVHGLVIDPETGKLDL
VVNGYNA
>PK3-2_02177 S-ribosylhomocysteine lyase
MPSVESFELDHNAVVAPYVRHCGVHKVGTDGVVNKFDIRFCQPNKQAMKPDTIHTLEHLL
AFTIRSHAEKYDHFDIIDISPMGCQTGYYLVVSGEPTPAEIVDLLEDTMKEAVEITEIPA
ANEKQCGQAKLHDLEGAKRLMRFWLSQDKEELLKVFG
>PK3-2_02178 hypothetical protein
MKKMWVVLLFSAFLLNGCGSGEDKANTAETPEVLDVKLTGPEKVNPGESAAYEAAVSYGD
EAVTDADEVEFEVWKEGEKDASQMFKAKQEKGVYRLDTTFKEDGVYTVQSHVTAKKQHSM
PTLKVQVGDADAASDHSKDEPSHHH
>PK3-2_02179 hypothetical protein
MSLTLLITVSILIVLAVLLVTIWTTVKAYNVKHTIDPPQETRSDSKNQ
>PK3-2_02180 General stress protein 20U
MSEQLIQAVNKQVANWTVMYVKLHNYHWYVKGKDFFTLHEKFEELYNETATYIDDLAERL
LALNGKPIATMKESLEKASVKEAEGNETAEQMVQSVYDDFTVIAEELKNGMDLADKVGDE
TTGDMLLAIHQNIEKHNWMLKAYLG
>PK3-2_02181 hypothetical protein
MDRDFGIFSFLAVSVSAAGFFFGGFQYSFLILLSLMAIEFISTTLKETIIHKLAFKKIFA
RLVKKLVTLALISVCHFFDQLLNTQGSIRDLAIMFYILYESVQIVVTASSLGIPVPQMLV
DLLETLKNKFKRKP
>PK3-2_02182 Putative 8-oxo-dGTP diphosphatase YtkD
MYEFKDYYQNTVQLSFDDQPFSDSPKHVWVICRFGGKWLLTEHEDRGYEFPGGKVEPMEC
AEEAALREVKEETGARVKSLKYLGQYKVLGKEKVIVKNIYFADIEKLEKQADYFETKGPV
LFHELPENLSRNKKFSFIMKDSVLPISLKKLKESGWIE
>PK3-2_02183 Putative aliphatic sulfonates transport permease protein SsuC
MRNSKETIDLLHEQYRFKQKKEKWNVHSFQLAIFILFFSGWEISSRLGWIDPLIFSSPSA
VWRLLLEKLSDGSLLSHIGVTLFETVLGFLLGTFMGTCLAALLWWSSRLARVLDPYLVIL
NAMPKVALGPILIVALGPSFISIIAMGAIISVIITTIVVYTAFQEVDENYIKVMKTFGAK
KWIIFKEVILPASSPAIISTLKVNVGLSWVGVIVGEFLVSKVGLGYMIIYGFQVFNFTLV
FLSLLIIAIFATLMYQGVELLEKKWTKGRT
>PK3-2_02184 Aliphatic sulfonates import ATP-binding protein SsuB
MSFLHVDHVTHTYFSVKEKTTAVRDIHFDAEKGDFISFLGPSGCGKTTLLSIIAGLIEPS
EGRVLIDGREPNQKEHNIGYMLQQDYLFPWKSIEENVLLGLKIADTLTEESKAAALGLLP
EFGLIDVEKKYPKELSGGMRQRAALARTLAPDPSLLLLDEPFSALDFQTKLSLENLVFRT
LKEYQKTAVLVTHDIGEAIAMSDTIFLFSNQPGTIHQIFTIPKELAAMIPFDARQEPSFQ
TLFQTIWKELNSLEKQQRNH
>PK3-2_02185 hypothetical protein
MLNKEVVYVNKWLRLGCACVGSIFLMIALTACKQEETLTKVKVAEVTHSIFYAPLYVAES
KGFFKEEGLDVDVNTTWGGDKTMTSLLSNGSDIALVGSETSIYVEAQGAKDPVINFAQLT
QTDGTFLVAREDAEHFDWNQLEGKTFLGQRKGGMPQMVGEYVLNKHKIDPHKDIDLIQNI
DFANIANAFASGTGDYVQLFEPQASLFEKKGIGHIVASFGEESGQVPYTTFMAKQSYLKK
HEDTAVKFTKAIYKAQQWVENHSAKDITDAIKDEFDDTDPDVIETSIERYKKQHSYSPDP
LLNEKEWELLQTIMDQSGELPKHIPYNKLVNKQIAEKVTSEK
>PK3-2_02186 hypothetical protein
MIVEKRRFPSSSRHVRLYTICYLSNGLRVKGLLAEPAAPGQYDGFLYLRGGIKSVGMVRP
GRIIQFASQGFVVFAPFYRGNQGGEGNEDFAGEDREDAFSAFRLLQQHPNVKKDRIHIFG
FSRGGIMGMLTAIEMGRHAASFVSWGGVSDMILTYEERQDLRRMMKRVIGGTPKKVPEEY
KWRTPFDHVDKIQAPVLLIHGEKDQNVSIQHSYLFEEKLKQLHKPVETWYYSKFTHYFPP
KENRRIVRQLTQWMKNR
>PK3-2_02187 putative protein YtmB
MGMPVEFNTLIVTKGNEVRIDENIFTLEKDGYRVYPMEIPMDVRKTKFGEKSGTAEVQKL
QWEDGRTIITYKLTSLHSVN
>PK3-2_02188 Phosphoenolpyruvate carboxykinase (ATP)
MNSVDLTADLQALLTSPNVRHNLSAAQLTEKVLSRNEGILTSTGAVRATTGAYTGRSPKD
KFIVKEEGTKNKIDWGTVNQPISEEAFERLYTKVVSYLKQRDELFVFEGFAGADEKYRLP
ITVVNEFAWHNLFARQLFIRPEGNDKKTVEQPFTILSAPHFKADPQTDGTHSETFIIVSF
EKRTILIGGTEYAGEMKKSIFSIMNFLLPERDILSMHCSANVGEKGDVALFFGLSGTGKT
TLSADADRKLIGDDEHGWSDTGVFNIEGGCYAKCIHLSEEKEPQIFNAIRFGSVLENVVV
DEDTREANYDDSFYTENTRAAYPIHLIDNIVTPSMAGHPSAIVFLTADAFGVLPPISKLT
KEQAMYHFLSGYTSKLAGTERGVTSPETTFSTCFGSPFLPLPAHVYAEMLGKKIDEHGAE
VFLVNTGWTGGGYGTGERMKLSYTRAMVKAAIEGKLEDAEMMTDDIFGLHIPIHVPGVPD
HILQPENTWNNKEEYKEKAVYLANEFKENFKKFAHTDAIAQAGGPLV
>PK3-2_02190 S-adenosylmethionine synthase
MSKNRRLFTSESVTEGHPDKICDQISDSILDEILKKDPNARVACETSVTTGLVLVSGEIT
TSTYVDIPKTVRQTIKEIGYTRAKYGFDAETCAVLTSIDEQSADIAMGVDQALEAREGTM
SDEEIEAIGAGDQGLMFGYACNETKELMPLPISLAHKLARRLSEVRKEDILPYLRPDGKT
QVTVEYDENNKPVRIDAIVISTQHHPEITLEQIQRNIKEHVINPVVPEELIDEETKYFIN
PTGRFVIGGPQGDAGLTGRKIIVDTYGGYARHGGGAFSGKDATKVDRSAAYAARYVAKNI
VAAELADSCEVQLAYAIGVAQPVSISINTFGSGKASEEKLIEVVRNNFDLRPAGIIKMLD
LRRPIYKQTAAYGHFGRHDVDLPWERTDKAEQLRKEALGE
>PK3-2_02191 Asparagine synthetase [glutamine-hydrolyzing] 1
MCGFVGVFNKHPLAQTADQEELIKQMNQMIVHRGPDSDGYFHDEHVGFGFRRLSIIDVEN
GGQPLSYEDETYWIIFNGEIYNYIELREELEAKGYTFNTDSDTEVLLATYRHYKEEAASK
LRGMFAFLIWNKNDHVLYGARDPFGIKPLYYTTINDQVYFASERKSLMVAQNDIEIDKEA
LQQYMSFQFVPEPNTLDINVKKVEPGSQFTIRPDGDITFKTYFKANFKPVQTEEDKLVKE
VRDAIYDSVNVHMRSDVPVGSFLSGGIDSSFIVSVAKELHPSLKTFSVGFEQQGFSEVDV
AKETAAALGIENISKVISPEEYMNELPKIVWHFDDPLADPAAIPLYFVAKEAKKHVTVAL
SGEGADELFGGYNIYREPLSLKPFERIPSGLKKMLLHVAAVMPEGMRGKSLLERGCTPLQ
DRYIGNAKIFEESVKKQLLKHYNPNLSYRDVTKTYFTESSSYSDINKMQYVDIHTWMRGD
ILLKADKMTMANSLELRVPFLDKVVFDVASKIPDELKTKNGTTKYLLRKAAEGIVPEHVL
NRKKLGFPVPIRHWLKNEMNEWVRNIIQESQTDAYIHKDYVLQLLEDHCADKADNSRKIW
TVLIFMIWHSINIEKRYMPEELSHQPKEVIFV
>PK3-2_02192 Proline-specific permease ProY
MQNQKQELHRGLEERHISLMSLGAAIGVGLFLGSASAIQLAGPGILAAYAISGLIMFFIM
RALGEMAIQKPVAGSFSRYARDYLGPLAGYLTGWNYWFLWVVTCMAEITAVGIYMGYWFP
DVPNWIWALSALVIMTGVNFLAVKAYGELEFWFALIKIVAILSMIVVGLLMIIAGVGNGG
IATGIGNLWNNGGFLPHGIKGVLLSLQMVMFAYLGIEMIGVTAGEVKNPQKSLAKAIDTV
FWRILIFYVGALFVIMSIYPWQEIGSQGSPFVLTFEKVGIPSAAGIINFVVLTAALSSCN
SGIFSTGRMLFNLAEQGEAPKAYGQLTKGGIPGKAVLVSAGALLVGVLLNYVVPAKVFTW
VTSIATFGAIWTWAIILLSQIRYRKSLQPEEKKHLKYKMPFFPFTSYVSLAFLAFVVILM
AYSPDTRVAVIIGPVWFLILLAVYYGKGFHKKNAAADSERNIS
>PK3-2_02193 Protein YrdA
MIYPYKEHMPDIHPTAFVADNATITGDVVIGEHSSIWFSVVIRGDVAPTRIGNRVNIQDL
SCLHQSPNRTLLIEDDATIGHQVTLHSAVIRKNALIGMGSIILDGAEIGEGAFIGAGSLV
PSGKTIPPGHLAFGRPAKVIRPLTEEDRQDMQRIRSEYVAQGQYYKSLQQT
>PK3-2_02194 Phospholipase YtpA
MWTWKADRPVAVIVMIHGASEYHGRYKWLIEMWRSSGYHVVMGDLPGQGTTTRARGHIRS
FQEYIDEVDTWIDKARTFELPVFLLGHSMGGLIAIEWFKQQRNPRITGIILSSPCLGLQI
KVNKALDLASRGLNVIAPSLKVDSGLSIDMATRNEDVIEADQNDSLYVRKVSVRWYRELL
KTIESAMVPTDAFIKVPLLVMQAGDDKLVDKTKVIKWFKGVASHNKAYREWEGLYHEIFN
EPEREDVFKAARAFTDQYI
>PK3-2_02195 Tetraprenyl-beta-curcumene synthase
MLTVPEHPFGLMAKVYRDIFPLVHQELDVWKQKSELIHNSELKAQATASIRDKTFHCEGG
GILALLSGNQKQKCVEFIIAYQTISDYLDNLCDRSTSLDPQDFRMLHASMQDALTVGAEP
QNYYQFREEQDDSGYLHELVKTCQRVLGSIEHYDMIKPYLLELCGYYCDLQVHKHVIEHE
RVPRLEKWFTQYESELPEMKWYEFSACAGSTLGIFCLVAYSFQPDFSENTAEKIRNSYFP
YIQGLHILLDYLIDQEEDLLEGDLNFCSYYESHEEMMKRLEHFIQKADEHLQGIPHENFH
RLINRGLLGVYLSDDKVAGQKEMGRLAKKLIKASGKTSFFFYINGRAYRKFQKMAWMKNS
KKKAQIIC
>PK3-2_02196 Ribosomal RNA small subunit methyltransferase H
MILKKILPYSKELLKMAAGEGDIVVDATMGNGHDTQFLAELVGENGHVYAFDIQESAVAN
TQERLGETYQARATLFHKSHDKIAESLPPETHGKVAAAVFNLGYLPGGDKSITTSGNSTI
QAIEQLLSIMKNEGLIVLVVYHGHPEGKAEKNDVLDFCRDLDQQAARVLTYGFINQQNDP
PFIVAIEKKAQISK
>PK3-2_02197 hypothetical protein
MMQNNPFPYSNTEKRYHTLNYHLREHFGHKVFKVALDGGFDCPNRDGTVAHGGCTFCSAA
GSGDFAGNRADDLITQFHDIKNRMHEKWKDGKYIAYFQAFTNTHAPVEVLREKFESVLAL
DDVVGISIATRPDCLPDDVVEYLAELNERTYLWVELGLQTVHERTALLINRAHDFNCYVE
GVNKLRKHGIRVCSHIINGLPLEDRDMMMETAKAVADLDVQGIKIHLLHLLKGTPMVKQY
EKGKLEFLSQEEYVQLVCDQLEIIPPEMIVHRITGDGPIELMIGPMWSVNKWEVLGAINK
ELENRGSYQGKLFQRLQEESAL
>PK3-2_02198 hypothetical protein
MATRQSVDEHLQQCMQAYDYAEEQLKIASKQEHYNDQEYSDAQMQLENAVNALNKLWLSS
NDQQREQLYRMRLQLQALQNNMILQHPLDV
>PK3-2_02199 hypothetical protein
MKNKKRNLPMLITASVIACSFFLVLVMIGFEWQKSVIDPFYL
>PK3-2_02200 HTH-type transcriptional repressor YtrA
MIQIDPRSSTPIYEQIIQQMKELCLKGIMKPGDKLPSVRELATIIIANPNTVSKAYKELE
REGIIETLRGRGTYISENAKTTLVEGKMTMIKEQLKQLIIDAHYAGVELEKLQEWIKEIS
ADVKGAQEDD
>PK3-2_02201 ABC transporter ATP-binding protein YtrB
MIELRQLSKTIDGNQVLKDVSLTIEKGEIFGLLGRNGSGKTTMLRLIQQIIFADSGTILF
DGVEIKKHPKVKQNIIYMPVQNPFYDKYTYKQLVDILRRIYPKFDVTYANELMNRYEIPE
TKKYRELSTGLKKQLSLVLSFAARPALILLDEPTDGIDAVTRHDVLQLMIDEVAERDTSI
LITSHRLEDIERMCNRIGFLEDNRLTNVMDLDELKEEYIKIQMAFDTDVNLAIREQNIPM
LDQAGVFYTVLIPKSDEEKKSFLRELKPKVWNELPVNLEEVFIAKFGGKRRW
>PK3-2_02202 putative ABC transporter permease YtrC
MVDRGLLYREWKQNQVVIVLSIVFLVLANPLTVYHSYSLNQTCLLHSDPKFCSFTVDYHI
HSMIEINWVIGIILAVCLLGLERSKGTMDFLLSLPYKRSQIFQTKFWLGAIVILFSQLIG
FLLAWLLILFLKPEQVNFLEHGSIGVMIISFMFYSLVMAAGALAGNAFAQLLIAIATSVL
PYLIIALPFYNIEIISGIQIWKVLTNFEYFHEFENNLMTFSPITYVDSSWVEESKYLLLI
PAVMSALFYFIGYISFIKHHNERNGYFFLWKTLDRPIQILVIVLGIFGFGLVGRSASQSI
VGYIIGMIIGGVVGFLISYFSIYKKVRH
>PK3-2_02203 putative ABC transporter permease YtrD
MPDYGLFYKEWRQNKALLVIAILVSILGNPLSIFNMYLTYQGCVTGKENWVGPCVFSVDY
LNGTFISFFWIWGVVLAVSQLGIERSKGLFDFTLSLPYTRGQIFNAKFMLGGMVIVVPQL
IGYVLSVLLLVLLKPDQAVYFHNYSLGMIIVSMLAYALVMAGGALTGNIFAQLLVSFTVA
ISPFLLISLPAINLEILFGGSIEFIYGPVPKWAQYLIPVTFVDSKWVENSPQYLVIPAIM
TFIFYIIGYISFVKLSNERNGYFFLWKRLDRPVQIIVIIIGIMGFGYFGFSASESFTGYV
IGMAAGAVIGFFISYFAIYKKTKHL
>PK3-2_02204 ABC transporter ATP-binding protein YtrE
MIDVQHIDHSFTIGKKGRENEVPVLKDVSLSVAKGEIACIVGRSGSGKSTLLNLISGYIS
PTKGRIVINGTDVTGFNEKEWAQFRLDHFGFIFQSFQLIPGLTTYENVEMPLALKGIKPS
ERKQKVQDMLKRVGLENHAAHYPNELSGGQQQRVSIARALILNPSIILADEPTGSLDSET
EQEVLDLIQQLNRERGITFVIITHDDEVASIGHSKFQLHDGVLKGGITVEV
>PK3-2_02205 ABC transporter permease YtrF
MRFKDQVHFIRRNMKKNRLRVFMTILATTMACAFLVVLSSVGFGIQKTITDMTMSQQIVT
KVSVMGKEGDKPIKKADLEKYDHVRSVVERTQVYEPNKATLGNRTNESSNLIFTNMNAEL
KANMELEKGRVAKSENEIVVGYDFAKRLLTKKESEEYNKKIEEAKGNPEDIKEPDGYTKD
ILNKTIELSVSKTDPKTGDVEKTKTYDFKIVGITKKPSQDWMEDSNIFISDQFKKDFSEF
LDFKGGNVETNIGVFADKFENVEQLTNDLTDDGYYVTSVTTELEGANTFFMVFKIGLIFV
GCIAVIISAIGIFNTMTMAVTERTQEIGIMKAIGASPSIIRRMFLMESAYIGILGCVIGI
IISYGVSYLVNLAVPMILAATSGSDAGDLNYTFSYIPVSLVIIAVVICGGVAVISGMNPA
RKATKTNVLTALRREL
>PK3-2_02206 Response regulator protein GraR
MSRLFKLLLIEDDESLFHEIKDRLTGWSYDVYGIEDFSQVLEEFAAVQPDCVIIDVQLPK
FDGFHWCRLIRSRSNVPILFLSSRDHPADMVMSMQLGADDFIQKPFHFDVLIAKIQAIFR
RVYHYNTEISAIKTWCGAAIDAEQNLVSNDKGSVELTKNEMFILKQLIEQKNKIVSREEL
IRSLWNDERFVSDNTLTVNVNRLRKKLDALQLGANIETKVGQGYIAKEEDHFYD
>PK3-2_02207 Sensor histidine kinase GraS
MIKGFLIERRSWIAAFLFQQALLLFIAFVAPSISFENVLYMVYLCVLFFMIFLWFRYRKE
TAFYKSLKTWENNLDVTAINEPETPFEAMVERSLTGQTEHLKQTAARHRLALENEKDELM
AWIHEVKTPLTAMHLLIDRMEDQALKSQLSYEWLRIHLLLDQQLHQKRISFIENDLSVES
IQLKPLIFKEIKDLQSWCIQKGIGFDIQLEAEEVLSDAKWLAFIIRQLLTNAVKYSEASD
IEINSFQKGERTQLEVKDFGRGIDQKDVPRIFDKGFTSTTDHHDQASTGMGLYLAKKAAA
PLLIHIDVHSELGAGTVFTLTFPKRNQFERVISV
>PK3-2_02208 Bacitracin export ATP-binding protein BceA
MMILEANKIRKSYGNKLNKQEVLKGIDIHIEKGEFVSIMGASGSGKTTLLNVLSSIDQVS
HGTININGNEMTSMKEKQLAEFRKQHLGFIFQDYNLLDTLTVKENILLPLSITKISKKDA
NRKFEEVAKELGIYDLRNKYPNEISGGQKQRTSAGRAFIHDPSIIFADEPTGALDSKSAS
DLLNKLSQLNQKRNATIIMVTHDPVAASYCGRVIFIKDGQMYTQLNKGGQDRQTFFQDIM
KTQGVLGGVQHEH
>PK3-2_02209 Bacitracin export permease protein BceB
MNINQLILRNLKKNLRNYYLYVFALIFSVALYFAFVTLQYDPAINEVKASIKGAAAIKTA
SILLVAVVTIFILYANTIFIKRRSKEIGLFQLIGMTKHKIFRILSAENVMLYFGSLAIGV
VAGFSISKLVLMILFKIVEVETNAKLHFSGQALIQTIIVFCGIYLLIMIMNYTFIKKQSI
LSLFKVASSTEDKVKRISFFQMLIGALGIVLILTGYYVSSELFGGKFKTMNELFGAMSFI
LGAVIIGTFLFYKGSVTFISNIIRKSKGGYLNISEVLSLSSIMFRMKSNALLLTIITTVS
ALAIGLLSLAYISYYSAGKTAEQNVAADFSFMNEKDAKQFENSLSESNISYVKKETPVLQ
AAFDVTNIMDGNPKEMQGDPSKLQLAVVSDKDVNGVDVAAGEAVFSGYTDLLQKIMILKD
SGSIKVKSKHETKPLHYKGLRDEFLVSYMFTSGGMPAVIVDDSLYKRLNKDKDPRIQLEQ
SKFIGINMKHEDQLEKANKLFQKVNKKDQHLSRLDTSIAQKSLFGLVMFIVGFLGLTFLI
TSGCILYFKQMGESEDEKPNYTILRKLGFTQGDLIKGIRIKQMYNFGIPLVVGLFHSYFA
VQSGWFLFGSEVWTPMIMVMVIYTGLYSIFGFLSVLYYKKVIKSSL
>PK3-2_02210 putative membrane protein YttA
MEMALAFLGFLACLISLSYGLYHLVRYVLKKEKRFSKKLFWPLLIGGLVLLFTGAGLSEP
DAATANAEKKYSALNAEYKSLTKEHEALEKEYKSVSSEAKKLKDNTEDQDKLKQLEKENS
ELKKTQKSLKAEMKELKEDTKTVKAENETLRQDKTKLENQLKETESQTASSHEDTGSSSN
NTSKSDETKTADKAEGCNIKGSKNRIYHTPGSTYYDRTTDPAEMFCSVEEAEAAGYRAPK
R
>PK3-2_02211 Na(+), Li(+), K(+)/H(+) antiporter
MWPLNTIYIHNHLGKSLTVAGLVLMLNSGASVAGNLCGGFLFDKIGGFKSIMLGIAITLA
SLMGLVFFHDWPAYIVLLTIVGFGSGVVFPASYAMAGAVWPEGGRKAFNAIYVAQNAGVA
VGSALGGVVASFSFSYVFLANAVLYLAFFFIVYFGFRNIQTKDASQTSMLDYDAVNGKAK
FAALIILSGGYVLGWLAYSQWSTTIASYTQSIGISLSLYSVLWTINGILIVLGQPLVSFV
VKKWAESLKAQMVIGFIIFIVSYSMLLTAKQFPMFLAAMVILTIGEMLVWPAVPTIANQL
APKGKEGFYQGFVNSAATGGRMIGPLFGGLLVDHFGIQALVLSLLVLLLISIATTLLYDK
RIKPAKETNKQASISS
>PK3-2_02212 Blue-light photoreceptor
MASFQSFGVQGQLEVIKKALDHARVGVVITDPALDDNPIVYVNQGFVQMTGYEAGEILGK
NCRFLQGKHTDPAEVDNIRTALQNKEPVTVQIQNYKKDGTMFWNELNIDPLEIEGKTYFV
GIQKDITQQKEYEKLLEDSLTEITALSTPIVPIRNGISALPLVGNLTEERFNSIVCTLTN
ILSTSKDDYLIIDLSGLAQVNEQTADQIFKLSHLLKLTGTELIITGIKPELAMKMNRLDA
NFSSLKTYSNVKDAVNVLPIM
>PK3-2_02213 hypothetical protein
MMKMLHQVLIACVIGGIMGILGHVKKEAGWRSPE
>PK3-2_02214 hypothetical protein
MTKRFIYLGFLEDWFIGMTASILLVLSADPDSGIQLVILSIISGYGGEAVLRSFDFVREM
NSGGDPAESKRQTKTPPE
>PK3-2_02216 Leucine--tRNA ligase
MSFQHKEIEKKWQTYWLENKTFATLDNNEKQKFYALDMFPYPSGAGLHVGHPEGYTATDI
LSRMKRMQGYDVLHPMGWDAFGLPAEQYALDTGNDPAVFTKQNIDNFRRQIQSLGFSYDW
DREINTTDPEYYKWTQWIFLKLYEKGLAYVDEVPVNWCPALGTVLANEEVIDGKSERGGH
PVERRPMRQWMLKITAYADRLLEDLEELDWPESIKDMQRNWIGRSEGAHVHFAIDGHDES
FTVFTTRPDTLFGATYTVLAPEHALVENITTAEQKEAVEAYIKEIQSKSDLERTDLAKTK
TGVFTGAYAINPVNGEKLPIWIADYVLASYGTGAVMAVPGHDERDFEFAKTFGLPVKEVV
KGGNVQEAAYTGDGEHVNSDFLNGLNKQEAIEKVIAWLEETKNGEKKVTYRLRDWLFSRQ
RYWGEPIPVIHWEDGTSTAVPEEELPLILPKTDEIKPSGTGESPLANIKDWVEVTDPETG
KKGRRETNTMPQWAGSCWYFLRYIDPRNPDQLASPEKLEKWLPVDMYIGGAEHAVLHLLY
ARFWHKFLYDIGVVPTKEPFQKLYNQGMILGENNEKMSKSKGNVVNPDEIVASHGADTLR
LYEMFMGPLDASIAWSESGLDGARRFLDRVWRLFVEDSGELNGKIVDGAGETLERVYHET
VMKVTDHYEGLRFNTGISQLMVFINEAYKAAELPKEYMEGFVKLLSPVAPHLAEELWDKL
GHSGTIAYEAWPVYDETKLVDDEVEIVVQLNGKVKAKLQVPADATKEQLEQLAQADEKVK
EQLEGKTIRKIIAVPGKLVNIVAN
>PK3-2_02217 Sulfurtransferase
MEIKEISTAALKEKIEADEELYLIDVREDEEVAEGMIPQAVHIRMGDIPEKMDTLDKDKE
YVFICRSGMRSMNVCRYLDEQGFKTVNVEGGMMAWEGETKPKN
>PK3-2_02218 Alpha-galactosidase
MKKITFIGAGSTIFAKNVLGDCLLTEALNGFEFALYDIDPKRLQESQLMLENLRDRYNPS
VAINSYDDRKLALQNASYVINAIQVGGYKPSTVIDFEIPKRYGLRQTIADTVGIGGIFRS
LRTIPVLFDIAKDMEEMCPDAWFLNYTNPMASLTGAMLRYTNIKTIGLCHSVQVCTKDLF
KSLGMEHDGIEERIAGINHMAWLLEAKKDGADLYPEIKKRAKEKQKTKHHDMVRFELMDK
FGYYVTESSEHNAEYHPYFIKRNYPELISELQIPLDEYPRRCVKQIENWEKMRDDIVNNK
NLAHERSKEYGSRIIEAMETNEPFTFGGNVLNTGLITNLPSKAVVEVTCVADRKKITPCF
AGELPEQLAALNRTNINTQLMTIEAAVTRQKEAVYQAAMLDPHTSAELSIHDIISMCDDL
FEAHGDWLPEYK
>PK3-2_02219 Melibiose/raffinose/stachyose import permease protein MelC
MKAARSKNLRSITLLAGIVACAHFIPFYILLTTSLKAKGDYSSKWLFPGDISFHNFSEAW
ERASLGNSFINTIIITGFSALLLIVFGSLAAYPLARRKTKLNKAVFALLISIMIIPPLTS
MVPLYRMVVDAGMVNTHAIAILINTAAYMPLTVFLYSGFIRSTIPKELEEAARIDGAGML
KIFFTIVFPLLKPITATICIISCVFIWNDYQFAIFFLQDQKVQTLTVAMAGFFGENANNL
HLVAAAALMAMMPMVILFLALQKYFIAGLSSGAVKG
>PK3-2_02220 Melibiose/raffinose/stachyose import permease protein MelD
MSEIARDVHVKQIKPKKQSSLWWMYIPALLSVLIFMIYPFVKGALITFTNWNGFSQVYQW
VGFAQYERLFSDPDTWHILKNTLLYGLGSTFFQNAVGLLYALLLNQSIKMKAITRTIVYL
PVMISPLIMGYIWYFFFAYDGGALNDLLGIFGISPINALASPTLNPWIIVMINTYQYVGI
AMVVYLAGLQSIPKDYYEAAQMDGAKQGQQFFTITLPLLMPSITINMVINIIGGLKLFDV
IVALTAGGPGNASQSMSTFMYDLYFKRQDAGYAATQGIFMAFVILIISFCALAYFKRKET
EMS
>PK3-2_02221 Melibiose/raffinose/stachyose-binding protein MelE
MKHPFVLFLSLILLILPGCSAEKSSADSAKKTLTIYSTMSTDSERATFRKLAAAFEKEHS
GIRVSLHFPGNDYENMMRVRMAANDLPDLFDTHGWGKIRYGEYTADLRDMKWTKNLDPNL
NSILKNKSGKVYAYPINQAKDGLAYNRNMLDRYGIAPPETMDDFVKALRTIKEKSKGKIV
PFWFAGYDKSSFAQYYDQFATPLLITDPAHNEKKQLIDGTFNWSKFTYLSNTLKQMQKEK
LINIDAVTAKKSQLIELMAQNKIAFTMQGGTLGQDVAQINPNVKVGIIPTPAIHSGDDPI
WIGGERYTLAAWKDSPHVKEAKEFIAFMARPANAKQMAEATSLPSGLTNVKAEIFYADDY
EHYQNVKVEPYFDRLYLPNGMWDVLGTAGQELAADILTPQEISKKLQREYKRLRKQSETQ
GAENNE
>PK3-2_02222 HTH-type transcriptional repressor MelR
MVRIKDIALKANVSSATVSRILNEDESLSVAGETRQRVIHIAEELGYQTVAKRRKARGQK
QRTQPLIGVLSCLSPDQERQDPYFSSIRKGIEKECFEQEIFITNSIHLGSFQEHIFRELD
GVIVIGRVHDEAVKHISGRLEHAVFINHSPDPQAYDSIGIDFESASRQAIDHLFNLGYKR
LGYIGGQEKEHTLKDGQSIRRTIEDKRLTAFLESAAPLPEHVLIGEYSMREGYRLMKKAI
AQGNLPEAFFIASDSMAIGALKALQEAGLQVPRDTAIVSFNGIEEAEFASTPLTTVKVYT
EEMGCTGVKLLLDRLNGRTLPHHVTLPTTLIVRQSCGYTAKEVNISKHSSR
>PK3-2_02223 hypothetical protein
MSTERRKQLFRLLGDLPDRRQISTEILRIEEREGNIIETLLLDVNGHEKVPAYFVKPASA
DGPCPAVLFQHSHGGRYDRGKSELIEGADYLKAPSFANELTALGYGVLAIDHWGFGDRRG
KTESEMFKEMLLTGKVMWGMMIYDSLRALDFMQSRPDVQPDRIGTIGMSMGGLMAWWTAA
LDDRIKVCVDLCSQVDHHVLINTQNLDRHGFYYYVPSLAKHFSASEIQSMIAPRPHLSLV
GVHDRLTPVEGVNKIEKELTAVYAGQKAIDCYRVVRSASGHFETAVMRHEAVRFLQKWL
>PK3-2_02224 hypothetical protein
MEVQDILDWAFRRHLNPLSWYIRPLFLLVLVYAAYKRSWKGIIITFVLMMSSMVWFPEPK
KNHLQMQKVLEFEQTLLSSPVSAVFTIAFMMVLLSFILAAFWKRSLVFGLILLNVALIGK
VALSLFFTGENGWAPLGNTIFGLMMVNGIGLFIKYRNRKKRRGIDI
>PK3-2_02225 6-carboxyhexanoate--CoA ligase
MQEETFYSVRMRASKNGSHEEGGKHISGGERLISFDEMTRTVNALLEKGLSHSRGKPDFM
QIQFEEVHEPIKTIQPLPVHTNEVSSPEEGQKLARLLLEREGVAREAIEKAYEQIPEWSG
VRGAVLFDIHSGKPIDQTKGKGVRVSRMDWPDANFEKWALRWHVPSNSRIKEALALASKV
SRHRAAVAELCWSDDPDYITGYVAGKKMGYQRITAMKEYGTEEGCRIFFIDGSKDINTYI
HDLEKQPILIEWEEEHDS
>PK3-2_02226 L-Lysine--8-amino-7-oxononanoate transaminase
MTHDLIENSKKHLWLPFTQMKDYDENPLIIESGNGIKVKDINGKEYYDGFSSVWLNVHGH
RKKELDDAIKNQLGKIAHSTLLGMTNVPATQLAEALIGISPAKLTRVFYSDSGAEAMEIA
LKMAFQYWKNIGKPEKQKFIAMKNGYHGDTIGAVSVGSIELFHHVYGPLMFDSYKAPIPY
VYRSESGDPDECRDACLRELEQLLKEHHEEIAALSIESMVQGASGMIVMPEGYLAGVREL
CTTYDVLMIVDEVATGFGRTGKMFACEHENVQPDLMAAGKGITGGYLPIAVTFATEDIYK
AFYDDYENLKTFFHGHSYTGNQLGCAVALENLALFETENIVEQVAEKSKKLHVLLQGLHE
LPHVGDIRQLGFMCGAELVRSKETKKPYPADRRVGYKVSLKMRELGMLTRPLGDVIAFLP
PLASTAEELEEMVSIMKQAIEEVTSLED
>PK3-2_02227 8-amino-7-oxononanoate synthase 2
MKIDAWLHERLDSVKEAGVYRNLRTMNGAPVPERRIDGKNQTVWSSNNYLGLASHSRLIS
AAQEALQQFGAGSSGSRLTTGNSVWHEKLEKKIAGFKRTEAALLFSSGYLANVGVLSSLP
ETEDVILSDQLNHASMIDGCRLSKADTVVYRHMDMDDLENKLNDTQRYQRRFIVTDGVFS
MDGTIAPLDQIISLAKRYHAFVIVDDAHATGVLGESGGGTSEYFGVYPDIVIGTLSKAVG
TEGGFAAGSAVFVDFLLNHARTFIFQTAIPPASCAAAYEAFEMIEASGEKRELLFSNINM
IRTSLKDMGYLVKGDHTPIIPVVIGDTRKTVTFAEKLQDNGIYAPAIRPPTVAPGESRIR
LTITADHSMGDIEHLLTSFHSIGKELHII
>PK3-2_02228 ATP-dependent dethiobiotin synthetase BioD 1
MKGFFVTGTDTEVGKTVISSGLAVLLREHNRDVGVFKPFLSGISRHHPESDTSLLKDMSQ
TGLSHEDITPFAFNAPLAPYVAGKLEGKAVTIGEVLRHWERIREKHECYIVEGAGGISVP
VGEDYLVSHVIKALQLPMIIVTRPHLGTINHTFLTVQYAKSMDLPIAGIVINGISDSPDD
DEKTNPEMIERLCGVPILGITPKLANVTKETVLHMAKDHINLSLLMNQVGV
>PK3-2_02229 Biotin synthase
MNQWMELADRVLAGAEVTDEEALSILTCPDEDILLLMHGAFQIRKHFYGKKVKLNMIMNA
KSGLCPENCGYCSQSSISKAPIQSYRMVNKETLLEGAKRAHDLNIGTYCIVASGRGPSNR
EVDQVVDAVQEIKETYGLKVCACLGLLKPEQAKRLKEAGVDRYNHNLNTSQRNHSNITTS
HTYDDRVNTVEIAKETGLSPCSGAIIGMKETKRDVIDIAKSLKALDADSIPVNFLHAIDG
TPLEGVNELNPLYCLKVLALFRFINPSKEIRISGGREVNLRSLQPLGLYAANSIFVGDYL
TTAGQEETEDHKMLSDLGFEIESVEEMKASLSVES
>PK3-2_02230 Biotin biosynthesis cytochrome P450
MTIASSTASSEFLKNPYPFYERLRAVHPIHKGSFLKYPGWYVTGYEEAAAILKDARFKVR
TPLPETSIKYQDLQCVQNRMMLFQNQPDHRRLRTMASGAFTPRMAECYRSYIDETVRRLL
DQVQGEKKMEVISDFAFPLASFVIANIIGVPEEDREQLKDWAASLIQTIDFTRSRKALTE
GNHIAVQAMAYFRELIQKRKRHPQQDMISMLLKRKEKDKLTEEELASTCLLLAIAGHETT
VNLISNSILCLLQHPEQLLKLKENPDLIGSAIEECLRYESPTQMTARVASEDIDISGVTI
RQGEQVYLLLGAANRDPIRFTNADVFDLTRSPNPHLSFGHGHHICLGSSLARLEAQIAVN
AILQRMTGLKLADSERRYRPLFGFRALEELPVTFE
>PK3-2_02231 Uronate dehydrogenase
MKKVLIAGGNGVIGRLLAEGLISDYEVTVLDKNQFDGTASSIQADAANYEELLEKIPKDT
DVILNLLAVKIKYDVMDIAEFEKMTDVFYRASYYLCRAAAELGIQKLVFASSNHVTDVYE
KDGRSLLGREITTSDYPLSKNLYGVLKLTSEQIGHLFYLENKLSVINLRIGTVVTDERDT
LYEKERTKKTLLSHPDLLSIFKAAIETNIRYGTYYAVSENPGRPWSIESAVNELGFSPQI
NTAELLEEEENGA
>PK3-2_02232 L-arabinose transport system permease protein AraQ
MGAIAHSLKSRLFDILIYGFLLMFALICVLPFIHVIAASFATVEEVVSKKFILIPTTFSL
DAYRYIFSTDIIYKSLLVSVFVTVIGTAVSMFLSSLMAYGLSRRDLIGRQPLMFLVVFTM
LFSGGMIPTFLVVKSLGLLDSYWALILPTAINAFNLIILKNFFQNIPSSLEESAKIDGCN
DLGIFFKIVLPLSLPAIATISLFYAVTYWNTYMTAILYLNDSAKWPIQVLLRQIVIVSSG
MQGDMSEMGSGSPPPEQTIKMAVIVVATIPVLLVYPFIQKHFAKGALLGSVKG
>PK3-2_02233 Lipoprotein LipO
MGNKWRVLLIVLVLALGGVLAGCKGADQSSAEGKADSDSKVKLSWMAILYHQQPPKDRAI
KEIEELTNTELDITWVPDAVKEDRLNAALAAGNLPQIVTIQDIKNSSVMNAFRSGMFWEI
GDYIKDYPNLNKMNKLINKNVTIDGKLYGIYRERPLSRQGIVIRKDWLDNLNLKTPKTLD
ELYEVAKAFTEDDPDKDGKDDTFGLTDRNDLIYGAFKTLGSYEGMPTDWKESGGNFTPDF
MTQEYKDTMNYMKKLRENGYMNKDFPVTSKTQQQELFSQGKAGIYIGNMVDAVNLRDHAS
DKSMKLEIINRIKGPDGKERVWASGGHNGLFAFPKTSVKTEAELKRILAFFDRIAEEDVY
SLMTYGIDGVHYNKGEGKTFTREESQVKDWQTDIQPLSALIAIDKAYLKTRGIRFGQRTR
S
>PK3-2_02234 hypothetical protein
MKKIIDDATYKYMIGDITESQFDKEVEKWESSGGKQIIQEYEEAFKQTK
>PK3-2_02235 HTH-type transcriptional regulator YesS
MKRSQYKFYYKLITFFCLLSTIPVILVGLFSYEHSQKTAISNVTEEKLDTLQQTQQSIEH
ILKTVDHSLTHYVSSPPLLRTLSEPLHSDQFQIYNQVNQELNYLQSFDTDLSNMTLVSYM
KKWYMNNSGLYRLNTDSLHEAAAAYTQHKASRSYWTLEENNHLISTKEGTSDNCRYNINL
IKQLPLNSTNTKGLAAASIPSCSLVKNMPDYSNANNLFIIDEKGRIILHNSMSDIGGSLQ
NDDFVQKMLAQTSKSGQFETVIDRIHYKVTYQKSDYNTWTYFSLVSLPELKKEAKSIGWI
TFAVCFILLTLSLLFSWLGSRHFYKPIRVLYESFARHGAIQEKQPTQNEFELIEQSFKQL
KDRNDDLEETMKQQATHLQQYFMVRLMLGKLTDEEVNNRFESLGLKQNWRHLALLVLQID
TLNHTPYEKKDMDLLLFAVNSLIERTIPSDKHLAPAVVDKQQATILINQNGTKEEFMDEL
NETARMIQEKAEAELQLSVSIGISQPFDALTKAKTAYAEGSEALKYRLKAENKSIIFYED
LDQKKTFKTHFPKQLQHELFDAVKAGDKEKADKCLHAILQAIFTQNTNPYQSQIAIARFL
NHVIELMHVLGIELFELEENKMLYDQIFELKTFEDTENWLKNEFIDPMTDKVNARADAQY
KNISDNIIHIIHHEFESDLTLDEISRRLHYNPNYLSSIFKKEMGISFSEYVSSYRHHMAK
SWLAETDMAVKDIAEKLKYKNSQNFIRSFKKLEGITPGNYRQQKRSM
>PK3-2_02236 putative multiple-sugar transport system permease YteP
MKTAEAQAPAVDAVIFKKEKRKRLLSKLIQQKYLYLMILPGCIYFLLFKYVPMWGIVIAF
QDYQPFLGILGSEWVGLKHFIRLFTEPTFFLLLKNTLVLFALNLVIFFPVPILLALLLNE
VRIALFKKFVQTLIYIPHFMSWVIVVSLSFVLLTVDGGLINELIAFFGGEKINFLLNEEW
FRPLYILQVIWREAGWSTIIYLAAITAVDPQLYEAAKMDGAGRLRQMWHITLPAIKSVIV
VLLILKIGDTLELGFEHVYLLLNATNREVAEIFDTYVYTAGLKQGQFSYSTAVGVFKAAV
GLILVMLANRLAKKFGEEGIY
>PK3-2_02237 Unsaturated rhamnogalacturonyl hydrolase YteR
MDQSIAVKSPLTYAEALAKTIMNTYTVEELPPANRWHYHQGVFLCGVLQLWEATGEKRYF
EYAKAYADLLIDDYGNLLFRRDELDAIQAGLILFPLYEQTKDERYVKAAKRLRGLYGTLN
RTSEDGFWHKDGYPYQMWLDGLYMGGPFALKYANLKQEPELFDQVVLQESLMRKHTKDSK
TGLFYHAWDEAKKMPWANEETGCSPEFWARSIGWYVMSLADMIEELPKKHPNRHVWKKTL
RDMIESICRYQDEVTGLWHQIVDKGDRSDNWLESSGSCLYMYAIAKGINKGYLDKAYEPV
LLKAYQGLIQHKTETTEDGAFLVKDICVGTSAGFYDYYVSRERSTNDLHGAGAFILAMTE
LEPLFRSAGK
>PK3-2_02238 Putative lipoprotein YteS
MHVIVFSDMQAGVQENIKKAAEHKAGKVDILPAFPEKLLTEITAREGDVFIVPEDMFQAY
DDPENFQPLDGLPPDKTYSYTTVDQTTGEKTVYAVQIKKGEKQLNGYSFRLNRNMAAFIP
VYAKKTEEALQLISQLTEAR
>PK3-2_02239 Putative oxidoreductase YteT
MKNIVICGVSSRALSMFIKPLMERFSTHYEITGLLDADPKRFAVCKKKFPELAHVPEFNE
DAFDDMMCVSKPDIVIVAGRDDTHITYILRSLQWDTDVITEKPMVTTVRDATRVLEAEAK
SRGKVTVAFNYRYSPFHRKMKEMILDGKIGRVTSVDLNWYIDTYHGASYFKRWNRSRPLS
GGLSVHKSTHHFDLVNWWLGQKPEEVFAYGALNYYGPDSEWNPLPEEDGRFCGTCRVKEK
CHYYSRWHPRSFRASVKDDHLQAGDQSGLYTSYRPDACIFDEEIDIEDTYVAAVKYDGGA
LLSYSIIFSAPYEGYRLTINGTKGRIESNEFHEPSRIPFAFPEQTIEYYPLFESKQTIQV
VKNEGGHGGGDPLLLEDLFLGKDPLRHYDILAGAEAGAYSIAVGEGMWRSVADKKPINIK
SLFQMQNV
>PK3-2_02240 hypothetical protein
MEHDGSMGRVLRFCEWIMRFAYTNLLWLFFTMIGLGVFGIMPATAALFAVMRKWIQGQDN
IPVLQTFWREYKAEFVRSNFLGAVLAIIGLIIYIDLAFIYPSHFLLHVLRFAIMIFGFLF
VSMLFYVFPLFVHFDWKKRLYVKFSLLLSVAYLQYTLVMLALTLALFFLLAYLPGIVPFF
SVSLISYCHMRIVYAVLLKVGQQEGEPQEKRHIREAFYPEPR
>PK3-2_02241 Sporulation protein cse60
MLKVAVFDEEHEKDLQTEINSFLKGISEEQLIDIKYTVSAACDPDGEQLYCFSALILYRK
>PK3-2_02242 Glycine betaine transporter OpuD
MKHISSVFWIVIVITAAAVLWGVVSPDSLQNVSQSAQAFITNTFGWYYLLVVSLFVGFCL
FLIFSPIGKIKLGKPDEKPEFGLLSWFAMLFSAGMGIGLVFYGAAEPISHYAISSPSGET
ETPQAFRDALRYTFFHWGLHAWAIYAVVALCIAYFQFRKGAPGLISSTLSPILGDKVNGP
IGKLIDCIAVFATVVGVATSLGIGATQINGGLSYLFDIPNNFLVQFILIAIVTVLFLISA
WSGLGKGIKYLSNANMVLAGLLMLFVLFVGPTVLIMNSFTDSIGQYIQNIVQMSFRLTPY
DPEKREWINGWTIFYWAWWISWSPFVGIFIARVSRGRTIREFLIGVLVTPCILAFLWFSI
FGVSAMDLQQKGTFNVAKLSTETMLFGTLDHYPLAMVTSILSLILIAVFFITSADSATFV
LGMQTTYGSLNPANSVKFSWGIIQSAMAAVLLYSGGLAALQNTAILAALPFSIVILLMIA
SLYKSLSKERREIKKTEKFDKPRSPRVKKAY
>PK3-2_02243 putative protein
MIKMKQFDVIVIGGGPSGLMAAIAAGEQGASVLLIDKGNKLGRKLAISGGGRCNVTNRLP
VDEIIKHIPGNGRFLYSAFSEFNNEDIIKFFENLGIQLKEEDHGRMFPVTDKAQSVVDAL
LNRLKQLRVTIRTNEKIKSVLYEDGRAAGIVTNNGEVIHSQAVIIAVGGKSVPHTGSTGD
GYEWAEAAGHTITELFPTEVPVTSAEPFIKQKTLQGLSLRDVAVSVLNKKSKPIITHKMD
MLFTHFGLSGPAILRCSQFIVKELKKQPQVPIKIDLYPDINEETLFQKMYKELKDAPKKA
IKNVLKPWMQERYLLFLLEKNGISPNVSFSELPRDPFRQFVKDCKQFTVLANGTLSLDKA
FVTGGGVSVKEIDPKKMASKKMEGLYFCGEILDIHGYTGGYNITSALVTGRLAGLNAGRF
ARS
>PK3-2_02244 Lipid II flippase MurJ
MSSKLLRGTFVLTLGTYISRILGMVYLIPFSIMVGATGGALFQYGYNQYTLFLNIATMGF
PAAVSKFVSKYNSKGDYETSRKMLKAGMSVMLVTGMIAFFILYLSAPMFAEISLGGKDNN
GLTIDHVVYVIRMVSLALLVVPIMSLVRGFFQGHQMMGPTAVSQVVEQIVRIIFLLSATF
LILKIFNGGLVIAVGYATFAALIGAFGGLIVLYIYWNKRKNSLLAMMPNTGPTANLSYKK
MFLELFSYAAPYVFVGLAIPLYNYIDTNTFNKAMIEAGHQAISQDMMAILTLYVQKLVMI
PVSLATAFGLTLIPTITESFTSGNYKLLNQQINQTMQTILFLIVPAVVGISVLAGPTYTF
FYGSESLLPELGANILFWYSPVAILFSLFTVNAAILQGINKQKFAVVSLVIGVVIKLVLN
VPLIKLMQADGAILATALGYIASLLYGFIMIKRHAGYSYKILVKRIVLMLVLSAIMAIAV
KIVQWVLSFFISYQDGQLQAAIVVVIAAAVGGAVYLYCGYRLGFLQKILGRRLPGFLKRG
KHAG
>PK3-2_02245 Ribosomal small subunit pseudouridine synthase A
MRLDKLLSNSGYGSRKEVKAVVKAGAVMVDGKPAKDVKAHVDPDKQEVTVYGEPVDYREF
IYLMMNKPQGVLSATEDSRQQTVIDLLTPEEMRFEPFPAGRLDKDTEGFLLLTNDGQLAH
RLLSPKKHVPKTYEVHLTSQISREDISDLEAGVYIEGGYKTKPAKAEIKANDNGNTVIYL
TITEGKYHQVKQMAKAVGNEVIYLKRLSMGPVSLDPALAPGEYRELTEEELHLLNEPQA
>PK3-2_02246 putative HTH-type transcriptional regulator YtzE
MKPSTNRMLTRIKSVYMFIQEKGLVTTQELVDEFGITPRTIQRDLNVLAYNDLVHSPSRG
KWETTRKKVKITS
>PK3-2_02247 ABC-type transporter ATP-binding protein EcsA
MTKLLEASIEQAGYTSRKKVLADVFFEVGKGELVGLIGANGAGKSTAIKAILGLSEDFEG
RIAWNDCSFAYIPEHPSFYEELTLWEHLDLISTLHGIEESEFTHRAQSLLQTFSLDHVMH
ELPVTFSKGMQQKLMLIQAFLSKPDMYVIDEPFIGLDPISTKRFVDMLKAEKDRGAGILM
CTHVLDTAEKICDRFYMIEKGSLFLQGTLKDIQDQTGLEGQSLLDCFYKAVQGDRS
>PK3-2_02248 hypothetical protein
MKGRSLFFRRLIDYYKYQFNVFHSVIDWTVALYIVLPALAFVIYQYNDLLHGRGLFYEWS
EVMEWRWLYAVCVLIVCTGAIHTFLMEADKVFLLQKKEMIYQLKRYALVYSFLVTLAKWL
LLFFIVFPLISHSVHITLAESAALSCYLFGLHTFFLSLKQERIRKPRSISRWIADILFRA
VLFSGSAVLIVFTESGVLAPIGILFFIFSFVRGLKKTASFSAFEAEVIEEKKSRLALAGL
VMMISQEAGVPKVKDRMRRKPLLYRNSKRIFKKRTICTGYKELFFKVMLRNGEYTRHMYM
LLSAFTILIFVSPIWLKLIALLVYTGVCRYILTLIFDKVMDAPFLIGTDKESDEYYRARK
SCINTLHYAFAACCFLAAAVSLLFT
>PK3-2_02249 Guanine/hypoxanthine permease PbuO
MFHLKEQQTSIKQEIIAGLTTFFTMVYIVVVNPVILANAGVPFDQVFTATIIASIVGTLW
MALAANYPIAIAPGMGLNAYLAFHVVSASDGGITYATAFSAVFTAGVLFIILSLTPLRKQ
LIEAIPNNLKYAITTGIGLFIAFIGLRQAGIVAADESNLVTLGNLHSPGVILTLVGLLIS
VVLMVRKVSGALFIGMAATALIAFFTGQLHFSKGFMSLPHLPDGLIISNPFSAFGDVVHH
GLYAVVFSFLLVTIFDTTGTMIGVAEQAGLMKNNKLPNVRKALLADSTATTVGAVFGTSP
TTAFIESSAGVAAGGRTGLTSLTVAVLFAASMFFSPLVSALSGIAAITSPALIIVGSLMM
SSVSNMNWKEMDEAFPAFLVILAMPLTSSISTGIALGFISYPIVKAARGKWREIHPLVIV
FAILFFIQLFIL
>PK3-2_02250 Putative dipeptidase
MNWEVEVIRKKEDLIRDTQEFLRINSVMDETTAGPGKPFGEGVNASLTSLLELGEKEGFT
TKNLDGFAGHIEWGEGDDIVGVLCHVDVVPPGDGWTSDPFSADIRNGRIYARGAIDDKGP
TMAAFYALKIVKDMNLPLSKRVRIIIGTDEESDWRCVEHYFKHEEMPTLGFAPDADFPII
NAEKGIIDASLLIPQRSNQANSETVLVSFQSGLRLNMVPDAAEAVIEGPKKEVILDSFKD
MLRATDQKGEADIENGQLILRMYGLSCHAMEPNNGINAGLLLCEFLQQAELDEAGRRFVQ
VVTDKFSNDTRGKKLNIDCEDDISGELTLNVGTLRYTEGRGGELGINIRYPVTAESKVIR
DTFESASEFELGEFKDSKPHHVSADHPLVKTLQKVYEGQLGKKADLISIGGGTYARSLKA
GVAFGPLFPGRPDSAHQKDEHIEIDDLLRSTALYAQAIYELAK
>PK3-2_02251 Cysteine synthase
MLKIVENTADLIGDTPLVRLNRLQPENAAQVYLKLEFFNPSGSVKDRAAYHMIIEAEQNG
LLKPGSVIIEPTSGNTGIGLAMNAAARGYKAILVMPDTMTKERINLLKAYGAEVVLTPGA
ERMPGSIKKAKELAEQIPNSYIPMQFDNTANPDAHRKTTAPEIARALEEIGKPLGAFVAS
SGTGGTITGTGEALKELFPDITVHVVEPAGSPVLSGGKPGAHKLVGTSPGFIPPILNQDV
YDEIIKITDEDAYTTTRRLAAEEGILVGPSSGAACFAAIETAKRLSPDQVVVCMTADTGE
RYLSTDLWSFV
>PK3-2_02252 RNA 2',3'-cyclic phosphodiesterase
MPDTRPHYFIGVPIPEGIANPIYHAAKNEPVLMFQKWVHPLDYHITLIFLGAADDTQIQQ
LEGSLAAIGSETNPFPIEFGKIDVFGDRRRPRVLHLEPKKNRTLEMLREHTKQAVLQAGF
QVEKRPYHPHMTLARKWTGEEGFPAHVPFESGEVSMIAERFSLFRIHLNKSPKYEEIYKF
HLS
>PK3-2_02253 hypothetical protein
MAQIIKIHDYISRYELDPYHYINQFVRLKKERWLSLLEAAERQHEERQSSAEEPEPLQKR
KKFSLKRRKEEIKADIQEERHQWFEEEDELHVRLPKSRMALASFYKRHLYEFQLKWASST
LSEISHLSNQVKQDRILRYLTQQLPDSYFIMYKPVLKIQQAAVELSIVIISPLEIFCVSF
LEAEEDSVYIGSKNRFWDKKTASQTESVLNPGLSLFRTDSVVAKIVKEKQAEIPVRKLLL
SRTSYIDYPEPPYGLEIADKRGAEEWIERQKKNTAPIKHHQVKAAKALLSYCMSDSYRRQ
EWLE
>PK3-2_02254 Putative lipid kinase YtlR
MSHWFFIINPTAGHRNGLRVWRSIQKELIKRKIEHRSFLTEHPGHAEVLARQISTIQEYK
LKRLIVIGGDGTMHEVVNGLKDVDDIELSFVPAGVYNDFSRGFSIKKIDLIQEIRKQKRP
LTRTFHLGSVNFLQDKSQVLYFMNHIGIGFDAYVNKKAMEFPLRRAFLFLRLRFLVYPLS
HLHASATFKPFSLACTTEGETHEFHDVWFAVVSNHPFYGGGMKAAPLANPREKAFDIVIV
ENQPFLKKYWLLCLMAFGKHTKMDGVTILKAKDITFYTKDKIPFHADGEIMGTTPFRLSS
SPSPLKIKT
>PK3-2_02255 Pullulanase
MVSIRRSFEAYVDDMNVITVLIPAEQKEIIKPPFRLETETAVFPLAVREEYRLEATYKYV
CVSDHPVTFGKIHAVRASSGDKTDLQIGAVIRTAAFDDAFYYDGELGAVYTADYTEFKVW
APAAVSAAVKLSHPNKSGLTFQMTRLEKGVYAVTVSGDLHGYEYVFCICNNSQWAETVDP
YAKAVTVNGEKGVVLRPDQMKRADPLKPFLNPADAVIYEMHIRDFSIHENSGMKNKGKYL
ALTETDTQTTKGCSSGLAYVKELGVTHVELLPVNDFAGVDEEKPLDAYNWGYNPLHFFAP
EGSYASNPHDPQTRKTELKQMIKILHQHGLRVILDVVFNHVYERENSPFEKTVPGYYFRH
DEFGMPSNGTGVGNDIASERRMARKFIADCVIYWLEEYDADGFRFDLLGILDIDTVLYIK
EKATAVKPGILLFGEGWDLATPLPHEQKAALANASKMAGIGFFNDMFRDAVKGNTFHLTA
AGFALGGGEAAKTVMHGIAGSSGWKALAPVVPEPSQSINYVESHDNHTFWDKMSLALPHE
TDSRKRSRQRLASAIILLAQGVPFIHSGQEFFRTKQGVENSYQSSDSINQLDWDRRETFK
EDVDYIRRLISLRKAHPAFRLNSAADIQRHLECLTLNEHLIAYRLHDLGAFDKWEDIIVI
HHASPESVEWKLPNDKTYRLLCDTSGFQHDPKEIKKAVAVNGIGTVILYLASDLKSFA
>PK3-2_02256 hypothetical protein
MNWLGQLLGSDWEIFPAGGATGDAYYAKHNGQQLFLKRNSSPFLAVLSAEGIVPKLVWTK
RMENGDVITAQHWMTGRELKPKDMSGRPVAELLRKIHTSKALLDMLKRLGKEPLNPGALL
SQLKQAVFAVQQSSPLIQEGIKYLEEHLHEVHFGEKVVCHCDVNHNNWLLSEDNQLYLID
WDGAMIADPAMDLGPLLYHYVEKPAWESWLSMYGIELTESLRLRMAWYVLSETITFIAWH
KAKGNDKEFHDAMEELHILMKRIVE
>PK3-2_02257 hypothetical protein
MGLHYEHQVHLLKDILTDHQLDCCGTVAEYEQLERVIKSLMANTELDSNFKNVLEDVYRY
SQSGISSKSIDSHIQEHQNSLSQWVEQMDSYS
>PK3-2_02258 tRNA (guanine-N(7)-)-methyltransferase
MRMRHKPWADDFLAENADIAISNPADYKGKWNTVFGNDNPIHIEVGTGKGQFISGMAKQN
PDINYIGIELFKSVIVTAVQKVKDTEAPNVKLLNIDADTLTDVFEQGEVKRVYLNFSDPW
PKNRHEKRRLTYSHFLKKYEEVMGKGGAIHFKTDNRGLFEYSLKSFSEYGLLLTYVSLDL
HNSNLEGNIMTEYEEKFSALGQPIYRAEVEWRT
>PK3-2_02259 putative quorum-quenching lactonase YtnP
METMTIGNITLTWLDGGVTHMDGGAMFGVVPKPLWSKKYPVNEKNQIELRTDPILIQKDG
LNIIVDAGIGSGKLTDKQKRNYGVTQESNVKTSLAALGLTAADIDVIAMTHLHFDHACGL
TEYEGEQLTSVFSNAVIYASAIEWDEMRHPNIRSKNTYWKENWEAVAGQVKTFEETLTIT
EGITLHHTGGHSDGHSILVCEDAGETAIHMADLMPTHAHRNPLWVLAYDDYPMTSIPQKQ
KWQAFAAEKDAWFIFYHDAQYRALKWDEDGSIKDSVKRIN
>PK3-2_02260 putative NAD-dependent malic enzyme 2
MKQFTVTNEGDIQTTLRGLEVLSVPFLNKGVAFTEEERKELGLKGFLPPKVLTIEDQAKR
AYEQYSAQPDDLSKNVYLTALHDRNETLFYRLLNDHLGEMLPVVYTPTVGTAIQRYSHEY
RKPRGLYLSIDDPDGMREAFKQYKDQSDTIDLIVATDAEGILGIGDWGVGGIAISIGKLA
VYTAAAGIDPSRVLAVVLDAGTNQESLLNDPLYVGNQHSRVRGERYDQFIDDYVALARET
FPNALLHWEDFGAKNARSILKRYKDKVCTFNDDIQGTGAVSLAAVLSCAKASKVPLKDHR
VVIFGAGTAGIGIAEQLREALVRDGLSEEESFQRFWCIDRNGLLTDDMDQLLDFQKPYAR
SADEVKDYQRNGEGGGIDLLEVVRQAKPTILIGTSTVSGAFTEEIVKEMASHVKRPAILP
MSNPTTLSEAKPQDLIEWTEGRALITTGSPFPPVEYNGVTYHIGQANNALVFPGLGLGTI
VTKSKLITDGMFEACARAIASMVNVGVPGAPMLPKVEDLRTVSATVAVEVAKTAMKEGVA
TEEPEDIIQAVQDAMWYPVYKPIRAI
>PK3-2_02261 hypothetical protein
MKLRHLLLGAGLGICTAVVVKQYVMKPYISSEKALRIVKSAFKQRGPIDGSWIYTQPEPY
NVNGETVQVYKTGITRSAFGELEQYEVMVDAKTGEIVDVIDTIAS
>PK3-2_02262 Putative aminopeptidase YsdC
MNQETKALFQTLTQLPGAPGNEHQVRAFMKQELSKYADDIVQDRLGSVFGVRKGEEGAPR
IMVAGHMDEVGFMVTSITDNGLLRFQTLGGWWSQVLLAQRVEIQTDNGPVPGVISSIPPH
LLTDAQRNRPMDIKNMMIDIGADDKEDAIKIGIKPGQQIVPVCPFTTMANEKKILSKAWD
NRYGCGLSIELLKELHGKELPNTLYAGATVQEEVGLRGAQTASHMIKPDLFFALDASPAN
DMSGDKNEFGQLGKGFLLRILDRTTVMHRGMREFVLDMAETHDIPYQYFVSGGGTDAGRV
HISNSGVPSAVIGICSRYIHTNASIIHIDDYAAAKEMLIKLVTACDKQTVDAIRENM
>PK3-2_02263 hypothetical protein
MEFIVYLAGEIHSNWREEIKEKTKSLKLPITFVGPMENHDRSDNIGEEIMGVQPNAILKD
DKASDMNNFRTAVLMNKADFVIALFGEKYKQWNTAMDASYAIAKGKPLIIIRPESLHHPL
KELSNKANITVETVNQAIKALSYVFETE
>PK3-2_02264 Thioredoxin-like protein YtpP
MKKIESTQELEKAVKDDWAVFMFSADWCPDCRFVEPFLPELEANFPEFTYYYVDRDKFID
TCAEWEIYGIPSFVVFNEGKEVNRFVSKDRKTKEEIEQFLTDSLAKA
>PK3-2_02265 hypothetical protein
MKMTSRKLSDILKQRLQHENRSFLFDREKDTLRVEDQTTKKGITLDLPPIIAKWELKKDE
AIDEIVYYVSEAMTAMEGNSQEMTGKESRIYPVIRSTSFPDKSSEDIPLIYDEHTAETRI
YYALDLGKTYRLIDQRMLEKENWTKERIRETAAFNLRSLPTVVKEDTVAGNFFYFFRAND
GYDASRILNEAILNEYKQRAEGELAISVPHQDVLILADIRNESGYDILGQMSMSFFAGGT
VPITALSFLYNEGKLEPVFILAKSRPKKD
>PK3-2_02266 hypothetical protein
MNAFYNKEGVGDTLLISLQDVTREQIGYEKHGDVVKIFNNETKETTGFNIFNASSYLNID
ENGPVALSETFVQDVNEILSRNGAEETLVVDLSPKFVVGYVESKEKHPNADKLSVCKVNV
GEETLQIVCGAPNVDQGQKVVVAKVGAVMPSGLVIKDAELRGVPSSGMICSAKELALPDA
PAEKGILVLEGDYEAGDAFQF
>PK3-2_02267 DNA translocase SftA
MSWLHKFFDLFLGESEGDNERETKPKPAQIPQQQEVHQHHPEGQLKRLEDPKIYYEYPKG
KFRFPVVPDGYQNQDLRRRRAPSEEPKSAPRPSAAPHRERPKKEKEQHTYQSSEPAKKPF
KPTNIPSPIYGFNQKPSVKKDVPKQPSETLKAPGKFEKEKVTLLSEEIERERGYPTPDRP
EQHVKEEPFFPDTQFKKQPSRDLNETAAGREEALAQRPAEEPSDTGIQQPEKETSFFSVE
QNEEQAATETMTDTVAEAQKDRSGSKISHEDTMLAAAKIQEEQRKKPLEKEEELVLHAEH
DEEQTAPESLRAAVSEAEKSEDPLDSTVNNYHEIAAEAAETPSVQEEQMEIQQEESSLFT
DHEHSAPEALEQAENEAKESDEPSDSIINNQADIPGEAEDTKIDVEPDGHSELVQDDRLE
QDSRPFSAAHENRQDIHENETHAAIEEPQKRPVMQEKRTEQSASPQKGPSVPFNVMMLKR
DTHKQQKAEERRGSYVFPNVALLDVPPAQVQDDTGWIEEQRQLLDLTLKNFNVRANVVHV
TQGPSVTRFEVHPEPGVKVNKITNLSDDIKLSLSARDIRIEAPIPGKNTIGIEVPNRASK
VVDLRQMIRSSAFRTSKSPLTAALGLDISGNPVVIDLKKMPHGLIAGATGSGKSVCINTI
LVSLLYKADPSEVKVLLIDPKMVELAPYNKIPHLVSPVITDAKAATAALKWVVEEMERRY
ELFAHSGVRDIDRFNQLTADHQTGEKLPYLVVVIDELADLMMVAPNDVEESIARIAQKAR
ACGIHLLVATQRPSVDVITGLIKANIPTRIAFSVSSQVDSRTIIDIAGAEKLLGRGDMLF
LENGSGKPVRLQGNFVSDREIDRVVSHVRNQMPPTYLFEQEELVRQGSALKEEDELFYEA
CEFVVEQNSASTSSLQRRFRIGYNRAARLIDMMEAEGMISEAKGSKPREVLITASDLINE
>PK3-2_02268 UDP-N-acetylmuramate--L-alanine ligase
MTVYHFVGIKGTGMSPLAQILHDNGYTVQGSDIEKFIFTQTALEKRNITILPFSADNIKP
GMTVIAGNAFPDTHPEIEKAMSDGIPVIRYHKFLGDYMKKFTSVAVTGAHGKTSTTGLLA
HVIQNAKPTSFLIGDGTGQGNENSEYFVFEACEYRRHFLSYQPDYAIMTNIDFDHPDYFS
SIDDVFDAFQEMALQVNKGIIACGDDEHLPKIHANVPVVYYGTGEENDFQARNIVKSTEG
TTFDVFVRNTFYDTFYIPAYGHHNVLNSLAVIALCHYEEIDASVIKHGLKSFGGVKRRFN
EKQLGDQVLIDDYAHHPTEIKVTIEAARQKYPDREIVAVFQPHTFTRTQQFLDEFAESLS
GADCVYLCDIFGSARENAGKLTIGDLQGKIHNAKLIEEDDTSVLKAHEKAVLIFMGAGDI
QKYMRAYENVMA
>PK3-2_02269 hypothetical protein
MIIILYLSVALIAVAFLVLVIYLSKTLKSLQLTLKNVASTLEGLEGQMKGITTETAELLH
KTNRLAEDIQEKSEKLNTVVHAVQGVGTSVQQFNTSMKQAAGSVSASVRENQDKINQVVT
WSQAAMEIWEKWKQKKKSAL
>PK3-2_02270 hypothetical protein
MSKDGINSKDFLIGTLIGGIIGATTALFLAPKSGKELRDDLGSQAVALRDKTDKMTADAK
EKGTQYVSIAKDKTSNITQLVADQSGQIMNKVKDLRDRSKSAKTDSASMQDMREEAMQAA
NEAKDQVLQTKEDVKDELKDAQKQAEHINR
>PK3-2_02271 hypothetical protein
MAKQLIRSEEEFKRIAEQEGTFVFFKHSITCPISQAAFHEFDAFANQHEDVPSYYLQVQE
ARPLSNFIAETYRVKHESPQVFIIQNGEVKWHTSHSQITETSIEQHLS
>PK3-2_02272 Protein AroA(G)
MSNTELELLRQKADELNLQILKLINERGNVVKEIGKAKEAQGVNRFDPVRERTMLNNIIE
NNDGPFENSTIQHIFKEIFKAGLELQEEDHSKALLVSRKKKPEDTIVDIKGEKIGDGQQR
FIVGPCAVESYEQVAEVAAAAKKQGIKILRGGAFKPRTSPYDFQGLGVEGLQILKRVADE
FDLAVISEIVTPAHIEEALDYIDVIQIGARNMQNFELLKAAGAVKKPVLLKRGLAATISE
FINAAEYIMSQGNDQIILCERGIRTYETATRNTLDISAVPILKQETHLPVFVDVTHSTGR
RDLLLPTAKAALAIGADGVMAEVHPDPSVALSDSAQQMAIPEFEKWLNELKPMVKVNA
>PK3-2_02273 Catabolite control protein A
MSNITIYDVAREANVSMATVSRVVNGNPNVKPTTRKKVLEAIDRLGYRPNAVARGLASKK
TTTVGVIIPDISSIFYSELARGIEDIATMYKYNIILSNSDQNMEKELHLLNTMLGKQVDG
IVFMGGNITDEHVAEFKRSPVPIVLAASVEEQEETPSVAIDYEQAIYDAVKLLVDKGHTD
IAFVSGPMTEPINRSKKLQGYKRALEEANLPFNEQFVAEGDYTYDSGLEALQHLMSLDKK
PTAILSATDEMALGIIHAAQDQGLSIPEDLEIIGFDNTRLSLMVRPQLSTVVQPTYDIGA
VAMRLLTKLMNKEPVEEHIVELPHRIELRKSTKS
>PK3-2_02274 hypothetical protein
MKRFDYLTPVGFVLGTIIIVIGIISGSGVSGFRSFLDLTSFFIVTGGFAQLFLSVSRRES
>PK3-2_02275 Chemotaxis protein PomA
MKELVKTFVSLSDHARKHGLLSLDDQAREIKDPFLKKGLLLAVDGWDEETIRLVMDSEIA
AMEERHRKGRRVFEKAGEFAPAWGMIGTLVGLVLMLKNLNDPHMLGPNMAVALLTTLYGS
LLANMVFNPIAAKLEEKTESEIFIKQVMVEGIIGIQSGKNPRNLESQLVVFSSREEWRKQ
PNQAKAKKGSVHEA
>PK3-2_02276 Motility protein B
MKLRRERFERRNGSGKNSQSSSNWMVTFTDLITLILVFFILLFSMSQIDLQKFKAAVESI
QKEGGTLQPDQTSVEKKAETSADAKKHEDQQDQLLKKVNTYIKDHHLKAQMTAKRDERGV
VLVLQEAVLFDSGEAKVLKNAETLLHQIAVLLQTIPNDIQVEGHTDSRNISTYRYPSNWE
LSAARASGVIQYFTSKEKLPSKRFIAVGYADTKPVKDNKTNEHMKENRRVEIVIKKSKTT
SS
>PK3-2_02277 Acetoin utilization protein AcuC
MRDSVFIYSPSYQTYMFHQEHPFNQQRVLLTYDLLRTINAFDDGDIVSPRLAEEEELALV
HTDDYIQAVKLAGAGKLPAAEGESYGLGTEDTPVFAGMHEAASLLVGGTLTAADWVMSGQ
ALHAANLGGGLHHGFRGRASGFCIYNDSAVAIQYIQKKYRARVLYIDTDAHHGDGVQFTF
YDNPGVCTLSIHETGRYLFPGTGQIQEKGSGKGYGYSFNIPLDAFTEDDSFLEAYQAAAS
EVAAYFQPDVIISQNGADAHYYDPLTHLSATIKIYEEIPRLAHSLAHQYCGGRWIAVGGG
GYDIWRVVPRAWARIWLEMKGIDPGDSIPPEWISKWQKQCPVTLPSSWSDPADLYPPIPR
KPEITEKNAQTVSKALYAIRSEQQQKTK
>PK3-2_02278 Inosine-5'-monophosphate dehydrogenase
MIVEQIMKRDVITLTKTDTLETAICKLKEFHIRHLPVVDEDRRVIGMITDRDMKQASPSI
FEESKRSRFLTRSVDSIMKNDVVCAHPLDFVEEISAVFYEHGIGCLPVVQHQKLIGILTK
TDLLRTFVKLTGADQPGSQIEIKVNDITKSLAEISSLCQDLQVKILSVLVYPHDDPGVKV
LVFRVKTMNPLPFLQALQRNGHHVVWPSEQRDLL
>PK3-2_02279 Acetoin utilization protein AcuA
MEHHKTYHSANIKTATGSLLIEGPVSPEDLAGYEFHNDLTAFRPPREQHEALVDIAGLPE
GRIIIARDGRTIIGYVTYLYPDPLERWSEGNMEDLLELGAIEVAPAYRGCSVGKTLLTVS
MMDEQMENYIVMTTEYYWHWDLKGMKKDVWEYRKLMEKMMNAGGLVWFATDEPEISSHPA
NCLMARIGKNVSQESIEQFDRLRFYHRFMY
>PK3-2_02280 Acetyl-coenzyme A synthetase
MNLKALPAVEGDHHLKNYEETYRHFDWAEAEKHFSWHETGKLNAAYEAIDRHAESFRKNK
VALYYKDANRDEKYTFKEMKEESNRAGNVLKRYGNVEKGDRVFIFMPRSPELYFIMLGAI
KIGAIAGPLFEAFMEGAVKDRLENSEAKVVVTTPELLERIPADKLPHLQHIFVVGGEAES
GTNIINYDEAAKQESTRLDIEWMDKKDGYLLHYTSGSTGTPKGVLHVHEAMIQQYQTGKW
VLDLKEEDIYWCTADPGWVTGTVYGIFAPWLNGATNVIVGGRFSPESWYGTIEQLGVNVW
YSAPTAFRMLMGAGDEMAAKYDLTSLRHVLSVGEPLNPEVIRWGHKVFNKRIHDTWWMTE
TGSQLICNYPCMDIKPGSMGKPIPGVEAAIVDNQGNELPPFRMGNLAIKKGWPSMMHTIW
NNPEKYESYFMPGGWYVSGDSAYMDDDGYFWFQGRVDDVIMTSGERVGPFEVESKLVEHP
AIAEAGVIGKPDPVRGEIIKAFIALREGFEPSDKLKEEIRLFVKQGLAAHAAPREIEFKD
KLPKTRSGKIMRRVLKAWELDLPAGDLSTMED
>PK3-2_02282 Tyrosine--tRNA ligase 1
MTNLLEDLSFRGLIQQMTDEEGLNKQLNEEKIRLYSGFDPTADSLHIGHLLPILTLRRFQ
LAGHHPIALVGGATGLIGDPSGKKAERTLNTADIVSEWSQKIKNQLSRFLDFDAAENPAV
IANNFDWVGKMNVIDFLRDVGKNFGINYMLAKDTVSSRIESGISYTEFSYMILQSYDFLN
LYRDKNCKLQIGGSDQWGNITAGLELIRKSEEEGAKAFGLTIPLVTKADGTKFGKTEGGA
IWLDKEKTSPYEFYQFWINTDDRDVVKYLKYFTFLSKEEIEAYAEKTETAPEKREAQKRL
AEEVTALVHGREALEQAINISQALFSGNIKELSAQDVKVGFKDVPSMDVDSSQELSLVDV
LVQSKLSPSKRQAREDIQNGAVYINGERQTEVNHILSSEDRIEGQFTVLRRGKKKYFLVT
YK
>PK3-2_02283 hypothetical protein
MNLMCTIAKERLQRDYWEQQALASVGRLEEEDESDDKKTPTA
>PK3-2_02284 30S ribosomal protein S4
MARYTGPSWKLSRRLGISLSGTGKELEKRPYAPGPHGPGQRKKLSEYGLQLQEKQKLRHM
YGVNERQFRTLFDKAGKLTGKHGENFMILLDSRLDNVVYKLGLARTRRQARQLVNHGHIL
VDGSRVDIPSYLVKPGQTIGVREKSRNLSIVKESVEVNNFVPEYLTFDAEKLEGTFTRLP
ERSELAPEINEALIVEFYSR
>PK3-2_02285 hypothetical protein
MVEQTKDQLSAFHYHMLDFLLTKSEKVTFTDSLIWLTSAIQTYFSSLSVSLTPSPSDSAA
KLADGEVRFSASKINASFYMIEDGSGGRFHLTCRQDGAIPEGLPDVVSSFLNQSMKQERL
YIKTIYQKKIYKMTELFHSLLDQTEVLKQLLESLTRTFSRFEFSLFISHDQDQCLGVPAK
ELYMEGEKSDSFALKVYLSGDILRKNESAAYIPIKGQQGTYGVLKAEGPGGSFLTDACLD
EMSLIANAAGKAFENAQLYEQSKTSIANLELINETSRRLNQRLTLEDTMNDLAVRMAESF
QAEEVGFFHIDHFENQTLLPGSTAFFKEAKSSDFFNEIKEKLHEGEKGIFIGNGQSVFGK
AGYGSLMAVPMIENDELLGFAILLKKEMYAFTFEMYKLFQALIHHATLAVTNSMLRDRLE
HLVITDQLTELYSRVYLDEKIQYSMKINQKGVFILVDIDNFKNVNDTYGHQTGDEILIQV
ASVIKSNIRKHDVGARWGGEELAIYLPNVTVAVGKRITERLVYAVRKNTKPAVTISCGIS
CWSAETRKSLKELVHEADEALYSAKRNGKNRLVIHESIE
>PK3-2_02286 Free methionine-R-sulfoxide reductase
MFHVEKQSGDKEKDYQLLLKQLEAMTEDETDQIANYANASALLYHSLPEVNWAGFYFAKE
EDGQLVLGPFQGLPACVRIPFGRGVCGTAYTNGKVERVEDVNAFPGHIACDAASQSEIVL
PIHVGGKVVGVLDIDSPVKNRFDEIDEQYLSQFAETLEKALAK
>PK3-2_02287 putative HTH-type transcriptional regulator YttP
MKVSTKDKIIESAVMLFNQKGFSGTSVREIAKSADVNVAHISYYFKGKGGLMEHLVSEFY
EGYSKTLETAADNITSQSTQEQLLQLVFDILSYQHNHRQLTRFVYREVTIDSTLNREIMS
TYLMKEKYIFQLIIEEGEKQREHLTLPLPHFILQLKSLLMMPYLQPQYISEVLYMQPHEP
YFYKMYFEEIKIWIRSVFRTGDVALIN
>PK3-2_02288 Histidinol-phosphatase
MQKRDGHIHTPFCPHGSNDTLRQYAEEALKKGFESITFTEHAPLPPSFTDPTPLKDSAMA
QASLESYINEMSGLKKEYHGQLTIRTGLEVDYIAEFEDEIKLFLDTYGPYLDDSILSVHF
LRTGSSYVCLDYDEHTFKELISACGSIEAVYEQYYRSIYSSIVASLGGYKPKRVGHITLV
QKFIKLFPYSMSEHIRGLVSKCLNAIEENGMELDFNTSGLRKTYAGGIYIEDWMLNEAKQ
KKIPLVFGSDAHQAGDVGYAYEAFLERC
>PK3-2_02289 Septation ring formation regulator EzrA
MEFVIGLLIVLLALFAAGYFFRKKIYAEIDRLESWKIEILNRSIVEEMSKIKHLKMTGQT
EEFFEKWREEWDEIVTAHMPKVEELLYDAEENADKYRFKKANQVLVHIDDLLTAAESSIE
KILREISDLVTSEEKSREEIEQVRERYSKSRKNLLAYSHLYGELYDSLEKDLDEIWSGIK
QYEEETEGGNYITARKVLLEQERNLDRLQSYIDDVPKLLADCKQTVPGQIAKLKDGYREM
KEKGYKLEHIQLDKELENLSNQLKRAEHVLMTELDIDEASAILQLIDDNIQSVYQQLEGE
VEAGQSVLSKMPELIIAYDKLKEEKEHTKAETELVKESYRLTAGELGKQQAFEKRLDEIG
KLLSSVKDKLDAEHVAYSLLVEEVASVEKQIEEVKKEHDEFREKLQALRKEELQARETLS
HLKKTIAETARLLKTSNIPGIPSHIQEMLENAHHHIQETVNQLNELPLNVEEAGAHLKQA
EDIVNRASLESEELVEQVVLIEKIIQFGNRFRSQNHILSEQLKEAERRFYEYDYSEAYEI
AAAAVEKAAPGAVQKIESQNTKEHQYQ
>PK3-2_02290 hypothetical protein
MLGLLYVFRKQKSLIGCGGLTPVFETGIKTPFKQPIADSLSVIGCLVLFEYEYCYNNECI
L
>PK3-2_02291 IS3 family transposase ISBsu1
MKDHPKRHLEKQIGTLCREHKYRYGYRKITAILKKRMCINHKTVQRIMQKNQWQCQVKVK
KRKKNGQPYAVVDNILDRNFQSDRPLEKLVTDITYLPYGQKQLYLSSILDLYNGEVIAFT
IGDKQDTDFVLDTLNQLPMLSENCVLHSDQGSVYTSYEYQKAVKTKGITMSMSRKGTPAD
NASIESFHSSLKSETFYLNSIDRTTTAIVERTVIEYIHYYNNIRIQTELNNQSPINYRQL
AV
>PK3-2_02293 hypothetical protein
MGTRVTYPVEVKQKAVEMRLAGVPMKGIMQKLNIKNKTQVQTWVRWHKAGETHRFEQPVG
KQYTYGKGPEYSSELEKLQAENRYLRQQNEVLKKYNELERKLIAKRQSNL
>PK3-2_02294 Branched-chain amino acid transport system 2 carrier protein
MKSSLSAKETIAIGLMLFALFFGAGNMIFPPELGQAAGENVWKAMTGFLVTGVGLPLLGV
VAVALTGTDAKGLADKAHPVFGTIFTVVLYLTIGPLFAIPRTGTVSYEIAAVPFVSGIPS
WLALLVFTFIFFAITYYLALNPTKLVDRIGKVLTPILLAVIAILVIKSIVTPMGDIRSPL
EAYASGSVFKGFLEGYKTMDALASIVFGIVVVNAVKDRGITNRKSVASVCIKAGLVAAAG
LGLVYVSLAYLGATSTDSVGLLGAGSKILSESSQHLFGSLGNIILGVAILFACLTTSIGL
VSSCGNYFSKLIPSLSYKAVVTIVTVFSFIISNFGLSNIILFSVPILSAIYPLAIVIILL
SFIEKSFKGRREVYILCLIATGIFSIIDGLNAASIPLDSLNKVLSQSLPLYSLGFGWVIP
AIIGGIAGYLISLVTGSNKKPANIN
>PK3-2_02295 Cysteine desulfurase IscS
MLYLDNSSTTKPYDEVLNTYEQTSSRYFGNPSSLHRYGAETEQLLQAAKNQMKRSLGLKK
YDIVFTSGATEANNLALKGAALSKIKAGKHIIATSIEHPSVTESLEQLTELFGFDVTYLS
VNEDGFVSIEELKQAIRPDTVLVSMMHVNNEVGSVQPIEEAGEVLKEHPSILFHVDYVQG
IYKVPLAIEKAGIDLCSISGHKFHGLKGTGALIVKEGTRLTPLITGGSQQKGIRAGTEHT
AGAVSLAKAINLAAADFETRHTAMAAAKELFIKRLSETEGVVVNTPQDNSAPHIINFSVP
GIKAEVLLHMLEEQNIFVSTTSACSAKEHKPSKVLLQMGKGEQIAGSSIRISLNYSQTSE
VAEPFMNALVPGIKKLKKMMR
>PK3-2_02296 putative tRNA sulfurtransferase
MNYDHILIRFGEISTKGKNRKSFIERLKQNVRLVLKDYPNLKYFSNRDRMTITLNGVDPE
ALFPHLKQVFGIQSFSLAIKCDSRLDDIKATALQAIEDQYQPGDTFKVVTKRAYKQFELD
TNQMNAEIGGHILRNTEGLTVDVRNPDIPLRIEIREEATFLTIRDEKGAGGLPVGSAGKA
MLMLSGGFDSPVAGFYAMKRGLSVEAVHFFSPPYTSERAKQKVMDLAKCLSHFGGSMTLH
IVPFTKTQELIQKQIPENYTMTATRRLMLQIADRIREKRNGLAIITGESLGQVASQTLES
MYAINAVTSTPILRPLIGMDKTDIIEKSREIGTYETSIQPFEDCCTIFTPPSPKTRPKKE
KIEHFESFVDFEPYIQEAVDNIETMTLYSEQEANDKFAELF
>PK3-2_02297 Small, acid-soluble spore protein 2
MAQNSQNGNSSNQLLVPGAAQAIDQMKLEIASEFGVNLGADTTSRANGSVGGEITKRLVS
FAQQNMGGGQF
>PK3-2_02298 Acetyl-coenzyme A synthetase
MLKREDLIAPMQYNLVNEMEKFSAAGQKTALLWEDESGKQESWSYEKLMEETNKIGAALA
DLGFKKGDKLIVMVPRVLEAYAVYLAILKSGMVVIPCSEMLRAKDLEYRIEHAEVKGAIV
YSAFIGAFRDVSTADKLIKLSIGENDAGWKNLLSIEADGSQFQTADTTREDMAFLSYTSG
TTGQPKGVVHTHGWAFAHLKTSAGAWLDISEKDIVWATAAPGWQKWVWSPFLAVLGSGAT
GFVYHGRFKAEKYLELLNRYKINVFCCTPTEYRLMAKVEGLDRYDLSALHSAVSAGEPLN
REVIDVFQKHFGIKVRDGYGQTESTLLVGVLKDMDIKPGSMGKPTPGNQVEIINEDGEIC
KSGEVGDIAVHLSTPALFKEYYKDPERMKTQIRGDYFLTGDRAKKDEEGYFWFESRNDDI
IISSGYTIGPFEVEDALVKHPEVKECAVVASPDEIRGSIVKAYVVLQDHEKRSDELVKML
QNHVKTITAPYKYPREIEFVESLPKTASAKIRRVELRKREEQLKANKKA
>PK3-2_02299 N-substituted formamide deformylase
MKAIWHGGFIYTMLEEGDRTEAVYVEDGVIKGTGSYECLKKKYGSPETEEISLNGAVMFP
GFVDSHLHLIGHGEKQLQLDLSALTSKEAILHAAMERERQLPEGDWLIGEGWNENQFETP
DYLNKHDLDRLFPNRPVLLKRICRHAIAVNSAALQAAGISRNTPDPDGGVIVKDGSGEPT
GLLFDKAQNLVLKALPPVSQHYVDEALTAAIEDCWSKGLTGGHSEDLSYYGDASVPLKAY
EKAAASGKYPFRCHLLVHHEAVDRWEQLEKPSGPYVEFGAMKIFADGALGGRTALLKEPY
QDDPSTNGVQVHDDETLDRLIQKARDKGMEIAVHAIGDLAFEKVLNAIEKRPPKNGRHDR
LIHAQVLNDELIEKAARLPIALDLQPHFVASDFPWVIDRLGKDRMNTAFAWKTLMSKGIL
CAGGSDAPIEPVDPLLGIQSAVLRKSSHEQNGPSYNESECLTVFEAIKLYTEGSAGIIYN
EKSRGKIAEGYDADFTVLSGDPFTIDRAQLHLLGIKKTVINGQIVYENE
>PK3-2_02300 NAD kinase 1
MTDQRRNVYFFHKQDQKTNEQASSLTQLAEEHGFTVVNQHSDANIIASIGGDGTFLQAVR
KTNFRDDCLYVGITKKGKAHLYCDFHSDEREKMVDAMTFEQIEVRKYPLIEVTVDNASPF
HCLNEVSIRSSIIKTFVMDVLIDDLHFETFRGDGMIISTPTGSTAYNKSVAGAVVDPLLP
CMQVSELASLNNNTYRTLGSPFVLSSDRKLTLRVVQDGNEHPIIGLDNEALSTRNVKTIE
IKLSDKKIKTVKLKDNSFWEKVKRTFL
>PK3-2_02301 Putative signal peptide peptidase SppA
MNAKRWIALVIALGIFGVSIIVSISMSFFESVKGAQTDLTSLTDESQEKTLENGSLSSKI
AVLEVSGTIQDNGDSSSLLGSDGYNHRTFLKNLERAKEDKMVKGIVLKVNSPGGGVYESA
EIHKKLEEIKKETKKPIYVSMGSMAASGGYYISTAADKIFATPETLTGSLGVIMESVNYS
KLADKLGISFETIKSGAHKDIMSPSREMTKEEKNIMQSMVDNSYEGFVDVISEGRGMSKA
EVKKIADGRVYDGRQAKKLKLVDELGFYDDTISAMKKDHKDLKNASVISYEESFGLGSLF
SMGANKMFKSEIDFLNMREILSQSGSPRMMYLYAK
>PK3-2_02302 hypothetical protein
MDATFEELERNDIKGPQEEAERLTHAYAGFWVRFWAFLLDWLVVWGLNHLLVSPLFTVLD
LPKTSGMFTLSAYSVTTLVVYLAYFALMTKFFRQTLGKMVFGLKVVSMKPDRKLTWSTVI
FREVVGRYIDKIWILYIVVAFSPTKQGIHDYIADTTVVHEKLYRK
>PK3-2_02303 hypothetical protein
MVYVLTAILILIGIVLLFRMKIHVAMEYLHADDNDKLTLKVTTLLGLIRIKKTIPAIKLN
KDDGTVDIKQKTESKMKKNSEKKKITQGDVQQSINKIQMILHQVTKLRKISASFLAHLHI
TKLEWVTVVGIQDAAVTGVLTGAVWGVKGGIAAMLYDHLDFVNKPVYEVIPSFQVPVSKT
HFQCIFFFRFGHAMLAAFKFVKYGRELSVLKKNPSARMTSKNDSSV
>PK3-2_02304 putative spore protein YtfJ
MADHPIQGLMKTAMENLKEMIDVNTIIGDPVETPDGSVILTVSKVGFGFAAGGSEFGGKP
AEKKSEDDETREQKLPFGGGSGGGVSITPIAFLIVGSTGIRMLHLDENTHLIEKILDAAP
QTLERIQQMFKKNNKNQGQGQNQNQMNNMNY
>PK3-2_02305 Thiol peroxidase
MAEITFKGGPVTLVGQEVKVGDQAPDFTVLTNSLEEKSLADMKGKVTIISVIPSIDTGVC
DAQTRRFNEEAAKLGDVNVYTISADLPFAQARWCGANGIDKVETLSDHRDMSFGEAFGVY
IKELRLLARSVFVLDENGKVVYAEYVSEATNHPNYEKPIEAAKALVK
>PK3-2_02306 hypothetical protein
MQKDHVGAVYELLDEAAIIIKNEWQISYIEALAEAGEMYFLEKTDQLKLPDEKNKQLQAL
LEKAEFGTYEHEWVRKAFQLAVLKGLKDISHPNRQMTPDTIGLFISYLVNKFMADKKELT
VLDPAVGTGNLLFTVLNQLSEKTANSYGIEIDDVLLKIAYAQANLLKKEIELFHQDSLEP
LFIDPVDTVICDLPVGYYPNDEGAEAFELKADEGHSFAHHLFIEQSVKHTKPGGYLFFMI
PHHLFESSQSDKLKQFFKDKVHINALLQLPKSIFKDEAHAKSILVLQKKGDETKAPSQIL
LANLPSFSNQKAMLDMMSQLDEWFTKEK
>PK3-2_02307 Acetate kinase
MTMFKWKSQIFFGEDEDIHREKSTKNEVVDTEYKGASIMSKIIAINAGSSSLKFQLFEMP
SETVLTKGLVERIGIADSVFTISVNGEKNTEVTDIPDHAVAVKMLLNKLTEFGIINDLNE
IDGIGHRVVHGGEKFSDSVLLTDETIKEIEDISELAPLHNPANIVGIKAFKEVLPNVPAV
AVFDTAFHQTMPEQSYLYSLPYEYYEKFGIRKYGFHGTSHKYVTERAAELLGRPLKDLRL
ISCHLGNGASIAAVEGGKSIDTSMGFTPLAGVAMGTRSGNIDPALIPYIMEKTGQTADEV
LNTLNKKSGLLGISGFSSDLRDIVEATKEGNERAETALEVFASRIHKYIGSYAARMSGVD
AIIFTAGIGENSVEVRERVLRGLEFMGYTGTLRLITCAAKKLSSAIRILR
>PK3-2_02308 Molybdenum cofactor biosynthesis protein B
MSVQEHKQEAPNIVRCKVITVSDTRTEETDKSGKLMISFLEDAGHHIAAYEIVKDEKDAL
QRAVLAGCMDEQTDAVLLNGGTGIANRDVTIEAITSLFSKELPGFGEIFRMLSYTEDIGS
AAIMSRAVAGVIQHTAVFSTPGSSGAVKLAMNKLLIPELPHVVREIRKDK
>PK3-2_02309 Argininosuccinate synthase
MAEQKKVVLAYSGGLDTSVAIKWLQEQGYNVIACCLDVGEGKDLAFVQQKALEVGATNSY
VIDAKEEFAQDYALISLQAHTMYEGKYPLVSALSRPLIAKKLVEIAEKEDAQAIAHGCTG
KGNDQVRFEVSIKSLNPDLEVIAPVREWQWSREEEIEYAASRGIPIPINLDSPYSIDQNL
WGRANECGVLEDPWAAPPEGAYDLTAPLEKTPDTPEVIEIAFEQGVPVSIDGVSYSLSEL
ILKLNEMAGAHGVGRIDHVENRLVGIKSREVYECPGAMTLIKAHKELEDLTLVKEVAHFK
PIIEQKMSEIIYNGLWFSPLKDALHAFLKETQKHVTGIVRVKLFKGHAIVEGRKSEYSLY
DEKLATYTKDDAFDHHAAIGFIELWGLPTKVNSIVKKKEQIKA
>PK3-2_02310 Argininosuccinate lyase
MKKLWGGRFQKTPEKWVDEFGASISFDQNLVTEDITGSLAHAAMLKKCGILTAEEELKIR
EGLNTLLKKAEEGALAFSVDYEDIHLNIEKMLIDEIGPLGGKLHTGRSRNDQVATDMHLY
LKNHVGHIIELIEAFQSALIEKAEANVETILPGYTHLQRAQPISFAHHLLAYFWMLERDK
ERFQDSMKRINKSPLGCGALAGTTFPIDRDYSAELLGFDSIYENSLDGVSDRDFILEFLS
NSSMLMMHLSRFSEEIILWCSQEFKFIELDDTYATGSSMMPQKKNPDMAELIRGKTGRVY
GDMMGLFTIMKGLPLAYNKDLQEDKEGMFDTVKTVEGSLQIFTGMIQTMTVNKDVMKQAT
KQDFSNATELADYLAKKGMPFREAHEVVGKLVYTCIEKGIYLSDMPFGDFQQASTLFEED
IYTVLDPYHAVEKRMSAGGTGFKQVEQALEKAKACVAAGVC
>PK3-2_02311 hypothetical protein
MKKEPERYIYDEQESQETTRLISEAYQSGYVDMHDQEPSSSAE
>PK3-2_02312 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MRHALITAGSKGLGRKVTETLLAKGYSVTVNYRRDEDAVSRLKEACPDCLDRLQFVKGDV
TKKEDLLRMAEAALNRFGRIDFLINNAGPYIFERKKLADYTDDEWYGMLEGNLSAVFHLF
KAVIPIMRKQQFGRIITYGFQGAAHAPGWLHRSAFGAAKVGLASLTKTIAIEEAEFGITA
NMVCPGDIVGDMKEASIEEARKRIGKEKTPIGRSGTGEDIARIIAFLCEENSDLVTGTVI
EATGGLNVINKNQTT
>PK3-2_02313 hypothetical protein
MKVTYHGHSVITVETKDHNIIFDPFLTGNSLTNVKPEDVKADVILLTHGHNDHVGDTEQI
AKQNNALVVAPNELAVYLGWKGLNVHPMHIGGSRQFDFGKVKLTQAFHGSAITDEENKTI
TYTGMPAGILLTVEDKTIFHAGDTALFSDMKLIGELNHIDLAFLPIGDNFTMGPEDAKLA
AEWLRAKQVVPVHYNTFPVIEQDPEAFADSLPGGVGKVMAVGETIEL
>PK3-2_02314 Inosine-5'-monophosphate dehydrogenase
MKTSPDSSGDVFYFPLSLRTNPPSPYNENRRLSLEVKGLATKHEQILTYIDSLPVGEKIS
VRRIAKEMKVSEGTAYRAIKEAENKGFVSTIERVGTIRIEQKKKENIEKLTYAEVVNVID
GQVLGGRAGLHKTLNKFVIGAMELDAMMRYTAAGNLLIVGNRINAHRQALEAGAAVLVTG
GFNTDDSIVQLADELELPILSTSYDTFTVAAMINRAIYDQLIKKEIVLVEDILTPADRTI
YLSPKEKLEKWYEKNFETGHGRFPVVDEQMKIHGILTSKDIAGHDRNAPIEKVMTKNPVT
VIGKTSVASAAQMMVWEGIEVLPVTDGHQKLIGMISRQDVLKALQMIQKQPQVGEKLDDI
VSRGFKDEDNDKEDQTVYEYEVTPQMTNQLGTISYGVFTTILTQAANRFLRSKKRGELVI
ESITIFFLKPVQMESVIEVKPRILEAGRKFGKMEVEVHSQGHIVSKAMLMVQLMERS
>PK3-2_02315 hypothetical protein
MLVLVFLIGLSACFYVYYKVKGVRAKQALEKEICSAKSSMALGSLVLFYGLNQMILFHSV
LTLVIGGVFIVIGAGSAWAGYKAYRHYNPLHAKEAERDHA
>PK3-2_02316 Bifunctional oligoribonuclease and PAP phosphatase NrnA
MKTELIRTISLYDTIILHRHVRPDPDAYGSQCGLTEILRETYPEKNIFAVGTPEPSLSFL
YSLDEVDNETYEGALVIVCDTANQERIDDQRYPSGAKLMKIDHHPNEDPYGDLLWVDTSA
SSVSEMIYELYLEGKEHGWKLNTKAAELIYAGIVGDTGRFLFPNTTEKTLKYAGELIEYP
FSSSELFNQLYETKLNVVKLNGFIFQNVSLSENGAASVFIKKDTLEKFGTTASEASQLVG
TLGNISGIRAWVFFVEEDDQIRVRFRSKGPVINGLARKYNGGGHPLASGASIYSWDEADR
ILADLETLCKEHE
>PK3-2_02317 hypothetical protein
MEVYSDRQLAKDQTARLRQGFSAYAETNSLASLIKKELQSHNLQVYEDLTDFGCWFIPVT
DEH
>PK3-2_02318 Sporulation membrane protein YtrI
MRVPQHYKKPGWQRFFAGMMCGAVISWFFFLFTYGTFQEEQVSLIEKQKEHVKDLNNQIS
IYQEDLHKLNEDNKRKLLIQSVSVKLLNGDKYKISQPDKTKFEEHVKDDISEVITKDIES
VYQTKDLLKRTIENKVYLINEKKYEATVKELTIYTRLTVELEISFAA
>PK3-2_02319 Sporulation membrane protein YtrH
MDQEAGFMVNFINSYFIALGVLIGGALIGGLGAYLAGEAPLTAITKLANRLKIWALVAAI
GGTFDAVYSFERGILEGNTRDIFKQLLLIISAMGGAQSGWLIISWLTQEHLSS
>PK3-2_02320 DNA polymerase III subunit alpha
MSFVHLQVHSGYSLLNSAAAVEELVREADRLGYASLALTDDHVMYGAIQFYKACKARGIN
PIIGLTASIFTDDNELEAYPLVLLAKSNTGYQNLLKISSVLQSKSKGGLKPKWLHSYREG
IIAMTPGEKGYIEMLLEGGLFEQASQAALEFQSIFGNRAFYFSYQPFKGNQALSEQILRL
SEETGIPVAATGDVHYIRKEDKAAYRCLKAIKAGEKLTDAPAEDLPDLDLKPLEEMQNIY
REHPEALQASVEIAEQCQVDVSLGQTRLPSFPTPDGTSADDYLTDICMAGLRSRFGTPDE
RYLRRLQYELDVIKRMKFNDYFLIVWDFMKYAHEKGIVTGPGRGSAAGSLVAYVLYITDV
DPIKHHLLFERFLNPERISMPDIDIDFPDTRRDEVIQYVQQKYGEMHVAQIITFGTLAAK
AALRDVGRVFGVSPKEADQLAKLIPSRPGMTLDEARKQSPQLDKRLRESSLLQQVYTIAR
KIEGLPRHASTHAAGVVLSEEPLKDVVPLQEGHEGIYLTQYAMDHLEDLGLLKMDFLGLR
NLTLIESIISMIEKKENIKIDLSSISYRDDKTFSLLSKGDTTGIFQLESSGMRSVLKRLK
PSGLEDIVAVNALYRPGPMENIPLFIDRKHGRAPVHYPHEDLRSILEDTYGVIVYQEQIM
MIASRMAGFSLGEADLLRRAVSKKKKEILDKERSHFVEGCLKKEYSVDTANEVYDLIVKF
ANYGFNRSHAVAYSMIGCQLAYLKAHYPLYFMCGLLTSVIGNEDKIAQYLYEAKGSGIRI
LPPSVNKSSFPFTVEDGSVRYSLRAIKSVGVSAVKDIYKARKEKPFEDLFDFCFRVPSKS
VNRKTLEALIFSGAMDEFGQNRATLLASIDVALEHAELFATDDDQMGLFLDESFSIKPKY
VETEELPLVDLLAFEKETLGIYFSNHPLSAYRKQLAAHGAASILQAQQAVKRPLSLGVLL
SKIKTIRTKTGQNMAFLTLSDETGEMEAVVFPEQFRQLSPVLREGALLFTAGKCEVRQDK
VQFIMSRAELLENMDAEKAPSVYIKIESSQHSQEILAKIKRILLEHKGETGVYLYYEKQK
QTIKLPESFHIDADYQVLYRLKELLGQKNVVLKQW
>PK3-2_02321 NAD-dependent malic enzyme
MSLREEALHLHKVNQGKLESKSKVEVRNAKDLSLAYSPGVAEPCKDIHEDINKVYDYTMK
GNMVAVVTDGTAVLGLGNIGPEAALPVMEGKAVLFKSFAGVDAFPIALNTNDVDKIVETV
KLLEPTFGGVNLEDIAAPNCFIIEERLKKETNIPVFHDDQHGTAIVTVAGLVNALKLSGK
SMSSIKVVANGAGAAGIAIIKLLHHYGVRDIVMCDSKGAIYEGRPHGMNDVKNEVAKFTN
QDRKDGSLQDVIVDADVFIGVSVAGALTKEMVQSMAKDPIIFAMANPNPEIMPEDAREAG
ASVIGTGRSDFPNQVNNVLAFPGIFRGALDVRATHINEEMKIAAVEAIASLVSEDELSAE
YVIPAPFDKRVAPAVAKAVAKAAMETGVARITVDPEEVAEKTRQLTIIGE
>PK3-2_02322 Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta
MLKDIFTKKKKYASVPSDQAKHDVPEGIMTKCPKCKKIMLTKELDKNMRVCMNCDYHFPM
NAKQRIESLMDEQSFEEFNQGMLSENPLGFPGYLEKLEKDREKTSLNEAIVTGKGTIGGH
PAVVAVMDSSFRMGSMGSVVGEKITLAIEKAKADKVPFIIFTASGGARMQEGILSLMQMA
KTSSALKLFSEEQGLIISVMTHPTTGGVSASFASLGDYNFAEPGALIGFAGRRIIEQTIG
EKLPEDFQTAEFLLKHGQLDAVIHRDDMKKTLENLLDIHQTGGDFEWLQD
>PK3-2_02323 Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha
MAARLEFEKPVIELQTKIAELKKFTQDSDMDLSAEIERLEDRLAKLQDDIYKNLKPWDRV
QIARLADRPTTLDYISHLFTDFFECHGDRAYGDDEAIVGGIAKFHGLPVTVIGHQRGKDT
KENLVRNFGMPHPEGYRKALRLMKQADKFNRPIICFIDTKGAYPGRAAEERGQSEAIAKN
LFEMAGLRVPVICIVIGEGGSGGALGLGVGNHLHMLENSTYSVISPEGAAALLWKDSSLA
KKAAETMKITAPDLKELGIIDHMIKEVKGGAHHDVKLQASYMDETLKQSLKTLLKLSEEE
LVQQRYEKYKAIGKVSVEDQFIGVN
>PK3-2_02324 ATP-dependent 6-phosphofructokinase
MKRIGVLTSGGDSPGMNAAVRAVVRKAIYHDVEVYGIYNGYAGLISGKIEKLEIGSVGDI
IHRGGTKLYTARCPEFKTVEGREKGIENLKKLGIEGLVVIGGDGSYMGAKKLTEHGFPCV
GVPGTIDNDIPGTDFTIGFDTALNTVIDAIDKIRDTATSHERTYVIEVMGRHAGDIALWA
GLAGGAESILIPEADYDMHEIIARLKRGHERGKKHSIIIVAEGVGSGVEFGKRIEEETNL
ETRVSVLGHIQRGGSPSAADRVLASRLGAYAVELLLEGKGGRCVGIQNNKLVDHDIIEIL
DTKHTVEQNMYQLSKELSI
>PK3-2_02325 Pyruvate kinase
MRKTKIVCTIGPASESIEMLTKLMESGMNVARLNFSHGDFEEHGARIKNIREASKKLGKN
VGILLDTKGPEIRTHTMENGGIELETGKELIVSMDEVVGTTDKISVTYEGLIDDVEKGST
ILLDDGLIGLEVLDVDAAKREIKTKVLNNGTLKNKKGVNVPGVSVNLPGITEKDARDIVF
GIEQGVDFIAASFVRRSTDVLEIRELLEEHNAQDIQIIPKIENQEGVDNIDSILEVSDGL
MVARGDLGVEIPAEEVPLVQKDLIKKCNALGKPVITATQMLDSMQRNPRPTRAEASDVAN
AIFDGTDAIMLSGETAAGNYPVEAVQTMHNIASRSEEALNYKEILSKRRDQVGMTITDAI
GQSVAHTAINLEAAAIVTPTESGHTARMIAKYRPQAPIVAVTINDSVSRKLALVSGVFAE
SGQNANTTDEMLEDAVQKSLNSGIVKHGDLIVITAGTVGESGTTNLMKVYTVGDIIAKGQ
GIGRKSAFGPVVIAQNAKEAEQKMTDGAVLVTKSTDRDMIASLEKASALITEEGGLTSHA
AVVGLSLGIPVIVGLENATSILAEGQEITVDASRGAVYQGRASVL
>PK3-2_02326 hypothetical protein
MRYLFLLFIVFPAIEIGIFLFSGKLIGILPTVLLMILTGIIGAAAAKKQGTEVYYKVQRD
LQYGKMPGEAIADGLCIFIGGLLLMLPGFLSDLAGACLLIPFTRSWCKPILFKWLRGMSK
NKRIIVK
>PK3-2_02327 Sodium-lithium/proton antiporter
MNQSYITIFFRTLFVISITAGSMAAAYYSFPLTYPFLIALILSSAIHPVVDYLDKVTGFP
RTINVLGVLAFFLLAAFGVLTILVAEIVTGTAYLAKTLPPHISTFISYCEKLFTTHIQPL
YNELTLLFQELETNQQASIVTHIQTLGDSAAKNAGLLLSHILEMIPKFFALLPNTAAVLI
FSLLATFFMTKDWHKLKAMLVSVLPDRVTANSKAISSELKKAMTGFIKAQAVLVFITMII
VFIGLSLLKVEHAATIAFLIGLVDLLPYLGAGSVFVPWILYLSVTGQLPQAIGIGVLYLV
VLIQRQLTEPKILSKSIGIDPLATLIALFAGFKLFGFLGLIAGPAVLVIIQAFITTGALK
EIWSYITVQQK
>PK3-2_02328 hypothetical protein
MFTQANLFLILLLAIALIAKNQSLLFAVSVLLIIKIVGLDQKVFPTIQSKGINWGVTVIT
IAVLVPIATGEIGFKQLGEAMRSSYAWIALGAGIAVALIAKNGLTLLENDPHITTALVIG
TILAVALFGGVAVGPLIGAGIAYIAMQLVKLFTS
>PK3-2_02329 Citrate synthase 2
MTATRGLEGVVATTSSVSSIIDDTLTYVGYDIDDLTENASFEEIIYLLWHLRLPNKKELE
ELKQQLAKEAAVPQEIIEHFKSYSLENVHPMAALRTAISLLGLLDSEADIMNPEANYKKA
IRLQAKVPGLVAAFSRIRKGLEPVEPREDYGIAENFLYTLNGEEPSPIEVEAFNKALILH
ADHELNASTFTARVCVATLSDIYSGITAAIGALKGPLHGGANEGVMKMLTEIGEVENAEP
YIRAKLEKKEKIMGFGHRVYKHGDPRAKHLKEMSKRLTNLTGESKWYEMSIRIEEIVTSE
KKLPPNVDFYSASVYHSLGIDHDLFTPIFAVSRMSGWLAHILEQYDNNRLIRPRADYTGP
DKQAFVPIEERA
>PK3-2_02330 Isocitrate dehydrogenase [NADP]
MAQGEKITVSNGVLNVPNNPIIPFIEGDGTGPDIWNAASKVLEAAVEKAYKGEKKITWKE
VYAGEKAYNKTGEWLPAETLDVIREYFIAIKGPLTTPVGGGIRSLNVALRQELDLFVCLR
PVRYFTGVPSPVKRPEDTDMVIFRENTEDIYAGIEYAKGSEEVQKLISFLQNELNVNKIR
FPETSGIGIKPVSEEGTSRLVRAAIDYAIEHGRKSVTLVHKGNIMKFTEGAFKNWGYELA
EREYGEKVFTWAQYDRIAEEQGKDAANKAQSEAEAAGKIIVKDSIADIFLQQILTRPNEF
DVVATMNLNGDYISDALAAQVGGIGIAPGANINYETGHAIFEATHGTAPKYAGLDKVNPS
SVILSGVLLLEHLGWNEAADLVIKSMEKTIASKVVTYDFARLMDGATEVKCSEFGEELIK
NMD
>PK3-2_02331 Malate dehydrogenase
MGNTRKKVSVIGAGFTGATTAFLIAQKELADVVLVDIPQLENPTKGKALDMFEASPVQGF
DAKITGTSNYEDTAGSDIVVITAGIARKPGMSRDDLVSTNEKIMRSVTREIVKYSPDSII
VVLTNPVDAMTYAVYKESGFPKERVIGQSGVLDTARFRTFVAEELNLSVKDVTGFVLGGH
GDDMVPLVRYSYAGGIPLETLIPKERIDAIVERTRKGGGEIVNLLGNGSAYYAPAASLTE
MVEAILKDQRRVLPTIAYLEGEYGYEGIYLGVPTIVGGNGLEQIIELELTDYERAQLNKS
VESVKNVMKVLS
>PK3-2_02332 Alkaline phosphatase synthesis transcriptional regulatory protein PhoP
MNKKILVVDDEESIVTLLQYNLERSGYHVITASDGEEALKKAETEKPDLIVLDVMLPKLD
GIEVCKQLRQQKLMFPILMLTAKDEEFDKVLGLELGADDYMTKPFSPREVNARVKAILRR
SEMAAPSSEMKNDEIEGQIVIGDLKILPDHYEAYFKEDQLELTPKEFELLLYLGRHKGRV
LTRDLLLSAVWNYDFAGDTRIVDVHISHLRDKIENNTKKPIYIKTIRGLGYKLEEPKMNE
>PK3-2_02333 Alkaline phosphatase synthesis sensor protein PhoR
MNKYRVRLYSVLVVCMILVFSVLGLFLQQLFETSDQRKAEEHIEKEAKYMASLLDAGNLN
DQANEKIIKDAGGALDVSASVIDTDGKVLYGSNGRAADTQKVQALVSGHSGVLSTADNKL
YYGLPLKNEGEKTGYVLLSASEKSYGLKGEMWGMLTASLCTAFIVIVYFYSSMTSRYKRS
IEAATNVATELSKGNYDARTYGGYIRRSDKLGRAMNSLAVDLMEMTRTQEMQRDRLLTVI
ENIGSGLIMIDGRGFINLVNRSYAKQFHINPNQMLRRLYHDAFEHEEVIQLVEDIFMTET
KKCKLLRLPIKIERRYFEVDGVPIMGPDDEWKGIVLVFHDMTETKKLEQMRKDFVANVSH
ELKTPITSIKGFTETLLDGAMEDKEALSDFLSIILKESERLQSLVQDLLDLSKIEQQNFT
LSIETFEPAKMLGEIETLLKHKADEKGISLQLNVPKDPLYVSGDPYRLKQVFLNLVNNAL
TYTPERGSVAINVKPGEKDIQIEVADSGIGIQKEEIPRIFERFYRVDKDRSRNSGGTGLG
LAIVKHLIEAHEGKIDVTSEPGRGTVFTVTLKRAAEKSA
>PK3-2_02334 DNA polymerase I
MTERKKLVLVDGNSLAYRAFFALPLLSNDKGIHTNAVYGFAMILMKMLEDEKPTHMLVAF
DAGKTTFRHGTFKEYKGGRQKTPPELSEQMPFIRELLDAYQVSRYELEQYEADDIIGTLA
KTAEKDGFEVKVFSGDKDLTQLATDKTTVAITRKGITDVEFYTPEHVKEKYGLTPEQIID
MKGLMGDSSDNIPGVPGVGEKTAIKLLKQFDSVEKLLESIDEVSGKKLKEKLEEFKDQAL
MSKELATIMTDAPIEVSVSGLEYQGFNREQVIAIFKDLGFSTLLERLGEDSEEAEQDQAL
EDINAKTVTDVTSEILVSPSAFVVEQIGDNYHEEPILGFSIVNETGSYFIPKDIAVESEV
FKEWVENDEQKKWVFDSKRAVVALRWQGIELKGAEFDTLLAAYIINPGNSYDDVASVAKD
YGLHIVSSDESVYGKGAKRAVPSEDVLSEHLVRKALAIQGLREKLVQELENNDQLELFEE
LEMPLALILGEMESTGVKVDVDRLKRMGEELGAKLKEYEEKIHEIAGEPFNINSPKQLGV
ILFEKIGLPVVKKTKTGYSTSADVLEKLADKHDIVDYILQYRQIGKLQSTYIEGLLKVTR
PDSHKVHTRFNQALTQTGRLSSTDPNLQNIPIRLEEGRKIRQAFVPSEKDWLIFAADYSQ
IELRVLAHISKDENLIEAFTNDMDIHTKTAMDVFHVAEDEVTSAMRRQAKAVNFGIVYGI
SDYGLSQNLGITRKEAGAFIDRYLESFQGVKAYMEESVQDAKQKGYVTTLMHRRRYIPEL
TSRNFNIRSFAERTAMNTPIQGSAADIIKKAMIDMAAKLKEKQLKARLLLQVHDELIFEA
PQEEIEILEKLVPEVMEHALTLDVPLKVDYASGPSWYDAK
>PK3-2_02335 Formamidopyrimidine-DNA glycosylase
MPELPEVETVRRTLTGLVKGKTIKSVEIRWPNIIKRPAEPEEFARKLAGETIQSIGRRGK
FLLFHLDHYVMVSHLRMEGKYGLHQAEEPDDKHVHVIFTMTDGSQLRYRDVRKFGTMHLF
NPGEEAGELPLSQLGPEPDAKEFTSAYLKERLAKTNRAVKTALLDQKTVVGLGNIYVDEA
LFRAGVHPETKANQLSDKTIKTLHAEIKNTLQEAIDAGGSTVRSYINSQGEIGMFQLQHF
VYGKKDQPCKNCGTMISKIVVGGRGTHFCAKCQKKSR
>PK3-2_02336 putative sporulation protein YtaF
MQMVSILLLALAVSLDSFSVGFTYGLRKMKIPFKAILVIACCSGAVMFISMLIGSFLTKF
FPVYVTEKLGGLILVGIGAWVLYQFFKPAKDKEYLLHEKTLLNLEVRSLGIVIHILRKPM
SADIDKSGVINGIEAVLLGFALSIDAFGAGIGAAILGFSPIVMSIAVAIMSSLFVSIGIN
AGHILSKWKWIDKMAFLPGLLLITIGLWKL
>PK3-2_02337 Dephospho-CoA kinase
MTLVIGLTGGIASGKSTVANMLIEKGITVIDADIIAKQAVEKGMPAYRQIIDEFGGDILL
PNGDIDRKKLGAQVFTNEEKRLALNAIVHPSVRQEMLKRRDEAIANREAFVVLDIPLLFE
SKLESLVDKIIVVSVTKELQLERLMKRNQLTEEEAVSRIRSQMPLNEKTARADQVIDNSG
TLEETKQQLDDIISRWT
>PK3-2_02338 putative oxidoreductase YtbE
MTTHLQATATLYNGVKMPWFGLGVFQVEEGSELVNAVKTAIVHGYRSIDTAAIYGNEAGV
GEGLRQGIEEAGISREDLFITSKVWNADLGYEETLAAFETSLSKLGLDYLDLYLIHWPVE
GKYKEAWRALETLYKEGRVKAIGVSNFQIHHLEDLMAAAEMKPMINQVEFHPRLTQKELM
AYCKKQGIQMEAWSPLMQGQLLDHPVLADIAQTYNKSVAQIILRWDLQHGVITIPKSTKE
HRIQENASVFDFELTQDDMNRIDALNENLRVGPDPDNFDF
>PK3-2_02339 Inner membrane transport protein YdhP
MTSANKSSIPALLALAVSAFAIGTTEFISVGLLPLISDDLHIPVTTAGLTVSLYALGVTF
GAPILTSLTSSMSRKTLLLWIMFIFIAGNTVAAAASSIGILLAARVISAFSHGVFMSIGS
TIAADIVPEDKRASAISIMFTGLTVATVTGVPFGTFIGQQFGWRFAFMVIIAVGIIAFIT
NGILVPSKLRKGTKTTMRDHLKLVTNGRLLLLFVITALGYGGTFVVFTYLSPLLQEVTGF
QAGTVAVILLGYGIAIAIGNMIGGKLSNRNPIAALFYMFIVQAIVLFVLTFTAPFQIAGL
ITILCMGLLAFMNVPGLQVYVVMLAERFVPSAVDVASAMNIAAFNAGIALGSYLGGVITD
SIGLIHTAWIGGLMVVGAVILTGWSRLMENRDRQEA
>PK3-2_02340 putative HTH-type transcriptional regulator YtcD
MEKKKYNISVEATLEVIGGKWKCVILCHLTHGKKRTSELKRLMPNITQKMLTQQLRELEA
DGVINRIVYNQVPPKVEYELSEYGRSLEGILDMLCDWGANHINRVYGDTFSVLEESVLND
KLKQES
>PK3-2_02341 Glyceraldehyde-3-phosphate dehydrogenase 2
MKVKVAINGFGRIGRMVFRKAMLDDQIQVVAINASYSAETLAHLIKYDTIHGRYDKEVVA
GEDSLIVNGKKVLLLNSRDPKQLPWREYDIDIVVEATGKFNSKDKAMGHIEAGAKKVILT
APGKNEDVTIVMGVNEDQFDAERHVIISNASCTTNCLAPVVKVLDEEFGIESGLMTTVHA
YTNDQKNIDNPHKDLRRARACGESIIPTTTGAAKALSLVLPHLKGKLHGLALRVPVPNVS
LVDLVVDLKTDVTAEEVNEAFKRAAKTSMYGVLDYSDEPLVSADYNTNPHSAVIDGLTTM
VMEDRKVKVLAWYDNEWGYSCRVVDLIRHVAARMKHPSAV
>PK3-2_02342 S-adenosylmethionine decarboxylase proenzyme
METMGRHVISELWGCDFDKLNDMDFIEKTFVNAALKSGAEVREVAFHKFAPQGVSGVVII
SESHLTIHSFPEHGYASIDVYTCGDLDPNVAADYIAEALHADTRENIEIPRGMGPVQIKQ
AQAKVL
>PK3-2_02343 Transcriptional repressor NrdR
MKCPSCQHNGTRVLDSRPVDDGKSIRRRRECESCHYRFTTFEKVEETPLIVVKKEGVREE
FSREKMLRGLIKACEKRPVPLKTLEDMCFDIEKELRNQGCSEVKSELVGEMVMDRLAKID
EVAYVRFASVYRQFKDINVFIDELKDLIKKER
>PK3-2_02344 Replication initiation and membrane attachment protein
MADYWKDVLPVDPYMVKSRSMLQDIDRQIITQLYQPLIGPVAFSLYMTLWGELEQNRLWG
GESTHRQLMGMTQSNLKTIHQEQGKLEGIGLLKVYMKESERQERLFIYELLPPLRPNEFF
EDGMLNVFLYNRVGKTKYQQLKQFFTHPAISEDAKDITRPFNHAFESLQPSEWKLTSDME
ETVRLAQGTEYTSVGQAPSYTITEEVFDFDLFLAGLSETMIPRKAMTQQVRDTIKKLSYL
YEIDPLQMQNVVMSAIDERDVITTEALRKAASDWYQIERNGQLPDLVEKTQPVHLREGEK
PAEGDSLDGKLIALLEAISPKKLLQDIADGTEPSKADLKIIEEIMFEQKLEPGVTNVLIY
YVMLKTDMKLSKNYIQKIASHWARKKVKTVREAMKLAIEENRQYLEWAEGKANQPSKRNK
KVVREEKIPDWMKEKETASDSESKQQKLQPQDLEEQKKKMMEEMQKLKKYSAY
>PK3-2_02345 Primosomal protein DnaI
MEPIGRSLQGVTGRPDFQKRLEQMKEKVMKDQDVQAFLQENEEIIDQQMIEKSLNKLYEY
IGQSKNCSYCSEDEDCNNLLEGYHPKLVVNGRSIDIEYYECPVKRKLDQQKKQKSLMKSM
YIQQDLLGATFQQVDISDPSRLAMFQHVTDFLKSYNETGKGKGLYLYGKFGVGKTFMLAA
IANELAEKEYSSMIVYVPEFVRELKNSLQDHSLEEKLNMVKTTPVLMLDDIGAESMTSWV
RDEVIGTVLQHRMSQQLPTFFSSNFSPDELKHHFTYSQRGEKEEVKAARLMERILYLAAP
IRLDGENRRHP
>PK3-2_02346 hypothetical protein
MKRKTALKWLAVLAVAGLIFWGNKRYLNVSPKEIRVWVLSFGVFAPLMFIGISIIRPLVL
FPVSVISIAGGLAFGPLLGTLYTLFGSMCASAVSFFAAGLFAAKKNGHYKKLEAVQKQME
DNGFFYIFLLRILPINFDFVSYAAGLSNVKALPYFAATAAGIIPGTIALNVLGASFLAGN
LPAFLVVLVLYIVFISLPFIFRKKMQNLFQESN
>PK3-2_02347 hypothetical protein
MLEIIFEDDHDAAAFLHLIQHSDDRNNIIVREGIRKIGIEKAKPAFSIQHFMEPILVKFF
LECKEDEHLLSLIEETYCFTDHDEQQQILQLAHSIIEGEADDLPFEPLKLSRKQSILDEL
QTICLEEGVFSIRSFQTFRLGQYYKQLRDITEAAIDEYKMEQEYQNFIQTLRDYVTAKQP
RIKKVHIVHDGSFTLWELRYVPEREKMKYIDRRFVRDHPMYIDSHLLAPLISIAPDEVVL
YTDQPEHMMARTIQNVFQERMEMLPLHAFSDTEIPVKHSEG
>PK3-2_02348 Threonine--tRNA ligase 1
MSDMVKITFPDGAVKEFAKGTTTEDIAASISPGLKKKSLAGKLNGKEIDLKTPINEDGTV
EIITEGSEEGLQIMRHSTAHLLAQAIKRIYKDVKFGVGPVIENGFYYDVEMEEAITPEDL
PKIEKEMKKIVNANLPIIRKEVSREEAKARFAEIGDDLKLELLDAIPEGETVSIYEQGEF
FDLCRGVHVPSTGKIKEFKLLSLAGAYWRGDSNNQMLQRVYGTAFFKKADLEEHLRMLEE
AKERDHRKLGKELKLFANSQKVGQGLPLWLPKGATIRRVIERYIVDKEISLGYEHVYTPV
LGSKELYETSGHWEHYQEGMFPPMEMDNETLVLRPMNCPHHMMIYKQDIHSYRELPIRIA
ELGTMHRYEMSGALSGLQRVRGMTLNDAHIFVRPDQIKDEFIRTVRLIQDVYEDFGLSDY
TFRLSYRDPEDTEKYFDDDEMWNKAQSMLKSAMDEIGHDYYEAEGEAAFYGPKLDVQVKT
AIGKEETLSTVQLDFLLPERFDLTYIGEDGKQHRPVVIHRGVVSTMERFVAFLIEEHKGA
LPTWLAPVQFQVIPVSPAVHLDYAKKVQERLQREGLRVEVDSRDEKIGYKIREAQMQKIP
YMLVVGDQEAENGAVNVRKYGEQNSETISLDDFVKKAVAEAKK
>PK3-2_02349 Pyrophosphatase PpaX
MKAVFFDLDDTLLWDEKSVRTTFAETCLQAEKKYGLDPQEFEAAVREAARELYMSYETYP
YTVMIGINPFEGLWSNFSEPISEGFQKLNKIVPEYRRNAWTNGLKTLGIDDPAYGEYLGE
FFAAERRKRPFVYYETFAVLDQLKGKYELLLLTNGDPSLQKEKLAGVPELAPYFNEIVIS
GAFGKGKPDVSIFEHCLKLMNIEKDDAIMVGDNLNTDILGASRAGIKTVWINRTDKKNET
DVTPDYIISSLHDLFPLLEK
>PK3-2_02350 Sensor histidine kinase YpdA
MIHLMIMMLERVGIIVILGFILAHTKLFRQALQNQDGYKGKAVLISIFSLFSIISNYTGI
EIQKNMIVNNDWVFAIDPSGSIANTRILGVEIGGLLGGPFVGAGIGILAGLHRFSLGGST
ALSCAVSSVLAGVLAGLIGRYFTKRYRMPTPRIAALVGIGMETLQMVIILLMAKPFSDAW
ELVSMIGIPMILINGTGSFIFLSIIQAIIRKEEQARALETHRVLTIADQTLPFFRQGLNE
NSCKSVAAIIHKLTGTDAVSLTDKEKILAHVGAGMDHHIPSKSLITGLSKKVIKTGEIMK
AISQEEIECTHSECPLHAAIVLPLTSNGNTIGTLKMYFKNPAGLSQVEEELAEGLAMLFS
TQLELGEAELQSKLLKDAEIKALQAQVNPHFLFNAINTISALCRTDVEKTRKLLLQLSVY
FRSNLQGARQLLIPLSKELNHLHAYLSLEQARFPGKYKIELNIDSRLEQIEIPPFVLQVL
VENALRHAFPKKQDMCKVTVCVLSDDTSVYLKVTDNGRGIPPDVLPELGKKPFPSKEGTG
TALCNLNQRLVGLFGQQAALNIRSEVHKGTEVSFQVPMQQMKEGEDHAQGVNS
>PK3-2_02351 Sensory transduction protein LytR
MLRVLIVDDEMLARDELAYLLKRTNEEMEINEAENIESAFDQMMDQKPDLLFLDVDLSGE
NGFDIAKRLKKMKHPPAVVFATAYDQYALKAFEVDALDYLTKPFDEERIQQTLKKYKKVN
RDIVEADQSSHSGQHKLALSVGESIVIVDTKDIIYAGTEDRHVNVKTFDTSYRVSDTLVV
IEKKLPDADFIRVHRSFVVNTEYIKEIQPWFNSTYNLIMKDGSKIPVSRTYAKELKKLLH
I
>PK3-2_02352 Antiholin-like protein LrgA
MSAKKVYGFLTQAFIFAVIMLVSNMIAAIVPIPIPASVVGLVLLFLLLCLKVIKLEQVET
LGTSLTSLIGFLFVPSGISVMNSLGVMQQYGLQIVLVILLATIILLGATGLFSQLILSLS
GKRKTEADMKTKTVQSPQNNKELVHH
>PK3-2_02353 Antiholin-like protein LrgB
MESTMSPYFGIVVSLAAFGIGTFLFKRTKGFFLFTPLFVAMVLGIAFLKIGGFSYADYNN
GGEIIKFFLEPATIAFAIPLYKQRDKLKKFWWQIMASIIVGSICSVTIVYLLAKGIHLDA
AVMKSMLPQAATTAIALPLSKDIGGISDITAFAVIFNAVIVYALGALFLKVFKVKNPISK
GLALGTSGHALGVAVGIEMGEVEAAMASIAVVVVGVVTVLVIPVFVQLIGG
>PK3-2_02355 Translation initiation factor IF-3
MVNEGIRAREVRLIGQNGDQLGIKSRQEALEIAGRANLDLVLVAANAKPPVCRIMDYGKF
RFEQQKKDKEARKNQKIINLKEVRLSPTIDEHDFNTKLRNAIKFLEKGDKVKASIRFKGR
AITHKEIGQRVLDRFSEACAEVATVETKPKMDGRSMFLMLAPKNEKQ
>PK3-2_02356 50S ribosomal protein L35
MPKMKTHRGSAKRFKKTGSGKLKRSHAYTSHLFANKSQKQKRKLRKSAVVSAGDFKRIKQ
MLANIK
>PK3-2_02357 50S ribosomal protein L20
MPRVKGGTVTRKRRKKVLKLAKGYFGSKHTLYKVANQQVMKSGNYAFRDRRQKKRDFRKL
WITRINAAARMNGLSYSRLMHGLKLSGIEVNRKMLADLAVNDLTAFNQLADAAKAQLNK
>PK3-2_02358 hypothetical protein
MVIAVYLVLINLCGFWVMGADKRKAQQHKWRISEDRLWLIAIVFGALGVWLGMQTFRHKT
KHASFKYGVPLLLVIEAILIGIYYSPFDL
>PK3-2_02359 Sigma-w pathway protein YsdB
MFAMVLRILLLALFAYCIYAAVKYVANPKRRLRMAQSKEHFYIIDEQNNTRKNFQLTYKG
VLFEGEKHIPSKDHPLFIHTIFVWTESPEKLKHFSAKDFENIEEKVLERYPNCKIDWDQP
IKLAKKAEER
>PK3-2_02360 Putative aminopeptidase YsdC
MAKLDETLTMLKDLTDAKGIPGNEREVRQVMKSYIEPFADEVTTDRLGSLIAKKTGAENG
PKIMIAGHLDEVGFMVTQITDKGFIRFQTVGGWWAQVMLAQRVTIVTKKGEITGVIGSKP
PHILSPEARKKSVEIKEMFIDIGASSREEALEWGVLPGDMIVPHFEFTVMNNEKFLLAKA
WDNRIGCAIAIDVLRNLQNTDHPNIVYGVGTVQEEVGLRGAKTAAHTIQPDIAFGVDVGI
AGDTPGISEKEAQSKMGKGPQIIVYDASMVSHKGLRDAVVATAEEAGIPYQFDAIAGGGT
DSGAIHLTANGVPALSITIATRYIHTHAAMLHRDDYENAVKLITEVIKKLDRKTVDEITY
Q
>PK3-2_02361 Extracellular endo-alpha-(1->5)-L-arabinanase 1
MKKKKTWKRFFHLSSAALAAGLLFTSAAPAEAAFWGASNELLHDPTMIKEGSSWYAFGTG
LTEERGLRVLKSSDAKNWTVQKSIFSTPLSWWSNYVPNYGQNQWAPDIQYYNGKYWLYYS
VSSFGSKTSAIGLASSTSISSGSWKDEGLVIRSTSSNNYNAIDPELTFDKDGNPWLAFGS
FWSGIKLTKLDKNTMKPTGSLYSIAARPNNGGALEAPTLTYQNGYYYLMVSFDKCCDGVN
STYKIAYGRSKSITGPYLDKSGKSMLEGGGTILDSGNDQWKGPGGQDIVNGNILVRHAYD
AKDNGIPKLLINDLNWSSGWPSY
>PK3-2_02362 L-arabinose isomerase
MLQTKDYEFWFVTGSQHLYGEETLELVEQHAKGICEGLSGISSRYKITHKPVVTSSETIR
QLLREAEYSETCAGIITWMHTFSPAKMWIEGLSSYQKPLMHLHTQYNRDIPWGTIDMDFM
NSNQSAHGDREYGYINSRMGLNRKVIAGYWDDAEVKKEISQWLDTAAALNESRHIKVARF
GDNMRHVAVTDGDKVGAHIQFGWQVDGYGIGDLVEVMNRITDDEVDTLYAEYDRLYVISE
ETKRDEAKIASIKEQAKIELGLTAFLEQGGYTAFTTSFEVLHGMKQLPGLAVQRLMEKGY
GFAGEGDWKTAALVRMMKIMAEGKRTSFMEDYTYHFEPGNEMILGSHMLEVCPTVALDQP
KIEVHPLSIGGKEDPARFVFNGISGSAIQASLVDIGGRFRLVLNEVNGQEIEKDMPNLPV
ARVLWKTEPSLKTAAEAWILAGGAHHTCLSYELTAEQLLDWAEMAGIESVLISRDTTIHK
LKHELKWNEALHRLQK
>PK3-2_02363 Ribulokinase
MAYTIGVDFGTLSGRAVLVHVETGEELASAVKEYRHAVIDTVLPKTGQKLPRDWALQHPA
DYLEVLETTIPSLLEETGVEPKDVIGIGIDFTACTILPVDSTGQPLCMLPEYEEEPHSYV
KLWKHHAAQKHADRLNQIAEEEGEAFLQRYGGKISSEWMIPKVMQIAEEAPYIYEAADRI
IEAADWIVYQLCGSLKRSNCTAGYKAIWSEKAGYPSDDFFNKLNPLMKTITNDKLAGPIH
SVGEKAGGLIEKMAQLTGLLPGTAVAVANVDAHVSVPAVGITEPGKMLMIMGTSTCHVLL
GEEVHIVPGMCGVVDNGILPGYAGYEAGQSCVGDHFDWFVKTCVPQAYQKEAEEKNIGVH
ELLSEKANLQTPGESGLLALDWWNGNRSTLVDADLTGMLLGMTLLTKPEEIYRALVEATA
YGTRMIIETFKESGVPIEELYAAGGIAEKNPFVMQIYADVTNMDIKISGSPQAPALGSAI
FGALAAGKENGGYDDIKEAAAHMGKLKDISYSPNAENAAVYEKLYAEYKELVHYFGKENH
VMKRLKTIKNLQFSSAAKKNS
>PK3-2_02364 L-ribulose-5-phosphate 4-epimerase
MLETLKKEVLAANLKLQEHQLVTFTWGNVSGIDREKERIVIKPSGVEYSDLTADDLVVLN
LDGEVVEGSLKPSSDTPTHVYLYKAFPNIGGIVHTHSQWATSWAQSGRDIPPLGTTHADY
FDSAIPCTREMYDEEIIHDYELNTGKVIAEIFQQHNYEQVPGVLVNNHGPFCWGTDALNA
IHNAVVLETVAEMAYHSIMLNKDVNPINTVLHEKHFYRKHGANAYYGQS
>PK3-2_02365 Sugar-phosphatase AraL
MASHDSAVSPAGILIDLDGTVFRGNELIEGAREAIRTLREMGKKIVFLSNRGNISRAMCR
KKLLGAGIEADVNDIVLSSSVTAAFLRNHYRFSKVWVLGEQGLVDELRLAGVRSANEPKE
ADWLVISLHETLTYKDLNQAFRAAAGGARIIATNKDRSFPNEDGNAIDVAGMIGAIEASA
QAKTELVVGKPSWLMAEAACTAMGLSAHECMIIGDSIESDIAMGKLYGMKSALVLTGSAK
PGEQRLFTPDYVLESIKDVTKLAEEGILL
>PK3-2_02366 Glycerol-1-phosphate dehydrogenase [NAD(P)+]
MNRIAADVQHAFELAGEKTFPIEVEEIVLDKQAADSLLDYVKRKNHKHIVLVCDSNTHRI
AGIDMENRLNQEGFQAECLIIPANEAGDVTADERSLIHVLIHTKKTTDVMIAVGSGTIHD
IVRFAAFQRELPFISYPTAPSVDGFTSAGAPLILYGTKTTIQTKAPSALFADLDLLKAAP
QSMVAAGFGDMLGKITSLADWEISRHLAGEPYSPTGAKIVQEALDACIAHTEDIAMKTET
GIHVLMESLIVSGLVMLALDHSRPASGGEHHISHWIEMELMEKNRPQILHGAKVGCAAVL
LTDTYRKLAKDDGLNEFSPRRREAIESAYKALPEGEVLADWLKSAGGPASFDEIGVGHDS
VKNAFRHAHTLRDRCTGLRIINENKTLINHGLYE
>PK3-2_02367 putative arabinose-binding protein
MKKLTACFLVLTMLLTLFIAGCSAERSSGKSGETELTFWTFNGLHEQLYVEMVKEWNKKY
PDRKIKLNTVVYPYGQMHDNLSISLIAGEGVPDIADVELARFSNFLKGSDIPLADLTPLI
EKERDKFVEARLTLYSKNGKLYGLDTHVGTTVMFYNMDVMKKAGVNPDDIKTWDDYHKAG
QKVRKVTGKPMGTVETNDSGTFLSMISQQNSGYFDKNGKLILNNDTNVKTLQYLKDMIND
KTMIPAPGGGHHSEEYYGFMNQGGAASVLMPIWYMGRFIDYMPDLKGKIAIKPLPAWKEG
GDRSAGLGGTATVVPKQSKHVELAKEFLAFAKGSKEGNKKLWTVLGFDPLRWDVWSSKEL
KEKNKYTDYFQNGTGIFSVLLDIKDEINPIYLHEDFAKASDLVNRSVLFDALKSQQKTPK
QALDRAAGELKQK
>PK3-2_02368 L-arabinose transport system permease protein AraP
MKPVKTGTVHPVPSAAKQSGWRDLFYSKKAAPYLFTAPFVLSFLVFFLYPIISVFIMSFQ
RILPGEVTFVGLSNYTALNNPTFYTALWNTLEYTFWTLIVLIPVPLLLAIFLNSKLVKFR
NIFKSALFIPALTSTIVAGIIFRLIFGEMETSLANSILLKLGFSPQNWMNNEHTGMFLMV
LLASWRWMGINILYFLAGLQNVPKELYEAADIDGANTMKKFMHITLPFLKPVTVYVLTIS
IIGGFRMFEESYVLWQNNSPGNIGLTLVGYLYQQGLAYNEMGYGAAIGIVLLIVILVVSL
ISLKLSGSFKGEG
>PK3-2_02369 L-arabinose transport system permease protein AraQ
MLRHSPQFSVYRIALTLFFIMLSLLYIFPILCLLLGSLKPSSELLRVGLNLDIDPKVMSL
DNYTFLFNGGSIYFKWFFNSLVLGLFTTVLTLFFSSMIGYGLAVYDFKGRNIIFVLVLII
MMVPLEVMMLPLFKLTVGLHLIDSYTGVILPFIVSPVAVFFFRQYALGLPKDLLDSARMD
GCTEFGIFFRIMAPLMKPAFGAMIILQSLNSWNNFLWPLIVLRSKEMFTLPIGLSSLLSP
YGNNYDMLISGSVFAILPVIIIFLFFQKYFISGLTVGGVKG
>PK3-2_02370 Intracellular exo-alpha-(1->5)-L-arabinofuranosidase 1
MKKARVIVDKEYKIGEVDKRIYGSFIEHMGRAVYEGIYEPDHPEADEDGFRKDVQSLIKE
LQVPIIRYPGGNFLSGYNWEDGVGPVENRPRRLDLAWQATETNEVGTNEFLSWAKKVNAE
VNMAVNLGTRGIDAARNLVEYCNHPKGSYWSDLRRSHGYEQPYGIKTWCLGNEMDGPWQI
GHKTADEYGRLAAETAKVMKWVDPSIELVACGSSNSGMPTFIDWEAKVLEHTYEHVDYIS
LHTYYGNRDNNLPNYLARSMDLDHFIKSVAATCDYVKAKTRSKKTINLSLDEWNVWYHSN
EADKKVEPWITARPILEDIYNFEDALLVGSLLITMLQHADRVKIACLAQLVNVIAPIMTE
KGGEAWRQPIFYPYMHASVYGRGESLKPLISSPKYDCSDFTDVPYVDAAVVYSEEEETLT
IFAVNKAEDQMETEISLRGFKSYKIAEHIVLEHQDIKATNQQNRKNVVPHSNGTSSVSEN
GLTAHFTPLSWNVIRLKKQS
>PK3-2_02371 Peptide transporter CstA
MNAVTIVIASMCILAIAYRLYGTFMMVKVLKVNDDKPTPAHTLQDGKDYVPTNKWVSFGH
HFAAIAAAGPLVGPILAAQFGYLPGLLWLLIGAVIGGAVHDIVVLFASMRKNGKSLSEVA
KDELGPVAGFCTGLSMLFIITITMAGLSMVVLHALERNPWGTFAVGITIPIAMGVGLFYK
KTGNLKLASTIGFLFLMAGVFIGPWVQTTALGDFLTLDTKTLAIALPVYAFFAAALPVWL
LLAPRDYLSSFMKIGVFIALIAGVFVVNPPIPFPAFTEFIKGGGPVLAGPVWPFISITIA
CGAISGFHAFVGSGTTPKMLNKWSDMKPVAFGAMLVECLVGIMALIAATALQPADYFAIN
STPEVFRTLGMDVVHLPELSREIGLDLEGRTGGAVTLAVGMTYIFTGMPFFSHLASYFFQ
FVIMFEAVFILTAIDAGTRVARYLIQDFFGEVYKPLKKTDWIPGSVFASALACLMWGYLL
YSGDIGSIWALFGVSNQLMASVGLIIGATIVLKIADKRRYILTCLIPLAYLYVTVNYAGY
WMVRNVYLNPDAAGYSVLNGVLSIIMLLLGFIIIVAAVKKWARMWKDPSLRMETSIPG
>PK3-2_02372 Metallothiol transferase FosB
MNLSMKYLILYVSDSKRAIHFYQDILGLPIRAEHGTYVEFETGSTILALNTRESARDITP
LDIPDTSASHTFEIGFVTENVEAVIKRVREQGVTIIGEPKVKPWGQTVAYIADPDGHYIE
ICSPME
>PK3-2_02373 Lactate utilization protein A
MTIEKEMKQIQQEFKERMDEGELLNCMRCGFCLPSCPTYIESGFQETHSPRGRIALMKAV
ADGMIEPDEDVERSLSLCLGCRACEPVCPSGVKYGQLLEEARDIIHQNKKHSLGARVMRK
AAFHELFPHQNRMRSAVSLIGLYQRSGLQSAVRKTGMLRVLPENLRTMEAVLPDVPKSKD
MKHRPRLLPSIGHRKKRVAFFSGCLMDTMFLPTNNATLKLLQLAGCDIVIPPEQACCGAL
HGHSGEKNAGKELAKQNIAAFEALDVDAVITNAGGCGAFLTEYDHLLKDDPEWSERAAAF
VQKLKDFSSVLVELDFHQMKLALETPQVITYQDSCHLRNVMHTSLEPRQLLQSIKGAEFR
EMNKADSCCGSAGIYNIVEAKMSMKILDSKMAAVKATEAIIIVTANPGCLLQMKLGIERE
GLSGNVKAVHLADLLLEAAGHKTS
>PK3-2_02374 putative FAD-linked oxidoreductase
MITKDIKEQLIQIVGPENFDDSNAGRLVYSYDATPQFQSMPDAVIAPRNTDEVSRILTIC
NEHQVPIVPRGSGTNLCGGTCPTEGGLVLLFKHMNRILEIDEENLTATVQPGVITLDMIR
AVESKGLFYPPDPSSMKISTIGGNINENSGGLRGLKYGVTRDYVIGLEIVLANGDIIRTG
GKLAKDVAGYDLTRLFVGSEGTLGIVTETIVKLVPKPETKKTLLALYENIDAAAQTVSDI
IAEKIIPATLEFLDQPTLLVIEDYAKIGLSTNAKAVLLIEQDGPLETVARDMEKIKAICK
KGDSVSVQTAQTEEEAYALTEARRSALSALARLKPTTILEDATVPRSEIANMVKAINDIA
AKYDISICTFGHAGDGNLHPTCTTDIRNEAEMKRVEQAFADIFEKAIELGGTITGEHGVG
AMKAPYLEMKLKKEGIAAMKAMKAAFDPRNILNPGKVFAKDARKRVVTER
>PK3-2_02375 Carbohydrate diacid regulator
MFLQPLLAKKIIAEVKKMYEREVIIVNTDGLIMASTNDERVGQFHEGALICANEKRNVII
TKEDEKRLKGVKAGLNLPVFSDRDVIAVFGLTGEPAEIQPYGELLRKMTELFIKESWHLE
QTQWHERMLESFMIDWLQLKEWSPGFLEKAQLLGVDLSSRRQMILIQGYEWSPHDIDQMK
RIWKSAYPSDLLIRWGNERILINHEVPKYEQRDRLSRQLLHICSFAHTANRQFAAAGAGR
AVASSSLTDSYEQAEKALAVSLKRKTPIFEEDLKLDMCLEEISPETRNEFPQRVFREVLQ
HHELMNTIRTFFHLDLSMKQTAKDMHIHINTLRYRLSKAEQLTGLNFGRTEDIATMYVAL
CFLDQNTK
>PK3-2_02376 Small, acid-soluble spore protein I
MDLNLRHAVIANVTGNNQEQLEHTIVDAIQSGEEKMLPGLGVLFEVIWQHASENEKNEML
KTLEGGLKPAQ
>PK3-2_02377 Putative TrmH family tRNA/rRNA methyltransferase
MKQIESAKNQKVKDWKKLHTKKERTKTNTFLIEGEHLVEEALKSPGKVKEILVKDETKIP
SDLDVSIQCYVLSEDAFSAVTETETPQQIAAVCHMPEEKLASAQRVLLIDAVQDPGNLGT
MIRTADAAGLDAVVLGDGTADAYNGKTLRSAQGSHFHIPVVRRNLHTYVDELKAEGVKVY
GTALQNGAPYRDMSQAQSFALIVGNEGAGVDAALLEKTDLNLYVPLYGQAESLNVAIAAA
ILVYHLRG
>PK3-2_02378 Phenylalanine--tRNA ligase alpha subunit
MEEKLKQLEQEALEQVEAASSLKVVNDIRVQYLGKKGPITEVLRGMGKLSAEERPKMGAL
ANEVRERIANAIAVKNEKLEEEEMKQKLAGQTIDVTLPGNPVAVGGRHPLTVVIEEIEDL
FIGMGYTVEEGPEVETDYYNFESLNLPKEHPARDMQDSFYITEETLMRTQTSPVQTRTME
KHEGKGPVKIICPGKVYRRDNDDATHSHQFMQIEGLVVDKNISMSDLKGTLELVAKKMFG
QDREIRLRPSFFPFTEPSVEVDVTCFKCGGNGCSVCKGTGWIEILGAGMVHPNVLKMAGF
DPEEYQGFAFGMGVERIAMLKYGIDDIRHFYTNDVRFISQFKQA
>PK3-2_02379 Phenylalanine--tRNA ligase beta subunit
MFVSYKWLEDYVDIKGMDPAVLAEKITRAGIEVEGIEYKGEGIKGIVIGHVLEREQHPNA
DKLNKCLVDIGAEAPVQIICGAPNVDKGQKVAVATVGAVLPGNFKIKKAKLRGEESNGMI
CSLQELGIESKLVAKEYAEGIFVFPNDAETGSDALAALQLDDAILELGLTPNRADAMNML
GVAYEVAAILDTEVKLPHTDYPAASEQASDYITVKIEDQEANPLYAAKIIKNVTIAPSPL
WMQTKLMNAGIRPHNNVVDITNFVLLEYGQPLHAFDYDRFGSKEVVVRKAAQNEMIVTLD
DQERKLSADHLVITNGTKAQAVAGVMGGAESEVQEDTKTILLEAAYFNGQTVRKASKDLG
LRSESSVRFEKGIDPARVRLAAERAAQLIYLYAGGEVLTGTVEEDHLTIEANNIHVSADK
VSSVLGMTISKEELISIYKRLGFTVGEANDLLVVTVPSRRGDITIEEDLIEEAARLYGYD
NIPSTLPETAGTTGGLTPYQAKRRKVRRFLEGAGLSQAITYSLTNEKKAAAFAIEKSLNT
VLALPMSEERSILRHSLVPNLLESVSYNLARQTDSVALYEVGSVFLTKEEDTKPVETERV
AGAVTGLWRKQLWQGEKKPVDFFVVKGIVEGLLDKLNVLDSVEFVQSERKQLHPGRTANI
LLNGSLIGFIGQVHPSLEKELDIKETYVFELDLHALLAADTAPLVYTAIPKYPSVTRDIA
LVTDKSVTSGQLESVIKEAGGKLLKEVSVFDVYEGEHMEEGKKSVAFSLQYVNPEQTLTE
EEVTKAHSKVLKALEDTYQAVLRG
>PK3-2_02380 Ribonuclease HIII
MSHSVIKVSLSAIDQMKMTYSGSLTASVPQGAVFQAKPPGCTITAYKSGKVLFQGKNAAA
ESARWGTAEPQVKKKTAKKPADPRYAPPADIAGMSVIGSDEVGTGDYFGPMTVVCAYVDK
TMLPLMKELGVKDSKDLKDPQIIEIARNLIKTIPYSLLVLKNEKYNSMQEKGMSQGKMKA
LLHNQAITHLLRKMDGVKPEAILIDQFAEPGVYFNHLKGRDIVKERTYFSTKAEGIHLSV
AAASIIARYSFLMEMDKLSREAGMTLPKGAGPHVDEAAAKLILKKGASALRTFTKLHFAN
TQKAQRLADKKRS
>PK3-2_02381 Cell division protein ZapA
MSDGKKTKTTVDIYGQHFTIIGEESRAHMRYVAGFVDDKMREINKKNPYLDINKLAVLTA
VNVVHDYVKLQEKYEKLERQLKEKD
>PK3-2_02382 hypothetical protein
MLDIIILILLLMGTLLGLKRGFILQFIRLTSFILSIAFAALFYKNVSPHLKWIPAPDFSA
GQPALSFFTGNLEAAYYNAIAFIVLFIIAKILLRIIGSFLSIVAGIPVIKQINQVLGAVL
GFLEVYLFTFVLLYVASVLPVDALQQMMRQSSLANVIINHTPYLSGLLQELWTQYGA
>PK3-2_02383 DNA polymerase/3'-5' exonuclease PolX
MHKKDIIRLLETIAVYMELKGDNPFKVSAFRKAAAALEQDDRSLSEIDDMMSLSGIGKGT
YSVIKEYIDEGKSSTLESLQKEVPEGLVPLLKLPGLGGKKIAKLYKELGVHDAESLKEAC
EQQKVQGLAGFGKKSEEKILQALGEAGKQPERFPIGYALRIARDIEEHLSQFTDIIKFSR
AGSLRRARETVKDLDYIIATDHPAEVREQLLALPNIKSVIASGDTKVSVILSFEYETSVD
FRLVTEEQFPTTLHHFTGSKDHNIKMRQIAKERGERISEYGVETVETGDIKTFPSEREFY
AHFGLPLIPPELRESGQEVETYSDSIELIEPGQIKGDLHMHSTWSDGAFSIREMAEACIK
KGYQYMAITDHSQYLKVANGLTAERLKQQAKEIDALNAEFENFRILKGVEMDILPDGTLD
YDDDVLAEMDIVIGSIHSSFNQPEHVIMKRLETALANKHVDIIAHPTGRLIGRRAGYEID
IDKLIELAKKTNTALELNANPARLDLRTEHLIKANEQGVTLVINTDAHNIDMLDDMKTGV
TAARKGWTETKNVLNARSLEDVEAFLKRND
>PK3-2_02384 Endonuclease MutS2
MQQKVLSALEFHKVKEQVIEHAASSLGKEMLLELKPSASIDEIKKQLDEVDEASAIIRLR
GQAPFGGLADIRGALRRAEIGSVLSPSEFTEISGLLYAVKQMKHFISQMAEDGVDIPLIH
QHAEKLITLADLERDINSCIDDHGEVLDHASETLRGIRTQLRTLESRIRDRLESMLRSSS
ASKMLSDTIVTIRNDRFVIPVKQEYRSSYGGIVHDTSSSGATLFIEPQAIVDMNNSLQQA
KVKEKQEIERILRVLTEKTAEHTEELFQDLHILQTLDFIFAKARYAKAVKATKPIMNDNG
FVRLKKARHPLLPPDQVVANDIELGGDFSTIVITGPNTGGKTVTLKTLGLLTLMAQSGLH
IPADEGSEAAVFEHVFADIGDEQSIEQSLSTFSSHMVNIVGILEQVNENSLVLFDELGAG
TDPQEGAALAMSILDDVHRTNARVLATTHYPELKAYGYNREGVMNASVEFDIETLSPTYK
LLIGVPGRSNAFEISKRLGLPDHIIGQAKSEMTAEHNEVDTMIASLEQSKKRAEEELSET
ESIRKEAEKLHKELQQQIIELNSKKDKMLEEAEQQAAEKVKSATKEAEDIIHELRSIKEE
HKSFKDHELINAKKRLEGAMPAFEKSKKPAKPKTQKRDLKPGDEVKVLTFGQKGTLLEKT
GGNEWNVQIGILKMKVKEKDLEFMKSAPEPKKEKIITAVKGKDYHVSLELDLRGERYENA
LSRVEKYLDDAVLAGYPRVSIIHGKGTGALRKGVQDLLKNHRSVKSSRFGEAGEGGSGVT
VVELK
>PK3-2_02385 hypothetical protein
MSDFWENELVEIAAYYSVAVLCLVLFLTVFELVTAYKNWEEIQKGNLAVAMATGGKILGI
ANVFQHSISQHNSLLQMIGWGVYGFVMLLISYFIFEFLTPRFKIDQEIENDNRAVGFISF
VISVGLSFVVAAGI
>PK3-2_02386 Long-chain-fatty-acid--CoA ligase
MQSQKPWLAEYPDDIPHELPLPTKTLQSILTDSAAQFPDKTAISFYGKKLTFHDILTDAL
KLAAFLQGIGLQKGDRVAVMLPNCPQSVISYYGVLFAGGIVVQTNPLYTEHELEYQLRDA
EASMIITLDLLFPKAIKMKTLSIVDQILITSVKDYLPFPKNILYPLTQKQKVHIDFDKKD
HVHTFASSIKQENIEILTIPKIDPEHDIAVLQYTGGTTGAPKGVMLTHQNILANTEMCAA
WMYDVKKGAEKVLGIVPFFHVYGLTAVMNYSIKLGFEMILLPKFDPLQTLKIIDKQKPTL
FPGAPTIYIGLLHHPELQHYDLSSIKSCLSGSAALPVEVKQKFEKVTGGKLVEGYGLSEA
SPVTHANFIWGKNKPGSIGCPWPGTDAAIYCEEKDELAAPYEHGEIIVKGPQVMKGYWNK
PEETASVLRDGWLFTGDMGYMDEEGFFYIADRKKDIIIAGGYNIYPREVEEVLYEHEAIQ
EIVIAGVPDSYRGETVKAFVVLKKDAKANAEELDAFARSRLAPYKVPKAYEFRKELPKTA
VGKILRRRLLEEEAEKHHIK
>PK3-2_02387 Fatty acid metabolism regulator protein
MKQKRPKYMQIIDAAVEVIAENGYHQSQVSKIAKQAGVADGTIYLYFKNKEDILISLSKK
KWANLLSGWKRI
>PK3-2_02388 Fatty acid metabolism regulator protein
MGQFIERMEEDIKEKTTAKEKLALVISKHFSLLADDHNLAIVTQLELRQSNLELRQKINE
ILKGYLNILDSILTEGIHSGELKEGLDVRLARQMIFGTIDETVTTWVMNDQKYDLAALSD
SVLELLVSGIHNK
>PK3-2_02389 putative enoyl-CoA hydratase
MNAISLAVDQFVAVLTIHNPPANALSSQILEELSSCLEQCETDAGVRSIIIHGEGRFFSA
GADIKEFTSLKGNEDSSLLAERGQQLMERIEGFPKPIIAAIHGAALGGGLELAMACHIRI
AAEDAKLGLPELNLGIIPGFAGTQRLPRYIGTAKALELIGSGEPISGKEALDLGLVSIGA
KDEAEVLEKAKALAAKFAEKSPQTLASLLELLYSNKVYSYEGSLKLEAKRFGEAFESEDA
KEGIQAFLEKRKPQFKGE
>PK3-2_02390 Electron transfer flavoprotein subunit beta
MNLFVLMKRTFDTEEKIVIEAGKIQDDGAEWIINPYDEYAIEEAIQLKEKHGGTITAVTV
GGEEAEKELRTALAMGCDQAVLINIEDDLEEPDQYSISQVLYHYMKDQEFDLILGGNVAI
DGGSGQVAPRLAELLDIPCITTITQLEINGTDAEAERDVEGDVEKIKTTLPLLVTAQQGL
NEPRYPSLPGIMKAKKKPLEELELDDLDLDEEDAEPKLKTIERFLPPKKEAGKLLQGEPA
EQAKELVSLLRSEAKVI
>PK3-2_02391 Caffeyl-CoA reductase-Etf complex subunit CarE
MGKKVIVLGEIRDGELRNVTFEAIAAGRTISGDGEVVGVLIGENVQSAAQELIHYGADKV
LTAEDPKLKAYTADGYSQVMRAIIDQEKPDSVICGHTAMGKDLSPKLAARLQTGLISDVT
DVSVTGENIVFTRPIYSGKAFERVISTDPMICATIRPNNIQASEKDAGRSGSIESVDVSL
TDLRTVIQEVVKKTADGVDLSEAKIIVAGGRGVKSKEGFQPLQELAEVLGAAVGASRGAC
DADYCDYALQIGQTGKVVTPDLYIACGISGAIQHLAGMSNSKVIVAINKDPEADIFKIAD
YGIVGDLFEVVPLLTQEFKQLNIHS
>PK3-2_02392 Intracellular exo-alpha-L-arabinofuranosidase 2
MSEHQAVIQTDIVKGTINKNIYGHFAEHLGRGIYEGIWVGTDSSIPNINGIRKDVLEALK
QLHIPVLRWPGGCFADEYHWANGVGDRKTMLNTHWGGTIESNEFGTHEFMMLCELLECEP
YICGNVGSGTVQEMAEWIEYMTFKEGTPMSDWRKQNGREEPWKLKYFGVGNENWGCGGNM
HPEYYTDLYRRFQTYVRNYSGNEIYKIAGGANVDDFHWTDVLMKKAAGLMDGLSLHYYTI
PGDFWKGKGSATEFTEDEWFITMKKAKYIDELIQKHVTIMDRYDPEQRVGLIIDEWGTWF
DPEPGTNPGFLYQQNTIRDALVAASHFHIFHQHCRRVQMTNIAQTVNVLQAMILTEGERM
LLTPTYHVFDMFKVHQDASLLDTETTSADYEWKGETLPQISISASKHAEGDINITICNID
HQNKAEAEIELRGLHKTADHSGVILTAEKMNAHNTFDNPYHVKPESFSRYTLNKNKLKVK
LPPMSVVLLTLRADS
>PK3-2_02393 Thioredoxin
MAIVKATDQSFSAETSEGVVLADFWAPWCGPCKMIAPVLEELDQEMGDKLKIVKIDVDEN
QETAGKYGVMSIPTLLVLKDGEVVETSVGFKPKEALEELINKHL
>PK3-2_02394 UvrABC system protein C
MNKQLKEKLALLPDQPGCYLMKDRQQTVIYVGKAKVLKNRVRSYFTGSHDAKTQRLVTEI
EDFEYIVTSSNLEALILEMNLIKKHDPKYNVMLKDDKTYPFIKLTHERHPRLVVTRNVKK
DKGRYFGPYPNVQAARETKKLLDRLYPLRKCSKLPDRVCLYYHLGQCLAPCVKDISEETN
RELVESITRFLKGGYNEVKKELEEKMQDAAENLEFERAKELRDQIAHIESTMEKQKMTMN
DLVDRDVFAYAYDKGWMCVQVFFIRQGKLIERDVSMFPLYQEADEEFLTFIGQFYSKNNH
FLPKEILVPDSVDQSMIEQLLETNVHQPKKGPKKELLMLAHKNAKIALKEKFSLIERDEE
RSIGAVQKLGEAMNIYMPHRIEAFDNSNIQGTNPVSAMIVFIDGKPYKKEYRKYKIKTVT
GPDDYGSMREVVRRRYTRVLRENLPLPDLIIIDGGKGQINAARDVIENELGLDIPIAGLA
KDEKHRTSNLLIGDPLEAVYLERNSQEFYLLQRIQDEVHRFAISFHRQIRGKSAFQSVLD
DIPGIGEKRKKMLLKHFGSVKKMKEASLEDIQKAGVPAAAAQLLYDKLQK
>PK3-2_02396 Aspartokinase 2
MGLIVQKFGGTSVGSVEKIQNAANRAIAEKQKGHQVVVVVSAMGKSTDELVSLAKAISDE
PSKREMDMLLATGEQVTISLLSMALQEKGYDAVSYTGWQAGIRTEAVHGNARITDIDTSA
LTGQLEEGKIVIVAGFQGMTEDSEITTLGRGGSDTTAVALAAALKADKCDIYTDVPGVFT
TDPRFVKSARKLAGISYDEMLELSNLGAGVLHPRAVEFAKNYEVPLEVRSSTETEAGTLI
EEESSMEQNLIVRGIAFEDQITRVTIYGLTGGLTTLSTIFTTLAKRNINVDIIIQTQAGD
NQTGISFSVKTEDANQAVAVLEEYKGALEFEKIETESKLAKVSIVGSGMVSNPGVAAEMF
AVLAEKNILIKMVSTSEIKVSTVVSENDMVKAVEALHDAFELSKHHSAV
>PK3-2_02397 putative protein YslB
MKSKFEASIDNLKEIEMNAYAYELIREIVLPDMLGQDYSSMMYWAGKHLARKFPLESWEE
FPAFFEEAGWGTLTNVSAKKQELEFELEGPIISNRLKHQKEPCFQLEAGFIAEQIQLMND
QIAESYEQVKKRADKVVLTVKWDMKDPV
>PK3-2_02398 Succinate dehydrogenase cytochrome b558 subunit
MSGNREFYFRRLHSLLGVIPVGIFLIQHLVVNQFAARGAEAFNSAAHFMDSLPFRYALEI
FIIFLPLIYHAVYGVYIAFTAKNNAGQYSYMRNWLFVLQRVTGIITLIFVSWHVWQTRIA
AQMGAEVNFDMMANILSSPAMLGFYIVGVLSTIFHFSNGLWSFAVTWGITVTPRSQRIST
YVTLIIFVALSYVGLKAIFAFV
>PK3-2_02399 Fumarate reductase flavoprotein subunit
MSQSSIIVVGGGLAGLMATIKAAESGMAVKLFSIVPVKRSHSVCAQGGINGAVNTKGEGD
SPWEHFDDTVYGGDFLANQPPVKAMCEAAPSIIHLLDRMGVMFNRTPEGLLDFRRFGGTQ
HHRTAYAGATTGQQLLYALDEQVRRYEVAGLVTKYEGWEFLGAVLDDDRTCRGIVAQNLT
NMQIESFRSDAVIMATGGPGIIFGKSTNSMINTGSAASIVYQQGAYYANGEFIQIHPTAI
PGDDKLRLMSESARGEGGRVWTYKDGKPWYFLEEKYPAYGNLVPRDIATREIFDVCVNQK
LGINGENMVYLDLSHKDPKELDIKLGGIIEIYEKFMGDDPRKLPMKIFPAVHYSMGGLWV
DYDQMTNIPGLFAAGECDYSMHGGNRLGANSLLSAIYGGMVAGPNAVKYVNGLESSAEDM
SSSLFDAHVKKEEQKWAEIMSMDGTENAYVLHRELGEWMTANVTVVRHNDKLLKTDDKIQ
ELMERFKKININDTTKWSNQGAMFTRQFSNMLQLARVITLGAYNRNESRGAHYKPDYPER
NDDEWLKTTMAKHVSPYEAPEFEYQDVDVSLITPRKRDYSKKKVAK
>PK3-2_02400 Fumarate reductase iron-sulfur subunit
MSEQKTIRFIITRQDTADSTPYDEEFEVPYRPNLNVISALMEIRRNPVNAKGEKTTPVTW
DMNCLEEVCGACSMVINGKPRQSCTALIDQLEQPIRLKPMKTFPVVRDLQVDRSRMFNSL
KKVKAWIPIDGTYDLGPGPRMPEKRRQWAYELSKCMTCGVCLEACPNVNSKSKFMGPAPM
SQVRLFNAHPTGAMNKSDRLEALMDEGGLADCGNSQNCVQSCPKGIPLTTSIAALNRDTN
LQAFRNFFGSDRV
>PK3-2_02401 hypothetical protein
MKLPAYIDMPFQEWKTSFSFFNEVSVRFSETDMFGHMNNVTPFVYFEEARISYFKKLNMM
NENKQTMTVVASQQCDYLRQVMPYEELRIYVKTSAVGSSSLTLHYLGENLNGEPCFTGAV
VMVQVSKESGKAVSWTDEEKETLLHTP
>PK3-2_02402 Spore germination protein GerE
MKEKEFQSKPLLTKREREVFELLVQDKTTKEIASELFISEKTVRNHISNAMQKLGVKGRS
QAVVELLRMGELEL
>PK3-2_02403 putative HTH-type transcriptional regulator YusO
MTSKPLEHVADIEKSLRHIAAIIKQKGREILNQYAITPPQFVGLQWLYELGDMTIGELSG
KMYLACSTTTDLIDRMQKNELVERVKDPADRRVVRIHLLPEGERIIQEVITKRQEYLCDM
FETFTDEEIAIFEKSLMKLQHEMKRK
>PK3-2_02404 Glutamate racemase 1
MEQPIGVIDSGVGGLTVAKEIMRQLPKENIIYVGDTKRCPYGPRPEEEVLQYTWELTNYL
LENHHIKMLVIACNTATAIALEDIRRSVGIPVVGVIQPGARAAIKVTENQHIGVIGTENT
IKSNAYEEALLALNPDLKVENLACPLLVPFVESGKFLDKTADEIVKTSLSPLKDTSIDSL
ILGCTHYPILKESIQRYMGEHVNIISSGDETAREVSTILSYKGLLNQSPIAPDHQFLTTG
ARDQFAKIADDWFGHEVGHVECISLQEPIRR
>PK3-2_02405 Spore germination protein GerM
MLKKGPAVIGATCLTSALLLSGCGLFQSDKAAEEIDPPQDVTYVNDEAGADSNTTAAEKT
ESEKNDTAKADQASSTVMRELYLIDKNGYVVAQTLPLPKSEGTAKQALEYLVQGGPVSEI
LPNGFRAVLPADTTVNVDIKKDGTAIADFSNEFKNYKKEDEQKIVQSVTWTLTQFSSIDK
VKLRINGHELKEMPVGGTPISDDLSRKDGINMETSGVNDLTATHPLTVYYLAENDDSEYY
VPVTKRIDNSETDDISAAINELAKGPSKVSGLLTDFSGDVKLVSKPKIKDGRVTLDFNQS
IFGSADEKTKMISSEVLNSIVLTLTEQPDVKSVSVKVNGKSELVNEKGEKLTEPVSRPSQ
VNTGSF
>PK3-2_02406 Ribonuclease PH
MRHDGRQHDELRPITFDLDFISHPEGSVLITAGNTKVICNASVEDRVPPFLRGGGKGWIT
AEYSMLPRATNQRTIRESSKGKISGRTMEIQRLIGRALRAVVNLEKLGERTIWIDCDVIQ
ADGGTRTASITGAFLAMAIAVGKLVKAGTIKTNPITDFLAAISVGIDKEQGILLDLNYEE
DSSAEVDMNVIMTGSGRFVELQGTGEEATFSREDLNGLLGLAEKGIQELIDKQKEVLGDS
LPELK
>PK3-2_02407 dITP/XTP pyrophosphatase
MKEAIIATHNPGKVKEFKEILEPKGYDVKSLAEIGFTEEIEETGHTFEENAILKAEAVAR
AVNKMVIADDSGLSIDNLGGKPGVYSARYAGEQKDDQANIDKVLSELKGIEKEQRTARFR
CALAVSIPGAETKTVEGHVEGYIAEEPRGEYGFGYDPIFIVKDKDKTMAELTSDEKNKIS
HRADALKKLSKLLEA
>PK3-2_02408 Putative metallophosphoesterase MG207 
MNVLIISDSHGLEEELQTIAKRHEAEVDLMIHCGDSELETGHPALEPYAVVKGNCDFTGD
FKDELLLTAGSKKILVTHGHLHGIKQTLLNVYYRAEELGADIICFGHSHIAGSEVLRGKL
MINPGSIRLPRVRRTESYAILTLENAVATVRFYDQAGHEIEDLQNKVTL
>PK3-2_02410 Tyrosine recombinase XerC
MTKRKGLLDVDVNGLLNGLTITSTSSTAPKEKIKQFEVLDHSMLVSDALETITRQMKVSG
NRRRTISDYVLHVEHFQSITNVNHVADITADTVYKWLDSMNVSNQTKLTRLKCLKAFLSR
CFDNGWIEIKFWKTINIKVDQKVKEGATERDVNVLLSLLDLSNFIQLRDATAVLVIFKTG
IRINTLTQLEERHIDFNNNVLNLEGSIMKNHQQIKLPFDDVIKRMLKVLIKQNAMIRDGY
GKKNSLIFITKYGDVISNSPTHNNIQKRLNKYAKMYGLKNINPHALRRGFAKSLLDKGTN
VAVISKALGHSDISVTTKYLHLDVDEVANSLRSYLDV
>PK3-2_02411 hypothetical protein
MDKNIIKEFIEDSKHVTFHFVYEENSGKIRVLNNHGYEISPESGTAIIEGMTKAYVNLSD
VEMNNIRMHNAENDLWNYSKSYGPRALETPFRNNLKGNWGFTCGMCGKKVSSKTDSSWWR
IAGSDYESNHKYCSEQCIQPVLSEIKQKIKIETYERFGVR
>PK3-2_02412 hypothetical protein
MERKLILTTEEFVMKFGTNAQKARVKRDGKLGSRTRESIIKTAEQEYVIEIIKQGRSNIY
ECNKRNEKVMKKDGRVRSGREQVEHRIPMDIIVATHLEYDMTKQASMSLGKWAIEFGLIT
DLEHDLLRSRHSSKMRQKHIDKAIENGIIEEEQTKLLDEFTQYCLEIYGQLAKTLEHMKK
CGIILFYENWKGYGKDGQIDINPEIMKQIQKTRRRLMKKYDVVEFNLIAHSNARKVKSFK
CEWKQALAEVEDENGNILGIKYYWKEYAMILKATSKAVQRYLEMYCADALESYLSEKEQF
INENEADYVLKRKVNIMKKAEKRHKQRLQEYKEQKIGFATEEEEVFIRLFYTQQELEDIF
AGYDLGVKGLHLQNLYMERMRQLFDLYNLIDTNFVGVS
>PK3-2_02413 hypothetical protein
MITMSGNFSFFQGKWDVLANLGETAERNVYHDPHTTVMKLRLFAETLTKFILAAENIKEA
YGTTQVDRINTLRRERLLEPELIDILEALRRKGNVAMHEADYGKVEEAKALLQLTFRLSI
WFMEVYGDWDFQAPEYTELQEQVEQSTETLQREYEEKVKKLEEELEAIRRQAEVEQEEVK
IERKKISKNFMRRQQLTEAETRTIIDGKLRAVGWEVDTTVLNHQKNGTLPEKNRNMAIAE
WKVNGGRVDYALFIGLKLVGFIEAKAKKKTIPGALESQTKVYAKNVAQVEDEVITPTTGE
YKVPFLYATNGRPYLRQLQEESGIWFWDSRKPLEHARPLEGWHSPDDLQLLLSQDDKDAN
KRLEEEDITKFGLRHYQQRAVLSAEEGLKEGQRRMLIAMATGTGKTRTAIALMYRLIKSK
KCRRILFLVDRNSLGKQTEDALKDTKIEGYSFADIYDVKSLEDMSPEVETKVQIATVQGM
VRRLFYSDNEKLPSVGQYDFIIVDEAHRGYTSDKEMSEEELEFRDQNDYISQYRRVIDYF
DAACLGLTATPALHTTEIFGMPIFKYSYSEAVLDGYLVDHEPPYLFKTELSQVGITLEKD
EEVEVYDVDKGEIQLEKMEDTIHFEVEQFNKRVITEPFNRAVLNKLVEYIDPTGKEKTLI
FAATDQHADLVVRLLKKAFKERGDEIEDDAIMKITGYIYKPLDAIKRFKNERLPNVVVTV
DLLTTGIDVPPITNIVFLRRIQSRILYDQMLGRATRLCPDIGKTHFNIYDAVGIYDKLQS
YTEMKPVVKKQNYSIGELYESLANAATEDEASFYRDQLAAKIQRRKQRLNEEGKQKFEEL
SNGKNVDEWAKEIQTYTPQEAKQHNMLFEYMEAYRVKGEKRYISNKEDEVTDVVRGYGEG
NKRPEDYLEGFVRFIQENINEIPALHLICTRPKDLTRQDLRELITILETKGFKQSHLQTA
WKQTKNEDIAADIISFIRQAALGEALVAHEARIKQAMQKVYSLHDWTPRQKKWLERIEKQ
LLQVPVLAPTAKEAFSEEPFKTSGGYKLLKREFGDYIDTVVTTINENLYIS
>PK3-2_02414 Type I restriction enzyme EcoKI M protein
MNNQEIVQKLWNLCNVLRDDGITYQQYVTELTYLLFLKMMKEQETEGVIPEGYRWDDLLD
KEGLELKTFYQRLLLELGSSENERLRLIYSDASTSIAEPKNLEKIIKSIDALDWYNAKEE
GLGNLYEGLLEKNASEKKSGAGQYFTPRVLIDVMVQLIDPKIGERCADPAAGTFGFMIAA
DQYLKNQTDDYFDIEPQEAEFQKKEAFVGMELVKDTHRLALMNALLHNIKGRLEQGDTLS
GNGKWMKNLDVILTNPPFGTKKGGERVSRDDLTFETSNKQLNFLQLIYNALKDDGNARAA
VVLPDNVLFESGIGSQIRRDLMNKCNLHTILRLPTGIFYAQGVKTNVLFFTRGTTDQDNT
KDVWVYDLRTNMTSFGKRNQLTMAHFENFMRAYVAEDRSKVGDERWNKFTREEIAKKDDS
LDIGLIADESLSPYENLPNPIESAEEAVAKLQQAMDLLNEVVEELRAVEEDKVVRK
>PK3-2_02415 hypothetical protein
MSKKKKTIEELLEEALLPEEEQPYEVPENWIWVKFDSVIKTSSNRASAIKQKDYEEQGRI
PVIDQGMQLISGYTNNQENEYTGELPVIVFGDHTRCLKWIDFSFAQGADGTKLLKPLKHF
YPKYFYYLLKIINLPNKGYSRHFKYLRASVLPIPPLNEQKRIVEKVERLLDKIEEAKQLI
EEAKETFELRRAAILDKAFRGELSKGLHVKEKNENNEDEIEFNHNNEEFYELPYNWRWVS
LESVCETITDGDHQAPPKSEEGIPFLVISNINKGVLDFQKTRFVPKEYYNKLHAKRKPKV
GDVLYSVTGSYGIPVLVDTDKEFCFQRHIAILKPSEDIRSKYLYYILKSRLVYNQATNYA
TGTAQLTVPLSGLRKIKIPLPSLNEQNYIVGKIERMFNKQAYAEKFCIISNENIEVLKQS
ILSKAFKGELGTNNPSEENAIELLKQVLQEQVK
>PK3-2_02416 hypothetical protein
MQVFIFALIIGVLYVIIHQFLLLIPANEDWQYNLGMLFQALSLSYIAAFLFYLVHNHYPY
LRAKKKYEPVINRELNDLWEICNSLTYAIGHHSKVTAYDSFPYNFNDSVPKQFRNLPVSL
KKEETKDITENKDTSVHRSYTLPLDNEFDEKNKPLVIIEMRFDKWSEAIEYVSSNISNTL
NKILKLKDVVEEETILKLFDLEKSINDFRIVAKIYEESDYKTFQNRYLEQQFIKFYEGTE
ELRKYNKKFKAPSNTPKD
>PK3-2_02417 Stress response protein YsnF
MKSIVGVYETPQETIAAIEGLLTKGYDSDDISVVTSRRDTDYLESRTGTEVNQAIDAHDG
ESESFFDKLKDYFTMDDTTAHSKALSDLDITTGEIDKYQEDLDDGKLLVAVETDADVNAP
VDNGNALSGGFSSTNEMADYTTKEEKTMPLREEQLKVDKEDVQTGEVEIGKEVKTEQRDM
DIPVRHDEIYVERRPVDENRTDASPVNDSETVRVPIVEEKLEVTKKPVVTDEVVVGKRTV
EENEHISETVKKEEPRLNKEGKVDGLDDDTLNNK
>PK3-2_02418 hypothetical protein
MKKWFVVFFLFIITLFQSLQTVSAETVEWKERADLPEPRVGASSGVVDGKIYVIGGGTVK
PGTYGNQTFVYDPKTNEWTRKADMPTARGELHQLLWMGKFMFWAECQTMELSTQ
>PK3-2_02419 N-acetylneuraminate epimerase
MGGMSNDGAVNTIEVYDPKKDKWEKLDDLPFERKVPAYQIYAQVIGKKIYVVGFENRFDG
TTYSYDLETKKWEKKQTLKNYEVTGASTAVIDNKLYLLGGTHYIPQIVYVYDPEKDAWVK
NGSGFTAGYYSALAYKGKILMTGGVNRIKVYDPKSQSATAVTNPKALYRMAHSSAIIDDT
LYVIGGREETSSFVGGYANSKIKSVISISLKDLNIPSDSEETPEDKDKGSTTPSEGDSGD
KDKGSTTPSEDNSAEDGDALLVVTMVNGLQKEYQLSMKEVNGFLKWYKQRDAGEGPGFYE
LDEHDNNKGPFESKKDYVVFKNILMYEVNKYK
>PK3-2_02420 putative N-acetyltransferase YsnE
MYIKIDDLTGHQVISLVNEHLHSMTLMSPPGSIHALGLEKLRGPAITFWSAWDNDELAGC
GALKELDRKHGEIKSMRTSLSHLRKGVAKQVLQHIIEEAKKRGYDRLSLETGSMASFEPA
RNLYEGFGFQYCEPFADYVEDPNSVFMTKVL
>PK3-2_02421 hypothetical protein
MNKSLADMQAFPAGFPSLPQPYYPASPSFYQQSYQPFGGYGGYGQPYSQAYSPLSTPSAM
YSSYPYASGFYGQQFSGAGFSGHGGGFSIPATHAGGFSGAPGVHGGFRY
>PK3-2_02423 Acetolactate synthase large subunit
MGTNVQVDSASAKCTQTMSGALMLIESLKKEKVEMIFGYPGGAVLPIYDKLYNSGMVHIL
PRHEQGAIHAAEGYARVSGKPGVVIATSGPGATNLVTGLADAMIDSLPLVVFTGQVATSV
IGSDAFQEADILGITMPVTKHSYQVRQPEDLPRIIKEAFHIATTGRPGPVLIDIPKDVAT
IEGKFSYDHEMNLPGYQPTTEPNYLQIRKLVEAVSSAKKPVILAGAGVLHGKASEELKNY
AEQQQIPVAHTLLGLGGFPADHPLFLGMAGMHGTYTANMALHDCDLLISIGARFDDRVTG
NLKHFARNAKIAHIDIDPAEIGKIMKTQIPVVGDSKIVLQELIKQDGKQSDSGEWKKQLA
AWKEEYPLWYVDNEEEGFKPQKLIEYIHQFTKGEAIVATDVGQHQMWSAQFYPFQKADKW
VTSGGLGTMGFGLPAAIGAQLADKDATVVAVLGDGGFQMTLQELDVIRELNLPVKVVILN
NACLGMVRQWQEIFYEERYSESKFASQPDFVKLSEAYGIKGMRISSEAEAKEKLEEALTS
KEPVVIDVRVASEEKVFPMVAPGKGLHEMVGVKP
>PK3-2_02424 Acetolactate synthase small subunit
MKRIITLTVVNRSGVLNRITGLFTKRHYNIESITVGHTETTGVSRITFVVHVEGENDVEQ
LTKQLNKQIDVLKVTDITNQSIVQRELALIKVVSAPSTRSEINGIIEPFRASVVDVSRDS
IVVQVTGESNKIEALIELLKPYGIKEIARTGTTAFARGTQQKASSNKTISIV
>PK3-2_02425 Ketol-acid reductoisomerase (NADP(+))
MVKVYYNGDIKENVLAGKTVAVIGYGSQGHAHALNLKESGVDVIVGVRQGKSFTQAQEDG
HKVFSVKEAAAQAEIIMILLPDEQQQKVYEAEIKDELTAGKSLVFAHGFNVHFHQIVPPA
DVDVFLVAPKGPGHLVRRTYEQGAGVPALFAIYQDVTGEARDKALAYAKGIGGARAGVLE
TTFKEETETDLFGEQAVLCGGLSALVKAGFETLTEAGYQPELAYFECLHELKLIVDLMYE
EGLAGMRYSISDTAQWGDFVSGPRVVDAKVKESMKEVLKDIQNGTFAKEWIVENQVNRPR
FNAINASENEHQIEVVGRKLREMMPFVKQGKKKEAVVSVAQN
>PK3-2_02426 2-isopropylmalate synthase
MRKINFFDTTLRDGEQSPGVNLNTQEKLAIAKQLERLGADIIEAGFPASSRGDFLAVQEI
ARTIKNCSVTGLARCVKGDIDAAWEALKDGAQPRIHVFIATSDIHLKHKLKMTREQVVER
AVEMVKYAKERFPVVQWSAEDACRTELPFLAEIVEKVIDAGASVINLPDTVGYLAPAEYG
NIFKYMKENVSNIQQAKLSAHCHDDLGMAVANSLAAIENGADQIECAVNGIGERAGNAAL
EEIAVALHIRKDFYQVDTGITLNEIKRTSDLVSKLTGMVVPRNKAVVGDNAYAHESGIHQ
DGFLKEKSTYEIISPELVGVTADALVLGKHSGRHAFKDRLTALGFQFDNEEINKFFTMFK
ELTEKKKEITDEDLVSLILEEKVTDRKIGYEFLSLQVHYGTSQVPTATLSLKNQENAELI
QEAATGAGSVEAIYNTLERCIDKDVELLDYRIQSNRKGEDAFAQVYVRVLVNGKESAGRG
IAQDVLEASAKAYLNAVNRQLVFQSNMSGLKNHTAVGS
>PK3-2_02427 3-isopropylmalate dehydrogenase
MKKRIALLPGDGIGPEVLESATDVLKSVAERFNHEFDFEYGLIGGAAIDKHNNPLPEETI
AACKNADAILLGAVGGPKWDQNPSELRPEKGLLSIRKQLDLFANLRPVKVFESLSDASPL
KKEYIDSVDFVIVRELTGGLYFGQPSKRYVNTEGEQEAVDTLFYKRTEIERVIREGFKMA
AARKGKVTSVDKANVLESSRLWREVAEDVAKEFPDVKLEHMLVDNAAMQLIYAPNQFDVV
VTENMFGDILSDEASMLTGSLGMLPSASLSSSGLHLFEPVHGSAPDIAGKGMANPFAAIL
SAAMLLRTSFGLEEEAKAVEDAVNKVLISGKRTRDLARGEEFSSTQAITEEVKAAIMSEN
TISNV
>PK3-2_02428 3-isopropylmalate dehydratase large subunit
MMPRTIIEKIWDQHIVKHGEGKPDLLYIDLHLIHEVTSPQAFEGLRQKGRKVRRPQNTFA
TMDHNIPTVNRFEIKDEVAKRQVTALERNCEEFGVRLADLHSVDQGIVHVVGPELGLTLP
GKTIVCGDSHTSTHGAFGALAFGIGTSEVEHVLSTQTLWQQRPKTLEVRVDGTLQKGVTA
KDVILAVIGKYGVKFGTGYVIEYTGEVFRNMTMDERMTVCNMSIEAGARAGLIAPDEMTF
EYCKNRKYTPKEEEFDKAVEEWKALRTDPGAVYDKSIVLDGNEISPMVTWGINPGMVLPV
DSEVPAPESFSAEDDKKEAIRAYEYMGLTPHQKIEDIKVEHVFIGSCTNSRMTDLRQAAD
MIKGKKVADSVRAIVVPGSQSVKLQAEKEGLDQIFLEAGFEWRESGCSMCLSMNNDVVPE
GERCASTSNRNFEGRQGKGARTHLVSPAMAAMAAIHGHFIDVRKFYQEKTVV
>PK3-2_02429 3-isopropylmalate dehydratase small subunit 1
MEPLKTHTGKAAVLNRINVDTDQIIPKQFLKRIERTGYGRFAFFDWRYDANGEPNPEFEL
NQPAYQGASILIAGENFGCGSSREHAPWALDDYGFKIIIAPSFADIFHQNCFKNGMLPIR
MPYDNWKKLVGQYENQSLQMTVDLENQLIHDSEGNQISFEVDPHWKEMLINGYDEISLTL
LLEDEIKQFESQRSSWLQA
>PK3-2_02430 hypothetical protein
MTHDKKNAKIIPFPHLKDRLVEKGMSSLKEKKYQEALEMFSEAMKYDDTESDLHLGMAIC
FLEMGELEEAKSVCEKMLKEGYGHYFTVLQVYMTILIQLKKYEEVKSTIEAVLEENQLPA
ESAEQFYKLLDFSRKMTDPEREDEAWAEEYEDTIDTEKVLASPEEQMNLIHSLKDRNVAK
YTGLLKTILQDPSAHPIIKTMIVMLLAEHEYSKPVHITKFGESLTIEPSEIVPPDAAPIL
HRVLRVLDETLGNENPTLYAAVEELWRRHLYVLYPFQPKLLSANLWAAALHKVGYEMHGI
EIEREELHMMYEFIDKELDEACTMIKDIEEISYL
>PK3-2_02431 Trigger factor
MSVKWEKQEGNEGVLTVEVDAETFKTALDDAFKKVVKQVSIPGFRKGKIPRGLFEQRFGV
EALYQDALDILLPVEYPKAVEEAGIEPVDRPEIDVEKIEKGESLIFTAKVTVKPEVKLGD
YKGLGIEKDDTAVTDEDVQNELKALQERQAELVVKEEGAVEEGNTVVLDFEGFVDGEAFE
GGKAENYSLEVGSGSFIPGFEDQLVGLEAGAEKDVEVTFPEEYHAEDLAGKPAVFKVKIH
EIKAKELPELDDEFAKDIDEEVETLAELTEKTKKRLEEAKENEADAKLREELVLKASENA
EIDVPQAMVDTELDRMLKEFEQRLQMQGMNLELYTQFSGQDEAALKEQMKEDAQKRVKSN
LTLEAIAKAENLEVSDEEVDAELTKMAEAYNMPVENIKQAIGSTDAMKEDLKVRKAIDFL
VENR
>PK3-2_02432 ATP-dependent Clp protease ATP-binding subunit ClpX
MFKFNEEKGQLKCSFCGKTQDQVRKLVAGPGVYICDECIELCTEIVEEELGTEEEVEFKD
VPKPQEIREILNEYVIGQDQAKKSLAVAVYNHYKRINSNSKVDDVELSKSNISLIGPTGS
GKTLLAQTLARILNVPFAIADATSLTEAGYVGEDVENILLKLIQAADYDVEKAEKGIIYI
DEIDKVARKSENPSITRDVSGEGVQQALLKILEGTVASVPPQGGRKHPHQEFIQIDTTNI
LFICGGAFDGIEQIIKRRLGQKVIGFGSDNKAADLEKEDLLSKVLPEDLLRFGLIPEFIG
RLPVIASLEKLDEEALVAILTKPKNALVKQFKKMLELDNVELEFEEEALSEIAKKAIERK
TGARGLRSIIEGIMLEVMFELPSRDDIEKCVITGATVTHGEPPRLLLKDGTEVNQDKTSA
>PK3-2_02433 Lon protease 2
MSWTGIALFIQLFFGIIIGLYFWNLLKNQRTQKVTIDKESKKEMEQLRKMRAISLSEPLS
EKVRPKSFQDIVGQEDGIKALKAALCGPNPQHVIVYGPPGVGKTAAARLVLEEAKKHKQS
PFKEQAVFVELDATTARFDERGIADPLIGSVHDPIYQGAGAMGQAGIPQPKQGAVTHAHG
GVLFIDEIGELHPIQMNKMLKVLEDRKVFLDSAYYSEENTQIPNHIHDIFQNGLPADFRL
IGATTRMPNEIPPAIRSRCLEVFFRELEKDELKTVAKTAADKIEKNISDEGLDLLTSYTR
NGRESVNMIQIAAGMAVTENRKDITIEDIEWVIHSSQLTPKHEQKIGAKPQVGIVNGLAV
YGPNSGSLLEIEVSVTSAQDKGSINITGIAEEESIGSQSKSIRRKSMAKGSVENVLTVLR
TMGMKPSDYDIHINFPGGIPIDGPSAGIAMATGIFSAIHKIPIDNTVAMTGEISLNGLVK
PIGGVIPKIKAAKQSGAKKVIIPYENQQSILKQIDGITIVAVKTFQEVLDEILVNPPTEQ
KPFHIEINKESV
>PK3-2_02434 Lon protease 1
MAEELKRSIPLLPLRGLLVYPTMVLHLDVGRDKSVQALEQAMMHDHMIFLATQQDISIDE
PGEDEIFTVGTYTKIKQMLKLPNGTIRVLVEGLKRAQIVKYNEHEDYTSVDIQLIHEDDS
KDTEDEALMRTLLDHFDQYIKISKKISAETYAAVTDIEEPGRMADIVASHLPLKLKDKQD
ILETADVKDRLNKVIDFINNEKEVLEIEKKIGQRVKRSMERTQKEYYLREQMKAIQKELG
DKEGKTGEVQTLTEKIEEAGMPEHVKETALKELNRYEKIPSSSAESSVIRNYIDWLIALP
WTDETDDKLDLKEAGRLLDEEHHGLEKVKERILEYLAVQKLTKSLKGPILCLAGPPGVGK
TSLAKSIAKSLGRKFVRISLGGVRDESEIRGHRRTYVGAMPGRIIQGMKKAGKLNPVFLL
DEIDKMSSDFRGDPSSAMLEVLDPEQNSTFSDHYIEETFDLSKVLFIATANNLATIPGPL
RDRMEIINIAGYTEVEKLEIVKDHLLPKQIKEHGLKKSSLQLRDQAILDIIRYYTREAGV
RSLERQLAAICRKAAKAIVAEERKRITVTEKNLQDFIGKRIFRYGQAETEDQVGVVTGLA
YTTVGGDTLSIEVSLSPGKGKLILTGKLGDVMRESAQAAFSYVRSKTEELGIEPDFHEKY
DIHIHVPEGAVPKDGPSAGITMATALVSALTGRAVSREVGMTGEITLRGRVLPIGGLKEK
ALGAHRAGLTTIIAPKDNEKDIEDIPESVREGLTFILASHLDEVLEHALVGEKK
>PK3-2_02435 putative GTP-binding protein EngB
MKVTKSEIVISAVKPEQYPEGRLPEIALAGRSNVGKSSFINSLINRKNLARTSSKPGKTQ
TLNFYIINDELHFVDVPGYGFAKVSKSEREAWGRMIETYITTREELKAVVQIVDLRHAPS
NDDVQMYEFLKYYGIPVIVIATKADKIPKGKWDKHAKVVRQTLNIDPEDELILFSSETKK
GKDEAWGAIKKMINR
>PK3-2_02436 hypothetical protein
MIGFSLLVSTVQKKEYVYEAVSMICFSLFLYFFKQIMAWLESAHIPTALLKEYWPFVFIG
ISLLLLLIKRKKSIR
>PK3-2_02437 hypothetical protein
MKQKSILFPCLLLAASVYAWLESGQAELFSEQDQWPVLLMLLGAAFVYQGKKKPSHPIFL
SVCFFLELACTFLQSQNGHGGRMILKCSSL
>PK3-2_02438 Glutamyl-tRNA reductase
MGVGGVIKAMHILVVGVDYKSAPIEIREKVSFQPNELAEAMVKLKEEKSILENIIVSTCN
RTEIYAVVDQLHTGRYYIKKFLADWFQLSKEELSPFLTFYESDAAVEHLFRVACGLDSMV
IGETQILGQVRDSFKTAQQEKTIGTIFNELFKQAVTVGKRTHAETDIGSNAVSVSYAAVE
LAKKIFGNLSSKHILILGAGKMGELAAENLHGQGIGKVTVINRTYLKAKELADRFSGEAR
SLNQLESALAEADILISSTGASDFVVSKEMMESANKLRKGRPLFMVDIAVPRDLDPALND
LEGVFLYDIDDLEGIVEANMKERRETAEKVELLIEETIVEFKQWLNTLGVVPVISALREK
ALAIQSETMESIERKLPHLSTREKKLLNKHTKSIINQMLRDPILKVKELAADVDSEEKLA
LFMQIFDIEEAAGRQMMKTVESSQKVHSFKKAESKAGFAPLVSE
>PK3-2_02439 Cytochrome c biogenesis protein CcsA
MIDTAMARLNEGTIVIYALSVLFYFIDFLQHNRKAGKMAFWLLSIVWTLQTVYLAYFMWA
TGRFPVLNVTEALYFYAWVLVTLSLVLTKLLRVDFIVFFTNVIGFSMIAIHTFSPTEQQS
AAFSGQLVSELLVIHITMAILSYGAFSLSFVFSVLYMFQYHLLKKKKWGKWLLRIEDLSK
LDYMAYVLNVIGVPMLLLSLILGVIWAYVSLETLYWFDAKVLGSFVVLLLYSYYLYIRLI
KELQGKVAALWNTACFLVLMINYFLLGSLSQFHWFS
>PK3-2_02440 Porphobilinogen deaminase
MRTIKVGSRRSKLAMTQTKWVIQKLKEINPSFAFEIKEIVTKGDRIVDVTLSKVGGKGLF
VKEIEQALLNEDIDMAVHSMKDMPAVLPEGLVIGCIPEREDPRDALISKDRVKLSEMKEG
AVIGTSSLRRSAQLLIERPDITIKWIRGNIDTRLQKLETEDYDAIILAAAGLSRMGWKQD
VVTEFLEPERCLPAVGQGALAIECRESDEELLALFSQFTDEYTKRTVLAERAYLNAMEGG
CQVPIAGYSVLNGQDEIELTGLVASPDGKIIFKETVTGNDPEEVGKRCAALMADKGAKEL
IDRVKQELDEDGK
>PK3-2_02441 hypothetical protein
MENDFPLKGKTVLVTRNKAQAKSFQQKVEALGGKAVLTSLITFRRALPNDAAKQVKKDLA
TSGWLVFTSVNGADFFFLI
>PK3-2_02442 hypothetical protein
MKTHSVSVDVMPKDYIGEQLAEALKQHAEPAERITVIKGNLSRGVIKQELVPLGFEVKEW
VVYETIPDEEGIEALKKAAGQYSFDYVTFTSSSTVHTFMHVLGEELKKWQANRSACISIG
PLTRDALLSYGITSHSPDTFTIDGMLELMCSMSREEERI
>PK3-2_02443 Delta-aminolevulinic acid dehydratase
MSQSFNRHRRLRSSKAMREMVKETRLHPSDFIYPIFVVEGLEGKKAVPSMPDVYHVSLDL
LKNEVEELVKLGIQSVIVFGIPEEKDDCGTQAYHDHGIVQKAITEIKKHFPEMVVVADTC
LCEYTDHGHCGLVKDGIILNDESLELLAQTAVSQAKAGADIIAPSNMMDGFVTAIREALD
KEGFINIPIMSYAVKYSSEFYGPFRDAANSTPQFGDRKTYQMDPANRMEALREAQSDVEE
GADFLIVKPSLSYMDIMRDVKNEFTLPLVAYNVSGEYSMVKAAAQNGWIKEKEIVLEILT
SMKRAGADLIITYHAKDAAKWLAE
>PK3-2_02444 Glutamate-1-semialdehyde 2,1-aminomutase
MRSYQKSKAAFKEAQKLMPGGVNSPVRAFKSVDMDPIFMERGKGSKIFDIDGNEYIDYVL
SWGPLILGHTNDRVVESLKKVAEYGTSFGAPTEVENELAKLVIDRVPSVEIVRMVSSGTE
ATMSALRLARGYTGRNKILKFEGCYHGHGDSLLIKAGSGVATLGLPDSPGVPEGIAKNTI
TVPYNDLESVKLAFQQFGEDIAGVIVEPVAGNMGVVPPQEGFLQGLRDITEQYGSLLIFD
EVMTGFRVDYNCAQGYFGVTPDLTCLGKVIGGGLPVGAYGGKAEIMEQIAPSGPIYQAGT
LSGNPLAMTAGLETLKQLTPESYKNFIKKGDRLEDGISKAAETHGIPHTFNRAGSMIGFF
FTNEPVINYDTAKSSDLKLFANYYKGMANEGVFLPPSQFEGLFLSTAHTDEDIEKTIQAA
EKVFAEISRG
>PK3-2_02445 hypothetical protein
MPQNHRLQFSVEESICFQKGQEVSELLSISLDPDIRVQEVNDYVSIRGSLELTGEYNIDQ
NKHTEEFYSDKRFVEEVRKREDGSAELTHCFPVDITIPKNKVSHLQDVFVFIDAFDYQLT
DSRILTIQADLAIEGLLDDTAVKEPEIPLYEAPAAFREDEPSEPPIQSAVETDAPPAVEV
LKDETPAEPPELFVSKAGLREELETEKAESEPPEFAVSEPEAREDAEPPELVAQEVYREE
SETKETEPEASEIEIQEIVKTEKETSEPAAALADVREEADSPAEPELCEDSRAEESPALE
AELHGETESSEEKAEKAAAPILEHASRQEGHLEHAESALRKEEKEAEHAEPALRQEEKEA
EHAEPALRQEEKEAERAEPALRQEEKEAEHAEPALRQEEKEAEHAESALRQEEKEAEHAE
PALRQEEKEAEHAEPALRQEEKEAEHAEPALRQEEKEAEHDESALRQEAEETPETVSETV
LSVEESREKKPGSAAYAENEEETVLFHFNQKASSEEASQEEAPVPAYRAFLPEQEEEDSF
YSAPKLLEEKEREEESFEIEVRKIAPAEESEEETPLQSFQLPDTSETERKEEYAVPRVAP
AAETKEPHSKESNNSLYLTKLFTREEDEFSRMKICIVQQEDTIERLCERYEITSQQLIRM
NSLALDDELKAGQILYIPQYNNSHA
>PK3-2_02446 hypothetical protein
MNGMEDTQSVLQEYGLTAQFIEPVSPLVWKVYTDYGVFALKKLKSVRGKQFTDHMVAIEE
KGFRSFVPVYRTNSGEFFSAGIQSGDSYYLMPWLQFDQEEEQDQKHAYLFRETARLHERT
AQEMKVSRDDIERYYGQTKKKWEHDKMFYEQFVDRAEKEWYLSPFELQAVTYFSETISAV
NFGLERLDDWYESAKEEGVSRVVMNHGSLSIHHFLYNDAGTGYFTNFERASIGPPQNDLL
GFYTKMFRGFPKTCPECVEWFYAYTKSFPLRETEVSLFLSYMAYPAAMYTVLNRYQTGNR
QHEKDECTQLLKAYWQMKNIEPFVMKIHQVEQEKKFQAENESTS
>PK3-2_02447 hypothetical protein
MKKRFSSYSLPPWVRQIRLVSAQVIIPITIFQGIRTIFFPTTFDVLLLAILIFLACALHL
DWI
>PK3-2_02449 Valine--tRNA ligase
METNEQTMPTKYDPAAVEKDRYDFWLKGKFFEAGSDQTKEPYSVVIPPPNVTGRLHLGHA
WDTTLQDIVTRMKRMQGYDVLWLPGMDHAGIATQAKVEAKLREEGKSRYDLGREKFLEET
WSWKEEYADFIRSQWAKLGLGLDYSRERFTLDEGLSKAVREVFVKLYKKGLIYRGEYIIN
WDPATKTALSDIEVIYKDVQGAFYHMSYPLADGTGSIEIATTRPETMLGDTAVAVHPEDE
RYKHLIGKTVILPITNREIPIVGDDYVDMEFGSGAVKITPAHDPNDFELGNRHNLERILV
MNEDGTMNENALQYQGMDRFECRKKLVKDLQEAGVLFKIEDHMHSVGHSERSGAVVEPYL
STQWFVRMQPLADAAIELQKKEEKVNFVPDRFEKTYLHWMENIRDWCISRQLWWGHRIPA
WYHKETGELYVGLEAPEDSENWEQDTDVLDTWFSSALWPFSTMGWPDVTAEDFKRYYPTD
VLVTGYDIIFFWVSRMIFQGIEFTGERPFKDVLIHGLIRDEQGRKMSKSLGNGVDPMDVI
DKYGADSLRYFLATGSSPGQDLRFSYEKVESTWNFANKIWNASRFALMNMDGMTYDELDL
SGEKSVADKWILTRLNETIEHVTQLADRYEFGEVGRHLYNFIWDDFCDWYIEMAKLPLYG
EDEAAKKTTRSILAYVLDQTMRLLHPFMPFLTEEIWQHLPHQGESITVSQWPVAVPEHTD
TEAAADMKLLVELIRSVRNIRSEVNTPMSKQVELYIKTSTDEIAARLEANRSYVERFTNP
SVLKIGTDIEAVDKAMTAVVSGAEVILPLEGLINIDEEIARLQKEFDKLTKEVERVQKKL
GNEGFMKKAPAHVIDEEREKEKDYVAKRDAVQKRMAELKG
>PK3-2_02450 Folylpolyglutamate synthase
MFTAYEEARSWIHGRLKFGVKPGLGRMEQLMARLGHPEKKIRAFHVAGTNGKGSTVAFIR
SMLQEAGYTVGTFTSPYIITFNERISVNGTPISDEEWTALVNQIKPHVKALDQTEYGQPT
EFEIMTACAFLYFAEFHKVDFVIFETGLGGRFDSTNVVEPLLTVITSIGHDHMNILGNTI
EEIAGEKAGIIKEGIPIVTAVTQPEALQVIRHEAERHAAPFQSLHDTCIIFNEEALPAGE
RFSFKTGEKCYEDIRTSLIGTHQRQNAALSILAAEWLNRENIAHISDEALRSGLVKAAWP
GRLELVQEHPQVFLDGAHNEEGVEKLAETMKQRFPDSRISVVFSALKDKPYQNMIKRLET
IAHSIHFASFDFPRASLAKDLYEASEISDKSWSEDPDDVLEFIESKKDSNGIVLITGSLY
FISEIRKRLK
>PK3-2_02451 Type 4 prepilin-like proteins leader peptide-processing enzyme
MLIILFIFGLILGSFYYTAGCRIPLHISIITPCSACSFCRQALTPTELIPILSFLLQKGK
CNSCGQKISFMYPAAELVTACLFATAGIRFGPSPELFPAVVFISLLIIVAVTDIHFMLIP
NRILIFFLPFLAAARLISPLDSWYASLLGAAAGFLFLALIAAITRGGIGGGDIKLFAVIG
FVLGVKMLAAAFFFSVLIGALYGGAAVLTGRLAKREPLPFAPAIAAGSMLAYFYGESIIS
FYIKMALG
>PK3-2_02452 Stage II sporulation protein B
MKKRKIKKNSKAAEKALKVTINGKEETVYEQETSETETDKSMTFSNWEEKRKAEQEVAAS
REHPDEDEFNWDSEEDKVFKEDPKVVPPYQKKKTKLYAKGKAGASKPVKRVAATIAFAAV
IGTGLGLFALNISGNKEVSAPASLDDSLGSQTAKAGDTSADKQSSGAEKQAAQTEGTYKT
YAVQAGKFSNEKGAETLAEQLTEKGYSAVSLSKDDGYTYVIAGLASDKDVSQQLGQLLID
SDFEAWGGKELSLSIESDMTDSFKETAELASKAILGKDITKASVEKIEKSLDETKASETG
EKKAILQALKELEDPSAESGWKAQQELLAVIK
>PK3-2_02453 dTTP/UTP pyrophosphatase
MTKPLILASQSPRRKELLDLLQLPYSIIVSEVDEKLNRNFSPEENVQWLAKQKAKAVADL
HPHAIVIGADTMVCLNGECLGKPKDQEEAAAMLRRLSGRSHSVITAVSIQAEHHSETFYD
KTEVTFWPLSEEEIWTYIETKEPMDKAGAYGIQGRGALFVKKIDGDYYSVMGLPVSKTLR
ALRHFDIKA
>PK3-2_02454 hypothetical protein
MIIHDLPLKLKDFPTKEKPRERLLKVGAENLANHELLAILLRTGTKHESVMDLSNRLLRS
FDGLRLLKEASVEELSSIPGIGIVKAVQILAAVELGSRIHKLANEEHFVIRSPEDGANLV
MEDMRFLTQEHFVCLYLNTKNQVIHKRTVFIGSLNSSIVHPREVFKEAFKRSAASFICVH
NHPSGDPTPSREDIEVTRRLFECGNLIGIELLDHLVIGDKKFVSLKEKGYL
>PK3-2_02455 Cell shape-determining protein MreB
MFGIGTRDLGIDLGTANTLVFVKGKGIVVREPSVVALQTDTKSIVAVGNDAKNMIGRTPG
NVVALRPMKDGVIADYETTATMMKYYINQAIKNKGMFARKPYVMVCVPSGITAVEERAVI
DATRQAGARDAYPIEEPFAAAIGANLPVWEPTGSMVVDIGGGTTEVAIISLGGIVTSQSI
RVAGDEMDDAIINYIRKTYNLMIGDRTAEAIKMEIGSAEAPEESDKMEIRGRDLLTGLPK
TIEITGKEISNALRDTVSTIVEAVKSTLEKTPPELAADIMDRGIVLTGGGALLRNLDKVI
SEETKMPVLIAEDPLDCVAIGTGKALEHIHLFKGKTR
>PK3-2_02456 Cell shape-determining protein MreC
MPNKRLMLLLLCIIILVAMIGFSLKGGRNTTWPEKVIGDTTGVFQNIFHTPAEFFAGIFD
NMNDLKNTYKENERLREKLDGQTQYEAKLQELEEENKSLRDELGHVKSIKDYKAILATVI
ARSPDNWAKQVTINKGSQQNVAKDMAVTNEKGALIGKIKSSGLNNFTSTVQLLSDTDRNN
RVATKISGKKGSKGYGLIEGYDKDKKRLKMTIIERKDKQDVKKGDLIETSGTGGVFPEGL
TIGEVTDIESDSYGLTKVAYVKPAADLTDLNNVIVVNRDVPTVDTEEEGS
>PK3-2_02457 Rod shape-determining protein MreD
MKRFLLPFVMMLVFSAESIFTDLVHFPFVTDDQVLVPRFLMLVLIFMSAFINQKHAMIYG
FIFGFLYDMNYTSLLGVYMFGFAGLCYLASKAFKVLHTNAFVVILIAVLAVCLLEFYVFG
IQSLIHKDIMTFNGFVLDRFIPTILLNIAAALILVLPFRIFFMSLKKELRDE
>PK3-2_02458 Septum site-determining protein MinC
MKTKKQQYVTIKGTKNGLTLHLDDACSFDELLDGLQNMLSIEQYTDGKGQKISVHIKLGN
RFLYKEQEEQLTELIASKKDLFVHSIDSEVITKKEAQRMKEEAEIISVSKIVRSGQVLEV
KGDLLLIGDVNPGGTVRAGGNIFVLGSLKGIAHAGFNGNNQAVIAASEMLPTQLRINHVL
NRSPDHIQKGSEMECAYLDTDGNMVIERLQHLAHLRPDLTRLEGGM
>PK3-2_02459 Septum site-determining protein MinD
MGEAIVITSGKGGVGKTTTSANLGTALAILGKRVCLLDTDIGLRNLDVVMGLENRIIYDL
VDVVEGRCKMHQALVKDKRFDDLLYLMPAAQTSDKTAVVPEQIKNMVQELKQEFDYVIID
CPAGIEQGYKNAVSGADKAIVVTTPEISAVRDADRIIGLLEQEENIEPPRLVVNRIRNHL
MKNGDTMDIDEIVQHLSIDLLGIVADDDEVIKASNHGEPIAMDSKNRASIAYRNIARRIL
GESVPLQVLEEQSKGMMAKIKSFFGVRS
>PK3-2_02460 Stage IV sporulation protein FA
MSHRADEIRKRLEKRRKQLSGSKRFSTQTVSEKQKPPSWVMVTDQEKHGTLPVYEDNMST
FNGKHPLVKTDSIILKCLLSACLVLVSAIAYKTNIGPVSQIKPAVAKTFETEFQFASASH
WFETKFGNPLAFLAPEHKNKEQQVEVSKDLVAPASGKVQQDFQDNGEGIKVETSSDAIDS
IKEGYVVEVSKDSQTGLTVKVQHADNTYSIYGELKDVDVALYDFVDKGKKLGSIKLDDHN
KGVYYFAMKDGDKFIDPIQVISFE
>PK3-2_02461 Stage IV sporulation protein FB
MNKWLDLILKIHVHPFLWIIAALGLLTGHMKALLCLLLIVLFHELGHAALAVFFSWRIKR
VFLLPFGGTVEVEEHGNRPLKEEFAVIIAGPLQHIWLQFAAWMLADFSVIHQHTFELFTF
YNLSILFVNLLPIWPLDGGKLLFLLFSKQLPFQRAHRLNLKTSLCCCLLLGCWVLFVIPL
QISAWVLFVFLAVSLFEEYRHRHYIHVRFLLERYYGKNRELEKLLPLTVKAEDKVYHVMA
EFKRGCKHPIIIEKSGQKLSQLDENEVLHAYFADKRTNSSMEELLLLY
>PK3-2_02463 50S ribosomal protein L21
MYAIIKTGGKQIKVEEGQTVYIEKLAAEAGETVTFEDVLFVGGDNVKVGNPTVEGATVTA
KVEKQGRAKKITVFRYKAKKNVHKKQGHRQPYTKLTIEKINA
>PK3-2_02464 hypothetical protein
MIQATIRRSHDKGILSFEMTGHANFAEHGQDLVCAGVTAVVFGAVNAVIVLAGFEPLLDI
GEDGGYFYFEFPESLDPEARQKAQLLIEGMIVSLETIERDYKDNLRVTTNII
>PK3-2_02465 50S ribosomal protein L27
MLRLDLQFFASKKGVGSTKNGRDSEAKRLGAKRADGQFVTGGSILYRQRGTKIYPGENVG
RGGDDTLFAKIDGTVKFERFGRDRKKVSVYPVAQ
>PK3-2_02466 Sporulation initiation phosphotransferase B
MKDVSKNQEENISDTALTNELIHLLGHSRHDWMNKLQLIKGNLSLQKYDRVFEMIDEMVI
DAKHESKLSNLKTPHLAFDFLTFNWKTHYMTLEYEVLGEIKDLSDYDQKLVKLMRKLFYL
FDQAVSRESENHLTVSLQTDHPDRQLILYLDFHGSFADLSAFDDIRQNGYEDVDIMRFEI
TSHECLIEIGLD
>PK3-2_02467 GTPase Obg
MFVDQVKVYVKGGDGGNGMVAFRREKYVPKGGPAGGDGGNGGDVVFEVDEGLRTLMDFRY
KKHFKAIRGEHGMSKNQHGRNADDMVIKVPPGTVVTDDDTKQVIADLTEHGQQAVIARGG
RGGRGNSRFATPANPAPQLSENGEPGKERYVVLELKVLADVGLVGFPSVGKSTLLSVVSS
AKPKIADYHFTTLVPNLGMVETDDGRSFVMADLPGLIEGAHQGVGLGHQFLRHIERTRVI
VHVIDMSGLEGRDPYEDYLTINQELSEYNLRLTERPQIIVANKMDMPEAAENLEAFKEKL
TDDYPVFPISAVTREGLRELLFEVANQLENTPEFPLYDEEELTQNRVMYTMENEEVPFNI
TRDPDGVFVLSGDSLERLFKMTDFSRDESVKRFARQMRGMGVDEALRERGAKDGDIIRLL
EFEFEFID
>PK3-2_02468 hypothetical protein
MKEETFYLVREDVLPDAMRKTLEVKKLLDRKKADSVADAVQKVDLSRSAFYKYRDAVFPF
YTMVKEQIITLFFHLEDRSGALSQLLQAVADSGSNVLSIHQTIPLQGRANVTLSISTSAM
EEDIHTLMNKLRKFDFVEKVEILGSGA
>PK3-2_02469 Bifunctional chorismate mutase/prephenate dehydratase
MHKGENIVMKVGYLGPAATFTHLAVSSCFQNGAEHVAYRTIPECIDAAVAGEVDFAFVPL
ENALEGSVNLTIDYLIHEQPLPIVGEMTLPIHQHLLVHPSRENAWKELEKIHSHSHAIAQ
CHKFLHRHFPNVPYEYANSTGAAAKFVSDHPELNIGVIANDMAASTYELKIVKRDIQDYR
DNHTRFVILSPDENILFEVNSKLSSRPKTTLMVMLPQDDQSGALHRVLSAFSWRNLNLSK
IESRPTKTGLGHYFFIIDIEKAFDEVLIPGAMQELEALGCKVKLLGAYQSYQL
>PK3-2_02470 Transcription repressor NadR
MTEELKLMGANRRDQLLLWLKESTSPLTGGELAKKANVSRQVIVQDISLLKAKNEPIIAT
SQGYVYMDTAAQQHQQAERIIACLHGPERTEEELQLIVDEGVTVKDVKIEHPVYGDLTAA
IQVGTRKEVSHFIKKITSTNAAYLSQLTDGVHLHTLTAPDEHRINQACQALEAAGILIKD
>PK3-2_02471 Putative cysteine desulfurase NifS
MIYLDYAATTPICEEALNVYQKLSIDMYGNASSLHDAGGKAKHILEYCRGKIAELIGGEA
NGIYFTSGGTESNLLAIQSLLNGLPKTKKHFITTAMEHQSIHNCAAFLEQHGFDVTIIQP
DEYGVITEEILAAHIRPETGLVSIQHANSETGIIQPIQRLSSFLHHRGILLHCDAVQTFG
KIPINTEELGIDALSVSSHKVHGPKGVGAVYIRPDVPWKPVYPLTAHEHGFRAGTVNVPG
IGAFIAAAELIISEMNKQISRNKTLRTYFLDQISNRSLPVTLAADTAQTECLPHIIGCFF
HAFEGQYVMLECNRSNICISTGSACSAGYHGPSATMKALRKTEQEALQFIRISFGRDTTE
EHLDKLLHTFTALWEQKKGEFDIDRRIKAYGSQQA
>PK3-2_02472 L-aspartate oxidase
MSKKTIAVIGSGAAALSLASAFPPSYEVTVITKKSAKNSNSVYAQGGIAAAYAKGDSIEA
HLEDTLYAGCGHNDLTIAADILQDGKNMIQNLLESEFPFDRNEQGDVCLGREGAHSYSRI
FHAGGDATGRLLVDYLLKQIDSKIELVEHETAVDLLIENGRCIGVMTKDSRGQIKVRYAD
EVVLAAGGCGSLFLHHTNDPSVTGDGLSLAYRAGAEVTDLEFTQFHPTLLVKNDVSYGLV
SEAVRGEGGYLADENGRRVMAGRHPLGDLAPRDIVSRVIHEEMAKGNRVYIDCTAISDFE
GRFPTITAICEKAGVDIQAGKIPVAPGMHFLMGGVSVNRWGETTVPGLYAIGETACTGLH
GANRLASNSLLEALVFGKRAAEHIMQKPIYNRQYQSEQKTGLTYKVPNTEMNELQSRMTS
QMSILREKSSLIELSIWLHTLPFQKVNVKDITIPQLELSHLWQTAKLMTFSALLREESRG
AHFRTDFPQADVRWQGRQIVHTKKGTKIRKNEGIWKNESFTAEKIAESLFS
>PK3-2_02473 putative nicotinate-nucleotide pyrophosphorylase [carboxylating]
MNHLQLKKLLNHFFLEDIGMGDLTSQAIFREQSCEAEIVAKSDGIFAGAAVIKEGFALLD
ENVQTILHKSDGDILRKGEVIAVLRGPAAALLSGERVVLNLIQRMSGIATMTMEAVRRLD
DEQIKICDTRKTTPGLRMLEKYAVRAGGGYNHRFGLYDGIMIKDNHIAACGSILEACKKA
RQAAGHMVNIEVEIETEEQLLEAIEAGADVIMFDNCPPDTVRHFANLTPNHIKTEASGGI
TLESLPAFKGTGVNYISLGFLTHSVKSLDISMDVALSNESGEECRYVNS
>PK3-2_02474 Quinolinate synthase A
MSILDVIKQSNDMMPDGYKGMSRKDMETRVAAIKKKLGSQLFIPGHHYQKDEVIQFADQT
GDSLQLAQIAEKNKEAEYIVFCGVHFMAETADMLTGEQQTVILPDMRAGCSMADMADMQQ
TNRAWEQLQHIFGDTIIPLTYVNSTAEIKAFVGKHGGATVTSSNAKKVLEWAFTQKKRIL
FLPDQHLGRNTAYDLGIALEDMAVWDPIKDELTAESEHKNVKVILWKGHCSVHEKFTANN
IRDVRERDPDIRIIVHPECSHEVVTLSDDSGSTKYIIDTINQAPAGSKWAIGTEMNLVQR
IIHEHSDKQIESLNPDMCPCLTMNRIDLPHLLWSLEQIEKGEPIGMIKVPKVIQQDALLA
LNRMLSIT
>PK3-2_02475 SpoIVD-associated factor A
MKIHIVQKGDSLLKIAEKYGVDIEEVKKLNTQLSNPDLIMPGMKIKVPSEGVPVRKEPKA
GKSPAAGSVKQEHPFAKEKPNSVVDVEDTKPKEKMSVPYVPPMPNLQENVYPEADVNDYY
DMKQLFQPWSPPKPEEPKKHHDGNMDQMYHMQDQFPQQEAMSNMENANYPNMPNMPKAPE
VGGIEEENVHHTVPNMPAVQPYYHYPAHFMPCPVPVSPILPGSGLCYPYFPAHAYPMYQP
YGYQPGFVSPQYDPGEYENQHHGHYGSYGAPQYASPAYGSPYGQMPYGPHYGSPQVMGAY
QPAAPGFMPYKDHDDCGCDDDHHQPYYSAPGYSGLGAYGTPNMPYGGANPNPNPYAAGVS
MPMGGISLL
>PK3-2_02476 Sporulation cortex protein CoxA
MIKTSKTCSIRPRGVFPLGKKMTIASLILMTAGLTACGANDNAQNDTRNNGNTRPIGYYT
NENDADRQGEGMIDNDGPVTELMEDQNGDNRNTTNVNNRDRVTADDRVPLATDGTYNNTN
NRNMNRNGTDNGYDNQENRRLAAKIANRVKQVKNVNDAQVMVTDDRVVIAVRSHTDFTKS
DRDNVTNAARNYANGRDVQVSTDKGLFTRLHKMNTR
>PK3-2_02477 putative transcriptional regulatory protein YebC
MAGHSKWKNIQKRKNAQDARRGKIFMKLAKEIYVAAREGGADPEANSALRLVIEKAKGAN
MPNENIDRAIQKAAGSQDGSSYEEITYEGYGPSGIAVMVECVTDNKNRTASNVRTAFNKN
GGSLGESGCVAFLFERKGVISIDRTERPIEEDELMLDVLEAGGEELQTEDGQYEVLTEPE
HFEDVKTALESKYSISSAEVTMLPKTYADADDQAVEKLEKLIDILEDDDDVQEVYTNYRS
>PK3-2_02478 Sodium/proton-dependent alanine carrier protein
MADFVTHLNAVLWSTPVIYILLGIGLIFSLKTRFLQVRHLKEMIILMFKGKSSEAGVSSF
QALSIALSGRVGTGNIAGVATAIAFGGPGAVFWMWTIAFIGAASAFVESTLAQIYKVKQG
GQYRGGPAYYIEKGLGIKWFAVLFAAAALIAMALLMPGVQSNSIAAGVQNAFGISPAITG
CILVLLLGFIIFGGVKRIASAAQMIVPFMAIGYILLSLIIIVMNISELPAVISLIFKSAF
ALDSAFGGLIGMAISWGVKRGIYSNEAGQGTGPHPAAAAEVSHPVKQGLVQAFSVYIDTL
FVCSATAFMILFTGMYNTQAADGSFIVQRLKGVEAGPGFTQAAIDNVLPGLGAGFVAIAL
FFFAFTTIMAYYYIAETNIAYLARGRESKWAMFGLKLIILAATFYGTVKTASLAWALGDA
GLGIMVWLNVIAIVLLAKPALLALKDYERQKKQGLDPIFDPKSLGIKNADFWEKEYTREN
ERVS
>PK3-2_02479 hypothetical protein
MNPIYGNMREKKGESHINTRSKIPLMMLALLIFFGGAIYWMLFSLKNVPKGTLVRSVESP
DGSYTLNTYVSRNTLSSDAARGELVNEKTLVKKTIYWNYPDSSPTVKWINHNTVKIGNQT
LHLDTDETYDWRKDDHWIREEPPQASVR
>PK3-2_02480 hypothetical protein
MEKIYCHSSEKGSEAVYLTVRGYRIKLSPEQMKLISAVKK
>PK3-2_02481 hypothetical protein
MLTKAEELAHSVIYRKNSRFDKVKEKSEELTLIGKGRSAYVFAFTEGDRKMALKVFFPEY
QATAIKEAAIYEKLAGSAFYPDIYETGDSFILMEYIKGETFYNCLKKGVAISDDMIQQVE
KALSDARAAGLNPSDIHLRNLILTETGAVRVIDVARFEQTKMCMQWNDLKSAYHALYKKP
IFPKKIPGFWLEMIAFLYKKDWLQKHFAQRKRKYS
>PK3-2_02482 Myo-inositol 2-dehydrogenase
MTKQIVTGIIGAGRIGKLHVQNIRRIPHMKIKAVSDIQESRIKSWADSHQVEYITSDYRD
LLHDPDIDAVFICSPTAVHAQMIIEAAEAKKHIFCEKPVSFSLEETKEALAAVRKHGVAL
QVGFNRRFDPHFKKIKTIVEKGEIGTPHLLKITSRDPEPPNIDYVRTSGGLFMDMSIHDF
DMARYIMGSEVTEVYAKGTALVNPSFAELGDIDTAVITLTFENGAMAVIDNSRQAVYGYD
QRVEVFGTKGSAAADNSRPTTVEVSTADFVLKDKPHFFFLERYKDAYEEEILRFAEAIGT
NRETVCTGNDGFQAERIARAAQQSLAFGMPVSIEHTEKIAF
>PK3-2_02483 Alpha-ketoglutarate permease
MNTAHAKGNVLNKIGIPSHMVWGYIGVVIFMVGDGLEQGWLSPFLVEHGLSMQQSASLFT
VYGIAVTISAWLSGTFVQTWGPRKTMTVGLLAFILGSAAFIGWAIPHMYYPALLGSYALR
GLGYPLFAYSFLVWVSYSTSHHILGKAVGWFWFMFTCGLNVLGPFYSSYAVPAFGEITTL
WSALLFVAAGGFLALFFNKDKFTPVQKQDQPKWKELSKAFTIMFENPKVGIGGVVKTINA
IGQFGFAIFLPTYLARYGYSVSEWLQIWGTLFFVNIVFNIIFGAVGDKLGWRNTVMWFGG
VGCGIFTLALYYTPQLIGHQYWVLMIIACCYGAALAGYVPLSALLPTLAPDNKGAAMSVL
NLGSGLCAFIAPGIVSLFIGPLGAGGVIWIFAALYFFSAFLTQFLTISEQSVDMYTEERL
IRENVQTNFEKTVKQ
>PK3-2_02484 Protein BofC
MKRFSTAYLLLGILCSAAACLIGAPPRALGAEVEHYEPLQVHVQLEKVYLDGDVSIEHKD
EKVLSMDEFWTAYAGWTLVEQKKGYVLFRKQMDDISPLSKVNGYIGVSDNGVISTFHGRP
ESASEPIQSFFQIDLERLESHMQKNLLKGIPFRTKAEFEDVIEHMKTYSG
>PK3-2_02485 Holliday junction ATP-dependent DNA helicase RuvA
MIEFVKGTIDYVSPQYIVIENGGIGYQIFTPNPFIYKERSQETIFTYHHVREDAFSLYGF
STREEKALFTKLLNVTGIGPKGALAILGSGDPGAVIQAIENEDEAFLVKFPGVGKKTARQ
IILDLKGKLADVVPEMIENLFNHEERLEKQTAETALEEALEALRVLGYAEKEIKKVLPHL
KEDIGLTTDQYVKKALQKLLK
>PK3-2_02486 Holliday junction ATP-dependent DNA helicase RuvB
MDERLVSSEADNHESVIEQSLRPQNLAQYIGQHKVKENLRVFIDAAKMRQETLDHVLLYG
PPGLGKTTLASIVANEMGVELRTTSGPAIERPGDLAAILTALEPGDVLFIDEIHRLHRSI
EEVLYPAMEDFCLDIVIGKGPSARSVRLDLPPFTLVGATTRVGLLTAPLRDRFGVMSRLE
YYTQEELADIVTRTADVFEVEIDEPSALEIARRSRGTPRVANRLLRRVRDFAQVLGDSRI
TEEISQDALERLQVDRLGLDHIDHKLLMGMIEKFNGGPVGLDTISATIGEEPHTIEDVYE
PYLLQIGFIQRTPRGRIVTPAVYHHFQMEAPRYD
>PK3-2_02487 hypothetical protein
MTEFPKIIMILGAVLLIIGAVLHFVGKMPGDIFVKKGNVTFFFPVVTCIIISVVLSILLN
LFGRMK
>PK3-2_02488 S-adenosylmethionine:tRNA ribosyltransferase-isomerase
MKVDLFDFELPERLIAQVPLEQRDASRLMVLNKHTGELTDSSFKHIISFFKEGDCLVLNN
TRVLPARLFGTKEDTGAKVELLLLKQENGDRWETLAKPAKRVKKGTVVTFGDGRLKAVCT
EELDHGGRKMEFQYDGIFYEVLESLGEMPLPPYIKEQLDDRERYQTVYSKEIGSAAAPTA
GLHFTEEILQQLKDKGVQIEFITLHVGLGTFRPVSADDVEEHNMHAEFYQMSEETAAALN
KVREKGGRIISVGTTSTRTLETIAGEHDGQFKASSGWTSIFIYPGYEFKAIDGMITNFHL
PKSSLIMLVSALAGRENVLRAYNHAVEEEYRFFSFGDAMLIL
>PK3-2_02489 Queuine tRNA-ribosyltransferase
MAEQPIRYEFIKECKQTGARLGKVHTPHGSFETPVFMPVGTLATVKTMSPEELKAMDAGI
ILSNTYHLWLRPGHDIVKEAGGLHKFMNWDRAILTDSGGFQVFSLSKFRNIEEEGVHFRN
HLNGDKLFLSPEKAMEIQNALGSDIMMAFDECPPYPAEYDYMKRSVERTSRWAERCLNAH
SRQNEQGLFGIVQGGEYEDLRTQSAKDLISLDFPGYAIGGLSVGEPKDVMNRVLEFTTPL
LPKDKPRYLMGVGSPDALIDGAIRGVDMFDCVLPTRIARNGTVFTAEGRLNMKNAKFERD
FRPIDEECDCYTCKNYTRAYIRHLIRCNETFGLRLTTYHNLHFLLHLMEQVRQAIREDRL
GDFREEFFERYGYNKPNAKSF
>PK3-2_02490 Sec translocon accessory complex subunit YajC
MTGTLGTLVPIILMFAVLYFLLIRPQQKQQKNVRQMQEELKKGDTVVTIGGLHGTVDSID
ESKVVIKTGDNTRLTFDRRAIREVSAAE
>PK3-2_02491 hypothetical protein
MSDGFVQKEQKPFNTGREETFMEETKQVGKGILYGLIAIFSAMLLTSLAVSLLLTATSLE
ESSFNWLITAISFLSLFIGGFISGGKGKERGWMIGALTALSFSLIILLFQYLGFGKTFTA
EQLLFHLGFLGVCMLGGIFGVNMRGNRSST
>PK3-2_02492 hypothetical protein
MEELLTITFRTIVLYFVILVIFRFMGKREIGELSILDLVVFIMIAEIAVLAIENVEDHLF
HTILPMLVLMIIQVTFAYLSLKNRKVRQLLDGKPTIIIKYGKIDEDAMKSQRYNFDDLMV
QLRENNIDRVADVSFAILEPSGKLTVVKKENSGEHRQLEMPLIIDGSIQTENLSRIGKDK
QWLYEKLRKHGYSNPSDISFCSFTDGELFIDEKDGHST
>PK3-2_02493 Stage V sporulation protein B
MAKQTFLKGTLILIAAGMVTRMLGFVNRVVIARFIGEEGVGLYMMAAPTFFLATTLTQFG
LPVAISKLVAEASARGDHQKTKNILVMSLTITGVLSLIFTPLFLFFAPVMAETMLTDKRT
LYPLLAITPVVPIIAISSVLRGYFQGKQNMNPLAVSQVLEQVIRISLVAVCTTIFLPYGI
EYAAAGAMLSSVAGELASLLYLFICFKYKKTIKIRKHFFQSIKNGKQTFTQLMSVSLPTT
GSRFIGNLSWFFEPIVVAQSLAIAGVATVAATKQYGELTGFAMTLLTLPSFITYSLSTAL
VPAISEGMEQKKLQVVEYRLEQAMRLCLLSGGISVVILFVFADELMRVMYGSSGAAVFIK
VMAPFFLLYYFQGPLQAVLQALNLAGAAMMNSLIGALVKTGLIFVLATRPSLGIMGAALA
IVTGMVLVTLLHAATVSKVLPISIKIKEYTLSFAVIVISGFISSAIKQYVSFGSSEAVNV
AGWISMSSFSYIILLLVFRLIKKDELRRIPIIGRLITR
>PK3-2_02494 Post-transcriptional regulator ComN
MEKHPADLYKDHVRPFLYSKLEEFKILGYDDVELESLWSYLTDKKWKKKTELHIYEMTSD
ILSVKIGEFMNYATVESFKTSNWLGSEEGQEALEELLR
>PK3-2_02495 Protein translocase subunit SecDF
MKKGRLIAFFLFVLLIGTGLGYFTKPAANNITLGLDLQGGFEVLYDVQPVKKGDKITKDV
LVSTVEALNRRANVLGVSEPNIQIEGNNRIRVQLAGVTNQNRAREILATEAQLSFRDTND
KELLNGSDLVENGAKQTYDAKTNEPIVSIKLKDADKFGEVTKKVMKMAPNNQLVIWMDYE
KGDSFKKEVQKEHPKYVSAPNVSQELNTKDVTIEGQFTVQEAKDLASILNAGALPVKLTE
KYSTSVGAQFGQQALHDTVFAGIVGIAIIFLFMLFYYRLPGFIAVITLSVYIYITLQIFD
WMNAVLTLPGIAALILGVGMAVDANIITYERIKEELKLGKSVRSAFRSGNRRSFATIFDA
NITTIIAAVVLFIFGTSSVKGFATMLILSILTSFITAVFLSRFLLALLVESRWLDRKKGW
FGVNKKHIMNIQDTDENTEPHTPFQKWDFTSKRKYFFIFSSAVTIAGIIILLVFKLNLGI
DFASGARIEVQSDHKLTTEQVEKDFQSLGMDPDTVVLSGEKSNVGVARFVGVPDKETIAK
VKTYFKDKYGTEPNVSTVSPTVGKELARNALYAVAIASIGIIIYVSIRFEYKMAIAAIAS
LLYDAFFIITFFSITRLEVDVTFIAAILTIIGYSINDTIVTFDRVREHMKKRKPKTFADL
NHIVNLSLQQTFTRSINTVLTVVIVVVTLLIFGASSITNFSIALLVGLLTGVYSSLYIAA
QIWLAWKGRELKKDSAQ
>PK3-2_02496 K(+)/H(+) antiporter subunit KhtT
MRVRESELPGIGQKVEMITRNNDKISIIIHHDGRRELYYFDENDHEECVASVQFDDAEAR
QISAILGGMAYKPKALESVEAALGDLIIEWFKAETGAPAVHHTIGDLDAGQEYHVTVIAI
IKKNQEKQLHPRSDTVIDEGDTLVISGERDGLKRLIREKLTANMA
>PK3-2_02497 hypothetical protein
MNKQWTIIFALIFTLIVAIFAVINVRSVEVDYLFGRSEWPLILVILGSVLMGALIVYSVG
IFQVMKLKREIKTLRKENKTAIHKQEDTKLADLNDTQDPSARLEKKD
>PK3-2_02498 hypothetical protein
MLASKMRWEIQRPDQDKVKSLTEQLHITPLVASLLVKRGFDTAESAKLFLHTKDADFYDP
FEMKGMREAAERIKQAISQQEQIMIYGDYDADGVTSTSVMLHTLQKLSAQVDFYIPDRFK
EGYGPNEQAFRSIKERGFSLIITVDTGIAAVHEANVAKELGLDVIITDHHEPGPELPDVH
AIVHPKQPGCTYPFKELAGVGVAFKLAHALLGELPDELLDLAAIGTIADLVPLHDENRLI
ATLGLERLRRTNRLGLKELIKLSGGDIGEANEETVGFQLAPRLNAVGRIEQADPAVHLLM
SEDLFEAEELAAEIDQLNKERQKMVSKMTDEAIDMVEQQGLDQTAIVVAKAGWNPGVVGI
VASKLVDRFYRPAIVLGIDEERGIAKGSARSIRGFNLFESLSECRDILPHFGGHPMAAGM
TLNAEDVPDLRNRLNEIADNTLTEEDFIPVQEIDLVCGVEDITVESITEMNLLSPFGMLN
PKPHVLVENAVLEDVRKIGANKNHVKMTVRNESSQLDCVGFHKGELEEGIVPGSRISIVG
EMSINEWNNRKKPQLMIKDAAVSEWQLFDLRGKRMWENTVSALPAAKRAIVSFKEDSTTL
LQGEELRREVHVISSEEQAKALDLDGAYIVLLDPPPSLDMLARLLEGKAPERIYFIFLNQ
EDHFLSTFPARDHFKWYYAFLLKRGAFDVKKHGSELARHKGWSVETINFMTKVFFDLGFV
KIENGVLSVVSGVKKRDLTDSQTYQAKQQLMELDQKLNYSSAEELKEWLNKLMKQDSEAY
ESTRRT
>PK3-2_02499 Adenine phosphoribosyltransferase
MDLKQYVTIVPDYPKEGVQFKDITTLMDKGDVYRYATDQIVEYAKEKQIDLVVGPEARGF
IIGCPVAYALGVGFAPVRKEGKLPREVIKVDYGLEYGKDVLTIHKDAIKPGQRVLITDDL
LATGGTIEATIKLVEELGGVVAGIAFLIELSYLDGRKKLENYDMLTLMKY
>PK3-2_02500 GTP pyrophosphokinase
MANEQVLTAEQVIDKARSYLSDEHIAFVEKAYLYAEDAHREQYRKSGEPYIIHPIQVAGI
LVDLEMDPSTIAGGFLHDVVEDTDVTLDDLKEAFSAEVAMLVDGVTKLGKIKYKSQEEQQ
AENHRKMFVAMAQDIRVILIKLADRLHNMRTLKHLPQEKQRRISNETLEIFAPLAHRLGI
SKIKWELEDTALRYLNPQQYYRIVNLMKKKRAERELYVDEVVNEVKKRVEEVNIKADFSG
RPKHIYSIYRKMVLQNKQFNEIYDLLAVRILVNSIKDCYAVLGIIHTCWKPMPGRFKDYI
AMPKPNMYQSLHTTVIGPKGDPLEVQIRTFEMHEIAEYGVAAHWAYKEGKASSEGATFEK
KLSWFREILEFQNESTDAEEFMESLKIDLFSDMVYVFTPKGDVIELPSGSVPIDFSYRIH
SEIGNKTIGAKVNGKMVTLDHKLRTGDIVEILTSKHSYGPSQDWVKLAQTSQAKHKIRQF
FKKQRREENVEKGRELVEKEIKNLDFEVKDVLTPENIQKVADKFNFSNEEDMYAAVGYNG
ITALQVANRLTEKERKQRDQEEQEKIVQEVTAESKPYPQGRKREAGVRVKGIDNLLVRLS
KCCNPVPGDDIVGFITKGRGVSVHREDCPNVKTNEAQERLIPVEWEHESQVQKRKEYNVE
IEILGYDRRGLLNEVLQAVNETKTNISSVSGKSDRNKVATIHMAIFIQNINHLHKVVERI
KQIRDIYSVRRVMN
>PK3-2_02501 D-aminoacyl-tRNA deacylase
MKLVVQRVTEASVTVDEEVVGQIGQGIMVLVGITHEDTEEDAAYLADKVVNLRIFDDSEG
KMNLSLLDIGGEILSVSQFTLYGDTKKGRRPNYMNAAKPDQALGLYEKWNDLLREKGIKV
ETGTFGAMMDVQLTNSGPVTLIMDSK
>PK3-2_02502 hypothetical protein
MSKKYFVLILCIIFAGALFPPFSAVTAAQGEAVIATDEMNVRSGPGLSYGITAEVNKGER
YPILKEDGDWVQIQLGSGEKGWVVSWLITKKDQAGTSSSTSSDTVTSTDPDLRMRTGPGT
SYEVIGKFPQGSQASVLEKNSGWIKISYQNATGWVSSEYVTSGSSNSAPDESDQTESSSA
STGTVGVSSLNVRASASHDAAVITKLDRGTKLTVLNEKNGWAHIEVNGLKGWVASHYLLT
SSDPAEDSANAGSSSSAKKAYIVYGGTNVRSAASTSASIVERAAKGDSYTITGSKGNWYE
IKLDNGQTGYVANWVVQTSKSAEEAGEPPVSDSPSGNGSLNNKTIIVDPGHGGKDSGTIG
YSGKFEKNLTIKTAKLLASKLRSAGADVYVTRQDDTFVSLQSRVSTSHYRNADAFISIHY
DSYADTSTRGSTAYYYSPAKDQELASDVHSEVVKRSSIPDRGVLFGDYYVLRENRQPAML
YELGYVSHPQEEAIVHSNSYQEKVTDGIESGLEKYFQ
>PK3-2_02503 hypothetical protein
MKYHPKMGRAFHDGEANLHYSDHADPDTTGYLTETASEFGLMSKEAAMRKNNRNKA
>PK3-2_02505 Histidine--tRNA ligase
MGYNIPRGTQDILPGESDRWQFVEQIMRDTCRTYQYKEIRTPIFEHTELFARGVGESTDI
VQKEMYTFQDRKGRSLTLRPEGTAAAVRAFNENKLFANPVQPTKLYYVGPMFRYERPQTG
RFRQFYQFGIEAIGSKDPAIDAEVMALAMSIYQKAGLENVKLVINSLGDQESRKSYREAL
VKHFEPRIEEFCSDCQSRLHTNPLRILDCKKDRDHELMKSAPSILTYLNEESAAYFEKVK
QYLNDLAISYEIDPNLVRGLDYYNHTAFEIMSNAEGFGAITTLAGGGRYDGLVEQIGGPE
APGIGFAMSIERLLAAIDAEKRELPVDQGIDCYIVTLGEKAKDYSVSLVYKLREAGISGE
IDYENKKMKGQFKAADRLNARFIAILGEDELAQNKINVKDAQTGEQIEVALDEFIHVMKA
NQKG
>PK3-2_02506 Aspartate--tRNA ligase
MFGRTYYCGEITEKAIGESVTLKGWVQKRRDLGGLIFIDLRDRTGIVQVVFNPDVSKEAL
AIAEGIRNEYVLDIQGKVVAREEGTVNPNLKTGAIEIHADGVNVLNAAKTPPFAISDQAE
DVSEDVRLKHRYLDLRRPAMFQTMQLRHNVTKAVRSFLDGNGFLDIETPILTGSTPEGAR
DYLVPSRVHEGEFYALPQSPQLFKQLLMVSGIERYYQIARCFRDEDLRADRQPEFTQIDI
EMSFMSQEDIMSLAEDMMANIMRETKGVELNLPLPRMTYDEAMNSYGSDKPDTRFGMLLT
DVSDIVKDTEFKVFSSAVANGGVVKAINVKGGAGDYSRKDIDALGAFAANYGAKGLAWVK
VEADGVKGPIAKFFDEQKQSKLIEALDAAEGDLLLFGADKFEVVAASLGALRLKLGKERG
LIDENLFNFLWVIDWPLLEHDPEEGRFYAAHHPFTMPVREDLELIETAPEDIKAQAYDLV
LNGYELGGGSIRIFEKDIQEKMFELLGFSKEEAAEQFGFLLEAFEYGAPPHGGIALGLDR
LVMLLAGRTNLRDTIAFPKTASASCLMTEAPGEVSDAQLDELHLSIKKKVKN
>PK3-2_02508 hypothetical protein
MLHQFSRNELAIGKEGLETLKNSTVAVLGVGGVGSFAAEALARSGVGRILLVDKDDVDIT
NVNRQLHALLSTVGQPKVDLMKARIADINPECEVIGLKMFYTEETYEQFFEYDLDYVIDA
SDTICYKIHLMKECLQRDIPLISSMGAANKTDPTRFQIADISKTHTDPIAKVVRTKLRKE
GIKKGVQVIFSDESPIVIREEVRKEVGNDDAKIRKAKMPPSSNAFVPSVAGLIMGGHVVM
DLLKDIEIKRVKDK
>PK3-2_02509 putative AAA domain-containing protein
MMKPLAYRMRPTKIEDIIGQQHLVAEDKIIGRMVQAKHLSSMILYGPPGIGKTSIATAIA
GSTSIAFRKLNAVINNKKDMEIVAQEAKMSGQVILILDEVHRLDKGKQDFLLPYLENGMI
ILIGATTANPYHAINPAIRSRTQIFELEPLTPELIKQALERALHDEHRGLGTYSVSIEDQ
AMEHFARGCGGDVRSALNALELAVLSTKESADGEIHITLETAEECLQKKSFSHDKDGDAH
YDVLSAFQKSIRGSDANAALHYLARLIEAGDLESIARRLLVIAYEDIGLASPQAGSRVLH
AIQTAERIGFPEARIPLANAVIELCLSPKSNSAILAIDEALADIRAGKIGDVPKHLKDAH
YKGAQELGRGIDYKYPHNYDSGWVEQQYLPDPLKNKQYYKPKQTGKFESALKQVYDKLMK
RK
>PK3-2_02510 HTH-type transcriptional regulator CymR
MLKISTKGRYGLTIMIELAKKHGEGPTSLKSIAQTNNLSEHYLEQLVSPLRNAGLVKSIR
GAYGGYVLGSEPDAITAGDIIRVLEGPISPVEVLEDEEPAKRELWIRIRDAVKEVLDSTT
LEDLASYTDGEQEAYMFYI
>PK3-2_02511 Cysteine desulfurase IscS
MERIYLDHAATSPMDERVLEKMIPHFSGNFGNPSSIHSFGRESRKWVDEARAQIAAEIKA
AEQEIIFTSGGTEADNLAIMGTALARKDLGRHIITTKIEHHAVLHTCEKLEEDGFEVTYL
DVDQSGRVSAKQVKEALRDDTILVTVMYGNNEVGTVQPIDEIGELLKEHPAYFHTDAVQA
FGLLPIDVKNSHIDLLSVSGHKLNGPKGTGFLYASKDVKLSPLLFGGEQERKRRAGTENV
PGIVGLREAIKLSSEERDEKNEKYQSFKTIIADTLENAGVAFEINGDKENSLPHVLNLYF
PGVSVEALLVNLDMAGVAVSSGSACTAGSVLPSHVLTAMFGEESDRLTSSIRISFGLGNT
AEQVKTAAKHVADVVKRLTQ
>PK3-2_02512 tRNA-specific 2-thiouridylase MnmA
MEKRPEDTRVVVGMSGGVDSSVAALMLKEQGYDVIGIFMKNWDDTDENGFCTATEDYEDV
IRVCNQIGIPYYAVNFEKQYYEKVFQYFLDEYKAGRTPNPDVLCNKEIKFKAFLEHALSL
GADYLATGHYARVDRSGGKVRMLRGIDENKDQTYFLNQLTEDTLSKVMFPIGELQKSRVR
EIAKEADLATATKKDSTGICFIGERNFKTFLSQYLPAQPGDMMTMDGEVKGRHDGLMYYT
IGQRHGLGIGGSGEPWFAVGKDLEKNILYVDQGFHNPLLYSDKITATNISWVRSDIMKGE
EITCTAKFRYRQEDHKVTVRMTGEGEAEVIFDEQVRAVTPGQAVVFYDGEECLGGGTIDD
VYKDGTKLWYV
>PK3-2_02513 TPR repeat-containing protein YrrB
MDYNQLGIEAMQEGDYEKAAEAFTKAIEENKEDAIPYINFANLLSSVNELERALAFYDKA
LELDNNAATAYYGAGNVYVVKEMYKEAKDMFEKALRAGMENGDLFYMLGTVLVKLEQPKL
ALPYLQRAVELNENDTEARFQFGMCLANEGMLDEALSQFAAVTEQDPGHADAFYNAGVAY
AYKENREKALEMLDKAIDIQPDHMLALHAKKLIDPS
>PK3-2_02514 ATP-dependent RecD-like DNA helicase
MQQHPDQLNMEEEPYLKGTVNTVIYHNDTNLYTVLKVKVTETSEAIEDKAVSVTGYFPAL
QEEETYTFYGKIVTHPKFGLQFQAEHFKKEIPTTKEGIIHYLSSDLFEGIGKKTAEEIVK
KLGDSAINKILADASVLYDVPKLSKKKADTLAGALQRHQGLEQIMISLNQFGFGPQLSMK
IYQAYESETLEKIQENPYQLVKDVEGIGFGKADELGSRMGLSGNHPERIKAAILYTLETT
CLSEGHTYIETEKLIIDTQSLLNQSAREGQRITEMDAANAIIALGENKDIVIEDGRCYFP
SLFYAEQNVAKRVKHIASQTEYDDQFPESEFLLALGELEERMNVQYAPSQKEAIQKALSS
PMLLLTGGPGTGKTTVIRGIVELYGELHGVSLDPSAYKKDEAFPVVLAAPTGRAAKRMSE
STGLPAVTIHRLLGWNGAEGFTHTEDQPIEGKLLIIDEASMLDIWLANHLFKAIPDHIQI
IIVGDEDQLPSVGPGQVLRDLLASQVIPTVRLTDIYRQAEGSSIVELAHQMKNGLLPNNL
TAPTKDRSFIRCGGSQIKEVVEKVVANALKKGYTAKDIQVLAPMYRGKAGINELNVMLQD
ILNPPKEKPREIKFGDVVYRTGDKILQLVNQPENNVFNGDIGEITSIFYAKENTEKEDMA
VVSFDGNEMTFTKKDFNQFTHAYCCSIHKSQGSEFPIVVLPVVKGYYRMLRRNLLYTAIT
RAKKFLILCGEEEALEWGVKNNDATVRQTSLRNRLSVQIEEMDAELEALQKELPFSVHDA
NIGMEGVTPFDFMKEEQL
>PK3-2_02515 hypothetical protein
MSQRRKAKPKPVQQKVVDHTLRTCHEIEGFPVYSERTSCYLGTISDICFSLKGNCLGFIL
AQKRFLHHHHALLQACDISCILDDRILASVSSDQLLPLPKSCFTYEQMRMKLVKSQEGDI
LGMLEDVYFCLDRGIIVAYELSDGFFSDLAGSKRQIQRADSLVEVRKDEIVLNG
>PK3-2_02516 hypothetical protein
MLICPNCKSKDIGKIGVNQYYCWGCFIELTVAKGKIATHQVEEDGTLSSLDDLFSEDERS
INF
>PK3-2_02517 Putative transport protein
MLQKPVQLLLWVAICLLVLLTVYVFFMLDMLWSPFWLVIKTIFIPLIISIFISYLLLPVT
EWLHRKGLPRTLSILVIYVLFFGGIGWALYKGGPVLIVQLTDLSENIPMFAETYNGLLLH
VHNHTDDWPDGMHHRIDKMIRQTEAFFAGTIERAISGIRNVLDYFLIAATIPFLVFYMVK
DIELMKKTVWYLTPKSWRKRGSAFLRDVDDSLGDYIRGQLLVCLILGVIAGITFWIFGLP
YPLILGLISGITNVIPYFGPFIGAVPALLIAMTISVKAILVVVITVFVLQFMEGNILSPF
IVGRSLKMHPVVIMLALLAGGELAGIVGMILAVPATAVLKVMMIHFLRIRTEH
>PK3-2_02518 Alanine--tRNA ligase
MKHLTSAEVRQMFLDFFKEKGHAVEPSASLVPHEDPSLLWINSGVATLKKYFDGRVVPEN
PRIVNAQKAIRTNDIENVGKTARHHTFFEMLGNFSIGDYFKEEAITWAWEFLTSDKWIGF
DKELLSVTVHPEDEEAYEFWAKKIGIPEERIIRLEGNFWDIGEGPSGPNTEIFYDRGEAY
GNDPEDPELYPGGENDRYLEVWNLVFSEFNHNPDGTYTPLPKKNIDTGMGLERMVSVIQN
VPTNFDTDLFVPIIKATESISGETYGKDNVKDTAFKVIADHIRTVAYAVSDGALPSNEGR
GYVLRRLLRRAVRYAKTINIHHPFMYDLVPVVAEIMADFYPEVKEKADFIAKVIKTEEER
FHETLNEGLAILSEMIKKEKDKGSSVISGADVFKLYDTYGFPVELTEEYAEDENMTVDHI
GFEEEMNQQRERARNARQDVGSMQVQGGALRDVTDESTFVGYSQTKADAKVIVLLQDGQL
IEEAHEGETVQIILDETPFYAESGGQIGDTGYLRSEQAVVRIKDVQKAPNGQHVHEGVVE
SGTVQKDLHVTAEVEDHMRSGVIKNHTATHLLHQALKDILGTHVNQAGSLVTENRLRFDF
SHFGQVTKEELEQIERIVNEKIWASIPVSIDLKPIAEAKEMGAMALFGEKYGDIVRVVQV
GDYSLELCGGCHVRNTAEIGLFKIVSESGIGAGTRRIEAVTGQGAYVEMNSQISVLKQAA
DELKTNIKEVPKRVAALQAELKEAQRENESLLAKLGNVEAGAILSKVKEVDGVSVLAEKV
NAKDMNHLRTMVDELKAKLGSAVIVLGAVQNDKVNISAGVTKDLIDKGLHAGKLVKQAAE
VCGGGGGGRPDMAQAGGKQPEKLEEALASVEDWVKSVL
>PK3-2_02519 hypothetical protein
MSSFDKTMKFNFSDDSAETNVNEVLITVYDALQEKGYNPINQIVGYLLSGDPAYIPRHRD
ARNLIRKLERDELIEELVKSYLEQHKEA
>PK3-2_02520 Putative pre-16S rRNA nuclease
MRILGLDLGTKTLGVALSDEMGWTAQGIETIKINEAEGDYGLTRLSELIKGYTIDKIVLG
FPKNMNGTVGPRGEASQIFAKVLETTYNVPVVLWDERLTTMAAEKMLIAADVSRQKRKKV
IDKMAAVMILQGYLDSLN
>PK3-2_02521 hypothetical protein
MEHGEKNITIVDEQGNEQLCEVLFTFENEEFDKSYVLYYPIETKDDEEVEILASSFTPNE
DGENGELFPIETDEEWDMIEETLNTFLADEDEE
>PK3-2_02522 Endolytic murein transglycosylase
MYINQQKKSFFNKKRIILSSIIVLLLIIGGAFLYGKSLLEPVEKDSKKTVNINIPSGSSV
SAIASILKKNDVIKSEKAFQYYVKYKGASGFQAGFYHLNKGMDLDAIIHKLTSGATSYAF
QITVTEGAQLTQIAAAIAEETKYSKKQVLAKLDDETFINQLKKEFPDTVTNDVFNKSIKH
PLEGYLFPATYPFNDPDTSLEDIIKAMIEQTNSYVETYKSEMKKKKLSVHKLLTMASLIE
EEATEKADRHKIASVFYNRLKKKMPLQTDPTVLYAAGKHKDRVLYKDLEIDSPYNTYKNT
GLTPGPIANAGMSSWEAALHPDQTDYLYFLAKSNGEVVFTKTLKEHNKAKEKYISSKSEK
>PK3-2_02523 tRNA 5-hydroxyuridine methyltransferase
MTDRYEQINDYIEALLKPRPENVKKLEAYAEEHHVPIMEKAGMEVLLQILAVKQPKKILE
IGTAIGYSAIRMALELPSAEIYTIERNEKRHEEAVNNIKEFQLDDRIHVFYGDALELAGA
VHVTAPYDVIFIDAAKGQYQNFFHLYEPMLSPDGVILTDNVLFKGLVAEDYSKIEPKRRR
RLVTKIHEYNHWLMNHPDYQTAIIPVGDGLAISKKKR
>PK3-2_02524 23S rRNA 5-hydroxycytidine synthase
MKKPELLVTPTSVADILPLIQAGATAFLVGEQRYGLRLAGEFTREDVTKAVEIAHKEGAK
VYVAVNAIFHNDKVGELGEYLAFLAETGVDAAVFGDPAVLMAARESAPGLKLHWSTETTG
TNYYTCNYWGRKGAARSVLARELNMDSIVETKENAEVEIEIQVHGMTCMFQSKRSLIGNY
FEYQGKVMDIEGKKKESGMFLHDKERDNKYPIFEDENGTHIMSPNDVCIIDELEELIDAG
VDSFKIDGVLKSSEYLIEVTKMYREAIDLCVENRDEYEAKKEEWIERIESIQPVNRKIDT
GFFFKETVY
>PK3-2_02525 hypothetical protein
MTAVNDKISTIVNGKRVITKKPELLAPAGNLEKLKIAVHYGADAVFIGGQEYGLRSNADN
FTIEEIAEGVEFAKQYGAKIYVTTNIFAHNENMDGLEDYLKALGDANVAGIIVADPLIIE
TCRRVAPNVEVHLSTQQSLSNWKAVQFWKEEGLDRVVLARETSALEIREMKEKVDIEIES
FIHGAMCIAYSGRCVLSNHMTARDSNRGGCCQSCRWDYDLYQTDGANAVALYGEEDAPFA
MSPKDLKLIESIPKMIEMGIDSLKIEGRMKSIHYVATVVSVYRKVIDAYCADPDNFVIQK
EWLEELDKCANRDTATAFFEGTPGYEEQMFGEHAKKTTFDFVGLVLNYDEDTQMVTLQQR
NFFKKGDEVEFFGPEIENFTHTIETIWDEDGNELDAARHPLQIVKFKLDKKIYPSNMMRK
GK
>PK3-2_02526 Uridine kinase
MGKSPVVIGIAGGSGSGKTSVTRSIYEQFKGHSILMIQQDLYYKDQSHLPFEERLNTNYD
HPLAFDNDYLIEHIQDLLNYRPIEKPIYDYKLHTRSEETVHVEPKDVIILEGILVLEDKR
LRDLMDIKLYVDTDADLRIIRRIMRDINERGRSIDSVIEQYVSVVRPMHNQFVEPTKRYA
DIIIPEGGQNHVAIDLMVTKIQTILEQNAIL
>PK3-2_02527 Transcription elongation factor GreA
MAQEKVFPMTAEGKQKLEQELEYLKTVKRKEVVERIKIARSFGDLSENSEYDSAKEEQAF
VEGRVTTLENMIRNAKIIEDDGGSNVVGLGKTVTFVELPDGDEESYTIVGSAEADPFEGK
ISNDSPIAKSLLGKKVDDEVTVQTPGGEMLVKIVKIS
>PK3-2_02528 Penicillin-binding protein 4B
MKISKRMKLAVIAFLIVFFLLLLRLAEIQLFFTESFSKKKINLIQESVKQRTEEVLISDG
RGSFLDRNGQALTGKSEPAVVLFPFLLTQDWPIKKVADIVGMSEDELHQTLAKAKKPVIL
QQKKIKTLSKQSIKKINSLKYPGIYGVYMENEDKPSLASHTIGSTNQDPALLRKKYPDQE
NLPITTEIGTTGLERTFDEFLLPEQDTKLLYHVDGKGNPLFGMDVKYTAEANTFYPLQVK
TTIDQSMQKAMEEVLDEQGLKKGGAVLLDIENSSVLGIVSKPDTDISRQNTLQNYMLTPI
YPGSVFKTVIAAAAIENDTVKPSQTFNCNLNLYGEPGDDKGTLSFDESFAQSCNYTFTSL
AEQLMKKDGSVIENMSEKLALTDRAGWEGKLYHETDFRQLYNEKSGVIWGDEKDKSVKKA
IAQTAIGQKNVKVTPLEVANMMATIARGGEKRQVKIAEQIEYKNGTTLVTFKDQKLKGET
IDKYTAQQLQKMLRRVVESPSGTGRRFQDLPYTVAGKSGTAQTGKFSKEKETLYEKWFAG
YFPADKPKYALVVLHMDTPGDKALTNSVFYDIVKKVHEIEINQK
>PK3-2_02529 hypothetical protein
MSNNQSRYENRDKRRKANLVLNILIAIVSILIVVVAANLFINSPSSKDVSKDSETAQKQE
SPASGKTEKKSDEDIKDSKKDTSDSEKDSEKSSDSDAKKDDSSKSDDSDSDSDSSSDSDD
PLKDAKVTEGGSSNDVEKTYENSDWKAVGTDQTGEHAATYDSSSQDWAEMLKAMSYASGV
SKENMTVLWLGNNGSPQDAKGKILDKTTGDKYQVTITWVDEKGWKPTKVEKLK
>PK3-2_02530 hypothetical protein
MNFQLDLIKDKVEFFEAGSLQELEKKINTQIENNKAIMLRVKSVSHQTAVADGRILYSAV
VHFAAEA
>PK3-2_02531 putative methyltransferase YrrT
MGREFIPLFEDWAATYDQTVQGFDIQYKEAFRGYDDILDAIVSRSGTHVLEFGPGTGNLT
AKLLDAGKSVFGIEPSPAMRKLAADKLSGRAEFVDGDFLTFPEPPFHADTIVSSYAFHHL
TDEEKRAAIKQYGKYLHLHDKIVFADTVFKDAQAYQQAIDKARSQGFYQLANDLETEHYP
TLDALKEMFTAEGFAVQFTQQNDFVWIMEAIKR
>PK3-2_02532 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase
MKLAVIGAMEEEVTILRSKLENAKTETIAHCEFTTGEYEGTEVILLKSGIGKVNAAISTT
LLLDRYKPDYVINTGSAGGFHHTLNVGDVVISTDVRHHDVDVTAFDYEYGQVPGLPAAYA
ADEKLISITEEAISELDGIQVAKGTIATGDSFMNDPKRVEEVRARFSDLYAVEMEAAAVA
QVCHQFKTPFVVIRALSDIAGKESHVSFDQFLEQAAVHSTELVLKVIKRIH
>PK3-2_02533 O-acetylserine dependent cystathionine beta-synthase
MTVITDITELIGNTPLLRLKNFDVPDGVAVYAKLEMMNPGGSIKDRLGDMLIRDALESGK
VKPGGVIIEATAGNTGIGLALSARKYGLQAIFCVPEHFSTEKQQIMQALGASIIHTPRQD
GMQGAIQKAIQLETEIKNSYCVLQFKNRVNPSTYYKTLGPEIWEALDGNIHTFVAGAGSG
GTFAGTASFLKEKKPAVKTVIVEPEGSILNGGEPHAHKTEGIGMEFIPDYMNKSHFDEIY
TVTDENAFRLVKEAAEKEGLLIGSSSGAALYAALEEAKKASAGTNIVTVFPDSSDRYISK
QIYEGGI
>PK3-2_02534 Cystathionine gamma-lyase
MKKKTLMIHGGITGDEKTGAVSVPIYQVSTYKQPKAGQHTGYEYSRTANPTRAALEALVT
ELEGGEAGYAFSSGMAAITAVMMLFNSGDHVVLTDDVYGGTYRVMTKVLNRLGIESTFVD
TSSREEVEKAIRPNTKAIYIETPTNPLLKITDLALMADIAKKEDILLIVDNTFNTPYFQQ
PLALGADIVLHSATKYLGGHSDVVGGLVVTASKELGEELHFVQNSTGGVLGPQDSWLLMR
GIKTLGLRMEAIDQNARKIASFLENHTGVQTLYYPGSSNHPGHELAKTQGSGFGGMISFD
IGSAERVDAFLGSLKLFTIAESLGAVESLISVPARMTHASIPRDRRLELGITDGLIRISV
GIEDAEDLLKDIEQALENI
>PK3-2_02535 Cadmium, cobalt and zinc/H(+)-K(+) antiporter
MGHNHTEGSNKKVLLISFIIITGYMMIEAIGGFLTNSLALLSDAGHMLSDSISLMVALIA
FTLAEKKASHNKTFGYKRFEILAAVINGVALILISLYIIYEAIERFSNPPEVSTTGMLTI
SIIGLVVNILVAWIMLSGGDTKNNLNIRGAYLHVISDMLGSVGAILAAILIIFFGWGWAD
PLASVIVACLVLRSGYHVTKDSIHVLMEGTPENIDVTDIIHTIEKTEGIQSIHDLHIWSI
TSGLNALSCHAVIDDQLTISESESILRKIEHDLEHKGITHVTIQMETAAHHHDNTILCQA
KIEKRRDHHHH
>PK3-2_02536 putative oxidoreductase CzcO
MYDTIVIGAGQAGISIGYYLKQSKQKFIILDKSDEVGESWKERYDSLVLFTSRMYSSLPG
MHLEGKKHGFPSKEEIVAYLKKYVERFDIPIQLRTEVISVQKLKNHFLIKTNQQEYQAEN
LVIAAGPFHIPNIPSVSKDLADHIHQLHSSQYKHPKQLVPGNALVVGGGNSGAQIAVELS
KERVTYLACRNQLIYFPLVIGKRSIFWWFDKLRVLHASNTSILGKFIQKKGDPIFGYELK
HAIKQKEIILKKRVISGKQNEVIFEDSSTLEVNNIIWATGFRNPLCWMKIEGVLDKEGRI
IHHRGVSPVEGLYFIGLPWQHRRGSALLQGVGKDAEYIVKQMNAK
>PK3-2_02537 hypothetical protein
MFTNCTPKQEGKHKKQENEQYESLYNHQRWLFFIISLAVLFPCLLKTEGQSRRLC
>PK3-2_02538 hypothetical protein
MAAPITTIKKETKTAEQMKLEKIEELKELLAENEDAVSKTMTIMNELNDLGIFDAATSML
RAKEDIAKIALGQVSREPVTNLINTMMAAGGALTKADPEFTGKLLESVMAGTEQAQSFLK
EDKKVGIFDLLKAMNDPDINRAVGFGLQFLKGMGKELQEK
>PK3-2_02539 Putative formate dehydrogenase
MNMMDVKSISVRVDGTEIQVRAGATILDILNENGIEYPQICHVPEVDPIQTCDTCIVEAN
GKLVRSCSTVAENGMSIDLSGNRVKEAQTEAMDRLLENHLLYCTVCDNNNGNCTLHNTAE
MMGIEHQKYPYTPKEDTSCAVDMSHPFYRYDPNQCIACGQCVEVCQNLQVNETLSIDWER
ERPRVIWDEGVPINESSCVSCGQCVTVCPCNALMEKSMLGQAGFMTGIKEDVMEPMIDLV
KNVEPGYGSIFAISEVEAAMRETRTKKTKTVCTFCGVGCSFEVWTKGRDILKIQPVSDAP
VNAISTCVKGKFGWDFVNSEERITKPLIRKNGAFVESSWEEALDLVASRLGSIKEQYGNG
SVGFISSSKITNEENYVIQKLARQVFETNNVDNCSRYCQSPATDGLFRTVGMGGDAGTIK
DIAKAGLVIIVGANPAEGHPVLATRVKRAHKLHGQKLIVADLRKNEMAERSDLFISPKQG
TDQVWLMAVTKYMIDQGWHDQAFIDENVNYFEDYKETLKTYTLDYAERVTGLSKENMIEM
AEMIRDADGTCVLWGMGVTQNTGGSDTSAAISNLLLATGNYRRPGAGAYPLRGHNNVQGA
CDMGTLPGWLPGYQHITDDKARAKFEEAYGVEIEGKPGLDNIQMLHSIEEGKMKAMYLVG
EDMALVDSNANHVHDILSSLDFFVVQDIFLSRTAQYADVVLPATPSLEKDGTFTNTERRV
QRLYQALPTLGDAKPDWWIIQEVANRLGANWNYSHPSDIFSEMASLSPLFGKASYEVLED
WNSFLWGSFTGESTPLLYEYGFNFPDKKARFALSDWTEPAAFPKEYDLHINNGRMLEHFH
EGNMTNKSKGIQAKVPNVFVEISPELAQERGVCDGSLVRLVSPFGAVKLNALITDRVRKN
ELYLPMNSTDKESAINFLTGPAADKRTNTPAYKQTKVRMEILGGCETAPLPKTNPRNKKR
HPQNGVEAERKWNRPGYVHLTD
>PK3-2_02540 hypothetical protein
MSKKIHEFNDIIRKLRKELFGKGPERIHTVFVENMAVSTLYGNLSASEQFIARTPEGREM
VHAARTSLIQDLYSKQTPEGMEELIGAKLVHLFSDIKIEENIAVSVFVFDQKIDDQKEVL
QS
>PK3-2_02541 putative formate transporter 1
MAFRKPDEIADAAIEAGVKKIKLPLASLLVLGFLGGAFIALGYLLDIRVIGDLPKEWGSL
SSLIGAAVFPVGLILVVLAGAELITGNMMSVAMALFSRKISVKELAVNWGIVTIMNLIGA
LFVAYFFGHLVGLTETGPYLEKTIAVAQGKLDMSFGKVLISGIGCNWLVCLAVWLSFGAQ
DGAGKILGIWFPIMAFVAIGFQHVVANMFVIPAAIFAGSFTWGQFIGNIIPAFIGNVIGG
ALFVGLIYFIAYHKKDRSRKEMKQVS
>PK3-2_02542 hypothetical protein
MTINLFFLTLTINKRFKSPEEFEREQQIEQIYDEMKESQLKHLYLTNWR
>PK3-2_02543 Putative methyltransferase YrhH
MLENRLYKRSNLWKLFSRKYKQTKTIEHLMIDSIDIQENDRILEIGIGNGTVFKNITEKL
EKGSLKSIDPSKRKVRQISRANRKNMGKGEIFHGYPENIPFADRTFNKVFSLHTVQSCTD
IKLALREIYRVLQIDGRFYIHIDTNTSGKEKLYMQLLKDQHFRDLSVIRRDSCLCIVAVK
>PK3-2_02544 HTH-type transcriptional repressor Bm3R1
MFSASSSKYDMIMKASVSLFTERGFDATTIPMIAERAHVGTGTIYRYFDSKETLVNVLFQ
ESIQRFTDKLKRDFSELPVREGFHHVFCCLIQFTKESDYALFFLETKKDAHYLNDTSRKM
IENLTHMLDDYFNKGKAEGVIRSLPSNVLIAIVLGAFLKIYQLVQTGDIQMDMDLMTELE
QCCWDAIKLHSFTSQK
>PK3-2_02545 Bifunctional cytochrome P450/NADPH--P450 reductase 2
MKQASAIPQPKTYGPLKNLPHLEKEQLSQSLWRIADELGPIFRFDFPGVSSVFVSGHNLV
SEVCDENRFDKNLGKGLLKVREFGGDGLFTSWTHEPNWQKAHRILLPSFSQKAMKGYHSM
MLDIATQLIQKWSRLNPNEEIDVADDMTRLTLDTIGLCGFNYRFNSFYRDSQHPFITSML
RALKEAMNQSKRLGLQDKMMVKTKLQFQKDIEAMNALVDRMIAERKANPDENIKDLLSLM
LYAKDPVTGETLDDENIRYQIITFLIAGHETTSGLLSFAIYCLLTHPEKLKKAQEEADRV
LTDETPEYKQIQQLKYIRMVLNETLRLYPTAPAFSLYAKEDTVLGGEYPISKGQPVTVLI
PKLHRDQNAWGEDAEDFRPERFEDPSRIPHHAYKPFGNGQRACIGMQFALQEATMVLGLV
LKHFDLMNHTGYELKIKEALTIKPDEFKITVKPRKTAAINVQRKEQADIKTEIKPKETKP
KHGTPLLVLYGSNLGTAEGIAGELAAYGRQMGFTATTAPLDDYIDKLPEQGAVVIVTASY
NGAPPDNAAGFVEWLDELEEDRLKGVSYAVFGCGNRSWASTYQRIPRLIDDMMKAKGASR
LTTLGEGDAADDFESHRESWENRFWKETMEAFDINEVSQKEDRPSLSITFLSEATETPLA
KAYGAFEGNVLENRELQAADSPRSTRHIELQLPDGKTYKEGDHIGILPKNSQELVQRVLC
RFDLQSTHVIKMSGSPHMAHLPMDRPIKVADLLASYVELQEPASRLQLRELASYTVCPPH
KKELEQLVSDDGIYKEQVLAKRLTMLDLLEDYPACEMPFERFLELLPSLKPRYYSISSSP
KVHANIVSMTVGVVKAAAWSGRGEYLGVASNYLAGLSTDDAAACFIRTPQSGFQMPDDPQ
TPIIMVGPGTGIAPFRGFIQARSVLKKEGNTLGEALLYFGCRRPDHDDLYREELDQAERD
GLVTIRRCYSRIENKPKEYVQHLLKQDTQKLIPLIEKGAHIYVCGDGSQMAPDVENTLRL
AYEAEKGASQEESTEWLRKLQDQKRYVKDVWTGM
>PK3-2_02547 hypothetical protein
MKENMLDILKNLNFTEYESKAYLALLQESPLTGYAVAKKSGVPRSKIYEVLESLVLRGDV
FVSHGNTPQYVPVPAKELIKNRRLKAEEHFDQAEKYFENFEQTANDRENIWNITGRSEIL
EKVKACILSAKKRILLEIWKEDFKEIESELRQAANQGVIVTIIAYGNITSDFATVYLHDM
SSEITEEYDGRWLVYSGDDSEVVAGIVSLGNDSRAAWTMHVGLVMPITEVIIHDLYLMEI
LKKHRGLLEESFGENLIQLRRKFSIHSDFKKHYLE
>PK3-2_02548 Leucine efflux protein
MHSLLAYIPIAAMMVIIPGADTMLVMKNTLRYGAKAGRYNILGLAAGLSFWTVIAILGLS
VVIAKSVFLFTTIKYLGAAYLIYLGIKSFFAKSMFSIDDMQSQAATMGTSPKRYYKTSFM
QGSLSNILNPKTVLVYVTIMPQFINLNGNINQQLIILASILTLLAVLWFLFLVYIIDFAK
KWMKNSKFQKAFQKVTGIILVGFGIKTGLN
>PK3-2_02549 D-serine/D-alanine/glycine transporter
MTGNSTKDNFGQEQKLSRGLKNRHIQLMAIGGAIGTGLFLGSGKSIHFAGPSILFAYLIT
GVFCFFIMRSLGELLLSNAGYHSFVDFVRDYLGNMAAFITGWTYWFCWISLAMADLTAVG
IYTQYWLPDVPQWLPGLLALIILLIMNLATVKLFGELEFWFALIKVIAILALIVTGIILI
AKGFSAASGSASLTNLWSHGGMFPNGSHGFILSFQMVVFAFVGIELVGLTAGETENPQKV
IPKAINQIPARILLFYVGALFVIMCIYPWNVLNPNESPFVQVFSAVGIVAAASMINFVVL
TSAASAANSALFSTSRMVYSLAKDHHAPGLLKKLTSSKVPSNALFFSTIAILIGVSLNYI
MPEQVFTLITSVSTICFIFIWGITVICHLKYRKTKPHEAKKIKFKMPFYPLSNYLTLAFL
AFILVVLALANDTRVALFVTPVWFILLIIMYKVNTIKGHKIK
>PK3-2_02550 hypothetical protein
MKVQLAQLLTMGYQIDHIEDFSILGKMAARNHRYLFFADGDKVFMFIDSLTFQMYCKDEE
VLHKEKKKIEQMLHPDFL
>PK3-2_02551 Transcriptional regulatory protein DagR
MIDVKRIDKIYHQLVHNFHDASLDHLLKVQGNSAKEIAEQLKMERSNVSFELNNLVRSKR
VIKIKTFPVRYIPVEIAERLCNRKWDTEMMEVKDLKLFSGNSKQNHQSISTNPLELMIGA
KGSLKKAISQAKAAVFYPPNGLHMLLLGPTGSGKSLFANRIYQYAIYSDILKAGAPFITF
NCADYYNNPQLLLSQLFGHKKGSFTGAAEDKAGLVEQANGGILFMDEIHRLPPEGQEMLF
YFIDSGSYNRLGESEHKRTSNVLFLCATTENPNSALLKTFLRRIPMTIHIPSLEERSLKE
RLDLTTFLLGKEAERIKKNLSVHIDVYNALIHSAKFGNVGQLKSNVQLVCAHGFLHNLDR
DEVIELTVRDLPDEIKQEWMSSSKNMQRSKAISEYVNITTIISPIVEDETTKIDEDLSFN
LYHLIEEKVKTLKKEGLSKKDINQYILTDVHLHVRSFFHHQAFQKDSLLTFVEDDVIQMT
KQLKEIAEHELDCTFDRKFIYFLSMHIDAFLKRGKQIDVLNTQETDEIRDTHVKEYRVAM
IFKDKIQEHFKVAIPEIEVIYLTMLIHSIKSLKENKRVGIIVAAHGNSTASSMVEVATEL
LGSTPIAAVDMPLTVSPSEITECLAEKMKQVHEGEGVLMLVDMGSLAMLESKLEEKTGIA
IKTISNVTTSMVLDAVRKVNYLNLNLHAIYQSVTKDFIELWERQPAASGKKKALVSICTT
GGGTAKKLEDILTTIVNKASDTPIHIITVSSIKLANSIKEIEKEYEILATVGTKNPKINA
PHVSLEVLIEGEGERLIQQAITKGSIPLSNGLNEANIIVRELCEDSLKKYLVFLNPHHMI
EMLLEWLQTVQDELGVIFNNAVLIKVIMHTAFAFERVIKQNPIAFSEEEEINDQLKEMVI
VTERTLAPYEEKLGLKISDDEKLFIAVIFAEEVHGQLF
>PK3-2_02552 PTS system fructose-specific EIIA component
MISVIISGHGDFPIALKESSGMIFGEENNLIAVPFLKGEGIQTLQEKYHQALKDIPEENE
VLFLVDIFGGTPYNAAASFVAEGERMDMAAGVNLPILLEVLSLREHVTLKALLNNLKTMS
QQSFQVCSEHLEKVKTANQETREDEL
>PK3-2_02553 PTS system fructose-specific EIIB component
MNIVLARIDDRFIHGQILTRWIKVHAADRIIVVSDDVAQDEMRKTLILSVAPSNVKASAV
SVSKMAKAFHSPRYEGVTAMLLFENPSDIVSLIEAGVPIKTVNVGGMRFENQRRQITKSV
SVTQEDIKAFETLSDLGVKLELRQLPSDASEDFVQILRNVTK
>PK3-2_02554 PTS system sorbose-specific EIIC component
MSSLQIILLLIIAAITGIASVLDEGQTHRPLVACTLVGLVLGDLKTGIILGGTLELMALG
WMNVGLAMAPDTAIASVISTILVITADQGIGEGIAVAVALAAAGQALTIFVRTITVFFIH
RADRYAKEGNIKGIEIMHITAMVFQALRVMIPTLIVALISVSAVQAFLGNIPDVITKGLQ
IGGGIIVVVGYAMVINMMNIPYLKPFFYIGFLLAAFTDFNLVGFGALGLCLALLYQQVMQ
KHNAHGAVAAASDSGSVAVYDDDDDDLDA
>PK3-2_02555 PTS system mannose-specific EIID component
MEKEKRLTKKEIFSMFIRSNFLLGSFNFERVQAMGYCYVMIPAIKKLYGPGAKRNEALQR
HLEWFNTHPWLTAPIFGVTAAMEEEMANNKGIDGKAISGMKIGLMGPIAGVGDPIFWGTI
RPVLAALGASLALGGNIAGPLLFFFLLNAIRLSTKYYGLKYGYVKGMEILQDLAGNRIQK
LTEGASILGLFVMGALVSKWTTINIPIVVSRIKDESGKVDVQTVQNVLDSIMPGALPLGL
TLLVAWMLRKGVNPLLIICGIFIIGILGYWAGFLA
>PK3-2_02556 Levanase
MKKRLSQAIIMFTLLLTMAFPVEAADSSYYDEDYRPQYHFTPEANWMNDPNGMVYYDGEY
HLFYQYHPYGLQWGPMHWGHAVSKDLVTWKHLPVALAPDDKGTIFSGSAVVDRNNTSGFQ
TGEEKPLVAIYTQDREGHQVQSIAYSNDKGRTWTKYAGNPVIPNPGKKDFRDPKVFWYEK
ENKWVMLLAAGDRILIYTSKNLKQWTYASEFGQGKGSHGGVWECPDLFELPVDGNPNQKK
WVMQVSVGNGAVSGGSGMQYFVGDFDGTHFKNENPSNKVLWTDYGKDFYAAVSWSDIPSS
DGRRLWLGWMSNWQYANDVPTSPWRSAASIPRELKLKTLTGGVRVVQTPVKELQTIRGTS
KKWKDQTISPTSQNVLAGLSGDAYELHAEFQVTPGSAAEFGFKVRTGGNQFTKVGYDRKN
AKLFVDRSESGNVTFNPTFNTGKQTAPLKPVNGKLQIRIFVDRSSVEVFGNEGQQVITDI
ILPDRSSNGLELYAANGGVKVKSLTIYPLKKVWGTSPFISNLAGWKTVNGTWADTIEGKQ
GRSDGDSFNLSSATGSDFTYESDITIKDGNGRGAGALIFRSDKDAKNAYLANVDAKHDLV
KFFKFEDGAASVIAEYKTPIDVNKQYHLKTEAEGDHFKIYLDDRLVIDANDSTFSEGQFG
LNVWDATAVFQNVNKEP
>PK3-2_02557 Putative cysteine protease YraA
MSKKIAVLVTDQFEDIEYTSPVKAYEEAGYSVTAIDLEAGKEVTGKHGEKVKIDKAISDV
DAGEFDALLIPGGFSPDLLRADDRPGEFAKAFVENEKPVFAICHGPQVLIDTDLLKGKDI
TGYRSIRKDLINAGANYKDAEVVVSHNIVTSRTPDDLEAFNRESLNLLK
>PK3-2_02558 putative formaldehyde dehydrogenase AdhA
MCNQHQTRVLSVSHAKAKFEQTTIERRELRPHDVLIDIQFSGICHSDIHSAFDEWGGGIF
PMVPGHEIAGIVKAVGTEVTKFTVGDRVGVGCFVDSCGECEYCQSGEEQFCTKGVVQTYN
SLDYDGNPTYGGYSQKIVVTDRFVVRIPDRLEMDVASPLLCAGITTYSPLKHWNVGPGKK
VAIVGVGGLGHLAIQFAHAMGAEVTVLSRSMNKKDEALELGADHYFATSDPATFTSLAGR
FDVILNTVSANLDVDAYLSMLRIDGTLVNVGAPAEQDTYSVFSLIMGRRSLAGSLVGGIP
ETQEMLDFAAEHGIAPKIEVIRADQVDEAYERILRSDVRYRFVIDISTL
>PK3-2_02559 HTH-type transcriptional regulator AdhR
MNIAQAAKQLGLTAATLRYYERVGLIPPVKRKESGIRDYDEEDIKWIEFIKCMRSAGHSI
EALIEYTTLFTEGDRTVEARKNILADERQRLIEKRREIDQTIKRLDTKIEDYDGKLRENE
AKLKSRPNTENLQG
>PK3-2_02560 hypothetical protein
MKELKQYTAWRAICDKTIHERMHLLEKRMRIVEVEIQALQQNLLVLNRKIEFYKEKIKGI
NMSLSCIKMKTKSHKNKWSKAEGDF
>PK3-2_02561 Phosphocarrier protein HPr
MIEKQYTIIASTGFARTATLLVRAASKFRSHMFLLYEGKSVDLKNPPKSLIDVMSLGIKP
GTHIKIRAEGIDEEQALHVIEDQLGRSGFTKS
>PK3-2_02562 hypothetical protein
MNPIIEYLTGMNVLTDQIIAMDLLIAAKNGVRNYAMAATEAGTPEVKEILIRHLEEALDM
HEQISSYMMEKGWYHPWNTDEQVKLNLQNIETAIQLPTL
>PK3-2_02563 hypothetical protein
MEYALHEVLEVQEMTAFKTLCLTKSKTMKALVSDPKLKEIMQQDVDITTRQLQEFASILS
NAKHE
>PK3-2_02564 putative zinc-binding alcohol dehydrogenase
MKAVTYQGVKNVVVKDVPDPKIEKSDDMIIKVTSTAICGSDLHLIHGFIPNLQEDYVIGH
EPMGIVEEVGPGVTKVKKGDRVIIPFTIACGECFFCKNQLESQCDQSNDNGDMGAYFGYS
GQTGGYPGGQAEYLRVPFANFTHFKIPETCEEPDEKLSVIADAMTTGFWSVDNAGVKDGD
TVIVLGCGPVGLFAQKFCWLKGAKRVIAVDYVNYRLQHAKRTNKVEIVNFEDHENTGSYL
KEITKGGADVVIDAVGMDGKMNDLEFLASGLKLHGGTMSALVIASQAVRKGGTIQITGVY
GGRYNGFPLGDIMQRNINIRSGQAPVIHYMPYMFELVTTGKIDPGDVVSHVLPLSEAKHG
YDIFDSKMDDCIKVVLKP
>PK3-2_02565 hypothetical protein
MKGSELPLNHDHLDPINSLNVPELADTTFAMDFLIRTKEGVRNIAVALTETASPDVRALL
RKQLMQGIAMHQEITELMISKKWFHPYELSEQYKLDQLSAKNTIMVGNMNLFPAETNRKG
MFDRTPDEH
>PK3-2_02566 hypothetical protein
MDHQTLAAHEAVDLHEIVNFKTLCIAKSKLMQGLVFDQDLKDLMQKDVQQAIQDLTDLQA
IYERAPFQAPVPESRPTPIIN
>PK3-2_02567 hypothetical protein
MTNQMGGMSLLIAALTWALMSVLLKRVPNHYSLIVVITYSNLVTLMILTPFVWVNADVVH
FSQLAHSTIWGGLLYLGIVSTVWAFILWNRRFQMLNASSGGLFFFFQPLVGTLLGWLLLG
NI
>PK3-2_02568 putative hydrolase
MRIVNNGTLQVSGANIHYEVRGTGPIILLIHGGGGDADKFHHVANHLANWYTVVTYDRRG
HSRSNLANQTEDYRVETHSDEAHRLLAKLTDKPAYVFGSSSGAVIGLDLCIRHPKQVSVM
IPHEPVLLQFLYGNELKQAEQFMEDLKKNHRSEVITLLSSLEPDASHVEQSKDVLTERLL
CNSTYFTEYEIQGILNYTLDIEALKMVFTSAPMKVLPAGGSASRDFFPYLCAKALAEQLE
TEIVEFPGNHAGYNTMHHKDFAERLHDILEKENKHRTMHN
>PK3-2_02569 hypothetical protein
MTYVKATAILPEKLISEIQKYVQGKTIYIPKPETSHQKWGACSGTRKLIDDRNASIKKAF
KNGKTIQQLSEQYYLSNETIKKIVYSK
>PK3-2_02570 Chitosanase
MKISLKKKADFWKKAAISSLVFTMFLTLMMSETVFAAGLNKDQKRRAEQLTSIFENGTTE
IQYGYVEPLNDGRGYTCGRAGFTTATGDALEVVEAYTKAVPNNKLKKYLPELRRLAKEES
DDISNLKGFASAWKSLGNDKDFRAAQDKVNDSLYYQPAMKRSDNAGLKTALARAVMYDTV
IQHGDGDDPDSFYALIKRTNKKAGGSPKDGIDEKKWLHTFLDVRYDDLMNPADEDTRDEW
RESVARVDVLRSIAKENNYNLNGPIHVRSKEYGNFVIK
>PK3-2_02571 3-methylitaconate isomerase
MVKANVTIMRGGTSKGVFFHESAMPNNKNEWEPFLLDVMGSPDKRQIDGLGGGNSLTSKV
AIIKKAYASDIDVHYTFGQVSISEEKVDFKGNCGNISAAVGPFAIEEGLVKATEPMTAVR
ILNTNTNKMIIAEVEVEDGQVKYDGDVTISGVPGSGSPIYLNFHDAAGSVTGHLLPTGNR
SEFLDTSQGQIEVSIIDYANPLVFVEASSIGLNGTELAEEFTDLQLAQFEELRSIAAEKC
GFASRFSATKLSPAVPKLAIVSKPEEYKDSTGAWHSNVEMDLHIRMMSMQKPHQALAITG
AICTTRALSAEGTIPARIAKIHSTKVRLAHSSGITETMLEPSGIKIVRTARRIMDGAVYT
HGDYQMM
>PK3-2_02572 HTH-type transcriptional activator CmpR
MDEKDWFLLKILYEEQSVTKTAERLFTSQPSITYRLNKIEEIFGIELFTKRHKGITFTAE
GEHLVSYARRMLQELQDTKDNISNLSKEVQGHLRLGVSSNFAQYKLPKLLREFSIMYPNV
QYSVQTGWSTDVMKLLDAGIVQVGILRGSHRWKGEKERLTREKLHIISKKPITIDQLPFL
PFIKYKTDASLKTIIDDWMHTNLKQAPIIAMEVDRQETCKEMVKHGLGYSIAPEICLRKS
DNLSTMDLYNDKGKPLMRDTWLMYDQKSLGIKIVKAFIDFLKGEQMVTI
>PK3-2_02573 Citrate transporter
MLTILGFSMVTVFTILIMTKKVSPIVALTITPIVFALIGGFGKDIGDMILEGIQTVASSA
ALLLFAILFFGILIDTGLFDPLIEKILSIVKGDPVKIAIGSAALAMLIALDGDGTTTYMI
TVSAMLPLYKRIGMNPMVMATLAMLSLSIISGMTPWGGPATRAISVLGLDPSDFFLPLLP
TMLGGMACVIFLAFLMGRKERNRIGIVKLEPRNITKDSSQPYMAATLDSEQLKRPRLIYL
NLFLVISIMVFIVLGTKHPSVLFLIGFVLALTINYPNVKTQKERIAEHSGNAITVVLLVF
SAGVFAGILSGTKMVDAIAGSLVSIIPSSMGEFFPVIVALISIPFTFVLSNDAYYFGMVP
IFAEAASAYGIEPVEIARASIMGQPVHLMSPLVASTLLLVSMLKIDLGSFQRFAVKWAVI
TSLVITLLAIITGAITIL
>PK3-2_02574 hypothetical protein
MKISFATRLGVLTFGSLLVLAGCQASGSSKGESHKTSSSVAEDASKTQEQSLGSHDHEHD
HSHAHDEETEKIYEGYFKNSQVKDRPLTDWEGDWQSVYPYLQDGTLDEVFSYKSKHEGDK
TAEEYKEYYKKGYKTDVDRIFIQKDTVTFFKNGKEYSGKYTYDGYEILTYDAGNRGVRYI
FKRAKEAEGLPQYIQFSDHSIDPTKAGHYHLYWGDDRKALLDEVKNWPTYYPSEMDGHDI
AHEMMAH
>PK3-2_02575 Aminoglycoside 6-adenylyltransferase
MRSEQEMMDMLLDFALNDERIRLATLEGSRTNKNIPPDNFQDYDISYFVTDMESFTESDW
WLEIFGNRIMMQKPEDMELFPPELGNWFSYIILFEDGNKLDLTLIPINEVEDYFAESDGL
VEVLLDKDTFITNKVIPNDRQYWIKKPTAREFDDCCNEFWMVSTYVVKGLARKEILFAID
HLNEIVRPNLLRMMAWHIASQQGYSFSIGKNYKFMKRYISNKEWEELMTTYSVNGYQQMW
KSLFTCYALFRKYSKAVSESLGYKYPDYDEGITKYTESIYSSLK
>PK3-2_02576 Spermine/spermidine acetyltransferase
MSIDIKAVTEDNRAAILALHVSENQISYIESAKVCLEDAKECHYYKPVGLYHEGDLVGFA
MYGLFPEYDEDNKNGRVWIDRFFIDEHYQGKGLGKKMLKALIQHLADLYNCKRIYLSIFE
NNIHALRLYQRFGFQFNGELDFNGEKVMVKEL
>PK3-2_02577 hypothetical protein
MFQTLDHFMKSWEFEADATQKLLNCLTDESLKEEITSQNWTLGRIAWHTVAAIRIITSNT
NLTFHAPDEDYPVPSSAQFIADSYHEASNAFVQALTNQWTDQTLQERINFIGQQLPNGSL
LMFLIQHQTHHRGQMTVLMRQAGLTVPGIYGPAKEEWTKFGLEPPKM
>PK3-2_02578 HTH-type transcriptional activator RhaS
MQIKDFMIDQSLKELTEHRTVELPVACYETRINQNRNGYIPLHWHDEIQFVLIRKGIAVF
QINEEKIEVHEGDGLFINSGCLHMAEEKDHSDCTYICLNVSPHFVLAQELYPNYVQPYIF
STNLSCLFLDGNQHWAQNILNAVKKINQLVQQKTSLYEIDITMQLTLMWKNLVVNGFQLE
YDQSEMIKSQRMKQMLNWIHLHYAEKMTLEDIAKAGQLSRSECCRYFKRMLNKTPLRYVL
DYRIQKSLLLLQHPETNVTEVSYQVGFNSTSYFISKFQQAMNMTPLTYKKIHMEN
>PK3-2_02579 putative inner membrane transporter YicL
MNASNRRMGLFYVITGATCWGIGGTVAKKLFQDDQVDVNWFVTIRLLTAGILLLMLQLFR
KDRSQIIEIWKNKASAGQLLVFGLFGMLAVQYTYMASIQHGNAAVATLLQYLSPVIIILY
SLFRKQSALTKQDMVTVLLALAGCFFLLTNGSISQLSVPEIAVVWGVLSGFAAAFYTLYA
VGLLNKFDSLVVVGWAMIIGGFALSFIHPPWQMDFKSLTAEAYVHLLFVTVFGTMIAFWF
FIKSLQSLSPKETSLLGSLEPLSAVVTTVVWLKEPFGFFQWVGAFCIIGITLILALHKEP
SMQSEKSILNHANKNM
>PK3-2_02580 Sucrose-6-phosphate hydrolase
MDRIQQAEEALKKAEEKMNTRYRLGYHIMPRANWINDPNGLIHYKGEYHVFYQHHPYDEN
WAQMHWGHVKSKDLIHWEHLPVALAPGDSFDESGCFSGSAVEYNGKLALIYTGHNVIDQE
EDIFYQNQNIAVSQDGIVFEKLQENPVIAKPPEDSSRHFRDPKVWKHRNSWYMAVGNSTK
ENVGRVILYRSPNLRDWEYKGVLAQSDGDLGYMWECPDFFELGGKHVLLISPQGIEADGD
LYKNLHQTGYLIGEYNDETNEFVYGDFTELDYGHDFYAVQTLLDDKGRRIAIGWMDMWES
EMPTKADGWCGALTLPRELTLRDDYKILMNPVEETALLRKSKHMDCANQLISGNYLAKTA
EELLEIQVVYDLTDCSAETVGLKIRGLEEEETAIKYSITDQKLTLDCSKMGKSRDSVRNA
PLEANGKLTLRIFIDRSSIEVFANHGETTMTSRIYPKKDRLGIELFSEKGNVMVDELTYW
ALKDIWKKDESLKKNIMHR
>PK3-2_02581 Sucrose permease
MKGSKSLYWKLSAYLFFFFFTWSASYSLFAIWLGQEVKLNGAATGIIFSVNAIFTLCMQP
LYGFISDKLGLKKNILFMISILIVFTGPFYIFIYGPLLQYDVFLGAIVGGIYLGTAFLAG
VGAIETYIEKVSRKYQFEYGKTRMWGSLGWATATFFAGQLFNINPNINFWIASLSAVILV
AIIMSIKIEMTDYDKERADSIRLKDVGGLFLLKDFWFLMLYVIGVTCVYGVYDQQFPIYY
ASLFPTSAMGNQIFGYLNSFQVFIEAGMLFLAPFIVNRLGPKKSLILAGLLMSFRIIGSG
IVIGPFGISSMKLIHALELPIMLIAIFKYLAANFDTRLSSVLYLVGFQFASQVGTSIFSP
IAGGLYDNIGFRQTYLFMGTLALCFTIISIFTLLDSKKGAAYAQPFRKNRYREDVTNG
>PK3-2_02582 Lactose transport system permease protein LacG
MINGMAGFAFAKLKFSGKKMLFGILLALLIVPFETILISQFTIIHKIGLVDTRLAVILPA
LAGAFNIYLFRNFFMAIPEEMIESAKLDGANTWQIFWRIMIPMSKPAVATVGTLAFIGSW
NDYIWPLMVLTDKSKFPIQVAITAINSTEPVYTNQVMAVLTISTIPLILIYIVAQRYILE
GLSGSGTGLK
>PK3-2_02583 hypothetical protein
MRRKFGPLTILEYTCLVLLAVLFIFPLIWMIASSMKPEAEIYNNMNSFKAFLPSLHLAEW
VSSYREVLTRFDLLMYIGNSLFMVCA
>PK3-2_02584 Lactose transport system permease protein LacF
MNKTILKETRPAFPLERKTVNKIRWRENAVAYMFLGPALLILFMFLMVPSIMAVYYAFTD
YYLLTPDLRQFIGFDNFIKLFQDPIFLKSLGNTITFVVFLIPLQIGAALGLALLLNKKRK
ANAFFKVAYFSPVVMSLVVISVLWMYLLNPNEGMINNVLAHFGLSPQPFLTSPKQAIFTI
VAVSAWQGAGFQMLIFLAGLQNIPEDVYEAAQLDGMNKWQRFIYITLPLLKPTSVFIFIT
TLISAFKLLVQPMVMTQGGPVNSTMTVVYYIYQTGFTDRMVGYASSIALLFGTIIGLVTL
AQRKLVKEDEDH
>PK3-2_02585 hypothetical protein
MKRWMLGSLSLLLMFAVWGCNKNESANSGGKKTISMWVHVSDDNEEGKVYKKRVDAFNKK
YASENVEAKIEFIPRSGNGGGYEDKVNAALTTNTLPDVITLDGPNTAAYAKSGVIAPLDE
YVKDQDDLLPSIKQQGTYQDKLYAIGVSESSVGIYYNKKMLKDAGIDLKTLPTVKDPWTW
KEFLALCKKLKNKYDKPAIDMQLQSKDEILTYALLPFVWSAGGDILSENGKKADGVFNKK
PTADAMTFIQTMLKEGYTTRTPVKQAFETEKYPMKMSGVWTITDLKTNFSNVDYGVMPYS
VSPKTKKLVSPSGSWQFAMTQASENKEWAARLVDWMTNKDSNIELSRSIAALPVRYSSEK
VLTKEFSDEMNVFMQQLKETGHARPVTPAYPQITRAFQQTIDDISFYDQNQDIQKVLDTR
VKEMQSAIDKAN
>PK3-2_02586 HTH-type transcriptional regulator DegA
MKPSIHDVAKIAGVSSTTVSRVLNNRGYISEKTKDKVYKAMEEINYFPNDLARSLFRKRT
NLIGLIIPNSSNPFFGELAFYIESICTSMGYKLLLCNSLNRIDKEEKYLEMLIRNQVDGV
IAVTYNRGILNYHQQNLPIVAIDHYLSEKVPVVGSDNFAGGKKAAELLIKKDCQHIVHIN
GPIELETPANLRRKAYEDVMREHGRQPITYEVPFHENYRNIISKLFDEQPAVDGIFASDD
IIAAGVITEAKKRGKDIPGQLKVIGYDGTETIQAILPELTTIQQPIELISKTAIEILEKQ
IEGEFDNLPLETYLPIQLFESGTT
>PK3-2_02587 hypothetical protein
MGDRRSIKTKSAIKHAFLKLLQEKEINKITVSDLSKKADIGRGTFYLHYKDIFDLYEQIE
DEIFEQLGSIYDASFPSEDPLNILTFIEKTTEYIYQNIEIFTLLTKPKMNVLSINKLKEF
FKTKMIEELSMIRQSASSITETEKFETTFIVSGVVGIIEEWINNGMIKTPTYISNIIHQL
LLKFED
>PK3-2_02588 hypothetical protein
MFLYRQPRDDKLNKVAKLFHESFNQYPFMDLLVKREKNYF
>PK3-2_02589 Polyketide biosynthesis cytochrome P450 PksS
MSSKQKKSVTIMTESQLSSRAFKDEAYDFYKDSRKSHPLYPLSLGSLGEGWLISRYDDAI
HVLKNEKLKKNYENVFTAKEEKRPVLLKNEESLTKHMLNSDPPDHNRLRTLVQKAFTHRM
ILQLEDKIQHIADSLLDKVQPNKFMNLVDDYAFPLPIIVISEMLGIPLEDRQKFRVWSQA
IIDFSDAPERLQENDHLLGEFVEYLEYLVRKKRSEPAGDVISALIQAESEGTQLSTEELY
SMIMLLIVAGHETTVNLITNMTYALMCHQDQLEKLRQQPGLMNSAIEEALRFHSPVELTT
IRWTAEPFILHGQEIKRKDVIIISLASANRDEKIFPNADIFDIERQNNRHIAFGYGSHFC
LGAQLARLESKIAISTLLRRCPKIQIKGEKEQIKWKGNFLMRALEELPVSF
>PK3-2_02590 Glutamate racemase 2
MKIGFFDSGIGGMSVLYEAIKVLPYEDYIFYADTLNVPYGEKSKIEVREYIFNAVEFLAA
QNIKALVIACNTATSIAVEDLRRHFDFPIIGIEPAVRPAIKKCAEERKRVLVVATHLTLK
EEKFHHLVKEIDHHALVDCLALPGLVEFAENFDFSEDKVIKYLKNELSSFDLKQYGTIVL
GCTHFPFFKNSFEKLFGINVDIISGSVGTAKQLKKILVDRNQLGKGSGSITFFNSGHKIE
DQEIISKYKTLFKILDGNQGSHVEHGIYGSGY
>PK3-2_02591 Nitronate monooxygenase
MNKFMKMFSLTKPIIQAPMAGGITKPRLASAVSNQGALGSLASGYLTPELLEQQMKEMFE
LTDAPFQINVFVPLGLETPSDDQIDSWKKNIPLANQVNQFTSVQEEWDDFYQKIDIISRY
KIKACSFTFDLPPEDAVKELKTSGCCLIGTASTVEEALLMEERGMDIVVLQGSEAGGHRG
AFLPSKGESAVGLMALIPQAADALSVPVIAAGGIIDHRGVKAALALGAQGVQIGSAFLIC
HESNAHPVHKQKILEANEADTKLTKLFSGKEARGIVNKWMEEKERFETQTLPYPYQNTLT
KAMRQQASLQNNHDQMSLWAGQGIRSLTEEISVKQLLNNLFHEDIKI
>PK3-2_02592 HTH-type transcriptional regulator GltR
MNIQLLQVFLTTAREGSISKAAQTLNYAQSNVTNKIQQLETDLQTTLFYRHNRGITLTPS
GQILVSYSEKILNTIEEARAAMGESSAPSGPLRIGSMETTAAVWLPQLLADYHNFYPNVD
LNLVTGPTEQQIQDVLHYELNGAFISGPIEHPDLVQEKVLEEEMVLVTSASHPNISSIHD
VQTQTMLVFREGCSYRAKLNNILQEEGLLPVKLMEFGILEAIIGCVSAGLGISLLPRSII
AAHEKQGRIRSHTISDKYSLVTTMFIRRKDTFITPALSAFLTRMRDHFQKNIS
>PK3-2_02593 Haloalkane dehalogenase
MATYHFVEIKGINVFYRKAGDPNKPVILLLHGFPTSSHMFRELIPILANDYYVIAPDYPG
FGHTTSPDREKFEYTFDHITEIVAAFVDRLSLKEYALYVFDYGAPIGFRLAMKHPERVTA
IISQNGNVYREGLGEKWAEREDYWENPTQEKRDSYRTAFAPDTIKNQYLDGTQNNQVSPD
GYTLDIAYMSRPGIDEKQLDLIFDYKNNVKLYPAFQQYLREYQPPLLATWGKNDVSFIPQ
GALAFKKDVPNSEIHLLDSGHFALETHVDEIGRLILNFMEK
>PK3-2_02594 putative amino-acid metabolite efflux pump
MKAVSPKQGFILIISLVMIWSLNWPVTKIALEYTPPFLFSGMRTFLGGLILLSIFWPKLR
NLNLRKNWGIYSISAIFNVILYYGLQTIGLHYLPSGLFSVIVFLQPILVGMMAWIWLQEK
MTKFKLIGLILGIIGELVISEGSFSGEISIVGVLLAVGTAVSWAIGTVYAKKIEQRVDVL
SMIIVQFIMGGIILTAIGASIENWRDIQLNFSYMFGLLFGAILVIALGWFIYFTLVRHGE
ASKVASYMFVIPIVALIIGALFLNEPITFNILVGIIMVTMSIYFVNRKPKKLDVVKIQS
>PK3-2_02595 hypothetical protein
MPLLRFDFIEGRESSLKNLLDVAHNVVVEAFGVPQQDRYQIVHEHPENHMIIEDTG
>PK3-2_02596 hypothetical protein
MTRESYPVEIKQKAVDMRFAGVPMKEIMQKLNIKNKKQVQT
>PK3-2_02597 hypothetical protein
MKTKKEPKVFLKLAKESDLPEFQKKLQEAFAIAVIETFGDCEDGPIPSDNDVQESFNAPG
AVVYHILQDGKKVGGAVVRINSQTHHNSLDLFYVSPEYHSQGIGLSAWKAIEAQYPETVL
WETVTPYFEKRNINFYVNKCGFHIVEFYNEHHSDPHIHRNGREDDKPLPDDDDFFRFVKI
MKKKD
>PK3-2_02598 hypothetical protein
MTVQKEGHGQPVSLRERVHFLDIVRGFALLGIIIVNYFLIVDSVKGFEMTSNDVLHNLVS
WFAEGKFVTLFSFLFGVGFMIFMDRAAQKVDSPSKLFARRLSILLGFGILHITFVWVGDI
LTFYAVSGFLLLAFYKRTAKTVLRWIIALIVFQFLTPVFTMLYNVINTAGPKNPNFSEFT
LFSHSSLTYMESISTRWTDMVTMAASSFSMIYSMFLMFLLGVYFVKMEFFKDMETKKPIW
KRIWIISTIAFLITQSSILLDMFNFSDISSVLGQNGGLTGSMFYMSSFAMLFLYVPQLRG
PMMIFTKVGRMSLTCYLLHSIIGTILFLRYGFGLAGHIQSAGTFMFSLAVYFVLMIFSTL
WLRRFKYGPMELIWRKLTYGKVNERSKATPHAAKSIQK
>PK3-2_02599 Transcriptional regulatory protein WalR
MTHRILVVEDDEDIGDLLEESLTRAGYEVLRAKDGKRALQLVNDTLDLVILDIMMPGISG
IETCQHIRKSSNVPILFLTARSSTLDKTEGLLAGGDDYMTKPFSEEELHARVIAQLRRYT
IYQEKKEQEETFLIGGKLRVSEEFNEVWKEEKQIKLSDLEYRILKLLMSKRNKIFSAQNI
YESVWGQPYFYCSNNTVMVHIRKLRSKIEDDPARPVYIKTEWGRGYRFGAS
>PK3-2_02600 hypothetical protein
MAHRKFTLTKKLALLIVVAAIVSGVIFLTLQKITDDLIEGYLSSEKYYHEESARYIQKFS
KYVSENELSTSDRKAFGEWVKKENYINLTIYKDQELQYDSIYSESDYGKEKLTQYAQNHS
HPVKFSDGEGRVIIDGFYSSRYYDLAFALDLLGATLIFLIIVLFGIRQSLRYLKTIHQEI
HILEGGELDYEMTIKGHDELAMIAKSIEDLRKAFLDKLKAIEELQAESRSLVTEMSHDMR
TPLTSLIMNLEFAKKEGGEAGTSKDRYVANAYGKALQLKSLSDNLFAYFLLDKEYEADLE
TVAVKEVIYDLISDQIAILHQEHFRVHISGELPETYINVNLEELGRVFDNVMSNLFKYAD
PEEEISITFVSDQEIFEIHVSNTIKLADITPESNGLGERSIARMMSRMQGQFHSIQKNSK
YCIVLRFWNTKM
>PK3-2_02601 Protein PsiE
MRFSNKFKKVPYLLQALLNVCLFFLALALSALLISETWYIVLFVYKSLFNKVDSYYEMLG
ELLIFFMYFEFIALIIKYFKSDFHFPLRYFIYIGITAVIRLIIIDHDQAISTFWWAMAIL
AMICGFFIANRRNSVVEH
>PK3-2_02602 hypothetical protein
MIEKYTTEVSLDFFNGDGADLKDTIEEIRLFAKTYENDKVTVLSVTENESSKGKNYKVLL
QHERDTDNLGRKYEYDEEKLFGFFEDEE
>PK3-2_02603 hypothetical protein
MKKVLLTILTFSLLISLFAIDGSNEVKAKGVASAQLQKSTINGLDKIVDKNGKKLITEEE
LLELFNSSDFSPNSTNQVNYFYTNVDNKTTILKLNLVVHNNRLTSVSLTDTEEKSSSITT
AVTNQEKASPQFHILKKLPKPKPKPKPKKPKITKNVPYKKNGGTIKKDFISEHAYKRHKY
DASRKSTSNRTQYGKDVDVAELRRLTMTQPDQAWSSRDKGGPWRTFYRKQFNKNISTKDT
STTHHRVIINTADSSKNTQFPLSFKN
>PK3-2_02604 Putative ribonuclease YeeF
MKIAFFNSIAGAAEDKGLSDAYIEESFLEHGLANAQKKAMKDILNDIDDILPLDLFSTET
FKNELADANDKRKKTIEKLGDLDEDLLTEYALSEPNEQFIKTDFQKLQEATGKGKNATPI
HYNAKAYHESDIQEKRRH
>PK3-2_02605 hypothetical protein
MKSKLFISLSAVLIGLAFFGSMSNGEMKEASRNVTLAPTHEFLV
>PK3-2_02606 Response regulator aspartate phosphatase A
MNILISITSAEVGMKINEWHRHIQKFNVTDAEMLKAEIERDIEVMEEDQDLLIYYQLMAF
RHKIMLEYTLPSDENRMKLSEYLKKIEGYKKKLDNMRAYYYNFFRGMYEFRNGKYTKAIT
YYKKAERKIPTISDKIEKAEFYFKLSEVYYHMKMTHISMHYAELSYNIYKKHELYSVRRI
QCHFVIAGNYDDLENHEKALPHLQEALKGAELLKSKNTHIYATAFFNLGNCYHKMDNLNK
AARYIEQALVQYRKINSDVLPQAYHDLALICFKQGKKKQALECFRKGIRSAVDFKDELFM
NLFEALDVLYLRNGDTPKLLNIFSRLENGKGYPYLEELALLGGNLFDYNGKIEDSIICFK
KMVYAQKQISKGECMYEI
>PK3-2_02607 hypothetical protein
MCLGKLRKLGIVPELQVQFAPNMHMAGYSKIVQKICQNEQMC
>PK3-2_02608 hypothetical protein
MSTVASEFNGGYTCCCVAVCSKKTCEVGPVGPVAPVAPVAPVTPVAPVAPVAPVAPVTPV
TPVAPVTPVAPVAPVAPVAPVSPVGPVAPVAPVSPVAPVSPVAPVAPVAPVAPVAPVAPV
APVAPVSPVAPVAPVTPVTPVAPVAPVTPVAPVSPVAPVTPVAPVSPVAPVSPVAPVTPV
APVAPVSPVAPVAPVTPVAPVAPVTPVTPVAPVVPVSPVGPVGPVAPVAPVAPVSPVAPV
APVSPVTPVVPVSPVGPVAPVAPVAPVSPVTPVAPVSPVAPVTPVAPVAPVAPVAPVAPV
APVTPVAPVSPVAPVAPVAPVAPVAPVAPVAPVAPVAPVAPVTPVAPVSPVAPVSPVSPV
APVSPVSPVAPVTPVSPVAPVTPVAPVAPVAPVAPVAPVIPVAPVSPVAPVTPVAPVAPV
APVIPVAPVAPVAPVSPVAPVAPVAPVAPASPVAPVSPVAPVGPVAPASPVDPVAPVTPV
APVSPVAPVAPVSPVAPVAPVAPVTPVAPVSPVAPVGPVSPVAPVAPVGPVGPVAPVAPV
TPVAPVAPVAPVAPVAPVAPVSPVGPVGPVAPVTPVSPVTPVAPVIPVAPVSPVAPVAPV
TPVAPVSPVSPVAPVTPVAPVTPVAPVAPVSPVGPVGPVAPVAPVTPVSPVTPVAPVIPV
APVSPVAPVAPVTPVAPVAPVSPVAPVTPVAPVTPVAPVSPVSPVGPVAPVAPVTPVSPV
TPVAPVAPVAPVTPVAPVTPVAPVGPVGPVAPVSPVAPVTPVAPVAPVTPVAPVAPVTPV
APVAPVAPVTPVAPVSPVAPVGPVAPVSPVSPVSPVAPVTPVAPVAPVAPVTPVAPASPV
TPVAPVSPVAPVSPVSPVTPVAPVIPVAPVSPVAPVAPVAPVTPVAPASPVAPVGPVSPV
APVAPVGPVGPVAPVAPVTPVAPVAPVAPVAPVAPVAPVSPVGPVGPVAPVTPVSPVTPV
APVIPVAPVSPVAPVAPVTPVAPVSPVSPVAPVTPVAPVTPVAPVAPVSPVGPVGPVAPV
APVTPVSPVTPVAPVIPVAPVSPVAPVAPVTPVAPVAPVSPVAPVTPVAPVTPVAPVSPV
SPVGPVAPVAPVTPVSPVTPVAPVAPVAPVTPVAPVTPVAPVGPVGPVAPVSPVAPVTPV
APVAPVTPVAPVAPVTPVAPVAPVAPVTPVAPVSPVAPVGPVAPVSPVSPVSPVAPVTPV
APVAPVAPVTPVAPASPVTPVAPVSPVAPVSPVSPVTPVAPVIPVAPVSPVAPVAPVAPV
TPVAPASPVAPVAPVAPVAPVAPVAPVSPVAPVAPVSPVGPVSPVAPVTPVAPVAPVTPV
APVTPVAPVSPVTPVAPVAPASPVAPVSPVAPVAPVTPVAPVAPVTPVAPVTPVAPVSPV
TPVAPVSPVTPVAPVSPVTPVAPVAPASPVAPVSPVAPVAPVAPVAPVSPVAPVAPVAPV
TPVAPVAPVAPVIPVAPVAPVAPVAPVSPVAPVTPVAPVAPVAPVSPVAPVTPVAPVGPV
TPVAPVAPVSPVAPVTPVTPVTPVTPVAPVTPVAPVSPVAPVSPAAPVSPVAPVAPVAPV
APVTPVAPVGPVAPVSPVAPVTPVAPVGPVTPVAPVSPVAPVTPVAPVAPVAPVAPASPV
APVSPVGPVGPVAPASPVDPVAPVTPVAPVSPVAPVAPVSPVAPVAPVAPVAPVAPVTPV
APVAPVGPVSPVAPVAPVAPVIPVAPVTPVAPVSPVAPVAPVTPVAPVTPIAPVTPVAPV
TPVAPVSPVSPVAPVAPVTPVAPVSPVAPVTPVAPVGPVGPVAPVAPVTPVSPVTPVAPV
IPVAPVSPVAPVAPVTPVAPVAPVSPVTPVAPVSPVAPVGPVAPVSPVSPVAPVTPVAPV
APVAPVAPVAPVAPVAPVTPVAPASPVAPVAPVSPVAPVAPVAPVSPVAPVSPVGPVAPV
TPVAPVAPVAPVAPVAPVSPVTPVTPVAPVSPVTPVAPVAPVTPVAPVSPVAPVTPVAPV
VPVSPAAPVAPVGPVAPVAPVAPVSPVAPVTPVSPVAPVTPVAPVTPVTPVAPVVPVSPV
GPVAPVAPVAPVTPVAPVSPVAPVTPVAPVGPVGPVAPVAPVAPVAPVTPVAPVGPVAPV
APVTPVAPVIPVAPVIPVAPVAPVTPVAPVAPVTPVAPVSPVAPVAPVTPVAPVAPVSPV
APVTPVAPVGPVAPVSPVSPVAPVTPVAPVGPVAPVSPVSPVAPVTPVAPVAPVAPVAPV
TPVTPVTPVTPVTPVTPVAPVAPVAPVSPVTPVSPVAPVTPVAPVAPVSPVAPVTPVAPV
APVAPVSPVAPVGPVAPVAPVAPVAPVAPVTPVAPVSPVAPVTPVAPVTPVTPVAPVAPV
SPVTPVSPVAPVSPVAPVAPVSPVAPVTPVAPVAPVAPVSPVAPVSPVAPVAPVAPVGPV
APVTPVTPVAPVSPVTPVAPVTPVAPVSPVAPVSPVAPVAPVTPVAPVAPVAPVAPVAPV
APVAPVSPVAPVAPVSPVAPVTPVAPVAPVAPVSPVAPVSPVAPVSPVAPVGPVAPVTPV
APVSPVAPVSPVAPVSPVAPVSPVAPVSPVAPVTPVAPVTPVAPVAPVAPVAPVSPVAPV
SPVAPVTPVAPVAPVSPVAPVTPVAPVSPVAPVSPVAPVSPVAPVTPVSPVGPVAPVAPV
GPVAPVAPVAPVIPVAPVAPVAPVAPVSPVTPVTPVAPVSPVAPVSPIAPVGPVVPVTPV
APVAPVIPVAPVTPVAPVAPVTPVTPVAPVTPVAPVAPVTPVAPVVPVSPVGPVAPVAPV
APVAPVAPVSPVTPAAPVSPVAPVTPVAPVGPVGPVAPVAPVSPVSPIAPVAPVGPVAPV
GPVVPVTPVAPVAPVIPVAPVTPVAPVAPVTPVAPVGPVGPVAPVSPVAPVAPVGPVAPV
GPVVPVTPVAPVAPVIPVAPVAPVIPVAPVAPVAPVSPVSPVAPVAPVGPVAPVGPVVPV
TPVAPVAPVIPVAPVSPVSPVAPVAPVGPVAPVGPVVPVTPVAPVAPVIPVAPVSPVSPV
APVAPVGPVAPVAPVAPVAPVIPVAPVSPVTPVAPVVPVSPVAPVSPVTPVAPVDPVSPA
APVAPVAPVSPVAPVTPVAPVVPVSPAAPVSPVAPVGPVDPVAPVDPVSPVAPVAPVSPV
APVGPVGPGTSRYSTKEISSISTDPKVNLLITITALTAFVGISIVLYISFQV
>PK3-2_02609 hypothetical protein
MIEHTNEHSISFITCVNDDTLYDLCLRHIQSLSVPPHMDVEIINIRDADSMASGYQKAMQ
DSDSKYKVYLHQDTFIINRSFIYDILHVFQQNDQLGMIGVIGAEEVPQSGIWWEASKKAG
KVIEYRSTYSYLSFEEIGQIVKTVQALDGLLLATQYDIPWRKEIFDGWHLYDTSQCFEFR
KKGYVVGIPYQKNPWVLHACGNEFDSHQYSYYLGKFIGEYLR
>PK3-2_02610 hypothetical protein
MEINESMKEYQLKDKEYYKGINWKLFDLVGPHAKNILEVGCAEGLFGAAVKEKTNCSYYG
IESYPPAAEKAAHHIDEVIMGDIETLKLSFQKNTFDHIIFGDVLEHLKDPWAVLGNLKPY
IKETGSILASIPHIGHITIFESLLSGKWTYTQAGLLDKTHLRFFTLQEMKKMFHETGYKI
NQIEPIPFTTDYYEKMISKLAHVRACMGIHYADFEKEVRVYQYVIKAEKR
>PK3-2_02611 hypothetical protein
MISISLCMIVKNEEAVIGRCLDSVQAIADEINIIDTGSVDKTKDIVARYTDRIFDFKWID
DFAAARNFSFQQATADYILWLDADDVFTEKDQKLLLDLKRTLEPHIDAVSMKYHLAFDEE
NNVTSSLRRYRLVKREKGFKWIGAVHEYLEVYGNLHHSEAAVSHMPLSHDADRNLRIYEK
MASSGKDFSPRDLFYYANELCDHGKIEKAIEYYLRFLKTKQGWVEDNIRACNKLADSYHS
LGLKEKELSWVLHTLVYGPPRAETCCRLGFSFLEKNDFQSAVYWYEKAIENKSAESLAFQ
NRACATWLPHLQLAVCYDKLGMHQLAYQHNESALQYRPHDSRMLANKKYFEGILQQQASS
GGEQHGNQ
>PK3-2_02612 hypothetical protein
MMKTSIIILTYNQLVLTKQCLKSIWKHTNSDCIEIIVVDNGSSDGTCDYLKQISSIKVIF
NETNKGFAKACNQGLEIATGDNILFLNNDTVVTSQWLEPMVKLLYQDDKIGMVGPVSNYV
SGSQQISVDYTSLEEIEYFSQRHGMEHRGKSRAVLRLVGFCLLVKKEVLDKIDGFDERFE
GGSFEDDDLCLRALQVGYQLKIALDSFVHHQGHATFSGNPDLNISRLYQVNRRIFIDKWK
QDVLAFTDPHPELTALVPSSSHSILHIGCGAGAGGVELLNRQTCTLYGIEEDALLRSIAA
TYYEQVISADVERCNFPYPEAFFDAMMVGDLLKYSNNPQRTIEALAVYLKPSGSLICSIS
NTAYADTLFSLLCETPSHNHFITLQNVNTLFPKHLYEIKSVTTHSAAPEPKIQLFLQELK
FLAGQFGLPLDSPSKHAHIDYMFVHAIKKKKNEAGVAM
>PK3-2_02613 hypothetical protein
MFISKHYDYRERGNKYMSIYHKVIGDGYPIVMLHGWTLDHQVMLNAMEPLFEKRSGWKRI
YIDLPGMGHSKPQPSIQNSDDILEAILRLLD
>PK3-2_02614 hypothetical protein
MAPLTIPDFDERVVPQKTVLKRDSDLISHLSSEEADEFCSMGIVQGKTEWERFRDEILLP
SKQTNYEFVNNIRQNGYGFTVTITS
>PK3-2_02615 hypothetical protein
MRAVQGGFAQLCHGKEAPLKKMNTGDWIIYYSPKMNFKESTPHQKFTALGKVVDNHIFQF
ELGNDFKPFRRKISFIHCTETPIRPLIPKLSFIKDEQRWGYSFRFGHFEISEKDFMLIAK
KMVDA
>PK3-2_02616 Thiosulfate sulfurtransferase GlpE
MHALDYFNARLEATISPMDYLKAKQMSPEKYFLIDVRNGPTHVRSVTIKDCNVIPEQELQ
SRLHEIPKDKEIIVYCWDVWCNTAAKVAKFLLEHGYKVKELTGGIAAWQEMNFPVTNSDQ
GNNIPDNCGC
>PK3-2_02617 hypothetical protein
MDRWNQSYGFLLGKVLQRLESKFAEGLNPYEINARQYGVLLFIKGNPYSSQKDISENLQI
DRTTMVGHIDHLETLGFVERTKNPNDRRSYSLNITEKGNDVLDSRWEFLMKTELEVLDPL
NQQERQLFKDFLIKIWKSL
>PK3-2_02618 hypothetical protein
MVYFVVFFCFAITLHNIEEAIWLPEWSQQSSKFQKPVTSNEFHFAVIVITMLAYLSAFGF
LYMPESDIAKWIFIGFLGSMVINAIFPHLMATILMKKYAPGLLTGLLLNIPVNSLVIYHM
FLKNLIVWKELIISTLVVGIILLALIPLLFKVGDKVSP
>PK3-2_02619 General stress protein 14
MKTLVIVIHPNLETSVVNKTWMNRLKQEKDITVHDLYGEYPNFIIDVEKEQQLLLDHERI
VFQFPMYWYSSPALLKQWEDDVLTHGWAFGTGGTKLHGKELLLAISLGAQESDYQAGGEY
NITISELTRPFQITANYIGMRFLPSFTQYGTLHLSKEDVKNSAEKLVDYLKAEH
>PK3-2_02620 RNA polymerase sigma-K factor
MHPPFVINNEILMHLRALKKTKKDVSLHDPIGQDKEGNEISLIDVLKSENEDVIDTIQLN
MELEKVKQYIDILDDREKEVIVGRFGLDLKKEKTQREIAKELGISRSYVSRIEKRALMKM
FHEFYRAEKEKRKKAKGK
>PK3-2_02621 hypothetical protein
MRYTNSHLEDWIENLYRKIDITEPEQINFERIAEALDIRLSFKPVTSFALKHSGIYNICL
DSRKSRTEQWYDFAHEFCHIYRHEGDKKTMPATWTDYLEWQSNYFTYHFCIPTFMLRNIN
LSYIQSHAIENIAWLFKVSPSFAKKRLSIYYRKLTQPLFNQTVTGNLCTPLL
>PK3-2_02622 hypothetical protein
MTNPEIESFIKDVDRIVHDGGPEEVLTCKIAERVRHLLQPIIFSLYSIGNRTLASGTPYE
ISEINGSITGQYLKDHMVRFRRC
>PK3-2_02623 Glycine betaine transporter BetL
MKKVTSVFWISLFISVIFVMWGAFAPQNLDHVSSSIQSFLTDKFGWLYILSVAIFLIYSI
YLIFSQYGKMKLGQQGDQPEYSRLSWFAMLFSAGMGIGVIFWGAAEPLIHFASPPQAEPE
TKEAAVKALRYSVFHWGLQTWGIYTIIALSIAYFKFRRGVPGLISATFQPLIGNKVNGVI
GKLIDIIAVFATIFGVATSLGLGAAQIGGGLAFISDIENTMTTKFIIIIIVTVLFTASAW
SGIGRGIKYLSNVNIILAVALLLLTIVIGPTRYIFETFFSTTLSYLKHLPEDSFASAPNS
PEYRQWIKDWTVFYWAWFIAWSPFVGTFIARISKGRTIREFVVGVLFIPTLFCIVWFAVF
GGGSLYQELQGINTSLTDLAQEEALFGMFSSLPFGTVAIILAVFLISTFFITSADSATFV
LGMQSTNGSLNPPNTVKLIWGIIQAATASVLLASGGLGALQTASVVSAFPFIFILLLMIV
SLNKALREDYHQELYYSEQKMDD
>PK3-2_02624 hypothetical protein
MSRSAKKDELLKVAERLFYEYGFRGVGLKQIISEANVATMTLYNHFPSKDNLVEEVLRQR
EERYWSYLDSHVESDSDSPFILAVEAHGRWLKEHSYKGDMFLRAIEDYAGTDNDIEKIAR
GHKHKLLQYFQKLAEGNGKTNQHDLAYQFTLLLEGTTSMTTLIGAEKATKYSIEMARTLV
QHTS
>PK3-2_02625 hypothetical protein
MILIDNAPFTTIGLETAKLCHERGIHIILITDHLSSPAASFSNITLKTQASQKQYTVVPT
IYLLESIVVELGRKTSNESVANLREISEILEAKNITQPFTFYPSE
>PK3-2_02626 hypothetical protein
MGKENDKKNESTDKHTSFSEIQEGSQRILRKLIDVRHTLPKKQKKLCDFLLDNYQSIGIL
TLADLAKNSGVGTTTVLRLIQNIGYDSYSDIKKEIRIESVATPSAWWYLQKSFTNIEDNK
HCLSQVGEESVEALKKTVTSSLQKDFDKAIELLLQCEKVYILGLRSSKGLGLYFGHLLEE
FFPKVVQLGHDIEFVFDRIVRATKKRL
>PK3-2_02627 N-((2S)-2-amino-2-carboxyethyl)-L-glutamate dehydrogenase
MSTEAVVSQEVLVRWLSQEECIQAGANNMDMILEYVEKVNKWLAEGKVVEPELLHLLWEE
GNYSGKRIGVHASLIRSEEMKVAAVKGIPSNPMNPINYQTPRSNGMIILYNEDTGYPFAV
MDDTIVSALRTGASSALGAKYCARPDSESIGLVGCGVIQNAHIEATSKVMKHIKTVRLYD
INKDKAKQFASKWEHLGYKFEICDEIEKAVAPSDIVYTATNVNLGNEYIPKEWIKKGSFH
SGVSMWDHKNEAILEGFNKYCMDYKLRLKDDKYPLSELTKAGRLDAEAITELGQVILNKQ
VCREDEDDTVFFVTLGICATDTANSYRIYKNAKEKELGTNVKLWSKPAMF
>PK3-2_02628 1-pyrroline-5-carboxylate dehydrogenase
MVVATFTNEQTVDWKKPQNEKILRGKIAEIQSEFSRHYPLIIGGQPIYSEKEIPSYNPSN
HKQILGYSSQATRRDIEEAVVYAWKAFEKWKSKTSQERADYLFKAADVIRKRKPELVAWH
VMEAGKNWVESDGEINEAIDFLEMYARKAMEMEKDVDLIKQPGIDNKLQYLPLGVGVIIP
PWNFPFAILTGMTAGAIVTGNTVLVKPSSVTPIIASKFMEIMAEINLPDGVVNFVPGSSK
EIGDFMVGHRDINFISFTGSKEAGVHIDEVAHKKIEKQRWIKRVITEMGGKDGIVVDESA
DLEAAAKAIVVSAFGFQGQKCSAGSRAIIHENVYEPLIEEIISRTKDLTQGSPVDNCEIG
PVIDRSSFAKISQYIEVGKKEAVLACGGETDDSVGYFIEPTIFIDAPADSRIMKEEIFGP
VLAICKVSSVQEGIQVFNNTEYGLTGSLFTKNRDHMEYAQKNMVCGNLFFNGKCTGAVVG
VQPFGGYYMSGTGAKTGSLDYLKHFVQSKTISENL
>PK3-2_02629 Carnitine monooxygenase oxygenase subunit
MKTTDGGTTIEGGWPQEAKFEPTFRGYEYSNQENFNREIEKIWMKSWLLAGRVEEVPNVG
DYFTVQFEKENLIIMRTQSGSIETYYNVCMHRGSLLCTEEKGHMSKGYITCPYHSWMYDS
ENGKLLSAPNIPKGIEGFSCENVRLNSVKTEIWDGYIWINLDPEAPSLEESFHLPKSWSI
YEKYDMKNLKVGAQKTYTVEANWKLIMENASECYHCGNIHPELSRVTPPNRPRKWIDKDI
PDTTVLKHVGAMELKPGLERVNMDGKAYRQPFENLTEEDVSKIFYLHIFPHCYICMSADY
VFIAALWPLAVDKTIIKGYWMFTPEVLENGEPIQDAIDIWDITSKEDWEACEWAQQGNQS
RVYENGGILTPIDWRVAKFKHYVHEELAKPV
>PK3-2_02630 Anthranilate 1,2-dioxygenase ferredoxin subunit
MSDNSTYILVGDLTSIEENEPKEIYAGTKTIVVGKVDSKVYAVDGICTHAYAELANGDLD
GHCLYCPLHFASFDIRDGSVIDGPPDQPLSTYEVILKDDQVWIKI
>PK3-2_02631 Rhodocoxin reductase
MLDYNTVLIIGGGIAGHHAARELRKEGFDGNITILEEEAEVPYDRPPLSKEYLAGEQEER
DFTLFSREDYEKLSVTLESGTAVKGIYPKDRKVKAADDRFFSYSHLILATGSSLRKLFVD
GHHLDGIHYLKSLADARKLKESLQKIKRIAIIGAGFIGLEAAAVCREKGIEVSVIETGEL
PMSRLFGREVGQYLYDIHTQKGVKFLTNDSVSSFEGNGKVEKIRTQNGKVVLCDAVIIGI
GVKPNTTISHPDLLVNKGYVIDEYGRTTLPHVYAAGDCAEWPYQNKSIVVSHWDNAMNQG
KFIAKKIVHNHSEPYRTVPFFWSNQYDQQFQFVGLPLPDANIVFRGSSDDGAFSRFYIDH
NQMIHGALMVNEPKNVVPSRKLIQKQHPMNIKQLSDPSIPLKKVQPL
>PK3-2_02632 Glycine betaine transporter OpuD
MKNQGVLKASLIMCGIFLFVGIVWTEWLSFTAGALLNLVLTYFDWFYLLSGSAFVIFCFY
FMFSKYGRIRLGKESDRPEFSTRSWIAMLFSGAMGVGILFWSVAEPVMHYSHPPYGDALS
AESAALSMKYVFFHWGFHPWAIFSLLGLGLAYVQYRKDLPATVSSIFYPLLGDKIYSPIG
KTIDVLAVFVTVIGVASTLGLGALQISGGLNYMYGIPNTFITQFGIIVASTFLFLVSALA
GLNRGMRILSNINMVLAGIFMLILFLIGPSKQILGVLISSTGSYLSDIVNLSFRLDGFNQ
SGNEWILDWTIFYWAWWMTWGPFVGAFFARISRGRTIKEYLAGVLLTPTAITFIWFAVVG
VSAIHQVHTLGNNRLIQAVNQDMTYALFSFLDFYQVGPILSVISCILILIFFITSADSAT
HVLCILSNGGQLKPDNLLKVFWGVMTAGSAIVFLLAGGLEAIKTVAIVVATPFTILLLFI
GYSVLKSLQKEPVIKEKTFHHDRYNKITSKQENHSKVSNEG
>PK3-2_02633 HTH-type transcriptional regulator Xre
MFSENLKKCRKQKKLTQQNMADKLGITRPAYTAYELGSREPDYKTLINISNILDVSLDYL
LKGESNEKTFQDEAKKVLNDPETFLAAKDGEVTDEILQAALEIITEQLKERRKSDK
>PK3-2_02634 hypothetical protein
MRKWLKKNRLEKGYTQEEVAKAAQIGRAYYTMIENGTRKPSVIVSKKIGEKLGFDWTIFF
DDICNETKHNSKDSA
>PK3-2_02635 hypothetical protein
MIGIYKGGLLIMKVILKKGPLFEQAEAKAYKYLSGILVQRMNEHQEKLAQQKKKDSA
>PK3-2_02636 hypothetical protein
MENNPYNMRNLPQIMRSTRKAAGLSQYQIGKLIGGKDQRYVSDVENGLAKLTPELCIKWF
EKCDAYEHIDLVHYLFKLHPTAAAPIDPALNECASNAVINMVHQLEEALQATKHLARWLT
DNRPGKTEELPMADIKQIFDLIAANKTLIYSLVRTHGLKMQELADRWTRKALVDQVAMAK
QEGRQAVSV
>PK3-2_02637 hypothetical protein
MSTNHFLKADVPIAKRKIESAEELSIMLSEALRDGDYEEAISLAGSIKVLTEDISRLANK
GRLYETALKMQQQGINLTVVSRCIG
>PK3-2_02638 hypothetical protein
MMVHFVHKPATALEVRKWCAMIRNNSEFHLLWDRRADKFREENMNGRKPNGDKQLAR
>PK3-2_02639 putative protein YqaI
MVENPMVINNWHDKLTETDVQIDFYGDEVTPVDDYVIDGGEIILRENLERYLREQLGFEF
KNAQ
>PK3-2_02640 hypothetical protein
MTSKRAEVLAKTSEMSHDEWLIERRKGIGGSDASIILGLNKWKTPLELWLDKTGQVPVSE
SQSEAAYFGSLLEDIVAKEFEIRSGKKVRRKKAILKHPEHDFILANVDRMIVGEKAILEC
KTTSAYNLKEWEDEEIPESYIVQAQHYLGVLGPEYQKAYFAVLIGGNKFVWKEIERDDEL
IDMIFEAEIEFWNDKVLGGQAPALDGSSAAEEYLKKRYAETENNKAIDLTATNRERIQQY
LLLKEQISELQSQAKELENQIKHEMKDAEYGFIGNYQACWKPVVSNRVDTKKLKEQFPDI
YEKVKKETHFRRFGIKEVS
>PK3-2_02641 Protein RecT
MATNQSIKNNIQKKQKSAPVQQQGATMKGLLSSPSVIKRFEEVLGKRATQFTASILSLYN
SEQMLQKTDPMSVISSAMVAATLDLPIDKNLGYAWIVPYGGKAQFQLGYKGYIQLALRTG
QYKSINCIPIHEGELQKWNPLTEEIEIDFEKRESDAVIGYAAYFELINGFRKTVYWTKAQ
VEKHKKKFSKSDFGWKNDWDAMALKTVLKAVLSKWGILSVEMQKAVIEEDETRERIDITN
EADSSEIIDSEPSNKDEPEKMSAQEVDPFDGKPVDIKEDELPFD
>PK3-2_02642 hypothetical protein
MDLKAMGYVVIPRLPFKEFRDEKIYDHLFKRAEYRPNQELELGQTIIKVVELAKDFNWSA
AQIKYSLDRMEKQGYIKLNRLPQKRGFIVTILHYADYIQLGNYMKKKALEPAEVEHQEVE
DKMKNAFELYENKVARSVGPIEAQRIGYMVDDYGEEKVMEAIKTAFQLKGKSASLSYIQA
ILSNPFTQKRKEKQYGYKQSSQYRHRISNDHAGTSGKVSPLFGNKTGRIRRKG
>PK3-2_02643 hypothetical protein
MGTKQAASEEKAEFDCPYCKDRGIVVYRVHKDTPWHLDDQLDLMVPDDMVPEDDFLLGKV
CSPDKASEWKDTYSKQCECVRRKKIARLMAASGITEEFEKLLFGNFITGGKPDMIKDAYE
CAVEYYKDFQKIKGERQNSIALLGQPGSGKTHLLTAIMNNLIKKKSVHCMYFPYVEGMGD
LKADFDNLEAKLYAMRKVEVLFIDDLFKPINGQPRATDWQVEQIQSVLNYRYLNHKPLLI
SSELTIDELLDIDEALGSRIHQMCRDYIVIIKGDRMQLNHRLGDWE
>PK3-2_02644 hypothetical protein
MKEKMNVKATGGLYIFGPSNRNKGKDLTSTIRLLEKKIKQMERMLSA
>PK3-2_02645 hypothetical protein
MDCIKFTVYGEPVAQGRPRGSIRNGKVHMRDPAKSKYFKQYVALVASQHRPETIITGPVS
MDVKVYRPMPKSVSNSSKKKEKAEKGLLRPTTKPDVDNYVKGVKDALNHLIYKDDSQVVD
LKVSKFYSEEPRVEVMIREVSA
>PK3-2_02646 hypothetical protein
MYNPREINIKKDFTIQQKVDPGKVQIIVLDGNQGTAHVLDAPEHGKTVIQTVKGSFARVD
HEIGYKVR
>PK3-2_02647 hypothetical protein
MKLKKVLTGTALSLALLVSAAPAFAASPTDTHSEESQTKEVSALGTLVVRGLPSDPDPGQ
TITINGTTYYLDSVTFYPDGSYIAYYSS
>PK3-2_02648 hypothetical protein
MGIVKDFLNELGLPEYIVAAVLLLNLLFVSWKPITAISSNILERKLYTKEKLFILKSYFH
FWNSVFWMVLFLSGAIIINLPEWITSNGNVITFLVLIFGELILLFIIALNEKDNEEDNEK
DNKKDNKKENSESEVNEHANDKIKAIQTLVHRSFKFFKGNLKRRLLLTIIFMLCLIIFYV
SSNLYLINSSSDLKGLSRVIFILIASFLIALPTPFFLRPISKFIGWTKEENVYLMHDDTK
WYVLYPINKELILLGNNSNPKRCDKTKILKLEDFHNKTLFLEKKNK
>PK3-2_02649 hypothetical protein
MNQLTLNIPQLDEEATKSKAEKLLNQYRLYLLQVPDDLLPKVTPTYSIVPPSITNEFHSS
TEEAALKRLDWEIQRDKFVKRIQRAVNRLSQRERKIIVMLYMQPEEKYDYEVYAEMDMSP
RSYYRVKAKALRKLAIALREEVYKK
>PK3-2_02650 hypothetical protein
MLHFENIEELRKFVSNEILLTHEATKYLGISSQRLHQLVQSGKLTPLKSTRSSSLFLKSD
LYDRKFEIEKSYGNNRLLEKEGNVNSIETVNDAINYFTLLALFKNKTKKCDPIYHHLTTQ
VDLTMPTVDIVTDISSITGFDEKEILFESEKVTKGFKMLKEDDYIVKIGSELYPKLLSKT
EQAPVYLFMRGNPNLLNFNTVSIVGTRNPSENGELRAQVLAERLGANRIVVASGLAKGID
TAAHKGALNRKNPTISVIGTPITKVYPKENEALQRVIEESGLVISQFAPSMSVQRWNFPM
RNAIMSGISLATVIIEAGETSGSLIQADYALKQGRLVFIPQSAVDNEKLKWPKKYVLRKG
AFKFSTIDELLEALTNYIHDSFNTSEEDIMTSPANISEGSVGYVYKNNRN
>PK3-2_02651 hypothetical protein
MFIKTIEIKNLIVYTKSFTEEEIKIIKKN
>PK3-2_02652 hypothetical protein
MLQNTINEAGIPSYQWVMISKDKEQIKYAIKQPIGTILISNSEFEYKDIGYLPDMKIDNV
NQIEEKLTKNTGYFSEVCSTLISKDISYGNEGSFFHFNVDREGIVFRVAALGRYFKTTHD
YFNCHQLSNRIRKSKFDFKSQLNLFASLFNPVIEIIHKQHPVNGVTRVPSRPNKVDRFKE
LVQIISEKNQIKDYSNILTCNINYPPHKELNSNQRFQNVKDVFSVNTSIDKDHIVIIDDV
IVSGATLFEAAKALYLAGASKVTAVVLGVNQFPTAFTYSNTQCPVCEGQMILKFNSKDNS
AFYGCENFSKNNCRHSESFLVGWHNILRRNSIDVNKEISEDSLFF
>PK3-2_02653 hypothetical protein
MNYFSREMIMLYGVGATLFIGILNLISSRRSNKKTIYVNAVTSERVKWMTNLKELISEYL
SLTTYYDDKPFLTGEDQANYFERLFYLQSNIKLQLNYADEKDQVINILIEKINQKIIGLY
SAKKIISNKDFPSEDLHKAMNFVLENKGEEFGNKIKKEKDYSIDKFLTEITNEAITVFNE
SFRDQYGYKGRDELRQLTDDLVNKCREYLKLEWEKVKKEAENGKIK
>PK3-2_02654 hypothetical protein
MLEKHIKAYKDYVKGLKYKDLAEKYGVSVNTIKSWKQRYGWERKKGAPSKKSMHTKKVGA
GAPPGNKNALGNKGGAAPEGNQNAVTHGFFSKFIPEETLSIMEGIQERSPVDMIWDQIQI
QYAAIIRAQKIMFVSDKEEMIKELKKKKAVLSETNEVEEEEYEFQFSWDRHATFLNAQSR
AMAELRNLIKQFDELAHSEDERRLKLEHMRLNINKKKIEIEELTEEDKPFEITIVNKGDD
SD
>PK3-2_02655 hypothetical protein
MLTKVMTVIKQVNPHFKEFLFDWNQKFQFLVGGYGSSKSYHVALKIVLKLLKEKRTALVI
REVYDTHRDSTFSLFDELVSDLKLDHIVRCVSSPMQIRFSNGSRIIFKGMDKPAKLKSIN
NISLIWIEECSEVKYEGFKELLGRLRHPTLPLHMILSTNPVGEDNWTFKHFFKDDREKRF
VLDDKELYEKRIIVSNDTYYHHSTADDNLFLPESYVQQLEELKTYDPDLYRIARKGHFGV
NGIRVLPQFEERPHEEVMTAISNINRPLKRVGMDFGFVESYNAVVRVAVDHEKKYLYIYW
EYYKNGLTDDKTAEELKEFAETKELIKADSAEPKTIRYFQQHGFKMVGARKHQGSRLQYT
KKIKRFKKIICSERCENTIYELKPLTYATDKLGNIIEDEFTIDPHTLSAIWYALDDYEVT
DLKEESKGRPQRIRPGRR
>PK3-2_02656 hypothetical protein
MSKQSVKARVIKAYPPTESTKQIYEDEFADSYDSNILPPPYNLKELKMIAEYSTILQQCV
DAYRTNIVGFGFDFEYSFDVNSPDVTNKEKNEAASEWTKLEEFVKYLHFDESAETLLGFV
IEDREKTGNGFIEVIRNGENKPAGIEYMDVQNVRVCKLSEPIEVDFTYFEQGQMKSIKRE
KRFRKYVQMIDGRMVYFKEYGDPRTLNLETGQYDEQTPFEKRANEVVHFKIGSGTYGKPR
WIGHIVNLYGARKAEELNFMYFKQGRHIPAAITIENGMLSEDSYTQLQDYMNGLEGVGNA
HKFLLLEAEGIAKGKNIHGDEEIAPVKVDIKSLAEILQEDALFLEYDQKSRDKIRSAFRL
PPLYTGEAQDYNRATADTARKITEEQVFQPERKLITGKLNALFLNDLEIHKVRLMLKGPD
FRDPLEIAKVLTPFITAGAVSPNDLRDLAGRVLGKTLEEWPEEEYNRPLGKTNESSASDP
LAALFKSKTGTPNMIGLLKDMRDVLEDLKDEQNR
>PK3-2_02657 hypothetical protein
MNKTDKLLKSLNAFIQKAEENQYKQLGEMVPDFPGKPNIPKYVEEYEKGIARLLRRQRKK
FLDGLKGFVSKDSKETLEALLVFFNQNLFAEDDFEEEFQELTEGFLQQTIEELAKVIMDS
IDPEVPFKVLSTRTVNWIKDWSKKLAGIMKLNTHEAVENVLTDAIENGSSIQDIELTLKD
MPQFDRERARKTAITEVLAASSAAQHESYVQSPAVKKKKWRHSGGKKNNPRENHIVLDGT
VIGVDEEFQIPGSSETCMFPRDSKLSAGERINCHCVLSPVVDNEILGLPAEEKGKMRSLN
LKG
>PK3-2_02658 hypothetical protein
MEYKNYLPLTDIDNDKLNFKGLSIEIAEFINAFPSDIPFSISLNGSWGSGKSTMLNFIEK
NLNEKCKVIRFNPWLITNKEDLILSIFEEMNEQITSLASKSSNIKEKLKSYSLKFMPTFV
KGLTYYESMKYNIDPSLTGVLAEEASKFTESLVKEKEFDKPLSVQKKELEYELRKVLSDG
NEKIVIFIDELDRLFPDEIITVFQMVKAILDFPGVLFVVAMDDEVVKNALSKKGIQNPVD
YLDKIFQKSYNLSSKYQIRTLTKSYIYPRLDLDNECHKYLKRCLDTYIMGHYELQIKDFT
HDQDLVLENCETEEDKKVNWELKQNTKRGSLLGSYQDLFKEFSNSLNLDNPRRFSKFSSY
ILENWPKLYKQIFNDRSKKDLYLHCTFILLVTNYFYPEYISVEYLDKKFEKSGLEVANMP
LFVQTVRTHLELIFPLYYSGENILRTTEFIYVCCNKIVSYPDRGKVFY
>PK3-2_02659 putative protein YqbD
MPRELVNAKITHVSYVDKAANQKQFFFMKSEKQPDFYKEVKVLAKEADEQKLVYGIVYEP
DTVDAHGDFMTAAEIEKAAHGFLKDAREIDKQHDFQGGVGEVVESYVAPADFEMNGETIK
KGSWVLVTKASEEVWEQIKKGEITGYSMAGTAETIEKQEEKPVSQVKTDEKGLFNLLKNF
FMGKQQQSYEEPVTKAGRKFSASNLQEIKNAHTALGNLLSQVETEEGEEEMTSEEVTKSI
QAALEPIEKRLADLEKEEDPKKTDKEKTDEEVEKEGEKLKKAISEAVQPLVDRIEAIEKK
RGTSKQTEESGSEQVQKSIWSGLF
>PK3-2_02660 Phage-like element PBSX protein XkdG
MRNQEVINKAEMTLSTLESGGIMNPTQASTFIRMVQDTPTILRDARVIQMDHDTQKIEKI
GFGQRILRAAQEGVALTKDQKSVPSTSTVNLSTKEVIAEVNITYDTLENNIEKDGLQNTI
MQMIAERAAVDIEELLVNGDTSSSDSYLAQLDGIRKQATSHIVDAAGEELTRQTFKRGYK
AVPPKYLRIPQEFRFYTSPGIEVEWKDRVADRQTNLGDAAVQGGLSSAFGVPVKGIANLQ
PYTIGEGDTAADVSDIILTHPKNIILGFSRNIRIEVDKDIRRRMFIIVLTAKLDSVFEEE
DAVAKIVKVKE
>PK3-2_02661 putative protein YqbF
MYTAKLIKGKTYNVMGITFRAGVSQTVSKKLYEYLNENPYFVLGKDLKNQKADPINYTES
ELKGMNKAEHESIISNLGGNPSDFKNADERIAYILKQIDNKGE
>PK3-2_02662 putative protein YqbG
MLLITPDELKSYSVFESVKTRPDELLKQDILEATADIILKVGHDFSDAEYIPLPETVRLA
LLKLSQFYALINGDESIIKGYTTEKIGDYSYTLGDGNSLQKPDVYALIKDYVKPGDPDLE
GVEAKVRMRSI
>PK3-2_02663 Phage-like element PBSX protein XkdH
MSYRSLLTHRCDIYHLQEKKENRKQKFGVPVEDVQPVFSYPDEPDIENQPCYFTEKSQSI
IQQEPNVAIYQSFLVHFPATADIRVNDRAVWDGTAYKLQKPRKIRNHHWEVTAVREVEYL
>PK3-2_02664 hypothetical protein
MKIKGLDQFIQSLNRASRGGLKGKYEEWLEAMGFEFLDIIQDEIIRMKTVDTRRLLNSFQ
KGDQDNIFSMTKGSLKLDVGTNLEYASYVNDGHFTIDPSKNQDRRWVPGRWKGDRFEYDP
AERKTGMLLKFQWVDGSGFWDNAMAIFQLMFERSLERKLQQWIDEEF
>PK3-2_02665 hypothetical protein
MNQEVGSIMGYLYKLYPVQVYEEEIPQDFAVPSLYFPPASTVDGVDTVSTFQKAYILNVK
LFHENAQKAHNEAERIADTLRSRRGIIPLTQESGEDTGDFIRLSRIETRVSDDYATIVLN
WTSRYWYEREEQRSLDGFKFKSGVK
>PK3-2_02666 hypothetical protein
MATKKEKAENAFYIKDLREHSRELFGVKPEVFDGALFHVHKTSITKTEAKKLITQFLQKE
VK
>PK3-2_02667 hypothetical protein
MNGGTFTPGKEKERAGIYFNFKTTAENRVSAGERGTVALPIASSWGEVKKFISISSIEDL
NKKVGLNIDDPSLLLLREAMKKASTVLLYRLTEGLRASADISEGVKATAVYGGTKGNDII
ISITENVIDSSKVDVTTYLDQSEVDKQTVSKAEELKPNNYVTFTGKGDLTVTIPLTGTSP
EDVSGALPVTSGIRLSGGTDKTPTNADYTAFLEAAETEYFDTIALPVEDNEQLKATFVAF
IKRLRDNQGQKVQGVLSNYKGDHEGIINVTGGVLLEDGTEITPEKATAWVAGASAGATFN
QSLTFVEYEGAVDVLNRIDNDEIVERLSNGEFLFTYDSRDKSVSVEKDINSLTSLTAEKN
KMFQKNKIVRVLDAINNDLTSQLKALIKSRKASGSDVPATNDGLQFVKTLITQYLSVLQD
NGGITDFDSENDITIALNNDRDGFQIDLAVQPVDAAEKFYFNVEVK
>PK3-2_02668 Phage-like element PBSX protein XkdM
MALKAQNTISGKEGRLFLDGEEMAHIKTFEANVEKNKSEVNIMGRRMTGHKTTGANGTGT
ATFYKVTSQFVLIMMDYVKKGSDPYFTLQAVLDDASSGRGTERVTLYDVNFDSAKIAGLD
VDSEALEEEVPFTFEDFDVPEKLKDTF
>PK3-2_02670 putative protein YqbN
MSEKQNEKVYDLSFFMPGQTIEAGEVKVPISKRFVDKEGNVVPFIFKAITTERIDELEKE
NTTYKNVKGRGRVKDLDSQRFYARIAVETTVYPNFKAKELREAYKTEDPVEVAKRVLSVG
GEYANWLNKAIEINGFDDDLEDLEEAAKN
>PK3-2_02671 putative protein YqbO
MAKLTATFELHDKISRKLRMIQGNAERLKRAANGPLIFEAEDRTERVMQRIDRSANRLTA
RARLLEVDLDDRVSNGLHSIRQQAEDLTEGSHEVTVSVNDQATPRFRLIRGGLSDLNRSH
AEPTVSVHDHASNQLDEIRRHVSDVDSEHAEPTVSIKDRASAALDAIEAKIDSLKDATIT
LAVAGGFSAGSVMGSGKSTMSQDAYVSATSNVNKKDVARMTDQIYFNNKAGSSREEVSLS
LRNLSQQTGASKKALAELTESSSKIAQLMNADQAEVDRAFSSMYNNLKLSGKQSGDLIAY
VYRNAGDQADDLLDTMNEYSSTFKDLKLTGGQIANAMIKGTKGGARNFDNLADSMREFNI
RRTEMSDSQVDAFKTLFGAKETKKMFKGFKDGSISGEESLFRVAKALSKVKDKTKRAAIA
TELIGTQYEDLKQPILDMAEGIGTSAKTSGELERSFTKLRDNNPMTPVSDAMRDFESISK
DMGTSLLTGLGPAFDKISSFINSKEGQEKLKEIKKDIADLGEEIGDKLNVAIEWSVNHWD
DLKTAIKVVIPSLIGLIGYLKILRPLLKGIGTVGSDAAGVIRKLIPKRTPEAGANTRSER
RNRKSNRNASTRTSKTATSPTSLPRSGSLTCCCCSDGGKNDRIRRRRGKRVGRRGNPNRM
NPSDSSIAVSSERLERRRSGRTVSTNPTRGSRSAIITKRSELYSAGRAAGSPSKFGKVLS
PLKSVGKFAKGVPLLGTALAATDLIGMNKDNVGEKIGSAGGGLAGAATGAAIGSVIPGVG
TAIGGIVGGLAGTMGGSSLGKAFDGSEVKKKLDSTLFDQKWWSEKWSGIKSNAKTSLNGL
SDTWSNVKEKVKSTLFNSEWWSEKWSGVKSWAQDKWNSASSVWESVKGKIKSTLFSEKWW
SGKWEGVKSWAQSKWDSASSVWQSVKGKLKSTLFSEKWWTGKWESVKSWSKNKWDNAKSI
WKSVKSSISETLFSKKWWSEKWQSVKELGSSILGGVKEVGGKVASSAKKTAGKAWGYVKS
GVNYLFGSGKEKPKKHATGGYITKPTISWIGEAGKEFVIPVENNKGRGKMLLSQAASKLG
MSVVDDIASASSAGGEPATSPLISRAAVTASVSPIIDTSSLDEQATSFGQQFTKGFNQGI
GDNVVSMESWKQKNVGQPMNNLISYSPNYGKQVVNGYAKGQNSTSTGTDGFLQTKVKTPF
QNTVNKSSSWGSGTVKGFASGQNSSQTGTDQYVSTHINKPFIRSKESSNGWGSGMIGNFV
SGMTSKTSEVHEAAKELAKKVEKAFREELDIHSPSRVMMSLGRFASIGIVKGLDSVDVKK
FAEKQAGSLAAAYSGMGAVSGNVKQWLMAAIMATKTPMSWLPGLMTIAQHESGGNPKAIN
LWDSNAKAGHPSQGLMQTIPSTFNAHKLPGMNNILNPIHNAAAAIGYIKSRYGSINNVPG
IRSMRHGAPYVGYANGGLITKEQIARVGEGNKREWIIPEERGIRGRYLLAQAAKALGMEV
TDPSQKGQTELSSGQVTAATTGSQQTTVTASGGKEVIIQFNGDQHFHNDQDMNSLVAKIK
QALVDELEQDINIGTKGVVAFD
>PK3-2_02672 hypothetical protein
MSLNRISTLERRESLLLTKSIYEFWISQGKDKLRLPVLPEQIDISNTIQNESVKVASFGE
ITFIDKPGAKEISFSSFFPKKHSPLAEYKGFPSPENAIAKIEKWAKAKKPVQFLITGTKI
NFTCSIEGFSYSEGQKDIGDRDYEIKLKEYKTAAPRKIKQKKKTKKKRPSKSAPKTYTVK
KGDTLWDLAGKFYGDSTKWRKIWNVNKKAMIKRSKRNIRQPGHWIFPGQKLKIPQ
>PK3-2_02673 hypothetical protein
MIELFVIKETEWLELVTESVSLEGQRYQAPRSITAKIITKQGTHSYYSVSEGDTVLFKWK
GKELFRGIVFSRNPEEHGLTFTAYDMLQYLVKNKDVYVFSNKRADEIIKRLARDFQIPTM
SIANTGHTIKSLVFKDDTSLYDMILKALKHTKSQTGRNYQLYSAKGKLGLRAWPDPSEVW
VLETGVNITGYQYSTSINDTATKVKLRRQKDNKTYTATASDSAGISKYGVLQYVETVSDN
INQAQLQQRAKVKQAQKKGVKKELKSIQAIGIPDLQSGLPVYISIPEVGVKKTYWIDTDK
HEFKGSTHTMTIDVVEKNSIPDGVSS
>PK3-2_02674 hypothetical protein
MRLSEAIKHLAVGAVDSESPVDIMPAEVVSVSPVEIKLNENEKLIIPSDLIIIPKRLRAG
GDEELKMGENVMVVSLKGGQSFFILDKI
>PK3-2_02675 hypothetical protein
MALSPEIEFDDIEDDSEVIETSQTYKIDFENGRITNEMITGLEAIRQFVYLSLHTERYAY
SVFSHDIGNELQDILADNETTDAYKKMEIPRLIEEALIYDDRVSSVSDFEIEKQGDSFHV
SFTVETDEGKLEIEEVLGEDV
>PK3-2_02676 hypothetical protein
MFEDQTFEVIMDRMLNSISADIDTREGSVIYNALAPAAAELAKSYIWLDTVLELVFSDTA
QGEFLDRRATEVGIERTAATKAVRAAEFTEGVTIPVGSRFFVDNLYFQYTADGTLECETA
GEAGNANISGQNLLSLDTIPGLQKAIVKEILIPGREEEDDDSLRARYFTRVRREAVSANK
AHYKQWAEEVDGVGKVKVFPLWNGDGTVKIVVTNANLEPASDILISKVKNYIDPEPGHGE
GQAPIGAFVTVESAVWKEIEISAEVLPEVNSSIDQVKQEIESGVLNLFKKMAFEDNVIRL
SQINNIVYNSPSVSDYADIKINGVAENLVLSDVEIPKLGQVNIIEQTR
>PK3-2_02677 hypothetical protein
MSKLDEMTAYLPPFLTKLKEMAELLKAESPEFEKQNNSIFDLTDQLFVTTATWGLERWEK
ILNVPRESGDTDEIRRLRLISKMSNIPPATYKAIEQALNRFLKNPSAQVRLLPREYRFNV
DIDIDDMQHMSELLETLENMKPAHLAYTLRAALNEPIKIKDTVILNNRRYRKASELRVGY
SVTLNNNEVVLV
>PK3-2_02678 hypothetical protein
MITQLYRERTAADLKNRISKVLLNGNETKIVELTIQGAVVTVLTQREEDIKHIKSVQILD
EQNNVITERTTNLDVSNNRTLDFRITFEVV
>PK3-2_02679 hypothetical protein
MVYDAKTDWLPDDPINEDDVNRWEKGIQDAHKDLAVHKNDMNNPHNTTKAQIGLGNVDNV
QQASKKEFEEHHNDLQRHITPVERENWNAKETTAGAQEKADKALLDAKHYVDTNYKNNNL
TLITGDNAIQDARTGGEEYPLGLTLMDIGQGNTTGYPLGYGIVKNEKYNNYRFTQYFYGT
GNESETYYDSTGVWIRHWWSGSGWTPWQKISGFAHANIGTTGVQYLKKIDHTKIAFNRVI
KDSHNAFDTKNNRFIAPNDGMYLIGASIYTLNYTSYINFHLKVYLNGKAYKTLHHVRGDF
QEKDNGMNLGLNGNATVPMNKGDYVEIWCYCNYGGDETLKRAVDDKNGVFNFFDIQELGG
RNYPRF
>PK3-2_02680 Phage-like element PBSX protein XkdW
MNIGEAILFKYPTADPTKDFIVQNNGDGTPSYIAEWNIRAPIPTEADLKSWWEELQSISA
FEPPVQVDLLAKELSKEKLARKQLEELNQTLGSELSKIKLQMLTLQGGKDS
>PK3-2_02681 hypothetical protein
MNYWIWALHYDWATPEMVKKAINFKDCSPEDLQKGVEKKLITAEQYKEITGEAI
>PK3-2_02682 hypothetical protein
MASYSFQFPTDATGKPGAAKPYREGNRDFIVPVAAISGNSELLTNAVLKATEVYTQYGQD
RLGQVLISKVKGHAYSDREGTLFIEESNDMNSWTTVSSLVVKANTLGETEWIHLTKRYFR
FRYVNGNLQQSEFLLYQSLGAGEEDININHTVPITAVAPFSVQLDKSGLTDDGRLKVQTE
GLDLSLLDTQAKTMDVVFHDKTETIGEGNPFTVGSFKTLLIEVYGMAETSELKFWGKSLS
GTKRALRGQKVDDGTFATSTKGKSEAWSFNITGFKEIVMELTALTNGNFSVRGTAVS
>PK3-2_02683 hypothetical protein
MEETSLFINFETLDLARVYLFGGVKYLDLLLVLSIIDVLTGVIKAWKFKKLRSRSAWFGY
VRKLLNFFAVILANVIDTVLNLNGVLTFGTVLFYIANEGLSITENLAQIGVKIPSSITDR
LQTIENEKEQSKNNADKAAG
>PK3-2_02684 N-acetylmuramoyl-L-alanine amidase CwlA
MAIKVVKNLVSKSKYGLKCPNPMKAEYITIHNTANDASAANEISYMKNNTSSTSFHFVVD
DKQVIQGIPTNRNAWHTGDGTNGTGNRKSIGVEICYSKSGGARYKAAEKLAIKFVAQLLK
ERGWGIDRVRKHQDWNGKYCPHRILSERRWDEVKAAIEKELKGLGGKTSTSKTSTAKKKT
TSSNSKKTTSSNSKKTTSSNSKKTTSSNSKKTSYTLPSGIYKVTSPMRKGDDVRQIQKAL
AALYFYPDKGAKNNGIDGVYGPKTSNAVKRFQLMHGLSADGIYGPDTKAKLEELLK
>PK3-2_02685 hypothetical protein
MRILLIWAALIIAVLYVVVHQFLLQIPANGDWQYNLGMLFQALSLSYIAAFLFYLVHNLY
PYLRAKKKYEPVIIKELNDLWEICDSLTYMMSHYSKVTVYNSWPYDYKNSVPEQLQNLPV
KVNNKETEINSDQEEHILPYDKEFDEKSKPLTIRELKFDKWSEAIEYVSSNISNTLNKVL
KLKDVVEEETILKIFDLEKSINEFRIVAKIYEDANKKTFRNGYLEKKFIMFYEGLEELRK
YNKKYNDPQKIKN
>PK3-2_02686 Antitoxin YqcF
MGVTQENKVIARTVLGAFGGKPKVTKYWDDNENSSIDILSVSDQPQEGITSYATLGLSDH
SINYEVNGTPLRIEIVAAMESASDIYANVLSTCAFNIINYNFSCAPGVIFKDVISMYNQE
TDMKHVIFVPPFLWEEDLELLEFNNKSVTWLMALPISEEELQVAEKHGPDYLQDLLESKQ
TDIFDIKRESVA
>PK3-2_02687 hypothetical protein
MDNKNKALINYFFKVMGDERFIQILEKFSNGEGYGIENVWCVFADDYKEWEEDYFGDEGI
AFYFDYPAVEEDEEVILDYENFYKYLNEIVGQYVERHPDNKLEVEKYMGTIKEKYNIKL
>PK3-2_02688 hypothetical protein
MQSIKWRKRSTFQEATNSQIKEVEEKLKIKFPTDYKEFIKDHNGCSPIDKKVVLFQDSRE
SINNLLSIGDPTRPIDLLSTIDNVKDRLVDKIIPFATDAGGNLFCFDYRMSSQEPVIVFW
DHEIAFEDKESSISYVCDSFTELINKLYEG
>PK3-2_02689 hypothetical protein
MKVFEAKTLMSEATDRAKEYKDLRTQMVNLRKALQSVAELDDSEFSGKGANNIKAFYHDH
VGVTDQWIDYIDMKIAFFNSIAGAVEDKGLSDAYIEESFLEHELANAHKKSKSIMSEQKK
AMKDILNDIDAILPLDLFSTETFKDELADANDKRKKTIEKLGDLDEDLLTEYAMSEPNEQ
FIKSDFQKLQEATGKGKNATPIHYNAKAYRESDIHKKKGDIEKRTEAYLKIKKEEAKERE
IKDLKKKLANGVSDPDEYLEIAKKIGYENLEPAQLQYVVQLEQAKQLKSVGESVINAGKT
ALDIIDGVNDGLNDAIDDTIYGIKDLVVGAWEFSQLPMELKLAKTITTVLSVPSYPKIIW
TNIVDSWNDKMINGDAYTRAHYISYAVGNIVGPKGAGAAVQTTTKLSKVGKVVEGGTAAS
HVNKGITKGNNLINPFYKNRYEPALVGIAQDIENTHNVKNTPILKKAIQSKHDQFVKAAP
YTYENSAGKTTTINLRMGHLKNDVHPVTKVPYDKDGFPIFESKHTLTLDKADFKKSRDQH
FDKLNKQLYKQIEEDPSLIKKLDLNEDDLLDLQDGITPEKYTWHHHQTPGKMELVDRVIH
AKTGHTGGYKIWGKDEK
>PK3-2_02690 Response regulator aspartate phosphatase H
MNPVLSSSEVGVKINEWYKMIRQFSVPDAEILKAEVEQEIQRMEEDEYLLIYFSLMKFRH
QLMLDYLEPITTKIRPTIDELLEKIEASNKGITGLLSYYSLFFRGMYEFDKREYVKAIGF
YREAEKHLTHVNDDIEKAEFHFKLAEAYYIMKQNHISMHHVKQAMDIYNQYELYKVRKIQ
CHFVISGNYVDFKHFEKSLPHLEKALELSKQLDRNERLLSSAYYNLGKNYADLGINDKAD
HYLNEAAKVSESAKLSNLPHSLFTYAKFLFKQGKTSEAIKMSKKGLSAAISQGDKLFVSL
QKYLEALYINAVDQAGIKKTIDYLERNKNYAYVEDIAIDTAEVFAKSKEFETSYVYHQKM
LETQKQIQRGECLYEF
>PK3-2_02691 hypothetical protein
MNFKKGVIIILTAVTLSLGLVITFTVEQGIAYHQLSDRNQT
>PK3-2_02692 putative HTH-type transcriptional regulator YybR
MKKNKVADSQETSFGYTLSIINGKWKLLIIYYLSKNNKVRYNELQRKIGKITYKTLSSTL
KEMESDGLIHRKEYPQIPPKVEYSLTEKGQTLWPIIQEMCQWGEHNKEK
>PK3-2_02693 Protein ADP-ribosyltransferase
MVTKQYQDNIDTILQKIQEADAIVVGGAAGMSAAAGYNWYRDDANFRKYFNAFAQRYGID
SIFGGFYYRFRTEEERWAYLATLINFVAEVPIGQPYKDLDQILRGKDYFILTTNQDTQFL
QVFPEEKVSAIQGNWTYLQCGSPCHDGIYPYAEQAKELCAHIEGTRIPSSMVPKCPECGG
HMELWVRSFVFLEGTKYRSEHIKYREFLQKNQNKKVLFLELGVGLMTPMFIKEPFMNMTY
SWPDAYYITINPDPEHGLLPGELKDKGLAVHEDIAQVLRSVVEKQLEERNHDAV
>PK3-2_02694 Protein ADP-ribosyltransferase
MIEKYRNVFEKIQEADSIVIGASNGLSISEGIHIFADDSSFQENFGDFRNKHGFRSIIQG
CFYPYPSQEEKWAFFSRMYEYFLINKESSTIMKNLYELVKDKNYFVVTSNIDAHFTQAGF
PKERLFEIEGNCRNLQCSHGCHNQIYPGDEILSEMAQNQEKGKVPPHLIPKCPECGGSMQ
VHIELDGNFLRDKSWKTMYQAYQEFIEKAHGKKLVLLELGVGARNQMIKAPFMNLTNLEE
CATYITFNKGGELYIPDVIATKSIGMEGDIAEVLQQLVQMK
>PK3-2_02695 hypothetical protein
MFLADTLNDLVYKPIKKPYEIWHKFMEQNVEFWLPESEWHTKTHCARVLFLALLIGHQKG
LSAKEIDALGMAAVFHDSRRLDDGIDKGHGRRAAEYYKDYCRGHDLPYDARTYYITYYHD
QDDSLGLSEIAKSSSLSERAILLYQIFKDADALDRFRLGPDALNVNLLRTEEAHRLVNFA
KYLLQKSRKTYS
>PK3-2_02696 hypothetical protein
MLTLQNISCRKAVKLIRENTDIINKHEIERSVKHMIDFLPRINELAKKQREEGLTNAEKV
EQQVLREDYLRVIRGQVLHTFSGMKVLDPLGNDVTPEKVRNLKIKDQ
>PK3-2_02697 tRNA-specific 2-thiouridylase MnmA
MVKAPKDTRVVVGMSGGVDSSVAALLLKEQGYDVIGIFMKNWDDTDENGFCTATEDYEDV
IRVCNQIGIPYYAVNFEKEYWDKVFTHFLEEYKLGRTPNPDVVCNKEIKFRSFLDHAMSL
GADYVATGHYARVVRENGKVHMLRGKDKNKDQTYFLNQLTQEQLSKVLFPIGDIEKTKVR
ELAANANLATATKKDSTGICFIGERNFKEFLSGYLSAQKGNMETFDGKVVGHHDGLMYYT
IGQRHGLGIGGNGDPWFVIGKDIERNVLYVGQGFHHEMLYSDSIIADNVSWISKGAILDK
FECTAKFRYRQQDNKVTVERLDDSKVKVTFGEPIRAVTPGQAVVFYQGEKCLGGGIINKV
YRDNKKLTYVG
>PK3-2_02698 hypothetical protein
MNHFETTKTLSKEERKLITSLLEKYTREEIEMALRHLNNS
>PK3-2_02699 Peroxyureidoacrylate/ureidoacrylate amidohydrolase RutB
MSTALIIVDIQNDYFPNGKMELSNPEIAAANAAKILEWFRQNNKENIFHVQHIASDPGLG
FFLPNTEGVKLHEAVLPLEHESIIIKHFPNSFLKTELESKLKEKGVTKLVVVGMMTHMCI
DATVRAAVDLGFETTLIEDACATRDLSYQDKVVPAEQVHYAFVSALESMYANVISTEDFL
QKNVNPSK
>PK3-2_02700 HTH-type transcriptional regulator LrpC
MELDNIDFQILQLLTQNSRIQWKDLGKQIHMTGQAVGNRIKKLEESGVIKAYSLIVDEMK
LGLTFTAFVIVYMKTANHNSFIHFINDRNEVVEAYRISGEGCYHLKIKVKTKEQLNLFLN
KILKYGNYSVNLSIQEIKQNNLLNASL
>PK3-2_02701 hypothetical protein
MVILFLLIIVIIIATYKRYYPVTGISCINKDEFETKDMTILDIRHYNDVANFSNDITLNI
PYAYLKRFYLEIPCDKIHIIAHDKVELNLGVRFLKRKGIHVNSYELATCKCKNKL
>PK3-2_02702 Copper-sensing transcriptional repressor CsoR
MEYDQKIKNRLRRIEGQIKGVLTMMEQGKDCREVVTQLAASRNAIDRALGVIVSTNLEHC
VRESIEQGEDTANLVKEAVDLLVKSR
>PK3-2_02703 Sulfur carrier protein DsrE2
MTEKTKHTTIVLFSGDYDKAMAAYIIANGAAAYDHEVTIFHTFWGLNALRKEELVPVKKG
LLEKMFGKMMPRGADKMGLSRMNFAGVGPKMIKNVMKKHNALTLPQLIEMAQEQGVKLVA
CTMTMDLLGLKEKELLDEIDYAGVAAYLADAEEGSVNLFI
>PK3-2_02704 Thiosulfate sulfurtransferase GlpE
MNSGVIINILLILFLLWIVFRRFLPMQGVKQITTAELKSELKNKGKQFIDVRTPHEFHTR
HIKGFRNIPLSNLLRQTNQLSKDREIFVICQSGMRSLKASKVLKKQGFKNITNIKGGMNT
WI
>PK3-2_02705 Thiosulfate sulfurtransferase GlpE
MVKANIVLDAKGLTCPMPIVKTKKKIKDLKVGEILEIEATDKGSTADLQAWANSTGHEYL
GTETEGEILHHFLRKGGEHSSESAPSIPEVSLEVFKQKVESEETLHILDVRELDEYEKAH
IPGVVHIPLGEVEKRSNELNKDDEIYIICHSGRRSEMAAQTMKKQGFKNVINVVPGMRDW
TGKTE
>PK3-2_02706 Sulfur carrier protein DsrE2
MSTRVAIIAANGGLFDAYKVFNIATAAAASDQEVSIFFTFEGLNLIHKQAHQELDMPKGK
EHFAEGFKKANVPSIPELIEMAQEMGVRFIGCQMTMDVMGLTKDDFVEGIEVGGAVTFLD
FAKDADVSLTF
>PK3-2_02707 Hydroxyacylglutathione hydrolase
MTVMAMTPKEVTKKIFNNEPLFILDVRNENDFSDWKIEGHDFHHLNVPYFDLLDGVEDIL
EKIPSDKEVLVVCAKEGSSVMVSEMLSEAGLSVSYLKGGMKAWSEHLEPVKVGDLKDGGE
IYQFVRIGKGCLSYMILSNGGAAIVDATRMAEMFIDFAKEKGVTITHVFDTHLHADHISG
GRVIAEKTKATYWLPPKDAEEVVFDYQPLEEGNDIIIGNTTIKIQPIYSPGHTIGSTSFI
VDDQYLLSGDILFIDSIGRPDLAGMAGDWVGDLRKTLYSRYQALSKDLIVLPAHFMIIDE
LNKDGSVGKKLSTLFAENHGLNIADEIEFRHLVTDHLPPQPNAYQEIRETNMGKVNPDEE
KQREMEIGPNRCAIR
>PK3-2_02708 Sulfur carrier protein TusA
MKSDKVLDAKGLACPMPIVRTKKAMNELESGQILEVHATDKGFKSDLAAWSKSGGHDVLE
QDEDGDVLKFWVQKG
>PK3-2_02709 hypothetical protein
MDIAFIITLFIIGFIGAFISGMIGIGGSVINYPMLLYIPSIVGVMSLTAHEVSGIGAIQV
FFATLGGVWAYRKSGFLNKKIIIYMGSSILIGSVLGSYFSHLVSEKGINFIYGILAIIAV
ILMLIPKRGQAHREGEEVIFNKWLASSIAFIIGGVSGILGAGGAFILVPIMLSILNIPVR
ITVASSLAITFLSSIGATVGKVITGQVLFVPALVLIIASLIASPIGAKAGQKVNTKFLQW
VLALLISATAFKIWLGFF
>PK3-2_02710 NADPH dehydrogenase
MGSKLFSPFYIKNVKLKNRIVMSPMCMYSANEEGKVSDFHRVHYASRALGQVGLIMTESL
AVTANGRIAQGDLGIWDDSQIQGLKELTSLLHSFGAKVGAQISHSGRNCNLKGVKPIAPS
AIPFDTNSKIPLEMSRDGIKQVVQAFRNAARRAREANFDVLEIHTAHGYLLNEFLSPLSN
KREDEYGGSKEKRYQILEEIINDVKKEWKGPLFVRISSTDYKEGGNTPDTFIYFGKRMKE
QGVDLIDCSSGGIAPVSVDSYPNYQVPAAEKIKNEVGIATGAVGLITTGTQAEEILTNNR
ADLIFIGRELLKNPFWPRKAAEELNEQIEAPVQYTRHGSVWI
>PK3-2_02711 putative HTH-type transcriptional regulator YybR
MSVKVCPDESACPVAVTVNVIGGKWKALILYHLLSGPRRFNELRKLLPDATQRMLTLQLR
ELEGDGIIHREIYKQIPPKVEYSLTNLGESLKPLILVMRDWGEEYEKTKPNI
>PK3-2_02712 hypothetical protein
MIAIYVRVSTEEQAIKGSSIDSQIEACIKKAGTKDVLKYADEGFSGELLERPALNRLRED
ASKGLISQVICYDPDRLSRKLMNQLIIDDELRKRNIPLIFVNGEYANSPEGQLFFAMRGA
ISEFEKAKIKERTSSGRLQKMKKGMIIKDSKLYGYKFVKEKRTLEILEEEAKIIRMIFNY
FTDHKSPFFGRVNGIALHLTQMGVKTKKGAKVWHRQVVRQILMNSSYKGEHKQYKYDTEG
SYVSKQAGNKSIIKIRPEEEQITVAIPAIVPAEQWDYAQELLGQSKRKHLSICPHNYLLS
GLVRCGKCGNTMTGKKRKSHGKDYYVYTCRKNYSGAKDRGCGKEMSENKLNRHVWGEIFK
FITNPQKYASFKEIEQSNHLSDELELIQKEIEKTKKGRKRLLTLISLSDDDDLDIDEIKA
QIIELQKKQKQLTEKCNEIQLKMKVMDDTSSSENALKRAIDYFQSIGADNLTLEDKKTIV
NFIVKEVTVVDSDTVYIETY
>PK3-2_02713 RNA polymerase sigma-K factor
MVTGVFAALGFVVKELVFLVSYVKNNAFPQPLSSSEEKKYLELMAKGDEHARNMLIEHNL
RLVAHIVKKFENTGEDAEDLISIGTIGLIKGIESYSAGKGTKLATYAARCIENEIVITKG
GCIHPSLIRFNIYGVRIHNGNFFHDKVNNCFFVFKS
>PK3-2_02714 Sporulation-specific extracellular nuclease
MKKWLAGLFFAAAVLLCLGVPQQIQGASLYDKVLYFPLSRYPETGDHIKDAIAGGHSDIC
TIDRDGADKRREESLKGIPTKPGFDRDEWPMAVCEEGGAGADVRYVTPSDNRGAGSWVGN
QMSGYPDGTRVLFIVQ
>PK3-2_02715 hypothetical protein
MHDQSHTTIGFTKTAAYFLYAVLAIIGLTIGYFIPQFAKWALSLPWIPFEGPLRLVTSFQ
GSPAAFITALLGMSAGIWFAHTVIAMLLSVKITDDTVELIKGKKVQTIRSDNIALVFIDH
KRLVLLGTAGYELAREEIDEKSVNIENAFKKHNYEWAAADPFKDQFRRWISDAPDLSPGA
HALLKARHKALKDEETDDVEEFRLELAQLGIVVRDKGTRQYWRKAETYPPNIEHREGS
>PK3-2_02716 6-phosphogluconate dehydrogenase, NAD(+)-dependent, decarboxylating
MGDCGAAVSGYCCRKRISLRWWSGERSFLKMIHNGIESGMMAAIGEGFEVLENSQFNFDY
EKVARVWNRGFVIRSWIMGLTERDAKLDQIKGVMHSSGEGIWTVETALDLQTATPVISMS
LLMRYRSLTDDTFTGKVVAALRNEFGGHATEKK
>PK3-2_02717 TVP38/TMEM64 family inner membrane protein YdjZ
MLKKILGIVIVITIIAVGFFQKEAWLDAIKAGGMFSVLFSMLLIAADVFFPIVPFALVAA
LNGAVFGMANGIWITLTGSMLGTMMLFFLARYSFRDWARKKVLAYPAIQSYEASFHKNAF
TAVLIGRLIPVIPSLLMNVICGLSQVRWHVFFFASFIGKIPNIVVVTIAGANFTSNKLLS
FSIYGAYILIIMLIIFKKFPHLLKVQKK
>PK3-2_02718 N-acetylmuramoyl-L-alanine amidase CwlH
MVMIKKDFIPASNDNRPGYAMTPAYITVHNTANTAKGADAKMHANYVKNPSTTVSWHFTV
DDSVIYQHLPIDENGWHAGDGTNGTGNRKSIGIEICENAGGDFEKATANAQWLIRKLMKE
HNIPLHHVVPHKKWSGKECPRKLLDHWDSFINGISSYDTPPKESSPSYPLPSGIIKLTSP
YRKGTKILQLQKALAALHFYPDKGAKNNGIDGVYGPKTANAVKRFQLMNGLTPDGIYGPK
TKAKLKSKLK
>PK3-2_02719 hypothetical protein
MKHFFILFLLLCVTAGCEGRGYEDVVAFGDSNTRGSNWDYRDYPKAQQWVNILKTAERGK
LDILNAGIGGQTTEDARLRFQTDVLDQKPKHLFIMFGTNDAAILTEGKPRVSKQRFRENL
VYFIKESRKHGIKPILMTCIPIIEGNGKHHLFYYSRYKAAAFEPKGGARNWHNSYNDITR
DVSKRLDVPLVDNWEHFIEADGGKATDEALIQSGLIDPSGNHMTPKGARIVYEGIQDEQV
LKR
>PK3-2_02720 hypothetical protein
MCSGYSYSYPFGSRPYGAGRAYGYAFIVVLVVVLLVVGGIYWLA
>PK3-2_02721 hypothetical protein
MRVLLKKFFLPDEFVKNIFHITPEKLKERNVKGIITDLDNTLVEWDRPNATPRLIEWFEE
MKEHGIKVTIVSNNNERRVKLFSEPLGIPFIYKARKPMGKAFNRAVRNMELKKEDCVVIG
DQLLTDVLGGNRNGYHTILVVPVASSDGFITRFNRQVERRILSALKRKGHIQWEE
>PK3-2_02722 putative protein YqeH
MEKVVCIGCGVAIQTEDKTGLGYAPPASLTKENVICQRCFRLKNYNEIQDVSLTDDDFLN
ILHGIGETDSLVVKIVDIFDFNGSWINGLQRLVGGNPILLVGNKADILPKSLKRERLIQW
MKREAKELGLKPVDVFLVSAGRGQGIKEVIDAIEHYRNGKDVYVVGCTNVGKSTFINRII
KEVSGEEDIITTSQFPGTTLDAIEIPLDDGSALYDTPGIINHHQMAHYVNKKDLKILSPK
KELKPRTFQLNDQQTLYFGGLARFDYVSGDRSPFICYMPNELMIHRTKLENADSLYEKHA
GELLTPPGKDEMDEFPELVAHTFTIKDKKTDIVFSGLGWVTVHDADKKITAYAPKGVHVF
VRRSLI
>PK3-2_02723 Shikimate dehydrogenase (NADP(+))
MKKLYGVIGNPIAHSMSPDIHNASLKDLGLDGHYHAFKVEEDDLEAAVKGIRALGVQGIN
VTVPHKVSIMDYLDHIDESAKVIGAVNTVRREGDKLVGYNTDGEGFVKSLMRVLDKPISE
LSFLMIGAGGAARAIFTTIARQTPKKFDICNRTLEKAKQLTEFTPSFHNKEVLSIKEAEE
RLERYDVIIHTTSVGMHPNVGDIPLSLQRAARSAVVCDIVYNPIQTALLKEANQKGLKTL
DGVGMFVEQAALSFQLWTGQEPNIEKMRSIVIGKLGGTEC
>PK3-2_02724 RNA-binding protein
MLTGKQKRFLRSKAHHLTPIFQVGKGGVNDNMIKQIAEALEARELIKVSVLQNCEEDKND
VAEALVKGSRSQLVQTIGNTIVLYKESKENKQIELP
>PK3-2_02725 Nicotinate-nucleotide adenylyltransferase
MKKIGIFGGTFDPPHNGHLLMANEVLYQAGLDEIWFMPNQIPPHKQDEDYTDSFHRVEML
KLAIQSNPSFKLELAEMEREGPSYTFDTVSLLKQRYPNDQMFFIIGADMIEYLPKWYKLD
ELLNLIQFIGVKRPGFQVETPYPLLFADVPEFEVSSTMIRERFKSKKPTDYLIPDKVKKY
VEENGLYES
>PK3-2_02726 hypothetical protein
MNREEALACVKQQLTEHRYIHTIGVMNTAIELAERFGADSKKAETAAIFHDYAKFRPKEE
MKQIIAHENMPSHLLDHNPELWHAPVGAYLVQREAGVQDEDILDAIRYHTSGRPGMTLLE
KVIYVADYIEPNRAFPGVDEVRKLAETDLNQALIQSIKNTMIFLMKKNQPVFPDTFLTYN
WLVSGN
>PK3-2_02727 Ribosomal silencing factor RsfS
MNQKSILKTAAAACDDKRAEDILALDMEGISLVADYFLICHGNSDKQVQAIAREIKDQAE
ENGIQVKKMEGFDEARWVLVDLGDVIVHVFHKDERSYYNLEKLWGDAPLADLELGMNQ
>PK3-2_02728 2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial
MIYQGFASVYDELMSHAPYDQWSEWIEASLPEKGRILDLACGTGEISIRLAEKGFEVTGI
DLSEEMLSYAQQKVSSNQPILFIQQDMREISGFDGQFDAVAICCDSLNYLKTKNDVIETF
KSVFRVLKPEGILLFDVHSSYKIAEIFPDSTFADQDEDISYIWQSFAGSEELSVIHDMSF
FVWNGEAYDRFDETHEQRTFPVDEYEEMLKTCGFQLHHVTADFTDSEPSGQSERLFFKAR
KSKTIVS
>PK3-2_02729 Pyrroline-5-carboxylate reductase
MKIGFIGTGNMGTILIESFIESKAADPSNMTITNRTIEKALHIKNRYNSINVTESLEKLV
SENEMIFVCVKPLDIYPLLARALPYLKKDHVLISITSPVQTEQLEQYVPCQVARVIPSIT
NRALSGVSLVTFGESCGESAKVKINELMEHISHPLQIESDITRVASDIVSCGPAFMSYLI
QRFIDAAVSETSVSKQDAILMCKEMLVGMGKLLETELYTLPALQEKVCVKGGVTGEGIKA
LESGVQDMFHRVFQNTHLKYEEDISAVKKQFHV
>PK3-2_02730 ComE operon protein 1
MNWVIQHKTAIILTASSAVFIAVIFFFTNGKNKEPAEQAVSTETENIDVKQEAAKDESNE
TIVIDIKGAVRHPGVYEMRTGDRVSQAIEKAGGTSQQADEMQVNLAELLQDGTVVYIPKK
GEETAVQQGAGVAVQSGEGKGALVNINTATIEELQDISGVGPSKAEAIVTYREENGRFQT
IEDITKVSGIGEKSFEKIKSSITVK
>PK3-2_02731 tRNA-specific adenosine deaminase
MERISWNQYFMAQSHLLALRSTCPRLSVGATIVRDKRMIAGGYNGSIAGGVHCADEGCLM
IDDHCARTIHAEMNAILQCSKFGVPTDGAEIYVTHYPCIQCCKSIIQAGIKTVYYAEDYK
TNPYAQELFEQAGVTVEQVELDEMIVDLKNREKLSFVAGLLEKLADAGLAEEDLKKIHEQ
ANTLFTSYV
>PK3-2_02732 ComE operon protein 3
MSMVVKTPDGEKWAASHRIQSADEKDRLSYIEPGMACQLTGSLEEPKHATVPGTFDYHEY
LYRQHIHWNYSVTSIANCSEPANLRHKLLSLRKYIVSFTNGLLPPDTAGIVQALTVGDRF
YVEDEVLNAYQKLGVVHLLAISGLHVGILTAGLFYIMIRLGITREKASILLLLLLPLYVM
LTGAAPSVLRAALMSGIYLAGSLVKWRIHSAGAICFSYIVLLLFNPYHLFEAGFQLSFAV
SFSLILSSSIFRKVKTSLGQLTMVSMIAQLGSLPILLYHFQQFSMISIPMNMVLVPFYTF
CVLPGAIAGVFLLSLSASAGRLFFSWFDFLMSWTNTLITKIAEIDVFTIIIARPEPALLF
LFTVTIILLLLAIEKRSFSQLMVTGCICCAALCLLFVYPRLSSEGEVDMIDIGQGDSMYV
GAPHQRGHVLIDTGGTLSYSSEPWREKQHPFSLGEKVLIPFLTAKGIKQLDALILTHADQ
DHMGEAETLLKHRKVKRLVIPKGFVSEPKDEKVLQAAREKGVTIEEVKRGDVLQIKDLQF
RVLSPETPDPASKNNSSLVLWMKTGGMSWILTGDLEKGGEQEVMNVFPNIKADVLKVGHH
GSKGSTGEEFIKQLQPKTAIISAGENNRYHHPHQEVLQILQRHSIRVLRTDQSGTIQYRY
KNRVGTFSVYPPYDTSDLTETN
>PK3-2_02733 putative protein YqeN
MVFDVWKSLKKGDVHPVYCLYGKETYLLQETVSRIRQTVIDQETKDFNLSVFDLEEDPLD
QAIEDAETFPFMGERRLVIVKNPYFLTGEKKKEKVEHNVSALESYIQSPAPYTVFVLLAP
YEKLDERKKLTKALKKHAFMMEAKELNAKETTDFTVSLAKTEQKTIGTEAAEHLVLLVNG
HLSSIFQEIQKLCTFIGNREEITLDDVKMLVARSLEQNIFELINKIVNRKRTESLQIFYD
LLKQNEEPIKIMALISNQFRLILQTKYFAEQGYGQKQIASNLKVHPFRVKLAMDQARLFS
EEEHRSIIEQLAVMDYEMKTGKKDKQLLLELFLLQLLKRNEKNDPHY
>PK3-2_02734 30S ribosomal protein S20
MPNIKSAIKRTKTNNERRVHNATIKSAMRTAIKQVEASVANNEADKAKTALTEAAKRIDK
AVKTGLVHKNTAARYKSRLAKKVNGLSA
>PK3-2_02735 Germination protease
MKKSELDVNQYLIRTDLAVETKEAMANQQAVPTKEIKGFIEKERDRGGIKIRTVDITKEG
AELSGKKEGRYLTLEAQGIRENDSEMQEKVSAVFAEEFSAFLESLKISKDASCLIVGLGN
WNVTPDALGPMAVENLLVTRHLFKLQPENVQEGYRPVSAFAPGVMGITGIETSDIIKGVI
EQSKPDFVIAIDALAARAVERVNTTIQISDTGIHPGSGVGNKRKDLSKDTLGVPVIAIGV
PTVVDAVTIASDTVDYILKHFGREMKDDRPSRSLVPAGMTFGKKKVLTEEDLPDQKQRQS
FLGIVGTLEENEKRQLIHEVLSPLGHNLMVTPKEVDSFIDDMANVLANGLNTALHEKVSQ
ENKGSYNH
>PK3-2_02736 hypothetical protein
MRNKRRNRQIVVAVNGGKAVKAIFLFIASLIVIFVLSGVLTSLRPELRPSSDSFYGIAEE
LPGDVFAHLLRMENHYFASDFSQTDSSFHLSRLSLKLATSINLEDPRSFLGRELPGFAQF
DTEILLAGQGTDYTNMPAESPPPSKVMEEEREANVAEIEKQQTQSDNAKKDPPKQTTGDK
KVVFVYHTHNTESYLPLLKGETDPDMARHSKANVTLVGDMFGKALESQGIGATVNKTDIQ
AKLNKKGLNYARSYDESRPVVKDALSTNKNLQYIIDIHRDSRRKKDTTATIKGKSYARVA
FVVGKKSKNFEENYKIASELHKLMEKKYPGLSTGVFSKGSPGDNGVYNQDLTDRALLLEF
GGVDNNLEELQRAADAAADVFSEMYWDAEKVNAESGETKKQ
>PK3-2_02737 hypothetical protein
MIAYFGKCLLLVTIMFLGVLFGMQQANNGMLSMKGYHDPSLKGAFTLTDGKNNEKEASIL
GETVTAKDIEEKQKELEQVETFNMFSKAGKALSDTVTNSAQSMYKWIRDMNQ
>PK3-2_02738 Elongation factor 4
MTDKEKRLERQSRIRNFSIIAHIDHGKSTLADRILEKTSAITQREMKEQLLDSMDLERER
GITIKLNSVQLKYKAKDGEEYIFHLIDTPGHVDFTYEVSRSLAACEGAILVVDAAQGIEA
QTLANVYLALDNDLEILPVINKIDLPSAEPERVRQEVEDVIGLDASEAVLASAKAGIGIE
EILEQVVEKVPAPTGDPEAPLKALIFDSLYDAYRGVVAYIRVVEGTVKPGQKIKMMATGK
EFEVTEVGVFTPKATPTNELTVGDVGFLTASIKNVGDTRVGDTITSAANPADEALPGYRK
LNPMVYCGLYPIDTAKYNDLREALEKLELNDSALQYEAETSQALGFGFRCGFLGMLHMEI
IQERIEREFNIDLITTAPSVIYDVYMTDGEKVVVDNPSNMPDPQKIERIEEPYVKATMMV
PNDYVGAVMELCQGKRGNFIDMQYLDANRVSIIYDMPLAEIVYEFFDQLKSSTKGYASFD
YELIGYKPSKLVKMDIMLNGEKIDALSFIVHRDYAYERGKVIVEKLKELIPRQHFEVPIQ
AAIGQKIVARSTIKAMRKNVLAKCYGGDISRKRKLLEKQKEGKRRMKQVGSVEVPQEAFM
AVLKMDDSPKK
>PK3-2_02739 Heme chaperone HemW
MKSAYIHIPFCEHICHYCDFNKYFIQSQPVGEYLNALEQEMINTVAKTGQPDLKTIFIGG
GTPTSLSEEQLKKLMDMIVRVLKPSSALSEFAVEANPDDLSAAKLKILKEAGVNRLSFGV
QTFEDDLLEKIGRVHKQKDVFASFERAREIGFDNISLDLMFGLPGQTLKHLEHSIDTALS
LDAEHYSVYSLIVEPKTVFYNLMQKGRLHLPPQEQEAEMYEMVMSRMEAHGIHQYEISNF
AKPGMESRHNLTYWSNEEYFGFGAGAHGYISGTRTVNVGPVKHYIDLIAEKGFPYRDTHE
VTTEEQIEEEMFLGLRKTAGVSKKRFAQKYGRSLDELFPSVLKDLAEKGLIHNSESAVCL
THQGKLLGNEVFGAFLGEL
>PK3-2_02740 Heat-inducible transcription repressor HrcA
MLTNRQLLILQVIINDFIKSAQPVGSRTLSKKDEITFSSATIRNEMADLEELGFIEKTHS
SSGRVPSEKGYRYYVDHLLSPVKLTKSDLDQIHSIFKEKIFELEKTVQKSAQILSDLTNY
TSIVLGPKLSENYLKQIQIIPIQPDMAVAILVTNTGHVENKTINFPAKMDLSDIEKLVNI
LNDRLTGVPMDELNERIFKEVVMYLRQHIKNYDNILDALRSTFHSTSHVEKLFFGGKINM
LNQPEFHDITRVRSLLSLIEKEQDVLKLVQSPHAGISIKIGKENDYEEMENCSLITASYT
VDQKQIGSIAIIGPTRMNYSRVVSLLQHVTSDLSKALTSLYDE
>PK3-2_02741 Protein GrpE
MSDEKQTVEQNETEEQEVIEEQAAAEEQQEETNESELLQSQINELQGLLEEKENKLLRVQ
ADFENYKRRSRLEMEASQKYRSQNIVAELLPALDSFERALQVKADNEQTKSLLQGMEMVH
RQLVEALKKEGVEAIEAVGQEFDPNLHQAVMQAEDENYGSNIVVEEMQKGYKLKDRVIRP
SMVKVNQ
>PK3-2_02742 Chaperone protein DnaK
MSKVIGIDLGTTNSCVAVLEGGEPKVIANAEGNRTTPSVVAFKNGERQVGEVAKRQSITN
PNTIMSVKRHMGTDYKVEIEGKDYTPQEVSAIILQHLKSYAESYLGETVSKAVITVPAYF
NDAERQATKDAGKIAGLEVERIINEPTAAALAYGLDKTDEDQTILVYDLGGGTFDVSILE
LGDGVFEVRSTAGDNRLGGDDFDQVIIDHLVSEFKKENGIDLSKDKMALQRLKDAAEKAK
KDLSGVSSTQISLPFITAGEAGPLHLELTLTRAKFEELSSHLVERTMGPVRQALQDAGLS
ASEIDKVILVGGSTRIPAVQEAIKKETGKEAHKGVNPDEVVALGAAIQGGVITGDVKDVV
LLDVTPLSLGIETMGGVFTKLIDRNTTIPTSKSQVFSTAADNQTAVDIHVLQGERPMSAD
NKTLGRFQLTDIPPAPRGVPQIEVSFDIDKNGIVNVRAKDLGTGKEQNITIKSSSGLSDD
EIERMVKEAEENADADAKKKEEIEVRNEADQLVFQTEKTLKDLEGKVDEEQVKKANDAKD
ALKAAIEKNEFEEIKAKKDELQTIVQELSMKLYEEAAKAQQAQGGANAEGKADDNVVDAE
YEEVNDDQNKK
>PK3-2_02744 Chaperone protein DnaJ
MSKRDHYEVLGVSKSASKDEIKKAYRKLSKKYHPDINKEAGSDEKFKEVKEAYETLSDDQ
KRAHYDQFGHTDPNQGFGGGGFGGGDFGGFGFDDIFSSIFGGGTRRRDPNAPRQGADLQY
TMTLSFEDAAFGKETTIEIPREETCDTCKGSGAKPGTNPETCSHCGGSGQLNVEQNTPFG
KVVNRRVCHHCEGTGKIIKNKCADCGGIGKIKKRKKINVTIPAGVDDGQQLRLTGQGEPG
VNGGPAGDLFVVFHVRAHEFFERDGDDIYCEMPLTFVQAALGDEVEVPTLHGKVKLKIPA
GTQTGTKFRLRGKGVQNVRGYGQGDQHIVVRVVTPTNLTDKQKDIIREFAEVSGNLPDEQ
EMSFFDKVKRAFKGD
>PK3-2_02745 Ribosomal protein L11 methyltransferase
MKWSELSIHTTHEAVEPISNILHEAGASGVVIEDPLDLIKERENVYGEIYQLDPNDYPDE
GVIVKAYLPVNSFLGETVDGIKETINNLLLYNIDLGRNHITISEVNEEEWATAWKKYYHP
VKISEKFTIVPTWEEYTPVHTDELIIEMDPGMAFGTGTHPTTVLCIQALERFVQKGDKVI
DVGTGSGILSIAAAMLEAESVHAYDLDPVAVESARLNLKLNKVSDTAQVKQNNLLDGIDG
QHDVIVANILAEVILRFTSQAFSLLKEGGHFITSGIIGHKKQEVKEALEQAGFTIVEILS
MEDWVSIIAKK
>PK3-2_02746 Ribosomal RNA small subunit methyltransferase E
MQRYFIELTKQQMEETPAFSITGEDVHHIVNVMRMNEGDQIICCSQDGFEAKCELQSVSK
DNVSCLVVEWTNENRELPIKVYIASGLPKGDKLEWIIQKGTELGAYAFIPFQAARSVVKL
DDKKAKKKRERWTKIAKEAAEQSYRNEVPQVMDVHSFQQLLQRMQDFDKCVVAYEESSKQ
GEISAFSAVISSLPKGSSLLIVFGPEGGLTEAEVERLTEKDGVPSGLGPRILRTETAPLY
ALSAISYQTELLRGDQ
>PK3-2_02747 Threonylcarbamoyladenosine tRNA methylthiotransferase MtaB
MATVAFHTLGCKVNHYETEAIWQLFKEAGYERRDFEQTADVYVINTCTVTNTGDKKSRQV
IRRAIRQNPDGVICVTGCYAQTSPAEIMAIPGVDIVVGTQDREKMLGYIDQYREERQPIN
GVSNIMKAKVYEELDVPAFTDRTRASLKIQEGCNNFCTFCIIPWARGLLRSRDPEEVIKQ
AQQLVDAGYKEIVLTGIHTGGYGEDMKDYNFAKLLRELDTRVEGVKRIRISSIEASQITD
EVIEVLDRSDKIVNHLHIPIQSGSNTVLKRMRRKYTMGFFADRLNKLKKALPGLAVTSDV
IVGFPGETEEEFMETYNFIKEHQFSELHVFPYSKRTGTPAARMEDQVDENVKNERVHRLI
ALSDQLAKEYASQYENEVLEIIPEEAYKETGEENMFVGYTDNYMKVVFKGTEDMIGKIVK
VKILKAGYPYNEGQFVRVVEDEIQEHMRLSS
>PK3-2_02748 hypothetical protein
MSATACLYNDGKGLVNKMLILISFTALILFFLAGMNMLRKGLISMAYSKIEDRLLLFTDH
PLKAFLISIVFTGILQSSSAFMVIVIGFVSAGVLSFKRTIPMILGTNVGSTFTTEFIAIK
MDVLIWILLIGGALFFLTGRYPLKQLGTSFLGLGIIFFCISGFSHLAGPLTKLKTGAEVL
YHVNDSNWAALLIGMVLTAIIHSSSVCIGILMSFMNEGIIELTQAMSVVLGSNIGTCVTA
VMAAVSGGYAAKQTAYAHVVFNVLGVALVFPFLAAATGFVEQLSADPAQRIAHFSLLFNV
VTALLFLPLTNLFYRLIHFLIPAK
>PK3-2_02749 30S ribosomal protein S21
MSKTVVRKNESLEDALRRFKRSVSKTGTLQEARKREFYEKPSVKRKKKSEAARKRKF
>PK3-2_02750 putative protein YqeY
MSLLERLNQDMKLYMKNREKDKLTVVRMVKASLQNEAIKLKKDSLTEDEELTVLSRELKQ
RKDSLQEFSNANRLDLVDKVQKELDILEVYLPEQLSEEELRTIVNETIAEVGASSKADMG
KVMGAIMPKVKGKADGSLINKLVSSQLS
>PK3-2_02751 hypothetical protein
MLHIKGFRVALLSIFLLSLLGVQLNAKAEKQTVYVIPVEKNVEQGLVSFLSRSLQDAKEA
HADHIILDINTPGGLVKSAIDIADSITESEIPVTAYVNKRALSAGAYIALQADHIYMAPG
GKMGAAAIIDGTGNAADQKAESLWLAEMEDAAVKNNRDPKYALAMADSDIDAKEVGAPKG
DLLTLNADKAIDVGYSEGTADNLSALVKKLGFEKAHISYAKESFAEKAARWLTNPIIVPI
LLTIAFLGLTVELFSPGVGIPGTVGFIALLLFFYGHLAAGLAGYETILLFIAGVILILLE
IFLPGGIIGLLGLGAIVASLFLAAGSFTVMAVSLLIASAVSITAFILLTRVLGKRMKFFK
KFILNDSTNTESGYVSNQTRTDLMGKVGVTFTPLRPAGTVIIDDERLDVVSEGSFTEKDK
KVKVIKVEGSRIVVREI
>PK3-2_02752 hypothetical protein
MDPSTLMILAIVAVAIIVLAVFFTFVPVMLWISALAAGVKISIFTLVGMRLRRVIPNRVV
NPLIKAHKAGLNVGTNQLESHYLAGGNVDRVVNALIAAQRANIELTFERCAAIDLAGRDV
LEAVQMSVNPKVIETPFIAGVAMDGIEVKAKARITVRANIERLVGGAGEETIVARVGEGI
VSTIGSSENHKKVLENPDMISQTVLGKGLDSGTAFEILSIDIADVDIGKNIGAILQTDQA
EADKNIAQAKAEERRAMAVAQEQEMRARVEEMRAKVVEAEAEVPLAMAEALREGNIGVMD
YMNIKNIDADTEMRDSFGKLTKDSSDEDRKS
>PK3-2_02753 hypothetical protein
MEDILTNPLIIAAIIGIISAIFGKKSKEEKKNSQNRKKPQQVQTASPQKKQPTEEAPIPV
PNRMEQVRREAEERRRETERNLKGLERDLAAAKQKAVYTKQKMLQVNKDTVVQGIVLGEV
FGPPRAKKPHHTMRSARKN
>PK3-2_02754 hypothetical protein
MGQRKNRVKAWLTRALEIPPDVMMDLPRITMVGRLHIYIENHRGLLLFSENEVRLMLKQG
QCIISGENFVIKAILPEEILLEGTIDVVRYVES
>PK3-2_02755 hypothetical protein
MLKSKLNIGFTIGFAMFFILLFLLSNMVWKIDVTGAKPETEHQMMQHLKEIGVKKGRLQF
LMMSPEKIQKSLTNGIDNITWVGVDLKGTTIHMKVVEKNEPEKEKYVSPRDIVAKKKATI
TRMYVQKGQPMAAIHDHVEEGQLLVSGLIGNEDDQQEVASKATIYGETWYRSEVTVPLET
LFNVYTGKVRTKHKLSFGSLAIPIWGMTFKKEELKHPKTEQEKHSLNFLGFKLPVSYIKE
QTRESEEALRKYTKEEAVQEGIKMGKQDVEDKIGENGEVKSEKVLHQTVENGKVKLIILY
QVIEDIVQTTPIVRETEE
>PK3-2_02756 PhoH-like protein
MTEHLLAMNQKLKSPDEALSLFGNQDSFLKLMEKDLNVNIITRGETIYVSGDEESFQIAD
RLLGSLLALIRKGIEISERDVIYAVKMAKKNELEYFESMYEEEITKNAKGKSIRVKTMGQ
REYVAAMKRNDLVFGIGPAGTGKTYLAVVKAVHALKNGHIKKIILTRPAVEAGESLGFLP
GDLKEKVDPYLRPLYDALHDVLGADHTERLMERGIIEIAPLAYMRGRTLDDAYVILDEAQ
NTTPAQMKMFLTRLGFGSKMIITGDVSQIDLPKGVKSGLAVAKEMLKGIDGISMIELDQT
DVVRHPLVAKIIEAYDKQN
>PK3-2_02757 hypothetical protein
MLNDPIARYRVIFMIAYGLDVSRGGSCVEKEGEDQKQSKKMAKL
>PK3-2_02758 Cyclic-di-AMP phosphodiesterase PgpH
MLKKKGKTKSSQKKWRSFKNARSMHVLLYLLLAAIMFALLFVHVKPETLDLDLFSVSDKT
IYAPATVEDQKATEEKKQAAEDAVEDQYTLKKEYTDNRIDLVSSIFDSISEVKKSAEESS
KSPSEKSMIKSVKDKLTSDVNDSISEESIKTLLKADGEDFSFVRDTVITAVNTVMSSEIS
SDKLSDAKDKVEKELKSNSIPSKYLGAATEIGRFAIIPNYVFDPKATEAKRQEASDNVQQ
VQIKQGQVLVEENDLIDREVYRKLELTGLLNNSNLFKPISGLLIMIGLFIATLVYYFEKQ
KQNLKFKNQSILLFSIITTLLLVIMEVVSLFQKMEYNNIGYLVPIAAGAILIKLLMNERI
AILGSIILAICGSMMFNQGVTGTFNYVIGIYYLISGISGVLFLGKHNARSKILQTGLFVA
FINMVVVLSLLLIQNTALSGLEIGTLMLMGVVSGFASSVLIIGLMPFFETGFGILSTMRL
IELSNPNHPLLRKILTETPGTYHHSVMVANLSEAACEAVGANGLLARVGAYYHDLGKTKR
PQYFIENQMNIDNPHDKLSPQLSKNIIISHTTDGANMLRSYKFPKELVDIAEQHHGTSLL
KFFYYKAKEKGDQITEEEFRYPGPKPQSKEAAIISVADSVEAAVRSMHNPNPERIEKLVR
GIISDKLQDGQFSECDLTFKELDTIAKTLCATLKGIFHSRIEYPEATKKVK
>PK3-2_02759 Endoribonuclease YbeY
MSLLIDIVDETGSISEEMLKEVENLLQFAAEREGVQDQAEVSVTIVTNEDIQQINKEYRG
KDAPTDVISFALEEEGEGEVEIVGAEIPPVLGDIIISADRTREQAEEYNHSFKRELGFLA
VHGFLHLLGYDHMTKEEEEEMFTKQKDLLDAYGLKRS
>PK3-2_02760 Undecaprenol kinase
MDSRDHRNELRRFFKSFVHAGRGIWETARSERNFQFHAAAACAVLVCGFIVGLSPIEWAI
IFLLIGGMFSLELLNTAIEHTVDLITDKHHPLAKAAKDAAAGAVCVFAVISCIIGLLIFL
PKL
>PK3-2_02761 Cytidine deaminase
MNRQELITEALKARDMAYAPYSKFQVGAALLTKDGKVYRGCNIENAAYSMCNCAERTALF
KAVSEGDTEFQMLAVAADTPGPVSPCGACRQVISELCTKDVIVVLTNLQGQIKEMTVEEL
LPGAFSSEDLHDERKL
>PK3-2_02762 GTPase Era
MTNESFKSGFVSIIGRPNVGKSTFLNRVIGQKIAIMSDKPQTTRNKVQGVLTTGTSQTIF
IDTPGIHKPKHKLGDFMMKVAQNTLKEVDLVLFMINAEEGYGKGDEFIIEKLQKMSTPVF
LIVNKIDKIHPDQLLLLIDEYRGRYPFKEIVPISALEGNNIETLLAQIEAYLPEGPQFYP
SDQVTDHPERFIISELIREKVLHLTREEIPHSIAVAIESIKGQDNGSIHVAATIVVERDS
QKGIVIGKKGSLLKEVGKRARADIEALLGSRVYLELWVKVQKDWRNKMSQLRDFGFKEDE
Y
>PK3-2_02763 hypothetical protein
MLNFTWNVFSQTGNVDTYLLFKELEKENIERPDELEDELARFDYPIL
>PK3-2_02764 DNA repair protein RecO
MLTKCEGIVLRTNDYGETNKIVTLLTREHGKIGVMARGAKKPNSRLSAVSQPFLYGSFLM
QKTTGLGTLQQGEMILSMRGIREDLFLTAYAAYIAELVDKGTEEKKPNPYLFEFILESFK
QLNEGTDPDVITFIAQMKMLGVMGLYPELNHCVHCKSQDGTFHFSVRDNGFICHRCFEKD
PYRVPIKPQTARLLRLFYYFDLSRLGNVSLKQETKAELKQVIDLYYEEYSGLYLKSKRFL
DQMESMKHLMGENKS
>PK3-2_02765 Glycine--tRNA ligase alpha subunit
MNIQDMILTLQKHWSSQGCVLMQAYDVEKGAGTMSPYTFLRSIGPEPWKVAYVEPSRRPA
DGRYGENPNRLYQHHQFQVIIKPSPDNIQELYLDSLRALGIDPLEHDIRFVEDNWENPSL
GCAGLGWEVWLDGMEITQFTYFQQVGGLECKPVSVEITYGIERLASYIQDKENVFDLEWT
SGFTVKDLFMMAEYEHSVYTFETSDVDMLFQLFSTYEKEAIKQMDNGLVHPAYDYVLKCS
HTFNLLDAKGAISVTERTGYIARVRNLARKVAKTYYEEREKLGFPMLKGEGSSHE
>PK3-2_02766 Glycine--tRNA ligase beta subunit
MSKQDLLLEIGLEEMPARFLNESMVQLGEKLTGWLKEKNITHGEVKLFNTPRRLAVFVKD
VAEKQDDIKEEAKGPAKKIALDADGNWTKAAIGFSKGQGADVKDLYIKEVKGTEYVFVQK
FQAGQETKSLLPELGSLVTSLHFPKNMRWGNEDLRYIRPIKWIVALFGQDVIPFSITNVE
SGRTTQGHRFLGHEVSIESPSAYEEQLKEQHVIADPNIRKQMIQSQLEAMAAENNWSIPV
DEDLLDEVNHLVEFPTALYGSFESEFLSIPEEVLVTTMKEHQRYFPVKDKNGDLLPHFIT
VRNGNRHAIENVARGNEKVLRARLSDASFFYKEDQKLNIDANVKKLENIVFHEELGSLAD
KVRRVTSIAEKLAVRLQADEDTLKHVKRAAEISKFDLVTHMIYEFPELQGIMGEKYARML
GEDEAVAAAVNEHYMPRSAGGETPSTFTGAVVAMADKLDTIASFFSIGVIPTGSQDPYGL
RRQASGIVAILLDRNWGISFEELLTFVQTEKENELLDFFTQRLKYVLNAEQIRHDVIDAV
LESSELEPYSALHKAQVLEQKLGAQGFKETAEALGRVISISKKGVRGDIQPDLFENEYEA
KLFDAYQTAKQNLQDNFSNKDYEAALASLAALKEPIDAYFDHTMVIADNETLKANRLAQM
VSLADEIKSFANMNALIVK
>PK3-2_02767 Transcriptional repressor CcpN
MVSTIELNKRQEHILQIVKENGPITGEHIAEKLNLTRATLRPDLAILTMSGFLEARPRVG
YFYTGKTGTQLLADKLKKLQVKDFQSIPVVIHENVSVYDAICTMFLEDVGTLFVVDRDAV
LVGVLSRKDLLRASIGQQELTSVPVHIIMTRMPNITVCRREDYVMDIAKHLIEKQIDALP
VIKDTDKGFEVIGRVTKTNMTKILVSLSENEIL
>PK3-2_02768 Putative pyruvate, phosphate dikinase regulatory protein
MSNRIIYVVSDSVGETAELVVKAALSQFNGSADDTHVRRIPYVEDIGTINEVISLAKADG
GIICFTLVVPEIREYLIAEADKANVLYYDIIGPLIDKMETAYGLTAKYEPGRVRQLDEDY
FKKVEAIEFAVKYDDGRDPRGILKADIVLIGVSRTSKTPLSQYLAHKRLKVANVPIVPEV
DPPEELFSVDPKKCIGLKISPDKLNHIRKERLKSLGLNDKAIYANINRIKEELEYFEKIV
DRIGCQVVDVSNKAVEETANIIHHLKTKSM
>PK3-2_02769 hypothetical protein
MEGWRITLLNEQEKTIFVDADACPVKDEILQTASEYEVSVLFVASFEHYQLSRSKEEKWK
YVDPHKEAADLYIANHVKPGDIVVTQDIGLASLLLNRNVSVMSERGHLYKEDTIDFALES
RHFSGKQRRKGIYAKGPKKLNKEDRERFITLLQKILSNDEGILH
>PK3-2_02770 DNA primase
MGNRIPDEIVDQVQKSADIVEVIGDYVQLKKQGRNYFGLCPFHGESTPSFSVSPDKQIFH
CFGCGAGGNVFSFLRQMEGYSFAESVSHLADKYQIDFPDDITVHSGARPESSGDQKMAEA
HELLKKFYHHLLINTKEGQEALDYLLSRGFTKELIDEFQIGYALDSWDFITKFLVKRGFS
EAQMEKAGLLIRREDGSGYFDRFRNRVMFPIHDHHGTVVAFSGRALGSQQPKYMNSPETP
LFHKSKLLYNFYKARLHIRKQERAVLFEGFADVISAVSSGVKESIATMGTSLTDEHVKIL
RRNVEEIILCYDSDKAGYEATLKASELLQNKGCKVRVAMIPDGLDPDDYIKKFGGEKFKN
DIIDASVTVMAFKMQYFRKGKNLSDEGDRLAYIKDVLKEISTLSGSLEQEVYVKQLASEF
SLSQESLTEQLSVFSKQNKPADSGGETKTRRAHLTTKARQKRLRPAYENAERLLLAHMLR
DRSVIKKVIDRVGFQFNIDEHRALAAYLYAFYEEEAELTPQHLMARVTDDHISQLLSDIL
MLQINQELSEAELSDYVKKVLNQRNWSMIKEKEAERAEAERQKDFLRAASLAQEIVTLNR
SLK
>PK3-2_02771 RNA polymerase sigma factor SigA
MADKQTHETELTFDQVKEQLTESGKKRGVLTYEEIAERMSSFEIESDQMDEYYEFLGEQG
VELISENEETEDPNIQQLAKAEEEFDLNDLSVPPGVKINDPVRMYLKEIGRVNLLSAKEE
IAYAQKIEEGDEESKRRLAEANLRLVVSIAKRYVGRGMLFLDLIQEGNMGLMKAVEKFDY
RKGYKFSTYATWWIRQAITRAIADQARTIRIPVHMVETINKLIRVQRQLLQDLGREPTPE
EIAEDMDLTPEKVREILKIAQEPVSLETPIGEEDDSHLGDFIEDQEATSPSDHAAYELLK
EQLEDVLDTLTDREENVLRLRFGLDDGRTRTLEEVGKVFGVTRERIRQIEAKALRKLRHP
SRSKRLKDFLE
>PK3-2_02772 Cytochrome c-550
MKWNPLIPFLLIAVLGIGLTFFLSVKGLDDSREIASGGESKSAEKEDANASPEDIYKANC
IACHGENYEGVSGPSLKGVGDKKDVAEIKTKIEQGGNGMPAGLVPADKLDDMAEWVSKIK
>PK3-2_02773 tRNA (adenine(22)-N(1))-methyltransferase
MADIGSDHAYLPCYAVLNHKASGAIAGEITDGPFLSAKRQVEKSGLSSHISVRQGDGLEV
IKKGEANAITIAGMGGSLIAHILEAGKDKLTGKERLILQPNIHAVHIREWLYKEGYALID
EVILEEDGKCYEVLVAEEGDRDAAYAGISLAAGMLVGPFLAKEKNKVFLKKWTQELKHTQ
NIHEQISQAASTEQNKQKLKELADRMELLKEVIDHG
>PK3-2_02774 GTP cyclohydrolase 1 type 2 
MAKSVNGQQVIQLFEQFSPKAYAVEGDKIGLQIGTLNKPIKNVMVTLDVLESVVDEAIEK
EVDLIIAHHPPIFRPLKHIATDQPAGRLIEKCLKHDIAVYAAHTNLDVADGGVNDLLAEA
LELSETEVLAPTYTDPLKKLAVYVPKEYEEQVRVALGNAGAGHIGEYSHCAFSSEGIGSF
KPLDGAKPFIGEVGELELVHEVRLETVFPKSIEKAVIRAMIKSHPYEEVAYDIYPVEQSP
AEKGLGRVGTLKNEMTLKEFALFVKDKLDVNGVRMVGEADSTVKKVAVLGGDGNKYIHHA
RRKGADVYVTGDLYFHVAHDAMMLGLNVVDPGHYAEKIMKEGVTRKLTSMCKDKKLDINI
FVSETDTNPFIFL
>PK3-2_02775 4-hydroxy-3-methylbut-2-enyl diphosphate reductase
MNVIKISPRGYCYGVVDAMVIAKNASLDKSLPRPIYILGMIVHNKHVTDAFEEEGIFTLD
GANRMDILKQVDKGTVIFTAHGVSPEVRRIAEEKGLVAIDATCPDVTKTHNLILEMKEKG
YHVIYIGKKGHPEPEGAVGVAPEIVHLVETEEDVKNLDIQAEKLIVTNQTTMSQWDVHDI
MELVKEKYPHVEYHQEICLATQVRQEAVSEQAKKADLTIVVGDPKSNNSNRLAQVSEEIA
GTKAYRIGDLSELKLEWLKGVNTVAVTAGASTPTPITKEVIRFLEQYDHEDSSTWISEHN
VPLKKILPKVKAKN
>PK3-2_02776 hypothetical protein
MFSPQQPMRNYPQPGPPRPMPNQRMMGRIPPNVRRPSFGPQQQGFQQTGQFLPQANAGAR
NGAGGGLKGMLSKFLPGGGGAGGAGAPGAGAAASGGAGLQGIQNIANPASLSSMLGNVQK
VLGMAQQVTPMIQQYGPLVRNLPAMMKLYSQLSKSDDAESSEENENQTESEETSETENNA
EAKTSEGNKKSKPKSSSLPEKSKTSDSKEHKPKTTVPKKNEAVSSSPKRTSGSSKPRLYI
>PK3-2_02777 DEAD-box ATP-dependent RNA helicase CshB
MKETKFELYELKPFIIDAVHRLGFYEPTDIQKRLIPAVLKKESVIGQSQTGTGKTHAYLL
PLLNKIDPAKDVVQVVITAPTRELANQIHHEALKITQGEEGSQIRSKCFIGGTDKQKSID
KLKTQPHLVVGTPGRIADLIKEQALSVHKAESLVIDEADLMLDMGFIADVDYIGSRMPED
LQMLVFSATIPEKLKPFLKKYMDNPKYAHVEPKQVTAAKIEHILIPSKHRDKDKLLFDIM
SNLNPYLGIVFANTKNTADHIAQYLTGKGMKIGLLHGGLTPRERKKVMKQINDLEFTYVI
ATDLAARGIDIKGVSHVINYELPDDLDFYVHRVGRTARAGSSGQAMTIYELSDEDSLVKL
EKMGIEFDYLELEKGEWKKGDDRQRRKKRKKTPNEADEIAHRLVKKPKKVKPRYKKKMSY
EMEKIKKKQRRNQSKKRK
>PK3-2_02778 putative endonuclease 4
MLRIGSHVSMSGKHMLLAASQEAVSYGANTFMIYTGAPQNTRRKKIEDLNIDAGRAHMQE
NGIDDIIVHAPYIINIGNTTNPSTFELGVDFLRSEIERTAAIGAKQIVLHPGAHVGAGAE
AGIKKIIEGLNEVIDPNQNVQIALETMAGKGSECGRSFEELAQIIEGVTHNEHLSVCFDT
CHTHDAGYNIVEDFDGVLNEFDKTIGIDRIKVLHINDSKNVKGARKDRHENIGFGEIGFD
ALQYVVHHEQLKDIPKILETPYVGEDKKNKKPPYRFEIDMLKEKQFDDTLLEKILQQ
>PK3-2_02779 hypothetical protein
MILFQRIILQRLNQATADDLLKYSKQYGISLTRPQAIEVANLLYGKNVNIFNESERTRLL
KQVEAITSKETAQTVNELFKQFTS
>PK3-2_02780 hypothetical protein
MTPTKQHKRETFSHFIFRVFMILAGAASAAVSIELFLIPNDFIDGGIIGVSLILDHLFKS
TPILNFALFVVVLNIPFMIFGYKYIGKTFLVSTMIGIVGLAVIESSLHHVEAITTQPILA
TVFGGLLLGFGVGLVIRNGGSMDGTEILGILLTKKLPFSVGEFVMFINVFIFIWAVFVFG
PEQAMYSFMTYYIAMKTIDAVIQGLDETKAVIIVSDQYDEISDAILHRLGRGTTKLKGKG
GYTDEEKDVIYAVVTRLEVTKLKSIVFEVDLNAFITIMNTHETRGGKFKNAIH
>PK3-2_02781 Zinc-specific metallo-regulatory protein
MNVQEALNLLKENGYKYTNKREDMLQLFADSDKYLTAKNVLSALNDDYPGLSFDTIYRNL
SLYEELGILETTELSGEKLFRFKCSFTHHHHHFICLACGKTKEIESCPMDKLCDDLDGYQ
VSGHKFEIYGTCPGCTAENHENTSV
>PK3-2_02782 Nucleotidase
MLRLGIDIDGTITAQDTFVPYLNRSFNLSISLNDMTDYDLTKLLNITQEEFWDWMNQNEA
IIYKEALLAQHAKQSLDLLKEEHKLIYITARRTHLTDITYEWFDRQNIHYDHIELVGGHH
KVEAVKNHNIDLFFEDHHGNAMMIAKEAGIPVILFNSPYNQLPDDSNIIRVNNWLEAVQW
MNKNKHHFIRVNN
>PK3-2_02783 hypothetical protein
MANDYEKRDNNSYYVDHGSEGTNITRDNDGFFEETAAEIAEPYRTADRSNDRDKDRSGGN
VNEGRGIGYIALALSIISLFVLPVLLGAAGIIVGYIARRRGAQGLGAWAMGIGVVSLVLG
IFIIPFF
>PK3-2_02784 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase (flavodoxin)
MSEITHRTKTRPVKVGPLTIGGNNEVVIQSMTTTKTHDVEATVAEINRLAEAGCQIVRVA
CPDERAANAIADIKKRISIPLVVDIHFDYKLALKAIEGGADKIRINPGNIGRREKVEAVV
QAAKEKGIPIRIGVNAGSLEKRILEKYGYPTADGMVESALHHIKILEDLDFHDIIVSMKA
SDVNLAIEAYEKAAKAFDYPLHLGITESGTLFAGTVKSAAGLGAILSKGIGNTMRISLSA
DPVEEVKVARELLKSFGLASNAATLISCPTCGRIEIDLISIANEVEEYISKIKAPIKVAV
LGCAVNGPGEAREADIGIAGARGEGLLFRKGKIVRKVPEETMVEELKKEIDILAEEHYAK
LEAEKAKLKEETQKA
>PK3-2_02785 hypothetical protein
MKRLTLVCSIVFILFILFYDLKIGTIPIQDLPVYEASAKTAAQGPAFKTVKVKPGDTVMS
IVGSAGSPDDIVKDFEALNPNVQASAIQAGTAYKFPVYP
>PK3-2_02786 hypothetical protein
MNVFQLFIKSTYSPRDIAKTRFQGIGKAILYVFLLSVLFAIPTAYYVSSGTVKSMNGFKT
VLNKDFPDFTISNGKLQTDEKKPTESQANGFVIVFDPTDAYGTEQIEAKQNAIGILQDKF
VLAIDGQAQEMPYSMMPSDLAKKDVIAGLNQNKTMIVTVLSILIFLVTAAGKFIEVSFLA
LIGLIIKNSQKKHLSYHQLWKLSAYSVTLSTVFFTIMRALEVTVPSEFLLNWFVNFVILF
LVLKEIPSKKAAV
>PK3-2_02787 hypothetical protein
MDMLYWLVIAAVFIIAFIGLVYPIIPSVVFIVAGFILYGFLFSFSPYSYMFWLVEAVFAA
VLFAADYVSNLLGVKRFGGSKAAIWGSTIGLLIGPFVIPVAGIILGPFIGAVCAELIVHQ
KDLKSAFKIGLGSLIGFLTGVIAKGIIQLLMIGYFLWTVL
>PK3-2_02788 Superoxide dismutase [Mn]
MAYELPELPYAYDALEPHIDKETMTIHHTKHHNTYVTNLNKAVEGNTALANKSVEELVAD
LNSVPENIRTAVRNNGGGHANHKLFWTLLSPNGGGEPTGALAEEINSVFGSFDKFKEQFA
AAAAGRFGSGWAWLVVNNGKLEITSTPNQDSPLSEGKTPILGLDVWEHAYYLNYQNRRPD
YISAFWNVVNWDEVARLYSEAK
>PK3-2_02789 hypothetical protein
MSKLKKVIGDVDVNKGLLFLLTIGGLYSLGIALSNTFVNVYLWKQSGKFIDLAIYNLSIV
TMQPITFYLAGRLAKKIDRVFILRFGVIFLAAFYLSVLLAGETAASRLVLIGAVLGVGYG
FYWLAFNVLTFEITEPDTRDFFNGFMGILSSSAGMIGPIVAGFVISRLENNTGYTVIFSL
SLSLFALAVVMSFFLKRRESKGRFMLSKVFGERHSNMNWRRITNAHFFQGLREGIFVFLI
SVFVFIETNSELALGTFGLVNSAVSFFAYYFASRLIKKKARKKSILLGGLILYGAMFLIL
FHMSFTTLLTYGVFIAIGYPLLLVPYVSLTYDVIGRARHARKARIEYIVLRELFLNAGRI
VSILCFLLIVALLKEDVGIPLSLAILGVGHPLIYYFVKDIRFKEKEEENETMEEDGQKRV
TEPNLLKGER
>PK3-2_02790 Penicillin-binding protein H
MRRNKPKKQNHKEKKKSLPIRLNILFLAAFVIFTWIIVELGIKQIVQGDDYKNQANKQEQ
SEVSSAVPRGKIYDRNFNAIVANKALNAITYTRSKSTTQDQRLKIAKKLSDMIKVDTKKV
TERDKKDYWILTRPKEAKNLITSEERQKVKDKKLSDDDLYQLQLKRINEKQLNELTDKDM
QILAIKRQMDSGYALTPQYIKNEDVSAKEMAVVSEHLDELPGVDVTSDWEREYPYKSLLR
SVLGSVSSSDEGLPSNLLDHYLSLGYSRNDRVGKSYLEYQYESLLQGQKAKVENITDSNG
NVTGTKTVSEGKAGKDLVLTIDIDLQKSVEKIIEKNLKSAKARPSTELLDRAFVVMMDPR
NGEVLTMAGKQIKQENGKYKIDDYALGNMTSSYAMGSAVKGATVLTGLQTGAINLNTVFQ
DEPLYIGSQDKNGKKSWTNLGPVNIQRALEQSSNVFMFKTAIALGKGEYKPHQALPIDTT
AFDTFRNYFSQFGLGVKTGIDLPNEMTGYKGTSRLTGFLLDYAIGQYDTYTPLELAQYVS
TIANGGYRLKPQLVKEVRDSNPEKGIGAVVQSVQPEVLNKVDMKSEYIKEVQAGFRRVAT
KGTAASQLASASYKPAAKTGTAQSFYDGPDKSKTGTAAYNTTLVAYAPADNPEIAISVVV
PWAYVDYSAKYTITNEIGREVLDKYFELKSKQDKEDTQQKNKDKIEENAESATSSDN
>PK3-2_02791 Phosphate-binding protein PstS 1
MKKNKLVLMLLMAAFMIIAAACGNAGESEKSNSDSAKGEGKASGSLTISGSSAMQPLVLA
AAEKFMEENPDADIQVQAGGSGTGLSQVSEGAVQIGNSDVFAEEKEGIDAKALVDHQVAV
VGMAAAVNPDAGVKDISKDELKKIFTGKIKNWKELGGKDQKITLVNRPDSSGTRATFVKY
ALDGEEPAEGVTEDSSNTVKKIIADTPGAIGYLAFSYLTDDKVTALSIDGVKPEAKNVAT
GEYPIWAYQHSYTKGEATDLAKEFLDYLKSEDIQKSIVTDQGYIPVTDMKVTRDANGKQS
>PK3-2_02792 hypothetical protein
MINNRENMSVSERLISSRQNRQLDEVRGRMIVTACALIMIAASVAITIFLGVKGLQSFLV
NGVSPIEFLTSLNWNPTDTDPKYGVLPFIFGSFAVTILSALIAAPLGIAGAIFMTEIAPN
WGKKVLQPVIELLVGIPSVVYGFIGLTVLVPFIAQFKSSGTGHSLLAGTIVLSVMILPTI
TSISADAMASLPKSLREGSYALGATRWQTIRKVLVPAAFPTLMTAVVLGMARAFGEALAV
QMVIGNTRVLPESLFDTAGTLTTIITLNMGHTTYGSVENNTLWSMGLVLLVMSFLFILLI
RYLSSRRKV
>PK3-2_02793 Phosphate transport system permease protein PstA
MNRKITDKLATGMFGLCAAIIAAILVGLFSYIIINGVSQLSFDFITTKSSAIAAGGGIRD
QLFNSFYILFITMLITIPLGVGGGVFMAEYAPNNKVTDFIRTCIEVLSSLPSIVIGMFGL
LMFVNLTGWGYTIIGGALALTVFNLPVMVRVTEDAIRSVPKDLKEASLALGVSRWHTVKT
VLIPSAIPSIITGAILASGRVFGEAAALLFTAGLTTPRLNFTEWNPFSETSPLNIFRPAE
TLAVHIWNVNTQGMIPDAEAIANGGSAVLVISVLVFNLAARWLGTMIYKKLTAN
>PK3-2_02794 Phosphate import ATP-binding protein PstB 3
MSGQMVKEKPERAVFVPQQRHVIEVKDLSIFYGNKQAVHHVNMDIEKNAVTALIGPSGCG
KSTFLRNINRMNDLIPSARAEGEILYEGLNILGGNINVVSLRREIGMVFQKPNPFPKSIY
ANITHALKYAGERKKAVLDEIVEESLTKAALWDEVKDRLHSSALSLSGGQQQRLCIARTL
AMKPAVLLLDEPASALDPISNAKIEELITELKSEYSIIIVTHNMQQALRVSDRTAFFLNG
ELVEYGQTEQIFTSPKQQKTEDYINGKFG
>PK3-2_02795 Phosphate import ATP-binding protein PstB 3
MSIATEAVMKQEVYEVNGMNLWYGQHHALKNINLSIHENEVTAIIGPSGCGKSTFIKTLN
LMIQMTPNVKLAGELNYNGSNILKDKVDIVDLRKNIGMVFQKGNPFPQSIFDNAAYGPRV
HGTKNKKKLQDIVEKSLKDVALWDEVKDRLHSSALSLSGGQQQRLCIARALATNPDILLM
DEPTSALDPISTRKIEELILELKNKYTIVIVTHNMQQAARVSDQTAFFYMGELVECDNTN
KMFSNPQDQRTLDYITGKFG
>PK3-2_02796 Endolytic murein transglycosylase
MTKRGIQAFAGGIILATAVLAAVFYLTDEDQAAAVKENKTVTEQDVNNYLDSKKMVSVNR
DEYQKLLDSKEKSLTNDSSSETKTDKVKTYKLKIKDGMSTADVSAILEKEGIISSAQDFN
DYVIDAGYHKEIRAGEFKVKSDMSFKKIVKTLTR
>PK3-2_02797 hypothetical protein
MEIAIIALFIVSIALIAFSYSQRDPMKDVEQELETLQLSAMQEIYKLKKKMTVLEEELLE
TNLVIRKSKHSDINQKIAKQILSKYNNGMSAEAIAKAEHVSVEDVNTIIKDNEKVLV
>PK3-2_02798 hypothetical protein
MDKRPFLYNIRHRLSFFRDTFDMIIQNAHTLTVRWEISEETMRLAEAVLFEKPQDMIKEL
RIVIKRKGIEAVRTKRTTYHKGEWTIRQAAGDAVYRAEYKIVNSMNVSLILTDTENIYLA
ENGVSDINSFQHEGATAKWEKQFSAYTCYGRGEKER
>PK3-2_02799 Alpha-maltose-1-phosphate synthase
MNILMLSFEHPYDPKSGLGVHLNRLISNLNPHINITVFTPSGRLFSYAQFEDFIADANFT
MVQHVLPCNERFDLIHAHDDMTAPAAHYLKERLGLPLAATIHGLESERKKACNEAPHPYR
QQTERLLIESADELIVLSTFMKRALDQAARKKVTVIPSPASMEEEKGEIPRSMNRRFLFS
FGRFVPEKGFSQLLKVFAILRRRQPDLHLVLAGEGPSLSSYEKLAASLNLKERVIFLPFL
HRRDIREFLSQCEMAVFPSFYEPFGLAAQESMEQGVLTAVSQSGGFCDYAVHEKTAVTVD
FTRAQEAADLLDRLLKDREKAHRIKESGRQQVIKLHNPRLITESYLQLYKRVINNSTIH
>PK3-2_02800 50S ribosomal protein L33 1
MRVNITLACTECGERNYISKKNKRNNPDRVEFKKYCPRDKKSTLHRETK
>PK3-2_02801 putative protein YqgN
MKSQLRKKTMEALSAISSEELLQKTARMYRHLFSLPEWKSASTIAVTNSRGLEIPTRPVI
EQAWEEGKQVCIPKCDPETKNMQFRTYQTADQLEIVYAGLLEPMIKKTKEVKPSQIDLMI
VPGVCFDTDGFRIGFGGGYYDRYLSDYKGKTASLLLECQLFTHVPRQPHDIPVHKLITED
RIMSCFS
>PK3-2_02802 hypothetical protein
MKKLLIYAIFAVSAVMFYQNRYRLMNTVLSQPGLRRSFIHFFLRIPFIRNKFIQQAF
>PK3-2_02803 Rhomboid protease GluP
MYLLDYTYWKIAAHLVNSGYGVIQAGESDEIWLEAPDKSSHDLVRLYKHDIDFRQEMVRD
IKEQAERVERIRTSLGKRQLKLLNVFFSADAPVDDWEEIAEKPFEKGPVSVEPAIVRGTM
LRDDLQAVFPSFHAEDRDSFEDAQMARERFLSLVLRQEAQRQKEAAVFQNGKPIFTYVFI
ALQVLMFFLLELNGGSTNTETLVAFGAKENSLIAAGEWWRLLTPIVLHIGIAHLAFNTLA
LWSVGTAVERMYGSGRFLLIYLAAGVTGSIASFVFSPYPSAGASGAIFGCLGALLYVALS
NRKMFLKTIGTNIIVIIIINLGFGFAVSNIDNSGHIGGLIGGFFAAAALGLPKAGALGKR
ALSAVLLIALAAGFLYYGLHSPSHQESALIQQANKLYQEGKYEEVTELLNGEAEQKDASA
DLLKILAVSDLQIGEYEQAASLLERAVKKEPKDHASYYYLALLYAEKNELAQAEKAIKSA
LKLKPKEQRYKELQQQIENNKES
>PK3-2_02804 putative protein YqgQ
MVRKMNTFYDVQQLLKKFGHIVYFGDRELEIEFMLDELKELYMNHMIEKEQWAKAAAVLR
KELEQTKKRKRFM
>PK3-2_02805 Glucokinase
MDEIWFAGIDLGGTTIKLAFINQYGEIQHKWEVPTDKTGDTITVTIAKTIDSKLDELQKP
KHIIKYIGMGAPGPVDMAAGVVYETVNLGWKNYALKNHLETETGIPAVIENDANIAALGE
MWKGAGDGAKDVILVTLGTGVGGGIIVNGEIVHGINGAGGEIGHICSIPEGGAPCNCGKT
GCIETIASATGIVRIAKEKLANAKQTTRLKATEQLSARDVFEAAGENDEIALEVVDYVAK
HLGLVLGNLASSLNPSKIVLGGGVSRAGELLRSKVEKTFRKCAFPRAAEAADISIAALGN
DAGVIGGAWIAKNEWLKQQNC
>PK3-2_02806 Lipoteichoic acid synthase 1
MRKTFFSKISFMLIAILLMWLKTYAVYKTSFHIKIDNLTQEFILFINPLSFLLLIFGLGL
FLKGKNRNRYIIAMSCLVTFVLLANMVFYRFYNDFLTIPVLFQTSNMGDLGSSIGTLLEP
TDLLLAVDIAVLIWLHIRQKAFHSDIPSTKNERAAYFLFVASVYFFNLGLSEAERPQLLT
RSFDREMLVKNISLFNFHIYDGVLQSKQSAQRALADSNSLTEIENYVTANAKDANKSLFG
AAKGRNVILVSLESTQSFVINEKVNGEEITPFLNDFIKQSYNFNNVYHQTGQGKTSDSEF
IVDNSLYPLGRGAVFFTNAGNQYMAAPEILKNNGYYSAVLHANNKSFWNRDLMYDSFGYD
SFFDINSYDVTDKNSVGWGLKDKEFFEQSSELMKNLPQPFYSRLITLTNHFPFDLDEEDQ
LIDEYDSSSQTLNKYFPTVRYQDEALKRFIEKLKEDGLYDNSIIVLYGDHYGISENHNEA
MGQFLGKEITPFEEVQLQKVPLVIHIPGMTDKKPQTIEKVGGQIDIRPTLMNLLGIDTKD
HIQFGNDLLSNEKLDFTVLRDGSFITDQVVYTDGACYDKETGQPLKEAKQCEAFADKAKQ
ELSLSDEIIYGDLLRFYDQKRLDHSSKRKEKQMLDQAS
>PK3-2_02807 hypothetical protein
MAFITVKPEIKHNLARMVRELKIDEELLRIANRFAQKHQLYCPGYVIEEHNDKEFQTIQD
IKSFLQPRQLDLSDNWVEQEKIYDHSAVQKEIKKSLMCFRLSHVGKSVVQYSAGQSGS
>PK3-2_02808 Gamma-D-glutamyl-L-diamino acid endopeptidase 1
MNASFHANEWITTSVLLKWFKEYCMSLCCNSSFFGFSPMELFSRTSLSLVPLVNPDGVDL
VLNGTEGMEARKDELERLNDHRPNFNEWKANINGVDLNKQFPSLWEIEKYRKPTVPSYRD
FPGTSPLTEPESIAMYRLISENPPDRLLALHTQGEEIYWGYKGLEPEESAAVVKDFEKVS
GNIYKGIRDIDSYAGFRDWYIHHYFKEGYTVELGKGQNPLPFQQFSHIYNATNGILWRAL
FFHE
>PK3-2_02809 hypothetical protein
MRSVCFILLSALLFSLSACEPSHQQQQQASAAKDEEKDIIPLSAEKADGAEGWINDSTIL
YTASDPTKTKLYAYRIFTGKAKKLYQTDGQIVDVQINPRKQMILLQITHSHKTAVVLLNA
KGEPLYQKDYETYELEAAWNQYDPYQIMVTVFSENWDFHTYQVDAKKDESFLSPVQVPFI
HWTSKNTFVYVKEGRDDKSGPLYTFDTASKAEQKLEDDVFYFDSFHQMSFTVKQASGEKG
TYQFKTPQTKSPVTAEWSLQMKYTSLAPMEYDYDEAEGLFYTFKQIGDAYKLATVNVATG
KAKDLFSLPRMEPIQISPNGKYALYGFHFEQIILLKSHETKQLIIDQKEME
>PK3-2_02810 hypothetical protein
MAIADVTIIPIGTETPSVSAYVADVQKILEGYKAEGKIKYQLTPMNTLIEGELSDLFTVI
QAIHEAPFQKGLHRVATNIRIDDRRDKKTTLESKIESVNKHLQQ
>PK3-2_02811 hypothetical protein
MLLVVIFGLVALFALWGVLRSVKNRNILGFLLAGATLFVFGWFTVMTVINSGYPTAH
>PK3-2_02812 putative metallo-hydrolase
MKWRRMPVGPIQANAYFLISDDQCLIFDPGGEGNKINQYIKEKGLTPLAILLTHAHFDHI
GALDEVREKWDIPVYLHQNEKKWLTDASLNGSGMLRGIEVTAKPADHLIEGDGELNIGPF
HLETLFTPGHSPGSVSYYVKDADLVISGDVLFQGGIGRTDLIGGDQETLLTSIHEKLLTL
PEHTLVLSGHGPETDVQTEQDQNPFLNGFSL
>PK3-2_02813 hypothetical protein
MNRMFRVLGFWTGIFAVMFYLGDMKDASLLFFGQTILFVFLSYLNLTERMYIYIFGAYLT
IFFAGFTYYSIFIMTPGGGGH
>PK3-2_02814 Regulatory protein MgsR
MEQIIFYSYPSCTSCRKTKHWLKAHQIEFNERHLFRETPTIEELKYILSLTTEGIDEILA
TRSQTFKNLNLNIEEMTVNEVLELLIEKPKLLRRPILVDNRKLVIGYNPGELLKLSKKKT
VHQSA
>PK3-2_02816 RsbT co-antagonist protein RsbRD
MIALDQHVTEHKEDIIKQWLETCTSKGSWRHSAKDQKKLEQKLKDQHEALVTIVAKSLRK
AEDVKDELNRWSLQCARDRAVHEVTVTKSVGQFNAFRQIMFEWIQKFSEASSQEISIRDI
YEWSRILNQTIDEIIEVFTEEYHQVTMIQLNAQKEMINELSAPIMPISNGIGILPLVGEI
DTYRARTILESVLQQCSALKLSYLFLDISGVPIVDTMVAYQIFKVIDSTKLLGIETIISG
IRPEIAQTVVKLGLDFSNVKTEQSLAKALANKGFKIEEC
>PK3-2_02817 hypothetical protein
MEFVNLLAVAILILLTGFFVAVEFSIVKVRRSRIDQLVAKGKKGAKAAKHVITHLDEYLS
ACQLGITVAALGLGWLGEPTVQTLLRPFFHKAGLNESLTHLLSLVIAFLAVTYLNVVIGE
LAPKSFAIQKAETITLMFAKPLIWFYKIMFPFIWLLNHSARLITGAFGLKPASEHELAYT
EEELRVLLAESYKSGEIRKSELKYMNNIFTFDKRMAKEIMVPRNEMVSLSLDEDSIPNLR
ETVKQTKYTRYPVVREDKDNVIGVINMKEVLFSMLTKDFSLEKQQIEPFIQPVIHVIETI
PIYKLLLKMQKERTHMAILIDEYGGTSGLVTVEDIVEEIVGEIRDEFDADEVPHIRELGK
DHYLLNAKLLISDVNNLLGTDLSDAEVDTLGGWFLTQNIDAEPESVVDDDGYSFKVKDID
SHHILFIEVKKAE
>PK3-2_02818 Magnesium transport protein CorA
MKAHTGKDWFWYQMGPQERNKARDLIHFSHWPQCEKWFENNHHINFLRVDTTETENEAVF
GSIVYDQGLGEEKDHTVFHFYITRQYFFTINFDFSILKGIKGKQVIQQMERADSTMEGFL
ILLGELMNAYLIGLDEFEVKLRKLRWQIKDDNSKSILNRVHLLHHELMVWKNLILSTKKI
EMALKETFLPQNEGKKVYQRIQLKIDRGFTYISEFEGELNSLLHSEEVITSHRGNEIFKA
LTIFTTLFTPVTALGALWGMNFSVMPELNWKYGYLFSLLLILTSTVLIYLYLKKKGWTGD
MLQERKKKKKTRKRRTL
>PK3-2_02819 Hypoxic response protein 1
MKIRDIMTKNVECCDPTASITELAKKMRDSNVGSIPICENGTLQGIVSDRDIVTRCLAEN
QMDAKASDIMSADIVSGHLDMSAEEAGQLMAERQIRRLPILENGRIAGIVALGDLSVEKD
TDQKAGEALSEISKSA
>PK3-2_02820 ComG operon protein 1
MDSIEKISRTLIEEAYITKASDIHIVPRERDAIIHFRVDHALLKKRNMKKEECVRLISHF
KFLSAMDIGERRKPQSGSLTLKLEEGNVHLRMSTLPTINEESLVIRVMPQYNIPSIDRLS
LFPKTGATLLSFLKHSHGMLIFTGPTGSGKTTTLYSLVQYAKKHFNRNIVTLEDPVETRD
EDVLQVQVNEKAGVTYSAGLKAILRHDPDMIILGEIRDAETAKIAVRAAMTGHLVLTSLH
TRDAKGAIYRLLEFGINMNEIEQTLIAIAAQRLVDLACPFCESGCSSVYCRQSRNTRRAS
VYELLYGKNLQQCIQEAKGNHANYQYQTLRQIIRKGIALGYLTTNNYDRWVYHETD
>PK3-2_02821 Type II secretion system protein F
MKQIRKTWPLKDQAQLLKRLGEMTAGGYTLLDGLRLMELQMNKRQVDDLADAITRLREGA
PFYQVLKSLSFHKEAVGICYFAETHGELPASMMQSGELLERKIAQADQLKRVLRYPLFLI
FTVAIMFYMLQSIIIPQFSGIYQSMNMETSRSTDMLFAFFQHIDLVIMLLALFAAGSGLY
YWLVFKKKSPARQMLIFVRIPLIGNLVRLFNSYFFSLQLSSLLKSGLSIYDSLNAFKHQT
FLPFYRCEAEQVIERLKAGESIEAAICENPFYETDFSKVISHGQLSGRLDRELFTYSQFI
LQRLEHKAQKWTGILQPMIYGFVAAMILIVYLSMLLPMYQMMNQM
>PK3-2_02822 ComG operon protein 3
MNEKGFTLVEMLIVLFIISILLLITIPNVTKHNQTIQKKGCEGLQNMIKAQMTAFELDHE
GQTPSLADLQSEGYVKKDAVCPNGKRIIISGGEVKVEH
>PK3-2_02823 hypothetical protein
MNIKLNEEKGFTLLESLLVLSLASILLIAVFTTLPPVYANTSVRQAAWQLKNDIMLAQQT
AMSSHQRTKILFQRNNYQLVMGNMVVERPFALGLSIEPQTLKDRLEFNEKGHPNTGGKIR
VKGQAAYDITVYLGSGRVNVERK
>PK3-2_02824 hypothetical protein
MWRENKGFSTIETMSALSLWLFLLLSVIPLWDKLLADENMTESREIGYQMMNESISKYMM
TGDEPASKTVTNNHISYALEWEEEGEYQNACISAAVYKEQPFCLSILRTDWLYAS
>PK3-2_02825 ComG operon protein 7
MYRTKGFIYPAVLFVSALVLLIVNFTAVQYVSRCLFEKETKEFYTGENLLQNGALLSIRH
VLEQRKGQKGSQQFAYGQVSYRIHDTSIKEQKEISLQARTESGIERTALIVFDQKQKKLL
SWTE
>PK3-2_02826 hypothetical protein
MKTNDYVKYMTQQLVKYIDTPRDERKERKEVRKETKTPASQQWFGILPYGFRLWLKRKK
>PK3-2_02827 putative protein YqzG
MMIKQCVICLSLLVFGTAAAHAEEAPLVTARHMSKWEELAVKEAKKRYPLAQVLFKQKVW
DRKRNDEAVKQYHLTLREGSKEFGVFVTISFDPYSQKVNKIAILEEYQ
>PK3-2_02828 TasA anchoring/assembly protein
MFRLFRKQQQAKTKLKFLLIFQLSVILSLTAAICLQLSDDTSAAFHDIETFDVSFQTCTD
FQHTDKNCHYDKRWDRSDLHLSDQTDTKGTVCSPIALFAELENTGEKLRKSKWKWELHKL
KNVRKPLKDGNVIEKGFVSNQIGDSLYKIETKKKMKPGIYAFKVYKPAGYPADGSTFEWS
EPMTLAKCNEKPTVPKEAKTAVKKEKETPQKDIQEKSNKEKTSQEAVSEEKQTQSVQKES
GEEDEKSNEADQ
>PK3-2_02829 Signal peptidase I W
MKLISNILYVIIFTLIIVLTLIVISTRSSGGEPAVFGYTLKSVLSGSMEPEFNTGSLILV
KEITDVKELQKGDVITFMQDANTAVTHRIVDVTKQGDHLLFKTKGDNNAAADSALVSDEN
VRAQYTGFQLPYAGYMLHFASQPIGTAVLLIVPGVMLLVYAFVTITSAIREIERKTKALE
TDTKDRTMST
>PK3-2_02830 Major biofilm matrix component
MGMKKKLSLGVASAALGLALVGGGTWAAFNDIKSTDATFASGTLDLSAKENSASVNLSNL
KPGDKLTKDFQFENNGSLAIKEVLMALNYGEFKANGGSNTSAEDFLSQFEVTLLTVGKEG
GNGYPKNIILDDANLKDLYLMSAKNDTAAAEKIKKQIDPKFLHASGKVNVATIDGKTAPE
YDGVPKTPTDFDQVQMEIQFKDDKTKDDNGLMVQNKYQGNAIQLQFSFEATQWNGLTIKK
EHTDKDGYIKENEKAHSEDKN
>PK3-2_02831 HTH-type transcriptional regulator SinR
MTLIGQRIKQYRKEKGYSLSELAEKAGVAKSYLSSIERNLQTNPSIQFLEKVSAVLDVSV
HTLLDEKHETEYDGQLDSEWEKLVRDAMTSGVSKKQFREFLDYQKWRKSQKEE
>PK3-2_02832 Protein SinI
MKNAKQEHFELDQEWVELMMKAKEANISPEEIRKYLLLNKKSAHPDPATRSHTVNPF
>PK3-2_02833 hypothetical protein
MRQQEVHDFLLRFFQANSCQIVDQGSGYMTVQLTVEMDKQIMNRPFYWHWREKTGGDPNP
MKITFITDKETAPKDLDGEFIYFGAPRLFQIFKAVKQNGRFTRMYEKIKSAGAKVPLQPW
LGINVTISYQSDMKKDKLLSLGLHLVSGTIIEDFQTKLTQLSLTSQICDYCFTISPMIKP
ESGLKRMENYIAKSAMQEPSDWAEQAVNRWKNDMTLLDKFYEHIEDKPEEYHLEKQALKA
LYQPKISVGIENGGLFYLQNNMSI
>PK3-2_02834 RNA polymerase-associated protein RapA
MNAEMIYDAKWPQEFAERLKNDGPWANWELYKLSAEIQKTLAIPEFEGLRAPLYLPSFTP
LPHQLEVAQKVVEKMNGKAILADEVGLGKTVEAGLILKEYMIRGLAKKILILVPASLVSQ
WVKELQEKFLIPAVEQKKSYVWEQCDIVVSSIDTAKRSPHREIVLSIPYDLVIIDEAHKL
KNSKTKNYEFVRNLVKKYCLLLTATPIQNRIEEIFNLVSLLKPGHLGSQNHFQEEFAKKK
SSLEAHEHLKDLVNKVMIRNRRHDTGLNWKQRYVETVPIEFSPSEQALYDEISSLKEGVN
KPASMFSIMTLQRECCSSREAVYMTLKKMLDQKEKQAPAIDEHTISVLIDRINQVTQNSK
ALQVVDLIKKIDDKVIIFTEYRATQIYLQWFLQQNGISSVPFRGGFKRGKKDWMKDLFRG
KIQVLIATEAGGEGINLQFCNHMINYDLPWNPMRLEQRIGRIHRLGQERDVHIYNMATKH
TVEEHILKLLYEKIHLFEKVVGELDDILTKIQVNNFEEHLHDILYHSATEEEMKIKMDNL
TSFLSYKKQQPAEKRGS
>PK3-2_02836 Aminomethyltransferase
MPKRTPLFELYKEYGGKTIDFGGWELPVQFSSIKKEHEAVRTAAGLFDVSHMGEIEVSGN
DSLSFLQRLMTNDVSALTPGRSLYTAMCYPDGGTVDDLLVYQKEENRYLLVINASNIDKD
LAWMKEHAAGDVQIDNQSEHIALLAVQGPKAEAIFKKLTASDVSALKPFAFIDEADIGGC
KALISRTGYTGEDGFEIYCRAHDAVYLWKQILDAGEAHGLIPCGLGARDTLRFEAKLPLY
GQELTRDITPVEAGIGFAVKHKKESDFFGKSVLSEQKENGAKRKLVGLEMIEKGIPRHGY
DVFHNGKSVGKVTTGTQSPTLGKNVGLALVAAEASEIGTVVEVEIRKKLVKAQVVKTPFY
KR
>PK3-2_02837 putative glycine dehydrogenase (decarboxylating) subunit 1
MKHRYLPATEKDKQEMLAAIGVSGINDLFADIPENVRYKKEYQIKKAKSETELTKELTKL
ASKNRDTLQYASFLGAGVYDHYQPVIVDHVISRSEFYTAYTPYQPEISQGELQAIFEFQT
MICELTGMDIANSSMYDGGTALAEAAMLASGHTKKKKIVVSKTVHPESREVLKTYAKGQY
IEVVEVPAADGVTDLDALRQTVCEDTAAVIVQYPNFFGRVEPLKDIEPIAHQGKSMFIVS
ANPLALGLLTPPGKFQADIVVGDAQPFGIPSAYGGPHCGFFAVTKKLMRKAPGRLVGQTE
DENGKRGFVLTLQAREQHIRREKATSNICSNQALNALAASVAMTALGKNGVKDIARQNLL
KASYAKQEAKKAGLTVMFDGPIFNEFVIKLDEPVKAVNQRLLAKGIIGGYDLGLTYPDLD
CHMLIAVTELRTKEEIDALIQELGDRHE
>PK3-2_02838 putative glycine dehydrogenase (decarboxylating) subunit 2
MSNQDQALIFELSREGRIGYSLPELDVPDIELQDLLSDTYIRDEDAELPEVSELDIMRHY
TALSKRNHGVDSGFYPLGSCTMKYNPKINEKIARIPGFAAIHPLQDEDTVQGALELLYDL
SKHLEEITGMDEVTLQPAAGAHGEWTGLMMIRAYHEARGDFKRTKVIVPDSAHGTNPASA
TVAGFETVMVKSNENGLVDLEDLKRAVNEETAALMLTNPNTLGLFEEQITEMADIVHDAG
GKLYYDGANLNAVLSKARPGDMGFDVVHLNLHKTFTGPHGGGGPGSGPVGVKKELIPYLP
IPVLIKKEGRFTFDYDRPHAIGRVKPYYGNFGINVRAYTYIRSMGPDGLKAVTENAVLNA
NYMMRKLAPYYDLPFDRHCKHEFVLSGKRQKKLGVRTLDIAKRLLDFGYHPPTIYFPLNV
EECIMIEPTETESKETLDAFIDAMIQIAKEAEETPELVQEAPHTTIVKRMDETKAARQPV
LRYEKNISGELVK
>PK3-2_02839 Thiosulfate sulfurtransferase GlpE
MSNMIVLIIFAAFIVYMIASYVYQQRIMKTLTEEEFRAGYRKAQLIDVREPNEFEGGHIL
GARNIPLSQLKQRKNEIRPDKPVYLYCQNSVRSGRAAQTLRKNGCTEIYNLKGGFKKWGG
KIKAKN
>PK3-2_02840 Octanoyltransferase LipM
MEKETWWFIDSGNASPAFNMALDEALLYWHSEKKIPPVIRFYGWNPATLSVGYFQNIKKE
INFEAVHKYNLGFVRRPTGGRGVLHDQELTYSVIVSEEHPEMPATVTEAYRVISEGILQG
FRNLGLDAYFAIPRTEKEKESLKNPRSSVCFDAPSWYELVVEGRKVAGSAQTRQKGVILQ
HGSILLDLDEDKLFDLFLYPSERVRERMQRNFKNKAVAINELREKRVTMDEARKAFKEGF
ETGLNIHLEPYELTQEELDFVHHLAERKYASDEWNYKR
>PK3-2_02841 HTH-type transcriptional regulator MntR
MTTPSMEDYIEQIYMLIEEKGYARVSDIAEALAVHPSSVTKMVQKLDKDEYLIYEKYRGL
VLTSKGKKIGKRLVYRHELLEQFLRIIGVDEEKIYNDVEGIEHHLSWNSIDRIGDLVQYF
EEDDARKKDLKSIQKKTEHHNQ
>PK3-2_02842 hypothetical protein
MYIDGVFSGGGVKGIALAGAYEALEEKGFRFKRVAGTSAGAIVAAFIASGYTSKEIHALI
EEVEGEKLLDQRYSFLPLKMLQWVSIYWRLGLYKGDTIEKWIADLLRAKGIRVFGDLQKG
SLRLIASDLTNGTMIVLPDDLVRYGLNPDMFPVARAVRMSCSIPYFFEPIKLKTDTGTAT
VVDGGVLSNFPIWLFSKERKRPVIGVTLAPRERERPKKNIRNAFELFGALFETMKDAHDA
RHIASRYEQNIIFLPVDDVMATDFYLTQQKKLALIELGKRRTEQFLKQWTY
>PK3-2_02843 hypothetical protein
MNHRVQPIIAVLIALGAFGFLYVLVTNPGEMAKMAVTVIVAGIIIYFIVKYVMNRNAGSE
GAAFKKAAKQSRRRMKEQKAKHRAGHKGRASHLRSVPSASKPKPMILKKKSQTQLTVIEG
KKNKKKNRALF
>PK3-2_02844 hypothetical protein
MSKHKIPPAYGGQAVVEGVMFGGKHHYVTAIRRTDGSIDFFKLPRKHNPKLNIVKKIPFL
RGIAAIIEASANGTKHLNFSSERYGLDPSEDETLEQDEKKSSGLSMYLSLAVIGVLSFLF
SKFVFTLVPVFLAELTRPIFSSDTAQIAVESLFKLILLLGYIYFLSMTPLIKRVFQYHGA
EHKVINCYEQNLPITVENVQNQSRLHYRCGSSFILFTIIVGMFVYLLVPTDPLWLRVIDR
VALIPVVLGISFEVLQLTNKVRDIPGLKFLGYPGLWLQLLTTKEPKDDQVEVAIESFNEL
LRLEEISEQNQKPSHSVI
>PK3-2_02845 hypothetical protein
MTSEKDTEQNEELNEKQGTPVSMAGRVAATGFCGGILWSFIAYIAYLFHFSEISPNMILQ
PFVLGDWKKHGLGTVISIILIGIISIGAAFLYFLLLKRLKTMWPGILYGLLLWLLVFFVF
NPIFPDVRTVTELKSDTIITTICIYLLYGLFVGYSISFEYNELNSEKLARALGTHRE
>PK3-2_02846 3-dehydroquinate dehydratase
MPHFLILNGPNVNRLGKREPEVFGRQTLTDIETDLFQFAEALRIQLTFFQSNHEGDLIDA
IHEAEEQYSGIVLNPGALSHYSYAIRDAVASSSLPMVEVHLSNLYAREEFRHQSVIAPVA
KGQIVGLGAEGYKLAVRYLLSQQGGE
>PK3-2_02847 Aminopeptidase YpdF
MKLEKIRNLFGQLGIDGMLITSSTNVRYMTGFTGSAGLAVISGDRAAFITDFRYTEQAKV
QVKGFEIIEHGGSLIQTTADTLEAFGIKRLGFEQNSMTYGTYASYSAVISEAELVPVAES
VEKLRLIKSSEEIKILEEAAKIADDAFRHILTFMKPGISEIAVANELEFYMRSQGADSSS
FDMIVASGLRSSLPHGVASDKLIESGDLVTLDFGAYYKSYCSDITRTVAVGKPSDQLKEM
YQVVFDAQALGVAHIKPGMTGKEADALTRDHIAAKGYGEYFGHSTGHGLGMEVHESPGLS
VRSSAILEPGMVVTVEPGIYIPETGGVRIEDDIVITENGNRTITHSPKELIIL
>PK3-2_02848 Elongation factor P
MISVNDFRTGLTIEVDGGIWRVVDFQHVKPGKGAAFVRSKLRNLRTGAIQEKTFRAGEKV
AKAQIETKTMQYLYANGDQHVFMDTSSYEQLELGAAQIEEELKYLLENMSVHIMMYQDET
LGIELPNTVELKVVETEPGIKGDTASGGTKPAKTETGLVVNVPFFVNEGDTLVVNTSDGS
YVSRA
>PK3-2_02849 hypothetical protein
MKFLLGNINSTVLTMAGLRVLSSMIELTAAIIMLVTNDVRKAVVVNSILAIVGPLIFIIT
MTVGIYQIAGQLSYAKLILIFTGVVLILAGVHK
>PK3-2_02850 hypothetical protein
MKEIAEVLPESMKNALSEIPEHQRLEIEEIRIRVNRPVELIRKGQPVFLTYAGTVEDAHL
ILSRLSNYSMYTLEEELKKGYVTIRGGHRVGLAGRVITENGGVKGLRDITSFNIRIAREK
LGIAEPLLPYLYQESWLNTLVIGPPQTGKTTLLRDLARLSSTGKNRMSPVKTGIIDERSE
IAGCLRGIPQHQFGQRVDVLDACPKAEGLMMMIRSMSPEVIIVDEIGRMEDTDALLEALH
AGVSVIVSAHGWSISDLMKRPSLKRLWEERAFDRYLELSRAKGPGTVSRIYDKDGNVLSG
TMGVKTC
>PK3-2_02851 Stage III sporulation protein AB
MLKLLGAVFIVVATTWTGFEVAKIYTERPRQIRQLRAALQSLEAEIMYGHTPLHTASQQI
AKQLAQPVSALFITFSDQLEKGSDSAKTAWEQSLKKVWDTMSLKKNEYEVLKQFGETLGI
HDRISQQKHIKLALTHLEALEADAEQAQAKNEKMIKSLGFLAGLLLILLLM
>PK3-2_02852 hypothetical protein
MGVDVNVIFQIAGVGIVVAFLHTILDQMGKKEYAQWVTLLGFIYILFMVATIVDDLFKKI
KAVFLFQG
>PK3-2_02853 hypothetical protein
MQIDIVQIVGLGLIATFLSLIVKEQKPTFAFLIVVFAGCAIFLYLVDQIYDIIRMIEKIA
INANVNMVYVETILKIIGIAYIAEFGAQLTKDAGQGAIASKIELAGKILILVMAVPILTV
IIETILGLIPSMS
>PK3-2_02854 Stage III sporulation protein AE
MKRFYWALLLAVLIIAGRADIVQATGDTEQTEDHAETAEQLAERTAASLETDKIGEFWND
IMTEYGGLLPESQKGSLIEFINGDKSFSAQEWLKALFSYLFHEVLANGKLLGTLILLTIF
CVILQLLQNAFQQSTVSKVAYSIVYMVLIILALNSFHVAINYATEAIQTMTSFILALIPL
LLALLASSGGAVSAAFFHPVILFLMNTSGLLIQNIVMPLIFLSAILSIVSTMTEQYKVTQ
LANLLRNIAIGALAVFLTIFLGVISVQGASAAVTDGITLRTAKFITGNFIPVLGRMFTDA
TDTVISASLLLKNTVGILGVAILICIAAFPAIKVLSLAFIYKLAAAILQPLGGGPVITCL
DVISKSVIYIFAALAIVSLMFFLSLTVIITAGNLTMMMK
>PK3-2_02855 Stage III sporulation protein AF
MSFLTEWLTTIVLFILFAIVIDMLLPSSSMQKYAKMVVSLLLIVVMLTPIFKLFNTDPEV
IFEYLTKNGQSESADIKNQVDSKKIEIQASQRAYILEEMAVQLKKKAEERFSHDEYKVGS
IKLTAGEKVDSEEDIKTIRVYMAPSSEKTVQTVAPVNIDTDHAYVTKEAAEQKEAKQIQT
QLADIWEIGSEKITVHMEGGESVGNE
>PK3-2_02856 hypothetical protein
MNKNGLWNVLKKQFLPGRTKDGEKPKLTKYHYFLFVFVLGVSFMLVSQLFSSPEKTENAK
MTTAVTSQVSADSKEKTAEVFKASKSDKPKDSIDDYEKEYENQLKEILETIIGVDDVSVV
VNVDATSLKVYEKNKSNKNTTTEETDKEGGTRSVTDQTSEEEIVMIKNGDKETPVVVQTK
KPDIRGVLVVAQGVDNVQIKQTIIEAVTRVLDVPSHRVAVAPKKIKEDS
>PK3-2_02857 Stage III sporulation protein AH
MLKKQTVWLLTMLSLVVVLSVYYIMSPESKNAVQMKSEKSASDSGEVATEKAPAKQDTKE
KSGTESETEKEDGTKGTKDSSADKETSAEASEKGTVVTETADDDLFTTYRLDLEDARSKE
REELNAIVSSDDATAKEKSEAYDKMTALSEVEGTEKQLETLIKTQGYEDALVNAEGDKIN
ITVKADKHSKSKATAIIDLVAKEIKTMKDVAVTFEPSK
>PK3-2_02858 Biotin carboxyl carrier protein of acetyl-CoA carboxylase
MLNIKEIHELIKAIDESTIDEFVYENEGVSLKLKKHETGTVQVMQQAPAAPVQVQAPQAV
QPQAQAAPAQEAPKQDENLHKITSPMVGTFYASSSPESGPYVTAGSKVNENTVVCIVEAM
KLFNEIEAEVKGEIVEVLVENGQLVEYGQPLFLVKAE
>PK3-2_02859 Biotin carboxylase
MIKKLLIANRGEIAVRIIRACRELGIETVAVYSEADKDALHVQMADEAFCIGPKASKDSY
LNVTNIVSVAKLTGTDAIHPGYGFLAENADFAELCEEVNVTFVGPSADAISKMGTKDVAR
ETMKQAGVPIVPGSQGIIENVEEAVSLANEIGYPVIIKATAGGGGKGIRVARTEEELIKG
IKITQQEAATAFGNPGVYIEKYIEDFRHVEIQVLADNYGNTIHLGERDCSIQRRLQKLLE
ESPSPALDSEIREQMGDAAVKAAKAVGYTGAGTVEFIYDYKEQRYYFMEMNTRIQVEHPV
TEMVTGTDLIKEQIKVASGMELSLKQEDVEFEGWSIECRINAENPSKNFMPSPGEIKMYL
PPGGLGVRVDSAAYPGYSIPPYYDSMIAKVITYGKTRDEAIARMKRALSEFVIEGIETTI
PFHLKLLEHETFVSGEFNTKFLETYDVMGS
>PK3-2_02860 hypothetical protein
MKDNSLLKMDQEDTHLGKVEIAPEVIEVIAGIAASEVDGVAEMRGNFATGVVERFGKVNH
GKGVKVDLADDGITIDVYCVVTFGVSIPKVAASVQENIRQTLLNMTSLSINEINIHIVGI
QFDTKAQEVQIDEEM
>PK3-2_02861 Transcription antitermination protein NusB
MKRRTAREKALQALFQIDVSDIAVNEAIEHALDEEKTDPFFEQLVHGVLEHQVQLDEMIS
KHLVNWKLDRIANVDRAILRLAVYEMAYAEDIPVNVSMNEAIELAKRFGDDKATKFVNGV
LSNIKSDIEQS
>PK3-2_02862 Bifunctional protein FolD protein
MTATIIDGKETAREKREQLAKEVEELKKQGVTPGLAVILIGDDPASHSYVRGKKKAAETM
GMNFKLDQFDSSLTEAELLSIIDQYNQDPEFHGILVQLPLPDHISEKAVIERISPDKDVD
GFHPLNVGKMLLGEDTFLPCTPHGIVELLKKTNIDLSGKEVVVVGRSNIVGKPVGQLLLN
ENATVTYCHSRTENITEHTKKADILVVAVGRANFISADQIKEGAVVIDVGVNRLESGKLC
GDVEFEGAKEKASFITPVPGGVGPMTITMLAHNTVKSAKRTLS
>PK3-2_02863 Exodeoxyribonuclease 7 large subunit
MGETAYVTVSALTKYIKRKFDVDPHLENIWIKGELSNVKIHTRGHIYFTLKDENARMQSV
MFARQSERLPFKPENGMKVLVRGGISVYEPSGNYQLYAKEMQPDGVGALYLAYEELKKKL
AGEGLFDDRYKKQIPAFPATIGVVTSPTGAAVRDVITTLKRRYPLVKVIVLPALVQGENA
SRSIVRRIEEANEKEMCDVLIVGRGGGSIEELWAFNEEIVARAIFASNIPIISAVGHETD
FTISDFVADIRAATPTGAAEIAVPHTTDLIERTKTAEVRMTRAMQQHLGQKKERIQTLQS
SYAFRFPKRLYAQKEQQFDLAYQQFQAQLTALLDRKNRQLERETYRLEALHPHEQLKQAR
TRYEEQTNQLRKNMNIQMKQLHFQFQTVLGKLNALSPLQVMERGYSLAYKEDELIKSVSQ
IDEKDQLEVKLKDGVLTCEVLEKRGEEK
>PK3-2_02864 Exodeoxyribonuclease 7 small subunit
MTDVKKNENMTFEEAMKGLESIVSKLEEGDVPLEQAINYFQEGMALSKMCHEKLQKVEKQ
MDFILKEDGELAPFSVQEEDEGDK
>PK3-2_02865 Farnesyl diphosphate synthase
MTNNLTSFLAERKKTIEKQLSVYTEKLDMPDSLKKSMLYSLEAGGKRLRPLIVLAVLNAY
GKSEKDGIPVGCAVEMIHTYSLIHDDLPCMDDDDLRRGKPTNHKVFGEATAVLAGDGLLT
ESFKLITSHVSDEVSAEKRLRLVNELISAAGTEGMVGGQVADMEAENRQVTLEELESIHE
RKTAKLLGFCVIAGAILADAPEKDIETLRAFSSHIGIGFQIRDDILDLEGSEEKIGKRVG
SDTTNDKSTYPSLLSLEGAKHKLDAHIKEAKRLIGGLSLQKDLLYELCDLIAARDH
>PK3-2_02866 1-deoxy-D-xylulose-5-phosphate synthase
MDLLSIQDPSFLKNMSIDELEKLSDEIRQFLITTLSASGGHIGPNLGVVELTVALHKEFN
SPKDKFLWDVGHQSYVHKLLTGRGKEFATLRQYKGLCGFPKRSESEHDVWETGHSSTSLS
GAMGMAAARDIKGTDEFIIPIIGDGALTGGMALEALNHIGDEKKDMIVILNDNEMSIAPN
VGAIHSMLGRLRTAGKYQWVKDELEYLFKKIPAVGGKLAATAERVKDSLKYMLVSGMFFE
ELGFTYLGPVDGHSYHELIENLQYAKKTKGPVLLHVITKKGKGYKPAETDTIGTWHGTGP
YKINTGDFVKPKAAAPSWSGLVSGTVQRMAREDGRIVAITPAMPVGSKLEGFAKEFPDRM
FDVGIAEQHAATMAAAMAMQGMKPFLAIYSTFLQRAYDQVLHDICRQNANVFIGIDRAGL
VGADGETHQGVFDIAFMRHIPNMVLMMPKDENEGQHMVHTALSYDEGPIAMRFPRGNGLG
VKMDEQLKTIPLGTWEVLRPGNDAVILTFGTTIEMALEAAEELQKEGLSVRVVNARFIKP
IDEKMMKDILKEGLPILTIEEAVLEGGFGSSILEFAHDQGEYHTPIDRMGIPDRFIEHGN
VTALLEEIGLTKQQTANRIRLMMPPKTHKGIGS
>PK3-2_02867 Hemolysin A
MTSKKERLDVLLVEKGLAETREKAKRAIMAGIVYSNENRLDKPGEKIDRDLPLTVKGNPL
KYVSRGGLKLEKALKEFPISVKDKIMIDIGSSTGGFTDCALQNGAKQSYAVDVGYNQLAW
KLRQDERVVVMERTNFRYATPADFTKGMPEFATIDVSFISLRLILPVLKTLLVPDSDCMA
LVKPQFEAGRESVGKKGIVRDPQVHADVLKRMISFSAAEGYICQGLSFSPITGGDGNIEF
LLHLHWPGEGQEGQELSEEEIIRIVGEAHKTLKEKKADVPE
>PK3-2_02868 Arginine repressor
MNKGQRHIKIREIITSNEIETQDELVDMLKQDGYKVTQATVSRDIKELHLVKVPTNNGSY
KYSLPADQRFNPLSKLKRALMDAFVKIDSASHMIVLKTMPGNAQAIGALMDNLDWDEIMG
TICGDDTILIICRTPEDTDGVKNRLLELL
>PK3-2_02869 DNA repair protein RecN
MLAELSIKNFAIIEELTVSFERGLTVLTGETGAGKSIIIDAISLLVGGRGSSEFVRYGEA
KAELEGLFLLESGHPVFNVCAEQGIDVSDDMIVMRRDISTSGKSVCRVNGKLVTIASLRE
IGRLLLDIHGQHDNQLLMEDENHLQLLDKFAGAEVESALQAYQEGYQRYMKLLKKLKQLS
ESEQEMAHRLDLIQFQLEEIESAKLELNEDEQLQEERQQISNFEKIYESLQNAYNALRSE
QGGLDWVGMASAQLEDISDINEPLKKLSESVSNSYYLLEDATFQMRNMLDELEYDPERLN
YIETRLNEIKQLKRKYGATVEDILEYASKIEEEIDQIENRDSHLQNVKKELDSVGKDVAV
EAANVSQIRKAWAKKLADEIHRELKSLYMEKSTFDTEFKVRTASHNEEAPVVNGQPVQLS
EQGIDLVKFLISTNTGEPLKSLSKVASGGELSRVMLAIKSIFSSQQDVTSIIFDEVDTGV
SGRVAQAIAEKIHKVSIGSQVLCITHLPQVAAMADTHLYIAKELKDGRTTTHVKPLSKQE
KVAEIGRMIAGVEVTDLTKRHAKELLKQADQVKTTG
>PK3-2_02870 SpoIVB peptidase
MPDNIRKAVGLILLVSLLSVGLCKPLKEYLLIPTQMRVFETQTQAIETGLSVDAHAQESS
EAFTVKKDPHEIKVTGKKSGESELVYDLAGFPIKKTKVQVLPDLKVIPGGQSIGVKLHSV
GVLVVGFHQINTSEGKKSPGETAGIEAGDIIIEMNGQKIEKMNDVAPFIQKAGKTGESLD
LLIKRDKQKIKTKLIPEKDEAEGKYRIGLYIRDSAAGIGTMTFYEPKTKKYGALGHVISD
MDTKKPIVVENGEIVKSTVTSIEKGTGGNPGEKLARFSSERKTIGDINRNSPFGIFGTLH
QPIQNNISDQALPVAFSTEVKKGPAEILTVIDDDKVEKFDIEIVSTTPQKFPATKGMVLK
ITDPRLLKETGGIVQGMSGSPIIQNGKVIGAVTHVFVNDPTSGYGVHIEWMLSEAGIDIY
GKEKAS
>PK3-2_02871 Stage 0 sporulation protein A
MEKIKVCVADDNRELVSLLSEYIEGQEDMEVIGVAYNGQECLSLFKEKDPDVLVLDIIMP
HLDGLAVLERLRESDLKKQPNVIMLTAFGQEDVTKKAVDLGASYFILKPFDMENLVGHIR
QVSGNASSVTHRAPSSQSSIIRSSQPEPKKKNLDASITSIIHEIGVPAHIKGYLYLREAI
SMVYNDIELLGSITKVLYPDIAKKFNTTASRVERAIRHAIEVAWSRGNIDSISSLFGYTV
SMTKAKPTNSEFIAMVADKLRLEHKAS
>PK3-2_02872 hypothetical protein
MFEKYGLLIALFILALCVNSNIITESRLLGILIDFISFTVMVSCVFAAWRIKTKHPESN
>PK3-2_02873 hypothetical protein
MNKGDVRMKKKKARKRDGLLLDVLTEAAGYLLFLPFRFLHKLFD
>PK3-2_02874 putative oxidoreductase
MRIQTKEDDQMNPKYKPLFEPFTFKSGVTIDNRITVAPMTHYASNDDGTISEAELDYIIP
RSKEMGMVITACANVTPDGKAFPGQPAIHDDSNIAGLKKLAQAIQAQGAKAVVQIHHGGT
ECPSELVPQQDVVAPSDVFDNGKKIARALTDEETENIVKAFGEATRRAIEAGFDGVEIHG
ANGYLIQQFYSLKTNQRTDRWGGSDEKRLAFPLAIVDEVKKAIAEHAKGAFLVGYRLSPE
EPETPGLTMTETFTLVDALGDKELDYLHISLMDVNSKARRGADPTRTRMDLLNERVGNKV
PLIAVGSIHSADDALAVIENGIPLVAMGREILVDPDWTVKVKEGREKQIETVIKGTDKEK
YHLPEPLWQAIVNTHGWVPYKD
>PK3-2_02875 hypothetical protein
MKQTVLLLLTVLLLSGCSIASADDSAPRFTEEGKYIGSADPHTIAVSLNGEETMIQVPKD
IRDECESLPDHTNVLVKYIKKDNGTLQLQDIQLQKNSS
>PK3-2_02876 hypothetical protein
MRLLWRSLALCGLALTLAPCAQAAEPIEGKTVYIDAGHGGKDSGAVGNGLFEKDINLAVS
EHGRTS
>PK3-2_02877 N-acetylmuramoyl-L-alanine amidase LytC
MAKASANQADLFVSIHVNSGVASASGTETYFQSDYEAENSRRLAADIQSHLISSLQTRDR
GVKESDFYVITYSQMPSVLAELGFITNSSDADKLGNENYQKKAADAIVNGIDSYYDQ
>PK3-2_02878 Glycerophosphodiester phosphodiesterase
MTKIFAHRGASGQYPENTMLAFEKGIEAGADGIEFDVQLAKDGRIVVIHDERLDRTTSLK
GFVKDTAYDVIKTANAAANHDQTYSDTKVPLLEDVLSWAEKKNFLLNIELKNSVIRYEGM
EEKVLEAVKRFNLEERVILSTFNHESLALCARLAPHIERAALTSDVLYQADRYITSIPAS
GYHPRLNSPGTADEVLKKMRNSSIKVRPYTVNRPEDIKRLIEAGADGIFTDFPAKAAAIA
KK
>PK3-2_02879 Acetyl-CoA acetyltransferase
MRKTVIVSAARTPFGKFGGALKEVKAVELGGIVMKEALHRAGVSGNEAEGNVMGMVVQAG
SGQIPSRQAARLAGMPWSVPSETLNKVCASGLRVVTLCDQMIRAYDADILVAGGMESMSN
TPYAVPAGRWGARMGDGELRDLMVYDGLTCAFDEVHMAVHGNTAAKEYGISRREQDEWAL
RSHVRAAKAADEGKFQDEIVPVSWTGRKGKPNTADKDEAIRRDTSLEQLATLSPIFTSGG
SVTAGNAPGVNDGAGAFVLMSEDKAAELGKRPLATILGFSTMGMQARELAAAPGFAINKL
LKNNDLTVQDIDLFEVNEAFASVVLTCEKIVGFDLEKVNVNGGAIALGHPIGASGARILM
TLVYELKRRGGGLGVAAICSGAAQGDAVLVQVH
>PK3-2_02880 putative 3-hydroxybutyryl-CoA dehydrogenase
MEIKQIMVAGAGQMGTGIAQTAAGAGFYVRMYDVNPETAEAGLKRLKKQLTRDAEKGRKT
DAEVKDVISRVSLSQTLEEAKHADIVIEAIAENMAAKTEMFRKLDHICPSHTILASNTSS
LPITEIAAVTNRPDRVIGMHFMNPVPVMKLVELICGLATSEETALDVKGLAEKMGKTAVE
VNDFPGFVSNRVLLPMINEAIYCVYEGVAKPEAIDEVMKLGMNHPMGPLTLADFIGLDTC
LSIMEVLHSGLGDSKYRPCPLLRKYVKAGWLGKKSGRGFYQYEERTS
>PK3-2_02881 Acyl-CoA dehydrogenase
MHVTQEQVMMRKMVRDFARKEIAPAAEIMEKTDEFPFQLIKKMGEYGLMGIPVPEQYGGA
GADVVSYILAIHEISRISAAVGVILSVHTSVGTNPILYFGNEEQKMKYIPKLASGDHLGA
FALTEPHSGSDAGSLRTTAIKKNGKYLLNGSKIFITNGGAADIYITFALTAPDQGRHGIS
AFIIEKNTPGFTVGKKERKLGLYGSNTTELMFDNAEVPEENLLGKEGDGFHIAMANLNVG
RIGIAAQALGIAEAALDHAVDYAKQRVQFGRPIAANQGISFKLADMATRAEAARHLVYRA
ADLHNRGLACGKEASMAKQFASDSAVKAALDAVQIFGGYGYMKDYPVERLLRDAKVTQIY
EGTNEIQRLIISKHLLGGT
>PK3-2_02882 Citrate/2-methylcitrate synthase
MEEKQHYSPGLDGVIAAETHISYLDTQSSQILIRGYDLIDLSKTKSYLELAHLLLEGRLP
EKSEMETLERSINSASSLPADILRLLELLPEHTHPMDSLRTGLSALAGYDRQIDDRSPSA
NKERAYQLLGKMPALTAASYRIINKKEPILPLQTLSYSANFLYMMTGKLPSSLEERIFDR
SLVLYSEHEMPNSTFAARVIASTQSDLYGALTGAVASLKGNLHGGANEAVMYMLLEAETT
SDFEQLLQTKLKRKEKIMGFGHRVYMKKMDPRALMMKEALQQLCDKAGDHRLYEMCEAGE
RLMEKEKGLYPNLDYYAAPVYWMLGIPIPLYTPVFFSARTSGLCAHVIEQHANNRLFRPR
VSYLGPRQQAKS
>PK3-2_02883 Citrate/2-methylcitrate dehydratase
MLKTDHVIEEITDYVLEKEITSSEAFTTAGHVLLDTLGCGILALRYPECTKLLGPIVPGT
IVPNGSKVPGTSYVLDPVRAAFNIGCMIRWLDYNDTWLAAEWGHPSDNLGGILAAADYVS
RVRLSEGKEPLTVRDVLEMMIKAHEIQGVLALENSLNRVGLDHVLFVKVATAAVATKLLG
GGREEIKNALSNAWIDNAALRTYRHSPNTGSRKSWAAGDATSRGIHLALMALKGEMGYST
ALSAPGWGFQDVLFNKQEIKLARPLDAYVMENVLFKVSYPAEFHAQTAAECAVILHPKVK
GRIDEIDRIVIRTHESAIRIIDKKGPLHNPADRDHCLQYITAIGLLFGDITAQHYEAETA
SDPRIDKLRNKMEVTENKTYTEDYLKADKRSISNAVQVYFKDGTSTEMVECEFPLGHRFR
RDEAVPKLLEKFSANLKTHFADKQHKHIYERCASYETLQTMRVNEFVDMFCM
>PK3-2_02884 2-methylisocitrate lyase
MSWIVNKQSSQEELAGRFRKLMSAPDILQIPGAHDGMAALLAKEAGFSAIYLSGAAYTAS
RGLPDLGINTSTEMADRAKDLVRAADLPLLVDIDTGFGGVLNAARTAREMHEARVAAVQI
EDQQLPKKCGHLNGKQLVPIKEMAQKIKAIKQAAPSLVVVARTDARAQEGLDAAMKRSEA
YIEAGADAIFPEALQAEDEFRQFAKRISVPLLANMTEFGKTPYYRADEFEDMGFRMVIYP
VTSLRAAAKAYERMFGLIKESGSQKEGLHDMQTRKELYDTISYYDYEALDKTIAKTVLPD
E
>PK3-2_02885 hypothetical protein
MSRLLALLILVLPGAISALGIKLMRDTLFGHALQPFGALWLQGLSGFIFFAFGLYVLAGF
ILYRDRKRNQVSPRFRKR
>PK3-2_02886 Anaerobic nitric oxide reductase transcription regulator NorR
MQKVLIVGAGKRGTALLHILIKTAIIEIIAVVDKDPEAPGLKEAEQYGIAVSSDWKPYIQ
QKPDIVIHTTGDQAVFDELLQKKNEDTIVMPGKMAYIVFQLMEEKQHLIQMLKEQTYKHD
RIFNSTHDGMIFIDINEEIILFNHMAEKMVGKKREEVIGRPIKEVIPSTKMPRILKTRVP
EYNQKQLLGDHLQIVTTRLPIIDEGGRLLGALCVFKDITDAVELAEEVTNLKQVRTMLEA
IIQSSDEAISVVDENGIGLLINKAYTKMTGLSEKEVIGKPANTDISEGESMHLKVLETRR
PVRGVRMKVGPNEKEVIVNVAPVIVDGILKGSVGVIHDVSEIKMLTAELNRARQIIRTLE
AKYTFDDIIGKSEQMLVALEQAKIGAKTPATILLRGESGTGKELFAHAIHNESDRKYNKF
IRVNCAALSENLLESELFGYEDGAFSGAKRGGKKGLFEEANNGSIFLDEIGELTQNMQAK
LLRVLQEKEIVRVGGTKAIPVNVRVIAATNVNIEKAMADGTFREDLYYRINRYPISIPPL
RHRLEDIEALSVRLIQKINRDYGRNVKGLSQQALRALSAYHWPGNVRELENVLGRAMIFL
NPHMEWIEKDHLPVFELEQKESVAEQGTGFDFPDIEGEKLSVAVEKFEAHLIQQTLERHH
FNRTKTARALGVSIRNLYYKMDKYGLANEGMQ
>PK3-2_02887 Phosphate acetyltransferase
MKLKDLIGKASMYKNKTIAVAHAEDEEVIRAVKLAAEHLSARFLLVGDSKKLNDLTSSMQ
GHHVEIVHADTPEESAQLAVRAVHLKTADVLMKGNVPTSVLLKAVLNRQEGLRSSSVLSH
VAVFDIPDFDRLMFVTDSAMNIAPSLEELRQILQNAVHVARAVGNNMPKAAALAAVETVN
PKMEATMNAAALAQMCKRGQIKNCIVDGPLALDNAVSQIAAVQKKISGDVAGSADILLVP
TIEAGNILYKSLIYFAKASVAAVITGAKAPIALTSRADSAENKLYSIALAICASEEYTH
>PK3-2_02888 Leucine dehydrogenase
MELFKYMEKYDYEQLVFCQDEQSGLKAIIAIHDTTLGPALGGTRMWTYENEEAAIEDALR
LARGMTYKNAAAGLNLGGGKTVIIGDPRKDKNEEMFRAFGRFIQGLNGRYITAEDVGTTV
EDMDIIHDETDYVTGISPAFGSSGNPSPVTAYGVYRGMKAAAKAAFGTDSLEGKTIAVQG
VGNVAYNLCRHLHEEGANLIVTDINKQSVQRAVEDFGARAVDPEEIYSQDCDIYAPCALG
ATINDNTIKQLKAKVIAGAANNQLKETRHGDQIHEMGIVYAPDYVINAGGVINVADELYG
YNAERALKKVEGIYGNIERVLEISQRDGIPTYLAADRLAEERIERMRRSRSQFLQNGHSV
LSRR
>PK3-2_02889 Butyrate kinase 2
MLHEEKRILTINPGSTSTKIGVFHNERSIFEKTLRHNIEELQRFDHIIDQYEFRKNHILE
TLHEQGINISKFDAVCARGGLLRPIEGGTYEVNDDMIEDLKSGYAGQHASNLGGIIAREI
ADGLNIPSYIVDPVVVDEMSVLAKISGMPEIERKSIFHALNQKAVARKAAASLGKRYENM
KMIITHMGGGITIGVHDRGRVVDVNNGLHGEGPFSPERAGTVPAGDLVDLCFSGRYSKEE
IMKKLVGTGGLFGYLGTNDAVKVEQMIQGGDEKARFIFEAMAYQVAKEIGAASAALKGEV
EAIVLTGGLAYGKSFVSSIRSYIDWISDVLVYPGENELQSLAQGALRVLLGEEQSKQYRI
E
>PK3-2_02890 Dihydrolipoyl dehydrogenase
MATEYDVVILGGGTGGYVAAIRAAQLGLKTAVVEKEKLGGTCLHKGCIPSKALLRSAEVY
RTAREADQFGVETAGVSLNFEKVQQRKQAVVDKLAAGVNHLMKKGKIDVYNGYGRILGPS
IFSPLPGTISVERGNGEENDMLIPKQVIIATGSRPRMLPGLEADGEHVLTSDEALQMEEL
PKSIIIVGGGVIGIEWASMLHDFGVEVTVIEYADRILPTEDQDISKEMENLLKKKGIQFV
TGAKVLPDTMTKTADDISIQAEKDGETVTYTAEKMLVSIGRQANIEGIGIENTDIVTENG
VISVNESCQTKESHIYAIGDVIGGLQLAHVASHEGIIAVEHFVGLNPHPLDPTLVPKCIY
SSPEAASVGLTEDEAKANGHNVKIGKFPFMAIGKALVYGESDGFVKIVADRDTDDILGVH
MIGPHVTDMISEAGLAKVLDATPWEVGQTIHPHPTLSEAIGEAALAADGKAIHF
>PK3-2_02891 2-oxoisovalerate dehydrogenase subunit alpha
MSTNRHQALGLTDQEAVDMYRTMLLARKIDERMWLLNRSGKIPFVISCQGQEAAQVGAAF
ALDREMDYVLPYYRDMGVVLAFGMTAKDLMMSGFAKAADPNSGGRQMPGHFGQKENRIVT
GSSPVTTQVPHAVGIALAGRMEKKDIAAFVTFGEGSSNQGDFHEGANFAAVHKLPVIFMC
ENNKYAISVPYDKQVACENISDRAVGYGMPGVTVNGNDPLVVYQAVKEARERARRGEGPT
LIETISYRLTPHSSDDDDSSYRGREEVEEAKKSDPLFTYQAYLKEIGLLTEEIEQTMLDE
IMAIINEATDEAENAPYAAPESALDYVYAK
>PK3-2_02892 2-oxoisovalerate dehydrogenase subunit beta
MSVMSYIDAINLAMKEEMERDPRVFVLGEDVGKKGGVFKATAGLYEQFGEERVMDTPLAE
SAIAGVGIGAAMYGMRPIAEMQFADFIMPAVNQIISEAAKIRYRSNNDWSCPIVVRAPYG
GGVHGALYHSQSVEAIFANQPGLKIVMPSTPYDAKGLLKAAVRDEDPVLFFEHKRAYRLI
KGEVPADDYVLPIGKADVKREGDDITVITYGLCVHFALQAAERLEKDGISVHVVDLRTVY
PLDKEAIIEAASKTGKVLLVTEDTKEGSIMSEVAAIISEHCLFDLDAPIKRLAGPDIPAM
PYAPTMEKYFMVNPDKVEAAMRELAEF
>PK3-2_02893 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MAIEQMTMPQLGESVTEGTISKWLVAPGDKVNKYDPIAEVMTDKVNAEVPSSFTGTITEL
VGEEGQTLQVGEIICKIETEGANPAEQKQEQPEASAAAESPAAETRAEAADQPNKKRYSP
AVLRLSGEHGIDLDQVTGTGAGGRITRKDIQRIIETGGVQERAEEPKTAAPAPESAPKPE
PKEEVSYPASAAGDKEIPVTAVRKAIASNMKRSKTEIPHAWTMMEVDVTNMVAYRNSIKD
SFKKTEGFNLTFFAFFVKAVAQALKEFPQMNSMWAGDKIIQKKDINISIAVATEDSLFVP
VIKNADEKTIKGIAREITDLAKKVRDGKLSADDMQGGRSPSTTQVLSDLFSRWGSSTTLR
LPSFK
>PK3-2_02894 Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex
MGIINYPQAAILQVESIVKRPVVMEHGMIAVRDMVNLCLSLDHRVLDGLVCGRFLGRVKQ
ILESIDEKTSVY
>PK3-2_02895 Multidrug-efflux transporter 1 regulator
MEESYYSIGEVSKLANVSIKALRYYDKIDLFKPAYVDPDTSYRYYTDSQLIHLDLIKSLK
YIGTPLEEMKKAQDLEMEELFAFYSEQEKQIREKLDFLSALEQTIAMVKKRMKRQMEFPA
LGEVFVLDEEETRIIQTEAEGIGPENVLNASYSKLKKFIESADGFTNNSYGATFPFQPYT
SIDEMTYRHIFTPVLTNKQISAITPDMEIKTIPKGRYVCIAYNFSPEHYFLNLQKLIKYI
TDRRLTVVSDVYELIIPIHYSPKKQEEYRVEMKIQIAQ
>PK3-2_02896 Tetracycline resistance protein, class B
MEKQNITLTILLTNLFIAFLGIGLVIPVTPTIMNELNLSGTAVGYMVACFAVTQLIVSPI
AGRWVDRFGRKIMIVIGLLFFSVSELLFGIGKTVEMLFISRMLGGISAAFIMPGVTAFIA
DITTIKTRPKALGYMSAAISTGFIIGPGIGGFLAEIHSRLPFFFAAAFALLAAVLSILTL
REPERNPENQEITGQKTGFKRIFTPMYFIAFLIILISSFGLASFESLFALFVDHKFGFTA
SDIAIMITGGAIVGAITQVVLFDRFTRWFGEIHLIRYSLILSTSLVFLMTMVNSYVAILL
VTVTVFVGFDLMRPAVTTYLSKIAGNEQGFAGGMNSMFTSIGNVFGPIIGGMMFDIDVNY
PFYFATVSLAIGIALTIAWKAPAHVKAST
>PK3-2_02897 Putative lipid kinase BmrU
MSHRKGLLIHNGNAGSKNIEKALGAVVPVLSQSLDEVIIRQTKKKDDAYHFCQSIDDSVD
TVFILGGDGTVHQCINGISALEKRPAVGILPGGTCNDFSRVLGIPQNLAKAAETLVSGKK
TSVDVCQMNDRYFLNFWGIGLITETSNQINETEKALLGKISYFTSALRTVSSAASFPMTL
KIDGEEIKEEAVMLLVMNGQYIGTNRIPLPDASIEDGLLDILICRNTNLTALRELMSMEQ
GTIDRFAGELSYIQASRIEIETDTAKKADMDGEVYTHTPAVIQALPHHIDMIVPANE
>PK3-2_02898 hypothetical protein
MNMDFNLFMNDIVRQARQEITAAGYTELKTAEEVDAALAKKGTTLVMVNSVCGCAGGIAR
PAAYHSVHYDKRPDQLVTVFAGQDKEATARARDYFEGYPPSSPSFAILKDGKIMKMVERH
EIEGHEPMAVVAKLQEAFEEYCEEV
>PK3-2_02899 Arginine-binding extracellular protein ArtP
MKKWLLLLVAACITLALSACGSSNSGSEGGKKKLIMGTSADYKPFEYKEGDNIVGFDVDL
AKALAKKTGYEIEVQDMDFNSLITALKSKQVDLVLSGMTPTPERKKQVDFSDVYYTANHM
IVSKKDSGITSLKDLKGKTVGVQLGSIQEEKGKELSPEYGFKTEDRNRISDLVQEIKSDR
FEAAIIEDIVAEGYFKSNDDLQGFVIPDAKAEEAGSAIAFRKDSELTDKFNKALKEMEDN
GELEKLKKKWFTGEK
>PK3-2_02900 Arginine transport system permease protein ArtQ
MNLDFSATIPQIPFILEGLAITLKIVIVSAIIGLILGIVLSLCKISTFRPLIWIADFYTS
VFRGTPLVLQLMIVYFGLPQLLGFQIDQFWAAVVALSLNSAAYVSEIIRAGINAIDKGQK
EAAVALGVPYGKMMKDLLLPQAFKNISPAILNELITLTKESAIVTVIGLGDVMRRAYQAG
AATYNYLEPLIIAGLIYYVLVLILTFIGKAVERKLKSND
>PK3-2_02901 Arginine transport ATP-binding protein ArtM
MIKVEKLSKSFGKHEVLKNISTTIAEGEVVAVIGPSGSGKSTFLRCLNLLEKPNGGTITI
KDKEITIPKTNTLKVRENIGMVFQHFHLFPHKTVLENIMYAPVNVKKESKQAAQEKAEEL
LRKVGLFEKRNDYPNRLSGGQKQRVAIARALAMNPEIMLFDEPTSALDPEMVKEVLQVMK
ELVETGMTMVIVTHEMGFAKEVADRVLFMDQGMIVEDGNPKEFFLSPKSKRAQDFLEKIL
>PK3-2_02902 hypothetical protein
MFKIGYRTIKTALGTALAIYISQLLHLQNFASAGIITILCIQITQKRSLQASWARFAACC
LAIVFSYLFFELIGYHPFVIGALLLIFIPITVLLKINEGIVTSSVIILHLYMSGGITLAF
IWNEVQLITVGIGVALLMNLYMPSLDRKLIAYRKKIEDNFAVIFAEIERYLLTGEQDWSG
KEIPETHQLITEAKNLAYRDVQNHILRYENLHYHYFKMREKQFEIIERLLPKVTSISITV
DQGKMIAAFIHDLREAIHPGNTAYKFLKRLADMRKEFEEMPLPATREEFEARAALFHLLG
EMEQYLVIKSYFKGIKAQKSLT
>PK3-2_02903 hypothetical protein
MRFFLCSIFMMMISPIWPLGENPLPGDPYVIVNKRTNELAVILDNKVEGVYSVATGKTDD
LTPEGEFSITVKAANPYYRKKNIEGGAPDNPLGARWIGFDAKGTDGRIYGIHGTNREESI
GKFVSNGCIRMQNDEVIHLFQTIPVGTRVLITDDSRSFEEIAIEHKALIKKQDVPIQ
>PK3-2_02904 hypothetical protein
MSQKLMKSVLIVILGVFILSTVLSGIVMFF
>PK3-2_02905 Ethylmalonyl-CoA/methylmalonyl-CoA epimerase
MNRLDHIGIAVFSIEEARNFYEDILGLAFLHQETVEEQKVNVAFFQAGSVKLELIEPLTP
DSPVRLFLEKKGQGVHHIAFLCTGLSEQLQALSDRQVQLIDPYPRQGANGKKIAFLSPRE
TNGVLVELCEPKGDQTDEHE
>PK3-2_02906 Propionyl-CoA carboxylase beta chain
MNMNEHIDHLYTRRRQAEQGGGHEKLSQQRQKGKLTARERITFLLDQDSFMELHPFMESQ
VLTREQRILGDGVVTGYGTIDGRSVYVFAQDFTVFGGTLGETHAKKICALMDLAAKNKAP
IIGLNDSGGARIQEGVVSLDGYGHIFYRNVLYSGVIPQISVILGPCAGGAVYSPALTDFI
FMAEQTGRMFITGPKVIEKVTGEQVDAESLGGAGIHNAVSGNAHFSGHTEKEVLTGVKKL
LSYLPLNGQTITPQPEKEASIPLLNHLVPADTTKPYDVRTVIKELADPQSFFEIQPFFAK
NIVIGFAMLGEKTIGIIASQPKHLAGSLTIDAADKAARFIRFCDAFDIPLLTIEDVPGFL
PGVQQEHSGIIRHGAKLLFAYAEATVPKVTLIIRKAYGGAYVAMNSKAIGADLVFAWPNA
EIAVMGSEGAASILYEKEIKASADPQKTKSEKTAEYKKQNAGPYKAAACGMVDDIILPEE
SRKRLIQAFHMLTHKTEERPKKKHGNIPL
>PK3-2_02907 Peptidase T
MVNEKRLLEEFLELVQIDSETKHEAEICKVLKQKFSDLGVDVKEDDTMDITGHGAGNLIC
TLKGTKQTDTIYFTSHMDTVVPGNGVKPVVEEGYVKTDGTTILGADDKAGLAAMFEAIKV
LKEENIAHGTIEFIITVGEESGLIGAKALDRSMITASYGYALDSDGKVGNIIVAAPTQAK
VRAAIYGKTAHAGVEPEKGISAITIASKAISKMPLGRIDEETTANIGRFEGGTQTNIVCD
EVHILAEARSLVPEKMETQVQKMKAAFEEAAAEMGGRAEVEIEVMYPGFKYQDGDQVVEI
AKKAAAKIGRPSELQTSGGGSDANVIAGHGIPTVNLAVGYEQIHTKNEKMPVEELVKTAE
MVVAIIEEAAK
>PK3-2_02908 hypothetical protein
MTERFQQKNISVPEGAWIMRQTWNDVLFAHWPVDVSILRAMIPPVLELDTYNGQAWVSML
PFMLTNLRARFLPAIPGARAFPELNLRTYVTYKGKPGIYFFSLDADHRLAVLGARTFFHL
PYFYADMKADKNGDGIDYVSKRRNDGEAAFHAAYRPISAPFTAEEDSLDYWLTERYRLYT
TYRSKLYYEDIHHHPWLLQHAEAEFPVNTVADAHNIALPASDPLLHYAKKQDVLFWPLRQ
WH
>PK3-2_02909 Membrane protein insertase MisCB
MVKTYQKLLAIGIFFIVLCSGNAAFAATNQVGGLSNVGFFHDYLIEPFSALLKGVAGFFH
GEYGLSIILVTIIVRVVVLPLFVNQFKKQRMFQEKMAVIKPQVDSIQAKLKKTKDPEKQK
ELQMEMMKLYQEHNINPLAMGCLPMLIQFPIVIGFYYAIRSTPEIASHSFLWFSLGQSDI
LVSLSAGAMYFIQAYVAQKLSAKYSAVPQNPAAQQSAKLMVFIFPVMMTIFSLNVPAALP
LYWFTSGLFLTVQNVVLQLSHHKNKKAAALTEPVK
>PK3-2_02910 Membrane protein insertion and folding monitor
MDVITMFVESINDVLFLVDFFTIILPALTAIGIAFLLRECRAGEQWKSKRTDEHQTVFQI
NRTDFLIIIYHRITTWIRKVFRMNSPVNDDEDASSLLL
>PK3-2_02911 DNA polymerase IV
MPGKGRIIFHIDMNSFYASVEMAYDPALRGKPVAVAGNVKERKGIVVTCSYEARARGVKT
TMPVWEAKRNCPELIVLPPNFDRYRSSSRAMFNILREYTDLVEPVSIDEGYMDMTDTPYS
SRALETAKEIQSRLQKELLLPSSIGIAPNKFLAKMASDMKKPLGITILRKRQVPDILWPL
PVEEMHGVGKKTAEKLKGLGIHTIKELAAADEHSLKRLLGINGPRLKNKANGIHHAPVDP
ERIYEFKSVGNSSTLSHDSSDEEELLGVFRKLSASVSDRLQRKEVMASKLFIMIRYADWK
TITRSITLKNPIDQKNEIMKEAEHLFFKHWNKNPVRLLGITGTDLVEKEQAYKQLDLFSF
NEDAKDEPIQQMMEKLNEKYGSKLIKKGAKIKKEESKTKGTSFNKDFFQDEKKS
>PK3-2_02912 6-phosphogluconate dehydrogenase, NADP(+)-dependent, decarboxylating
MSKQQIGVIGLAVMGKNLALNIESRGFSVSVYNRSSSKTEEFLQEAKGKNVVGTYSIEEF
VQSLETPRKILLMVKAGTATDATIQSLLPHLEKDDILIDGGNTYYKDTQRRNKELAESGI
HFIGTGVSGGEEGALKGPSIMPGGQKVAHELVKPILEAISAKVDGEPCTTYIGPDGAGHY
VKMVHNGIEYGDMQLISESYFILKQVLGLSADELHEVFAEWNKGELDSYLIEITADIFTK
KDEETGKPLVDVILDKAGQKGTGKWTSQSALDLGVPLPIITESVFARFISAMKEERVKAS
GLLSGPEVKPVTENKEELIEAVRKALFMSKICSYAQGFAQMKAASEEYNWDLKYGEIAMI
FRGGCIIRAAFLQKIKEAYDREPELDNLLLDSYFKNIVESYQGALRQVISLAVAQGVPVP
SFSSALAYYDSYRTAVLPANLIQAQRDYFGAHTYERTDKEGIFHTEWMK
>PK3-2_02913 Glucose-6-phosphate 1-dehydrogenase
MKTNQQPKAVIVIFGATGDLAKRKLYPSIHRLYQNGQIGEEFAVVGVGRRPWSNDDLRQT
VKTSISSSADKHIDDFTSHFYYHPFDVTNPSSYQELNVLLNQLEDTYQIPNNRMFYLAMA
PEFFGTIAKTLKSEGVTATTGWSRLVIEKPFGHDLPSAQALNKEIREAFTEDQIYRIDHY
LGKQMVQNIEVIRFANAIFEPLWTNRYISNIQITSSESLGVEDRARYYEKSGALRDMVQN
HIMQMVALLAMEPPIKLNTEEIRSEKVKVLRALRPIEKDEVDDYFVRGQYQAGEINGLPV
PAYTDEDNVAPDSNTETFVSGKLLIDNFRWAGVPFYIRTGKRMKEKSTKIVVQFKDIPMN
LYYGNENNMNPNLLVIHIQPDEGITLYLNAKKLGGAAHAQPIKLDYCSNCNDEMNTPEAY
EKLIHDCLLGDATNFAHWDEVALSWSFVDSISEAWAANKTLSPNYESGSMGPKASDDLLA
KDGLNWWNI
>PK3-2_02914 Ribonuclease Z
MELLFLGTGAGIPAKARNVTSVALKLLEERRSVWLFDCGEATQHQILHTTIKPRKIEKIF
ITHMHGDHVYGLPGLLGSRSFQGGEDELTVYGPKGIKAFIETSLAVTKTHLTYPLVIKEI
EEGTVFEDDQFIVTAVSVIHGVEAFGYRVQEKDVPGSLKADLLIEMNIPPGPVYQRIKKG
ETVTLEDGRIINGNDFLEPPKKGRAVVFSGDTRVSDKLKELARDCDVLVHEATFAKEDRK
LAYDYFHSTTEQAAVTAKEAGARQLILTHISARYQGEASLELQKEAADVFPNSVAAYDFL
EVNVPRG
>PK3-2_02915 50S ribosomal protein L33 2
MRVNVTLACTETGDRNYITTKNKRTNPDRLELKKYSPRLKKYTLHRETK
>PK3-2_02916 Haloalkane dehalogenase
MNSAWMEKTYTIDGCAFHTQHRRGSNGVTIVFEAGYGTSSETWKPLMADIDDEFGIFTYD
RAGIGKSGQSTAKRTAEQQVKELESLLKAADVKPPYLAVSHSYGAVITGLWACKNSCDII
GMVLLDPALGDCASFTFIPEEMHKSYTKKMMLEGTRAEFSKSLHELKQRQIHLGNMPLLV
LSSGERTQKFAIEQEWQNLHSSILSLSNQSGWIQAKNSSHNIHHDEPHIVHLAIYDVWCA
ACQQAASLYQAVN
>PK3-2_02917 NADPH dehydrogenase
MARKLFTPITIKDMTLKNRIVMSPMCMYSSHEKDGKLTPFHMAHYISRAIGQVGLIIVEA
SAVNPQGRITDQDLGIWSDEHIEGFAKLTEQVKEQGSKIGIQLAHAGRKAELEGDIFAPS
AIAFDEQSATPVEMSAEKVKETVQEFKQAAARAKEAGFDVIEIHAAHGYLIHEFLSPLSN
HRTDEYGGSPENRYRFLREIIDEVKQVWDGPLFVRVSASDYTDKGLDIADHIGFAKWMKE
QGVDLIDCSSGALVHADINVFPGYQVSFAEKIREQADMATGAVGMITDGSMAEEILQNGR
ADLIFIGRELLRDPFFARTAAKQLNTEIPAPVQYERGW
>PK3-2_02918 Protein RocB
MNWQTKDELLTLLTSLVQHESITGSKGEAALAEYLYFILKDKPYFQKHPDDVTLHPMDDG
RSFLTALVKKKNVKKTVLLLSHFDVVDIEDYGEFKHMACKPAELLSSFLEKKELLPERVR
TDAESGDWLFGRGTMDMKAGLAVQLSMLERAMNGEFEGNLLLITVPDEEVNSRGMIQAVP
VLKQMEKKHEITLTACLNAEPMFEKFPGDQQQYFYTGSIGKVLAGFFCKGIETHVGEPFS
GINANLMVSEINRLLELNADYCEKVDGEVTPPPVNLMQKDLKESYSVQTPHTAVTLFNVL
SIKRSASELHQMLLKTAEQAAEEITANIRKKTQDFQQFEPFKPFERAVTVLTFDELVARA
KKRVGNSETERVLNYAFANRGDLGDRDFSTKIVSELASLCKEDAPLIVLFYSPPFYPAVS
SKDDELIRHTADRLMHYAADEYGIALREVQYFPGLSDLSYLQLEKQEVDAYTNNMPLFNR
GYSLPSGKDKALYVPVLNVGPAGKDPHKWTERLYMPYSFEVLPDLLSFTISALFKQSETA
GQQL
>PK3-2_02919 Pyrroline-5-carboxylate reductase
MKKIGFVGAGSMAEAMINGFLQSGITKPEHIYITNRSNDERLIELKETYGVRPCRDKNEF
FTQTDIIILAFKPKDAAESINSIRPYIKDQLVISVLAGLTVETIQHYFGRQLAVIRVMPN
TSAAIRKSATGFSVSAEASQDDIIAATCLLETIGDATLVEEQHLDAVTAIAGSGPAYVYR
YIEAMEKAAQKVGLDQETAKALILQTMAGATDMLLQSGKQPAQLRKEITSPGGTTEAGLH
ALQESRFEEAIIHCIEETAKRSAEIKEQFAGAALERHS
>PK3-2_02920 hypothetical protein
MTTADVIAIRVPTPFAVGDVLVYLVKGDALTLIDVGPNTKEAVRALQEQLAAVNVKMSDI
EQVVLTHHHADHAGLLDVFSDEIEVIGHPFNEPYISRNQAFMDWQKRFFQKLLPELGVPF
ETSKADKLIRSAYAFSCTRSLTKAVREGMSIDGLQGWSVLEMPGHAESHIVLFHEKSGRM
LGGDLLLANSSSNPILEAPKTGDIRSKPLVDYQRSLRRLSEIDPTILFPGHGEIITSVQA
LIDKRFDKQRNRTEDVRRMLEEKPMTAFQVCQQLFPAVYEKELFLTMSETAGHLDVLESE
EVIMSYREGNTAYFKTIKR
>PK3-2_02921 putative oxidoreductase
MKHIAGKRIWITGASGGLGERIAYLCAAEGAHVLLSARREDRLFDIKRKITEEWSGQCEI
FPLDVGRLEDVALVRDQIGSVDVLINNAGFGIFETVLDSTLDDMKAMFDVNVFGLIACTK
AVLPQMLEQKRGHIINIASQAGKIATPKSSLYSATKHAVLGYSNALRMELSGTGIYVTTV
NPGPIQTDFFSIADKGGDYVKNVGRWMLDPDDVAGQIIAAIFTNKREINLPRLMNAGTKL
YQLFPALVEKLAGRAFMKK
>PK3-2_02922 D-serine dehydratase
MPINQEALHVLLKDPFIQKLIDAEPVFWANPGKKEGPLFHADEWKSEIAEAEKRLRRFAP
YIAEVFPETKDAKGMIESPLFEVQHMKEKLEAVYQQPFPGKWLLKCDHELPISGSIKARG
GIYEVLKHAEKLALQEGMLQETDDYRILQEERFAAFFSRYSIAVGSTGNLGLSIGIIGAA
LGFRVTVHMSADAKQWKKDLLRQKGVTVMEYESDYSEAVKEGRRQAEQDPFCYFIDDEHS
RQLFLGYAVAASRLKTQLDCMNIQPSLETPLFVYLPCGVGGGPGGVAFGLKLLYGDHVHV
FFAEPTHSPCMLLGLYSGLHEEISVQDIGLDNRTAADGLAVGRPSGFVGKLIEPLLSGCY
TVEDDTLYILLYMLAVSENQYLEPSALAGMFGPIQLFSTEEGRRCMQKHHMEHAIHVVWG
TGGSMVPQEEMAAYNRIGADLLKNEMKK
>PK3-2_02923 Pantothenate kinase
MKNKELNLHTLYTQHNRESWSGFGGHLSIAVSEEEAKAVEGLNDYLSVEEVETIYIPLVR
LLHLHVKSAAERNKHVNVFLKHPHSAKIPFIIGIAGSVAVGKSTTARILQKLLSRLPDRP
KVSLITTDGFLFPTAELKKKNMLSRKGFPESYDVKALLEFLNDLKSGKDRVKAPVYSHLT
YDREEGVFEVVEQADIVIIEGINVLQSPTLEDDRENPRIFVSDFFDFSIYVDAEESRIFT
WYLERFRLLRETAFQNPDSYFHKFKDLSDQEADEMAASIWESVNRPNLYENILPTKFRSD
LILRKGDGHKVEEVLVRRV
>PK3-2_02924 hypothetical protein
MHHIELYVSDLEASRRFWGWFLKELGYKEHQKWGSGISWKKDRFYLVIVQAEERFLEPEY
HRCRVGLNHLAFHAESKLQVDLMTEKLTAKGYRVLYRDRHPFAGGDGHYAVYCEDPDRMK
VELVAPSD
>PK3-2_02925 hypothetical protein
MNIGDVVFQLFVLIVFAAVIFAAVTSFKYAKNRKTQLDRMEKKLNSRSEDHD
>PK3-2_02926 Na(+), Li(+), K(+)/H(+) antiporter
MKKCKEIHSISWTIIIGTIFGRMATSMSIPFLAIYLTAVQGASASYAGLVIAASSSVGIL
ASFYGGYISDKFGRKNMMLVSIFGWMLVFIGFAAASHLWVFFVVNALNGLCKSLFEPASK
ALLSDMTEEKTRLLVFNLRYAAINIGVVFGPVLGLYFGSSQSTAPFLVPAVIYGLYGLVL
AIQFKKHSSSSAQDQSRNMSVREAFMVTQKDHLFTIALVGIALCTFGYSQFSSTFPQYMA
QNPLIGNGTKLYGLMLTLNAIVVLATQFPIVHFAKRFSPLCSLMLGNVMVSISMAIFTIS
HGVSSLVMIVIIFTIGEVLLFSMMDLFVDQIAKPGLKGTYFGAIGFSQLGNVIGPWVGGI
CIDLFGAGRPIFIFSVLSGITLLGLPFLAFAYRQMKVEMTKHRSALEKPL
>PK3-2_02927 hypothetical protein
MKTGTGRWTEEETVCAFRMNERRFMKISNTLENGQLTVLQAYPGDFYAGSIMILRRVKKS
CLAFSAGLSAVCHLRTVICYRGRLFFKEKPHQRLKEMTV
>PK3-2_02928 hypothetical protein
MEKFVEKMMGQALRQYGRNVAIDPLSPYEKQSLKAALEERRNEEPDEDLHAHIEDIIYDY
VTNQGLFS
>PK3-2_02929 DNA polymerase IV
MMKEKVIFLVDMQSFYASVEKAENPHLKNRPVIVSGDPERRGGVVLAACPLAKQKGVANA
SRLWEAQEKCPEAVVLRPRMQRYIDVSLQITAILEEYTDLVEPYSIDEQFMDITGSQKLF
GTPEEIAKSIQGRIMREIGVYARVGIGPNKALAKIGCDNFAKKNKNGIFTLTKENMKTEM
WPLPVGSMFGVGSRMKHHLNRMGISTIGGLAAFPLDLLKKKWGINGHVLWMTANGIDYSP
VSTSSLDGQKAIGHGMTLPRDYEHFDKEIKVVLLELSEEVCRRSRNAGVMGQTVSVSCRG
ADFDWPTGFNRQVKLAEPTNSTQDVYEAVCGLFLRFWDGKPVRRLGVNLSQLSSDDIWQL
NLFQDYAKKMSLGYVMDGIKNRFGDTAIIRAASLTAAGQAFERAAKIGGHYK
>PK3-2_02930 hypothetical protein
MNDHLKRGNLLWEGSRMFLPEHKQSLLERKRHKQKLQKPILDPDKLEEMNQILCAAMEFA
QDITVSCFQDGEIVRCTGKICRYEEFEKTVWVKGDEDQLYKLKLDQVLDIVL
>PK3-2_02931 putative protein YqjY
MDIRTITSSDYEMVTSVMNEWWGGRQLKEKLPRLFFEHFQDTSFITSEHNSMTGFLIGFQ
SQSEPETAYIHFSGVHPDFRKMQIGKQLYDVFIEAVKQRGCTRVKCVTSPVNKVSIAYHT
KLGFAIEKGTKTVNGISVFANYDGPGQDRVLFVKNI
>PK3-2_02932 putative protein YqjZ
MNFLSKTPEPPYYAVIFSSVKSENDTEYGETAERMVSLAADQPGFLGVESVREADGRGIT
VSYWDSMDAINNWKHHTEHQAAKEKGKSVWYASYAVRVTKVERQRLFAGENE
>PK3-2_02933 hypothetical protein
MIEFLQHKEDITAREIIAVQQPAYIKEAELIGFDGIPALQEKAKDIQASHEQFAGYRKDG
KLIGVISYEKNMHHLTICRLVVHPDGFRKGIGRALLRFVIDQNEDAEKIEAVTAENNTPA
VSLYTQAGFQKAENVKAAEGLLLSVFQLCPKRKVKVVLYNEKWAELFDEEKERLKLVFGP
EISAVHHIGSTSIPNMAAKPVIDILIEVKSIEAVNQYDSKMKAIGYTPKGENGIAGRRYF
QKGGNKRTHHVHIYEKGNQAIERHLLFRDYLRAHPKIAEEYAILKKRLAIQHPDSINQYI
QGKDEWIKTAEEHAKRWKEGRNNADGSVVCYNNENDENGGLTL
>PK3-2_02934 hypothetical protein
MNIHVTDAAKQALQQAFDANPGKKAQLRYDAEGCGCAVSGVPTIWLAEELTGQCEQLETN
GIPLYIQSSQKVFFDDQMTIDYNEKAKTLALKSPAEMLSPRMSILVK
>PK3-2_02935 hypothetical protein
MEQKLKSMKNTAQNKTWVSFLNQNHPYTLLHWSIGGAESVKKDVWLLQDEMTFETQEFTT
IDLAIEWIRENMDGITDVL
>PK3-2_02936 hypothetical protein
MKKILLAIGALLTAVIAIGIVFSNIILFIKKKTDEDIMKRETDDGHDVFDSFERMKKIPF
SVPSAYGYDIKGYYVAPHDTSNTIIICHGVTMNVLNSLKYMHLFLDLGWNVIVYDHRRHG
QSGGKTTSYGFYEKDDLSEVVSWVKNKTGHRGLIGIHGESMGAATALLYAGEHCDDGADF
YIADCPFARFDEQLAYRLKAEYRLPSWPLLSIADFFLKLRGGYRAREVSPIAVIEKIKKP
VLFIHSKDDDYIPVSSTERLYEKKPGPKALYIAENGEHAMSYTKNRDTYRKTVREFLDKI
KDSTE
>PK3-2_02937 hypothetical protein
MKKQKSADKYQLKDDLQSDIKAKLMEMKSQLKEEDEKRQEREKAEQIRKKKEIEKNKSFE
DLLNESQMDWQKYK
>PK3-2_02938 1-deoxyxylulose-5-phosphate synthase YajO
MRKRKLGTSDLEISEAGLGCMSLGTEKNKALSILDEAIELGINYLDTADLYDRGRNEEIV
GDAIQNRRQDIILATKAGNRWNDENDGWYWDPSKAYIKEAVKKSLARLKTDYIDLYQLHG
GTIEDNIEETIEAFEELKQEGVIRYYGISSIRPNVIKEYVKKSNIVSIMMQFSLFDRRPE
EWLPLLEEHQISVVARGPVAKGLLTEKPLDQAADSIKQNGYLSYSFEELTNARKAMEGVA
SDLSMTEKSLQYLLAQPAVASVITGASKIEQLRENVKAANARRLHDEEIKALQSHTKQDI
YEAHRS
>PK3-2_02939 Cell division inhibitor MciZ
MKVHRMPRGVVLVGKAWEIRAKLKEYGRTFIYVKDWIAKP
>PK3-2_02940 ADP-ribose pyrophosphatase
MKSLEEKTIAKEQIFSGKVIDLYVEDVELPNGKTSKREIVKHPGAVAILAVTDEGKIIMV
KQFRKPLERTIVEIPAGKLEKGEEPEYTALRELEEETGYTAKKLTKITAFYTSPGFADEI
VHVFLAEELSVLEEKRELDEDEFVEVMEVTLEDALKLVESREVYDAKTAFAIQYLQLKEA
LQAQK
>PK3-2_02941 hypothetical protein
MKKIYADLHIHIGRTFTGRAVKITGAKTLTLDRILVEASEHKGIELLGIIDCHSPEVMLE
LEEGISSGKYRELAGGGIRYRSTTLLLGSELEIYDEACSGPIHVLVFMPRLAEMKQFSNW
LSARLKNIHLSSQRIYETGLNLQKKVKEMGGLFIPAHIFTPHKSLYGKGVKSSLTEVFDP
AMIDAVELGLSCDTDMASHVSELNQYTFLTNSDAHSLGKIGREYNELYVQSVDFTEFALA
LRGQDDREITANYGLDPLLGKYYQTACEACGEPAVSGETACANCGNSRFTKGVSERLREL
SDQAEVRVSRPRYVHQIPLQFVPGVGPKTLDKLKKAFGTEMAVLHEAAEEELARVVPSKT
AALIVKARSGKLELKAGGGGTYGKIKP
>PK3-2_02942 hypothetical protein
MNLDRLTELRKKKNWSLQYTADLLGIAKSTYAGYESGYRRPSLEALAMLADLFDTTCDEL
LGREKQKQTAPQTIELATWSSLDFHISVDGKPLSEDEIIQLITFIRTKRKVQEELS
>PK3-2_02943 L-asparaginase 1
MKKLLMLTTGGTIASVEGENGLAPGVKADELLSYVSKLDNDYTMETQSLMNIDSTNMQPE
YWVEIAEAVKANYDAYDGFVITHGTDTMAYTSAALSYMLQHAKKPIVITGSQIPITFQKT
DAKKNITDAIRFACEGVGGVYVVFDGRVIQGTRAIKLRTKSYDAFESINYPYIAFINEDG
IEYNKQVTEPENDTFTVDTSLCTDVCLLKLHPGLKPEMLDALKSMYKGVVIESYGSGGVP
FEGRDILSKVNELIESGIVVVITTQCLEEGEDMSIYEVGRRVNQDLIIRSRNMNTEAIVP
KLMWALGQSSDLPVVKRIMETPIADDVVL
>PK3-2_02944 Aspartate ammonia-lyase
MLNGQKEYRVEKDFLGEKQIEADVYYGIQTLRASENFPITGYKIHEEMINALAIVKKAAA
LANMDVKRLYEGIGQAIVQAADEILEGKWHDQFIVDPIQGGAGTSMNMNANEVIGNRALE
IMGHKKGDYIHLSPNTHVNMSQSTNDVFPTAIHISTLNLLEKLLKTMEDMHSVFKQKAQE
FDSVIKMGRTHLQDAVPIRLGQEFEAYSRVLERDIKRIKQSRQHLYEVNMGATAVGTGLN
ADPEYIKQVVKHLADISGLPLVGADHLVDATQNTDAYTEVSASLKVCMMNMSKIANDLRL
MASGPRAGLAEISLPARQPGSSIMPGKVNPVMAELINQIAFQVIGNDNTICLASEAGQLE
LNVMEPVLVFNLLQSISIMNNGFRSFTDNCLKGIEANEKRMKQYVEKSAGVITAVNPHLG
YEAAARIAREAIMTGQSVRDLCLQHDVLTEEELDIILNPYEMTKPGIAGKELLEK
>PK3-2_02945 Malate-2H(+)/Na(+)-lactate antiporter
MKDVRLPTLFEIIIVLGSFLALVMSFTVFLDLPIQLALFISWFIAMILGIRLGYSYKDMQ
NAILHGISNGLEAVLILVSVGALIGTWIAGGVVPTLIYYGLEFIHPSIFLLATLIICSIM
SVATGTSWGTVGTAGIAMIAIGEGLGIPLPLVAGAILSGAYFGDKLSPLSDSTVLASSLS
KVDVLDHVRAMLYLSIPAYVITAILFTITGFMYGGKNIDLDKVEFLKSSLQNTFDIHIWM
LIPAVVVIVLLAMKKPSMPVIVIGALLGAIWAAVFQGMNIADAIATAYNGFSIKTDVEFL
NGLLNRGGIVGMLSSLVVIIFGLGFGGLLEKLGVLKVIVSMFEKKLTSAGNVTLSTLIVA
FLANIFGCAMYVSLILTPKIMEDSYDRLHLDRRVLSRNSEVGGTLTSGMVPWSDNGIYMA
GILGVSTFSYLPFMWLSFVAIGLAIIYGYTGKFIWYTKNNTGKAEKLG
>PK3-2_02946 NAD-dependent malic enzyme
MIAKHMIRTLMIETPSVPGNLGRVATAIGLLGGDIGEVETVKVGPNYTMRNITVQVENEE
QLQEVIMAVQALGEGIRLHTVSDEVLSAHEGGKIQMKSKMPIRSLAELGRVYTPGVADVC
RLIEKEPEKASIYTTISNSVAIVTDGTAILGLGNIGSVAGMPVMEGKAALFDQLAGISGI
PILLDTSDPEEIIKTVKHISPGFNGILLEDIGSPHCFEIEDRLKEELNIPVMHDDQHGTA
VVTLAAAISACRSAGVDLKEARVGQIGLGAAGVAICRMFMAYGVKAVYGTDKSEAAMSRL
EQYGGQAVASIEELMETCDIVIATTGVPGLIKPAFVRSGQVILALSNPKPEIEPEDALQA
GAAYAADGRSVNNVLGFPGIFRGALNAKSKEINHDMLVAAAEAIAACTKPGDVVPQPLDS
KVHHEVAAAVEHAALTAVK
>PK3-2_02947 hypothetical protein
MAKSRARKKREHLLRNGGRDVLLSRGSSPSFSTHERMTKSKKEILNKRKYKNPYDHTAFD
DKDFFVPAKAS
>PK3-2_02948 Stage II sporulation protein M
MRKISYKDMFLGHVKDHLSLYIFVSVLFFMGIIFGAIIVNSMTISQKEDLYYYLSQFFGQ
LSDGKQASASDMFGQSIFHNAKYLGLMWILGISVIGMPIIFIMIFLKGIVVGFTVGFLVN
QMGISGFFLSFVSVLPQNVLLIPAYLIMGTCAIAFSLKLIRQLFVKRSLHDAPIQWFGRY
AFVLLVILFLALISSLFEAYLSPVLMEKLTSRLF
>PK3-2_02949 Ferric uptake regulation protein
MENRIDRIKKQLHSSSYKLTPQREATVRVLLENEEDHLSAEDVYLLVKEKSPEIGLATVY
RTLELLTELKVVDKINFGDGVSRYDLRKEGAAHFHHHLVCMECGAVDEIEEDLLEDVEEI
IERDWKFKIKDHRLTFHGICHRCNGKETE
>PK3-2_02950 hypothetical protein
MGRFLKTALDALKVFILFTGFTALFYYAMIWVNQEYENYHRYDKPEGSAVKVVEMDQDEK
GGWFDRLIFFYQNGE
>PK3-2_02951 Tyrosine recombinase XerD
MKDQIKDFIHYVMVERGLSQNTVVSYERDLKSYSLYLTETLHVTDWNHITRVHIIQYLKH
LKDSGKSGKTSARHLASIRSFHQFLLREKVTDKDPSVHIETQKTERALPKVLALNEVERL
LDTPKLTSPFGYRDKAMLELLYATGIRVSEMIDLKTADVHLSMGFVRCFGKGRKERIVPI
GEAAASAIEEYITKARGKLLKNNVSDALFLNHHGKQISRQGFWKNLKKIALEAGIKKELT
PHTLRHSFATHLLENGADLRAVQEMLGHADISTTQIYTHVTKTRLKDVYKQFHPRA
>PK3-2_02952 Phosphopentomutase
MPAYKYNRVFLIVMDSVGIGEAPDAADFNDEGANTLGHIAEHMNGLHMPNMAKLGLGLIG
DIKGVEKTEHPLAYYGKMQEASNGKDTMTGHWEIMGLYIEKPFKVFPEGFPDELLQELEK
RSGRKIIGNKPASGTAILDELGQEHMETGALIVYTSADSVLQIAAHEEVVPLEELYRICE
TARELTLDPKYMVGRIIARPFVGEPGQFKRTPNRHDYALKPFDRTVMNGLKDSGLDVISI
GKISDIYDGEGITSSRRTVSNMDGMDKVIDTLGEDFTGLSFANLVDFDALFGHRRDPEGY
GRALEEFDARLPEVFEKMKEDDLLIITADHGNDPIHHGTDHTREYVPILAYSKKHKQAQM
LPLADTFADIGATIADNFQTNKPKYGKSFLSLLQ
>PK3-2_02953 Purine nucleoside phosphorylase 1
MKDRIERAAAFIKQNLPESPKIGLILGSGLGILADEIENPVKLKYEDIPEFPVSTVEGHA
GQLVLGTLEGVSVIAMQGRFHFYEGYSMEKVTFPIRVMKALGVEALIVTNAAGGVNTEFR
AGDLMIITDHINFMGTNPLIGPNEADFGARFPDMSSAYDKDLSSMAEKLAKNLNIPIQKG
VYTAVTGPSYETPAEVRFLRTMGSDAVGMSTVPEVIVANHAGMRVLGISCISNAAAGILD
QPLSHDEVMEVTEKVKAGFLQLVKAVVGQYE
>PK3-2_02954 D-alanyl-D-alanine carboxypeptidase DacF
MKRLLSTLLIGIMLLTFTPSAFAKQDGKGTSELAHEAKSAVLIERDTGKVLYNKNSNERL
APASMTKIMTMLLIMEALDEGKIKMSDKVRTSEHAASMGGSQIFLEPGEEMTVKEMLKGI
AIASGNDASVAMSEFISGSEEEFVKKMNKKVKELGLKNTSFKNPTGLTEEGHYSSAYDMA
IMAKELLKYESITKFTGTYEDYLRENTDKKFWLVNTNRLIKFYPGVDGVKTGYTGEAKYC
LTASAKKGNMRAIAVVFGASTPKERNAQVTKMLDFAFSQYETHPLFKRNETVAKVKVKKG
KQTFVELTTSEPISILTKKGEDMKNVKKEIKMNDNVSAPIQKGQELGTLVLKKDGEVLAE
SPVAAKEDMKKAGFLTFLKRTMGDWTKFK
>PK3-2_02955 Anti-sigma F factor antagonist
MSLGIDMHVKESVLCIRLTGELDHHTAETLKQKVTQSLEKDDIRHIVLNLEDLSFMDSSG
LGVILGRYKQIKQIGGEMVVCAISPAVKRLFDMSGLFKIIRFEQSEQQALLTLGVAS
>PK3-2_02956 Anti-sigma F factor
MKNEMHLEFSALSQNESFARVTVASFIAQLDPTMDELTEIKTVVSEAVTNAIIHGYEENC
DGKVYISVTLEDHVVYMTIRDEGMGITDLEEARQPLFTTKPELERSGMGFTIMENFMDDV
SIDSSPEMGTTIRLTKHLSKSKALCN
>PK3-2_02957 RNA polymerase sigma-F factor
MDVEVKKNGKNAQLKDHEVKELIKQSQNGDQQARDLLIEKNMRLVWSVVQRFLNRGYEPD
DLFQIGCIGLLKSVDKFDLSYDVRFSTYAVPMIIGEIQRFIRDDGTVKVSRSLKELGNKI
RRAKDELSKTLGRVPTVQEIADHLEIEAEDVVLAQEAVRAPSSIHETVYENDGDPITLLD
QIADNSEEKWFDKIALKEAISDLEEREKLIVYLRYYKDQTQSEVAERLGISQVQVSRLEK
KILKQIKVQMDHTDS
>PK3-2_02958 hypothetical protein
MERRIFIRLRHRVLAHPGDIITVGDAAQIEGQVQLKKKLSAMPLYQVTEKDKNIVILDII
HVLRAIHLQEPALDIQTVGGAETIVEIQYRKRQISTVLFIGVWLLLFIGSCLAIMNFHED
VSMRDVHIALYEIITGERNDYPYLLQIPYSIGLGLGMIVFFNHIFKKRLNEEPSPLEVEM
FNYQLDLDQYVAMHENQETIKDLHDR
>PK3-2_02959 hypothetical protein
MIVSVLFIIFVGLGGGITVGAGFVAFLTVMGIIPRLMQLTKTMRFVQAYEAAVILGAVCG
GWETLHMNHLFLTKWIAVPVGLLAGVFVGMLAAALTEVLNVLPILAKRIGLRSKIIILLM
AIVIGKIVGSLFHWLYFIDHS
>PK3-2_02960 hypothetical protein
MTNIKENYKSKVKTYQPKPPYVWNCVKAFLVGGLICAIGQGLQNFYIHFFDFNEKTAGNP
TAATLILISALLTGFGIYDRIGQFAGAGSAVPVTGFANSMASAALEYKSEGLVLGVATNM
FKLAGNVIVFGVVAAYIVGMIRFAFEKLMS
>PK3-2_02961 Stage V sporulation protein AD
MKLTGKQTWVFENPLFVNSAGTAAGPKEKEGPLGSLYDKTYDEMHCNQKNWEMAERQLME
DAITSALQKNNLTKDDIDLLLAGDLLNQNVTANYVARHLKIPFLCMFGACSTSMETVAVA
SALVDGGFAKRALAATSSHNATAERQFRYPTEYGGQKPDTATSTVTGSGAVVISQTPGDI
QITSATVGKVSDLGITDPFDMGSAMAPAAADTIKQHFIDLNRTADDYDLILTGDLSGVGS
PIVKDILKEDGYPVGTKHDDCGLLVYTPDQQVFAGGSGCACSAVVTYSHIFKQLREGKLN
RVFVVATGALLSPTMIQQKETIPTIAHGVVFERAGGAS
>PK3-2_02962 hypothetical protein
MDYLLAFVCGGAICIVGQLLLDIFKLTPAHVMTSFVVIGAILDGFGIYDKFIEFAGGGAT
VPIVSFGHSLLHGAMHQAHIHGFIGIGMGIFELTSAGISAAILFAFIVAVIFKPKG
>PK3-2_02963 hypothetical protein
MTTKRKVILVTDGDVYAAKTIEYAASKVGGRCISQSKGNPSIRSGAELVKLITSAPYDPV
FVMFDDSGLQGEGPGETALTYVATHPSIEVLGVIAVASKTHQAEWTRVDVSIDRNGEITE
YGVDKVGEREFDEHRMSGDTVYCLDKLDLPLIVGIGDIGKMGRKDDISKGSPITMKAVEF
ILERSGYHDGPQGRENSGLSESS
>PK3-2_02964 Spore germination protein XA
MTDHKEEKIRVYRNPAKNEAYFKNRVGMGTSYDVGVRKLNILDKEIQLYYLNGLCDTAYI
IHLMRELVAINNRKEDPDELIDIVENRLLNSQVEKVKTLDETTDQVLSGLVAVIVEGAGF
AFIIDVRSYPGRNPEEPDTEKVVRGARDGFVENIVVNTALLRRRIRDERLRVKMTKVGER
SKTDLSICYIEDIADPDLVDIVEKEIASIDVDGLTMADKTVEEFIIKQGYNPYPLVRYTE
RPDVAANHVLEGHVIIMVDTSPSVIITPTTLFHHVQHAEEYRQAPAVGTFLRWVRFFGII
ASTILLPIWFLFVLQPDLLPENMKFIGLNKDTHIPVILQIFLADLGIEFLRMAAIHTPTA
LSTAMGLIAAVLIGQIAIEVGLFSPEVILYVSLAAIGTFTTPSYELSLANKMGRLVLMIL
VALFHIKGLVIGFTVLIIAMASIKSLQTPYLWPLIPFNGKALWQVLIRTAKPGAKVRPSI
VHPRNRLRQPTNS
>PK3-2_02965 Diaminopimelate decarboxylase
MTLFLHGTSRQNQHGHLEIGGVDALYLAEKYGTPLYVYDVALIRERAKSFKQAFITAGLK
AQVAYASKAFSSVAMIQLAEEEGLSLDVVSGGELYTAVAAGFPAERIHFHGNNKSREELR
MALEHRIGCIVVDNFYEISLLEDLCKETGHSIDVLLRITPGVEAHTHDYITTGQEDSKFG
FDLHNGQTERAIEQVLQSEHIQLLGVHCHIGSQIFDTAGFVLAAEKIFKKLGEWRESYSF
VSKVLNLGGGFGIRYTEDDEPLHATEYVEKIIEAVKENAARYGFDIPEIWIEPGRSLVGD
AGTTLYTVGSQKEVPGVRQYVAVDGGMNDNIRPALYQAKYEAATANRIGEAHDKTVSIAG
KCCESGDMLIWDIDLPEVKEGDLLAVFCTGAYGYSMANNYNRIPRPAVVFVENGEDHLVV
KRETYEDIVKLDLPFKTSVKQ
>PK3-2_02966 putative protein YpuA
MKKIWIGMLAAAVLLLTVPKVSLADAAVGDVIVTLGADLSESDKQKVLDEMNVPDNATTV
TVTNKEEHEYLGKYISSAQIGSRAISSSSITIAKKGSGLNVETHNISGITDEMYLNALMT
AGVKDAKVYVTAPFEVSGTAALTGLIKAYEVSSDEAISEDVKQVANQELVTTSELGDKIG
NENAAALIAKIKEEFAKNGVPDNKADIEKQVDDAASDLNVTLTDSQKDQLVSLFNKMKNA
NIDWGQVSDQLDKAKDKITKFIESDEGKNFIQKVIDFFVSIWNAIVSIFK
>PK3-2_02967 Peptidyl-prolyl cis-trans isomerase B
MKTGYFLLEDGNKIEFELYPEAAPGTVANFEKLANEGFYDGLTFHRVIPGFVSQGGCPHG
TGTGGPGYTIKCETQGNPHTHEAGSLSMAHAGKDTGGSQFFIVHEPQPHLNGVHTVFGKV
TSGLEFAKNMSNGDVMKEVRVEG
>PK3-2_02968 hypothetical protein
MIDYPININNVSGNSVVNIGGAFIIRPLTVSKSVFGSGGLNTGIVFENNFVSKAKMINHQ
FTDQNVTKAF
>PK3-2_02969 hypothetical protein
MNNKGCIKCGSTEAGQKEIATTGTGLSKLFDVQHNRFLVVYCKNCGYSEFYNKESSTAGN
ILDLFFGG
>PK3-2_02970 hypothetical protein
MFSSFDDFKHMMKAKRDAGYVTCEIGCRKHSSNLHDVNQFVKHHGYHGLDGSMERSR
>PK3-2_02971 Signal peptidase I S
MKSENVSKKKSILEWAKAIVIAVVLALLIRNFIFAPYVVDGESMDPTLHNRERVFVNMTV
KYIGEFDRGDIVVLNGDDVHYVKRIIGLPGDTVEMKNDQLYINGKKVTEPYLAANKKKAK
QDGIHLTDDFGPVKVPDDKYFVMGDNRQKSMDSRNGLGLFTKKQIAGTSKFVFYPFNEMR
KTN
>PK3-2_02972 hypothetical protein
MSRIKTKITILLVLLLLLAGGYMYINGIELKDVPTAIGQTLSSEEEEYTIEEYKVTQIDG
TEYHGEAENGTKIIFNGKKLNQDLSDIKEGDKIKAYFSKSKRIDGLIKVAKVND
>PK3-2_02974 Riboflavin biosynthesis protein RibD
MEEYYMKLALDLAKQGQGQTESNPLVGAVVVKDGQIVGMGAHLKYGEAHAEVHAIHMAGA
HAKGADIYVTLEPCSHYGKTPPCAELIINSGIKRVFVAMRDPNPLVAGRGISMIEEAGIE
VKEGILADQAEKLNEKFLHFMRTGLPYVTLKAAASLDGKTATSTGDSKWITSETARQDAQ
QYRKNHQSILVGVGTVKADDPSLTCRLPNVAKQPVRVILDTELSIPEDAQVICDQAAPTW
IFTTARADEEKKKRLTAFGVNVFTLGTERIQVPDVLKILAEEGIMSVYVEGGSAVHGSFV
KEGCFQEIIFYFAPKLIGGTHAPSLISGEGFQSMKDVPLLQFTDITQIGRDIKLTAKPIN
E
>PK3-2_02975 Riboflavin synthase
MFTGIIEETGTIESMKKAGHSMALTIKCSKILEDVHLGDSIAVNGICLTVTDFTKNQFTV
DVMPETVKATSLNDLSKGSKVNLERAMAANGRFGGHFVSGHVDGTAEITRIEEKSNAVYY
DLKMDPSLTITLVLKGSITVDGVSLTIFGLTEDTVTISLIPHTIGETIFSEKTIGSKVNI
ECDMIGKYMYRFLHKANENKTQQTITKDFLNENGF
>PK3-2_02976 Riboflavin biosynthesis protein RibBA
MFHPIEEALDALKKGEVIIVVDDEDRENEGDFVALAEHATPEVINFMATHGRGLICTPLS
EEIADRLDLHPMVEHNTDSHHTAFTVSIDHRKTKTGISAQERSFTVQALLDSKSVPSDFQ
RPGHIFPLIAKKGGVLKRAGHTEAAVDLAEACGSQGAGVICEIMNEDGTMARVPELNEIA
KKHQLKMITIKDLIQYRYNLTTLVEREVDITLPTDFGTFKVYGYTNEVDGKEHVAFVMGD
VPFGEEPVLVRVHSECLTGDVFGSHRCDCGPQLHAALTQIAAEGRGVLLYLRQEGRGIGL
INKLKAYKLQEQGYDTVEANEELGFLPDLRNYGIGAQMLRDLGVQNMKLLTNNPRKIAGL
EGYGLSISERVPLQMEAKEHNKKYLQTKMNKLGHLLHF
>PK3-2_02977 6,7-dimethyl-8-ribityllumazine synthase
MNIIQGNLVGTGLKIGIVVGRFNDFITSKLLSGAEDALLRHGVDTNDIDVAWVPGAFEIP
FAAKKMAETKKYDAVITLGTVIRGATTHYDYVCNEAAKGIAQAANTTGVPVIFGIVTTEN
IEQAIERAGTKAGNKGVDCAVSAIEMANLNRSFE
>PK3-2_02978 Protein RibT
MLIRYKKSFEKIAMGLLSFMPNEKDLKQLQQTIKDYETDTDRQLFLWKEDEDIVGAIGVE
KKDSEVEIRHISVNPSHRHQGIGKQMMDALKHLFKTQVLVPNELTQSFFERCQGQQDQDI
SYNN
>PK3-2_02979 hypothetical protein
MYPKAYIDYLVEFHATRDYFECHEILEEYWKEDPPKKRKRYWVGFIQLAVALYHHRRQNT
AGAKRLMANSIRILQSEKQAVEGLGLDHSRLLKLMQSIYEQIATGSSYRSIMLPIKDEKL
EEACRIECIKKEYTWGQPSTLTDTFLIDKHRLRDRTDVILEREKEIERRKKSRG
>PK3-2_02980 Segregation and condensation protein A
MKIDTFEGPLDLLLHLINRLEIDIYDIPVAKITEQYLLYVHTMRVLELDIASEYLVMAAT
LLSIKSRMLLPKQEEELFEDELLEEEDPREELIEKLIEYRKYKDAAKDLKEREEERQKSF
TKPPSDLSEYAKEVKQSEQKLSVTVYDMIGAFQKVLKRKKITRPMETTITRQEIPIEGRM
NEIVHSLKSRGTRINFMDLFPYEQKDHLVVTFLAVLELMKNQLVLIEQEHNFSDIYITGS
ESIHGA
>PK3-2_02981 Segregation and condensation protein B
MGLDIVNWKAIVEALLYAAGDEGLTKKQLLTVLEIEEPELNTIMADVAEEYRGDMRGIEL
IEYADTYMLSTKKDFAPYLKKLIEVPSKGLSQASLEVLAIVSYKQPITRAEIEEIRGVKS
ERILHSLVSKALLCEVGRADGPGRAILYGTTPTFLEQFGLKTLDELPPLPENAEEDVLQE
EADLFFEN
>PK3-2_02982 hypothetical protein
MKEAKCERQRHEGKIPSEMGHSIVRAQTQKTGEFLSMVVNTVNDYLNQTTLESLQAELPV
EKGYCCDVLSTLRRMTVFCEGGAEACRRLLMQETFQEARAEKTLYNVYHQCIEEFFMPKK
DTWCENSRASYTGVSAIEFYHAVPASLEQLLLPLSAAFLKMREELSHYEASGSNMASIR
>PK3-2_02983 D-alanyl-D-alanine carboxypeptidase DacB
MRIFKKAVFMVIISFLIANVNVNTAHAAIDVSAKSAIVIDGASGRVLFAKDEHEKRRIAS
ITKIMTAVLAIESGKMDETVTVSANAVRTEGSAIYLTEGQKVKLKDLVYGLMLRSGNDAA
AAIAEHVGGSLDGFVYMMNQKAEQLGMENTRFQNPHGLDDHENHYSTAYDMAILTKYAMK
LKDYQKISGTKIYKAETMESVWKNKNKLLTMLYPYSTGGKTGYTKLAKRTLVSTASKDSI
DLIAVTINDPDDWDDHMNMFNYVFDHYQTYLIAKKGDIPKLKGTFYESKAFIKRDITYLL
TKEEKEDVKIKTTLLKPKKAWEKDASKIPDIVGHMNIMFNDETIAKVPIYYENERHQKPK
KQFFETFKSIFLNAAGGAKWSI
>PK3-2_02984 Spore maturation protein A
MVNIIWVSLTVIGLVFAMCNGTLQDVNEAVFKGAKEAVTISFGLMSVLVFWLGLMKIAEQ
SGLLDIFSRMCRPFISKLFPDIPPDHPAMGYILSNLMANFFGLGNAATPLGIKAMEQMKK
LNGNRSEASRSMITFLAVNTSCITLIPTTVIAVRMAYSSKTPTDIVGPSILATLISGIGA
IIIDRYFYYRRKKKGR
>PK3-2_02985 Spore maturation protein B
MEIINWLSLAMIPIIIAGILLYGTIKKVPTYESFVEGGKEGIEIAFSIIPYLVGMLVAIT
VFRSSGALDFIMDLLKPVFSAIGIPAEVVPLALIRPISGTAALGMTTDLIAVYGPDSFIG
RLASVMQGSTDTTLYVLTVYFGAVGIKKMGDALKVGLLADLIGVVASIIIVTLLFGSA
>PK3-2_02986 Ribosomal large subunit pseudouridine synthase B
MERLQKVIAHAGVASRRKAEELIKEGKVKVNGKVVTELGVKVTGSDQIEVNGLKVEREEP
VYFLLYKPRGVISAAQDDKGRKVVTDFFKEIPQRIYPIGRLDYDTSGLLLLTNDGEFANK
LMHPKYEIDKTYVAKVKGIPPKELLRKLERGIRLEEGKTAPAKAKLLSLDKKKQTSIIQL
TIHEGRNRQVRRMFEAIGHEVIKLKREEYAFLNLRGLHTGDARELTPHEVKRLRALAEHG
KNAF
>PK3-2_02987 Thiol-disulfide oxidoreductase ResA
MKKKRRLFIRTGILLVLICALGYTIYNAVFAGKESISEGSDAPNFVLEDTNGKRIELSDL
KGKGVFLNFWGTWCEPCKKEFPYMANQYKHFKDQGVVVVAVNVGESKIAVHNFMKSYGVN
FPVVLDTDRQVLDAYDVSPLPTTFLINPEGKVVKVVTGTMTESMIHDYMNLIKPGETSG
>PK3-2_02988 Cytochrome c biogenesis protein CcsB
MKQVKCECGHVNPVGTVLCESCGRALQETQPPLADMRYDGSARRSQTYNKTIIDKIWNFF
SSVKVGIWLIVITLAASAFGTIFPQEAYLPPGAQADTYYKEQYGMFGQLYYLLGFHHLYG
SWWYLLLIASIGISLVICSLDRVIPLYRALKNQGVRRSPAFLKRQRLFSETDTVLNGEAK
EKIVALLKKKHYRIREKEGSILAEKGRFSRWGPYVNHIGLIIFLIGAMLRFVPGMYVDET
LWVREGETAAIPGTDGKYYLKNNQFSVETYNSKAEKKVFADAIDRVGDGRVAKNFQTDAV
LYKREGKIVYGEKPKLKKVTEENIRVNQPLRFDSFSVYQVDYKENQLDQMVFQLIDKKTK
KSFGSLKINLLDPDSVYDLGNGYKVEIASYLPDFYFNQDGEPSTKTKIPNNPAFVFNIIT
PDKPKGEKSFVAIQETIEGSGSNKYKLKFDHVETKNITGLTVRKDLTLWVLAVGGAIFMI
GVIQGMYWQHRRIWLHSQGGAVMVAGHTNKNWYGLRKDLSFVLADSGLTEPKDQKELIKT
EK
>PK3-2_02989 Cytochrome c biogenesis protein CcsA
MAELSGNFLYAAFLVYLIAVPIFGGAIRGNKDKKGKPNRWANIGITLSIIGFLCHLCYFI
TRWAASGHAPVSNMFEFTTAFGMMLVLAFIILYFIYRLPSLGLFTLSIALLLIAYASMFP
TDISPLIPSLQSNWLYIHVTTAALGQAILAISFVAGVIFLLKHVDQTKPGKKTFWLEAIM
FILVTTVAFIVITSAFRLAGYEAEFNWVDKNKEKSVMVYEMPALVGPHGGELLTEGRMEP
LAELPALFSGRKVNTVIWSFGAGFVLYGALRLIIRKRISALLHPLVKNVNLDLVDEVGYR
AVSIGFPIFTLGALIFAMIWAQLAWTRFWGWDPKEVWALITFLFYAAYLHLRLSRGWHGE
KSAWLAVIGFAIIMFNLIFVNLVLAGLHSYA
>PK3-2_02990 Transcriptional regulatory protein SrrA
MDQMNETKILVVDDEARIRRLLRMYLERENYVIDEAENGDEAIAKGLEANYDLILLDLMM
PGTDGIEVCRQVRDKKATPIIMLTAKGEEANRVQGFEAGTDDYIVKPFSPREVVLRVKAL
LRRASQTSYFNANTPTKNVLVFSHLSIDHDAHRVTADGTEVSLTPKEYELLYFLAKTPDK
VYDREKLLKEVWQYEFFGDLRTVDTHVKRLREKLNKVSPEAAKKIVTVWGVGYKFEVGAE
>PK3-2_02991 Sensor histidine kinase ResE
MKFWKSVVGKLWFTILSLVLIVLFILTVLLLEFIENYHVEEAENDLTQLANKVAVIIENH
EDQALARSITWELADNLTSIAIIQDEKKHWYSPNDKNRLSSITVEQIQHDKDLNKALQNH
KKVSKRTGLSDTDTDNERLIVGVPYEKDGKKGMVFLSQSLLAVKDTTKHTTRYIFLAAGI
AIVLTTFFAFFLSSRVTYPLRKMREGAQDLAKGKFDTKIPILTQDEIGELATAFNQMGRQ
LNFHINALNQEKEQLSNILSSMADGVITINIDGTILVTNPPAERFLQAWYYEQNMNIKEG
DNLPPEAKELFQNAVSTEKEQMIEMTLQGRSWVLLMSPLYAESHVRGAVAVLRDMTEERR
LDKLREDFIANVSHELRTPISMLQGYSEAIVDDIASSEEDRKEIAQIIYDESLRMGRLVN
DLLDLARMESGHTGLHYEKINVNEFLEKIIRKFSGVAKEKNITLHQDISLTEEEFMFDED
KMEQVFTNLIDNALRHTSSGGSVSIAVHSVKDGLKIDIKDSGSGIPEEDLPFIFERFYKA
DKARTRGRAGTGLGLAIVKNIVEAHNGSITVHSRMDKGTTFTFYIPTKS
>PK3-2_02992 ECF RNA polymerase sigma factor SigX
MEETFQLLYDTYHQDLYQFLFYMVKDKSQAEDLLQEVYIRVLNSYHTFEGRSSEKTWLLS
IARHVAIDWFRKQQTIRQRILGTFDWDTQDVRDQQLLPDELAVQHENVREIYAALDQCTI
DQRAVIILRFIQGYSIQETANALRFSESKVKTTQHRGLKVLRKHMELLREELMDDEVRME
RRTDKGVVKSTSGS
>PK3-2_02993 Anti-sigma-X factor RsiX
MKSEWNEEQIKELLNQLPAVKDHRSPQDIYKRLTMANSKKKPAVRWIGPACAAVIAVYIA
FIISPHFFDQAQPQQKEASQENAVTKTDTADSPKAALPLDQPSFVVPEKEQNNYITVAIA
DAETSTIIPVSIKKTNADQTIQDMLSKSGELGILDHNAITIPSFIDEVEIKEKTKQKELS
IRVRQPATAFSVKDDTLLKELLIESLKWSPYEKIKFLSEQNESGVRIGSYGTFTEISIPK
QSKRAYYLYQNKQGQDFFVPSKKTFDTVKEAIKEMESSSQEDTAPLIQTGAVQSVTKKQK
HLYIRFSKDSEVEDSIAGILMLEGLLLTAKEFGFTEVTFTETRTKKSADMT
>PK3-2_02994 3-dehydroquinate dehydratase
MNVLTIKGVSIGEGMPKIIVPLMGKTEKQILNEAEAVKSLNPDIVEWRVDVFEKANDREA
VVKLISKLRESLADKLFLFTFRTHKEGGIREIDESSYMALLEAAVQTKAIDLIDIELFTG
DANVKAFVSLAEENNVFVVMSNHDFEKTPAKNEILSRLRKMQDLGAHIPKIAVMPNDTGD
LLTLLDATYTMKTKYADRPIITMSMAATGLVSRLSGEVFGSACTFGAGEEASAPGQIPVS
ELRNVLEVLHKNT
>PK3-2_02995 IS3 family transposase ISBsu1
MHLGISRASYYRWKKNLMKGHPKRHLDKQIGTLCREHKYRYGYRKITAILKKRMRINHKT
VQRIMQKNQWQCQVKVKKRKKNGQPYAVVDNILDRNFQSDRPLEKLVTDITYLPYGQKQL
YLSSILDLYNGEVIAFTIGDKQDTDFVLDTLNQLPTLPENCVLHSDQGSVYTSYEYQKAV
NTKGITMSMSRKGTPADNASIESFHSSLKSETFYLNSIDRTTTAIVERTVIEYIHFYNNI
RIQTKLNNQSPINYRQLAV
>PK3-2_02997 IS3 family transposase ISBsu1
MGTRVSYPVEVKQKAVEMRLAGVPMKEIMQKLNIKNKTQIQTWLRWYKAGDTHRFEQPVG
KQYTYGKGPEYASELEKLQAENRYLRQQNEVLKKYNQLERKLIAKRQSNL
>PK3-2_02998 D-3-phosphoglycerate dehydrogenase
MFRVLVSDKMSNDGLQPLIESDFIEIVQKNAADAEDELHTFDALLVRSATKVTEDLFKKM
TSLKIVGRAGVGVDNIDIDEATKHGVIVINAPNGNTISTAEHTFAMISSLMRHIPQANIS
VKSREWNRTAYVGSELYGKTLGIVGLGRIGSEIAQRARAFGMTVHVFDPFLTEERAKKIG
VNSRTFEEVLETADIITVHTPLTKETKGLLNKETIAKTKKGVRLINCARGGIIDEAALLE
ALESGHVAGAALDVFEVEPPVDNKLVDHPLVIATPHLGASTKEAQLNVAAQVSEEVLQFA
KGLPVMSAINLPAMTKDEFAKIKPYHQIAGKIGSLVSQCMKEPVQDVAIQYEGTIAKLET
SFITKSLLSGFLKPRVDSTVNEVNAGGVAKERGISFSEKISSSESGYDNCISVKVTGDRS
TFTVTATYIPHFGERIVEINGFNIDFYPTGHLVYIQHQDTTGVIGRVGRILGDNDINIAT
MQVGRKEKGGEAIMMLSFDRHLEDKIVKELTDIPDIVSVKLIDLP
>PK3-2_03000 hypothetical protein
MALSPRAVFTAGFGEIPEPTVQSGWEKMEVHKRFEIGFSNVSLPSLIFETPLLYMKRFFY
WLEKNLSVFE
>PK3-2_03001 hypothetical protein
MKVKKLVVISMLSSIAFVLMLLNFPFPGLPDYLKIDFSDVPAIIAILIYGPLAGIAVEAI
KNVLQYIIQGSMAGVPVGQIANFIAGTLFILPTAFLFKKLNSAKGLAVSLLLGTAAMTIL
MSILNYVLILPAYTWFLHSPALSDSALKTAVVAGILPFNVIKGIVITIVFSLIFIKLKPW
IEQQRSAHIHYIKKLPQGSFFCYFYSNLSGSPSNGSSATLMESVGHPSNASIISSSSTSG
TSTTPLFSSSVTNAMPSSS
>PK3-2_03002 hypothetical protein
MDRLSLNYFDIMALDCLCKINGERSGSAVFHLFKGKRSSQTIQDAGLFQTAKYFGMAAQC
SRSDISASLNKLEQHSYLEPMSETDTYKVTACGAAALKHALSEKPWPVYCHGAYYQQAAG
VLWKRLSLLVQVLSHKLRGSRQYIPVTKDHKTLHWVKKYLSRHTDHIEMANSLFSMLEAH
LHEIDEKAAQIFVYSLTSHDRIGYTSRQLADTMREDEWYVYIMFWASVHYFIHSLPECED
TLLKDLLSDVHLDNALTESTRKTWQMVKRGIPIHRIAEIRKLKTATIEDHIVEISLHEPA
FMINDYVSAEDQIQIAEFAKRMRTNKIKQIRDGLGQRFSYFQIRLALTKQVQQYD
>PK3-2_03003 ATP-dependent RNA helicase DbpA
MTKLQQTLHHFFGFTSFKKGQEDIIRSILSGKDTIAMLPTGGGKSLCYQLPGYMLDGMVL
IVSPLLSLMEDQVQQLKARGEKRAAALNSMLSRQERQFVLEHIHRYKFLYLSPEALQSPY
VLEKLKTVPISLFVIDEAHCISEWGHDFRPDYSKLGQLRKQLGHPPVLALTATATKDTLQ
DVMNLLELQHAERHLNSVNRPNIALRIENAADTAEKIDRVIQLVENLQGPGIVYCPTRKW
AEELAGEIKNRTSSRADFYHGGMESGDRILIQQQFIHNQLDVICCTNAFGMGVDKPDIRY
VIHFHLPQTAEAFMQEIGRAGRDGKPSVSILLRAPGDFELQEQIIQMESVTAEEIANVIR
VLEKTDERDERRLRDVLMQYGIGETQARMMIHLFMQGKTSIELMKREISYRMELKMEKMR
RVSFLLQRDGCLRESLLTYFDESYEPDDGYLPCCSQCGFDLSLYEQKGERSKMTPLDSWS
SELHRIFSMQTVGELN
>PK3-2_03004 hypothetical protein
MSDRDMLKQLYLTQLLIIIVAAGAGFFFFEDVRDVLKLWDIRDMRIIWYGVSIAIIVILA
DMAVMKWCPPHLYDDGGINKKIFSKRSIPHIIFLTLLIAFAEEMLFRGVLQTHIGLWAAS
LIFAVLHFRYLSKWLLFIMVTAISFLLGLIYEWTGNLFVPVTAHFVIDAVFACQIRFEHV
RRDIHDEHVESGEKKSPGSL
>PK3-2_03005 hypothetical protein
MTNMSRVERRKAQDLYEDQNAASAEDYFDDDGESLPTRQSVKNQREQKKKQGKTKTPLFT
VLAVLFVFVPVIVLVTLFYLKSHPDNHDDYEDVFYDSSQSKYEILPKSEDKKDTADTDKN
TKETALQKESKKSLKMLRQMGRQTQRLIRNSQL
>PK3-2_03006 hypothetical protein
MESLWNQLDQFTDAPTKQMLQALVKRKQKFENYALQCRRWRWASLICLGLLCLMIMVKSP
APQLVLQEMLSHTFYLFWMMATAFAYCTSYYFKKKEEKAEGDFHKLRCEIIQKSTDLWPQ
PDKWKARESVFQMMKHRYDINLYFESK
>PK3-2_03007 putative protein YpbG
MKLSVKIASVLTVAAAAMTAKMYSTAKGNHLKTHTFPLSKMKGKPPLTIFFISDIHKRLI
DQDLLEKTRRYAPHLVIIGGDLAEGGVPIARIEENIKRLADFGVPVVFVWGNNDYEVKQH
KLYSIFKAHGVITLRNESVPFSYNGHTIAIAGVDDIRMEMDHYEKAIKELDKSRLNILVC
HNPEIHEQINEADGIDVIFSGHTHGGQIRFGKFGPYELGKTGIVKNAAYLISNGYGTTKV
PLRLGAEPETHIVTLYAPE
>PK3-2_03008 Adapter protein MecA 2
MRLERLNYNKIKIFLTLDDLTDRGLTKEDLWKDSFKVHQLFKDMMNEANTELGFEANGPI
AVEVYSLQAQGMVVIVTKNQDADSEEDEYDDDYIEMQVKLDESADIIYQFHSFEDIIQLS
ESLQRIGITGGTVYHYDGQYFLSLEDLGSHTAEGVVAVLAEYGNPTTLTIYRLQEYGKLI
MDGNAVETIQTHFS
>PK3-2_03009 Cryptic catabolic NAD-specific glutamate dehydrogenase GudB
MAADRNTGHTEEDKLDVLKSTQTVIHKALEKLGYPEEVYELLKEPMRLLTVKIPVRMDDG
SVKIFTGYRAQHNDSVGPTKGGIRFHPNVTEKEVKALSIWMSLKCGIIDLPYGGGKGGIV
CDPRDMSFRELERLSRGYVRAISQIVGPTKDVPAPDVFTNSQIMAWMMDEYSRIDEFNSP
GFITGKPLVLGGSHGRESATAKGVTICIKEAAKKKGIDIKGARVVVQGFGNAGSYLAKFM
HDAGAKVVGISDAYGGLYDPEGLDIDYLLDRRDSFGTVTKLFNDTITNQELLELDCDILV
PAAIENQITEENAHNIQAKIVVEAANGPTTLEGTKILSDRDILLVPDVLASAGGVTVSYF
EWVQNNQGFYWGEEEVEEKLEKMMVKSFNNIFEMAKNRRIDMRLAAYMVGVRKMAEASRF
RGWI
>PK3-2_03010 Ferredoxin--NADP reductase
MIQEKAIIIGGGPCGLSAAIHLKQIGIDALVIEKGNVVNSIYNYPTHQTFFSSSEKLEIG
DVAFITENRKPVRIQALSYYREVVKRKNIRVNAFEMVRKVTKTENNTFVIETSKETYTAP
YCIIATGYYDHPNYMNVPGEDLPKVFHYFKEGHPYFDKDVVVIGGKNSSVDAALELVKSG
ARVTVLYRGTEYSPSIKPWILPEFESLVRNGTIRMEFGASVEKITEDEVVFRSGEKELIT
VKNDFVFAMTGYHPDHQFLEKMGVEIDKETGRPFFNEETMETNVEGIFIAGVIAAGNNAN
EIFIENGRFHGGHIAEEIAKRENH
>PK3-2_03011 Protease PrsW
MFAIISAGIAPGIALLSYFYLKDQYDNEPVHMVLRSFFLGVVLVFPIMFIQYVLEKENVG
GGSFFVSFLSSGFLEESLKWFILMVSVYPHAHFDEHYDGIVYGASVSLGFATLENILYLI
GHGVEHAFVRALLPVSCHALIGVIMGFYLGKARFSADKARVKWLILSLAVPSLLHGSYDF
ILIALSNWIYYMFPFMLFLWWFGLRKAKKARSVNMMQV
>PK3-2_03012 Spore cortex-lytic enzyme
MKSKGSIMACLILFSFTISTFINTETISAFSNQVIQRGATGDDVVELQARLQYNGYYNGK
IDGVYGWGTYWAVRNFQDQFGLKEIDGLVGAKTKQTLISKSKYYREYVMQQLQKGNTFTH
YGKIPLKYQTKPSKSATQKARQQAEARQKQPAEKTTQQPKANKQQNNTPAKARKQDAVAA
NMPGGFSNNDIRLLSQAVYGEARGEPYEGQVAIAAVILNRLNSPLFPNSVAGVIFEPLAF
TAVADGQIYMQPNETAREAVLDAINGWDPSEEALYYFNPDTATSAWIWGRPQIKRIGKHI
FCE
>PK3-2_03013 Sporulation protein YpeB
MIRGILIAVLGIAIVGTGYWGYKEHQEKDAVLLHAENNYQRAFHELTYQMDQLHDKIGTT
LAMNSQKSLSPALVDVWRITSEAHNSVSQLPLTLMPFNKTEELLSKIGDFSYKTSVRDLD
QKPLDKKEYTSLNKLYQQSEDIQNELRHVQHLVMSKNLRWMDVEMALASDEKQSDNTIIN
SFKTVEKNVGAFSTGTDLGPSFTSTKKEDKGFSHLKGKQISEQEAKQIAERFAPDDNYSI
KVVKSGKKTNRDVYSISMKDPDHKAAIYMDITKKGGHPVYLIQNREVKDQKISLNDGSNR
ALAFLKKNGFETGDLEIDESAQYDKIGVFSYVPVENKIRMYPEAIRMKVALDDGEVVGFS
ARDFLTSHRKRDIPKPAITEAQAKSKLNKNVQVRETRLALITNELGQEVLCYEMLGTIEN
DTFRMYINANDGSEEKVEKLKNAEPIYKDL
>PK3-2_03014 putative protein YpfA
MIEIGENVLLEYIEENELKKAKSKAVSIENNELLIAYPVDIVTGRTVILHNDMEVTVEFV
GKDEVPYRFTSRIKGKVKDKLQMICLEVPPREKMKRIQRRQYVRTDAVLDVQIQPVNKEG
FRTLSYNISAGGIAVILAEGRSFQSGESLRLIISLSAEEENTRQIETEAVVRRIFDDPKS
GKCKMTLEYTGIAASDQQFLLQYCIRRQLKKRRKARME
>PK3-2_03015 hypothetical protein
MKTFERLLTKILFIQAIILLGVQFLFHYQHIEPYVSKVIQYEGVDKLEENSRIETFKH
>PK3-2_03016 Cytidylate kinase
MEKKLSIAIDGPAAAGKSTVAKIVAEKKSYIYIDTGAMYRAITYAALQENVDLTNEEKLA
ELLKRTDIELITTKEGQKVLVNGIDVTEAIRTDEVSNQVSIAAKHRSVREEMVKRQQQLG
EKGGVVMDGRDIGTHVLPNAEVKIFLLASVEERAKRRYEENVKKGYDVNYETLIEEIARR
DKLDSEREVSPLRKAEDALEIDTTSLSIQEVANKILEAVEQKSR
>PK3-2_03017 30S ribosomal protein S1 
MTEEMNQIDVQVPEVGDVVKGIVTKVEDKHVDVEIINVKQSGIIPISELSSLHVEKASDV
VKVDDELDLKVTKVEDDALILSKRAVDADRAWEDLEKKFETKEVFEAEVKDVVKGGLVVD
IGVRGFIPASLVEAHFVEDFTDYKGKTLSLLVVELDRDKNRVILSHRAVVESEQANKKQE
LLQSLEVGSVLDGKVQRLTDFGAFVDIGGIDGLVHISQLSHSHVEKPSDVVEEGQEVKVK
VLSVDRDNERISLSIKDTLPGPWSQIGEKVKPGDVLEGTVQRLVSFGAFVEILPGVEGLV
HISQISNKHIGTPHEVLEEGQTVKVKVLDVNENEERISLSMRELEEAPKADQEDYRQYQA
KEETSTGFQLGDLIGDKLNKLK
>PK3-2_03018 Isopentenyl-diphosphate delta-isomerase
MTRAERKRQHINHALSTGQKRETGLDDITLVHVSLPDLALEQVDISTKIGELSSSSPIFI
NAMTGGGGQHTYEINKSLARAARQAGIPLAVGSQMSALKDPSERFSYEIVRKENPNGLIF
ANLGSEATADQAKEAVDMIGADALQIHLNVIQEIVMPEGDRSFSGALDRIEQICSKVNVP
VIVKEVGFGMSKESAGKLYEAGAAAVDIGGYGGTNFSKIENLRRQRHISFFNSWGISTAA
SLAEIQSVFPGYTMIASGGLQDALDVAKAIAMGASCAGMAGHFLKVLTDSGEERLLEEIQ
LILEELKMIMTVLGAKTIADLQKVPLVIKGETHHWLTERGIDTSSYSVR
>PK3-2_03019 hypothetical protein
MGKDRQEKKLKASGRVESDRDQSIHYDGATSLEQNGEFKKRKS
>PK3-2_03020 hypothetical protein
MEQFYYYWSMWFLWVLTTFIFEKTKRRFAVSIFILTNIILSIHDITLYFSLNAAYMMFFI
CGCVYAGYLGMYHFRYLMVFLTLVAGYAFVYLFALYDPVWFIIKPEWAAVILIVLLTASV
ERDFEKQLALFILGMCQGELVYSFVIQKLAGALAVGGFQWLNACSAGMILLFGISKYEQL
ASQMGQKSKRSNKGATKMS
>PK3-2_03021 hypothetical protein
MSDYIYPIIAGVIAGIATRLYMLKTDYRQYPTYVHGKVIHIALGLIAAGLGAIIMPALLQ
EEFTAITFLTLAATQFRDVRNMERNTLTQMDSYELVSRGSTYIEGIAIAFESRNYIVIFT
ALLTTSAYVFLSIWAAVIAAVVCFLLAMKFMSGSVLKDIVDIKYIKPHFDGPGLFVDNIY
MMNIGLPEKQELILKHGMGFILTPKNFNSAATIANLGQRQAILFDVSNVLGVYRDSGEPS
LTPIAKRDLDDGRVAVFVLPQIHHPETAVQIISNVPTLENAIRMPTEFIKNQDKVIG
>PK3-2_03022 hypothetical protein
MSESLTKVILSVITTNRNRAAGGAPVFFCNDQKEMELFAKNLEAILDGIAHRIGDDVYLI
VKHF
>PK3-2_03023 GTPase Der
MGKPVVAIVGRPNVGKSTIFNRIAGERISIVEDTPGVTRDRIYSSAEWLNYDFNLIDTGG
IDIGDEPFLAQIRQQAEIAMDEADVIIFMVNGREGVTAADEEVAKILYRTKKPVVLAVNK
LDNTEMRANIYDFYSLGFGEPYPISGTHGLGLGDLLDAAAEHFKNIPETKYDEEVIQFCL
IGRPNVGKSSLVNAMLGEERVIVSNVAGTTRDAVDTAFTYNQQEFVIVDTAGMRKKGKVY
ETTEKYSVLRALKAIDRSEVVAVVLDGEEGIIEQDKRIAGYAHEAGKAVVIVVNKWDAVD
KDESTMKEFEENIRDHFQFLDYAPILFMSALTTKRIHTLMPAIIKASENHSLRVQTNVLN
DIIMDAVAMNPTPTHNGSRLKIYYATQVAVKPPSFVVFVNDPELMHFSYERFLENRIRDA
FGFEGTPIKIFARARK
>PK3-2_03024 Glycerol-3-phosphate dehydrogenase [NAD(P)+]
MKRVTMLGAGSWGTALALVLADNHHDVTMWGHRADLIHQINDQHENKDYLPNVKLPESIA
ATTDIEKAVSDADFIIVAVPTKAIREVLRQAVPFITKKAVFVHVSKGIEPDSLLRISEIM
EIELPNDTRKDIVVLSGPSHAEEVGMRHPTTVTSSSKSMRAAEEVQDLFINHNFRVYTNP
DIIGVEIGGALKNIIALAAGITDGLGYGDNAKAALITRGLAEIARLGTKMGGNPLTFSGL
TGVGDLIVTCTSVHSRNWRAGNLLGKGYKLNDVLEEMGMVVEGVRTTKAAYQLSQKYDVK
MPITEALHQVLFNGQKVETAVESLMARGKTHEMEDLVNTFENQVK
>PK3-2_03025 hypothetical protein
MSLALMKMWFALGSMGLMFLAVASIYLSRFKFQNRFLKIAVSSFAFTCMLISGIIVFVVV
FSGPVNE
>PK3-2_03026 hypothetical protein
MGKLKCAMIFAAAVFLSGCLYPNERKSSVHAIPYQDQLKQVQSAVDEFQKANGGLLPIQT
KDMSTPLYQKYPIDFNRLAPRYMAEPPSTAYESGGDYQYVLVDVENDPTVKLIDLKMAER
IREVKLRVQMYRQEHQYPPYKGVLSRDLFTLDDNKLGDGTSLTVTSPISGDSLPLMIDGD
GEIYADYRTELASFLKKSKKTVKPGSEIQDMIWQETPFVPAFSVKYTVNDKQEPVFLEND
MKKE
>PK3-2_03027 Stage IV sporulation protein A
MEKVDIFKDIAERTGGDIYLGVVGAVRTGKSTFIKKFMELVVLPNISNEADRARAQDELP
QSAAGKTIMTTEPKFVPNQAMSVHVSDGLDVNIRLVDCVGYTVPGAKGYEDENGPRMINT
PWYEEPIPFHEAAEIGTRKVIQEHSTIGVVITTDGTIGDIARSDYIEAEERVIEELKEVG
KPFIMVINSVRPYHPETEAMRQDLSEKYDIPVLAMSVESMRETDVLNVLREALYEFPVLE
VNVNLPSWVMVLKENHWLRESYQESVKETVKDIKRLRDVDRVVGHFSEFEFIESAGLAGI
ELGQGVAEIDLYAPDHLYDQILKEVVGVEIRGRDHLLELMQDFAHAKTEYDQVSDALKMV
KQTGYGIAAPALADMSLDEPEIIRQGSRFGVRLKAVAPSIHMIKVDVESEFAPIIGTEKQ
SEELVRYLMQDFEDDPLSIWNSDIFGRSLSSIVREGIQAKLSLMPENARYKLKETLERII
NEGSGGLIAIIL
>PK3-2_03028 DNA-binding protein HU 1
MNKTELINAVAEASELSKKDATKAVDSVFDTILDALKNGDKIQLIGFGNFEVRERSARKG
RNPQTGEEIEIPASKVPAFKPGKALKDAVAGK
>PK3-2_03029 GTP cyclohydrolase 1
MKEVNKEQIEQAVRQILEAIGEDPNREGLLDTPKRVAKMYAEVFSGLNEDPKEHFQTIFG
ENHEELVLVKDIAFHSMCEHHLVPFYGKAHVAYIPRGGKVTGLSKLARAVEAVAKRPQLQ
ERITSTIAESIVETLDPHGVMVVVEAEHMCMTMRGVRKPGAKTVTSAVRGVFKDDAAARA
EVLEHIKRQD
>PK3-2_03030 Transcription attenuation protein MtrB
MNEKHSSDFVVIKAVEDGVNVIGLTRGTDTKFHHSEKLDKGEVIIAQFTEHTSAIKVRGE
ALIQTAYGEMKSEKK
>PK3-2_03031 Heptaprenyl diphosphate synthase component 1
MIFLQDIYGTLANLNTKLKQKLSHPYLAKHISAPKIDEDKLLLFHALFEEADIKNNDREN
YIVTAMLVQSALDTHDEVTTARVIKRDENKNRQLTVLAGDYFSGLYYSLLSEMKDIYMIR
TLATAIKEINEHKIRLYDRSFKDEHDFFESVGIVESALFHRVAEHFNLPRWKKLSSDFFV
FKRLMNGNDTFLDVIGSFIQLGKTKEEILEDCFKKAKNSIESLLPLNSPIQHILLNRLKT
ISQDQTYHQKVEEG
>PK3-2_03032 Demethylmenaquinone methyltransferase
MQDSKEQRVHGVFEKIYKNYDQMNSVISFQQHKKWRDKTMRIMNVKEGAKALDVCCGTAD
WTIALAKATGKTGEVKGLDFSENMLSVGQQKVKAGGFSQIELLHGNAMELPFDDDTFDYV
TIGFGLRNVPDYLTVLKEMRRVVKPGGQVVCLETSQPEMFGFRQAYFMYFKYIMPFFGKL
FAKSYKEYSWLQESAREFPGMKELAGLFEEAGLKNVKYHSFTGGVAATHIGWK
>PK3-2_03033 Heptaprenyl diphosphate synthase component 2
MSNIIRLLAESLPRISDGNENTDVWVNDMKFKMAYSFLNDDIDVIERELEQTVRSDYPLL
SEAGLHLLQAGGKRIRPVFVLLSGMFGDYDINKIKYVAVTLEMIHMASLVHDDVIDDAEL
RRGKPTIKAKWDNRIAMYTGDYMLAGSLEMMTRINEPKAHRILSQTIVEVCLGEIEQIKD
KYNMEQNLRTYLRRIKRKTALLIAVSCQLGAIASGADEKIHKALYWFGYYVGMSYQIIDD
ILDFTSTEAELGKPVGGDLLQGNVTLPVLYALKNPALKNQLKLINSETTQEQLVPIIEEI
KKTDAIEASMAVSEMYLQKAFQKLNTLPRGRARSSLAAIAKYIGKRKF
>PK3-2_03034 Nucleoside diphosphate kinase
MEKTFIMVKPDGVQRQLVGDILSRFERKGLQLAGAKLMRVTEQMAEKHYAEHQGKPFFGE
LVEFITSGPVFAMVWEGENVIEVTRQLIGKTNPKEALPGTIRGDYGMFVGKNIIHGSDSL
ESAEREINIFFKNEELVSYQQLMAGWIY
>PK3-2_03035 Chemotaxis protein methyltransferase
MAVVHQTSAFPIDLKSAEKLIFLLKQYNFLRKQAILGQKDSETGRVEMDTYSVFTAKWKQ
LTGVDLTLYKEAQMKRRLTSLYEKKGFQSFKDFAAALEKDQALLNETLDRMTINVSEFYR
NYKRWEVLETAILPLIKTSKPLKIWSAACSTGEEPYTLAMLLDQQKGLSGYQIMATDIDE
KALEKAKKGVYQERSLQEVPTSVKDRYFTQNANRSYEVKPEIKKNITFKKHNLLADRYEQ
DFDLIVCRNVFIYFTESAKEELYLKMAHSLKKNGVLFVGSTEQIFNPEKFGLNPADTFFY
QKR
>PK3-2_03036 Chorismate synthase
MRYLTAGESHGPQLTTIIEGVPAGLYITEEDINFELARRQKGHGRGRRMQIEKDQAKIMS
GVRHARTLGSPIALVVENNDWKHWTKIMGAAPITEDEEKEMKRQISRPRPGHADLNGAIK
YNHRDMRNVLERSSARETTVRVAAGAVAKKILSELGIKVAGHVLQIGAVKAEKTEYTSIE
DLQRVTEESPVRCYDEEAGKKMMDAIDEAKANGDSIGGIVEVIVEGMPVGVGSYVHYDRK
LDSKLAAAVLSINAFKGVEFGIGFEAAGRNGSEVHDEIIWDEEKGYTRATNRLGGLEGGM
TTGMPIVVRGVMKPIPTLYKPLKSVDIETKEPFSASIERSDSCAVPAASVVAEAAVAWEI
ANAVVEQFGLDQIDRIRENVENMRKLSREF
>PK3-2_03037 3-dehydroquinate synthase
MKTLHVQTASSSYPVFIGQDIRKEACELLTSLNRPLTRIMLVTDEEVDRLYGEEMLHLLQ
EKWPVKKVTVPSGEQAKSMDMYTKLQSEAIRFHMDRSSCIIAFGGGVVGDLAGFVAATFM
RGIDFIQMPTTLLAHDSAVGGKVAVNHPLGKNLIGAFYQPKAVLYDTDFLRSLPEKELRS
GMAEVIKHAFIYDRAFLEELLNIRSLHDITSDQLNDMIFKGVSIKASVVQQDEKEEGIRA
YLNFGHTLGHAVEAEYGYGQITHGDAVALGMQFALFISEKAADCEMDRKHLVSWLKSLGY
PSQIKKETETSVLLDRMMNDKKTRGGKIQFIVLNELGKVADHTFSRNELESWLNKWRMEE
TS
>PK3-2_03038 Chorismate mutase AroH
MMIRGIRGATTVERDTEEEILQKTKQLLEKIIEENKTKPEDVVQMLLSATPDLHSVFPAK
AVRELSGWQYVPVTCMQEMDVTGGLKKCIRVMMTVQTDVPQDQIRHVYLEKAVVLRPDLS
LTKNTEL
>PK3-2_03040 Anthranilate synthase component 1
MNFQSNISAFLQDSLSCHTIPIVETFTVDTLTPIQMIEKLDREITYLLESKDDTSNWSRY
SFIGLNPFLTIKEEQSRFTAVDQDGKSLYTGNELKEVLNWMNTTYNIKTPELGIPFVGGA
VGYLSYDMIPLIERSVPPHTKETGMEKCMLFVCRTLIAYDHETKNVHFVQYARLNGEETE
SEKINVFHQNHQELQDLIEKMTDQKNIKELFLSADSYKTPSFETVSSNYEKSAFMADVEK
IKEYIKAGDIFQGVLSQKFEIPISADAFELYRVLRIVNPSPYMYYMKLQDREIVGSSPER
LIHVQDGHLEIHPIAGTRKRGADKEEDEKLKLELMKDEKEKAEHYMLVDLARNDIGRVAE
YGSVSVPEFTKIVSFSHVMHIISVVTGRLKKGVHPVDALMSAFPAGTLTGAPKIRAMQLL
QELEPTPRETYGGCIAYIGFDGNIDSCITIRTMSVKDGVASIQAGAGIVADSIPEAEYEE
SCNKAGALLKTIHIAEDMFHSKEDKADEQISTIVR
>PK3-2_03041 Anthranilate phosphoribosyltransferase
MNRFLQLCVDGKTLTAGEAETLMNMMMAAEMTPSEMGGILSILAHRGETPEELAGFVKAM
RAHALTVDGLPDIVDTCGTGGDGISTFNISTASAIVASAAGAKIAKHGNRSVSSKSGSAD
VLEELEVPIQTTPETVKKSIAANNMGFLFAPLYHSSMKHVAGTRKELGFRTVFNLLGPLS
NPLQAQRQVIGVYSVEKAGLMASALETFQPKHVMFVSSRDGLDELSITAPTDVIELKNGE
RREYTVSPEDFGFKNGRLEDLQVQSPKESACLIQNIFENKSSRSALSITAFNAGAAIYAA
GITSSLKEGTELALETITSGGAAAQLERLKQKEEEIYA
>PK3-2_03042 Indole-3-glycerol phosphate synthase
MLENIIKQKKEEVRTLVLPEEQPFEKRSFKEALASPNRMIGLIAEVKKASPSKGLIKENF
VPVQIAKDYETAQADALSVLTDTPFFQGKNSYLSDVKRAVSIPVLRKDFIIDSLQVEESR
RIGADAILLIGEVLDPLHLHELYLEAGEKGMGVLVEVHDATTLERILKVFTPDILGINNR
NLKTFETSVKQTEQISSLVPKESLLVSESGIGSLEHLTFVKKHGARAVLIGESLMRQTSQ
QKAIYALFGE
>PK3-2_03043 N-(5'-phosphoribosyl)anthranilate isomerase
MKKPALKYCGIRSLQDLQLAADSQADFLGFIFAESKRQVSPRDVKKWMRKVRVEKQVAGV
FVNESIETMARIAEDLNLDVIQLHGDEEPADADALRMLTGCEIWKALHHHENTIQEIARY
KGNVDGFVIDSSVKGARGGTGVAFSWDCVPEYQQAALGKRCFIAGGVKPDTITDLLKWQP
IGIDLASGIEKNGQKDRNLMKLLEERMNRYVSISK
>PK3-2_03044 Tryptophan synthase beta chain
MYPYPNEIGRYGDFGGKFVPETLMQPLEEIETAFKEIKDDPAFRTEYYKLLHDYSGRPTA
LTFADRVTEYLGGAKIYLKREDLNHTGSHKINNALGQALLAKKMGKTKIIAETGAGQHGV
AAATVAAKFGFSCTVFMGEEDVARQSLNVFRMKLLGAEVVPVTSGNGTLKDATNEAIRYW
VQHCEDHFYMIGSVVGPHPYPQVVREFQKMIGEEAKDQLKRIEGALPDKVVACVGGGSNA
MGMFQAFLDEEVELIGAEAAGKGIDTPLHAATISKGTVGVIHGSLTYLIQDEFGQIIEPY
SISAGLDYPGIGPEHAYLHKSGRVTYDSITDEEAVDALKLLSEKEGILPAIESAHALAKA
FKLAKEMDRDQTILVCLSGRGDKDVNTLINALEEEVKAHV
>PK3-2_03045 Tryptophan synthase alpha chain
MFKLDLQASEKLFIPFITAGDPSPEVSIQLAKSLQKAGATALELGVAYSDPLADGPVIQR
AAKRALDHGMNIVKAIKLGGEMKKNGVNIPIILFTYFNPVLQLNKEYFFALLRENHIDGL
LVPDLPLEESASLQAECKNHEVTYISLVAPTSESRLKTIIEQAEGFVYCVSSLGVTGVRN
EFNSSVYPFIRTVKDLSAVPVAVGFGISNREQVMKMNEICDGVVVGSALVRKIEELKDRL
INAETRDQALQEFEDYATAFGGLYSLK
>PK3-2_03046 Histidinol-phosphate aminotransferase
MRIKEHLKQLKPYQPGKPIEAVKAEYGLDKVVKLASNENPYGCSKAAKEALHHEIQQLAL
YPDGYSAALRTRLSEHLNVSETSLIFGNGSDEIIQIICRAFLNDKTNTITAAPTFPQYKH
NAVIEGAEVREIALRSDGSHDLDAMFEAIDEQTQVVWICSPNNPTGTYTSEGDLLAFLER
VPSRVLVVLDEAYYEYVTAEDYPETVPLLNKYSNLMILRTFSKAYGLAALRVGYGIADEN
LIRQIEPAREPFNTSRLGQAAAIAALDDQAFIASCVEQNKAGLQQYYDFAKTHGLKCYPS
QTNFVLIDFNRPSDELFQALLEKGYIVRSGNALGFPTSLRITIGTKEQNEEILAILAEIL
>PK3-2_03047 hypothetical protein
MNRMKDTILLAGLGLIGGSIALAIKKKHPGKRIIGIDISDEQAVAALKLGVIDERADSFI
SGAKEAATVIIATPVAQTLLMLDELAHSGIEHQLLITDVGSTKQKVVHYADQVLPSRYQF
VGGHPMAGSHKSGVAAAKEFLFENAFYILTPGQKTDRQAVAQLQNLLKGTNAHFVEMSPE
EHDGVTSVISHFPHIVAASLVHQTHHSEELYPLVKRFAAGGFRDITRIASSSPAMWRDIL
LHNKDKILDRFDEWIREIETIRTYVEQEDAEKLFRYFKTAKDYRDGLPLRQKGAIPAFYD
LYVDVPDHPGVISEITAILAAERISITNIRIIETREDINGILRISFQSDDDRKRAEQCIE
ARAEYETFYAD
>PK3-2_03048 3-phosphoshikimate 1-carboxyvinyltransferase 1
MKREKVQALNGEIHIPGDKSVSHRSVMFGALAKGTTTVKNFLPGADCLSTIDCFRKMGVQ
IEQNGSDVVIHGKGIDSLSEPESLLDVGNSGTTIRLMLGILAGRPFYSAVAGDESIAKRP
MKRVTEPLKQMGAKIDGRAGGEFTPLSVSGSSLKGIDYVSPVASAQIKSAVLLAGLQAEG
TTTVTEPHKSRDHTERMLSAFGVELSEDQTSVSITGGQKLTAADIFVPGDISSAAFFLAA
GAMVPNSSIVLKNVGLNPTRTGIIDVLQNMGAKLEIKPSANSSAEPYGDLVIETSDLKAV
EIGGDIIPRLIDEIPIIALLATQAEGTTVIKDAAELKVKETNRIDTVVSELRKLGAEIEP
TADGMKIYGKQTLKGGATVSSHGDHRIGMMLGIASCITEEPIEIKQTDAIHVSYPTFFEH
LNKLSNKS
>PK3-2_03049 Beta-barrel assembly-enhancing protease
MNTLIQEAIKLVEAGETEKGLNTLSKAENQLHDEDKAIAAQLYYEWGNVEKAISLISDLH
DLYPNETELTNFYAELLIDIDEEEKALAVLETIPETDPSYPESLLLMADLYQMQGLFEVS
EQKLLQAKSILDNEPVIDFALGELYFTQGAYAKAVQYFKTTAEEQSEIGGVNVHQRLAES
LSASGEFEDAIPSYEKAVDENPDPNTIFGYGFTALQAGLVKTAIKQLSDLKELDPSYSSL
YMPLSKSYEAEGMYEEALKTAKEGIRYDEYNKELFLYAAKMALKIGKSEEGKKLLQEALA
LDPGFVEALHTLLAVYHKEEDYEQIIDLIQEVRGYGEEDPKYNWYLASAYTELEQYEEAK
QSFEAAFLHYREDRDFLYEYASFLLEEGLQKEALPLLKKVLEIDGTNEELEETILRIEDE
FSR
>PK3-2_03050 hypothetical protein
MQTPVSVNEKKDFIRWFLNHYQLKRRECVWILNYLMSHDSLMEKVHFVEQAEFCPRGIIM
STHCVEEVPFRFYKENVMTTDAEKSFHDIRLNKQQDLFIQLNFRSAYSSPEYAAVLESNP
HIPKDLFENKKDQGLAEQILEHAISTFQREKLLKDIDEALDRHDKEAFEQLSRQLNQLT
>PK3-2_03051 hypothetical protein
MKWRITDAKDYLQSKDYIDTAVIPLISIKVGAHFKMAAEKGEFTQLLSDELERQLKGRVY
LLPPYTYVDRNEKTVQGLKDLREELISEFRHVVLLTSDESWNSENALGKIIVTPSVPLEH
LNDSLKRKILDERTGEILNVLLQLWSTP
>PK3-2_03052 Cytochrome b6-f complex iron-sulfur subunit
MGGKHDISRRQFLNYTLTGVGGFMAASMLMPMVRFALDPVLKATGKQDMVQVVSVDELTK
EPQRFDFKINQVDAWYESEESRSAWVFKNGDEIVALSPICKHLGCTVNWNSDPKNPNKFF
CPCHYGLYEKDGTNVPGTPPLAPLDHYEQEVKDGFLYLGKAKPKGEG
>PK3-2_03053 Menaquinol-cytochrome c reductase cytochrome b subunit
MLNKIYDWVDERLDITPMWRDIADHEVPEHVNPAHHFSAFVYCFGGLTFFVTVIQVLSGM
FLTMYYVPDIKNAWESVYYLQNEVAFGQIVRGMHHWGASLVIVMMFLHTLRVFFQGAYKK
PRELNWIVGVLIFFVMLGLGFTGYLLPWDMKALFATKVGLQIAEATPLIGTQVKTLLAGH
PDIVGAQTLTRFFAIHVFFLPAALFGLMAAHFIMIRKQGISGPL
>PK3-2_03054 Cytochrome b6-f complex subunit 4
MHRGKGMKFVGDSRIPAEKKPNIPKDYSEYPGKTEAFWPNFLLKEWMVGAVFLIGFLVLT
IVHQPPLERMADPTDTGYIPLPDWYFLFLYQLLKYEYAAGSFTVVGAMIMPGLAFGALLL
APFLDRGTERRPWKRPVAVGMMLLAISAAVFLTWQSVATHDWAKAEEQGKITKEADIDTN
AEGYKIFKEQGCISCHGDNLQGGAAGPSLVDTGLKPDEIKKIAVEGKGKMPAGVFKGNDK
QLEELAKFISETTAK
>PK3-2_03055 hypothetical protein
MKWFQYVLGQRPLLILVLAINFLGTVYGYYWYLPQLLETPARFLIFVPDSPTATFFFLFV
LLAFIMKRNAPLFEALALVTLVKYGLWAVAMNFLVLAVTGDLPWEGYMLIASHFAMAVQG
VLYSPYFRFSYWHLAIAAVWTLHNDVIDYLFDMMPQYSMLSDYMTDIGYGTFWLSIFSIG
LAYYLVVSKKQTKLELM
>PK3-2_03056 hypothetical protein
MKRKLTICLLIALIFYNGNAKAAERGSLEKLNDLSDTVFQMTRQSKYEEALQVLAYFEKT
LKSAGKKQQEPMLTGAQIRQITLGYNDMVRSLKQADTSDTQKLRAAAQFRMLMDAVDNRS
DPLWGSLEKPIMEAFAELKQDIQKNGSTSFHEKWNEFISLYDLIYPSLTIDVSEDQLETV
SKHIDVIEQEEFQQMTESTKLERLSLLQQDLKNVFDRVEEDDADPSLLWVIITTGSIIIT
ALTYVGYRKYKAEKNKLKKRDYPK
>PK3-2_03057 hypothetical protein
MLGEIRLKNIFFILIGAAIFSFGLVHFNMQNNLAEGGFTGITLLLYALFHISPSISNLVL
NIPIFFIGWRLLGRTMFVYTLVGTVALSLFLSIFQRYEIHMPLQHDLALAALFAGVFIGA
GLGIIFKFGGTTGGVDIIARLVNKYFGIPMGRTMFAFDACVIVLSLLTYLSYKEAMYTLV
AVFVAARLIDFIQEGGYAAKGATIISSKNDLIQKKILEEMERGVTILKGQGSYSKEDIDV
LYCVVPKNELVMLKSVINSVDPHAFVAVSDVHDVLGEGFTLDENKNPLPR
>PK3-2_03058 putative protein YpjD
MSDKTMKDIQAEVDRYIGQFKEGYFSPLAMMARMTEELGELAREVNHRYGEKPKKATEDD
KSMEEEMGDVLFVLVCLANSLDISLEEAHDRVMHKFNTRDKDRWTRKEEGK
>PK3-2_03059 4-hydroxy-tetrahydrodipicolinate reductase
MSNETIKVVIAGPRGRMGQEAVKLAERTPHFDLVGAIDHTYDQQKLSDVMSVESDALIYT
DIRACFNETQPDVLIDLTTPEIGKVHTKMALEHGVRPVVGTTGFSEADLKELTSLTEEKG
IGAIIAPNFALGAVLMMKFSKMAANYFEDVEIIELHHDQKLDAPSGTALKTAEMISEVRK
EKQQGHPDEKEILPGARGAEQNGIRLHSVRLPGLIAHQEVMFGMDGQTLQIRHDSYNRAS
FMSGVKLSVEQVMKIDQLVYGLENIID
>PK3-2_03060 Methylglyoxal synthase
MKIALIAHDKKKQDMVQFTTAYRDILSQHELYATGTTGLKIQEATGLQIERFQSGPLGGD
QQIGALIAANALDLVIFLRDPLTAQPHEPDVSALIRLCDVYAIPLATNMGTAEILVRTLD
EGVFEFRNLLRGEEPNV
>PK3-2_03061 N-acetyl-alpha-D-glucosaminyl L-malate deacetylase 1
MYNADVLAFGAHSDDVEIGMGGSIAKFVKQGKKVMICDLTEAELSSNGTVSLRKEEAAEA
GRILGAEKRIQLTLPDRGLLMSDQAIRTIVSVIRTCRPKAVFMPYKKDRHPDHGNAAALV
EEAIFSAGIHKYKDEKSLPAHKVSKVYYYMINGFHQPDFVIDISDTIEAKKQSLNAYKSQ
FIASKDSVSTPLTNGYIEIVEAREKLYGKEAGVGYAEGFFSKRMLMLDHDVLGGER
>PK3-2_03062 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MKKLKIGITCYPSVGGSGIIATELGKQLAEKGHEIHFITSSIPFRLNTYHPNIHFHEVEV
NQYAVFKYPPYDLTLASKIAEVAEREDLDIIHAHYALPHAVCAYLAKQMLKRNIGIVTTL
HGTDITVLGYDPSLKDLIRFAIEASDRVTAVSSALAAETYDLIKPEKKIETIYNFIDERV
YLKKNTAAIKEKHGILPDEKVVIHVSNFRKVKRVQDVIRVFRNIAGKTKAKLLLVGDGPE
KSTACELVRKYGLENQVLMLGNQDRVEELYSISDLKLLLSEKESFGLVLLEAMACGVPCI
GTNIGGIPEVIKNNVSGFLVDVGDVAAATARAMSILEDEQLSKRFTYAAMEMLKNEFSSQ
KIVSQYEQIYADLAEPE
>PK3-2_03063 CCA-adding enzyme
MEQVFIKALPVLHTLIEAGHQAYFVGGAVRDSYMKRTIGDVDIATDAAPDQVERLFQRTV
DVGKEHGTIIVLWEDETYEVTTFRTESEYEDYRRPSDVQFITSLEEDLKRRDLTINAMAM
TADGKVLDYFGGKKDIDQKLIRTVGKPEDRFQEDALRMLRAVRFMSQLGFTLSPETEEVI
TQEKSLLSHVSVERKTIEFEKLLQGRASRQALQTLIQTGLYEELPGFYHKRENLVAASKF
PFSALTSREELWAALLIDLDIDTKDAPLFLKAWKLPGKVMKEAIHIAQTYSQSLDPMSMY
KAGERSLLSAAKISQLQQNEKLDEEKLKGIQNAYQSLPIKSLKDLDISGKDLLTLRNRPA
GKWVSEELQRIEQAVVTGKLSNQKKHIEEWLKTCGQH
>PK3-2_03064 Bifunctional ligase/repressor BirA
MRSTLRKDLIELFSQAGSEFISGQKISDALGCSRTAVWKHIEELRKEGYEVEAVRRRGYR
LVKKPGKLSESEIRFGLKTEVMGQNLLYHDVLSSTQKTAHELANDNAPEGTLVVADKQTA
GRGRMSRVWHSQEGNGIWMSLILRPDIPLQKTPQLTLLAAVAVVQGIEEAAGIQTDIKWP
NDILINGKKTVGILTEMQAEEDRVRSVIIGIGINVNQQTDDFPDELKDIATSLSQAAGQK
IDRAGIIQQILLCFEKRYRDYMTHGFTPIKLLWESYALGIGTNMRARTLNGTFYGKALGI
DDEGVLLLETKEGIKKIYSADIELG
>PK3-2_03066 3-methyl-2-oxobutanoate hydroxymethyltransferase
MKTKLDFLKMKETEEPIVMMTAYDYPAAKLAEQAGVDMILVGDSLGMVVLGLDSTVGVTV
ADMIHHTKAVKRGAPNTFIVTDMPFMSYHLSKEDTLKNAAAIVQESGADALKLEGGEGVF
ESIRALTLGGIPVVSHLGLTPQSVGVLGGYKVQGKDEQSAKKLIEDSIKCEEAGAMMLVL
ECVPAELTAKIAEMLSIPVIGIGAGVKADGQVLVYHDIIGHGVERTPKFVKQYTRIDETI
ETAISGYVHDVRHRDFPEEKHSFQMNQTVLDGLYGGK
>PK3-2_03067 Pantothenate synthetase
MRQITDISQLKETIRQYQSEGKSIGFVPTMGFLHEGHLTLADKARQENDAVVMSIFVNPA
QFGPNEDFEAYPRDIERDAALAENAGVDILFTPDAHDMYPGEKNVTIHVERRTDVLCGRS
REGHFDGVAIVLTKLFNLVQPTRAYFGLKDAQQVAVVDGLISDFFMDIELVAVDTVREED
GLAKSSRNVYLTAEERKEAPKLYRALQTSAELIRAGERDPEAVIKAAKEMIESTGGTIDY
VELYSYPELEPVSNIEGKIILAVAVAFSKARLIDNIIIDIREMERI
>PK3-2_03068 Aspartate 1-decarboxylase
MYRTMMSGKLHRATVTEANLNYVGSITIDEDLIDAVGMLPNEKVQIVNNNNGARLETYII
PGKRGSGVICLNGAAARLVQEGDKVIIISYKMMSDQEAASHEPKVAVLNDQNKIEQMLGN
EPARTIL
>PK3-2_03069 3'-5' exonuclease DinG
MNKQRFVVIDVETTGNSPKKGDKIIQIAAVVIENGQITERFSKYINPNKSIPAFIEQLTG
ISNQMVEHEQPFEAVAEEVFHLLDGAYFVAHNIHFDLGFVKYELHKAGFQLPDCEVLDTV
ELSRIVFPGFEGYKLTELSEELQLRHDQPHRADSDAEVTGLIFLEILEKLRQLPYPTLKQ
LRRLSQHFISDLTHLLDMFIYENRHTEIPGYARFSSFSVREPESIDVHVNENGNFSFEIE
NWEAGNEKALSELMPGYEKRDGQMMMMKEVAEAFANREHALIEAPPGIGKTIGYLIPAAL
FAKKSKKPVIISTYSTLLQQQILTKDLPIVQDLFPFPVTAAILKGQSHYLCLYKFEQVLH
EDDDNYDAVLTKAQLLVWLTETNTGDVAELNLPSGGKLLWDRLAYDDESYKRSRNENVTG
FYERAKQIAMRSDLVITNHSLLLTDEGSQKKRLPESGTFIIDEAHHFERAASEHLGKRAT
YIELHTKLSRIGTLKEQGLLKKMRQLFQRNSLPVDSFFELEEWIQHIQAESDSFFSSVHS
FVKRRKPKEDLNRLVFKVNKESQDKSWPILTDGAERLCSMLTHLHQLFEAQSALMEKHLT
GMKSKAVFLADEYQRSMKGLQQYCQTLQKLFFESDDEEAVWIEIDAKGAKNAVAIYAQPL
EPGELLADQFFARKNSVVLTSATLTVEDSFQFMIERLGLGDFFPRTMRIESPFSYDDRMR
VMIPKEVKSIQDTGQTEFIQDTARYIELMAKEKQPKILVLFTSHDMLKKVHQELKRAMSA
SGIQLLAQGITGGSPGKLMKTFKTSNQAILLGTNHFWEGVDFPGDELTTVMIVRLPFRSP
DHPLHAAKCELARKKGRNPFQTVSLPEAVLTFRQGIGRLLRTAGDKGTIVILDRRIKTAG
YGQLFLNALPTTSVSEMTDSELEAYVARENQ
>PK3-2_03070 hypothetical protein
MESKIEILSTITVEHSDDLYKIVDTLNRTLKRDNLMFGLALDEENKNQAVFTIYRT
>PK3-2_03071 putative protein YpmB
MRKKALIFTVIFGIIFLAVLLVSANIYKSAMAQKEEGHEAAAAEAKKETDLASVDQVETF
VGKEKYYVVKGTDKKGTALYVWVPDDKKAKILSKEAKEGISQDKAAKIIQDEGLVSKQKE
VHLGREGNVLLWEVTYLDKEGQYSLSYVDFTTGKILKNITP
>PK3-2_03072 Aspartate aminotransferase
MKLAKRVSALTPSTTLAITAKAKELKAAGHDVIGLGAGEPDFNTPQHIIDAAVRSMNEGH
TKYTPSGGLAELKNSIAEKFKRDQNIEYKPSQIIVCTGAKHALYTLFQVILDEGDEVIIP
TPYWVSYPEQVKLAGGKPVYVEGLEENHFKISPEQLKNAITEKTKAIVINSPSNPTGVMY
TEEELSALGEVCLEHDILIVSDEIYEKLTYGGKKHVSIAQLSDKLKEQTVIINGVSKSHS
MTGWRIGYAAGSEDVIKAMTNLASHSTSNPTSIAQYGAIAAYNGPTEPLEEMKEAFEHRL
NTIYAKLVEIPGFSCVKPEGAFYLFPNAKEAAQSCGFKDVDEFVKALLEEEKVAIVPGSG
FGSPDNVRLSYATSLDLLEKAVERIKRFVEKHS
>PK3-2_03073 Asparagine--tRNA ligase
MLKTTINQVYKHVGEEVTIGAWVANKRSSGKIAFLQLRDGTGFIQGVVVKAEVEESIFQT
AKSVTQETSLYIKGIVKEDERSPLGYELAVTGIEVIHEATDYPITPKEHGTEFLMDHRHL
WLRSKRQHAIMKIRNEIIRATYEFFNNEGFVKVDPPILTGSAPEGTTELFATKYFDEDAY
LSQSGQLYMEAAAMALGKVFSFGPTFRAEKSKTKRHLIEFWMIEPEMAFVEFEENLQVQE
NYVSFIVQSVLKNCKIELNTLGRDTSKLEQIKAPFPRITYDEAIDFLKEKGFDDIEWGDD
FGAPHETAIAEHYDKPVFITRYPTSLKPFYMQPASDREDVVLCADLIAPEGYGEIIGGSE
RIHDMELLEARLKEHGLDSDAYKWYAELRKYGSVPHSGFGLGLERTVAWISGAPHVRETI
PFPRLLNRLYP
>PK3-2_03074 DNA replication protein DnaD
MKKQQFIDMQEQGTSTIPNLLLTHYKQLGLNETELILLLKIKMHLEKGSYFPTPNQLQEG
MSISVEECTNRLRMFIQKGFLFIEECEDQNGIKFEKYSLQPLWGKLYEYIQLAQNQTQER
KAEGEQKSLYTIFEEEFARPLSPLECETLAIWQDQDQHDVQLIKHALKEAVLSGKLSFRY
IDRILFEWKKNGLKTVEQAKIHSQKFRRVQTKQNEPQKEYKRQVPFYNWLEQ
>PK3-2_03075 Endonuclease III
MLNLKQIEFCLDKIGDMFPHAECELVHSNPFELVVAVALSAQCTDALVNRVTKTLFQKYK
RPEDYLAVSLEELQQDIKSIGLYRNKAKNIQKLSKMIIEDYGGEVPRDRDELVKLPGVGR
KTANVVVSVAFGVPAIAVDTHVERVSKRLGICRWKDSVLEVEKTLMRKVPKEDWSVTHHR
LIFFGRYHCKAQSPRCAECPLLSLCREGQKRDKKGLVKR
>PK3-2_03076 putative protein YpoC
MTQAKEVLASYEEYLRSLRPVISSDMKDVLLVNPVYFDFSTESQGVLPWEDRGKYVPLLF
NVWEDIKESLLPVFQTRKSRCDQNDMLKGIVCLLASFHWTAGERVKSLDWAELTEKSFPA
KPINWAERVEFILLKPTQYHCFIQLDELFTEMKKHFYKYHAMNR
>PK3-2_03077 Penicillin-binding protein 1A/1B
MSDQFNSREARRKANSKSSPSPKKGKKRKKGGLFKKTLFTLLILFVLGVVGGAVTFAVMI
SDAPKLDENKLKTPYSSTIYDKNGKEIAEYGSEKRSYVSIDEIPDVVKEAFIATEDARFY
EHHGIDPVRIGGALVANFTDGFGAEGGSTITQQVVKNSLLSHQKTLKRKVQEVWLSLQLE
RNYSKDEILEMYLNRIYFSPRAYGIGKAAEEFFGVTDLSKLTVEQAATLAGMPQSPTAYN
PVKNPDKAEKRRNIVLSLMKKQGFISDSQYNKAKKVAVKDEGVVSQKEYEKSNSNKYSAF
VEEVMKEIEEKSDVNPGTDGLKIYTTLDTKAQDKLDELMDGDTVGFTEGMQGGVTLLDTK
NGEVRAIGAGRNSTVGGYNYATQAQRQPGSTIKPILDYGPVIENKKWSTYEQIDDSAYTY
SDGTPIRDFDRSYKGLMSMREALAQSRNIPALKAFQAVGKDTAVDFANGLGLGLNKDTVY
ESYSIGGFGKGNVGVSSLTMAGAYSAFGNNGTYNEPHFVKSIEFNDGTKLDLTPKSKSAM
SDYTAFMITDMLKTAVNTGTGKLAQVPGVEVAGKTGTTNFEESEIQRYNIASDGARDSWF
VGYTPQYTAAVWTGMGENEAGKKSLSAEEQKVAKRIFAQLIADVDDGSGSFEKPDSVVEA
TVEKGSNPARLAGPNTPSDKKLTEYFVKGTAPSTVSKTYEKEEKEEKEKLSGLSVKYDKD
NQSLTLSWNYDGDATFAVKQSVDGGSYSEIQNSSAKEAVISGVQPGSVYKFEVTAVSDEG
KSTASTSYEVPKAEDDEDKKDQQQTDDEKQDDEKTQDDTQTDDPQKDDGQTDQDQTDDST
NDQDKKQDNTNTNPSDNSNQDQSNDNDNSNNQDTSDGDSNSGKNDSSDSDTNKNKTDTTD
KTQTNSSSTTEKTN
>PK3-2_03078 Holliday junction resolvase RecU
MIRYPNGKTFHPKQSVSSQNSQKRAPSYSNRGMTLEDDLNETNKYYLTNQIAVIHKKPTP
VQIVNVHYPKRSAAVIKEAYFKQSSTTDYNGIYKGRYIDFEAKETKNKTSFPLQNFHDHQ
IEHMKQVKAQDGICFVIISAFDQVYFLEADKLFDFWDRKEKNGRKSIRKDELEEAAFPIS
LGYAPRIDYISIIEQLYFSPSSSAKG
>PK3-2_03079 hypothetical protein
MNVKEQQTIRKLLSRIERQTKIKNADNISRTNAYKAFYDRHPEIKWSLLASFVSRNAGWS
MTDLKGSLFQLGLRERQQKWFFLAYERANWLIFSDAYPQLLLYHWSKKIGEPLFHHLHMF
GVSQFMMEEWARFWHERNTERLMYALIINEQNTIQTPIIQNPSFKKNVFDTIPFYLSDWF
HFNTVIFPAADGVLYGISVKRFSKTEERIRLGKQLSQLLFSPELFASFYHFLHSVPHTGS
RFDMEKMIGITKRTSPMLRTCYPELIHSLDGKKTDWFHGKIKKALFRREELPKQIEVTDW
YLQKKRQLHALFAVEHWLKK
>PK3-2_03080 Small, acid-soluble spore protein M
MKTRPKKAGQQKKSESKAIDSLDKKLGGPNRPST
>PK3-2_03081 hypothetical protein
MSGYVSKTDILRMLSDIEDELTRAEQSLNHSLNAFEADMRETESERLSVLEDEIMDLHIC
INELSQSPEHRYAFEKVYRIG
>PK3-2_03082 putative protein YppE
MQSQTLLEMTEQMIETAEKGADRYQEGKNSDHSYDFFETIKPAVEENDDLAARWAKGALE
LIEARRPKYVHREQIETVKDNFLELVLQSYVHHIHKKRFKDITESVLYTLHAVKDEIARE
DSR
>PK3-2_03083 hypothetical protein
MNVSYLSKRFAEMKKYETDCMNKLMDFAKFLYIQGHLNTTEFRNSMKVLEANGAESPAYE
LN
>PK3-2_03084 hypothetical protein
MNRSSQGYPRQMGYYDPQQMQGYYQQASPMQYYPQPHYGQQGYYQPYAPIQSMPMQPPVF
SNPYPIPRPNQQQPSQLQSIMSQFKKANGQFDFNKMMDTTGQVMSAMNQVGSLIKGFTSF
FK
>PK3-2_03085 hypothetical protein
MEFYDDKKNELQKKEEIISEAMDQLFQSSAFGNLLSGFQNLINSSLKDVQTTIDLRERDT
GLYVDITIPATFQDGEIVVDVTSRYLHVTLQEKQKQQHEASFTSMTRTVQLPYEVRQEDM
ETSWNEQTMTLFFPKNKHE
>PK3-2_03086 PTS system glucose-specific EIIA component
MVNEGITVVVNEKGENTLLKKLFGMGKTQEKVTEEVIYSPADGTVMDLADVPDPVFSQKM
MGEGIAVEPSNGEIVSPAEGEVIQIFHTKHAVGIRTRSGIELLIHVGLETVNMNGEGFTA
HIKEGDKVKVGDPLITCDLELIKEKASSTVIPIVIMNGDAVGSIVPAGEKAARKGETMLL
TIKAK
>PK3-2_03087 ATP-dependent RNA helicase DbpA
MKKKSLTELISELKGNENVVNWHEIEPREARTRPMPESIDDRIKAALSKRGIDELYTHQY
SAFHYVQNGESIVTVTPTASGKTLCYNLPVLQSIAQDETNRALYLFPTKALAQDQKSELN
EIIDEMGIDIKSFTYDGDTSPAIRQKVRKAGHIVITNPDMLHSAILPHHTKWVSLFENLK
YIVIDELHTYRGVFGSHVANVIRRLKRICRFYGSDPVFICTSATIANPKELGEQLTGKPM
RLVDDNGAPSGRKHFVFYNPPIVNKPLNIRKSATAEVNELAKEFLKNKVQTIVFARSRVR
VEIILSHIQELVKKEIGTKSIRGYRGGYLPKERREIERGLREGEILGVVSTNALELGVDI
GQLQVCVMTGYPGSVASAWQQAGRAGRRHGESLIIMVANSTPIDQYIVRHPEYFFNRSPE
SARINPENLIILVDHLKCAAYELPFKADEEFGPMDVSDILEYLQEEAVLQRNGERYHWAS
ESFPASNISLRSASQENVVIVDQSDIANVRIIGEMDRFSAMTLLHDEAIYLHEGIQYQVE
KLDWDHKKAYVRKVDVEYYTDANLAVQLKVLEIDKTKEKSCTSLHYGDVTVNALPTIFKK
IKMTTFENIGSGPIHLPEEELHTSAAWLEMKTADADIGEKTLEQLLFGISNVLQHIVPVY
IMCDRNDVHVVSQIKAAHTGLPTIFLYDHYPGGIGLAEEVFKRFSDIKEAAKQLIKRCPC
HDGCPSCIGTEIEGIKAKERILQMLDQMS
>PK3-2_03088 hypothetical protein
MSLKGKLQRMKKHMVLDEGEHKIEAGKQENHFAQKHAVIPFLEEWEAFGMRPFFFEDEYC
LIREVEYPLSHRHGLYSFSELDEVITLWNQSSLSHTLSAKGYKKSSLFFFDTETTGLGGG
AGNTIFLLGHARVYEDRVTVKQHLLPKPGNEVALYQSFLSEVDITSLVTYNGKAFDWPQV
KTRHTLIRDRLPKLPEFGHFDLLHGARRLWKHKMDRVSLGTVEKEELGIRRQEDTPGYLA
PMLYFHFIKAQEPDLLKGVLHHNEMDVLSLISLYIHMSKKILSESHAPKEHSEAYAMAKW
LMALKETDQAVKQLEALKEKPFEDLDRAMLDLSLLYKKQNRLAEAVPLWEKLSRSQNEKC
RYTAVIEHAKFLEHKKKAFGKALHITEQLLSEAAFLSEKETEKLHVRIARLKRKYSS
>PK3-2_03089 hypothetical protein
MKVLAITGYKPFELGIFKQDDKALYYIKKAIKNRLIAFLDEGLEWILISGQLGTELWAAE
AAYDLQEEYPDLKVAVITPFYEQEENWKEPNKEQYEAVLAQADYEASLTHRPYESPLQFK
QKNQFFIDKSDGLLLLYDPEKEGSPKYMLGTAEKRREQDGYPIYFITMDDLRVTVEEDNY
S
>PK3-2_03090 Cell cycle protein GpsB
MLADKVKLSAKEILEKEFKTGVRGYKQEDVDKFLDMIIKDYETFHQEIEELQQENLQLKK
QLEEASKKQPVQSNTTNFDILKRLSNLEKHVFGSKLYD
>PK3-2_03092 Ribosomal RNA large subunit methyltransferase K/L
MKKYTLIATAPMGIEAVVAKEVRDLGYECKVDNGKVIFEGDALAICRANLWLRTADRIKV
QVDSFKAKTFDELFEKTKAINWRSFIPENGKFPVIGKSVKSTLASVPDCQRIVKKAIVEK
LKLESGKANDWIEETGAEYKVEISLLKDQAVIMLDSSGTGLHKRGYRVDQGGAPIKETLA
AALVQLTNWTPDRPFVDPFCGSGTIAIEAALIGQNIAPGFNRDFVSEDWEWIGKELWDKA
RLEVEEKANYDQPLTIFASDIDHRMVQIAKENAEEAGLGDFIQFKQMQVKDFTTNLEFGV
IVGNPPYGERLGEKKAVEQMYKEMGQAFEPLDTWSVYILTSNENFEEAYGRKATKKRKLF
NGFIKTDYYQYWSKVRPQRKKTENA
>PK3-2_03093 hypothetical protein
MLNSEHFNLIQRALDATANELKELGADSSPSVMSHAQNDLEKAVEHIYSTDHPFLSSHVI
NRK
>PK3-2_03094 putative ATP-dependent helicase DinG 
MTTSRLPFSLTKTKNFYEELNNWIGDVFYDILPEKGFDLRDEQVFMAFQLERAFKEKKVM
FAEAGVGTGKTLVYLLFAISYARYVGKPAIIACADETLIEQLVKKEGDISKLAEHLDLKI
DTRLSKSHEQYLCLKKLEKTMQRSDDDKWLDLYESLPSFVHESQAMQRFYPYGDRKQYAN
LSNAEWSDVSYDSFQDCLTCDMRHRCGLTLSRDYYRKSTDLIICSHDFYMEHVWTEESRK
REGQLPLLPDHSAVVFDEGHLLEFAAQKALTYRVKQSTLDLFLERLLQNDIREEFAELIE
DALAANDEFFYVLSEESKEVAGSHRLEIKDDQRVKKAADELCRLLDKIGEALVFESEMYT
IDQYELSVVEEYVEQMAYSLSLYQKDAISWLEQKETESTFVVMPRTVAEVLGEKVFSKKI
PYIFSSATLSEGGSFDYIADSLGIRDYLSLTVDSPYDYDEQMTVNLYAKTEMAAEQKTAE
TIETIKRYKGRTLVLFPSFEELNEFKQLSAAWELPYPIYFEGDEEISSLVEKFQEEEETV
LCSVHLWEGLDIPGDALNNVTIWSLPFPPHDPVFTAKRNGAKKDPFEEVDLPYMLLRVRQ
GIGRLIRSNQDSGSIHIYAGGENARIIEEVKKVLPVEPQMM
>PK3-2_03095 2-dehydro-3-deoxy-D-gluconate 5-dehydrogenase
MSYLHEAFSLEGKTALVTGPGTGIGQGIAKALAGAGADIIGTSHTSSLSETQQLVEQEGR
TFTSFSLDMSKPETIKDAAAELFENRQIDILVNNAGIIHREKAEHFSEENWQHVLNVNLN
SLFILTQLAGVQMLKRGYGKIINIASLLSFQGGILVPAYTASKHAVAGLTKSFANEWAAS
GVQVNAIAPGYISTANTKPIRDDEKRNEDILKRIPAGRWGKADDIGGTAVFLASRASDYV
NGHILAVDGGWLSR
>PK3-2_03096 4-deoxy-L-threo-5-hexosulose-uronate ketol-isomerase
MENRYSVHPEQVKRFTTEELRSHFLMDTLFTENKLTMYYSHEDRVVIGGAAPGQRELKLD
AGDFLKTDFFLERREIGIINVGQPGAVRVGDDEYVLETKDFLYIGMGNQDVAFTSLNGEK
AKFYFISACAHQSYPTQKAALSELTPDRLGDEAASNVRSLYKVIHQDGIKSCQLMMGITM
LDQNNNWNTMPAHVHDRRMEAYLYLDLEKDSKVFHFMGQPDETRHLVVGNEQAVLSPAWS
IHSGAGTSNYSFVWAMAGENYTFTDMDVVPMDGLK
>PK3-2_03097 HTH-type transcriptional regulator KdgR
MKKKTTGHSTIQDVAEYAGVSKSTVSRYINGKIDAISPEKVKNIKKAIAELNYRPSKMAQ
GLKIKKSKLIGFVVADITNPFSVAAFRGVEEVCDQYGYSIMVCNTDNSPEKEREMLLKLE
AHSVEGLILNATGENKDVLHAFTEQHIPTILIDRKLPDLKLDTVTTDNRRITKEILQKIY
SKGYTDVALFTEPVSSISPRAERAAVYQEMAAAQNVNGLVRMYEIDVKNKEQLKAALRSF
HKEMPEQKKAILALNGLIMLKIISCMEELGLRIPLDIGIAGFDDTEWYKLIGPGITTIAQ
PSHDMGRTAMERVLKRIDGDKGAPQTIELEAEVIMRQSL
>PK3-2_03098 2-dehydro-3-deoxygluconokinase
MKLDAVTFGESMAMFYANEYGGLHEVSAFSKGLAGAESNVACGLSRLGFQMGWMSKVGDD
QLGTFILQELKKEGVDVSRVVRSQDGNPTGLLLKSKVKEGDPQVTYYRKNSAASTLTSAE
YPKDYFQGAGHLHVTGIPPALSADMKDFTYHVMNDMRNAGKTISFDPNLRPSLWPDQATM
VHTINDLAGLADWFLPGIAEGELLTGEKTPEGIADYYLKKGVSFVAIKLGKEGAYFKTRE
SKGFAEGFRVDRVVDTVGAGDGFAVGVISGILDGLPYKDAVQRGNAIGALQVQAPGDMDG
LPTREKLAAFLSAQRTVYQKKGDY
>PK3-2_03099 KHG/KDPG aldolase
MEPKIVENRLKEARLIAVIRSKDKQEACQQIENLLDKGIRAVEVTYTTPGASNIIESFRN
REDVLIGAGTVITAQQAGEAAEAGAQFIVSPGFSAGLAEHLSFLKTHYIPGVLTPSEIME
ALTSGFTTLKLFPSGVFGIPFMKNLAGPFPQVTFIPTGGIHPSEVPDWLKAGAGAVGVGS
QLGSCSKEDLQAVFQV
>PK3-2_03100 2-keto-3-deoxygluconate permease
MKIKATIERVPGGMMIIPLFLGAALNTFAPGTAEFFGGFTGALITGTLPILGVFIFCVGA
TIDFRSSGYIARKGITLLLGKVGFAALLGVIAAQFIPDEGIQSGFFAGLSVLAIVAVLNE
TNGGLYLALMNHMGRKEDAGAFAFISTESGPFMTMVTFGVTGLAAFPWETLAATVIPFLL
GCILGNLDHDLRDLFSKVVPAIIPFFAFSLGNTLNFGMLIQSGMLGIFIGVAVVILSGSS
LFLLDRFVARGDGVAGVAASSTAGAAVAVPYALAEANASFAPVAESATAIIATSVIVTSL
LTPLATVWVDKKINEKKRKTPPPKNQMTIN
>PK3-2_03101 Carboxypeptidase 1
MEIHTYEKEFFDLLKRISHYSEAVALMHWDSRTGAPKNGSEDRAESIGQLSTDIFNIQTS
DRMKELIDALYERFDDLSEDTKKAVELAKKEYEENKKIPEAEYKEYVILCSKAETAWEEA
KGKSDFSLFSPYLEQLIEFNKRFITYWGYKEHPYDALLDLFEPGVTVKVLDQLFAELKEA
IVPLVKQVTASGNKPDTSFITKTFPKEQQKELSLYFLQELGYDFDGGRLDETVHPFATTM
NRGDVRVTTRYDEKDFRTAIFGTIHECGHAVYEQNIDEALSGTNLSDGASMGIHESQSLF
YENFIGRNKHFWTSYYKKIQEASPEQFKDISLDDFVRAINESKPSFIRVEADELTYPLHI
IIRYEIEKAIFSNEVSVEELPSLWNQKYQDYLGITPQSDAEGILQDVHWAGGDFGYFPSY
ALGYMYAAQLKQKMLEDLPEFDTLLERGEFHPIKQWLTEKVHIHGKRKKPLDIIKDATGE
ELNVRYLIDYLSNKYSNLYLS
>PK3-2_03103 Xanthine phosphoribosyltransferase
MEALKRKIEEEGVVLSDQVLKVDSFLNHQIDPLLMQKIGDEFAARFAKDGITKIVTIESS
GIAPAVMTGLKLGVPVVFARKHKSLTLTDSLLTASVYSFTKQTESQIAVSGTHLSDQDHV
LIIDDFLANGQAAHGLVSIVKQAGASIAGLGIVIEKSFQPGREELVNLGYRVESLARIQS
LEEGKVSFVQEVHS
>PK3-2_03104 Uric acid permease PucK
MKNGFGKTLSLGIQHVLAMYAGAIIVPLIVGKAMGLTVEQLTYLVSIDIFMCGVATLLQV
WSNRFFGIGLPVVLGCTFTAVSPMIAIGSEYGVSAVYGSIIASGILVILISFFFGKLVSF
FPPVVTGSVVTIIGITLMPVAMNNMAGGEGSADFGDLSNLALAFIVLSIIVLLYRFTKGF
IKSISILIGILIGTFIAYFMGKVQFDNVSDAAVVQMIQPFYFGAPSFHAAPIITMSIVAI
VSLVESTGVYFALGDLTNRRLTEKDLSKGYRAEGLAVLLGGIFNAFPYTAFSQNVGLVQL
TGIKKNAVIVVTGVILMAFGLFPKIAAFTTIIPSAVLGGAMVAMFGMVIAYGIKMLSRID
FAKQENLLIVACSVGLGLGVTVVPDVFKQLPSALTLLTTNGIVAGSVTAVVLNIVYNVFS
KAEKTEQKADAIEQKTAV
>PK3-2_03105 Alpha-pyrone synthesis polyketide synthase-like Pks11
MAYILSIGTSLPAYNVNQEKAAEFARYMFEHSFKDIDRLLTSFKNGQIQSRQFVKPIEWY
KEGHSFEEKNQIYIEETLKHSREAVRECLSHPEFFQEAIPYEKVDAVFFVSSTGLSTPSI
EARLMNELPFSPYTKRIPLWGLGCAGGASGLARAAEYCKAYPEAFVLVIAAELCSLTFQP
EDKTKSNLIGTSLFGDGIAAALLCGEKADRRMSKLQLVPKTTDSQSVLMKESEDVMGWDF
TDQGFKVIFSRDIPTLVEKWLKTNVQIFLDKHQLSFSDISVFLAHPGGKKVIDAYSKSLE
LSPEKLSTAQSILQKHGNMSSATILYVIKDHLLNGYKKEAEQGLIGALGPGFSSELLLFS
WEKGA
>PK3-2_03106 hypothetical protein
MFWLLIAILIAQRGAEMAVARQNEQKVKQQGAIEFGESHYPYIIIMHILFLLSLIAEVLL
MNKQPSSWWIGIAAAIVSVQAVRYWALCSLGAYWNTKILVVPGAELVKKGPYKWMKHPNY
TVVILEILLIPLLYQAYITMCLFSIVNAVLLTVRIRAEDKALEEYSIK
>PK3-2_03107 GTPase Der
MTEHNRKELLHKTGELYKRFNENKDEQRAAKLAAVMQKAADEEVYIAFTGHYSAGKSSLL
NCLLMENILPTSPIPTSANLVGIRNGEKRVRLHTTDGACAELEGAYQKDRVQQYCKDGEQ
IESVEIFDRYTEIDPGVAYIDTPGIDSTDDAHFLSAASILHQADALFYVVHYNHVHAEEN
VKFLRSIKESIPNVYFIVNQIDRHDETETSFVDYKAQVEEMLCNEGIPKEALYFTSVTEP
NHPFNQIGVLREELKRIEQQAKNNLQTLTEQKVRNLLKEHTEMLLKDETDGPSFAEQLDT
QTELVQSLRDQLDEAAKQATEAENKMQEEVNRILKNANLTPFEMRELAAAFLESREPSFK
TGFFFSKAKTAQERDKRRNAFFSDVTKRTEAEADWHMIDTFHKLAKAFDVHTAESEKLIQ
AYHTPLEIDIIELAVKHGAAFSSEYVLQYTKDLAELIRKEAKRKAGDIIKALSAMVKERV
SDDLQTINGRLIQETEKLAFLQERARLEKHAREKADRMWAIWKEESECPIHIDTDWFKTK
KKTVNAPEQKRSQGKQTQQLMQKQEIKMEQELPLQDQIERFYTLSGLLGEYSMLSKQTSA
FRERIKRLEERNFTLALFGGFSSGKSSFANALVGERVLPSSPTPTTATINKITKPANDNI
NKTADVVFKTEDDITADILQLTGMQKEPAGRSFTEKWKKAVKKSRLQEEHVKLISNFLLA
YEKYQSYIQEQKTLTIPLSELKPYVAEEATACAVKEVTIYYTCPLTEKGITIVDTPGASS
MNKRHTELAFQYIKDADAFFYMTYYQHSFSKGDRSFLRKLGLVKESLSMDKMFFVINAAD
LAKDKTELETVTDYVSAELVKEGIHDPQLFTVSSKEELLGKQESFYNQFPKVRKHLDRFI
EVDVKKASAAQLSSEANKLCETVFQLYQSQHQSKEEKEAQKQRLILSFERTAAEIEKRRS
SETIIEKVKKDTKEQLYHITQRLSFFSNDLLKSAFHPGLQNGDWKKNVGKAMKTALQEYQ
FEYVQEIKTLDIRMSGFIEQHIAEEWLESFQKTLNEDGYFSIYAGEKHSNGIQLKEVEPE
LDERVFEQEQKEIKSPKHFFEQKGKSAFIEAVRTKLNKITEHWVTNEEESLISHYTDHLR
RLQEDMAEKAMEQIKDQKDTYLEGYAEGEHAKEIEKAYQACISWQRSDNTIKM
>PK3-2_03108 hypothetical protein
MSEVHKAISAHSSKQHEHIKAFMRLENMREMAIEEAVSKCKNDEPFTTEAINEITEQMNQ
LAKKGIVPTRRLVSKEMVREYVSRM
>PK3-2_03109 hypothetical protein
MLGRTKLGNRNAQANNNAKKKNGFQTHFDSYAGREAEKLIASNKRHND
>PK3-2_03110 hypothetical protein
MIHKTVSLIKEMLFFIFALLYGKIEGMKEEGVIL
>PK3-2_03111 5'-3' exonuclease
MKHNKLLLVDGMALLFRAFFATAVHRNFMINDSGVPTNGVNGFLKHLITAMETFQPTHVV
CCWDMGSKTYRNDLFQDYKANRSAPPVELIPQFDLAKEAAAELGIMNIGFAGYEADDCIG
TLAALFADEADITIVTGDRDLLQLLTDKVSVALLQKGIGNYKVYTKETFYEETGVLPKAL
IDIKALMGDSSDNYPGVKGIGEKTAYKLIREYETVDLLLENLSLLPKGQQGKIQQGLSDL
EMSRKLAEIHCSVPLDCTLRDALFTLQMEQAADMLRRHQIKGIERMLEKLNAREIV
>PK3-2_03112 Small, acid-soluble spore protein L
MKKKDKGRLTGGVTPQGDLEGNTHTDPKTELEERAKKSNTKR
>PK3-2_03113 14.7 kDa ribonuclease H-like protein
MPTEIYVDGASAGNPGPSGIGIFIKHEGKAEAFSIPIGLHTNQEAEFLALIEGMRLCASR
GYQSVSFRTDSDIVERAAELEMVKNKMFHPYVEEIIRLKAAFPLFFIKWIPGKQNQKADQ
LAKEAIRLNDKN
>PK3-2_03114 queuosine precursor transporter
MGLFVWIGFATVCANLQVVKTVELFGLTATLGNVMYGTIFFATDVLNEKYGPAEAKKAVW
LGFSTLLTLTFVMQGVLHFEPASSDISQTALETIFGSLPRVALGSLLAFIFSQTLDVYVY
SAIRRIFPSDRLLWLRNGGSTAVSQLFDTFIFTGVAFFGIYPAGVWLHIFISTYLIKFAV
SLISLPYAYAAKKMIPNDERSL
>PK3-2_03115 hypothetical protein
MIAKMIQNELLNKMKKLPFRGKIGLIIAQARLLMNGKVIVMKLRPHMKIEAKGTGSVSFL
GEDWLTAQQARMLARELGRFPYMKDLKFEDEKGGSWTLKELEKLTEELAQEPDDITVYFD
GSFDKESELAGLGIVIYYSLGGIRHRLRKNKSFRLKTNNEAEYAALYEAIREVRELGASR
NSITIKGDSLVVLNQLDGSWPCYDPSHNEWLDKIEALLESLKLTPTYETIQRKDNQEADG
LAKKILSHQFVESHMKLDRNGDDDIG
>PK3-2_03116 hypothetical protein
MIFKELTELQDEYCKDCFIKKQFRKEFGKTYAHSFCINKCTVGEKLKAYGDVLTNR
>PK3-2_03117 hypothetical protein
MTSEFHDEDQTGFTDKRQLELAVETAQKTTGAATRGQSTTLVDSAYQAIEDARELSQSEE
LGALDDPEFVQQQQQLLDDSQHQLDEFKE
>PK3-2_03118 Regulatory protein DegR
MDDKDLKAILHKTFIEIYSDLEELADIAKKGKPSMEKYVEEIEQRCKQNILAIEIQMKIK
>PK3-2_03119 Cold shock protein CspD
MQNGKVKWFNNEKGFGFIEVEGGDDVFVHFTAIEGDGYKSLEEGQEVSFEIVEGNRGPQA
SNVVKL
>PK3-2_03120 Processive diacylglycerol beta-glucosyltransferase
MNTNKRVLILTANYGNGHVQVAKTLYEQCVRLGFQHVTVSNLYQESNPIVSEVTQYLYLK
SFSIGKQFYRLFYYGVDKIYNKRKFNIYFKMGNKRLGELVDEHQPDIIINTFPMIVVPEY
RRRTGRVIPTFNVMTDFCLHKIWVHENVDKYYVATDYVKEKLLEIGTHPNNVKITGIPIR
PQFEESLPVEPIYKKYNLSPNKKVLLIMAGAHGVLKNVKELCENLVKDDHVQVIVVCGKN
TALKESLSALEAENGDKLKVLGYVERIDELFRITDCMITKPGGITLTEATAIGVPVILYK
PVPGQEKENAIFFEDRGAAIVVNRHEEILESVTSLLADEATLQRMKKNIKDLHLENSSEV
ILEDILKESEMMTAKQKAKALS
>PK3-2_03121 Homoserine O-acetyltransferase
MPHSRHTDINMEQLQAAPELNILTASKEAGVCLIVSKDEKQVFLTGHPEYDTNTLLQEYE
RDLERNLSTVEAPKHYFAEDSKEPVNRWKAHATLLFMNWLNYYVYQETPYEWD
>PK3-2_03122 Homoserine O-acetyltransferase
MPINIPTHLPAKQVLESEHIFVMDESRAFHQDIRPQKIIILNLMPKKIQTETQLLRLLGN
SPLQVHFTFLIPSTHTPKNTAREHLDEFYTTFSNIRHKKFDGMIITGAPIEHLAFEDVSY
WEELKEIMEWSKTNVTSTLHICWGAQAGLYYHYGVEKIQLPKKSSVCLNIQFFQNTKDW
>PK3-2_03123 Hydroperoxy fatty acid reductase gpx1
MSIYDMRVRTITGKDMTLQPFAGKVLMIVNTASKCGFTPQLKQLQELYDTYQQEGLEILG
FPCNQFMNQEPGGEADIQEFCETNYGVTFPMFSKVEVNGKNAHPLFVYLTEHAKGMLGTK
AIKWNFTKFIVDKSGEIVGRYSPNTNPKELEDVIVKLLGQ
>PK3-2_03124 putative protein YedJ
MKEMKQAEQIRIWVQSLLTGESSGHDWHHVSRVADLAVYIGEKENADLFIVETAALVHDV
IDVKLPDTIRLSVSEVYDQLVFLGVGKEDADRVRHIITRMSFREREKLAEEPLSIEGKAV
QDADRLDALGAVGIARTFMFAGAKGHGLYGDDQSAYAHFFHKLLRLKDMMNTDTARELAE
ERHDFMLAFVRQLEKDIPGINAKTS
>PK3-2_03125 hypothetical protein
MKIKSIEPTPSPNTMKVILTEELPAGKSNNYKPDQAEGAPPVIAEILKIEGIKGVYHVAD
FLAVERNARYDWKDILPQVRTAFGMESAESAEENRSDQESFGEVKVFVQMFSGIPMQVKL
TDGEREERFGLPERFQQAILKLRSEASNVVFERAWKEQGVRFGDFNEIGHDVTEELQAAY
SDDRLKRLTEAAAQGKGEAKQYVQRKAYKVTLDMLDDGDWKKRYAHLEQMDPKEEDIPVL
QKALDDPKVSIRRQAVVYLGMIETPDVLPLLYKALEDKAVSVRRTAGDCLSDIGDPQAIP
AMIKSLSDSNKLVRWRAAMFLYEVGDDSAIEALRAAEDDPEFEVSLQVKMALERIEHGEE
AKGSVWKQMTESRKKGE
>PK3-2_03126 Dihydroxy-acid dehydratase
MAELRSNMITQGIDRAPHRSLLRAAGVKEEDFGKPFIAVCNSYIDIVPGHVHLQEFGKIV
KEAIREAGGVPFEFNTIGVDDGIAMGHIGMRYSLPSREIIADSVETVVSAHWFDGMVCIP
NCDKITPGMLMAAMRVNIPTIFVSGGPMAAGRTSDGRKISLSSVFEGVGAYQAGKINESE
LQELEQFGCPTCGSCSGMFTANSMNCLSEALGLALPGNGTILATSPERREFVRKSATQLM
ETIRKDIKPRDIITVKAIDNAFALDMALGGSTNTVLHTLALANEAGVEYSLERINEVAER
VPHLAKLAPASDVFIEDLHEAGGVSAALNELSKKEGALHLDALTVTGKTLGETIAGHEVK
DYDVIHPLEKPFTEKGGLAVLFGNLAPDGAIIKTGGVQNGITRHEGPAVVFDSQDEALDG
IINRKVKAGDVVIIRYEGPKGGPGMPEMLAPTSQIVGMGLGPKVALITDGRFSGASRGLS
IGHVSPEAAEGGPLAFVENGDHIIVDIEKRILDVQVPEEEWEKRKANWKGFEPKVKTGYL
ARYSKLVTSANTGGIMKI
>PK3-2_03127 hypothetical protein
MSMAYEEYMRQLVVPMRRELTGAGFEELTTAEEVENFMEKAEGTTLVVVNSVCGCAAGLA
RPAATQAVLQHDKSPDNTVTVFAGQDKEATAKMREYFTGQEPSSPSMALLKGKEVVHFIP
RHEIEGHDMEEIMKNLTAAFDAHC
>PK3-2_03128 Ribosomal RNA small subunit methyltransferase J
MITTSYRPSEHTIKTAKQLSKELNIPYCGRNKQTVENLLKTAERDLLVVGKERFELYTKQ
GAKFFFHPNTAMFRAKRFIRGEQEPMLRAAGLSEGDTFLDGTLGLGSDAIIASMAVGDTG
SVIGIEKNHLVSVLVKTGLHSWETGIAELQAAMRRIQVKHGDCFEYIRQLPDNSVDVVYF
DPMFHEPVETSDGIAPLRDLAEDSVLHEGYIKEAVRAARKSVVLKDHWKSPRFEQFGFNV
MKRKTALFHYGVIQTASKTSP
>PK3-2_03129 hypothetical protein
MKLWMRKTLVVLFTIVTFGLVSPPAALMADKPSGQPSSLEQNDYTAFYDEHDLYDDYESE
NRRDPELLFQSYKEQLLDSAEDQSFLKFGSKIAPVIEDDYRKEILPKIENVISDYLATLQ
DDETYQDVVISSMPSAGKTEKIFNVYNRTTGEDLLRFHVRRDHPPHDGYWFNFHYHTAED
GFQSHHELGSIYWDRNTPPNWMSA
>PK3-2_03130 putative protein YpjQ
MKKYTMNEMVDITKDMLNKRGVMIEDIARIVQKLQEKYNPNLPLSVCMENVEKVLNKREI
IHAVLTGLALDQLAEQKLLPEPLQHLVETDEPLYGIDEIIPLSIVNVYGSIGLTNFGYLD
KEKIGIIKELDESPDGIHTFLDDIVAALAAAAASRIAHTHQDLQDEEKEQDQKPVIS
>PK3-2_03131 Thymidylate synthase 2
MKQYKDLCRHVLKHGEKKGDRTGTGTISTFGYQMRFNLHEGFPMLTTKKLHFTSIAHELL
WFLKGDTNVRYLQENGVRIWNEWADENGELGPVYGSQWRSWRGADGETVDQISRLIEDIK
TNPNSRRLIVSAWNVAEIDNMALPPCHCLFQFYVSDGKLSCQLYQRSADVFLGVPFNIAS
YALLTMMLAHVTGLEPGEFIHTFGDVHIYQNHIEQVNLQLTRDVRPLPKLRFAREVDSIF
NFAFEDFIIEDYDPHPHIKGAVSV
>PK3-2_03132 IS1595 family transposase ISSsu9
MISFIFAMDANRLIGKDNDLPWHLPNDLAYFKKVTSGHSIIMGRKTYESIGRPLPNRRNI
VVTSEPASTFPGCAVVSSLKEVLDICSGSEECFVIGGAQLYTALFPYADRLYMTKIHHEF
EGDRHFPEFDETNWKLVSSERGIKDEKNPYDYEFLMYEKKNSSETGGF
>PK3-2_03133 hypothetical protein
MVRYSLLVVYIVYMLLKNMKQLFNQRMLDPRLSYKKQMTLVYEQPKAFLEGCIGITGSVV
TIDQPEPIPPGPVLYVHSRLRLAELALIAGYIEEPAGFIANPRVFRLPFIGQWLDRMDVI
SDGNSEKVYEDVTKQLEKGQSLILSLDGSIDPVELAARYHLPLVMVETKGTDDLQKGSFL
KRLKPADIEMSFSKAYIPAHEKQLRA
>PK3-2_03134 hypothetical protein
MFTIKEEIANAITHGIGVLLSIPALVFLIIFAAHYGSSWDIVSFTIFGVSMLLLYLSSTL
LHSITHKKTKDILEIIDHSAIYVLIAGTYTPFLLGPLKGTLGYTLLVIVWSLALGGIVFK
IFFVKRFILLSTLVYLIMGWLMIIAVKPLYASLSGAGFSLLLLGGILYSVGTIFYIWKKV
PFHHAIWHSFVLGGSAAMFFCVLFYCVKVPFIS
>PK3-2_03135 Anaerobic nitric oxide reductase transcription regulator NorR
MNTEPIPNTFQHLIGEHQTFLEAKRIAKQFSLSELPVLITGKIGTGKNHFAHAIHQESSR
SNEPFISINCSTHSEESLTHELFGPSGNSGAFQKTARGTLFLDEVWRMPASVQAQLLKAL
DSDTEKPRMICASADGCAEHTFRQDLFYRLNILTLTLPELSERKSDIPLLTQYFLSNSSQ
QLLIDPSVFPILEQHTFEGNVRELKNAADYMAAVSSGGTIHLYDLPPYIRGTIDGKTSKK
KPKLLTLMEKAEFLFILETIKVLNEKGEPASRRIISEHSKNTQTSLTPQQVRSRLDYLEK
KDYVTKSRGRAGTKISLEGLNFLETLKNQMI
>PK3-2_03136 L-threonine dehydratase biosynthetic IlvA
MKPLVKENSLIQVKDILKAHQNVKDVVIHTPLQRNDRLSERYECNIYLKREDLQVVRSFK
LRGAYHKIKQLSSEQTENGVVCASAGNHAQGVAFSCKHLGIHGKIFMPSTTPRQKVSQVE
LFGKGFIDIILTGDTFDDAYKSAVECCEAESRTFIHPFDDPDVMAGQGTLAVEILNDIDT
EPHFLFASVGGGGLLSGVGTYLKNVSPDTKVIAVEPKGAASYFESNKAGHVLTLDKIDKF
VDGAAVKKIGEETFRTLETVVDDILLVPEGKVCTSILELYNECAIVAEPAGALSVAALDL
YKDEIKGKNVVCVVSGGNNDIGRMQEMKERSLIFEGLQHYFIVNFPQRAGALREFLDEVL
GPNDDITRFEYTKKNNKSNGPALVGIELQNKADYGPLIERMNRKPFHYVEVNKDEDLFHL
LI
>PK3-2_03137 hypothetical protein
MLLKSLEFKRGDGIQVKVTEIPVLKEDEHYFFMLHHHLQFYLKEVFSSNSRAKVYSFRQY
MKRRMKWADYQAVFHQEVLKHNA
>PK3-2_03138 SCO1 protein 
MKVIKGLTAGVFFLLLCACGGQQIKDPLNYEVEPFTFQNQDGKNVSLESLKGEVWLADFI
FTNCETVCPPMTAHMTDLQKKLKAEKIDVRIVSFSVDPENDHPKQLKKFAANYPLSFDNW
DFLTGYSQSEIEEFALKSFKAIVKKPEGQDQVIHQSSFWLVGPNGKVLKDYNGVENTPYD
DIIADVKSAGTLK
>PK3-2_03139 Spore germination lipase LipC
MKLRIFSIMASLILLLTACTSIRTASEGKHKAHEPKTKEHIVIAAVGDSLTEGVGDPEGK
GYVGMVADSIRSDKQVKTVDVKNYAVKGNRSDDLLEKLKDKKVQKGIKDADYVFFTIGGN
DLMKVLRQNFLQLTVEPFQEAEKPYEKRFRKVISEVRELNDHAELIYVSMYNPFTFTLSE
LNEINGVVTDWNHIAEKELKKDKHAKIIYIEDLFNQKSDSSRISEEDDFHPNGTGYSLIA
KRVYQAIKKEGLPKE
>PK3-2_03140 hypothetical protein
MNKWKRLFLILLAINIVLAAGFVALVMLPGEQAQVKDSSESEYGFQVTSTKESLAAFVNS
YLNDKASNKLDYKVEIDDDVHVAGKIKAFSTSIDAFVAFEPSVKKNGDVELNVTKFSLGK
LSIPISFVLNYMDSFYELPSFVHVHPGDKSIEVRLSEMPLTNGMYVKADKINLENDDIEF
SYYHPKQ
>PK3-2_03141 hypothetical protein
MKRVYQYFSLLSFTFSLYFGWLAYHHLAAEDMDQMYLNISYCALFLSVMVFTFGMRDRKK
TDKP
>PK3-2_03142 Multidrug export protein MepA
MKAYDFTQGNVLKQLVLFSTPIMLGNALQVSFQFIDSLWVGNLLGAKALGAAAVSSTIVL
TVLSFILGLNNATLTILSQQKGKDDEKGMASYINAFVVLLTGLSIGFGAAGFFLSELLLR
LLKTPESMIPLAESYLQIQFIGILFLFGYNFISTVLRALGDSKTPLRFIAFAVVLNTVLA
PLFISVFRMGIAGAAYSTILSQGIAFLYGLLYVIKHKLVPFSIPRVPKWEESALILKLGI
PAGLQMMVITGGMMAIMSVVNSYGEHVVSGFGAVQRLDSIITLPAMAAGTAVNSMAGQNI
GIGNYKRVGTIAKLGVMAVISCMLVIAVMIWVFGKYLMRLFISEPDAVAFGEQYLRWIAF
FYPFIGINFVLNGIVRAAGAMLQVLALNVISFWVLRYPFTALFSAWLGQKGIGLGIGMSF
LLSSCAAYLYYRYGRWKTMKLFTEK
>PK3-2_03143 hypothetical protein
MKVRTQMMYDMETLLRKVFKQIRNEINEILDKELSRNEFTILRILSEQGPKKVTEFAPIL
EVSASHITAVTDALVEKEWITRIRSKEDRRIIRIHITEAGEKVLQHFNEKKTEYFFKRFD
CYSDAELASLIELFSKLDKKR
>PK3-2_03144 Peptide methionine sulfoxide reductase MsrA
MSEKKEIATFAGGCFWCMVKPFDEQPGIEKVVSGYTGGHTENPTYEEVCSETTGHREAVQ
ITFDPDVYPYEKLLELFWQQIDPTDAGGQFADRGSSYRAAIFYHNDKQKELAEASKQRLE
ESGVFKDPIVTDILKAEPFYEAEDYHQHFYKKNPGHYQRYRTGSGRAGFISEHWGAK
>PK3-2_03145 Peptide methionine sulfoxide reductase MsrB
MASNKEEKIKSLNRMQYEVTQNNGTEPPFQNEYWDHKEEGLYVDIVSGKPLFTSKDKFDS
HCGWPSFTKPIEEEEVEEKLDTTHGMIRTEVRSRTADSHLGHVFNDGPGPSGLRYCINSA
ALRFVPKDKLKEEGYESYLHLFDK
>PK3-2_03146 UDP-N-acetylglucosamine 4,6-dehydratase (inverting)
MPKQHTAELKPFFHNKTVLVTGGTGSIGSQIVKRLLLLTPKQVIVFSKDDSKQYVMSQKY
AEDKRLLFVLGDVRDHRRVSQVMKGVDVVFHAAALKQVPTCEDHPFEAIQTNLIGGQNVV
EAALLHRVQHVINISTDKAVSPVNTMGATKLLSEKLFHQANRHVQNRGTVFCSVRFGNVL
GSRGSVIPILFEQMMEGEPLTITDKNMTRFFMSIDDAATLTLQSAAITKGGETFIFKMES
LKLEELIHGFEKYASQHGLPRPAAVEVGKRPGEKLHEELTSPHEIESLYEWGNLYAILPE
PEKHPDFRRVNLPGYQSDQAPLITKDRIAQIIEELHQEKKA
>PK3-2_03147 3-phytase
MKVTKTMLLSTAAGLLLSLTTNSVSAHHVNAEHHFKVTAQTETDPVASGDDAADDPAIWV
NEKHPEKSKLITTNKKSGLVVYDLDGKQLHFFEFGKLNNVDLRYDFPLNGEKIDIAAASN
RSEGKNTIEVYAIDGDKGKLKSITDPKHPISTDISEVYGFSLYHSQNTGAFYALVTGKQG
EFEQYEIVDNGKGYVTGKKVRQFKLNSQTEGLVADDEYGNLYIAEEDVAIWKFNAEPGGG
SKGQAVDRVTGDHLTADIEGLTIYYAPDGKGYLMASSQGNNSYAMYERQGSNRYVANFDI
TDGEKIDGTSDTDGIDVLGFGLGPKYPYGIFVAQDGENIDNGQAVNQNFKIVSWEQIAQH
LGGKPDLHKQVNPRKLKDRSDG
>PK3-2_03148 hypothetical protein
MKVLYIQSGYGGIYSYFDRWAEDCFRRTHTDYMCADKPETESLAKIEAFQPDFALMMVGD
RVPHDWLAWLKGKGIPMYVWLTEDPFYIDISLQVIKHADAILTIEQNAALYYRELGCQHV
YHIPIPVNHRLFKKMDTEHSFHSNLLIIGYPYPNRVQLMKEAVHLPYTVRVIGTEWRKYL
PKKVLKQPHIDVVSTWVPPEQAVHYYNGADIVINAHRPYHFAFNKNHIRIKNASFNNRTF
DIAACEAFQLTDLPAAHPFSSFISYHSINDFKEKAAFYINHPEERHQAAASNYKETVPAN
TFDELPAKLKAIHLALT
>PK3-2_03149 hypothetical protein
MSSENAQLKKDLIKTFLSPLFSTEGGVNVDNHIKDMLEAAIDQKVDESEMITAESTSLPA
RWIFARITPGTTISIVTDSGDMIGPVVFVAFDQVHGIVFVTQESSVTPAGQATTLIDVDK
VESVTFFS
>PK3-2_03150 hypothetical protein
MDLENHVNQEENQDELHFIQLLLIVLIRQSSSEGNPSDLRRQLVFAKELGVPVSAVHLSN
GDTLQNVIVKEVLTDLVIFQNPLNNTRSNVALSSIVSWGAF
>PK3-2_03151 hypothetical protein
MGEKVSIILTSYNKPDYLQNAIESVMKQTHDLWELFIMDDHSNEETTAVIHKYLHDRRIR
YQNSFIHPAERLKTTRYATLINAALPFTDGDYISYLTDDTVYHPERLSRMVQTFSDKPEA
QAVYSKQKVIHVNERGEEISHFYRNANAVLDQAAFQVDHCSVMHRRSLLDRIQHKYGSYW
DDDTKHWNHGDSIFWARINNFAPFLPINEVLDTTYKTPDSFQNAYRFLPADLIDGSFVKG
SDQNVYFLDQDVRHPVGERWGSLYLNRTVAVPDPYLFQYRIGKFLNIPNYILVKEADHPA
IFYIEAGKKRRIVDQYAFQFYQFKRKDILPLEKEELEALPEGIPITRDRSGLIENPPGRR
LFFMEREPFLFLNGVFHPISEQVARKFFLHHKPIPASFRNIQQFPIGKPFYPVYDEIIKK
LNIETD
>PK3-2_03152 hypothetical protein
MTGHYSKTEHQYILLTSESASFDHYSVYRDPKLPQIFSHNFVQLHDAFPLEQLLDFLPSV
PKLLDANYLHLKASPQHVFQLGLKQSLVKSGFVVEDELLYDMKLNDWKGQAGHPLTAWGT
AKSLSDGSSIMKIYDSIYIGEAIAEQKLKRKYPFYEAGTIILVVCYSDEAQKIPIGCGEL
FIHPQEKTAKIEEVAILDQFQRKGFGSILVKEMLSIAKSLGMEAAYLVATSTDGATLFYE
KLTFKKHERVHTVFHYFLT
>PK3-2_03153 Putrescine--pyruvate aminotransferase
MSSYLIKPELSSAYPVVSYAKGSYVYDQTGKRYLDGSSGAVTCNIGHGVREVTEKLKEQL
DQVSFAYRSQFTSEPAEQLAALLAQKLPGDLNWSFFVNSGSEAIETAMKIAIQYWQEKKQ
TQKSIFLSRWSSYHGITLGALSLSGFYERRYRFTHLLERYPAISAPDGYRRNHGTEEDFV
QAAADELETAIKRIGSQFIAGFVAEPIIGAAGAAITPPPGYYERLSAVCRTHDVLFIADE
VMTGLGRTGRMLATEHWHTVPDIAVLGKGLGAGYAPIAAAVVSDSIIETIKQGSGVIMSG
HTYSAHPYSAKAALEVLRYVLNHGLITQSEKKGAVLKKKLIEAASQSGIIGDVRGKGLLL
GVEFVADQKTKEVFPPEQAVTQLIVGEAKKRGLIVYPAKAGIDSGEGDAVIIAPPFTISD
GEIEELISIFSETIAAVEKIEKGLKSNGAISKNNQH
>PK3-2_03155 putative succinyl-CoA:3-ketoacid coenzyme A transferase subunit B
MGLGVAEREQIAKRAASEIKPGMIVNLGIGIPSLVPNFLPADMQVMLQAENGVLGIGESP
DKGEEDEQLCNAAGYPVRAVKGASYFDTTMSFAMIRRGKIDITILGALQVSRSGDLANWL
VPGKKVPGMGGAMELAQKAKKVVVVMSHTDQKGRPKLTETCTLPLTAAGCVDLIITEKAV
LEVDGHHFILKELMNGSTIDEVIRLTEAEIKIDMPFS
>PK3-2_03156 N-formyl-4-amino-5-aminomethyl-2-methylpyrimidine deformylase
MQDIERKVIGWLDQHSAKAIRLLKRLIGEKSTLGSEFNAQAVVLEKLRQFHMDIDVWEPS
LKQLKQHPYFKSDRSDFHESPNIVAKKTGAGGGRSLILNGHIDVVPEGSVKDWKYEPYQA
VEENGKIYGRGSTDMKGGNTSLLFALEALHACDVKLKGDVLFQSVVDEECGGAGTLSAIM
RGYRADGALIPEPTNMKLFIKQQGSMWFRITVRGLAAHGGTRYEGVSAIEKSMHVITAIQ
ELEKVRNARISDPLYDNIPIPVPVNIGTISGGAWPSSVADRVVIEGRCGVAPQEKPEAVK
LELENWLKDLEYRDEWFKRHPIKVEWFGAQWLPNDLPDDHPLISVLQSAYQKMKQTAPII
EASPWGTDGGLLYHAGDTPVIVFGPGETKTAHQANEYIEVEAMIESAKIIALFVMDWCGL
HTDREDADAQVDKE
>PK3-2_03157 N-acetyltransferase YodP
MLKSIKSNGVTAVLDHDGFNKRIRVVRYDGAIEKVLPDIAAAAKEEDAEKIIVYTKQHDE
AVLAKQLFAPEGFLEGYYLGHPASIMVRYLKENRRQTDSYIEEQEMIEALYRTAPRLSNE
NTPVFTMRKAETNDMYQLSMLYKKVFRTYPAPIFDPAYIEKTMNENTMYYVMLDHDRLIS
AASADINPELGHAEITDCAVLSEYRGHSLTSFLIDALERELVAKDIFHVFSLARAASFGM
NAVLYHSGYQYGGRLINNCYIAEGLENMNIWCKHL
>PK3-2_03158 L-lysine 2,3-aminomutase
MASKWYKPKRHWKEIELWKDVPEEKWNDWLWQLTHTVRTVDDLKKVINLTEDEEEGVRIS
TKTIPLNITPYYASLMDPDNPRCPIRMQSVPLSEEMHKTKYDLEDPLHEDEDSPVPGLTH
RYPDRVLFLVTNQCSMYCRYCTRRRFSGQIGMGVPKKQLDAAIAYIRETPEIRDCLISGG
DGLLINDQILEYILKELRSIPHMEVIRIGTRAPVVFPQRITDQLCEILKKYHPVWLNTHF
NTSIEMTEESVEACEKLVNAGVPVGNQAVVLAGINDSVPIMKKLMHDLVKIRVRPYYIYQ
CDLSEGIGHFRAPVSKGLEIIEGLRGHTSGYAVPTFVVDAPGGGGKIALQPNYVLSQSPD
KVILRNFEGVITSYPEPEKYIPNQADAYFESVFPEIADKKEPIGLSAIFADKDVSFTPEN
VARIKRREAYTANPEHETLKDRREKRDQLKEKKFLAQQKKQKGAESGGDSS
>PK3-2_03159 hypothetical protein
MKTCEWCGELEAVPGWNTVYWELPDGTRAIELTDTPAMVCASCGMTYQEETIIKEIEDQL
LLIQTKKLPESLTYQQLMETERILKRNYFDFS
>PK3-2_03160 hypothetical protein
MKSFYHYLLKYRHPKPQDSISEFANQAYEDHSFPKTSTDYHEISSYLELNADYLHTMATF
DEAWDQYEAEVHGR
>PK3-2_03161 hypothetical protein
MKQNKPKFQVGDIVVVIMYGTVGTITKVHQIDKHYLYEVNHNEVLYFESSIQLYKDYEGV
IVDMEKLDIEYEFLIGDVVYVKDYGKELFRIIGHRTEIWRYLEDGWEDIIYELTRLKDGE
WLETEEEDLTLVLRKYEMDQFVHQLLFVHYVGETGHEIGEDIASSALLQFEGDDEDQDTL
HILAVSIVDELLDIYNDYKILYEMFQDEEYKDMMMFVLESLKEHFS
>PK3-2_03162 hypothetical protein
MIAKMMEALDGERFDIIMEKTLKGMTHVMIWGCLPYFLYVLIRLFTN
>PK3-2_03163 hypothetical protein
MKEIDLVIDTEEIAEFFYRELARRGYIPSEDELFEIADITFDYLIEKCMIDEELDEDD
>PK3-2_03164 Phosphatidylglycerophosphatase B
MWYKPVSLFLFFLFLAAAIHANAVQSADEAISKAAALIRQPWLNDVMTGITHLGASSFLL
PLIVIIGAGLFFYRKTWDGLLMLLVFGADRLLNKVLKEWIERERPDFAPLVHESSFSFPS
GHSMNAACVYPVIAYFLVKHLPFLSKHKKMVYTIAGVITILVGISRVYLGVHFVTDVLGG
FSLGLLLFFLVKGFDEKIKRFRQK
>PK3-2_03165 hypothetical protein
MMLSVFKKKSCSYDVTIFQTPRFGEKKGYRAVYRTELNGSDHQDVLKRAFSLFNVFDTVP
SDYDARFMATGDVILIDEGRKGKTYYKLLPAGWRKINRLIVQTT
>PK3-2_03166 hypothetical protein
MGKKQRNRITGQKKNNHIPAKDVIAAEEAHGKEYSAAKRKP
>PK3-2_03167 Purine nucleoside phosphorylase DeoD-type
MSVHIGAEKGQIADTVLLPGDPLRAKFIAETYLEDVECYNEVRGMYGFTGTYKGKKISVQ
GTGMGVPSISIYVNELIQSYDVQNLIRVGSCGAIRKDVKVRDVILAMTSSTDSQMNRVAF
GSIDFAPCADFELLKNAYDAAKDKGVPVTVGSVFTADQFYNDDSQIEKLAKYGVLGVEME
TTALYTLAAKHGRKALSILTVSDHVLTGEETTAEERQTTFHDMIEVALHSVSQ
>PK3-2_03168 Putative carboxypeptidase YodJ
MMKKSGKWFSLAAALSVTAIVGAGCSMSNGDAQKDTKSTAETKQTEQKTNDTKKTNTQDS
EFSLESKYFNDIKKVDGLETIQNPENILALVNKQYALPGNYEPSDLVIPDVEFSFEEKIQ
KRYIRKEAADALKTMFDAAKKEGYELAAVSGYRAYDRQKVIFDNEVSLKGEKKAREAVAY
PGESEHQTGLAMDISSRSNGFELNEAFGSTADGKWVQDNAYKYGFIIRYPKNKEDITKYE
YEPWHLRYVGKKAAKVIQDNDLTLEEYFEKVKKI
>PK3-2_03169 hypothetical protein
MERYYHLCRNHQGKVVRITERGGRVHVGRITSVTRDRVFIAPTGGGPRGFGYGYWGGYWG
YGAAYGISLGLITGVALAGLFFW
>PK3-2_03170 2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial
MSRYLEMLSLFGVAGAHPGGLAFSKAVLQKAAPSPDQPILDAGCGTGQTAAYLGHLLYPV
SVVDKDPIMLEKAKKRFANEGLAIPAYQAELEHLPFSSESFSCVLSESVLSFSHLTSSLQ
EIARVLKPGGMLIGIEAAIKKPMPAADKKQMLDFYGFTCLHEETEWHKLLRSYGFQKTEA
LTLLPDDMEFEPTTEMDLSQTIAPIYYDTLQAHYELMQIYSEYMGHCIFIAYK
>PK3-2_03171 Carboxy-terminal processing protease CtpA
MKRQLKLFFIVLITAVVASALTLFITGNSSILGQKSASTGDSKFDKLNKAYEQIKSDYYQ
KTDDDKLVDGAIKGMIQSLDDPYSTYMDQEEAKSFDETISASFEGIGAQVEEKDGEILIV
SPIKGSPAEKAGIKPRDQILKVNGKSVKGMTVNEAVALIRGKKGTKVKLELNRAGVGNID
LSIKRDTIPVETVYSEMKDNNIGEIQITSFSETTAKELTDAIDSLEKKGAKGYILDLRGN
PGGLMDQAITMSNLFIDKGKNIMQVEYKNGSKEVMKAEKERKITKPTVVLVNDGTASAAE
IMSAALHESSGIPLIGETTFGKGTVQTAKEYDDGSNVKLTVAKWLTADGEWIHKKGIKPQ
VKAELPDYAKLPYLDADKTYKSGDSGTNVKVAQQMLKALGYKVKVNSTYDQDFVSVIKQF
EKKEKLKETGVLTGDTTTKLMTELQKKLSNNDTQMEKAIETLKKEM
>PK3-2_03172 putative symporter YodF
MQGNLTALLITAFIVLTVVCIGFLAGRDKSSRTSVEEWSVGGRRFGGLLVWFLVGADLYT
AYTFLGLTSTAYTGGSVAFFAIPYSVLAYFIAYFFLPKLWKVAKIHKLTTLADYARERFD
SKLLASLVAIVGVLMLIPYICLQLSGIQDTLQVAGTGYINVKFVVIISFILVALYTFFSG
IKGPTFTAIIKDILVWVIMLFMVVTLPLIHFNGWTPMIDTLVKEAPQMLTIPAEGPKGIP
WFITASIVSALALFMWAHAATGVFTAKSADAVRKNSMFLPLYNIVLILVIFLGFIAFLVL
PEDTNPRLALLHLIQTSYGGVAQGFAYATIALASLIPCSIMAIGASNLFANNLYRDLIHP
NVSQSKLTLVTRSMVFVVIGLALLFGMLFPTALVTLQLLGVSGMVQIFPAIAVSLFWKRQ
TKEATVIGLLVGLAVTFIVYTTQSAHGIYEGFWGLAANIAAVVILNPLFVKKAGSNPVIE
GLFGKKQDANPNQKGA
>PK3-2_03173 hypothetical protein
MVKKALIVILILLPFAQLALLPLVNRIEPIIFGLPFFHFWLLLWIIITPLCSFGIYQIQK
KDGGFE
>PK3-2_03174 Putative ring-cleaving dioxygenase MhqE
MKTEGLHHITAFARNPQENLRFYTEVLGLRLVKKTVNFDDPGTYHFYFGNQNGDPGTIMT
FFPFQGSGQGTVGKGQAGRVYFSVPKGSLSFWKERLEKNGLNLEEKTLFGEKGLMFDDTE
DLPLAIMEDAKSGKSEWTPEGISEQEAITGMKGVLLYSYDPQATIQFLIESFGYAKAAEE
NQIVRLTSLAAIGGLVDVHLHPEKRGVGGYGTVHHVAFRTTKEEQAKWLPIIAQNHFPSS
EILDREYFTSIYFREKGGILFEIATDEPGFMTDETFDELGTSLKLPEWLEKHRQHITDVL
PKL
>PK3-2_03175 Putative hydrolase MhqD
MKHIYEKGTSDNVLLLLHGTGGNEHDLLSLGRFIDPHAHLLGVRGSVLENGMPRFFRRLS
EGVFDEKDLVERTTELKDFIDEAAETHQFDRGRVIAVGYSNGANIAASLLFHYQDVLKGA
ILHHPMVPIRGLKLPDMTGLPVFIGAGKYDPLCTKEESEELYRYLRDSGASASVFWQDGG
HQLTQHEAEQARDWYKATIV
>PK3-2_03176 Putative NAD(P)H nitroreductase YodC
MTNTLDVLKARASVKEYDTNAPISKEELTELLDLAAKAPSAWNLQHWHFTVFHSDESKAA
LLPVAYNQKQIVESSAVVAILGDLKANENGEEVYAELASQGYITDEIKQTLLGQINGAYQ
SEQFARDSAFLNASLAAMQLMIAAKAKGYDTCAIGGFNKEQFQKQFDISERYVPVMLISI
GKAVKPAHQSNRLPLSKVSTWL
>PK3-2_03177 HTH-type transcriptional regulator YodB
MCPKMESAFSLLGKRWNGLIIHVLMDGPKRFKEITETIPMISQKMLAERLKELEQNEIVE
RQVLPETPVKVIYTLTEKGTALQAVFQEMQTWADQFCEPGETMCEKEK
>PK3-2_03178 hypothetical protein
MPLLRFDLIEGRDEKSLQLLLDTAHQAMVEAFGVPERDRYQIVHQHPANELIIQDTGLGF
QRTKGLVIISMTSKARTESQKEKLYALLAEKLEAECGVSPEDLMVSITENGDADWSFGLG
EAQFLNGKL
>PK3-2_03179 High-affinity gluconate transporter
MPILIVAVGVLILLFLIIKVKLNTFVSLIVVSFLVAIGLGMDINKIAVSIEAGIGGQLGH
LALVFGLGAMLGRLVSDAGGGYRIAITLIDKFGRKRIQAAVVIASFIIGIALFFEVGLVL
LIPIVYAIAKELKMPFLYLGIPMAAALNVTHGFLPAHPAPTAISVAYGAHIGQVLLFGII
IAVPTTLIAGPLFNTFAMKRFPGAYQKRGNLSALGPRKEF
>PK3-2_03180 Gnt-II system L-idonate transporter
MGVATVFSLLLQEHSRGKDIIEFIGTPGTAMLISLLLALYTMGYARNIPMQEISKSLSES
ISQIAMMLVIIGGGGAFKQVLIDGGVGDYVADLFSQTNMSSLLVAWIIAAVLRLCLGSAT
VAALTTAGMAAPLMQAGSVNPGLMVLATGAGSVIACHVNDAGFWMVKEFFGLSMKETFQT
WTLLTTVLSVTGLGCVLLAGLVM
>PK3-2_03181 hypothetical protein
MYPHHSFYRGNPDPIGYPARNPFLFGAPLVGGLLGGFLGSALFNAPRPYAYPPGPYGYGG
APYGFGAGAPYGGYPGFY
>PK3-2_03182 Spore germination protein GerT
MFEWNKYFPFHNQFSKEALKKADPKEVETYVNRVMESVFGGDYAAQFPFRDPLPQKKQPA
KPEAKPDVDLFETADHVFVKVPINESRLEQVRIKHTSHELLLENFPDSDHPKKINLPCLV
KRKGTKAVFKDGLLEVMFQKQQDYNMSEVEIIR
>PK3-2_03183 Protein RarD
MQYSETKKGVLYTAVSFIMWGLFPLYWKLLAQLPALDILAHRIIWSFVFMCILLFFLRQW
KTGWQELRSLKKKGGILSLFLASILISINWFVYIWAVNHGFLLEASLGYYINPLVSVLLG
ILFLKEKLNRLQLVAVSIAAAGVIISAFQYGSIPYVALLLAFSFGLYGLSKKRTSLSSAI
GLTLETFMIMPIALGYLLLSGHAQPAGAESGETWMLLFFAGVFTALPLLLFAEGAKRLPL
YQVGILQYIAPTITLLIGLFVYHEPFSSSKAFTFSCIWAALLLFTFSQVKWKRASKSH
>PK3-2_03184 hypothetical protein
MDKDKEIVKAYASLWNNRSFVSDDAEAVAEAIDLELLDKRTHPRLRKPMLEKYIAAIQRI
VNSQLEPAVKYQLVKLHTERAEHLKEERGEQS
>PK3-2_03185 putative protein YojF
MKAIIKEDVQASLERYADRPVYIHLETTTGSYSAHLNEKNMTVVAYIRNAKVTYHQAKIK
GSGPYRVGLKTEEGWIYAEGLTEYTVDEDNRLLMAGHLPGGKLAISLQISEKPFTV
>PK3-2_03186 putative N-acetyl-alpha-D-glucosaminyl L-malate deacetylase 2
MKEHVLVILPHPDDESYGVAGLIALNRKKDIPVTYACATLGEMGRNMGDPFFANRETLPL
LRKQELINACKEMDINDLRMLGLRDKTLEFEDDEYLADIMEKIIDDVKPSLIVTFYPEHG
VHPDHDACGEAVIRALYRKKKEDRPRTLCMAITRNREEVLGEADVVLDIKEVADIKMNAL
RAHRTQTEGMLRELEEKLKNNEPVMATWFEEERYWTYQWND
>PK3-2_03187 RsbT co-antagonist protein RsbRC
MAKNKKLYEYLSQHAETISSTWYETIEETDPNSIYASIDPSVIHNLKSQNLAFNYKINRI
FIDDEEVYLPILKEWAFEVTQDPEHLKTPIHYIIREFVRVRDLYVSYVKEFVHLNQDTVK
GEEAEDLYHSLIKAFDLVIHIFIEEMYKSTSLQLQAQKDMITELSAPVIVLFHSVGLLPL
IGDIDTVRAKLIMENTLHQCAEKKVTQLYIDLSGVVIIDTMVAHQLFSLIEALRLIGVSS
TLSGIRPEIAQTAVQLGLSFEDISLRSTLASAIASDLKLKKV
>PK3-2_03188 Multidrug resistance protein NorM
MKETRNARQKIKQLLHILIPILITQAGLSLMTFLDTVMSGKVSPADLAGVAIGSSLWTPV
YTGLAGILMAVTPIVAQLLGAEKKQKIPFTVLQAVYVAALLSIAVLAIGYAAVGFILGRL
HLETHVHQIAKHFLGFLSLGIFPLFVYTVLRSFIDSLGKTRVTMMITLSSLPINFVLNYV
FIFGKFGMPALGGVGAGLASALTYWCICIISFFIIHKSAPFSGYGIFLTMYKFSWKACKT
MLKIGLPIGFAVFFETSIFAAVTLLMSHFDTVTIASHQAAMNFASLLYMLPLSVSMALTI
VVGFEAGAARFRDARSYSLIGIMMAIGFSLLTAACILLFREQIAGMYTSNPDVLRLTQHF
LIYALFFQLSDAVAAPIQGALRGYKDVNYTLAAAFVSYWVIGLPVGYAVGTFTSLGAFGY
WIGLIAGLAAGAVGLFFRLAKLQKHYSQKQYV
>PK3-2_03189 hypothetical protein
MEIERIIQYICTFLGVISLSFIYAQMFRKTKPTKKE
>PK3-2_03190 Cyclic di-AMP synthase CdaS
MRYEQMSENAFKGKIQVYLEQILGDASLILKTLHEKDQCLLCELDDLGHVFQDMQGIASS
FYLQSYIEQFTPAFIELAKAIKALSEHKHGALIVIERADPVEHFIQKGTSLHAEISASLI
ESIFFPGNPLHDGALLVRENKLVSAANVLPLTTKEVDIHLGTRHRAALGMSGHTDALVLV
VSEETGKMSFAKDGVLYPVISPRT
>PK3-2_03191 Oleandomycin glycosyltransferase
MANVLMIGFPGEGHINPSIGVVKELKSRGENITYYAVKEYKEKIAALNIEFREYHDFRGD
YFGKNATGDEERDFTEMICAFLKGCKDIATHIYNEVKHESYDYVIYDHHLLAGKIIANML
KLPRFSLCTTFAMNEEFLKEMMGAYIKGSFEDSPHYESYQQLVETLNADYQAGIKKPFDV
FSSDGDLTIVFTSREFQPMAEQFGDRYVFVGPSITERAGNNDFPFDQIENENVLFISMGT
IFNNQKQFFNQCLEVCKDFEGKVVLSIGKHIKASELNDIPENFIVRPYVPQLEILKRASL
FVTHGGMNSTSEGLYFETPLVVIPMGADQFAVGNQVEKIGAGKVLKKEQLSESLLKETIQ
EVMNNYVYAEKAKEIGQSLKAAGGCKKAADSILEVVKQKKQSANA
>PK3-2_03192 D-gamma-glutamyl-meso-diaminopimelic acid endopeptidase CwlS
MKRKIVAGLAVSAVVGSSMAAAPAEAKTIKVKSGDSLWKLSRQYDTTISALKSENKLKST
VLYVGQSLKIPDGSKKSKTSSSSPSKTSTYTVAYGDSLWMIAKNHKMSVSELKSLNSLTS
DLIRPGQKLKIKGTSGSSGSNGSKKNSGSNSSGSSKSTYTVKLGDSLWKIANSLHMTVAE
LKTLNGLTSDTLYPKQVLKIKGNSSSNSGNSGSKKPSNSNSSKTTTYKVKAGDSLWKIAN
QLGVTVQSIRDKNNLTSDVLQIGQVLTISGTTKSNNSKQTKPKDNSGSNVQIGSKIDRMI
TEAKKYVGVPYRWGGNTPAGFDCSGFIYYLINNVSSISRLSTAGYWNVMQKVSQPSVGDF
VFFTTYKSGPSHMGIYLGGGDFIHASSSGVDISNLSNSYWKQRYLGARSYF
>PK3-2_03193 Superoxide dismutase-like protein YojM
MYRLLLLMMLTALGVAGCGQKKPPDPPQRVPEKKAVETSAFGHHVQLVNREGKAVGFIEI
KESDDEGLDIHISANRLRPGASLGFHIYEKGSCVRPDFESAGGPFNPLNKEHGFNNPMGH
HAGDLPNLEVGADGKVDVIMNAPDTSLKKGSKLNILDQDGSAFIIHEHADDYLTNPSGNS
GARIVCGALSGSNEKQ
>PK3-2_03194 hypothetical protein
MTTQLQHLTLPEDIQQKLLSYKDEPIAPEFQSLIGTSGYEAEDEAILFDAIIALAMGKNV
LLKGPTGSGKTKLAETLSSYFHKPMHSVNCSVDLDAEALVGYKTIENQSGQATIEFVSGP
VTKAMKEGHFLYIDEINMAKPETLPILNGVLDYRKMMTNPFTGEVIRAKGGFGVIAAINE
GYVGTVPLNEALKNRFVIIDVPYIKGKLLKQVLMSQSALKDEKLIDRFITLSSDMIVQAN
NGQVSEEAASIRALIDTCDLAAYIPPRRAIERGIVEKLDDDREKAAVRNIAETLFE
>PK3-2_03195 hypothetical protein
MKFIKFNDSTIDSFLFMMLTDLAKTLTKSEAVEVEYGVQSYYNPFEKKIYMSHFWKDRAA
EDMEAGLKSDVYLRSVGTKYSSLHEFANFLDDIHQHLAFKSFAKQLFMLLEDIRIEECIK
HERPGTKHVFAKRKDMYRKHFSTQLTLNLERSIFTDALFCAIYVKLTTESPLETLPSMRE
DIDLMCPFIEQQLLRVYEADSTRHVLKIVEDLMDGLEEVLDKDMLNTYFFLPELDYATAA
EQPLFEEEKKAPKLSDDITLPKKSDGDEDIHEEEMPTWHRETEAPAKSFLQFDIEHGAKS
DLGKDASREGDDGDQALGSVQGSARQTKRKDYSKLEALESQKDQPNGAGMADGKENKYAF
PICKEPQTATSEEELSYKQQAKTIESYQKRLKQMIQKTLEHKKTLPRTDLHAGRLNNKLL
RYFTERNPRLFYKKQEPSSEIDAVFTLLVDCSASMFDKMDETKRGIVLFHEALKSVAVPH
QIVGFWEDTNDATETSQPNYFNTVIPFQSSLRQGTGPAIMQLEPEEDNRDGYAIRQMTKK
MLQRSEAQKFLIVFSDGEPAAFGYEQNGIVDTSEAVIEARKRGIEVINVFLSNSEIEESQ
MKIIQDMYGKFSIFVPDVDQLPDVLYPLLKKLLRKSIG
>PK3-2_03196 2-oxoglutarate dehydrogenase E1 component
MFQNSMKQRMNWEDFYGPNLGYALELYDQYTQDPTSIDPDLKEMFDELGAPPSDIKEVSG
TKEKGHVTADLIQKIASAVRLAEDIRTYGHLNASVNPLRKDGKKSELFPLSDYGLTEEEI
KAIPASVICKDAPKNITNGLEAIQYLRNTYKRTISFEFDHVHDFKEREWLTKMIESGELF
QKSSAEKLSAVLERLTEVEGFEQFLHRTFVGQKRFSIEGLDALVPVLDDIIAQSVKSGTT
SVNIGMAHRGRLNVLAHVLGKPYEIIFSEFQHAPNKDLVPSEGSIGISYGWTGDVKYHLG
ANRELQDAETKSARITLANNPSHLEFINPIVEGSTRAAQETRTQSGYPVQDETKSLAILI
HGDAAFPGEGIVAETLNLSSLKGYQVGGAIHIIANNMIGFTTESAESRSTKYASDLAKGY
EIPIVHVNADDPEACLSAVKFAVEYRKTFNKDFLIDLIGYRRYGHNEMDEPSTTQPMLYD
AVRKHPTVKQIFAEKLVNEGMLTEEVVQNIEKSVTKRIEDAYQKVPAKKEHTACEIELPE
PVSNGFPDVDTAIDFDVLRKLNGELINWPESFNVFGKLKRILERRAKAFDDDRKVEWSLA
ESLAFASILKDGTPIRLTGQDSERGTFAQRNLVLHDSETGEEFVPLHHLSDCGTSFAVHN
SPLSEGSVLGFEYGYNVHSPETLVMWEAQYGDFANAAQVYFDQFISAGRAKWGQKSGLVM
LLPHGYEGQGPEHSSGRIERFLQLAAENNWTVANLTSAAQYFHILRRQAKMLLREEIRPL
VIMTPKSLLRNPNTVSEVQELSESRFQPVYEQSGLSHDYEKVTRLVLSSGKVSIDISDHF
NKLEDGKEWLHIARIEQLYPFPAKGVKELFAKLPNLKEIVWVQEEPQNMGAWSYISPYLT
EIAPEGVSVQYIGRRRRSSPAEGDPTVHKKEQERIVSDSLTRKN
>PK3-2_03197 Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex
MAEIKVPELAESISEGTIAQWLKQPGDYVEQGEYLLELETDKVNVELTAEESGVLQEVLK
DSGDTVQVGEIIGTISEGAGESSAPAPSEKAESKEEKKAEPAAQEVSEEAQSEAKSRTIA
SPSARKLAREKGIDLSQVPTGDPLGRVRKQDVEAYEKPASKPAPQPKQQQPQAQKAQQSF
DKPVEVQKMSRRRQTIAKRLVEVQQTSAMLTTFNEVDMTAVMNLRKRRKDQFFEQNEVKL
GFMSFFTKAVVAALKKYPLLNAEIQGDELIVKKFYDIGIAVAADEGLVVPVVRDADRLTF
AGIEKEIGELAKKARNNKLTLSELQGGSFTITNGGTFGSLMSTPILNSPQVGILGMHKIQ
LRPVAIDEERFENRPMMYLALSYDHRIVDGKEAVGFLVTIKNLLEDPEQLLLEG
>PK3-2_03198 Pantothenate precursors transporter PanS
MDIIRKISHYAGQTFGIWVIVFAVLGFSFPSLFTWISSYITIFLGIIMFGMGLTLQADDF
KELVRKPWHVIIGVIAQYTIMPLVAFGLAFGLHLPAEIAVGVILVGCCPGGTASNVMTFL
AKGNTALSVAVTTISTLLAPVLTPILIMLFAKEWLPVSPGSLFISILQAVLFPIIAGVIV
KMFFKKQVAKAVHALPLVSVIGIVAIVSAVVSGNREHLLQSGLLIFSVVILHNVIGYLLG
FLCAKLLKMDYPSQKAIAIEVGMQNSGLGAALATAHFSPLSAVPSAIFSVWHNLSGSMLA
TYWSKKAKKKQAASDSSNLPL
>PK3-2_03199 hypothetical protein
MKEANQWSSKLGFILAAAGSAIGLGAIWKFPYVAGTSGGGAFLLIFILFTVLIGLPLLLG
EFIIGRKTQKDAVQSYKTLAPGTKWHWIGYLGMATCFILLSFYSVVGGWILIYITKGFTG
GLSQTSGFDTIFASTISNPYLAVGGQLLFMVVTILVVAKGVSSGIEKASQVLMPALFILF
IILMVRSVTLDGAMEGLKFFLMPDFSAIDANTILYAMGQSFFLLSVGVSVMVTYSSYLEK
QENLVQSAVSVTVLNVLVAVMAGIAIFPAVFSFGLKPDQGPVLLFNVLPTVFNQMPFGII
FLLAFLILFLFAALTSAFSMLEILVAVLSKGDVNKRKRFAWLGGIAIFIVGVPSALSYGV
LSDVSIFHLSIFDAADYLVSNILMPLGALLISIFVPLKIPKQDLFDELKSGSNLKRKWFA
VWLLLIRYLSPVAIIIVFLHVIGIF
>PK3-2_03200 hypothetical protein
MKRESYQTEMFNWCEALKDQIQKRGQLEQFEDQIDKMIEALEDDRTTEEDWYKQAAALYR
DITESGDTSERRAYVPIGKHVLPKLPYKYSALEPYISREIMVLHHTKHHQSYVDGLNKAE
LELKKARASKNFDLVIHWERELAFHGAGHYLHSIFWFSMHPNGKRRPTGALFQMIDLSFG
SYSAFKEHFTQAAKKVEGVGWAILVWAPRSGRLEILTAEKHQLLSQWDVIPLLPLDVWEH
AYYLQYKNDRASYVDHWWNIVDWREAEKRYEQAKEVVWKLY
>PK3-2_03201 Sporulenol synthase
MGILQEKVRRFQKKTIAELKDRQNADGSWTFCFEGPIMTNSFLILLLTSLDEDENEKELI
SALAAGIREKQLPDGTFINYPDETSGNITATVQGYVGMLASGYFHRSDPHMKKAEQFIIS
HGGLRHVHFMTKWMLAANGLYPWPVLYLPLSLMALPPTLPVHFYQFSTYARIHFAPMAVT
LNQRFALKNRNISSLRHLDPHMTKNPFTWLRSDAFEERDLSSILTHWKRIFHAPFAFQQL
GLQTAKTYMLDRIEKDGTLYSYASATIFMVYSLLSLGVPKHSPVIRKAIYGIKSLVTKCS
GMPYLENSTSAVWDTALISYALQENGVTETDGSITKAAAFLLNRQHTKIADWSVKNQNAA
PGGWGFSNINTNNPDCDDTAAVLKAIPRRFSPSAWERGVSWLLSMQNNDGGFSAFEKNVN
HPLIRLLPLESAEDAAVDPSTADLTGRVLHFLGEKAGFTEYHQHIQRALNWLFKHQEQNG
SWYGRWGVCYIYGTWAALTGMHACGVSQKHPAIQKALRWLKSIQHDDGSWGESCKSAEIK
TYVSLHRGTVVQTAWALDALLTYENPEHPSVVKGMQYLTDSSSHDADSLAYPAGIGLPKQ
FYIRYHSYPYVFSLLAVGKYLNSIEKERANET
>PK3-2_03202 Phenylacetaldehyde dehydrogenase
MSSLTMQVTKRLETFLQGTKKLYMDGKFVPSASGATFDTPNPATGDTLMTLYEAQAADVD
KAVKAARKAFDQGEWRTMSPASRSRLMYKLADLMEEHKTELAQLETLDNGKPINETTNGD
IPLAIEHMRYYAGWCTKITGQTIPVSGAYFNYTRHEPVGVVGQIIPWNFPLLMAMWKMGA
ALATGCTIVLKPAEQTPLSALYLAELIDQAGFPDGVINIIPGFGEDAGEALTNHEAIDKI
AFTGSTEIGKKIMSTAAKSIKRVTLELGGKSPNILLPDANLKKAIPGALNGVMFNQGQVC
CAGSRVFIHKDQYDEVVNEMASYAESLRQGAGLHKDTQIGPLVSKEQHERVLSYIQKGKD
EGAKAVTGGSCPFEEGYFVAPTVFANVEDEMTIAQEEIFGPVLTAIPYETVDEVIERANH
SEYGLAAGLWTENVKHAHYIADRLQAGTIWVNCYNVFDAASPFGGYKQSGLGREMGSYAL
DNYTEVKSVWINLED
>PK3-2_03203 hypothetical protein
MIHKNWLEKETIKKVKCVQTNAKKYIVNRVLTPGKEYEVKNETEEFLFVIDNTNKVGGYY
KEYFEEV
>PK3-2_03204 hypothetical protein
MGIFSVSRSTDAKKLEALLVEGERIESIYKLRVDQICFTNKRIIFFDNKMFSKKKVRVFL
PYKSIESFAIQEAGMFDPDTGLLLMTRSKTFELEFAKDTDLSEVQAVLTKHLCS
>PK3-2_03205 General stress protein 16O
MSLTKEQTQHLYHKLLDMQKELSGEKKKTESMAEEVGELSNGVDNHMADHGTLVTDRMTD
QTVREIDRELLEEVNHALQKMKDGTYGVCEKTGQDIPYERLEAAPYARMTVEAQADMEDD
LETDAPSYEREFHEQVKDLSNKETIDQKSSQTYEILDREQDSQ
>PK3-2_03206 FMN-dependent NADH-azoreductase 1
MSTVLFVKSSDRTAEEGVSTKLYEAFLAAYKENNPADEVVELDLHKENLPYLGRDMINGT
FKAGQGMEMTEEEKKQAAVADKYLNQFVKADKVVFAFPLWNFTVPAVLHTYVDYLSRAGV
TFKYTQEGPVGLMGDKKVALLNARGGVYSEGPMASLEMSLNFMKTVLGFWGVQDLHTVVI
EGHNAAPDQAQEIVEKGLQEAKDLAAKF
>PK3-2_03208 ATP-dependent DNA helicase RecQ
MLHRAQSLLAHYFGYEKLRIGQEEAIRSVTEARQNTACIMPTGGGKSICYQIPALMFEGT
TIVISPLISLMKDQVDALEEAGINAAYINSTQSNQEIYERLNGLKEGAYKLFYITPERLT
SAEFIRILQGIDVPLVAIDEAHCISQWGHDFRPSYRNIEILFRELHDKPVIMALTATATP
EVHEDICKQLHIQKENTVYTGFSRDNLTLKVAKGENKDRFIDEYVQNNKHEAGIIYTATR
KEADRIYERLKRHQVSAGRYHGGLADDVRKEQQERFLNDELQVMVATSAFGMGIDKSNIR
FVLHAQIPKDMESYYQEAGRAGRDGLDSECVLLFSPQDIMVQRFLIEQSEHEEKQKQDLK
KLRQMVDYCHTEDCLQRFILMYFGEKEPDACGQCGNCTDTRTAHDVTREAQMVLSCIIRM
KERFGKTMVAQVLAGSKNKKVLENGFADLSTYGILKHQSVGEISDFIEFLISDDFIRMSD
GTFPTLFVSSKGRNVLKGELSVTRKEALKAAAITENDELFERLRMVRKEIAAEQGVPPFV
VFSDQTLKEMSGKQPVNDEELLSVKGVGEQKRAKYGRLFLQEIQAYARVTD
>PK3-2_03209 Cell wall-binding protein YocH
MKKTIMSFVAVAALSSTAFGAHASAKEITVQKGDTLWGISQKNGVNLKDLKEWNKLTSDQ
IIAGEKLTISSEETTTTGQYTIKAGDTLTKIAQQFGTTVNNLKVWNNLSSDMIYAGSTLS
VKGQATAANTVTENTQTSAPQTEPKQEAVQKEQPKQETVQQQPKQETKAAAETSVPTEEK
AVQSNTNNQEASKELTVTATAYTANDGGISGVTATGIDLNKNPNAKVIAVDPNVIPLGSK
VYVEGYGEATAADTGGAIKGNKIDVFVPNKGDASNWGVKTVSVKILN
>PK3-2_03210 Transcriptional regulatory protein DesR
MISIFIAEDQQMLLGALGSLLNLEDDMEVAGKGTTGQDAVDFVKKHQPDICIMDIEMPGK
TGLEAAEELKDTGCKIIILTTFARPGYFQRAIKAGVKGYLLKDSPSEELANAIRSVMNGK
RIYAPELMEDIYSEANPLTDREKEVLELVADGKNTKEIAQELSIKSGTVRNYISMILEKL
EVKNRIEAITRSKEKGWFK
>PK3-2_03211 Sensor histidine kinase DesK
MIKNYFTFQKLSGITPYIWTIFFILPFYFIWKSSSTFIIIVGIILTLLFFSVYRFAFVSK
GWAIYLWAFLLIGISTASITLYSYIYFAFFIAYFIGNIKERVPFHILYYVHLISAAVAAN
FSLVLKKEFFLTQIPFVVITLISAILLPFSIRSRKERERLEEKLEDANERIAELVKLEER
QRIARDLHDTLGQKLSLIGLKSDLARKLIYKDPEQAARELKSVQQTARTSLNEVRKIVSS
MKGIRLKDELINIKQILEAADITFIYEEEKWPENISLLNENILSMCLKEAVTNVVKHSQA
KTCRIDIQQLWKEVVITVADDGTFQGEEKFFSKGHGLLGMRERLEFANGSLHIDTKNGTR
LTMAIPNNSK
>PK3-2_03212 Fatty acid desaturase
MTEQTIAHKQKQLTKQVAAFAQPETKNSLIQLLNTFIPFFGLWFLAYLSLNVSYLLTLAL
TVIAAGFLTRIFIIFHDCCHQSFFKQKRYNHILGFLTGVLTLFPYLQWQHSHSIHHATSS
NLDKRGTGDIWMLTVNEYKAASRRTKFAYRLYRNPFIMFILGPIYVFLITNRFNKKGARR
KERVNTYLTNLAIAALAAVCCLIFGWQSFLLVQGPIFLISGSIGVWLFYVQHTFEDSYFE
ADENWSYVQAAVEGSSFYKLPKLLQWLTGNIGYHHVHHLSPKVPNYKLEIAHEHHEPLKN
VPTITLKTSLQSLAFRLWDEDKKQFVSFRDIKHKPFSSPPDSAENQKLRKNA
>PK3-2_03213 Microcin C7 self-immunity protein MccF
MFAAKLKKGDEIRIVSPATSMSKLSNEAKIQAKTTLERLGYRVTIAEHANECNEFDSSSI
ESRVHDLHAAFFDPGVKAILTTLGGFNSNQLLRYLDYEKIKQHPKILCGYSDITALGNAI
YQKTGLVTYSGPHFSTFAMKKGLDYTKDYFLSCCASDDPFEIHPSSEWSDDRWYLDQENR
RFYPNSGPVVIQEGYAEGTLIGGNLCTLNLLQGTEYFPETKNTILLIEDDYMSDIHMFDR
DLQSLIHLPAFSHVKAILIGTFQKASNVSIDLVKAMIGTKKELSGLPIIANINAGHTSPI
ATFPIGGTCRIEAVSSASRIWIDKH
>PK3-2_03214 hypothetical protein
MFTVKEKNRQELEEELNDLEFQIYRMQENMKDLSKDAKVLGIDQSKHEEWLIVSSIDDGQ
TCKIMLTDCKTAYRGKGSFSLVASYKDDAIHIGDIKGPPNHGFGSICMKYLKDIARDHNI
PKVTGDIAKRDWNHVDRLIHFYEKHQFQVCVDHDTQSGSIKWVDL
>PK3-2_03215 hypothetical protein
MAIDSLINKLQYVQLEPPDKILSLYLNTDMRDPDQQGGEWKIALKSGFGRLKEYLAASDP
EEEKCLDGIRMKIDQYLNEMGKDMPRSLVFFVSDSGIWEPIKLQIPVETRFYWEETAVLD
QLKDLRHTYPSTAFILTQQYEVKIIETVLGKIEAVEHYEYDMINESWENCHSSANKAAPF
DENRMREHVTENQTRLYKRLAANLDQKAAAKRWERMVIAGDKETADLLDQHMNKPIHSKI
QKNLLNVNEHKAVEHLIKEA
>PK3-2_03216 hypothetical protein
MNQTENKPKNYTGIVLTLTVLINGLIAVLFFMPKLDQFSHANIHILPMLNAIFNSFTFIF
LLAALIMIKQKNIKAHKRFILAAFTTTLLFLICYVVYHSIAENTLYGGEGIMRPIYFFIL
ITHICLSAIIVPLALFTLIRGFSMQVERHKKIARWTMPLWLYVSLTGVIVYLMISPYY
>PK3-2_03217 hypothetical protein
MKKKRKGCFAAAGFMMIFVFVIASFLLVLLFFNRDLIKQLPIDTKTIVLERLTDYKPLVE
DELDNQGLSNYTSLILGMMYQESKGKGNDPMQSSESLGLKRNEITDPQLSVKQGIKQFTL
MYKTGKEKGVDLDTIIQSYNMGAGYIDFVAEHGGTHTEELAKQYSEQQVKKNPELYTCGG
NANNFRYPYCYGDYTYAEKVKEKTKTVEESLQVATLETMESKAHE
>PK3-2_03218 HTH-type transcriptional repressor CzrA
MTEFKETERTAADLDEETLFLVAQTFKALSDPTRIRILHLLSQGEHAVNGIAEKLNLLQS
TVSHQLRFLKNLRLVKSRREGTSIYYSPEDEHVLDVLQQMIDHTKHD
>PK3-2_03219 Protein csk22
MHLTLQSVYPAMIIIFFLYKKIKRSIGYQPLKPRWLFIRMILFWLFAFGLSIFSIIHPFL
YGYLIFGILGGWLLVFFAKKNISFEKRRGKIYFRTHIWVEVILLTLFLSRFLYRVTELYL
TSPDLNSLGSYSQSIGTDPLTIGVFFMIAVYYIGFSSFVIKLSRNDLDQIGHNKKEKDIL
AR
>PK3-2_03220 hypothetical protein
MKLERLLAMVVLLISKKQVQAAELAELFEVSVRTIYRDIETINRAGIPIVTSQGSGGGIG
IMETYRLEREWLKEEELFAIASALQSVSAMYEPVSHSTAYQKIKHLIPEQSAEAFKHQTE
KWFIDMTAWGHTEDQKALREKISAAIDHLSTISFTYTNATGETLHRETEPYTLVCKAGHW
YLYAYCLVRNDFRFFKLNRMKDLTILHQSFIRKDIQLETLPWDKNWYQKDRLTELVILVQ
PPACQRIREWFGNEVLHCDEDEACRAVITLPEDQWLIGFLLQFGKDIEVLKPLHIRDKVK
DIIHQMQKVYVT
>PK3-2_03221 hypothetical protein
MGFSHMTHLGQKRFAGLSQRTTLDKLMVLVNNKTNTVSFY
>PK3-2_03222 Hydroxyacylglutathione hydrolase
MRVTQYQTVWQLTFFPALFPVNCYLVEEENEVTLIDAALPGSYKGIIQAVNQLGKPLQHI
LLTHAHGDHVGSLDALTQAFPHAKVMISERDSFLLQGDTSLRHDEPQTPIKGGVPKHVQT
KPHQLLTGDETIGSLLAIPTPGHTPGSMSFLDTRNGTVIAGDAFQLRGGIAVSGQIKWTF
PFPAFATWNKEEAIKSAQLLADIFFYGYININLCPLRYRCTLIIHFKVTCKRTQMTLIPR
PNFLPRFKHNLFNRADSGSENGIIGSWQINIFIGFRKSAALLLKRSD
>PK3-2_03223 hypothetical protein
MSPRIGLSQKMIVDAAAEIADQEGLNSVTLAALSKKMNVRPPSLYNHINGLQAIRTELAV
SGLTRLYEQMAVSVTEQKGDAAMHSLAHAYVDFAVENPGYYEASLLKVQDERAEIVSEEI
VRLVSKLLIENGYASDKTAIHATRGLRSLLHGFTALIAKEAFEREEDISESLSYSISTFL
SGLIINNKNIM
>PK3-2_03224 hypothetical protein
MDDIHKIERLAAASWPSYIQNSMGQWLLRANFGVTKRANSVWTSAEMPEGDFQQEAEYFY
KSLGLPVCFHISNASPKGLDAGLADSGYEKADECFQMTALCRDIMNHTEGNSRFTYKWEH
EPSSVWIDEFIRLEGFSPERHQGYTNIFKRMPPCKTFLTMYDQGSLTALGTVSVIDGYGG
LSNIVVAEERRGKGAGTQVIRILTEWAINNGAERMFLQVMKENLAAVSLYEKIGFSPISE
HHYRIKR
>PK3-2_03225 HTH-type transcriptional activator RhaR
MDSLQEIICEKRTYTRLYHSHKHAYSQFLFPLEGSIDLETEGRQVKLNPDHFLYIPPECE
HRFRSIGRNECLVLDVPLYAMKLDEYRAGSGIEAALDPFWSSIRYLLTEEAKAGTANSLH
MLVQYIKEKLQSHTYDSIAYIHSHLFERLTIKKLADIEHYHPAYYSSWFKKQTGKSPQNY
IADLRLEEAKRMLMEKKETLTVVSEALGFQNLSSFTRWFTKSTGMPPRLYQNTLYSGKK
>PK3-2_03226 putative chaperone CsaA
MAVIEDFEKLDIRTGTIVKAEEFPEARVPAIKLVIDFGAEIGMKQSSAQITKRYQPEDLI
NKQIIAVVNFPPRRIAGFKSEVLVLGGIPGQGDVVLLQTGQPVPNGTKIG
>PK3-2_03228 hypothetical protein
MDSIYRSRNISKFKFNGVYSPLANDKYIENECKELIGFLLKEIERIDYKKKLNQTAYPSA
LLQENTTDELIKFISKRLKKMEDDPSGRGYQIIDGLNRNIRSSFDDKNLYRFSACFFNLD
ISRLDEKGLLRVLNTLIEETNRINKEKIAFGEPKKIEPIKSLD
>PK3-2_03229 putative ribonuclease YokI
MKVFEADSLLSEADKRTKEYKELRSQMVKLRKAFKDVADLDDSEFSGKGANNIKAFYHDH
VGVTDQWIDLIDMKLAFLSSVSAKLEDAKMSDAYIEESFLEHELANAYTKSKSIMSEQNK
AMKDILNDINDILPLEIFSTEDFKDKLSSADDKREKTIDKLNKLDEDLKTEYSETEPNEQ
FIQQDFKKLQESTGKGKNATPIHYNAKAYRESDIHKKKGDIEKHSEAYLSVKKEEAKERE
IKELKKKLNDAVSDPDEYLKIAKKVGYENLEPAQVQLAVQIEQAKQLEGAGEITWDIVKG
VGVGLYDVGKDTVTGIWDFITDPGETLSALGNAIIHPMKTYDAISAAIEESYQKDMVNGD
AYSRSRWVTYAIGSVAAALVGTKGAGAINKADAAGKVINKASQAGKKIKDVKIPDLLPYN
PKYDLAMAGDVPYNVVDGENLKNQLMSFAKGSDKEVKPFDVVDYRPSNSPLENHHGVMDV
WAKHNVPNYVSRGSNTPTVALTKEQHNATKKIYREWLYEKTGKKVGGKVNWKEVSPREIQ
ELTEKMFDAANVPKEARQQYYNAFNQYNFRK
>PK3-2_03230 Antitoxin YokJ
MSIDMLIKKIASTSDCRLFEADGLPVIDEMHQLPKDISEFYEQCGGAVLYENADYPIYIV
RPAEFELANPIIVGELCEEDISSEWYIVCTDGKGEYLTIDLNEERKGKCYDSFFDRHGIV
GETQVIASSFTDLIQRLLENKGKHWYWLRDDYISLGDAYDGVEIE
>PK3-2_03231 hypothetical protein
MSFNNIKQKLKEFTIDAETDTSINANEQLKEIEMNIGNKLSSDYKDFLKKYGGCYLESKK
TSDEIEYDVCYKPIEKDPWMGKDDDTQLLEGFYGLANDHNSLQKAIDTYSDRFPRNIIPI
ASSAGGNEICIDIDDEKILFWDHESSHPEKDFFLIANSFEEFILSLIDEPIETDDNVSDV
EIEILDNDFGKLLFGKNN
>PK3-2_03232 Antitoxin YobK
MIYSKIENFINENKQNAIFTEGASHENIGRIEENLQCDLPNSYKWFLEKYGAGGLFGVLV
LGYNFDHASVVKRTNEYKENYGLTDGLVVIEDVDYFAYCLDTNKMKDGECPVVEWDRVIG
YQDTVAESFIEFFYNKIQEAKDDWDEDEDWDD
>PK3-2_03233 hypothetical protein
MGGFYFFGGLLLTFLLGVGLLSLGAYILWKLIKMR
>PK3-2_03234 hypothetical protein
MIDYSQFPRKNILCIDMKSFYASVSAVTMGLNPLTCFLAVVGNTERQGSVVLAASPALKK
DFGIKTGSR
>PK3-2_03235 Protein UmuC
MKLFIRVSTEITKLFYRFVPEKCVHTYSIDESFLDAGKEDPGEMAKAIQRSMWREFGLMC
TVGIGDNMLLSKLALDLESKKTKSGIARWRYEDVPNKLWKVHPLSNMWGIGGRMERNLNR
MGISTVGQLAKFPLELLEKKFGIMGNQLYYHAHGIDLSEIGAPLMQGQISFGKSQILLKD
YTRREEIKAVLLEICEEVARRARTHNKVGRTISLGIGYSKDELGSGFHHPKTIDLPTNIT
MNIYKCCLLLFNKFYLGKTVRSISVTLSNIEDDVNQQLSLFEVDNEKRRKLGFVMDGIRS
KYGSKAMLRAVSYTSAGTALHRAGLTGGHKS
>PK3-2_03236 hypothetical protein
MKTKLIICAVLLFGVAGTVGASYLQQQNDTLKVAERAET
>PK3-2_03237 Response regulator aspartate phosphatase I
MKTEKVIPYDLVATKMNHWYVAIKKNWVGRAEEMRKEVMQEIKIMEENQDVLLYYSLLEF
RHKLMLSYMYPNAIKDIEKNYGKLKEYEGHENLTGMLEYYYYFFMGMFYFRQKELTFSLN
HYRQAEKYLDSIDSEDIEVEKAEFYFKLSEVYYHMKQTYFSMNYAMRAYNIFKKQPDVDG
NSTYGVQKVRCQFVIFGNLLDSMKFDDALKRAYKAYQEAEELNKNEKNRGHLIRSALFNI
GLCYNQMEELDKAFFYFNKSLQIIEPENHDYAAKTLFVISFLKGRQNDTKNAQAFYEQSK
QIAEQYNNEVVIEKLKMVKGLFLDSDLNLVREAFQFFRERCMYPDMESYGVVIADFLTGK
KEAWGAIEFYRLANEARRQIKRGEAI
>PK3-2_03238 hypothetical protein
MNSTICKVGIVGMLSIGWLLSPFATGVEAKEEARNNQTTTLSVNQPVNVLKTASVLNSQN
SKPTGDDWESAGTEYGSTKFEKYSLAAVVQTLGFALNLPSGGWSSYLAGLANMIILGEYP
VVYFKDRKEFKMAGATLMTRHNVTIYEDKDRNKKIGSDSFIITDRGGPKAADK
>PK3-2_03239 hypothetical protein
MPNIISKEQDEAIKYFRNKLNLSDKDLYIPLINFELLRDKNEQYANVLFVAL
>PK3-2_03240 hypothetical protein
MNTYFYSHKGFDSDACYTVLAKAENEKDAFDIIGERVGSSVKRNMKIDDIQVLKFDDDNT
FVID
>PK3-2_03241 hypothetical protein
MKILNFKFDNSFFELHAAFTTNLDLLTDYDIQMDMLMMSKAILKKAGITNFLIQDTYFIV
EDSNSVYCTYHFQETN
>PK3-2_03242 hypothetical protein
MQVLRILIVHVLSALSAAVVYVLGIDYDGYIPYFLISAILFIYYLIFATPVQYFVNRKPK
RFNLKYLLIYIFFSFLVWLFFAVITDPKTTIDFLTGYEIYLFSITFALIFWVWDSVFLQN
KTKTAIKQD
>PK3-2_03243 hypothetical protein
MLKEFTGNHFDFIATDRVEGDTYKNHSLVIEKNPGCGDVEIKGKYGIGHDEPDDCPF
>PK3-2_03244 hypothetical protein
MIKSNLKHILDERKISIRQLSREIDHEYPTVRKLYRDEMERYPRELLDKVCTHLNIELHE
LLIFQKDHNHIDHSG
>PK3-2_03245 hypothetical protein
MDKLINPTKHSFYFRLSKYDCYKVRTGKCSLDLNDKEFNALEGEEREYALKCRRLAAHYI
KPDMHKKHSSIYANINACGHISFSDGQHRMCICKRSGVDKLLVHLSNNRDYVCHICQDKK
INS
>PK3-2_03246 hypothetical protein
MGILNFFKNKDKNEQRENRNNSINSVEVNNETEVALEKENFPILIQETDFSRKYEEKSAF
FEYIDFKVAGTSHYQKDIKKAIKIEDEDSFFFDEKYGGMTNKEILESTFDEPIFIYHNAL
FSNCELRLEENNKYDPEAIAVYVNDCKVGHVPRKNFQEGKKYIYDQLKGGIRHPISASLY
GGKYKVNRDDTKIETGETDYKIECQIVIKTDQ
>PK3-2_03247 hypothetical protein
MGLYKPLDSYAYTLVFSSLSYGLIFGLYMFVYSGFITIALVTIAIIGFYALITYLVFAVP
LQMWLRRRGKKFNLINLIIYTAIAFVAALSFFVVTNPTSALAMLKSLNYYIMSIVAALIY
WFWDSIFLRN
>PK3-2_03248 hypothetical protein
MLKVAKISVSCIALVLCVYSLFNQNELLLLVVQLFVAALLSVVGVEAILSKQKLSGYLLF
GSAAFLLVVNVVKFMI
>PK3-2_03249 hypothetical protein
MLILVIDLNYLLRCFVVYNYQFQKFHQNWDDAMYPVPFDYRNDYLNFNPYVESFESDERV
TFPLRGSQHTELGDHRRMATNIIISSSGRLDATTKTWTSKKWKGFTGTVVVFLTDSRGNI
LYATASRRYGVNGTALGGHNRTDTWYEIIPRSVLNKTTAYAIHHAYTPTPRINPTEFKKW
SDAIAPLVKAYSEGQQREIYLFPEVHEAIELEPFTSINTEESY
>PK3-2_03250 hypothetical protein
MDKETAAGMERNLASLFFKNKLNVIGFFMLMGLLPLVMSAFD
>PK3-2_03251 hypothetical protein
MKKSLINRKLDKDIKKEFDSIGRTFDSYVDFGQEMYKKLFEEFKEDELSTPLFTIFIHIL
NMIDSISILSKKGATEGIIPLCRSLFEAAVYFEHAYTEPRKEGIIAYHVHYIQQEIKYRN
MFNTSTNSGKETFKVLRKELPHFNLDENSLDHDKTKYLYQFLEKDEVKEVYQDWIEKKPK
QWYSLYTNCKNLRELSRKLGIETLYIMLYKTASDFIHAGATLRNIKVSDGNGGVSVRNFE
EMPFYCNMAFFIINRVYQLISLEQFNLWYPQEAQKVVARTSQIQIKAEYEIGVLK
>PK3-2_03252 hypothetical protein
MSSNDNFIAQAQYFSCKEYKINKERLSKDLVVRTEGNIEFAWNPNFKI
>PK3-2_03253 hypothetical protein
MYGQRLRQLRKSHKLTMEQLGEKIGIAKSSYGGYEAESKKPPLDKLIILAKLYDVSVDYI
LGLTYDPDPKVERKNLKEFLEKPDIHWDGYKLTPEMLDPIRKILKMVTANNN
>PK3-2_03254 hypothetical protein
MVSKKNKIAAALLAFFFGGLGIHKFYLGRVGQGILYILFCWTGIPSIIAFIEFIIFLCGS
EEAFDQKYNFYYFQQQSKA
>PK3-2_03255 Endo-1,4-beta-xylanase A
MFKFKKKFLVGLTAALMSISMFSATASAAGTDYWQNWTDGGGVVNAVNGAGGNYSVNWSN
TGNFVVGKGWTTGSPFRTINYNAGVWAPNGNGYLTLYGWTRSPLIEYYVVDSWGTYRPTG
TYKGTVKSDGGTYDIYTTTRYNAPSIDGDNTTFTQYWSVRQTKRPTGSNATITFSNHVNA
WKSHGMNLGSNWSYQVLATEGYQSSGSSNVTVW
>PK3-2_03256 Alcohol dehydrogenase
MFVKAVVATKDKSIAIVQKDLRPLQHGEAKVKMEYCGVCHTDLHVKNADFGDVTGVTLGH
EGVGIVTEIGKGVTSLQKGDRVSIAWMFESCGRCEYCLTGRETLCRDVKNAGYTVDGAMA
EEAIIKADYAVKVPENLDPAAASSITCAGVTTYKAVKVSEIKPGQWIGVFGVGGLGNLAV
QYAKNVFNAKVIAFDISDEKLEFAKSLGADIAVNSLNEDPVAKAKEVTNGLGLDATVITA
VAKTPFNQAIDVVKAGARVVAVGLPIDKMDLEIPRLVLDGIQVVGSLVGTREDLREAFQF
AAAGKVVPKVTKRPIQDVNDIFEEMEQGKVTGRMVIDFTE
>PK3-2_03257 Flavin-dependent L-tryptophan oxidase RebO
MNSLMNDDMVKIIRNGLNRSHHPKHIIVVGAGLAGLVSTSLLKNAGHRVTILEASGRAGG
RVCTLRSPFSDGLYFNVGPMRIPNKHLLTLEYIKKFRLPTNVFINRTPLDIIYTNGIKTR
LHIFERNPQILKYPVAPNEQGKSAEELMLSVLQPILQFINQDPARSWQIVEQQYKNYSLS
SFLNTYFSYGAIDMIGVLLDMEAYMGMSLVEVLRESIYFTFPTQFYEITGGMDQLPHAFL
PQLHTNILYHQKMMKISQTENSVTIHCQHQQTAEHAAFTADLAIVTIPFSTLRFVKIEPY
HSFSYYKRRAIRELNYMSATKIGIEFKSRFWERIGQRGGKSITDLPIRFSYYPSTGIGGA
GHAVILASYTWADEALMWDSLSEGERIQYTLLNLCEIYGDIVWSEFVSGASFSWSQNPFS
AGAFTAFEPGQELELNPYIPVPEGRIHFAGEHISLTHAWMQGAIESGIRAAYEVNRLP
>PK3-2_03258 hypothetical protein
MECLVSFSTDKATLNDIQSFEVKHQLTLPDDYQKFITLHNGAKIFQILADGENIGGGLYL
FSLEEIEEELKYEDLFEGINGIPIGHLLEGCHLMIDKDKLKKGDPNYLFILEIGECTPLN
VNFEIFLDRYILSNGEAYWEWRYYTAENYYRTR
>PK3-2_03260 hypothetical protein
MTKHQIYTMSVARVYPLYVTKVEKKGRTKTEVDEIIRWLTGYSQEELEAQLEKQTDFETF
FTEAPQLNPLRALIKGVVCGVRVEDIEEPTMQEIRYLDKLIDELAKGKAMEKILRK
>PK3-2_03261 hypothetical protein
MPVNKFREGIVFMKLKHASVFILAIVLIGFVSVYLTNNQKDVQEARRGHTASISYFTDGH
SLEVASRSLIL
>PK3-2_03262 Response regulator aspartate phosphatase A
MKQTHMSMHHIVQAIDSYKAHENYTVRVIQCSFVIGLNYLDMDYPEKAIPHFKDALDQAR
EIEMSRLIGSSLYNLGLCSFAEEAYEKASEYFKEGIRVYQDNGYEHSNRVLDILLMLTKT
TFEMRNHSEGTSWCAHGLSLSKNLNDEIMAKMFEFIHALYVDNDKEKLNSILNDFELKSM
LSDVEDLASDAAKYYNEKEDHKVAVAFYEKVLYARKQIQRGDCLYET
>PK3-2_03263 Response regulator aspartate phosphatase H
MISSSKVGVKINEWYKYIRLFNVPDSEIMKAEVEEEIKHMKKDQDLLLYYSLMCFRHQLM
LDYLKPKTMKDERPKISDLLEEIESSQSDLEGILEYYFNFFRGMYEFEQYEFLNAISFYK
QAERKLSLVADEIERA
>PK3-2_03264 putative protease YdeA
MKTKRVYLYVFHTMSDWEYGYLIAELNSGRYFKKDIAPLKVVTVGANKETITTMGGLHIK
PDISLDECNLERYDLVILPGGNTWGEDIHQPILKKVGEALKLGTIVAAICGATLGLANDG
YLDSRKHTSNDLEYLKMVCPAYKGEELYEKGPAVSDENLVTASGIAPLEFAMEVLKKLDV
FAPDTLHSWYKLNQTHKSEYFFELMNTLNRN
>PK3-2_03265 hypothetical protein
MQIHFTKSGKQDNHHKWLGTVLLSWGTFVFALFVATLIGSMASQAGASKLLKQGIQAGIV
TLMTVPLLYILLKRMSSRPFCSIGLSGWRQAIPKAIMGAMYVIVLSGSGFAIAHLLGWIK
ITQIHFSVHLVTALLLNMIIAFFYEAFPEELTFRGTVYYALNRRWSCFMALLLQPILFVL
APITVSGLQYIAGIESPAITLDYIVLLLAFGFILQLLRIVSGSLWTSIAFHLAFLENSRF
FVLQGKERFITYEEFVPGAGALFVIFFMLLIVGTLLLIPVAIARRYRKNKRNDKMIHI
>PK3-2_03266 hypothetical protein
MLKASKLIISCVALILCVYSLYSQSEFLLVSLQILVALLFVVVGVESLSKKQTRSGYLMF
GSAAFILVVNVVKYVI
>PK3-2_03267 putative cystine transporter YijE
MVKVMLGIISVTLIWGYTWVAMKVGIHDIPPLLFSALRLFIGAVPLFLILFIQRKKLSMR
KEHIKSYIIMSLLMGLGYMGILTYGMQFVDSGKTSVLVYTMPIFVTVISHFTLNEKMNVY
KTIGLICGFFGLLFIFGKEMLNIDQSALFGELCVLAAALSWGIANVFSKLQFKHIDIIHM
NAWHLLMGALMLLVFSLILEPAHSAEWTYQAVWSLLFNGLLSTGFTFVVWFWVLNQIEAS
KASMALMFVPVLALFFGWVQLHEQITMNIIIGALLICCGIFMNTFKFSRYQM
>PK3-2_03268 HTH-type transcriptional regulator GltC
MVMNMNHLHIFVKVGEKLNITEAAKELFISQPAVSKAIKSMESSLQLKLFIRDKHHGLML
TDVGKEILLLARQMKGIESKIYQVASRENKLLSGKVKIGSFPAVSTNIMPQAIAAFRENY
PLIRIELVEGTSDQIKGWVEDRTVDIGITASPFEPFDHQLLCNDYMVAVIPPQYDELKHK
KHVDLKTYQDDLIFCKGGHEIAMSNTFQQHHIELKENLTVQNAETLINMVKNNLGIGIIS
NFTLSSVSHQLIKKDIFPRITRDIGVIAHSFDEITPAALEFIKELKAVAN
>PK3-2_03269 hypothetical protein
MKALKQLIRFGWEQALSCLFPVVIFASLAITQIIPLPFLPRYDWLLIICVLMQLWMVRSG
LETRDELKVITLFHLIGLALELFKVHMGSWSYPEEGYSKIFGVPLYSGFMYASVASYLCQ
AWRRLKVELVKWPPYFAVVPLAAAIYLNFFTHHYSVDIRWWLSGLVIIVFWRTWVIYEVN
GTRYRMPLALSFVLIGFFIWIAENIATFFGAWTYPNQTDSWSLVHLGKVSSWLLLVIVSF
LIVATLKQVKEQSPAKAETGELFLG
>PK3-2_03270 hypothetical protein
MAIIINIDVMLAKRKMSVTELSERVGITMANLSILKNGKAKAIRLSTLEAICKALECQPG
DILEYRSDEDTQEL
>PK3-2_03271 hypothetical protein
MNRVSTLFLKIAVILIGIPILALCIFAVPKIATYTAEVFPNMAYIPYLVFIFLYVSAIPF
YFALYQAFKLLSFIDKNKAFSKMSVRALKNIKYCAVTISTLFAAGMPVFYLMAEIDDAPG
IIVIGLVIIFASMVIAVFAAVLQKLKRSD
>PK3-2_03272 hypothetical protein
MIHIWITGLLLLAQPSGPPDSLTVTQQGRTIATVNRENFTMPFPGTPMIDHEKYRTFIEQ
LNKQIYREPINAKLDNQGVIIPGRVGYKLYQQAFMERFYAYFYGQGPSKVEVPGLNIYPK
VDSEMLAHISTQQLGQYVTYFNSNNKSRSHNISLSAEAIDNHVVFPNETFSFNQVVGMRT
RDKGYKSAPIIVKGELSEGVGGGICQVSSTLFNAVDRAGLRIVQRYSHTRSVPYVPPGRD
ATVSWGGPDFLFKNQYNQPILIRAKRHGGSMIVTLYSSDVINNKLRKVPKAPSQIPKEIK
ADRQ
>PK3-2_03273 hypothetical protein
MKRILFSLCGLLFAFTFVQSKAHALTFTVLPITQKTDQWSVEVSEAKGGTGFAAPKEGKY
NVYSLEVKNIGKEAAMVDVQLFRNDPDSITRFSLFGCPDECVKQKEDAKALAESLNDGSP
LRFNHFMLAEKASELEVVIIWTQKGQEGRYLKQTFKFTEDGVN
>PK3-2_03274 hypothetical protein
MIRSITLPEEKTKITVGKPIKDESNVKVTAIYDYREEPEEAFWVHLSDGSEMFVDDHKVF
IEYE
>PK3-2_03275 hypothetical protein
MAKKLYSCLICGYKGLSENPLYKGEYQKTFDICPCCDFEFGYSEDHDVRLGFIVTPDHLI
EAAFQLYRKQWIESGMKIAHPEYIPDEVKNGDCLKFEVLLKQLKNLNLDMDNFEIDGFN
>PK3-2_03276 hypothetical protein
MKKDFGDSISNKVYEYRVLARMSQQELAEKVGVSKQTIFVMEKGNYVPTLLLAFRIAEFF
NADVNEIFTYEKGNDQNEN
>PK3-2_03277 hypothetical protein
MKINSISDAITNAIFSPVKSWAEYSPGNWNIILGVGLLLLMGSMIFTYVLYKKIGKEDER
TNKIFLKSSFYMLVAIILCDMIFPKEYMWNIFFCTNMRWHV
>PK3-2_03278 hypothetical protein
MSYIEITKDNIEDNHICCALGAKQYENAINQKKRWLKARMDKGLVFYRLNERAKVFIEYL
PADEVWVPINAPNFMYINCLWVSGRYKNNGHAKRLLDKCIADAKARGMDGIVHIAGKKKL
PYLSDKHFFEHMGFTLLDEAGPYFQLMALTWNSLAASPAFKQQVKSDFVNEKGITIYYTA
QCPFAVGMLEDLRELTEKKGIQFQSIQLSSKEEAQKSPAIWTTFSVFFEGEFVTHEIMSI
NKFEKLLHQLLFA
>PK3-2_03279 hypothetical protein
MKKLLLCVSILTVILSGAALTQLSTDSPSSIQVAESRSEGKEKIKEYSPPHGSGLFILKF
KQTIVDEVTFQTYLYS
>PK3-2_03280 Response regulator aspartate phosphatase G
MSKIASEVVATALNDWYIAIKKQKVNESVKYYSEIKKQFDDMEEDQEVLAYYSLLEERHK
MLLHYHEENHYKSTLTLLKIIKPLFRKPTTNWNTIFIYLKPCTKHITKISIELLIYTD
>PK3-2_03281 hypothetical protein
MRKKNNMKKWLLVIAALLMICIVTLFVMVSGHKVKYEGSGKSGLWVSNLEKSGKTSIGPN
YFLNLYWQGSKKDEKRTVVEKITFYIDGKKYDDREDYDLSEYTGEEMPGGGHMEDHIATF
DYMPEDEVIGHDLLVKVEWKTGGKKQTEEIKLHKKPWYKR
>PK3-2_03282 Oxalate decarboxylase OxdD
MEKQPIKHEDRNVPQPIRSDGAGAIDAGPRNIMRDIQNPNILVPPVTDEGMIPSLRFSFS
DAPMKLDHGGWSREITVRQLPVSTAIAGVNMSLTAGGVRELHWHKQAEWAYMLLGRARIT
AVDPEGRNFIADIGPGDLWYFPAGVPHSIQGLEHCEFLLVFDDGNFSEFSTLTISDWLAH
TPKDVLSANFGVPENAFHSLPSEQVYIYQGNVPGSVASEDIQSPYGKVPLTFKYELLNQP
PIQTPGGSVRIVDSSNFPISKNIAAALVQIEPGAMRELHWHPNSDEWQYYLTGQGRMTVF
IGNGTARTFDYRAGDVGYVPSNAGHYIQNTGTETLWFLEMFKSDRYADISLNQWMALTPK
ELVQSNLNAGTVMLDSLHKKKVPVVKYPGT
>PK3-2_03283 hypothetical protein
MKALTFLSSLTAVGISILGQCLGVLDDSYSVGNAWFVGVLAGLMTLLILIDSQVMTKSYI
VSLSTISGILGVGILYFPAAIINIFLSVKLNKKKKEDLK
>PK3-2_03284 hypothetical protein
MDLPTWAYIICIIIGAAGFLSLMWFSYFTDKAEK
>PK3-2_03285 hypothetical protein
MINARAETITEKPAFRKPLVSKRCIIPADSFYEWKRFDPKTKIPMRIKLKSSALFAFAGL
YEKWNTHQGDPLYTCTIITTKPNELMKDIHDRMPVILTHNHEKEWLNPRNTDPDYLQSLL
LPYDADDMEAYQVSSLVNSPKNNSPELLDEQNRM
>PK3-2_03286 hypothetical protein
MCGRFTLFSSFDDIIDQFDIDQFLPIDEYHPSYNIAPSQNILAIINDGSNHRLGKLRWGL
IPLGQKMKRSVIK
>PK3-2_03287 hypothetical protein
MKKFLLLFLALFLVTIHAGNASAAIVKNEEKVSFTMIENQKTFMMYDESNPNRFPSQFGY
RFTIYDAEGCTIHARMFRMSLSGNEIMLSEKNFTGNHYDFSATDQAEAMPYKNHYLELTK
DQGCGEVKVKGLYGYQFDNVYEY
>PK3-2_03288 Diacetyl reductase [(S)-acetoin forming]
MSKTAIVTGSAGGLGRGIAERLCKDGFNVVLHDINEALLNDTVSVFKEKHFRVIGVKGDV
SKRVDQFNLVKETVEQFGRLDVFVNNAGIEAVSPFLEITEEQLNRLFQVNVNGVVFGTQA
AADQFIKQESKGKIINACSIAGHESFEMLGAYSAAKHAVKSFTHSAAKELAKYKITVNAY
CPGIAKTKMWDRIDEEMVKQNDDLQPGEAFEKFSSEIALKRYQTPEDVANLVSFLASDAS
DYITGQAILTDGGLVYR
>PK3-2_03289 Pectin lyase
MKRFCLWFAMFSLLLVLLPGKALGAVDFPNTSTNGLLGFAGNAKNEKGISKASTTGGKNG
QIVYIQSVNDLKTHLGGSTPKILVLQNDLSASSKTTVTIGSNKTLVGSYAKKTLKNIYLT
TSSGSGNVIFQNLTFEHSPQINGNNDIQLYLDSGINYWIDHVTFSGHSYSTSGSDLDKLL
YIGKSADYITISNSKFANHKYGLILGYPDDSQHQYDGYPHMTIANNYFENLYVRGPGLMR
YGYFHVKNNYSNNFNQAITIATKAKIYSEYNYFGKGSEKGGILDDKGTGYFKDTGSYPSL
NKQTSPLTSWNPGSNYSYRVQTPQYTKEFVTKYAGSQSTTLVFGY
>PK3-2_03290 hypothetical protein
MIGSIFLINARLSKNIQIVLKDILTIEIEERIDTPLTAAAYRNTLLSLLCLTAGIVDVIG
YLSLGHVFTANMTGNIVLLGLAIGKSLQVTVFNSLTALIGFICGVIISTLMVGKAENTLW
PSAVTKALALEAFILFVFACLSFYSAFVPVYVLIILLSISMGIQTIAAKKLGIAGISSTV
LTGTLASLLEDLSGRLFFKKPKKTFIRDSVLRALAIILYCVGAIIVALAEPEFYNVIIWV
PIVLIFGIMMTAKLKLSEEK
>PK3-2_03291 hypothetical protein
MLILRHIHYHSYTKGRVFMKESIRMNEYAHQPNFLFLFTELVLHNYKRNETNCWPIYSYY
FSSLSFNLAVIMMPNISTIGTQMMTL
>PK3-2_03292 Expansin-YoaJ
MKKKISAIVGVVLLMILCFSPQALAAYDDLHEGYATYTGSGYSGGAFLLDPIPSDMEITA
INPADLNYGGVKAALAGSYLEVQGPKGKTIVCVTDLYPEGARGALDLSPNAFRKIGNMKD
GKIDIKWRVVKAPITGNFTYRIKEGSSRWWAAIQVRNHKYPVMKMEYAKDGKWINMEKMD
YNHFVSTNAGTGSLTVRITDIRGKVVKDTIPQLPESGTSNAYTVPGHVQFPK
>PK3-2_03293 4-hydroxyphenylacetate 3-monooxygenase oxygenase component
MGIINGKEFIDRLNKLENEIWYDGEKIEGNISDHPAFKGIIKTKSSLYDLQMKDEFINEM
TYRHSGDHDRIGLSYLQPKTKHDLRKRRKMIEQWAKHTHGMMGRSPDYMNTVIMSFASSA
ELFRNKEKCFPEHIIDVYKQAAKHDLSFTHTFITPQVNRSQSYFGLSEKPISAKVIDRTK
KGLIIQGARLLATQGGLTDEILVFSAPKFSFETDEAFAFSIPSNTKGVKFITRESFVLSE
SAFNHPLSSRYEEMDSIVVFDHVLVPWNRVFFYDNVEAANDFMTKSSFHAFTFHQVVIRQ
MVKIEFLLGVAQLLVDTINVSEYQHIQEKLSEIIVGLETIKALIDKSENDAQLDEFGYMR
PSLIPLQVISTIIPALYPRFTEIIQLIGASGMVTLPTENAFDSEIREDLDQYLQATNTNA
VDRVKIFRLAWDLTMSSFGTRQTHYERYFFGDPIRISSRLYTSYPMQQQVNMVKAFLHED
AGN
>PK3-2_03294 Putative methyl-accepting chemotaxis protein YoaH
MKVKTKLLGIISILVISIIGIGGSSVFMISSTVKKNEELKDKMEFQKEMKHIQYRLTGLS
NDERGFLITGDKEYDEGMNEKADDILKSLDRVNDLIDEEKYQSNIEDIQTSFTQYRALNK
QVLKTYSSDPKKAKTIHFGEERTLRKEVVDPAVKKLSDRLDQEVQDLKDEIRSNGTMSQW
FIIIVTGISVVLGIVLSLLLLKSIMVPLRSMNKQLEEIAHGEADLTKKVIVKNKDEFGQL
AQSFNSFTHSLTQIVKQISSSSEQVAASSEELSASAEESKTTSEHISGAMQMAADSNVKQ
NSMTEKSVESITELLDSISSVASNTGNIADLSSSMRDKAEIGSKSVNKMLDQMKFIDTSV
GSAGNGLQALVESTAEISDISSLITNISEQTNLLALNAAIEAARAGEQGKGFAVVAEEVR
KLADETNKSANHIQSVVTTIQNESVETVNNIKVVQENVSSGIALSQETTGNFNEILNLVE
QVTSQIQEVAAATQQLTSGVEVIQHTVHTLAAGTKETSANTEAVAKASQEQLNSMEEISY
AAESLSQLAEELQTVINRFKY
>PK3-2_03295 hypothetical protein
MTQKNGADRPDDYKRFSSIDKEYDFQQSISSKVGTESVNTETQTHNKENIDDTTNLAGKS
FDPSDYKGATQLEQGLAETHEQVSDDYFEGTIDQNLD
>PK3-2_03296 hypothetical protein
MSKKGIQNSSIEQVRNDHETETAFKADDPKKHGSDAKRTK
>PK3-2_03297 hypothetical protein
MNKIVSYYLKTLGLSSLTFGLFLGFYSYIMYDEMVIALLTAAIALLYGFMMYGLFAFPLQ
MMLQKKARTFNVKYLLIYSIIAFIAVFLFYVINEPASIAWKLQSYLYYMLSIAAAVIYWF
WDSLILYKHTASGV
>PK3-2_03298 HTH-type transcriptional regulator DegA
MKTTIHDVAEKAGVSISTVSKVINHQPVAVKSKQKVLHAMQELNYKPSVLASALTGKRTS
TIGFLLPNIALIVEMA
>PK3-2_03299 hypothetical protein
MDVFIAIGIALAGYFIGEGIKQMNHPKANEQSDILLIKERDIYFYIGHFLGITAVEAKQL
AEDTKDIPYIEINGKRYVQKHMLKEWAFTLVEKHQSE
>PK3-2_03300 Dimethyl sulfoxide reductase DmsA
MKSFVTQQNGIFKSVCSLDCPDQCGLLVHKKDGKIVKVQGDPDHPVTAGNICNKVRNMTE
RIYDEKRLTTPLKRTGAKGQAIFEPISWEEAINTITSRWKRLIDQDGSESILPYSFYGNM
GKLTAEGMDRRFFYRMGSSQLERTICSKAGSEGYKYTMGISAGIDPEETIHTKLFIFWGI
NAVSTNMHQITIAQKARKQGAKIVVIDVHKNQTGRLADWFIPIKPGTDSALALGIMHILF
KENLHDEAFLSEYTVGYDKLREHVKQYNPENVSMITGISTEDIYQLARMYGETSPSFIRI
GNGIQHHDNGGMIVRTIACLPAITGQWLHKGGGAIKHNSGILEYNTNALQRPDLLKGRTP
RSFNMNQLGKVLLETDPPIRSLFIYGTNPAVVAPEANKVRQGLLREDLFTVVHDLFLTET
AAYADIVLPATSAFENTDFYTSYWHHYIQLQQPVIERYEESKSNTEVFRLLAEAMGFTEQ
ELKDTDEELIRQALDHPDNPYLAGIHYDSLSKHSFMKAKREKPLFPGELPTPSGKIELYS
EKMKQAGFPALPTHTPLVSDNEHPFMYVPAPNHNFLNSTFSNNSKHIKLEKAPKLFINTK
DAEKYGIVDGDPVRIWNGRGECELAAAVGEQVLPGVVVSQGLWADEQGKKQLVNALTPDR
LSDMGGGATFFSGRVQIEKA
>PK3-2_03302 Putative 2-hydroxyacid dehydrogenase YoaD
MTVLVTAPYNEEGRKELEKLFGSVAYQSWKEQGRAYREDELIQLLKETHAIGLITELDQV
TDSVFASVPDLSFVGVCRGMPSNVDVAQASKRGIPVFYTPGRNAHAVAEMFIGNVISFLR
HTSTSNQWLKDGKWDSDYLQAYVKFKGNELTGKTVGMVGFGAVGQRIAKLLTAFDCNVKF
YDPYVQDDHPLYEKVSLKTVFSDSDIVSVHLPRTEETLGLIDRAYFDLMKESAIFVNTSR
AVVVNREDLLSVLKEHKIRGAILDVFYHEPPEESDYELISLPNVLATPHLAGATYEVEDH
HVTILNKALKKWKSDKTLNIPTLYNKDELKTEV
>PK3-2_03303 Putative sugar kinase YoaC
MKKQKGYLVFDIGTGNARVAVVSVSGIVQTVEREDIEYFTETLYPDSRYFSPQVLCKQVI
RLAKRALSRSRDIDIIGLTSTSQRQGIVLIDQNGDSFLGLPNIDNRGREWEESIPNREEI
YRRTGRLPTALFSALKLYGLKQRQPSLWEKTASFTSISDWVTYQLSGILTYEPSQATETL
LFDVKQSTWSEEMCGIFGFSPSILPPLVKAGTVIGTITNEYASELGLSIYAKVIAGGGDT
QLAVKSTGAALKDIVIVSGTTTPITKITAKHDDTKHKAWLNCHTDQEQWLVETNPGITGL
NYQKLKQIFYPNESYEVMEEEISALANEDNACVAALGSYLSTEKNALTKGGFLFDAPLSA
HLKRAHFVRAALQEIAFSIKWNFDILTEVTSFERDYVWVCGGGFQSQALTQYIADLLQKK
VYVQEGYQQASVVGAAVICNETFQLTEEMSANVRVIEPQDCRVELALYEDWKQAQRFFSG
AESKVPV
>PK3-2_03304 Putative transporter YoaB
MLDKIGIPKRLVWGFLGVVLFMMGDGLEQGWLSPFLIENGLTVQQSASIFSIYGIALAIA
SWFSGVCLEAFGAKRTMFMGLLFYVIGTAAFIVFGFEQLNLPVMYVTYFVKGLGYPLFAY
SFLTWVIYRTPQNKLSTAVGWFWIAYCLGMFVFGAWYSSYAIKAFGYLNTLWSSIFWVCL
GAFFALFINKDRFEKKKRKRSETAEELLKGVTILFTNPRVLTGGIIRIINSIGTYGFPVF
LPMHMAQHGISTNVWLQIWGTIFLGNIVFNLIFGIVGDKFGWKNTVIWFGGVGCGIFTVL
LYYAPVFSGGSLAVVSVIGFIWGGLLAGYVPIGAIVPTVAGKDKGAAMSVLNLAAGLSAF
VGPALAWLFIGLVGAQGVVWIFAVLYLASAVMTKCIHIPEEKAVQEETSPQYAS
>PK3-2_03305 Transcriptional regulator SlyA
MICYRQYIVYLGGDIMDYSKELKDLFLMQQSYATLFSVLNKIQSRGDDYYESLTSRQFMT
MVAILHLPEEETTFNNIAKKLGTSKQNINRLVSGIEKRGYVTTVPSKRDKRAVNVKITAS
GKRVMEECGEKAVYFMADLFKGFSTEELETLWVLLKKLYSFDGEEQDGFEKDAADFDIEQ
NRDDLKNNLLQEFAKRRM
>PK3-2_03306 Linearmycin resistance ATP-binding protein LnrL
MKNVAAVEDLKMQFGNKTAVNGISFEVREGEVLGLLGPNGAGKSTTIHLLSGVLSANSGN
VTILGHNVKKGSKEMKKGIGVVPQDIAIYEEISAEKNVHFFASLYSLKGEKLKARVKEAL
ELVQLYDRKDDKPKTFSGGMKRRLNIACAIAHQPKLIIMDEPTVGIDPQSRHHILESIKE
LKTRGASIIYSTHYMEEAEAIADRIMIMNEGRIIANGTKEELYREVNKEMTYAFQLTHVQ
PLNKNAIREIKGVTEVDFSDHQLKVTVQQNHDHLSEIIAELSAQGCNILSMNKKEASLET
VFLELTGRNLKIRRAK
>PK3-2_03307 hypothetical protein
MSLLKLITFDFMNIVRNPVLVIANTAFPFVLILVMGFVTKNSFGAGGVSSYDYYGVNMMI
FAAALIAMTASNTFMEEKVKKANLRIVYAPVSTAGIYLSKLLSTWIFSVIMYSVNVLIAQ
TIFHLNFGGQYLPYFILLLYVFLFFGCCFGTMFCCLFKNEEQANGLMQIPIAFFVFFGGV
FFGIHRFGETVNHISLFSPVKWVTECSFRLIYDHDFSMLLPVMSGLLFASIICIAISHVV
CKPEGYVC
>PK3-2_03308 hypothetical protein
MLSLFQNRWERILTKKAIIIIAVIIIPLMIGVAIMFSGKPVFKETIAFVTEQDDVQHMPS
DSAFRVVAVHQKPKFSDLVLGKYAAIVEKNQREYKVTTLKSKADQQMIQQFFETGKMPGG
YLGEDKLRTERGTGTNILGFIVMLVLMQGVALASLYPEDRMLKTFRRILVSPVHVGKYLL
VQFIFTFLCLYIPTSLAIGITKVFFHAEIGFRLDILAGLLGVLIMLATGFAIFMASVMDR
NISLVSSGISVVTCVLSGCFLSFAPHHPLLNALCAILPQKAYMTFIHGIEMGHTMWEYKT
QVVYILMWSAVFCFLGGFITRRRTNKGIYE
>PK3-2_03309 IS1595 family transposase ISSpgl1
MFPVLETNRLTLRQITDQDAEAIFTCFSNDEVTRYYGLENMESIEQAISMVQTFAALYQE
KRGIRWGIERKDTKELIGTIGFHALAKKHRRAEIGYEIIPAHWRNGFALEAISEAVSYGF
ASLGLTRIGAVVFTQNEASNQLLVKMGFQKEGVLRQHMYQNGIPYDTNVYSILKSSE
>PK3-2_03310 hypothetical protein
MINRSCLEEFAEKIHALPSSLTKQDLLTDPFRLHQENDLDIYYSPHNEYINRDASIVIAG
ITPGFSQMKTAYETAAESLRQGRSLEQMAADTKKAAGLSGSMRHNLITMLDSCGLLQAID
IQSAAQLFGDLRHMLHTTSIIKYPVFVQQKNYTGYRPAITHSPILSTYAFGHFPAELNKV
TGPALLIPLGKAAETVCGTLITQHSLRNFSCLHGFPHPSGANGHRLKQFSKNKEQLERQI
HSFASSALNSL
>PK3-2_03311 hypothetical protein
MVIVYISLAVLVISIIFLGFNVIQNKKKIDPALKELTSVTQAMQKQVEGLKTEAQLLTQK
QKKIQQDVQMKKNAFQQTAAEVKEVPQAVKEVWQAGHFNSR
>PK3-2_03312 Oxidoreductase UcpA
MQNLKNKTALITGGGRGIGRATALALAKEGVNIGLIGRTAANVEKVAEEVKALGVKAAFA
AADVKDAEQVNQAVAQVKEQLGDIDILINNAGISKFGGFLDLSADEWENIINVNLMGVYH
VTRAVLPEMIERKAGDIINISSTAGQRGAAATSAYSASKFAVLGLTESLMQEVRKHNIRV
SALTPSTVASDMSIELNLTDGNPEKVMQPEDLAEYMVAQLKLDPRIFIKTAGLWSTNP
>PK3-2_03313 Replication termination protein
MKEEKRSSTGFLVKQRAFLKLYMITMTEQERLYGLKLLEVLRSEFKEIGFKPNHTEVYRS
LHELLDDGILKQIKVKKEGAKLQEVVLYQFKDYEAAKLYKKQLKVELDRCKKLIEKALSD
NF
>PK3-2_03314 Pyrroline-5-carboxylate reductase
MAEGMISGIVRANKIPKQNICVTNRSNTERLAELELQYGIKGAAPSELCIEDMDVLVLAM
KPKDAEIALSSLKTRIQPHQLILSVLAGITTSFIEQSLLNQQPVVRVMPNTSSMIGASAT
AIALGKYVSEDLKKLAEALLGCMGEVYTIQENQMDIFTGIAGSGPRIFII
>PK3-2_03315 Pyrroline-5-carboxylate reductase
MEFIEKTGEEAGLDKQLSRSIGAQTLLGAAKMLMETGEQPEVLRDNVTSPNGTTAAGLQA
LQKSGGGEAISQAIKHAAKRSKEISDDIEKTAATLSGVIK
>PK3-2_03316 Glutamate 5-kinase 1
MTPDTNMKRVVVKIGSSSLTSLHGEISIRKLEALVDQVVKLKDAGYEVILVSSGAVAAGY
RKLGFIRRPENLPEKQASASIGQGLLMEAYSKLFLAHGYVASQILITRSDFSDEHRYNNV
RNTMNVLLERGIIPIINENDTVTVNRLKFGDNDTLAAKVAGLIDADMLVILSDIDGLYDG
NPRANPEAKRIQRVCEITPDIEVCAGDPGSVIGTGGMRSKLDAFKIVMASGIKGFLGQAD
ASDILYQAVHEEAEGTYFEAEGTLPLNHKEQWIAFNSGPEGEMILSDDYSRKVTNGQSSL
YLDGVQEIKGKFKSGSVVRLMNSQGAEIGLGIVNYSSVQLQEPEKKEELINKAVIDQEAF
VCHVDLSLPVN
>PK3-2_03317 HTH-type transcriptional regulator GltC
MELRQLRYFMEVAEREHVSEAADHLHVAQSAISRQIANLEEELDVTLFEREGRNIKLTPI
GKEFLIHVKTAMKAIDYAKEQIDEYLDPHRGTVKIGFPTSLASQLLPTVISAFKEEYPHV
EFLLRQGSYKFLIEAVRTRDIDLALLGPVPTNFPDITGKILFTEKIYALVPLNHPLAKQK
AVHLIDLRNDQFVLFPEGFVLRKMAIDACKQAGFAPLVSTEGEDLDAIKGLVSAGMGVTL
LPESTFAETTPRFTVKIPIEFPQVKRTVGIIKPKNRELAPSANDFYEFVIQFFSKLEQYQ
>PK3-2_03318 Glutamate synthase [NADPH] large chain
MTYNQMPKAQGLYRPEFEHDACGIGLYAHLKGKQTHDIVKQGLKMLCQLDHRGGQGSDPD
TGDGAGLLVQIPDAFFRKECKDINLPEKGRYGVGMVFFSQKEDERKKSKSKSMH
>PK3-2_03319 Glutamate synthase [NADPH] large chain
MAQKSCPFVRQVFIGASSDLKDNLSFERKLYVIRKQAENWGVTEGLDFYFASLSSQTIVY
KGLLTPEQVDAFYSDLQDEAFVSAFALVHSRFSTNTFPTWERAHPNRYLVHNGEINTLRG
NINWMSAREQQFVSESFGEDLNKVLPILNADGSDSSILDNAFEFFVMAGRKPAHTAMMLI
PEPWTENTHMSKEKRAFYEYHSSLMEPWDGPTAISFTDGKQIGAILDRNGLRPARYYVTK
DDYIIFSSEVGVIDVEQENVLYKNRLEPGKMLLIDLEEGRIISDEEVKTQIATEYPYQKW
LEEELVQVNPDPESREEEQFTDLLTRQKAFGYTYEDIQKYLIPVIKEGKDPLGSMGNDAP
LAVLSDRAQSLFNYFKQLFAQVTNPPIDAIREQLVTSTMTWLGAEGDLLHPSERNVRRIK
LYTPVLSNEQFYALKTIVHPDLKSQKIDVLFSEDIERGLKDMFTQAEKAINQGVSLLILS
DKKMNKRLTPIPPLLAVSALHQHLIRKGLRTKVSIIVESGEAREVHHFAALIGYGADAIN
PYLAYATYKQEIDEGRLDISYEEAVSKYGKSITEGVVKVMSKMGISTVQSYRGAQIFEAV
GISREVIDRYFTGTASQLGGIDIKTIAEEAQRRHLEAYQDDYSKTLEPGSDFQWRNGGEH
HAFNPKTIHTLQWACRRNDYNLFKQYTKAADEERIGFLRNLFAFDGDRKPLKLEEVESAE
SIVKRFKTGAMSFGSLSKEAHEALAIAMNRIGGKSNSGEGGEDPKRFVPDENGDDRRSAI
KQIASGRFGVKSHYLVNADELQIKMAQGAKPGEGGQLPGNKVYPWVADVRGSTPGVGLIS
PPPHHDIYSIEDLAQLIHDLKNANRDARISVKLVSKAGVGTIAAGVAKATADVIVISGYD
GGTGASPKTSIKHTGLPWELGLAEAHQTLMLNGLRDRVVLETDGKLMTGRDVVMAALLGA
EEFGFATAPLVVLGCVMMRACHLDTCPVGVATQNPELRKKFMGDPDHIVNYMMFIAEEVR
EYMAALGFKTFDEMIGRTDALHVSERAKGHWKASQLDLSTLLYQPEGVRTFQSPQNHKID
QSLDITAILPAVQEAIESGKEAEVSIEINNTNRVAGTITGSEISKRYGEEGLPEDTIKLQ
FTGSAGQSFGAFVPKGMTLYLDGDSNDYVGKGLSGGKIIVKSPEGFNSASDDNVIIGNVA
FYGATSGEAYINGRAGERFAVRNSGVNVVVEGIGDHGCEYMTGGSVVVLGDVGKNFAAGM
SGGIAYVLAEDVKAFKRKCNLEMILFESLEDEKEIEQIKAMLEKHAAYTNSQKAASLLDQ
WEDSVKKFVKVIPKNYKQMLASIEEQKAAGLSDEEAVMYAFEANTKPKQNTASSGQKQAV
VQ
>PK3-2_03320 Glutamate synthase [NADPH] small chain
MGKPTGFMEIKREKPAERDPLTRLKDWKEYSAPFSEEASKRQGARCMDCGTPFCQIGADI
NGFTSGCPIYNLIPEWNDLVYRGRWKEALERLLKTNNFPEFTGRVCPAPCEGSCTLAISD
PAVSIKNIERAIIDKGFENGWIQPRIPKKRTGKKVAVVGSGPAGLASADQLNQAGHSVTV
FERSDRAGGLLTYGIPNMKLEKGIVERRVKLLTQEGIDFVTNTEIGVDITADELKEQFDA
VILCTGAQKQRDLLIEGRDSKGVHYAMDYLTLATKSYLDSNFKDKKFIDAKGKDVIVIGG
GDTGADCVATALRQKAKSVHQFGKHPKLPPARTNDNLWPEQPHVFTLEYAYEEAEAKFGR
DPREYSIQTKKMVADKNGQLKELHTIQMEKVKNEHGKYEFRELPGTEKVWPAQLVFIAIG
FEGTEQPLLKQFGVDSVNNKISAAYGDYQTNIDGVFAAGDARRGQSLIVWAINEGREVAR
EVDRYLMGSSVLP
>PK3-2_03321 Alcohol dehydrogenase
MKAVIHNGKAGLQGLSVQDVPSKKPGYGQVKIKVKSAGLNHRDLFLMNNKSERDPHLILG
SDGAGIIEEVGEGVKNVAVQTEVIIFPTLNWDLTENVPPVPEILGGPSDGTLAEYVIVPS
QNAFKKPAYLSWEEAGVLPLSALTAYRALFTKARLKKGEHLLIPGIGSGVATYALFMAKA
IGATVSVTSRSEEKRKKALHLGADYAFNSYSNWDEQLQGEKADVVLDSIGPALFSEYFRH
VKPNGRIVSFGASSGDDLLFPVRSLFFPQINVLGTSMGSCEEFHDMLAFIEKHKLRPVID
RTYPLERTFEAYTRMREGRQFGNIGIVME
>PK3-2_03322 HTH-type transcriptional regulator YofA
MESGDLKIFQAVAREGSITKAAQMLNYVQSNVTARIHNLEEDLNIRLFHRTNRGMKLTAA
GENLLQYANQVLALLDEAEKSAQMSQQPKGPLRIGSLETTAVTHLPEHAASFLRRFPEVD
LSVNTADTHNLMQQVLDHKVDGAFVYGPVDHTDIRQIPVSRDELVLISSHEGTAEDMLRQ
PMLFFGAGCSHRARVKRLLEEAGIQKQKIIEFGTLEAIVRGVSAGLGTALLPRSAVDCCE
QRTNVWIHQLPAAYQDLEIVFIYRKDFFITSAFQRFMDEVDEMKKM
>PK3-2_03323 Glutathione hydrolase proenzyme
MKRTVNVCLTALLSVLLVAGSVPFHTEAKKPPKSYDEYKQVDVGKDGMVATAHPLASEIG
ADVLKKGGNAIDAAVAIQFALNVTEPMMSGIGGGGFMMVYDGKTKDTTIIDSRERAPAGA
TPDMFLDEDGKAIPFSERVTKGTAVGVPGTLKGLEEALDKWGTRSMKQLITPSIKLADKG
FPIDSVLADAISDYQEKLSRTAAKDVFLPNGEPLKEGDTLIQKDLAKTFKLIRSKGTDAF
YEGKFAKALSDTVQDFGGSMTKKDLEDYDITIDEPIWGDYQGYQIATTPPPSSGGIFLLQ
MLKILDDFNLSQYDVRSWEKYQLLAETMHLSYADRASYAGDPEFVNVPLKGLLHPDYIKE
RQQLISLDQINKKPKAGDPWKYQEGSANYKQVEQPKDKVEGQTTHFTVADRWGNVVSYTT
TIEQLFGTGIMVPDYGVILNNELTDFDAVPGGANEVQPNKRPLSSMTPTILFKDDKPVLT
IGSPGGATIISSVLQTILYHIEYGMELKAAVEEPRIYTNSMSSYRYEDGVPEDVLSKLNG
MGHKFGKSPVDIGNVQSISIDRENGTFKGVADSSRNGAAIGINLKRK
>PK3-2_03324 hypothetical protein
MYLTIKETAEYTNLSEDYIKSLVLEGKIRAVHDGEQFLIFKEQFKTHLEQLENYKALVQE
ILNEPIPEDIDVKDED
>PK3-2_03325 Tyrosine recombinase XerC
MHIVQPIRSLEKIQQVKQYLLNKNKRDYFLFIFGINSALRISDILPLQVKDVKNKDHLWA
TESKTKKKRKILILESLKQEIYEYTNDMKENEYLFKSLRTRKPISRIQAYRILREAAAAC
GLEEIGTHTLRKTFGYHFYQRTKDIAELQRILNHSSPSITMRYIGIDEDTTRAAYKVFGG
L
>PK3-2_03327 putative protein YoeB
MKKCFLFLTTIALILSLSTNAFAKNTSGDLSQKQALQLALSAREHFWNTMSGHNPKAKKA
VCPSGTFEYQNLQYMYMCSDLGTKAKAVNYLTPIFTKTAIEKGFKDYHFTVSKGKLAVPI
GDGDNLLNWKKSTAKLLSKKGGTVTYEFTVPTLDGSPAAKRKVTFVKENKEWKVNQFDAV
I
>PK3-2_03328 Multidrug export protein MepA
METSQEHLVQKKSNPSVWRSMSLFLVPLLLSNVLQSVGQLVGMMAVGRWLGVDAVAAVSS
FFPLFFLLISFTIGIGSGSSILIGQAYGAKNEERLKAVVGTTLTFTFLLGVVLAVIGSIF
TLDILRLMGTPENVIHVSASYARILFYAMPFMFLYFAYTTFLRGTGDSKTPFYTLIVSTV
INIALLPVLILGMFGFPKLGIYGSAYATVISTIATFIVLMVYLRKRNHPLQFDKTVRRYL
KMDKELLALLLRLGIPSSINMILVSLSEIAVISFVNHYGSNATAAYGVVNQVASYVQMPA
VSLGIAVSIFAAQSIGANEFDRLKQVIRVGIWLNYIIGGVLIILIYVFSQQILGLFLTEK
DTLYIAHRLLMITLWSYLLFGNAQIISATMRASGTVLWPTVISIFAIWGIEVPVAFVLSH
YTKLEILGVWVGYPAAFAVSLLLIYGYYQFVWKKKQITRLIQ
>PK3-2_03329 Aldose 1-epimerase
MANFIENITYLGTPAIKAENKHLEMIVVPEWGSNVISLVDKTTKFQLLREPETAESFQDT
PTLYGIPILFPPNRISDGTFSFQGRTYHFDINEKEKHNHLHGFLYQEKWDVVTMKQTDEE
VIVETEIDLSVLPHVYKQFPHHAVVRMTYMLKGNTLYKHATIMNKGKEAFPWGIGYHTTF
MFPEESSLFSLTADQQWELDERLLPTGKLKDVPNKEALHEGMDLRQKELDDVFLSAYQKR
GGGNQAVIYHQHAHISIVYKADEQFKHWVVYNADGKQGYLCPEPYTWVTNAVNLNLPSSL
TGLQVLEPGEETTAKSSITIELNHQ
>PK3-2_03330 D-alanyl-D-alanine carboxypeptidase DacC
MKKSIKLYVAVLLLFVVASVPYMHQAAQAVEKQDALAGQIDKILADHPALEGAMAGITVR
SLDTGAVLYEHSGDIRMRPASSLKLLTAAAALSVLGEDYTFTTEVLTDGRLKGKKLNGNL
YLKGKGDPTLLPSDFEEMAEKLKQSGVKVIKGNLISDDTWYDDTRLSSDMPWSDEYTYYG
AQISALTASPNEDYDAGTVIVEVTPGKKEGEKPVVSVSPKTDYVTIKNDAETTGAGQKKE
LTIEREHGTNTVSIEGSVPVDTSKTKEWIAVWEPTGYALDLFKQALNKQGITVKGKVMAG
AAPGSSDVLISHRSMPLSKLFVPFMKLSNNGHAEVLVKEMGKVKKEEGSWEKGLEVLNST
LPKFGVDPKSLVLRDGSGVSHIDAISSDQISQLLYDIQDEKWFSSYLNSLPVAGNGDRMI
GGTLRNRMKDTPAQGKVKAKTGSLSTVSSLSGYAETKSGKKLVFSILLNGLIDEEDGKDI
EDQIAVILANQ
>PK3-2_03331 Plipastatin synthase subunit A
MSEHTYSLTHAQRRVWFTELLDPGTSICNLTACVKFRGNIDLEALEEALNHSISRNDAIR
FQLLEGEDSEPRLCLTEYKYTPLEIIDFSNVEMIEIEQWIQDQARIPFKLFNSPLYQFCI
LRIHTHEVWLFAKFHHIIMDGISLNVLGNQIIDLYQKMKKQDSLPDHPEPSYLSYIEKES
QYLQSSRFVKDRLFWTQTFQPPPEYHSLAGQTSLQKQSTSASRDTITLSPHLGQKIQIFC
EEHKINIISLFMASFYICISRLTSKRDLAIGTYYGNRGSKAEKEMLGMFVSSLPIRITVD
PDTDFLSFVRRVGREQLSVMRHQRFPYNLLVNELRKEQKDLHNLIGISMQYQPFQWHNAD
GFDYETALYFSGYTANELSVQIQERIDTGTIHLNFDYQNTLFSLEDIKRIQNHLLMLLEN
ALQHPHKFIKELDMTDVREKQKLLYEFNKTIAVSPEAPTLHRLFERQAAVTPERTAIRFS
GGALTYAELDMYASRLAAHLAARGVTKESIVGVLSERSPDMLVAVLAVLKAGGAYLPLDP
AYPEERLSYMLKDSGAALLLTQPGCSAPNFSGETLEVDLASLAGEKAENHVFVPADGGSL
AYVIYTSGSTGQPKGVAVEHRQAVSFLTGMQHQFPLQEDDIVMVKTSFSFDASVWQLFWW
SLSGASAYLLPPGWEKDPALIVKAIHQEKVTTVHFIPAMLNSFLDQAEIERLSDGTSLKR
VFAGGEPLAPHMAARFASLLPHVSLIHGYGPTEATVDAAFYVLNPERDRDRLRIPIGKPV
PGARLYVLDPHLAVQPSGVAGELYIAGAGVARGYLNRPALTEERFLEDPFYPGERMYKTG
DVARWLPDGHVEFLGRLDDQAKIRGYRIEPGEIEAALRSIEGIREAAVTVRTDSGEPELC
AYIEGLRRNEVRAQLERLLPGYMIPTHMIEMEQWPVTPSGKLDRNALPAPGGAADAETYT
APRNVTEMKLAQLWEDVLKNGPVGIHDNFFDRGGHSLKATALVSRISKEFDVQVPLKDVF
AHPTVEGLASVIREGTDSPYEAMKPAEQRETYPVSSAQKRIYVLQQLEDGGTGYNMPAVL
ELEGKLDPERLDRAFKELIKRHESLRTSFEQDEGGEPVQRIHDKVPFALQTAVLGEQTEQ
EAAAAFIKPFDLSRAPLFRAQIVKVSDERHLLLVDMHHIISDGVSVNILIREFGELYNNR
TLPALHIQYKDYAVWQDGYKKGDAYQTQETYWLKQLEGELPVLDLPADHTRPPVRSFAGD
KVSFTLDQEAASGLQKLARENGSTLYMVLLAAYTALLSRLSGQEDIIVGSPIAGRPHKDL
EPILGMFVNTLALRIRPEGGKPFVQYLQEVRETALEAYEHQDYPFEELVDKLQLTRDMSR
NPVFDAMFILQNMEKQDVKLEEVKVRDANVAQHISLFDITLIATETDGALCCELEFSTEV
FLKATIKRWASHFIEFLHAAISNPETRLSQLNILSEKEKQKILTEFNKTKVEFSQKDVAF
HRIFEARAQETPEHIAVIDDETEISYRLLNEKANRLARTLQRRKGTRPTVAVLAKRSIDA
IVGVLAVMKAGGVYIPIDSNYPKARIEYILRDSGADILLLQQELKHLISNASESEMSHIC
LDAEVSYEENSCNLNLSPAPEDAAYIIYTSGTTGAPKGVIVTYRNFTHAALAWRQIYELD
RKPVRLLQIASFSFDVFSGDLARTLTNGGTLIVCPDEKRLEPAEIYKIMSSKRITMMEST
PALIIPVMEYIYRNQLKLPDLDILILGSDMVKAQDFKTLTERFGQSMRIINSYGVTEATI
DSSFYETSMGEEWTGDNVPIGSPLPNVRMYVLSQTGQIQPIGVAGELCIGGAGVAKGYHN
KPDLTRMKFTENPFVSGERLYRTGDRACFLPNGTIRLLGRMDYQVKINGYRIETEEIESV
LLQTGLVREAAVTVQHDKNGHAGLAAYIVPSDVNTNALRAALTKELPAYMVPAHLIPLEN
MPLTLNGKLDRNALPAPDNMLSRPYTAPVNDIQKTMAYIWEDVLSMSRVGIHDSFFELGG
DSIKALQVAARLATEGWSMTIRDLFRYPTIQELSGHITPLASQADQGPAEGEADLTPIQR
RFFGQAQAFHDHYNQSVVLFSEKGFNANALRLALRKITEHHDAIRMVFQQDQNGHVVQYN
RGINHKDYELFGLHIADWTTELLERTHLDEKLSAEETVIQSKMNVQKGPLLQAGLFKTAG
GDHLLIALHHLVIDGVSWRILLEDLAAAYQQALEKQEIQLPPKTDSYLSYASGLAHIVEN
KQLLAEKPYWQTILDAHNAFLPKDTENMPDRLQLNSDSSMFVLSGDWTEKLLFETQQAYG
TDANELLLTALGMALYEWTGHDQVVISTEGHGREGHVPNIDISRTVGWFTSIYPILLDMG
IPEPFEDQLAYRIKTTKDMLRRVPNKGTGYGLLTHIGELRHKEPEVSFNYLGQFSEEKEA
DTFELSYYQPRYEIAGEREREYELDINALITDGRLQVKAVYTQVFSKHSIECFMDRFHRH
LIETIEHCSQKKAREKTLSDFSNKELTLSALSSIEDLVKDL
>PK3-2_03332 Plipastatin synthase subunit B
MAQSAQIQDIYPLSHMQEGMLFHSLMDFSSKAYIEQTSFTITGNLCVDSFQKSLNLLVSR
YDIFRTIFIKEVPDLTGPQQVVLSNRELTVYREDISRLADQEQQTLIDAFMTKDREKGFD
LQKDPLMRLALFDRGDSQYTCVWTHHHIIMDGWCLGIILKEFFSMYDSLSNNRPVQLGST
VPYSRYIEWLGEQDQEETAAYWSGYLKEYGNTASIPRIKRRPANRDYKAAQISFSLAPEM
VKKLTEAAQNWGVTLNTLFMSIWGVLLHRYNAADDAVFGSVISGRPSAIDGIESMVGLFI
NTIPVRIRSAEGMTFSSLVKAVQEDILSSEQHGYYPLYDIQNHSPLKQGLIDHIFVFENY
PVQLDQALRIESENEENALKLGDISMSEQTNYDFNIVIVPGESFYIKFSYNAAVYKHEEM
LRIQGHLKQALDCILANPDIAVSDINIVPPEEQKLIQLFNETKRSYANKTISQLFEEQAH
KTPEAAALKMGDEYWTYRQLNERANQIAHALIEKGVGSGDIVAVMMGRSMEMPAALLGIW
KAGGAYMPLDPNFPTERLSFLLKDSQAAQLLIEEDLITFIPPHYEGEMIPIERTERHQTA
APDVPPGDLAYLIYTSGTTGRPKGVLIDHQGIANTLQWRREEYGMAEQDISLHLFSYVFD
GCVTSLFTPLLSGSCVLLTTDDEAKDVLALKRKIERYKVSHMIIVPSLYRVLLEVMTAED
AKSLRIVTFAGEAVTPDLLEMSEKICPSAELANEYGPTENSVATTILRQLNEKERITIGH
PIANTKVFVLHGNQMQPIGAAGELCISGAGLARGYYKQPELTEKAFSDHPFLEGERVYRT
GDAGRFLPDGTIEYLGRFDDQVKIRGYRIELREIETVLRQAPGVKEAAVLARDVSAEEKE
LVAYIVPEKGNSLPDLYRHLAGTLPAYMIPASMINISRMPLTSSGKLDRSALPEPEPERN
ASLTYMPPRTLIEADLAHIWEDVLNKQQIGIRDDFFQLGGQSLKAAALVSRIHKKLNVEL
PLSEVFSNPTVESMAVKLMSLKEHAFTQIEPADHRDVYPLSFSQKRLYALHQLADDSTGY
NMPAVLELNGNLDRQRLRSVLTELVNRHEALRTVFVLDRGEPVQIIYPELDFDLKELEME
SEKMLESAIESFIKPFDLSSGPLFRACVISMGNKRGFLLLDMHHIIADGVSMSTLVQEFT
DLYCGKELPALNLHYKDFAVWQQEKYPKELYKKQEAYWLNQLGGSLPVLDLPLDKIRPRL
PDFSGGTIEVHIDKDTADELHHLMAETGTTLYMILLAVYSILLSKLSRQEDIVVGSPAAG
RPHADLERVIGMFVNTLALRSQPEGHKTFSSYLQDIRHLALTAYEHQDYPFEELADKLDT
HREVNRNPLFDAMLVLQSSEDFQFEVPGLSISSVTPKHDISKFDLTLHAEEHSGGIRCRF
EYSTALFEEETIARWASYFIELLKSVMADTEMRISDIQLLPAAERHLLLEEMGQYAAFPR
NENIVSLFEKKAGEYPEQLAVVCGDSQLTYRELNEKAERTAAMLIKQGVSTGDIVGLMLD
RSPDMVIGILSILKAGGTYLPIDPEYPQERISFMLNDSGAEILLTERGQNKPADYSGHIL
YIEESENDSIPTDLKIQETLADQPAYVIYTSGTTGQPKGVLVEHRNVISLLKHQNLPFEF
GHEDVWTFFHSYCFDFSVWEMFGALLNGSTLVVVSKETARDPQAFRLLLKKERVTVLNQT
PTAFYSLMHEDQNHSDRLNIRYVIFGGEALQPGMLQSWNDKYPYTDLINMYGITETTVHV
TFKKLSAADIAKNRSNIGRPLSTLQAYVMDAHMNLQPIGVPGELYIGGEGVARGYLNRVE
LTADRFVPNPYLPGDRLYRTGDLAKRLSNGELEYLGRIDDQVKVRGHRIELGEIQAALLQ
HPIMKEAAVITRPDEQGQTAVYAYIVTKDQQAVNTSDIRASLKTMLPDFMLPARLMQINS
IPLTVNGKLDQKALPEPEKNAYPADDISPRNEIEKVMAAIWEELLNVDELGVNANFFELG
GDSIKALQVCARLKQRGFETTVREMFEHQTLGELSARVRKAVHVIDQGPVEGEITWTPVQ
QWFFSQSLEINHFNQSVMLYRTERFDEIALRKVLKSLVTHHDALRIVCKYEDGHPVQLNR
GIDLPDEELYALELFDVKGNLTEAHNRIKETASQMQKHICLETGPLLHAGLFRTDNGDHL
FLTIHHLVIDAVSWRILFEDFSTAYKQAVTGESIQLPQKTDSYLTYSQRIADYSKSRQMQ
REAAYWDERENCHIEPIPKDNDAAPNTFKETEVIDFELSRDDTELLLTAAHKAYSTEMND
ILLTALGLALQQWTGSDQFKISMEGHGRESYLEDIDISRTVGWFTSIYPVWLDMSDSDHK
NNDERLSHLIKQTKDMLHRIPHKGAGYGVLKYISKRWGSEKNSPEISFNYLGQFDQDIQS
KAFEVSDIKPENEISPNWERPYALDISGAVSSGCLNMHIIYNRLQFEEKTIQTFAGHFKQ
TLENIIEYCTGKESREWSASDFTDEDLTLDELSEIMGAVNKL
>PK3-2_03333 Plipastatin synthase subunit C
MPQQPEIQDIYPLSFMQEGMFFHSLYDEQSRAYFEQASFTIHGQLDLERFQKSMDVVFDR
YEIFRTAFIYKNVAKPRQVVLKHRHCPVHFEDISHLNERDKEHCTEAFKEQDKSKGFDLQ
TDVLMRISILKCAPDRYVCIWSHHHILMDGWCLGIVIKDFLHLYQALDKGQLPDLPPVQP
YGTYIKWLMQQEREEAAEYWKKRLQHFEKSTPLPKRTDQIKDGTLQQITFTIPEKETSDL
QKIAAASGATLNTVFQALWGIMLQKFNRCSDAVFGSVISGRPSELKDVENMVGLFINTIP
IRVQSDSLSFSDLVSRMQKDMTEAEAYSYFPLYDIQAQSALKQELIDHIIVFENTPTQQE
IEGLNQAGSFDFSVKDFEMEEVTNYRCSVKVIPGRTLYVRIHFHTGAYQPNMMSEIKGYL
QHMISDVISDPSLPVSKMTLLDEDKTRKIVSQNNRTVSVSPEAPTLHGLFERQAAVTPER
TAIRFSGGALTYAELDMYASRLAAHLAARGVTKESIVGVLSERSPDMLVAVLAVLKAGGA
YLPLDPAYPEERLSYMLKDSGAALLLTQPGCSAPNFSGETLEVDLTSLAGEKAENHVFVP
ADGGSLAYVIYTSGSTGQPKGVAVEHRQAVSFLTGMQHQFPLQEDDIVMVKTSFSFDASV
WQLFWWSLSGASAYLLPPGWEKDPALIVKAIHQEKVTTVHFIPAMLNSFLDQAEIERLSD
GTSLKRVFAGGEPLAPHMAARFASLLPHVSLIHGYGPTEATVDAAFYVLDPERDRDRLRI
PIGKPVPGARLYVLDPHLAVQPCGVAGELYIAGAGVARGYLNRPALTEERFLEDPFYPGE
RMYKTGDAARWLPDGHVEFLGRLDDQAKIRGYRIEPGEIEAALRSIEGIREAAVTVRTDS
GEPELCAYIEGLRRNEVRAQLERLLPGYMIPAHMIEMEQWPVTPSGKLDRNALPAPGGAA
DAETYTAPRNVTEMKLAQLWEDVLKNGPVGIHDNFFDRGGHSLKATALVSRISKEFDVQV
PLKDVFAHPTVEGLASVIREGTDSPYEAMKPAEQRETYPVSSAQKRIYVLQQLEDGGTGY
NMPAVLELEGKLDPERLDRAFKELIKRHESLRTSFEQDEGGEPVQRIHDKVPFALQTAVL
GEQTEQEAAAAFIEPFDLSRAPLFRAQIVKVSDERHLLLVDMHHIISDGVSVNILIREFG
ELYNNRTLPALHIQYKDYAVWQEGYKKGDAYQTQETYWLKQLEGELPVLDLPADHTRPPV
RSFAGDKVSFTLDQEAASGLHKLARENGSTLYMVLLAAYTALLSRLSGQEDIIVGSPIAG
RPHKDLEPILGMFVNTLALRTRPEGGKPFVEYLQEVRDTALEAYEHQDYPFEELVDKLGV
TRDMSRNPLFDVMFVLQNMDQESIHLDDLHLKPAANNGHQTSKFDLTLYAHEQPRGLLTF
QMEFSTDLYKKKTIEKWLQYFINMLLSIIQDNKAAIGTINILNEDETHYLIHELNRTKIE
YPRNETISRLFEMQAEQTPNAIAIVSDTQELTYAELNSWANQIASLLQRKGVGPDRVVAL
LTGRTPELIAGMLGILKAGGAYLPIAADLPVERIAYILSDSGATLLLQSEKVEKQLLDIE
CEQIIIEDIQKQGETKNIESLTGPHSLAYIIYTSGSTGKPKGVMIEQRSVIRLVKNSNYI
AFTAADRLLMTSSIGFDVVTFEIFGPLLNGAALHLSDKQVFLDCHQLKRYIEHHGITTMW
LTSSLFNHLTEQNETTFSQLNHLIIGGEALSASHVNRIRNVCPEVSIWNGYGPTENTTFS
TCFHIQKTYELSIPIGRPIGNSTAYILNKWGMLQPIGAVGELCVGGDGVARGYLGRPDLT
KEKFAPNPFASGDRLYRTGDLARWLPDGTIEYVGRIDDQVKVRGYRVELGEIESAIRQIE
GVKEAAVLARTGQTGSKELFGYISVKAGTNAEQVRSLLARSLPNYMIPAYIIEMDTLPLT
SNGKLNRKALPEPDFASKETYVPPRNELEEQLALIWQEVLGIQRIGIEDSFFELGGDSIK
ALQVSARLGRHGLSLQVSDLFRHPKIKDVSPFIRKTERIIEQGPVEGNVPWTPVQQWFLS
QDIEERHHFNQSVMLFHSDRLSEAALRASLKKLAEHHDALRMVYRNDDGKWIQINQGIHE
SQLYSLRIFDLSQTDSGWETQIKQEVADLQQSINLQEGPLLHAAWFKTLTGDYLFLAIHH
LVVDGVAWRILLEDLSAGYQQASSGQAIQLPPKTDSYQEYARRIQEYAQSSKLIREEAYW
RSAEEQQAAELPYEMTLHENTDCGKRDSVSFSLSEADTDVLLQSVNHAYGTDTQDLLLTA
ASLAICEWAGGSKLRIAMEGHGREHIMPELDISRTVGWFTSMYPALISFENQREELGTAV
KTVKDTLGRIPNKGVGYGMLKYLTHPENKSITFSKTPEISFNYLGQFDDIERQGSFRPSS
LGSGKDITLTWKREQIIEMSAMAADKKLHFSLSYPSARFHRNTMDQLINRIEHFLLDIMK
HCAGKQKAEKTLSDFSSQSLTAEDLDSISSLVEEL
>PK3-2_03334 Plipastatin synthase subunit D
MTKANSIQDIYPLSYMQEGMLFHSLLQKDSRAYVEQASFTIEGKVNPQFFQNSINALVER
HDIFRTIFISQNVSSPQQVVLRERNVIVLEEDITHLNEAEQSQFIEQWKEKDRDRGFHLQ
KDVLMRIALIQTGESQYSCIWTFHHIMMDGWCLSIVLKEFLHIYASYVNASPITLEPVQP
YGKYIKWLMEQDKEQAVSYWDHYLSGHEQQTVLPKQKKTKGKSRQEHVTFSLSKEESSRL
SELAAKEEVTLSTIFHTIWGILLQKYNNNDDAVFGSVISGRPAEIEGIEQMVGLFINTIP
VRVQGEKTPFLQLIKDMQKDRLAAEAYSYHPLYEIQARSAVKQGLIDHILVFENYPVQQE
IQMLNKQEHASELFQIHNFTVADETNYSFYLMVAPGEEIHIKMSYDAEQHDRSFVLSVKG
HLLNAVSQILNNPNLPPSEIDITTDHEKQQLIGKIADHAPVYETIHAMFEAQAEKTPDAY
AVIDQACSLTYRELNKSANRLARQLRMKGVARQEPVAVMMERSAAFITGVLGILKAGGAI
VPIDPYYPADRISYILNDCGCSHVVSQAHLSSSLENNYFITHAEDIESQEDGSNLQSVNN
ADDLLYMIYTSGTTGKPKGVQFEHRNMANLLKFEYTHSGIDFEADILQFATPAFDVCYQE
IFSALLKGGTLHIVPEAIKRDVPQLFAFINKHQTNIVFLPTAFIKMIFNERQFANSFPYG
VKHLIAAGEQLMISDLFQGVLRERGIHLHNHYGPSETHVVSTYTIHPGDRIPEFPPIGKP
IGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTRDKFSSDPFRSGAIMYRT
GDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDIKETAILIRQDRSGEHE
LCAYYCSVQKLDAIDLRRYMASELPEYMIPAKWVWVDSIPLTPNGKVDQSALPEPDASIC
GNSYTAPRNLLEAKLSQIFEDVLKNGHIGIQDNFFDHGGHSLKATVLMSRIAKEFHVQVP
LKDIFANPTVEELASIIRGAEENQYAAIEPAEERETYPVSSAQKRIYVLQQLDEGVAYNM
PAVLELEGALDVAKLSAVCKELIRRHEPLRTSFVSGTDGEPVQRIHTEVPFTLSTETSIE
GFVRPFDLSQAPLFRAGLIKVANEKHVLLVDMHHIISDGVSVQLLIREFTDLYANRQLKP
LRIQYKDYAVWQQQFKKGDSYQKQETYWQQQFSGDLPVLELPTDKRRPAERQFTGGKVTF
QMDKELTDRIKRLAHKNRSTLYMTLLALYSAFLSRLSGQDDIVIGSPIAGRPHADLEAVL
GMFVNTLALRTCPAGNKTFEEFLKEVRQTALEAYEHQDYPFEELVDKLSVQREMSRNPLF
DTTLVLQNMEQQKLKMKDVELQWSDLHHPISKFDISLYVTEHDAELFCQFEYSTALFEKA
TIQRWADLFTTLVEHTAVSPETELDNIPILTKEEEREFIESCHPVQGTGYPMNQTLHYAL
EMQAAKTPDQTAVVFEDGAMTYKELNEQANRIAWELIERGVKSETTVAIMGRRSPEMLTG
IYGILKAGGAYLPIDPDYPEERISFLLEDSGTNILLLQSDGLHVPAFAGEVVYLNQTNSG
LKHRLSNPNADVLPQSLAYVIYTSGSTGRPKGVEVEHRSAVNFLNSLQSRYQLNQSDVIM
HKTSYSFDASIWELFWWPYAGASVYLLPQGGEKEPEVIAQAIEEQSITAMHFVPSMLHAF
LEHIKYRPVPIKTKGLKRVFSGGEQLGTHLVSRFCELLPNVALTNSYGPTEATVEASFFD
CPLHEKLERIPIGKPVHHVRLYILNQKQRMLPAGCIGELYIAGAGVARGYLNRPALTEER
FLEDPFYPGERMYKTGDAARWLPDGHVEFLGRLDDQAKVRGYRIEPGEIEAALRSIEGIR
EAAVTVRTDSGEPELCAYIEGLRRNEVRAQLERLLPGYMIPAHLIEMEQWPVTPSGKLDR
NALPAPGGAADAETYTAPRNVTEMKLALLWEDVLKNGPVGIHDNFFDRGGHSLKATALVS
RISKEFDVQVPLKDVFAHPTVEGLASVIHEGTDSPYEAMKPAEQRETYPVSSAQKRIYVL
QQLEDGGTGYNMPAVLELEGNLDPERLDRAFNELIKRHESLRTSFEQDEGGEPVQRIHAE
VPFALQTAVLGEQTEQEAAAAFIKPFDLSRAPLFRAQIVKVSDERHLLLVDMHHIISDGV
SVNILIREFGELYNNRTLPALQIQYKDYAVWQDGYKKGDAYQTQETYWLKQLEGELPVLD
LPADHTRPPVRSFAGDKVSFTLDQEAASGLHKLARENGSTLYMVLLAAYTALLSRLSGQE
DIIVGSPIAGRPHKDLEPILGMFVNTLALRARPEGGKPFVQYLQEVRETALEAYEHQDYP
FEELVDKLGVTRDMSRNPLFDTMLVVQNNDYEPLHLHDLKMKPAEVSHLVSKFDLTLQAS
EGDGNIHFLFEYSTALFEKTTIERWASHLTNVLRIIGKNPEVTLNRIDILTQEERNQLLN
EFNTGKANQYEEQTISQLFEQQAARTPKASALVIGDKTLTYQELDEWSNGIAHTLRSRGV
KPDTPVGIMMPRSFSMIAAILGVWKAGGCYVPIDPEYPSERKRYILSDSGTKLLLTVNEA
DRRADDDFEGEILTVQDAKAYDKSPLPQVSSAHHLAYIIYTSGTTGRPKGVMVEHKGIAN
TLQWRRSAYAFNETDTILQLFSFSFDGFLTSMFTPLLSGAKAVLLYEEEAKDILAIKHQL
SRHRITHMIIVPVLYRALLDVVQPEDVMALRVVTLAGEAADRELIDRSMAICPHTELANE
YGPTENSVATTVMRHMEKQTYVSIGQPIDGTQVLILKSNHQLQPIGVAGELCIAGTGIAR
GYVNLPELTESAFIQNPFKPETRMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKE
IEAVIRCINGVQDAAVVAHETASGQTELSAYVVTKPELSTNTVRSALQNKLPVFMHPAYI
EKLDSLPLSPNGKLDRRALPKPVSKREAERPFLVPASKMEQILADIWKEVLGAEKIGTAD
SFFELGGDSIKALQVSARLHRIGKQMAVKDLFSHPTIQELAAYIRDSHTSSSQASVEGDV
QWSPVQKWFLSQDIKEKHHFNQSVMLHRSTSIQEEALRKTLKAIACHHDALRMVFSQSEQ
GNWNQYNRPISHSDDALYGLQMIDLSAPEDTNGNRAYEPIIKHHVRDIQQKMDLKNGPLL
QAGLFRTTDGDFLFLSAHHFVVDGISWRVLLEDLSLGYRQAAGGEDIKLPPKTSSFKAYA
KKLSGYAESQQLIKQLKYWRETEEYQTEALPFDQIDGPIANERKRSTISFTLNDKETAAL
LKDANSAYNTDTQDLLLASVILALRHWTNQSAFKLSLESHGREDVLDGVDVSRTVGWFTA
IYPLLVKLSADLPDSEEGMVHVLKTTKDTLRRVPDKGFGYGVIKYLTPPDKKDINFTGAP
EISFNYLGQFESGSPAEAPEEDAFSFSPLGAGDDISTTWNREQSLDISAIAAEGKMTVNM
TYDIARFQRKTIEQLSETCRQFLLQLIEHCQNKSETEKTISDFDDQELTEDALQEIADML
SFH
>PK3-2_03335 Plipastatin synthase subunit E
MDNIKKIKNIYPLSHMQEGMLFHSFLRKEEGAYVEQSLFTIKGSLSYEWFQRSIQTIIDR
HDIFRTVFLPHVPHLSGPRQVVMTEREFHLYSEDISHLPTNGQNEYIECFKEKDKQKGFD
LQKDMLMRISLFKTAEEEHVCVWSHHHILMDGWCLGIVLQEFMRIYQSIHAGKPLSLDPV
RPYSTYISWLTNRDKETAAEYWDSYLKNYSAPSPLPRVSDEETKEGYQREDLIFSLNKPL
TDKLKETAKQHGVTLATFIQAVWGVMLQQYNRTDDVVFGAVVSGRPSEIPGVEQMIGLFI
NTIPVRIKTFQGETFQELVRRCQKEMLEAEPFTCQPLFDIQANTALKQELIDHIIVFENY
PIQQKIADSADQTDSPLQIDQVKVSEQSGYHFNLVVAPGEELIIKFSYNAFIYDAAWINC
IKRQFTQALSTAAHHPDTPIADFSFLDAAEKEQIVTQFNNTKTEYPKDHTIIDLFREQAE
KTPDHIALVCGNLSFSYEELDKRSNSLARALYQKGFRKNDTAGILAAHSAEFMISVLAVL
KAGGAYLPLDAELPPERVSFMLEETQAKMLIIQKGLEQKAPFSGTCIISDAQALMEENDI
PINISSSPDDLAYIMYTSGSTGRPKGVMITNRNVVSLVSNSNYTSASVDDRFILTGSISF
DAVTFEMFGALLNGASLHIIDKSTMLSPDRFGAYLLENGITVLFLTTALFNQLAQVQADM
FRGLHTLYVGGEALSPALMNAVRHACPDLALHNIYGPTENTTFSTFFKMERDYAGPIPIG
KPISNCSAFILDANGRLLPIGVPGELCVGGDGVAKGYLNRDDLTKAVFSPHPYLSGERIY
RTGDLARWLPDGNLEYISRIDRQIKIRGKRIEPAEIEARLLEMEGVQEAAVTLREIDGEG
QLYTHYVGDDKRTEKEIRADLARVLPDYMIPQHWVRVDRMPLTGNGKIDRNALPIPENKP
EKRKDITLPRNLVEEELANIWKHVLGVNTISIDDDFFALGGHSLKALQVIHTLKHQQQID
IPIDLLFEYPTIAQLAEKLYSKQLTAADEQHVIKLNQHAARNLFCFPPISGFGIYFKDLA
LLLNDKASVYGFHFIEHDTRIEQYVNCITDIQPEGPYVLLGYSAGGNLAFEVAQAMERKG
LEVSDFIIVDAYLKEQPMPIETGNDESAAYLPEAVREKVLKKKRNYQEYWAQLLNEGHIK
ANIHFIEAGIQTETSENTGLTKWKGAAYGNYSEYTGFGAHKDMLEGTYAEKNTDIILDIL
DKITSNKALLHKR
>PK3-2_03336 hypothetical protein
MDHLSWLTFIMLILASYRLTHLIVFDKITEFIRKPFMKKKKIVDQNGHVNEKSVPASNFG
YMLNCYWCAGVWCAILIGLGYLFLPRIAVPVIFILAIAGAQAILETAVGVGVKLIDVLKS
LQTMMNDKKS
>PK3-2_03337 hypothetical protein
MKVQQKPIVRFLVSLIIGTFVISVPFMANAQPDRELRAVWIASVLNIDWPSKKGLTIEEQ
KQEYIKLLDDVQTMGMNAVIVQIKPTADAFYPSAYGPWSEYLTGVQGKDPGYNPLAFMIE
ETHKRNLEFHAWFNPYRITMNHTDLNKLSEDHPARKHPDWVAAYGKQLYYHPGIPEARDF
IVKGIEEVVKQYDIDAVHMDDYFYPYKIAGQEFPDQAQYEQYGKNAFSNIDDWRRDNVNQ
LVKQINQTIKAAKPHVKFGISPFGVWRNAADDPTGSNTKAGVRNYDDLYADTRHWIQQGD
IDYIAPQIYWSIGFNAAAYDVLADWWSNEVKNKPVHLYIGQAAYKINNNFDPPWSDPEEY
VRQITLNRQLALVKGSMHFSLKDLIKNPLGIKDRLITELYSQPALIPQMPWLDSTVPKKP
KLTKVTEDKNGNLLHIQDHPSNQKSKETAYYAIYRAEGKKNKTLLATARKTNEQETFLDN
TADPNKKYTYYVTSADRLHNESKASKRKTK
>PK3-2_03338 Acyl-CoA dehydrogenase, short-chain specific
MNFELTKEQQMVREMVKDFAKKEIAPYAEHVDQTGEFPLQTFKKMGELGLMGIPFPEEYG
GSGGDTISYALAVEEIGKACGSTGLSYAAAVSLGASPLYYFGTEEQKRAHLTPLASGKAL
GSFGLTEPNAGSDAGGTQTKAITNGDEYVINGEKCWITNASYARTVIVTAVTGKNKDGKN
IISALIVPTGTPGLTITSPYDKMGVRGSNTAEILLEDVRVPAGNLLGDPTKGFKQFLYTL
DGGRISIAALAVGIAQAALEASLAYAKERKQFGQPISSFQAIQFKLADMAMEIELARQMV
LKAAWLKDHNRPFTKEAAYAKLFASEMATRACNQAIQIHGGSGYMKEYGVERMLRDAKLM
EIGEGTSEIQRIVIARQLLT
>PK3-2_03339 3-[(3aS,4S,7aS)-7a-methyl-1,5-dioxo-octahydro-1H-inden-4-yl]propanoyl:CoA ligase
MAELIHSTIGRLLEQTAEAYPDQEAVVYPDRNIRYTYAQFNSLCRQTAKGLMGMGIGKGD
HVAIWASNIPEWLAVQFATAKIGAVLVTVNTNYQAHELDYLLKQSDAAALLVMDSYRGTS
YTDILNSLIPELQEAEPGQLTSERYPFLKTLVYIGEKRLPGMYHWDDTEILAKTVTDAEL
EARMNSLEKDDVINMQYTSGTTGFPKGVMLSHSNVTNNAANIAECMALTSQDRMCIPVPF
FHCFGCVLGVLACVSVGAAMIPVQEFDPVTVLKTVEKEKCTALHGVPTMFISELHHPDFD
AYDLSTLRTGIMAGSPCPSEVMKAVIEEMGMKDITIAYGQTEASPVITQTRANDSFIRRV
ETTGRALPHAEVKIVEPGTCREVQRGVQGELCTRGYHVMKGYYKDEEATRKAINPNGWLF
TGDLAVMDEDGYCRITGRLKDMLIRGGENIYPREIEEFLYRHPAILDVQVVGVPDAKFGE
EAAAWIKLKDGKTVSSEELKAYCKGKIARHKIPRYVIFTDEYPMTASGKIQKYKLREKTI
EMFNLSSCQ
>PK3-2_03340 2-oxoglutarate carboxylase small subunit
MFTKVLIANRGEIAMRIIRTCSRLGIKTVAVYSEADRDAPHTKAATEAYLIGESRVSESY
LNIERIIETAKKTNADAIHPGYGLLSENSRFAERCKQENIVFIGPAPDIIAKMGSKIEAR
KAMESAGVPVVPGVSESLGNIQAACRTASQIGYPVMMKASAGGGGIGMQLVQNEEALTKA
YEGNKKRAADFFGDGSMYIEKVIEHARHIEVQLLADQHGHTVHLFERDCSVQRRHQKVIE
EAPSPFVDDELRMKLGQTAVKAAKAIGYMNAGTIEFLVDSNQNFYFLEMNTRLQVEHPVT
EEITGLDLVEQQLRIAAGHTLAFSQQDIKRNGHAIEVRIYAEDPKTFYPSPGTITAFSLP
DQKEVRHECAVAKDSTVTPFYDPMIAKMIVKGQTRAEAIEKLETALRDYRVEGIKTNLPI
LIQAAGSKAFKEGDVTTDFLKQHL
>PK3-2_03341 Biotin/lipoyl attachment protein
MTVKIQMAGNLWKVHVKAGDHIEKGQEVAILESMKMEIPIVADRSGTVKEVKKHEGDFVN
EGDVLLELSDFTQ
>PK3-2_03342 Hydroxymethylglutaryl-CoA lyase YngG
MLYPKKVKIKEVGPRDGLQNEPVWITTEDKITWINQLSRTGVSYIEITSFVHPKWIPALR
DAIDVAKGINREKGVTYAALVPNQKGLENALEGGIEEACVFMSASETHNRKNINKSTAET
LHTLKQVSDDAKKANLSTRAYLSTVFGCPYEKNVPIEQVIRLSEALFEFGISELSLGDTI
GAANPVQVETVLEALLARFPANQIAMHFHDTRGTALANVVTALQMGITVFDGSAGGLGGC
PYAPGSSGNAATEDIVYMLEQMNIKTNVNLDKLLSAAKWIEEKMGKQLPSRNLKVFKSS
>PK3-2_03343 Short-chain-enoyl-CoA hydratase
MEEPILFTVQNDHIAVITLNRPQAANALSAEMLRSLQSILQEIEFNSNIRCVILTGTGEK
AFCAGADLKERIKLKEDQVLESVSLIQRTAALLEALPQPVIAVINGSALGGGLELALACD
LRIAAESAVLGLPETGLAIIPGAGGTQRLPRLISRGKAKELIFTGRRVTAQEAKEIGLIE
YVMASCDLMPKAEELAAAISANGPIAVRQAKFAINKGLETDLATGLAIEQKAYEHTIPTK
DRREGLQAFQEKRRAVYKGL
>PK3-2_03344 putative propionyl-CoA carboxylase beta chain 5
MDYEKERTERAEQIRKGGAEKYHQSNQEKGKLFVRERLALLFDDDIELEDAFFAECMSDG
LPADGVVTAIGKIGGRTVCIMANDSTVKAGSWGAKTVEKIIRIQETAEKLNCPLIYLVDS
AGARITDQINVFPGRRGAGRIFYNQVKLSGRIPQICLLFGPSAAGGAYIPAFCDIVVMVD
GNASMYLGSPRMAEMVIGEKVSLEEMGGARMHCSISGCGDILAETEEEAIRLARVYLSYF
PAHYQEKAPTQEKRPPKHFDIPLADVIPQNQNAPFDMHELIERVIDEGSFFEIKALFAPE
LITGLARIHGQPVGIVANQPKVKGGVLFHDSADKAAKFITLCDAFHIPLLFLADIPGFMI
GTKVEQAGIIRHGAKMISAMSEATVPKLSVIVRKAYGAGLYAMAGPAFEPDCCLALPTAQ
IAVMGPEAAVNAVYAKKIAELPKEERAHFISSKRQEYKEDINIYRLASEMIVDAVIPANS
LRGELAKRLKAYMTKEMTFTNRKHPVYPV
>PK3-2_03345 Oligoribonuclease NrnB
MYHLYSHNDLDGVGCGIVAKLAFGKKVEVRYNSVNGLNAQVQYFLEKAKESNRQDSLFIT
DLAVNEENEERLNEYVHAGGKVKLIDHHKTALHLNEHEWGFVQVEYDDGRLTSATSLLYG
YLVENGFMKSTNALDQFTELVRQYDTWEWERYDQKQAKRLNDLFFLLSIDEFEEKMIQRL
SAHDEFFFDDFEEKLLDLEDVKIERYLRRKKREMVQTFVHEHCVGIVHAESYHSELGNRL
GKENPHLDYIAILSMGSKRVSLRTIHDYIDVSEIAGRYGGGGHAKAAGCSITDEVYELFV
AEAFRIDPVRPDAFRNIYNLKESANGSLYENRAQMRFFLFPLDNEWNIQINGETQDETFA
AFEEAEWFIKRNYAASLVRDEVFVAFLAEHLKLANQHRR
>PK3-2_03346 hypothetical protein
MKNVGSLISEILTWLTNMGYAGIAIGLMIEIIPSEIVLAYGGYMVSEGTIGFIGAIIAGV
IGGTIAQIFIYWIGRYGGRPFLDKYGKYLLIKKHHIDMSENWFQKYGAGVVFSARFIPVV
RHAISIPAGIAKMPFPKFVVLTVLAIIPWSILFVYLGIQLGSQWDDVENIAGTYTTPIMI
LAIVVIALYFVIKKRAVIFKR
>PK3-2_03347 UTP--glucose-1-phosphate uridylyltransferase
MRKKVRKAVIPAAGFGTRFLPATKAQPKEMLPIVDKPAIQYIVEEAVESGIEDILIITGR
NKRSIEDHFDRSAELEFNLREKGKTETLKEMQQIADLANIHYIRQKEPLGLGHAVLCAEH
FIGDEPFAVLLGDDIMVSEKPALRQLMDVYDAYGTEVVGVQSVLHEEVSKYGIINTSGTH
GHVYEVKDVVEKPSPDEAPSEIAVMGRYVLNSSIFPVLKSIGRGAGNEIQLTDALREVCR
KQPIHARLVEGNRYDIGDKLGCFKASTEIGLMRPDMRSQLLAYLEDVIKRETKEMLR
>PK3-2_03348 hypothetical protein
MLKEKIKTLGRFCTVGVGNTLIDFGVFFLLTACHVPYLPAQICSYSAGVINSYVWNRSWT
FRVKRKAGGKEIVRFLMINIAASGITFLLLYLFQKGGCTLLVSKLAATIGGMMVNFIGNR
IWVFGDSLKNIQDQE
>PK3-2_03349 Malonyl CoA-acyl carrier protein transacylase
MNNLAFLFPGQGSQFVGMGKPFWNDFVLAKRLFEEASDAISFDIKKLCFNGDMNELTKTM
NAQPAILTVSVIAFQVYMQEIGIKPRFLAGHSLGEYSALVCAGALSFHDAVTLVRQRGIL
MQNADPQQQGTMAAVTQLSLQTLQEICSKVSTEECPADVACMNSDQQHVVSGHREAVERV
IRMAEEKGAKYTYLNVSAPFHSSMIRSASEQFQTVLHQYSFRDAAWPIISNVTAHPYSSG
NSIYEHLKQHMTMPVRWTESMHYLLLQGVTEVIEVGPNNVLSGLLKKITNHIAPYPLGQT
SDIHQLSNSAERNKLVVRLRKKQLNKLMIQTVIARNYNKDSLAYSNMTTPLFTQIHELKE
RMERLGDELSEQELEHSIHLCKLICKAKQLPAWEQLRILK
>PK3-2_03350 D-alanine--D-alanyl carrier protein ligase
MYTSQFQTLVDVIRERSNISDRGIRFIESDKNETVVSYRQLFDEAQGYLGYLQHIGIQPK
QEIVFQIQENKSFVVAFWACLLGGMIPVPISIGEDDDHKLKVWRIWNILNHPYLIASRKV
LNKIKKYAEEHDLHDFHQQLNGKSDIIQDQTYDYPASLYEPDADELAFIQFSSGSTGDPK
GVMLTHHNLIHNTCAIRNVLSIDSKDSFLSWMPLTHDMGLIAYHLVPFLVGINQHLMPTE
LFIRRPILWMKKAHEHKASILSSPNFGYNYFLKFLKNEPDWDLSHIRVIANGAEPILPEL
CDEFLTRCAAFNMKRSAILNVYGLAEASVGAASSKPEEEFVPVYLHRDYLNLGERAVNVS
KEDQNCASFVEVGQPIDYCQIRISDGANERVADGIIGHIEIKGDNVTQGYYNNPESTDKA
LTSDGWIKTGDLGFISKNGNLVVTGREKDIIFVNGKNVYPHDIERVAIEMKEVDLGRVAA
CGVYDQKTRNGDIVLFVVFKKSPEKFAPLVKEIKKHLYKRGGWSIKEVLPIRKLPKTTSG
KVKRYELARQYEAGNFSIESAAINQFLESSPEKSGQTPIHEIETELLSIFSHVLDGKKVH
LTDSYFDMGANSLQLSQIAERVEQKFGRELAVSDLFTYPSITDLAAYLSESRAEIKHDVT
AKPSHVTPKDIAIIGMSLNVPGASTKSDFWDLLEKGENAIREFPASRLKDAADYLKSIQS
EFNGNQFVKGGYLDEIDRFDYSFFGLAPKTAQFMDPNQRLFLQSAWHAIEDAGYAGDSMN
GSRVGVYAGYSKVGYDYERLLSANYPEELHQYIVGNLPSVLASRIAYFLNLKGPAVTVDT
ACSSSLAAVHMACKSLISGECEMALAGGIRTSLLPLRIGLDMESSDGYTKTFSKDSDGTG
SGEGAAAVLLKPLQDAVRDGDHIYGVIKGSAMNQDGTTAGITAPNPAAQTEIIETAWKDA
GIDPKTLSFIEAHGTGTKLGDPVEFNGLCKAFEKYTAKKQFCAIGSVKSNIGHLFEAAGI
VGLIKSVLMLNHKKNPPLAHFKEPNPLIHFHSSPFYINQEVAEFTPGDEPLRGGISSFGF
SGTNAHVVLEEYTSQSEYAPENENEPHLFVLSAHTKHSLYELTQQYRQYASDDSQASLKS
ICYTVSTGRAHLDHAIALIVSNKQELRDKLASVVQGDSHLPGVHMGYKNLKEMQPAHKEE
LNKQAADLIEQRIRTHDERITWLNRAAELFVQGAVIDWRALYAGETVQKTPLPLYPFERN
RCWAEADHLRLNKGEERGEAALNMNQTKAHIESFLKTVIGNASGIRADELDLNAHFIGLG
MDSIMLSQVKKAIADEFGVDIPMDRFFDTMNNLQSVIDYLAETAPSSFASAAPPQENVPA
QEKLAISEAQPESSHREDHQGHMLEKIIASQNQLIQDTLQAQLNSFNLLRNSGHSNVKEY
AKAQEKSIPSVKQGNPTVTAEKKLAQDAKPYVPFQPQNLHEQGHYTAQQRQYLADFIGKY
ADKTKGSKQYTDKTRFAHANNRNLSSFRSYWKEIVYPIIAERSDGSKMWDIDGNEYIDIT
MGFGVNLFGHHPSFITQVIDDSIRSSLPPLGPMSDVAGEVADRIRTCTGVERVAFYNSGT
EAVMVALRLARAATGRKKVVAFSGSYHGTFDGVLGLASTKGGAASANPLAPGILQSFMDD
LIILHYNNPDSLDVIRSLGDELAAVLVEPVQSRRPDLQPEAFLKELRAITQQSGTALIMD
EIITGFRIGLGGAQEWFGIQADLVTYGKIIGGGQPLGIVAGKAEFMNAIDGGTWQYGDDS
YPQDEAKRTFVAGTFNTHPLTMRMSLAVLRHLQTEGEHLYEQLNQKTASLVDQLNRYFEQ
SQVPIRMVQFGSLFRFVSSLDNDLFFYHLNYKGVYVWEGRNCFLSTAHSADDIEHIIQAV
KDTVKDLRRGGFIPEGPDSPDDGGHKESGNYEISPEQKQLVMASHYGNEASAALNQSIML
KVKGELQHTPLTQAVQHIVDRHEALRTVIHVDDEVQQVQERMNIEIPVIDFTGYPDEKRE
SEIQKWLTEDAKRPFHFHEQNPLFRIHVLTSAQDEHLIVLTFHHIIADGWSIAVFVQELE
SNYTAIVQRQSFPPKEAAASFRQYLDWQQAQIDSGHYEEGVRYWRDHFSEPTQQAVLPSA
ASARYPNGYEGDRCTVRLGRPLSEALKSLSIRMKNSVFVTMLGAFHLFLHQLTKQTGLVI
GIPAAGQSHMKQHDLIGNCVNMIPVKNTSSSESTLSGYLGSMKESVNHAMRHQAVPMTLV
ARQLPHDQVPDMRIIFNLDRPFRKLHFGKAEAEPIAYPVKCMLYDLFLNITDANQEYVLD
FDFNTNVISPEIMKKWGAGFTKLLQKMVEGGSVPLDAMMMFSNEEEDVLQELYADHQQRV
SSIVSKTANFSDAYEAPANETERQLAQIWEELFGLERVGRSDRFLDLGGNSLQATLMLSK
VQKTFHQKVSIGQFFNHQTVKELARFIENEKKVMHLPMKAAEKKAYYPTSSAQQRVYFLH
QMEPDQLAQNMFGQISIIGQYDEQALISSLQQVMQRHEAFRTYFDIIDGEIVQKLENEVD
FNVHVRTMSRDEFDTYADRFVKPFRLEQAPLVRAELIKIDNEQAELLIDMHHIISDGYSI
NILTNELLALYHRKPLPDIEFEYKDFTEWQNQWLNEDAMKQQETYWLEQFQDEIPVLQLP
TDDSKAAERSSEGQRVTCSLQPDVIRSLQDLAKKTETTLYTVLLAAYKVLLHKYTGQEDM
VVGTPASGRNHPDIENIIGIFIQTVGIRTKPRVNRTFTDYLEEVKRQTLDAFENQDYPFD
KLVEKLKVQRETTGKSLFNTMFVFQNIEFHEIRHNECTFKVRERNPGVSLYDLMLTVEDA
GQQIELHFDFKPGQFEKDTIEQITRHYTSILNSLAKQPEMTLSSIPMLSETELQQLLTEF
NDTKTPYPHNETVSRWFEMQAEQRPDHDAVIFGNERYTYRQLNERANQLARTLRTKGVQA
DQFVAIISPHCIELIVGILAVLKSGGAYVPIDPQYPEDRIQYMLSDSRAEIVLTQRCLLD
QLPYDGDVVLLDAENSYHEDRSNLDLFSNTHDLAYMIYTSGSTGNPKGVLIEHQGLANYI
WWAKEVYVKGEKTNFPLYSSISFDLTVTSIFTPLVTGNTIIIYDGEDKSEVLSAIMRDSR
IDMIKLTPAHLHVLKEMNVADGTAIRKMIVGGENLSTRLAKSVSEQFKGRLDIFNEYGPT
ETVVGCMIYRYDAKRDKREFVPIGTPAANTDIYVADASKNLVVIGVIGEMYISGPGVARG
YWNRPDLTAEKFVENPYIPGAKMYKSGDLAKRLKDGNLVYVGRIDEQVKIRGHRIELGEI
EAAMHNAEAVQKAAVTVREEEDGLKQLCAYYVSEKPIPAAQLREQLSLELPEYMVPSYFV
RLEHMPLTSNGKINRKVLPAPEASLQQTAEYVPPGNEVESKLTDLWKEVLGISHAGIKHN
FFDLGGNSIRAAALAARIHKELDVNLSLKDIFKFPTIEQLADKALHMEKNRYAPIPAAKE
MPYYPVSSAQRRMYLLSHAEGGELTYNMTGAMSVEGTVDPARLNAAFQKLIERHEALRTS
FELYEGEPAQRIHQTVEFTIEQIQASEEEAEARVLDFIQSFDLAKPPLMRAGLIELEPSR
HVLVVDMHHIISDGVSVNILMKDLSRLYEGYELDPLPVQYKDYAVWQQSDIQKRNIKSQE
AYWLNQFRDDIPVLDMPADYERPAIRDYEGESFEFVIPEHLKQRLRQMEENTGATLYMIL
LAAYSVLLSKYSGQEDIVVGTPSAGRTHLDVEAVVGMFVNTLVIRNHPAGRKTFDAYLNE
VKENMLNAYKNQDYPLEELIQDLQLSKDPSRNPLFDTMFVLQNLDHAELTFDSLELKPYQ
FHHPVAKFDLTLSIQSDQDNYHGLFEYSKKLFKKSRIEALSNDYLHILSVILEQPSILIE
QIELSGSNEEEENMLDSIQLNF
>PK3-2_03351 D-alanine--D-alanyl carrier protein ligase
MSVFKTQEMYWDNLFDEDDGLSAFPYFKAADNTSLSRTGYQEKCICRSLSPEVSQRIMTM
ANHSDMAAYLILLAGIECLLYKYTDRTSLILGIPTISKQKSSHSAVNTIVLLKNRLTSQS
TFKTVFEQLKEAVQDSLKNQNLPFRKMVRHLNVQYNDERMPLIHTIVSLNEIHSLQFKED
VATDTLFHFDLENDGIQLKLFYNGNLYDEGYMDQIAAHLDQLLSIILFQPQAAIHTAEVV
PETEKQKLLFDFNDTGADYSGSRTVYQLFEEQAQRTPEHAAVKFKNSHLTYRELNEKASR
LARTLRNCGVQADTLVAILADRSLEMIVSIIAIWKAGGAYVPLDPEYPKERLQYLLHDAN
ADVLLVQRHFKNSLTFDGPTIDLNDESSYHTDCSLLSPVAEHNHLAYVIYTSGTTGLPKG
VMVEHGGIVNSLQWKKAFFKHSAKDRVLVLYPYVFDAFILNFFSPLISGATLHLLPNEEN
KDLFAIQNTMKQERITHFSTSPRLLKTMIEQMNAEDFIHVQHVVVGGEQLEIDTVEKLYS
LQPHVQINNEYGPTENSVVSTFHPVQSADEQITIGKPVANHQAYILGAHLQIQPIGVPGE
LYVGGAGVARGYLNQPVLTEEKFVQHVHLPGQKMYKTGDLARWLPDGRIEYLGRIDHQVK
IRGYRIEIGEVEAAIFNLEKVREAAVVAREDEDGAKQLYAYYVGEPSLTAAQFRDDLSRK
LPDYMIPSYFIHLEHIPLTSNGKIDLKALPASEEKTRMDNEYIAPRNPTEELLASIWQEV
LGAERIGILDNFFDFGGDSIKSIQVSSRLYQAGYKVDMKHLFKYPAIADLSQFVAPVGRK
ADQEEVNGRTNLTPIQHWFFEQKMPNAHHYNQAVMLYSAEGFKEDPLRRTMERVASHHDA
LRMIFEKTPNGYAPRITGTDESELYHLDVMNYKGETDPAQAIADKANEIQSSMVLDQGPL
MKLGLFQCPDGDHLLIAIHHLVIDGVSWRILLEDFASGYEQAEHGQTIQLPQKTDSFPFW
ADQLSKYAAETDIEQEIAYWADLTSIKPQSLPKDNISEGSLLRDSEEVKIQWTKEETEQL
LKHANRAYNTEINDLLLTSLGLAVHRWTGIEDIVVNVEGHGREPIIPDADISRTIGWFTS
QYPVVLKMEAGKDLSQRIKSVKEGLRRIPDKGMNYSIVKYVSGRPEAGSLQLNPEISFNY
LGQFDQDLKHQAFRISPFSTGLSMNENQERTAVLDLNGMIAEGKLSLTLSYSNKQYERST
MAKFARSLKESLQEVIAHCVSRQQTTLTPSDILLKDITIDELEQLLEQTSELGETENIYP
LTPMQKGMLFHSLFDPSSGAYFQQTMFDLHGDLNIASFSKSLDSLSKKYDIFRTNFYRGW
KDQPLQIIFKTKKIGFEFIDLREMKESHKKEMIQEYVRKDKMRGFDLEKDALMRLLILRT
DEKAYRFIWSFHHILMDGWCLPLITKEIFEHYFALLQQKQPEQSAITPYSQYIEWLGRQD
AKEAMGYWDQYLAGYEEQTILPKDCHAAEERYIPDKVTCDISSDLTLKMKQTAGRRHVTL
NTLLQTAWAVLLQKYNRSRDVVFGSVVSGRPAGIPNVETMIGLFINTIPVRFRCEAGTTF
AELMKEAQERAVASQQFETHPLYDIQARTTQKQNLITHLMIFENYPVDQYMESIGRQNGS
SITISNVQMEEQTNYDFNLTVIPGDEMSISFEYNATVYDRASIERVREHFMQILQQVVTD
ADIQVDQVELLTEGEKRTLLHTLNDTAAPFPQTPVYQLFEKQSQRTPDQAAVIDRDRQLT
YGELNKRANQLARTLRAKGAQADHPVAVISRNSIESVVGILAVLKSGGAYVPIDPEYPQD
RIRYMLDDSQAGIVLMQQDVREQLAYEGDTVLLDDESSYHQDDSDLAPISEASHLAYVIY
TSGSTGRPKGVLIEHRGLTNYIWWAKEVYVKGEKTNFPLYSSISFDLTVTSIFTPLVTGN
TIIVYDGEDKTALLASIVQDPRVDIIKLTPAHLQVLKEMNIADKTAVRRMIVGGENLSTR
LAKSIHEQFEGKIEICNEYGPTETVVGCMIYRYDAVKDRRESVPIGTAAANMSIYVLDEN
MKPAPVGVPGEIYISGAGVARGYLNRPELTAEKFVDDPFASGAKMYKTGDLAKWLADGNI
EYAGRIDEQVKIRGYRIELGEIEAALLQEEAIKKAVVTAREDVHGFKQLCAYYVSGGQIT
GSRLRKHLSHCLASYMIPAYFIELDEMPLTSNGKINKKALPAPDFELQDRAEYKAPRTNV
EEILVSAWEAVLGAENVSILDNFFDLGGDSIKSIQVSSRLNQNGYKMEIKDLFQYATIAE
LTPHIKQNLRIADQGEVKGKVSLTPIQHWFFDHITIDPHYYNQAVMLYAPEGFQETPLRQ
TLQKLAEHHDALRMTFQQTENGYEAQNAEIAQSGLYHLEVLNLKAESDPGQTIEAKANEI
QGSMRLSDGPLMKIGLFQCADGDHLLIAIHHLIVDGVSWRILLEDIVSGYRQAENGQVIQ
LPQKTDSFQLWAKRLSEYAQSETIKQEQEYWTKIEQTHVKPLPKDFHETHTTSKDSETET
VEWTKEETELLLKQANRAYNTEINDLLLTSLGLSISHWSGLEQIPIHLEGHGREQMSQDM
DVSRTVGWFTSLYPVVLHAQSGKEISDYIKLTKEGLRHIPHKGIGYGIARYLSGAMPSKL
NPEICFNYLGQFDQDLQQHAIQLSPYSCGSDSSGNQERSYVLNINGMITEGRMRFTISYS
SKQYTKETIKRLSETIQSRLRTIITHCVHKEQSELTPSDILLKGMSIDELDQLLVQLPHA
GEIENVYPLTPMQKGMLFHSLLDEDSHSYFEQASFDLQGELKIDCFKASLERLFETYAVF
RTRFYSGWNDTPLQIVYKTQKPQIHFADFRDIEEHLREDAIAAYQREDKAKGFDLARDSL
MRIAIIRMEDSKYHLIWSFHHIVMDGWCLSLITKEVFEYYNALQEGRETELPSVAHYSDY
IEWLHLQDQGAAKRYWSEYLDGYKGETRLLHKRPKHEQKAYAYANVTCELDQEQTKQLQQ
IANQHQVTLNSLIQTLWGILLQKYSGSQDVVFGSVVSGRPAEIPGVEQMIGLFINTIPVR
IRCEEDSSFADTMQMVQQNALASQAYDTFPLYEIQAQTEQKQNLIDHIMIFENYPIGQQV
EEASRYDTELNVMNFHMQEHSHYDLNVVVIPGKQLAVHFGFNENEYEKSQVERICGHFEQ
LMQQVLKQPSVKIDELELLTQREKEDLLSHFQSVGKKYQREQTIHEWFEEQAHRTPDHTA
VVFEGNQLSYGELNRRANQLARTLQAKGVQSDQLVGIMTERSLEMIVGILGVLKAGGAYL
PIDPDSPPERVRYIFSDSGISVLLYRGKLQDNICFSGTCIDLMEEHAYHEKDSGLALSYQ
SSQLAYAIYTSGTTGKPKGTLIEHRQVIHLIEGLSSQVYSAYDAELNVAMLAPYNFDASV
QQMYASLLLGHTLFIVPKDVVSDGAALCRYYRQHCIDITDGTPAHLKLLIAAGDLQGVPL
QHLLIGGEALSKTTVNKFVQVFGKPGDAPAISNVYGPTETCVDASLFNIEFSAEAWARSQ
IHVPIGKPLGSNRMYILDSKKRLQPAGVQGELYIAGDGVGRGYLNLPELTDEKFSADPFV
STDRMYRTGDLARLMPDGNIEFIGRIDHQVKIHGFRIELGEIESVMLNIPDIQEAAAIAL
KDADGDYFLCGYYTADKPIQISELRESMARHLPGYMIPAHFVQLDKMPLTPNGKLNRQLL
PAPVKNRDKGIEYVLPQTPAEIQLTAIWQDVLGLEQVGIRDHFFDIGGHSLRATALIAKI
QKQMHVQIPLRDVFRFPTIEQLAREITTMEQTGYAGIPAIEKRPYYPVSSAQKRLYILNH
LEGGELSYNMLGLMAVEGKLDRDKLQQAFLTMIQRHESLRTGFKMAGGEPVQYVLDHAEF
EAEWYQAEENDADLYIRQFIRPFDLEKPPLLRVGLIELQPDRGILLFDMHHIISDGTSMS
VLIKEFIRIYEGETLPPLRIQYKDYAVWQTGQARLKQIQNQEAYWLELYSGDVPVLHMPT
DYKRPSARDFAGATMHFTLDKQKSEGLKQLASQTESTLYMVLLASYTLLLSKYSGQEDII
VGSPIAGRPHADLEPIIGMFVNTLAMRNHPEKGKTFTQYLAEVKENALKAYEHQDYPFEA
LVDQLDIARDLSRNPLFDTMFVLQNTEQEKLEINDVTFKPYPSEHTMAKFDLTLTAVEEE
SGIHFTMEYLTALFKPETIERMMGHFVQLIDSVIKQPEAELASVDMMTQEEISEIQKLFN
DTATAEKRNPAAIHQLFEQQAALNPDHEAVIFGNQTLTYRQLNERSNQLARILQDKGVGT
DQVVAVLTDRSANMIIGILAILKAGGAFLPIDPELPDERRAFLIKDSGASVLLTSAGHII
PLLFKGEVLLLDDPLLYQGGTDNLNLSYSENDLMYVIYTSGTTGKPKGVQLEHKTMTNLL
AYEQGHTRLRFDRVLQFAAMSFDVCYQEMFSALSSGGTLCIISNEAKREIRQLNEFVKMH
RIQTAFLPTAFLKLLASEKHHFEPFAECVDHIIAAGEQLIVTSMLRDMLARHHVTLHNHY
GPSETHVVTMYTVDPDTEQELQPIGKPISNTEIFISNEAGTLQPVGIVGELCISGVSLAR
GYHNRELLTLETFVPHPYDPNQRMYKTGDLARYLPDGNIEYAGRMDHQVKIRGYRIELGE
PEAALLEHVQEAVVLARENEDGQSDLYAYFTAEQSLSISQLKENLAEQIPGYMIPSYFIQ
LEKLPLTSNGKVNRRALPMPEASLQTGIDYVAPRTSMEKQLIGIWRDILKIKEIGVKDNF
FDLGGHSLRGMTLIAKIHQQFSKNISLREVFQCPTVEEMAQAIAKAKDIRPDYIPAAKEK
DVYAVSSVQKMVYLSTQIEGGELSYNMPGVLTLEGKIDIDRLQTAFQKLIYRHESLRTGF
EMIHGEPVQVIKPQVEFSMERYKAAPDEVEELFRAFVRPFDLSQAPLLRAGLIELEQDRH
VFMFDMHHIITDGASMNIFVEELIQLYGGKDLAPLRIQYKDFTEWKHQKEQRERIKRQEE
YWLGVFHEELPSFELPKDFARPPVRSFDGKRHNFVLDKTVIQGVKQLEDLTGSTAYMILF
SAYSILLAKYSGQDDIVIGTPIAGRMHEDLQHLIGMFVNTLAIRTAPMPEKTFMDYITET
KETMLKAYENQEYPFEELVEKLGVKRDLSRNPLFDTMFVLQNTEQTDIEVDSLAVKSYEQ
TNTTAKFDLQLNFVMDQDEIQGSFDYCTKLFKKKTIAVMAKDYVMILSAILRNPSIPLKE
IQLSEKVNKRKHLASTIELDF
>PK3-2_03352 Linear gramicidin synthase subunit D
MSEFKQQELFWGRMFHTEDRPSAFPSFQMSDSTLKRDVSSASDCIHSSLSSDVSRRILTM
TNQTPMAVYLVLLIGVESLLYKYTGEESVITGVPTFEDETDEDLRLDQLMLIKQNINADS
TFKSIFHELKHMLDEAILYQDVPFDKMAGQLRLNYNTNHLPIIHTVVSLEQIHSDRFIET
AASDALFQFAMREDTIDVKLFFNEQAYDREYMLQVIRHLNRLFSIMLFQPDLTLGQVDIL
SEAETNTFLADYHHTKTEYPRDKTIYQLFEAQVKRTPDQPAIILGEKQFTYHQLNERANQ
LARTLRAKGVRADRLTAVISEHSIELVVGILAVFKAGGAYVPIDPDYPKHRIQYIVEDSQ
ADIILTESHLRKQLDMAGTMVFIDDESSYHEDGSDLEPISSTKDMAYVIYTSGSTGKPKG
VAIEHQGLTNYIWWARRVYVKGEKTNFPLYSSIAFDLTVTSIFTPLITGNAIIVYRGENK
VALLDSIVHDSRVDIIKLTPAHLQLLKEMNIPPECTIRKFIVGGDNLSTRLARNVSGQFG
GRIEIFNEYGPTETVVGCMIHSFDQQNDRRESVPIGAPADNMNIYVLDKSMKPVPIGVPG
EIYISGDGIAREYLNRPELTAERFLRNPFVQEAKMYRTGDLARRLADGNIEYLGRIDHQV
KIRGYRIEIGEVETALFQIPPIQEALVIAQETNGETTLCAYFTALHSLTAGEIREHLSRQ
LPAYMIPAYFIQLTAMPLTSNGKIDRQALPASTGNLTGNTYTAPRTELEKILAGVWESVL
GAERVGINDHFFELGGDSIKSIQVTSSLYQSGYKLDIKHLFKHPTISGVVPFIEPVTQIA
EQGEIKGPTLLTPIQHWFFAQQYPDPHHYNQSVMLYFKEGLDESKLRGVMKKIAEHHDAL
RMVYVPTDHGYEARNRGIDEGDLFSLEVFSLLEEINPAQTIESISNDIQQSIHLAEGPLM
KLGLFQCQDGDHLLIAIHHLVVDGVSWRILLEDITLAYEQLKNGEAITLPKKTDSYLLWA
ERLKRYAESADFEAENQYWFGQLHIPQHKLPKDNEQESGIAEDREIIIVQWTEAETECLL
KKSNRAYTTDINDLLLTGLCTAVHRWTGHEEILVHLEGHGRESIFQDLDISRTVGWFTSQ
YPVSLQIQADQDISQRIRTVKEQLRQIPQKGIGYGLIKYFSDHPKASDLTVHPEISFNYL
GQFDQDFENGGIEVSPYSGGKIASDRHPIAYTLDINGMISDGRLSLAISYSGKQYRRETM
ETCAAFLKNSLKEVIDHCTAQKQIQLTPSDISLKDITIAELDQFAQQTKHIGDIENIYPL
TPMQKGMLFHSLIDAASRAYFEQASFDLKGDLDIEAFTMSLSQLADRHEILRTHFYTEWK
DQPLQIVLREKPIEITVEDIRNMEDEQRGKLIADFVQKDKERGFDLTRDALMRVSILRTD
DDQARLIWSFHHILMDGWCLPLVTKEVFETYYELLDRRKPEREAVTPYSRYIEWLEDQDH
NNASAYWKKYLDGYEGQTVLLKEPVSNQAEGYQKQRLACRLGKQLSEEIRQTASKHHVTV
NTFIQSAWGLLLQRYNNSQDVVFGSVVSGRPAEIPGIESMVGLFINTIPVRITAQPEMTV
EQVLKMSQEQALASQAYDTFPLYEIQAQTEQKQQLISHIMVFENYPVEKQMEHMKPNRDA
LDIINFHVEEHTHYDFNFIVMPAGNIEIHFVYNGNVYEHTSVKRMEEHFMQIIKQMVNSQ
AIRVQDLDILTADERSLLIEACNDTAANYPKEKTLYQLFEEQAERTPAQVAIVFGDEKLT
YRQLNERANQLARTLRAKGVRADLLTAIISELSIDLVVGILAVLKAGGAYVPIDPDYPKH
RIQYILEDSKAEIVLTQYHLRQRFTHAGTIVLLDEESSYHEEHSNLERISDAKDLAYVIY
TSGSTGMPKGVLIEHRGLTNYIWWADSVYVKGEKTNFPLYSSIAFDLTVTSIFTPLVSGN
AIIVFGGEDRAALLSSIVQDSRVDIIKLTPAHLQLLNEMDIHHECRIRKLIVGGDNLSVS
LARSISERFQDQIEIFNEYGPTETVVGCMIYSFDPQKDRRESVPIGTAAANMNIYVLDGG
MKPVPIGVPGEIYISGAGIARGYLNRPELTAEKFVEHPFAAGEKMYKTGDVARWLPDGNI
EYVGRMDHQVKIRGYRIEIGEVEAVLLQLESVKEAVVIAIEEEGSKQLCAYLTGDESLHT
AQLKRHLLNKLPAYMIPAYFVQVEKMPITANGKIDRKALPAPEGNRLTGTEYAAPETLIE
KQLTEIWKNILGLTDPGIKDNFFDAGGHSLKVLQLIHQINAGMGLNMHYQAVYDFPTIET
MARAIQAAVFESKTDNVFVKLNQEDSIPVFCFPPLIGYGLVYNEMAKRLDGSCTVYAADF
LEEPSYEKEIVDLYAESMIGIQEQGPFVLLGYSSGSNLAFEVAKALEKRERVVSDVIMLD
SKITVSVTHSSETEIEEIVHLNMDIIPDYYRDILTIPSIKDKIRSYLAYHNELINSGAVN
SNIHHLLCGDLTDRGWTQSTVQHYLEYKLKGDHVTIFEPHNIEENVEAIRSIIKRIEERH
HQGLVLDEQLSMGSFAGDAKFDKM
>PK3-2_03353 Arabinoxylan arabinofuranohydrolase
MSKKCCVCLWVLALLLSCFTGKSAYAASTTIAKHAGNSNPLIDHHLGADPFALTYNGRVY
IYMSSDDYEYNSDGTIKDNSFANLNKIFVISSADMVNWTDHGAIPVAGANGANGGRGIAK
WAGASWAPSAAVKKINGKDKFFLYFANGGGGIGVLTADSPTGPWTDPIGKALVTPNTPGM
SGVVWLFDPAVFVDDDGAGYLYAGGGVPGGSNPTQGQWANPKTARVMKLGPDMTSVAGSA
STIDAPFMFEDSGMHKYNGKYYYSYCINFGGAHPADKPPGEIGYMTSSSPMDSFSYRGHF
LKNPGAFFGGGGNNHHAVFNFKNEWYVVYHTQTVSSALYGAGKGYRSPHINKLVHNPDGS
LQEVAANFAGVKQLSNLNPYNRVEAETFAWNGRILTEASSAPGGPVNNQHVTNIHNGDWI
AVGNADFGSGGARTFKANVASAGGGKIEVRLDSVNGKLAGTLNVPPTGGTQNWREIETAV
SGATGVHNVFFVFTGTGTGNLFNVDYWQFTQR
>PK3-2_03354 Glucuronoxylanase XynC
MMSSVKKTICLLLVCFTMLSVMLMGPGAAEVLAANDVTVNISAEKQVIRGFGGMNHPAWV
GDLTAAQRETAFGNGQNQLGFSILRIHVDENRNNWYKEVETAKSAIKHGAIVFASPWNPP
SNMVETFNHNGDTSAKRLRYDKYAAYAQHLNDFVTFMKSNGVNLYAISIQNEPDYAHEWT
WWTPQEILRFMRENAGSINARVIAPESFQYLKNLSDPILNDPQALANMDILGTHLYGTQV
SQFPYPLFKQKGAGKDLWMTEVYYPNSDNNSADRWPEALDVSQHIHNSMVEGDFQAYVWW
YIRRSYGPMKEDGTISKRGYNMAHFSKFVRPGYVRIDATKNPNPNVYVSAYKGDNKVVIV
AINKSNTGVNQNFVLQNGSASQVSRWITSSNSNLQPGTNLNVTDNHFWAHLPAQSVTTFV
VNR
>PK3-2_03355 hypothetical protein
MARNRFHEKPDIDPKSLETSQWPKVLAETFLYIPDNILLKI
>PK3-2_03356 hypothetical protein
MKTYDAFPEPIGGYTVGRTQMDFEYKASDHSKRELTAFMYYPSDSSEGKTPSTYMFPEVY
EMLHDQPLVTEYLKEKDFFSIDIKTHCYDDLALSGKEKRYPVLFYVCGGGGSPEWGTVIC
TDLASMGYVVVSIGHQNSTMYKRKDGRLFNVSKDFSDVIMAFSEDQEMRALAGKMEMRPD
DETAIEMCRNVLQLPILDKLTEYSELQAEDVRYVANYLYKLDSGELNSIFKRRLLLDIGM
GIVGHSYGGPTTAIVCRDDDRFACGIGLDSGAFGLLDSDLKKPFLLLFCEPNYNMNAIIG
ANNSMETYYFSVDRVAHLDYCDIVFTSAYEELRGERDAMEMRNLVTDYTKNFFNHYILQK
AASVENLAYDGVDLIKKTSNKVT
>PK3-2_03357 hypothetical protein
MGNRTQLVKILADISNDVRFHHVIQQNEEVYVVDEALKQYMMLFKEMNHVINGPDYPGKE
KDIQHQKEQIDAYGTQLQQGFSTDYDYDVFADSVIKCAYGDMTLEDLEAVYYGLTTPFFD
STQ
>PK3-2_03358 Endoglucanase
MMSNMKRSISIFITCVLSAVLTIGGLLGSTASAAGAKTPVSMNGQLSLKGTQLVNQDGKA
VQLKGISSHGLQWYGDFVNKDSLKWLRDDWGITVFRAAMYTADGGYIDNPSVKNKVKEAV
EAAKELGIYVIIDWHILNDGNPNQNKEKAKEFFKEMSSLYGSTPNVIYEIANEPNGDVNW
KRDIKPYAEEVISVIRKNDPDNIIIVGTGTWSQDVNDAADDQLKDANVMYALHFYAGTHG
QSLRDKANYALSKGAPIFVTEWGTSDASGNGGVFLDQSREWLNYLKSKKISWVNWNLSDK
QESSSALKPGASKTGGWPLSDLSASGTFVRENILGTKDSTKDSPETPAQDQPEQKNSISV
QYRAGDGSVNGNQIHPQLHIKNNGKTTVDLKDVTVRYWYNAKNKGQNFDCDYAQIGCGNV
THKFVTLHKPKQGADTYLELGFKNGTLSPGESTGEIQLRLHNDDWSNYAQSGDYSFFKSN
TFKTTKKITLYNHGKLIWGTEPN
>PK3-2_03359 Amino-acid carrier protein AlsT
MEAFFNSLINIPSDFIWKYLFYILIGLGLFFTIRFGFIQFRYFIEMFRIVGEKPEGNKGV
SSMQAFFISAASRVGTGNLTGVALAIATGGPGAVFWMWVVAAVGMASSFVESTLAQLYKV
RDGEDFRGGPAYYIQKGLGVRWLGIVFAVLITVSFGLIFNAVQSNTIAGALEGAFHVNKT
VVAIILAVLTAFIIFGGLKRVVAVTQLIVPVMAGLYILIALYVVFTNISAFPSVIATIVK
NALGIEQVVGGGLGAIIVIGAQRGLFSNEAGMGSAPNAAATAHVSHPAKQGFIQTLGVFF
DTFIVCTSTAFIILLYSVTPKGDGIQVTQAALNHHIGGWAPTFIAVAMFLFAFSSVVGNY
YYGETNIEFIKTSKTWLNIYRIAVIAMVVYGCVAGFQIVWDMADLFMGIMALINLIVIAL
LSNVAYKVYKDYAKQRKQGLDPVFKAKNIPGLKNAETWEDEKQEA
>PK3-2_03360 hypothetical protein
MKKVTILKASILFLAIASFHLFSIPHAFDIGHHYKAVADQQEMHEMKAGQNADDEKKSII
GAFALTALWAMAVLLLTAESKSTGYTRRRQRKKSFILAKFYQSSYFGKLHVQHHPII
>PK3-2_03361 hypothetical protein
MLFILRMVILGLFSFTALNLFVWQGIEVIHAVTDLFTNHES
>PK3-2_03362 DNA topoisomerase 4 subunit A
MSQPELFHDLPLEEVIGDRFGRYSKYIIQDRALPDARDGLKPVQRRILYAMHTDGNTFDK
NFRKAAKTVGNVIGNYHPHGDSSVYEAMVRMSQDWKVRNVLIEMHGNNGSIDGDPPAAMR
YTEARLSPIASELLRDIDKNTVEFVPNFDDTSKEPVVLPAMFPNLLVNGSTGISAGYATD
IPPHHLGEVIDAVIKRIQMPSCSVDELMEVIKGPDFPTGGIIQGVDGIKKAYETGKGKII
IRGKAEIEGIRGGREQIVITEIPFEVNKANLVKKMDEYRIDKKVEGISEVRDETDRTGLR
VVIELKKEADAKGILNFLYKNTDLQVTYNFNMVAIHNRRPMLMSLPSILDAYIGHQKEVV
TNRSVYELQKAKDRHHIVEGLMKALSILDEVIATIRSSSDKRDAKNNLIAKYDFTEPQAE
AIVSLQLYRLTNTDITALKEEAEELGKKIEELESILSNDKKLLKVITNSLKALKKKYADA
RRSVIEEKIEEIKINLEVMVASEDVYVTVTKDGYLKRTSQRSFAASNGQDFGMKDTDRML
HQFEMNTTDVLLLFTNKGSYIYCPVHQLPDIRWKDMGQHFSNIITIDRDETIVKAIPIKE
FDPSAYLLFFTKNGMVKKTELTHYKAQRYSKALVALNLKGEDELIDVHVTNGESQIFMAT
HLGYGLWFGEDEVNVVGARAAGVKGINLKEDDFVVSGDILQQSDSIVLFTQRGAVKRMSL
SEFEKTSRAKRGVVMLRELKKNPHRVVGLFACGLEQRLMAETEKGDRKELQAKDLRTNDR
YSNGSFFIDEEESGKVTAVWRVHTEQ
>PK3-2_03363 DNA topoisomerase 4 subunit B
MYLVEGDSAGGSAKQGRDRRFQAVLPLRGKVINTEKAKLADIFKNEEINTIIHAIGGGVG
ADFSIEDINYDKIIIMTDADTDGAHIQVLLLTFFYRYMKPLIEHGKVFIALPPLYKVSKG
SGKKEIIEYAWSDEEMDDVLKKVGKGYTIQRYKGLGEMNADQLWETTMNPESRTLVRVKI
DDAARVERRVTTLMGDKVEPRRKWIEKNVAFGLDEESNILENENLSVAEEV
>PK3-2_03364 DNA topoisomerase 4 subunit B
MARKQQFDYNEDAIQVLEGLEAVRKRPGMYIGSTDARGLHHLVYEIVDNSVDEVLAGHGD
HIIVKIHKDNSISVQDRGRGMPTGMHKLGKPTPEVILTVLHAGGKFGQGGYKTSGGLHGV
GASVVNALSEWLTVTIERDGFVYQQRFENGGKPVTSLEKIGKTKKTGTLTHFKPDPTMFS
TTTYNFETLSERLRESAFLLKGLKIELIDERNDQREVFYYENGIEAFVAYLNEEKDALSE
VVSFEGEHHSIEVDFAFQFNDGYSENILSFVNNVRTKDGGTHESGAKTAMTRAFNEYARK
VALLKEKDKNLEGTDIREGLSAIISVRIPEELLQFEGQTKGKLGTSEARSAVDAIVSEQL
AYFLEENRDTATLLVKKAIKASQAREAARKAREEARSGKKRKNQKLH
>PK3-2_03365 putative protein YccU
MQNPSKAEMKEILDKSKRIAVVGLSDRPDRTSYMVSKAMQDAGYEIIPVNPTIDEALGVK
AVSSLQEIDGPIDIVNVFRRSEQLPGVAEEFLKTDAPVFWAQQGLANEEAYQMLKEKGRT
VIMDLCIKVAHAVTK
>PK3-2_03366 Glycerol-3-phosphate acyltransferase
MLIALLIILAYLIGSIPSGLIVGKLAKGIDIREHGSGNLGATNAFRTLGVKAGSIVIAGD
ILKGTLATALPFLMHVDIHPLLAGVFAVLGHVFPVFAKFKGGKAVATSGGVLLFYAPLLF
ITMVAVFFIFLYLTKFVSLSSMLTGIYTVIYSLFVHDKYLLIVVTLLTIFVIYRHRANIK
RIINKTEPKVKWL
>PK3-2_03367 putative protein
MNMTINEDALKWYKEELDLESGDQVRFFVRYGGCSNVQKGFSLGVAKDAPQEAGVTAEAD
GITFFIEESDLWYFDNHDLLVSFSEDADEPVFEYQ
>PK3-2_03368 hypothetical protein
MAFGVKREELNRWKQAVKRGEIAFLTHYWLDDRFPEAKTVTKAGCADIDKLIQWGAAYGL
QKEWIHKKSEYPHFDLLGETQKYILEQENLTDHLIRFHL
>PK3-2_03369 1,4-dihydroxy-2-naphthoyl-CoA hydrolase
MHVSKKEIEVRYAETDQMGIVYHANYLVWMEVGRTALIQDLGFLYSDMEKKGVLSPVVDI
NISYKKPLHYGETATVHTWIEEYNGFKTVYGYHIYNPAGELSIEATSSHICVDKESFKPI
QFRKAFPDWHAAYEKARK
>PK3-2_03370 Small, acid-soluble spore protein Tlp
MTKNQNQYQQPNPDDRSDNVEKLQDMVQNTIENIEEAEASMEFASGEDKQRIKEKNARRE
QSIEAFRNEIQDESAARQNGYRS
>PK3-2_03371 Small, acid-soluble spore protein N
MGNNKKNGQPQYAPSHLGTKPVKYKANKGEKMHDTSGQQPIIMQTKGE
>PK3-2_03372 Thiol-disulfide oxidoreductase ResA
MLKKWLAGIVLIILAGYMGWNLYETYSKKEIGIEEGQQAPDFSLKTLSGKESSLQDSKGK
KVLLNFWATWCKPCRQEMPAMEQLQKEHPDKLAVVAVNFTSAEKSEKQVQAFADAYDLTF
PILLDKKGINADYNVMSYPTTYILDEKGVIQDIHIGTMTKKEMEQKLDLD
>PK3-2_03373 Aconitate/2-methylaconitate hydratase
MENLAKWGTAELKEIDVPFKPSRVILQDFTGVPAVVDLASLRKAMAAVGGDPDKINPEIP
VDLVIDHSVQVDKAGTEDALAINMDLEFERNAERYKFLSWAKKAFNNYQAVPPATGIVHQ
VNLEFLASVVHAIEEDGELVTYPDTLVGTDSHTTMINGIGVLGWGVGGIEAEAGMLGQPS
YFPVPEVIGAKLVGKLPNGTTATDLALKVTQVLREKGVVGKFVEFFGPGVAELPLADRAT
IANMAPEYGATCGFFPVDEEALNYLRLTGRDPEHIDVVEAYCRSNGLFYTPDAEDPQFTD
VVEIDLSQIEANLSGPKRPQDLIPLSAMQETFKKHLVSPAGNQGFGLNAEEEEKEIKFKL
LNGEETVMKTGAIAIAAITSCTNTSNPYVLIGAGLVAKKAVELGLKVPNYVKTSLAPGSK
VVTGYLVNSGLLPYMKELGFNLVGYGCTTCIGNSGPLSPEIEEAVAKNDLLITSVLSGNR
NFEGRIHPLVKGNYLASPPLVVAYALAGTVNINLKTDPIGVGKDGQNVYFNDIWPSMDEI
NSLVKQTVTPELFRKEYETVFDDNKRWNEIETTDEALYKWDNESTYIQNPPFFEEMSVEP
GKVEPLKGLRVVGKFGDSVTTDHISPAGAIGKDTPAGKYLQEKGVSPRDFNSYGSRRGNH
EVMMRGTFANIRIKNQIAPGTEGGFTTYWPTGEVTSIYDACMRYKEDKTGLVVLAGKDYG
MGSSRDWAAKGTNLLGIRTVIAESFERIHRSNLVFMGVLPLQFKQGENAETLGLTGKEVI
EVDVDESVRPRDIVTVRAIDEDGNVTTFEALVRFDSEVEIDYYRHGGILQMVLREKMKQS
>PK3-2_03374 Aconitate/2-methylaconitate hydratase
MANEQKTAAKDVFQARKTFTTNGKTYHYYSLKALEDSGIGKVSKLPYSIKVLLESVLRQV
DGFVIKKNTWKIWQSGELPN
>PK3-2_03375 Small, acid-soluble spore protein O
MMVKRKANHVINGMNDAKSQGKGAGYVENDQLVLTEAERQNNKKRKTNQ
>PK3-2_03376 Small, acid-soluble spore protein P
MTNKNTSKDMHKNAPKGHNPGQPEPLSGSKKVKNRNHTRQKHNSSHDM
>PK3-2_03377 Spore coat protein M
MTHSKRDDANDFDSMDEWLRQFFEDPFAWYDETLPIDLYETSQQYIIEADLTILQPTQVT
VTLSGCEFILTVKSSGQTFEKQMMLPFTLNDKSIQTECENQILTVAVNKDTKDGSSFSLQ
FPLS
>PK3-2_03378 hypothetical protein
MLEGWFLWFILFWVITMVVLLSIGGFFMFRKFLKRLPKEDGRSELDWQDYYIENSRHLWS
NENKEFLNELVSPVPELFRDAAKAKIAGKIGELALKEKVSKIDQQLMIKGYILATPKRDH
TFLKRHLRDKQIDLEPYQTLLK
>PK3-2_03379 hypothetical protein
MMIIVSSIIAVLMAVTVMVVRIKSSDKPVSPRKIILPPIFMSTGALMFLFPVFWVTGTEF
LEAITLGVIFSIFLIKTSKFEIKNNEIYMKRSKAFVFILVGLLVIRIVMKSILSTSIDYG
ALSGMFWILAFGMIVPWRIAMYLSYRKLHNELQSANIQMN
>PK3-2_03380 Chemotaxis protein CheY
MTRVLVVDDAKFMRVKIREILEEANYIIAGEAADGEQAADLYKKLRPDIVTMDITMPVKN
GIKALRDILTFDPKAKVIMCTAMRQQRIVAEAIELGAKDFIVKPFEETKVLEAVSRVIGN
>PK3-2_03381 hypothetical protein
MGDMNYFLTFGAGFLSFISPCCLPLYPAFLSYITGVSIDDVKTEKLLLQKRSLFHTLCFL
LGFSIIFIALGYGTSFIGSLFRDYHDAIRQIGALLIILFGFITLGVFRPEAIMKERRIHF
KHKPSGFFGSVLIGMAFAAGWTPCTGPILAAVITLAGTNPGSAVPYMMLYVLGFAVPFLL
LSFFITKLKWIRKNQLLIMKAGGVLMIVIGVLLFFDWMSLIIILLSDLFGGFTGF
>PK3-2_03382 Aspartyl-phosphate phosphatase YnzD
MIREHLLNEIEKKRAELLQIVMANGMTSHITIELSQELDHLLIQYQKQRLRAVAGDE
>PK3-2_03383 hypothetical protein
MTLWVGILVGVVALLIGVALGFFIARKYMMSYLKKNPPINEQMLRMMMMQMGMKPSQKKI
NQMMKAMNNQTK
>PK3-2_03384 Sporulation inhibitor of replication protein SirA
MERHYYTYLIKEEFANHYFGRESVIFELFQDYHWTSLTKQQYEMTEKQIQYITQPIPILH
MHQRLKMNLNNADYRQLDYIYRLALPKAKGHATFMMKEHMIEIVASGDYEAETIFFEVLR
KVSPCFLAMDFNSKRYGWLNPVKERNFV
>PK3-2_03385 Transketolase
MDTIEKKSVATIRTLSIDAIEKANSGHPGMPMGTAPMAYTLWTKFMNVSPANPGWFNRDR
FVLSAGHGSALLYSMLHLSGFDLSIEDLKGFRQWGSKTPGHPEFGHTAGVDATTGPLGQG
IAMAVGMAIAERHLAETYNRDSFNVVDHYTYSICGDGDLMEGISSEAASLAGHLQLGRLI
VLYDSNDISLDGDLDRSFSENVKQRFEAMNWEVLYVEDGNNIEELTAAIEKARQNEKKPT
LIEVKTTIGFGSPNRAGTSGVHGAPLGKEESKLTKEAYAWTYEEDFYVPSEVYEHFATTV
KESGEKKEQEWNAQFDKYKEVYPELAEQLELAIKGELPKDWDQEVPVYEKGSSLASRASS
GEVLNGLAKKIPFFVGGSADLAGSNKTTIKNAGDFTAVDYSGKNFWFGVREFAMGAALNG
MALHGGLRVFGGTFFVFSDYLRPAIRLAALMGLPVTYVFTHDSIAVGEDGPTHEPVEQLA
SLRAMPNLSLIRPADGNETAAAWKLAVQSTDQPTALVLTRQNLPTIDQTAEEALAGVEKG
AYVVSKSKNETPDALLIASGSEVGLAVEAQAELAKENINVSVVSMPSMDRFDKQSDEYKN
TVLPADVKKRLAIEMGASFGWGKYTGLEGDVLGIDRFGASAPGETVINEYGFSVPNVVNR
VKALLNK
>PK3-2_03386 hypothetical protein
MISNAKIARINELAAKAKAGVITDEEKAEQQQLRQEYLKGFRSSMKNTLKSVKIIDPEGN
DVTPEKLKREKRNNKLN
>PK3-2_03387 Resolvase YneB
MKALIYARVSTNKEQQETSLKRQEEELTAIAAENGMEVVKVISEKASGYEMDRYGVFELL
DEIKNAGIDVILVQDETRLGRGNAKIALLHCIYREGVKVYTTAHRGELELSEADSMVLEI
VSIVEEYQRKIHNMKIKRGMKRAVKNGFKPQKNLKNQHENSGKERIEVPISEIVRLRANK
LTFAEIAATLRGFGYDVSKATVHRRFQEYIENEETAQ
>PK3-2_03388 Cell division suppressor protein YneA
MNKESIIFVGLFTVILSAVILLLSYTSNGQELNQYVKIEVRQGDTLWSIADQIADTKKIN
KSDFIEWVADKNHLQTSDIQPGDELVIPLKKKHQDAYELATVR
>PK3-2_03389 LexA repressor
MTKLSKRQLDILTFIKAEVKSKGYPPSVREIGEAVGLASSSTVHGHLARLETKGLIRRDP
TKPRAIEILDEEVDIPQSQVVNVPVIGKVTAGSPITAVENIEEYFPLPDRMVPPDEHVFM
LEIMGDSMIDAGILDKDYVIVKQQNTANNGEIVVAMTEDDEATVKRFYKEDTYIRLQPEN
PTMEPIILQNVSILGKVIGVFRTVH
>PK3-2_03391 Metallothiol transferase FosB
MEIKGINHLLFSVSHLDTSIDFYQKVFDARLLVRGKTTAYFDLNGIWLALNEEPDIPRND
IKASYTHIAFTIEDHEFEEISAKLKRLHVNILSGRERDERDRKSIYFTDPDGHKFEFHTG
TLQDRMRYYKQEKKHMDFYD
>PK3-2_03392 hypothetical protein
MTVTAMTFYGFELFMFIICLQPMVFFKNNNLGGQMKHIIALASKIAFTLALLYVILDRVY
HAPFLSVMFIALFLGFVSYLSGDMLVLPRTNNITASLADFGLSFVILWVFVLTQTRNDFP
PFAAALLSAACLTVFEYFFHRYLLKNVLDETFRNELSARDNTLQYQTEAADELFPDVTNE
KHEE
>PK3-2_03393 hypothetical protein
MKPAKVSLLRRLLHSLKHVDCNIAKRFPSTLKIVKILFVFMVFTPISSIYAEDAYQNFEE
LKNNEDPSDYGIVTKETGSPVLVLAIHGGGIEGGTSEVARELSKEYSMYLFEGLQSSGNS
VLHITSTHFDEPQALKMTEIHEYVISLHGYAEEDQQIEVGGTDRERAAVLVEKLQNAGFP
AVLLSTDHPHAGVSPNNIANQSKTGLSIQLEMSTGFRRSLFGVFSLKSRSVTQNERFYDF
TEVMSRFLKSNY
>PK3-2_03395 hypothetical protein
MFYISCFLILWLAAGFAVGMKRMYVDQLFDKDVIERLEKEAGDHRQADRVIKQRILYITA
VTLSGFIAVYHEVKTIPHRRKIRKIEKNIMKLNKAKKRRMKRK
>PK3-2_03396 hypothetical protein
MLKRNGLISALCFMGFLAAEAPHISVAEALVLLSILFFVPGIFPFVFHQLPLRTAQFLEL
GFIQCYPIAAFFAVLALVTDIGGFALIWWLYTVFMALYAILRLWKTKIHRIEETSVLFGL
IYLAGGGFWFFAYAAHMQMMQFGPLIILLTAVHFHYSAFLIPIFNGLLGRIIRKNRILYS
WITSVILFSPLLIALGITFSKTLDVIAVGIYMAALYLHAFLVFTTDFRSRMGKCLIRLSS
AVLMITITFSMIYSFGVFRQDVTLTINQMIWIHGFVNAFFVILPALIGWRIEDPKSFDAG
SVKTFSRIYGKRRIGKDFLAARQAESNAQFRGLVDDMGSLRSKDFSPEKLAPCIPSFYEQ
TIDYDVKAKVTWSTWFRPLAMVYEWFSRRTGQIHLSTNRDWYRMYSTIKGVDSKKDGREK
VRAWIRTNEKNETVFTALYSVYRSNGEGYMNISLPLPFSSMTGILKPYHQKKKLVLTSRR
RKSRAGDEGIYLQTRAGTFPLPLSETFLIEAALDNRLTAVHHMWLFGIKFLTVHYSIIHI
TRSNERT
>PK3-2_03397 hypothetical protein
MSSIYEKSINNYHLLHPKLQKRYQLDGSHTFSGTGTMSEISGGSFLVRMLLKLGVFFRCF
FSERGKDIPFSIQNRTCLLNREHTGIEWNRTFFFQGKKRFFDAIMIYDEKEERILDFFGK
PHLLLSVLAFEASPDGSLTITSGKQWLLICGKRIPLPKWLTGTSVVCETFDESKNCFTIQ
VHVQNTILGTLFFYKGTFQEEERESC
>PK3-2_03398 hypothetical protein
MRQKPIYVEIEMSSDLDTLWEYTQNPSLHKEWDLRFSNITYLHRQPYERQKFLYETRIGF
GLKISGTGETVGVFNKCSSERVSSLAFGSDHPLSLIQHGSGYWKYIKQNNGKTTFLTQYQ
YKTAYGLPGRWIDRLLFRPLLGWATAWSFDALRLWIEQNKHPKHTIRSAVVYVLMSLFFS
LFWFYQGFTGFETSIFAGTVEIGLGMIWLIPLKRKWIIHAVQACIFAGFAFLGSEIFLWI
LLSVCSAASGVLSLQLPSTRHTKRKRKK
>PK3-2_03399 Spore germination protein B3
MKRKIKHQVSAIVIVCLLMICVTGCWSSREIEELGLTFGIAIDKGKETKTEKDFKEEGGS
YPKEDNMTLTYQFVNEKAAGAGTSGGGGGGQGSQKAYINVSETGDSLQQIGSEIALRRDR
EVYSPHLKVVVMSEDVLRTYPIDKMLDQFFRDNEIRLSCLVLSAKGEAREALQLKESGEI
PAFRLVGLGENEHKVSRILPPVTLAKLIGKLHSGSSFLLQNVVAANGAIKYSGAAVISGK
SKKMIGTLNEYETEGITWITGEGKGGVVKSHDKKSRQVMAYDINKIKSNIHSIVKGRDIS
FHVDIESEGDLVENWNTKETLDTEFIKRIETNTEKEIKKIVGNGIEKIQHEYKADVAGFN
ESLRLEHPRLWKKVKNNWDDTFSKAGITFSVNATITHYGTVKTQ
>PK3-2_03400 Spore germination protein YndE
MVKKSLMYSPTSKITTAQATVIIINYMLAAGVLTLPRTVTEQTKTPDGWISILLGGVIAV
IAGIIMVKLSQQYPEETFYEYSGHIVGKWIGGLISIVFITYFLALGAFEVRVMSEIVEFF
LLEGTPSWAIIMTVLWIGLYSITQGLDPIARLFEMIFPITVIIFLTIALMSIGIFEINNL
RPVLGDGIMPALKGVKTTTLSFTCSEIMLIIVAFMKKPKNAVKAVVFGTGVVTCFYIITL
IMVIGALSVDGVVTRTWPGLDLMRSFEIPGLIFERFESFLLVIWIMQLFATFIITFYAAS
LGVSQVFKKKPLSCMFGLLPVIYILSCMPKNENDVFILGDAVSHMALYIFGALPILLLVI
SKWRKRGET
>PK3-2_03401 Spore germination protein A1
MRGIEIDHLPESGYVEQLIEDNYLSPFPQVQNTERPDRVISGLMEGRVAILLDGTPFALL
VPVTFNMMLQSPEDYYERWFPSSLIRLLRFIAAIITLFAPALYISFISFHPGLIPTKLAI
SISGTRMGVPFPSFIEALFMEIAIEILREAGLRLPKPIGPAIGIVGGLIIGEAAVQAGIV
SPIMVIVVALTAISSFAIPHYSTGIALRMLRFGAMFCAAMFGLFGVIMYYLLLSSHVVKL
KSFGVPYASPAVPYHLKDWKDFVIRMPLLVMKRRPKMMNTDNTKRVK
>PK3-2_03402 Spore germination protein B1
MRWRSNQYKTKKQHKEPDHSKAERQDHDVITGNIGYDIEHVKRKIGHNGDVHFRELELTH
LHVKAALIFVDGLSDQDLMNKGISALVMEQSNQASDEISQSGKGILTSQYIKNQIVSVSD
VIESEKISDIVLNVFMGSTALLIDGMPQAFLLGTVKKQNRSIEEPLSEALVRGPRSGFTE
ELSTNTALLRQQGKNDQLTLQKFEVGTRLKKDLMIAYMNDIADRQVVEEVKKE
>PK3-2_03403 putative chromate transport protein
MHKHKRNSFKTLIEILIVSTRLGFTSFGGPIAHLGYFYEEYIRKRKWLDEKSYADLVALC
QFLPGPASSQVGIGIGVLRGGLIGGIVSFLGFTLPSVLALIIFALLLKSTDIEQAGWIHG
LKIVAVAVVAHAITGMAQKLTPDIKRKTIALFALVVSLLWQTVFTQAGIIIVAAAIGFLL
FQESIDKKESAFHFPISKTFGAVCLSLFLGLLVLLPALRETADLRWLSMFDSFYRAGSLV
FGGGHVVLPLLEQEFVPAGMISKEAFLAGYGAAQAVPGPLFTFAAYLGAVMGGWQGGMLA
AVAIFLPAFLLILGALPYWDALRRNSNLKGALAGVNAAVVGILISAFYFPIWTSTILNPI
DFAFTAVLFSMLAYWKLPPWVIVISGAIGGLLLNHL
>PK3-2_03404 hypothetical protein
MLGKIKAAIDNSPGKPARIVVNEKTFQQLKEEMRFVYVSKPKTIMGIPVEVSEQAESFKL
EF
>PK3-2_03405 hypothetical protein
MYEKENTVREWKVYIVVFSFMIVCAAAIVMFDSEILLSQIILREFDAFISFILLTNVLFF
WKKSKRIAYFSGVLAVINFIMVISLI
>PK3-2_03406 putative protein YndB
MDHNNENTLPDITKSITLEAPIRKVWETISTSEGITKWFMPNDFQLKEGQEFHLQSPFGP
SPCKVLTVQAPTELSFAWDTDGWVITFHLEDLGEKTRFTLIHGGWKEPNEIIGKANEKSS
VIREKMDGGWTAIVNQRLPKAIEE
>PK3-2_03407 hypothetical protein
MMRFTKVIGFLSVLGFAAVFPLTAQAEQAGTAGAGEWDKLGTYTYTYSSPTVYSSGGDFR
VCLSGSTPFSVSLHVYEDDAGDNPDDYVGSNYFSPGECHTFSSIRKFVDGTNNKAEFFVT
DYSGKSKTVSFYD
>PK3-2_03408 Sec-independent protein translocase protein TatAy
MELSFTKILVILFVGFLVFGPDKLPALGRAAGKALSEFKQATSGLTQDVRKSDSESKEDK
QI
>PK3-2_03409 hypothetical protein
MGYYKKYKEEYYTVKKTYYKKYYEYDKKYYDHHDKKDYDCDYDKKYDDYDKKYYDHDKKD
YDYVVEYKKHKKHY
>PK3-2_03410 hypothetical protein
MFLDKEPLLLCMALKEFTKISLHLQYLEAGTNTHSYKLIKLCTKYSM
>PK3-2_03411 hypothetical protein
MLIQSDTFNIMIMKGPAHNRFKQFEIFLKIKEQMLKDTIIKRMPAIVCQPLKKG
>PK3-2_03412 putative protein YncM
MTKQLSKGGILVKKVLIAGAVGTAVLFGTISTGIPGLPAADTQVAKAASQLPKGIGGRAY
LNSTGAVFTAKIKLPDTVKHNDSVSTSYIYSGFRATNGTEADIGLQYSDQYKVWKPLMKV
GSKNEETYIEGKDKFTYTKGFRPGSTVQMTIYKNLNGNTRMTLWGTNNDGYTGRIITEIQ
GTNIGAISKWKTLATAAVSYESQRDAIKTTFSTSFNNITIDNKAVTPVIDTQDNAKVSVS
GNNVTISVNK
>PK3-2_03413 hypothetical protein
MKYRKTGPFGMILVIVALLVSMYFMFNTKALIPAGYDLAIHGIVISRTIMIAFTLYLVSK
LGYFLLNKKD
>PK3-2_03414 hypothetical protein
MNIEQKKKLIPQGSYCYNEDKLCPFWSVREDRPAYENGYCSYMEKGDWDINKESTPETGL
LWDQVKECGEKLDQDDWRGNMFSSFHYKKD
>PK3-2_03415 hypothetical protein
MFKDFFHSHPFIKNLLEILITAISLGVWFNVNINHYLSVIFGFLTAGIINSVLGCTWEPK
KKAA
>PK3-2_03416 Thymidylate synthase 1
MTQFDNQYNSIIKDIINNGISDEEFHVRTKWDSDGTPAHTLSVISKQMRFDNSEVPILTT
KKVAWKTAIKELLWIWQLKSNDVNELNKMGVHIWDQWKQEDGTIGHAYGFQLGKKNRNLN
GEKMDQVDYLLHQLKNNPSSRRHITMLWNPDELDSMALTPCVYETQWYVKQGKLHLEVRA
RSNDMALGNPFNVFQYNVLQRMIAQVTGYELGEYIFNIGDCHVYTRHIDNLKIQMEREQF
EAPELWINPEVKDFYDFTIDDFKLINYKHGDKLSFEVAV
>PK3-2_03417 hypothetical protein
MRKSLYKHNEKVTGFEFDNIGSVKIRYFLKIKLDNTFDKVCTFICKNPSDADATVSDPTI
NILSELLHTRENCYEIGTIYIVNVYPFYEPNSENLFELLKNINTLSPDKHRFMKTKNLGT
ILRICGESDHVIAAWGENPNGFPKEIYNQDIHKLENELRSNGITTGHLHWKGKELTDTGY
YFHPGRKSVSDLMIKW
>PK3-2_03418 putative deoxyuridine 5'-triphosphate nucleotidohydrolase YncF
MTMQIKIKYLDETQTRISKIEQGDWIDLRAAEDAAIKKDEFKLVPLGVAMELPEGYEAHV
VPRSSTYKNFGVIQTNSMGVIDESYKGDNDFWFFPAYALRDTEIKKGDRICQFRIMKKMP
VVELVEVEHLGNEDRGGIGSTGTK
>PK3-2_03419 hypothetical protein
MATSGESYFVVDGELDDELFHDYAIVEGTDLAIRLNTNQYYTIFVELQAFPFGKTVNQVK
TYEEFVDSGCELVLLIADNSYVSIYCKNKNTIEKLYFNALKNDFEEVQFITDENDTRTGL
TVW
>PK3-2_03420 hypothetical protein
MFKKIVIGSILVSSITGLSNTYASATSIDHAPKKISTFATTQSDIILEEEETFRGDGKFY
FDYYGSEDGEIRVFVENTGSNPFEFKIVKPGGGTIASGYTVKPGRSVTLTLDVSYYRTGT
YYIRCQNDDGAKIKAFAKVRAL
>PK3-2_03421 Alanine racemase 2
MAVVKANGYGHGSAEVARHALEHGASELAVASVEEGIVLRKAGITAPILVLGFTALSCVK
KSAAWNITLSAFQVDWIKEANEILGNEASSNRLNIHINVDTGMGRLGVRTKEELLAVVKA
LTKSEFLRWTGIFTHFSTADEPDTALTKLQHEKFNSFLSFLKNLGIDLPTVHMSNTAAAI
AFPEFSADMIRLGIGLYGLYPSAYIKQLNLVELETALSLKARIAYVKTMRTEPRTVSYGA
TYIAEPDEVIATLPIGYADGYSRALSNRGFVLHRGKRVPVAGRVTMDMIMVSLGEGGDGK
QGEEVVIYGKQKGAEISVDEIAEMLNTINYEVVSTLSRRIPRFYIRDGEIIKVSTPILYV
>PK3-2_03422 Major myo-inositol transporter IolT
MNEYRNRRLKLIMISATFGGLLFGYDTGVINGALPFMARSDQLNLTPVTEGLVTSILLLG
AAFGALLCGRLADRYGRRKMILNLSFLFFLASLGTAIAPNVSIMAVFRFLLGLAVGGASA
MVPAFLAEMAPHEKRGRMVTQNELMIVGGQFLAYVFNAILGVTMANTGHVWRYMLILCAV
PALMLFASMLKVPESPRWLISIGKKSEALRVLKQIREEKRAEAECREIQAAVEKDTGLEK
VSLKDFSTPWLRRLLLIGIGVAIVNQITGVNSIMYYGTQILKESGFGTKAALIANIGNGL
ISVIAVIFGIWLVGKVRRRPILLIGLAGTTTALLLIAIFSILLDGSAALPYAVLSLTVLF
LAFMQGCVGPVTWLVIAEIFPQRLRGLGSGISVFFLWILNFIIGFAFPILLSSVGLSFTF
FMFVALGVLAIGFVYKFMPETKGRTLEELEKHFRSRHDKNTPEKSVIEA
>PK3-2_03423 Endo-1,4-beta-xylanase A
MYGWTKDPLVEYYIVDNWGTYRPTGMPKGTFTVDGGTYDIYETTRINQPSIIGIATFKQY
WSVRQTKRTSGTVSVSEHFKKWESLGMPMGKMYETALTVEGYQSNGSANVTTTVLTIGGQ
SK
>PK3-2_03424 Xylulose kinase
MKYVIGIDIGTSAVKTILVNQNGKVCAETSKSYPLIQEKAGYSEQNPEDWVQQTIGALAE
LVSKSNVQAKDIDGISYSGQMHGLVLLDKDRQVLRHAILWNDTRTTPQCIRVTETFGDHL
LDITKNRVLEGFTLPKMLWVKEHEPDLFKKTAVFLLPKDYVRFRMTGAIHTEYSDAAGTL
LLHITRKEWSDEICNQFGISASICPPLVESHDCVGSLLPNVAAKTGLLEKTKVYAGGADN
ACGAIGAGILSSGKTLCSIGTSGVILSCEEDKERDFKGKVHFFNHGKKDSFYTMGVTLAA
GYSLDWFKRTFAPNESFEQLLQGVESIPIGANGLLYTPYLVGERTPHADSSIRGSLIGMD
GAHKREHFLRAIMEGITFSLHESIELFREAGKSVHTVVSIGGGAKNETWLQMQADIFNAR
VIKLENEQGPAMGAAMLAAFGSGWFESLEECAEQFIREAAAFYPKEQNVQKYKNLFDLYK
NIYTHTKDLNTALKSFRKN
>PK3-2_03425 Xylose isomerase
MAHSHSSPINYFGSANKVVYEGKDSTNPLAFKYYNSQEEIGGKTMKEHLRFSIAYWHTFT
ADGTDVFGAATMQRPWDQYKGMDLARARVEAAFEMFEKLDAPFFAFHDRDIAPEGSTLKE
TNQNLDIIVSMMKEYMRTSNVKLLWNTANMFTNPRFVHGAATSCNANVFAYAAAQVKKGL
ETAKELGAENYVFWGGREGYETLLNTDVKFELDNLARFMHMAVDYAKEIEYTGQFLIEPK
PKEPTAHQYDTDAATTIAFLKQYGLDNHFKLNLEANHATLAGHTFEHELRMARVHGLLGS
VDANQGHPLLGWDTDEFPTDLYSTTLAMYEILQNDGLGSGGLNFDAKVRRSSFEPDDLIY
AHIAGMDAFARGLKVAHKLIEDRVFEDVIQHRYRSFAEGIGLDIVEGRANFKTLEQYALN
HKSIKNESGRQERLKAILNQYILEV
>PK3-2_03426 N-acetylglucosamine repressor
MDIADQTFVKKVNQKLLLKEILKNSPISRAKLSEMTGLNKSTVSSQVNTLMKENLVFEIG
QGQSSGGRRPVMLVFNKKAGYSVGIDVGVDYINGILTDLEGTIVLDQHHHLECNSPEITK
DILIDMIHHFITHMPQSPYGLIGIGICVPGLIDENQKIVFTPNSNWRNIDLKPFIQDKFN
VPVFIENEANAGAYGEKVFGAAKNHDNIIYASISTGIGIGVIINNHLYRGVSGFSGEMGH
MTIDFNGPKCSCGNRGCWELYASEKALLKSLQTKEKKVSTQDIIDLAHLNDIGTLNALQN
FGFYLGIGLTNILNTFNPQAIILRNSIIESHPMVLNSIKSEVSSRVYSQLGNSYELLPSF
LGKNAPALGMSSIVIDHFLDMVTM
>PK3-2_03427 Beta-xylosidase
MKIINPVLKGFNPDPSICRVGEDYYIAVSTFEWFPGVQIHHSKDLVNWRLVAHPLQRVSQ
LDMKGNPNSGGVWAPCLSYSDGKFWLIYTDVKVVDGAWKDCHNYLVTCDTIHGDWGEPIT
LNSSGFDASLFHDTDGKKYLLNMLWDQRVDRHSFGGIVIQEYSDKEQKLIGKPKVIFKGT
DRKLTEAPHLYHIGNYYYLLTAEGGTRFEHAATIARSANIEGPYEVHPDNPILTSWHDPE
NPLQKCGHASIVQTHTGEWYLAHLTGRPIHPDEDSIFQQRGYCPLGRETAIQKLYWKDGW
PYVEGGKEGSLEVEAPSIPKTTFEATYPEVDEFEDSTLNIHFQTLRIPFTNELGSLTQVP
NHLRLYGHESLTSTFAQAFVARRWQSLHFEAETAVEFYPENFQQAAGLVNYYNTENWTAL
QITHDEELGRILELTICDNFSFSQPLKNKIVIPREVKYVYLKANVERENYYYFYSFNRED
WRKIDIALESKKLSDDYIRGGGFFTGAFVGMQCQDTSGNHIPADFKYFRYNEK
>PK3-2_03428 Isoprimeverose transporter
MLSENLKKISMVEKVGYASGDFACNLIYATVSTYLLFFYTDVFGLSAATAGTMFLLVRII
DALADPFIGTIVDRTHSRFGRFRPYLLFGAFPFAVLAILCFTTPDFSDMGKLIYAYITYV
GLSLTYTTINVPYGALTSAMTRNNQEVVSITSVRMLFANLGGLVVAFFVPLLAAYLSDTS
GNESLGWQLTMGILGLIGGCLLIFCFKSTKERVTLQKSEEKIKFSDIFEQFHVNRPLVVL
SIFFIIIFGVNSISNSVGIYYVTYNLGREDLVKWYGLIGSLPALVILPFIPRLHQLLGKK
KLLNYALLLNIIGLLAILFVPPSNIYLILFFRLIAAAGSLTAGGYMWALIPETIEYGEYR
TGKRMGGLIYAIIGFFFKFGMALGGVVPGLVLDKFGYVANQAQTPEALTGILITTTIIPV
FLLVLAMIDINFYNLDDKKYKNMIRELENRDKVYLDNIEDFKA
>PK3-2_03429 hypothetical protein
MELSIRQERTHEYDTTEDIVKRAFLNETYSDKKEHFLVNTIRKSDAFIPELSLVAVNVKD
IVGHVLLSKIKIVDGDNAVDSLALAPVSVAPEYQRKGIGSQLIHAALKKAKELDYRSVIV
LGHKDYYPKFGFKPASLWNIKAPFEVPDEAFMALELSKDSLEKVKGVVHYSKAFSA
>PK3-2_03430 hypothetical protein
MKLYNEFINIAKTFNKELDTIPLLYGSLGLEKVTGLDFSPEDIDILIPLIFLEGKWGRLK
KIMEVQGYTMVDLHEHEFRKTNIKVGIAHIEDVKPFADVDYKNLEIFEDDRAKYHLLTID
DYLKVYHKSLLDGYRRTKKNNKDQIKINILNKLIQN
>PK3-2_03431 hypothetical protein
MNKKKGEIQRKYREQMREKTEQHKEDGGSHTFEIVVVLAIIILIFFFNSVFKAF
>PK3-2_03432 hypothetical protein
MIGRLFEVLTDFFIPGIARPIGVLAGILVLLSLKSRNTEMQVFIVSSSTALGIMGAGVLY
LPAAIVNVLIGFKLNKKLKEENTKEQI
>PK3-2_03433 hypothetical protein
MKIKEYMDERFPSLELIPSIYNQWGLGIHFCLGENIYQLKENEELNLKRFGIVYDQISTI
FNELFEHNDDILLVTNMYKHKTKCVRKLKVYQPYLKCKNDLKRIHVNTYPYPFEIDKAEE
YEMQQFSLLCKPRDLRVTELLKAASNEDFPLQPRFGGYSIDYPDVFFVNITKDIIFFIYD
DRGCEVIALDFERIRPLYEKHHDWVEEYKYIYQEGQN
>PK3-2_03434 hypothetical protein
MIDSIKFEAHIRRKEDQYPTVRDEMERYPRELLDKICTCLNIELYEL
>PK3-2_03435 rifamycin-inactivating phosphotransferase RphC
MDTLVLGFNEMEKTQLLLVGGKGLNLGELSKIQGIRVPEGFCVTTAGYQKVIEQNETYHV
LLDRLTMLKVEDRDQIGEISSKIRRIIMEAEIPSDVVKAVSQYLSQFGEEHAYAVRSSAT
AEDLPHASFAGQQDTYLNIIGKDAILQHISKCWASLFTERAVIYRMQNGFDHRQVYLSVI
IQKMVFPKASGILFTADPITSNRKLLSIDASFGLGEALVSGLVSADCYKVREEGIVEKRN
ATKKLAIYGKEEGGTETKQIDLDQQMSQTLTDGQILQLARLGRQIEAHFGQPQDIEWCLA
DDTFYIVQSRPITTLYPIPEANDQENHVYLSVGHQQMMTDPIKPLGLSFYLLITPAPMRK
AGGRLFVDVASRLKTRAGRETLLNTVGSDPLTKDALTTVIERDFIKLLSNDQTAPIPGGG
HTDMPAQFENDPTIVSDLMKRNQTSIEELKQNIQAKSGSDLFDFILEDIQQLKKILFDPQ
STAVFMAAMNASAWINENMNEWLGEKNAADTLSQSVPGNITSEMGLALMDVADVIRPYPE
VIDYLQYAKEDNFLDELVTFDGGRETQDAIYDYLRKYGMRCPGEIDITRPRWSEKPITLV
PMILSHIQNFEPNAGNRKFEQGRRVALEKEQELIDRLKQLPDGEQKAKETKRMIDLIRNF
IGYREYPKYGIVSRYFVYKQALLKEAEQLVQAGVIHEKEDIYYLTFEELHEVARTKKIDD
QIISKRKDEYKLYEKLTPPRVITSDGEIITGEYKRENLPANAIAGLPVSSGVIEGRARVI
LNMENADLEEGDILVTSFTDPSWTPLFVSIKGLVTEVGGLMTHGAVIAREYGLPAVVGVE
NATRLIEDGQRIRVNGTEGYIEIL
>PK3-2_03437 hypothetical protein
MINVIYDIKTLEGSCYIEVLPDRYNDKCWNASFIFFTEGNFGYIVPVFEKCYKNLIISVS
MK
>PK3-2_03438 hypothetical protein
MLGINVEKSNENLIINWQLSKVENPIKEINDVFLDPNYGEKREAQ
>PK3-2_03439 SPbeta prophage-derived endonuclease YokF
MKKAILSFAALTLSLSLAACGSNDAEKASSEKETQQDVKDAEQKTDQKETTTEKSTGKSD
SKDKKEMVDVTLDRAVDGDTIKVSYNGNVDTVRYLLIDTPETKKPNSCVQPYGEDASKRN
KELVNSGKLQLKFDKGDRRDKYGRLLAYVYVDGKSVQETLLKEGFARVAYVYEPNTKYID
QFKKDEQEAKSEKLSIWSKNGYVTDRGFNGCVKEKTTAVKKATTSKPTATQPTAPKVSNN
SSVKSENEASSSTSTRETETFKNCTELRKKYPHGVPSSHPAYQSKMDRDHDNYACER
>PK3-2_03440 hypothetical protein
MALLRFISLYGIAIIILMVIANFAPFLAMPLYYVAMATLVFLIVYLIYYYSQKFRGRKK
>PK3-2_03441 putative ribonuclease YokI
MKVFEAKSLLSEADRRAKEYKELRSQMVNLKKAFKAVADLDDSEFSGKGADNIKAFYQDH
AGVADNWIDLLDMKIAFLTSISGTLEDASLSDAYIEESFLEHELANAYTKSKSIMSEQKK
AMKDILHDIDDILPLDLFSTEDFKDELADAEEKRKKTVDKLGSVDEALVTEYAQSEPNEQ
FIKKDFQKLEESTGKGKNATPIHYNAKAYRDSDIHKKKGDIEKQTEAYLKIKKDEAKERE
IKELKKKLADRVTDPDEYLEIAKKVGYENLTPEQLEFVSFLEQRKAFMDNGKEVLQIIGD
GAKGAIVGVYDLAKDTGEGAIQFGWNIGWTIDNLNKDPQKVLDTVLEYDYQAAFQSMVDT
LKDNWDTKMIHGDAYTRLHYVTYLGGSLLLLKGGKSSVSTGSKDLATVGKVASEKIKNGN
PSVKPYINRYTPALEGILQDAGNPINVKNTPLLKSIAENEKSSVLFKSEKPNGGNHRDTG
SLKVNIPDSSIKHSDIGDFTKNPKTGDISKMKGGGHGQSNIEFLEKII
>PK3-2_03442 hypothetical protein
MKAKRSGSNQSWFPESWTESDIAAAGAKIAELPEFTNAENGVTIFGEYKGVRVGVIKTNG
EIGTIFPDATKQP
>PK3-2_03443 hypothetical protein
MNLEKKMEAILIKRKKLNLNDDYGIQKSWDEIIEVLSENEENTISYLENCNKEDLYWISE
VFEDLAESLQSKELINCLRKLDEKYPDLEMTNDIDIAESYIE
>PK3-2_03444 hypothetical protein
MIEIEVSDPVFRFLGGHFHQDIESPEDALNKYLNEASQKLKERDLIALTEFVNSNYSEAD
KNEFIEEAADGIYFPEDDITPLEWLKQVTEQIKEHLKTI
>PK3-2_03445 N-acetylmuramoyl-L-alanine amidase XlyA
MVNIIQDFIPKRNKNRPAYPMNPHYITVHNTSNTAKGADAASHARYVKNPETATSWHFTV
DDKEIYQHLPLNENGWHAGDGNGTGNRKSIGIEICENSDGDFEKAVSNAQWLIKKLMKEQ
GISFANVVPHKHWSGKECPRKLLNRWDSFKAGISGAASSPTKTVKKTAGDTYTVKKGDTL
SEIAKEHGVSVANLQSWNNIKDPNKITVGQKLKLTGSSTSSTKPSSKKTSYALPSGTFKV
TNPMRKGDDVRRIQKALAALYFYPDKGAKNNGIDGVYGSKTANAVKRFQSVSGLTADGIY
GPKTKAKLEEFLK
>PK3-2_03446 hypothetical protein
MEETTVFISFDTLDLARVYLFGGVKYLDLMLVLNIIDILTGVVKAWKFKELRSRSAWFGY
VRKMLSFLVVIVANIVDTILSLNGVLTFGTVLFYIANEGLSITENLAQIGVKIPAAITDR
LHVIENDNEQTNEKDEQAAG
>PK3-2_03447 hypothetical protein
MDYWFRNIKTIYGWGRQYYTNADVARFVVLNRITEEQYKEITGLTYPATEPVVIDLGS
>PK3-2_03448 hypothetical protein
MILIYPYREDGFYAGQPVELFPDAETGKYNIPPNATDKPPEKNGSGMWLPWFDVEKQEWI
EKADQEYKDSLKGPADPPSALDELKAQHALTTVQLAESQNLIESQAKMISDLFLMMAEGG
KA
>PK3-2_03449 hypothetical protein
MPYKDESLTFTINGRRKSPVQTNIQYTTQDKGTAKLAFQLMKDGVPLPLSAAVVKLVLLM
SDGSRFVRNIEITDKLNGRLTYVLTDEEIRHVGIVQAELDVSYTNQQAMSIHEFSFEIKK
ALIDTDILPSVEYYIDDFESLKHKINELYNETIQTVEELRKKFEDLENIETKEGAQKKAD
AVQANLDTHKNDKSNPHGVTKTQVGLGNVDNVQQATKAEFNTHNTDSTRHITSTERSNWN
AKETTTGAQNKVDTAEKNAKTYTDQHIDNKSNPHGVTKGQVGLGNVTNDKQATKTEFDTH
VKDVTAHISEAERTKWNGAQLFKITNDVGGVLISIADTDDFLDRIVKAGKTFGTFYSTGK
PTNAPSTLSTRGFFHFTSIDSNSNGTFGYVVAMDYKNNMYSNYVDGNLGWSGWKRLLTEN
DTDSAPWLNATYKNGAKTGDRQLQFKKVAGALHLTGHIVTDREVVFASIPSSYAPSKGVM
ELIAVSGITGMSKLIVFPSGDLKLTGLMANDSSKVTGYYIDKVIPLN
>PK3-2_03450 hypothetical protein
MSSPFYNAIKTCYLSGYWDGKEELLSMAVDQGKITEEEMNEIKRLRQDEASPSIEE
>PK3-2_03451 hypothetical protein
MWAYQYDENYIYDCPVEIQYIEDDDGNVKRVVPENATEISPGYLVLAKWTGTEWVESASA
EYIESLETADSVEESDGAKALKAVADILETMVRGDAG
>PK3-2_03452 hypothetical protein
MLTLRKYFGTIRNALYEEQLANDLGSIETAVNGIERDVTNHKRTDNAHTSSQVAHGGGLT
VYEEIEIAKARIRNLVLNADGTNIKETIDARVDKRGKVYPSLRDHLIANETDLENLGSIV
QKEMGFDFTTVPPVYHTNLNLADKTILQCFVIDELTGDIYATQVASGNQDKSESFIITRM
NQNGVMLDSMKLVHGGHGTTIGLERENGKMYIWSNYNVVDSNGNTVGNDLVRFPYTAGAT
LNGGSGGIKRYNKFNDYYTIPVIDRENGFIAFRIRLKDDNSLVELRKLSDVKNGVNKVLG
KVIIPNDLFYLQGLTIDGYDLYWYTGDTNNKTYPCEITQFSFKDGSLKKRISCDFGYGPD
GKYEDGFREPESIFLYKDPKTGKKSLFAGVATGAVGKRLAKVYAYHSKENAAKFGIDLAQ
GYQGYKLTQNNGYSKRLPDGLKSLKEFRQPGFYYMLTTETKTLSDHPDSGNAGWWLNIAP
ADRAGSVIQTLTRNATARPIKILTRVVTNDGNVGEWSEISASGKLPWANLPLKNGAKNPD
SNNRLQFAIQGGFLFVRGRVTIPKKDGVDFATLPASARPKKNAFKSCPVAGTTGERKIVF
RSNGNISALGLFVKNESNATYTYIDEIIKLD
>PK3-2_03453 hypothetical protein
MAAADFIKSLVPGAQNVYKKYNVLASLVIAQGCLESAYGTSGLAQKAHNLFGIKGTYNGQ
YVLMWTSEQDKYGNVTRIQAKFRKYPSYAESLADLGSLYNRLDRYKAVVGESNYKKACQA
VKDGGYATDVNYPSKLISIIDKYNLTQYDNITTLPDDPDVPENPDTPVEDPVFPSKEYAG
KDISLNKNLPSDVDFPQLFVSTTDGTDVVEITGVIVDLTDDTTGKKSFTFTITKTQQNAA
EFDLLINDNILYIDERKFNHQKYYITDVDLKQSKNVITKTITANHIYSVLLVENRVEETV
SKKLRLKEALDIALKGTDFTYVLEAPESDFPSAEEENFGEKNSTELMDQIIEDYDLEIDV
DNYKIHVYKKMGQEVDFTLDSRYNMPGINIKTNSQNCTTRAWGYGAMAKDSNSTDKKPKY
VFEPILYVHPEEKKFLREGKPRWADPIKDETIKKPGSMVSALKKHVNPYPETTVSVDYQY
IYEPKLLSIEKPFWKGDTIHVLADTADGITFEDDVRLVTIQYNPLNPYSSPKLTFANFRK
DIQDIAVNQAKKIRDQKRYIDQLLQTLR
>PK3-2_03454 hypothetical protein
MLDLYIDFNDGRGERELTSLLPRFSVRSFTPDSPNIERETTTMSRINGLVLPQHPRDVVY
KERSIKVEFLLDSIIAETFYQNRHELYALLVQPFPYYISTDLFPNRRFLVTCDGNFSIPK
DKQKNHATFTVEFTDILGLAESKFTSSTSQNFSGEHWSSGMGILMRDDLEYHFKNKKRFS
IYNPGDAIVNTLQHNYNVTFWAKGKNVTIVNHTNGEKLKIEQELQRSQKVTFIKQYTVIK
DKRIKTSGRLPSLDIGWNEFEIQNSNDFEIKFDTHFYYK
>PK3-2_03455 hypothetical protein
MSKDIKVKLYSNSSQFNTEMRGIAVQMKNIKSEFEKNRTAVGVWGNQLKTAQVTARTLSQ
QLEQHKQKVKALQRAYADAAIKKGKDAKETQSLARRLNNATAQMNRTQHALNETTQKIKE
MESASRRAAARIRQMGQRMNSVGGTMRNVGSSVAMTSGMAFGGLVLTFKDAIQTGMEFEK
QMSKVQAISGGTASEVAKLKEQAKELGATTVFTASQAADAQGFLAMAGFKVNDIYDAMPG
MLSLAAAGQLELGAAADITSNIMSSFALKAKESGHASDVIAYAAANANTNVEQMGEAMKF
LAPNAHSLGWGMEESAAAIMAFGDSGLQGTLAGQAFGTSLTRLAAPSRKAAKEIERLGFN
FFDAAGNMKSMPEVVAEMEKGMKGMTKEQQAATLKTIVGAEAYKHWTILLQKGSKALGEN
TKALEKSDGAAKKMADTMLDNAHGSIVAFESALEGAKIKLTESLLPALGDLADKGVDIIS
TFNNMDSSTVQTIAKTALLATGVLGVTTAVATLTAGIGALLAFTGPIGLAIVGGTALLGG
ITVATYAYNEELKNQKKKQEEAREAALLYGEGVSKATQKSAAAYVDLREKAELQLFELSR
VSGEEAEKMSSKLVTTYSQMRDSLIKELEGLKKDALVVLKGLFEDTDENTKKQGEKITDK
MVGAIDKDMQEARKKVKELEQLQKDTGLVSSKMNESQKAKFNEILSYFEQSTSKFAANQK
EAIAMQKAVSEQQGKLSFKQAKQYNDDIKKVYEDGQQAAKKDLDYRNDVIEKLYAQGYID
AEKRNTLLSKSTADYDKALAKNTAAYEKNSSALFSKMSRDGQLLDLETGKALKRQDEYVS
NSMGIMVKTEESESAYQERWANKQIEFLQSLGKSKEEAIATTQQALQEFYQGVGMTEGEA
RAEASKVVSAVEDEMNKPGNTQAAGQKVVRDFASGLKQAKPAVIGEGTVLQQALNNSLKS
DTSTPAQAGKSKGNAFKSGLNSTKNSNVQSGSVLRQAVLSELNKGGGQASSAGQNKGNKH
KSGLNSTKGANTSAAGSLSSSVTNTLGKTTDGGGGKKAGTMFSSGVNSKKGSASSAGKNV
SNSAKTGLKSAKTNSVGQDFVTGFINGMGSQNGSLFSAAWNLGKSALSALKKSIDSHSPS
KLTQSEGHNFSDGFAIGIQNKSKLAKKSAVSMAQSTMSSFKRELSQMAFDIKGAADQLIS
MKSELVVRNEVDTPSLNQKLDALITLLSKGLTGDGGGSAGMSQTPIVIYPAPVQIDGQHV
ANILFEKGDGKILDQKSADRYNQSAYKGGVRG
>PK3-2_03456 hypothetical protein
MDMYNALEEVGFSQNQIDEMDIVYHLKRLARRKETTENPKSNENDQVYIDQILG
>PK3-2_03457 hypothetical protein
MEALTITLRIDGKDKKFVTPDFISGKLFRSAAAIAEDFESNDTDRLFTEKQNEFVCDVFG
NKFTLDQFEEGIDSRLAGRTIYATANYVLGNITEASALLNPNQNADGEELGE
>PK3-2_03458 hypothetical protein
MSGRVLTGLDMFHIAEVLKDTKNELEFSVLEELPGAVSMKLDPKSETETFYADNGAYAQL
SSLGDIDGEMEVADLPLDMQARIFGKTVEKGIHFSSADDRPLEIALGFRAKISTGGYRYY
WALKGKPELVPVEHKTEEGKPSPQSTQVKIKFSPLTNVKKGKRRWEAKAEEGNGINADTW
FRQVVYNEDSFASGENDEVVDVGK
>PK3-2_03459 hypothetical protein
MTMDPVRELVKTLTSSSKLDELVTGGIHNLTANDVNAFPRVVFYELKDADAGYADNKAYC
FEVRFQISIFTQAATRKFEKPIANEIDKLMRSIGYGRYDSQPLYEEDTKVYHKAMRYVKG
YFKEE
>PK3-2_03460 hypothetical protein
MADMSFDGIDDLTQYFEKIGGDVEKVEPVALKAGGEIIAERQRGHVNRSDKQQPHMQDNI
TVSNVRESKDGEKFVAVGPNKKVAFRGKFLEWGTSKMPPYPFIEKGGQEGEGPAVDLMER
ILTAPIK
>PK3-2_03461 hypothetical protein
MWGAVEGSGSLGNNETMIAGALGVKSPKKITVRYRKGIKQDMRIVERFPKNKTERVFDIL
DTNDPDDLQEELEIICQEVGING
>PK3-2_03462 hypothetical protein
MDLEAIKNYLKVEHEEDDRQLLRQIAAAKSYIINGIGRYIEGNPQFELVLQMLVEHWYEN
KGIYESGGTGSSIPFTAENILTQLRYTSVEEQENEEKDQQTPASPDLSKENQDTG
>PK3-2_03463 hypothetical protein
MAEDYLYESGGVKTSSEKGADGKAITPVYLKENSEKNPVYVKGLQGEPGPQGEPGPKGDP
AVIEEGSITHEMLGDKSVRSNNIGTGSVMMDHLNAEVKAVFDQLQKQIDELKNEVQTLKG
TDEVPQE
>PK3-2_03464 hypothetical protein
MRVTKNYTTDGGDRTVIGGILDIDGGTVLKDGQEISLGGGNQTEMGAGSVTHEMLQDKSV
RSNNIGTGSVMEEHLNSAITERISSLEDRLKALETAKTEPAATE
>PK3-2_03465 hypothetical protein
MPMQMSKKEIQLRQQFTEKKQQADKALQEGKTDEARALLDEVKQLKNQIELMTEGRSLDV
PDLPGGVNFVPEQERNPEGRTGDTGAKEERQKMFAQAFMKSLRGKRLTDEERDLFESEEF
RAMSGKNEEDGGILIPEDISRLIKELKREQVHQLEQYVTVEPVATRSGSRMLEKNSDLTP
FAVLEEMDEIQETDQPKFSKLSYNIVDYAGILPLSNTLLQDTDQAIMTYVAKWFVKKSIT
TRNALILAILDSLKKVEFKGLDPIKKALNVTLDPAISSGAIIMTNQDGFDYLDQLKDADG
KYLLKDIPSEPTNKMLFGRRVVVISNKILKTKSGKAPVIVGDLKEAIVLFDRQQQSIAST
DVGAGAFETNTTKVRAIEREDVKLWDSEAVVYGQLTLPAE
>PK3-2_03466 hypothetical protein
MKDKEVRQLTTPIEIRSEGEGQSEFIEGYALKFEKWSERLGWFKEIISRNALDSADLSNV
IALFNHQQDFPLARNTVSGDAGRLDLEIDGIGLKFRFKPSDTSYARDLMENVRSGVINQC
SFAFSLDYGDADADEWRLNEDEDIYERRINKIHRIFDISLVTTPAYSDTEAVVGARSLEK
VEQLKESRNASDETLKWNWNYLTLYSRSKVFFCV
>PK3-2_03467 hypothetical protein
MLIDRMFEKRSGSTDIDGFNDLFVNLFGGRKTASGETVNERNSLVQPDVFACVNVLSDDI
AKLPIHTFQKTENGIKRNPDHPTAYAVYARPNPYMTAFIWKKLMMTHVLTWGDGYSYIQF
GEHGYPEALYPLRPETTNAYISPITGMLWYQTVVNGKAVELYDHEVLHFKGLSTDGIHGK
SPIGVVREHIGAQSAATKYNAKLYKNEATPRGILKVPAFLDEKPKENVRKEWKRVNQGEN
IAIIDNGLEYQSISMPLQEAQFVESMKFNKAQISMIYKVPLHKLNELDKATFSNIEHQSI
EYVRNTLQPWIVNFEQELNVKLFMDHSQRSGHYVKFNVDSELRGDSQSQAEYFKTMHETG
VLNKNEIRELIERNPIQHGDKYLASLNYVFLDFMEEYQRLKAGGAVKGGDIKNEG
>PK3-2_03468 hypothetical protein
MKKISVFFSAMFNPRVMKRGFSFFLLILNDLLFITGAGFILTAAYRWNTNIGLILTGVFF
MFYAYLLTKKAR
>PK3-2_03469 hypothetical protein
MQEVTAEILIERVWSYAEKIRSGEIKASKKHRWAVERFFRDVERLADDDCPYYFDAEAVV
DFYEWARQFRHVEGILAGQPIELTDFQLFIAANIYGFYKKENGARRFRKVYIQLARKNAK
SQFLALVASYEIFPTQEKHRVFIAGWSREQSDEVYQAILEQLHHAPILKGKYSSANGRVK
KYKTNSIIQPLSREARKLGDGKNPSIGIVDEYHAHETSEIYDVLDSGMVARRSPLMAVIT
TAGFHMERPCFREYQYTSKILDPDIDTENDDYFVMICELDPEDDIKDESNWIKANPIVAT
YPEGMESLRSALKVALEVPEKMRSFLTKNMNRWVDQKDNGYMKMSKWRACKGEIPDMQSM
AVYLGLDLSMTTDLTSVGWVGVLNGIYYVGQHSFMPEGRAKEKMATDKVPYDLWREMGYI
TYTPGDAVDYQLVEKWILEFIFKNRFQPQETGYDKWNALHLAQRLEAKGHNMVEIPQRIN
HLSLPTKDFRQNVYDGKIVHGDDPVLNWAINNAIMKIDPQENIMLDKAKSPQRIDPIAAV
INAYARAMYFGTSGRVDLNEHFGSGNFSF
>PK3-2_03470 hypothetical protein
MARPRQPVDLLLVKGRKHLTQQEIEERRAQEIKAPSDKVKAPSYLPKDLKREFKKIADEL
KNIGIMTNLDVDALARFLFARKLYLQVTEQLLERGPMKTVIVRKFDDEGNVIGEEEKVVP
NDDYSELLINQDKLFKQCRQASSDLGLTISSRCKLVIPKKDDGKPKSKEEERFGGRM
>PK3-2_03471 hypothetical protein
MGTEHQTCMCDECGTMLLVKGCSKVRKHDEGIREHYIKCPRCRTEYTSYYTNADIRRMQQ
KVKKLFALRATMKKETAFDLYTKKLKEAQKKLEAAMLQLKEEMSTPTLKSLRGERRRPRS
PPHFEKFPK
>PK3-2_03472 hypothetical protein
MQKSMKPCNEPACSNLTREGYCEHHKRASPAYDQYRESAAKRGYNSKWRQARLGYLSKHP
FCVSCMMEGRRVPATVVDHIKPHKGDMKLFWDSSNWQPLCAPCHSRKTAKEDGGFGNRTS
NVHV
>PK3-2_03473 hypothetical protein
MGLVNMFNNKATIYEVFITNEIFSISNYIDLVEDSINIRHTNYKAEILKKEPDIESDLLK
YTDPLHKEFNMIFRYSLLIIIHSFLEEKIIELCEENTDENKYKTKWESFKKNKKNKNDNK
NKAKDNSTLENSRCFIKEELKRNFPEKNDAWTKIKDVNLIRNCLVHCGGYVYRDRNPHRV
EKAINQIDGIYIGAYNKIVIEKEFCSNYLRTINEFLSDLYKNY
>PK3-2_03474 hypothetical protein
MDELIKTFGVLPTALTAAAAIIVPFITFILGRINEDHKVKFEYRTFMVMDEITGKYHLKN
APFVKEGAKLLLPNSYESLERLIIGKRLDQDANFTDVSRFNYLQVRTVGKSIITGGYIKI
KLGNDDESIIETSLPFMLPDDEVYIPLDINYGNVTNRKYGIKRIDVWYQLQTGQRMKYKS
VRSFKEEENETIIEDSHSVKKFHLYYWRIQNLRGKNMGWYYLNLNKDKQKNSSN
>PK3-2_03475 hypothetical protein
METFQLIISILSTIFTAVAAIASFYAAKAAAKSNKINLEEIQKRDKPVLDVPSKKFKGPL
EKNLLGQWEEGVKDPLKHGAANYFLDLNNIGNAYARNVVMQFEYEGLDDFIALYSEGGWA
YKDNILSFYLEKKEKQNFHFITFHHFSPKDQISNKIRLPIFPQYENLGTVQSSKYNTEST
KIHIPLFYLLLLNINEYAHREIKLFDLFLVIEYTDPFDVKYKQKFSVKPRFNSVEITEKE
MEFYGRVICEEVSA
>PK3-2_03476 Tyrosine recombinase XerC
MNFVQPIRDPECIFYIKRFLKEQNMRNYMLFVTGINSGLRISDILQLRVRDAKRPYFNLI
EKKTKKKKRIDMTPALQREFKAYVEGKEDHEFLFKSREGINKPISRSMAYKILRAAAEYV
GLDDIGTHTLRKTFGYHFYKQTKDVAMLQEIFNHSDQRTTLRYIGINQDAMNNAMKKFKI
>PK3-2_03477 hypothetical protein
MIKMDKQKNTIDQLTLNIPQIDEEATKLKAEKLLDQYRLYLLQVPDDFLPKVTPTYSIVP
PSITNEFHSSTEEAALKRLDWEIQRDKFLKKIQRAVNRLSQRERQIIVMLYMQPEEMYDY
EVYAEMDLSQRSYYRVKAKALYRLAFALREEVYKDGGTTE
>PK3-2_03478 hypothetical protein
MVEALKKIIWNKYVKFAVIFIVSLLVIILGAFFFEWINKPIWSSNFIVFSSYVLMYYYLI
SVLISPLEQIKPPEKLYHWLNNPIIYEQDSFLKDLKEVDIDKKNLLENLNNFRVELLIYT
NHDLTKLRMLKAHVRTKNIEGSLDTINRTLIALLAGPLFLFVIKNNSIIEYLKIPIKNAN
QELISIMTVLLILLFFLSVIINFVFLFSGNKTRLKFIEEMADACIEELKTK
>PK3-2_03479 hypothetical protein
MTVSLKKLDDLELTLLYSSLLKELKHRGIIRTNNVVGELGEYLAINFYNKTKGLPKLQAA
PTGTQNIDALSIKGDRYSIKTTTGSVTGVFYGMNDPEIREPDIQKFEYVIIVLFDKEYSL
KGIYELSWESFIKHKRWHKRMRAWNLTITKALLSDSEIIFEKKSKLLN
>PK3-2_03480 hypothetical protein
MKSIELFAGIGGIALAAEWAGIETVAFCEREPFCQKVLNKNFRGVPIFDDVRTLNRQLLE
EKGVIEPGGTIDIISGGFPCQPYSIAGKRRGTEDDRDLWPEMFRIIKELRPTWVVGENVA
NFARMELDRTLFDLESAGYKGQSFIIPACAVDAKHRRDRTFVVAYSDSNRRNSRANNWRK
RQLYTNQKWNNQTTLKKREELQSEFGEARSILPDTNNTRLSRSKNTREVERKRKECYQQS
SGLHKERWGSWTAEPDVGRVAHGIPNRVDRIKGLGNAVVPQQIYPIFKSIREFYDYKT
>PK3-2_03481 hypothetical protein
MIPLQVELQRAVKATKDEAMTIYEAAEHLKVNVEEVPMIVAQADDLRMIGNDAIIAKRDK
TNGWLIGAMVLVLFFATAIGWE
>PK3-2_03482 hypothetical protein
MNELSDKQTCPYCDYTEEDSYSNWDSDSDGIVTCTSCHKEYFSLPHYHFEGWQVERICEE
CGHEESECFCEGEAK
>PK3-2_03483 hypothetical protein
MDKLQEIKARISKLKGYENAKLTDQYWMAKEHIDFLIDRTELSVKQQEIIEENKRQQEVT
VHQFKQAQKDIQQLSGDRNRYKQALEKIITNLNFAITVAQNELEGDAK
>PK3-2_03484 hypothetical protein
MENRNSTLLLYHMGAFTVNCPKHIENLEQVLNQIENDKNYVIVIDGNNRSFKLTEMPEHG
KTIVQTSKGNLSRIDFEIGYKM
>PK3-2_03485 hypothetical protein
MTENKNLRQHGEVITWVMTEEERLEYIKKHPIIPTEEPQTKLQVFPMNDWM
>PK3-2_03486 hypothetical protein
MEWTERQHLIEWLTILGGYGKAFLERQSDDEIETLYNLRIKQLNEE
>PK3-2_03487 hypothetical protein
MILSGSASPFEKATIHQLMVIVRYEECPPDYKNAAMQLLIKKGAGTVGMDRTSALD
>PK3-2_03488 hypothetical protein
MSVVVLADRLEIALTDLYFEWSLVQMRQVVDYWYDGKSIYDMAELLNRKPDEIILLIVDF
ARGRVLPPRPYGLNANKRISIKRTHLRSKKENLRRFVQDSPVYIPFIEKNFVWNDSEIKR
FREMWEVNESIICISEELNRDIDEVLFLVMDQASRDFIQPRMNGLLGKDATEHDLIRQRL
PF
>PK3-2_03489 hypothetical protein
MKQGKSPTRAQKDIIKQNGLNPNNWLVSKNLQYEQRLIIVHRYTGTVRKCLA
>PK3-2_03490 hypothetical protein
MVQAVMPGVWEFNPERKLTDAERKKEINKLIALIDQKIADYQNMRRNVV
>PK3-2_03491 hypothetical protein
MEEITRLRAAAVKGEISRRMTFHTDEAGNPVYCNKHTRIIGGEEKPYPVQLMKLRDGSVK
CPMCEREQRNKEIEEEAEAWRRQIGRKVLSTHSLIADPTLVKATFETFHCYNNEDTQNKR
RMLELVDRIKAGVVMNIFLTGESNAGKSHLAISALKEFNKKSSEEYAKSALFVNSDALMR
RIKKSFEDSSEKLTESKAIELLTRVDYLVIDDLGSEVGDTDNEKRPAPDFIQRVWYGVST
GRQGKVTIVTTNLTGVALAKLYDRKTVNRLTAHLERVDFVEKQKDKGRKTPALPI
>PK3-2_03492 hypothetical protein
MSEVKWIKLSTQMFEDEKIKLIEQMPESDTILIIWVKLLAQAGKTNASGYIYLNQNIPYT
DEMLATIFNRPLPIVRMALNTFQQFGMIEVDENKFISIANWEKHQNVEGMDRVRKLNAER
NRKYRERKKQLQLSAPEKKHDVSVTSHDGTDIDKELDKEKDLKDILSGKSDGESSSKKKK
RRFLTN
>PK3-2_03493 hypothetical protein
MLKKIAPERKGLDEMFLVSHVWQNNRFHLVISESESTHQKALDKLLSQGGKVIRSERADN
LLGTVIVNGKRSPWPLTKSERIEQNV
>PK3-2_03494 hypothetical protein
MKIELEQPDIERITNDVIANVSAALIPKIQEMISVLSSQDQLLTKKEVYEGILKCTARTA
EELYFSQPDFPVFELPGRPGSGKTQKRFSRRAVEAWIAQKNCTRAERIG
>PK3-2_03495 HTH-type transcriptional activator BcrR
MFMRELGPKIQTKRKANNLTQTCLAEELKLSRSYISKIETGKIYPSLKTLDRISQVLNVP
VEYFF
>PK3-2_03496 hypothetical protein
MSNNTGVKLKKLRKSKKLTLRDLADKLGVTHSYLSKIERGVTNPSLKMINSLAEFFDVDQ
SYFFTDEKNLDNFTDEELELTFERDLSIENLREKYNLTLGGKEVSDDEIKVILEVLKAYR
ESKGGSRSD
>PK3-2_03497 hypothetical protein
MKKEISLDEYLEKLKQLLEKESVGARAAL
>PK3-2_03498 hypothetical protein
MKKTIIGVLITLAIALAFVFSAKNEDAPGSKSNIVVPSNGTKQLADPPVGMSYKLSKEAP
KPKKEKAIFY
>PK3-2_03499 SPbeta prophage-derived uncharacterized protein YopK
MDVRNHLKRIIESSDEKQKEIADKIGISPAHLSKFLNGQEISLWMVLEIVRYLDKDNEVE
IMRQCCLEATKKNIKTAFEYAHSKSLDSVTCMLLNKTLDGNNRELKEWAIVYQWQLWSKY
NRVYSEVDYLEMLKKLQPNSHDLKTLLQILEMLCFYYSEKYDLSLHYIKKIHNMLPEIKD
PFIKKAFLSRTDEALANMYLKFENNIDKSRGSADKLIERNFSVNSVTNGYFILGLSYLFE
SYEKTSSFFKKGIQLNNTKERYFVANDLREQLAITNLFWNKQVPKEYIVTDFIKAVVNKA
NLKYFYDDKYYSALAFYFDGRREGSQEKLLLSLHVFCEKKDYFRANLPKMELLKLGVDYN
ILKREVKNGEKDNYRSFDYFSNSTSICF
>PK3-2_03500 Tyrosine recombinase XerC
MASYRKRGHTWEYRISYQDPFTLKNKVKSKSGFKTKKEAQLAAAEQETLLATDFEYDTVT
ISLKQFLLSWLNEYKKDTVRKNTYELHERNIKNHILPYFKNIKVTDVKPIMYQKFLNSLT
DKGYSKRTVEIIHGTMFNAFSKAVIIGKLTKNPCFGATVSNKNEKKKDTLQYMISDDIPK
FLQEAYKYNYIYYIFFRALLETGLRKGEAAALQWTDINLRENYIDIKKTLDFAAKTTDEL
FGETKTYESKRTISIGASLSAALQKHKKWQFENKQMLQDDYRHDLNLVFSRVDGNILPKS
TLFNAFNRILKRANMDKMPIHALRHTHAVLLLESGADMKYIQERLGHKSMMVTADVYSHV
SKKLDQNRIKDYENYVSSIVELDF
>PK3-2_03501 Glutamine synthetase
MAKYTREDIVKLVKEENVKYIRLQFTDILGTIKNVEIPVSQLEKALDNKVMFDGSSIEGF
VRIEESDMYLYPDLNTFVIFPWTAEKGKVARFICDIYNPDGTPFEGDPRNNLKRILKEME
DLGFSDFNLGPEPEFFLFKLDEKGEPTLELNDKGGYFDLAPTDLGENCRRDIVLELEEMG
FEIEASHHEVAPGQHEIDFKYAGAVRSCDDIQTFKLVVKTIARKHGLHATFMPKPLFGVN
GSGMHCNLSLFKDGVNSFYDESADLQLSETAKHFIAGIVKHATSFTAVTNPTVNSYKRLV
PGYEAPCYVAWSAQNRSPLIRIPASRGISTRVEVRSVDPAANPYLALSVLLAAGLDGIKN
KLEAPAPIDRNIYVMSKEERMENGIVDLPATLAEALEEFKSNEVMVKALGEHLFEHFIEA
KEIEWDMFRTQVHPWEREQYMSQY
>PK3-2_03502 HTH-type transcriptional regulator GlnR
MSDNIRRSMPLFPIGIVMQLTELSARQIRYYEENGLIFPARSEGNRRLFSFHDVDKLLEI
KHLIEQGVNMAGIKQILAKAEAEPEQKQNEKTKKPMKHDLSDDELRQLLKNELMQAGRFQ
RGNTFRQGDMSRFFH
>PK3-2_03503 hypothetical protein
MFDTLTHGELLKKTAMEVEADIADVHKQIEEISERNEWRVLQSYRKHKVSDTHFTPSTGY
GYDDIGRDTLESIYADVFGGEAGLVRPQIISGTHAISIALFGVLRPGDELLYITGKPYDT
LEEIVGVRGGENAGSLKDFQIGYNAVDLTEDGKIDYDAVAAAINPKTKVIGIQRSKGYAN
RPSFLISEIKEMIRFVKEINENLIVFVDNCYGEFVEELEPCHVGADLMAGSLIKNPGGGL
AKTGGYLVGKAKWIEACSYRMTSPGIGREAGASLYSLQEMYQGFFLAPHVVSQSLKGAVF
TARFLEQLGFISNPKWDAERTDLIQSVEFSDREKMIAFCQAIQYASPINAHVTPYPAYMP
GYEDDVIMAAGTFIQGASIELSADGPIRPPYVAYVQGGLTYSHVKNAICSAVDSLMEKQL
I
>PK3-2_03504 GTPase HflX
MNEQETRQEKAILVGCQLPHITDEHFENSMEELASLTKTADGKVLTSVTQKRNRADAATY
IGKGKVEELKALVEELEADLLIFNDELSPSQLKSLATAIEVKMIDRTQLILDIFAKRART
REGKLQIELAQLQYALPRLTGQGINLSRQGGGIGARGPGETKLETDRRHIRNRIHEINTQ
LSTVIRHRSRYRERRKKNGVLQIALVGYTNAGKSTWFNRLTSADSYEEDLLFATLDPMTR
KMVLPSGYSVLLSDTVGFIQDLPTTLIAAFRSTLEEVKEADLILHLIDSSNEDYAGHEKT
VLTLLEELEADDIPMLTAYNKRDQKLPDFIPTAGRDHIMVSAKFENDADTFKEAIQRYLR
QELLTSFEAHVPASEGKLLSRIKSETMVDRFYFNEENERYDISGYVQEEQSIIGELKKYM
>PK3-2_03505 Stage V sporulation protein K
MEDKQHEFILILAGYSREMDHFLSLNPGLQSRFPISIDFPDYSVTQLMEIAKRMIAEREY
QLSQEAEWKLKDYLMTVKSTTSPIKFSNGRFVRNVIEKSIRAQAMRLLMGDQYLKSDLMT
IKSQDLSIKEEASGSV
>PK3-2_03506 hypothetical protein
MLILKGDQKLSTDNIMHLIGKINALIYARVSTTDQANKGFSIESQIERCKERAISKFGYK
ESEIIALVEPGGMGDDPNRPALNHALYLLEKGLGKKFIVLHPDRLTRDNTLQGVVSRRIW
GMGVDIEFIEFEVNPHDPESMLMYNIQGSIAQYNKAKIHANSKRGRLAKAKKGEFPSFKR
LYGYKFNTVTDLPEYNEEEKEILLEMKDMLLNKKMSSNEIAKELSRRGVAAPNGKTWYQA
TVSRMLQNEDYTGDFYYGKSKVVQINGKKKQVPTNKDEWILIKIPPMWDKATREQIIERL
KSNFKGRSRATKDYLLKNKAKCGRCGGACGSGITSKTKSGVYKYYSCRAKTAKGYQNGKK
VISCEGKNWRVDIVDEVFWNWFIKLMKNPEKFLESFLEEASDQKKIDELKAKASRLEKQL
GEIDEEIANYVILFGKGKIKESMFDQLSQPLEQNKEHIENEIKIINSQLAANKQTEDKKQ
KMIEYIGSFSKMIKNEITIEEKRQFLDFFIEKVTLFDDDHMEVVWKSSSLNNENSHVDFL
NGEQGGEFINSHKRLNYIQAYGRQTA
>PK3-2_03507 hypothetical protein
MSKRRECAENYKVTTVINKDVENWVEEVISTKEFYDFAATLMYKYKKA
>PK3-2_03508 hypothetical protein
MGANNQGKVFEANIEKSATDQKLFFYRIKDVNPMFLKRGAAVSKNKYDCFLHFNGYLFPF
ELKSTKNKSISFSEKIIKGQQIKHLKEAAQYPNIIPGFLFQFREPENKVYFVHIDDFLTY
KNIAEKQLEHTYKNKVNKASISIAICEEIGTEVRWMKKKVNYTYYLNKLCDELIKKSKLL
DNPLNSYIDDKSSMGVVHQ
>PK3-2_03509 hypothetical protein
MKKQWRPVDSRLNELMHEYSVSIEDLVERTGLPKQRINDYVSGFKSNMNIGTAMTFADAI
GCSIEELYVWNFKERRQLIK
>PK3-2_03510 hypothetical protein
MKTVKEAIEEKDLQRAHRNLINLADNNEELMQEIRWVKKGTTL
>PK3-2_03511 hypothetical protein
MIKIEKGNILDATEDIIVQQVNCKGVMGAGVAKAILNKYPNVKKEYQSFRNFNLNKGLTD
KDLLGLVNYVRVSDGKVIANVFGQINIKKNRFDKTVYTKTEALTRGLKEVKELSKQLNKS
VAIPYGIGCGLAGGDWNIISELIDSIFSDYKVTIYKLD
>PK3-2_03512 hypothetical protein
MNKPLLTLTYGLGIAEAFIMGFTIAQKYFVPAIISGILTLIIGYFHVCKGSKTE
>PK3-2_03513 hypothetical protein
MIITAWVLLIMFGLFALSDLNLTEDEAKHIKFFIIMKFVSVFIAAIAAGVIWGGLFQ
>PK3-2_03514 hypothetical protein
MKNTEFKITSFLEEYKRGDEMRRDFIIHEGYTAIEEIIKEVNQRGSLNEADIYYGTPKPQ
LSFSDVELGYMLISMMEYATNLVGNPVDEECEFENKLAYFEYKDEIVQIFEVYGQGTESW
FSKPSDDTIDKLNNTAYGVYLIQFDDFINYTKNKDSESKKLSSSSTILNDITGGYTVGRG
SK
>PK3-2_03515 hypothetical protein
MQNKLTWFDLNYRTDSESKISCCLFRVFDLIKDSLHIYFNIKNSKDIYDCLIQAERQNKD
NLFVEWFLNKGIPKLRSIDLNNLPKDDRFLAMLELDEYILKSEMDFADPEEIRSCIISFV
SSLHQYINLCKEELNEEYRV
>PK3-2_03516 hypothetical protein
MKNAVERFDWWGVTLTGKYKTVKTLYQLMDINKKLFENLYKVQADTIEELVSKLYEQVPE
YEKKFLNFINKQLPNLRMCLQFELPYNSQLISSIEYEIYISSAETDCEYPFDARDCIITF
FQRIPEIIGSYKEGFSAE
>PK3-2_03517 hypothetical protein
MKWNYRLFINDVFWKGYGGYPTVQQLEVERRSYKNSGFYKGGKIKIEVA
>PK3-2_03518 hypothetical protein
MKRIENPKLNDVKILKKDVSSFAVELEKGDKVQIIGIGERGYDLKHVDSGEVVKECGWDL
FE
>PK3-2_03519 hypothetical protein
MQLGKPVLGFSSGVQEDIGLFLTVSSRQIEFSFLRKGNFRVALKKVEDFIGKQFQGETVG
VIYHDNVSRLRDIPKVDVIKLR
>PK3-2_03520 Small, acid-soluble spore protein C
MAQQSRSRSNNNNELLIPQAASAIEQMKLEIASEFGVQLDAETTSRANGSVGGEITKRLV
RLAQQNMGGQFH
>PK3-2_03521 hypothetical protein
MSLLFKFGLMKLSLESLERVKNDTENRIKDGLHSNNQTYIEDQTRKHQDILDELARRKQP
TVVYTK
>PK3-2_03522 hypothetical protein
MVKESEIHSTNEQISALVEKKYQIETTLLEKQRDLLRLETQQNKEKLELLFELSEVLIQL
EDEEWVSCSIALEIIKRNRRKYLDLFNLNDEKAYINKDKFRVLHDEFFVLKHQLNEI
>PK3-2_03523 hypothetical protein
MKKTAIALLVSTLGLTGAAASADAATKSEPTALPQNNLVASASTGSFHALGSATAVKNGI
GKAYLGSSKSGSLSYKTVVNSFTPNNVTKISIMGYQYSAGNGNSSANVTYILRKSNGTEV
ARVTPSGGNYISSQFYKVFSVNLSDVSGKSLYVEAKNNDSNAGVTVNVDVYWDYNT
>PK3-2_03524 Thymidylate synthase 1
MTQFDKQYNSIIKDIINNGISDEEFHVRTKWDSDGTPAHTLSVISKQMRFDNSEVPILTT
KKVAWKTAIKELLWIWQLKSNDVNELNKMGVHIWDQWKQEDGTIGNAYGFQLGKKNRSLN
GEKVDQVDYLLHQLKNNPSSRRHITMLWNPDDLDAMALTPCVYETQWYVKQGKLHLEVRA
RSNDMALGNPFNVFQYNVLQRMIAQVTGYELGEYIFNIGDCHVYTRHIDNLKVQMEREQF
EAPELWINPEVKDFYDFTIDDFKLINYKHGDKLLFEVAV
>PK3-2_03525 hypothetical protein
MPVYKYKPEFVSKVIECKTERLTDSIEARYCLSIKLNNSLDSSFVYIMLNPSIAGRDVSD
LTINKLCKFSHTLNEVGTIHIANLYPFYETNSTMLSSLIKNLQHENTNLFDTVMATNRQV
LSSLVRISKKVVLAWGDCPDLFDKQFHKKQCNDFMLLLKEANQTQVYVIKTHFDKLLTVK
NSPRHPSRPMLKGLEPYNECS
>PK3-2_03526 hypothetical protein
MFFIAYVTLFLAAYLIALNINEVRLIVRGESNAYRKVKNVLDNSTLENVKRNKNLIYLFT
LLKGISFIVPLAYIGLVTHDNILMLAWTAVSLIYTVLSMFKVLDVLEGETVSQSRYIYLA
YVFGNLIFALSIIFHIM
>PK3-2_03527 hypothetical protein
MKVKINGVEFEGTPEEINGLINLHGYKNMLEDDLLMRNFGQLSRVNRSRPTNLFKVGDYD
FHDSPKCLIST
>PK3-2_03528 hypothetical protein
MFKDKNKIIKSIEKINKLEEGLALFEEGDEEYLSVLVKIQGLYDEIADTALECFKEMTTK
IRKTGQKRIGKGIDQLPYTIKENIADQVNELKGSSLDESKN
>PK3-2_03529 putative deoxyuridine 5'-triphosphate nucleotidohydrolase YncF
MQIKIKYLDETQTRISKIEQGDWIDLRAAEDVAIKKDEFKLVPLGVAMELPEGYEAHVVP
RSSTYKNFGVIQTNSMGVIDESYKGDTDFWFFPAYALRDTEIKKGDRICQFRIIKKMPAV
ELVEVEHLGNEDRGGHGSTGTK
>PK3-2_03530 hypothetical protein
MYFIETQEGLIGKEVAYVWANQFCEQTTIITKDGGVFMACQQADWDDGYETRILYPHEAK
KILHPLKRELHEKGMIDETEWEEYENELKKKQEAEREKYLKEKEENDRKLYEELRAKFEQ
>PK3-2_03531 Thioredoxin
MKLIKLEQPNCNPCKMVSNYLEQADIHFETVDVTQEPEVAARFGVMGVPVTILLIDQGEE
VNRSVGFKPNELDELLKELR
>PK3-2_03532 hypothetical protein
MIELRKDSLVGKTYVNNSNQKYKVVQVFKEMNRYKYRIRFLKTGYGRVVEKVEMKRGKIK
DKFEKSVFGVGYMGNVKMTNHKKEYNVWSGMLERCYHPRGCGYESYGAKGVTVEKRWHCF
ENFLEDLPLIKGYDEALFSQGKIHLDKDKIQISVPINQRKYSLATCCFLTMKENNNYRDL
ENIKKEIFALSPEGVLIEAKGIREFARDHGLIKQGIMRCLSGRAKTHKGWKFKYKREAI
>PK3-2_03533 Ribonucleoside-diphosphate reductase subunit beta
MKNPNPNAIHTAADWSRHEDDFTQMFYNQNVKQFWLPEEIALNGDLLTWKYLGKNEQDTY
MKVLAGLTLLDTEQGNTGMPIVAEHVDGHQRKAVLNFMAMMENAVHAKSYSNIFLTLAPT
EQINEVFEWVKNNKFLQKKAGIIVSIYKSIHKNDDISLFKGMVASVFLESFLFYSGFYYP
LYFYGQGKLMQSGEIINLIIRDEAIHGVYVGLLAQEIYNKQTPEKQKELYKWALSLLQEL
YENEVEYTEDIYDQVGLAPDVKKFIRYNANKALNNLGFDHLFEEEDVNPIVINGLSTKTK
SHDFFSMKGVGYKKATVESLRDTDFIFD
>PK3-2_03534 hypothetical protein
MEIERIIAVVKNNSFPPFSPAIMHTSGKKKGTVEKVSIDDLSLSEKQKFNSLIKNVIKNN
>PK3-2_03535 Ribonucleoside-diphosphate reductase subunit alpha
MSVYTDYDQEDEIGLDISCNLGSMNIVNVMSNQSIASTARIAVDSLTTVTRKTNIVNAPA
VARANTLMRSIGLGQMNLHGFLAQNKITYESEEAKDFANTYFMMINFYSLQRSMEIARET
GETYYKFDGSTYKSGEYFEKYVTNDYNPQYEKVKKLFGDQHIPNNEDWMKLKEDVMKYGL
YHSYRQAIAPTGSISYVQSSTAGVMPIMERIEERTYGNSKTYYPMPGLSPQNWFFYKEAY
DMDMFKVVDLIATIQQHVDQGISFTLFLKDTMTTRDLNRIDLYAHHKGIKTLYYARTKDT
GQDSCLSCVV
>PK3-2_03537 Ribonucleoside-diphosphate reductase subunit alpha
MTNTIPKWIKLNNEIMIQKDGKYQFEKDRVAVHSYFVDHINQNTVFFHDLKEKLDYLIKN
DYYEKEFLDQYTFEQIKSIYKIAYSYKFRFPSFMSAFKFYNDYALKTNDKTKILERYEDR
VSIVALYCADGDYEKAVEEVHAMMKQEYQPATPTFLNAGRKRRGEMVSCFLLEVDDSLNA
ISRAIDISMQLSKLGGGVALNLNKLRAKGEAIKDVENATKGVVGVMKLLDNAFRYADQMG
QRQGSGAAYLSVFHPDITDFLDTKKISADEDVRVKTLSIGVVVPDKFIELAREDKGYYMF
YPHSVYKEYGQYLDEMDINDMYDELVENPRVRKAKGNTRKLLEQLAILRSESGYPYIMFA
DNVNKVHPNEHISKVKFSNLC
>PK3-2_03538 Protein NrdI
MIITYESKTGNVKRFVKALQHKLDIEAIEITDDTIINQEFIHITYTIGFGEIPERTLNFI
NKNKNKIRGVVVSGNKVWGDNYGLAGDKLSAKFHIPLLLKFELSGTKQDLQKIIQEVKLI
DKHNTKVDQAQ
>PK3-2_03539 hypothetical protein
MGAARRIDPTQPYVKKKNIISFTIATENTHIHLADGQSFPVLEGEIIATDQQGNQFVELE
KNLDDYVPVKKSSLYESMAQGYMEMGDINREISEAFNYAENEAETLTTKLITGAYND
>PK3-2_03540 hypothetical protein
MNAKFGLYVKGAHVKTYDDAVKAHKDAIFAQEEIGVPHEVIQMNLHMDEAIEFLNKYDSS
SKSAQDAQNFW
>PK3-2_03541 hypothetical protein
MGIKAAVFEIKAICYAHEGFNNVSPSVQGAALEQLGKDIVNNLLENGVDDVKINGDYVEE
LEVEKPVMKYFEVFDPYYALIKAYTKEKAMELYTDTVTDDDDGELSDEMTEVGQVYAAIQ
HGRAPGEDKELMPFKQVLEEISNDEEMVLLIDGSLL
>PK3-2_03542 hypothetical protein
MAYDESNGKLINPKISDVIEVLQEQLEFYGDTPFKCCVNGEYTENEIQVDFYKNVLLFHL
EEA
>PK3-2_03543 hypothetical protein
MILREIAVYEEKFHNYLPKETSMVLHYKNIEAVENEDLITINTGKNSTAYKVFDLDELQK
DPLKMKATSYEGETKVVSVNINKIHFNIAGDQAVKLEFKVLKSVVISVGEPGIYSLL
>PK3-2_03544 hypothetical protein
MAKLLIEYEGTYDLKESVCENKIMSGRTLVRDLGDFVTYGLTLNQNPKVNIKRVDDKGCV
IQEINDVSLSISENENRQKILDNLTALLRKSL
>PK3-2_03545 hypothetical protein
MNKDTKDIWSGFFIGSSSLIVVGLLIFVEALTMSLIVYYGLNHVLNPLLIDTYNIQNVHV
TLPHAFVIGVLLNVFVKGVKRSDQEKDENIFKKAGKSLLHSALALIVLYVSTLFI
>PK3-2_03546 hypothetical protein
MRHQATIEGLVMQESYYSHRAPGTERWITQPVCKVTRTEPIFEGYIDIEPIEIGGKVYIP
GLNEYVIVTDRQRNIHNEWTYQTDRVIKTIIDEKSLRECEEHTNKKAKINDTQNQRLIKT
SWWKRLITKN
>PK3-2_03547 hypothetical protein
MKFHILEHKQMRDIGFTDHVKTKWYFIKSIQPNITFNLTIHKDSLKSEIDVLDERYLQPF
DYQYYMEAYTREQLEFPYIIHDKVQEIMANFIEQGIITEYEMGSYI
>PK3-2_03548 hypothetical protein
MKDKLTSAVHFIEVNRDEMGDKESLNMLLKALNKIINEGR
>PK3-2_03549 hypothetical protein
MQNWMGVKILQLVINILEITGLLLIGIVSLDTYGTKRRIKPQIALGLLVLAGLLFLAGLV
LLIINNV
>PK3-2_03550 hypothetical protein
MNNEKWVVEVYAGKEFVGKMTGLDGKVAVFNKGEQAMTAAQELKAGGSLGVWCKLAKLDG
CENIAASH
>PK3-2_03551 hypothetical protein
MQTLDAPIYEVKQKSDWYKSEKKRKEDINSFFDKFEEKYGVKEGFSFYHSEYFGVYEGTE
AYEVFKNDIVKNPVDGFYAFKKRSKFFKEIKTMIDQIEEVNPFRSHDELGLNNMTGRQWI
GDSSLESKLNSLLKETVWLLLIIKII
>PK3-2_03552 hypothetical protein
MTNTWFISDPHFGHKNIIKYEGDKRPFKDTEHMDNVIIENFNKTVSEGDTVFWLGDMFFC
NSKRIEYIVSRLKKTRNILIRGNHDKGISDTKFRRLGFDPHRMYLYEDYILTHEPISQVN
MNRLIEEFQLCCNVHGHTHSEETGLEKLSHVCVSVENTDFKPVTMDWINSKRWEGARNPH
WK
>PK3-2_03553 hypothetical protein
MNQEKWVIVVRRDGDQNNGKVYNNFVTGEDLIFTNLEEAEKFAMRIETEGRGLWTLVEPY
SKHVLTEKAFDNNFVATMKANRESTHE
>PK3-2_03554 hypothetical protein
MNHICDICKEYINGKTICLRISDDKTYVDFNCCEGCAKGYSEKVKKECSNLSVKKTLEYL
RLNNKYKISG
>PK3-2_03555 hypothetical protein
MINILSKILFILSGCALLIFGIILKNGSMAFGLFALFFIAAIIVRVFHKRTEDH
>PK3-2_03556 hypothetical protein
MNKSFYRTILALVAVFVLAFATFPQNSDAKSTISTDNIDKDKVKSEAEFIADHTIDVSKK
TKEKLLSKANKAIEDGDIKYHKSNEKVFDNASVRAIKYDDGTVTYSVSYLYVDTEKVDRV
SSFNVSFDSDMNIEEYYEVDMKKISSTQNEMSYWVNGVKDEDKSGVFETEKSLEDQTSSS
NMMSTQSWTGCVSDCLGDKNISQWAITGLAILCGAACTAGVPATAGTACYACVNTAGIIG
VNAFFDCMEKCK
>PK3-2_03557 hypothetical protein
MRISDPIKETLVQNMDQLSSKIDELFIYLENELPSTTERQWKTIDKKFGEVFTKSNELQN
YISCL
>PK3-2_03558 hypothetical protein
MKKYYVRCKDSKGENASLVIEALSPEHAKEQAYEVNEVRDIYNVSLGEGRSRNYLERKYS
PYIKNDNGKAIIIFS
>PK3-2_03559 hypothetical protein
MLTDQEKIDLVNALDFVVIEPHTQSIYVHNDEKTNGVLAKVLHTISVDEYIESFKKGSLI
DIFPAAMQEAGAEGFKDGQFVIMPKKFYVDQCYAMSKEIERLTNQIDLHNIKPNTYRGLI
H
>PK3-2_03560 hypothetical protein
MDSYPESLKKETEEIKERVRNGNIKEDRIKEIAETTVEFLKSEEKRHKYFSEVAAAMADN
LSEFFKSYLKGE
>PK3-2_03561 hypothetical protein
MESKVFINPVSSYAYKRKNELGIVIGFVGYKPKNHKSRLCYKVRFESDGMIDYVPVSDVE
QGHYRLMSV
>PK3-2_03562 Modification methylase MboII
MTNNILANLEFNKIYQMDCIEGMRMISDQSVDMVITDPPYTTPTITAFGRQKIRNVADLS
IQETYIKSLKSEFDRVLKPNAPVFIFCDENYYPSIFRAFYDWKHTQMIVWDKNKIGMGKP
FRKRHELLFYANRGSMDYNRTEGITHYPTVLNYKPVGQERVHGAQKPVDLVSDIIKGFSN
EGDIVLDCFMGSGTTAVASLQNKRKYIGFELNPEFIEVANKRLKDLHNN
>PK3-2_03563 hypothetical protein
MKTAIKSLLALSLVFGAFIASPLATPKASAATYGQTYTDMRVGDSNVFMWGDQYQVLNGQ
GVLTVNQYGMVNAIGPGKATVVVYKNGVIIWVHYVTVTR
>PK3-2_03564 SPbeta prophage-derived uncharacterized protein YorR
MALIILEGPDCCFKSTVAAKLSKELKYPIIKGSSFELATSGNEKLFEHFNKLADEDNVII
DRFVYSNLVYAKKFKDYSILTEQQLRFIEEKIKVNAKVVYLHADPSIIKERLSVRGDEYI
EGKDIDSILGLYREVMSIAGLHTYSWDTGQWGSDEIVEDLIQLFE
>PK3-2_03565 hypothetical protein
MFKKGQKVIVDFTDEIGAVAKVDYRYNQVEVKYPDGTYQVVGFHKIRKVED
>PK3-2_03566 SPbeta prophage-derived uncharacterized protein YorP
MPKYWSYPVGLAVEINNNARYGCPHHVGRKGKIIEHLHSATYDYAVSDETGDITYFKEHE
LTPLKGGLTYV
>PK3-2_03567 hypothetical protein
MKCIQIEMSFTDEYGQVTRLNKTYKPSIIEEHKGEIPGLLLDDFKRFLSSLGFNEKQVSR
IVTED
>PK3-2_03568 hypothetical protein
MFILDKEAKVKSTGERGIIEAIYPETETVELCYYDGTYDERRFDDVVMATSS
>PK3-2_03569 hypothetical protein
MKIFKKLIDKHKKYVYHRINEMTLFATIGLLGVGLVYSAKNLYTHQDNQVSIKESFYLNK
KEVRQKLIHEIDAVRILPRLKSEEEKQAESRKKYLNATITYPTEENKKAAKHTKTKKVQK
IIKKRSEDKPASKSTDVKAVKSHEVIATAYTALCSTGCTGKTKTGYDVANTSYYNGKRII
AVDPEIIPLYSLVQVSYEGNSYQAYAIDTGGDIKNDRIDILMDSEQEANAFGRKNVIVSW
>PK3-2_03570 hypothetical protein
MIIKPKLETDITKLYEKHWVNDFDEINTLFHKDEPKLCVLDSETTGLHIIKDKPFMWVFG
WMLPKEKRTDEIKGRVFAFDSKAEILLQVIALTKKCVMTVGHNVKYDLHMLINGGISEKV
VYGLKNITDTMGLCRFSFDAVSARDGGDVLGLKKVSEKYIDPKAGEFEKEVKKELRKIND
AKRNILKELLKPYKGWGLGKIKEAYKVKKRNEMDYFTKEKKQRWLKVPEEIENVYFKWME
ENPFADYSEVDRDIMMEYVHSDGIYTLELVEFTYSTVLKRKQKAILEQENKLIIELLKME
RVGMKVDMPYLHNCFKKCEDEIQKLYEELWGIVGEYFTVSQGTVIADYFEKKLGERPETT
DKSFLKKHKDDRVSQLITRLRRLEKWQSTYISRIIEVAQYDNHFYTQYGQFNTVSGRLGS
DAQQFPKERILTEEGELYEKENGEGKAPIEYEIFSPRRAFIVEGGNYNKIAYFDLSQIEL
RAQANYTVLLKKPDLNLCRAYMPFKCTHYITGEEFRFDTKEERARWYEKKEDGTSVWLLE
NGESWTPTDVHSETSHNTLMALAFKCVDKYKQYEHEKESPVDEKSFKKFWRYIGKMFNFM
RNYGGGAKKASEALEVSMEIANALVSGWSNTFPEVSYYQKQVAAKVQKNSYATNMYGRVY
FLSNTDKAYKVGNYLVQGSCADMLKGYVIRIGEFLRENNCKTLPLANIHDELQFLVYKGE
EWIFPHIKRIMEDVEWMQVPVVVDLEITETTWADKKEVQIKAA
>PK3-2_03571 Putative SPbeta prophage-derived single-strand DNA-specific exonuclease YorK
MIYKLIGENDYKNPIYTIIKNRDINADTFFNLNSSVINHYSLLNNMDKGINCLLKHIELK
NNIFIQVDSDCDGYLSSAILINYLNQAFPGTKVKWRLHDKKDHGASLETIPEDTHLLIIP
DAGSNQYALHQELKERGIDTLVLDHHECEKESNAAIIINNQLSNEYQNKRLSGVGIVYKF
CKALDDKLGLDLADSFLDLVAIGNIGDVIDLREPETRYYVKKGLKQIKNPLIKEIVGRQS
FFLDGNINIHFTAFSIVPFINAAIRYATMEEKTDMMKALLGSQESVYYPRKKIYEPIVKS
VARRISNTKNRQKKSLEKPVNVLIEQLIKENKTNDKVIVLDVSDELKSSFTGLVATQLAK
KFKRPVMLGRKTKEGKFGGSARGYEKSGIKDFKQLLTETGLFNFCEGHANAFGFEIEAEY
FENLSTQLNSIIEADVLLEDVHEVDFIIPAADMDATLIKSIHKYRDDWGSTVEEPLIAIE
GIQINNTDVRVYKNRTSTFVINVGEYKLTKPYYKGDFDELFDNGDETFYLDVVGKCKVNK
YENKSAPAVEIVDIEVTDSFLF
>PK3-2_03572 DNA primase
MSDLQTIRERIYKEEKIQDVLEALGCWGISTEQGGKLFVAGLPDGDNERSVQVKNTPSLT
SNIRSKGISGSIFDVISYILYEAKSEDDKKACLSKSKFWLCNKLNYLEYIDGFYKLTKEK
EKPQPNRWLHKLQKNRNKEDGITDENEILPESVLDQYGNIPYLGWYNEGLSLRTQKLFGV
GIDVRSDRVTFPVHNKSGQLIGVKGRYIGNDPVVNDKYKYLYIQPCNKSIEFYNLHRALP
HIKRLKEAIVVEGGKTTWYLTQWGFKNCISIEGDSMSDEQIRILKNLGIGIKFVFAYDKD
KDAKFIVSEVSRLTGRLRYGIYDKDNLLSDKDSPTDKGYDVWTSLYETKFKINR
>PK3-2_03573 hypothetical protein
MTKQKYIEEFVEPSHIHEALFVGYLWSNPMLYQRYRTHKVSSETFTESIWYFYYTVGSQM
FENGIRDFDDKTVYSFLVSRPKEKNKKSYIDAYNDFGGFESIEELMNECKKDSHNEEYHF
NEIQKYESLRKLQQASLIDITNCELIHKLTAMTLKQLQLYMQYKHKETFAHINSGDVIEH
DLVDGLDETIEDLDSGESMGSPLHDSPRLNRKIKGWKDGSLYYLVLSSGVGKSSIAMEKF
ILSLFENQEKAILAINEESVKKWRSLLLATISSKVLKKPINREKLYEGNFKQEMLNKLNA
AKDWAWERGQGLIKTLELKKYRVEDILSRVELYRPKGYNKLIIDTFKPDRSQKDTARWEA
FSNSAQELHDLIKEDNQNVGTLATVQLKLGKETRFLDLDSTGKSMEINEVAAVVMMGRLL
FADEYTGSKSKYELKPYNYKKDGLGNWYEEEYKLDPKKTYLVLFLAKNRFGSEEEQIIYE
VNYSINSFEEVAYVKVPRIGGSF
>PK3-2_03574 hypothetical protein
MREVKCQWCGSKGVKKEMLCEAKPTGKYNKNGTEKYIRKYFHDKCYVQYEKDKAFKEKEA
NEFDELYLYLKDLHRLEGLSKRMIERLQDLRNGTVKYQSQKVKRYKKGVPFRDILDTYKY
SEQQLHKARDYKQFESPWHEFAYFLSIVVSNINEVKERNRRLAQQDSIRTSVIKKQIQLQ
DEIGLEVKRNKNKKDELDISSLL
>PK3-2_03575 hypothetical protein
MSFRKKIKNNTPKVELQSIMTLVAGGYKTGKTRLWKEVTELHYSNPEEALLLSFEDGYET
WQLDNIVPLHDEGTDKNLWKVWDYFKKTVVPELVQEAKTGRIVKLIGVDTADRAIDACTA
WILYDRNKRYGKTFESLQDISESTNGKENGWTALYEELKKPFDTLKNAGYGLMFLAWTKE
KETTLYDGMKYNSVQLMMPNSGRKVFESQASLICCLHNEVSVLDKQGNELEDNIKDKKGR
DKASNFHDTKVMMYFRPSEYVEIAGGRYTELPEKVEYSAENFLKTFENAVLGQIKKTNRT
VHEIKKEEEQLREEKVQEAAEKAANDPQTYLDEITFLVSDQPPAVKHQLADAYATKFDGQ
KNYKQLNSVEDLKEALIITKSVLNAV
>PK3-2_03576 hypothetical protein
MAYKKKDDIKINKKHGGKEFTNNFRFVGLVKPVRKKDPETDSWYDAEIFETTVTQTKKNR
RVLQFNIETAPYNELKVELSGMERDLVYAYSSVHKKTVPLPWADRNDKTKLPDETYHVIT
PEWDVTEQLAKIVKPGMWVEVQGQYEFDSFENNNGEEIKLVKRIIKRVYPLKNGEVEIKG
VKDGDQFKVYDSEEDGIWLGSGKAKEGVAKVKVGWLNPDGGDLFITKITDDGEGKRFKVS
YTDDVVETDKIKVSNNIQSEVRVVEADGKYNYVSYVRDFASEDFKEHNKFEMQLGIKSTY
QDEETKDTKVNGVYLDHGKEKSVPKDVELIVYYKEPEEGKKPFADAFVGLKRGDFLVVEG
IDNNRAQFTQVQVAESEEENPFEDVGEKVASFETVSTGTRKGLEVLRYIGGTWKSEFLSE
EEISNEKKPNEDPFAEVTVDDDDLPF
>PK3-2_03577 hypothetical protein
MEVLGITEKALSYYRENVKGNKTITPDQALLKMIRNVSLVKETHPERVKKRLFCTEYAYG
NMIIKVNRKKQVFEIVNKSGCFSDQNDWKFPKRRYIELSKELGIKDCKISKITYSKKS
>PK3-2_03578 hypothetical protein
MPNIISKEQDEAIKYFRNKLNLSDKDLYIPLINFELLRDKNEQYANILYELYKNDPYLFI
RALKEGYVVNQPIAFDEAIVRFFNGEELAVVHKTTGKRFNVNIKMKKLPDGFTLQTMDMW
LWSEIV
>PK3-2_03579 hypothetical protein
MNLYEIMLEHFAPKGSERGIFTYVLAQSDEEVYEWLKTDPSLSDGRVVYTPYQDNEADGK
TYAIYNQSFDIVGHEKYKDRMIRLKGELNDEVELTDLYYGMTLVGWRMVKSDIPTEQIEL
LKDTGISMEFA
>PK3-2_03580 hypothetical protein
MKFKLDKDYMINELGLPESSILEEITDTSRWSIHYRIVFSYQGRFFETFYSKGATENQYE
SPWEFEDQVDCYEVELKEVKVRKWIRKESQ
>PK3-2_03581 hypothetical protein
MKLIGIKANNCFLVSDNIESKRYFHSQLDELLFDGKRATETYKSDWFKLDKEPSVIEKQM
PAKKINHRYELKEGFQQTDLTPQVINVSYIDEESEYYEVKGLYELKFEEVPQQNEKIEFE
MNVIEEIDGELKLQSHNFNLNYNLLDRIQTHPMLLETKPCYLSREESYKIIRNHIKANIN
PKFARVTSDYDFCFTVVKVLELYKPHEYVVDLNAMYKRRKPKLEKRFQTKREVEIYKVAP
KAYQSYPIVEPFSGKDVEDLKSNIKKFLDDLMAKINEPLVECKCCKGRGVILNEI
>PK3-2_03582 hypothetical protein
MQQQTVEVKEVDVLIRGIWRKKKFTDIQKGQTFKIEENGRTKKYIARTDPYWDDMYETYI
IDLLDKNKIRRSK
>PK3-2_03583 SOS response-associated protein YedK
MCGRFTLFSEFDVIIEQFNIDQFLPEDEYHPSYNVAPSQNILTIINDGSNNRLGKLRWGL
IPPWAKDEKIGYKMINARAETLAEKPSFRKPLVSKRCIIPADSFYEWKRLDPKTKIPMRI
KLKSSNLFAFAGLYEKWNTPEGIPLYTCTIITTKPNELMEDIHDRMPVILTDKNEKEWLN
PKNTDPDYLQSLLLPYDSDDMEAYQVSSLVNSPKNNSPELIESH
>PK3-2_03584 DNA ligase
MFVSPMLLHSIKEPFDDENYITELKFDGIRLILSKFDNQIKLYTRHNNEVTSKFPELLDL
DIPDGTVLDGEVIVAAPGGAPDFEAVMERFMSKKSAHKIVYCVFDVIYKDGQSIAAKPLT
ERKITLNSLELNHPNVFVIEGIQGNGLAYFNLAKEKNLEGIVLKKADSPYEINKRSHNWL
KVINYDYTEVLITGYTKKDIKFLLSYPDGTAAGFMEFMPHAERGKFHSMKQVKSESDEYI
FIEPILCKVKHRFMTKHGKLRIPSFESWRV
>PK3-2_03585 hypothetical protein
MFLLNNPIELMSNVTTLFDFAGIVAAVGSALSI
>PK3-2_03586 hypothetical protein
MNQDIQFLKELQQELKTQDIDSQAAPRFWTVGDYEWVEAREKTQNAILYTCHILQNHMF
>PK3-2_03587 hypothetical protein
MNLRKILLSSALSLGMLVSAAPVLATSSSSEVIVKSDEYDYDTIYQLSPLPNFKPSLEYN
GYTYTLTRYYFDYSIGFYTAIYTKVV
>PK3-2_03588 hypothetical protein
MIKRNLLSNHVDEIIGEYYAAKGYSVQSIDHQENGQLIVVAERVAKERDSEEVGLAFDFI
HKRPHRKKYLA
>PK3-2_03589 hypothetical protein
MNYLMDGNIAMADHIVWETELGNNIGMDIVTYMEQHGVSKAEAEKAILPLYEEELKALEN
KSQ
>PK3-2_03590 hypothetical protein
MIKSIILPEENTKITVGKPISKESNAKVVAIYDYREEPEEAFWVHLSNGNDLFVDNEEVV
VEYE
>PK3-2_03591 hypothetical protein
MKRFILVLSLLSIIVAYPIQTNASPMPCSVILEPVDKNLKNAKGVALIYKVQLNPPSAAR
TNISILAVHLPAPSSFGNYDSYEGFATKPGEISWRFKLYPTPEEESPSWAGRIDTISAEM
KNVKVQVRLSNSSTQKLGPSILTKNIESCY
>PK3-2_03592 hypothetical protein
MEMEEMILLKEITIFDLNKIIPGTKVKVTWYKGSEMEYTHQGEVIINNGEKFYYNYVDKE
GYVGHCHVNALDLKNYPDSLIVEIKS
>PK3-2_03593 hypothetical protein
MKKLFVLIFSVIFTLTAFVSSASAATTGSVTSSSGTSSKMITGAGMYMKFTCKYAGITEA
YAGACQITRQGENVAVLNVGGGSLNKPFRSTDVWLNKNETYVLSSNFLTDSWSTGSITAT
ISER
>PK3-2_03594 hypothetical protein
MKRTVDLTENREFMKIGSNQSKSLLKRYLKKRVYPWSVEAEVRQNDLYSNGLLLTGNDSE
REKQKESAAFEKTCHCCGKWDSFHMTITKSTLCKSCEEMLEYSVVGNVPWRKQFG
>PK3-2_03595 hypothetical protein
MELLQPNQYFEMIKSKKNKVTDKELQRYYDNCLVLLNKYKQTNQIKAAKKLIFHLESIEK
EREIVKLGIDTFVYRDDIEEYIDNIAKDTVKIIELENYEREIPDDVIIKYNKVKDKLDRF
YVVFTDYTGKVERQIEKERRDKDPILFGTFQDESSGTLIERFYFIGDWEDEYCDLTLDKM
ISEVQEAKESNIAMTINTPQDIQQLKKQLNNMNKIANGFRMNNPRFTVVNEKKNWFKKLF
KRTK
>PK3-2_03596 hypothetical protein
MGMFDSFIGQIKCPNCKNQQKTEVQFKWSECLLLDYELGDVVPGAQEGFYVEDDWFNERC
SNCKTEFMPNVVLKNGKVIAFISKEELQRTDIEHLQDIPYKYMKNLRYDTEKALAKGFTK
ETADFKKQPFKENQSITAFEREWQVVKGWRKDFNPEKSSEFIKLSGCATRKSDYWFVYIV
VEATGLKRFVEVSDRIKHWSDNDDRYGNMLFSETYGFKDEHFLFSEIF
>PK3-2_03597 hypothetical protein
MIRATEKQLRLIGRMEQYISARFTGNTIREASEFITNHMDEYQEEREMADESKVLYDDIF
YEEGW
>PK3-2_03598 hypothetical protein
MDAKDKEMFVSIKEKQKELAKEWDKFCEEPGYRMPDERQADFLERMFLIHYVDKYLDIKE
GVE
>PK3-2_03599 SPbeta prophage-derived uncharacterized protein YopX
MNTPYRVWDGEQMHYWDEPGMSLEIIGTHWFLRHMDSKGHKNLIAGSHEEGTALMWGTGL
KDKKGKDIYQKDITEESYIRPMSKENIIDRYVIERKNGFDRMEHISGKEGFYRHLWLRCD
EVEVIGDTYQNPELLEGAE
>PK3-2_03600 hypothetical protein
MLLDEKLDKLTKAVLRLQAYKEEKNLRRVIGEFHSIIDYAYEGMYIAEDMLREEVSKSKE
VGTY
>PK3-2_03601 SPbeta prophage-derived uncharacterized protein YopT
MAGYLNNIALNLEIVLKNKADSPEVSETLVTRICENLLLSKEVSFLKADGSVENFKLSDM
EYEITNTEELPE
>PK3-2_03602 hypothetical protein
MIKVEIGQCLIPELCRKKDITINELSEITGIKKQQLSDYNRLVKVDMSIRTAKRIAAALD
CNVEDLYEFKVERH
>PK3-2_03603 hypothetical protein
MFNSEIKEKYLDTLSEGMIMQMRPIFAKAEITETLYNKDIYDFTSMQILELIRSFDQTTI
GSVRRTLALLSLYIDWAISYKLSKGLTNLARTISEEELYECLGDKKLYITYSELEEMESQ
LVNYQSKAVLRLLFEGVSGLAHSELLSLTKKQVEDAMLNGNVLTLHDSKHGERKLKVSSE
CLVIALNAAQETKYKLKNGKAKGQTKEVFLVENDYVVKTKRTSNKGDGQASKFVITNLIT
DISEFFKINFLTPNTIVRSGHLYRAYQLYKEKGVIDNSVRYQIIDDFNLRVKSKYRAVYS
MQDYINEEEVNKYYAEELGLKETTI
>PK3-2_03604 hypothetical protein
MTVIFDQSANEKLLSEMKDAISKNKHIRSFINDIQLEMAKNKITPGTTQKLIYDIENPEV
EISKEYMYFLAKSLYSVLESERFNPRNYFTETDMREIETLWEGSVEEDIKFPYTFKQVVK
YSDDNYFFPITAKELFMLFENKLLHYNPNAQRTNKTKKLEGSDIEIPVPQLNKQSVEEIK
ELFLEGKLIKSVFTFNARVGSASCGEELKYDDDTMSLTVTEDTILDVLDGYHRLIGITMA
IRQHPELDHLFEETFKVDIYNYTQKRAREHFGQQNTINPVKKSKVAEMSQNVYSNKIVKF
IQDNSIIGDYIKTNGDWINQNQNLLITFSDFKKAIERSYSKKDFSTQADILKTARYLTSF
FDALATQYVDEFLGDIAKERKRSFMNNYLFFNGYVVLAKKLQLDGVSLDDLESKLTDVLS
SIDFSKKNKLWDELGVVDQNGNAKSPQKIWNFFNNLKIDE
>PK3-2_03605 hypothetical protein
MQNKVKQLKNNAVYDDIEGFLINKDIRSSSGNSNYMMPSSTRRVSNTRKNYEGDIKQFFS
VIKGKDVKRLVPDDLVVSKSELSNYVKYLQEKGLVNNSINRKMTSLKMLYTYLEHDYKDY
IDLSVFNTVERLKTVTKNWDKTTHTEAERIAQDMYINERQKPLMKKLFVKFAIRTSFRVT
AILRVRWKDIKLDESTGHYIVTVIDKGSQVVSTGINQVFYEELLQLKEEDVSETELVFQG
LSEQSLRHSLKRSKKRLGIPPERELVLHSFKGVGIDYVYENSGHDLLAAKEQGNHKNTLT
TERYMSRKINIANSAGVTMDEKIDLNPLYEATKEDFISFFENTDLVTLKKFIKHVNER
>PK3-2_03606 hypothetical protein
MSERIKQLLVKRGITIEELSRETMIDIQKLNKIIEMPDESDVTTIKLIALVLNVSIDELL
DEKGGEDNAK
>PK3-2_03607 hypothetical protein
MHVVELRSTNHKDIIDADFVLNAKQTYIESVLNIRKMIVNAKTEDDLHGAKIEIAALLKD
LNRVLLGGDGLKRSIENNPHFRSLIHFVKNLKRHIAIEFEEFIYQP
>PK3-2_03608 hypothetical protein
MSAISYLKNSMTMHKTIYQKKVESLVKNDLFFHEKSIEKSKIMKNENVRKQLTKGYMKLL
SEYKED
>PK3-2_03609 hypothetical protein
MKKLIMALVILGALGTSYISADSSIQQASGDYEVAGMPRGA
>PK3-2_03610 SPbeta prophage-derived uncharacterized protein YopK
MELIRIAMKKDLENDNSLMNKWATVAGLKNPNPLYDFLNHDGKTFNEFSSIVNIVKSQYP
DREYEFMKDYCLNLDVKTKAARSALEYADANMFFEIEDVLIDLMISCSNMKSKEYGKVYK
IHRELSNSVITEFEAVKRLGKLNIKTPEMNSFSRLLLLYHYLSTGNFSPMAQLIKQIDLS
EISENMYIRNTYQTRVHVLMSNIKLNENSLEECREYSKKALKSTNILRFQVFSYLTIGNS
LLFSNYELAQENFLKGLSVSVQNENYNMIFQQALCFLNNVWRKENKWINFESESIMDLQE
QAHCFINFNENSKAKEVLDKLDLLVHNDNELAMHYYLKGRLEQNKACFYSSIEYFKKSND
KFLIRLPLLELQKMGENQKLLELLLL
>PK3-2_03611 hypothetical protein
MNEFSHFKLKIDAKPTMFHGKTVRSNLTQSLWLKKIRTQILIENNYSCVICKHHPNEENY
KELHVHEIEEYDFDNGVVKLIGLDLICANCHAFQHFKRSQLVLSAEQLDRLIIHFIKVND
CSIEEYKRYKKKLQRSIFEQNIDRIMFQQKSTRTKIDHIRFAILGDIPFKELVIERLKQK
DVYYEYS
>PK3-2_03612 hypothetical protein
MIKEILKNKVNKPIILHDCTFFNNLIHSSIEEAGFFEQTRFAKVNKIGSNYNEDLIPLPN
VSKGYMIFNLNNLFHMLDFDPDAPEYYSIIGYNGNRKYFINDLHFYNMNHNFKMNEMSFA
EFHFNEVKLLK
>PK3-2_03613 hypothetical protein
MKQKRTFIVIFITFLILLGLLFYFISSLGLGLSSPQYSGISAISTSIAAIGGLLLLLVTY
LGYNESRLQRLAQEEPAVSVRLIPHHKNINFYYWVIKNTGNSPAYDINIKIIPDIEYKGT
TINKLNIFNRLPILEKGEEISFFYNSVVNYLESDNPKLVKAYITYFTAPKESKGARKITR
DFDIDFEERLGLLYLGKKDMNDLVKEIEELKQALILNAMRNKND
>PK3-2_03614 hypothetical protein
MNDRDMAIDNVMKFLKDDTQKVLLLRGYDNDAKVKVALSCLNEVFNKGIIRTSNNMNSVA
GSINNAFGEEILPSSIKSTTAYRMGRMTVKINSYEGRTKSNPSGNETTFTLYYPVQRALD
DSKRYKNLLNEIKKTYSRKIILITTNEWSIQNWDIENNVDEVFFYNVENDNPELMSNLKN
NGAIK
>PK3-2_03615 hypothetical protein
MPLIDYFYVLQFENKEYFKSFKLDEDGYLTSSELHGASKLQTMYEVIEVASELKTKCNVQ
CEVREIQVVMR
>PK3-2_03616 hypothetical protein
MIALAYFLIIWLGVGLLTGIKFIFVDQINDEDFKELMDKETVAGMERNLASLFFKNKFNV
IAFFMLSGLLPLAMRITKLFKRG
>PK3-2_03617 hypothetical protein
MIKAYTIGNEIPDKIKSCIDDWNYWTWITVANNSIANKDAKRLIELIEPETDKIAVYKAE
NDIDVFVSYMIPVR
>PK3-2_03618 hypothetical protein
MITVWYKYNDEGSEAKLNHIEDGWINGDYPKPKDPSYSNQEAWKKSSWKRKHAYLDEQYH
VLNVPPAYWIKQ
>PK3-2_03619 hypothetical protein
MGILNFFKNKVKNEQNENRNNNINTSEVNNETEVTSKKENFPILIQETAFSRKYEEKSAF
FEYIDFKVAGTSHYQKDIKKAIKTEDENSFFFDEKYDGMTNKEILESTFDEPIFVYHNAL
FSNCELRLEENNEYDPEAIAVYVNDFKVGHVPRKNFQEGKKYIYDQLKSGIRHPISASLY
GGKYKVNRDDTKIETGETDYKIECQIVIKTDK
>PK3-2_03620 hypothetical protein
MIKSNLKHIIDERKISIRQLSRDIDHEYPTVRKLYHDEMERYPRDLLYKVCTYLNIELQE
LLIFEKGHNHIDRSG
>PK3-2_03621 hypothetical protein
MDFKVILRRGLDDVEEPFNMKGVINMQVLRIFIVHVLSALSAAVVYVLGIDYDGYIPYFL
ISVILFIFYLIFAAPVQYFLNRTPKRFSLKYLLIYIFFSFLVWLIFAVTTDPKSTIDFLM
GYEIYLFGISFGLIFWVWDSVFLQNRIMTAAK
>PK3-2_03622 hypothetical protein
MKILNFKFDNSFFELHAAFTTNLDLLTDYDIQMDMLMMSKAILKKAGITNFLIQDTYFIV
EDSNSVYCTYHFQETN
>PK3-2_03623 hypothetical protein
MRIEVRKFSVHGKIYTLAEYGLFMLEKSYQESDGATKNPYIMSTKEIEDFAIDLLKERMF
EDEEVFECV
>PK3-2_03624 hypothetical protein
MAKCNDCCNERFFYLEVSVSAKQLIDTTGGARNGKIYDVDHSDSGIDNIFNEGNFICKNC
DSKDVYHEDGEGDYRLYNRDREENK
>PK3-2_03625 hypothetical protein
MKIPKRIERAIEEASIHFEIAVKYSNEIRKWLEDRGIGNDTTFDMLIDCIEEGVGDGEEF
KEFIESHTKKELTQENSLF
>PK3-2_03626 hypothetical protein
MRGKAIYLSVEEMKLIELCLDNVEPDDFIDPNRSSEGMAKSNFKANHGAYKAWHSVSDKI
FKALREGAE
>PK3-2_03627 hypothetical protein
MNKNTMGNLGEIRQLQNNLALKRAKLSSVELNDEELNKIDEMLSNFDTVLRNLSLNKNAL
RDYQFGGLLSVLEDMKKKNY
>PK3-2_03629 hypothetical protein
MFEIPCEKCGGKGVIPYYRHIDGGECFDCSGSGIEEVSKEEYDAYLENEKFKKRVKEKGT
FVVFNKTTDEFEYFKSEKEVTGKYGNFYSFGRKYAGYSAYFFDKHKDLVLKQNYYGDNSF
IQEFRKQGIIDKQDKQKEWIGILRGWLKTAIDNKKDANKIHELKIMIEKAEQGLKAIS
>PK3-2_03630 hypothetical protein
MFKDNPEFYPTPTQLIRKMTSKIEWKHINSVLEPSAGKGNLVEAIHNQFKYTKNYRRNSK
YDIDTIEQDENLRHILKGKDYRVIADDFLTFNTYKRYDLIFMNPPFSSGVKHLLKAIELI
EKQQRSGQIVCLLNAETLKNPYSKDRKFLIRKLEEINAEVEYIQNAFQGSERSTEVETAL
IYINIEKQEYSSVLMEELKKDVSHRINEDYKATQLVNADFIKGIVEQFNYEIKAGLKLIN
EYNSLKPLMLHSFNDNSTPILRLQIDKNNEENDIENAYIKQIRAKYWNTLFSNDQFMGLF
TSNLKRKYLQHVEELKDYDFSLFNIYTLRIQMSKEMTQGVEDTILNLFEEFSHKHYYDES
SKNVHLYNGWKTNKSYKINKKVIIPLNGYSWLGRYTPTDYKVLEKLKDIEKVFNYLDNGL
TEDINIDETLKLAEHYGETKKIELKYFYLTFYKKGTCHIEFKDMELLKKFNIFGSQKKNW
LPPSYGKVKYQDMPPEEKDVINDFEGEQSYNNTINNISYYVIDTSKILMLTS
>PK3-2_03631 hypothetical protein
MTAVLRINEELNGIELYFDSKPEQEVLTHLKSNGFRFSGFKNCWWNKRTEKSMQVANDIT
KQKNTSSNTITNTSRRDKGVKMSLWDATKWNEFEVNKEQEVKEMAKEIRKHVRQRFPQCK
FSVTTGGSYLHSTINIKIKSSPYEKGSAYLTAIYDYCNSLLNNYRHCYSPADPYTDYAGS
YNFYGHVSLDWEYKETEQTEEIKEEMALFDSKMEEFQEAEKEKKEFQEYLKEQELKNAEY
KRQQQEEKKQIENIYSNIVVKQLNEEQQYFVIDSQFANLNKNSTLDQYKDEVTKGDFTLE
NVKITKEVHFNTEAALNNFSNMLLNEFDFLAETGGSFTEDNRINSMIDYYNMDDLEKNTV
KWNLYGVGVYYNGELQFIVDAQGYSYARYVGLVDNAKIEKSISHKQTLNEEVQELKNQAD
KLEDISTSVIEELNMFETWKKEDWNKYKAAFKEKLRLNNFKLSKNVIQQVDIEELKISLY
RILQEVDSIQEQFKNAELEKGEKYTLFYISDLGSLITERVTYDSYQPMKYAQYDNAIKLT
YKPENKRNLYYRHFYSDLLMFKGWHSLTDTVLNNVEVRPEGIKIIHSKYHSCDKRQFDEV
LDYLNEKSFEPLINTYKNSL
>PK3-2_03632 hypothetical protein
MERVKVIDSIMGSGKTSAAIDMINNSGTDENFIFITPYLDEVDRIKKSISSKQIYEPKVK
KKGDKTQYKFESFHELLSQNKNIVATHNLFKNANDETKELILSGNYTLILDEVMEVVEQL
RVKKHDLTTLFESKLIYVEDGFVKWNEEKKDYETRYDDIRDMALNNNLMYFKDNILIWNF
PADIFKLFKEVYILTYMFDAQIQRYYYDINNIKYQKYVSEFIEGQYRFTKHNTEYESILK
AQLRNKIKIYEGNLNTVGQLDYSLSSNWYKNKSPYTIKKVKNNVFNYFNNIVKSSSDEAM
WTTYSEHKNKVKGNGYTKGFVSCNARATNDFKHKKHLVYTINRYVNTVLYNYFKEKYQIT
IDQDAFALSELVQWIWRSAIRDGEEITLYIPSLRMRGLLVEWLNG
>PK3-2_03633 hypothetical protein
MEKKFLDAIQQLTKELEMLKKDIDSIKEATVRIDKDLFEYRKEISKVKQDDSVLIMQQHK
DN
>PK3-2_03635 hypothetical protein
MQKDSEKVTYMFSNLIGFLETTIIEGTASQDENILYEDYKLFGTIDKQSYTYKNLVHKYL
KSDY
>PK3-2_03636 DNA-directed RNA polymerase YonO
MKGKKDGLNKQVHIYSIDTSAFYNDQENKLHNKILKSYRYRDYLKKLEHVDKKHKKYITQ
RIISLKENLYNAFNNHNQIRTLRTDSLKDNNVISLFDSVLTRTLGIKENSLSEEIMVVQT
YHFQILRDIIDKGFIHNNEKYVYFTSSAGQIRTKKSCFIKQSTLDKYQNALTCGLSVEQI
NAQGGSSINKWNSYMALSNSASSPWEIDIDKTIVVNDLETNVSSLVDYIDRDTYEITRKI
MDIPIEHTDGCGMMLPSLSQKNFMVRLPWVKGLLVPFDFRKFAEKHSSFIVKDVYGKEWD
IIKDDIQIIFTKSQFKMWKYYDSWDDYRSKFKKYGCLGAKLNEEDPSVEGKLTYQMLQTL
TDITDEELKQISSKTVSEITQLGTDKETMMTVLGATEKNKHKTSLQEALLIYPELLNDDH
TKEIIKNKKKSMIKDAKSGKLLVSDARYTYLCPDLYAFCERLFLGIENPKGLLSGSDVHC
SLYDEGYIDILRSPHLFREHGVRWNKKDKEYENWFITPGVYTSIHDPISKLLQFDNDGDK
ALIISDELIVNIAKRNMENIVPLYYEMSVAQKQEINSRNIYEALTLAYGINIGEYSNNIT
KIWNSDNINLNVIKWLCMENNFTIDFAKTLFMPTRPDHVDEKIKDYIKNKVPHFFINAKD
KEEHSVESINESTVNKLDSIIPNERINFNAVAGKFDYRFLLKNKKVKLDEVLINKYKLLD
RNKKWLMNDEDLKSGQKLYVYKIIKDRLMDLHDNEHYITDVLVKHLYKKKSKFKSTLWEC
FGEVILENIRDNFKNFKACYSCGSMYKSASNKSKYCTKCALEAEKKNHRLRQKKYSKKKM
TK
>PK3-2_03637 DNA-binding protein HU
MNKTEFVGAVAEKLGVTKKEANPKVEAVFNVIVETLTKGESIKIPGVGTFEVRERAARKG
RNPQSGEEIDIPATKAPAFKAAKALKDAVKA
>PK3-2_03638 hypothetical protein
MIDKVLNAFILIGVLLVVGAVTVFKDFEYHQYLRFGGAIMIAFGFMFGYDKVKAKKKSE
>PK3-2_03639 hypothetical protein
MAKKVHTVNLKGNYTYIDGIIEEETKTDIERYDLNSILKSFDGRKVKISITEEDELPQIN
E
>PK3-2_03640 hypothetical protein
MTAILDPVLQREKDESFTDYHIRLFKNKDTYHIDTKTIATLLNKDQGTNYDESKWRKDFK
QYERWNDYIMSRNLDEEILRKYEEVRLQSEKEKIRTRDQKREYRKSIANQARFEKIKDDV
VQAIANLESKRPLRFTFPLPAAAEKHGLALFSDWHFGMEIDNRINKFNKEIFDERIEHLT
NKVIEYGKKNHVSTLHVANLGDLIGGLIHVSTRVQANEDAVEQIKYVSETLAEVLSMLAS
EFQEIKFYNIAGNHGRLSPSKNDVGIKENFEYLINWYLEARLRDIKNISIEPEQDGFIPA
KISNQEVVFVHGHYDRVDQCVTRLPQLLGYIPSYIFGGHIHHNYEKEYGSTTVVVNGALV
GADDYAMQGRFGTKPSQKFMVFDDNGIEATYIIRFKNI
>PK3-2_03641 hypothetical protein
MADYKEVYESFWKQIIEDETGNINKDQLMKELCDYKYLLDSIPAVYEEVTCNTVSKPFVD
PIYVIESHREAFINKRIALDDLRNMSVAAKHYSPYETVVSLGAIEGLLK
>PK3-2_03642 hypothetical protein
MTNEDFKYLNKHLETLAQLKQSGYKCDKEISTVISKLHKIMGLASKSKVNFYTLGSNVEN
ENIADYKIGVDFPKGNRLLIVDPRTDYTTVLLVNVKDSKFENIKRRIAPQTFGYQADLLV
KILKEKRPDKLLIDTCGIGKGLMDMVIEKLKTQDIEMSPSGDLTYS
>PK3-2_03643 hypothetical protein
MVGRKPKEKEKLLCAACQKEKDKDSGFYNSRSKLYEKIGKVPICKSCLKKNIDYSNMDSV
YTVLQQIDVKFDPLYWEQAVQRKTDTFSAYITMANSLKQFNGTGWKDSILEQQEKAIAAE
TQRDSVEQVSDEIIDKWGIGYTPDEYHQFERKYNKLIRNYGEKTALHTEGLLSYIRFRVK
EELATAKGEVKEAKEWGQMASKAATDAKINVSQLSKSDISGGVDVLSQLFEAVETELGII
PLLPRLTAQPYDDADLIIWAIINYYRRLEDKEKVAYKDIYHFYDEMLEEDFKSKGLTTEE
IENLKKARNNVFRDLEDVYKEPLYDTGDEE
>PK3-2_03644 hypothetical protein
MLKPEVGGIELDLYQRVMMRTLSRFPQNYFCIPRGGSKTLTQIMVAYHTAICFPNVTLAI
TASTKESAVKIWKEKHDEILRFYPSIADEIKSESFSKDTGRVEFQNGAIIDNLANAQSSK
GLRRRRGSLEESALIDKDLYDDAIEPIFNIPRTTMTGEIDPAELNGQINRFSTSGYKNSD
EYEKILTMVKETGDLKGSFVFGSDWRIPIHFGRQKMSTINKARQGNVTRFRQNYLCDWIG
ASDGALINISKLIKARTITQPELSCPRDKNKNFLLNEYVIGVDVARSAAESNNKTAIIVL
KIIRNCNNLIRQVQVVNIIEPPNGLSFKEQSIMVKRVFKNYGGNQDLSLSRVKAVVVDGN
GVGGGLIDRLLEDVTDPETNEELGCWATINTDQKPDVPNSPEVVYNLKSQGINQDIITQF
LDYVESGKLKLLKAFEDIKNQKDIADDVMVEAACIQTQLFIDEVANLRIKKNQNSFTVEQ
VVKRIDKDRYSAIAYALYYIAQFLEKEESDEEYSFGFFFN
>PK3-2_03645 hypothetical protein
MDTQKEPSYEYNTDLSNLDSLFFNTSNTSVSYDRVKTWLNNHNLYNKQIRNASKFLYNSN
GIYRNVIDYMVSLPTLDRVVYGNSNDHDQLKLDKRTYGIALRKINDKNIVRDSLRKLSLY
GTSFHYFESVAAENFPKTLSDYEVDSISEINDTKEFNCSILPLPIDYCKIVGRKNSSYLV
AFDVSYFDQFTSKGRSLKLKRWPKEFRQGYVEYKKDLNKRWLVLDNNKTITVKGSADLED
QWGRPIGLAAFVDMVYDDYFVDTKRNILDDLNSTLIYQTLPEGEKKGVSSLTQKQQEQQH
NSIKNALVSKGAVKGIKFFSLASGTKLDKLETNVDFLKVKGEDELIKRISTNLGFAGSAL
NGQDGNYSSQSTNIEMVSSQIFSWLEQISSEFNKVINANIIKNPKSYVEVYYLPLTHVNR
KEKVQNMKDLYTSGRGSLTAWIAATGWNPDAYLSLMEYEKEEGFDEKFPVHATSYTMSKN
DKSAGRPEDDSSQNENTIKSKTNNSNGTPSGS
>PK3-2_03646 hypothetical protein
MRSAILEINNQRKVSGRTFVKWVVLEIHENNAQYNKNGITWIEKHVNANLNSIKDMPLCV
EFIDCENSEPFGHGMTEIKDGTPLFENSTVVGVTTNGYIDTIEVNGQQKRVLIGEGFIYN
QRYPKFVQWLKSKMFDGEFPETSVEISAVEGSSSIEYDGGYKEKGRIPMRFDFTGDAILG
IDPADDAAVLLELNNNHKEEQSMAKTQDEALVELNNKLNIENKALETKVAELNEALKKKD
EELNAAVKAAKDEKAKVEEKEKEIKKAKEEKEKADAELNSLKEFKQNAENEKLKSELNQD
LNKYTEKEKSVAKEKIELFSKSPSLELKTQILSEINSSIAQSFIAQRQKNQSTETNSTND
KDIFSEINDAGQESSVSINDLY
>PK3-2_03647 hypothetical protein
MFKFGTIGAFKQVRNNPRCKATKDLVPGLVVLPDDSTGLAPTPTDATAAKGDIYVVGNII
DKPEVRNKADFKVLKDEYVRAFRVTDLADLPVELSQDTVQGFDALIVGDVIVPAGDGTGQ
WTKAGEDVADYKVKLKVLEKTTFGGKGLYLKVQA
>PK3-2_03648 hypothetical protein
MKIELNNVKWDSDVFANPKLNSKSPIIEIFSAIATGKDISKFGNKADTVMKHVKDLAAQA
VLGNPVAKAEINTIVRLAIEPKLISAVKLFDFMGTFRQIGYDQQPMMTTYAHESIRSGFQ
ASRGDVPFATTTWNEYPIGTQTISAGYAVNYREIQSGNLDKVAEGMEQVQTDMMNKAMYY
VVNEMYNAIKSATGVKYFSENAGIQKSAVDDTIKKVRRFGQPSIVGDYSVVSQLNDFAGF
QAVAGDATSTKLPESVMDEIRKTGLLSTYKGSSVVELPNAYNLTELNKTGDNFKTYLPEG
LLFFIPQGAKSPLQVFQRGGLTSMTGNDIVSGTEITRFDMEIGAGVAKGQEYQIGLIRDE
NFEITPE
>PK3-2_03649 hypothetical protein
MSINLDKKIAIKNLCSWDLYFKKLESHGDFRLPANGIRQITVGEVQSQVFDNVKMFVGTD
GQGSHAKIFIDDKETRVHLGFEAAENDSEQEVITPERIKQILAYKTQKTFEENVTKDIKL
ESEKAQLFEIAKKEKVNDYKKIKFIEEFTGFKFDTES
>PK3-2_03650 hypothetical protein
MTPYEKIINVFHSLFQSNEVLPEGLEKQFLINAISDYETDLTDLGFHEETNTFDVSLSRA
QTQLLGMLMYRGYLGRYRDRALKLNNVIGRDIQLTGLANTKAQVNRAYESLCDDIDQKIS
KLKTNNFE
>PK3-2_03651 hypothetical protein
MSIDWYLSSSSNYLSGWENDEFNTNKYEIFKEILANSPETYDIELNHKPQQVIIQTTQDS
ETKKVLTVLGLLNRGDLIKYDDSYWIVNSRPTDNKMNDSATIRLCNTSFFLTSEDKLVDT
GKINEITGKPIFEKVPGEITEVPCIFERTTSINGTELAVNLPDGQANITIPYLVHEKLKI
GLTLTFFGEDYQVDDIDFSKVYGDHGTIKLVAKKKVGEKT
>PK3-2_03652 hypothetical protein
MSMTVEQMTKIFRLVMDDVELNRLLYYKTDPLSPSHPDVQSLENYYDSTNDSPAIINTIF
KRAPKTDDLSDSPLCRMCVYLGNALPKPTNQSFMLLNQDLMIDVYTHINTFEISEYRSLK
IIDRVSKLFFNKNIAGFGVTVDYRRLLISNPPDGYLGYKMIFTFGASK
>PK3-2_03653 hypothetical protein
MNELKDFFFLGKPIQTEIGEIDFIRLKDYPLYAKELSMLRMNKKSLIKEYSRFNEDGSLD
PFIIEMKKRDLYEIVHSVLPDFHEAYFKVFSKVLINKDSLSLIGKHNFPRLRKLILDMHC
ITEDKVVDNDELQEFHDISKSLKQQDSQSDLKDIVSCVAAFNGYTYEEISEMTMYQLYLS
FYRMAEVMNYNTTTLFATVSPDVKVSDWSSHINLYKEESYHLSTKDAKNIEQLFGG
>PK3-2_03654 hypothetical protein
MAKQTVIHEVGKITAKRLSDNKIIASGVTQMTQFSQQVQQDFLKGGWGNRDLYVINSSKE
VSGNVRNAFFDLDFMAMQQGVKIENETISVWEDESLTVSDTGTVTLSYLPLSKVSLTNED
GDQIEVDAASKTVTVPDTFATKGEALAVHYQIEVEAETVEINGEKFSENYYFEIHTIEYD
PKTSKIYSDLYIQLPKVNFSGEADMSFEAGNAYTPEIGYRALADNNGKIGNFARVKRKAD
GTKGVVTSDEGTGGTGSSQSSDLGGTTE
>PK3-2_03655 hypothetical protein
MEVGLNNDQPLNVNVANTSLDVNITNTASVPVLVKNTAAIKTQVQKSYSEFVVTEADTVA
TGATKSYTVDLIDSLGVFRTYGVAMYTTQTDSSNSKVLASIYSVPKNIPFYSATTSGNDN
SVLFNSIAFVQNYPLQKQLTFTAPKIHLTVKAAGTVDLTGLKIVVWGME
>PK3-2_03656 hypothetical protein
MTFDEVCGLFKQFDGLEQKFLLLSDGSYISVDDFKQRFEGDFNEYEPFTSLQSSPSSTPA
WEGIWNKLQEDGLFE
>PK3-2_03657 hypothetical protein
MLTETTENVVITIPDKTSFTFHEATTSPSEGEEFVVGHFRELTVKISGSSTSREIKFYAV
DENGEKTALSGTNKTDFQLGSSTLNTNEYWDFDIVGLFKVMFEVVSVTGDVTVKGIAVS
>PK3-2_03658 hypothetical protein
MSSSRYVGQLKQNNIQINSLRESNDRAEKHMLEHEQTLTEKTNLFMEYQQNELKKHTDDQ
SNPHLVTKEQVGLGNVLNNVQATKEEFDEHVNDSLNPHSVTKSQVGLANVLNEKQATKTE
FDQHAQDTIIHITASERTTWNAAESNSKKYTDAHSQNTNNPHKVTAIQVGLGNLTNDKQA
TKLEFDAHIKDNERHITSTERSKWNSAQLTKISGDDGQPLVSITSDFHSELLNSPTLTYF
GYDKAALEAPPSNGRGFWTCSADKLYGQAIVLTNDNKTYRKSLINGAWSSWERLISSSEI
DNVPWLSVTYKNGAKTGSRPLQYRKVAGTLQLSGHVVTNRDVVFASIPTEFSPTQGAVKS
VEVSGTFGRSKLFVNSNGDLQLSGVSADNSAAITGYYIDVVVPLN
>PK3-2_03659 hypothetical protein
MIQVYKYDENFMFVEPLVVTEIDEKGDYIFPDNCTSVPLPDSPSYYLPRFDLSKQVWIET
ASQEYIDSLSPPPEEPSDVELLGQSLAEARILILKQNRIILNLQNEVKNLKDGTTA
>PK3-2_03660 hypothetical protein
MSNFWVIALNKNWATLDQVKEAYYYDDVTKEELKEGVDNNLITPEQYQEIVGEAYTSVTL
STE
>PK3-2_03661 hypothetical protein
MASKKLSLSLIEESVNKYDKKEKVQLTDDVHVFIYPYFSPSRLTKMLTEMISDQQKAEDK
GIDFSKINTVQWVFFSIVKEFSDLGIPNDIKNKVKWYLKLVDSEYFPMIINSFPKESMKK
LKDATEALEKITEDLLTMSHEEINKLILEKVEEIETGSGEVSGENN
>PK3-2_03662 hypothetical protein
MKLVAKTIKDIKIMVEQAAIQSVHKSSSNVKKIMVKTGQEHIDEDVYGAYDPLLYERTGQ
VKDAFITTNESNGVSLDNIREDDGKDVATVIETGKGYTYPDSYEYGYGKPRPFMKNTAET
LKDGRLTEALKSDLKADGIKTY
>PK3-2_03663 Tyrosine recombinase XerC
MTKIKKNMLRDRAKKLPEITDEMWQHVNDELRTIVDEFIAVQNFSPATKKQYQSGLRQFG
YYVYQSMNNKPLYKLTKRDILRYLSYLRDNRKLSSSAQSFKKACVSSMFNYIENVIADDE
DFKEYRSFRNLTRGLPPIPKNKVYDKVKITFNEYKDMMDVLEKDENYLGMAWLATAFNVG
ARRSEIIQFKTEILDYPIPDGKTFVYSHNVRLKGQGDDGKVEPYMINLEALKYMRLWVEK
RGYESEYIFSTKYGGEVKQASKSWADYFCSNVLSDILQRRVNPHIFKASCVTYLLESGVD
LKLVSKYVAHHEDVSTTIAHYDLREFEEEKNKIFS
>PK3-2_03664 hypothetical protein
MRKKRVITCVMAASLTLGSLLPAGYASAKEDSKTTPSYEELALHYKMKSEKISSNGKLVE
IEYVSGNETHKVQMNGNDHTVKVDGIEQKGLNFEYDENVANRTNYENNNLKSNEFTTQAA
KPKKGYHYVGTLSGHTKAAKNALSVTMSLVGIVPGLGWGSKAATILFSYWAKEQIPDAYY
KYDLYEKGAMTDSWYQYATVQFFEDKAHKKKMGKPWTSTPAKVDLPNS
>PK3-2_03665 hypothetical protein
MNNKKNIFDIVMYIIFGVLSLFLVAKTDYGTGVLVFVAILYLAVIAYKIKQVFSNSDS
>PK3-2_03666 hypothetical protein
MLNKKVLKHNLVEMNPKELIKFIKHEFPINGQDYHTHARKVQIIKSLSPSELSSAIARME
GIKSQYDPSKTWGIGSLILGTSFIGFQVLFGVNLSKITEGNRLNALIYVLITIIICLWTL
RNIIKDKENATTADYLKELLIQIKSEKNQ
>PK3-2_03667 hypothetical protein
MGYKIMAYGGYFLFCLFFLLMDSWRGMGICLIIAGLALLALEPYKIKSQKNIDKLKENAE
TLKHFDSGFNPDNFFNTYKTKIAFKESESLVKIYHLNRDEHIEEYAIPFSNIIESEIALG
NQIISKVSKSGIVAGGLLAGGIGAAIGGLSASSIQNEMVKSVTLKITVEDLSKPIHYIDF
LPTQEVEGYNTQGYKKDSSIIQQALKNAEYWHGVMDVIIKKANKVAQ
>PK3-2_03668 hypothetical protein
MSQNLKIILTPQADTSSKTVEQLNQQIKSLEKKLNSLKLNTNIDSTTLKALQEFSSAVDT
YQKNLKSYNQTVKETSTVIKNADGSVEKLTQQYKKNGEILQRETKIINNRNTALKQETQE
VNKLTQATEKLGQVQKKTEQRNMQGQPTKVVQKNRHGFDDIVYTTDPKTNSTSSKTTTNY
DQQRRAIEQLKQDLEKLRQQGIVTDTTISSLGRKINTAQSAQQIEALQNRIRMLDDKSAA
VAKNNELKKTIELYQRQAQVNVQNLNTRYGNSMGNSNRQAVQDYLNAVNSLNVSTGSNNI
RSQIQSLNMQFRELASNAQTAANQASSFGAELTQTFKSMSTYLISGSLFYGAISGLKEMV
SQAIEIDTLMTNIRRVMNEPDYKYNELLQESIDLGDTLSNKITDILQMTGDFGRMGFDES
ELSTLTKTAQVLQNVSDLTPDDTVNTLTAAMLNFNIAANDSISIADKLNEVDNNYAVTTL
DLANSIRKAGSTASTFGVELNDLIGYTTAIASTTRESGNIVGNSLKTIFARIGNNQSSIK
ALEQIGISVKTAGGEAKSASDLISEVAGKWDTLSDAQKQNTSIGVAGIYQLSRFNAMMNN
FSIAQNAAKTAANSTGSAWSEQQKYADSLQARVNKLQNNFTEFAIAASDAFISDGLIEFT
QAAGSLLNASTGVIKSVGFLPPLLAAVSTATLLLSKNTRTLASTLILGTRAMGQETLATA
GLEAGMTRAAVASRVLKTALRGLLVSTLVGGAFAALGWALESLISSFAEAKKAKDDFEQS
QQTNVEAITTNKDSTDKLIQQYKELQKVKESRSLTSDEEQEYLQVTQQLAQTFPALVKGY
DSQGNAILKTNKELEKAIENTKEYLALKKQETRDSAKKTFEDASKEIKKSKDELKQYKQI
ADYNDKGRPKWDLIADDDDYKIAADKAKQSMLKAQSDIESGNAKVKDSVLSIANAYSSID
ISNTLKTSISDVVNKLNLKDDLDPEELEKFSSSLGKLQEKMQKALDSGDENAFDNAKKDL
QSLLETYSKSDSSIDVFKMSFDKAQRNIKDGDKSLSSVKSEVGDLGETLAEAGNEAEDFG
KKLKEALDANSVDDIKAAIKEMSDAMQFDSVQDALNGDIFNNTKDQVAPLNDLLEKMAEG
KSISANEANTLIQKDKELAKAISIENGVVKINRDEVIKQRKVKLDAYNDMVTYSNKLMKT
EVNNAIKTLNADTLRIDSLKKLRKERKLDMSEAELSDLEVKSINNVADAKKELKKLEEKM
LQPGGYSNSQIEAMQSVKSALESYISASEEATSTQEMNKQALVEAGTSLENWTDQQEKAN
EETKTSMYVVDKYKEALEKVNAEIDKYNKQVNDYPKYSQKYRDAIKKEIKALQQKKKLMQ
EQAKLLKDQIKSGNITQYGIVTSTTSSGGTPSSTGGSYSGKYSSYINSAASKYNVDPALI
AAVIQQESGFNAKARSGVGAMGLMQLMPATAKSLGVNNAYDPYQNVMGGTKYLAQQLEKF
GGNVEKALAAYNAGPGNVIKYGGIPPFKETQNYVKKIMSNYSKSLSSATSSIASYYTNNS
AFRVSSKYGQQESGLRSSPHKGTDFAAKAGTAIKSLQGGKVQIAGYSKTAGNWVVIKQDD
GTVAKYMHMLNTPSVKAGQSVKAGQTIGKVGSTGNSTGNHLHLQIEQNGKTIDPEKYMQG
IGTSISDASQAEAERQQGIAQAKSDLLSLQGDISSVNDQIQELQYELVQSKLDEFDKRIG
DFDVRIAKDESMANRYTSDSKEFRKYTSDQKKAVAEQAKIQQQKVNWIQKEIKTNKALNS
AQRAQLQEELKQAKLDLISVQDQVRELQKQLVQSKVDETLKSIEKSSSKTQGKIKDVDNK
ISMTEEDEDKVKYYSQQIKLIQQQQSEAKKYIKQLEAQKKAAKGFPDIQEQITEEIENWK
DKQKDFNLELYNTKKSIKDIYKSLADEVVSIYKEMYEKMRDIELKAHQKATQDLIDEIDK
TDDETKFQKELKERQDSIQKLTDQINQYSLDDSEYGKSKVKELTEQLQKEQLDLDDFLKD
RETNKRKEALQDQLERDEESINNKYDDLVNDERAFKKLEDKLMNGKITDIAKQLNEFSKF
ININMESIGKSISNNLIDKLKEASNALNTAVKGNTTGKKVSSFASGGYTGTGLGAGKLAF
LHDKELILNKTDTANILDTVKAVRETAVDNSPKWGQGVKLADLINKGITSIPSLVPNVNQ
SILSNSLIPNLKKIDIPSKTITSSGDKTINLTNTFHIDKLMGGESGARSMFESIKNEVVK
LNGSM
>PK3-2_03669 hypothetical protein
MIRESQYFMFNNIPSYELGAVNVNTEGGLLEESFIANRTVNETYTRLSSEPYVDNVKLEP
YEIPLNFYIENHLDEKNVRRVARWLNVDDYKPLSFSRNLDIIYFALPINATDLVHNCSND
GYVKLTMKVFPYKYGQETTTHWFDVTSGVKNIEIENIGDVDIPLSLEFKKIGDGDITVEN
LTLYRTPLRFTGIKHHEVINVDSNKKLITSSISGYECYDQVNEEYVILTRGKNRIKINGE
CYIRLKYRYKYL
>PK3-2_03670 hypothetical protein
MLNKFKPGEILLSLAKPNKKKIANIADFSNVSLNLSFADLNDLSFNIPLKARYNFLMKPN
HVAKLMREWYLIKAEFLNRVEWFVITGLTKSENEEQTIQVRCQGLPYILHKNKIRSYQGV
SKNLQEVATDCLKGTRLNIGYIDPSFNEKRRSFDITSTRYEFLKTIWETFEAVPVFDTVK
NTVSFYKKETVSKYKGVQFSPERFMIDMEDTIDIDEVVTRLNITGKDGIVINSVNPTGQS
YLDDFSYFLYPFKRDENRNVIKHSDYMDDDLCHAILDYNELVNKEGSSFHLLLNQKRDLE
TQKTTQENKLFTLENIELQQILDKITVAKKAGDDTKDLIKQRDAKLLEVTAKKAEISRIN
SQITNISQEIEKLKNRLSMDKFLGEELKKQLSYFIFEDDWANDNIFDETELYEKGLEELS
NRNAPPVDIRTNIVNLFNVNSEKAFWDRIYLGDIIRVVNKNFRTDVKATLSGMTFDFDQQ
SIQVTLSNGKRARSLEQEFANTLYTAKKASTEFNKKKIDYDTLLVNYNARNDRISSPVAN
PTILNNGTAITHVVNDNGSVDISIEWQFPNSKEDKYNIDGFLVHCYSDTSSDTYIFGSKM
SSEQYLSVSYDKRIATLTGQVSNKYYTFGIQAYRTVEASIDSSGRILSDIIQPLFPSENP
YLPSNSVEVKGSLSGKVNGLYTISTETKPEDPETGTIWINPQNNKQELFNGEEWIVSSAG
SADSLNGFTASTTTSPNSIPVRNELGIISGSIDGNAELLGGRAASDYALANNIPLPPKFA
KGVYIGDGTPSKQIPLSFTPDLVKITPISTEDSMLVIESPTGGYAYQCTASGLSLIGGDL
SYGALGDKIFLTGSDENFRGNKLNVKYIWEAYQQN
>PK3-2_03671 hypothetical protein
MINLTDFAELYNDPILSKKRKGSVDDPYLTYNETLTVYNGRVLLTEIPNREFRVEVIGSN
KEWREIEDGELEDNYFKVDYLMGVVFFNVSNEGKSLTFNYSGEGASFFPASRIWIKRQGN
MVIETLQGLIDEAEDTIIRMNERIAECERVTKRCQEVTAWCRQATSNYEEVVENTRKIYK
PSVYTYSDIFTYYPTPQIGWTVTVKETKIVYRWDGFEWVDIGTSEVYEGFNILLSATEPF
NANYIWYKDASFSPEKKRVVVSDTAPDSGQVWYKTD
>PK3-2_03672 hypothetical protein
MAGFYRYDQNLDKYVPMPVELLASEGEEYTAPKITQKFNEVETKTTEILNKVLTDDRYFT
VTSSFKQDTTLGIEYYVTKVTPKTTEAKKSMVQKTFAYDFEKSIDPTSSYFGTTNRETVL
SMAKRKRSVVAINASGWRSNGEVMGLQIKDGVLYKDYDAAGYTGAEACVFFDDGTMKVYG
NREVDADILISKGARNSFAFGIWLVKDSKPRTAQMTTWADLNVKHPRQAIGQRSDGTLVI
ITVDGRSLRSSGITAYDMPSLFLSEGCVNAFLLDGGGSSQTAVEGKYINNISDGIERAVV
DTLTISYPDDDTDSRFFEVQEGRGLATSLNRRVEFIESKPTWNVLDLGFSPDGLIDNTAK
FKKALSDLSEKGGGKLHFPKGTYLIGKQNTTSASEKIELPSNVSIVGERRSYTKILRNPN
HSLDELLRITDHNYIEGIEIDGNSSVNKSSCRLIAGGNIKSFKMKDCSLVNATDRGVSIH
GIGKSITIEGMYISNIANECINVAEGEIIKLIDSEITFSGTALWVGNAANIFTKNNLAKS
LKTFVRYKNSQNAICSGNIITNNIDRAIWGSVREAIFSDNVFKQCHSDYHLYFIQEDTGT
NDLIVTGNSVYSDVEGTAFIRTPSDIDRRRVSGNVGNIPSLNLD
>PK3-2_03673 hypothetical protein
MTIQARKMLVSPGKYPIKGRYAMTAEYITFHNTANDASANNEISYMRNNNETVSYHFAVD
DKEVVQGLPTNRSAFHCGDGEYGTGNRKSIGVEVCYSNSGGERYRKAEALAIKFIAQLLK
ERGWGVDRVKKHQDWSGKYCPHRVLDEGRWNAVKAAIAAELKALGGNTSSSSSKPPTKVV
KTNGSYVKNTVIADSLNVRTQRNANSSIVLTLPKGSTVQYQKGSTQNGWGYIKYTNSKGA
TYSGYVNVKYIKSDAELGQSAPKPKSTSKPNSSGIKSVGKIKVVGVKSAAIVMDRPDKNK
AKNLGTVDLGDTVSISGSVKGSNNAKGYWEVIYKGKRGYISGQFGSKM
>PK3-2_03674 hypothetical protein
MDNFEQSTISRLSALEEKAKHTNNKIDSLEERTNVIGRIATLVEQQVEINKDSQAQSREQ
FSTLNEMSNSLKNLSKSYEKLDNRVEILERSDSTRKIDPSQFTKDLVFKVLPSVIATIIG
AWLLIHFGLK
>PK3-2_03675 hypothetical protein
MTKINWKVRLKKKTFLVAIFSAALLFVQAIASAFGYDLTVFGDELTEKFNALLTFLTAMG
IIVDPTTQGISDSEQAMDYDSPR
>PK3-2_03676 Response regulator aspartate phosphatase A
MEQMISSSKVGVKINEWYKYIRLFSVPDSEILKAEVEEEIRHMKEDQDLLLYYSLMCFRH
QLMLDYLEPKTLNEERPKISDLLEKIESSQTDLKGILEYYFNFFRGMYEFEQYEYLNAIS
FYKQAERKLSLVADEIERAEFHYKVAEIYYHMKQTHMSMHHIVQAIDSYKAHENYTVRVI
QCSFVIGLNYLDMDYPEKAIPHFKDALDKAREIDMSRLIGSSLYNLGLCSFAEEAYEKAS
EYFKEGIRVYQDNGYEHSNRILDILLMLTKTTFKMRNHSEGISWCAHGLSLSKNLNDEIM
AKMFEFIHALYVDNDNEKLNSILNYLELKSMLSDVEDLASDAAKYYNEKEDHKVAVAYYE
KVLYARKQIQRGDCLYET
>PK3-2_03677 hypothetical protein
MKLKHASVFILAIVLIGFVSIYLTNTQKDVQEARRGHTASIGFTDGHSYEIASRGHTS
>PK3-2_03678 DNA polymerase IV
MIDYSQFPRKNILCVDMKSFYASVSAVTMGLNPLTCYLAVVGNTERQGSVVLAASPALKK
DFGIKTGSRLFEIPEDPRIHIVNPQMKLFIRVSTEITKLFYRFVPEKCVHTYSIDESFLD
AGKEDPEEMAKAIQSSMWREFGLMCTVGIGDNMLLSKLALDLESKKTKSGIARWRYEDVP
NKLWNVHPLSKMWGIGGRMERNLNRMGISTVGQLAKFPLELLEKKFGIMGNQLYYHAHGI
DLSEIGAPLIQGQISFGKSQILLRDYTRREEIKAVLLEICEEVARRARTHNKVGRTISLG
IGYSKDELGGGFHRSKTIEFPTNITMDIYECCLMLFNKFYSGKTVRSISVTLSNIEEDVN
QQLSLFEVDNEKRRKLGFVMDGIRSKYGSKAILRAISYTPAGTALHRAGLTGGHKS
>PK3-2_03679 hypothetical protein
MLRDRGTIKWTSMMLPEHLTQLKQDLIDVSKIEKPSLDDQQIEEMDLLVSEALEFNKELK
FKLFNNGFVENVNGRVHYINFEQHRLHVKDQNDNTIYINMNNIIGVTYND
>PK3-2_03680 hypothetical protein
MSLISKLTSKKQKDKEFKNILASIEPLKEDYYTLGGKLPFSKEYSTYVPYALENQYDSSL
VGVAFDYLARFRIGQFTNKEEARDHLIAYQGLRKLSNKTKNYSLTDTFYIPLINDILDFI
RSESKISPDICQKALKLAKLEQLYRSRTIGETNVDFYTCIDSSDEIVNDLISLLEVFENK
FINSGILTKNSEVVFNPSFGVSSPLVGGADADIWIDGTLYDFKTTKKNSLDKNDNLQLIG
YFILNELAQEVHAAIGAPPLLDIDRLGFYKARYGEIEFYDIEKLITKEMRDQTLVELAKY
FSENPGKLNLVHDPFFVEDAKEVLKSISERGI
>PK3-2_03682 hypothetical protein
MWVNLLEEIRKTEAKYGDELNSPITDQEIRNFEEAVLGKFPVNEIPSGYKKFLQTVNGLD
FNGLVIYGLDQELLREENDEEVYGFIETNEQWHENDEQKKYLFFGDSDTAWYCLDVIENE
YLELDKPSGTLMNKFNDFNAMLADALKVSLDN
>PK3-2_03683 hypothetical protein
MKVFEAESLLSEADKRTKEYKELRSQMVKLRKAFKDVADLDDSEFSGKGANNIKAFYHDH
VGVTDQWIDLIDMKIAFLSSISAKLEDAKMSDAYIEESFLEHELANAYTKSKSIMSEQKK
AMKDILNDINDILPLEIFSTEDFKDKLSSADDKREKTIDKLNKLDEDLKTEYAETEPNEQ
FIQQDFKKLQESTGKGKNATPIHYNAKAYRESDIHKKKGDIEKHSEAYLNVKKEEAKERE
IKELKKKLNDGVSDPDEYLEIAKKVGYENLEPAQVQLAMQIEQAKQLEEAGEITWDIIKG
VSVAAYDVVKDTVVGAKDLAVGTWEFSQLSEEQKLLKMTGAIIETPAYAKIIWKDLSDSW
NDKMVNGDAYSRAHFITYAVGSLVGLKGGGSILKGSSKLATTGAAKVDKVLGAGEKAVTN
SVKTGIDKGKTFINSISLNNNRLAYAGILQDIENTHNVKNTSILKEAIDQKNSVLYKSAG
SDDFVGTLKGEQVLLKGVKVKEISYTKRSPEETAKLRRKFNSSIKKQFLKGLSNDPNKVK
KLKKAGLTDKDIARMKDGLNPKGYQVHHKLPLDDGGTNDMDNLILIKNDPYHKAITNEQN
SLTKGLTPGETKKINWPIPNGEIYPSEK
>PK3-2_03684 hypothetical protein
MEEGKLIHLTLAGIKEAVSKYGTFPMIQPGGFVLEDVTFEFNEPATEDEIRKLESHFNVS
LPKDYKEFLALHNGLEFLDGIEILSIEDVMKYNETEDLPEKCFLIGYHFDGRYVIDSNRY
EKGDLDYLFYLDAIDHFDEAVDLRANFEIWFDRLLSSNGNKYWEVERDVKAYYKNIN
>PK3-2_03685 hypothetical protein
MLGINVEKSNEKLIINWQLSKIEIPIREIHDVFLDPNYGGEEKSAVRIGFPYGSRIG
>PK3-2_03686 SPbeta prophage-derived endonuclease YokF
MKKVLLGFAAFTLSLSLAACSSNDSEKVSTEKETPQASTDAEKKTEQKESTKEKTADKSK
EKDKKELVDVTLDRAVDGDTIKVRYNGKKDTVRYLLIDTPETKKPNSCVQPYGKDASKRN
KELVNSGKLQLEFDKGDRRDKYGRLLAYVYVDGKSVQETLLKEGLARVAYVYEPNTKYID
QFKKDEQEAKTEKLSIWSKNEYVTDRGFSGCVKEKTTAVKKATTSKPAATQPTTPKTSSE
TSTTTENEASSESTGETETFKNCTELRKKYPNGVPSSHPAYQSKMDRDHDNFACER
>PK3-2_03687 hypothetical protein
MRNSNFYNNLYFGIGGEHLVMSDFLMRGFEAVKITPDFGYDILVTNKHKLLTKQAEEEIQ
LYLQVKTRLIYPAASSTDLDILIEKKNYSYLLSDKDSYLVIVTVKGVLANDSWSEDPLQT
FDFNVISDSQRNLDRSIYQYFIPHNFTWLNHNDLKYLDDNNFISECNINGVQYLKIRYDI
NNRIYDNKNEYHELSDSRTSLFSMTNMNYWTYNNTNLFF
>PK3-2_03688 hypothetical protein
MDQSQIEILSLIITTIGVIVALLIALFPKLFPAIGSFLISLNLYVWVIILLLLIIAVLIY
IVIRR
>PK3-2_03689 hypothetical protein
MHFEELKTVGEISKELNISDWIILDLFKSQNVDKLSFQELSKRRRTKDFAFLYDLHFNKK
MSLKEISRAYDYSSPYIRQVFKDQGIQHLSFKNQHKS
>PK3-2_03690 Stage V sporulation protein K
MLERAVTYKNNGQINIILNGQKQVLTNAEAEAEYQAALQKNEAKHGILKEIEKEMSALVG
MEEMKRNIKEIYAWIFVNQKRAEQGLKVGKQALHMMFKGNPGTGKTTVARLIGRLFFDMN
VLSKGHLIEAERADLVGEYIGHTAQKTRDLIKKSLGGILFIDEAYSLARGGEKDFGKEAI
DTLVKNKVLTFMSLLNSISLSLNVSINTYGSNI
>PK3-2_03691 Sporulation-specific N-acetylmuramoyl-L-alanine amidase
MVKIFIDPGHGGSDPGATGNGLQEKTLTLQIALALRTILTNEYEGISLLLSRTSDQYVSL
TDRTNAANNWGADFFLSIHVNSGGGTGFESYIYPGVGAPTTTYQSAVHSEVIQAVDFADR
GKKTANFHVLRESAMPALLTENGFIDTLADANKLKTSSFIQSLARGHASGLEQAFNLKKT
SSSGLYKVQIGAFKVKANADSLASSAEAKGFDTLVVLRDGLYKVQIGAFSSKDNADALAA
RAENAGFDAIVILES
>PK3-2_03692 hypothetical protein
MGKMDEMILVAPRDDVFKKESLTFQGVNSEDSKVAEIMAQIEAGYREMRRGDAEEDSLYK
QPIPYVVIKREDEVFLYERLSGGGESRLHNKLSLGFGGHMNAIEGAASFAEVLKLNTDRE
LDEELQINEEDKQPIVTLGLINDDENSVGKVHIGILSALQLKPGSHVEVKEKEQIAGRWM
KVSELKQDDIYNRLETWSQFVVDILQ
>PK3-2_03693 Ribonucleoside-diphosphate reductase subunit beta
MTKIYDAANWSKHEDDFTQMFYNQNVKQFWLPEEIALNGDLLTWKYLGKNEQDTYMKVLA
GLTLLDTEQGNTGMPIVAEHVDGHQRKAVLNFMAMMENAVHAKSYSNIFMTLAPTETINE
VFEWVKQNKYLQKKAQIIVGLYKAIQKDDEISLFKAMVASVYLESFLFYSGFYYPLYFYG
QGKLMQSGEIINLILRDEAIHGVYVGLLAQEIYNKQTEEKKAELREFAINLLNELYENEL
EYTEDLYDQVGLSHDVKKFIRYNANKALMNLGFDPYFEEEEINPIVLNGLNTKTKSHDFF
SMKGNGYKKATVEPLKDDDFYFGDEKEQI
>PK3-2_03694 Ribonucleoside-diphosphate reductase subunit alpha
MSQNQVPKWIQLNNEIMIQKDGKFQFDKDKEAVHSYFVDYINQNTVFFHDLKEKLDYLIE
NQYYEEEFLSLYSFEDIKAVFKTAYAKKFRFPSFMSAFKFYNDYALKTNDKKKILERYED
RISIVALFFANGDTEKAKEYVNLMINQEYQPSTPTFLNAGRKRRGELVSCFLLEVNDSLN
DISRAIDISMQLSKLGGGVSLNLSKLRAKGEAIKDVENATKGVVGVMKLLDNAFRYADQM
GQRQGSGAAYLNIFHRDINDFLDTKKISADEDVRVKTLSIGVVIPDKFVELAREDKAAYV
FYPHTIYKEYGQHMDEMDMNEMYDKFVDNPRVKKEKINPRKLLEKLAMLRSESGYPYIMF
QDNVNKVHANNHISKVKFSNLCSEVLQASQVSSYTDYDAEDEIGLDISCNLGSLNILNVM
EHKSIEKTVKLATDSLTHVSETTDIRNAPAVRRANKAMKSIGLGAMNLHGYLAQNGIAYE
SPEARDFANTFFMMVNFYSIQRSAEIAKEKGETFDQYEGSTYATGEYFDKYVSTDFSPKY
EKIANLFEGMHIPTTEDWEKLKAFVAEHGMYHSYRLCIAPTGSISYVQSSTASVMPIMER
IEERTYGNSKTYYPMPGLASNNWFFYKEAYDMDMFKVVDMIATIQQHIDQGISFTLFLKD
TMTTRDLNRIDLYAHHRGIKTIYYARTKDTGQDSCLSCVV
>PK3-2_03695 Protein NrdI
MVQIIFDSKTGNVQRFVNKIGFHQIRKVDEIDHLDTPFVLVTYTTNFGQVPASTQSFLEK
YAHLLLGVAASGNKVWGDNFAKSADTISRQYQVPILHKFELSGTSKDVELFTQEVERVVT
KSSAKMDPVK
>PK3-2_03696 hypothetical protein
MKHKVIVNHWEEICEDDSCYEYGTSIIVNGKELIREASIISALKAVLEEIGADVEIEETV
ESEKCCDSLRKKNLDY
>PK3-2_03697 putative protein YmzC
MFESEAELRRIRIALVWIAVFLLFGACGNHDTVIETDSGNSGDETPQPTSFPLEHNHFGV
MEDGYIKIYEYNESRNEVKLKKEYADDELE
>PK3-2_03698 RNA-binding protein Hfq
MKPINIQDQFLNQIRKENTYVTVFLLNGFQLRGQVKGFDNFTVLLESEGKQQLVYKHAIS
TFAPQKNVQLELE
>PK3-2_03699 tRNA dimethylallyltransferase
MNNTKQPVVILVGPTAVGKTNLSIQLAKSLNAEIISGDSMQVYKGMDIGTAKITEQEMEG
VPHHLIDILDPQDPFSTADYQGLVRNKISEIAKRGKLPMIVGGTGLYIQSVLYDYTFTEE
ANDPAFRESMQMAAEREGAEFLHAKLAAADPEAAAAIHPNNTRRVIRALEILHTSGKTMS
QHLKEQKRELLYNAVLIGLTMDRDTLYARINQRVDMMMEAGLLPEVKRLYNRNIRDCQSI
QAIGYKELYAYFDGFVTLSDAVDQLKQNSRRYAKRQLTWFRNKMQVTWFDMTPPVDMKLK
KKEIFTHIAGKLEL
>PK3-2_03700 hypothetical protein
MGEPRKEKDVNTLGLYQSDWSKAPPHAHAYHVKTTREQGHYHLIEGFTQPANGSNIDQHT
HYFTGITSFDNGHFHRYYGISGPAIPLADGTHYHELEETTYLAYNKPIKIQYGGVVYSPG
DDGRKTHRHALKGKTREIVGNEPFGW
>PK3-2_03701 hypothetical protein
MNELEHFSAEDTRIFGRPFGFGRPGFGYGFGRPGFGFGFGFGRPFGFYGGPFFGGLVGGL
VGSALFNPYFYGGYPYYPYAPFPYYY
>PK3-2_03702 Multidrug resistance protein EbrA
MLIGYIFLTIAICSESIGAAMLKVSDGFKKWKPSALVVIGYSLAFYMLSLTLNHIPLSLS
YATWSGAGTVLTTVIGVKWFKEELNVKGLIGILLLLSGVVLLNWQ
>PK3-2_03703 Multidrug resistance protein EbrB
MKGLLYLALAIISEVFGSTMLKLSEGFTQAWPIVGVIAGFLSAFTFLSFSLKTIDLSSAY
ATWSGVGTALTAIVGFLLFGETISLKGMIGLTLVIAGVVVLNQSKAPAKD
>PK3-2_03704 hypothetical protein
MADHHFYLKANWPGNRNDVGTIESGNLITSISIPKEMDGPGEGTNPDEMLLGAAATCYII
TLAAMMERSGLEKDDLQMESEGIVDVTKGVFTYKKIIHRPSVVLKQDASKEDVALAHKLC
EKAELSCMISRAIQGNVELQLEASVKRAGE
>PK3-2_03705 hypothetical protein
MRRFLLNVVFVLAIVLFLRYVHYSLEPEPSNQPDTYSNFSSLAENESPADYDISYNEKKG
SKVLIMSPHGGRIEGGVSELVRYFNNEYSTYLFEGFKSQDNQTLHITSTNFDEPLAEKKI
KEHQYVVAFHGYKGESKNTLVGGTDRKRAKMIVRALERRGFSAELASSKSGLAGLNAENI
NNQGETGLSIQLEISREQREAFFDDFYYKNRKYTKNSEFYAYVRAIKTVLENEYS
>PK3-2_03706 hypothetical protein
MNFFLHRSLESQMPICIIYMKKDGTISKRTIIVRQKSKTQIKAFCFSKQQIRTFLLDSIL
SCDIVRTNKQNRYLTGR
>PK3-2_03707 Serine protease AprX
MFGYSMVQMVRANAHKLDWPLRESVLQLYKPFKWTPCFLHRFFETKLKNRKKMSVIIEFE
EGCHETGFQMAGEVLQKEKRSKLKSSFNKINCCSAEVTPSALDSLLSACSDIRKVYLNRE
VKALLDTATEASHAKEVVRNGKTLTGKGVTVAVVDTGIYPHPDLEGRIIGFADMINQKTE
PYDDNGHGTHCAGDVASSGASSSGQYRGPAPEANLIGVKVLNKQGSGTLADIIEGVEWCI
QYNEDNPNEPIDIISMSLGGDALRYDNEQEDPLVRAVEEAWNAGIVVCVAAGNSGPDSQT
ISSPGVSEKVITVGALDDNNTASRDDDTVASFSSRGPTVYGKEKPDILAPGVNIISLRSP
NSYIDKLQKSSRVGSQYFTMSGTSMATPICAGIAALILQNNPDLTPDEVKELLKNGTDKW
KDEDPNVYGAGAVNAENSVTAQ
>PK3-2_03708 hypothetical protein
MPYYICETCGVQHAQTVNPPISCLICEDERQYIHPDGQSWTTLEDMRKKGNLQNILKKEE
EHLYSIKTEPEFAIGQTAHLIRHNGFNVLWDCISYLDQKTIDQITELGGIQAIALSHPHY
YSTQVEWAEAFQAPIYIHEDDKEWAARPSNHIHFWTGEMLKLKPGLALHRLGGHFKGGAV
LHWSSGNEGKGCLLTGDIIAVAADRNWVSFMYSYPNLIPLPASKVEEIAAKVKPLQFNRI
YNAFSKVVKENADEAVQRSAVRYIKALNSELFHT
>PK3-2_03709 hypothetical protein
MAHTNTQLSQWLESKVGQTLDIRKGELTHDEEISDLDQIALQLHKVGIRSTNHPDDYVAR
EELVLEGEGTTFTEEGDVPLPQNAYEIPLLGDIHIHQENEGLKIVTDRAVYTIDVQPS
>PK3-2_03710 Polyketide biosynthesis cytochrome P450 PksS
MEKLMFHPHGKEFHQNPFSVLGRFREEDPIHRFELKRFGGTYPAWLITRYDDCMAFLKDN
RITRDVKNVMSQEQIKMLNVSEDIDFVSDHMLAKDTPDHTRLRSLVHQAFTPRTIENLRG
SIEQISEQLLDEMEKEQKADIMKSFASPLPFIVISELMGIPKEDRAQFQIWTNAMVDTSE
DNRELTNQSLREFKDYIAKLIHDRRIQPKDDLISKLVHAEENGSKLSEKELYSMLFLLVV
AGLETTVNLLGSGTLALLQHKEEREKLKQHPDMIATAVEELLRYTSPVVMMANRWAIEDF
TYKGHSIKRGDMIFIGIGSANRDPNFFDNPEILNINRSPNRHISFGFGIHFCLGAPLARL
EGHIAFNTLLKRFPDIELAIAPDDIQWRKNVFLRGLESLPVSLSK
>PK3-2_03711 Polyketide synthase PksR
MLNTEDILCKMLFAQLQSIGFFTESKSQPVLENFYGRWFEESQSILERHQFLKRTENGYV
PTRSVGTMGELWKEWNEQKSDLLQDNNMKAMVTLVETALKALPDILTGKASATDILFPNS
SMDLVEGVYKNNQVADYFNDVLADTLTAYLEERLKQDPEAKIRILEIGAGTGGSSAAVFQ
KLKAWQTHIKEYCYTDLSKAFLIHAENKYGPDNPYLTYTRFNVEEPASEQHIEAGGYDAV
IAANVLHATKNIRQTLRNAKAVLKKNGLLLLNEISDHNIYSHLTFGLLEGWWLYEDPDLR
IPGCPGLYPDTWKTVLESEGFRYVSFMAEQSHQLGQQIIAAESNGVVRQKKKNEMEEDAG
PLQMNAVKTQAQESDSLIEKTAQFVKHTLAKSIKLSPERIHEDTTFEKYGIDSILQVNFI
RELEKVTGDLPKTILFEHNNTKELVDYLIKEHESKLRTALLQETPQPPKNEAPVPTERAA
GKPFSSTTRRFAGEQRVNETQQASMSELQKEKTSNSQVAQKNDLGTEDIAIIGISGRYPM
SDSLEELWAHLIAGDNCITEAPESRWRTSLLKTLSKDPILPSDKKRYGGFLQDIQSFDHH
LFEVEKNRVMEMTPELRLCLETVWETFEDGGYTRTRLDELRDSDTGVGVFIGNMYNQYFW
NIPSLEQAVLSSNGGDWHISNRVSHFFNLTGPSIAVSSACSSSLNAIHLACESLKLKSCS
MAIAGGVNLTLDLSKYDSLERANLLESGNQSKSFGAGTGLVPGEGVGAVLLKPLSKAIED
RDHIYAVIKSSFANHSGGRQMYTAPDPKQQAKLIAKSIRQSGIDPETIGYIESAANGSAL
GDPIEVIALTNAFQQYTNKKQFCAIGSVKSNLGHLEAASGISQLTKVLLQMEKGTLVPTI
NATPVNPNIKLENTAFYLQEQTEPWHRLNDPESGKQLPRRSMINSFGAGGAYANLIIEEY
MERAPEKHIGSRQQELTAVFSAKTKWSLLSYLESMQLFLEKEAALDIEPIVQALHRINHD
LEHRAAFTVTSTRELIEKIKVLRTSEESSLQQGIYTSFDLQPFSGSAHDEREINAAAQWA
AGASIAFKEAAQGNRSGWVRLPHYAFDHHTSFHFDVPLGHGKSSALESKKNQVIQDQFTY
DEPYVQGHVFNNERVLVGATYSSMAIEAFLNMFPEENSGRISKLSYINPIVIKQGETIEL
QAKPLQKDHAIELQIMYRELASDTWKPAAIGQCQKSLFETKKVNIESLKQSLTELHHINQ
MYQAGNGPEWGELFKTVTHLYRDNKSILAKIRLPQSGLANGHQYTVSPLITNSAYLAILS
FLEQFDIEGSFLPFGINDIEFTKHAIQEDGWLLITLVKNTGDMLLFDVDVINESSETVLR
YSGYSLKQLRISNQRGNKNQAINVSNLKDRIRSYVTNKLAASMAEPSKLSLQKAHIMNLG
IDSSQLVALTREMESETKIELNPTLFFEYPSVQELTDFFADKHEASFVRLFGEAEQQEDR
PAQIESEMKQVPSYEMETDQTIEHAADGVAIIGMSGQFPKANSVTEFWENIIHGKNGISE
VPKERWDWRKFASAEQDEQSSLQWGGFIEGIGEFDPLFFGISPKEAEQMDPQEFLLLIHA
WKAMEDAGLTGQALSSRPTGVFVAAGNTDSAVIPSLMPNRISYALDVKGPSEYYEAACSS
ALVALHRAIQSIQHGECEQAIVGAVNLLLSPKGFIGFDSMGYLSAEGQAKSFQNGANGFV
RSEGAGVLIIKPLQKAIEDSDHIYSVIKGTGVSHGGRGMSLHAPNPAGMKDAMLKAYQGA
QIDPKTVTYVEAHGIASPLADAIEMGALTSGLSQPELELSQEVREEAPCYISSLKPSIGH
GELVSGMAALMKVSMAMKHQTIPGIAGFSSLNDQVSIKGTRFRMTAENQQWENVKDGAGR
IIPRRASINSYSFGGVNAHVVLEEYIPSPKAPVHMNENEAHIVVLSAKNHDRLKAVVQQQ
LDYVNNQQELSLQHYAYTLQIGREEMGDRLALVVRNKEELAIGLQDCLTAAEKAEKPKTS
VPVFSGNAEEGSSDIETLLDGHLREMVIETLLSENHLEKIAFCWTKGVRIPWEQLYQGTG
VRRIPLPTYPFEKRSCWNGFQAIEDTPAVSHDEHINSSDHHMLADVLGMAPEELLPHKPL
RQYGFDSISCIQLLQQLQSKIDPHITLTELQACQTVEDMTDLIARKQKDTPLQNEHARTF
PELIPLNDAKRGRPVFWFHGGVGGVEIYQQFAQKSQRPFYGIQARGFMTDHAPLHGVEQM
ASYYIEIIRAIQPEGPYDVGGYSLGGMIAYEVTRQLQSQGLAVKNMVMIDSPYGSETKEN
ETSIKTSMLQTINTMLASIAKPDKLTDVLISREEVDTRTGDDEFLSELIDLAQRRGLNKP
EKQIRAQTQQMMKTQRAYDVESYTVKPLPDPEAVKCYYFRNKSRSFFGDLNIYFTFSNEK
APFDQAAYWEEWERQISHFHLVDVDSSNHFMILTEPKASKAMLEFCEKLYSNKGVVNANF
LKAFRKKHEAKQEKEDELVKR
>PK3-2_03712 Polyketide synthase PksN
MNHKELLDAFRSGELTISEVEKQLQGMKRQLKSPLSEGQKGLWMLQKMSPDMSAYHIPLC
FRISKPLHAETFKKALLFVQKQYPVLTSVVQEENGIPFQTVQSSEALNFEEEDISAMKSA
EILPFLIEKAKKPFHLEAGPLWRTHLFHRSKEECMVLITIHHIIFDGVSMLTLISALFEA
YQQLLSGIEPVPHPLTADYYDFVEWETRMLNGTEGEEHLAYWKEQLSGNLPVLDLPADRP
RSSARKFKGQAYKSLLPHHLRNQIKAFARTHHVNESVVFLSIYKALLHHYTKQEDIIVGV
PTMGRHEESFESLIGYFINMMAVRSKNIGSQSFTAFIRELQLTMADGLDHAAYPFPALVR
ELKVDRSASDSPVFQTAFLYQNFFQTTGLQKVLEPFQTLGIEYIEDIRQEGEFELALEIY
EQENETVLHFLYNPDLYELSSIENMMENYLKLAQHVIDDPSLSLETYSLKLHQEQNSLLK
QWNATEANMRNDKCIHEIFEEKAKQIPNAVAVIFEDKSLTYKEVDEKSTSVAIYLQHQGI
GPEHPVGICAERSFDMIIGILGILKAGGAYVPLDPSFPQERLEYMLKDSQTSIVLTQPNV
HHRISELTGSRVKAINIDWACRNGYTDQQSSDLKREVKPEHLAYIIYTSGSTGQPKGVMV
EHQSIMNTLNFLESRYPVTDEDAYLLKTNYVFDVSLSELFGWFVGNGRLVILPPNGEKSP
QLCMDYIERYQVTHINFVPAMLHVFLETAKDNEQLTDHGPLKYMMVAGEAFPKELVKKAV
SIFTNCRVENIYGPTEASIYAAYFGCGKGDIASHHTPIGRPVSNVKIYIVDQHLKPVPIG
KPGELCIAGAGLARGYYNQPGLTAEKFIDNPFEPGTKLYKSGDSARWLPDGNIEYLGRID
SQVKIRGFRVELGAIETKLSEYPGILDQAVVVKQLDGHRQLAAYYTEESGHTPADPKDLR
RYLKSSLPEYMIPSHFIRLDELPLSPSGKVNRKELEKREIVLNRKKPNHSQLTEIEDRVL
RIWEETLKVSGFGPEDGFFDAGGDSLLAVAVAERIKKELDCEFSVTELFEYSTIRAVSQY
ILEMKNSDQVMTQGEDNHDLVKNGKFQHQTIPPYFDDSVAIVGISCQFPGAKNHHDFWKH
IKEGEESIQFFSEEELRENGVPEELIQHPDYVPVQSAIEGKDLFDPGFFQISPKDAEYMD
PQLRLLLLHSWKAIEDAGYVAKEIPGTSVYMSASSNSYRSLLPKEATEGHESPDGYVSWV
LAQSGTIPTMISHKLGLKGPSYFVHSNCSSSLVGLYQAYKSLTSGESQYALVGGATLHAQ
SAIGYVHQNGLNFSSDGHVKAFDASADGMAGGEGVAVILLKKAVDAVKDGDHIYAIMRGI
GVNNDGADKAGFYAPSVKGQTEVIQHVLDTANIHPETVSYIEAHGTGTKLGDPIEMSALN
KVYKQYTDKTQFCGIGSVKTNIGHLDTAAGLAGCIKVAMSLYHNELAPTINCTEPNPNIN
FESSPFYVVRERKALEKRKDVHRAALSSFGLGGTNAHAIFEQYENLSDVRTENEGNLPCL
IPVSAKNKERLHAYVKELLIYISQNEQAHISLRDVAYTFQVGREAMDSRVIFMANDLKEW
KQQLEALVNGKPLAESCIQGEKTRMTSAQQLHGNAEAEELAASQISKRELKKLAEMWAKG
FHVEWRRLYQHTKPRRISLPTYPFAEERYWPESSASDMTTIEPLRLHPLVHHNTSVLSEQ
RFSSIFTGQEYFIAEHIIKGMAILPAAVTLEMARAAIEQGIGGLEDHETGIRLKNVVWVR
PVVAGDEPVQVNIGLYDEDGGHILYRMYGEPESANEEPVLYNQGIAELIQVKQEKALELA
EIKQRCDQSRMDADLFYEGMIGADYGPGYKSVEAVYKGDGQLLAKLSLPASVLHTSDDYV
LHPSVMDGALQAAEYLQNVVRAELSDREDFKAALPFALEELEVYRPCVTDMWVYVQFNSK
NKPGDLIQKVDIDVCDEHGTIYVRLKGFSTRVMEADIQSEPSKINAETLLLQPVWQEQKA
AEGAALKPYAEHHVFLCEYDHDTRKQIEATLEDVHVYSLEARPSSVDGRFHSYTEQVFKK
VQEILRTKPIGDILIQIVTSSEGEQQLFSGLTGLLKTAGQENAKLIGQMIEVSSEESGES
IAGKLIENQMSTDSYIKYHNGTRYSADWRDIKPANGDISKPWKDDGVYLITGGAGGLGLI
FANEIAEQTKNATIILTGRSPLSESISKTLKELQGKGAEVTYQQTDVTDKIEVYQLIGGI
QKTYGRLDGILHSAGIIKDSYIVNKSAVDLHDVLAPKVKGLVYLDEASKDLPLDFFILFS
SLSGSLGSIGQSDYAAANVFMDMYAGYRNGLADLRQRHGKTLSVNWPLWSDGGMKVDQET
EKRLVQLAGIVPMIAKKGIQALYQAFHSEANQVMVIEGDVQKIKQNMLEKTASAPLEKKE
TEGVTEQIKSIDTDSLLDKVKAMLKREVAKLLKVKLETIDDHAEMTVYGFDSISMTEFTN
HINRAYKLELTPTVFFDHPTIHAFGKHLSEEYQAVFAKTFAVRAASAQVPAAKQEQALPV
KAKRRRKQQVALPNAAQNDAGPEPIAIVGISGIFPMAKDVEAYWNILKEGKDCMTEIPKD
RWDWREYEGDPAKEVNKTNVKWGGFIDGIADFDPLFFGISPREAEQMEPQQRLLLTYAWK
AIEDAGYSAKRLSGTKTGVFIGTGNTGYSSLLSKANSSIEGSAAANTSPSVGPNRVSYFL
NLHGPSEPIDTACSSSLVAIHHAISSIEEGTCDMALAGGVNTIILPEVYISFDKAGALSK
EGKCKTFSNQADGFAHGEGAGILFLKKLKAAEEAGDHIYGVIKGSAINHGGRAASLTTPN
PKAQADVIQSAYEKAGIDPKTVTYIEAHGTGTELGDPVEINGLKSAFQALGVNEGDSSDY
PHCGLGSVKTNIGHLSLAAGAAGIIKILMQLKHKTLVKSLHCETVNPYIQLKNSPFYIVR
ETEEWKALKNERGEELPRRAGVSSFGIGGVNAHVVIEEYIPEAADENIPSVTPEYPGIFV
LSAKNETRLKEHAQQLAEALDKETYRDANLARIAYTLQAGRDAMEERLGIISGSAKDLQK
KLHDFAAGKNDVEDVFRGRIDKGTLQMLTEDEEIQEAVEKWMGRGKYAKLLELWVKGLDV
DWTKLYGENVPKRISLPTYPFAKDRYWISDLIKESGSPEVNKETSRRGAAVLHPLMHQNT
SNLSEQRFSSIYTGEEFFLADHVVKGQRILPGVAHLELARAAVEQAAEVQGVPCTIKLKN
AVWVRPIVVEDQPKQVHIRLLPEENGEITYEIYGNPEAAGEQSIVYSQGSAALSPAENLP
AVDLQSLREQCQESHFTVNEVYETYQMIGFVYGPAYRGMEKIYTAEHFVLARLSLHPSAL
NTLGQYNMHPGLMDSALQASSILTGAGDNRLTLPFAVQELEVFGACSSEMWVYARYSQGS
KATDKVQKRDIDILDVNGNVCVRMKGLSFRAAEGGSGAAESERTLETLMFEEQWMPKGCE
KERLEPHYERHIVLLCDMNGLSKNSVESRMMGAECVVLESSREGLAERFQDYAEQALETV
QGLFNSKPQGDVLIQLVTSAQRKQYSFSGLSALLKTATLENKKLTGQTIEIDSHENIESV
IEKLKENKRHAGDQHIKYEKGKRYINDLCEIQMADREISLPWRDKGIYLITGGAGGLGFI
FAKEIARQAAQPVLILTGRSALNAGQQAQLNELQRLGARAEYRRVDVTQAEAASELITSI
TSDYDDLNGVIHSAGLIKDNYLMNKTNEELTEVFAPKVKGLVNVDEATEHLALDFFILFS
SISSVAGSAGQADYAMANAFMDSYAAYRNALVTAMYRHGQTLSINWPLWKEGGMRANKEI
ENMTLKNTGVTPMRTETGIQALYKGLASGKDQVIVMEGIGDMMREKLTQKPSSVDVPTKT
AQVSVTSETKMDQDSLLDHIQEALKQAISQLLKIKPEEIDPDMEFNQYGFDSITLTEFAN
TLNEQYKLDLTPTIFFEHATVYAFAAYLSEEYPNTFIAQSPAEAEMPIQPVEQSMKNLTF
SAETRFAKPSVTPVQKAADHGSEPIAIVGMSGVFPKAKDIEEYWKNLKTGADCITEVPKD
RWDWQEYYGDPLKEANKTNVKWGGFIDEVADFDPLFFGISPLEAEQMEPQQRLLMTYAWK
AIEEAGYSAKSLSGTKTGIFIGTGNTGYSSLLSNVDIEGSAAANMSPSAGPNRVSYFLNI
HGPSEPIDTACSSSLVAIHHAVCAIENGNCEMAIAGGVNTVVTPQGHIAYDKAGALSKEG
RCKTFSDRADGFAVSEGAGILFLKKLTAAERDGDHIYGVVKGSAVNHGGRANSLTTPNPK
AQADVVKTAYEKAGIDPRTVTYIEAHGTGTELGDPVEINGLKAAFKELYEKTGDPAVHGS
HCGLGSAKTNIGHLSLAAGVAGVIKVLLQLKHKTLVKSLYSETINPYIRLEGSPFYIVQE
SREWQTLRDEAGRELPRRAGVSSFGIGGVNAHVVIEEYIPKETAHSAQAPAVTAQHPGIF
ILSAKDEDRLKDQALQLADFISKQSITAHDLTDIAYTLQEGRDAMEERVGIIAFSAEDLL
EKLNLFIAGHVSAKYVSGRADKGIVQTLRSDDEIQKMLKSSWEPGIYARLLELWIKGLEI
DWSKLYGGKQPKRISLPTYPFAKERYWITDMKEEAATHHTANIVETAALHPLVQSNTSDL
SEQRFSSTFTGAEFFFTDHKVKGAPVMPGVAYLEMVQAAVTRAVRGIQDQQSVIHIKNVV
WVQPIVTDGHPVQVDISLEPQQDGEIAFTIYTEDAHNGRKTHCQGSAAISGAGDIPVQDI
SMLQDQCRLSTLSHDQCYELFQAIGIDYGPGFQGIDRLYIGRNQALAQLSLPPGVTHTLN
EFVLHPSMADSALQASIGLKLNSGDEQLSLPFALQELEIFSSCTDKMWVSVTSRPNEEKI
QRLDIDLCDEQGQVCVRIKGISSRVLEEDTQPQDEPKSPDIKASLEASLLMAPVWDQVQL
ERSNIPPIDERVVILGGNDNSRKAVQRQFPFAEELHIEPNASIHEIASQLEALGSFDHIV
WLSPSRVTECEIGDEMLEAQDQGVMQMFRLIKAILSLGYGEKKMSWTVVTANTQCVDQHD
IADPVDAAVHGLIGSMAKEYPNWQTKLIDVGKQENLPVSEIFSLPADQEGNTWAYRNQLW
HKLRLIPVHNNQPVHTKYKHGGVYVVIGGAGGIGEAWSEYMIKTYQAQIVWIGRRKMDAA
IQSKLDRLARLGPAPFYIQADAANREELERAYETMKKMHREINGMIHSAIVLQDRSLMNM
NEECFRNVLSAKVDVSVRMAQVFRHEPLDFVLFFSSVQSFARASGQSNYAAGCSFKDAFA
QRLSQLWPCSVAVMNWSYWGSVGVVSSPDYQKRMAQAGIGSIEAPEAMEALELLLGGPLK
QLVMMKMAIETNDEAEQAEETIEVYPETHSSAIQKLRSYHPGDSTKIQQLL
>PK3-2_03713 Polyketide synthase PksM
MITEQLHISLNNPIMSNHKVYGQALLPGLAYIDLIYQVFHEHGYAYQELELKNLTIFYPL
TADETHDVALTIHVSESKEGTWSIIIDGQKQHGDSLSDKRQYVTADMHRKERTAFAETID
LNQWKRTAGRILNLDEIYEQCRSQQLVHTGMMKAEGQIYETKEGALIDLAVGQEALRHSE
AFLFHPTLIDGSGIGSSCLLLDQTLYLPLCYESFSASERLQKGCTARILSSSVRQKNELT
YMTIEYFNSSGQKVAELKQFAGKSVRDGAGFHSEKEIHAVSQNPGRRYTEFETYLRQLLA
EQLERPAEQMDIHAGYYELGLDSPSLLKMVQEIGAKLEAELSPTLLFEYTTIAELAAHLA
DHYSMGEADDTVRQSPAPIQASSDADPSSPEIGEDIAIIGMAGRYPKAKNIQEFWEHLKA
GTDCITEIPNSRWEWKENNGSDSPAGKPFSKWGGFIEDADCFDPQFFRISPREAETMDPQ
ERLFLETCWEAIEDAGYTPETIASPQGEHKRKHVGVFAGVMHKDYSLIGAEALSEHNPFP
LSLNYAQIANRVSYYCNFHGPSMAVDTVCSSSLTAVHLAIESIRNGECEAALAGGVNLSL
HPAKYISYGSVGMHSSDGYCHTFGEGGDGYVSGEGVGTVLLKPLRKAEQDGDRIYAVVKG
SAINHVGKVSGITVPSPVAQADVIEACLEKTGIDPRTISYIEAHGTGTSLGDPIEIQGLV
KAFSRNTQDKQFCSIGSVKSNIGHAEAAAGISGLTKTVLQLHHKTLVPSLHSEELNPYLQ
LDQTPFFVQHETKKWEQPSLTENGMAVTYPRRAGLSSFGASGSNAHLILEEYIPSESHLE
PVLSKSEEIMIPLSARNKDRLQAYAIKLLDFLSEDVNLAALAYTLQTGRVEMEERAAFIV
KDIKDLTAKLQAFANGEEEIGGCWTGQAKEIQEAAGLKSVNTLRNNTTTDSDLKKIAESW
VHGNPVIWDDLYGDRKPLKISVPTYPFAKERYWIPAPETKTSTVSHTLHPLVHRNTSDFT
EQRFSSVFTGEEFFLSDHVVQGQKILPGVAYLEMAREAAEKAAGDLEDEQRVVSLKDIVW
IRPITMGSEPKEIHIGLYPEDNGDISFDIYSSSENKKETPLMHSQGRAVISSEADIPVLD
LASIQTECSLDTVTSEQCYTAFRKIGLDYGKGYQGIESLLVGQDQLLAKISLPAFLKDGK
QHFTLHPSLMDSAFHATVGFIVSSVNAGAQAQQLSLPFALQELDIFSPCPEEIWSYIRYS
SDSKAEDKVRKYDIDLCDENGNVCVRMKGASMRALDGEQQTEPKTAADSPLTGHTMMIPV
WEPVSPVKESDAVITGTRAVLCGGSEGERTLIKRHYPQVSFIDIRPADDIDVITDKLQVY
GSIDHVLWIAPSHPENVCSDRQEESVLHLFKLVKACLQLGYSEKKLEWSLVTVQAQPVAQ
QETVHPAHASIHGLAGTIAKEYPHWKIRLLDLEKDCTWPVYQMFTLPADRLGHAWAYRNQ
QWHQQQLIPYRHSPSTEALYRKGGVYVIIGGAGYIGEAWSEYMIRRYQAQIVWIGRSQIN
AAIQSKLDRLSAFGPKPFYIAADAADKHSLQQAYDQVKKRHPQIHGIVHSAMVLFEQSLE
NMTVEEFTAGLAAKIDVSIRMAQVFHQENVDFVLFFSSLVAHIKNVKQSHYASGCAFADA
FAHELSKSWACPVKVMNWGYWGNSEAAEDEQYVQLMNQIGLGLIEPAEGMKALEALLSGP
VSQTAFIHTTKPVAVEGVNQNEFITLYPENPQTEAESLKDRLPKTGQLQRVAHEELDDLL
YRLLLGQLQTAGLFDGHRLSVERLSQYKTREFYEKWLLQSSEFLLQQDYLKKDGDSLVRK
GPAEDMALLWQEWNAKKEKWLKDGNTKAMVVLAETMLQSLPDILTGKVPATDIMFPHSSM
ELVEGIYKHNQVADYFNKVLADTLIAYLNERLKHDPEASIRIMEIGAGTGGTSAGIFEKL
KPYQKHIEEYCYTDLSKAFLLHAEKEYGTENPYLTYQLFDVEKPIDQQEIEAGGYDVVIA
ANVLHATKNIRQTLRHTKAVMKNNGMLLLNEMAGNSLFPHITFGLLEGWWLYEDPAVRIP
GCPGLHPDSWKAALESEGFESVFFPAEAAHDLSHQIVAASSNGLVRCMMKKVTLPEKDVS
QAPYKEQGYAHTIDSEKAGQSNHALLREKSTEYMKKLIGETLKIPAGKIDSSEQLEKYGI
DSIVVVQLTNTLRKEFDHVSSTLFFEYQTIDALVEHLIKTKTEALMKLTGLDRHVQQQTP
AASKNESSQKPEQAAKRARRYRKLGFSGEKETPAPDFASRDVAIIGISGRYPQAETAEDF
WNNLKEGRNCIEEIPKERWDWKDYYDKEKGKEGSIYTKWGGFIKDMDKFDPLFFQISPLE
AERMDPQERLFLQTAYASIEDAGYTPDTLCSTRKIGVFAGVMNKNYPTGYGYWSIANRIS
YLLNFQGPSLAVDTACSSSLTAIHLALESIYSGSSDCAIAGGVNIVVDPVHYQNLSVMNM
LSASDTCKSFGDDADGFVDGEGVGAIVLKPLKKAIADGDHIYGVIKASAINSGGKTNGYT
VPNPHAQAQVIKEAIERADIPARTISYLEAHGTGTALGDPIEIAGLTKAFEEDTQKKQFC
AIGSSKSNIGHCESAAGIAGLTKILFQFKYGQIAPSLHAQQLNPNIEFSHTPFVVQQQLG
EWKRPVIDGQEVPRRAGLSSFGAGGSNAHMILEEYIPRTESQTPGSHPPALIVLSAKNRE
RLQEKAEQLRTAVQEKRYSETDLIRIAYTLQTGREAMEERLGFIAESVEDLERKLNDFIE
NKADSLYLDRIDQNKKALAVLSTDEDTEKIIEAWISKGKYTKLLDLWVKGLSFDWGKLYG
IQTPVRISLPAYPFAKERYWAPGPEKAPAPLEQHHEQQAEELFEVMTFQEVWKEETATLT
SKRFKTLICFLTDSEKQAAFASSVKNIDQDTKVIFISQGEVYSKQSPYSYQIVRQEPVTF
EKAFQSIQQEHGEPDAILYMWPAEDTSCIKDHSCIVYLLQGMSAAKLHPSRLLLAGRFEN
GLDRSYLESWIGFERSLGLVLPYTKVTGIFQPAEQESMDDWTRKMWTELQASTEQTVLYQ
NGKRYVSHIEQTTIQPNSSKLKSGGTYLITGGLGGLGYLFAKHLAKHYAANLILTGRSPF
NDEKQKKIKELTDLGGEAMYAEADVSDPIAMGDCVKRGKDRFGAVNGVIHAAGIESDSAI
FEKEIDSFRRIIEPKINGTIALDEWLKNETLDFICYFSSSSAILGDFGCCDYAIGNRFQM
AYAQYRNELHSGSTFVINWPVWKDGGMKIGNEETTDMYLKSSGQRFLEAEEGIRIFEHIL
SQDDAQHLVIAGQSSRVSRFLRMIEPAIQEPTIQAPAVQEKRDEIKTLSVEKRLEHDLKE
HIHTLLKISKDKLNLNKYWADFGFDSIYLAKFSNVLSKHFNIEVTPALFFGYSTLQELIC
FFLTEHKELIEAFYRDDALEAQKPPEADAEIPAAPESDPDKKSVRQHHAEPIAVIGMSGR
FPQADSVRELWDNLENGKDCISEIPKERLDWGGANRYSEKAVPRWGAFLKDIDRFDPLFF
QISPKEAESMDPRQRIFLEEAWHTFEDAGYMGHRINGKSCGVYVGVEEGEYAHLTGDTDY
INGTQNATLSARIAYALDLKGPNMALTAACSSGLVAIHQACSALRQGDCEMALAGGVSLN
ISQMSFEALTRAEMLSTNGQCKVFDQDANGLVPGEGVAAVLLKPLSKAIADKDHIYGCIK
ASGVNYDGKTNGITAPNPFSQAELIESIYEKNEINPLDIQYVMAHSTGSNLGDPLEVQAL
TSVFSKYTKQKQFCMISSIKPLVGHTFAASGVVALISMLMAMKHQTIPATHHCESDNPYI
QFKDSPFVLCKENRPWLRKNQKPRIGTISTTGISGTNAHAVIEEYIPEKQPSTLRHKDSA
QVIVLSAQNDDRLQAAVRNLIVYLEQNQNLSLPDVAYTLQSGRKAMEARLAIVVNNQEQL
VRKLKEYAEAMKNGGVSGQQAALYTGDAEGMLEEQDEAFLQALVKERNLENIAECWAKGY
QIPWELLHEGGDVRMISLPGYPFARERYWISSGEAVKPHTQDRKTEIEEPNGETHIQKVI
VQFLARELGITEDRINFNRNFLDYGMDSILGRKLMRHIEKTTQMKMTGREILECQTVKAL
SAHLALKAERHNQIAASHQTNNTYTDEQIIGLMQEVAQGKLDFKSVQNIIEGSKSYES
>PK3-2_03714 Polyketide synthase PksL
MKNLTKQLTLSLKNPFVYHHVVYGQNVLPGLAYIDMIYQIFREHGYECSELQLRNLSIYQ
PLTVGQNAVIVLDIQCTEKKEGKWQISAKGFEKRDGNKASEEKLYMKADMHVQAPVVFEE
TLELNQIKAAAQNIVQLEDVYEQCRRQELVHSEYMKAEGCIYEEEDGVLLDLSLGSEAMH
HAEGFMFHPTLIDGSGVGANNLLTSLLKGEQRLYLPLFYESFSASALLQTHSMTRIKRSS
VRQEKELIYVTLEFFNASGEKVAELKNFTSKLVREAELISGKQQDVQEQQELEKDIAVDT
QAADTGFSSGSMGAYGGAEQFVSQLIADKINKPIEQIEKQVGYYQMGLNSSGLLEVVETI
SDKIGESLSPTLLFEHTTIAELSAFLAEEYAEHFSASGSLEQNERELVFDSVNGHKADEA
FRAAPSEAAGDIAIIGLAGRYPKANNIHEFWHNLKEGKDCISEIPESRWDWRRFEGIKSP
SGKDISKWGGFIDDPDCFDPQFFRITPREAETMDPQERLFLETCWETIEDAGYTPKTLAK
PKGRNKRQHVGVFAGVMHKDYTLVGAEEASAENVFPLSLNYAQIANRVSYFCNFHGPSMA
VDTVCSSSLTAVHLALESIRHGECDVALAGGVNLSLHPNKYMTYGVWDMFSSDGHCRTFG
KDGDGYVPAEGIGAVLLKPLRQAEEDGDRIYAVIKGSAVNHVGTVSGISVPSPVSQADLI
ETCLEKTGIDPRTISYVEAHGTGTSLGDPIELQGLVKAFRQYTQDRQFCSIGSVKSNIGH
AESAAGISGLSKVALQLHHQTLVPSLHSEELNPYVDFEKSPFYVQHETKTWKQPVIKEKE
EDILYPRRAGISSFGATGSNAHIILEEYIPQTAEQDVSLPSDSDIPAVIPLSARNQERLR
VYAKRLLDFLHEGIQIRDLAYTLQVGREPMEERVAFVADGIQELTGQLKAFIEGDKTIQH
CWNGRVSRESDLSLSAETVHKSLQQRNFDLIAKQWTKGAAINWKLLYEGKKPKRISLPTY
PFEKVRYWVPKADGAPRSKRKGHVLHPLLHQNVSDMSGVRFHSAFTGREFFLKDHVIKGE
RVLPGAALLEMVRAAVEKAAADQFPTGFSLRNIVWVRPFAVTEQQADIHVRLYPEDNGEI
AFEICQEPESAENAPVVYGQGSAVLCEPDESPVINIEELKARYSERTLSPSVCYGAYAEM
GIDYGDSHRAIDSIYVGKSGVLAKLTMPSMISDTQNRYVLHPSMIDSAFQASIGLRLGDA
ASLADKKAMLPFALQDVRIFKGCEASMWARITYSEGSAREDRIQKLDIDLCNEEGQVCVR
MKGYSARVLEQTDSLSETIDTLLFEHVWEENAPVEEQEFIEYETHKVIICDFGEQMESIR
NHLDCTIMHHPTEAIDDRFEVYAVHLFEEIKQLMHSKNGGHTFIQVAVPALNEPQLLSGL
TGLLKTAELENPKLTGQLIELDTEVSASNLFEALEENRRCPRDTHIRYWQGKRFVSKWKE
TSGEHLSADMPWKDKGVYLITGGAGGLGFIFANEIANQTNDAVVILTGRSPLDERKQAML
QDLQKLGVRAVYRKADLTEKRSVDALIEEVSNAYGGLDGIIHSAGMIKDNFIMKKKKEEV
QSVLGPKVSGLIHLDEATKEIPLDFFILFSSGAGAVGSAGQADYAMANAFMNAFSEYRNG
QAALHKRYGKTLSVCWPLWKDGGMHIDAETARMLTKETGMVAMETGHGIQALYHGWASGR
PQLLVASGVANRIRAFLYETGHGQGQTYNTKNKNDNQDTEKADIVLGVDDETLREKAENY
VKQVLSSVIKLPAGQIDAEAPLEDYGIDSIMIMHVTSQLEKVFGSLSKTLFFEYQDIRSL
TRYFIDSHREKLLDILGIETDKPSVEEKSEPEKKDITVTPRKSGFLPLQKNEQKQSSEKE
TEEIAIIGISGRYPQADNIDELWENLRDGQDCITEIPEDRWDHRLYYDEDKDKPGKTYSK
WGGFMKDVDKFDPQFFHISPREAKLMDPQERLFLQCVYETMEDAGYTREHLGRKRDSELG
GSVGVYVGVMYEEYQLYGAQEQVRGRSLALTGNPSSIANRVSYYFDFHGPSIALDTMCSS
SLTAIHLACQSLQRGECEAAFAGGVNVSIHPNKYLMLGQNKFMSSKGRCESFGEGGDGYV
PGEGVGAVLLKPLSKAVEDGDHIYGIIKGTAINHGGKTNGYSVPNPNAQADVIKKAFVEA
EVDPRTVSYIEAHGTGTSLGDPIEMTGLSKVFTQGTNDKQFCAIGSAKSNIGHCESAAGI
AGLTKVLLQMKHRQLAPSLHSNVLNPNIDFLNSPFKVQQELEEWKRPIISVNGKDVEYPR
IAGISSFGAGGVNAHILIEEYVAKSEQERSPAGKQPAVIVLSAKNEEKLQKRAERLLHAI
REQRYAEADLHRIAYTLQVGREAMNERLAFVVEHMQELEEKLNEWVSGMDNREDVYRGQV
KRNKESIAAFAADEDMSKTIEAWMKKGKYAKVLDLWVRGLRIDWNTLYQDQKPRRISLPA
YPFSRDRYWIDVNAKAEEKRTAEPAVTLQPVIQKPSIAREASGKPANIALQPLTANQDRL
QRVTLPLPSNTETEMITAEELCDELTASLAEVLYMDQNEVDPDEAFIDIGMDSITGLEWI
KAINKRYGTSLNVTKVYDYPTTRDFAVYLAHELSAQFGERRAANDAPKQTEMYAPVKPKT
AAAKPDNISLQPLEHQQPLQEEPEEAIQYAAAEISASSQYTGAIETLHEELRETIANVLF
MEPHEVDIDEAFIDIGMDSITGLEWIKAVNKQYGTSFSVTKVYDYPTIHDFAEMLKSELG
THLDRKQEMTEQHEVSEAVKQPEALPKEKPADRPLQPVQYQKKEHEKKTSPIHQDHREDA
IAIVGMSGRYPGASNVREYWDNLVHARNAIRDIPASRWDVDKYYDPALNKKGKVYCKSMG
MLDDIEQFDPLFFNIPPSEAELMDPQHRIFLQEGYKAFEDAGYSARTLNEKKCGVYLGIM
SNEYGVMLNRQARANATGNSFAIAAARIPYFLNLKGPAIPIDTACSSSLVGTHLARQALI
NKEIDMALVGGVSLYLTPESYISMCEAGMLSPDGQCKAFDNGANGFVPGEGAGALVLKRL
KDAEADRDHIYGIIIGSGINQDGKTNGITAPSAKSQMDLERDIYDTYDIHPESISYVEMH
GTGTKQGDPIELEALSTVFQEKTDKKQFCAIGSVKSNIGHTSAAAGVASVQKVLLCMNHK
TLVPTLNYTTPNEHFQFDHSPLYVNTELKPWETVNGKPRRACVSSFGYSGTNAHIVIEEY
QPENKNDRLTKQPHSTLFVLSAKKEQQLKAYAKVMKDFANSTEEINLEDMAYTLQTGREA
MDYRLAFLADSKEAVINALDDYLADVPNSSIFAAHAKSKKSEIKLFETDHDAKALLQTWI
EKKRLEKVAELWVKGLQIDWNGLYGDHWPRRISLPAYQFAEEYYWLPNQEDKPENSGSYP
PYSEPIMKRCFLHKQWQHCPIEPAERTNQTVAILANEETMALAEELSAYFSNYRIFDIQE
LDFVSAADLERIAGAVDLIGCGTGREQSINWISWLQNLIEQGRTSKHHLTILGVTKGLES
YANETVHLSGATRAGLYRMLQSEYSHLTSRHVDMDSAASHEEMARLIADEFYNDRTESEV
CYRNGQRYRAYLAEKPENYEITHKQVSFSSDKVLLITGGTRGLGALCARHFVKTYGVKHL
VLIGQKELPSRDQWNLVRDADASLAEKIKVIQELEAMGAEVQVLSLDLTDSLAVEQSLKT
VQETMGPIGGVIHCAGKVNKQNPAFIRKSLEEIEQVLEPKVEGLQTLFHLLKDEPLAFFA
LFSSMSAAIPVLAAGQADYAMANAFMDYFAEAHKDDYPIVSIQWPNWKETGLGEVRSKAI
EQTGIVSLRNDEGLQLLDQVLSDTHHAVVLPAIPDTNTWRPDNLMQPALFVEDRSQPKTK
EQAGTQNLFHETVDWLVTLFSDELKIAAEDFETDEPFQEYGIDSIILAQLVQQMNQALNG
DIDPSILFEYPTIESFANWLISKYDVSAVLHHSVSERQTPDESAMKQEPIPEQRPQQNSH
GKTARLAEDIAIIGLTCRFPGAETLEAYWELIRDGRSAIIPVPHERFGSSCSNYAGIIDE
INRFDHKFFMMSESDVRAMDPQALAVLEESLKLWYHAGYTEKEVKGMRAGVYIGGRSQHK
PDPSILSKAKNPIVAGGQNYLAANISQFFDLRGPSIVLDTACSSALVGLNMAIQDLRSGD
VEAAVVGGVNLLDADALQMFQERGLLCDKPSFHIFDKRANGVILGEGVGMVLVKTVSQAL
EDGDSIYAVIKAAAVNNDGRTAGPSSPNLEAQKDVMQTALEKSCKKPEEISYLEANGSGS
TVTDLLELKAIQSIYRSGSKSPLGLGSVKPNIGHPLCAEGIASLIKVALMLKHRQLVPFL
SGDEHMPHFELEKTDLYFCKSQADWRETTPAAAINCFADGGTNAHLIVEAWKDSAERPIR
RKPLPLPELNRQPVLTEPSAQTTQKKELSGTGASKEMFWKTFK
>PK3-2_03715 Polyketide synthase PksJ
MKKLVLTGREELPPREEWARFKTSNTSAAQKIQAIRELEAQGVQVQMLSFTLSDDAQVGQ
TLQHIRQTLGPIGGVIHCAGLTDMDTLAFIRKTPDDIQRVLEPKVSGLTTLYRHVGNEPL
QFFVLFSSVSAIIPQLSAGQADYAMANSYMDYFAEAHQNNAPIISVQWPNWKETGMGEVT
NGAYRESGLLSITNSEGLRFLDQILSKTLEPVVLPAVTTQTNWEPELLMRRRKRHEEGLR
ESTLQSPPVKDNEGISKSEGLLSETQSWLIDLFTEELRIDREDFEIDGLFQDYGVDSIIL
AQVLQRINRKLEAALDPSILYEYPTIQRFADWLIGSYSDTLSALFGDRISDTSAPSKNKT
EAGASDPAEDCAPAVQIQAPATLSPGSHAEDVAVVGLSCRFPGADTLETYWSLLSEGRSS
IGPVPAERWGCKTPFYAGVIDDVSHFDPDYFLLHEEDVRAMDPQALLVLEECLKLLYHAG
YTPEEIKGKPVGVYIGGRSQHKPDEESLHYAKNPIVTVGQNYLAANVSQFFDVRGPSVVV
DTACSSALVGMNMAIQALRSGDIQSALVGGVSLLNSDASHRLFDQRGILSKHSSFHVFDE
RADGVVLGEGVGMVMLKTVKQALEDGDTIYAVVKAASVNNDGRTAGPATPNLEAQKEVMK
DALAKSGKKPEDISYLEANGSGSMVTDLLELKAIQSVYRSGYAPQLSLGSIKPNIGHPLC
AEGIASLIKVVLMLKERSFVPFLSGEKEMAHFDKKKANITFSRTLEKWTDSRPAAAINCF
ADGGTNAHVIVEAWEEDEKRAIKRSPISPPQLKKRAFSHGESKPEAETLNKAAANIWDTY
EVEV
>PK3-2_03716 Polyketide synthase PksJ
MRNNDNTRILANPSVSYGEPLHISEEQPATIPEVLYRTAAELGDTKGIIYLEPDGTEVYQ
SYGQLWNDALRIVKGLRQSGLKAKQNVILQLGNNSQLLPAFWGCVLAGIVPAPLAVPPTY
AESSSGTQKLKDAWTLLDKPVVLTDRDMHQEMLDWAKEQGLEGFRAIAVENLLSAEAETD
WHQPSPEDLALLLLTSGSTGTPKAVMLNHRNIMSMVKGIIQMQGFTREDVTFNWMPFDHV
GGIGMLHLRDVYLGCQEINVSSDTILMEPLKWLDWIDHYRASVTWAPNFAFGLVTDFAEE
MKNRKWDLSSMRYMLNGGEAMVAKVGRRMLELLEPHGLPADAIRPAWGMSETSSGVIFSH
EFTRAATSDDDHFVEIGSPISGFSMRIVNDHNELVEEGEIGRFQVSGLSVTSGYYRRPDL
NESVFTEDGWFETGDLGFLRNGRLTITGRTKDAIIINGINYYSHAIESAVEELPEIETSY
TAACAVRVDQNSTDQLAIFFAASEKMNDEQMSQLLKNIQSHVSQVIGVTPEYLLPVQKEE
IPKTAIGKIQRTQLKTSFENGEFDYLLHKPNRMNGSVQDEEMQQADHAKRIREEIQEYLF
TCLTDELNVSRDWVEPNANIQNLGVNSIKLMKLIRSIEKNYRIKLTAREIHKYPTIERLA
GYLSEHESIGSLSADKEGAGTFKTEPERRQASFQPLSEVQKGLWTLQKMSPEKSAYHVPL
CFQFSSGLHLETLQKAFRLVLNQHPILKHVIQEKDGVPFLKHEPALSIDIKTKDISGMNE
SAIPSFLRKKVKEPYVKEKSPLVRLMSFSRSEQEHFLLIVIHHMIFDGVSSVTFMRSLFD
NYKLLLEGRQPEVSVSPAMYHDFAAWEQNVLTGKTGERHRSYWQKQLSGTLPNLQLPKVS
TSSADFEFEEETYTRRLSREFMNRIRTFAKEHSVNVSTVFLSCYMLLLSRYTGQKEQIVG
MPAMVRPEERFDASIGHFLNMLPIRSELNQEDIFSEFMSKLQLTMLDGLDHAAYPFPSIV
RDLNIPRSQTGSPVFQTAFFYQNFLQSGSYQNLLSRYADFFTVDFVEHIHQEGEYELVFE
LWETEEKMELNIKYDTGLFDAGSVSAMFDQFVNVAEQAMLKPSQPLKEYSLLPEAEEQMI
LKTWNATDKTYPYTCFHELFEQQAKKTPDRSAVSYEDQTLTYRELDERSTRLAIYLQAHG
VGPDRLAGIYVDRSLDMIVGLLAILKAGGAYVPLDPSYPAERLEHMLKDSEVSITLTTSA
LVNTLSWNGVKTVLLDQDWDEISQTASDRKVLTRTVTPENLAYVIYTSGSTGKPKGVMIP
HKALTNFLVSMGETPGLSPEDKMLAVTTYCFDIAALELYLPLIKGAHCYICQTEHTKDVE
KLKRDIQTFKPTVMQATPATWKMLFYSGWKNEEKVKILCGGEALPETLKQYFLHTASEAW
NMFGPTETTIWSAVQRINEDCSHATIGRPIANTQMYITDSQLAPVPAGVPGELCIAGDGV
AKGYYKKPELTNARFIDSPFKPGSKLYRTGDMARWLPDGRIEYIGRIDNQVKIRGFRIEL
GDIESRLSEHPGILECVVVAAEENGSHKLAAYYTAKHANASLEARELRRYVKDALPAYMV
PTSFIQLDHMPLTPNGKVDRNSLKHEELTAKQPKQREISPLSIQDAVFTIWQEVLKISDI
EREDGFFDVGGDSLLAVTVADRIKHELSCEFSVTDLFEYSTIKNISQYIAEQRMADIRVS
VPKEEAIHSDQCNRTSDLPDYYEDSVAIIGISCEFPGAKNHEEFWENLRNGKESIAFFSK
EELQRFGISEEKAENASYVPAKSSIDGKDRFDPSFFQISPKDAEFMDPQLRMLLTHSWKA
IEDAGYAAKQVPQTSVFMSASNNSYRALLPSDTTESLETPDGYVSWVLAQSGTIPTMISH
KLGLKGPSYFVHANCSSSLIGLHSAYKSLLSGESAYALVGGATLHTESNIGYMHQPGLNF
SSDGHIKAFDASADGMLGGEGVAVVLLKKAAEAVKDGDHIYALLRGIGVNNDGADKVGFY
APSVKGQADVVQKVMNQTKIQPESICYVEAHGTGTKLGDPIELAALTNVYRQYTNKTQFC
GIGSVKTNIGHLDTAAGLAGCIKVVMSLYHQELAPSLNYKEPNPNIDLHSSPFYVVDQKK
TLSHDHKTHRAALSSFGLGGTNTHAIFEQYKRDFDHRKIDGTCIIPLSAKNSERLQEYAE
DILAYLERRDLDAGQLPDFAYTLQVGREAMEYRVAFTADHVNELKQKLTDFMKGKTAIEG
CFHGSKHNDREMSWLTEDEDSAELIRKWMAKGKVNKLAEIWSKGAHIDWLQLYKGKRPYR
MSLPTYPFAKERYWPSRDDRKPSGQLSGNQTEIGFIHPLLHQNTSDFSEQKFTSVFTGEE
FFLRDHVVRGKPVLPGVAYLEMAHAAIKLAAGSHNGQGIRLNHTVWVQPVVVDKHSAQVD
IGLFPEEDGKITFDIYSTQEDGDDPVIHSQGSAELVSAATTPVADLAEISRRCGKGKMSP
DQFYEEGRSRGMFHGPAFQGIKNVDIGNREVLAQLHLPEIVSGTKEQFVLHPSIMDSALQ
TATICIMQELTDQKLILPFALEELEVIKGCSSSMWAYARLSDSDHAGDTVQKADIDVIDE
SGNVCVRIKGFSTRVLEGEVHSSKLSSRHERLMLEPVWKEQSGGLEDGDPSYTEHIVVLF
ETEGSVTDNLTSNMKDASVITLHAAEGHIAERYQLYAQNVFELMKRKIDEHSAGRIIIQT
VVPLKKEKQLFAGVSGLLKTAELEFSKLTAQVIEVEKPEEMNDLHLKLKDDSRRPADKQI
RYAAGNRFVKGWREMALPSAEELHMPWRDEGVYLITGGAGSIGLLFAKEIANRTVRSTIV
LTGRSVLSERKENELAALRGMGAEVVYREADVSDQRAVRRLMEEIKEKHGTLNGIIHGAG
SIQDHFIVHKTNEEFQKVLQPKVSGLLHVDECSKDFPLDFFVLFSSVSGCLGNAGQADYA
AANTFMDAFAAYRSSLAASKKRFGSTISFNWPLWAEGGMQVGAEVEQRMLRTMGMVPMPT
DSALEAFYQGIVSEKPQVFVMEGQLQKMKQKLLSAETAGKRKGQKNGDQAHGQIQKLEAA
FIQMVGAILKVNTDDIDVHTELSEYGFDSVTFTVFTNKINEAYQLELTPTIFFEYGSIHS
LAEYVMAAYPGEWNQDVAVHDTDERSSSLHTLNSLSASLSNMVSAILKVDRADIDVHTEL
SEYGFDSVTFTVFTNQINDAYQLELTPTIFFEYGSIQSLAEYLIDEYEETFAQEPEKSEV
REELQTISSAEPKATTRRKRRFTQPVIAQAERNKNQTGDFEPIAIVGISGRFPGAMDIDE
FWKNLEEGKDSITEVPKDRWDWRECYGNPDTEVNKTDIKWGGFIDGVAEFDPLFFGISPR
EAHYVDPQQRLLMTYVWKALEDAGCSPQRLSGTGTGILIGTGNTGYKDLFHRANLPIEGH
AATGHMIPSVGPNRMSYFLNIHGPSEPVETACSSSLVAIHRAVTAMQSGDCEMAIAGGVN
TILTEEAHISYSKAGMLSKDGKCKTFSADANGYVRGEGVGMVMLKKLADAERDGNHIYGV
IRGTAENHGGRANTLTSPNPKAQADLLVRAYRQAGIDPSTVTYIEAHGTGTELGDPIEIN
GLKAAFNELSNKRSIPDQRCGIGSVKSNIGHLELAAGISGLIKVLLQMKHKTLVKSLHSE
TLNPYLQLTDSPFYIVQEKQEWKAVTDHDGNELPRRAGISSFGIGGVNAHIVIEEYISKA
NSEQTVPVQPHMIVLSAKNKNRLKDRASQLLEAVRKKKYTDQDLHRIAYTLQVGREEMDE
RLACIAGTIQELEEKLQAFVDGKEETEAIFRGQSNRNKDTQAIFTADEDMAMAIDAWIRK
RKYAKLADLWVKGVSIQWNTLYGETKPRLISLPSYPFARDHYWIPAKEHSQPDKKELADA
AEERTACILTKQWSLSPIGSTVPGTRTISILYNPETADLAAEVSAYFPNHLLLDVSRTDC
RQSDIDWKAFDGIVDVIGCGENDEDRLDWIEWLQRLVEFGHKEGLRLLCVTKGLESFQNT
SVQMAGASRAGLYRMLQSEYSHLTSRHMDAEGMIDHHRLAKQIADEFYSDSQDTEVCYRD
GLRYQAFLQAHPETGKGAEQRLTFPNDHVLFITGGHGASAYYAPDILRSTME
>PK3-2_03717 Putative polyketide biosynthesis enoyl-CoA isomerase PksI
MTHSVVELIEIEPDIIQVKMHDRTHKNAFSQELTDGLIQAFEFIRQKTNYKAVILTGYDN
YFASGGTKEGLLRIQQGLTKFTEDNLYSLALDCEIPVIAAMQGHGIGGGFVMGLFADIVI
LSRESVYTANFMKYGFTPGMGATFIVPKKLGFSLAQEILMNAGSYRGADLEKRGIPFKVL
PRAEVVDYAVELANELAEKPRNSLITLKDHLVAPLREQLPRVIEQELMMHEKTFHHDEVK
TRIKGLYGN
>PK3-2_03718 putative polyketide biosynthesis enoyl-CoA hydratase PksH
MTYQTIKARFQESVCYITFYRPEANNTINDTLIEECLHVLNQCETSAVTVVVLEGLPEVF
CFGADFQDIYQEMKSGRKQASSQEPLYDLWLKLQTGPYVTISHVRGKVNAGGLGFVSATD
IAIADETASFSLSELLFGLYPACVLPFLIRRIGWQKAHYMTLMTKPISVQEASEWGLIDA
FDVQSEVLLRKHLLRLRRLNKKGIARYKQFMNSLDHQVSRSKAIALTANQDMFSDRQNQM
GIIRYVETGQFPWEDQ
>PK3-2_03719 Polyketide biosynthesis 3-hydroxy-3-methylglutaryl-ACP synthase PksG
MVSAGIEAMNVFGGTAYLDVMELAKYRHLDTARFENLLMKEKAVALPYEDPVTFGVNAAK
PIIDALSEAEKDRIELLITCSESGIDFGKSLSTYIHEYLGLNRNCRLFEIKQACYSGTAG
FQMAVNFILSQTSPGAKALVIASDISRFLIAEGGDALSEDWSYAEPSAGAGAVAVLVGEN
PEVFQIDPGANGYYGYEVMDTCRPMPDSEAGDSDLSLMSYLDCCEQTFLEYQKRVPGASY
QDTFQYLAYHTPFGGMVKGAHRTMMRKVAKVKTAGIETDFLNRVKPGLNYCQRVGNIMGA
ALFLALASTIDQGRFDSPKRIGCFSYGSGCCSEFYSGITTPQGQERQRSFGIEKHLDRRY
QLSMDEYEQLFKGSGMVRFGTRNVKLDVEMIPGIMQFTQEKPRLILEEISEFHRKYRWIS
>PK3-2_03720 Polyketide biosynthesis malonyl-ACP decarboxylase PksF
MIQAIQQVLSGEVDVCIALGALMDLSYMECEALRGLGAMGTDKYANEPEKACRPFDQNRD
GFIYGESCGALVIERKETAVRRGIKPYAALSGWSIKLDGNRNPNPSLEGEVHVIQEALER
AGLSPEDIDYINPHGTGSFIGDEIELKALHACRLSHAYINATKSITGHGLSAAGIVEIVS
VLLQMKKSALHPTRNLDHPIDDSFYWVNEKSISYRIKNALSLSMGFGGMNTAVCIQNIEK
CGGES
>PK3-2_03721 Polyketide biosynthesis malonyl-ACP decarboxylase PksF
MTKCNLSEVVVAGAGVTAAIGQGKEAFASSLLSGRHAFDVMERPGRQKNSRFIGAEIASL
SYPDRLSKKLLRKASFSSRAALVTLSEAWEEAQLDDVDSARIGLVVGGSNFQQRETLQLY
ESYQDRSGFISPAYGLSFMDSDLCGLCTDQFGITGLAYTVGEPRPAAS
>PK3-2_03722 Polyketide biosynthesis acyl-carrier-protein AcpK
MDKQRIFEVLITNICEVLPELDGHRFEPEDQLVELGADSVDRAEIITMVLEDLSLKIPRI
ELSGVKNIGELAEVLYDKVQSV
>PK3-2_03723 Polyketide biosynthesis protein PksE
MITYVFPGQGSQQKGMGQGLFEQYQHLTDQADQILGYSIEKLCTEKSYLDLNHTQYTQPA
LYVVNALSYLKRAEETGRKPDFAAGHSLGEYNALFAAGAFDFVTGLRLVKKRGELMGRIT
GGGMAAVIGLTKEQVTAVLEGHHLRDIDVANENTPRQIVISGQKNEIEKAQTVFENTKDV
KLFHPLNVSGAFHSRYMNKAKQEFKQFIDSFLFAPLAIPVISNVYAEPYHQDRLKETLSE
QMDSTVKWTDSIRFLMGRGEMEFEEIGPGTVLTGLIHRIKNEAEPLTYIPKKTSAISVHL
KEEPNVQAGITAESLGSAEFKEDYHLTYAYLAGGMYRGIASKEMVVKLSRAGMMGFFGTG
GLSLNEVEDAILAIQGDLREGQAYGINLVHNMKHTESEEKLIDLLLKHQVKTVEASAFLS
VTPALIRYRAKGVKRNPNGDIKCSNRLIAKISRPEVAESFLSPAPENMLQKLLGENKITA
NEAELLRNIPIADDICVEADSGGHTDGGVAYSLMPAMTSLRDEMMKKYQYPKKIRVGAAG
GIGTPDAAMAAFMLGADFIVTGSINQCTVEAATSDKVKDLLQQMNVQDTAYAPAGDMFES
GSKVQVLKKGVFFPARASKLYELYQRYGSIRELDAKMLTQLEEKYFKRTIEDIYKDITMH
YPAAEIEKAEQNPKHKMALIFRWYFRNSSNLAISGSEHSKVDYQIHCGPALGAFNQWVKG
SELENWRNRHVDEIGKKLMIETAALLHERMQSMYQSSH
>PK3-2_03724 Polyketide biosynthesis acyltransferase PksD
MVEYSLYKVLEDRGIYPDYVLGSSLGEFTAAAVSGVSDSENVLDSILEQAIVIQNSCEKG
KMLAILDKPQLLNDDPQLFRNSALISINYDSHFVISGEEENIKQLTEALKEKQILCQLLP
VSYAFHSSLIDPAESGYAEFLRSISIQNPSIPLVSSLTGNRLFKMDKHFFWDAVRKPMRF
REAIQYLETRHTCRFIDLGPSGTLSAFVKQLIQGDSANRCCSIMTPFHQELKNLNTVESF
RKPERKFTR
>PK3-2_03725 Polyketide biosynthesis malonyl CoA-acyl carrier protein transacylase PksC
MITYVFPGQGSQKQGMGSDLFHEFKELTDQADEILGYSIKRLCLENPYSNLKKTQFTQPA
LYVVNALSYLKKIREAETMPDFVAGHSLGEYNALFAAKAFDFETGLKLVRKRGELMSMVS
NGGMAAIMGLNEEQVAKALKEFHLHDVDIANVNAPYQIVISGKKDEIEKAASLFETMTEV
TMVLLLNVSGAFHSRYMNKAKEEFEQFLHTFHFSPPSIPVISNVYAKPYTYEFMKQTLAD
QINHSVKWTESISYLMRKGQMEFEEIGPGNVLTGLIHRIKKDAEPMTR
>PK3-2_03726 putative polyketide biosynthesis zinc-dependent hydrolase PksB
MNLTYKVHPIKTRYQGWTNYCYIVEDIVSRSAIVVDPSWELNKITNKLSELEVELTAIAL
THSHYDHVNLVESLTQMCNAQVYMSKKEIDYYQFRCRNLIGLHDHQTIKIGNTSAQCLLT
PGHTAGGMCYLFSESIFTGDTVFTEGCGICEDDGSSAEEMFKSIQRIKSEVLPYVRVYPG
HSFGKAPGHSIEDLYQHNIYFQIDKKEYFVKFRTRKNQKGIFDFK
>PK3-2_03727 HTH-type transcriptional regulator BetI
MPKQIDHEKRRKQIAEATWRVILERGMEGASARNIAKEAGLSLGALRHYFSTQDELLVFA
MKLVQEKVRARINDIAIKDLPPKETVLHILLEIVPTNEETIREMEVWFAFTVYARHKKDM
FDANHDGIYSGMQNLIAYLDECSLLKQDADKDIEAERLYALIDGLALHAMLDPVRVNKDR
IKRVIMQHVESICTEKIRETEERNP
>PK3-2_03728 hypothetical protein
MNGIAWMIVFCEIAFWVVIVLGLAVRYLFKQRTLGLLFLALTPVIDLILLAATGVDLYRG
ASATAAHGIAAVYIGISIAYGKQMIQWADERFQYYVTKQGSKPLKRYGMDYAKHYAKSWI
RHVLAYLIGAGLLAGMIYFINDSARTEALNGILKMWTVILGIDFLFTASYFIWPKKEKAS
ENLKS
>PK3-2_03729 hypothetical protein
MSQNEQNEQFKDLNLSSKLIVIVSIILIAAIALAVIFGGFFFGMKGLFSILGITYDSNQT
LVLFLLVCFAAGLIIDPLTKIVSIILAKSFLLKKTALFAFTLYFVSNFITICFADYFMQS
ISIPDVLLFVISALLALIELAFGNQPEAA
>PK3-2_03730 hypothetical protein
MEVCFWAFILFLMVYEPIFGYFDFQRFKRNIKTGENARVKYDVRTMIGLWISALFIAALV
AFTDLSFIQVGFTKPAIQIDPLGPLASYLFLGFGLLYVILVMYCIIGS
>PK3-2_03732 hypothetical protein
MAKKILFSLLALAIIVAGVSLLMHFNSRKVAEDKIDHYISDYGIPQKEIESEEYPMFNSV
SAPTGFTKAVFVKNENNKGNYYIFDYDPSTKKITFSGVVDGNEVSINDKLIKKLKYQPSH
KVLNQE
>PK3-2_03733 hypothetical protein
MKLKKALTGSVLSLALLVSATPAFATTSTSTNTTPEAKALETCTTKPFGPYYSRNEIPNF
INDGVKKWYLKGVSSWDGVWYGYYESCN
>PK3-2_03734 DNA mismatch repair protein MutL
MNVAKVIQLSDELSNKIAAGEVVERPASVVKELVENAIDADSTVIEIDIEEAGLASIRVL
DNGEGMETEDCKRAFRRHATSKIKDENDLFRVRTLGFRGEALPSIASVSHLEITTSTGEG
AGTKLVLQGGNIISESRSSSRKGTEIVVSNLFFNTPARLKYMKTVHTELGNITDVVNRIA
LAHPEVSIRLRHHGKNLLQTNGNGDVRQVLAAIYGTAVAKKMLPLHVSSLDFEVKGYIAL
PEITRASRNYMSSVINGRYIKNFPLVKAVHEGYHTLLPIGRHPITFIEITMDPILVDVNV
HPSKLEVRLSKETELHDLIRDGIKDVFKKQQLIPSAQLPKKSASVIKNEQQFITFDEKPA
ERKVPEKSAAPSYSPMKLSSVVKEPVDVEEELPPLQFDAPPIVDQEQSIEVPDVSEEQPE
ALEQEYHEEQPQPTSERVPIMYPIGQMHGTYILAQNENGLYIIDQHAAQERIKYEYFREK
VGEVEPEVQDMIVPLTFHYSTNEALIIEQHKQELESVGVFLESFGSNSYIVRCHPAWFPK
GEEAELIEEIIQQVLDSKHIDIKKLREEAAIMMSCKGSIKANRHLRNDEIKALLDDLRST
SDPFTCPHGRPIIIHHSTYEMEKMFKRVM
>PK3-2_03735 DNA mismatch repair protein MutS
MAGYTPMIQQYLKIKAEHQDAFLFFRLGDFYEMFFEDAKKASQELEITLTSRDGGAAEKI
PMCGVPYHSASAYIEQLIKKGYKVAICEQTEDPKAAKGVVKREVVQLITPGTVMDGKGIH
ESENNFIASVSACSNGYGLALSDLTTGENLAVLIERLEDVISEIYSVGAREIVVSGNLDA
DTVTQLKERCGATISIEDGETDEHVTIIEHLNHEDVRKTFLRLYTYLKKTQKRSLDHLQP
VQVYELEEAMKIDLYSKRNLELTETIRSKNKKGSLLWLLDETKTAMGGRLLKQWIDRPLI
RVNQIEERQEMVETLMSHFFEREDLRERLKEVYDLERLAGRVAFGNVNARDLIQLKESLK
QVPGIKQLVASLAHDKAKERAERIDPCGDVLELLEEALYANPPLSLKEGNLIKDGYNQKL
DEYRDASRNGKDWIARLEQQEREYTGIRSLKVGFNKVFGYYIEVTKANLHLLEEGRYERK
QTLTNAERYITPELKEKEALILEAENNISELEYELFTELREKVKRYIPRLQQLAKQMSEL
DALQCFATISENRHYTKPAFSKDEVEVIEGRHPVVEKVMDSQEYVPNNCMMGDNRQMLLI
TGPNMSGKSTYMRQIALISIMAQIGCFVPAKKAVLPIFDQIFTRIGAADDLISGQSTFMV
EMLEAKNAIVNATKNSLILFDEIGRGTSTYDGMALAQAIIEYVHDHIGAKTLFSTHYHEL
TVLEDKLQRLKNVHVRAEEYNGTVVFLHQIKEGAADKSYGIHVAQLAELPEDLIARAQDI
LKELEHSGNKPEVPVQKPQVKEEPAQLSFFDAAEKPAEAPKLSKKEKQVLDAFKSLNILD
MTPLEAMNEMYKLQKKLH
>PK3-2_03736 Spore coat protein E
MSEYREIITKAVVAKGRKFTQCTNTISPEKKPSSILGGWIINHKYDAEKIGKTVEIEGYY
DINVWYSYADNTKTEVVTERVKYVDVIKLRYRDNNYLDDEHEVIAKVLQQPNCLEVTISP
NGNKIVVQAEREFLAEVVGETKVVVEVNPDWEEDDEEDWEDELDEELEDINPEFLVGDPE
E
>PK3-2_03737 putative protein YmcA
MTLYSKKDIVQQARNLAKMISETEEVDFFKRAEAQINENDKVSAIVNQIKALQKQAVNLK
HYEKHEALKQVEAKIDALQEELEEIPVIQEFRDSQTEVNDLLQLVAHTISNQVTNEIITS
TGGDLLKGETGSKAKYSNNSCSF
>PK3-2_03738 tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase
MNEKQKLESGQVTPSDKKSEKDYSKYFEAVYIPPSLKDAKKRGKEAVAYHNDFKISEQFK
GLGDGRKFYIRTYGCQMNEHDTEVMAGIFMALGYEATNSVDDANVILLNTCAIRENAENK
VFGELGHLKALKKNNPDLILGVCGCMSQEESVVNRILKKHPFVDMIFGTHNIHRLPELLS
EAYLSKEMVVEVWSKEGDVIENLPKVRNGKIKGWVNIMYGCDKFCTYCIVPYTRGKERSR
RPEEIIQEVRRLASEGYKEITLLGQNVNAYGKDFEDMTYGLGDLMDELRKIDIPRIRFTT
SHPRDFDDRLIEVLAKGGNLLDHIHLPVQSGSSEVLKLMARKYDRERYMDLVRKIKEAMP
NASLTTDIIVGFPNETDEQFEETLSLYREVEFDSAYTFIYSPREGTPAAKMKDNVPMRVK
KERLQRLNALVNEISAKKMKEYEGKVVEVLVEGESKNNPDILAGYTEKSKLVNFNGPKES
IGKIVRVKIQQAKTWSLDGEMVGEAIEVK
>PK3-2_03739 8-amino-7-oxononanoate synthase/2-amino-3-ketobutyrate coenzyme A ligase
MKEFEFLKAELDRMKENHTWQEIKQLESMQGPSVTVNHKNVIQLSSNNYLGFTSHPRLIK
AAQEAVQQFGAGTGSVRTIAGTFTMHQELEKKLAAFKKTEAALVFQSGFTTNQGVLSSIL
TKEDIVISDELNHASIIDGIRLTKADKKVYQHVDMSDLERVLRKSMNYRMRLIVTDGVFS
MDGNIAPLPDVVELAEKYDAFVMVDDAHASGVLGENGRGTVNHFGLDGRVHIQVGTLSKA
IGVLGGYAAGSKVLIDYLRHKGRPFLFSTSHPPAVTAACMEAIDVLLEEPEHMERLWENT
AYFRSMLVKMGLTLTQSETPILPIIIGDEGAAKAFSDQLLSRGIFAQSIVFPTVAKGKAR
IRAIITAEHTKEELDKALDAIEKTAKELQLL
>PK3-2_03740 L-threonine 3-dehydrogenase
MQSGKMKALMKKDGTFGAVLTEVPIPDIDKHEVLIKVKAASICGTDVHIYNWDQWARQRI
KPPYVFGHEFSGIVEAVGENVRSVKVGEYVSAETHIVCGECVPCLTGKSHVCTHTAIIGV
DTVGCFAEYVKVPADNVWKNPADMDPAIASIQEPLGNAVHTVLESQQAGGTTAVIGCGPI
GLMAVAVAKATGASQVIAIDKNEYRLALAKQMGASYTVSVEKEDPLKIVSALTGGEGADL
VCEMSGHPSAIAQGLAMAANGGRFHILSLPEHPVTIDLTNKVVFKGLTIQGITGRKMFST
WRQVSQLLSSNVLDLSSVITHRFSLEEFEKGFELMRSGQCGKVILIP
>PK3-2_03741 Stage V sporulation protein S
MEILKVSAKSSPNSVAGALAGVLRERGAAEIQAIGAGALNQAVKAVAIARGFVAPSGVDL
ICIPAFTDIQIDGEERTAIKLIVEPR
>PK3-2_03742 2',3'-cyclic-nucleotide 2'-phosphodiesterase
MRILFIGDVVGSPGRDMVKEYVPKLKTKYKPHFTIINGENAAHGKGLTEKIYHGFIQAGA
DAITMGNHTWDKREIFDFIDDVPNLVRPANFPEGTPGKGMIYVKANGKELAVMNLQGRTF
LPPLDDPFLKADELIAEAAKRTPYIFIDFHAEATSEKLALGWYTDGRASAVVGTHTHVQT
ADNRILPKGTAYITDVGMTGPYDGILGTDRETVIKRFKTNLPVRFTVAEGRTTLSGVVID
IDDQTKKAVKIERILINDDHMFFE
>PK3-2_03743 Ribonuclease Y
MTPIMMVLISILLILLGLVVGYFVRKTIAEAKIAGARGAAEQILEDAKRDAEALKKEALL
EAKDEIHKLRIDAEQEVRERRNELQKQENRLLQKEENLDRKHEGIDKREAMLEKKDHSLN
ERQQHIEEMESKVDEMIRMQQSELERISSLTRDEAKQIILERVENELSHDIAIMTKETEN
RAKEEADKKAKNILSLALQRCAADHVAETTVSVVNLPNDEMKGRIIGREGRNIRTLETLT
GIDLIIDDTPEAVILSGFDPIRRETARIALDKLVQDGRIHPARIEEMVEKSRREVDDYIR
EMGEQTTFEVGVHGLHPDLIKILGRLKFRTSYGQNVLKHSMEVAFLAGLMASELGEDAKL
AKRAGLLHDIGKAIDHEVEGSHVEIGVELATKYKEHPVVINSIASHHGDEEPTSIIAVLV
AAADALSAARPGARSETLENYIRRLEKLEEISESYEGVEKSFAIQAGREVRIMVKPDSIN
DLEAHRLARDIRKRIEDELDYPGHIKVTVIRETRAVEYAK
>PK3-2_03744 Putative penicillin-binding protein PbpX
MTSPTRRRTAKRRRRKLNKRGKLLLGLIAALICFTIWNALHRNSEENEPSQETAAVSDTG
QKKEVKKKAAEKTEERIKTVDRNQKISNYLKEIGFSGTAMIVRNGEVITNKGFGYADRKQ
HIQNNPLTSYYVGSSQKALIATAILQLEEKGKLQTSDPVSTYLPHFPNGQTITLKNLLTH
TSGINGHIEGNGEIAPDDLIKDIERQGIKRQPGVWDYKDSNYSVLAYIVAEVSGEPYEQY
ITNHIFKPAGMTHAGFYKTYDKESYPAVGYKLKGGRAVTPYMPDLSQLYGAGDIYMSAID
MYKFDQALIDGKLYSQKSYEKMFTPGSSSTYGMGFYVAPGSYSNHGVMPGFNILNSFSKS
GQTVVVLLSNIQNNAKLGQVNNKIYQLLNQE
>PK3-2_03745 Protein RecA
MSDRQAALDMALKQIEKQFGKGSIMKLGEKTDTRISTVPSGSLTLDTALGIGGYPRGRII
EVYGPESSGKTTVALHAIAEVQQQGGQAAFIDAEHALDPVYAQKLGVNIEELLLSQPDTG
EQALEIAEALVRSGAVDIVVVDSVAALVPKAEIEGDMGDSHVGLQARLMSQALRKLSGAI
NKSKTIAIFINQIREKVGVMFGNPETTPGGRALKFYSSVRLEVRRAEQLKQGNDVMGNKT
KIKVVKNKVAPPFRTAEVDIMYGEGISKEGEIIDLGTELDIVQKSGSWYSYEEERLGQGR
ENAKQFLKENKDIMLMIQEQIREHYGLDNHGAVQKQAGDAQEELEFEE
>PK3-2_03746 Putative competence-damage inducible protein
MEFPKKAEIIAVGSELLLGQIANTNAQFISKQLAEIGVNVFYHTAVGDNPERLKQVIRIA
EERSDFIIFSGGLGPTKDDLTKETIANVLGRPLVLNDEAFQSIEDYFKRTKRTMSPNNRK
QALVIEGSDVLANHFGMAPGMLTEHESRFYMLLPGPPSELRPMFENEAKPLLLKKMGSNE
KIVSTVLRFFGIGESQLEADLEDIIDAQTNPTIAPLAADGEVTLRLTAKHADEKETERLL
KETEAVILERVGEFFYGYDDTSLVEELSKACKEKGMTISSAESFTGGLFSEWLTDLSGAS
TLFAGGVVCYTNDVKQNMLGVKKETLDRFGAVSKECASELAKGVQKLTGSDIGISFTGVA
GPDTQEGHEPGHVFIGISANGKEEVHEFHFAGSRTGIRKRGAKYGCHLILKLLEQK
>PK3-2_03747 CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase
MFNLPNKITLARIALIPIFMIIMLAPFDWGRLEFGGESIPVAHLAGAILFIIASTTDWVD
GYYARKLNLVTNFGKFLDPLADKLLVSAALIILVQFDLAPAWMVIVIISREFAVTGLRLV
LAGTGEVVAANMLGKIKTWAQIIAVSALLLHNLPFELVSFPFADLALWVAVFFTVVSGWE
YFSKNWEALKTSN
>PK3-2_03748 hypothetical protein
MTELGIRLKEAREEKAMSLDDLQAATKIQKRYLTALEEGNYDIIPGKFYVRAFIKQYAEA
VGLDADQLFEEHKKDIPNTYHDDVSEKISGMNLQKEMPKPASKALELLPTILVILGVIVV
IAIVYAIIQFANHKNSDDNNAASEKSITQSESKYEIPKDSTLKENQNNSSEKETDTKKET
KEKEDKKEESDSDKLEIKAAGTEGSLTTYEVSGADKIELELKASDSSWIRVRDENSSSLK
EGTLKKDETYKKDITDQKQVEIRTGYAPNLKIKINGKVLSYELDPKKVMAQTIKIVNKKE
EKSS
>PK3-2_03749 hypothetical protein
MAKLEWYFEYEIQVNRPGLLGDISSLLGMLSINIVTINGVDLSRRGMLLRCRHIDQIKRL
ESILKTMETIKVTKLREPRLRDRLAVRHGRYIQRDADDKKTFRFERDELGLLVDFMAELF
KKEGHKLIGIRGMPRVGKTESIVASSVCASKRWLFVSSTLLKQTIRSQLIADEYSTENVF
IVDGIVSTRRGSERHLQLVREIMRLPATKVVEHPDIFVQNTEYTLDDFDYIIELRNDPDE
VITYEHAEEPQMFDQSGFSSFDF
>PK3-2_03750 putative protein YflH
MSVLENWDSWKNFLGDRLNYAQDKGMSQDTITDLATEIGSYLANEVESKNEQEKVLADLW
SVASKDEQHAIANMMVKLVENNSTH
>PK3-2_03751 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MNKTALITGASGGIGKSISETLAAEGYNLLLHYNTNQNAAAELAEKLRETFDVHAEILQA
DLSVPEGADKLSSSIVQPIDAIVLNSGRSHFGLITDVDNATVQEMVQLHVASPYMLTRNL
LPHMIGNKSGAIVAVSSIWGETGASCEVLYSMAKGAQHSFVKGLAKELAPSGIRVNAVAP
GAVDTNMMNQFSPSEKEEIADDIPIGRLARPEEIADATAFLLSEKASYITGQILSVNGGW
HC
>PK3-2_03752 hypothetical protein
MIKPIEYEQLQETLYHEKMPNGLDVYVLPKKGFNKTYAVFTTKYGSIDNRFIPLDKNEMV
HVPDGIAHFLEHKLFEKADGDVFQDFSKQGASANAFTSFTRTAYLFSSTSNVERNLETLI
DFVQDPYFTEKTVEKEKGIIGQEINMYDDNPDWRLYFGVIENMYKEHPVRIDIAGTVESI
SHITKDLLYECYETFYHPSNMLLFIVGPVEPESIISQVRENQEKKPYTDQPEIKREEVKE
QEAVFRKEKEIKMNVQGPKCLVGLKSKNPFRLGKELLKHELSMNLLLESLFGKSSAQYES
LYEKGYIDETFSFDFTAEYGFGFAAIGGDTPEPDQLAENISSMLLRAGELITAEKIELAR
KKKIGTFLKALNSPEYIANQFTRYAFLDMSLFDVVSVLEQITLEDVQKVIQEEIAADRLT
VCKVVPKS
>PK3-2_03753 hypothetical protein
MSYVNEIKTKHGGLTAHIVETEKFKTVSLIFKMLAPLTKDQVTKRALLPHVLLRGTKSHP
KTSELRSYLDELYGTSVSADLSKKGERHVITFRLEIPNEKYLKDQTPLLEKGLQLLAEIV
FSPALEGGAFQSQYVAQEKRTLKQRIQAVYDDKMRYSNLRLIQEMCKNEPYALHVNGEID
DVDAITADQLYETYQSAIQKDQLDLYVVGDVDSSQVQSAIDKYFQTEERTLRTIENNQAE
GEAQPKEVIDEEDVKQGKLNIGYRTSITYTDQDYPALQVFNGLFGGFSHSKLFINVREKA
SLAYYAASRIESFKGLLMVMSGIEVENYEQAVSIIAEQFQAMKNGDFSEQDIAQTKAVIR
NQVLETIDTAYGLSEFLYQQAAAQVDIPIEDFLANIEKVTKEDIVKAGEKIQLDTTYFLK
GTEGAS
>PK3-2_03754 Bacillibactin exporter
MKNIIALSSVPLVMTLGNSMLIPVLPMMEKKLSVTSFQVSLIITVYSVVAIICIPIAGYL
SDRFGRKKILLPCLLIAGLGGLVAAIASTYMKNPYAMILAGRVLQGIGSAGAAPIVMPFI
GDLFQGDDEKVSAGLGDIETANTSGKVLSPILGALLASWYWFVPFWFIPFFCLISFLLVL
FLVAKPEEDEDAPAVSEFIKSVRKIFKQDGRWLYTVFIIGCVIMFLLFGVLFYLSDTLEN
KYAIDGVAKGGLLAIPLLFLSTSSFIAGKKIGKDKVRMKFCVVTGMTLLTLSFIALWWNH
GFYFLFIFLSFGGIGIGMALPALDALITEGIESEQCGTISSFYNSMRFIGVALGPPVFAA
LMSNANWLIFILSAFCSIVALFLVLFTVDAKKSEKEEKNLGTV
>PK3-2_03755 HTH-type transcriptional repressor NagR
MSTKADNRHLYLKVIERIKEDIKNGIYTEKEKLPSEFELSKKLGVSRATLREALRILEEE
HVIIRRHGVGTFVHSKPLFLSGIEQLNSVTKMIEQANMAPGTIFLSSQVLMPSEDDTKRF
HLAEGQELFYLERVRTANGQPIVYCIDKIPMDILPDSFSHQQESMFDLLEKNSGSVISYA
VTDIEPIGYHDTISPVLECDPETALLLLKQTHYDQHDKPVLYSLNYFRADKFRFHVLRKR
F
>PK3-2_03756 DNA translocase SpoIIIE
MAKKKRKTRKKQAKQLNIKYELNGLLCIAISIIAILQLGVVGQTFIYLFRFFAGEWFILC
LLGLLVLGVSLFWKKKTPSLLTRRKAGLYCIIASILLLSHVQLFKNLTHKGSIESASVVR
NTWELFLMDMNGSSASPDLGGGMIGALLFAASHFLFASTGSQIMAIVMILIGMILVTGRS
LQETLKKWMSPIGRFIKEQWFAFIDDMKSVKTNMKSSKKTKTPGKKQKPARKKQQMEPEP
SDEEEDSEMISPLIHSEPIISSFSDRNEDEEPPVIEKRADPVSEPLQDIQPETGDQETVS
APPMTFTELENKDYEMPSLDLLADPQHTGQQADKKNIYENARKLERTFQSFGVKAKVTQV
HLGPAVTKYEVYPDVGVKVSKIVNLSDDLALALAAKDIRIEAPIPGKSAIGIEVPNAEVA
MVSLKEVLDSKLNDRPDAKLLIGLGRNISGEAVLAELNKMPHLLVAGATGSGKSVCVNGI
ITSILMRAKPHEVKMMMIDPKMVELNVYNGIPHLLAPVVTDPKKASQALKKVVNEMERRY
ELFSHTGTRNIEGYNDYIKRSNNEEGAKQPELPYIVVIVDELADLMMVASSDVEDSITRL
SQMARAAGIHLIIATQRPSVDVITGVIKANIPSRIAFSVSSQTDSRTILDMGGAEKLLGR
GDMLFLPVGANKPVRVQGAFLSDDEVEKVVDHVITQQKAQYQEEMIPEETTETHSEVTDD
LYDEAVELIVGMQTASVSMLQRRFRIGYTRAARLIDAMEERGVVGPYEGSKPREVLLSKE
KYDELSS
>PK3-2_03757 hypothetical protein
MILYTVMPQEIVFAEQNQETNAHEQIEYKGVPLLVEMKGNEAEVIQIMSTNPMHFLHPDI
SPGQRLKLNV
>PK3-2_03758 Translocation-enhancing protein TepA
MENTEEERPEKNDAKDSIMNKIQQLGETTLPQLPQDTNIHCLTIIGQIEGHVQLPPQNKT
TKYEHVIPQIVAIEQNPKIEGLLIILNTVGGDVEAGLAIAEMLASLSKPTVSIVLGGGHS
IGVPIAVSCDYSYIAETATMTIHPVRLTGLVIGVPQTFEYLDKMQERVVKFVTSHSNITE
EKFKELMFSKGNLTRDIGTNVVGKDAVEYGLIDHSGGVGQAINKLNELIEEARSEEGRMI
Q
>PK3-2_03759 Ribonuclease J2
MKKKNTENVRIIALGGVGEIGKNLYVIEIDSDIFVVDAGLMHPENEMLGIDVVIPDISYL
IERADRVKAIFLTHGHDENIGGVFYLLNKLSVPVYGTKLTLALLREKLKQYGHNRKTDLR
EIHSKSVITFESTKVSFFRTIHSIPDSVGVSFKTSLGSIVCTGDFKFDQTPALNQTCDIG
EIAKIGNSGVLALLSDSANAERPGYTPSEAAVSGEISDALYNSDNRVIIAVFASNINRIQ
QVIHAAAQNGRKIAVAGKNLQSVLQLARKLGYIEADDELFISVQDVKKYPKREVAIITAG
NQGEPLAALTRMANKAHKQLNIEKGDTVVIASTPIPGQELIYSKTVDLLARAGAQVIFAQ
KRVHVSGHGSQEELKLMINLLKPKYLIPVNGEYRMQKAHSKIAEEIGMKRSDIFLIEKGD
VVEFRGQNVKIGDKVPYGNILIDGLGVGDIGNIVLRDRRLLSQDGILIVVITLDKQKKHL
VSGPEIITRGFVYVRESEGLIVQATELVRSIVTEATETSNVEWSTLKQAMRDALNQFLYE
KTKRKPMIIPIIMEV
>PK3-2_03760 4-hydroxy-tetrahydrodipicolinate synthase
MNGRVPVIAGTGSNNTKDSIKLTKKAEEAGVDAVMLVTPYYNKPSQEGMYQHFKAIAAET
SLPVMLYNVPGRTVASLAPETTIRLAADIPNVVAIKEASGDLEAITKIVAETPEDFSVYS
GDDALTLPVLSVGGRGVVSVASHIAGSDMQQMIKNYTNGQTANAALIHQKLLPIMKELFK
APNPAPVKTALQLRGLDVGSVRLPLVPLTEDERLSLSSTISEL
>PK3-2_03761 4-hydroxy-tetrahydrodipicolinate synthase
MNFGNVSTAMITPFDNKGNVDFQKLSTLIDYLLKNGTDSLVVAGTTGESPTLSTEEKLRF
LNIR
>PK3-2_03762 Aspartokinase 2
MKIIVQKFGGTSVKDDKGRKLALEHIKEAISEGYKVVVVVSAMGRKGDPYATDSLLGLLY
GDQSAISPREQDLLLSCGETISSVVFTSMLLDNGVKAAALTGAQAGFLTNDQHTNAKIME
MKPERLFSVLANHDAVVVAGFQGATEKGDTTTIGRGGSDTSAAALGAAVDAEYIDIFTDV
EGVMTADPRVVENAKPLPVVTYTEICNLAYQGAKVIHPRAVEIAMQAKVPIRVRSTYSKD
KGTLVTSHHSSKVGSDVFERLITGIAHVKDVTQFKVPAKIGQYNVQTEVFKAMANAGISV
DFFNITPSEIVYTVAGNKTETAQRILMDMGYDPMVTRNCAKVSAVGAGIMGVPGVTSKIV
SALSEKEIPILQSADSHTTIWVLVHEADMVPAVNALHEVFELSK
>PK3-2_03763 Aspartate-semialdehyde dehydrogenase
MGRGLHVAVVGATGAVGQQMLKTLEDRNFEMDTLTLLSSKRSAGTKVTFKGQELTVQEAS
PESFEGVNIALFSAGGSVSQALAPEAVKRGAIVIDNTSAFRMDENTPLVVPEVNEADLHE
HNGIIANPNCSTIQMVAALEPIRKAYGLNKVIVSTYQAVSGAGNEAVKELYSQTQAILNQ
EEIEPEIMPVKGDKKHYQIAFNAIPQIDKFQDNGYTFEEMKMINETKKIMHMPDLQVAAT
CVRLPIQTGHSESVYIEVDRDDATVEDMKTLLKEAPGVTLQDDPSQQLYPMPADAVGKND
VFVGRIRKDLDRANGFHLWVVSDNLLKGAAWNSVQIAESLKKLNLV
>PK3-2_03764 Dipicolinate synthase subunit B
MSSLKGKRIGFGLTGSHCTYEAVFPQIEALVNEGAEVRPVVTFNVKSTNTRFGEGAEWIK
KIEDLTGYEAIDSIVKAEPLGPKLPLDCMVIAPLTGNSMSKLANAMTDSPVLMAAKATIR
NNRPVVLGISTNDALGLNGTNLMRLMSTKNIFFIPFGQDDPFKKPNSMVAKMDLLPQTIE
KALMHQQLQPVLVENYQGND
>PK3-2_03765 Dipicolinate synthase subunit A
MLTGLKIAVIGGDARQLEIIRKLTEQQADIYLVGFDQLDHGFTGAVKCNIDEIPFQQIDS
IILPVSATTGEGVVSTVFSNEEVVLKQDHLNKTPAHCVIFSGISNAYLENIAAQANRKLV
KLFERDDIAIYNSIPTVEGTIMLAIQHTDYTIHGSQVAVLGLGRTGMTIARTFAALGANV
KVGARSSAHLARITEMGLVPFHTDDLKEHVKDIDICINTIPSMILNQTVLSSMTPKTLIL
DLASRPGGTDFKYAEKQGIKALLAPGLPGIVAPKTAGKILANVLSKLLAEMQAEEGK
>PK3-2_03766 hypothetical protein
MRLSELSGKEIVDIKRAERLGVLGQTDLEINEQDGQITALLIPTVKWFGLRKQGHDIRVP
WHHIQKIGSDMIILDVPEEMSPRED
>PK3-2_03767 putative zinc protease
MIKRYTCQNGVRVVLENNPTVRSVAIGVWIGTGSRHETPEINGISHFLEHMFFKGTSTRS
AREIAESFDRIGGQVNAFTSKEYTCYYAKVLDEHANYALDVLADMFFHSTFDENELKKEK
NVVYEEIKMYEDAPDDIVHDLLSKATYGNHSLGYPILGTEETLATFNGDSLRQYMHDYYT
PDRVVISVAGNISDSFIKDVEKWFGSYEAKGKATGLEKPEFYTEKLTRKKETEQAHLCLG
FKGLEVGHERIYDLIVLNNVLGGSMSSRLFQDVREDKGLAYSVYSYHSSYEDSGMLTIYG
GTGANQLQQLSETIQETLATLKRDGITPKELENSKEQMKGSLMLSLESTNSKMSRNGKNE
LLLGKHKTLDEIINELNAVNLERVNGLARQLFTDDYALALISPSGNMPS
>PK3-2_03768 hypothetical protein
MYKKFVPFAVFLFLFFVSFEMMKNPYAVDYIGAMKKDTVTVTASKDPLYEELLQKAPDYE
VKPQNARIDKVWKSIPGYNGLKVNIEQSYKKMKKHGEFRENDLVYSQVRPSVHLESLQPE
PIYKGNPDKPMVAFLINVAWGNEYLEKMLPILEKHRVKATFFLEGNWVRNNERLAKKIAE
DGHEIGNHSYNHPDMSKLTTGRISEQLDKTNEQIEQTIGVKPKWFAPPSGSFRKAVIDIV
AEKQMGTVMWTVDTIDWQKPAPSVLQTRVLSKIHNGAMILMHPTDPTAESLEALITKIKD
KGYALGTVTELMDETRLLK
>PK3-2_03769 Polyribonucleotide nucleotidyltransferase
MGQEKHVFTIDWAGRTLTVETGQLAKQANGAVMIRYGDTAVLSTATASKEPKPLDFFPLT
VNYEERLYAVGKIPGGFIKREGRPSEKAVLASRLIDRPIRPLFADGFRNEVQVISIVMSV
DQDCSSEMAAMFGSSLALSVSDIPFEGPIAGVTVGRIDDQFIINPTVDQLEKSDINLVVA
GTKDAINMVEAGADEVPEETMLEAIMFGHEEIKRLIAFQEEIVAAVGKEKSEITLYEIDE
ELSEKVKALAEKDLLKAIQVHEKHAREDAINEVKNTVVAKFEDEEHDEDTIKRVKQVLSK
LVKNEVRRLITEEKVRPDGRGVDQIRPLSSEVGLLSRTHGSGLFTRGQTQALSVCTLGAL
GDVQILDGLGVEESKRFMHHYNFPQFSVGETGPMRGPGRREIGHGALGERALEPVIPSEK
DFPYTVRLVSEVLESNGSTSQASICASTLAMMDAGVPIKAPVAGIAMGLVKSGEHYTVLT
DIQGMEDALGDMDFKVAGTEKGVTALQMDIKIEGLSREILEEALQQAKKGRMEILNSMLA
TLSESRKELSQYAPKILTMNINPDKIRDVIGPSGKQINKIIEETGVKIDIEQDGTIFISS
TDESSNQKAKKIIEDLVREVEVGQLYLGKVKRIEKFGAFVEIFSGKDGLVHISELALERV
GKVEDVVKIGDEILVKVTEIDKQGRVNLSRKAVLREEKEKEEQQS
>PK3-2_03770 30S ribosomal protein S15
MAITQERKNQLISEFKTHESDTGSPEVQIAILTDSINNLNEHLRTHKKDHHSRRGLLKMV
GKRRNLLTYLRNKDVTRYRELINKLGLRR
>PK3-2_03771 Bifunctional riboflavin kinase/FMN adenylyltransferase
MKTIHITHPHHLIKEEQAKSVMALGYFDGVHLGHQKVIGTAKRIAEEKGLSLAVMTFHPH
PSHVLGRDQEPKDLITPLEDKINQIEQLGTEILYVVTFNEVFASLSPKQFADQYIIGLNV
QHAVAGFDFTYGKYGKGTMETMPHDLDGKAECTMVEKLTEQDKKISSSYIRTALQNGDIE
LASVLLGQPYFIKGIVIHGDKRGRTIGFPTANVGLNNSYIVPPTGVYAVKAEVNGEVYNG
VCNIGYKPTFYEKRPEQPSIEVNLFDFDQEVYGAAIKIEWYKRIRSERKFNGIKELTEQI
EKDKQEAIRYFSNLRK
>PK3-2_03772 tRNA pseudouridine synthase B
MVNGVLLLHKPVGMTSHDCVMKIRKLLKTKKVGHTGTLDPEVSGVLPICVGRATKIVEYL
TEKSKTYDAEITLGFSTTTEDQTGETVDTKPVNQDIDKAAVEKVLNSLKGKQEQIPPMYS
AVKVNGKKLYEYARAGIEVERPKRMITIVDIALTTAIKHNGETASFRFTVTCSKGTYVRT
LAVMIGEKLGYPAHMSHLIRTASGDFSLDECFTFEELEAQVQSGTVGEHTVPIERALNHL
PKWIISDTLAKKVENGALLETPEQFSEMTSEDRIAVFTESGSCLAIYFPHPAKKGLLKPA
KVLMQKSEQ
>PK3-2_03773 Ribosome-binding factor A
MSMRANRVGEQMKKELGDIISRKLKDPRIGFLTVTDVRVSGDLQIAKVYISVLGDEKKRE
EALKGLAKAKGFIRSEIGSRIRLRKTPEIEFEFDESIDYGNRIETLIHELHSEKPSE
>PK3-2_03774 hypothetical protein
MIGFAECECIIYDAGSLKEKRAVLKRILIRVQNKFNVSISEIGYQDTWQRTSFGIAAVSS
SRVQTEKELQRVLAFIDSFPEIERTITRTEWF
>PK3-2_03775 Translation initiation factor IF-2
MLLGVMATINQELDKDTIELIASEYGVETEEVIVLEETELEKYEEPDNEEDLEIRPPVVT
IMGHVDHGKTTLLDSIRKTKVVEGEAGGITQHIGAYQIEENGKKITFLDTPGHAAFTTMR
ARGAEVTDITILVVAADDGVMPQTVEAINHAKAAEVPIIVAVNKIDKESANPDRVMQELT
EYGLVPEAWGGETIFVPLSALTGKGIDELVEMILLVSEVEELKANPNRQAKGTVIEAELD
KGRGSVATLLVQTGTLHVGDPIVVGNTFGRVRAMVNDIGRRVKTAGPSTPVEITGLNDVP
QAGDQFLVFKDEKTARSVGEARASKQLEEQRSDKAKLSLDDLFEQIKQGDVKDINLIVKA
DVQGSAEALTAALQKIEVEGVKVKIIHTGVGAITESDIILASASNAIVIGFNVRPDGNAK
STAEAENVDIRLHRIIYKVIDEIEAAMKGMLDPEYEEKVIGQVEVRQTFKVSKIGTIAGG
YVTEGNITRDSGLRLIRDGVVIFEGEVDVLKRFKDDVKEVSQGYECGITIKKYNDIREGD
ILEAFVMQEIERT
>PK3-2_03776 hypothetical protein
MAKMRVYEYAKALNVSSKEILTALKNMDLEVNNHMAMLEEKAIKQLDAKYKKGGAAAKSQ
KPAETNKNKQPQGVNQQSAGNQPNKIRDGKKNDVQNNQFNKNKKNNNNKKIINATTTIKT
NISKSL
>PK3-2_03777 putative ribosomal protein YlxQ
MSGMEWFPLLGLANRARKVVSGEDLVIKEIRNARAKLVLLTEDASSNTAKKVTDKCNYYK
VPYKKVESRAVLGRSIGKEARVVVAVTDQGFANKLISLLD
>PK3-2_03778 hypothetical protein
MNKHKKIPLRKCVVTGEMKPKKELIRVVRSKEGEVSVDPTGKKNGRGAYLTLDKECILAA
KKKNTLQNQFQSQIDDQIFEELLELAEKVKK
>PK3-2_03779 Transcription termination/antitermination protein NusA
MSSELLDALTILEKEKGISKEIIIEAIEAALISAYKRNFNQAQNVRVDLNRETGSIRVFA
RKDVVDEVYDQRLEISIEEAQGIHPEYMVGDVVEIEVTPKDFGRIAAQTAKQVVTQRVRE
AERGVIYSEFIDREEDIMTGIVQRLDNKFIYVSLGKIEALLPVNEQMPNESYKPHDRIKV
YITKVEKTTKGPQIYVSRTHPGLLKRLFEIEVPEIYDGTVELKSVAREAGDRSKISVRTD
DPDVDPVGSCVGPKGQRVQAIVNELKGEKIDIVNWSSDPVEFVANALSPSKVLDVIVNEE
EKATTVIVPDYQLSLAIGKRGQNARLAAKLTGWKIDIKSETDARELGIYPRELEEDDDEP
LFTEPETAESDE
>PK3-2_03780 Ribosome maturation factor RimP
MSKKVTDTVQEMAQPIVDSLQLELVDIEFVKEGQSWFLRVFIDSDDGVDIEECAKVSEAL
SEKLDEADPISQNYFLEVSSPGAERPLKKKADFEKSLGKNVYIKTYEPIEGVKVFEGELA
EFDGQTVTVEITIKTRKKRINIPYDKIANARLAVTF
>PK3-2_03781 DNA polymerase III PolC-type
MPEVPSLMMFLGRDTVLMEQLSVNRRQFQILLQQINMTDDTFMTYFEDGEIKKLTIHKAS
KSWHFHFQFKSLLPFQIYDTLTMRLTQAFAHIAKVTSSVEVQDAEFSESLVQDYWSRCIE
ELQGISPPIISLLNQQKPKLKGNKLIVKTKTDTEAAALKNKYSSMIQAGYRQFGFPDLQL
DAEIFVSEQEVQKFREQKLAEDQERAMQALIEMEKKDKESDEDQVPSGPLVIGYQIKDNE
EIRTLDSIMDEERRITVQGYVFDVETRELKSGRTLCIFKITDYTNSILIKMFAREKEDAA
VMKSLKKGMWVKARGSIQNDTFVRDLVMIANDVNEIKAKTREDSAPEGEKRVELHLHSPM
SQMDAVTGIGKLVEQAKKWGHEAIALTDHAVVQSFPDAYSAAKKHGIKMIYGMEANLVDD
GVPIAYNAAHRLLEEETYVVFDVETTGLSAVYDTIIELAAVKVKGGEIIDKFEAFANPHR
PLSATIIELTGITDDMLRDAPDVVDVIRDFREWIGDDILVAHNASFDMGFLNVAYKKLLE
VEKAKNPVIDTLELGRFLYPEFKNHRLNTLCKKFDIELTQHHRAIYDTEATAYLLLKMMK
DAAEKGIQYHDELNENMGQSNAYQRSRPYHATLLAVNSTGLKNLFKLVSLSHIHYFYRVP
RIPRSQLEKYREGLLIGSACDRGEVFEGMMQKSPEEVEDVASFYDYLEVQPPEVYRHLLE
LELVRDEKSLKEIIANITKLGEKLNKPVVATGNVHYLNDEDKIYRKILVSSQGGANPLNR
HELPKVHFRTTDEMLEAFSFLGEEKAKEIVVANTQKVASLIDDIKPIKDDLYTPKIEGAD
EEIREMSYQRARSIYGEQLPEIVEARIEKELKSIIGHGFAVIYLISHKLVKRSLDDGYLV
GSRGSVGSSLVATLTEITEVNPLPPHYVCSECQHSEFFNDGSVGSGFDLPDKICPHCGTP
LKKDGHDIPFETFLGFKGDKVPDIDLNFSGEYQPQAHNYTKVLFGEDNVYRAGTIGTVAE
KTAYGYVKGYAGDHNLHMRGAEVDRLVQGCTGVKRTTGQHPGGIIVVPDYMDIYDFSPIQ
FPADATGSEWKTTHFDFHSIHDNLLKLDILGHDDPTVIRMLQDLSGIDPKTIPTDDPEVM
KIFQGTESLGVTEEQIGCKTGTLGIPEFGTRFVRQMLEDTKPTTFSELVQISGLSHGTDV
WLGNAQELIHNNICELSEVIGCRDDIMVYLIYQGLEPSLAFKIMEFVRKGKGLTPEWEEE
MKNNNVPDWYIDSCKKIKYMFPKAHAAAYVLMAVRIAYFKVHHALLYYAAYFTVRADDFD
IDTMIKGSTAIKAVMEDINSKGLDASPKEKNLLTVLELALEMCERGYSFQKVDLYRSSAT
EFIIDGNSLIPPFNSIPGLGTNAALNIVKARGEGEFLSKEDLQKRGKVSKTILEYLDRHG
CLESLPDQNQLSLF
>PK3-2_03782 Proline--tRNA ligase
MRQSLTLIPTLREVPADAEAKSHQLLLRAGFIRQNTSGVYSYMPLAYKVIQNIQQIVREE
MEKIDAVEMLMPALQQAETWQESGRWYTYGPELMRLKDRHGREFALGATHEEVITSLVRD
EVKSYKRLPLTLYQIQSKFRDEKRPRFGLLRGREFIMKDAYSFHASAESLDETYQKMYEA
YSNIFARCGINVRPVIADSGAMGGKDTHEFMALSAIGEDTIAYSDESQYAANIEMAEVLY
QEAPSDEEPKALEKVHTPNVKTIEELTAFLQVSADACIKSVLFKADDRFVLVLVRGDHEV
NDIKVKNLLHAEVVELAAHEEVIQQLGTEPGFVGPVGVNQDVEIYADQAVKAMVNAVAGA
NEGDHHYQNVNVTRDAQIKEFADLRFIKEGDPSPDGKGTIRFAEGIEVGQVFKLGTRYSE
AMNATYLDENGRAQPMMMGCYGIGVSRTLSAIAEQHHDEKGLIWPKSVAPYDLHILALNM
KNDGQRELAEKLYADLKAEGYEVLYDDRAERAGVKFADSDLIGLPIRVTVGKRADEGIVE
VKIRETGESTEISVDELSAFISKQ
>PK3-2_03783 Regulator of sigma-W protease RasP
MNTVIAFIIIFGTLVFFHELGHLLLAQRAGILCREFAIGFGPKIFSFKKNETVYTIRLLP
VGGFVRMAGEDPEMIEVKPGYTVGLLFNKEDQVEKVIINQKEKYPDALVIEVETADLEHD
MKITGYEQGKEDELSSYTVSETSFFIVDGEEVQIAPFNRQFGSKPVWQRIKAIAAGPIMN
FILAYVILVMLGFVQGVPSNDPVLGQLTDNGRAAEAGLKEGDYIQSINGEKMRSWTDIVS
AVKENPEKEMDVAVKRDNKTLHISVTPEAVKDENKKTIGRFGSYAPTEKGVLSAVAYGAT
STVDVTKAILTNLSKLVTGQFKLDMLSGPVGIYDMTDQVAKTGLVNLFQFAAFLSINLGI
VNLLPIPALDGGRLLFLFIEAIRGKPINREKEAFVVFIGVAFLMLLMLVVTWNDIQRLFL
>PK3-2_03784 1-deoxy-D-xylulose 5-phosphate reductoisomerase
MKNICLLGATGSIGEQTLDVLRTHQDQFQLVSMSFGRNIDKAVPMIEAFQPKFVSVGDLD
TYYELKQMSFSFECQIGLGEEGLIEAAVMEEVDIVVNALLGSVGLIPTLKAIEQKKTIAL
ANKETLVTAGHIVKEHAKKYDVPLLPVDSEHSAIFQALQGEQAKNIDRLIITASGGSFRD
KTREELESVTVEDALKHPNWSMGAKITIDSATMMNKGLEVIEAHWLFDIPYEQIDVVLHK
ESIIHSMVEFHDKSVIAQLGTPDMRVPIQYALTYPDRLPLPDAKRLELWEIGSLHFEKAD
FDRFRCLQFAFESGKIGGTMPTVLNAANEVAVAAFLAGKIPFLAIEDCIEKALSRHQLIK
KPSLSDIQEVDKDTRGYVNSILT
>PK3-2_03785 hypothetical protein
MKQRILTGVLAAIVFLFLVIVGKLPFTILVYAMGSVALFELLRMKKLKLVSLPGLIGLLL
LWLFLLPSQYSFFEAGGISKMEITLFAVLLLLTYTVLVKNTFTFDEVGFITLAAIYIGMC
FHYFIEIRNLDQYGLTYIFYACVVIWSTDSGAYFVGKSLGKRKLWPEISPNKTVEGFAGG
IVIALVLATIFQLVTHLPIPYIYLLLITLFLSVFGQLGDLVESALKRHYDVKDSGKILPG
HGGILDRFDSFLFVMPFLYFLLALFS
>PK3-2_03786 Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)
MLNILKNWKNQQNAASNLERYTKEDILKGEIPEHIAIIMDGNGRWAKKRSLPRIAGHHEG
MKVVKRTTKLANELGVKVLTLYAFSTENWKRPKMEVDFLMKLPEEFLNTYLPELVEENVQ
VRIIGDETALPAHTLRAIEKAVQDTAQNDGMILNFALNYGGRTEIVTAAKSLAEKVKEGS
LNIEDIDESLFSNYLMTESLQDPELLIRTSGEIRLSNFMLWQVAYSEFVFTDVLWPDFKE
DHFLQALGEYQQRGRRFGGI
>PK3-2_03787 Ribosome-recycling factor
MSKEVLTQTKEKMEKAIAAYSRELATVRAGRANPSLLDKVTVEYYGAQTPLNQLSSINVP
EARMLVVTPYDKSAIGDIEKAILKADLGLTPTSDGNMIRIAIPALTEERRKELVKVVKKY
AEDAKVAVRNVRRDANDDLKKLEKNGDITEDELRASTEDVQKLTDEYVSKIDSVTKDKEK
EIMEV
>PK3-2_03788 Uridylate kinase
MEKPKYKRIVLKLSGEALAGEQGNGINPTVIQSIAKQVKEIAELEVEVAVVVGGGNLWRG
KTGSDLGMDRATADYMGMLATVMNSLALQDSLETLGIQSRVQTSIEMRQVAEPYIRRKAI
RHLEKKRVVIFAAGTGNPYFSTDTTAALRAAEIEADVILMAKNNVDGVYNADPRKDESAV
KYESLSYLDVLKDGLEVMDSTASSLCMDNDIPLIVFSIMEEGNIKRAVIGESIGTIVRGK
>PK3-2_03789 Elongation factor Ts
MAITAQQVKELREKTGAGMMDCKKALTETDGDMDKAIDLLREKGIAKAAKKADRIAAEGS
TLIKTDGNKGVILEVNSETDFVAKNEGFKELLNTLADHLLANAPADVEEAMGQKMENGST
VEEYITSAVAKIGEKITLRRFTVLTKDDNSAFGAYLHMGGRIGVLTVLNGTTDEEIAKDI
AMHVAAVNPRYISRDQVSEEEANHERQILTQQALQEGKPENIVAKMVEGRLNKFFEEICL
LDQAFVKNPDEKVKQVVAAKNATVQTYVRYEVGEGIEKRQENFAEEVMNQVKK
>PK3-2_03790 30S ribosomal protein S2
MSVISMKQLLEAGVHFGHQTRRWNPKMKRYIFTERNGIYIIDLQKTVKKVEEAYNFTKNL
AAEGGKILFVGTKKQAQDSVKEEAQRSGMYYVNQRWLGGTLTNFETIQKRIKRLKDIEKM
QENGTFDVLPKKEVVQLKKELERLEKFLGGIKDMKDLPDALFIIDPRKERIAVAEARKLN
IPIIGIVDTNCDPDEIDVVIPANDDAIRAVKLLTSKMADAILEAKQGEEEAEVAEETAPQ
TETTTA
>PK3-2_03791 hypothetical protein
MSTLLWLLSFTLHGVLLYAVMILYMRLAAVKETEKQQKKILEETENTLAAFLLELKEENE
KLIENTDSSLNQAEEETQKPDLLHFEKDSKRDAVQEENLPEHIEGLITEVERQEESVNSD
AQSFEDQIIELYEEGYSASQIAQKLKSGKTEIELFLKFRSKGVKDS
>PK3-2_03792 RNA polymerase sigma-D factor
MQSLNYEDQVLWTRWKEWKDPKAGDDLMRRYMPLVTYHVGRISVGLPKSVHKDDLMSLGM
LGLYDALEKFDPSRDLKFDTYASFRIRGAIIDGLRKEDWLPRTSREKTKKVEAAIEKLEQ
RYLRNVSPAEIAEELGMTVQDVVSTMNEGFFANLLSIDEKLHDQDDGENIQVMIRDDKNV
PPEEKIMKDELIAQLAEKIHELSEKEQLVVSLFYKEELTLTEIGQVLNLSTSRISQIHSK
ALFKLKNLLEKVIQ
>PK3-2_03793 Chemoreceptor glutamine deamidase CheD
MSTTEAVVVKVGIADVKIARFPDTIRTSGLGSCVGLVLYDKEKQTAGLVHVMLPDSTLSK
TAELNRAKYADTAVKTTIDMLIEAGCRKFALKAKLAGGSEMFKFKSTNDLMKIGPRNVLA
IKEQLSLYHIPIISEDTGGSSGRTIEFEPKSCMLHIRTVKQGEKTI
>PK3-2_03794 CheY-P phosphatase CheC
MSIFNGIKEEQMDILREVGNIGAGHSASAMAQLLNRKIDMEVPFAKLLSFDELVDFFGGA
DIPVASIFLRMEGDLTGSMFFIMPFYQAEQFIRELIGNPNFDIEDLGEDHMSSSALHELG
NILAGSYLTALADLTQLQLYPSVPEVSLDMFGAVISEGLMELSQVGEHAIVVDTSIFDQS
HQQELKAHMFMLPDYDSFEKLFVALGASL
>PK3-2_03795 Chemotaxis protein CheW
MTAEIKTGEKMIVFMVNGKEYAISVTQVKSIEKWQKPTRVPGVEPYICGVINLRGVVTPV
IDLRKRLNLPEYEITDETRIIIIAYRDTEIGWIVDEANDVITVHESEIESAPESIQKDTD
VSIEQIVKQENRLLNIIDANAVLDKESSQSAVPDQA
>PK3-2_03796 Chemotaxis protein CheA
MDMNQYLDVFIDESKEHLQTCNEKLLLLEKDPTDLQLVHDIFRAAHTLKGMSATMGYTDL
AHLTHLLENVLDAIRNGDMAVTSDWLDILFEALDHLDAMVQSIIDGGDGKRDISEVSAKL
DVNGAHAETAASAEPAEAQNTASDWEYDEFERTVIQEAEEQGFKRYEIKISLNENCMLKA
VRVYMVFEKLNEVGEVAKTIPSAEVLETEDFGTDFQVCFLTHQSAEEIEQLINGVSEIEH
VEVIQGAPLTSAEKPEESKPADSPAPVPVKQEKQKQPAKNDEQAKHTAGGSKTIRVNIDR
LDSLMNLFEELVIDRGRLEQIAKELEHNELTETVERMTRISGDLQSIILNMRMVPVETVF
NRFPRMIRQLQKELNKKIELSIIGAETELDRTVIDEIGDPLVHLIRNSIDHGIESPETRL
QKGKPESGKVVLKAYHSGNHVFIEVEDDGAGLNRKKILEKALERGVITEKEAETLEDNEI
YELIFAPGFSTADQISDISGRGVGLDVVKNKLESLGGSVSVKSAEGQGSLFSIQLPLTLS
IISVLLIKLEEETFAIPISSIIETAVIDRKDILQTHDREVIDFRGHIVPVVYLKEEFKIE
DTRLDAEQLHIIIVKKGDKPTAFVVDSFIGQQEVVLKSLGDYLTNVFAISGATILGDGEV
ALIIDCNALII
>PK3-2_03797 Protein-glutamate methylesterase/protein-glutamine glutaminase
MIRVLVVDDSAFMRKMISDFLTEEKQIEVIGTARNGEEALKKIELLNPDVITLDVEMPVM
NGTDTLRKIIEIYNLPVIMVSSQTEKGKECTINCLEIGAFDFITKPSGSISLDLYKIKEQ
LVERVVAAGLSGKRKHPAPQAVRPEPIVRAVKSELSKPKLGSGRQIVCIGTSTGGPRALQ
KVIPKLPKDLNAPVVVVQHMPEGFTASLAERLNHLSDIQVKEAQDGEAALNGCVYIAPGG
KNISVSKNSGGLQIVLDNLDTPSRHKPSADYLFRSVGKLADYEKVAVIMTGMGSDGTAGL
KDMLTAGNVKTIAESEESCVVYGMPKAAVKAGLIHEIKHVEDIAASITSCVKKERV
>PK3-2_03798 Flagellum site-determining protein YlxH
MNRFDQAAALRAKMEKRQRVLPMVYSQKAKTLAVISGKGGVGKSNITLNMALALQDKGKK
VLLIDLDIGMGNIDILMGNSSSATIIDVLTERRPLMQSLSVGPKGLRYISGGTGLDVMFQ
LDQRKWAFFANELSHALSQFDYVLFDMGAGLSKDQLPFILSTEDILIITTPEPTAIMDAY
SAVKHLVLTENKLSMKVAVNRCRDQKEGLDAFTRLSRTIHMFLDVQVQFAGSVSDDPIVS
KAVVEQVPFFIKSPQAKASRSVRLLADALFEREETRHKEDKQTFIEKLSSFLMRRA
>PK3-2_03799 Flagellar biosynthesis protein FlhF
MKIKKFTAASMQEAALLIRKELGNEAVILNSKKIKKRKWFGLVNKPAVEVIAVLDQDFLE
KKTPQKAAEPKQTLKTPVSSPKIEERTYLPQFSVQHETGDFSAYQSVLPEPLRKAEKLLE
ETGIKESTKTSTLKKLLRFSVEAGGLTEENVVGKLQDILCDTLPAADKWQEPIQSKYIVL
FGSTGAGKTTTLAKLAAISMLEKQKKIAFITTDTYRIAAVEQLKTYAELLQAPLEVCYTK
EEFQQAKELFSEYDHVFIDTAGRNFKEQQYIDELKETIPFGSSIQSFLVLSATTKYEDMK
QIVKRFSGVPVNQFIFTKIDETASLGSVFNILAESKIGAGFITNGQNVPEDIQTVSPLEF
VRMLCR
>PK3-2_03800 Flagellar biosynthesis protein FlhA
MSTRDLSVLISVVLIVAMLVIPFPPWLLSILIIINISLALIVLLTTMNMQEALQFSIFPS
LLLLLTLFRLGLNVSTTRSILSHGEGGKVVETFGNFVVGGNVLVGLVVFIILIIIQFIVI
TKGAERVSEVAARFTLDAMPGKQMSIDADLNAGMITEQEAKHRREKVAREADFYGAMDGA
SKFVKGDAIAGIIIVMINVIFGIVIGMLQQGMSIQEAASHFTMLTVGDGIVSQIPALLIS
TATGIVVTRAASEGNLGHDITGQLFAYPKLLYVTAATILLLGIFTPIGIFLTGPLAGLLA
FGAYTLSKSGKENEEVDEILEEEAEVDELKSPESVIQLLHIDPIEFEFGYGLIPLADANQ
GGDLLDRIVMIRRQLALELGLVIPVVRIRDNIALQPNEYRLKIKGNEVAKGELLLDHYLA
MSPTPEDDLIEGIETVEPSFGLPAKWISESVKDEADMLGYTVVDPASVVSTHITEKIKQH
AHELIGRQETKQLIDHLKETYPVLVEEVTPNPLSVGDIQKVLAKLLKEKVSIRNLVTIFE
TLADYGKLTTDSDLLTEYTRQALAKQITAQFAKENEVLKVVTCSGRVEKAIADGVQQTEH
GNYLSLEPDISESIVRSVAKEAEQLSLRQENAILLCSPPVRMYVKQLLERYFPDLPVLSY
NELEANVEVQSIGVVDI
>PK3-2_03801 Flagellar biosynthetic protein FlhB
MKLRIDLQFFAGEKTEKATPKKRKDTRKKGQVAKSADVNTAISLLVIFLSLIAIGPYMRD
KLLSFIETFYTDSLTMKLSESNVHTLFISLLEDMGMILAPILLVALVAGVVSNYMQVGFL
FSAEVIQPKLEKLDPIKGFKRIYSMRAIVELIKSILKITVVGFAAFAVLWLHYGEILRLP
LLTPEEALSFVSKLTLWMGLSGAGALLILAGLDYLYQRFDYEKNIKMSKQDIKDEYKKSE
GDPIIRSKIKQKQREMAMRRMMQEVPKADVIITNPTHYAIALKYDEEKMDAPYIVAKGVD
HLALKIRKIAKEHDVMMVENRPLARALYDQVEIDQAVPEEFFKVLAEILAYVYKTKQKVY
>PK3-2_03802 Flagellar biosynthetic protein FliR
MNSIIDLFPAFLLVFIRISAFFVTIPLFGHRNVPAVHRIGFAFFLAVICFSTIDKPPSLE
IDGQYMLLAFKEALVGLCLGLIAYMMIAAVQIAGSFIDFQMGFSIANVIDPQTGAQSPLI
GQFIYTMALLFMLSVNAHHLLLDGIYYSFQYISVDQAFPNFGDEKFAYFIAKSFNAMFII
AFQMSAPVVASLFLVDLALGIVARTVPQLNVFVVGLPLKIAVSFIMLIVCMSVIFVVVRN
VFGLTIETMRNLLALVGVS
>PK3-2_03803 Flagellar biosynthetic protein FliQ
MLNVSSEFVISMAEKAVYVTLMISAPLLAIALLVGLIVSIFQATTQIQEQTLAFIPKIVA
VLLALIFFGPWMLSTILSFTTELFSNLNRFAG
>PK3-2_03804 Flagellar biosynthetic protein FliP
MNEFINIFSSSDPENVSSTVKLLLLLTVFSVAPGILILMTCFTRIVIVLSFVRTSLATQS
MPPNQVLIGLALFLTFFIMAPTFSEINKEALTPLMDNKISLDEAYTKAEEPIKEFMSKHT
RQKDLALFMNYAKMDKPESLKDIPLTTMVPAFAISELKTAFQIGFMIFIPFLIIDMVVAS
VLMSMGMMMLPPVMISLPFKILLFVLVDGWYLIVKSLLQSF
>PK3-2_03805 hypothetical protein
MKKSQYFIAFICFFVLFSVHPIAAAAADSDNSTVNEWFQKKDEKTADKSEQKEEKTTQTA
DETEGAAAPSVSAFDFVKMIFALLFVIVLIYGLVKLMNKRNRLLKPFQYVENIGGTSVGQ
NRSIQLIKVGKSVLVVGVGETIQLLKEIEDEKEIEVILSQHEEAMSSKIEWKKFVKPLKG
SEIQQQQKLPSFSKALKEQLEELKQNRSEGKKKGPRHHE
>PK3-2_03806 Chemotaxis protein CheY
MAHRILIVDDAAFMRMMIKDILVKNGFEVVAEAENGAQAVEKYKEHSPDLVTMDITMPEM
DGITALKEIKQIDAQARIIMCSAMGQQSMVIDAIQAGAKDFIVKPFQADRVLEAINKTLS
>PK3-2_03807 hypothetical protein
MENNRLSQDEIDALLNGTGSTPDEPEVPEVHDLSEMERDAIGEIGNISFGSSATALSTLL
NQKVDITTPSVTVIPKSKISDAFPEPYVAIEVNYTEGFSGSNLLVVEQNDAAIIADLMIG
GDGKGADPSLGEIHLSAVQEAMNQMMGSAATSMSTVFSKKIDISPPRVELLDVTEEKGTD
RIPDDEMLVKVSFNLKVGELIDSSIMQLYPLTFAKDLISSLMNTESAEEETTAQPNVTYE
QPKEPVMPEPRIEPQQQQQPPKRQGTPKKAAPVQVSPVEFSAFDPNEAAQAPINNLDMLL
DIPLSITVELGRTKRSVKEILELSAGSIIELDKLAGEPVDILVNQRIVAKGEVVVIEENF
GVRVTDILSQAERINNLK
>PK3-2_03808 Flagellar motor switch protein FliM
MSGEVLSQNEIDALLSAISTGEMDAEELKKEEKEKKVKVYDFKRALRFSKDQIRSLTRIH
DNFARLLTTHFSAQLRTYIHISVSSVDQVPYEEFIRSIPNMTILNLFDVHPMEGRIMMEV
NPTIAYTMMDRVMGGIGISHNKVDSLTEIETKIISNLFENALGNYKEAWQSIADIEPEMT
EFEVNPQFVQMVSPNETVVVISLNTQIGEISGVINLCIPHIVLEPLIPKLSVHYWMQSDR
NEPKPEETKSLEKRIMTAQIPVVAELGTSELTIEEFLSLEVGDCITLDKSVTDPLTVLVG
DKPKFLGQAGRVNRKQAVQILDHDIRGEQDGE
>PK3-2_03809 hypothetical protein
MKKKLMIILLIILIVIGALGAAAYFVLGGKSEKSEAKKSIDEIVASSVDVEEITTNLKSD
NIVRLAIKLETDSDKSKEELEKRDFQVKDAVISLLADTNAKEIEGDKGKEAFKKELKGKI
NSYLQEGKVEKVYITSFNLQ
>PK3-2_03810 Flagellar basal-body rod protein FlgG
MLRSLYSGISGMKNFQTKLDVIGNNIANVNTVGFKKSRVTFKDMVSQTIAGGSAAGATIG
GTNSKQIGLGSSSGTIDTIHSTSATQSTGRTLDLAIDGDGYFRIDTGDGTAYTRAGNFYL
DNTGTLVTGDGYHVLGMDGGTIKIPTDAQSFSIGSDGKVSIVDAGGQTQDGGQIGIVTFA
NSDGLDKIGSNLYRQSLNSGTASAANQPGDGGTGALKSGFIEMSNVDLTDEFTEMIVAQR
GFQSNSKIITTSDEILQELVNLKR
>PK3-2_03811 hypothetical protein
MTSISSEYKLPEKTSTVSTSNSSLGKDEFLKILMTQVQNQDPLNPVDDKEFISQMATFSS
LEQMMNLNTTMTQFVQNQDPFTTYLDWMGKEVSWTADGGATEKTGTVSSVKQSKGKYYLV
LNDGTEISPSNVLSVAQSSK
>PK3-2_03812 hypothetical protein
MKLLELAGPLLQTTAGTGAKTINSSQGVFQNWLLSETGSKETLEQGKGTPISGDQLVQDA
LKKISDWLISSPEDQDNQKAELLQTLSKLAGKQLDETAQQMLQSLLQAVESKMFGGADQL
LAEAEKIISKGKTTLPANDSAADINGKLKSDTEQSSQENEVSVNDKELVLIQMFISQLLE
VNKLTDRGNGNEAHDIYQNGDQFLSALEKKGVSQQLIQDLKQQIFTKDESSSKLYSMTAS
ELKSFQSLMEQMSMLPQKGTKEWSLAESQLKAFLLSKSSESSQDFGRRVLAPLSQSSTSK
NASDASGTIQPVDNKSGLQMLFSGYRGTGGVQTLDLQQISSELPASETKTVADQVISAWK
QMKYTPFGRSTGSFTIRLNPEHLGFVTIKLTNENGMFQSKIIASSQSAKELLEQHLPQLK
QSLPNMAVQIDRFTLPVQSGDQPLYGQLADEQKQQQEGQRQQRQKKQSNDFGDLLDEVSK
VEMEEEE
>PK3-2_03813 hypothetical protein
MSGKKKESGKFRSVLLIIILPLMFLLIAGGIVLWAAGVNVLKPIQEAAAKTPVLKELVPE
TENKKDTATSKDSSNTAALEKTIKDQKSEISILNKDLETSKSEIDRLNQKIRSLEKTAED
QKKSSEDHTEGTSDSKASSKNDKVISVYKSMDSGKAAKIIAQLKEQEALKILNGLSKKQL
ADILAKMTPEQAATYTEKIAASQE
>PK3-2_03814 Flagellar FliJ protein
MAYQFRFQKLLELKENEKDQFLSEYQQSVSEFENVAEKLYENMSKKELLEQNKEKKLKSG
MSVQEMRHYQQFVSNLENTIYHYQKLVIMKRNQMNQKQEILTEKNIEVKKFEKMREKQFK
MFALEDKAAEMKEMDDISIKQFMIQGH
>PK3-2_03815 putative ATP synthase YscN
MKTQSLIDCIEMTDSYKRYGKVKRVIGLMIESKGPASSIGDVCLIYAKGQSGKVIKAEVV
GFQEENILLMPYLEAASIAPGSIVEATGESLRVKVGAGLIGQVIDAFGKPLDGKLLAKGL
SPVSTEQSPPNPMKRPPIREKMGVGVRSIDSLLTVGKGQRIGIFAGSGVGKSTLMGMIAK
QTEADLNVIALVGERGREVREFIEKDLGEEGLKRSIVVVATSDQPALMRLKAAYTATAIA
EYFRDKGQNVMFMMDSVTRVAMAQREIGLAAGEPPTTKGYTPSVFAILPRLLERTGANEH
GTITAFYTVLVDGDDMNEPIADTVRGILDGHIVLDRALANKGQFPAVNVLKSISRVMSNI
STRQHLDAANKFRELLSTYQNSEDLINIGAYKRGSSREIDEAIQFYPQLIQFLKQGTDES
ALLEESIAALTSLTGNEE
>PK3-2_03816 hypothetical protein
MSNIIKQETSFSPRKERRKLSIQEVRIDHSHLLQAEENPEALMARVKEEADRISEQANSH
IENIRRQIEQEKNDWAAEKQNLIEAAKAEGFEQGMALGKAEAIQQYAELIDRANSITEMS
RKAVEDKLEDANEEIVELAVALAKKVWQQKSDDKEAFLLLVQQVVNEVKEYDDISIYVDP
YYYETIFQQKDEIQQLLYKECRLGIYADEKAPKGSCYIETPFGRVDASVDTQLMQLKDKL
LTALEAGAAE
>PK3-2_03817 Flagellar motor switch protein FliG
MARRDQDKLTGKQKAAILMISLGLDVSASVYKHLTDEEIERLTLEISGVRSVDHQKKDEI
IEEFHNIAIAQDYISQGGLSYARQVLEKALGEDKAENILNRLTSSLQVKPFDFARKAEPE
QILNFIQQEHPQTMALILSYLDPVQAGQILSELNPEVQAEVARRIAVMDRTSPEIINEVE
RILEQKLSSAFTQDYTQTGGIEAVVEVLNGVDRGTEKTILDSLEIQDPDLAEEIKKRMFV
FEDIVTLDNRAIQRVIRDVENDDLLLSLKVASEEVKEIVFNNMSQRMVETFKEEMEFMGP
VRLKDVEEAQSRIVSIVRKLEEAGEIVIARGGGDDIIV
>PK3-2_03818 hypothetical protein
MNRTLMQMKNKTSEFWKNRSKSQKILMISALAAIIMIGIIISVFASSTKMAPLYKDLSAE
EAGQIKEQLDSKKVPNELSNGGTVISVPEDQVDSLKVQMAAEGLPKTGSIDYSFFGQNAG
FGLTDNEFDMVKVKATQTELSNLINEMDGIKNSKVMINLPKDAVFVGEEQSAASASIVLQ
IQPGYTLDQSQINGLYHLVSKSVPNLKEDNIVIMDQNSTYYDKSDSDAGSYADSYSSQQG
IKSQVEKDIQKHVQSLLGTMMGQDKVVVSVTADIDFTKENRTEDIVEPVDKENMEGIAVS
AEKVSETYQGDGAANGGTAGTGDEDVTNYKADGENTDSGNYEKSSNKINYEVNRIHKEIA
ESPYKVRDLGIQVMVEPPNAKNTASLSTERQEDIQKILSTVVRTSLDKDATQNQNLSDED
INNKIVVSVQPFDGKVNLDTSTDKSSGIPLWAYIAGGVLIAAIIVLIIMLVRKKRAQEDE
FEEYEYEVPQEPINLPDINEDENETAETVRRKQLEKMAKDKPEDFAKLLRSWLAED
>PK3-2_03819 Flagellar hook-basal body complex protein FliE
MNVVNAISPFQVQNTQNTQNATNQVNNSQKTDSSNQTSFSELLKNSISSLNESQVASDNM
TNALAAGKDVNLDEVMIAAQKASISLTAATEFRNKAVEAYQEIMRMQM
>PK3-2_03820 Flagellar basal-body rod protein FlgC
MTAFHSLNVSASALTAQRVRMDVVSSNLANMDTTRAKQVNGEWVPYRRKMVSLQSKGESF
SSILNSQMSGSGNAGNGVKVSKITEDDSEFNLVYDPTNPDANAEGYVQKPNVDPLKEMVD
LVSSTRSYEANVTAMNATKGMLMKALEIGK
>PK3-2_03821 Flagellar basal body rod protein FlgB
MSLFSGTIQNLENALNRADIKQKVITNNIANIDTPNYKAKKVSFQNLLDQESSRLDAIKT
DYRHVDFSDTDSNYSIVTSGNTSYQQNGNNVDVDKEMTELAQNQINYQALVERMNGKFNS
LKTVLTGGK
>PK3-2_03822 GTP-sensing transcriptional pleiotropic repressor CodY
MALLQKTRIINSMLQAAAGKPVNFKEMAETLRDVIDSNIFVVSRRGKLLGYSINQQIEND
RMKKMLEDRQFPEEYTKNLFNVPETSSNLDINSEYTAFPVENRDLFQAGLTTIVPIIGGG
ERLGTLILSRLQDQFNDDDLILAEYGATVVGMEILREKAEEIEEEARSKAVVQMAISSLS
YSELEAIEHIFEELDGNEGLLVASKIADRVGITRSVIVNALRKLESAGVIESRSLGMKGT
YIKVLNNKFLIELENLKSH
>PK3-2_03823 ATP-dependent protease ATPase subunit ClpY
MEKKPLTPRQIVDRLDQYIVGQQNAKKAVAVALRNRYRRSLLDEKLKDEVVPKNILMMGP
TGVGKTEIARRIAKLSGAPFIKIEATKFTEVGYVGRDVESMVRDLVETAVRLIKEEKMNE
VKEQAEENANKRIVRLLVPGKKKQSGVKNPFEMFFGGSQPNSEDEAESQEEANIEEKRKR
MAHQLALGELEDYYVTVEVEEQQPSMFDMLQGSGMEQMGMNMQDALSGLMPKKKKRRKMT
VREARKVLTNEEASKLIDMDEVSQKAVQRAEESGIIFIDEIDKIAKSGGASSSADVSREG
VQRDILPIVEGSTVVTKYGSVKTDHVLFIAAGAFHMAKPSDLIPELQGRFPIRVELSKLT
VDDFVRILVEPDNALLKQYQALLQTEGISLEFSDEAIHKIAEVAYHVNQDTDNIGARRLH
TILERLLEDLSFEAPDVTMEKITITPQYVEDKLGTIAKNKDLSQFIL
>PK3-2_03824 ATP-dependent protease subunit ClpQ
MSSFHATTIFAVQHKGRSAMSGDGQVTFGQAVVMKHTARKVRKLFNGKVLAGFAGSVADA
FTLFEKFEAKLEEYNGNIKRAAVELAKEWRSDKVLRKLEAMLIVMNQDTLLLVSGTGEVI
EPDDGILAIGSGGNYALAAGRALKKHAGESMSASEIARAALETAGEICVYTNDQIILEEL
E
>PK3-2_03825 Tyrosine recombinase XerC
MENVKNFVKLFVEYLQIEKNYSQYTIVNYVDSIEEFETFLRVQGINGFEEAAYQDTRIFL
TEAYEKGLSRRTISKKISALRSFYKFLMREKLVEENPFQLVHLPKQEKRIPKFLYQKELE
ELFEVSDISQPTGMRDQALLELLYATGMRVSECCSITVNDVDLFMDTVLVHGKGKKQRYI
PFGSYAREALKVYMNSGRQCLLMKAKEPHDLLFVNQRGGPLTARGIRHILSGLVQKASGT
LHIHPHMLRHTFATHLLNEGADLRSVQELLGHSNLSSTQIYTHVSKEMLRNTYMSHHPRA
FKKN
>PK3-2_03826 Methylenetetrahydrofolate--tRNA-(uracil-5-)-methyltransferase TrmFO
MNQQTVNVIGAGLAGSEAAWQLAKRGIQVKLYEMRPVKQTPAHHTDKFAELVCSNSLRSN
TLANAVGVLKEEMRALDSAIIAAADECSVPAGGALAVDRHEFAQSVTNRVKNHPNVTVIN
EEVTEIPEGPTIIATGPLTSESLSAQLKELTGEDYLYFYDAAAPIIEKDSLDMDKVYLKS
RYDKGEAAYLNCPMTEEEFDRFHEALTSAETVPLKEFEKEIFFEGCMPIEVMAKRGKKTM
LFGPMKPVGLEHPVTGKRPYAVVQLRQDDAAGTLYNIVGFQTHLKWGDQKEVLKLIPGLE
NVEIVRYGVMHRNTFINSPSLLKPTYQFKNRSDLFFAGQMTGVEGYVESAASGLVAGINA
AKLVLEEELVTFPQETAIGSMAHYITTTNQKNFQPMNANFGLLKELPVKIKNKKERNEQY
ANRAIETIQTISKTI
>PK3-2_03827 DNA topoisomerase 1
MSDYLVIVESPAKAKTIERYLGKKYKVKASMGHVRDLPKSQMGVDIEQNFEPKYITIRGK
GPVLKELKTAAKKAKKVYLAADPDREGEAIAWHLAHSLDLDLNSDCRVVFNEITKDAIKE
SFKHPRMINMDLVDAQQARRILDRLVGYKISPILWKKVKKGLSAGRVQSVALRLIIDREK
EINDFKPEEYWTIDGTFLKGQETFEASFFGKNGKKLPLKSEADVKDILSQLKGNKYTVEK
VTKKERKRNPALPFTTSTLQQEAARKLNFRAKKTMMIAQQLYEGIDLGREGTVGLITYMR
TDSTRISNTAVDEAAAFIDQAYGKEFLGGKRKPAKKNENAQDAHEAIRPTSVLRKPSELK
AVLGRDQMRLYKLIWERFVASQMASAVLDTMSVDLTNNGLTFRANGSKVKFSGFMKVYVE
GKDDQLEEKDRMLPDLKEGDTVLSKDIEPEQHFTQPPPRFTEARLVKTLEELGIGRPSTY
APTLDTIQRRGYVALDNKRFVPTELGQIVLDLIMEFFPEIINVEFTAKMEKDLDHVEEGS
TEWVKIIDNFYTDFEKRVKKAESEMKEVEIEPEYAGEDCELCNSPMVYKMGRYGKFLACS
NFPDCRNTKPIVKQIGVKCPSCGEGNIVERKSKKKRVFYGCDRYPECEFVSWDKPIERKC
PKCGKMLVEKKLKKGIQVQCVECDYKEEPQK
>PK3-2_03828 DNA processing protein DprA
MDQAAACLMICRINQLLSPSLLLKWWKADPSMSLTSSVLETVTRGKIKTASLKNKIEEHY
PKLQRLLDAYYGQGIIPIPISSKRYPIWLKTIYDPPAVLFAKGDMTLLSKGRKIGMVGTR
HPTAYGIQVVNHLTKELCRKDWVIVSGLASGIDGMSHAASIKAKGRTIGVIAGGFQHIYP
RENLQLADHMAKHHILLSEHPPETKPQKWHFPMRNRIISGLSEGIIVVQGKEKSGSLITA
YQALEQGREVFAVPGSLFDPYAGGPIKLIQQGAKAIRSADDIFEELPERNVQYTEPF
>PK3-2_03829 Succinate--CoA ligase [ADP-forming] subunit alpha
MSVFINKDTRVIVQGITGSTALFHTKQMLEYGTNIVGGVTPGKGGTEAEGVPVFNTVAEA
VQTTGANASVIYVPAPFAADAIMEAVDAELDLVICITEHIPVLDMVKVKRFMEGKKTRLI
GPNCPGVITPEECKIGIMPGYIHKKGHVGVVSRSGTLTYEAVHQLSEAGVGQSTAVGIGG
DPVNGTNFIDVLKAFNEDPDTHAVIMIGEIGGTAEEEAAEWVKANMTKPVVGFIGGKTAP
PGKRMGHAGAIISGGKGTADEKIKTLNACGIEVAETPSVMGETLIKVLKEKNLFETCKTH
>PK3-2_03830 Succinate--CoA ligase [ADP-forming] subunit beta
MNIHEYQGKEVLRKYGVSVPEGKVAFTAEEAVEKAKSLSSSVYVVKAQIHAGGRGKAGGV
KIAKSLDEVKAYAEELIGKTLVTHQTGPDGQVIKRLLIEEGCDIKKEYYVGLVLDRATSR
IVLMASEEGGTEIEEVAEKTPEKIKKAVIDPAVGLQGYQAREIAFAINIPKELVGKAAKF
MLGLYKAFVEKDCSIAEINPLVVTGDGNVMALDAKLNFDSNALYRQKDILEYRDLDEEDP
KEIEASKYDLSYISLDGNIGCMVNGAGLAMSTMDIIKHYGGEPANFLDVGGGATAEKVTE
AFKIILSDQNVKGIFVNIFGGIMKCDVIAEGVVEATRQVGLTLPLVVRLEGTNVDLGKKI
LSESGLNITSAESMADGAQKIVSLV
>PK3-2_03831 Flagellar biosynthetic protein FlhB
MKEQTPIRKAVALHYDEQKDKAPRVIATGKGHVADNIIKEAKKAGVPISEDRTLVELMRH
LTVDDQIPEALYETVAEIFSFIYRLDESVKNKK
>PK3-2_03832 hypothetical protein
MNIRNDVQKALQHLFGQTAATQETTNVSEALNGEKRLLLGKVLRLLGDQHALIQVGNQTI
QGKLETQLRPQAYYWFSYEKKTSEQTGRLQVVQSFDQNPKTIQDAAGKLLNAMSVKASNA
ALMMTGAMLKSKTPVTENDIKTAVRWMDTLPASDTKKAIETVLFALKRDLPIHPEVLSGV
HAVKSPVPLHQHVSQLLQAINQNPQQGQMTAKLKEAVTALYNSEIDVHAERLIAKLTSLT
DNTKALTSGNTAGNREISAPAESSGKASLPLANTGEQRSIQGEPVKAAADIPIKEARQLL
AKLAESAEKNSLQIVKEAANWIKAAASSGDSKPQEASAVLQAAQVTDQEAEVFLKVVQQT
APHLADKADVLSFLSKVKTAIGARDELAFIKAFEQGGSAVTPDDIQSIKLALHAARASHE
VAEPVKQEADQLFHKLNGQLFMQQDHPSYSQIVMSFPLFSKSGVQDMTVLFKGKKEADGK
LDPSHCRLLFLLQLDTLKETVVDCLIQQKIMTITIETDFELQAAIDPMVPALKQGLKEMG
YSLSGVYAKKRIHSEEKASIDQYVTSFSDQEVDVKI
>PK3-2_03833 Ribonuclease HII
MNTLTVKDIKDRLQGVKDEQDPFLAQCENDPRKSVKTLVEQWLKKQAKEKALKEQWVNMT
SYERLARNKGFRLIAGVDEVGRGPLAGPVVASAVILPEECEILGLTDSKKLSEKKREEYY
ELIMKEALAVGIGIVEASVIDEINIYEASKMAMVKAIYGLSDTPDYLLVDAMTLPLDTNQ
SSIIKGDAKSVSIAAGACIAKVTRDRMMSDYAKTYPMYGFEKNKGYGTKEHLEALAAYGP
TELHRKTFAPVQSFS
>PK3-2_03834 Ribosome biogenesis GTPase A
MTIQWFPGHMAKARREVTEKLKLIDIVYELVDARIPMSSRNPMIEDILKNKPRIMLLNKA
DKADAAVTQQWKEHFENQGIRSLSINSVNGQGLNQIVPASKEILQEKFDRMRAKGVKPRA
IRALIIGIPNVGKSTLINRLAKKNIAKTGDRPGITTSQQWVKVGKELELLDTPGILWPKF
EDELVGLRLAVTGAIKDSIINLQDVAVFGLRFLEEHYPERLKERYSLDEIPEDIAELFDA
IGEKRGCLMSGGLINYDKTTEVIIRDIRTEKFGRLSFEQPTM
>PK3-2_03835 50S ribosomal protein L19
MQKLIEDITKEQLRTDLPAFRPGDTLRVHVKVVEGNRERIQIFEGVVIKRRGGGISETFT
VRKISYGVGVERTFPVHTPKIAKIEVVRYGKVRRAKLYYLRELRGKAARIKEIRR
>PK3-2_03837 tRNA (guanine-N(1)-)-methyltransferase
MKIDFLTLFPEMFEGVLGSSILQKAQDKDAVQFQVVNFREYSDNKHNTVDDYPYGGGAGM
VLKPQPVFDAVEDLTAKAAAAPRIILVCPQGERFTQRKAEQLAKEEHLLFICGHYEGYDE
RIREHLVTDEISIGDFVLTGGELPAMMIADSVVRLLPGVLGKEASHIEDSFSTGLLEHPH
YTRPADYKGLKVPDTLLSGNHEKIKEWRNKESIRRTYVRRPDLLKDYPLTEQQRKWISEW
EKE
>PK3-2_03838 Ribosome maturation factor RimM
MTKRWFNVGKIVNTHGIKGEVRVISKTDFAEERYKPGNTLYLFMDGRNEPVEVTVNTHRL
HKQFHLLQFKERPSLNEVEELKNAIIKVPEEDLGDLNEGEFYFHEIIGCEVFTEDGELIG
KVKEILTPGANDVWVIGRKGKKDALIPYIESVVKHIDVSEKKIEIELMEGLIDE
>PK3-2_03839 hypothetical protein
MQIIHRVAVMQVLTERSKEKLLASFAEKKQMLERECSQLYFQLRKHEKEQQNPDMIEQFK
KAIEKRKDNIKIIDFQIAQVHTLPLGSEMKEKEVDALLTIEAGDDWHEKTAANTIVIKDG
KVIEIRQR
>PK3-2_03840 hypothetical protein
MTDQHLEDLIVQIVTPLVDHPDDIRVIREETDQKIALRLSVHKSDTGKVIGKQGRTAKAI
RTAVFAAGAQSSKKVQFEIFD
>PK3-2_03841 30S ribosomal protein S16
MAVKIRLKRMGAKKSPFYRIVVADSRSPRDGRFIETVGTYNPVAKPAEVKIDEELALKWL
QTGAKPSDTVRNLFSSQGIMEKFHNAKQGK
>PK3-2_03842 Signal recognition particle protein
MAFEGLADRLQQTISKIRGKGKVSEQDVKDMMREVRLALLEADVNFKVVKDFVKKVSERA
VGQDVMKSLTPGQQVIKVVKEELTELMGGEESKIAVAKRPPTVIMMVGLQGAGKTTTSGK
LANLLRKKHNRKPMLVAADIYRPAAIKQLETLGKQLDMPVFSLGDQVSPVEIAKQAIEKA
KEEHYDYVILDTAGRLHIDHELMDELTKVKEIANPEEIFLVVDSMTGQDAVNVAQSFNEQ
LGLTGVVLTKLDGDTRGGAALSIRAVTNTPIKFAGLGEKLDALEPFHPERMASRILGMGD
VLTLIEKAQASVDEDKAKELEQKMRTMSFTLDDFLEQLGQVRNMGPLDELLQMMPGAGKM
KGLKNIQVDEKQLNHVEAIIKSMTVLEKEQPDIINASRRKRIAKGSGTSVQEVNRLLKQF
DEMKKMMKQMTNMSKGKKKGFKLPFM
>PK3-2_03843 hypothetical protein
MSLEKTTRMNYLFDFYQSLLTSKQKSYMSLYYLDDFSLGEIAEEYEVSRQAVYDNIKRTE
AMLEQYEEKLLLLKKFQERKEMFNKLKELASGSKEEEEITALIEALEKLD
>PK3-2_03844 putative protein YlqB
MKKIGLLFMLCIAAVFTIFVPAKQADAAEAPYKASITNISTDGGVYGKINYGQGQFWRVK
YNITISGKLLDQNGQPVPNAPVRFEADTKVGNTTQTASGTTDANGTFAVPMYLGPAAGYY
TYYTSVSVHYYDIIPFRVYSGDSRLVSTDNSLYHFAYQVRR
>PK3-2_03845 Signal recognition particle receptor FtsY
MSFFKKLKEKITKQTDSVSEKFKDGLEKTRNSFQNKVNDLVSRYRKVDEDFFEELEEVLI
SADVGFTTVMELIDELKKEVKRRNIQDPQEVQSVISEKLVEIYNRGNEQISGLNIQDGRL
NVILLVGVNGVGKTTTIGKLAHKLKQEGKSVVLAAGDTFRAGAIEQLEVWGERTGVPVIK
QAAGSDPAAVIYDAVHAAKARNADVLICDTAGRLQNKVNLMKELEKVKRVIEREVPEAPH
EVLLALDATTGQNAMAQAKEFSKATNVTGIALTKLDGTAKGGIVLAIRNELHIPVKLVGL
GEKVDDLQEFNAESYVYGLFSDLVEKADD
>PK3-2_03846 Chromosome partition protein Smc
MFLKRLDVIGFKSFAERISVDFVKGVTAVVGPNGSGKSNITDAIRWVLGEQSARSLRGGK
MEDIIFAGSDSRKRLNLAEVTLTLDNDDHFLPIDFHEVSVTRRVYRSGESEFLINNQPCR
LKDIIDLFMDSGLGKEAFSIISQGKVEEILSSKAEDRRSIFEEAAGVLKYKTRKKKAENK
LFETQDNLNRVEDILHELEGQVEPLKIQASIAKDYLEKKKELEHVEIALTAYDIEELHGK
WSTLKEKVQLAKEEELAESSAISAKEAKIEDARDKIQALDESVNELQQVLLVTSEELEKL
EGRKEVLKERKKNAVQNREQLEEAIVQYQQKETVLKEELAKQEAVFETLQAEVKQLRAQV
KEKQQALSLHNENVEEKIEQLKSDYFELLNSQASIRNELQLLDDQMSQSAVTLQRLADNN
EKHLQERRDISERKAACETEFARIEQEIHSQVGAYRDMQTKYEQKKRQYEKNESALYQAY
QYVQQAKSKKDMLETMQGDFSGFYQGVKEVLKAKERLGGIRGAVLELISTEQKYETAIEI
ALGASAQHVVTDDEQSARKAIQYLKQNSFGRATFLPLSVIRDRQLQSRDAETAAGHSSFL
GVASELVTFDPAYRRIIQNLLGTVLITEDLKGANELAKLLGHRYRIVTLEGDVVNPGGSM
TGGAVKKKNNSLLGRSRELEDVTKRLAEMEEKTALLEQEVKTLKQSIQDMEKKLADLRET
GEGLRLKQQDVKGQLYELQVAEKNINTHLELYDQEKSALSESDEEKKARKRKLEEELSAV
SEKMKQLEEDIDKLTKQKQTQSSTKESLSNELTELKITAAKKEQACKGEEDNLARVKKEL
TETEIALKEAKEDLSFLTSEMSSSTSGEEKLEEAAKHKLNDKTKTIELIALRRDQRIKLQ
HGLDTYERELKEMKRLYKQKTTLLKDEEVKLGRMEVELDNLLQYLREEYSLSFEGAKEKY
QLETDPEEARKRVKLIKLAIEELGTVNLGSIDEFERVNERYKFLSEQKEDLTEAKNTLFQ
VIEEMDEEMTKRFNDTFVQIRSHFDQVFRSLFGGGRAELRLTDPNDLLHSGVEIIAQPPG
KKLQNLNLLSGGERALTAIALLFSILKVRPVPFCVLDEVEAALDEANVFRFAQYLKKYSS
DTQFIVITHRKGTMEEADVLYGVTMQESGVSKVISVKLEETKEFVQ
>PK3-2_03847 Ribonuclease 3
MSKHSHYKDKKKFYKKVEQFKEFQERISVHFQNEKLLYQAFTHSSYVNEHRKKPYEDNER
LEFLGDAVLELTISRFLFAKYPAMSEGDLTKLRAAIVCEPSLVSLAHELSFGELVLLGKG
EEMTGGRKRPALLADVFEAFIGALYLDQGLEPVESFLKAYVFPKINDGAFSHVMDFKSQL
QEYVQRDGKGSLEYKISNEKGPAHNREFEAIVSLKGEPLGVGNGRSKKEAEQHAAQEALA
KLQKHHMKQ
>PK3-2_03848 Acyl carrier protein
MADTLERVTKIIVDRLGVDEADVKLEASFKEDLGADSLDVVELVMELEDEFDMEISDEDA
EKIATVGDAVNYIQNQQ
>PK3-2_03849 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MLNDKTAIVTGASRGIGRSIALDLAKSGANVVVNYSGNEAKANEVVDEIKSMGRKAIAVK
ADVSNPEDVQNMIKETLSVFSAIDILVNNAGITRDNLIMRMKEDEWDDVININLKGVFNC
TKAVTRQMMKQRSGRIINVSSIVGVSGNPGQANYVAAKAGVIGLTKSSAKELASRNITVN
AIAPGFISTDMTDKLAKDVQDEMLKQIPLARFGEPGDVSSVVTFLASEGARYMTGQTLHI
DGGMVM
>PK3-2_03850 Malonyl CoA-acyl carrier protein transacylase
MSKIAFLFPGQGSQFIGMGKELYEQVPAAKRLFDEADETLETKLSSLIFEGDAKELTLTY
NAQPALLTTSIAVLEKFKESGITPDFTAGHSLGEYSALVASGALSFKDAVYTVRKRGEFM
NEAVPAGEGAMAAILGMDAEALKQVTDKVTEEGHLVQLANLNCPGQIVISGTAKGVELAS
EQAKENGAKRAIPLEVSGPFHSELMKPAAEKLKEVLDSCDIKDADVPVISNVSADVMTEK
AEIKEKLIEQLYSPVRFEESINKLIAEGVTTFIEIGPGKVLSGLVKKVNRRLKTIAVSDP
ETIELAIQTLKEENENA
>PK3-2_03851 Phosphate acyltransferase
MRIAIDAMGGDHAPKAVIDGVTKGIEAFDDLHITLVGDKTTIESHLTTTSDRITVLHADE
VIEPTDEPVRAVRRKKNSSMVLMAQEVAENRADACISAGNTGALMTAGLFVVGRIKGIDR
PALAPTLPTVSGDGFLLLDVGANVDAKPEHLVQYAIMGSVYSQQVRGVTSPRVGLLNVGT
EDKKGNELTKQTFQMLKETANINFIGNVEARDLLDDVADVVVTDGFTGNVTLKTLEGSAL
SIFKMMREAMTSNLTSKLAAAVLKPKLKEMKMKMEYSNYGGASLFGLKAPVIKAHGSSDS
NAVFHAIRQAREMVSQNVAQLIQEEVKEEKTDE
>PK3-2_03852 Transcription factor FapR
MRRNKKERQELLQQTIQVTPFITDEELAGKFGVSIQTIRLDRLELSIPELRERIKNVAEK
TLEDEVKSLSLDEVIGEIIDLELDDQAISILEIKHEHVFSRNQIARGHHLFAQANSLAVA
VIDDELALTASADIRFTRQVKQGERVVAKAKVTAVEKEKGRTVVEVNSYVGEEIVFSGHF
DMYRSKHS
>PK3-2_03853 ATP-dependent DNA helicase RecG
MKQHQQTSIANIKGIGPETEKTLNELGIYDISDLLNYFPYRYDDYELRDLEEVKHDERVT
VEGKVHSEPSLTYYGKKRNRLTFRLLVGRYLITAVCFNRPYLKKKLSLGSVVTVSGKWDK
HRQTISVQELKNGPHQEDQSIEPVYSVKENVTVKMMRRFIQQALTQYADALPDPLPEKLR
TSYKLPNYQQALKAMHLPETREALKLARRRFVYEEFLLFQLKMQAFRKAEREQTQGIRQR
FSNEELMRFIKSLPFPLTNAQSRVLREITADMSSPYRMNRLLQGDVGSGKTAVAAIALYA
AILSGYQGALMVPTEILAEQHADSLVSLFEKWDVSVALLTSSVKGKRRKELLERLAAGEI
DILVGTHALIQDEVEFKALSLVITDEQHRFGVEQRKKLRNKGQDPDVLFMTATPIPRTLA
ITVFGEMDVSVIDEMPAGRKQIETYWVKHDMLDRILAFVKKELKQGRQAYIICPLIEESD
KLDVQNAIDVYNMLSDIFRGKWNVGLMHGKLHSDEKDQVMREFSANHCQILVSTTVVEVG
VNVPNATIMVIYDADRFGLSQLHQLRGRVGRGEHQSFCILMADPKSETGKERMRIMSETN
DGFELSEKDLELRGPGDFFGKKQSGMPEFKVADMVHDYRALETARQDAANLVASDAFWKE
PEYGALREQLLKSGAMEGEKLS
>PK3-2_03854 L-serine dehydratase, alpha chain
MFRNVKELIEITKEKQIPISEVMIAQEMEVTEKTKEEIFQQMDHNLTVMEAAVQKGLEGV
TSQTGLTGGDAVKLQAYIRSGKSLSGPLILDAVSKAVATNEVNAAMGTICATPTAGSAGV
VPGTLFAVKGKLNPTREQMIRFLFTAGAFGFVVANNASISGAAGGCQAEVGSASGMAAAA
IVEMAGGTPQQSAEAMAITLKNMLGLVCDPVAGLVEVPCVKRNAMGASNAMIAADMALAG
ITSRIPCDEVIDAMYKIGQTMPTALRETGQGGLAATPTGRELEKKIFGGALGSSETTSAN
>PK3-2_03855 L-serine dehydratase, beta chain
MKYRSVFDIIGPVMIGPSSSHTAGAARIGRVARSLFGREPERIVVSFYGSFAETYKGHGT
DVAIIGGLLDFDTFDERIKTAIQIAEDKGIDIEFRVEDAVPVHPNTAKITISDEKGELEL
TGISIGGGKIEITELNGFELRLSGNHPAILVVHNDKFGTIAGVANVLAKFSINVGHMEVA
RKDIGQLALMTIEVDQNIDGHVLDELSKLPNIIQVTKIAD
>PK3-2_03856 putative protein
MSIRILDGRTFAEMILAGAQNLSQNASAVDALNVFPVPDGDTGTNMNLSMTSGAREVEQM
DTDDIGKVGSALSKGLLMGARGNSGVILSQLFRGFSKSIETKKEINALEFAQALQAGVDM
AYKAVMKPVEGTILTVAKDAAKKAMALAEKETDITALMAAVTEEAEASLNRTPDLLPVLK
EVGVVDSGGKGLLCVYEGFLASLKGETVPQKVVLPSLDDMVSAEHHKSAQSMMNTEDIEF
GFCTEVMVRLDQSKREFDEGTFRQDLSQFGDSLLVIADESLAKVHIHAEEPGNVLNYAQH
YGELIKIKIENMREQHTSIISQESKPADNEKTPAKQPYGIVTVAMGEGISDLFKSIGASV
VIEGGQTMNPSTEDIVEAVKSVNAETVFILPNNSNIIMAANQAASVMDEQVFVIPSKTVP
QGMSALLAFNPDQEAEANEANMLSAIQQVKSGQVTYSVRDTHIDGKDIKKGDFMGILNGT
IIGTAEDQLSAAKMLLSEMIGEDDEIVTILYGEDASQEEAEELEAFLSEKYEEIEVEIHN
GKQPLYSYIVSAE
>PK3-2_03857 putative protein
MSIELRTKYGQIDISNEVIAMVAGGAAIDCYGIVGMASKNQIKDGLTEILRKENFSRGVQ
VRQEGEQIHIDMYIIVSYGTKISEVAHNVQTKVKYTVNQTIGLAVDSVNIYVQGVRVTNP
>PK3-2_03858 50S ribosomal protein L28
MARKCVITGKKTTAGNNRSHAMNASKRTWGANLQKVRILVNGKPKKVYVSARALKSGKVE
RV
>PK3-2_03859 Thiamine pyrophosphokinase
MKTINIVAGGPKDLIPDLTGYTAEHILWIGVDKGTVTLLDAGIIPDEAFGDFDSITEQER
RRIEKAAPALHVYQAEKDQTDLDLALDWALEKQPDIIQIFGITGGRADHFLGNIQLLYRG
VKTNIKIRLIDKQNHIQMFPPGEYDIEKDENKRYISFIPFSEDIHELTLADFKYPLNKCH
ITLGSTLCISNELIHSRGTFSFAKGILIMIRSTD
>PK3-2_03860 Ribulose-phosphate 3-epimerase
MIKVAPSILSADFAALGNEIKDVEKGGADCIHIDVMDGHFVPNITIGPLIVEAVRPVTDL
PLDVHLMIEEPDRYIPAFAKAGADILSVHAEACPHLHRTIQIIKEQGLKAGVVLNPHTPV
QVIEHVFDDLDLVLLMTVNPGFGGQKFIHSVLPKIKEVKRMADERGKTDLLIEVDGGVNK
ETAPLVIEAGANLLVAGSAVYGQPDRKKAISEIRGSK
>PK3-2_03861 Small ribosomal subunit biogenesis GTPase RsgA
MPEGKIIKALSGFYYVLDESEDSDKVIQCRGRGIFRKNKITPLVGDYVVYQAENDKEGYL
LEIKERTNELIRPPICNVDQAVLVFSAVQPSFSTALLDRFLVLVEANDIQPIICITKMDL
IEDQDTQDAIQAYAEDYRNIGYDVYLTSSKDQDSLADIIPHFQDKTTVFAGQSGVGKSSL
LNAISPELGLRTNEISEHLGRGKHTTRHVELIHTSGGLVADTPGFSSLEFTDIEEEELGY
TFPDIREKSSSCKFRGCLHLKEPKCAVKQAVEEGELKQYRYDHYVEFMTEIKDRKPRY
>PK3-2_03862 Serine/threonine-protein kinase PrkC
MLIGKRISGRYQILRVIGGGGMANVYLAEDMILDREVAIKILRFDYVNDNEFIRRFRREA
QSASSLDHPNIVSIYDLGEEDDIYYIVMEYVEGMTLKEYITANGPLHPKEALNIMEQIVS
AIAHAHQNQIVHRDIKPHNILIDHMGNIKVTDFGIATALSSTTITHTNSVLGSVHYLSPE
QARGGLATKKSDIYALGIVLFELLTGRIPFDGESAVSIALKHLQAETPSARRWNPSVPQS
VENIILKATAKDPFHRYETAEDMEADIQTAFDADRLNEKKFTVQEDEEMTKAIPIIKDEE
LAKAAGEKEAELTSDQENKTKKKGKRKKWPWVLLTVCIVLVTAGILAVTVFPSLFMPKDV
KIPDVSGMEYEKAADLLEKNGLQVDSEVLEISDEKIDEGLMVKSDPKADSTVKEGATVTL
YKSTGKAKTEIDDVTGQTVDQAKKALKDQGFKHVTVSEVNDDKSAGTVIDQNPSAGTELV
PSDDQVKLTVSIGPEDITLRDLKTYSKEAASGYLEDNGLKLIEKEAYSDDVPEGQVVKQK
PAAGTAVKPGNEVEVTFSLGPEKKPAKTVKEKVEIPYEPENEGDELEVQIAIDDADHSIS
DTYEEFKIKEPTERTIELKIESGQKGYYQVMVNNKVVSYKTIEYPKDE
>PK3-2_03863 Protein phosphatase PrpC
MLTALKTDTGKIRQHNEDDAGIFKGKDEFLLAVVADGMGGHLAGDVASKMAVKAMGEKWN
EAETIPAAPAACEEWLIEQILAVNSKIYDHAQAHEECQGMGTTIVCALFTGKTVSVAHIG
DSRCYLLQDDDFIQVTEDHSLVNELVRTGEISREDAEHHPRKNVLTKALGTDQSVSIDTR
SFDIEPGDKLLLCSDGLTNKVEGTELKDILQSDSAPQEKVNLLVDKANQNGGEDNITAVL
LELALHVEEGEDQC
>PK3-2_03864 putative dual-specificity RNA methyltransferase RlmN
MAELNKTKERKELRTEQPSIYSFELDEIKQWLTDNGEKPFRAAQIFEWLYEKRVSSFEEM
TNLSKGLREKLNTHFVLTTLKTAVKQTSQDGTMKFLFELHDGYTIETVLMRHEYGNSVCV
TTQVGCRIGCTFCASTLGGLKRNLEAGEIVAQVVKVQKALDETDERVSSVVIMGIGEPFD
NFNEMLAFLKIINHDKGLNIGARHITVSTSGIIPKIYEFADQKMQINFAISLHAPNTEIR
SRLMPINRAYKLPDLMEAVKYYINKTGRRISFEYGLFGGVNDQVEHAEELADLLEGVKCH
VNLIPVNYVPERDYVRTPRDQIFAFEKTLKSRGVNVTIRREQGHDIDAACGQLRAKERQD
ETR
>PK3-2_03865 Ribosomal RNA small subunit methyltransferase B
MKKNSVRDIALEALIKLEQNQAYSNLLLKSVIKSNELSDQDRGLLTELVYGTLQNKIALD
YMLKPFINKPQKVKPWVIQLLRLSLYQMEYLEKIPDRAAIHEAVEIAKIRGHKGIASFVN
GVLRSIQREGVPSFDAIEDPVRRLATETSHPEWLVKEWADAYGFDAAEKICRIHLIPPKQ
TLRVNQMKADRAGLLDQMAAEGIEVENGDLAEDAVKLLKGSIAGTHFFQNGDVSIQDESS
MLVARALDPKPGETVLDACAAPGGKSAHIAELMENKGSVTSLDLHKHKVKLIKEAADRLS
LTIIDAKTMDARKAGETFENGQFDRILVDAPCSGFGVIRRKPDMKYTKKPDDSARLAEIQ
LSILREIAPLVKKGGTLVYSTCTMDRTENEEVIHAFIQEHPDFEPDLSLEKRLPEKARPF
VRDGRVQILPHYFGTDGFFICSMRKKG
>PK3-2_03866 Methionyl-tRNA formyltransferase
MTRIVFMGTPDFSVPVLRTLIEDGYEVVGVVTQPDRPKGRKKVMTPPPVKEEALRHGIPV
LQPEKVRLTEEIEKVLALKPDLIVTAAFGQILPKELLDSPKYGCINVHASLLPELRGGAP
IHYSILQGKKKTGVTIMYMVEKLDAGDMISKVEVDIEETDNVGTLHDKLSVAGAKLLSET
VPNVIAGSISPEKQDEEKATYAPNIKREQELLDWSRTGEELYNQVRGLNPWPVAYTTLNG
QNLKVWESKKTPAPTKAEPGTVVAVEKEGIIVATGNETALLLTELQPAGKKRMKGEDFVR
GAHVEAGDKLGANNEKE
>PK3-2_03867 Peptide deformylase 1
MAVKKIVTHPAEVLETPAETVTAFDKKLKKLLDDMYDTMLEMDGVGLAAPQIGILKRAAV
VDIGEDSGRIDLVNPEILEKSGEQTGIEGCLSFPGVYGDVTRADYVKVRAFNRQGKPFIL
EARGFLARAVQHEMDHLDGVLFTSKISKYYTEDELADMEG
>PK3-2_03868 primosomal protein N'
MNFAEVIVDVSTKNIDRPFDYKIPDHLKGMIKTGMRVIVPFGPRKIQGFVTAVKEASDLS
GKSVKEVEDLLDLTPVLTEELMNLSSWLSDKTLSFKITALQAMLPAALKAKYEKELKIPH
GADIPPQVERLFSETKTLLYSDIPDHETLKLIQKHVQKGVIDVTYKVAQKTNKKMVRHIQ
ANASKEELAKQTEGLSRQAAKQQAILHFFIAEPESAKIPAADLCKKTDASSATIKTLIQK
GLLKESYEEVYRDPYQDKMFKKTEPLPLTDEQSAAFEPIRQTLDNDEHKVFLLHGVTGSG
KTEIYLQSIEKVLAKGKEAIVLVPEISLTPQMVNRFKGRFGSQVAVMHSGLSTGEKYDEW
RKIHRKEVRLVVGARSAIFAPFENLGMIIIDEEHESSYKQEEMPRYHAKEVAIKRAEHHS
CPVVLGSATPTLESYARAQKGVYELLSLKHRVNHQVMPEVSLVDMREELRSGNRSMFSVE
LMEKLEETIAKGEQAVLFLNKRGYSSFVMCRDCGYVPQCPHCDISMTYHRYGQRLKCHYC
GHEEPVPHTCPECASEHIRFFGTGTQRVEEELTKVLPNARVIRMDVDTTSRKGAHEKLLS
AFGEGKADILLGTQMIAKGLDFPNVTLVGVLSADTTLHIPDFRAAEKTFQLLTQVSGRAG
RHEKPGHVIIQTYTPSHYSIQLTKTHDYETFYQHEMAHRREQSYPPYYYLALVIVSHEEV
AKAAITAEKIAHFLKANCANDTKILGPSASPIARIKDRYRYQCVIKYKQETQLSALLKKI
LEHYKREIEQKHVMISIDMNPYMMM
>PK3-2_03869 Cysteine/Cysteine sulfinic acid decarboxylase
MLNNRNVLLCVSGGIAVYKACALTSKLVQAGANVKVIMTESACRFVSPLTFQALSRHEVY
TDTFKEQNPSVISHIDAADWADLIIVAPATANVIGKLANGIADDMLTTTLLAATAPVWIA
PAMNVHMYDHPAVKRNISVLYQDGYRFIEPSEGYLACGYVGKGRLEEPENIVKLAEKHFA
EEKNAPLEGKRVVITAGPTREAIDPVRFFTNKSTGKMGYALAEAAVQLGAQVTLISGPVS
LDQPKGLAQFIPVQSAADMREAVLSVYDSSDIVIKTAAVADFTPKTVFDHKMKKQDGGMT
LELNRTADILKELGEKKNGQILVGFAAETQDVEHYARKKLAAKNLDMIVANDVKANGAGF
GADTNIVTIFFKEGQKRELPIMSKLDVSFEILQEIAALSTQTGERS
>PK3-2_03870 DNA-directed RNA polymerase subunit omega
MLDPSIDSLMNKLDSKYTLVTVSARRAREMQIKKDQMIEHTISYKYVGKALEEIDAGLLS
FEKEDRE
>PK3-2_03871 Guanylate kinase
MKERGLLIVLSGPSGVGKGTVRQAIFSQEDTKFEYSISVTTRSPREGEVNGVDYFFKTRE
EFEQMIADNKLLEWAEYVGNYYGTPVDYVEQTLQDGKDVFLEIEVQGALQVRNAFPEGLF
IFLAPPSLSELKNRIVTRGTETDALIENRMKAAKAEIEMMDAYDYVVENDNVETACDKIK
AIVLAEHLKRERVAPRYKKMLEVE
>PK3-2_03872 Extracellular matrix regulatory protein A
MTIKLINIGFGNIISANRMISIVSPESAPIKRMIQDARDRGMLIDATYGRRTRAVVVMDS
DHIILSAVQPETVAHRLSVKEEIMDEGQG
>PK3-2_03873 hypothetical protein
MIRSMTGFGSASKTQDDLSVSVELKSVNYRFKEVNARLPRPLLYVEDKLKQTILQHIQRG
RIELFVSVDSDMLVEKRLEIDWPLLDEFVAAARDMKKRYQLSAEPDVMDFFKLDHVVQIH
EEQTQNDKLEALITAAAEEAVKGLCEMREKEGLLLAKDCLTHIDQLEELVKETELLAADV
VFRYRERLYARIKEWTEDVLDESRLVTECAIFADRSDITEEITRLKSHFAQFRDILAEGG
AVGRKLDFLVQELNREANTIGSKANDHQITKLVVEMKSSIEKIKEQVQNIE
>PK3-2_03874 Calcium-transporting ATPase
MRAGEWTSAMKFHEMGQTDLLEATNTSMKQGLTEKEVKKRLDKHGPNELQEGKKTSALLL
FFAQFKDFMVLVLLAATLISGFLGEYVDAVAIIAIVFVNGILGFFQERRAEQSLQALKEL
STPHVMALREGSWTKIPSKELVPGDIVKFTSGDRIGADVRIVEAKSLEIEESALTGESIP
VVKHADKLKKPDVSLGDITNMAFMGTIVTRGSGVGVVVGTGMNTAMGKIADMLESAGTLS
TPLQRRLEQLGKILIVVALLLTVLVVAVGVIQGHDLYSMFLAGVSLAVAAIPEGLPAIVT
VALSLGVQRMIKQKSIVRKLPAVETLGCASIICSDKTGTMTQNKMTVTHVWSGGKTWRVT
GAGYEPKGSFTLNEKEISVNEHAPLQQMLLFGALCNNSNIEKRDGEYVLDGDPTEGALLT
AARKGGFSKEVVESRYRVIEEFPFDSARKMMTIIVEDQDRKRYIITKGAPDVLMQRSSRI
YYDGSAALFSNERKAETEAVLRHLASQALRTIAVAYRPIKAGEIPSMEQAEKDLTMLGLS
GIIDPPRPEVRQAIKECREAGIKTVMITGDHVETAKAIAKDLRLLPKNGKIMDGKMLNEL
SQEELSNVVEDVYVFARVSPEHKLKIVKAYQENGHIVAMTGDGVNDAPAIKQADIGVAMG
ITGTDVAKEASSLVLVDDNFATIKSAINEGRNIYENIRKFIRYLLASNVGEILVMLFAML
LALPLPLVPIQILWVNLVTDGLPAMALGMDQPEGDVMKRKPRHPKEGVFARKLGWKVVSR
GFLIGAATILAFIIVYHRNPENLAYAQTIAFATLVLAQLIHVFDCRSETSVFSRNPFQNL
YLIGAVLSSILLMLVVIYYPPLQPIFHTVSITPGDWMLVIGMSAIPTFLLAGSLLTRKK
>PK3-2_03875 Rqc2 RqcH
MSFDGMFTYGMTHELNEKMTGGRITKVHQPYKHDVIFHIRANGKNQKLLLSAHPSYSRVH
ITTQAYENPSEPPMFCMLLRKHIEGGFIEKIEQAGLDRIMIFHIKSRNEIGDETTRKLYV
EIMGRHSNIILTDGEDNVIIDGLKHLSPSMNSYRTVLPGHDYKLPPAQDKISPLEATEDD
ILRHLSFQEGRLDKQIVDHFSGVSPLFAKEAVHRAGLANKVTLPKALLELFAEVKGHRFI
PNITTVNGKEYFYLLELTHLKGEARRFDSLSELLDRFYFGKAERDRVKQQAQDLERFVVN
ERKKNANKIKKLEKTLEYSENAKEFQLYGELLTANLYMLKKGDKQAEVINYYDEESPTIT
IPLNPNKTPSENAQAYFTKYQKAKNSVAVVEEQIRLAQEEIEYFDQLIQQLSSASPRDIS
EIREELVEGKYLRPKQQKGQKKQKPHNPVLETYESSSGLAILVGKNNRQNEYLTTRAAAR
DDIWLHTKDIPGSHVVIRSSEPDEQTIIEAATIAAYFSKAKDSSSVPVDYTKIRHVKKPN
GAKPGFVTYDSQHTVFVTPDADTVIKLKKS
>PK3-2_03876 Precorrin-2 dehydrogenase
MLPLHISLEKKKVVIAGGGSIALRRLKTVLSEGADITLVSPDVEPEIKQMADNRSIKWIS
RTIEKGDYLDAFLIIAATDNAAVNKEIAQTASPFQLVNCASHAELGNVYMPKIVKRGHVT
VSVSTNGASPKHTKELAGKVDKLISGDFVAEVDRLYQVRRKK
>PK3-2_03877 Sirohydrochlorin ferrochelatase
MKQAILYVGHGSRIKKAQQEAAAFLEGCKAHVSAPVQEISFLELQEPTIETGFEACVKQG
ATHIAVVPLLLLTAAHAKHDIPEEIARAASRYPSVRVSYGKPIGIDEEVVKAVYHRMKDI
GVPYENARVVLIGRGSSDPDVKRDVTGIADLLQNMIPVKEVIPCFMTACGPNYKEVFSEL
KKDDGMTTFIVPYLLFTGMLMNEIEQEVQKLKADNPNVYLSSYIGFHPHVKNAFLNRVRE
TAENPEGQFDFDGGSYASAAH
>PK3-2_03878 Uroporphyrinogen-III C-methyltransferase
MGKVYIVGAGPGDPDLLTIKALKAIEKADVILYDRLVNKEILQYAKEHADLIYCGKLPDF
HTMKQETINRFLVKYAQKGKTVVRLKGGDPFVFGRGGEEAECLSENGIPFEIIPGITSGI
AAAAYAGIPVTHRDAGSNVAFVTGHYKKEEDFEEKWKALATGIDTLVIYMGIKNVQQIER
KLLENGRDGSTPAAFIHWGTTDKQKSVFCTVDTLSETVIKEDIKNPSLIVIGNVVNYHYK
LEWFESELKKQDLSEAL
>PK3-2_03879 putative adenylyl-sulfate kinase
MTNRDIVWHEASITKEEYQQKNKHKSSILWLTGLSGSGKSTIANAAARELFEQGYQVIVL
DGDNIRHGLNKDLGFSDEDRKENIRRIGEVAKLFVQQGTIVITAFISPFREDREQVRQLV
EAGEFNEIYIKCDLDICEQRDPKGLYKKARNGEIPFFTGIDSPYEEPEAPELVLDSGQHD
REECKNQLIEFVKQKLS
>PK3-2_03880 Sulfate adenylyltransferase
MSLAPHGGTLVNRVDESYDVSSIQKEIELDLISFADLELIGIGAYSPIEGFFNEKDYVSV
VENMRLSSGIVWSLPITLPVDAQKAAELSIGETAKLTYEGETYGVIQIEDLYVPDKQKEA
VNVYKTDEQEHPGVKKLFSRGDTYVGGPITLIKKASKQFPEFTFEPAETRRQFADNGWET
IVGFQTRNPVHRAHEYIQKTALETVDGLFLNPLVGETKSDDIPADVRMESYQVLLDNYYP
KDRVFLGVFLAAMRYAGPREAIFHALVRKNYGCTHFIVGRDHAGVGDYYGTYEAQELFDT
FKPEELGITPLKFEHSFFCEKCGNMGTAKTCPHGREHHVILSGTKVRGMLRDGVLPPAEF
SRAEVVEVLIRGMKKKEEAGVS
>PK3-2_03881 Sulfate permease CysP
MELAAILFSLFFAMNIGASGAAASMGVAYGSGAIKKKTYALILCAAGVLAGAVIGGGEVV
KTISSGIIPEQTITLAIVCIIIGAAALSLFTANLLGIPLSTSEVTVGAVVGVGVAYKVLF
VNNILVIVSFWVFVPLFAFGFTYFVSKLFRYFKIEIKSSKKQKILGIVLLGAGFFEAFSA
GMNNVANAVGPLVAAGVLDVVKGTLYGGAFVALGALLLGRRVLETNGKKITRFSKGEGIL
LSGTGAGLVIISSVFGMPVPLAQVTSSSIIGIGMAKNGPNVFHKQVVQTMLKVWIVSPFL
SLSISYLLVSLFLKADYYSIFIMVSVLLAAGGAVSLTKAIRKERRSVHEQGGGI
>PK3-2_03882 Phosphoadenosine phosphosulfate reductase
MLTYDNWEEPTITFPDDDPYKGALSVLKWAYGHYGNQLVYACSFGIEGIVLIDLIYKVKK
DAEIVFLDTGLHFKETYETIERVKERYPGLNIILKKPDLTLEEQAGEYGDKLWEREPNQC
CYLRKVVPLREALSGHPAWLSGLRRDQGPSRANTNFLNKDEKFKSIKVCPLIHWTWKDIW
RYTSRNELDYNPLHDQGYPSIGCAPCTAPAFTAEDLRSGRWNGMAKTECGLHE
>PK3-2_03884 Orotate phosphoribosyltransferase
MKQIIAKHLLDIQAVFLRPNEPFTWASGILSPIYCDNRLTLSFPEVRNDVASGISKLVEE
HFPEAEMIAGTATAGIPHAALAADRLNLPMCYVRSKPKAHGKGNQIEGAVQKGQKTVVIE
DLISTGGSVLEAAAALQAAGCEVLGVVSIFTYGLSKAQEAFAKAELPYYSLTDYDTLTEV
ALENGNIHSDDLKKLQTWKLNPESKDWFKK
>PK3-2_03885 Orotidine 5'-phosphate decarboxylase
MTNNLPIIALDFASAEETLAFLAPFQKEPLFVKVGMELFYQEGPSIVKQLKERNCELFLD
LKLHDIPTTVNKAMKRLAGLGVDLVNVHAAGGKNMMQAALEGLEEGTPAGKKRPSLIAVT
QLTSTSEQMMKDELLIQRSLIDTVVHYSKLAEESGLDGVVCSVHEAKAIYEAVSPSFLTV
TPGIRMSEDASNDQIRVATPAIAREKGSSAIVVGRSITKAADPVKAYKAVRLEWEGIKQ
>PK3-2_03886 Dihydroorotate dehydrogenase B (NAD(+)), catalytic subunit
MLEVKLPGLDLKNPIIPASGCFGFGKEFARFYDLSCLGAIMIKATTKEPRFGNPTPRVAE
TGAGMLNAIGLQNPGLESVLQNELPWLEQFDTPIIANVAGSQVEDYVEVAEHISKAPNVH
ALELNISCPNVKTGGIAFGTNPEMAADLTKAVKEVSDVPVYVKLSPNVANITEIATAIEE
AGADGLTMINTLIGMRLDLKSGKPILANKTGGLSGPAVKPVAIRMVHEVSQAVNIPIIGM
GGVQTAEDALEFLLAGASAVAVGTANFVNPFACPDIIEQLPSVLRQYGYQSIEECIGRSW
NHDKQPAHHRA
>PK3-2_03887 Dihydroorotate dehydrogenase B (NAD(+)), electron transfer subunit
MKKAYLTVCSNQQIADRVYQMVLKGELVQGFTAPGQFLHLKVSEAVTPLLRRPISIADVN
FEKNEVTIIYRVDGEGTRLLSLKQQGELVDVLGPLGNGFPVNEVQPGKTALLVGGGVGVP
PLQELSKRLNEKGVKVIHVLGFQSAKDVFYEEECRRYGDTYVATADGSYGETGFVTDVMK
QKNLEFDILLSCGPTPMLKALKQEYAHKEVYLSMEERMGCGIGACFACVCHTNESETSYV
KVCLDGPVFKAQEVAL
>PK3-2_03888 Carbamoyl-phosphate synthase large chain
MPKRVDINKILVIGSGPIIIGQAAEFDYAGTQACLALKEEGYEVILVNSNPATIMTDTEM
ADRVYIEPLTPEFLTRIIRKERPDAILPTLGGQTGLNLAVELSERGVLEECGVEVLGTKL
SAIQQAEDRDLFRTLMNELNEPVPESEIIHSLKEAENFVSQIGFPVIVRPAYTLGGTGGG
ICSNETELKEIVENGLKLSPVHQCLLEKSIAGYKEIEYEVMRDSQDHAIVVCNMENIDPV
GIHTGDSIVVAPSQTLSDREYQLLRNVSLKLIRALGIEGGCNVQLALDPDSFQYYIIEVN
PRVSRSSALASKATGYPIAKLAAKIAVGLSLDEMMNPVTGKTYAAFEPALDYVVSKIPRW
PFDKFESANRKLGTQMKATGEVMAIGRTLEESLLKAVRSLEADVYHLELKDAADISDELL
EKRIKKAGDERLFYLAEAYRRGYTVEDLHGFSAIDVFFLHKLFGIVQFEKELKAKAGDTD
VLRRAKELGFSDKYISREWKMKESELYSLRKQAGIAPVFKMVDTCAAEFESETPYFYSTY
EEENESVVTDKKSVIVLGSGPIRIGQGVEFDYATVHSVWAIKQAGYEAIIVNNNPETVST
DFSISDKLYFEPLTIEDVMHIIDLEQPMGVVVQFGGQTAINLADELSARGVKILGTSLED
LDRAEDRDKFEQALGELGVPQPLGKTATSVDQAVSIASDIGYPVLVRPSYVLGGRAMEIV
YHEEELLHYMKNAVKINPQHPVLIDRYLTGKEIEVDAVSDGETVVIPGIMEHIERAGVHS
GDSIAVYPPQSLTEDIKKKIEQYTIALAKGLNIVGLLNIQFVLSQGEVYVLEVNPRSSRT
VPFLSKITGIPMANLATKIILGQKLAAFGYTEGLQPEQQGVFVKAPVFSFAKLRRVDITL
GPEMKSTGEVMGKDSTLEKALYKALIASGIQIPNYGSVLLTVADKDKEEGLAIAKRFHAI
GYNILATEGTAGYLKEASIPAKVVGKIGQDGPNLLDVIRNGEAQFVINTLTKGKQPARDG
FRIRRESVENGVACLTSLDTAEAILRVLESMTFRADQMPAVNTNQEAAVTI
>PK3-2_03889 Carbamoyl-phosphate synthase small chain
MKRRLVLENGAVFEGEAFGSLEHSMGEVVFNTGMTGYQEILSDLSYCGQIVTLTYPLIGN
YGINRDDFESITPFVKGLIIKELCELPSNWRSAYTLDEYLKMKNIPGLQGIDTRKLTRMI
RTAGALKGTFASPDEDVEAVLKRLNETELPRNQVSQVSAKTAYPSPGRGKRIVLVDFGMK
HGILRELNKRKCDVIVVPYNITAEEVLQLKPDGIMLSNGPGDPKDVPEAIEMIKGVLGKV
PLFGICLGHQLFALACGANTEKMKFGHRGSNHPVKELATGKVALTSQNHGYTVSSISETQ
LEVTHIAINDDTIEGLKHKTQPAFTVQYHPEASPGPEDANHLFDRFIEMIDTTEKEGEAV
CQNA
>PK3-2_03890 Dihydroorotase
MSYLIKNGWILNENGEKTEADIRVTGEIISEIGKLDAADEETVIDAKGLLVSPGFVDLHV
HFREPGGEKKETIETGAKAAARGGYTTVAAMPNTRPVPDTKEQMEWVQNRIKETSCVRVL
PYASITIRQIGDEMTNFEALKEAGAFAFTDDGVGIQTAGMMYEAMKRAAAIDKAIVAHCE
DNSLIYGGSVHEGTFSKANGLNGIPSVCESVHIARDVLLAEAANCHYHVCHISTKESVRV
VRDAKKAGIRVTAEVSPHHLLLCDEDIPGLDTNYKMNPPLRGAEDRAALIEGLLDGTIDF
IATDHAPHTEEEKNTEMKLAPFGIVGLETAFPLLYTHFVKNGSWSLKQLIDYMTIKPCEA
FGLPYGTLQTGQAADITLIDLEKEAVIDKETFLSKGKNTPFNGINCTGWPVATMAAGKLA
YEEGRLVK
>PK3-2_03891 Aspartate carbamoyltransferase
MKHLTTMSELNIEEIKDLLQTAVDLKSGKTDNQLTGTFAANLFFEPSTRTRFSFEVAEKK
LGMNVLNLDGTSTSVQKGETLYDTIRTLESIGVDVCVIRHSEDEYYKALVSQVNIPILNA
GDGCGQHPTQSLLDLMTIYEEFNTFKGITVSIHGDIKHSRVARSNAEVLTRLGARVLFSG
PSEWRDEENTFGTYVSTDEAIESSDVVMLLRIQNERHQSAVSQEGYLKKYGLTVERAERM
KQHAIIMHPAPVNRGVEIDDSLVESRKSRIFKQMQNGVFIRMAVIQRALQTKVERGEAAY
VISH
>PK3-2_03893 Uracil permease
MSKKKVNLGVRDVPTPFSWVSFSLQHLFAMFGSTILVPKLVGMSPAVALVTSGIGTLAYL
LITRGQIPAYLGSSFAFISPIILVKATGGPGAAMVGAFLAGLVYGLIALLIRQLGTGWLM
KILPPVVVGPVIIVIGLGLASTAVNMAMYADPNASELVYSLKHFSVAGVTLAITIICAIF
LRGFLSLIPVLIGIIGGYLFALSQGIVNFQPVLDAKWFAVPEFIIPFKDYSPSVTLGIAA
AMVPVAFVTMSEHIGHQMVLSKVVGQDFIKKPGLHRSIMGDSVATILASLIGGPPTTTYG
ENIGVLAITRVFSVFVIGGAAVIALCFGFIGKISALISSVPSAVMGGVSFLLFGIIASSG
LRMLIDNKIDYENNRNLIITSVILVIGVGGAFIQVSQGGFQVSGMALAAIVGVILNLILP
QAKEEQADTSEQHHI
>PK3-2_03895 Bifunctional protein PyrR
MNQKAVILDEQAIRRALTRIAHEMIERNKGMNNCILVGIKTRGIYLAKRLAERIEQIEGN
PVTVGEIDITLYRDDLSKKTSNEEPLVKGADIPVDITDQKVILVDDVLFTGRTVRAGMDA
LVDVGRPSSIQLAVLVDRGHRELPIRADYIGKNIPTSKAEKVMVQLDEVDQNDLVAIYEN
E
>PK3-2_03897 Ribosomal large subunit pseudouridine synthase D
MNQIDITASEEQKSERIDKFLASAENDWSRTQVQQWVKDGQVVVNGSPVKANYKIQPGDQ
VTVTVPEPEALDVLAEPMDLDIYYEDQDVLVVNKPRGMVVHPAPGHLTGTLVNGLMAHCT
DLSGINGVMRPGIVHRIDKDTSGLLMVAKNDMAHESLVNQLVNKTVTRKYTAVVHGLISH
DDGTIDAPIGRDKKDRQSMTVTRDGKNAVTHFHVLERFQDFTLVECQLETGRTHQIRVHM
KYIGFPLAGDPKYGPRKTIDFNGQALHAGILGFDHPRTGEYVEFEAPLPEDMAELIENLR
ENG
>PK3-2_03898 Lipoprotein signal peptidase
MLYYVIALLIIAADQLTKWLVVKNMELGQSIPIIDQVFYITSHRNTGAAWGILAGQMWFF
YLITTAVIIGIVYYIQRYTKGQRLLGVALGLMLGGAIGNFIDRAVRQEVVDFIHVIIVDY
NYPIFNIADSSLCVGVMLLFIQMLLDSGKKKKEQ
>PK3-2_03899 hypothetical protein
MNDQLTAIYTELLLTKEELQSRLFEYSCFQVSTSPQAAINHKQKATLIYHIKEELQDVLL
ALSKIENGTFGYCEETGASIPLSKLAVLPTARTANDFLYSVQFEKKTLPLWKSTDIEYGQ
ALYE
>PK3-2_03900 hypothetical protein
MEKGPAKKAGLFFVPRVTSFRTAGKILWALDHHSQATI
>PK3-2_03901 Isoleucine--tRNA ligase
MDFKDTLLMPKTDFPMRGNLPNREPDIQKKWEEEEIYRLVQERTKDRPKFVLHDGPPYAN
GDIHMGHALNKILKDFIVRYKSMSGYNAPYVPGWDTHGLPIETALTKNKKVNRKEMSVAE
FRKLCEEYAWKQIEGQREQFKRLGVRGDWENPYVTLKPEYEAQQIRVFGEMAKRGYIYKG
LKPVNWSPSSESALAEAEIEYQDKRSASIYVAFGVKDGKGVLENGERIIIWTTTPWTIPA
NLGISVHPELEYSVMAVGEDRFVVASALVENVAAACGFDQYEVTRTIKGKDLENIIAEHP
LYGRDSLVMLGEHVTTDAGTGCVHTAPGHGEDDFIIGQKYGLDVLCPVDAKGVMTSEAPG
FEGMFYDDANKVITQQLDEKGALVKLEFITHSYPHDWRTKKPTIFRATAQWFASIKDFRS
DLLDAIKETKWVPEWGEQRLHNMVRDRGDWCISRQRAWGVPIPVFYAENGEPIITDETIE
HVSELFRQHGSNIWFEKEAKDLLPEGFTHPGSPNGTFTKEQDIMDVWFDSGSSHQAVLEE
REDLVRPADLYLEGSDQYRGWFNSSLSTAVAVTGKAPYKGVLSHGFALDGEGRKMSKSIG
NVVVPAKVMKQLGADILRLWVSSVDYQADVRVSDAILKQVAEVYRKIRNTFRFLHGNLFD
FDPKTNAVAVEDLREVDQYMLTKLNKLIEKVKKAYDEYEFAVVYHSIHNFCTIELSSFYL
DFAKDIVYIEHADHPDRRSMQTVFYETLLALVKLSAPILPHTADELWSHLTFVEEQSVQL
TDMPETITVPNSEATEEKFDRFMAIRDDVLKALETARNEKIIGKSLEANLKLYPNKENQE
LLASIKENLSQLFIVSELTISEENEAPNDAQSFATGKIAVEKAEGEMCERSRVISKDVGA
NPKYPTLSLRNAEIVEKYYQN
>PK3-2_03903 Septum site-determining protein DivIVA
MPLTPNDIHNKTFTKSFRGYDEDEVNEFLAQVRKDYEIVLRKKTELEAKVNELDERIGHF
ANIEETLNKSILVAQEAAEDVKRNSQKEAKLIVREAEKNADRIINESLSKSRKIAMEIEE
LKKQSKVFRTRFQMLIEAQLDLLKNDDWDHLLEYEVDAVFEERE
>PK3-2_03904 hypothetical protein
MSDIYQHFRKDERAFIDQALEWKSVVQEQYRMKLTDFLDPREQVILSAVTGQADVRIAFS
GGYDRAERKRAILYPEYITPEESDFELQAFHVRYAEKFVSVDHRSLLGALMGIGLKRQKF
GDIVFSETAVQLIVSADTADFVASQLTQAGKAAVSLEKIDLSDLNIPAVDVEIRDDTVSS
LRLDAVCASMSRQSRQKSQMLVKNGLVKVNWKAVEDPSYMVAEGDMLSIRGFGRCSLTKI
EGKTKKDKWRVTFERQK
>PK3-2_03905 hypothetical protein
MILYQVFSVLSLLITIYSFALIIYIFMSWVPSTRETAVGRFLASICEPYLEPFRKIIPPI
AMLDISPIVAILVLRFATTGLWGLYRMIAF
>PK3-2_03906 Cell division protein SepF
MSMKNKLKNFFSMEDEEYEYEYIETERESQEEHEQKEKPAYTSNKPAGKQNVVSLQSVQK
SSKVVLSEPRVYAEAQEIADHLKNRRAVVVNLQRIQHDQAKRIVDFLSGTVYAIGGDIQR
IGSDIFLCTPDNVDVSGTISELISEDEHQRW
>PK3-2_03907 Pyridoxal phosphate homeostasis protein
MRVVDNLRHINERINEACNRSGRSSDEVTVIAVTKYVSPERAQEAVDAGITCLGENRDAE
LLRKQEMIKGNPEWHFIGSLQSRKAKAVVNSVSYIHSLDRLSLAKEIEKRAEGTVQCFVQ
VNTSLEPSKHGIKKEEVIPFIQELSGFEHIVVAGLMTMAPLTDDQDQIRSCFKALKELRD
QVQKLKQPNAPCTELSMGMSNDFEIAIEEGATYIRIGSSLVGNETGGVQQ
>PK3-2_03908 Polyphenol oxidase
MNTYHPFSLTTPSTLMIQDWIQTNQNNREVIAGFTTKNGGVSQKPFESLNTGLHVHDKDA
DVVKNREYIADMFNIDLQSWVFADQTHDNRVQKVTQRDRGKGAREYHTALKATDGLYTNE
KNVFLALCFADCVPLFFYDPVKSLVGVAHAGWKGTVKQIGREMVKQWTEQEGSNLSDIYA
VIGPSISGACYTVDDRVMDAVRALPVSADRAVNQTSKAQYQLDLKELNRLILIDSGLANE
QISVSGLCTESEPSLFYSHRRDQGKTGRMMSFIGMKEA
>PK3-2_03909 putative sporulation protein YlmC
MISISEFQVKDVVNVSNGKKLGSIGDIDINVTTGKIQAIILGGNGKVLGFFGKEEELIIP
WRNIVKIGEDVILVRLSEPHA
>PK3-2_03910 N-formyl-4-amino-5-aminomethyl-2-methylpyrimidine deformylase
MNQQIDSLLKKAEDQKEELIQLAKTLISYQTPAPPARNTDGIQTWIAGFLNGMGFSIDKW
DVYPGDPNVVGLLKGTDSAEFQSLIINGHVDVAEVKEDEEWEHEPFHPIEKNGLLIGRGA
SDMKGGLACVLFAVKLIREAGIELPGDLILQSVIGEEVGEAGTLECCKRGYHADFAVVAD
TSDMHIQGQGGVITGWIIIKSSQTFHDGTRRNMIHAGGGTFGASAIEKMAKIIEGLGELE
RHWSIMKSYPGFKPGTNTINPAVIEGGRHAAFIADECRLWITVHFYPNETHDQVAAEIED
YINRLSDSDIWLRENRPVFNWGGSSMIEDRGEIFPALEVDPGHPGVSALTASYEKVKRER
PVIDVSQTVTDGGWLYNAGIPSVIYGPGDLHNAHSVNEEVSIEQLADYTKIMLDFIISWC
SSKKEQ
>PK3-2_03912 putative ABC transporter ATP-binding protein YlmA
MILQLDNVSLKRNGKWILKDIDWKVEEKENWVLYGLNGAGKTALLNMLCSYYFPTSGEMQ
VLGHEFGKTELGEKLRRKIGLVSAALQQKFYPADSAFEIALSGAYASIGLYETPSAEIRE
KAIGLLEDLGAIEYADRRYETLSQGEKQRALIARALMADPELLILDEPVTGLDFIAREKL
LDTITYIANKETAPSILYVTHHAEEILPVFDKALLLKQGEVFTSGEIKEMLTDHILSAFF
DTPIHVLWNQDRPFLTRAEPITNA
>PK3-2_03913 RNA polymerase sigma-G factor
MSRNKVEICGVDTSKLPVLKNEEMRKLFRQLQDEGDDSAREKLVNGNLRLVLSVIQRFNN
RGEYVDDLFQVGCIGLMKSIDNFDLSHNVKFSTYAVPMIIGEIRRYLRDNNPIRVSRSLR
DIAYKALQVRERLISETSKEPTAEDIAKVLEVPHEEIVFALDAIQDPVSLFEPIYNDGGD
PIYVMDQISDERNKDSQWIEELALKEGMRRLNDREKMILRKRFFQGKTQMEVAEEIGISQ
AQVSRLEKAAIKQMNKNIHQ
>PK3-2_03914 RNA polymerase sigma-E factor
MKKLKLRLTHLWYKLLMKLGLKSDEVYYIGGSEALPPPLSKDEEQVLLMKLPNGDQAARA
ILIERNLRLVVYIARKFENTGINIEDLISIGTIGLIKAVNTFNPEKKIKLATYASRCIEN
EILMYLRRNNKIRSEVSFDEPLNIDWDGNELLLSDVLGTDDDIITKDIEANVDKKLLKKA
LEQLNEREKQIMELRFGLVGEEEKTQKDVADMMGISQSYISRLEKRIIKRLRKEFNKMV
>PK3-2_03915 Sporulation sigma-E factor-processing peptidase
MTRERKESDVKIYLDVIWLLNFCFDALLLLLTAFILKRHVKKRRLIGGAFIGSSIVLLMF
TPFSPIVEHPAGKLAFSVAIVMVTFGFKRFRYFFQNLFSFYFATFLMGGGIIGAHSLLQS
NSIVRNGVMITNQTGFGDPISWLFIVAGFPVLWFFSKRRIEDIETKNIQYEERVSVQADL
GGQTLHVRGLIDSGNQLYDPLTKTPVMIIYIDKLEPIFGAAEAMIIRNTDPLEAIQQLDD
SFRFLDKMRLIPYRGVGQQNQFLLCIKPDHVTIMTKEEMISADKCLIGISTTKLSADGEF
DAIIHPKMLSGKVIKHVS
>PK3-2_03916 Bacillopeptidase F
MRKKTKNRLISSVLSTVVISSLLFPGAAGASGKVTSASVKKELQSAESIQNKISSSLKKS
FKKKDKTTFLIKFKDQADTEKAANAAVKKAKSKKLTAAKTEYQKRSAVVSSLKVTADESQ
RDVLTYLNSQKNKGNADQIHSYYVVNGIAVHASKEVMEKVAQFPEVEKVLPNEKRQLFKS
SSPFNMKKVQTAVKATDGVEWNVDQIDAPKAWALGYDGTGTVVASIDTGVEWNHPALKEK
YRGYHPENPDEPDHEMNWYDAVAGEASPYDDLAHGTHVTGTMVGSEPDGTNQIGVAPGAK
WIAVKAFSEDGGTDADILEAGEWVLAPKDAEGNPHPEMAPDVVNNSWGGGSGLDEWYRDM
VNAWRAADIFPEFSAGNTDLFIPGGPGSIANPANYPESFATGATDINKKLADFSLQGPSP
YDEIKPEISAPGVNIRSSVPGQTYEDGWNGTSMAGPHVSAVAALLKQADASLSVDEMEDI
LTSTAEPLTDSTFPDSPNNGYGHGLVNAFDAVSAVTDGLGKAEGQVSVEGDDQEPPVYQH
EKVTEAYEGANLPLTLTAEDNVSVTSVKLSYKLDQGEWTDVTAKRISGDHLKGTYQAEIP
NIKGAALSYKWMIQDFGGHVVESDTYDVTVKPSITVGYKQDFESAPGGWIAGGTNNNWEW
GVPSSGPNKAASGEKVYGTNLAGNYANSANMNLVMPPVKVPDSGNLFLQFKNWHNLEDDF
DYGYVFVLPEGEKNWEQAGVYNGKKSSWTDEEIDLSAYKGQNIQVMFNLQSDESIAKEGW
YIDDVMLSDKAAGKTAKKNKLGVEKPSGKQKKKPVNPKKAKPSANTAVKHQSKDKQPQVL
PIRAQVSVVETGKSTYSDQSTGKYTLTHKAGDYTLMAEAYGYQSKTQKVSLQADQTTQAN
FTLEEMKKGTLKGTVINKTTGEPVKGASVYVVEDAAVEPATTNDKGEYTLEAYEGAYTIK
VTAPGYYSDEFSIDLKGDVTKETVLKPFVGYPGEIAYDDGTAENANSYIAAGNGWAVKMT
LADGKDKGMLTGGLFRFWDTEFPDPGGTEFKVEVYDATGEDGAPGKKIAGPFNAEALRNG
EWTKVDLSSKGIMVDKDFYLVYIQSKPDPYSPGLAMDETGKNSGRNWQYIDGQWQPGDEA
DGNYMIRALVDYEAAVPEITSPADKSYTNKENVTVKGKASPGTTVHIYNGEKEAGETKAA
ADGTFQAGVSLSEGENELTAAASTDNGTTDASSPVTVTLDQDKPELTLDNPKDGEKTNRE
ALTVKGSVSDDNLKEVKVNGKKATVTDGSYSARILLENGSNEVKVTASDLAGNKTTKKAV
IDVNFDQPVISGLIPGEDKTLKAGESVKIAFSSAEDLDATFVIRLPLTNARASVQNATEL
PLREISPGRYEGYWTATSSIKANGAKVEVIARDDYGNETRKTANGKLYINTEN
>PK3-2_03917 Cell division protein FtsZ
MLEFETNIDGLASIKVIGVGGGGNNAVNRMIENEVQGVEYIAVNTDAQALNLSKAEVKMQ
IGAKLTRGLGAGANPEVGKKAAEESKEQIEEALKGADMVFVTAGMGGGTGTGAAPVIAQI
AKDLGALTVGVVTRPFTFEGRKRQLQAAGGISAMKEAVDTLIVIPNDRILEIVDKNTPML
EAFREADNVLRQGVQGISDLIATPGLINLDFADVKTIMSNKGSALMGIGIATGENRAAEA
AKKAISSPLLEAAIDGAQGVLMNITGGTNLSLYEVQEAADIVASASDQDVNMIFGSVINE
NLKDEIVVTVIATGFIEQEKDVTKPQRPSLNQSIKTHNQSVPKREPKREEPQQQNTVSRH
TSQPADDTLDIPTFLRNRNKRG
>PK3-2_03918 Cell division protein FtsA
MNNNELYVSLDIGTSNTKVIVGEMTDDSLNIIGVGNVPSEGLKKGSIVDIDETVHSIRKA
FDQAERMVGFPLRKAIVGVNGNYINIQDTNGVVAVSSENKEIQVEDVRRVMEAAQVVSVP
HEQLIVDVIPKQFIVDGRDEITDPKKMLGVRLEVEGTLITGSKTILHNLLRCVERAGIEI
TDICLQPLAAGSAALSKDEKNLGVALIDIGGGSTTIAVFQNGHLTSTRVIPLGGENITKD
ISIGLRTSTEEAERVKKQFGHAYYEEASEDEVFEVTVIGTNQKQTFTQQEAANIIEARVE
EILEIVSEELRSMGITDLPGGFVLTGGQAAMPGVMSLAQDVLQNNVRVASPNYIGVRDPQ
YMTGVGLIQFACRNARIQGRKIGFKMPEEAVQEIAVSSSEEQEQHHHQNEVQQRPKGKQK
TQAEHNKQSKMKKLLSMFWE
>PK3-2_03919 hypothetical protein
MWLPVLGLVLGIAIGLMTNLTIPSEYSNYLSLAVLAALDTLIGGIRAHLQGTYDEMVFVS
GFFFNIILAISLAFLGVHLGVDLYLAGIFAFGVRLFQNIAVIRRNLLTKWTLSKKNKKNV
I
>PK3-2_03920 hypothetical protein
MVIFGLMIAVQFNSLQHPQVRDTRDMWDIREELTSEQKKQEKLLAEINKYDKLLNSYSQT
KEMTKETALNNTLQTLKKTAGMTDITGSGIVITISPLFSESLTGEPIENPPPDLLKKLIN
ELNSFGAEHIAINERRVVNHTVIRDINGTTKIDGYGLDDYPLTVKVLAEDPDMLYSRVKG
SGLEDLFASENLALKAGKSESKLTLKAYDRPLDVQQLKPLKD
>PK3-2_03921 hypothetical protein
MRGKSAVLLSLIMLVAGFLISFSFQMTKENNKSAAETDEWKKEYALRDELLKQEKENKNL
EKELYQKQNKVRQAENKLKKEKTEYYNVLEDTQKYRMYIGEVGVQGEGVEVTLEDASYIP
EGENVNSYIVHESHIFQVVNELYISGAAAVAVNGQRLTHDSYIKCNGPVVTVDGVQHPAP
FTISAIGDPDVLLPSLNIAGGLIDQLSMDHISVSAEKEKNVQMKPILKTKE
>PK3-2_03922 Cell division protein DivIB
MNPGHDREKIVNIEERIPKIKEQRKQKANRRLISFIMLFFMMVLIIVYLQTPISKVSTVS
VTGNENVSKKEIINLSDINSGDTEFWSLDKKKTEKKIQQNKLVKKAEISKSLPNKINIAI
EEYKAIAYLEKDEVYYEVLENGSVLPNEVTPDDAGPILVNWTNAKKRSQMAKQLDALSNS
LKQSISEIYYTPVKMDENRIKLYMNDGYVVTASIKTFADRMKTYPSIISQLSSNKKGIIH
LEVATYFEEFGKNEKAAKKEDEN
>PK3-2_03923 UDP-N-acetylenolpyruvoylglucosamine reductase
MEKVIQELKEREVGKVLASEPLANHTTMKIGGPADVLVIPSSVDAVKDIMDVIKKYDVKW
TVIGRGSNLLVLDEGIRGVVIKLGAGLDHLELDGEQVTVGGGYSVVRLATSLSKKGLSGL
EFAAGIPGSVGGAVYMNAGAHGSDMSEILVKAHILFEDGTIEWLTNEQMDFSYRTSVLQK
KRPGVCLEAVLQLEQKDKESIVQQMQSNKDYRKNTQPYSSPCAGSIFRNPLPNHAGNLVE
KAGLKGYQIGGAKISEMHGNFIVNAGGASAKDVLDLIDHVKKTIREKYEIDMHTEVEIIG
ENR
>PK3-2_03924 UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MRIAISGGGTGGHIYPALAFIKEVQRRHPDVEFLYIGTENGLEKKIVERENIPFRSIEIT
GFKRKLSFENVKTVMRFLKGVKKSKSYLAEFKPDAVIGTGGYVCGPVVYAAAKMGIPTIV
HEQNSLPGITNKFLSKYVNKVAICFEEAKSHFPSEKVVFTGNPRASEVVSIKTGRSMAEF
GLSEDKKTVLIFGGSRGAAPINRAVIEMQDALKSRDYQVLYITGEVHYEKVMNELKSKGA
ADNMVTKPFLHQMPEYLKAVDVIVARAGATTIAEITALGIPSVLIPSPYVTANHQEVNAR
SLGQHDAAIVLKETELSGEKLIDALDRIVLNEQTLKEMSERTKSLGVPDAAARLYSVLEE
LKK
>PK3-2_03925 putative peptidoglycan glycosyltransferase FtsW
MVYSASAVWADYKFDDSFFFAKRQLLFAGIGVIAMFFIMNVDYWTWRTWSKLLLVICFFL
LVLVLIPGVGMVRNGSRSWIGVGAFSIQPSEFMKLAMIAFLAKFLSEKQKNITSFRRGFI
PALGIVFSAFLIIMCQPDLGTGTVMVGTCIVMIFVAGARIAHFVFLGLIGLSGFVGLVLS
APYRIKRITSYLNPWEDPLGSGFQIIQSLYAVGPGGLFGMGLGQSRQKFFYLPEPQTDFI
FAILSEELGFIGGSLILLLFSVLLWRGIRIALGAPDLYGSFVAVGIISMIAIQVMINIGV
VTGLIPVTGITLPFLSYGGSSLTLMLMAVGVLLNVSRYSRY
>PK3-2_03926 UDP-N-acetylmuramoylalanine--D-glutamate ligase
MENDQFLQNQHFLILGLAKSGYAAASILHEKGIYVAVNDQKAFEENEPAQKLSEKGIEVV
CGEHPVSLFDQHKVTILIKNPGIPYENIMVQEAEKRGIPVWTEIELAYYLTNAKFIGITG
SNGKTTTTTLIYEMLKADSQKALIAGNIGTVASEVAYHADGDEWIVTELSSFQLMGTHAF
RPEISLILNIFDAHLDYHHTRENYEKAKQKVYLHQTASDQAIVNQDDETVVRLAEAGKAE
IVPFSARKTLEQGAYVKDGMIMFNGEAILPLEEVVLPGAHNLENILAAIAVVKTAGVSNE
AVKKVLTSFTGVKHRLQYVTTVKDRKFYNDSKATNILATSKALSAFDKPVILLAGGLDRG
NGFDDLKPYMKHVKAVLTFGQTAPKLEKLGNELGIQHVKRVDNVEQAVSAAFALSNEGDV
ILLSPACASWDQFKTFEERGDMFIDAVHMLK
>PK3-2_03927 Phospho-N-acetylmuramoyl-pentapeptide-transferase
MLEQVILFTILMGFLISVLLSPILIPFLRRLKFGQSIREEGPKSHQKKSGTPTMGGVMII
LSIIVTTIVMTQKFSEISPEMVLLLFVTIGYGLLGFLDDYIKVVMKRNLGLTSKQKLIGQ
IIIAVVFYAVYHYYNFATDIRVPGTDLSFDLGWAYFILVLFMLVGGSNAVNLTDGLDGLL
SGTAAIAFGAFAILAWNQSQYDVAIFSVAVVGAVLGFLVFNAHPAKVFMGDTGSLALGGA
IVTIAILTKLEILLVIIGGVFVIETLSVILQVISFKTTGKRIFKMSPLHHHYELVGWSEW
RVVVTFWAAGLLLAVLGIYIEVWL
>PK3-2_03928 UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase
MKLTKLLTYLTTEPSVNDSQDPEITSIEMDSREVKKGSLFVCVKGYTVDGHDFAHKAVES
GAAAIVAERELDVDVPVIIVRQSLRALSVLSDAFYGQPTKKLQLIGITGTNGKTSTTHMV
DEILKKAGKRTGLIGTMYMKVGDETLPVKNTTPESVTLQKTFKKMNDKQVDTAIMEVSSH
ALSLGRVHGCDYDIAVFTNLTQDHLDYHKTMDEYRQAKSLLFSQLGGAFNHEHPKRAVLN
ADDEASAYFEKVTAAHISTYGIKNNADVMAKNITITAQGTSFNLVTNKGTKHITMSLVGQ
FNVYNVLAAVATCIAAGIPFEIITEAVEELQGVRGRFELVNQQQEFPVIVDYAHTPDSLE
NVLKTCRDMTEGKLFVVVGCGGDRDKTKRPKMAKIAVELADEPIFTSDNPRSEDPRAILK
DMEAGVENAYYHSIANREQAIFFAIANAKKGDVVLIAGKGHETYQQIGNETFDFDDAEVA
ARAIVELNKNKTNS
>PK3-2_03929 Stage V sporulation protein D
MRVSNVTVRKRLLFVLLFGVIVFLIIDTRLGYVQFVMGEKLTSLAKDSWSRNLPFEPERG
EILDRNGVKLATNKSAPTVFVVPRQVQNPMKTSKQLAAVLNMSEEKVYKHVTKKASIEKI
TPEGRKISNEKAKEIKALDLKGVYVAEDSIRHYPFGSFLSHVLGFAGIDNQGLLGLEAYY
DDDLKGEKGSVKFYTDAKGKKMPDEADDYTPPKDGLDMKLTVDSKVQTIMERELDNAEAK
YHPDGMIAVAMNPKNGEILGMASRPDFDPADYQSVDPSVYNRNLPVWSTYEPGSTFKIIT
LAAALEEQKVNLKRDQFYDKGHAEVDGARLRCWKRGGHGLQTYLEVVQNSCNPGFVELGE
RLGKDKLFKYIKDFGFGQKTGIDLQGEGTGILFPLDRVGPVEQATTAFGQGVSVTPIQQV
AAVSAAVNGGTLYTPYIAKEWIDPVTKKTVKKQSPIAKKQVISGETSKQIRYALESVVAE
GTGRNAFVEGYRVGGKTGTAQKVKNGKYLENNHIVSFIGFAPADDPSLVVYVAVDNPKGT
IQFGGTVAAPIVGNIMRDSLPEIGVKPRKNQIEKKYQWNDTKTIEVPNVVGMSVSDLESL
LVNLNVDASGKGSKIVKQSPAAGTKVKEGSKIRVYLTEEDEKEAAD
>PK3-2_03930 Penicillin-binding protein 2B
MPKKNKFMNRGAAILSICFALFFFVILGRMAYIQITGKADGEVLATKATEQHEKKRTIEA
SRGSILDRNGKVIAEDTATYKLIAILDKKMTTDKKHPQHVQNKEKTAEALSKVIKMDKAD
ILDILNKDVKQVEFGSAGRDITYAQKQKIEKLKLPGISFLRDTKRYYPNGIFASNLIGYA
EVDQKTNEISGAMGLEKVLDNYLKERDGYVTYESDKSGWELPNSKNKITAPKNGDNVYLT
IDQKIQTFLEDSMTKVAKKYNPKKIMAAVVDPKTGKVLAMGQRPSFDPNTRDVTNYYNDL
ISYAYEPGSTMKIFTLAAAMQENVFNANEQYKSGTYKVGGGKVYDHNGGVGWGPISFKDG
VLRSSNVAFAKLANEKLGFDRYNEYLHKFGFYQKTGIDLPGEVSSKMNFKYDYDKASTAY
GQASAVTPIQQLEAATAVANDGKMMKPYVIDHIVDPDTRKTVYQNKPESAGTPISASTAK
NVRNILGDVVSSDIGTGRPYKIEGFDVAGKTGTAQIAGTNGYLKGQDNYIFSFMGMAPKD
NPELLIYVAVQQPQLEDDETGSDPVSEIFNPTMKNSLHYLNIEPTEKSDSDKEETKAQTM
PDLTDQTVTAAQKKAKEENLTPIVIGSDVAVKEQYPKADEEVLTNQKVFLKTGGKIKMPD
MTGWSRREVLQYGELAGIHIEVSGQGYAVSQSVKKDKEIKDKTVIKVKFKNPD
>PK3-2_03931 Cell division protein FtsL
MSNLAYQPEKQQRHAISPEKKVIVKKRASITLGEKVLLVLFAAAVLSVSLLIVSKAYAAY
QTNIEVQKLEEQISSKNKQIGDLEKTVADLSKPQRMMDIAKKNGLNLKDKKVKNIQE
>PK3-2_03932 Ribosomal RNA small subunit methyltransferase H
MFQHKTVLLRETVDGLNIKPDGTYVDCTLGGAGHSTYLLQQLSEKGRLIAFDQDDTALQH
AKETLSDYKGQLILMKSNFRYLKECLNEEGITEVDGILFDLGVSSPQLDTPERGFSYHHD
APLDMRMDQSATLTAKEVVNEWRYEDLVRIFFKYGEEKFSKQIARKIEEARIKSPIQTTG
QLVDLIKDAIPAPARRSGGHPAKRVFQAIRIAVNDELKVFEEALEQAIEVLKPGGRVSVI
TFHSLEDRICKTTFKEKSSLPELPPGLPVIPEEFEPELKLITRKPITASQEELEENNRAR
SAKLRIAEKRK
>PK3-2_03933 Transcriptional regulator MraZ
MGQEIMFMGEYQHTIDAKGRMIVPAKFREGLGEQFVLTRGLDQCLFGYPMHEWKQIEEKL
KALPLTKKDARAFTRFFFSGATECELDKQGRVNIASSLLNYAKLEKECVVIGVSNRIELW
SKVIWEQYTEEQEDSFAEIAENMIGFDI
>PK3-2_03934 Putative cysteine ligase BshC
MQLTELSIKNQNVFVQHYIDGKEEMSSFFDYSIHHKDMWRERLKDLSSRFFAREELAAYL
SSYHNKFGSSAMQSAIEKLKDPSSAAVVGGQQAGLLTGPLYTIHKIISIIVLAKEQEKQL
QVPVIPIFWVAGEDHDLDEINFVHTSGENGPVKKKLPQSYWKKSSAAGTSLDQEKCAAWI
DDVFAAFEETDHTNSLLDNVKRCLRESVTFTDFFELLIADLFQEEGLVLLNSGDPGIKKL
ETAMFQKILRENDKLASAVSDQQALMREAGYKPIIESGKEQANLFYEYEEERFLIEKDNG
RFVINELDLGWTMDELYTHMEEHPERFSNNVVTRPLMQEYLIPTLAFIAGPGEINYWGEL
KQAFAVMGFKMPPVMPRLNITILERHIEKKLLERNISLQDAIEHGTESQRETYFEHQIPE
EFTAVMDQAKNQIEAIHKTVRQEALKVDHSMEPLLLKNAAFIQDQLQFLERAVTKRIEEK
EGYVLKDYERIQNSIRPLLAPQERIWNIMYYLNRYGPKFFMTFKNLPFSFQNQHQVVKL
>PK3-2_03935 2-dehydropantoate 2-reductase
MKIGIIGGGSVGLLCAYYLSLHHDVTVVTRRKEQAAAIQSEGIRLYKGGKEFSTDCSADT
SINSGFDLLVVTVKQHQVQSVFPLLERVAKTNILFLQNGMGHIHDLKDWRAKHSIYVGIV
EHGAVRKSDTAVDHTGLGAIKWSAFDDADPDPLNILFQHSHSDFPIRYETDWYRLLTGKL
IVNACINPLTALLRVKNGELLTTPAYLAFMRLVFQEACRILRLEDEEEAWERVRIVCGQT
KENHSSMLVDVIEGRQTEADAIIGYLLKEASLQGLNAVHLEFLYGSIKALERIANKVF
>PK3-2_03936 putative N-acetyltransferase YlbP
MVKVERLLINYKTLEEFKKFKEYGIQELSMLEDLQENIIENDSTSPFYGIYFGDKLVARM
SLYQVNGKSNPYFDNRQDYLELWKLEVLPGYQNRGYGTALVEFAKSFKMPIRTNPRMKSA
EFWNKMNFETVKYDMARDKGENPLIWHPDMDQEMTPGESA
>PK3-2_03937 Prespore-specific transcriptional regulator RsfA
MTITRQDAWTQDEDLLLAEVVLRHIREGGTQLSAFEEVGRALTRTAAACGFRWNSYVRKQ
YQSGIELAKKQRKELRKQIGVHSVNMPNSMKQTAAAAPEGKRDLSIQDVIQFLEQFKETP
SAQEFQLEREKLKEQIQSLQKELDDLRSENQTLRNQLEMTEEDYKALIDIMDRARKMVVS
KEDGRMKKAAQET
>PK3-2_03938 50S ribosomal protein L32
MAVPFRRTSKMKKRLRRTHFKLNVPGMTECPSCGEMKLSHRVCKACGSYNGKDINVKSN
>PK3-2_03939 hypothetical protein
MKWTIYQLHQIPKQSFEFDETVELNELTKLNSDIRRISPVRVKGRADIKSKQVSFDFTIS
GEMILPCSRTLVDVPYPFEISTKELFIFHQTDDIEDDDVHIVEDDTIDLTPIVKEEILLE
IPMQIFCESEQEKGAAPQEGKDWQVISEEDKKKQVDPRLAALEKLLKQDDES
>PK3-2_03940 hypothetical protein
MIIAFMIVFVNIFSLQHNAAIQVSLTAEYAMNTLKIKIRRKSFHLQMYHTFLNIARKAEK
I
>PK3-2_03941 tRNA(Met) cytidine acetate ligase
MKAVGLVVEYNPFHNGHLYHAQTAKRKTGCDTAVAVMSGHFLQRGEPAVVSKWARTKMAL
QSGVDLVIELPYLYAVQKAEIFARGSVSILNKLECEALFFGSENGDIEPFLKTAKLIDEH
KHTFDQRIKEELKKGASYPAAAAIAFSSILHNESALDLSKPNNILGYHYVTSILSGGYLM
KPYTTARISSDYHDADLPEGENHIASATSIRKAMIEQNLEACLHFLPAASAYELAHYRKS
FGLWHTPESYFSYLKYSLSTVTAKELQQIYEVEEGLEHRILRSIRKASSYQEFMELLKTK
RYTWTRLQRMNTHILTRTKKQDMHKLLDDEEVPYIRLLGMTKKGQAYLSEKKKTLSVPLV
SKLSSFSHPALDLDIKASRIYSLPIEEPLRTEFDLQEYGHAPIRYDEDEQRFLNR
>PK3-2_03942 putative protein YlbL
MLRKKHFSWMLVILILIAVLSFIKLPYYITKPGEATELASLIKVEGGYPETGSLSLMTVK
VGPANPFTYVWAKMHPYYEIVPDESIKEEGESDKEYMKRQLQMMQSSQENAVIAAYQKAG
KKVSYSFNGIYASSVVENMPAKGKVEVGDKIISADGKNYQSAEKLIDYISSKNAGDKVTL
KIEREEKEKRVTLTLKQFPEEPDRAGIGVSLYTDRNVKVEPDIDFEIENIGGPSAGLMMS
LEIYNQLTKTDETKGYDIAGTGTIDVDGKVGPIGGIDQKVVAADKAGKDIFFAPNQNGAS
NSDYKNAVKTAKDIDSDMKIVPVDTMQDAVDYLNKLKAKST
>PK3-2_03943 hypothetical protein
MAKPKIGLALGSGGARGLAHLGVLSSLHKHQIEVDMIAGSSMGALVGSFYAAGHDVATMK
KVAEAFKRRFYADYTVPKLGFLKGDRVRQLVHAYTFGKPIEELQIPLGIVACDLQTGEKI
VFRKGAVSDAVRASISIPGIFIPQRLDGRLLVDGAVVDRIPVSVVKDMGADIIIASDVSR
VRKTETAVHIFDVIMQSMDILQNELVRHQTIAADIMIRPSLETYSSSSFANIEAMISAGE
EATNRMISKIRKEIENWEGS
>PK3-2_03944 Sporulation integral membrane protein YlbJ
MNLSKIHTLLIASFFLFLTATVISHPQASFEASKTGLSMWWEVVFPSLLPFFILSELLIG
FGIVRFVGVLLEPFMRPIFRVPGVGGFVLAMGMASGNPAGAKLTARLRQEKQISRVEAER
LASFTNSSNPLFIFGAVAVGFFQNASLGILLASAHYLGNLAVGLTMRSYGRKEEQQHRRK
KTIPFPSIKDALHALHTARLAEKRPLGKILGDAVTSSVQTLLMVGGFIILFSVFNRLLSV
VQLTDILSVLTKGALTLFQLPAQLDIPLLSGMFEITLGSKLVSETDVSLLQKAIVVSFIL
GFSGFSVQAQVAGILSETDIRFKPFFIARLLQGVYAAVFVMLLWKPLYTAWHDPYRYVFK
SLNSGEVPTAFINGWNLLVQIGPAVTLCALFAYIIIFSYRLTNGTKKG
>PK3-2_03945 Phosphopantetheine adenylyltransferase
MASIAVCPGSFDPVTYGHLDIIRRGAHIFEQVYVCVLNNSSKKPLFSVEERCELLREVTK
DIPNITVETSQGLLIDYAKRKNAKAILRGLRAVSDFEYEMQGTSVNRVLDESIETFFMMT
NNQYSFLSSSIVKEVAKYNGPVSEFVPPEVELALQQKFRQG
>PK3-2_03946 Ribosomal RNA small subunit methyltransferase D
MRVISGSKKGRSLKAVPGTSTRPTTDKVKESIFNMIGPYFDGGRGLDLFAGSGGLGIEAL
SRGFEHCIFVDRDFKAIQTVKSNLKTLELTKHAQVYRNDAERALHAAAKRETGFRGIFLD
PPYKEQKLKALLTMIDEYQMLEEDGFIVAEHDREVVLPETVGDLVMTRKETYGLTGVAIY
KKRG
>PK3-2_03948 hypothetical protein
MIVYLHSLKQSKMLRKFGNVHYVSKRLKYVVLYCDMDQIEKTMDKIASYSFVKKVEPSYK
PFLKLEFESKLDKAKEYDYKIGI
>PK3-2_03949 hypothetical protein
MYATMESVRLQSEAQQLAEMILQSETAENYRNCYKRLQEDEEAGRIIRSFIKIKEQYEDV
QRFGKYHPDYREISRKMREIKRELDLNDKVADFKKAENELQSILDEISVEIGTAVSEHVK
VPTGNPYFDGLSSCGGGCGSGGSCGCKVS
>PK3-2_03950 hypothetical protein
MRKEVQEFILANEERKRFIREQPIWYRRLSRKPDDLSSFQLEMMNFYEKTIPHRVNQFTN
GIQMAQMMMQMFQAMRTKD
>PK3-2_03951 hypothetical protein
MANQHANHSINDFKQFVKKHPKLIKEVRKEQRSWQDVYENWVLFGESDPIWDPYREPKEA
AEAVPETEPKNDFVSKMVTAVKKMDVNQMNEQINKMSQSISSLQSLLNTFSGSGQKQSQP
GSGQHPFSFRKD
>PK3-2_03952 hypothetical protein
MRCKQDNVNRHGGDRLKNILRAMVILLIICGTYVLFIQYGSVPERKSNDSEPQVSNEEAQ
SGKRIHMPTSGLLSFMGKSADDVTKKLGEPERIDPSAYDYDWWVYNQGKDQYIQIGVLNN
KVVTLFAAGNDINAKPFKIGESTGDVFKTTQVAPFVNVEYKGNSYRFEFSEEDINTRPTV
KVGKMYVQLYMDKFEGKLSSIRAFDAQTFVKQRPYEVVYRGELIKPEAVSDDKWKKIQTT
SEKQILDLTNVIRFKHGLAKLEWDQPTAEVAFGHSEDMKENNYFSHDSKKYGTLKDRLED
GHVEFQQAGENIAYNYVDGPAAVEGWLNSEGHRKALLNSDYTHLGVGVDRKYYTQNFIKR
W
>PK3-2_03953 Hypoxic response protein 1
MTKIKDLMTADLQYCTVLDNVYEAAVKMKDANVGAIPVVDEDGETLVGIVTDRDLVLRGI
AIKKPNSQKITDAMTEKPVSVEEDASVDEVLHLMASHQLRRIPVTKNKKLTGIVTLGDLS
LSEQTNERAGSALSDISEGDNREEGFFH
>PK3-2_03954 hypothetical protein
MLKFTESGLEGVKAELSWLDDLMESKGLIRAGQWDYERVTYDKKFSTIEGTFYLRIQGIA
AEGDVGSGRAVIQLMPPLLGKHYYPHGVEYGETEEFPVQVVTKSKALIQDISDMLKTVQM
>PK3-2_03955 hypothetical protein
MNQLEVFGFRAMWSPYLFCILLGITVLYLYLYRRMSSKPNRITGKEMACFLSAMLFLYAA
EGSPVDLLGHIMFSAHMVQMAVLYLVVPPLLIAGIPAWLWEKIIFKPAIKPVFSFFTTPL
IALLLFNGIFSLYHVPLIFDTVKTDPFYHTLITWLIFVLAFLMWWPLVHKVERLRQLSGL
MKLGYIMADGMLLTPACALIMFSGAPLYATYTDPSAWAEAMKLCVPVDMMGQVPLTGPEM
FNTLPLLEDQQLGAVMMKIIQEIVYGTFLAIIFFQWVKKEREKDGQEEPPYIQQTIS
>PK3-2_03956 Cytochrome c oxidase subunit 4B
MVGKKSRGHINSDLEFKKKKHAQEMRYQVLSFGLMIGLTIVAFLTVATDGVGSWFTIPFI
ILLAAIQVIFQLYYFMHMNQKGHEAPALFLYSGIFVAFITVLAFVTIIWW
>PK3-2_03957 Cytochrome c oxidase subunit 3
MQIEEKFTAETFPASPEKVTLEGKNKFLGFWLFLGGETVLFASLFATFLALRNSNAGDPP
TTEMFDVTLVFIATMLLLTSSLTSVYAMYHMKNFSFGKMQLWLGITILLGAGFLGLEIYE
FKHYTHEFGFTITSSALGSAFYTLVGTHGAHVAFGLMWISTLMIRNAKRGLNLYTAPKFY
VASLYWHFIDVVWVFIFTVVYLMGMVG
>PK3-2_03958 Cytochrome c oxidase subunit 1
MLNALTEKRTRGSMLWDYLTTVDHKKIAILYLVAGGFFFLVGGIEAMFIRIQLAKPENAF
LSAQAYNEVMTMHGTTMIFLAAMPLLFALMNAVVPLQIGARDVSFPFLNALGFWLFFFGG
IFLNLSWFLGGAPDAGWTSYASLSLHSKGHGIDFFVLGLQISGLGTLIAGINFLATIINM
RAPGMTYMRLPLFTWTTFVASALILFAFPPLTVGLALMMLDRLFGTNFFNPELGGNTVIW
EHLFWIFGHPEVYILILPAFGIFSEVIPVFARKRLFGYSSMVFAIVLIGFLGFMVWVHHM
FTTGLGPIANAIFAVATMAIAIPTGIKIFNWLLTIWGGNVKYTTAMLYAVSFIPSFVLGG
VTGVMLAAAAADYQFHDTYFVVAHFHYVIIGGVVFGLLAGVHFWWPKMFGKILHETMGKI
SFVLFFIGFHLTFFIQHFVGLMGMPRRVYTFLPGQGLETGNLISTIGAFFMAAAVILLLV
NVIWTSVKGEYVGADPWQDGRTLEWTVSSPPPEYNFKQLPFVRGLDPFWIEKQAGHKSMT
PAEPVDDIHMPNGSILPFIISFGLFVAAFGLLYRSDYAWGLPVIFIGLGITFFTMLLRSV
IDDHGYHIHKEELPNDDKGVKA
>PK3-2_03959 Cytochrome c oxidase subunit 2
MVKHWRLISLLALVPLLLSGCGKPFLSTLKPAGEVADKQYDLTVLSTLIMVVVVAVVSVI
FFYVIVRFRRSRVGENTIPKQVEGNKFLEITWTVIPILLLIILVIPVVLYTLELADTSPM
DKKSRKAEDTLVVNVRANLYWWEFEYPDYGIITSQELIVPTDQRVYFNLKASDVKHSFWI
PSVGGKLDTNTDNENKFFLTFDSKRSKEAGDMFFGKCAELCGPSHALMDFKVKTMSAKEF
QGWTKEMKNYKSTTESDLAKQGEELFKEKNCLSCHAVEPNDKRAEAARTAPNLATFGERA
KVAGVKDANEENVKVWLKDPDSIKPGNKMTGTYPKLSDSETDALYEYLKGLKAESK
>PK3-2_03960 Protoheme IX farnesyltransferase 2
MANSRILNDTAIDGQIEETTAWKDFLSLIKIGIVNSNLITTFTGMWLALHISGLSFLGNI
NTVLLTLIGSSLIIAGSCAINNWYDRDIDHLMERTKVRPTVTGKIQPNQALWSGILLVAL
GLIMLLMTTVMAAVIGFIGVFTYVVLYTMWTKRRYTINTVVGSVSGAVPPLIGWTAVEGN
IGVVAWVLFMILFIWQIPHFLALAIKKTEDYRAANIPMLPVVYGFEVTKRQIIVWVACLM
PLPFFLGSLGLPIVILGLLLNIGWLILGLMGFRSKNIMKWATQMFVYSLNYMTIYFVAMV
VLTLF
>PK3-2_03961 Heme A synthase
MNKALKALGVLTTFVMLIVLIGGALVTKTGSGQGCGRQWPLCHGRFFPELNPASIIEWSH
RFASGISIILVLSLAFWSWRKITPIFRETTFLAIMSIIFLFLQALLGALAVVFGSNALIM
ALHFGISLISFASVLILTLLIFEADKSVRKLVKPLQIGKKMQFHMIGILIYSYIVVYTGA
YVRHTESSLACPDVPLCSPLNNGLPTQFHEWVQMGHRTAALLLFVWIIVAAVHAMTSYKD
QKQIFWGWISCLIFITLQALSGIMIVYSELALGFALAHSFFIACLFGVLCYFLLLIARFR
YESRQS
>PK3-2_03962 Deoxyribodipyrimidine photo-lyase
MKVVIIWFRRDLRLEDNAALSQAISYSKQKQAYLLPIFQIDPHFVDMKYDTSHEYFFKAL
SVFANEARQKGLYLHLFYYQAIQMFRLLMDSYKIDAVFYNRDEAGCGAQRDHEVSAFLRK
NGIHPSPWTDAHLHGAGEIVKQDGSMYKVFTPYFRAWSKAEKPKMMKLDDHFLCSKQMIR
NQTLSKQGDQVLEHVVQSGKRHWEHVDVAIAKQALFRFLDEKLAAYHENRDFPFVNGTSK
LSCFLKTGVLSPRMVYYAALQHESPQGAKDVFIKELAWRDFYNMVYAAHPYMADTEIDER
FRNIRWNHDQMLFQAWCEGRTGFPIVDAGMRQLNKEGWMHNRLRMITASFLVKDFLIDWR
LGEAYFSEKLIDYDPASNIGGWQWAASVGTDAVPYFRIFNPVTQSKKFDPDGLFIRRYIP
ELQHVPDEFLHEPWKMPIQIEESSSCTIGEDYPKPLIDHQVQRRLAIETYETAKNM
>PK3-2_03963 Pyruvate carboxylase
MSQQSIQKVLVANRGEIAIRIFRACTELNIRTVAVYSKEDSGSYHRYKADEAYLVGEGKK
PIDAYLDIEGIIDIAKRNKVDAIHPGYGFLSENIHFAKRCEEEGIVFIGPKSEHLDMFGD
KVKAREQAEKAGIPVIPGSDGPAETLEAVEQFGQANGYPIIIKASLGGGGRGMRIVRSES
EVKEAYERAKSEAKAAFGNDEVYVEKLIENPKHIEVQVIGDKQGNVVHLFERDCSVQRRH
QKVIEVAPSVSLSTELRDQICEAAVTLAKNVNYINAGTVEFLVANNEFYFIEVNPRVQVE
HTITEMITGVDIVQTQILVAQGHSLHSKKVNIPEQKDIFTIGYAIQSRVTTEDPQNDFMP
DTGKIMAYRSGGGFGVRLDTGNSFQGAVITPYYDSLLVKLSTWALTFEQAAAKMVRNLQE
FRIRGIKTNIPFLENVAKHEKFLTGQYDTSFIDTTPELFIFPKQKDRGTKMLTYISNVTV
NGFPGIGKKEKPAFDKPLNVKVSTDQQPARGTKQILDEKGAEGLADWVKEQKSVLLTDTT
FRDAHQSLLATRFRSHDLKKIANPTASLWPELFSMEMWGGATFDVAYRFLKEDPWKRLED
LRKEVPNTLFQMLLRSSNAVGYTNYPDNVIKEFVKQSAQSGIDVFRIFDSLNWVKGMTLA
IDAVRDTGKVAEAAICYTGDILDKNRTKYDLAYYTSMAKELEAAGAHILGIKDMAGLLKP
QAAYELVSALKETIDIPVHLHTHDTSGNGIYMYAKAVEAGVDIIDVAVSSMAGLTSQPSA
SGFYYAMEGNARRPEMNVQGVELLSQYWDSVRKYYSEFESGMKSPHTEIYEHEMPGGQYS
NLQQQAKGVGLGDRWNEVKEMYRRVNDMFGDIVKVTPSSKVVGDMALYMVQNNLNEKDVY
EKGEQLDFPDSVVELFKGNIGQPHGGFPEKLQKLILKGQEPITVRPGELLEPVSFEAIKQ
EFKEQHHLEISDQDAVAYALYPKVFSDYVKTTESYGDISVLDTPTFFYGMTLGEEIEVEI
ERGKTLIVKLISIGEPQPDATRVVYFELNGQPREVVIKDESIKSSVQERLKADRTNPSHI
AASMPGTVIKVLTEAGTKVNKGDHLMINEAMKMETTVQAPFSGTIKQVHVKNGEPIQTGD
LLIEIEKA
>PK3-2_03964 putative peptidoglycan glycosyltransferase FtsW
MLKKMLKSYDYSLIFAIVLLCGFGLVMVYSSSMITAVSRYGVSSNFFFMRQLFALIAGGA
LFILMALFPYKALAHQKFQKGILLVSVLALISLFVFGHVAGNAQSWFKIGGMSIQPGEFV
KLVVILYLAAVYAKKQSYIDHLLTGVAPPVVMTLIICGLIAMQPDFGTAMIIGLIATCMI
LCSGFSGKTLVRLLLLGGIVLILVSPILYLNQDQILTKGRLARFESLEDPFKYANSSGLQ
VINSYYAIGSGGIFGLGLGESIQKYGYLPESHTDFIMAVIAEELGIFGVLFVIFLLGFVV
IKGFYIARKCEDPFGSLLAIGISSMIAIQSFINLGGVSGLIPITGVTLPFISYGGSSLVL
LLGSMGILANISMFVKYSENKKKREPLATKGMKKKQLKKTVYQ
>PK3-2_03965 hypothetical protein
MASEMIVDHRQKAFELLKVDAEKILKLIRVQMDNLTMPQCPLYEEVLDTQMFGLSREIDF
AVRLGLVDEKDGKDLLYTLERELSALHDAFTSK
>PK3-2_03966 Glutaminase 2
MVCRHNDELEALVKEAKKVTDRGEVASYIPALAKADKHDLSVAIYYSNNVCLSAGDVEKT
FTLQSISKVLSLALVLMEYGKDKVFSYVGQEPTGDPFNSIIKLETVNPSKPLNPMINAGA
LVVTSLIRGKTVKERLDYLLSFIRRLTNNQKITYCREVAESEYSTSMINRAMCYYMKQYG
IFEDDVEAVMDLYTKQCAIEMNSLDLAKIGAVFALNGRHPETGEQVISKDVARICKTFMV
TCGMYNASGEFAIKVGIPAKSGVSGGIMGISPYDFGIGIFGPALDEKGNSIAGVKLLEIM
SEMYRLSIF
>PK3-2_03967 hypothetical protein
MSVIQVKGNVTYPITIDPSVWIFDDRKFSFDRKGDGQDTHLQSAGDESGLDPERVIREGR
IAPPTLKTEKQYEKQKLMNGSFAMKLGTVLKNAEPLSSATQCVFVTSSGKTAVPLESALN
SIVHFSESGKPIQEGGPVHIYFEDPVNHEQSVTDIKEIEIV
>PK3-2_03968 hypothetical protein
MSKIYVLDTNVLLQDPNAIFSFEENEVVIPAVVLEEVDSKKRYMDEVGRNARHVSKLIDA
LRQKGRLHEHVPLDTGGTLRIELNHRSFHQLQEIFIEKTNDNRILAVAKNLSLEEETKEN
GRPVILVSKDVLVRVKADAIGLLAEDFLNDRVVDNDEMYSGYKDLYISQQLFSSFYGKNQ
ISVNDIKQHAFYPNQFALMKDELGGSSSAIGIADKTGTVLKRLVFDDEHIWGIRPKNVQQ
TMALELLLREDIPLVTLIGKAGTGKTLLALAAGLLQTEDLGIYKKLIVARPIVPVGKDIG
YLPGEKEEKLKPWMQPIFDNLEFLFNAKKPGELEAILAGIGSIQVEALTYIRGRSIPDQF
IIIDEAQNLTRHEVKTLLTRVGEGSKIVLMGDPEQIDHPYLDSLNNGLAYVVERFKGQPI
SGSVKLLKGERSGLAQLAADLL
>PK3-2_03969 hypothetical protein
MRILFIMIQLTLILSACAYQQGRQDQNVEKESTRQQETKPIHVKDTTQETKDNRTRTDIA
KHLVSVAEKNPDVKDATAVVLGGYAVVGIDVDDTLDRSKVETIKYSVAQALKNDQYGANA
VVIADPDTVSRLSEMSREISEGHPVTGILDELAAIVGRVLPEVPNDVIDNEDEPQTKQQN
DQLNRKQQQEMEQEQNDQSDHHMKKNTND
>PK3-2_03970 hypothetical protein
MRVKCSICDKIETIDDDTLIAKRLRNRPIHTYMCQECHDRIAQKTEERLKTGKFTFHPGQ
QKKEKVKK
>PK3-2_03971 hypothetical protein
MNDVSERLSFFAALYQVDRQPAAGMWLLYGTIFVLAVIVFKLGFAKRLPLLKSAVVYVFL
ALGCTVLTFLGVFLPVAEGLIVAALILIIYKIRLYQSKKGQSANS
>PK3-2_03972 GTP-binding protein TypA/BipA
MKLRNDLRNIAIIAHVDHGKTTLVDQLLHQAGTFRANEHVAERAMDSNDLERERGITILA
KNTAINYKDTRINILDTPGHADFGGEVERIMKMVDGVVLVVDAYEGCMPQTRFVLKKALE
QNLNPVVVVNKIDRDFARPEEVIDEVLDLFIELDANEEQLEFPVVYASAINGTASLDPKQ
QDENMEALYETIIKHVPAPVDNAEEPLQFQVALLDYNDYVGRIGIGRVFRGTMKVGQQVS
LMKLDGTAKSFRVTKIFGFQGLKRVEIEEANAGDLIAVSGMEDINVGETVCPVDHQDPLP
VLRIDEPTLQMTFVVNNSPFAGREGKYVTARKIEERLQSQLQTDVSLRVEPTASPDAWVV
SGRGELHLSILIENMRREGYELQVSKPEVIIKEIDGVRCEPVERVQIDVPEEHTGSVMES
MGARKGEMVDMINNGNGQVRLIFTVPSRGLIGYSTEFLSLTRGFGILNHTFDSYQPMQAG
QVGGRRQGVLVSMENGKATSYGIQGIEDRGVIFVEPGTEVYEGMIVGEHNRDNDLVVNVS
KMKQQTNVRSATKDQTTTIKKARIMSLEESLEYLNDDEYCEVTPESIRLRKKILNKNERE
KAAKKKKTAGLS
>PK3-2_03973 hypothetical protein
MKKMNWLLLLFAFAAVFSIMLIGVFIAEKSAIGIIASIVLVCAVMGGGFTVKKKMREQGL
LD
>PK3-2_03974 hypothetical protein
MKKTFVKKAMLTTAAMTSAALFTFGPDAASAKTPADNTAIHVQHQTITNEDLNTFISILN
QCIYKQDGVYYFDSEKAVELGMTKEEAQVIAKLWESTSEFFSVVSQCVYVEDGNYKFDTE
KAIELGFTEKEALALEQFFSAVSLKIHILQAAIVLQDGVYSYDKDAAVQAGATPLQADVY
EKLFGALSQEQLAAIYDMIHPQA
>PK3-2_03975 hypothetical protein
MTCFLVRDLLPLYLEGDCKRETEHVIEEHLKTCGSCSEMYDLMAEPFELEGRQDVEETFL
PEEEMRFKQRYYGLLIVKAACWFGAAVAVMLMIKLLI
>PK3-2_03976 RNA polymerase sigma factor YlaC
MKHRDSIEDLYRQYYQEILNYLFRRTHHLETAKDLAQDTFVKALNGLASFRGHSSIRTWL
YTIAHHTFVNWYRRDVKYQFTDISKNDGLTQTTYEQPEQYLSRTVKSETLMQELLRLKDH
HQSVLILREFQELSYEEIAEILGWSLSKVKTTLHRARLELKKNMMKRREDERI
>PK3-2_03977 hypothetical protein
MNHKEKESVFLDLYDLYKDGELEDESMEWMKQHESLFQKIAEDLKSKTCLKRSPDAEEES
RIRYMKVYLSSMYICFILLAIWMTVWFYF
>PK3-2_03978 hypothetical protein
MLELFSHYVLHFERYFILSKQSTLLIQWAIVVLAGLYVLVHHPKINRYRTMFLAGVLLRI
VLLAGVSVELIHQVQATNFTSAYLREDGNELRPLVHFLLYGYVLLTAFHYMLMPRDHNAK
GMFYTFDLAVVSLPIVQMIFSFFSYWKEYSDGMEPIAFVFLFFIITLPIVLNVVFFKLYW
RTNKILLGLFYTLIIGLLVLLLAPYPNQISKDYGAVMPYTIYLTMAGFLMSYHLFQKSAK
VYVRVNKWLTRSVVVFFVLLLNPIYNAGTAAFAVSKPINVHDSFNFVGEHISSEKSEQIV
KSFFPTNETLYLHDTKMDVHYFYSFESMSYEAELDEVSQLINHYQYLKKPRGKTLTEQEY
VRKSVAFLERHGRVLNKGHIETKVSKEDSQTAVRIYLKNQFRKKEDNDDGTVFYWEKETL
MSFSEDPSIYQLDSLLHVHITEQDIHGKMKKMFTALNIPKQPYQITDVESNGLLGGLVHV
ETKDGIAVEFESESGSLQSISLPMKKNISLTNNQLQRQILSVFDADVSEIKIKSRHSDKA
VYSDSSHSYEFFEDQGQLNVYVYSDTLDKSFPYTYSNGRLAYEKVASAYTDVIYKKRMRP
IIVQRGNERHYAWLIIIQPFGSNRHDAYVVDGETQEVKSLYES
>PK3-2_03979 Bacillolysin
MGLGKKLSVAVAASFMSLSISLPGVQAAESHQLKENQTNFLSKNAIAQSELSAPNDKAVK
QFLKKNSNIFKGDPAKRLKLVESTTDALGYKHFRYAPVVNGVAIKDSQVIVHVDKSDNVY
AVNGELHNQPAAKTENSQKVSSEKALALAFKAIGKSPDAVSNGAAKNSNKAELKAVETKD
GSYRLAYDVTIRYIEPEPANWEVLVDAETGSILKQQNKVEHAAATGSGTTLKGATVPLNI
SYESGKYVLRDLSKSTGTQIITYDLQNRQSRLPGTLVSSTTKTFTSSSQRAAVDAHYNLG
KVYDYFYSNFKRNSYDNKGSKIISSVHYGTKYNNAAWIGDQMIYGDGDGSFFSPLSGSLD
VTAHEMTHGVTQETANLIYENQPGALNESFSDVFGYFNDTEDWDIGEDITVSQPALRSLS
NPTKYDQPDNYADYQNLPNTDEGDYGGVHTNSGIPNKAAYNTITKLGVSKSQQIYYRALT
TYLTPSSTFKDAKAALIQSARDLYGSTDAAKVEAAWNAVGL
>PK3-2_03980 hypothetical protein
MGTRVSYPVEVKQKAVEMRLAGVPMKEIMQKLNIKNKTQVQTWVRWRRRDPMDALFDKKG
NQEAYPLIIYKDAARAGQNRIQRLFASAC
>PK3-2_03981 hypothetical protein
MPQLAEFVKEGYTVASVQYRGSGDAAFPAQLQDVKTAVRFLKANAAAYNIDPHNIGVWGD
SSGGHLALLLGLTEGLKEFDGDLEYAPISSRVQAIADWFGPTVYWQ
>PK3-2_03982 hypothetical protein
MKKPSVTSLISAFARAYHSRYDTPLIFDDFIAKDLINEKEFKDISENMIEGISFFNKEVA
ERLQNDPEEILKWVTHIQLSPTPLARASYCERVLQNELMLGAKQYVILGAGLDTFCFRHP
EWAHSLQVFEIDHPATQQFKKNKLKDANLTIPEHLHFVPMDFTNMFSYQPLFDKGFENTK
TFFSLLGVSYYLTREENASLISNLFSRLPSGSSIVFDYADETLFTAKGTSNRVEHMVKMA
AASGEPMQSCFTYQEIENLLGSAGLLIYEHLSPDDINGLFFNNRTDDLSAFETIHYIHAV
KK
>PK3-2_03983 hypothetical protein
MLESRAFEQDDLCLLEKLAEAHPVWKEEEFGEKDADSYIISYSMYNGSWLVWEKDGQPVA
ISYHLEWAPSNGKPWLGTVLVDPAEEKKGHARMIVEQISKLLRAKHKAMFAGVPIDRNEW
ILFLSQCGFEQLKTEKDEKGKSFMILVKPLAEAAV
>PK3-2_03984 Inositol-1-monophosphatase
MTNWTEIDEIAKKWVREAGARIKQSMHESLTIETKSNPNDLVTNIDKETEKFFIERIQET
FPGHRILGEEGQGDKLHSLEGIVWIIDPIDGTMNFVHQQRNFAISIGIFENGEGKIGLIY
DVVHDELYHAFSGRGAYMNETKLAPLKETVIEEAILAINATWVTENRRIDSSVLAPLVKR
VRGTRSYGSAALELANVAAGRIDAYITMRLAPWDYAAGCVLLNEVGGIYTTIEGESFTYL
ENHSVLAGNPSIHKTIFEEYLHAGK
>PK3-2_03985 hypothetical protein
MRQVVKEGFKEEKNNRVAVWRLEVDYELATLYEAMQKENEEQIEQSKNKLERLRKEWIRI
NG
>PK3-2_03986 hypothetical protein
MTQMRFTEEDFNTFTIEGLDARMEVLKETVRPKLTALGEHFAPTLSALTGDEMFPHVAKH
ARRSVNPPADSWVAFANSKRGYKKLSHFQIGLWESHVFVWFAIIYESPIKEEYGKLLEAN
QETITKNIPDSFVWSADHTKPGVHKQSEMDKEQLKTLFERLQTVKKAELLCGIQLQKEEV
LNMNNQEFLQRIDDAFQQLAFLYRFTQKVSQA
>PK3-2_03987 hypothetical protein
MEYQYPMNEDWTTEEAVDVIAFFQQVELAYEKGADREELLKAYRRFKEIVPGKAEEKTLC
GEFEEQSTYSPYRTVKQARESDQAKIKM
>PK3-2_03988 Arginine decarboxylase
MSQHETPLYTGLKKHASRQPVQFHIPGHKKGAGMDPEFRQFIGENALSIDLINIEPLDDL
HAPKGIIKQAQDLAAEAFGADHTFFSVQGTSGAIMTMVMAVCGPGDKIIIPRNVHKSIMT
AIVFSGAIPIFIHPEIDNELGISHGITLESAKRALTEHPDAKGLLVINPTYFGVAADLKS
IVELAHSFDVPVLVDEAHGVHIHFHDELPLSAMQAGADIAATSVHKLGGSLTQSSILNMR
EGLVSKDRVQSILSMLTTTSTSYLLLASLDVARKRLATEGHQLAEETLKLANQTRDRLNQ
IEGMYCVGSEILGSKAAYSYDPTKLIISVKNLGLTGHDVEKWLRESFNIEVELSDLYNIL
CIFTPGDSQNDADRLVEALTEIAHHMSEKDVTHQQTEVLLPEIPLLAMTPRDAFYANTEV
IPLKEASGRIIAEFVMVYPPGIPIFIPGEIITEENISYIFKNLDAGLPVQGPEDSTLNMI
RVIKEQKAIQ
>PK3-2_03989 hypothetical protein
MGTRVSYPVEVKQKAVEMRLAGVPMKEIMQELNIKNKTQIQTWVRWYKAGDTHRFEQPVG
KQYTYGKGPEYASELEKLQAENRYLRQQNEVLKKYNELERKLIAKRQSNL
>PK3-2_03990 IS3 family transposase ISBsu1
MHLGISRASYYRWKKNLMKGHPKRHLEKQIGTLCREHKYRYGYRKITAILKKRMRINHKT
VQRIMQKTQWQCQVKVKKRKKNGQPYAVVDNILDRNFQSDRPLEKLVTDITYLPYGQKQL
YLSSILDLYNGEVIAFTIGDKQDTQTLS
>PK3-2_03991 IS3 family transposase ISBsu1
MLHSDQGSVYTSYEYQKAVNTKGITMSMSRKGTPADNASIESFHSSLKSETFYLNSIDRT
TTAIVERTVIEYIHYYNNIRIQTKLNNQSPINYRQLAV
>PK3-2_03994 hypothetical protein
MGTIVCQDCNEAIHYFEDEKVTTLYGTCCGQCQCPVDEE
>PK3-2_03995 hypothetical protein
MRYRVIFPILIIVFALSGCTLSTINPVKKSRIDNIHHTQILFFSDENQIDQEAPYYDALL
DLEKDYPEQIDKMKVYDNKKGWEDEIETVPTLMVVDQRHVVVKIEGCVKKKEDIIKPLQH
VLPK
>PK3-2_03996 Dihydrolipoyl dehydrogenase
MVVGDFPIETDTLVIGAGPGGYVAAIRAAQLGQKVTVVEKATLGGVCLNVGCIPSKALIN
AGHRYENAKHSDDMGITAENVSVDFTKVQEWKASVVNKLTGGVAGLLKGNKVDVVKGEAY
FVDSNSVRVMDENSAQTYTFKNAIIATGSRPIELPNFKYTERVLNSTGALALKEIPKKLV
VIGGGYIGTELGTAYANFGTELVILEGGDEILPGFEKQMSSLVTRRLKKKGNVEIHTNAM
AKGVEERPDGVTVTFEVKGEEKTVDADYVLITVGRRPNTDELGLEQVGIEMTDRGVVKTD
KQCRTNVPNIYAIGDIIEGPPLAHKASYEGKIAAEAIAGEPAEIDYLGIPAVVFSEPELA
SVGYTEAQAKEEGLDIVAAKFPFAANGRALSLNETDGFMKLITRKEDGLVIGAQIAGASA
SDMISELSLAIEGGMTAEDIAMTIHAHPTLGEITMEAAEVAIGSPIHIVK
>PK3-2_03997 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MAFEFKLPDIGEGIHEGEIVKWFVKPNDEVDEDDVLAEVQNDKAVVEIPSPVKGKVLELK
VEEGTVATVGQTIITFDAPGYEDLQFKGSDESDDAKTEAQVQSTAEAGQDVAKEEQAQEP
AKATGAGQQDQAEVDPNKRVIAMPSVRKYAREKGVDIRKVTGSGNNGRVVKEDIDSFVNG
GAQDAAPQETAAPQETAAKPAAAPAPEGEFPETREKMSGIRKAIAKAMVNSKHTAPHVTL
MDEVDVTNLVAHRKQFKQVAADQGIKLTYLPYVVKALTSALKKFPVLNTSIDDKTEEVVQ
KHYFNIGIAADTEKGLLVPVVKNADRKSVFEISDEINGLATKAREGKLAPAEMKGASCTI
TNIGSAGGQWFTPVINHPEVAILGIGRIAEKAIVRDGEIVAAPVLALSLSFDHRMIDGAT
AQNALNHIKRLLNDPQLILMEA
>PK3-2_03998 Pyruvate dehydrogenase E1 component subunit beta
MAQMTMIQAITDALRTELKNDENVLVFGEDVGVNGGVFRATEGLQKEFGEDRVFDTPLAE
SGIGGLALGLGLNGFRPVMEIQFFGFVYEVMDSVSGQMARMRYRSGGRWTSPVTIRSPFG
GGVHTPELHADSLEGLVAQQPGIKVVIPSTPYDAKGLLISAIRDNDPVVFLEHMKLYRSF
RQEVPEEEYTIELGKADVKREGTDLSIITYGAMVHESLKAAEELEKDGISAEVVDLRTVS
PLDIDTIIASVEKTGRAIVVQEAQKQAGIAANVVAEINDRAILSLEAPVLRVAAPDTVFP
FSQAESVWLPNHKDVLETARKVLEF
>PK3-2_03999 Pyruvate dehydrogenase E1 component subunit alpha
MAAKTKKAIVDSKKQFDAIKKQFETFQILNEKGEVVNEAAMPDLTDDQLKELMRRMVFTR
VLDQRSISLNRQGRLGFYAPTAGQEASQIATHFALEKEDFVLPGYRDVPQLIWHGLPLYQ
AFLFSRGHFRGNQMPDDVNALSPQIIIGAQYIQTAGVALGLKKRGKKAVAITYTGDGGAS
QGDFYEGINFAGAYKAPAIFVVQNNRYAISTPVEKQSAAETIAQKAVAAGIVGVQVDGMD
PLAVYAATAEARERAINGEGPTLIETLTFRYGPHTMAGDDPTKYRTKEIENEWEQKDPLV
RFRAFLENKGLWSEEEEAKVIEDAKEEIKQAIKKADAEPKQKVTDLMKIMYEKMPHNLEE
QFEIYTQKESK
>PK3-2_04000 hypothetical protein
MKDALKRLSGKKIGVFCAMTLLLTGCMGKDPVDSLHHSLEKAAESEKPFQEEQKTLEELE
TKENQLYDDVMKLNMDDYKKIVALSDEALENVSKREEHLKIENDSIKKSESEFEEAKTSA
EHIKDKHIKEKAVTAASHMQKRYTSYGSMYEEYKKALQLNKKLYKQLKDKDLTRDDLDQQ
IDKVNASYEKVLKYSGEFNEQTEKYNKARDDLYDAAGYHVKKS
>PK3-2_04001 hypothetical protein
MYGYGYGGGCCSYGGYGYGGYGYGRTFALIVVLFILLIIVGAAYLGGGCC
>PK3-2_04002 Peptide deformylase 2
MITMENIVRDGHPALRETAEPVELPATDAEKQQLADMIEFVKNSQNPELAEKYKLRPGVG
LAAPQVNIKKRMIAVHAEDDSGKLYSYALFNPKIVSHSVEKSYLTSGEGCLSVDEAIPGY
VPRYARIRVKGTTLKGENIDIRLKGFPAIVFQHEIDHLNGVMFYDHIDNENPFKEPENAI
AIER
>PK3-2_04003 Putative bifunctional phosphatase/peptidyl-prolyl cis-trans isomerase
MMRVGFADQDDKGEVTMDSKLIFFDIDGTIYDHDKNIPESTRKTVAELQRQGHHVFIASG
RSPFLVKPILEELGINSFISYNGQYVVFENQVIYKNPLPEEAISRLLKQAGEGKHPVVFM
AEDTMKATVADHPHVLEGIGSLKTDYPETDELFYEGKEIFQLLLFCQDEEEKAYAAFPEF
DLVRWHEFSTDVLPHGGSKAEGIKKVIERLPFDISDTYAFGDGLNDLQMIEFVGTGVAMG
NAVPELKEIADFVTKPVDDDGIAFAVKELGLLK
>PK3-2_04004 hypothetical protein
MIYKVFYQEKAEEVPVREKTDSLYIEGVSERDVRTKLKEKKFNIEFITPVDGAFLEYEQQ
SENFKVLEL
>PK3-2_04005 Ribonuclease J1
MKFVKNDQTAVFALGGLGEIGKNTYAVQFQDEIVLIDAGIKFPEDELLGIDYVIPDYTYL
VKNEDKIKGLFITHGHEDHIGGIPYLLRQVNIPVYGGKLAIGLLRNKLEEHGLLRQTKLN
IIGEDDIVKFRKTAVSFFRTTHSIPDSYGIVVKTPPGNIVHTGDFKFDFTPVGEPANLTK
MAEIGKEGVLCLLSDSTNSENPEFTMSERRVGESIHDIFRKVDGRVIFATFASNIHRLQQ
VIEAAVLNGRKVAVFGRSMESAIEIGQTLGYINCPKNTFIEHNEINRMPANKVTILCTGS
QGEPMAALSRIANGTHRQISINPGDTVVFSSSPIPGNTISVSRTINQLYRAGAEVIHGPL
NDIHTSGHGGQEEQKLMLRLIKPKFFMPIHGEYRMQKMHVKLATDCGIPEENCFIMDNGE
VLALKGDEASVAGKIPSGSVYIDGSGIGDIGNIVLRDRRILSEEGLVIVVVSIDMDGFKI
SAGPDLISRGFVYMRESGDLINDAQELISNHLQKVMERKTTQWSEIKNEITDTLAPFLYE
KTKRRPMILPIIMEV
>PK3-2_04006 Adenine deaminase
MNKEALVNRLNASARRQKADIVIKNGKIMDVFNQEWIYEDIAITDGVIVGLGEYEGENII
DAEGQMIVPGFIDGHVHIESSMVTPVEFAKAVLPHGVTTVVTDPHEIANVSGEKGIAFMI
EQARQTPLNIHFMLPSSVPAASFERSGAVLKAADLKPFYEEEEVLGLAEVMDYVSVQQAE
EDMVQKLLDARVAGKRIDGHLAGLSTDLINIYRTAFVLNDHEVTTKEEALDRIRRGMYVM
MREGSVAKNTLKVLPAVNEKNARRFFFCTDDKHVDDLLSEGSVNHQVKMSMQAGLDPFLA
YQLGSLNAAECYGLDTKGAIAPGFDADLLFVSDLENVTVSMTMVKGQTVAEDTKAIFPDS
AAAAVPEQALLDSVKLAAPLKKQNFHMPIDSKRKINVIQIIPNQLETRLVHVPAPAASIF
EPDTDLDLLKIAVIERHKGLKEIGLGVVKGFGFKSGAIATTISHDSHNIIAVGTNDTDMA
AAVNKLQEIGGGLTIIKNGEELHSVPLPIAGLLSDQSAEQVNKSLHTLHEKLSLLGFTGG
FNPFLTLSFLALPVIPDIKMTTTGLFDVKSFQHISLQ
>PK3-2_04007 Ktr system potassium uptake protein A
MKKEFAVIGLGRFGGSICKALSEEGVEVMAMDIDEDKVNEYAKIASHAVIGDSTDESVLK
NLGLRNFDHVIVAIGENIQASILTTLILKELGVHTITVKAQNDYHEKVLSKIGADHIVHP
ERDMAKRIAHNIVSNNVLDYLELSEEHSLVEIVANSRLAGNTLLDLDIRAKYGINIVAIK
RGKEVIVSPLATEVIHQEDILIVIGSVTDISRFEKRVLHTK
>PK3-2_04008 Putative gamma-glutamylcyclotransferase YkqA
MSSLLFVYGTLRKHEENHHLLAQSPCINEQARTKGCLFAAKEGPAAVFEDEGYICGEVYE
ADELCIHKLDQFYQGYHKQTVLVETDAGIKKALIYFMNNDECAGFQKISSGDWKEHQMIS
KSQKLIYYFAYGSCMDNARFQKAGVDHYFQDPVGRAVLKGYSTRFTLKREDGSRADMMED
GGTTEGVLYRIPFSALSYLYKREGVESLTYRPAFVDVEAGGKRYTDCLTFLVLQKEAETA
PPQHYQIEIERGAELYLSPGFAEKLKRHMNSLPKG
>PK3-2_04009 Adaptive-response sensory-kinase SasA
MIWDTLHILLNYLSKNGTIKRETQAAGGLMRKYQARIISIILAMIFIMFWDYLFYIIGKN
PINWPVDIVYTAVTIISVWMLAYYIDEKQQLVKKMKDNEWKYKQLSEEKNRIMDNLQEIV
FQTNAKGEITYLNQAWASITGFSISECMGTMYNDYFIKEKHVADHINTQIQNKASSGMFT
AKYVTKSGTIFWGEVHYKLYYGRDDQFTGSLGTMSDITERKEAEDELIEINERLARESQK
LSITSELAAGIAHEVRNPLTSVSGFLQIMKTQYPDRKGYFDIIFSEIKRIDLVLSELLLL
AKPQAVTFKMHQLNEILKQVATLLDTNAILSNIVIEKNFKETDGCMINGDENQLKQVFIN
IIKNGIEAMPKGGVVTISTAKTASHAVISVKDEGNGMPQEKLKLIGKPFYSTKEKGTGLG
LAICLRILKEHDGELKIESEAGKGSVFQVVLPLTSDS
>PK3-2_04010 Putative transition state regulator Abh
MKSIGVVRKVDELGRIVMPIELRRALDIAIKDSIEFFVDGDKIILKKYKPHGVCLMTGEI
TSENKDYGNGKITLSPEGAQLLLEEIQAALKE
>PK3-2_04011 Cell shape-determining protein MreBH
MGENMFQSTEIGIDLGTANILVYSKNKGIILNEPSVVAVDTTTKAVLAIGADAKNMIGKT
PGKIVAVRPMKDGVIADYDMTTDLLKHIMKKAAKSIGMTFRKPNVVVCTPSGSTAVERRA
ISDAVKNCGAKNVHLIEEPVAAAIGADLPVDEPVANVVVDIGGGTTEVAIISFGGVVSCH
SIRIGGDQLDEDIVSFVRKKYNLLIGERTAEQVKMEIGHALIEHVPDAMEIRGRDLVTGL
PKTIMLQSNEIQDAMRESLLHILEAIRATLEDCPPELSGDIVDRGVILTGGGALLNGIKE
WLSEEIVVPVHVAQNPLESVAIGTGRSLEVIDKLQKAVK
>PK3-2_04012 hypothetical protein
MLRDLGRRVAIAAILSGIILGGMSISLANMPHSPAGGTVKLNHP
>PK3-2_04013 Aminopeptidase 2
MDSFSQKLNTYAQLAVEVGVNVQKGQHVVVNASTDVRDFVRLIVKHTYEKGAKNVTVNWQ
DDEVAKLKYELAPFEAFEEYPEWEAKGREELAKKGAAFISVVSSNPDLLKGADSKRIAAF
QKAAGKALHTYRQYIQSDKVSWTVVGAASAGWAQKVFPGRSEEEAIQLLWEEIFKATRVN
EDNPVEAWINHDQNLHEKVDHLNEKHYAALHYQAEGTDLTIKLPKKHVWAGAGSVNESGH
EFMANMPTEEVFTLPQKDGVDGVVSSTKPLSYGGNIIENFTLTFENGRIVDIKAEKGEDI
LKELVETDEGSHYLGEVALVPYDSPISQSNILFYNTLFDENASNHLAIGSAYAFNIEGGK
QMSREELVKEGLNESITHVDFMIGSKDMNIDGITADGKREPIFRNGNWAF
>PK3-2_04014 2-dehydropantoate 2-reductase
MKFLVVGAGGVGGYIGGRLAEQGNDVTFLVRQKRAEQLKETGLVIHSEKGDVSFQPALIT
AGDTGRFDVVIIASKAYSLGQVIDDVKSFIDQESVIVPFLNGYRHYEQLFTVLSKEQVLG
GLCFIESALDNKGEIHHTSASHRFVFGEWNGGRTERITALEEAFSGVKADVIISGHIEKD
IWKKYLFIAAQAGITTLFQRPLGPILETEGGRHTAQTLIAEIGAILRKEGVPADPDLEEE
SFRTMTSMSYHMKSSMLRDMENGQTTEGDHLHGFLLGKAKRLSLAAPILETVYANLQMYE
AEK
>PK3-2_04015 putative ABC transporter ATP-binding protein YbiT
MIAVNNVSLRFADRKLFEDVNIKFTPGNCYGLIGANGAGKSTFLKVLSGEIEPQTGDVHM
SPGERLAVLKQNHFEYEEYEVLKVVIMGHKRLYEVMQEKDAIYMKPDFSDEDGIRAAELE
GEFAELNGWEAESEAAILLKGLGISEDLHTKKMEDLGGSEKVKVLLAQALFGKPDVLLLD
EPTNHLDLQAIQWLEEFLINFENTVIVVSHDRHFLNKVCTHIADLDFNKIQIYVGNYDFW
YESSQLALKLSQEANKKKEEQIKQLQEFVARFSANASKSKQATSRKKLLEKITLDDIKPS
SRRYPYVNFTPEREIGNDVLRVEGLTKTIDGVKVLDNVSFIMNREDKIAFTGRNELAVTT
LFKIISGEMEADSGTFKWGVTTSQAFFPKDNSEYFEGSDLNLVDWLRQYSPHDQSESFLR
GFLGRMLFSGEEVHKKANVLSGGEKVRCMLSKAMLSGANILILDEPTNHLDLESITALNN
GLISFKGAMLFTSHDHQFVQTIANRIIEITPNGIVDKQMSYDEFLENADVQKKLTELYA
>PK3-2_04016 hypothetical protein
MRLLTLTEYCLLIFFTGFYLAVTGFTAKDIGLYIGIALIYIFSHIFSKRLLEKRGKEHKQ
VHLFFSVLAIIGSVFITVLGIALVASFSN
>PK3-2_04017 Signal peptidase I T
MTEEKNTKTEKTAKKKTNTYLEWGKAIVIAVLLALLIRHFLFEPYLVEGSSMYPTLHDGE
RLFVNKTVNYIGELKRGDIVIINGETSKIHYVKRLIGKPGETVQMKDDTLYINGKKVAEP
YLSNNKKEAEKLGVSLTGDFGPVKVPKGKYFVMGDNRLNSMDSRNGLGLIAEDRIVGTSK
FVFFPFNEMRQTK
>PK3-2_04018 PTS system fructose-specific EIIABC component
MKITELLTKHTIKLNIESKEKENVIDEMVTVLDKAGKLNDRQAYKEAILNRESQSSTGIG
EGIAIPHAKTASVINPAIAFGRSKDGVDYESLDGQPAHLVFMIAATEGANNTHLEALSRL
STLLMREEIRKQLLEAESEDAIIDIINQHDKDEDEEEEEEEAAPAPAGKGKILAVTACPT
GIAHTFMAADALKEKAKELGVDIKVETNGSSGIKHKLTAQEIEDAPAIIVAADKQVEMER
FKGKRVLQVPVTAGIRRPQELIEKAMNQDAPVYQGSGGSSASNDEDEARGKSGSGIGNAF
YKHLMSGVSNMLPFVVGGGILVAISFFWGINSSNPDDPTYNTFAAALKFIGGDNALGLIV
AVLAGFIAMSIADRPGFAPGMVGGFMATQANAGFLGGLIAGFLAGYVVILLKKAFTFIPQ
SLDGLKPVLIYPLFGIFITGVLMQFVINTPVAAFMNFLTNWLESLGTGNLVLMGIILGGM
MAIDMGGPLNKAAFTFGIAMIDAGNYAPHAAIMAGGMVPPLGIALATTIFRNKFSQRDRE
AGITCYFMGAAFVTEGAIPFAAADPLRVIPAAVIGAAVAGGLTEFFRVTLPAPHGGVFVA
FITNHPLLYLLSIVIGAVVMAIILGVLKKPVTEK
>PK3-2_04019 Tagatose-6-phosphate kinase
MIYTVTLNPSVDYIVHVEDFTVGGLNRSSYDTKYPGGKGINVSRLLKRHHVPSKALGFVG
GFTGEYIKTFLREENLETAFSEVKEDTRINVKLKTGDETEINGQGPVISDEDFKAFLEQF
QSLQEGDIVVLAGSIPSSLPHDTYEKIAEACKQQNARVVLDISGEALLKATEMKPFLMKP
NHHELGEMFGTTISSVEEAVPYGKKLVEQGAEHVIVSMAGDGALLFTKEAVYFANVPKGK
LVNSVGAGDSVVAGFLAGISKQLPLEEAFRLGVTSGSATAFSEELGTEEFVQQLLPEVKV
TRL
>PK3-2_04020 Lactose phosphotransferase system repressor
MLTPERHQLIIDQIEKHDVVKIQALINLTNASESTIRRDLSTLEERGFLKRVHGGAAKLS
DIRLEPDMLEKSSKNLHDKLKIAEKAASLLEEGDCIYLDAGTTTLHMIDFMDKSKDIVVV
TNGVMHIEALIRKEISFYLLGGYVKHRTGAVIGGASLIAMDQYRFDKSFLGVNGVHTEAG
FTTPDPDEALLKQKAVKQAKHAYVLADPSKFGEISFSAFAGIGDATIITTDAEELTFDNY
QEKTVVKVVKP
>PK3-2_04021 putative ABC transporter permease YknZ
MSLLENIRMALSSVLAHKMRSILTMLGIIIGVGSVIVVVAVGQGGEQMLKQSISGPGNTV
ELYYMPSDEELASNPNAVAESTFTENDIKGLKEIEGIKQVVASTSESMTARYHEEEIDVT
INGINDGYMKVNSLEIESGRTFTDNDFLAGKRAGVISQKMAEELFDKTSPLGEIVWINGQ
PVEIIGVLKKETGLLSFGLNEMYVPFNMMKSSFGTSDFSNVSLQVESADDIKTAGKEAAQ
LVNDNHGTEDSYQVMNMEEIAAGIGKVTAIMTTIIGSIAGISLLVGGIGVMNIMLVSVTE
RTREIGIRKSLGATRGQILTQFLIESVVLTLIGGLIGIGIGYGGASLVSAIAGWPSLISW
QVVCGGVLFSMLIGVIFGMLPANKAAKLDPIEALRYE
>PK3-2_04022 putative ABC transporter ATP-binding protein YknY
MIQLSNVRKSYQIGKETFDVLHSINLGIQQGEYVSIMGPSGSGKSTIMNIIGCLDRPTSG
TYKLDGENISSYKDKELAAVRNRSIGFVFQQFQLLPRLNAKKNVELPMIYSGIGKKERQE
RAEKALEKVGLADRMLHMPNELSGGQKQRVAIARAIVNEPKLILADEPTGALDTKTSAAI
MDQFTALNAEGTTIVLVTHEPEVADCTNRIVMVRDGHIVPASSGQRRVGE
>PK3-2_04023 Putative efflux system component YknX
MKKVWIGIGIAALVALFIGINIYRSAAPTSGSAGQKIQTGSLEENEISSTVMVPGTLKFS
NEQYVFYEADKGTLEDIKVKEGDKVKKGTTLVTYTNEQLSLEKEQNQLTAESNQLQIEQT
QEKIKALDNKEKDLAKQVGKKEAEKQIESERTELQMQEKTAEIELKQTELQRQSLANRVS
DLEVKSEIEGTVISVNQEAASKKSDIQEPVIHIGNPKDLVVSGKLSEYDTLKVKKGQKVT
LTSDVIQDKTWKGTVSAVGLVPDQQESTAAQGTEQAVQYPLQVKIKGSLPEGKPGFKFIM
NIETDKRKANTLPSKAVKKENDQYYVYTVKDGKAKRVDVKIGEVTDDLTEIKEGISQDDQ
VILNPSDQVTDGTEVKA
>PK3-2_04024 Membrane protein YknW
METNVEKNSGTATEKPSLFGVITSPSVQFKRIRERPVVWGPLFIVAAILIVGAVLQSLGT
DYNELLKSTDTQGLTAEQMETVGTITKFGAMAGAIFGGIAALFIAPLIYWLCVKISGGVT
TYKKMLSLGLFVSLISSLGLLINGIVVFTTDANPFYSMTSLAGIIPSEGALASVLNTLEI
FSVWSYVLLAIGLHKTGGISKKAGWISAIVLFGILLAFSFFSGLINSVAGA
>PK3-2_04025 putative ABC transporter ATP-binding protein
MKQSKKQGILERFYYSSDEIIEKPFNWAQMWRLLSYVKPYRKTILPLSFLTVLIGTAVKL
VIPILIGVYVLDQAITARNSELLIQLILIISGLYILNYAANVLRIRWMNQLGQHVIYDLR
HHLFTHVQRLSHRFFDQRSAGSILVRIMNDINSLQELFTSGVINLLTDLLLLAGVIIILF
TLSPELTIAIMVTLPIMFFISTSLRKKIRRSWQTVRLKQSKLNSHLNESIQGIRVTQAFT
QEEENMAYFDGVNQENYQSWREATRKNAMFRPLVEMTNAIGTAVLIWYGATLIMNETITI
GVFVSFAFYLGMFWEPISRLGQVYNQLLMGMASSERIFEFLDEQPNVKEKPDAIHKKKIN
GEISFEEVEFSYDEKRKALHAVSFSIPAGSTLALVGHTGSGKTTIANLISRFYDATGGTI
KIDGVPIQDLSLASLRSQISIVLQDTFIFSGTIMGNIRFGRPDASDEEVMKAAQAVGADE
FISGLAEGYQTEVEERGSVLSAGQRQLISFARALLADPAIIILDEATASIDTETEVKIQR
ALKTLLKGRTAVMIAHRLSTIRDADRIIVLDHGKKMEEGNHEQLLAKGGIYAGLVKAQYS
TAIE
>PK3-2_04026 Putative multidrug export ATP-binding/permease protein
MFYWPYRKVFMWSLLAMLLMTAITVVYPIILQITIDEIVLGRQYQLAAWVSLGFIAVMTL
KGTATFFHQYLGDMFGIKSVYRLRNGLYEKLQRLSFSYYDNAKTGDLMSRLTADVEGLRF
FLSYGLAELIRFGLLVAISLSVMFYYSVPLTLVTIAVLPFLAVAVYQFDKRVHPAFRGIR
KSFAKLNTKVQENISGINTVKSLSREDFQISTFNKANAEYRSQYLQTSSIWSAYFPLMEF
IGNICIVALLSYGGYLVMQNQLNPGELVAFFSLVNYMMWPIMNLGFVINMFSQAKASGER
LLEILEKEEEITDHADALHKQKLIGSVHFKNVSLAYGKEQTNALCNVSFEANSGKVIGLL
GPTGSGKSSVTQLLTRFYSPVGGMITIDQKPITDYSLKTLRSNIGVVLQESFLFSSTIQS
NISYGRPDASMKDIIEAAKRAQAHDFIMELPDGYNTMLGERGMGLSGGQKQRIAIARAIC
LNPGILILDDATSAVDMQTEHSIQLALKEVMKNRTTFIIAHRISSLKHADEILVFDKGRI
CERGTHPELLEKGGYYKKIYDLQYRDVKMINEPHQVG
>PK3-2_04027 hypothetical protein
MIKILLFAGLAEQAGTQALEIDMQQATTDEIKARLKEQYGLESIDTAMIAVNESYVKENT
SVSSGDTVAIIPPVSGG
>PK3-2_04028 Molybdopterin synthase catalytic subunit
MERFEITKTPIITEDIIKKVEKRAAGAITTFIGTVREWTNGKRTVRLEYEAYEPMAVQML
AQIGTEIEEKWEGASAAITHRIGVLDIGEAAVVIAVSSPHRKAAYEANEYAIERIKQIVP
IWKKEIWEDGEQWIGDQLETTAYPNGKPDLSEGEQHD
>PK3-2_04029 hypothetical protein
MALVRPFPIVQVVGFQNSGKTTFIERILEKTSEQGLNLGCLKHHGHGGEPQTFTEGKDTD
RYQAAGAGVTAVEGAGVLQLTARRNWDLPRLIELYRFLETDCLLIEGFKKAPYPKVVILR
KKEDLEALQAVNTIAIIYRKKEHMTEHEGLPVFHADDPAAVDFVFSQLKGESA
>PK3-2_04030 Molybdopterin molybdenumtransferase
MLEKRTPIPVDEAVRRVSHFQKQGETEWVALEESLHRFLAEDVTADHHVPAFDRSPYDGF
AVRACDTDEASRENPVRFEVVDHIGAGAISEKELGPFQAVRIMTGAQIPEGADAVVMIEL
TQTFEENEKAFMSLKRRFQPGDNISKTGEDAQKGIVLLRKGTRVTPGVTALLATFGYASV
PVVRKPVVGIIATGTELLNVSDPLEPGKIRNSNASMVYAQVIEAGASPLYLGKISDDLDK
SFAAVKEAMKKVDFLITTGGVSVGDFDFLPAIYEKLGADVLFNKVAMRPGSVTTVAHAND
MLLFGLSGNPSACYVGFELFVKPMIQTWLLNEKPHSICAEAVLTKDFPKPNPFTRFVRAF
VYHQEGKLLAEPVGLDKSSSVTSLAEANAFIILPGGTRGYESGRTVHVLLIREENGSDWP
WSDLSRSSKL
>PK3-2_04031 hypothetical protein
MEERYSRQIRFKQIGEEGQKKLADSHVLVVGAGALGTAGAEGLARAGVGTITIIDRDYVE
WSNLQRQQLYTESDAKLRMPKAMAAKEHLLRINSGIHIEAHVTEGTAETLEPLIEKADVV
IDATDNFETRMLINDLAQKTKTPWVYGACVSSQGMYMTIIPGETPCLSCLFEQIPVGGAT
CDTAGIIPPAVHIVSAYQQAEALKLLTGQKEAIQRGFVTFDVWNNSHMNINVNHVRREDC
PSCGAHAVYPYLQDWNTPKAAVLCGRDTVQVRSESLKRIPKQELFNRLKTIGRVEANAFL
LHIFYEDFRIVIFNDGRALVHGTNDVKEANSVLARVIGL
>PK3-2_04032 putative molybdenum cofactor guanylyltransferase
MEHINVLLAGGASRRFGEPKAFVKWKGQMFYEWAKKALGEHTVIISRPEFIDRFQENGEN
KVYQDAEPFQGMGPLAGIYTAFKKTDGELYTVLSCDTPLIQRRTMLELERLMTAGTDAVV
PISEGREQPLIAMYHKRIMPILYDQLSKKRLRISNLLDRISVCYVQAEEIGADQAEFINI
NTRDDFRYLEEKTHSFRRD
>PK3-2_04033 Sporulation protein cse15
MKRSGPFFHDVSQENLYLKSELSRCHKLIAELEASYFHQKNNKLLKENNDMKEKLQQLSA
ELTNMSTKEKHASHTSHTLHQIRAELLDKIVALQELLSAETYKRKAEIQEKHKLHIAKIK
IEEENKHLHQRISHLQASIEQEQNALLQAKQQTELIKAENGRLKEQMVEKEYQLKHIKIE
VDHMKDRIIETKERLLEIEKTKEKLFHETIISYKRQLDESDAWIASHFADIDGGTKQKEK
TEEKTPAVYTQPNHVETILEDVTKQIHALQKQLARAQSSDQAMSHTIEELKSRAAEEKPY
QKWVYKLNLEKENKPSQKKPQ
>PK3-2_04034 Repressor Rok
MFNEREALRLRLEQLNEAEVKVIREYQIERDKIYAKLRELDRNGSPSDIKKDFRSEKKPD
SLPVLAELAAQEIRSYQPQSQQQSVQPQLQTISSLPAGIPDGTTRRRRGTARPGSKAAKL
REAAIKTLKRHNAAIKSSELQKEIEKESGLEIPNMTTFMQSLIKMYPEVKKPYRGQYILE
GEIESAESAESANE
>PK3-2_04035 Thiol-disulfide oxidoreductase YkuV
MKLRQPMPELTGETAWFNGEVTREQLIGEKPTLIHFWSISCHLCKEAMPQVNEFRDKYQD
KLNVVAVHMPRSEDDLDLGKIKEIAAEHDITQPIFVDNDHALTDAFENEYVPAYYVFDQT
GQLRHFQAGGSGMKMLEKRVNRVLGETEQASE
>PK3-2_04036 Alkyl hydroperoxide reductase C
MAERMVGKQAPRFEMEAVLASKEFGKVSLEENMKSDKWTVLFFYPMDFTFVCPTEITAMS
DRYDEFEDLDAEVIGVSTDTIHTHLAWINTDRKENGLGQLKYPLAADTNHEVSREYGVLI
EEEGVALRGLFIINPEGELQYQTVFHNNIGRDVDETLRVLQALQTGGLCPANWKPGQKTL
>PK3-2_04037 putative MscS family protein YkuT
MDFIKQYDWAGLITNAGVLLIKLIIMILLYFIIRSLGMKIIKHLFAKFEEQNSLSIGRAH
TLRSLTLNIFAYILIFIFFVMILDLFHYDPSALLAGAGIVGLAVGFGAQGLVSDIVTGFF
ILLEKQLDVGDYITVSTFDGIVEQVGLRTTQIRSFDGTLHYIPNRNITNVSNHSRGTMQA
LVDIKVPAERNIDEMIHILQQVCDETAAALPQIKEGPNVIGIQELGTSEIVIRVIAKTEN
MEQWRVERVLRKEIKTALDRAFPKETE
>PK3-2_04038 hypothetical protein
MAKKIGIEQSLSDVEAALKEKGYDVVMMKSPSDAKGCDCCVVTGLDNNVQGVADTVTQAP
VITASGMTAEEICSEVESRIQ
>PK3-2_04039 N-acetyldiaminopimelate deacetylase
MKKEELIAIRRDLHRIPELGFQEFKTQQYLLNVLEQYPQDRIEIEKWRTGLFVKVNGTEP
EKMLAYRADIDALSIEEQTGLPFASEHHGNMHACGHDLHMTIALGIIDHFVHHPVKHDLL
FLFQPAEEGPGGAEPMLESDVLKKWQPDLITALHIAPELPVGTISTKSGLLFANTSELVI
DLEGKGGHAAYPHLAEDMVVAASTLVTQLQTIISRNTDPLDSAVITVGTITGGSAQNIIA
ETAHLEGTIRTLSEESMKKVKERIEDIVKGIEIGFRCKGKVTYPSVYHQVYNTSGLTEEF
MSFVAEHQLATVIEAKEAMTGEDFGYMLKKYPGFMFWLGADSEHGLHHAKLNPDENAIET
AVNVMTGYFSVYAN
>PK3-2_04040 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase
MKMMDANEIISFIQNSTKSTPVKVYVKGELEGINFGESAKAFINGNSGVVFGEWSEIQTA
IEENQSKIEDYVVENDRRNSAIPMLDLKNIKARIEPGAIIRDQVEIGDNAVIMMGASINI
GSVIGEGTMIDMNVVLGGRATVGKNCHIGAGSVLAGVIEPPSAKPVVIEDDVVIGANAVV
LEGVTVGKGAVVAAGAIVVNDVEPYTVVAGTPAKKIKDIDEKTKGKTEIKQELRQL
>PK3-2_04041 Flavodoxin
MGKILLVYATMSGNTEAMADLIEKGLQEAEAEADRFEAMDIDDAQLFNEYDHIIMGTYTW
GDGDLPDEFLDLAEDMDEIDFSGKTCAVFGSGDTAYEFFCGAVDTLETKIKERGGDIVLP
SVKIENNPEGEEEEELMEFGRQFAKKSGCAV
>PK3-2_04042 hypothetical protein
MFHKGATAVTASAFSGYFVAVQREGIFHYSLEQGWRKLFRLKSKIHCISYIGPYLFGVGE
KGTVIRSSDEGKTWTMSSFPTNATVWAITGRNDGFVCAHGKHCIYVSDDFGVSWRVVKPF
AEFDHPPVIRSLCLHGGSLFIGTQIHEYFGGIWAYDFTRDTVRIVKKEESRMTASMLVFN
ENWLVAAMGSVKGKHGAVTVRNILTHEEFTIQSSMIRKEESFLDISEDDGIIYVTTTQDE
NGYSRIYQADLEARALKWFDTIKGHGWRVANQKENFFCAGLYECKFVQPYEVSAMIH
>PK3-2_04043 Flavodoxin
MAKALITYASMSGNTEDIAVIIRDTLQENELDIDCLEIDDVDVTALTSYDYVLIGTYTWG
DGDLPYEAEDFFEEVKQLQLNGLKTACFGSGDYSYPKFCEAVNLFSSMLQEAGAAVYQET
LKIELAPETDEDVESCRAFAKGFLAWADYMNKEKSHVS
>PK3-2_04044 HTH-type transcriptional regulator CysB
MQLQELHMLVVLAEELNMRKAADRLFVSQPALSQRLQTIEKAWGTKIFLRSQKGLTVTPA
GEKIIQFANDATLEQERIRENIDELEGEIHGTLKLAVASIIGQHWLPKVLKTYVEKYPNA
KVSLITGWSSEMLKSLYEDQVHIGIIRGNPEWKGRKDYLMTDHLYLVDTEISCIEDIAHT
ERPFIQFKSDSTYFQEIQHWWHQKFKTSPKQTILVDQIETCKQMALHGIGYAILPSVTLQ
NEDKVNKMPLLDTKEHPIGRDTWLLGYEPAFELKQVQAFVQVIKDMLDQENPF
>PK3-2_04045 CBS domain-containing protein YkuL
MISLQSDQLLEATVGQFMIEADKVAHVQVGNNLEHALLVLTKTGYTAIPVLDPSYRLHGL
IGTNMIMNSIFGLERIEFEKLDQITVQEVMLTDIPRLHINDPIMKGFGMVINNGFVCVEN
DEQVFEGIFTRRVVLKELNKHIRSLNK
>PK3-2_04046 putative protein YkzF
MSLIGERFTEEEQKLLLNILINHEYAIELLSSEINDIETGTKNVDGTTYKKLVTLYDRFR
FEN
>PK3-2_04047 hypothetical protein
MADSFLFYNLSEAQMTFQDVMERLKTFVRKDPRSSYVLSIGTDSQVYRDYTKFITALHLH
RTGKGAWGCLKNHTVDRPIHSLREKISLETAYSQETAAHILDGHLMDITDLLLPFTGEGA
DLTFEVHLDIGKKGLTKDLIQEMTGRITSMGIEAKIKPHSYTAFSYANRFTK
>PK3-2_04048 putative protein YkuJ
MSQLMGIITRLQSLQETAEAANEPMQRYFEVNGEKICSVKYFEKNQTFELTVFQKGEKPN
TYPFDNIDMVSIEIFELLQ
>PK3-2_04050 putative EAL-domain containing protein YkuI
MLDPLDILTNIDDVLPYYQAIFSAEEQKIVGYEVLGRILADSEIQSLGPFFLDAGIPEEY
KLEVDNRIIRQALDRFLEADSDLLIFMNQDANLLMLDHGESFLELLKEYEAKGIELHRFV
LEITEHNFDGDIEQLYHMLAYYRTYGIKIAVDNIGKESSNLDRIALLSPDLLKIDLQALK
VSQPSPSYEHVLYSISLLARKIGAALLYEDIEANFQLQYAWRNGGRYFQGYYLVSPSETF
LERDVLKHRLKTEFHQFITHEKKKLETVYEHSEQFYKRVHQAVTSLRKNSLSSDDDFIKK
LAEELTDCSFRIYMCDEEGDQLTGNVFKQDGEWIYQPEYAEKNWSWRPYFLENIMRMRNL
RKGFFSDLYSDLETGEMIRTFSYPMEDQMYLFIDLPYSYLYEQDGLI
>PK3-2_04051 putative 2,4-dienoyl-CoA reductase
MDKKAVIITGGSSGMGKAMAKKQAESGWYVMVTGRNQDALQETKREIETFEGQVACFQMD
VRSDSAASDMITETIKAFGRLDALINNAAGNFICPAERLTPNGWKAVIEIVLNGTFFCSQ
AAAKHWIEQEQKGVILNMAATYAWGAGAGVVHSAAAKAGVLSLTRTLAVEWGSQYGIRTN
AIAPGPIERTGGAEKLFESEKAKARTMNSVPLGRLGTPEEIAALAAFLLSDEASYINGDC
ITMDGGQWLNPYPF
>PK3-2_04052 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MKKMSRRQFLKGTFGALAAGALATGGGYGYARYLEPHMIETTEHTIKSSLIPHGFDGFKI
VQFSDTHLSDYFTLEDLKTVILTINEFTPDLIVFTGDIIDDPDTYQDHQAVIPLLRKLNA
PFGKLCVYGNHDHGGYGTAVYKSLMTAGGFTVYRNGYQRLSLADGSEIEIASLDDLMLGK
PDYEGTLSRLSDRLFSILLVHEPDAALKTTGYPVNLQLSGHTHGGQIQLPFYGPIITPPY
GKVYTEGMYQAGSTHIYVNRGLGMTRLPLRFLAKPEITVFTLKSTN
>PK3-2_04053 Putative L,D-transpeptidase YkuD
MGSSSILICKKERMRKLLTYQVKQGDTLSSIAADFRISTAALLQANPSLQAGITVGQRIV
ITGLPDPNTIPYHIAVSIGAKTLTLFQNNRVIKTYPIAVGKILTQTPTGEFYIINRQRNP
GGPFGAYWLSLSKQHYGIHGTNNPSSIGKAVSKGCIRMHNKDVTELASIVPNGTRVTINR
>PK3-2_04054 hypothetical protein
MDIFKNRNFVRLFFAALASQMGTTVGNMAFAFFLLDRFSSQPSYTTLAELMYSLPTIFVF
LIVGVVADRFDRKKVAENCDWIRAGLTVVLFFTLFTGNIPLVFCILFIRSAVTKFFFPAE
NSLVQAILPKEHYAKAAGLNQMLFSIFMVFGVGIGAFMYNTIGIEGAIILDFVSFIISGL
LIRSCRIPKEARQPNGAFSWRTASVKDSINDFREGILYILKNKLLASLIFGFFIFGFVNG
GFAVLPMFTMKYGLAPDRYEWHTSVFTIALGFGLLAGSVIGTVISKKVKPHFLMSIPIFI
AGMLIFVLGYTNVLWVYYAAAFTLGMCIGPINIAIGGWMPKIVHPKLMGRVSGLQDPFMM
FAQSLTLGLVALLFPKFVSNIDYLYYGMGVIILLVFIFYVVALPKYSAQAAEVNVQEAFQ
ELPKKKAKSI
>PK3-2_04055 hypothetical protein
MDDHAYTKDLQPTVENLSKAVYTVNRHAKTAPNPKYLYLLKKRALQKLVKEGKGKKIGLH
FSKNPRFSQQQSDVLISIGDYYFHMPPAKEDFEHLPHLGTLNQSYRNPKAQMSLTKAKHL
LQEYVGMKEKPLVPNRQQPAYHKPVFKKLGESYF
>PK3-2_04056 Chemotaxis protein CheV
MSLQQYEILLDSGTNELEIVKFGVGDNAFGINVMKVREIIQPVEVTSVPHSHQHVEGMIK
LRGEILPVISLFSFFGVEPDGSKDEKYIVTEFNKRKIVFHVGSVSQIHRVSWEAIEKPTS
LNQGMERHLTGIIKLEDVMIFLPDYEKIIYDIESDSGVDTYNMHTEGFDERRTDKKLIIV
EDSPLLMRLLQDELKEAGYNNISSFENGKEAYEYIMNLAENETDLSEQIDMIITDIEMPK
MDGHRLTKLLKENPKSSDVPVMIFSSLITDDLRHRGEVVGADEQISKPEISDLIKKVDTY
VIE
>PK3-2_04057 hypothetical protein
MGTLVIFKENEMTVLEDISEETYLHMKKESADLQEEHPPYMIWHEDLHFDYGY
>PK3-2_04058 putative N-acetyl-LL-diaminopimelate aminotransferase
MEHLLNPKAREIEISGIRKFSNLVAQHEDVISLTIGQPDFFTPHHVKAAAKKAIDENVTS
YTPNAGYLELRQAVQLYMKKKADFNYDAESEIIITTGASQAIDAAFRTILSPGDEVIMPG
PIYPGYEPIINLCGAKPVIVDTTSHGFKLTARLIEDALTPNTKCVVLPYPSNPTGVTLSE
EELKSIAALLKGRNVFVLSDEIYSELTYDRPHYSIATHLRDQTIVINGLSKSHSMTGWRI
GFLFAPKDIAKHILKVHQYNVSCASSISQKAALEAVTNGFDDALIMREQYKKRLDYVYDR
LVSMGLDVVKPSGAFYIFPSIKSFGMSSFDFSMALLEDAGVALVPGSSFSKYGEGYVRLS
FAYSLDTLKEGLDRLELFVLKKRESMQTINNGV
>PK3-2_04059 Sporulation kinase A
MEQDTQHVKPFQTKTDIHAVLASNGRIIYISANSKLHLGYLQGEMIGSFLKTFLHEEDQF
LVESYFYNEHHLMPCTFRLIKKDHTIVWVEAAVEIVTTRAERTEREIILKMKVLEEETGH
QSLNCEKHEIEPASPESTTYITDDYERLVENLPSPLCISVKGKIVYVNSAMLSMLGAKSK
DSIIGKWSYEFIEEEYHDIVKNRIIRMQKGMEVGMIEQTWKRLDGTPVHLEVKASPTVYK
NQQAELLLLIDISSRKKFQTILQKSRERYQLLIQNSIDTIAVIHNGKWVFMNESGISLFE
AATYEDLIGKNIYDQLHPCDHEDVKERIQNIAEQKTESEIVKQSWFTFQNRVIYTEMVCI
PTTFFGEAAVQVILRDISERKQTEELMLKSEKLSIAGQLAAGIAHEIRNPLTAIKGFLQL
MKPTMEGNDHYFDIVFSELSRIELILSELLMLAKPQQNAVKEYLNLKKLIGEVSALLETQ
ANLNGIFIRTSYEKDSIYINGDQNQLKQVFINLIKNAVESMPDGGTVDINITEDEHSVHV
TVKDEGEGIPEKVLNRIGEPFLTTKEKGTGLGLMVTFNIIENHQGVIHVDSHPKKGTAFK
ISFPKK
>PK3-2_04060 Penicillin-binding protein H
MTEIGREPKKKRKGNRAIRMNLFFLAVFVLFTALIFKLGVVQIVEGEQHEEDAEKVNAKT
AYYPAPRGKMYDRNQKVAVDNQSVPEIVYVSTSSTKTEDKIKTAKRLAALIHIDTEFLKE
RDLRDYWIASHPKKAVALLKDSESNLKGAQAYKLQIERVPDQELKAIQQDDEEMEIAAIY
TRFSSGNAYEPQIVKAMNPNKSNSNGKNGTLLDEKKSSKQRPKNDLTYDEISIVSEHLEE
LPGIDIVNDWTRKYPYDKTLYSVFGGVTTPDQGLLSDRKDFYLTRGYANNDRVGKSYLEY
QYEDYLNSHKEKVEYIEDNKGNVVSQKTIDKGSRGYDLRLSFDMELQAEVEKIIEEEVRN
SRARGNYMLDRAFVVMMDPNNGDILSMAGKKIDLETNKIQDYAIGAFTTQYEMGSAVKGA
TVLAGYQDGIPHYKYYVDMPLYLAGYGNRPKKSYMNMGTINELTALQKSSNVYMFNVAMH
IAGVTYKPHGPLPADQKDLNKMRNYYSQFGLGVKTGIDLPQESAGMQTTPDAVGGLILDL
AIGQYDTYTPLQMAQYISSIANGGYRVQPRIVTSIHEPGNKEGLGKTIEQRKPNILNKIN
NTESDIQQVKTGMKLVTTSGTAKNTFTEDVSGKTGTAETFYYGTNRNWWGKKTYNLTFVG
YYPSKNPKVAFSVVVPSVDDDDKINKIIAKRAIHAFAELEKKHSKK
>PK3-2_04061 hypothetical protein
MKKSFILSAAAAVGFITFGGVQQASAKELSCQPVVTVKTGNTVQNMSLNDVVKKLHIKTN
IKTLKAANEKDLEKLLQKYAKQSNMNIQDVQKTETAKPAQKTTEKAAAEKNTASKAPATE
QNTASKAPAAAEKTNTTTSAPSSVSAYEKKVVELTNAERQKQGLKPLQIDETLSKSARAK
SQDMKDKNYFDHQSPTYGSPFDMMKSFGISYKTAGENIAKGQKTPEEVVKAWMNSEGHRK
NILNPNFTHIGVGYVESGSIWTQQFIGK
>PK3-2_04062 2-hydroxy-3-oxopropionate reductase
MKKTIGFIGLGVMGKSMASHILNDGHPVLVYTRTKEKADSILQKGAVWKETVKDLSKEAD
VIITMVGYPSDVEEVYFGSSGIIENAKEGAYLIDMTTSKPSLAKKIAEAAKENALFALDA
PVSGGDIGAQNGTLAIMVGGEKEAFEACLPIFSLMGENIQYQGPAGSGQHTKMCNQIAIA
AGMIGVAEAMAYAQKSGLQPENVLKSITTGAAGSWSLSNLAPRMLQGNFEPGFYVKHFIK
DMGIALEEAELMGEEMPGLSLAKSLYDKLAAQGEENSGTQSIYKLWVK
>PK3-2_04063 Methyl-accepting chemotaxis protein McpC
MFKKLHMKIAVFVSIMLIVTVVLLMLSSYLTLKPMITEDGKNTTQNVTQSLEQNIELQLK
SYATSLSRLANGELAHTFVTKPSKEASRLFNDDIKQIKDSDDYVAMAYIGTAKKEMFTYP
KADFADDYDPASRPWYKAAAETPNQVVWTEPYKDVVTGDMIVTASKAILDGQKVIGVASY
DLKLSAIQSMVNKQKVPYNGFAFLADASGNLLAHPSNQGKNISKDQTLKAIVSEKKGIQD
ENGEMVVYQTIGETGWKVGTQFDTDKLMWISDKMNRANLWISLIALIITMILSYFLAKTI
TGPIQQLIVKTKAVSAGDLTVHAESKSKDEVGILTRDFNQMVENMKEMVEQVRLSSGKVS
DTSEQLTAVSAETNETSGQIAKAIEEVAAGASEQASEVETINEKSENLSTKIRQIAQEAG
GMKERSKSSEDASYKGLDALGQLLMKSNEANTETKKVETMLIDLENQTKNIEEVVTAISN
ISDQTNLLALNASIEAARAGESGRGFAVVADEVRKLAEQSALSTKHISETVKLIQLETKE
ASHAMVEASRMNDEQNSAIHETGEVLNTITAEMQTLVQGIDHIYEEIQRMSEEQLAISEA
IQSISAISQESAAAAEEVNASTDEQLITLDKVKHSTDTLKHASQELMNTITKFTL
>PK3-2_04064 hypothetical protein
MIILKQVYVHNGKKFEPLTIRNYTETDIKGLISLQRECFPSPFPQELLWSEEQLDSHINT
FPEGALCALVNGKIVGSMTALIVHFEPESPDHTWAQATDNGSIKNHDPHGNTLYVVDISV
SPHYRKLGIGKWLMNTMYELTVDKRLARLLGGGRIPFYHQYAHEISAVLYVEDVMEGKKK
DPVLSFLLHCGRSPIRVVSNYVEDKESLNFGVLMEWKNPFYKKASCSSQQPV
>PK3-2_04065 Spore photoproduct lyase
MQNPFVPQLVYIEPRALEYPLGQELQDKFEKMGIEIRETTSHNQVRNIPGKNHLQQYRNA
KSTLVIGVRKTLKFDSSKPSAEYAIPFATGCMGHCHYCYLQTTMGSKPYIRTYVNVEEIL
DQADKYMKERAPEFTRFEASCTSDIVGIDHLTHTLKRAIEHFGQSELGKLRFVTKFHHVD
HLLDAKHNGKTRFRFSINADYVIKNFEPGTSPLDKRIEAAVKVAKAGYPLGFIVAPIYIH
EGWEEGYRHLFEKLDAALPQDVRHDITFELIQHRFTKPAKRVIEKNYPKSKLELDEEKRR
YKWGRYGIGKYIYQKDEEHALREALESYIDTYFPNAKIEYFT
>PK3-2_04066 hypothetical protein
MSNQFNAGDTVYVIYRNPHAANVAHIKEAEIVHHPYHEGELSLFIYETYHPFAEDDAVFA
SYEEAKSLYKELFDINPYE
>PK3-2_04067 Phosphoenolpyruvate-protein phosphotransferase
MQELKGIGASAGIAIAKAYRLEEPDLTVEKKNISDSEAEVSRFDEAIARSKEELEKIKEH
ALKELGQDKADIFSAHLLVLSDPELLNPVKEKISTDSVNAEFALKETSSMFVTMFESMDN
EYMKERAADIRDVTKRVTGHLLGVEIPNPSMISEEVIIVAEDLTPSDTAQLNREFVKGFT
TDIGGRTSHSAIMARSLEIPAVVGTKAATGTIQNGVTVIVDGINGDVIIDPSAETVKEYE
EKHNAYLAQKAEWAKLVNEPTVSKDGHHVELAANIGTPDDVKGVLENGGEAVGLYRTEFL
YMGRDQLPTEDEQFDAYKTVLERMEGKSVVVRTLDIGGDKELPYLQLPKEMNPFLGYRAI
RLCLEEQEIFRTQLRALLRASTYGNLKIMFPMIATVNEFKEAKAILLEEKEKLVKAGQAV
SDDIEVGMMVEIPSTAVIADQFAKEVDFFSIGTNDLIQYTMAADRMNERVSYLYQPYNPA
ILRLITLVIEAAHKEGKWVGMCGEMAGDEIAIPILLGLGLDEFSMSATSILPARTQISKL
SKQQAESFKEKILSMSTTEEVVAFVKETFK
>PK3-2_04068 Phosphocarrier protein HPr
MAQKTFKVTADSGIHARPATVLVQTASKYDADVNLEYNGKTVNLKSIMGVMSLGIAKGAE
ITISATGADENDALNALEETMKSEGLGE
>PK3-2_04069 PTS system glucose-specific EIICBA component
MFKALFGVLQKIGRALMLPVAILPAAGILLAIGNAMQNKDMIQVLHFLSNDNVQLVASVM
ESAGQIVFDNLPLLFAVGVAIGLANGDGVAGIAAIIGYLVMNVSMSAVLLANGTIPSDSI
ERAKFFTENHPAYVNMLGIPTLATGVFGGIIVGVLAALLFNKFYTIELPQYLGFFAGKRF
VPIVTSISALILGLIMLVIWPPIQHGLNAFSTGLVEANPTLAAFIFGVIERSLIPFGLHH
IFYSPFWYEFFSYKSAAGEIIRGDQRIFMAQIKDGVQLTAGTFMTGKYPFMMFGLPAAAL
AIYHEAKPQNKKLVAGIMGSAALTSFLTGITEPLEFSFLFVAPVLFAIHCVFAGLSFMVM
QLLNVKIGMTFSGGLIDYFLFGILPNRTAWWLVIPVGLGIAVIYYFGFRFAIRKFNLKTP
GREDAAAETAAPGKAGEAGDLPYEILQAMGDQENIKHLDACITRLRVTVNDQKKVDKDRL
KQLGASGVLEVGNNIQAIFGPRSDGLKTQMQDIIAGRKPRPEPKTSAQEEVGQQVEEVIA
EPLQNEIGEEVFVSPITGEIHPITDVPDQVFSGKMMGDGFAILPSEGIVVSPVRGKILNV
FPTKHAIGLQSDGGREILIHFGIDTVSLKGEGFTSFVSEGDRVEPGQKLLEVDLDAVKPN
VPSLMTPIVFTNLAEGETVSIQASGSVNREQEDIVKIEK
>PK3-2_04070 PtsGHI operon antiterminator
MNGSFTVKKVLNNNVLIASHHKYSEVVLIGKGIGFGKKQDDVIEDKGYDKMFILKDEKEQ
KQFKKLLDYVDEKLVDISNDVIYHISNRTNHSLNEHIHIALTDHIAFAIKRQQQGFDMKN
PFLMETQSLYPEEYQIATEVIDMINEKAGICLPEGEIGFIALHIHSALTNRPLSEVNQHS
QLMTQLVEVIEDAFQMKVNKESVNYLRLIRHIRFTIERIKTEEPTKEPEKLMLLLKNEYP
LCYNTAWKLIKILQQTLKKPVHEAEAVYLTLHLYRLTNKIS
>PK3-2_04071 HTH-type transcriptional regulator DegA
MANIKDIAEKAGVSVTTVSRVINNHPYVSENKRNRVLEAMEALEYTRNIHAVHLSKGCSN
MIGVVLPTISLPYFAELIAGIADAAAESGIHLSLFQTSYDVQKEIFALSQLKQRQVDGLI
FCSKALADEKLIEWEGPILLCQNSDISRFPTISIPHQQAFRYGLDYLIAKGHKKIAICLA
RKKGMNSHFRIKAYKEALEEIGEVFREDWVIEKAITINDGKALFHKWKKWKEKPTAIFVA
NDQVSAGLLLEARAQLVKVPDELAILSVDNHEISQALDITTIDIQTKEMGKQAFAMLKKR
IQGQSIERKVLDYRLVERSTV
>PK3-2_04072 hypothetical protein
MGFFILIGLCLTVLGGSCLAVKPLNQKHEIKPFRTFDDFFI
>PK3-2_04073 putative peptidase
MNRIQRVSSWLKEAGHTAAFIHTKENVFYLTGFYTEPHERLMGLFIFQEEEPFFVCPGME
AGQARNAGWNHEIIGYADHENPWELVEKALKKRNISIHTLAVEKDSISLSRAEQLKHSVG
GAQFVSAEETLNQFRLIKEDNEIRLLKEAAKLADYGVEVGTAALREGISEVEVLAQIEYE
LKKKGIQGMSFSTMVLFGEKSGQPHGNPGAATLKKGDFVLFDLGVILDGYCSDITRTFAY
KSINPKQEDIYETVLQAEKAAIEASKPGVRIGDLDLTARGIIEKAGYGDYFPHRLGHGLG
ISVHEYPSMSQANDTLLQEGMVYTIEPGIYVPEIGGVRIEDDVHVTKDGAVALTQYPKEL
IILP
>PK3-2_04074 hypothetical protein
MPIKGAEIPKTVKSITAFRLKKFISKTEQLPAIELYYQYTGRGAGNKMDRKMKAP
>PK3-2_04075 Zinc-transporting ATPase
MNEQVIVQRDPHEPLKTDQRENNWIQHAELIAALVSGALILAGWLLSGHQVVSITLYLLA
FVIGGFAKAKEGIEETLESKTLNVELLMIFAAIGSALIGYWAEGAILIFIFSLSGALETY
TMNKSSRDLTSLMQLEPEEATLMVNGETKRVPVADLQAGDMIVIKPGERVAADGVIESGS
TSLDESALTGESMPVEKNTGDAIFTGTVNRNGSLTVRVTKANEDSLFRKIIKLVESAQNS
VSPAQAFIERFENAYVKGVLIAVGLLLFVPHFALGWSWSETFYRAMVFMVVASPCALVAS
IMPAALSLISNGARNGMLVKGSVFLEQLGSVQMIAFDKTGTVTKGQPAVETIRIAEGFSE
TEVLEAVYAIEKQSSHPLAQAITTYAESRGVNQSGYISIEETSGFGVMAEVSGAKWKIGK
AGFIGEQMASQFIKQTASDVIQSGHTIVFVKKDDQIAGCIALKDQIRPEAKEVMEELNRL
GIKTAMLTGDHEDTAQAIAKEAGMTTVAAECLPDQKVNEIKRLKEEFGTIAMVGDGINDA
PALKAADVGIAMGGGTDVALETADMVLMQNDLKKLVNMCRLSRKMNRIIKQNIVFSLAVI
CLLICANFLQVMELPFGVIGHEGSTILVILNGLRLLK
>PK3-2_04076 Sporulation thiol-disulfide oxidoreductase A
MLTKRLLTVCLLLLGMIAWFPDAAAAEEKQPAVPAVFLMKTIEGEDISIPNKGQKTILHF
WTSWCPPCKKELPQFQSFYDAHPSGSVKLVTVNLVNSEQNQQAVEDFIKANKLTFPIVLD
SKGELMKEYHIITIPTSFLLNEKGEIEKTKIGPMTAEQLKEWTEE
>PK3-2_04077 Sporulation protein YkvU
MLISLFVLVVSDVVVLVYLYSQFIIARRAISGQQHIHLRGKDVRKRLLAVSIPTTGLRIF
HAVVNAIEPFLVKGALLAAGVAGTAAIDQYGMLAGVAVTIGSFPAFIAHSLMVVMIPSIS
EAYALSQYDIVLKRLKQSIFITFGYGIPAVWIMFQFAEPLTHLFFHSPEAQYYLQLLWPY
FLFHLFVMPLQACLIGMGFVKEAFYHNVWSHIVALSMMYVLGSMENLQMLGIILGMNTGM
ILLTSLHYATICKALRVSVFLTGGNRTPRIEG
>PK3-2_04078 Sporulation protein YkvU
MNRFVKGIILLSIAAFFAECLEFVVNMILARELGEHGMGLYMSILPTIFLIIVIASLELP
ISISKFIAESNPKLHESMLRHAFRMTAVFTAFSTAAASIALPFIPVFDTYHPFIKGIVIG
LIPVVAFTSIARGYFMGVQKMGKIAIANVMKKIIQLLCLFLFFNGTHLNWTWLC
>PK3-2_04079 putative protein YkvT
MTTKFTALAVFLLCFMPAAKIEHTQASLLSTKKTKHEEAKWLTHIDRDRDESFPSLSADK
DQKKIKPIKLSAHTEKKEKDKPAKATEKKETYTQSEKELLSRLVHAEAKGESYEGKVAVA
SVVLNRTEEKGFPDTIRGVIYQKNAFEPVSNGSINQKPDKESIAAAEEALSSKNRETDAI
FFYNPKTASDDWIRSRKIVEKIGRHVFAI
>PK3-2_04080 hypothetical protein
MLRPEEITELIEQLRTGAINELRVQKEHFLDFRAVLSKQADFKHFRGIAQQGGDVIFQYL
EQPRS
>PK3-2_04081 hypothetical protein
MKIAKVGNVIEFKNGLTGVVEKVNENSVIVDVTIMDNYRDLELDSLTVVNHKNYKIIKDS
Y
>PK3-2_04082 putative protein YkvR
MKTLRLNDVTLEIAAYQEEREPKRKISFTLNVTSETYHDIAVLLYEKTFNVEVPERNLAF
RGEITNYSTSLTNLYEPGSVSEFYIEITEIEQNADL
>PK3-2_04083 hypothetical protein
MVIKINKKLDYFSSFDPTKESKPISLGNLCKDIEEGRLTLPIFQTGIRWKVEKSIELLNF
QLTGKAAVAPISINVIENKNIAVPQVKFISRDLVPEEELSGKHSVNDGQQRLSCNYKAYT
DDEEFRNVVLDIATGKFLLNSGTMRKSQIPVGKLYNKDPKVFEEFVRNNPEMQVFEVQSL
LTRIRNKFLAYYYTVNYAKDLSEEEQREWFEVLNLAGSKVTETEVHLTEMLVKGVDYYRD
YAEKFGDKLKESGLDGLFVQKATEISVPLAALNPAYEIIKQKPHSANFSPMPSDVKASLI
SKLKAEELRTIFSWTLEALDKALIFIESKGLFEAKRIDYLTYLLGAFVVLGNAELNPAQE
DFLVDWYENVEFAKKDNGVRRKIFDDLIAVVKL
>PK3-2_04084 NADPH-dependent 7-cyano-7-deazaguanine reductase
MTTRKESELEGVTLLGNQGTNYLFEYAPDVLESFPNKHVNRDYFVKFNCPEFTSLCPKTG
QPDFATIYISYIPDEKMVESKSLKLYLFSFRNHGDFHEDCMNIIMNDLIELMDPRYIEVW
GKFTPRGGISIDPYTNYGKPGTKYEKMAEYRMMNHDLYPETVDNR
>PK3-2_04085 7-carboxy-7-deazaguanine synthase
MAKGIPVLEIFGPTIQGEGMVIGQKTMFVRTAGCDYSCSWCDSAFTWDGSAKKDIRWMTA
EEILTELKAIGGDAFSHVTISGGNPALLKQLDAFIELLKENNIRAALETQGTVYQDWFTL
IDDLTISPKPPSSKMVTNFQKLDHILTSLKENNRQHAVSLKVVIFNDEDLEFAKTVHKRY
PGIPFYLQVGNDDVHTTDDQTLIAHLLGKYEALVDKVAADAELNLVRVLPQLHTLLWGNK
RGV
>PK3-2_04086 6-carboxy-5,6,7,8-tetrahydropterin synthase
MLSQIYPQAQHPYSFELNKDMHISAAHFIPRESAGACSRVHGHTYTVNITVAGDELDDSG
FLVNFSVLKKLVHGNYDHTLLNDHEDFSQDDRYSLPTTEVVAKTIYDNVQAYLDTLENKP
SCVQVFVRETPTSYCVYRPKKGGLNG
>PK3-2_04087 7-cyano-7-deazaguanine synthase
MKKEKAIVVFSGGQDSTTCLLWALKEFEEVETVTFHYNQRHLQEIEVAKSIAEKLGVKNH
LLDMSLLNQLAPNALTRNDIEIEVKDGELPSTFVPGRNLVFLSFASILAYQIGARHIITG
VCETDFSGYPDCRDEFVKSCNVTVNLAMEKPFVIHTPLMWLNKAETWKLADELGALDFVK
NNTLTCYNGIIADGCGECPACHLRSKGYEEYMAMKGERA
>PK3-2_04089 hypothetical protein
MEQSKGSASQLAFVYVGTVVGAGFATGREIVEFFLKFGWFGLLGIIVSGGMFTFLGAKLM
IISKRINAKSYQEMNIFLFGETAGRIINVFMLFILLGVTSVMLSGAGALFEEQLGMSAQI
GMLITIGLSLIVMTRGVKGIFGVNVFVVPLLIIFSMIVVADSFIFSESRNAAQWVWPHRW
DWLLSAFSYGALNLSLAQAVLVPLANEMSSEKVIKKGALIGGAMLTIVLSASFLSLSTLP
DVFLYDIPMAQVVYLFARSVHLIYLLIIFGEVFTSVIGNLYGLEKQVQSFLPMKSKYIFA
AIMIVAYITSQIGYGKLISTIYPLFGYVSLAFIGALICKKVPRRRSL
>PK3-2_04090 ATP-dependent Clp protease ATP-binding subunit ClpE
MRCQHCHKNEATIRLNMQINSVHKHMVLCETCYNELTRKPSMSMGPQSFGFPFEQAFQPK
DQSAAKQSEKKGLLDELAQNITNGAKAGLIDPVIGRDEEVARVIEILNRRNKNNPVLIGE
PGVGKTAIAEGLALKIAEGDVPNKLKNKELYLLDVASLVANTGIRGQFEERMKQLITELK
ERKNVILFIDEIHLLVGAGSAEGSMDAGNILKPALARGELQVIGATTLKEYRQIEKDAAL
ERRFQPVMVQEPSIEQAILILQGIKDKYEAYHGVTFSDEAIRACVTLSSRYIQDRHLPDK
AIDLLDEAGSKANLLIDELNDEDAAERLTAIEAEKTKALEEENYELAAKLRDEEIALEKK
LNSSSAHSDVTVEAEHIQEIVEHKTGIPVGKLQADEQTKMKELEAKLHERVIGQEAAVQK
VAKAVRRSRAGLKSKNRPVGSFLFVGPTGVGKTELSKTLADELFGTKDAIIRLDMSEYME
KHAVSKIIGSPPGYVGHEEAGQLTEKVRRNPYSIVLLDEIEKAHPDVQHMFLQIMEDGRL
TDSQGRTVSFKDTVIIMTSNAGTGEKQTKVGFQSDDSVIEEQTLIDSLSMFFKPEFLNRF
DSIIEFRPLEKEHLVKIVGLLLGELEETLAERGISLSVTDEAKEKIAELGYHPAFGARPL
RRTIQEWVEDEMTDLLLDNSEITSFHVTAEDHTIKVQAK
>PK3-2_04091 Chemotaxis protein PomA
MKTMDKTSLIGIILAFVALSVGMVLKGVSFNALANPAAILIIIAGTISAVVIAFPTKEIK
KVPALFRVLFKENKQLTIEELIPMFSEWAQLARREGLLALEASIEDVDDAFLKNGLSMAV
DGQSAEFIRDIMTEEVEAMEDRHQAGAAIFTQAGTYAPTLGVLGAVIGLIAALSHMDNTD
ELGHAISAAFVATLLGIFTGYVLWHPFANKLKRKSKQEVKLREVMIEGVLSVLEGQAPKV
IEQKLLMYLPAKDRLKFAEQGEAQNGEKKEEEA
>PK3-2_04092 Motility protein B
MARKKKKKHEDEHVDESWLVPYADILTLLLALFIVLYASSSIDAAKFQMLSKSFNEVFTG
GTGVLDYSSVTPPENESDGIDEVKKEKEEKEKNKKEKEKAADQEELENVKSQVEKFIKDK
KLEHQLETKMTSEGLLITIKDSIFFDSGKAMIRKEDVPLAQEISNLLVINPPRNIIISGH
TDNMPIKNSEFQSNWHLSVMRAVNFMGLLIENPKLDAKVFSAKGYGEYKPVASNKTAEGR
SKNRRVEVLILPRGAAETNEK
>PK3-2_04093 HTH-type transcriptional regulator MhqR
MTEKSLKLFIVLSRAYRSINDHMNKHIHKHGLNPTEFAVLELLYHKGDQPLQQIGDKILL
ASGSITYVVDKLEQKELLIRKASPTDRRVTFAQITEKGIGLLNDIFPDHAAEIDEMISVL
SEEEVEMCTEMLKRVGLNAKQFHNK
>PK3-2_04094 Sporulation kinase D
MKILKGACGRVKLYIILVVIPAIVISFFVYEKEKDTIAAEHKQEASVLLNLHRNKINYLI
GETKARMTSLSIAIDRPVDIKKMQSILEKTFDSEPRFSGLYFLNAKGDVTASTTELKTNV
NLADRSFFAKAKETKKTVISDSYSSRITGQPIFTICVPVLDSKRNVTDYLVAAIQIDYLK
NLINLLSPDVYIEVVNQNGKMIFTSGQASHAEDQKPVSGYLDDISWNMKVYPNPVTIEEL
TKSLLLPLSSSIVLLNILFILVLYYLLKRQTQLERSENEAQKLELIGTLAASTAHEIRNP
LTGISGFIQLLQKKYKGEEDQLYFSIIEQEIKRINQIVSEFLVLGKPTAEKWELNSLQDI
IGEIMPIIYSEGNLYNVEVELQYLTEQPLLVKCTKDHIKQVILNVAKNGLESMPEGGKLT
ISIEALDKKAVIKVVDNGEGISQEMLDHIFLPFVTSKEKGTGLGLVVCKRIVLMYGGSIH
IESEVRRGTEVTITLPVSAS
>PK3-2_04095 hypothetical protein
MKELAIFITEMVNQFHDAFISLCGMFGIHLTDKEMHFWVIGVFGIFFFGVTHAVFIWLSK
WSMTALSFIYTVTVIIVIVFAIEIQQKVTGRGNMEFLDATEGLKGFLVFFMFFLLLKLLW
RFIKTLFFGGAASKSNGNARSRR
>PK3-2_04096 Aspartyl-phosphate phosphatase Spo0E
MGGSSEQERLLVSIDEKRKLMIDAARKQGFTGHDTIRHSQELDCLINEYHQLMQENEHSQ
GIQGLVKKLGLWPRRDVMPAYDANK
>PK3-2_04097 hypothetical protein
MKKRKAMMLGAAGGKAILKRKNRKKFIQHVTVFFQMLRDWRNGDYPRSQVKTLLLLTAAI
LYIAMPLDIIPDVILGLGIIDDAAVLGLIWMLIKKEMSQYEKWRLQ
>PK3-2_04098 Acireductone dioxygenase
MATIRIHDEANTTIENQEEVASFLDSQEVIYEQWDIAKLPEQLSEKYDLTEEEKQQILDT
FETEIKDISARRGYKAQDVISLSDSNPKLDELLENFKREHHHTDDEVRFIVSGHGIFVIQ
GKDGTFFDVRLNPGDLISVPENIRHYFTLQEDRKVVAVRIFVTTEGWVPIYEKDSVNQ
>PK3-2_04099 Methylthioribulose-1-phosphate dehydratase
MAAKQERWRELAEVKRELAERDWFPATSGNLSIKVSDEPLTFLVTASGKDKRKETDEDFL
LVDQNGEPAENGHSLKPSAETLLHTHLYNKTNAGCCLHVHTVNNNVISELYGDQRNITFR
GQEIIKALGLWEENAEVTIPIIENPAHIPTLAALFAEEVSEDSGAVLIRNHGITAWGRTA
FEAKRVLEAYEFLFSYHLKLKTLQHQLVQ
>PK3-2_04100 2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase
MTTRKPLIICDFDGTITMNDNIISIMKTFAPPEWTALKDGVLSKTLSIKEGVGRMFGLLP
SSLKEEITKFVLEDAKIRQGFREFVAFVKEHELPFYVVSGGMDFFVYPLLEGIVEKDHIY
CNHASFDNDYIHIDWPHSCKGTCSNQCGCCKPSVIHELSEPNQYIIMIGDSVTDVEAAKL
SDLCFARDYLLNECRERNLNHLPYQDFYEIRKDIENVTEVQEWLQNKNAGESSLK
>PK3-2_04101 2,3-diketo-5-methylthiopentyl-1-phosphate enolase
MSELLATYLLTEPGADTEKKAEQIATGLTVGSWTDLPLLKQEQMQKHKGRVIKVEEREGT
LASGKQAVITIAYPEINFSQDIPALLTTVFGKLSLDGKIKLLDLHFSEAFKRTLPGPKFG
VYGIRKLLGEFERPLLMSIFKGVIGRDLSDIKEQLRQQALGGVDLIKDDEIFFETGLAPF
ETRITEGKQILKETYEQTGHKTLYAVNLTGRTADLKDKARRAAELGADALLFNVFAYGLD
VMQSLAEDPEIHIPIMAHPAVSGAFTSSPFYGFSHALLLGKLNRYCGADFSLFPSPYGSV
ALPREDALAIHEECVREDAFNQTFAVPSAGIHPGMVPLLMRDFGIDHIINAGGGVHGHPN
GAQGGGKAFRAIIDAVLEAQPIDEKAEQCKDLKLALDKWGKVEAV
>PK3-2_04103 Transaminase BacF
MKFEQSHVLKELPKQFFASLVQKVNRKLAEGHDVINLGQGNPDQPTPEHIVEEMKRAVAD
PENHKYSSFRGSYSLKSAAAAFYKREYGIDLDPETEVAVLFGGKAGLVELPQCLLNPGDT
ILVPDPGYPDYWSGVTLAKAKMEMMPLVKDRSFLPDYSSIPAEVRDQAKLMYLNYPNNPT
GAVATSEFFDETVSFAKENGVCVVHDFAYGAVGFDGNKPLSFLQTEGAKNIGIEIYTLSK
TYNMAGWRVGFAVGNASVIEAINLYQDHMFVSLFRATQEAAAAALLADQTCVAEQNARYE
SRRNAWITACREIGWDVTAPAGSFFAWLPVPEGYTSEQFSDLLLEKANVAVAAGNGFGEY
GEGYVRVGLLTSEERLKEAAYRIGKLNLFTQKSIDKIL
>PK3-2_04104 Omega-amidase YafV
MKWTISCLQFDISYGKPSENIKKAEFLIEKESQHADVIVLPELWTTGYDLANLDELADED
GRSAQSWLKKTAKKHGVHIVAGSVAVRKDSDVYNTMYIADKKGQIIKEYRKAHLFQLMDE
HLYLSAGSEDGYFELDGVKSSGLICYDIRFPEWIRKHTTKGANVLFISAEWPLPRLDHWK
SLLIARAIENQCFVAACNCTGSNPDNEFAGHSLIIDPWGRVLAEGGREEGIVRAEIDLQE
SVEVRESIPVFDDIRKDLY
>PK3-2_04106 Methylthioribose kinase
MTVTKTPLYETLNESSAVALAVKLGLFPSKSTLTCQEIGDGNLNYVFHIYDQEHDRALII
KQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVMEDLSHL
KIARKGLIEGESYPYLSQHIGEFLGKTLFYSSDYALEPKVKKQLVKQFTNPELCDITERL
VFTDPFFDHDTNDFEEELRPFVEELWNNDNVKIEAAKLKKSFLTSAETLIHGDLHTGSIF
ASEHETKVIDPEFAFYGPIGFDVGQFIANLFLNALGRDGADREPLYEHVKQAWETFEETF
SATWEKDSLDVYAKIDGYLTDTLSHIFEEAIGFAGCELVRRTVGLAHVADLDTIVPFDKR
INRKRLALETGAAFIEKRSEFKTITDVIELFKLLVKE
>PK3-2_04107 Methylthioribose-1-phosphate isomerase
MTHSFAVPRSVEWKETAITILNQQKLPDVTEYLELTTKEEVFDAIVTLKVRGAPAIGITA
AFGLALAAKDIETDDVTKFRRKLDDIKHYLNSSRPTAINLSWALERLSHSIENAISVNEA
KTNLVHEAIQIQVEDEETCRLIGQNALQLFKKGDRIMTICNAGSIATSRYGTALAPFYLA
KQKDLGLHIYACETRPVLQGSRLTAWELMQGGIDVTLITDSMAAHTMKEKQISAVIVGAD
RIAKNGDTANKIGTYGLAILANAFDIPFFVAAPLSTFDTKVKSGADIPIEERDPEEVRQI
SGVRTAPSDVPVFNPAFDITPHDLISGIITEKGIMTGNYEEEIEQLFRGEKVH
>PK3-2_04108 hypothetical protein
MKPSRSEKIAVFAKLFVKLHIISSAQKDEMITVNKNKRKNR
>PK3-2_04109 Methylated-DNA--protein-cysteine methyltransferase, constitutive
MNYYTTAETPLGDFIIAEEDGQITRLFLSQEDWMDWKETVQTTEHKETPYLAEAKKQLHE
YFAGERKTFSLPLSQKGTPFQQKVWEALAMIPYGESRSYADIAAAVGSPKAVRAVGQANK
RNDLPIFVPCHRVIGKNSALTGYAGSKTDIKAFLLNIEQISYKEK
>PK3-2_04110 Sporulation kinase E
METLGVQDNSELQEELKRLKEENARLKKELNQHQVIVNNTLDAIFICDNEMRIVQANEAT
ERMLQVDAEDLKKRSVLDFLFSIPKDELNLAVKKFLKKGFLWKEVPIRLDGGATKYIEFL
AKRGIGEDFFFVVMRDISSKKILEREFSMNEQLFKDLFDRAVDGIVLFDKDGGFIDANLS
FCKSFEINHNELSHLSLYKFIDSGSRKDLDNIWKTLNRKGKAKGELPVKLRSGVQKLFEF
TITSNIISGFYMSIMRDITEKRSMELQLFKSEERFREIFENAMDAIIIWSNDGRIVKANQ
SACKIFELPMNLLLKRRLCDFLVDSQQKYSLTKRKYAKYGEIREELLFQMGNGQFKELEF
TSKRTILENQHLTILRNVSDRKRMEKELRESELKFRKVFNGSMDGNVLFDNQYRIIDANP
LASNILGLSHEEIKKHSLLDIISSYEIENLASPVRQINFDEMDNEIPFLLSSRDNRKLEF
SFKRNIIQNMNLAIFKDVTERKELEERLRKSDTLHVVGELAAGIAHEIRNPMTALKGFIQ
LLKGSVEGDYALYFNVITSELKRIESIITEFLILAKPQAIMYEEKHVTQIMRDTIDLLNA
QANLSNVQMHLDLIDDIPPIYCEPNQLKQVFINILKNAIEVMPDGGNIFVTISTLDHDHI
LISLKDEGIGMTEDKLKRLGEPFYTTKERGTGLGLMVSYKIIEEHQGEIMVESAEGKGTV
FHLTLPVRQNAEERRIDE
>PK3-2_04111 hypothetical protein
MNKSRDSYFDNAKFLLIFLVVFGHILRSFINDNNFMLYLYKFIYTFHMPAFILVSGYFAK
GFKRPGYVKKLAVKLIIPYLIFQIIYSVFYYIMQDESMANVNPIDPQWSLWFLVSLFFWN
LLLYPFSKLSKLWALFVSCGIAVLIGYLDFVSNTLSLSRTFVFLPMFLVGFYLNKHHFDL
LRSKRGKQIALGVLAAVFVICWGIDFDYSFLFGSKPYSSFGDVTFASGLSRIGWYVLAFA
ATFSFLALVPQKRYFFTKWGTRTFYVYLLHGFIIKTLRQAGLEDGLTDYQSLVILLLLTA
ALTLVLSSNFVKTVAQPFIELRMTSLLQVVRGTGKNAYLK
>PK3-2_04112 hypothetical protein
MKKNRHSRDMQNHKKPMNKKVLEEEFSSEFGDYNAGKIIETLEVTKPDKKKEKKRK
>PK3-2_04113 hypothetical protein
MKRKAEVDEAIKNNNTPTESMDPNSYKTQYHDDPNFRGANRNSKQGQQGGM
>PK3-2_04114 Ktr system potassium uptake protein B
MKFKLGKLIQALSPAQLIALYYFLAVTVAVILLSLPAAHKPGAEWTFIDALFTAVSSVSV
TGLTVVDTADTFSTIGIFILAFVLQFGGIGIMTLGTFIWLIMGKRIGLKERKLIMVDQNQ
SQFSGIVNLMKQVLFLILWIEFFGGLILGTYFLTYYDSFQEAYLHGFFASISATTNGGFD
ITGRSMIPFRHDYFVQFITMLLIVFGAIGFPVLVEVKDFLFSKHRRYPFTLFTKITTITF
GSLVLFGAIGIYVLEANHAFAGKSWHDILFLSLFQSTATRSGGLATIDISQLSDATIFFI
CALMFIGASPSSVGGGIRTTTFALNLLALFHFARGNKSVKVFKRELHPADLMKSLVVTMM
AILLVFGATLILIITEKHSLPELLFEVCSAFGTTGLSLGITADLSNVGKCVIMIVMFIGR
IGILTFLYLIGRKEIEANYHYPKERVIIG
>PK3-2_04115 Protease HtpX
MAKRIFLFILTNILVLTTIGIVLSVLSSVTGVGTYFTADGGIDLMALLVFSLVVGFVGSF
TSLAMSRWMAKTMMGVRVLNPNKHTLSYEEQQLVDRVHRLSRSAGLTKMPEVGIYRSPEV
NAFATGPSKRRSLVAVSSGLLEQMDDAAVEGVLAHEVAHIANGDMVTMTLLQGIVNTFVV
FLSRIAAWIASRFVKEDLAPIVHFIAMIVFQIVFSILGSLVVFAYSRHREFHADRGGADL
AGKDKMIHALRTLKSYSSRIIEDDQTAVQTLKINGKKRSSLFSTHPDLDERIRRLEAK
>PK3-2_04116 hypothetical protein
MNIFKLTRTDMVRLLYSLKGQGEISPLDILVQSANMSAEKAANHLEIPEFLTRYERKKQK
KEYGLSTNEIVELGNLCELTSLKSTAIQNWVKRDIKDLIGHPELGKKYSVEQAVILLIVR
DLKSIYDFEHIRAILKVAFNTISDRSDDVISPLAYYESCACVLDAVHHQEAPSMKESNLQ
EIVEQETERLRGRFEELNDSQWLKIRQIIAITVLSILTFHIQATAHKMTADIL
>PK3-2_04117 Small, acid-soluble spore protein D
MASRNKLVVPGVEQALDQFKLEVAQEFGVNLGSDTVARANGSVGGEMTKRLVQQAQSHLN
GTTK
>PK3-2_04118 Anti-sigma-I factor RsgI
MRRGIIVEKNRKFVTLLTPDGQFLKAKNDRRSYEIGEEIMLPSESRMGRRASFFDFLKLR
PFKMGIFTMTAIMLFIFIVLPVFSNNKAYAYMTIDINPSVEMALNSDYEVIELTPLNDEG
KKVVNDIDDWEKTDFKKVIDDIITDCNEHGYVEKSKEILISTVYENTEDNTYKKAVKKQL
NDVTEKYKTTYRMESLESDMQTREKAKKEGVSTGSYIKSNEKTDNKEPKDDSGKPSGEED
QKGAGNEDENTDQTDGQDSKQGDDEQLEDADSGDQKEDTTADPTEDNDKDTNVKESDENK
NTEKDGDHEQTPIQDPQDKGNEDNSAEKNKNQYHRDWNNGEQGKNRSSSSGDNASDRRNP
NGYSSDNHSAQTEDSPSDPGE
>PK3-2_04119 hypothetical protein
MDAALLLEYGWVLLVLIGLEGILAADNALVMAVMVKHLPEEKRKKALFYGLAGAFVLRFG
SLFAISFLVNVWQVQAIGAIYLLYISASHLLKRYVFKKEDTHKETKQSGFWPTVLKVELA
DIAFAVDSILAAVALAVTLPATPLPKIGGLDGGQFIVILAGGIIGLVIMRFAASMFVKLL
KERPSLETAAFVIVGWVGVKLALYTLAHHDIAVVSEHFIHSGAWKLTFWGVLAAIAICGW
FMSGAKKQPEDAQNEQKNSSRERA
>PK3-2_04120 hypothetical protein
MAIEELVMSWIEAFKSLSYFGIFLALCIEFIPAEIVLPLAGYWVSKGDMTLFGAVMAGSL
GGVAGPLTLYWIGRYGGRPFLERFGKYLFIKPEALDKSDEFFRKHGGFVAFSGRFLPGIR
TLISIPCGIAKMNVWVFSFYTFIAMLPITFVYVYLGVKLGENWKEVGSILDQYMLPIGIA
ILALFVFYLLMKKRKKRTNSEHFSVFLKNKR
>PK3-2_04121 hypothetical protein
MEIQVTYNTTLICLSILIACAASYISLELSRKVTINTGLKSNIWLIGGSLIMGFGIWSMH
FVGMMAVHMEMPMQYEFMPLIASIGAAVSGSFVSLYFVSRHILTYYRLLTGSVVLGASIA
SMHYLGMSAISRVMIIYNPFLFTVSIIIAIASSFVSLKIFFDLALKKHSDHLMFYKVISS
IVMGIGISGMHYTGMLAASFRIDMAPPGSHMEVHTFHWSFFVTLIIFCIQTLLLFSSHAD
RKFIKQSERIKDNEQRFQSLIIHNIDAIFILSLEGEIISSNRAGEDMIRKFGFSMHDWRN
YTSQKIQRLFEQVKKDKQAINSDSDLITEKGQFHLNITLIPVEVNQELDSIYVICKDMTK
QYRAEKEIHRMAHYDSLTDLPNRRHAISHLTEVMNREHTLNFSTVVFFLDLNRFKVINDA
LGHNVGDQLLQLAAKRLSSVVPDNGFIARLGGDEFIIILTDANTGTGEADVLARKIIQKF
KKPFSIQDHTLVTSVSIGIAISPKDGTDGLELMKKADMAMYAAKERNKSKYRYYSFSIGN
KETVKLNQEMVLREAIENDRFVLHYQPQFSAQSQKMTGAEALIRLVTPDGQLCPPGEFIG
VAEETGLIIDIGKWIIDEACKQARAWYDKGYNLSVAINISARQFQSEDLIPLIKDALDKY
QLPPHLLEVEVTESMTMDNLDHSKKVLTSLTELGIRISIDDFGTGHSSLSYLKDFPIHRL
KIDKSFIDDIQTHPKSEQITGAIIAMGHQLSLQVIAEGVENSAQKQLLYEKGCDHLQGFF
FSRPIPPEQLEQLILDQPSH
>PK3-2_04122 Non-homologous end joining protein Ku
MHTMWKGSISFGLVNIPIKLYAATEDKDIKLRSLHKEDHAPIKYEKICTNCEKTLGPDEI
VKGYEYVKGKYVVLTDEDLKSLKQEHEEKAVEIVDFVQLQDIDPIYFNRSYFVGPGDNGT
KAYTLLREALRSTGKIGIANMTIRSKQQLAILRVYENCIVMESIHYPDEVRSAAHVPGVP
DQSNVNDKELQTAITLIDELTAEFEPEKYEDTYRQALLQRVNDKLENKETAVTPDKAPPR
EDVIDLVSALQASIDRTRRPNRETPAAAPAQAAEPKGAGDKKRKTTRQKASGTS
>PK3-2_04123 Bifunctional non-homologous end joining protein LigD
MAFTMQPVLTSSPPIGAEWRYEVKYDGYRCILRIHSAGVTLTSRNGLELNSTFPEITQFA
KSAFQHMEKDLPLTLDGEIVCLVNPCRADFEHLQVRGRLKRPDKIQESANARPCCFLAFD
LLERSGVDVSSLSYLERKQSLYDFMSAAKLPASPDPYARETIQYIPCYDHFDSLWEMVTK
YDGEGIVAKKTTSKWLEKKRSPDWLKYKNFKQAYVCITGFNPNNGFLTVSVLKNGVMTPI
ASVSHGMRDEEKSAIREIMEQHGHQTPSGEFTLEPSICATVQYLTILQGTLREVSFVGFE
LHMDWTECTYAQVIRRSKPVHPKLQFTSLDKIIFEKNKKTKEDFIQYVIEASDYLFPFLN
NRAVTVIRYPHGSRSESFFQKNKPDYAPNFVQSFFDGSHEHIICEDMSTLLWLANQLALE
FHVPFQTIKSRRPAEIVIDLDPPSRDDFLMAVQAANELKRLFDSFGITSYPKLSGNKGIQ
LYIPLSPEAFTYDETRQFTQLIAEYCTNAFPELFTTERLIKNRHGKLYLDYLQHAEGKTI
ICPYSTRGNELGTVAAPLYWHEVQSSLSPAMFTVDTVIDRIKKQGCPFFDFYRNPQDEPL
SAILHQLKKKS
>PK3-2_04124 putative glycosyltransferase YkoT
MKQTQPVLTIVVPCFNEEEVFQETSRQLTEVVDGLIEEKLISEGSKILFVDDGSKDRTWA
LIAMESIRNKKITGLKLACNVGHQKALLAGLHKAKNRSDCVISIDADLQDDISVIRDFML
KYHEGCEIVYGVRRSRKTDTFFKRTTALGFYRLMNKLGIKLIYNHADFRLMNKRSLEELA
RYPEANLFLRGIVPMIGFKSAEVLYDRKERVAGKTKYPLKKMLSFAFNGITSFSVTPIRF
FTFLGFVLFFLSALAGIGAFIQKLLGHTNAGWASLIISIWFLGGLQLMGIGIIGEYIGTI
FSEVKRRPKYAIDIDLYNEPLSPLQREEKDRLEKKYS
>PK3-2_04125 hypothetical protein
MLRLMRQHKTETFYLWIALFLLLLYVSPLYILKEDAHIRVHDNLDSNIAWYKVLADSGEI
VGKVDAAIPQIINGLPRDAFGTEWSGIVWLHAFFSSMTAYAISQTITRFVAFFGMYVLLK
KHVVPEPKAAFIRIGVSLAFALTPFWPSGMLSTLGYPLALWAFLNIRKGDISWREWLTLG
LLPLYSSFVLGFFFFLAGMACFWLYDAITKRRWNLIFLGSIAFMTSIYLFVEYRLVYSML
FEHAPMHRIEFISSRHDILHSLRLSVKNFVYGHNHVMTVHTLVILPILLLVFAAVLFKRN
RTKPESVYLFLCVLNYGLSLWYALWFNKIWAVPKQKFAFLAEFNFARFHFLRPLVIYVSF
ALALYLIWRMGRGWKWLVYAAVAAQLMVLAPFNEEYTYGVHYNAPTFREFYASEQFKEIK
EYIGRPQDSYRVASIGLHPSIAQYNGFYTLDTYNNLYPLSYKYEFRKIIEKELEKNARLK
QYFDEWGSRCYLFVDELGKRYDFKKNSKKTINNLQLNTDVFRKMGGRYIFSSVPIMNADQ
NHLALVKTFDHKDSAWRIYLYETR
>PK3-2_04126 putative protein YpbG
MFTTLLSLAILACVPFIYKANRNTKDVKVNTISIDQKDGLPARKKLNILHLSDLHLENIS
VSPEELYHLTKNQPVDIIALTGDFLDRKRNIPKLAGYLNALQKLKPAYGMYAVFGNHDYV
LKEKDFQRLKHVLEDNGCITLQNEHVRIETAAGPVNIIGIDDYSTNRSDITGSYQNLENG
CHLVLTHDPNIILDMKDVHYDYLLSGHFHGGQIHWPKPYHLVKMGKLVRMNMIKGLHYHH
DKPFYISEGLGQTGVNIRVGSRPEVTFHQI
>PK3-2_04127 hypothetical protein
MVLLKKYGNYILRRTTAKYKGVFDYEEGEEMKACFLCIWRVVDPIYFFFSRLTLVDKDCK
SVFRVRLTKYKGHHVVLSDGTHIRKNDVLVKIHLHNIKLIRELQSIESAVRKGIIIYQKV
YQSMPMLLEYINNHKKSEKIKGIIGITMLDKGVERLGFDVVTPANPFYRCFKKISHMPIL
YLTSKPVSLRQLPNSSYLFISKAKLQKTYQKKTDALVSTVFFI
>PK3-2_04128 Processive diacylglycerol beta-glucosyltransferase
MKNILIFPFLSISTGHHHVADALQAELESQGLASEKIDIFSHAYRRLEKLSSEAYLKWIQ
YFPKTYSGIYRLLACGEYQNDKRYTMYEWLFTQQMRHILQEKQPDIAFCTHALPSYLLNR
LKPEYPNLKVVNVYTDFFVNQLWGRENIDDHFVPIIDVKKQLMSEGIDQKNIYLTGIPVH
RMFEMGSADTCHHHPPYTIIITGGSMGIGGILKWVQDLSPGGNILYKILCGRNEKLYCDV
KSLDHPLIEAIPYLHSKAEMNRLYEQAAGIMTKPGGVTISECLRKRLPIFIYHALPGQEE
MNLRLLEERKLVTDMRKWDMQKAEERIAAFFQSNEQVKEYEKHVNEYLDEISDRRIEDVL
KSIIRHKKNTLLIQRV
>PK3-2_04129 HTH-type transcriptional regulator MhqR
MMRLSFNEEEVERAMNLYRVFARAFKSVSEHSIRDSKEHGFNPTEFAVLELLYTRGPQKL
QQIGSRLLLVSGNVTYVIDKLEKNGFLVREQDPKDKRSVYAHLTDKGNEYLDKIYPIHAL
RIARAFSGLSPDEQDQLIVLLKKAGIHSQHLLFR
>PK3-2_04130 Stress response protein YkoL
MSNLLKSALEKERSHYSEKLFQIGVYNKEVMNKMTISELRKEYAYFFRSIANHKKNPYTR
>PK3-2_04131 hypothetical protein
MEEEKAVSLAKEIIELDIKRDEMLETFMQLAGEHAFQLLRSVQNGLYRKSS
>PK3-2_04132 HTH-type transcriptional regulator TnrA
MTTEDHSYKDKKVISIGIVSELTGLSVRQIRYYEERKLIYPQRSSRGTRKYSFADVERLM
DIANKREDGVQTAEILKDMRKKEQMVKNDPQVRKKMLEGQLNAHFRYKNR
>PK3-2_04133 Magnesium transporter MgtE
MVQNMTYDELILRIIILLRDGKIRDFRSVIDELQPYDMAFIFKEMPEKHRARYLSYLTVD
DITDMIGELEREFQLAVLNKVGKTRATLAMNKMDNDDLAQLLEEMDEELKEQLLSSMEAS
ESKAVQLLMNYPADSAGRMMTNRYVWIPQHYTVKDAVVKLKSFAEIAESINYLYVINESK
QLVGVLSYRDLILGEPEEKVQDLMFTRVISAGALQDQEEVARLIERYDFLAIPVVEENNV
LVGIVTVDDIIDVVIREADEDYEKFAASGKDITFDTKAYVAAYRRLPWLILLLFIGLISG
SIISYFEDALQQVVALAFFMPMVSGMTGNTGTQSLAVVIRGLSKEEMNKKTIVRLILREF
RTSIYIGAVCSVLIAIIAILWQGNALLGFVVSSSLLFTLIIGTMSGTIIPIILHKLKVDP
AIASGPLITTLNDILSLLIYFGIATAFIHSL
>PK3-2_04134 hypothetical protein
MDSPHSSQSEEVPIYYDSKTIDYTMRRRSAAPSAEAGTSP
>PK3-2_04136 hypothetical protein
MEKKEEQYINQAEFVPHPTKEGEYALFLHETYHLLSEDDETQTTE
>PK3-2_04137 putative protein YkoJ
MLKKRWMVGLLAGCLAAGGFSYNALAKENNEHTQTASSKTSALTEQEAESIAKTVVDGTV
EDIDRDIYNGKEAYEVEIEKDGEDYDVYVDINTRQALNDPLQEKAEQVAITKEEAEEIAL
KQTSGTVTESKLDEDDGTYIYEIEIQTKQGDESEFDISAKDGRIIKQEIDD
>PK3-2_04138 hypothetical protein
MNKTIKAVFTSAAAVLAVIVCTFFIIRQTHEDVLSKEAVVKKIEASYEGEVTKATQSKDK
KTYDITLENPKGTYFIKADAKSADILSMNRVKAVNPSAMTEKEAEHLALKRVPGTVKKQT
EQNRVAAYIIQKEDGETYEVKVDMEAKAVMSADQISSKDQQKTRITKKEAKTIAERETGG
TADDVDLEEHEGTLIFEVDIDLPDDKEATVKINAYTGKIANIVYED
>PK3-2_04139 Adaptive-response sensory-kinase SasA
MKLKTKIHLYTSLSLLVLLMLIHTAVYLIFSSALTSKDAARLADETDNIAEALHAAETEG
VALQDMLQAYLPANGMVRVVNGDQKAVMTITKEKVYKDFPLSFHSGEAADVRKHDGKLYA
EAAVPVIWTDGQVVSLQLVERLENTEESLFLLKIILIAASAAVCIASFFAGSLLARRIIN
PIRRLMMTMKDIQREKAFKTISLEGQSHDELYQMGLTFNEMAMMLKEHYDKQQQFVQDAS
HELKTPLTIIESYSSLMKRWGAKKPEVLEESIEAIHSEAVHMKKLTNQLLTLAKSHKGLE
LDMKTIDLIEVSRAVMQTLHSVYQRDILLETDKESLLVTADEERIKQLLTILLDNAIKYS
EKDIVVSAGMRNGRPFLSVSDEGIGIPEEHIPHLFERFYRADEARNRKTGGTGLGLSIAK
QIADEHGIELSVKSKPGQGTSVTMQFREQDGGGR
>PK3-2_04140 Response regulator MprA
MEKGHILIVEDEEKIARVLQLELEYEGYNITIKHNGTEGLNAAAEGGYSLVLLDVMLPGL
SGLEVLRRLRKTDQQTPVILLTARDSIPDKVTGLDIGANDYVTKPFEIEELLARIRAALR
QNGTKAEDVGAFLTYDDLRVNEKTREVRRGDKEVELTPREFDLLVYMLKHPQQVLTREQI
LSSVWGFDYIGDTNVVDVYIRYIRKKLDYPYEKQLIHTVRGVGYAIKG
>PK3-2_04142 Putative HMP/thiamine-binding protein YkoF
MEHICGTSRIAGFRFSLYPMTDDFISVIKSALKKTDTSKVWTKTDHISTVLRGSIDHVFD
AAKAIYLYAANSEKHIVMNGTFSIGCPGDTQGDTYLSEDDKRVNEDAVRSLNAEAPCQFA
LYPMNEPDYMGLIMQAVDIAKAEGTFVQGVHYASELDGDAHDVFRTLEAVFRMGEQQTNH
VTMTVNLSANSPSRKNRKQG
>PK3-2_04143 Putative HMP/thiamine permease protein YkoE
MKSWKVKEIVIMSVISIVFAVVYLLFTHFGNVLAGMFGPIAYEPIYGIWFIVSVIAAYII
RKPGAALVSEIIAALVECLLGNPSGPMVIVIGIVQGLGAEAVFLATRWKAYSLPVLLLAG
MGSSAASFIYDLFVSGYAAYSTGYLLIMLVIRLISGALLAGLLGKAVSDSLAYTGVLNGM
ALGKELKKKRKRASEHASL
>PK3-2_04144 Putative HMP/thiamine import ATP-binding protein YkoD
MQAFDELLKVEELSFSYEEDEKPVFQNISFELHKGECALLLGPSGSGKSSLALCLNGLYP
EACDGIQSGHVFLLQKPVTDTESIAQHAGVVFQDPDQQFCMLTVEDEIAFGLENLQIPKE
EMTKKIDAILEKLRITHLKEKTISTLSGGQKQKVALACILAMEPELIMLDEPTSLLDPYS
AREFVHMMKDLQREKGFSLIVIEHQLDEWTPWIERTIVLDKSGKKALDGRTNDLFQHEAE
TLKEFGIAIPKVCDLQEKLSMPFTLSKETLFKEPFPAGHPKMKEAPSGKSALEVSSLSFA
RGQQTIFKDISFSLREGSLTALVGPNGTGKSTLLSVLARLMKPKSGKIHLYDKPVQSYKE
NELRKRMGFVFQNPEHQFVADTVYDELLFGQKVSAETEKKAQHLLHRFGLAHLADHHPFA
ISQGQKRRLSVATMLMHDVKVLLLDEPTFGQDARTAAECMDMIQRIKAEGTAVLMITHDM
ELVSSYADSVLVLHDTSLAFDGSPAQLFSQETALVQKAKLTLPLLYEWMAYQEEVRDEAA
VTSH
>PK3-2_04145 Putative HMP/thiamine permease protein YkoC
MKQPLHLINPTVKAAAVFCCVVMLSFIYNPYTPACFYIIIVAGVLSAAGISLKKWFLFTI
PFLILAFGCVWTAAVFGKVPTTPENFLFQAGPISVNRENVSVGISLGFRILCFSALSMMF
VFTTDPILFMLSLVQQCKLSPKLAYGVIAGFRFLPLLKDEVQLIQQAHKIRGGAAENGFK
EKISALKRYTIPLLASAIRKAERTALAMESKGFTGSRNRTYYRTLTVNHRDWLFFCLVLL
LFAGSFLISLYFAS
>PK3-2_04146 RsbT co-antagonist protein RsbRB
MKLNEKLYAFFSEHVEQMAEEWIETMEESDPNSLYALHNATVTEELKEQDREFYRHLNYM
YVLPEKQFLEEFQEWVIELTNDQKHLDTPVQYVIREFMRNRKLYTKYFEKFAEENKSAFE
SGEKQKWADLIVKVFDFTIYTFVDHAEMNAKQQLNAQREMILELSSPVITLSKSTALLPL
VGDIDTERAKFILENTLHACAKRRVEHLLIDLSGVVVVDTMVAHQIFKLIEALNLIGVRS
TLSGIRPEIAQTAVQLGIDFSNITIKTNLAQALNYHQ
>PK3-2_04147 Major intracellular serine protease
MNGEIRLIPYVTNEQIMDVNELPEGIKVIKAPEMWSKGVKGKNVKIAVLDTGCDTSHPDL
KSQIIGGKNFTDDDGGKEDAISDYNGHGTHVAGTIAANDSNGGISGVAPEASLLIVKVLG
GENGSGQYEWIINGINYAVEQKVDIISMSLGGPNDVPELKEAVKNAVKNGVLVVCAAGNE
GDGDERTEELSYPAAYNEVIAVGSVSVARELSEFSNANKEIDLVAPGENILSTLPNKKYG
KLTGTSMAAPHVSGALALIKSYEEESFQRKLSEPEVYAQLIRRTLPLDIAKTLAGNGFLY
LTAPDELAERAEQSHLMTL
>PK3-2_04149 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase
MTTIKTSNVGFPRIGLNREWKKALEAYWKGNTDKDTFLQQIDDLFLSAVKTQIDQQIDVV
PVSDFTQYDHVLDTAVSFNWIPKRFRHLTDATDTYFAIARGIKDAVSSEMTKWFNTNYHY
IVPEYDESIEFRLTRNKQLEDYRRIKQEYGVETKPVIVGPYTFVTLAKGYEPSEAKAIQK
RLVPLYVQLLKELEEEGVKWVQIDEPALVTASSEDVRGAKELFESITSELSSLNVLLQTY
FDSVDAYEELISYPVQGIGLDFVHDKGRNLEQLKTHGFPTDKVLAAGVIDGRNIWKADLE
ERLDAVLDILSIAKVDELWIQPSSSLLHVPVAKHPDEHLEKDLLNGLSYAKEKLAELTAL
KEGLVSGKAAISEQIQQAKTDIQALKQFATGANSEQKKELEQLTDKDFKRPVPFEERLAL
QNESLGLPLLPTTTIGSFPQSAEVRSARQKWRKNEWSDEQYQNFINAETKRWIDIQEELE
LDVLVHGEFERTDMVEYFGEKLAGFAFTKYAWVQSYGSRCVRPPVIYGDVEFIEPMTVKD
TVYAQSLTSKHVKGMLTGPVTILNWSFPRNDISRKEIAFQIGLALRKEVKALEDAGIQII
QVDEPALREGLPLKTRDWDEYLTWAAEAFRLTTSSVQNETQIHTHMCYSNFEDIVDTIND
LDADVITIEHSRSHGGFLDYLKDHPYLKGLGLGVYDIHSPRVPSTEEMYDIIVDALAVCP
TDRFWVNPDCGLKTRQQEETVAALKNMVEAAKQARAQQKQLV
>PK3-2_04150 Guanine deaminase
MNHEKFLKRAVDLALEGVKAGVGGPFGAVIAKDGLIIAEGQNNVTTSNDPTAHAEVTAIR
NACKALGTYQLDDCILYTSCEPCPMCLGAIYWARPKAVFYAAEHTDAAEAGFDDSFIYNE
IDKPAGERTIPFYQVTLLKHLSPFQAWRDFSNKKEY
>PK3-2_04151 hypothetical protein
MKRPKLSVCMIVKNEERHIARCLESVQHIADEIIVVDTGSNDRTEDICSSFHAQIYHHKW
EQDFSQARNASLQHAKGEWILVLDADEELDPDTGSLLPSLLTDSLPSLGCVNVVNYTGKQ
WDENEALEQRQIRLLRNQRNITFTGRVCERPEGEEASATFSLPCIIHHYGYLEQEAQQKH
KRNMSLLNAALLTSSADPSLIFQKAAEYDRGNEHDKALRLAIDCINEHKRKKQIPPPAYY
YLKYKLLIDAERYEEAEQDINEALAHYPDYCTLHYYKGIIKYQHKKAREAITAFEACQQT
NSENHLYIQVKGAADFRSSCWLGVCHAELHQPMTAVLYAQKALKANPKCSRAQRLFSELT
KDQAAHA
>PK3-2_04152 Organic hydroperoxide resistance protein OhrB
MALFTAKVTARGGRAGHITSDDGVLDFDIVMPNAKKEGQTGTNPEQLFAAGYAACFGGAL
EHVAKEQNIEIDSEIEGQVSLMKDESDDGFKIGVTLVVNTKDLDRDKAQELVNAAHEFCP
YSKATRGNIDVKLELK
>PK3-2_04153 Organic hydroperoxide resistance transcriptional regulator
MFFRYNRMECQKELVNKMENEFDHMKLENQLCFLLYASSREMTKQYKPLLEKLNVTYPQY
LVLLLLWEHETLTVKKMGELLYLDSGTLTPMLKRMEQQDLITRNRSEEDERSVLISLTED
GESLREKAADIPGTILGLSKQSGEDLKQLKSALFTLLETLHQKS
>PK3-2_04154 Organic hydroperoxide resistance protein OhrA
MSQPLFTASVSAVGGREGKVISSDRVLELDVAMPGTPRAKKLEKATNPEQLFAAGYAACF
DSALQLVARTERVKVETEVTAHVSLLKDEADQGYKLGVTLQVKGKGVSASELQELVQKAH
GVCPYSKATSRNIDVTLEVAE
>PK3-2_04155 Gamma-glutamyl phosphate reductase
MSEVSVKAKLAKEAAAEMIMKTTAEKDEALSLIANGLRNELDFLLSENAKDIENGKENGL
TPDVIDRLTLDEKRIRDIADAVELLIDLADPVGESLETIEKENGLFIEKIRVPLGVVGMI
YEARPNVTVDAATLCLKTGNAVVLRGSSSAIHSNKALVSVIHRALEQSALPIHAVQLIED
TSRETAKELFTLNDGLDVLIPRGGKKLIDLVVKESTVPVLETGAGNCHIFIDETAKPQMA
EKVVVNAKTQRPSVCNAIESLLIHKAWADRYGKELLVQLENAGVDIRGDEFVCELHPSSK
KASEEDWETEFLAPVLSVKTVENVQEAVKHIQTYGTNHSEAILTEDDKHAVYFQTAVDAA
AVYHNASTRFTDGFEFGYGAEIGISTQKLHARGPMGLPALTSTKYIIKGTGQIRE
>PK3-2_04156 Glutamate 5-kinase 1
MKKQRIVVKIGSSSLTNSNGSIDEAKISEHVQAISLLKKAGHEMILITSGAVAAGFSSLG
YPSRPVTIKGKQAAAAVGQTLLMQQYMNQFKQYALTPGQILLTRNDFSKRERYRNAYATI
MELLERGVIPIINENDSTSVEELTFGDNDMLSALVSGLIHADQLMILTDINGLYDANPNE
NPEAKRFDYLPEITSELLGYAGSAGSKVGTGGMKSKLLAAQTALSLGVKVFIGTGSGEQK
LADILDGRGDGTYIGDKELSSVNNTRQWIQFHSPISGEILIDAGAEEAMIHNGSSLLPAG
VVGVKGNFPKGAVVEVRGPGGVIGKGQTHYSSEEIMEARGKRSDELGFERTFEVIHRNDW
VNLKD
>PK3-2_04157 Formyltetrahydrofolate deformylase
MKSYMTQRLNEYRDGNEDKGRLLVSCPDQPGIVSAVSAFLFEHGANIIESNQYTTDPEGG
RFFLRIEFDCAGIHEKKEILQEAFASVAGKFDMTWSLTLASELKRVAIFVSKELHCLHEL
IWEWQTGNLMAEIAVVISNHEEARELVERLNIPFHYMKANKDIRAEVEKKQLELLEQYKI
DVIVLARYMQILTPDFVSAHPNRIINIHHSFLPAFIGANPYKRAYERGVKLIGATSHYVT
NDLDEGPIIEQDIERVDHRDNAEALKNIGRTIERSVLARAVKWHLEDRVIVHENKTIVFN
>PK3-2_04158 putative guanidinium efflux system subunit GdnD
MLHWISLLCAGCLEMAGVALMNQYAKEKSVKWVLLIIVGFAASFSLLSYAMETIPMGTAY
AVWTGIGTAGGALVGILFYKEPKDAKRIFFIALILCSAVGLKILS
>PK3-2_04159 putative guanidinium efflux system subunit GdnC
MKWGLVVFAAVFEVVWVVGLKHADSVLTWGGTAVGIIVSFYLLMKATNSLPVGTVYAVFT
GLGTAGTVLSEIILFHEQVGWPKLLLIGVLLIGVIGLKLVTPDESGEKGGEA
>PK3-2_04161 Acetyltransferase
MSAKTKLVTDRIRLRCVEDRDQASLFELFNDPDVMKYYSGLKDKRQTREWINWNKRNEKG
YGVSLWIAEDKRTGDFLGQCGIVPQQIENQTVMEIGYMFAHRHWGNGYAQEAAWACLDYG
FNDRLFGKMAALIDPDNKASIRVAEKIGMLYDRTIRKWNKPIAVYERKSYN
>PK3-2_04162 hypothetical protein
MKDLSIRHDMAPTVSLLYSAVEENSLRLATIVGHMTHSELYYKGRCQTKNSTAQLLHHIT
NVDIRWVWRIKDNRIPDHIEQAYGPMTDESGRLPEPVNQPGLNELLKRHQLVVNELKSVC
HTLTENDLHQPLIFDGDTATVRWGIWHMADHNRYHQAHIEALKKEWKQDAAIYER
>PK3-2_04163 hypothetical protein
MLWLVWAFLLKPVIVFSIAYILFRLAGKKAVSQMNNFDLLLTFAIGTIISEPILTSRLPM
SIYYAGAFLVLYLLMSKLSLSNKWRWLLVVSPTVLIRNGDIEEHGLRKERLTVNELLGKL
REKGYADPADIDLAIIEETGEVSVIPNEEARAVQVRDLNMEAERNFIPIPLILDGEILDH
NLKYLQKNRSWLFEKLEEKGYSPKLLSSITLGTMNARGDISLDLNTSNEPQHDPYLYKPG
NNN
>PK3-2_04164 hypothetical protein
MKHQQTNAYWPYDLSSAPHPSGCKEQQTFDRLADLELKMEQLIRAIEINNELLRTMQELQ
NRVCTSGGGSVIVRM
>PK3-2_04165 Flavohemoprotein
MLDNKTIEIIKSTVPVLQQHGETITGRFYDLMFQDHPELLNIFNQTNQKKKTQRAALANA
VIAAAANIDQLGNIIPVVKQIGHKHRSIGIKAEHYPIVGKYLLIAIKDVLGDAATPDIMQ
AWEKAYGVIADAFIGIEKEMYEQAEQQAGGWKEYKPFVIAKKEQESKEITSFYLKPEDGK
PLPEFQAGQYISIKVRIPDSEYTHIRQYSLSDMPGKDYYRISVKKDGVVSSYLHDGVREG
DSIEVSAPAGDFVLDSSSQKDLVLISAGVGITPMISMLKTSVSKQPERQILFIHAAKNSE
YHALRHEVEEAAGHSTVKTAFVYREPTEEDRASDLQFHEGQIDQQFLKELIANTDADYYI
CGSSSFITAMHKLAAELGSAPESIHYELFGPQLSMAQSV
>PK3-2_04166 hypothetical protein
MHLAKRSDTKGEKGMETPETKFCKESKVVKTSRVFPLDTNNHNTLFGGKLMSYIDDIASI
SAARHCRRETVTASMDSVDFLKPIGQRESVCLESYVTWVGTSSMEVFVKVIKEHLMTGER
ELAATSFLTFVALDSNGKPVPVPKVVPETEEEIMLHNTAVQRANERKNRKKHSQALANAL
GTDKPW
>PK3-2_04167 Arginine deiminase
MDVSIPKHQHKTVCRTEYGSLEKVILCRPEHMTIKDVINETQKHFEDDNIHVKTATDQHS
RLVETLRSHNIEVILLPVRDGLPEQVFTRDIGFVIGEKAFLSSMTEPIRQGEEAVITEFF
HSQGISYTRMLNTSIEGGDVIIDGDTVYVGISQRTDISAIGQLEEVLPEYTIVPVQLHEN
FCTWTAYLTSYLKGKR
>PK3-2_04168 Arginine deiminase
MLAKRYDLIEVPEDEQFTLGTNVLSIGRKTIISLPCNRHVNQQLSKRGYHIIEIDLSEII
KSGGSFRCCTMPLIRDE
>PK3-2_04169 6-phosphogluconolactonase
MTKYIGYVGTYTKGGSEGIYSFELDTEKKTLTEPKLAAKLGNPTYVTPNKDNTILYSIEK
ADGQGGVAAYQIDKTSGELTFLNHQLIDGPSPCHVSVDDQNQFVLTANYHSGKVHAFPVQ
EDGSLQSPASEAAHTGKGPHERQEKPHTHYAGFTPEHNYVVAIDLGTDKLYTYKMKDGAL
TESGSHSFAPGAGPRHIAFHPKEKYAYVMTELSNEVIALEYNPTAGEFREIQVVSAIPED
FTDNSQGSAIHVTQDGRFVYVANRGHDSIAVFEVNQYSGELAFVERVSTEGNWPRDFVFD
PTEAFLVASNEETGSLVLFERDKETGRLTVLPSTVSVPFPVCVKFLHQA
>PK3-2_04170 Oligopeptide transport ATP-binding protein OppF
MTPLPLLEVSQLKMHFDAGKKRTVKAVDGVTFQIHEGETFGLVGESGCGKSTLGRVLMRL
YQPTEGSVKYRGTNLHALSEKEQFAFNRKLQMIFQDPYASLNPRMTVREIILEPMEIHNL
YNTHKARLLVVDELLEAVGLHPDFGSRYPHEFSGGQRQRIGIARALSLNPEFIVADEPIS
ALDVSVQAQVVNLLKRLQKEKGLTFLFIAHDLSMVKHISDRIGVMYLGHMMEITESGTLY
REPLHPYTKALLSSIPIPDPELEDKRERILLKGELPSPVNPPSGCVFRTRCPEAMPECGE
SRPQLQEIEAGRFVACHLYRTAETREKVR
>PK3-2_04171 Gamma-D-glutamyl-L-lysine dipeptidyl-peptidase
MMHTVISAVANIWTAPDSPRQSDQAMLRPTVLIRDWLERLTYEERLGLCTDNVIQTQVLF
GEKVLVTAEQDDWVSVIVPSQPSRKDPRGYPGWMNKNQLKKTSPIHTQNEVMISKPSAFL
YNSKGEKEIELSFLTVLPFIAEENGYIKVSTVLGERFVKQTDAVPVRKQKGTAEDIIQTG
AFFLGLPYLWGGISGFGFDCSGFMYSIFKANGYSIPRDAGDQAKAGEEVPIDDMKAGDLL
FFAYEEGKGAIHHVGLSVGGGKMLHSPKTGKSIEILSLKETIYEKELCAVRRCFSG
>PK3-2_04172 L-Ala-D/L-Glu epimerase
MKITRIETSRIAVPLTKPFKTALRTVYTAESVIVRITYDSGAIGWGEAPPTVVITGDSMD
SIESAIHNVLKPALLGKSLSGCEAILHDIQHLLTGNQSAKAAVEMAVYDGLAQMCGLPLY
QMLGGYRDTLETDYTVSVNSPEEMAADAENYLKQGFQTLKIKVGKDDIATDITRIQEIRK
RVGSTVKLRLDANQGWSPKEAVTAIRKMEDAGLGIELVEQPVHKEDLAGLKKVTDATDTP
IMADESVFTPRQAFEVLQTRSADLINIKLMKAGGISGAEKINAMAEACGVECMVGSMIET
KLGITAAAHFAASKRNITRFDFDAPLMLKTDVIKGGITYSGSTIAMPDRPGLGITGAAH
>PK3-2_04173 putative murein peptide carboxypeptidase
MLNQKPKALKKGDTVGVIAPASPPDPKKLETALLFLEELGLQVKLGKALKNQHGYLAGQD
DERLADLHEMFRDEEVKAVLCACGGFGTGRIAAGIDFSLIRKHPKIFWGYSDITFLHTAI
HQNTGLVTFHGPMLSSDIGLNDVHPLTKASYEQLFQETEFTYTEELSPLTVLVPGKAEGE
LVGGNLSLLTSTLGTPFEIDTRGKLLFIEDIDEEPYQIDRMLNQLKMAGKLTDAAGILVC
DFHNCVPVKREKSLSLEQVLDDYIVSAGRPALRGFKIGHCSPSIAVPIGVRAIMNAAEKT
VVIEAGVSEGALKT
>PK3-2_04174 Dipeptide-binding protein DppE
MKRVKKLWGMGLALGLSFALMGCTANEQAGKENGNDKAKTSGEKVLYVNNENEPTSFDPP
IGFNNVSWQPLNNIMEGLTRLGKDHKPEPAMAEKWSVSKDKKTYTFTIRENAKWTNGDPV
TAGDFEYAWKRMLDPKKGASSAFLGYFIEGGEAYNSGKGKKDDVKVTAKDNRTLEVTLEA
PQKYFLSVVSNPAYFPVNEKVDKENPKWFAEADTFVGNGPFKLTEWKHDDSITMEKSDTY
WDKDTVKLDKVKWAMVSDRNTDYQMFQSGELDTAYVPAELSDQLLDQENVSIVDQAGLYF
YRFNVNMEPFQNENIRKAFAMAVDQEEIVKYVTKNNEKPAHAFVSTGFTQPDGKDFRKAG
GDLITPNESKAKQLLEKGMKEEHYDKLPAVTLTYSTKPEHKKIAEAIQQKLKNTLGIDVK
LANMEWNVFLEDQKALKFQFSQSSFLPDYADPISFLEAFQTGNSMNRTGWANKEYDQLIK
QAKHEADEKTRFSLMHQAEKLLVNEAPIIPVYFYNQVNLQNEHVKGIVRHPVGYIDLKWA
DKN
>PK3-2_04175 Oligopeptide transport ATP-binding protein OppD
MEKVLSVKNLHVSFTTYGGTVQAVRGVNFDLYQGETFAIVGESGCGKSVTSQSIMGLLPP
YSAKVTDGSILFKNKDLCRLSDKAMRSIRGADISMIFQDPMTALNPTLTVGDQLGEALLR
HKKMSKKAVREEVLSMLSLVGIPDPKERLKQYPHQFSGGMRQRIVIAMALICEPDILIAD
EPTTALDVTIQAQILELFKEIQRKTNVSVILITHDLGVVAQVADRVAVMYAGKIAEIGTR
KDIFYQPQHPYTKGLLNSVPRLDLDGAELIPIDGTPPDLFSPPPGCSFAARCPNRMIVCD
RVYPGQTIRSDTHTVSCWLQDQRAKHAVLSGDAKD
>PK3-2_04176 Dipeptide transport system permease protein DppC
MKRVNLPVQTDERQPEQHIQVPDEWFVSNQEINREADSVKRPSLSYTQDAWRRLKKNKLA
MAGLFILLFLFVMAVIGPFLSPHSVARQSLTEQNLPPSADHWFGTDELGRDVFTRTWYGA
RISLFVGVMAALIDFVIGVIYGGVAGYKGGRTDSIMMRIIEVLYGLPYLLVVILLMVLMG
PGLGTIIVALTVTGWVGMARIVRGQVLQIKNYEYVLASKTFGAKTFRIIRKNLLPNTMGA
IIVQMTLTVPAAIFAESFLSFLGLGIQAPFASWGVMANDGLPTILSGHWWRLFFPAFFIS
LTMYAFNVLGDGLQDALDPKLRR
>PK3-2_04177 Dipeptide transport system permease protein DppB
MMKRFWAMAATILVITTLTFVLMKVIPGSPFNEERGTNEAVQKNLEAYYHLDDPLIFQYF
FYLKSIITFDFGPSIKKPSDSVNDMLERGFPVSFELGMTAIVIAVISGLVLGVIAALRRN
GFLDYAAMSLAVLGISIPNFILATLLIQQFAVNLKLFPAATWTSPIHMVLPTAALAVGPM
AIIARLTRSSMVEVLTQDYIRTAKAKGLSPFTIIVKHALRNALMPVITVLGTLVASILTG
SFVIEKIFAIPGMGKYFVESINQRDYPVIMGTTVFYSVILIIMLFLVDLAYGLLDPRIKL
HKKG
>PK3-2_04178 D-aminopeptidase
MKLYMSVDMEGISGLPDDTFVDSGKRNYERGRLIMTEEANYCIAEAFNSGCTEVLVNDSH
SKMNNLMVEKLHPEADLISGDVKPFSMVEGLDDTFAGALFLGYHARASTPGVMSHSMIFG
VRHFYINDRPVGELGLNAYVAGYYDVPVIMVAGDDRAAKEAEELIPNVTTAAVKQTISRS
AVKCLSPAKAGRLLTEKTAFALQNKDKVKPLTPPDRPVLSIEFANYGQAEWANLMPGTEI
KPQTTTVQFQAKDMLEAYQAMLVMTELAMRTSFC
>PK3-2_04179 Pyrroline-5-carboxylate reductase
MEQIGLIGYGSMADMIARQLLKHKQIKENELFIETRTKGERLEALMSDYPHVSADSLENW
AETCRLIFICVPPLHVIETLRRLHPYVNRHTHIVSIAAGVPLRLLESETEAGISRVIPAI
TSEAEAGISLVVHSEALTADKKERLNELLSVFSRVREIKESNVDAASNLTSSAPGFIAAV
FEELALSAARNSSLSKEEAFDFLIHSLYGTGKLLIEKKMSFEETLERVATKGGITGEGAE
VIRASMPDVFDQVFERTLKKYELLTEQAEKQT
>PK3-2_04180 Serine protease Do-like HtrA
MMDNYRDENKTEGHENEVFLAKENDQSTSYSARNVIHDQEKKKRGFGWFRPLLGGVIGGS
LALGIYTFTPLGDHDAQDTAKQSSSQQQTQSVTAKSTSSESGKSSSSSSSSSAFKSEDSS
KISDMVEDLSPAIVGITNLQAQSNSSLFGSGSSGSSSDSSENTESGSGSGVIFKKENGKA
YIITNNHVVEGASSLKVSLYDGTEVTAKLVGSDSLTDLAVLQISDDHVTKVASFGDSSDL
RTGETVIAIGDPLGKDLSRTVTQGIVSGVDRTVSMSTSAGETSINVIQTDAAINPGNSGG
PLLNTSGKIVGINSMKISEDDVEGIGFAIPSNDVKPIAEELLSKGQIERPYIGVSMLDLE
QVPQNYQEGTLGLFGSQLNKGVYIRQVASGSPAEKAGLKAEDIIISLKGKETDTGSELRN
ILYKDANIGDTVEVKILRKGKEMTKKIKLDQKEEKTS
>PK3-2_04181 putative glycosyltransferase
MSRHIQYSVVVPVYNEELVIHETYQRLKEVMDQTKENYELLFVNDGSKDRSIEILREHSL
IDPRVKIIDFSRNFGHQIAITAGMDYAQGNAIVVIDADLQDPPELILDMIEKWKEGYEVV
YAVRTKRKGETFFKKQTAAMFYRLLSSMTDIDIPIDTGDFRLMDRKVCDEMKRLKEKNPF
VRGLVSWVGFKQTAVEYVRDERLAGETKYPLKKMLKLSMDGITTFSHKPLKLASYAGVLM
SGAGFLYMFIVLYLKLFTDSTITGWSSLIVIQLLFSGIVLLILGMIGEYIGRIYDEAKDR
PLYIVQKSYGIENKRLYRDQHMS
>PK3-2_04182 hypothetical protein
MEKKKRELDIVLILILLASAFLNIYNIWKDDTVNPYYTAAVTSMMQSFHNFFYASFDAAG
FITVDKPPVTYQIQTISALIFGMHGWSVILPQALAGVGSVLLMYLLIKPTFGKTAARIAS
FVMACTPIAVAVARTNNVDALLVFFLLLATWLLFKAIRKGKLIWLLAAFFVVGVGFNTKM
LQAYMILPAFLLFYLIAANATIKKKIISLVSALAVLAAVSLSWPLIVDNIPASKRPYIGS
SQTNSVLELAFGYNGIQRLTGQNSGGGQGGPNGDASKEMSSSDNSSSQTQAPPSQSSNSS
SSSDDKTSNANMTAPPSNGQMPSGGEMPSGGQGGPPSGGDGGQGGPGGDGGKGGTGTGSK
MQSGSGMFGTGTPGPLRLFQQELSDQISWLLPFAIFGITGLLIAGARERRRLSAQQKETI
FWVAWLVPIAGFFSVAEFFHHYYLIMLAPPIAALVGAGWVALVHLYRNQTGWKSWLLPTA
IIATTGFELFILRNYYDQIRVGWSIGVGVIGALSAIALLVFKQRQKPISYYVSLAALLAL
LVMPIYWASTPLLYGGNSSQPETGPQLASMSGKGMGMSDATVNEKLIKYLEENNSGAEYL
FATTDSNTAAPYIIKTKKAVMTIGGFSGSDPAITLTQFKKLIKEGKVKYFLASGMGRGGN
NDIVEWVQKNGKKVSSDTWQSSSDQQASSDQITSNTDSADTSSNSKTSGENGKMSGGPGG
MNQSAALYELNADE
>PK3-2_04183 Putative ring-cleaving dioxygenase MhqA
MKVNGIHHVSALTADAQKNLDFYKKVLGLKLVKKSVNQDEPTMYHLFYGDEVANPGTELT
FFEIPRIAPFHAGTNSISSIGLRVPSTEALHYWKERFEEHQVAHSGITKRAGRDILAFQD
HEGQRLVLTADEKGKGYGLPVKQSGIPEEFSFRGLGPVELTVPYAESTLHVLTNILGFTE
ISREAVEGQGTAVILESGDGGAATEIHLIERNDLPRERQGKGSVHHVAFRVRDEEELAGW
HQIISREGYSNSGIVERYYFKALYFREPNGILFELSTDGPGFMVDENLDELGQTIALPPY
LEHRRAEIEAKLKPIH
>PK3-2_04184 Serine/threonine exchanger SteT
MHTEDNGLKKEIGLLFALTLVIGTIIGSGVFMKPGAVLAYSGDSKTALFAWLLGGILTLA
GGLTIAEIGSQIPKTGGLYTYLEEVYGEFWGFLCGWVQIIIYGPAIIAALGLYFGSLMAN
LFGWGSGLSKVIGIIAVLFLCVINIIGTKYGGFVQTLTTIGKLIPIACIIIFGLWKGDQH
IFTAVNESISDMNFGAAILATLFAYDGWILLAALGGEMKNPEKLLPRAMTGGLLIVTAIY
IFINFALLHILSANEIVTLGENATSTAATMLFGSIGGKLISVGIIVSIFGCLNGKVLSFP
RVSFAMAERKQLPFAEKLSHVHPTFRTPWIAISFQIAVALIMMLISNPDKLSEISIFMIY
IFYVMAFFAVFILRKRTKGEKRAYSVPLYPFMPILAIAGSFFVLGSTLITDTLSCGLSIL
IGLAGLPVYYWMKKRKAS
>PK3-2_04185 hypothetical protein
MIRRKKDKFSLLLTEIAKNIDETAEYFVNFKVTNQTTLKEFADTLKEYETKGDNHVHVMI
KELNKAFITPIEREDILQLTNSLDDVLDGIEHFSAMMEIFSITSSDEHIDKFSGYIRECA
KEILITIELLAENRLNDIQPHAIKIKEYEHSCDNLHRKSLKNLFGNETDPIKVIQYREIY
ETLEEIADSCQSVANNLETIIMKNA
>PK3-2_04186 hypothetical protein
MDILLILTILIVICALAFDFINGFHDTANAIATSVSTKALKPRHAIIMAAVMNFIGAMTF
TGVAKTITKDIVDPYTLENGSVVILAALIAAIAWNLITWYYGIPSSSSHAIIGAIAGAAV
AAAGFASLNYKGFIKIIEALILSPILAFVVGYILYTIVKLIFKDSNLAKTNKQFRRVQIL
TAALQSYTHGTNDAQKAMGIITMALITANLHTSANDIPTWVQFACATAMGLGTSIGGWKI
IKTVGGKIMKIRPVNGVSADLTGAAIIFGATFIHLPVSTTHVISSSILGVGASHRVKGVN
WGTAKRMLITWVITLPISATLGAIAYFILNMIF
>PK3-2_04187 Stage II sporulation protein SA
MLLFFQIMVWCIMAGLGLYVYATWRFEAKVKEKMSAIRKTWYLLFVLGAMIYWTYEPSSL
FADWERYLIVAVSFALIDAFIFLSAYVKKLAGSELETDTREILEENNEMLHMYLNRLKTY
QYLLKNEPIHVYYGSIDAYAEGIDKLLKTYADKMNLTASLCHYSTQADKGRLTEHMDNPA
DVQTRLDRKDVYYDQDGKVVLIPFTIETQSYVIKLTSDSIVTEFDYLLFTSLTSIYDLVL
PIEEEGEG
>PK3-2_04188 Stage II sporulation protein SB
MERAYQNGCEPRAAKPFKILKKRSTTSVASYQVSPHTARIFKENERLIDEYKRKKA
>PK3-2_04189 hypothetical protein
MQKDIKLNNVKGVLIFLVVFAHLLGVSKSGLENMIEIIYSFHMPAFIFLNGYFSKRPSIK
KVINLVLLYVIFQTFYCVYRYYAGNFSVIQFTYGRPHTHLWYIVSLGSWYALAIILKKIN
GRNVSKAVLLFLLLVISFFSRFYADEIIEFIKIYYSDMHTQTLSILRTFVFLPFFLAGFY
CSKELMSKIYSLLDKFKFKLFSTLAVSVLIFIILDKHNDKFDQLFFGFLGYQKFNIENHS
YTGIVFFHYSLAVLGIFLLLNAVGAGKNKLTQWGENSLAIFLFHMIFVFPLFTHNSWLNE
QNPDTRLILFFTMTLGITSLFGSRAFNQIVKYIIYPMKYLEIIYARLLNQTDKNDEYKKR
HIV
>PK3-2_04190 N-acetylmuramoyl-L-alanine amidase XlyA
MVNIIQDFIPVGANNRPGYAMTPLYITVHNTANTAVGADAAAHASYLKNPDTATSWHFTV
DDTEIYQHLPLNENGWHAGDGNGSGNRASIGIEICENADGDFEQATANAQWLIKTLMSEH
NINLANVVPHKYWSGKECPRKLLDTWDSFKAGIGGGGSQTYVVKQGDTLTSIARAFGVTV
AQLQEWNNIEDPNLIQVGQVLIVSAPSYAEEPELYPLPDGIIQLTTPYTSGEHVFQVQRA
LAALYFYPDKGAVNNGIDGIYGPKTADAVARFQSVNGLTADGIYGPATKAKIRALLVL
>PK3-2_04191 hypothetical protein
MKTLDKGTVIRTVLLLVALINQTMLMLGKSPLDIQEEQVNQLADALYSAGSVIFTIGTTL
AAWFKNNYVTEKGKKQRDLLKENNLTK
>PK3-2_04192 hypothetical protein
MQQEADVNVFQQDLADMKGEQKALEQRVSALERVSDRQDQQIMTLNEKLNKIEENTTWIK
RTITGAIITAVCTGIIGGAIAIMYNLLQH
>PK3-2_04193 hypothetical protein
MVKYQYEFPLDKTGKAGAVKPYRGEKNDFVTPVSNLSGVAEILTNAALKATEAYSQLGQD
RLGAVLVSKVKGWAYADREGTLFIEESDNNNAWTTTAAVNVAAGVLTETEWVYLSKRYYR
FRYVNGNLQQSEFVLYQSVGAGEMDVNVNQKAPLQIDLSEIQTGDGRLKVKAGTTFDHVF
HENAESAGEGTALSANGASHLLVEVYGTAETSEVKFWGKSMSGQKLPIRGVKSDDASAAC
STLGKAEAWTFDMKGFKEIIMEIASITGGTLSIKGTAVSS
>PK3-2_04194 hypothetical protein
MNYWVLALYYEWATTDMVKQAVAYKDCSIEDLAEGVNKKLITSDQYKEITGKAM
>PK3-2_04195 Phage-like element PBSX protein XkdW
MILYDAIMYKYPDAVARKDFELRNDGNGSYIEKWNLRAPIPTQQELESWWEESKKNPPYE
PPDQVELLAQELSQEKLARKQLEELNKTLGSELSDIKLSLLSLKGDRAE
>PK3-2_04196 hypothetical protein
MAYEEKTDWLPDDPINEDDVNRWEKGIKDAHTDLAAHKNDMNNPHNTTKAQVGLGNVDNV
QQAAKKDFDKHDQDQVRHITSTERENWNAKETPSEAQNKADQAEANAKAYTDSFAARRDN
PNQVTKAQVGLGNVVNMKQASQADFDAHLSNTKVHVSEGERNKWNAAQLIKLTGDDGKRI
QLQDGTDILTLSSGFYYAVGKSVVNNPIEGDSAWYNYDIIEGGSGGKTIVAYQSWGITMW
IGMVHTDGEFRGWKQISTTDIVDKVQSVLELHKNDKTNPHSVTKQQVGLGNVENVKQETP
DGAQKKADTAFSQSKDYTNSTAFITRPLNSITDANDLNLPPGTYRLDTNYMNANPVLQNQ
FPLNDNRTGLLIIYPSANKWATRQDWFSISTKTLYTRVAVNGTDYTNWYTLETSEGSQSK
ADKALADAKNYVDSNYTNNKLTVLTGSNAIQDARTSGNEYPAGLTFMDIGANNTTGYPLT
YGIVKNEKHSTNRFTQYFYGTGNESSTYFTNTGSWIRHWWVDSGWTAWQKISGFAHANIG
TTGKQLLIKGESQKVNFNRKIKDSHNCFDPTNNRFIVPNDGMYLVNAGIYIENYLEYANY
ETSIYVNGSRYKNIAHYRISPSNPEDNTNINIGIYGAATVSVNKGDYIEIYLYVGYNGQT
QRYITDSLGWYNYFDITEIGGRNYPVR
>PK3-2_04197 hypothetical protein
MISTIYRERTAADLKSRIDHVLLNGQKTEIVELAIDGATVTVLTKREEDIKHIETVQIFD
ELGNVITERKTDLDVSENRTLDFRFTFEVV
>PK3-2_04198 hypothetical protein
MSKLDDMTAYLPPFLTSLKEMAELLKAEAPEFDKQNNSIFDLTDQLFVPTATWGLSRWEK
ILNVPRESGDTDEIRRLRLISKMSNIPPITNKAIEQAVNRFLKNPSAQVRLLPGEYRFNV
DINVDDLQHMNELIEAIENMKPAHLAYTLRGGLNETLQIKDTVILNHRRYRTASELKVGY
SVTLNNNEVVLT
>PK3-2_04199 hypothetical protein
MFEDQTFEEIMERMLNSISADIDTREGSVIYNALAPAAAELAKSYIWLDTVLELVFSDTA
QGEFLDRRATEAGIERTAATKAVRAGEFTSGVTIPAGSRFYVDNLYFQYTADGTLVCETP
GEAGNANLTGRNLLSLDTIPGLETAVVKEILIPGREEEGDDSLRERYFTRVRREAVSANK
MHYKEWAEEVDGVGKAKIFPLWNGDGTVKIVVTNANLEPASDILIQKVKDYIDPEPGQGE
GQAPIGAVVTVESALWKEVEISAEVLPEINHSIDEVKSEIEEGVLHLFKKMAFEDNVIRL
SQINNIVYNSPSVSDYSNIKINGTSENLVLSDVEIPKLGQVKIIEQTR
>PK3-2_04200 hypothetical protein
MALTPEVEFEDIEDDSEVIETSKTYKVDFENGRITNELITGLEAIRQFVYIALQTERYAY
SVYSHNVGNELQDVLTDHETTDAYKKMEIPRLIEEALVYDDRISAVTDFEIEKQGDAFHV
SFVVETDEGTLEFEEVIGENV
>PK3-2_04201 hypothetical protein
MRLSEAIKHLAVGAVDAESPVELLSAEVVSISPVEIKLKENSKLIIPADALIIPKRMRSG
GDDALEPGDRVMTASLTGGQSFFILDKV
>PK3-2_04202 hypothetical protein
MLIELFVIKDTEWLELVAESVSLEGHRYQAPRSIEATIVIKQGDQTYYSVTEGDTVLFKW
KGKELFRGIVFARTPDEHTLAFSAYDVLQYLVKNQDVYVFSNQRADQMIKRIANDFQIPT
ASIANTGHTIKSLVIKNDTPLYDIILKALKQTKSQTGRHYQLYSEKGKLGLRAWPDPSEV
WVLETGVNITGYQYSTSINDTATRVVLRRQKDNKTYKASAKDGSGLNKYGVLQYTETVTD
DINQAQLQQRADVRLAEKKGVKKELKNIQAVGIPEVQSGLPVYISIPEAGIKKTYWVDTD
RHEFKGTKHTMTIDVVEKNTMPEGVS
>PK3-2_04203 hypothetical protein
MNYKKTLTLEQRGSWLLTKSVYEFWISQGKEKLRFPVLPEAIDIANSVQNDSVKITGLGE
LTFIEEPGAKEISFSSFFPKRYTPIAEYQNLPSPENAIAKIEKWMKAKKPVQFLITGTKI
NMACSIESLKYSEGDKEIGDRDFDIVLKEYKTASPRKIKRKKKTKAKRPSKASPKTYTVK
KGDTLWDIAGRFYGNSTQWRKIWNANKTAMIKRSKRNIRQPGHWIFPGQKLKIPQ
>PK3-2_04204 hypothetical protein
MAKLTARFEMEDRVSKKLRKIQNGFRALEKYRKMTQRNRAIDIRKESKTVLRTIDRIQKS
LKKKLGAQMISISAEDNASTVIQKVQTQLQGLPASVSIKIGASDQATEKFERLRELIAGF
KGFTIMLSAEDQISPAVQKIQRYMENALQNGYSVTIRVIDHVMKTVGRISAGIDALTGKD
NKLELAINDKVSDKLDSLQKRIDSMGSSGSPDKAASSAGGNAGGIASMFDPETILTALDK
FAASFMEKVDEIATKFSPETILTELDKFTTSFMNKVDAIATKFSPETILTELDKFTTSFM
SKVDAIATKFSPETIVSQLDKFTTSFMGKVDTIAMKFSPETIVSQLDKFTTSFMGKVDTI
ATKFSPETIMAQLDKFTTSFMSKVDAIATKFSPETILTQLDKFTTSFMSKVDAIATKFSP
ETILTELDKFTTSFMSKVDAIATKFSPETILAQLDKFTTSFMGKVDAIATKFSPETLLKQ
LDKFTGSFMKKVDEIASKFSPEAIFKQLDKFTGSFMKKVDEIASKFSPEAIFKQLDKFTG
SFMKKVDEVASKFSPEAIFKQLDKFTDSFMKKVDDIVSKFSPETIFNELDKFTDSFMKKV
DDVVSKFSPETIFNELDKFTDSFMKKVDDIVSKFSPDAIITKAEDFVTNIVDKISEKFNF
LNPDKIANKAEKFFDNIVSKIAKKFEKFSPDKIIEKMGEFFEKIIKGIAEKLGNLDFGGL
LGGKSSGSKGKQKASKANTNNSTSSNSNRTKKPSMNQKASGSKSKKSGGKWGGACGCCCA
GISTGKSKKVKNRNGSSYKGNKSNPVSTPKSAKAAKGGSGKGFSGLLKTLGESKGLKGGL
KGLKGAAKGIPGLGEILSLTDLAGINKDNAGEKVGSAGGGLAGAAAGAAIGSVVPGVGTA
IGGVVGGIAGTFGGESLGKAFDAGALNDTWNSITEGAQNAWSAIQETWGTVSTWFMDNVW
TPVSSAVVGVATSIWSNILNAWTTIQTIFSTVSTWFMDNVWTPVSTAVVGVATAIWSKIV
NAWTTIKNVFSAVASWFMSNVWGPVKSAVIGAATTIWDKMTGAWNKIKSVFSTVSGWFMD
TVWNPVKNTVSDVGKGISDAFKKAIDTVKNIWKGLSGWFKKNIQEPLTKVGEAISDAFSK
AFGWVKQIWDKAGGVASKVINFVTGGGDPNKGKDPDKKATGGYITKPTISWIGEAGKEFV
IPVDNNRGRGKMLLSQAASKLGMQVVDDMGAASSTAGSPVSVSGGATASPLSGSASPAMD
TANLTGQASTLGQQFSEGFGKGISNQPVKMEDWKKKNINTPFTQMISASPNYGKQTVSGY
AKGQNGTATGTDGFLQSKVKTPFQATVNKSSSWGTGTVKGFAQGQNSTQTGTAQYVSSHV
DKPFLRSKDTSNSWGSGMIGNFVTGMNSKSSEVKQAAKDMAKRVEQAFREELDIHSPSRV
MMSLGRFASIGVVKGLGSVDVKKYAEKQAGSLAAAYSGMGGMSGNVKQWIMAALMATKTP
MSWLPGLMTIAQHESGGNPNAINLWDSNAKAGHPSQGLMQTIPSTFNDHKAPGMGNIKNP
IHNAAAAIGYIKSRYGSINNVPGIKSMNHGGPYVGYANGGLITKEQIARVGEGNKREWII
PEERGIRGRYLLQRAAQALGMEVTDPSQSQQSELSSGQVSAVTSGTRQTIQTAGTKEIKI
EFNGDQHFHNGQDADSLVAKIKQALLDELQKDINTGTKGVVAFD
>PK3-2_04205 putative protein YqbN
MSEKNENVYDLSFFMPGKTIEAEEIKVPISKRFVDKKGNIVPFIFKAITTERIDELEKET
TTYKNVKGRGRVKDLDSQRFYARIAVESTVYPDFRSKELREAYKTADPVEVAKRVLSVGG
EYANWLNKAIEINGFEDELEDLEEEAKN
>PK3-2_04206 Phage-like element PBSX protein XkdM
MALKAQNTISGKEGRLFLDGEEMAHIKTFEANVEKNKSEVNIMGRRMTGHKTTGANGTGT
ATFYKVTSKFVLLMMDYVKKGSDPYFTLQAVLDDKSAGRGTERVTLYDVNFDSAKIASLD
VDSEALEEEVPFTFEDFDVPEKLSDTF
>PK3-2_04207 hypothetical protein
MNGGTFTTGKEKERAGIYFNFKTTAQERVSLGERGTVALPVASSWGEAKTFVSISSVEDL
NKKVGLSIDDPSLLLLREAKKNAQTVLMYRLTEGVRASADIAEGVKATAVYGGSKGNDII
IRINPNVLDSAAFDVTTYMDESEVDKQTVKKAEELKANGYVTFTGTGDLSSTIPLTGSEG
DTAAETLNASAGIRLSGGTDKAPVNSDYTDFLAAAETENFDVIVLPVAEGDQLKATFAAF
IKRLRDGQGQKVQGVTANYAGDYEGIINVTEGVLLEDDTEVTPDKATAWVAGASAGATFN
QSLTFVEYEGAVDVLHRLDHDTIVERLGKGEFLFTFDARDKSVSVEKDINSLVTFTAEKN
KKFAKNKIVRVLDAVNNDLTRELKALIKSRKGSGNDIPASEDGLQYVKTMITQYMTTLQD
AGGITGFDSDEDITISMNEDRDGFLIDLAVQPVDAAEKFYFNVEVN
>PK3-2_04208 hypothetical protein
MNSETGSIMAFMYSQWSVPIYERELPDQFQVPSLYVPSPSVFEETDTVSTFKKTYSLSVK
LFHHDSIQALDEADRLADAIREARNMVPLLSESGEKTGDMVRITRIETRVGDRGEAVMVI
RWSSRYYYYKTEQPVLQDIDMNSGVK
>PK3-2_04209 hypothetical protein
MKIAGLKQLNASLKEAASGGFSQQASRWLEECGQDFLEIVQSELISTQTVDTEKLLSSFE
KGAEDNLWIVQSGGLSLEVGTLLDYASFLNDGHWTSKENVRWVPGRFQGSQFMYDPAAST
GMALKRKWIPGTSYWDHAMLLYEQLFEKSLESKLRQWLKKL
>PK3-2_04210 Phage-like element PBSX protein XkdH
MSYQHMLIHRCDIYHEEAQAPSAGRFGIPSDKLQPVISYPDTPDEQDVPCYFTEKTQQLI
QKEPNQTVYQSFLVHFPLSADIRVNDKVIWENHNYKLKLPKRIRHHHWEVIAVRDESL
>PK3-2_04211 putative protein YqbG
MLIEPTDVASYSIYDRVKNRPEELLARDIIEAEAEAALITGHRFEDSVYDPLPDKAKLAL
VKLAQYFALVNSDESASSSYQSEKMGDYSYTVSGEGGIQRPEVYHLLEEFITPGYVPESS
RLKVRSL
>PK3-2_04212 Phage-like element PBSX protein XkdG
MRNQDIIRKAEMSLSALKSGGLMNPAQASAFIRMVQNTPTIFSESRVIQMENDSQKFEKI
GFGQRILRAAQEGKALSNDELTVPTTSTVQLNTKEVIAEINITYDTLENNIEKDGLQQTI
MQILAERAAVDIEELIVNGDTASADPYLAQLDGIRKQAVSHIVDMNGEELSRATFKKGLK
AVPPKYLRIPQEFRFYTSHGLEVEWKDRVADRQTNLGDQAVQGGLSTAFGVPVKGVSNIQ
PYTVGEGDAQYDASDIILTHPKNIILGFSRNIRIEVDKDIRSRKFIIVLTAKLDSKFEEE
DACAKLINVKE
>PK3-2_04213 putative protein YqbD
MARELRNAKISFVSYVDKAANQTEFFFTKSAGLPAFEKKVRLFTKSEQDEQKLVYGIVYE
PDVPDAHGDFMTAEEIEKAAHGFLAEAREIDINHSFEGGTGVVVESYVAPDDFMIGSKQI
TKGSWVLVTRASDEVWEQIKAGIITGYSMAGTADVYEEEPVEKAGFFSVFKQMLADKTGK
ETEEMRKEDMRESFEHALYPLLKRLERIEKNTDTEEKPEQTGDDDRLKKLVEDMLAPLIE
RIEALEKARGASKQTADEAGGNTEQVKKSIWSGLL
>PK3-2_04214 hypothetical protein
MMHNQTVRATVFKANGTAPQTKQIYEDDFSELYGEDIIAPPYNIIELKTIAEYSTILQQC
IDAYRVNITGFGFDVEYTFDVNASDVDQTKKKRAEKDWSRLEAFYKCLHFDESAEMILGY
AIEDREKTGNGFMEVLRDGMGKPAGIEYLDVKNMRVCGAGEPVEVSFMYEENGKMKRIKR
QKRFRKFVQMINGKKVFFKEYGDPRKMDMRTGEYVNTLAEKYQANEAIHLKIGSGVYGVP
RWVGNIVNLYGARKAEELNFMYFKQGRHVPAAITVENGMLSEASYRELQEYMNDLEGVEN
AHKFLLIEAEGIAKEKDLHGGEDITPVSVEIKSLAEILQNDALFLEYDEKSRNKLRSAFR
LPPLYTGEAQEYNRATADTARKITEEQVFQPERKTLVNKLNTLLLPELNIHDVRLTLKGP
DFRDPLEIAKVLGPFITAGAVSPNDLRDLAGRVLGKTLEEWPEEIYKRPAGQDAEKTNLT
ALMQELKESIEDIKTS
>PK3-2_04215 hypothetical protein
MIVKEINPHFEDYVFNWEQTYQFLVGGYGSSKSYHTALKIVLKLLKEKRTALVIREVFDT
HRDSTFALFQEVIEELGLTKAAASLSSPLQLRFQNGSRIMFKGMDNPAKLKSVHNISLIW
IEECSEVKYEGFKELIGRLRHPGLKLHMICTTNPVGTSNWTYRHFFRDERNKRFVLDDSE
LYEKRTIVKGDTYYHHSTANDNLFLPKSYVKQLDGLKAYDPDLYRIARKGRFGVNGIRVL
PQFEVLPHDQVKERIAAIGQPILRTGMDFGFEESYNAVIRLAVDPEKKYLYIYWEYYQNK
MTDDRTAEELREFIDTQELIKADSAEPKSIQYFRQQGFRMVGARKFPGSRLQYTKKVKRF
KKIFCSDRCENVIYELKTLTYAKDKSGALIEDEFTIDPHTLSAIWYALDDYEVADMKETA
HKRIRPNRERRRS
>PK3-2_04216 hypothetical protein
MKEISFVDVKDSGLVDGTIVTEAKLGKEGIAIKLADKMKALEKLSLYFDLFPDQFKQKIE
NEKLKLAKQKAEKTDDSQAPIEIMIKRKEDKP
>PK3-2_04217 hypothetical protein
MKTQQREQALAIYQQHQGKITNRSIADIIGVSAKTIGIWKKQDKWKEALFSETRNEQKQR
RIDNDELNERQRLFCLYYVKSFNATQSAIKAGYSPDSAHVTGSRLLKNEKVAAEIRRIKK
EMVNEMFIEAMDVLQVYIKIAFADITDYVTFGKKRFKLSGNRGRCSMKMITRL
>PK3-2_04218 hypothetical protein
MQDLLFEYKRTLKQTRTQYKTLTEADESVLSAEELKDKKIIRNMITDLEYVTEWLEKGRQ
PGIRRAIDRRDAYQRLMIKDPRIIESFSSAMMFEPDGQVSEEDRERIREALSLLTDREKE
MFLLHKVECFSYERIADLLGVKKSTVQTTIKRAIIKMQRQQEEMNRSLA
>PK3-2_04219 hypothetical protein
MINPKKLLHIDSITLESQLEEGKIRVIIVDGIKQEAWITEAPEHGKTLVETRKGDLARVE
FEIGYKLN
>PK3-2_04220 hypothetical protein
MKVLEKTKQAEKSPAPWRAVPCGDTKPIYIYSAYSEEEKERFPYSNGRLIAAVFDLSSYS
QKRNAALMAAAPELLEASEAALDFLKGNSDHSKERIIQLLEKAKNRAESEREE
>PK3-2_04221 hypothetical protein
MCKLCQTKKVIVEHTGIGAVFHPCPNCRSGTDLTPVIRKLEHMLKAGKARLNVRD
>PK3-2_04222 Chromosomal replication initiator protein DnaA
MCSCMAERKVKRLLGASEITHAFRQLGFREFRTEGKPQAIKDAFECAKEYVADYEQIKDS
RKNSIALLGQPGSGKTHLLTAAANELMRTRHVPVIYFPFVEGFTDLKNDFDLLEQKLSRM
KQAGVLFIDDLFKPVNGKPRATDWQLEQMYSVLNYRYLNHKPILLSSELTIETLVRVDEA
LGTRIYEMCSDYLVIIKGAAYELNHRLEGVR
>PK3-2_04223 hypothetical protein
MKTDKSYPFPTYSGLLNSEHYDKIGPALWLFLWFISSTTKEIEKDGVSWGIVLGHKPLKA
REMAAVFGVSEKTVRRWLELLEANEYIKAVRAPYGLMISVKHSKKFSFRSDKMAQQSIKE
RPFSPQTPDTDVRSDKDKTNTYTAADDAVDHIAKRFTQLRSAQEGRTVYPSSRDYQAIAR
IVAIGVPVTQTIKWLEECFQAFENRRTAASETIKAFRYCSKFIEDRFFAQQAKKNAAIQD
ERMERHDKTNNRAHFGRAEKRETSITGGQTGRIRCKQV
>PK3-2_04224 hypothetical protein
MYPIQIVFSENPIDQRHLGQAGGTISFTACGLPVFRFETREQFQTYMMLKGEAAAHENR
>PK3-2_04225 HTH-type transcriptional regulator Xre
MIGGRLKSLRGKRTQEEIASHIGVSRARYSHYENGRSEPDYDTLQKLADYFQVTTDYLLT
GKDKKSDDDIFSDPDLQLAYRDMQDFSPESKQQAIEFINYLKEKEKNRKPKNK
>PK3-2_04226 hypothetical protein
MGDYLSHLEEYVKNLYGRMGITSPHHIDMLKIAKDLDIWVHFEDMGSMMVKYDGMYSIVL
NQRKSREEQWEDFGHELCHVLKHAGNHFQMNKLFRELQEFQANQFMYHFCVPTFMLLQME
LPQWRSQALATIAAVFRVTKEFAEKRLEMFERRKAGIQFQKRLAYLLSNKRPNVYEEGDQ
QHLQVAEEKALYHIGKNS
>PK3-2_04227 putative manganese catalase
MFYHIKELQYQAKPAHPDPVYAKKLQEVLGGQYGEISVMMQYLFQGFNCRADAKYKDLLF
DVGTEEIGHVEMLATMISRLLDNAPADVQENAYKSDPAVAAVLSGMNPQHAIVAGLGAMA
ADSEGYPWNAKYIISSGNLLADFRANLNAESQGRLQVTRLYAMTDDPGVRDMLSFLIARD
TYHQNMWYAAIKELEERERDIVVPTTFPRELEKREVAYDLFNFSRGDESSQGRWAQGEAF
DGRGEFRYIPAPIAFASAPHLKPAPMWLQNTIPPMSKY
>PK3-2_04228 hypothetical protein
MKDMYDSFTALSASESEYRIIYEEKTGSEHIVLGPHGGRIEPGVSELVLAFSDQCSIYLF
EGVKKRNNRSLHLTSTRFDEPLALEKVNAHHYALAFHGYHDPKTPHTLVGGADRHKAELI
CERLNEAGFSAELTSEKDRLAGVHPKNIVNRTKREMGLQLEVSSAQRKALFRNFGCRDES
YIQNDLFCRYVEAVKLGFYD
>PK3-2_04229 hypothetical protein
MGFIDGLLGNASTLSTAAAKEELAHILLEGENVNAAFKLVRDILVFTDKRLILVDKQGIT
GKKTEFQSIPYKSISRFSVETAGRFDLDSELNIWISGAELPAVSKQFKKDESIYDIQKVL
AAVCM
>PK3-2_04230 N-acetylmuramoyl-L-alanine amidase CwlA
MSIQVKKNLVSEAKYALKCPNAMSAEYITIHNTANDASAANEISYMIGNTSSTSFHFAVD
DKEVIQGLPLNRNAWHTGDGTNGTGNRKSIGVEICYSKSGGPKYEAAEALAISFVAQLLK
ERGWGIDRVRKHQDWSGKYCPHRILSEGRWDQVKAAIEKELNGAVSSKKASVSSSASEYH
VKKGDTLSGIAASHGVSVKTLQSINRITDPNHIKVGQVIKLPQPASSSKSHAASSYPLPS
GVIKVTSPLTKGTNVKQVQTALAALYFYPDKGAKNHGVDGVYGPKTANAVKRFQSVSGLT
ADGIYGPKTKAKMEAKL
>PK3-2_04231 hypothetical protein
MNTYLMLTARTDQFNQEHVAGHYEFLDRLQGEKRLKMFGPFSDATGGAYVIEAGSLEEAA
EIGHADPLVANGSSELTIKEWKLK
>PK3-2_04232 hypothetical protein
MKSKWMSGLLLVAVGFSFTQVMVHAGETADTEGKTFHIAARNQT
>PK3-2_04233 Response regulator aspartate phosphatase A
MKQTIPSSYVGLKINEWYTHIRQFHVAEAERVKLEVEREIEDMEEDQDLLLYYSLMEFRH
RVMLDYIKPFGEDTSQLEFSELLEDIEGNQYKLTGLLEYYFNFFRGMYEFKQKMFVSAMM
YYKRAEKNLALVSDDIEKAEFAFKMAEIFYNLKQTYVSMSYAVQALETYQMYETYTVRRI
QCEFVIAGNYDDMQYPERALPHLELALDLAKKEGNPRLISSALYNLGNCYEKMGELQKAA
EYFEKSVSICKSEKFDNLPHSIYSLTQVLFKQKNDAEAQKKYREGLEIARQYSDELFVEL
FQFLHALYGKNIDTESVSHTFQFLEEHMLYPYIEELAHDAAQFYIENGQPEKALSFYEKM
VHAQKQIQRGDCLYEI
>PK3-2_04234 putative ATPase YjoB
MTNIPFIYQYEEKENERAAAGYGTFGYLITRIEETLYDQYGVFYELYASDDPNTEYWELL
VEDVRSGSLEPEHVAYIFEKLEKKTFAYDEDEKEPDYTVHKSIRNSVYAYPEKGVAFARI
PYFQDGSIMSFDCLFAVNDEKMRAFLEGVRPRLWEKSKRKVTVFTDGDGGTSREQEAIVR
EVQRSQVIMNPLLKKEIYRSIDQFFHSDKSFYQTYDIPYKRGILLYGPPGNGKTTLVKSI
AGSIDAPVAYWQITEFTSSETIEEVFQAARRLAPAVLVIEDIDSMPEDVRSFFLNTLDGA
TSKEGLFLIGTTNYPEEIDPGLMNRAGRFDRAYEIGLPDEELRLEYMKMRGFGIFLSEGE
IKNAAKLSEGFSFAQLGELYVSSALQWHQEGNHHIETMVKDMTGEQRKSRQGSWMERNKV
GFH
>PK3-2_04235 putative protein YjoA
MSQSNQIVSHFLSHRNVTNELAEKISKDHYSYKPAETSMSAEELVKHILTSFHLFANVIK
EGNASPFQNKQEETETDLNVLAKAYTEKTVAILEQLTQEQLDREIDLTAAFGRKVTGSAL
LQLAMEHEIHHKGNLFVYVREMGHTELPFYQQRM
>PK3-2_04236 hypothetical protein
MSVSIILMGLFVGALVGLTGVGGAALLTPLLIVLGINPSIAVGTDLVYNSITKLFGVASH
WRQKTINFTLVKYLAIGSIPSASLAIGILHLFPAFHQHQEEIIKHALGYVLTLVAISIIV
RLFLDRKLRPNRWQLMPLENKRALTILIGVVFGFIVGLTSIGSGSLFAIAMIYLFNMKAS
QIVGTDIAHAFLLVTAAGILNASFGSVDYMLAANLLIGSIPGVLIGSHLSPRFSPRPLQF
IMASIILISGLKLI
>PK3-2_04237 Altronate dehydratase
MKSFIKIHKQDNVLLALRDIEKGERLNADGVSIEVKDDIKRGHKIALQPIKENDGIIKYG
FPIGHASQDISIGEHIHVHNTKTNLSHIQTYSYTPRFDQNPYTNENRTFKGFRRENGDAG
VRNELWIVPTVGCVNGIAEKMLQRFVKETGDIAPFDNVLVLKHQYGCSQLGDDHENTKQI
LLNAIRHPNAGGVLVLGLGCENNELAGMKEALQDVNLDRVKFLESQSVTDEMEAGVALLK
EIHEAAKGDRREDIPLSELKIGLKCGGSDGFSGITANPLLGRFSDYLIAQGGSTVLTEVP
EMFGAETILMQRAANEEVFHKIVDLINDFKQYFIKHDQPVYENPSPGNKAGGISTLEDKS
LGCTQKAGISPVMDVLKYGEVLKTKGLTLLSAPGNDLIASSALAAAGCQIVLFTTGRGTP
FGTFVPTVKVATNTQLYEAKPHWIDFNAGLLAEDDVHEEYVLREFIHYMIEVASGGLVNH
EKNDFRELAIFKSGVTL
>PK3-2_04238 Altronate oxidoreductase
MQKLNKNMYDHYTQYPEKILQFGEGNFLRGFVDWQIDQLNQHTDFNGSVAVVQPRGSEKI
KRLNQQDGLYTLFLQGMKDGEAVNEHMIINSISRGIDLFSDYEAYKKLAWSEELRFIISN
TTEAGIVCDETDRLEDRPQKTFPGKLTAFLYFRYQAFKGDLTKGCVLIPCELIENNGEKL
KETILQYADLWKLEEGFTQWIHEANTFCNSLVDRIVPGFPVDSIGEITADLGYQDDLIVV
GEQYYLWVIEGPDWIEEELPFAAAGLHTKIVSDLAPYRTKKVRILNGAHTAMTPVALLYG
LKTVRDAVEHPEVGRFIRELIGDDILPGLKMEGLSQYADDVLNRFKNPYMKHYLESIALN
SISKFKTRNLPTIQEYAEQKGQLPERLVFSFSALLYFYQGDEKLQDDPAVLQFFKEVWHQ
ENGDMLRIASKVLAEERLWGADLTGIPKLTERVADYLNHIHELGMQRALEQCCTQRGEVR
>PK3-2_04239 putative HTH-type transcriptional repressor ExuR
MVTIKDIAKLANVSHTTVSRALNNSPYIKEHTKKKILELAAQLNYTPNVNAKSLAMQKSH
TIGLFFTSITNGTSHSFFADTIKGVNQAISEDYNLYVRGIDDLKNYDSVTPMRYDGIILM
SQSDIDNSFIYHIREKNIPLVVLNRDIDDRSITNILSNDKEGSQEAVEYFIKNGHQDIAI
IEGIEGFKSSQQRKEGYLAALIHHHIPIKHEYSVKGQYDMESGFQAMERLMALPNPPTAV
FCSNDDMAIGAMNAIFAKGLRVPDDISVIGFDDIGFSQYITPRLSTVKRPVEKISVLGAQ
KLLSLISEPETKAEKILENTAFMVRDSVRQLTT
>PK3-2_04240 Hexuronate transporter
MIAIAFSWKVSFVLIMIIGLVWAVLWIKFVKEKPQAAMGAEPAIKAETSPEEKIPLTFYL
KQKTVLFTAFAFFAYNYILFFFLTWFPSYLVEERGLSVESMSVITVIPWILGFIGLAAGG
FVSDYMYKKTARKGVLFSRKVVLVTCLFSSAVLIGFAGLVATTAGAVTLVALSVFFLYLT
GAIYWAVIQDVVDQNNVGSVGGFMHFLANTAGIIGPALTGFIVDRTGTFSGAFLLAGGLA
VFASLAVIRFVRPISGKPAGTEAENPVSY
>PK3-2_04241 Hexuronate transporter
MFSKDKLPVILFLFLAGVINYLDRSALSIAAPFIQDDLTLSATQMGLIFSSFSIGYAIFN
FLGGVASDRYGAKLTLFVAMVVWSLFSGAVALAFGFVSLLIIRILFGMGEGPLSATINKM
VNNWFPPTQRASVVGVTNSGTPLGGPFPVRLSV
>PK3-2_04242 putative oxidoreductase UxuB
MIPLHGNLAGKTAVITGGSGVLCSEMARELARHGMKVAILNRTAEKGQAVVKEIAAAGGT
AFAVSADVLDRGSLIQAKEDILGRFGSVDLLINGAGGNHPDAITDVETYEEAGEGQTFFD
MDERGFSTVFSTNFTGAFLASQVFGKELLKADSPAIINLSSMSAYSPMTKVPAYSAAKAS
INNFTMWMAVHFAETGLRVNAIAPGFFLTKQNHDLLINQDGTLTGRSHKIIAGTPMKRFG
KPEDLLGTLLWLADEAYSGFVTGITVPVDGGFMAYSGV
>PK3-2_04243 Mannonate dehydratase
MNITFRWYGRGNDTVTLEQVKQIPGVKGIVWALHQKPVGGVWEKEEIRAETEYIQSYGFH
AEVVESVNVHESIKLGNEERGRYIENYKQTIRNLAEFGVKVICYNFMPVFDWTRTDMFRP
LEDGSTALFFEKAKVERLEPQELIRTVEQASDMTLPGWEPEKLARIKELFAAYRTVDEEQ
LWDNLSFFLQEILPVAESHGVQMAIHPDDPPWPIFGLPRIITGEESYKRLRAISDSPSNC
ITLCTGSMGANPVNDMVEIAKTHAGIAPFSHIRNVKIYENGDFIETSHLTKDGSINIQGV
MEELHKQDYDGYVRPDHGRHLWGEQCRPGYGLYDRALGIMYLHGLWDAYEAITKKEVEA
>PK3-2_04244 putative zinc-type alcohol dehydrogenase-like protein YjmD
MKAVQVRKAYDLVAAEMKKPILSKDDDVLVKVKRVGICGSDMHIYHGTNPLATLPRVIGH
EVTGQVEEVGANVRSLKAGDHVVIEPISYCGTCYACRKGRPNVCAKLSVFGVHEDGGMRE
YIVLPERQLHVVSKDLPWEEAVMAEPYTIGAQAVWRGRVEKGDTVLIQGAGPIGICVLKM
AKLAGAAVMMTDLNSERLAFAKENGADAVVNAQTEHVAERVREWTGNEGANVVIDAVCLP
ATFELSIEAVSPAGHVVVLGFDERAAQISQLPITKKEVTITGSRLQTNQFPKVVELLNKG
QLAHNGLVTHTFSVDDVHHAFQFIKEHPDQVRKAVITFD
>PK3-2_04245 putative oxidoreductase YjmC
MKTVTIPAEEARELVRNKLTGASLNERDAEKVADVLVHADLRSVQSHGVLRTEHYVNRLR
AGGINPEAHPVFKETGPVTGVLDGDDGFGHVICDVAMDRAIDMAKKNGVGMVTAVNSSHC
GALSYFVQKAADEKLIGIAMTHTDSIVVPFGGRSPFLGTNPIAYGVPAKRKKPFILDMAT
SKVAFGKILQAREEGKDIPEGWGVDENGEAVTDPDKVVSLSTFGGPKGYGLSIVVDVFSG
LLAGAAFGPHIAKMYSGLEQKRKLGHYVCAINPSFFTGRDAFLEQMDAMLDELQKSPPAV
GAERVYVPGEIEQLHEERNKKNGISIARSVYEFLKRR
>PK3-2_04246 putative symporter YjmB
MRTELANKVVSIETEKRLTLKEKISYGFGDFGNGFMFDLGQIYLLKYFTDVAGIPAAMAG
GIFLVSKLFAAITDPIVGSSIDYRKNIGKRGKFRPYLLIGSIVLAALTVLIFLSPNVSPT
GKLIYAYASYMIWGIGYSFVNIPYGSLGAAMTQNSEDRTSISTFRQIGSLGALFITSVAV
MPLLVKFDNPKVGYPVVMGLFAALGVLWFYICYRNCKERIVISEAPKEKLTLSSVVKTFI
TNKPLLTLVLMTIFSISAYNIKSAMLVYFAQYNLGNVELMAYMNFIIIGSSFLGVIFLPK
LVKMFGKKRTAMIGFGISVAADLVNFMLPSNVYVFTILASIAFIGISIPNGITWALVSDI
IDYGEWKSGERKEATTYSLFNFSRKLAQSLSGFLSGIGLGIIGYVPNAVQTAQALIGIKA
LLLLYPAIALALAMIIIGFLYKLTDQQHAQIVQDLHQKS
>PK3-2_04247 Uronate isomerase
MKDGEDMEPFMGENFLLQNETSVILYHHYAKDMPIIDYHCHLSPKEIYENKTFQNITEAW
LYGDHYKWRIMRANGIEETYITGDAPDEEKFMAWAKTVPMAIGNPLYNWTHLELQRFFGI
YEILNEKSAPAIWNRTNELLQGEGFGARDLIVKSHVKVVCTTDDPVDSLEYHLLLKEDKD
FPVSVLPGFRPDKGLEINRAGFPDWVQALEDAAAISITTYDEYLNALEKRVRFFHSAGGR
VSDHAIDSMVFAETTKEEAGRIFSDRLQGTEVSYEDEKKFKTYTLQFLCGLYAELDWAMQ
FHINALRNTNTKMMKRLGPDTGYDSMNDEKIAKPLYKLLNSVEIKNQLPKTILYSLNPND
NYIIASMINSFQDGITPGKIQFGTAWWFNDTKDGMLDQMKALSNVGLFSRFIGMLTDSRS
FLSYTRHEYFRRIFCNLMGEWVENGEVPHDMELLGSIVQGICYDNAKHYFQFQEEKANV
>PK3-2_04248 NADH dehydrogenase-like protein YjlD
MSKHIVILGAGYGGVLSALTVRKHYTKEQARVTVVNKYPTHQIITELHRLAAGNVSEKAV
AMPLEKLFKGKDIDLKIAEVSSFSVDKKEVALGDGSTLSYDALVVGLGSVTAYFGIPGLE
ENSMVLKSAADANKVFQHVEDRVREYSKTKNEADATILIGGGGLTGVELVGELADIMPNL
AKKYGVDHKEIKLKLVEAGPKILPVLPDDLIERATASLEKRGVEFLTGLPVTNVEGNVID
LKDGSKVVANTFVWTGGVQGNPLVGESGLEVNRGRATVNDFLQSTSHEDVFVAGDSAVYF
APDGRPYPPTAQIAWQMGELIGYNLFAYLEGKTLETFKPVNSGTLASLGRKDAVAIIGAN
STPLKGLPASLMKEASNVRYLTHIKGLFSLAY
>PK3-2_04249 putative protein YjlC
MPETIDQTNASVSQSQQDLIDQLLKPEVQESLTVLVDQLPKLTELVNILTKSYDFAQSVA
TDEVLKSDTVGAITEILEPVKETAKEVAATAIEAKDRADASSETIGLFGLLRMLKDPQAQ
KLFRFANSYLEVMNERENQK
>PK3-2_04250 hypothetical protein
MEAKLQTHFFQDDGRIPNHPDFPLVVYQNALKDTGQAELIVNRHGWSNSWSGSVFPYHHY
HSNTHEVLIAVRGEAVIQFGGEQGGAIPFKSGDAAVIPAGVGHKKISASPDFMVIGAYPG
GVQYNLKTGEPEEREEAMTQIKQVSLPASDPITGKRAPLLEIWVE
>PK3-2_04251 hypothetical protein
MKAIVIGILASLFFAVTFILNRAMELSGGSWLWSSSLRFIFMMPFLCLIVIMRGTFIPLL
QEMRKKPIFWIKWSFVGFVLFYAPITFAAGYGPGWLVAGTWQITIVAGVLLSPLFFVKKD
MPGGPQLIRQKIPLISLGTSVIILIGAALIQLQHAESLSGKMLLFSVLPVVIAAFAYPLG
NRRMLEEYGGRLDTFQRVLGMTLASLPFWLIVAAYSWWSDGLPTAGQTVQSFIVAVSSGI
IATVLFFWATDMVRDNPQKLAAVEATQSGEVIFALLGEIVLLSGVFPSLLSFAGLFIIIA
GMVLHTFASQPGKPKKKTQSNLTA
>PK3-2_04252 Glutamine transport ATP-binding protein GlnQ
METNDQTQNIPAISFRSVRKSYEQDGQTYDVLQDVTGDIRQGAIVAVLGPSGSGKSTLLS
MCNLMRTPDSGEVNIYGKEVREWNVNKLRRTAALAFQSAPVLDGTVRDNLSLVQRLHQSQ
LHSPEELASLAGLPPELLDRSAKDLSGGQRQRLSLARTLASPSSILLLDEITSALDPVSV
LEIEELIKRQHQEKKWTVMWVTHNMEQAKRVADTVWFMADGRLLEIAETEAFFSDPQHEA
AKEFLKGGTR
>PK3-2_04253 putative iron export permease protein FetB
MDYLSLSLTMIFVLIALFLSKSFKAGVEKDMIIATIRAAVQLLIIGYVLSLIFRGDHPVF
ILLMVLLMLAVAAQNVIKRKKNTIGSFWRVFAALAIVEIVTQGILLSLHIIPLTARYVIP
ISGMVIGNSMVLSSLFLNRLSSEIGVRKEEIQLILSLGGTPKQSIQRILTSAMKMSMIPT
LESQKTLGLVQLPGMMTGQILAGADPIQAVRFQLLIVFTTMASAALTCVILSVLSYPPLF
TAHQQLKENK
>PK3-2_04254 hypothetical protein
MGKGLHGKRVAIGGSRKTEEISTIIEKQGGTPVIRPLQGTVYLAEKQVEPDLRTFVEEKA
DWVIFTTGIGTETLVDMAEKIGLKDEFLQAIRQAKAACRGYKTLAALKKLGITPEASDED
GTTRGLIRSLEPHDFSGKTVMVQLHGEKAPALIAFLEEKGASVLPILPYQHIPPEEETVE
RLCRELMNGEIDAVCFTTAIQVRSLFDFAKGHGYINEVKAVFEERAIAAAVGKVTAEALR
EEGITRLLAPEIERMGAMIIELSKYYEEKE
>PK3-2_04255 hypothetical protein
METKKEEYETKGYDTSIVYEFNEYPDERSGRCDNCDYTLFKSSVKSGKFLRECRRCGMKK
NI
>PK3-2_04256 hypothetical protein
MQNILEMKFDLNTIDHLGVKLYNSFPPVIAELVSNSYDADANLVNVNINYENKEVTVCDD
GNGMSFEELNNNFLVIGRNRRIQDGSDLSPRYKRPVTGKKGLGKLAIFGIAEEIEITSVK
DGIKNSFIMNYNEIKQTERENGTYKPRLIQHNVNTSESNGTSFIIRNMTNNKITDILSLA
ESLSGKFNFFDENFKTIITSETECIKITNELYQNRLQKEFEWHFPQDFQNSVENNVKIKY
LADKGVSGYIFTNKTPLQKNMPALFFMHEKN
>PK3-2_04257 hypothetical protein
MTFFNERSNDRFHSYVSGFFHADFVDDDELLDYVSTDRRSLLWDQTEELIKLKEGLDELI
KKIGYNWKEKRKETQENRINKIIGDTFYEGLSPSDRDILKKFQNQISYNIENTEEAEKVA
ELMTSLKRQLHFEYFKNYVSKLTEENTSLEEIEEMSQDWEQIEIYEMSKIAVGRIETINK
FDNFIKTNASETKEIQPFLEKFPWILDPRMTKFDREITFSRILKENFPDEELTERNRRID
FICSNVSGKVHIIELKRPNIRLSSKEINQAVEYHTFLKKNTTEISEIKTFLVSDNINLEP
TAQTIYDALHAQEVLTIRTYTDMLNEARHYHKQFIDAAEEISAAKEEY
>PK3-2_04258 Modification methylase HaeIII
MNVIDLFAGAGGLSEGFRQAGFNIIAHVEMDQNASLTLKTREAFYYLKERNKLDLYKKYL
KNELTRDELYSNIPEAILDKVINAEISDLTINDIYNRIDSLLGNEKVNLVIGGPPCQAYS
LVGRARDPKKMKNDPRNYLYKEYIRFLKKYSPDYFLFENVLGLLSARKGEIFEKIKLEMN
RAGYNIDYKVLNSKDFGVLQSRRRIILIGWKKNLNFNFPSFEVEESGSTIRDLFYDLPEI
QAGEIKKPGNTYKNEVKSYVITNGIRSLDWDILSQHQARPQRELDLEIYKYCVEVWNSER
RKVKYNQLPYHLITHKNTKTFLDRFNIIPYDGISHTIVSHISKDGHYYIHPDIKQNRSIS
IREAARIQSFPDSYYFETSRTAAFKQIGNAVPPMMAKKIALKLKSILF
>PK3-2_04259 Oleandomycin glycosyltransferase
MKKYHISMINIPAYGHVNPTLALVEKLCEKGHRVTYATTEEFAPAVKKAGGEALIYHTSL
NIDPKQIKEMMEKNDATLSLLKESLSILPQLEDLYKDDQPDLIIYDFVALAGKLFADKLQ
VPVIKLCSSYAQNESFQLGNEEMLKKIKEAEAEFKAYLEKEQLPAVSFEQLAVPEDLNIV
FMPKSFQIQHETFDDRFCFVGPSLGKRTEQESLTIEKSDRPVMLVSLGTAFNAWPEFYKM
CIEAFRDSSWQVIMSVGKSIDPESLDDIPAHFTIRQSVPQLEVLEKADLFISHGGMNSTM
EAMNAGVPLVVIPQMYEQELTAKRVDDLGLGVHLPKEEVTVSMLQEAVQAVSGDQEVLSR
VKNMQKDVKEAGGAERAAAAIEAFMKKSAVPQ
>PK3-2_04260 Putative cytochrome P450 YjiB
MNVLNRRQALQRALLNGKNKQDAYHPFPWYESMRKDAPVSFDEENQVWSVFLYDDVKKVI
GDKELFSSYMPQQSSSIGNSIINMDPPRHTQIRSVVNKAFTPRVMKQWEPRIQEITDDLI
QKFQGRSEFDLVHDFSYPLPVIVISELLGVPSEHMDQFKEWSDLLVSTPKDKSEEAENAF
LEARNKCEEELAAFFAGIIEEKRKKPAQDIISILVEAEEAGEKLSGEELIPFCTLLLVAG
NETTTNLISNAMYSILETPGVYDELRNHPELMPQAVEEALRFRAPAPVLRRIAKRDTEIG
GHLIKEGDMVLAFVASANRDEAKFDRPHRFDIRRHPNPHIAFGHGIHFCLGAPLARLEAN
IALTSLISAFPHMECVSITPIENSVIYGLKSFRVKI
>PK3-2_04261 hypothetical protein
MTTQTDFKKQVVGILLSLAFVLFVFSFSERHEKPLVEGKHQENWHTVVDKASVEIYGSRL
VEEKQLKQKLGHKQADSILTLMKLANEKHVAL
>PK3-2_04262 hypothetical protein
MQTKWLERAQRIQAIAQAGLAFSKDVFDRERYEELMKLSAEMMADYSQTDIEVITDLWNR
ESGYPTPKADVRGAVFRENQILLVREKHDELWSLPGGFCEIGLSPAENVVKEIKEESGYD
TDPSRLLAVLDSHKHPHPPQPYHYYKIFIECSITGGQGETGIETNHAAFFSEDRLPPLSP
KRNTPSQLSMLFDFLRHPDKKTIFD
>PK3-2_04263 putative lipoprotein YjhA
MKKVLLLLFVLTIGLALSACSQSSDASEKEKPKEKKSQEELEKELDKELKKGGEPKTKKD
DQIHKIGETFKAGHTNFTVNKVDRVQKSEYSEFGGAVDSKPKTIKDNEERLIIEVTIENI
GKDSMQYNFLGLDFKDKKNQSVRPVFSIEEKGRILMTGTLTSGKKVTGILSYVIPKGEQK
HYTLVYNPFLADTNSSNTEERVKDDIDYLVKLD
>PK3-2_04264 hypothetical protein
MAKAIKRIQKIEVTEEEQRTRDLREIEDALVDHKEAILETLHMLGHMNERGVLPLLRGLF
GQGDKVLDILVKKADTEETANTLKNLLLLFGTLGMLDVKQLEPLILKVNAGVASAVEQKN
SEEKTGYFDIIRSLKDPEINKSITLLFSFLKGMGQDTNELERTTQPPEHQKHHQEPREKR
GMNKRD
>PK3-2_04265 Putative formate dehydrogenase
MAEQKTITINGVEMEVSEEQTVLQLLNNSSIEVPQVCYHPSLGPIETCDTCIVSINGELK
RSCSAELKDGDVIDTLSPDVKKAQVIGMDKILYNHELYCTVCDYNNGGCEIHNTVKEMKI
NHQSIPFDHKPYHKDESHPFYRYDPDQCILCGRCVEACQDVQVTETLTIDWDRKRPRVIW
DNDVPINESSCVSCGHCSTVCPCNAMMEKGMEGEAGYLTGIINETLRPMIEITKGVETGY
GSILAISDMESAMRDERIKKTKTVCTYCGVGCSFDVWTKGRDILKVEPQEEAPANGISTC
VKGKFGWDFVNSEERLTKPLIREGDRFREAEWEEALSLIASKFTDVKEEFGPDSLAFITS
SKCTNEESYLMQKLARGIIGTNNVDNCSRYCQSPATAGLFRTVGYGGDSGSITDIGQADL
VLIIGSNTSESHPVLSTRIKRAHKLRGQKVIVADIRKHEMAERSDLFVQPRAGSDIVWLN
AIAKYLIENGKADERFLRERVNGREEYVKSLAPYTLEYAEEKTGIDQETLIHMAEMIGQA
DSVCALWAMGVTQHIGGSDTSTAISNLLLVTGNYGKPGAGSYPLRGHNNVQGASDFGSMP
DKLPGYENVTDEQVRQKYERAWGVPLPKEPGMTNHEMIEKIHSGQLKAMYVKGEEMGLVD
SNINHVHAAYEKLDFFVVQDIFLSRTAEFADVVLPASPSLEKEGTFTNTERRIQRLYQVF
EPLGESKPDWQIIMEVANKLGAGWHYEHPGDIMEEAAMLSPIYAGVTYERLEGYNSLQWP
VGADGKDSPLLFTERFPFPDGKAKLYPVQWTEPEEFGEEYDIHVNNGRLLEHFHEGNLTY
KSKGISKKTPEVFLEISPELASERGIQDGTLVRLTSPFGNVKVKCLITDRVKGKEVYLPM
NDSGEAAINLLTGSHADKDTDTPAYKETSAKMEILKREGTNPLPKINHRNGNPQPQIGVQ
VQKKWARKDYIFPGDAVKRGIGHNG
>PK3-2_04266 putative protein YjgB
MKKTISAITAAAAVTSSFTGFGAATFSAPAKAAAQTNTLSEHTNQSAANLVKNLYSTAYR
GEMPHQAHGLTINKSTKGDVHARLGEPERPVGGDNRFDLYHWNMGQPGYGFSYHKDMTIS
EIRYFGTGVERQLNLGGVTPEVLQNEIGPANRVLTVPFTDEIDYVYDTGRYELHFVIGKE
QTADYVNLKAK
>PK3-2_04267 hypothetical protein
MKKASHIEALFDYQNEQFYSGTGGNSNCIGFDIAP
>PK3-2_04268 hypothetical protein
MNFVMEKTFEQYEKLFSMEEQKREDEFRYTMMKPFENMWNAIQVPLKAKEPNGYDVMMAV
KMLGYLDVFDAETGLKALRILKKSHAAETAASALRQCMRFAERKQLRVNADEIKFGLYIA
DPTKLQLQKGYCGFGGIPGFIHVWIDPNRYNLPRLPSIIAHEFHHNLRFSYADFHHGSVS
VGDYLVIEGLAESFAKELFGEEQLGPWVTRFDQEDLQYSIEVIREVLDVKGFSEVSRYMF
GDQIAKEQGFEPAGLSAFAGYAVGYHAVQSFMDKHQVTINEATLLDAETILSQCGLFSK
>PK3-2_04269 putative protein YjfB
MDIPALSVAMHQASLAQNVEIALTKKMLDTAQQNADQTLKMIQDPTLGQTIDVKA
>PK3-2_04270 hypothetical protein
MKRLFTKASLMLFAALFVFAAKGAPANAETHTYDGKSPYYNDCASSGSTKKSSNLVNASN
QVIGVVELKFSSTCKTAWAKITMNNTLTTGFEANAEITRNTDGKRYNCDSAGGNGKAVAG
QKSCYTPMVYDLDPRTSYAFGKYSGPNLNVWATTGSY
>PK3-2_04271 Peptidoglycan-N-acetylmuramic acid deacetylase PdaC
MDAALKSFAEKEVRQFQKETKDADQEHTTKRNELNVDYKIVHYAKQTVAIVFHEYKYIGG
AHGQNVTKTFNYDFSKQAFLSIDDIFKEDADYLHKLSLIAYHELKKDKAIAADDALLKEG
TAPKKDNFSRFAIKEDYIEFYFDTYQVAAGNLGEQSIAIKKSLLKDIVKEQYMDKAKNKN
KIKEQKPKHEVISLPKEETIDPNQKVIALTFDDGPNPATTNQILDSLKKHKGHATFFVLG
SRVQYYPETLKRMLKEGNEVGNHSWSHPLLTRLSVKEALKQINDTQDIIEKISGYRPTLV
RPPYGGINDELRSQLKMDVALWDVDPEDWKDRNKKTIVDRVMSQAGDGRTILIHDIYRTS
ADAADEIIKKLTDEGYQLVTVSQLEEVKKQREAN
>PK3-2_04272 Peptidoglycan-N-acetylmuramic acid deacetylase PdaC
MFAKRIKWFHVLIAVVCVAGLIGFFHNSLKKETVMNKVKMDSQYGNVEIATLVNDGKTFN
YAVNYPVFKNKKWMRH
>PK3-2_04273 Spore coat protein T
MDFPLNEQTFEQITPYDERQPYYYPRPRPPFYPPYYYPRPFYPFYPRPPYYYPRPRPPYY
PWYGYGGGYGGGYGGGYGGGYGY
>PK3-2_04274 Protoheme IX farnesyltransferase 1
MENARDSAAISETKYIKASNRVTVYDFIKLAKPGIIISNSIAAFGGFWIAFASADKPLSG
IAFLMTMVTAMLGTAFVMASGTVYNNFFDRHMDAKMARTRSRASVTGKMPPAMIVTYGSV
LGIAGLAMLYSLNPLTALLGLAAFILYAIIYTVWVKRTSVWSTFAGSFPGAAPPLMGYCA
VTGEISMAAVLLYAVMFLWQPPHFWAIGIRRKEEYRAAGVPLLPVVKGNHITKVKMIRYI
AVLVPVTLLLPFSLGTGHLSPFYFLAALVLGGIWIKKSIQGFKTDDDVKWAKDMFIYSLI
YFCLLFLIMMIDSFVMFLIR
>PK3-2_04275 hypothetical protein
MYFLTILLLYFSLHPIAGWGTYCLFVYGFIFSCIGFKKKVHFPIHLLRILFIFFMPLFNV
LLFLFSLGESTAATGSIDPPLSLSEKICFFSEAVFICSPELYRWLNKKTGISINQNDQR
>PK3-2_04276 hypothetical protein
MKGILLIMQLGFSFMVFLFLAAVNWYQGSELVSDRFDWNYTAKISKHLNGIDTITSSKQI
SQLDFFIYSAKHYPVMSMLMILSLLYVLATLFLLIYSVKFNRHEIHLDC
>PK3-2_04277 hypothetical protein
MAFSNSQTELVLRTFQICISQKPTFENLTNQGNKIRKFNGFPNSCGDYAAVMQASHNNDL
LAGK
>PK3-2_04278 hypothetical protein
MKEYEFVRVELSTMKRRPKEDYQQIIHDYANRGWKFVQIFAPSIDAYGAAAYFEIIFERD
AEEA
>PK3-2_04279 Cys-tRNA(Pro)/Cys-tRNA(Cys) deacylase YbaK
MAKKMAKTNAVRLVEQQNISYELLGYETEGGQPADGITVSEKIGYPVEYVHKTLVATAGA
NHYYVFVVPVAEELDVKKAAKVAGEKKVEMIAMKKLLEVTGYVRGGCSPIGMKKWFPTYI
DAAAETLDFIIVSAGKIGMQLKVAPQDLAKACDASFAEIV
>PK3-2_04280 hypothetical protein
MYHYFYGPALIPSFSHTPNTQRSPDYSERQRRREITLNVDGFIPPSASEDLGDGFYSYAW
TNQQVINPGEYLVCYLEGRDINVVNGGFTPRDTAPLYAIASFPRRRNQWVIIIHNPVQTQ
RAISLYLIAKR
>PK3-2_04281 hypothetical protein
MVLLETNRLLLRTIDIPLLNAASKRNHQAIQDLGYQTNGEWPDPDFFEAIPYFREKLVKN
NGTKGFDSWLILKKHNHEIVGGTWFLGDPDTNGMIEIGFATNKSHRRNGYCAEAAHKLIN
WALNQDIVNSITARCEHDHLGSQHILKKLGFTLDHKSKDFMHWRYVIT
>PK3-2_04282 putative protein YjdF
MKLTIYYDGQFWVGVIEAVNSGKLRAFRHVFGKEPKDPEVLDFIHHQLLHTISQTEQEGV
SLKGQRQKKINPKRLQRQVSKEVKHAGVTSKAQEAIKLELEARKQKKKQLTKEMREYEKE
QKYILRKQKAKKKHKGK
>PK3-2_04284 hypothetical protein
MKKWLQIISALFLSSFVLMGCNNDQDDNDNNAPDVEENDQDNNGNNQDNDNNNAPGVDED
DTINKDDEKDNDPDPEDPVEDPEDTDKDKKDE
>PK3-2_04285 hypothetical protein
MKKRKIAICLALLLGVVGVSSASYALSELSTYKVADRAAT
>PK3-2_04287 Serine/threonine-protein kinase PknD
MVKPGTVVEFNTEKQFIHVKTLGQGGTGDTHLFKDETTDMFFAFKKYAPKDTNYIDENYK
RFVDEIKILFTLSHPNIVRVYNYYLYPEHKLGYLQMEYIDGVSIAEFEPVWKDWPEIFTE
TISAFEYLEFNNILHRDIRPANIMIDKQENVKVIDFGFGKKLLGQEMDGRSVLLNWPVTQ
LPNETADKGIYNHQSEIYFVGKLFSNIIGENLPNFKFKYIIDKMIQLDPRERYLNFQDIS
VDISQGVLAKNFTEEEKNLYRDFAEILSKYIVSHSNRYEPVKDPNIIINQLSTLIRNSSL
EEHIQDNQQLIDCFINNPYIFKTIKDIPLSIVVDFYRFLQSLSADKQKIVLDNIDVRLSN
IKIEIDIDDDDLPF
>PK3-2_04288 hypothetical protein
MKIKKDEAKEREIKDLKKKLADGVSDPDEYLEIAKKVGYENLTPEQLEFVSFLEQRKAFM
DNGKEVLQIIGDGAKGAIVGLYDLAKDTGEGAIQFGWNIGWTIDNFNKDPQKVLDTVLVY
DYQAAFQSIVDTLKDNWDTKMIHGDAYTRLHYVTYLGGSLLLLKGGKSSVSTGSKDLAKV
GKAAGGTIKKSGQSVKRFVKPPVNRYTPALEGILQDAEKTINVKNTPLLKSIAEDKKESV
LRESESSNNTDIGNVKQGDSTPLAPGGGLAAHESLLKDTLGRPTKN
>PK3-2_04289 hypothetical protein
MIDTNIFEPVFQFLGGIFHQDIETPESALDEYLEEIPKEEQETDIAALKDFINSDYSDEE
KNDFIDEATDGVDIRSYGVSPLVWLEQVIQKIEKNIEIL
>PK3-2_04290 hypothetical protein
MNGIEFLESVSQLGQIILLFSGYALYWRLGKTKKERSLTKYETFLRFFVMFGIFAWALSF
LALHLW
>PK3-2_04291 hypothetical protein
MLKRLFFLASIFFLAIATIAPAASATQLNPKDGLDGLTEEQIEKSVAEVEYIFTKILVFD
KEAGYTVNEDELEKAPYPPAQKEGMIAFANYMNKEYNYSDVKINSVQGCLEDALNLSKGA
LNQVQKAIKNGDWLTVVGFLGTIGLAVSPAAVFAFFLLCGAPVAKIAPQEN
>PK3-2_04292 hypothetical protein
MEYSFEFKRDPLGYLRIVLPTELEYFSDIIEDIVSVGEADEYLKIIQEVLDGSSEEYEIQ
LNTTIAYIKKDQTAVEHLYTESENAKSSMETEKLKNLLLVWRDKIPERYKSVD
>PK3-2_04294 hypothetical protein
MHSLISSDDVWVLWGFIAVWAAVSIGLEQRFKWASAVSGAIIALAGAMVFTNMGVLPVES
PVYDTVWAYVVPLAIPLLLFQINVRLIFKESRRLLFIFLISSAGTVLGSILAFFLLKQHI
PYLDKIGGMISASYIGGGINFAAMAAKFETPGEFVSATVVADHFMMAFLFFILISIPALK
WFQRHYAMPFEEKVKAAGNNGNHAESYWKRKNISLKDIAFNAGAAFVLVAVSVKVSGYFK
SMFSHPLLTGTLGDQYLMLTSLTVLIIFLFPRFFERLNGSQELGTFLIYLFFVVIGIPAD
LRLIVTNAPLILLFVFIIAISNLAVSLAVGKLFRVQLEEILLAVNATVGGPTTAAAMAIA
KGWRELVAPIMLVGTLGYLIGNYVGTFMGNWFSSFL
>PK3-2_04295 [Ribosomal protein S5]-alanine N-acetyltransferase
MLEGNTIYLRPLDVTDAEDNLRLQSENRDFFEQFSMIRADDYYSVEGQRKRIAEYQERMK
KDTEYHFGIFTASDDTLIGTVSLFQIIRGALQTAFIGYFLDKAHNGKGLMTEAVRLIVDY
AFHELKLHRIEAGVMPRNLGSMRVLEKAGFHKEGIARKNVKINGVWEDHQVLAILNPDDE
>PK3-2_04296 Cystathionine beta-lyase MetC
MSNHNWTLETQLVHNPFKTDGATGAVSVPIQHASTFHQSSFEEFGAYDYSRSGTPTRTAL
EETIAALEGGTRGFAFSSGMAAISTAFLLLSQGDHVLVTEDVYGGTFRMVTEVLTRFGIE
HTFVDMTDSNEVARNIKPNTKVIYMETPSNPTLGITDIKAVVQLAKENGCLTFLDNTFMT
PALQRPLDLGVDIVLHSATKFLSGHSDVLSGLAAVKDEELGKQLYKLQNSFGAVLGVQDC
WLVLRGLKTLQVRLEKASQTAQRLAEFFQKHPAVKHVYYPGLSDHPGAEIHKGQSTGAGA
VLSFELESKEAVKKLVENVSLPVFAVSLGAVESILSYPATMSHAAMPKEEREKRGITDGL
LRLSVGVEHADDLERDFEQALKEIAPVAVR
>PK3-2_04297 Cystathionine gamma-synthase/O-acetylhomoserine (thiol)-lyase
MKREGVSYMSQHVETKLAQIGNRSDEVTGTVSPPIYLSTAYRHRGIGESTGFDYVRTKNP
TRQLVEDAIASLENGARGLAFSSGMAAIQTIMALFKSGDELIVSSDLYGGTYRLFENEWK
KYGLTFYYDDFSDEDCLRSKITPNTKAVFVETPTNPLMQEADIERIARITKEHGLLLIVD
NTFYTPVLQRPLELGADIVIHSATKYLGGHNDLLAGLVVVKDEKLGEEMFQHQNAIGAVL
PPFDSWLLMRGMKTLSLRMRQHQANAQELAAFLEEQEEISDVLYPGKGGMLSFRLQKEEW
VNPFLKALKTICFAESLGGVESFITYPATQTHMDIPEDIRIANGVCNRLLRFSVGIEHAE
DLKEDLKQALYQVKEGAVSFE
>PK3-2_04299 hypothetical protein
MAPKNGTVQEKKFFSKELSEEMTLLVYLPSNYSPLYKYHVIIAQDGHDYFRLGRIGRQIE
ELLSKREIDRSIVIGVPYKDVKERRKTYHPEGSKFSAYKRFIAHELVPFADDEYPTYQVG
YGRTLIGDSLGATISLMTALDYPNMFGNIIMQSPYVDKHVLGAVKQSDDIKHLSIYHQIG
TKETDVHTTDGNILDFTEPNQELKQLLEKKLSDYYFEPFDGDHKWTYWQPLITPALKKML
>PK3-2_04300 Putative phosphoesterase YjcG
MKYGIVLFPSKKLQDLANSYRKRYDPSYSLIPPHLTLRASFECAEEKADQLVSHLRNIAK
ESHPIVLKMTKYSSFAPVNNVIYIKAEPTEELKTLNEKLYTGVLSGEQEYNFVPHVTVGQ
NLSDDEHSDVLGQLKMQEVSHEEIVDRFHLLYQLDNGSWTVYETFLLGGGE
>PK3-2_04301 putative N-acetyltransferase YjcF
MKAVIAKNEEQMKDAFYVRKEVFVKEQNVPAEEEIDELENEAEHIVVYDGEKPVGAGRWR
MKDGYGKLERICVLKSHRSHGVGGIIMKALEEAAADGGASGFMLNAQTQAVPFYKKHGYR
VLSEKEFLDAGIPHLQMIK
>PK3-2_04302 hypothetical protein
MKAEQIQRDLESLHYWDARVLQLDSYFFGDEIRMIFEDTDSNVKLSFSGCSSFSFVTTAD
DRIKPLKDLAKSQIPYFLQDIEISAIQSEGKELLKSKILMPPLNVEIVCLTISINKVA
>PK3-2_04303 hypothetical protein
MIYAGHIQNQQYAQYANRTIGYKQDYAGTEKISYVPFQRVYKELEKQQDNQTAAERKVNE
MKRKRSLHKEGIRYQKGFFINEYR
>PK3-2_04304 Putative ATP-dependent DNA helicase YjcD
MKCARLNDRTIHLHTYSREHYQFLFEEGIKGHLFCSHCGKSVLLRLNIADPPEFIHRQPG
YFPACEEACEPKPAKEEKKEDDQESGVFRLPKGKAIAADSSPAITEWQQPRSIKPGTPFI
QKTIEPDTSLFPSVGLNTDQLKAVTETEGPLLVLAGAGSGKTRVLTARAAHMIEHLGIPP
ENMLLVTFTTKAVAEMKDRMAKQYGLQPAKVRRLVTGTFHSLFYKILYHYDSAKWNGEHL
LKMEWQREQYIKKALYEEGIDEKEFPVDQALQQIGFWKNTYVPNERIPLKDEWEKQVYRL
YEHYERQKKEQNQFDFDDMASACYELFIDRPDLLEQYQSRFTYILIDEFQDINPVQYKIM
QMLASPEQNLCCVGDDDQSIYAFRGSSPSFILDFQKDYPGAKTIYLTANYRSTHPIVSSA
DIVVKKNKNRYAKMLEAARDDVQVPVLFYPYDEEEEATMVVSDIKEKIQNGANPEDFAVL
YRTNSGGRAIYERLHHSSIPYTADRGVQSFYSRRIVRQILAYLYASQNEDDTEAIKHLLP
ALFLKQSALNTLKALSITEDCSMVKALAKLPDLKPFQLDKIKKIVPFFASLRTMKPVEAI
TFAEGKMGFSEYLKKRGNEGNKLEKGSDDLRDIKVVAKKFKTIPDFLAHVDHMRAAEKNK
TVENGVQLMTIHRSKGLEFKTVYVLGTVDGSIPHDFSLETARKGDEAPLEEERRLLYVAM
TRAKQHLYLSCPSNRRGKTSHRSRFLYPLLQQAKQPLHN
>PK3-2_04305 hypothetical protein
MDNQFFKNIEKKTGVNMQDVMNLAGSLQNANFKDENTVRSVIKRVAQLANRRVPKELEDK
IVQSITSGKEKLDFGTISKMMDNK
>PK3-2_04306 hypothetical protein
MGFGYGFGGGGYGGCGYGGYAGGYGGGYGSTFVLLVVLFILLIIVGASFYNF
>PK3-2_04307 hypothetical protein
MNEFEKWIDGRYKPHEQKQKEHEDTMGRIRNDLDKFDKAGMAFEEEIEELAGKTEALLKK
YQARYDQS
>PK3-2_04308 Sporulation protein YjcA
MVINGLTIVLLSLAVFRLARLFVFDTIMAPLRSLFHEEKEEKDADGNIETYIVIKGTGVR
AFIGELLSCYWCTGVWCAGFLILCQALIPQAAQWLILLLAIAGLAGIIETLVSKWLQE
>PK3-2_04309 Spore coat protein V
MSFETKVESLHPDIFERLSSEFEQQIEVIDCENITIDTSHITSALSIQALATTLIILVTQ
LVIADEDLADTVASEILILDNSQIKKRTIIKIINSRNIKITLSADEIITFVQILLQVLNS
MLLEFDIL
>PK3-2_04310 Spore coat protein W
MSDNDKIKEELENLPEVDPMMKMLVQNIFVKHGITKDKMKKVSDEEKEMLLNMVKDLQAK
SAELAEKQKKKKEEEAVQEQKSDKPLSRREQLIEQLRQRRQNNNNSNQS
>PK3-2_04311 Spore coat protein X
MESRPYSWVALDPDCDHPLDHKEKEKEDRKCNCDICCNGNGFGNDNAFINQDLAQANLNK
QVSDETIIIRDSCDINVSSTDVQAVASVVTALNAAVLTVALTSIADGVIAELVAQDLLQL
TANKQVNRQKLLIECSRGVNVTTVDADIAVLISTATNVLIAVLAITLIL
>PK3-2_04312 Spore coat protein Y
MSCGKTHGRHENCVCDAVEKILAEQEAVEEQCPTGCYTNLLNPTIAGKDTIPFLLFDKKG
GLFSTFGNVGGFVDDMQCFESIFFRVEKLCDCCATLSILRPVDVKGDTLSVCHPCDPDFF
GLEKTDFCIEVDLGCFCAIQCLSPELVDRTSPNRDKKHHHNG
>PK3-2_04313 Spore coat protein Z
MSQKTSFCVREAVENIEELQNAVEEDCPTSCHSKLLSPTHSLGDTVPFVLFTSKSNPLVA
FGNVGELDNGPCFNTVFFRVEKVHDSCATLSLLIAFDEHKHILDFTDKDTVCEVFRLEKT
NYCIEVDLDCFCAVNCLNPRLINRTHHHHH
>PK3-2_04314 hypothetical protein
MSNKKRNADKKPLMYIVQPNYAETTRSSMQEIVIKRKADKPAPPKEEEKPAYHEKQQEEA
VAKDVQQAEQKPAAEPASQQTQEVKEPEDIKNQQEQKAEPQAVEETVNVKQEPPKAEKKE
EPALEAEKPEKEPEAVHNADKAEEKAPPARKVRKPMSKMTIHEKIDFLTKLPHNMPRALC
LIEANGRTYRGVIVGRRNDSVLLRTTGNGAPTELAIDDITSLHPLGF
>PK3-2_04315 Enoyl-[acyl-carrier-protein] reductase [NADH] FabI
MNFSLEGRNIVVMGVANKRSIAWGIARSLHEAGARLIFTYAGERLEKSVHELAGTLERND
SIILPCDVTNDAEIETCFASIKEQVGVIHGIAHCIAFANKEELVGEYLNTNRDGFLLAHN
ISSYSLTAVAKAARPMMTEGGSIVTLTYLGGELVMPNYNVMGVAKASLDASVKYLAADLG
KENIRVNSISAGPIRTLSAKGISDFNSILKDIEERAPLRRTTTPEEVGDTAAFLFSDMSR
GITGENLHVDSGFHITAR
>PK3-2_04316 Hydroxymethylpyrimidine/phosphomethylpyrimidine kinase
MSIYKALTIAGSDSGGGAGIQADIKTFQELDVFGMSAITAVTAQNTLGVHGVYPLTVEAL
RQQIDAVAEDLRPDAVKTGMLWNAEMIEEVARKIDEYGFNRVIVDPVMIAKGGASLLRDE
SVATLKELLIPRSYAITPNVPEAETLTGMTIRSLDDRKKAAEQLVKMGAQHVIIKGGHQP
EDNSITDLLFDGNMFMQISHPYIDTKHTHGTGCTFAAALAAQTAKGDSIHQAFEVAANFV
REAVENTLGIGSGHGPTNHFAFKRNSLKTSR
>PK3-2_04317 hypothetical protein
MTDRYSRQELFAPIGPAGQKKLKEARAVIIGAGALGTASAEMLVRAGVGSVKIADRDYVE
WSNLQRQQLYTEDDVKREMPKAAAAEHRLRSINSDVDVTGFVMDVTAENIFELIKDASII
VDAADNFETRLIVNDAAVKEGIPFLYGACVGSYGLTFTVVPGSTPCLHCLLDTLPIGGAT
CDTAGIISPAVLQVAVFQVADALKLLTGEECEPVLRSFDLWKNERSEVRAAGLKQDACSS
CGTKDFPFLTYENQTKAAVLCGRNTVQIRSSFTKEADLDVLAGQLRQAGLEVAANPYLIS
CRSENMKMMLFRDGRALIHGTNDIARAKSIYHKWLG
>PK3-2_04318 Thiazole synthase
MLTIGGKSFQSRLLLGTGKYPSFEIQKEAVAVSESDILTFAVRRMNIFEASQPDFLEQLD
LSKYTLLPNTAGASTAEEAVRIARLAKASGLCDMIKVEVIGCSRSLLPDPVETLKASEQL
LEEGFIVLPYTSDDVVLARKLEELGVHAIMPGASPIGSGQGILNPLNLSFIIEQAKVPVI
VDAGIGSPKDAAYAMELGADGVLLNTAVSGANDPVKMAQAMKLAVEAGRLSYEAGRIPLK
QYGIASSPGEGLPV
>PK3-2_04319 Sulfur carrier protein ThiS
MMLQLNGKDVKWEKDTGTIQDLLASYQLENKIVIVERNKEIISKEHYHEVELCDRDVIEI
VHFVGGG
>PK3-2_04320 Glycine oxidase
MKRHYDAVVIGGGIIGSAIAYHLAKENKSIALFESGTIGGRTTSAAAGMLGAHAECEERD
AFFDFAMHSQRLYKGLREELYTLSGIDIRQHNGGMFKLAFSQEDVLRLRKMDDLDSVNWH
TKDEVLDKAPYTSGDIFGASFIQDDVHVEPYFVCKAYAKAAKALGAEIFEHTPVLHVERE
GEALSIETPNGTIWTDHAAVASGVWSGMFFKQLGLNNSFFPVKGECLSVWNDDIPLTKTL
YHDHCYIVPRKSGRLVVGATMKPGDWSEKPDLGGLESVMKKAKTMLPAIQNMKVDRFWAG
LRPGTKDGKPYIGRHPEDSRIVFAAGHFRNGILLAPATGALISDLIMNKEVNQDWLHAFR
IDRKEAVQI
>PK3-2_04321 Thiazole tautomerase
MELHAITDDRKPVEKLARAIIAIQNEVDFIHIRERSKSAADILKLLELVSEGGVDKRKLV
MNGRVDIALFSTIHRVQLPSSSFSPKQVRARFPHLHIGRSVHSLEEADQAEKEDADYVLF
GHVFETKCKKGLEGRGVSLLSDIKQRTSIPVIAIGGMTPDRLKDVKQAGADGIAVMSGIF
SSADPLEAARRYSRKLKEMRYEKAL
>PK3-2_04322 Aminopyrimidine aminohydrolase
MKFSEECRSAAAEWWEGSFVHPFVQGIGDGTLPIDRFKYYVLQDSYYLTHFAKVQSFGAA
YAKDLYTTGRMASHAQGTYEAEMALHREFAELLEISEEERKAFKPSPTAYSYTSHMYRSV
LSGNFAEILAALLPCYWLYYEVGEKLLTCVPGHPIYQKWISTYGGDWFKQQVEEQINRFD
ELAENSTEEVRAKMKENFVISSFYEYQFWGMAYQKEGWSDNGIKEVEECGASRHN
>PK3-2_04324 Glutathione-regulated potassium-efflux system protein KefB
MAHTSVASLVVVLIVAFLTPILLHRFKLSIPVVVAEIIMGLIIGKSGLNLVVEGDTWLQT
LSMLGFIFLMFLSGLEIDFSSFEKGKKKQLLPNGKEAPNTFAAASIIFGGIFILSLLLSY
GFVLAGFIQNAFLMTLIISTISLGVVVPTLKEERIMNSNIGQVILLVAVIADLATMILLA
VFSSLYGEDSGNMWLLMILFAAGVVLYFFGRVFKHRSFVQSMSKGTIQIGTRAIFTLIIV
LVALSESLGAENILGAFLAGVLVSLLSPNKELVQQLDSFGYGFLIPIFFVMVGVKLDVWT
LFQDPKILIMIPLLLLALLVSKIIPVLYLKKWYDNRTVLASGFLLTSTLSLVIAAATIGQ
QLHVISANMSGALTLVAVIASIFTPVFFKKLYKREEQPEEKKTIAFIGANQMTLPVTLEL
PEEEYDVRVVHVYQENAEEKLSESVFMVETISDYEPETLDSLGIFDADILVVATGNEDMN
ADIALLAKEKGTERVIASVGSPENEAALKERGISIFSILLSTKTLLRALIEAPGVMKLLT
NQESSLYQINMENSKYDGVILREFPLTGDVIFVRIFRGVDSIVPHGDTRLKLGDRLIVTG
SRGYVTDLKKTLEG
>PK3-2_04325 Bis(5'-nucleosyl)-tetraphosphatase PrpE [asymmetrical]
MAYDIISDIHGCYDEMTALIQKLGYTIKNGVPVHEDGRVLVFAGDLTDRGPKSIEVIRFV
AGAYEKGAVRYVPGNHCNKLYRYLKGNPVKVMHGLETTAAELEELSKEERKAVSEQFMKL
YETAPLYDILHNGELVVAHAGIKADDIGKYTGRVKDFVLYGDVTGETYPDGRPVRRDWAA
SYNGKAWVVYGHTPVKEPRKINRTINIDTGCVFGNKLTGFRFPEIETVSVPSSLPYDESR
FRPI
>PK3-2_04326 hypothetical protein
MEHFFIRKNITSAEVGMTVKEYAGELGISKRLLTDIKFGGGDLLINGEHVTVKYVLREGD
LLVVKFPEEQVSETLLAEPVPLDILYEDEHVLVINKQPYVSSIPSREHPSGSIANGIIHH
YQKNGVRATVHLVTRLDRDTSGVMLVAKHRFAHSILSSAQKNGLVKRRYTAVVHGRMTQA
EGTVDAPIGRHPDSIIERMVTPDGQKAVTHFYVTRATDGMTSVTLQLETGRTHQIRVHMS
YLGHPLCGDTLYGGTRRHIGRQALHSERLSFIHPLTQENMTFHAALPQDMKELIKGENP
>PK3-2_04327 NAD kinase 1
MKFAVSSKGDQVSDTLKSKIQAYLLDFDMELDENEPEIVISVGGDGTLLYAFHRYSDRLD
KTAFVGVHTGHLGFYADWVPHEIEKLVLAIAKTPYHTVEYPLLEVIVTYHENEREERYLA
LNECTIKSIEGSLVADVEIKGQLFETFRGDGLCLSTPSGSTAYNKALGGAIIHPSIRAIQ
LAEMASINNRVFRTVGSPLLLPSHHDCMIKPRNEVDFQVTIDHLTLLHKDVKSIRCQVAS
EKVRFARFRPFPFWKRVQDSFIGKGE
>PK3-2_04328 GTP pyrophosphokinase YjbM
MDDKQWERFLVPYRQAVEELKVKLKGIRTLYEYEDDHSPIEFVTGRVKPVASILEKARRK
SIPLHEIETMQDIAGLRIMCQFVDDIQIVKDMLFARKDFTVVDQRDYIAEHKESGYRSYH
LVVLYPLQTVSGEKHVLVEIQIRTLAMNFWATIEHSLNYKYSGNIPEKVKLRLQRASEAA
SRLDEEMSEIRGEVQEAQAAFSRKKKGSEQQ
>PK3-2_04329 hypothetical protein
MQNRIEILNATLSDDQLRLACEAEGNEAERKPSGQMLVDSDHFAFVYILELADSFEYVII
KEHVWPELKQAHAQRNPVVLEAGGETIELSGLHEELEYLLENIKDNANYGEEMEDKVKRV
FL
>PK3-2_04330 Putative triphosphatase YjbK
MSQEIEIEFKNMLTKQEFENITAALQLTEKDFTDQKNHYFDTDSFALKQKHAALRIRRKN
GEYVLTLKEPAAVGLLETHQRLSEVSDLAGFSVPEGSVKDQLHKLQIDTDAIHYFGSLAT
NRAEKETEKGLIVLDHSRYLNKEDYEIEFEAADWHEGKQAFEKLLQQFSIPQRETKNKIL
RFYEEKRKSI
>PK3-2_04331 Membrane-bound lytic murein transglycosylase F
MNVTNWAALLQLQALQSISNARSTGTQNAENPLSSFSSLLSQYTNGLTSQQQSTASSASS
SPLSLLNSASSTAPSLLSAYGLNSYTNSNSGYITKVAEGTETAAADSSSNKREAKQISSG
DFSIDSAIKKAADKYGVDEKLIRSVIKQESGFNAKAVSGAGAMGLMQLMPSTASSLGVSN
PLDPQQNVEGGTKYLKQMLDKYDGNVSMALAAYNAGPGNVDRYGGIPPFQETQNYVKKIT
SAYYA
>PK3-2_04332 Group 2 truncated hemoglobin YjbI
MGQSFNAPYEAIGEELLSQLVDTFYERVASHPLLKPIFPSDLTETARKQKQFLTQYLGGP
PLYTEEHGHPMLRARHLPFPITNERADAWLSCMKDAMDHVGLEGDIREFLFGRLELTARH
MVNQTEAEDRSS
>PK3-2_04333 hypothetical protein
MTNYQHEQYFAHCHGHPKKPLEIYMFVDPLCPECWSLEPVIKKLKIRYGRFFTLRIIASA
SLTALNKKRKKHLLVEAWEKIANRSGMSCDGNVWLEQDQPLSSPYMAALAFKAAELQGRK
AGMQFLRNMQESLFVSKKNITDENVLLEIAEKTSLDLEEFKNDLHSQSAVKALQCDMKIA
AEMDVSVNPTLTFFNTQHEDEGLKVPGSYSYDVYEEILFEMLGDEPKPSETPPLECFIEY
FRFVASKEIALVYDLSLEEVEKEMKKLAFAKKVTKVEAKHGMFWKSLSTYSDEYQSCEK
>PK3-2_04335 hypothetical protein
MMYTVISIVCIAVFFCLNILGMMHMLPLYITSPLLFLSILFTLYRLNHRKTFKGF
>PK3-2_04336 Oligoendopeptidase F, plasmid
MRGTKGKVFRVFTAFLAFVLFITAYDLTKGSEKPEDIHNTSLLRNSGFFNWLESKKTRGI
TMAEEKKANQLPERSEVKAEDTWRLEDIFPNDEAWNKEFQAVKELIPNLSKYKGKLADSA
DHLYEALTYQDKVMERLGRLYTYAHMRSDQDTGNSFYQGLNDKAGNLYTQAASATAYLVP
EILSIEEDKLQQFILEKEELKLYSHAIEEITKERPHVLSEKEEALLAEASDVLGSSSNTF
SVLNNAEITFPSIKDEEGNEKQITHGNFINFLESENREVRKNAFDAVYKTYGQYKNTMAT
TLSGTVKKDNFYARVKKYKSAREAALSNNSIPEEVYDNLVKTINKHLPLLHRYIALRKKV
LELDEVHIYDLYTPLVKDAGMKVTYEEAKDYMLKGLAPLGEEYASILKEGLENRWVDVYE
NKGKRNGAYSSGSYGTNPYILMNWHDNANNLFTLVHEFGHSVHSYYTRKHQPYPYGNYSI
FVAEVASTTNEALLGEYLLNNLDDEKQRLYILNHMLEGFRGTVFRQTMFAEFEHLIHTKA
QEGEPLTPELLTNVYYDLNKKYFGDGMVIDKEIGLEWSRIPHFYYNYYVYQYATGYSAAQ
ALSSQILKEGKPAVDRYIDFLKAGSSQYPIDVLKKAGVDMTSPEPIEAACKMFEEKLDEM
EELLMKVKQS
>PK3-2_04337 Competence protein CoiA
MFSAVTEDGEMFHLLGARQSRKLKQRRFFCPVCGGELAVKLGLQKAPHFAHRQNKSCSID
IEPESAYHLEGKRQLYVWLQTQQASPALEPYIKNINQRPDILAKIKGRMLAVEYQCATIA
PEVFQKRTAGFKQEGIIPQWIMGHSRLKRTAPSFYQLSAFHWQFIYAHPRRELLSYCPET
RLFLRISSIIPFYTNNSFCSIQMIPIHQASVENLFFNEPEPSLRYDHWTKAIHRFRHKPH
QFISKETNRLRLLFYEKRRTPLSFLPTEVFIPVIKGAVFKSPVFVWQGFLYLFMTDLGYK
RAPIRFSAVLQQCKLHIYKKNISLRYECSEECLSEAVKQYIDFLCKKGFLRETQKEIYVL
NQPKEGIRSIQDLIERDRACFIE
>PK3-2_04338 Adapter protein MecA 1
MEIERINEHTVKFYMSYGDIEDRGFDREEIWYNRERSEELFWEVMDEVHEEEEFAVEGPL
WIQVQALDKGLEIIVTKAQLSKDGQKLELPIPEDKKQEPASEDLDALLDDFQKEEQAVNQ
EEKEQKLQFVLRFGDFEDVISLSKLNVNGSKTTLYSFENRYYLYVDFGNMTDEEVENQLS
ILLEYANESSISIHRLEEYGKLIISEHALETIKKHFAS
>PK3-2_04339 hypothetical protein
MEHDYLISLLVIVGIDLILGGDNAVVIAMASRNLPDKQRQQAIIFGTFIAVAMRIGLTSA
AVYLLNIPFLQCAGGIFLLYLGYQLLIEKKDTQHIKSSTSLWRAIRTIVLADLFMSLDNV
IAVAGASHGEFSLVIIGLCVSVPVIIWGSKLIHIALEKIPLLIYAGSGLLAYTGGEMIVR
DKKLSFFMAQHGAVETLLPILTVAFVILASIYYQQVEKK
>PK3-2_04340 Regulatory protein Spx
MVTLYTSPSCTSCRKARAWLEEHEIPFEERNIFSEPLSIDEIKQILRMTEDGTDEIISTR
SKVFQKLNVNVESMPLQDLYRLINEHPGLLRRPIIIDEKRLQVGYNEDEIRRFLPRKVRS
FQLREAQRLAN
>PK3-2_04341 Putative acetyltransferase YjbC
MNWYEKLSEYFPIEEMKSKAHMEALLKERSDIYHKDEDKHHILMFAEFDSFIFVDYLYVS
KDARGQGLGGKLIAKLKKKNKPILLEVEPVDEDDTDTEKRLRFYQREHFKHAQSIGYRRR
SLATNEVNKMEILYWSPRTESEEEILEAMKQTYENIHTYKDEKWYGESYEKTDEVLKIID
EEKQKNIFDQLS
>PK3-2_04342 hypothetical protein
MTDSVFLAGLVLSFMSFASIAASFCISPVLRNLGFKKVLAFANLLRAVFTILMAYSVSHN
GQVYFWITLLFVFCFSFAGAFFQPARFALLPIIVPKEQYVKANGVISLSNQLFLTAGWGL
GGLLTYAVPFELVVGAAICLFVLSGASISVLLVNEKETEGTVETASDGNIWRHLMIIPVV
RDITVMDMIEALAGSVWSSAILLAFTAAVLHETEVWWGMFNASYFIGAIVGSVIAIRFSA
FFAQNMGYAIVFSSLVMSALTLLFSFSPIPFLCALACAAMGPFYQVRDICQETMLQEVIP
EQMRIAIIAAKNAILTPWSGITYSIMGFVADTAGAKTAFLAAAALYGITFVIALAQPRLL
HYKRENRVQ
>PK3-2_04343 Oligopeptide transport ATP-binding protein OppF
MTEKLLEIKHLKQHFVTPRGTVKAVDDLSFDIYKGETLGLVGESGCGKSTTGRSIIRLYE
ATDGEVLFNGENVHGKKSRKKLLEFNRKMQMIFQDPYASLNPRMTVADIIAEGLDIHKLA
KTKKERMQRVHELLETVGLNKEHANRYPHEFSGGQRQRIGIARALAVDPEFIIADEPISA
LDVSIQAQVVNLMKELQKEKGLTYLFIAHDLSMVKYISDRIGVMYFGKLVELAPADELYE
NPLHPYTKSLLSAIPLPDPDYERNRVRKKYDPSVHQLKDGETMEFREVKPGHFVMCTEAE
FKAYS
>PK3-2_04344 Oligopeptide transport ATP-binding protein OppD
MTRLLEVKDLAISFKTYGGEVQAIRGVNFHLNKGETLAIVGESGSGKSVTSQAIMKLIPM
PPGYFKRGEILFDGKDLVPLSEKEMQNIRGKEIGMIFQDPMTSLNPTMKVGKQITEVLFK
HEKISKEAAKKRAVELLDLVGIPMPEKRVNQFPHEFSGGMRQRVVIAMALAANPKLLIAD
EPTTALDVTIQAQILELMKDLQKKIDTSIIFITHDLGVVANVADRVAVMYAGQIVETGTV
DEIFYDPRHPYTWGLLASMPTLESSGEEELTAIPGTPPDLTNPPKGDAFALRSPYAMKID
FEQEPPMFKVSDTHYVKSWLLHPDAPKVEPPEAVKAKMRKLANTYEKPVLVREGE
>PK3-2_04345 Oligopeptide transport system permease protein OppC
MQNIPKNMFEPAAANAGDAEKISKKSLSLWKDAMLRFRSNKLAMVGLIIIVLIILMAIFA
PMFSRYDYSTTNLLNADKPPSKDHWFGTDDLGRDIFVRTWVGARISIFIGVAAAVLDLLI
GVIWGSISGFRGGRTDEIMMRIADILWAVPSLLMVILLMVVLPKGLFTIIIAMTITGWIN
MARIVRGQVLQLKNQEYVLASQTLGAKTSRLLFKHIVPNAMGSILVTMTLTVPTAIFTEA
FLSYLGLGVPAPLASWGTMASDGLPALTYYPWRLFFPAGFICITMFGFNVVGDGLRDALD
PKLRK
>PK3-2_04346 Oligopeptide transport system permease protein OppB
MLKYIGRRLVYMIITLFVIVTVTFFLMQAAPGGPFSGEKKLPPEIEANLNTHYGLDKPLF
VQYVSYLKSVAMWDFGPSFKYKGQSVNDLINSGFPVSFTLGAEAILLALALGVLFGVIAA
LYHNKWQDYTVAILTIFGISVPSFIMAAVLQYVFSMKLDLFPVAGWESWSYTFLPSIALA
SMPMAFIARLSRSSMIEVLNSDYIRTAKAKGLSRPAVTVRHAIRNALLPVVTYMGPMAAQ
VLTGSFIIESIFGIPGLGAHFVNSITNRDYTVIMGVTVFFSVILLLCVLIVDVLYGIIDP
RIKLSKAKKGA
>PK3-2_04347 Oligopeptide-binding protein OppA
MKKRWSIVTLILIFTLVLSACGFGGNGGSNGEGKKDSKGKTTLNINIKTEPFSLHPGLAN
DSVSGGVIRQTFEGLTRINADGEPEEGMASKIETSKDGKTYTFTIRDGVKWSNGDPVTAQ
DFEYAWKWALDPNNESQYAYQLYYIKGAEAANTGKGSLDDVAVKAVNDKTLKVELNNPTP
YFTELTAFYTYMPINKKIAEKNKKWNTNAGDDYVSNGPFKLTAWKHSGSITLEKNDQYWE
KDKVKLKKIDMVMINNNNTELKKFQAGELDWAGLPLGQLPTESLPTLKKDGSLHVEPMAG
VYWYKFNTEAKPFDNVNIRKALSYAIDRQSIVKNITQGEQIPAMAAVPPTMKGFEDNKEG
YYKDNDVKTAKEYLEKGLKEMGLSKVSDLPKIKLSYNTDDAHAKIAQAVQEMWKKNLGVN
VELDNSEWNVYIDKLHSQDYQIGRMGWLGDFNDPINFLELFRDKDGGNNDTGWENPEFKK
LLNQSQTETNQTKRAELLKKAEDIFIDEMPVAPIYFYTIPWVQDENLKGTILTGTGEIYF
RNAYFQ
>PK3-2_04349 Tryptophan--tRNA ligase
MKQTIFSGIQPSGSVTLGNYIGAMKQFVELQHDYNSYFCIVDQHAITVPQDRLQLRKNIR
SLAALYLAVGLDPEKATLFIQSEVPAHAQAGWMMQCVAYIGELERMTQFKDKSKGNEAVV
SGLLTYPPLMAADILLYGTDLVPVGEDQKQHLELTRNLAERFNKKYNDIFTIPEVKIPKV
GARIMSLNDPLKKMSKSDPNQKSYITLLDEPKLLEKKIKSAVTDSEGIVKFDKENKPGVS
NLLTIYSILGNTTIEELEAKYEGKGYGEFKGDLAEVVVNALKPIQDRYHELIESDELDRI
LDEGAERANRTANKMLKKMENAMGLGRKRR
>PK3-2_04350 hypothetical protein
MLFLHDVWVNWFEGEENGYNVCHFHEWRKEDTVELLDQVPLLRVPSVLFHYIENDLSELP
KGLLEEVHQKSYIRKNHERTKLEYCFVVTDGIGILAVDTIGYTIPVRKSRLIPRQEQLVY
EMVKDVEPETYEFEPKKLESSKEYHILSLAPEHVRGLTRKERQIKQLMFMALDQLKGLKN
RAEIGYWYTEWNPHMYEQIKRMSFEEIWDMLYNETIEGWSDKHLAFCENLIKGQPFFEKL
WEMENESKVN
>PK3-2_04351 Dipeptide transport system permease protein DppC
MSELHTTPSPEIRLKENISKKPETMTKIFWEKFSKNKLAILGAVILFIIIMSAIFAPLIA
PYPQEQQSLLDKYRAPGLEHLMGTDKFGRDIFSRILYGARVSLLVGFASVVGSILIGTVL
GALAGYFRGIVDAVIMRLVDIVLSIPDIFLLITLVTIFKPGVDKLILIFCLTGWTTTARL
VRGEFLSLRSREYVLAAKTIGTKTHKIIFSHILPNALGPIIVSATLKVGSVILAESALSY
LGFGIQPPIASWGNMLQDAQNFTVMIQAWWYPLFPGLFILMTVLCFNFVGDGLRDALDPK
NIK
>PK3-2_04352 Dipeptide transport system permease protein DppB
MVTYIIRRTLSSIPILLGITILSFVIMKAAPGDPMTLMMDPTISQADRAQFIEKYGLNDP
EYVQYLKWLGNMVQGDFGTSIIRKGTPVSELILARLPSTLLLMLVSTILALIISIPFGVI
SAKKPYSKLDYGITFTSFIGLAIPNFWFGLILIMVFAVNLGWFPTGGVATLNADFSFLDR
IHHLLLPAFVLATADMAGLTRYTRSNMLDVLNQDYIRTARSKGFKENRVLFKHGLRNALL
PVITIFGLMIPSFIGGAVVVEQIFTWPGLGKLFVDSAFQRDYPVIMAMTVISAVLVVIGN
LIADILYAIVDPRIEY
>PK3-2_04353 Oligopeptide-binding protein AppA
MKRRKTALMMLSVLMVLAIFLSACSGSKSSSSSEKKSTGKPQQGGDLVVGSIGAPTLFNS
LYSTDESSTDIEQMIYSFLTKTDENLNVKMSLAESVKELDGGLKYDVKIKKGVKFHDGEE
LTADDVVFTYNIPLNKDYKGERGSNFEMLKSVEKKGDYEVLFTLKYKDPNFYNNTLDSYG
ILPEHILKDVPVAELEDNEFNRKNPIGSGPFKFKEWKDGQYVKLVANDDYYDGRPYLDSV
TYKIIPDANAAVAQLQAGDIDFFNVPSTDYKTAESFNNVKVVTDLALSYTYIGWNEKNEL
FKDKKVRQALTTALDRETMVQTVLDGDGKVAYIPESPVSWNYPKDIEVPKFKYNVKKAKK
MLKEAGWEDTDGDGILDKDGKKFEFTLKTNQGNKVREDIAVVVQEQLKKVGIKVTPQIVE
WSALVEQTNPPNWDYDAMVLGWSLSTFPDHYDIFHSSQSEKGLNNMWYKNPEVDKLLKNA
KSISDRGEYSKAYEKIYQKLAEDQPYTFLYYPNNHMAMPANLEGYVYHPKRELYQIEKWW
LAQ
>PK3-2_04354 Oligopeptide transport ATP-binding protein OppF
MTAANQETILELRDVKKYFPIRSGLFQRKVGDVKAVDGVSFSLHKGETLGIVGESGCGKS
TAGRTMIRLYKPTEGQILFKGQDISNLSEEKLRKSVRKNIQMVFQDPFASLNPRKTLRSI
IKEPFNTHNMYSLRERNEKVEELLARVGLHPSFASRYPHEFSGGQRQRIGIARALTLNPE
LIIADEPVSALDVSIQAQVINLMEELQEEFNLTYLFISHDLSVVRHISDRVGVMYLGKMM
ELTGKHELYDNPLHPYTQALLSSVPVTRKKGSVKRERIVLKGELPSPANPPKGCVFHTRC
PVAKPICKEQIPEFKEAAPSHFVACHLYS
>PK3-2_04355 Oligopeptide transport ATP-binding protein OppD
MSTLLEVNNLKTYFFRKKEPIPAVDGVDFHIRKGETVALVGESGSGKSITSLSIMGLVQS
SGGKIMDGSIKLEDKDLTSFTENDYCKIRGNEVSMIFQEPMTSLNPVLTIGEQITEVLIY
HKNMKKKEARQRAVELLQMVGFSRAEQMMKEYPHRLSGGMRQRVMIAIALSCNPKLLIAD
EPTTALDVTIQAQVLELMKDLCQKFNTSILLITHDLGVVSEAADRVIVMYCGQVVENATV
DDLFLEPLHPYTEGLLTSIPVIDGEIDKLNAIKGSVPTPDNLPPGCRFAPRCPKAMDKCW
TNQPSLLTHKSGRTVRCFLFEEEGAEQS
>PK3-2_04356 hypothetical protein
MSVEQTYNWLGQADSIDDLAHYIVPLFSNAEKKNWKGILGHLQHHGMFKNIKEGIQTASK
LKEKGFYEHILKEEQYLKNKWQGPDVSIVPLPVDERNRRIRLDFGSKSGLAFQDKMFLFL
SSDLNFASVSALMTHEYHHVCRLDHLTKEEKDVTLLDTIIMEGLAEYAVYERFGRSQTAD
WTSWYTPEQLQALYEKKIAPHQEIKRDNRLFSQLLFGKGYQPKMLGYAVGFNIVKKYLTA
NKANTADGLSIPAETFLNATL
>PK3-2_04357 3-oxoacyl-[acyl-carrier-protein] synthase 2
MSKKRVVVTGLGALSPLGNDVDTSWNNAINGVSGIGPITRVDAEEYPAKVAAELKDFNVE
DYMDKKEARKMDRFTQYAVVAAKMAVEDADLNITDEIAPRVGVWVGSGIGGLETLESQFE
IFLTKGPRRVSPFFVPMMIPDMATGQISIALGAKGVNSCTVTACATGTNSIGDAFKVIQR
GDADVMVTGGTEAPLTRMSFAGFSANKALSTNPDPKTASRPFDKNRDGFVMGEGAGIIVL
EELEHALARGAKIYGEIVGYGSTGDAYHITAPAQDGEGGARAMQEAIKDAGIAPEEIDYI
NAHGTSTYYNDKYETMAIKTVFGEHAHKLAVSSTKSMTGHLLGAAGGIEAIFSVLAIKEG
VIPPTINIQTPDEECDLDYVPDEARRQELNYVLSNSLGFGGHNATLIFKKYQA
>PK3-2_04358 3-oxoacyl-[acyl-carrier-protein] synthase 3 protein 1
MKAGILGVGRYIPEKVLTNHDLEKMVETSDEWIRTRTGIEERRIAADDVYSSHMAVAAAK
KALEQAEVAAEDLDMILVATVTPDQAFPTVSCMIQEQLGAKKACAMDISAACAGFMYGVV
TGKQFIESGTYKHVLVVGVEKLSSITDWEDRNTAVLFGDGAGAAVVGPVSDDRGILSFEL
GADGTGGQHLYLNEKRHTIMNGREVFKFAVRQMGESCVNVIEKAGLSKEDVDFLIPHQAN
IRIMEAARERLELPVEKMSKTVHKYGNTSAASIPISLVEELEAGKIKDGDVVVMVGFGGG
LTWGAIAIRWGR
>PK3-2_04359 hypothetical protein
MQLDVFSKMMFGDSPKQTAEKEEQEEEVSQTNEEETINYMHIMDQIGSIMNSLDQIKPAL
KELAPMISAIKKKIM
>PK3-2_04360 hypothetical protein
MQHEKSLEFLQIAMKYLPEAKEQLEKSGIELSMETMQPFMNLFTTVMAEAYELGKSDANS
ETE
>PK3-2_04361 Purine-binding protein
MIKRLVMIFSVLLLLSGCGQTPFKGKIEKVGMLFPDTINDLVWGTKGYKGLLNIQSKYNV
DVYYKEGVKTDEDIINAIEDFHKRGVNLLYGHGSEYAEVFNLVSEDYPDMEFVISNSKSK
ADNVTSVHFSGEAMGFFGGMTAAHMSKTNQVGVIASFTWQPEVDGFIKGAKYENPDIEVN
TKYTDHWDDDTTAVKLYQKMKNEGADVVYPAGDGYNVPVIQQIKKDGLYAIGYVTDQSEL
GENTVLTSTVQNVDKAYEIIAEQFNKGTLEGGDHYYDLKTRVVEMGTFSPLVDKDFQQRI
AKLIKTYNKTGELPKNE
>PK3-2_04362 hypothetical protein
MESTLIVGADEFFGLSLCERMMDEGIHVDVILAETEDEMRQMYLEERLMWLGRNELFRQL
EHIGERKYDTICIQFGGFLPLDQFDSPYILVYEQDRKEWEKREKTGSETTVILPEMYGPW
KEETGEDGYYADDVADELLRFLLEPSRDSKKLVFDLQVTEKTSKEEAKTKIFEWKRQFSS
IFDKY
>PK3-2_04363 hypothetical protein
MGITERYFQLGTEQNVIHLPYRPNGFGIFILGDRTHFVGNDSSFWLQHYGRNQLLNMLRN
EGYTLFNSNLFGRHWGAEKAVTYAKQLIHFVLKQEILNPKIHILAEGMGALVADELLRFS
PDHIRSAAMLNPCLDLQAHYESEKENKFFYKQFLKEVSESHGISEKEAEALRYKTIESYP
SGVPVHMWQRMTGAPYPYSVHAEVFKEKQQKQGSPVDMTFHLFEHPSRIYASICKFFHSH
EKEL
>PK3-2_04364 hypothetical protein
MRYIIAFIWTFLLSHMACYLTASMNSVAYDFKSSSVIAVVLYVLIMVLAEIMPMNKNASQ
H
>PK3-2_04365 hypothetical protein
MGQQHQFRPGQKAPNNGIYVEIGETGSMVKNPQKIHLSAGEMFPETSNHNRLWTYKRKP
>PK3-2_04366 Ornithine carbamoyltransferase
MHTVTQTSLYGKDLLTLKDLSEQDINALLTEAGELKQNKIQPIFQGKTLAMIFEKSSTRT
RVSFEAGMAQLGGSALFLSQKDLQLGRGETVADTAKVLSGYVDAIMIRTFEHEKVEELAK
EADIPVINGLTDKYHPCQALADLLTIKEIKGELKGVKVAYIGDGNNVAHSLMIGCAKMGC
DISIASPKGYEVLDEAVEAAKSAALQTGASITLTADPIEAVKDADVIYSDVFTSMGQEAE
EQERLAVFAPYQVNEALVSHAKPDYTFLHCLPAHREEEVTAEIIDGPNSAVFQQAENRLH
VQKALLKAILYKGE
>PK3-2_04367 Carbamoyl-phosphate synthase arginine-specific large chain
MPKDTSISSILVIGSGPIIIGQAAEFDYSGTQGCIALKEEGYRVILVNNNPATIMTDEAF
ADEIYFEPLTAESLTAIIKKEQPDGLLANLGGQTALNLAVALEETGVLKEHGVKLLGTSV
ETIQKGEDREKFRSLMNELNQPVPESEIVDNETDAIRFAESIGFPVIIRPAYTLGGKGGG
IAPDKEAFTAMIKQALLASPINQCLVEKSIAGFKEIEYEVMRDSNNTCITVCNMENIDPV
GVHTGDSIVVAPSQTLTDEDYQMLRTASLTIITALDVVGGCNIQFALDPFSKQYYVIEVN
PRVSRSSALASKATGYPIAKMAAKLAVGYTLDELKNPLTGSTYASFEPALDYVIVKFPRW
PFDKFKNADRKLGTKMKATGEVMAIERNLEAAIQKAAASLELKNIGTHLPELSGLSIEAL
WELAVTPDDRRFFVVMELLSRSVTIHDIHAKTKIDPFFLHTFDNIIKLENRMMEEGGDLS
FDLLKKAKEKGFSDATIASLIGKTEEEVRELRKEMGIAPSFKIVDTCAAEFDAKTNYFYS
TYFGESDGDISRKEKKRALIIGSGPIRIGQGVEFDYSAVHGVLTLQELGFETIMINNNPE
TVSTDYEIADRLYFEPMTTEHILNVAEQEKIDFAIVQFGGQTAINAAEALEKAGITLLGT
SFETLDVLEDRDQFYQLLDELGLNHAKGEIAYTKEEAAAKADEIGYPVLIRPSYVIGGMG
MIIVDSQAQLSQLLNGEDSMPYPILIDQYVSGKEVEIDLISDGEDIFIPTYTEHIERAGV
HSGDSFAILPGPSITSGLQQGIKDAAQKIARKLSFKGIMNIQFVIDSGNILVLEVNPRAS
RTVPVVSKVMGVPMIPLATRLLAGASLKDLNPAVQNHHGVAVKFPVFSSHAIQDVDVKLG
PEMKSTGEGMCVAYDADSALKKIYTRVWNLKGSIYLQNGPEDMKELAENAGFTVHKGTFA
SWMEQQGKALHINLSGSEEARKERLEAMTHGITVFTEEETVRAFLQSGSGQPQPVSLKDL
YKKEVASCTQ
>PK3-2_04368 Carbamoyl-phosphate synthase arginine-specific small chain
MEGYLVLEDGTAFGGELDGHENCTGEAVFFTGMTGYQEVLTDPSYKGQIIVFTYPLIGNY
GINEKDFESKKPQVKAAVVYEACDHFSHHEAVYSLKEYLQKWNIPLLTHVDTRAVVKKIR
ANGTMGATVTASKEAAEVALQPENVAEQASAQEISTFGDGNKHIALIDFGYKKSIASSLV
KRGCKVTVVPYQQMETVYDIKPDGIVLSNGPGDPKAIQPYLGKIKSIISRYPTLGICLGH
QLIALAFGGNTFKLPFGHRGANHPVIDRETKRVFMTSQNHSYVVDEQSIKEEELTIRFHH
VNDTSVEGLAHKKLPVMSVQFHPEAHPGPAESEWIFDDYLKNVIPARREIAHA
>PK3-2_04369 Acetylornithine aminotransferase
MSSLFQTYGRWDIDIKKAKGTYVEDQNGKTYLDFIQGIAVSNLGHCHEAVTEAVKNQLDS
VWHVSNLFQNSLQEQAAQKLAEHSAGDLVFFCNSGAEANEGAIKLARKATGKTKIITFLQ
SFHGRTYAGMAATGQDKIKTGFGPMLEGFHYLPYNDPSAFEGLREEDGIAAVMLETVQGE
GGVNPASAAFLTAVQSFCKEKEALLIVDEIQTGIGRTGKGFAYEHFGLSPDIITVAKGLG
NGFPVGAVIGKKQLGKAFTPGSHGTTFGGNMLAMAAVNATLQIVFQPDFLQEAADKGTFL
KEQLEAELNSPFVKQIRGKGLMLGIECDGPVVDIITELQTLGLLVLPAGPNVIRLLPPLT
VTKHEIAEAISKLKQAIAQHSAVNQ
>PK3-2_04370 Acetylglutamate kinase
MKKTIVFKCGGSVIRELSEEFFQNLKELMASGWKLAIVHGGGPEITNMLKRLNIKTEFSG
GQRKTTKPVLEVAEMVLSGSVNKFFVAELAKHGLRAAGISGKDGGLLEADYLDPETYGEV
GEIKKVDPSMVNALMEKNIIPVIAPLSMTSACKTLNVNADLAASAVAGALEADKLMFVTD
VDGIMKEKQRFDVLTPEEVQMLIEQEVITGGMIPKVNSALSALSDQVSEVMIVNGKGAFF
TEQTFQGTKIVKAKEAVS
>PK3-2_04371 Arginine biosynthesis bifunctional protein ArgJ
MIQLSEDQIVKVTGDVSSPKGFQAKGVHCGLRYSKKDLGVIISETPAASAAVYTQSHFQA
APIKVTQDSLKHGSVLKAVIVNSAIANACTGEQGLKDAYTMRESLASQLGIEPELVAVSS
TGVIGEHLDMEKIQAGIELLKQTPAGSGDFEEAILTTDTVIKQTCYELAIGGKTVTIGGA
AKGSGMIHPNMATMLGFVTTDAAIEEKALQKALREITDVSFNQITVDGETSTNDMVLVMA
NGCAENECLTEDHPEWPVFKKALLLTCEDLAKEIARDGEGATKLIEAQVQGAKNNLDANV
IAKKIVGSSLVKTAVYGTDANWGRIIGAIGHSAAQVTAEEVEVYLGGQCLFKHNEPQPFS
ESLAKEYLEGDEITIVIKMDEGDGNGRAWGCDLTYDYIKINASYRT
>PK3-2_04372 N-acetyl-gamma-glutamyl-phosphate reductase
MKIGIVGATGYGGTELVRILSHHPHAEECILYSSSGEGNVYSEVYPHLTGLADQKLKPID
MNTIKHEIDIMFLAAPPGVSSELTPQLADAGIPVIDLSGDLRIQEPAEYEKWYKRTAAPK
EVIHEAVYGLAELNQKQIQQAKLIANPGCFPTAVLLGLAPLAQKKLLNESFVIVDAKTGV
SGAGRKASMGTHFSELNDNFKIYKVNEHQHTPEIEQALQEWQPGLGPITFSAHLVPMTRG
IMATMYTQVTADLSADDLHHLYSEFYQDSYFVRVRPKGQFPQTKEVYGSNFCDIAVTLDE
RTNRVTIVSVIDNLMKGAAGQAVQNFNVMNGWNEETGLTMTPIYP
>PK3-2_04373 Multidrug resistance protein MdtG
MGKNKLKWLTLSQSSVFFASSLIFPFYILFVKNIGSSYTQFGFSYGLFGLSGALIYPLLG
RLSERLDSRYFLLANSWGMAVLLLYVPHIGSVGQVYIVQVLLGLFGAMQKHGEKVLIADF
TDNGERGKKIGNYHFWTAVFSAAAIMLGGFLADFFTVQMIFYASSILYFLSGLMMMKTG
>PK3-2_04374 hypothetical protein
MKKKLLAFALCTGAYAALFAYSVHSESELKTDTSEMTDVSRLMPVKIKQTVKGQEEETLI
DTVNEANRKNIKISIAGAQHSMGGHTYYEDGIVLDMTGYNKILAFDQEKKTIRVQSGATW
NDIQKYVNPYGLAVKVMQSQNIFTIGGSLSANAHGRDICYGSLIDTVKSFRLLKADGTIV
TVTPKDDLFTAVIGGYGLFGVILDVTLELTDDELYVTQTEKMDYSTYADYFTKHVKGNPN
VRMHLARISTANKGFLKDMYITDYVLADHQDQLSSYSDLKEDEYTGATKFALGLSRRYEW
GRNWLWNTQQSYFLGQNGTKISRNNVMRSESKFLEYENNDNTDVLQEYFVPVKEYVSYID
HLRQTLSDEDLNLLNITIRYVQKNERADLSYAKDDMFSLVLLINEGFSKEDQADTARIIR
RMTDVAIKHGGSYYLPYMTYQTKAQMRQAYPNSEAFFQKKRTYDPDERFMNYFYQRYK
>PK3-2_04375 hypothetical protein
MMYLLAVLCPPLAVLISGKPFQALLNLILTCIFWLPGAIHACFIVADRRAEKRARR
>PK3-2_04376 Fe-S protein maturation auxiliary factor SufT
MEEALKENIMGALEQVVDPELGVDIVNLGLVYDVDMDEDGLTHVTMTLTSMGCPLAPIIV
DEVKKALADIPEVKETEVHIVWNPPWTRDKMSRYAKIALGIQ
>PK3-2_04377 hypothetical protein
MIQIENQTVSGIPFLHIVKEENRNRAVPLVIFIHGFTSAKEHNLHIAYLLAEKGFRAVLP
EALHHGERGEGMAVEELAGHFWDIVLNEIEEIGVLKTHFEKEGLIDGGRIGLAGTSMGGI
TTLGALTAYDWIKAGVSLMGSPSYVELFQQQIDHIKSQGIDIDVPEEKVQELMKRLELRD
LSLQPEKLRQRPLLFWHGAKDRVVPYAPTRTFYDTIKSHYSEQPERLQFIGDENADHKVP
RTAVLKTIEWFDTHL
>PK3-2_04378 5-amino-6-(5-phospho-D-ribitylamino)uracil phosphatase YitU
METKPYVIALDLDGTLLKDDKTISENTLRTIQRLKNDGHYVCIATGRPYRSSSMYYQQME
LTTPIVNFNGAFVHHPQDDSWGRYHTSLPLDVVKQLVDISESYNVHNVLAEVIDDVYFHY
HDEHLIDAFNMNTTNVTVGDLRQNLGEDVTSVLIHAKEEDVPAIRSYLSDVHAEVIDHRR
WAAPWHVIEIIKSGMNKAVGLQKISDYYGVPSERIIAFGDEDNDLEMLEFAGCGVAMGNG
IDKVKQIANRTTAANEEDGVARFLREYFSL
>PK3-2_04379 hypothetical protein
MGKRSKSRRFIQQGKDSIGLHAAKFPYRSTLEEAHQHAAARDSAERQVEF
>PK3-2_04380 hypothetical protein
MRNELFQQAKSFVQQAVMVTNGFEEGDQEQAILRAKNAVSSAYANSTDAERRQLHQFQNQ
LDKLQ
>PK3-2_04381 hypothetical protein
MKRLLVMLLPVLLLIGCGKDEQTEPDKEVSGEMENQEVVLSVDAIQEPEQIKFNMSLKNQ
SERAVEFQFSTGQKFELVVYDSEHKERYRYSKDKMFTQAFQNLTLESGETYDFSDVWKET
PEPGTYEVKVTFKGRAEDLKQVQAVQQFEVK
>PK3-2_04382 hypothetical protein
MVLDQTKKLLIVIIGALLNAAGLNLFLIPADVYASGFTGVAQLLSSVIVQYAPFYISTGT
LLFLLNIPVGILGWLKVGKSFTVYSILSVALTTVFMGILPETSLSHDILLNAVFGGVISA
VGIGLTLKYGASTGGLDIVAMVLAKWKDKPVGTYFFILNGIIILTAGLLQGWEKALYTLV
TLYVTTRVIDAIHTRHMKLTAMIVTKKADEIKEAIYGKMVRGITTVPAKGAFTNEQKEMM
IIVITRYELYDLEKIVKEVDPKAFTNIVQTTGIFGFFRKD
>PK3-2_04383 Fatty acid-binding protein
MTVHLIADSAADLPRSYFEENGIGFIPLRVSLGDKEFEDAVTIDADQIFEAMQNGETPKT
SQASPQTIKNVFLQYAETGDSALYIAFSSGLSGTYQTAVMIANEVKEEFPDFDLRVIDSK
CASLGYGLAVRHAADLCINGNTIQEIETSVKNFCEQLEHIFTVDDLTYLARGGRISKTSA
FVGGLLNIKPLLQMEDGKLVPLEKIRGQKKLFKRIIELMKERGDHWGNQTVGISYAANEE
KAADMKQLIEDAFKPKEIIIHPIGSAIGSHAGPGTLAIFFLRK
>PK3-2_04384 hypothetical protein
MEIRIDILLILISMLFFWIAYLAGIKKQTWILSGFHESQIRDKNRLARIAGYFFLNSGIF
ILLNGFISFQGQDQLIPPMILAYGAGVIIYVNKKLI
>PK3-2_04385 Conserved virulence factor B
MRPGQQLTLSIDHQTDFGYFLTDGEDTILLHNSEITEDIEDRDEVEVFIYVDQQERLAAT
MKIPVISADEYGWVEVVDTVGDMGVFVDVGLSKDALVATEHLPPYEDVWPQKGDKLYCML
KVTNRGRMFAKPAPEDIISELFTDASEDLMNKELTGTVYRLIATGSFVITDDGIRCFIHP
SERKEEPRLGSRVTGRVIQVKEDGSVNMSLLPRKQDAMSVDAEYILTYMRARNGAMPYND
KSQPDDIRERFNMSKAAFKRALGHLMKNGKVYQEDGWTYEKK
>PK3-2_04386 hypothetical protein
MAKESSFDIVSKVELPEVQNAIQIALKEISTRYDFKGSKSDISLDKEELVLVSDDEFKLS
QLKDVLVGKLIKRNVPTKNIDYGKVENASGGTVRQRAKLVQGIDKDNAKKINTIIKNSGL
KVKSQVQDDQVRVTGKNKDDLQQIITAVRGADLPIDVQFINFR
>PK3-2_04388 Bifunctional homocysteine S-methyltransferase/5,10-methylenetetrahydrofolate reductase
MGLLEDLQKQVLIGDGAMGTLLYSYGIDRCFEELNISKPEEIQRIHKAYVEAGANIVQTN
TYGANYIKLSRHGLEDDIKKMNQEAVKIARASAGDAYVLGTMGGIRTFNKNAYSLDEIKR
SFREQLYLLLHEEPDGLLLETYYDLEEAREVLKIARKETDLPIMLNVSMHEQGVLQDGTS
LSEALRSIADLGADIVGINCRLGPYHMIEALSEVPIFDDVFLSVYPNSSLPSLEEGRLVY
ETDDTYFQNSASEFRKQGARIIGGCCGTTPNHIRAMAEAVGGLAPITEKEVKTRAKEFIS
VQHERTEPGLNELAAEKRSIIVELDPPKKLSFDKFLSAAAELKEAGIDALTLADNSLATP
RISNVACGALVKQKLDMRSLVHITCRDRNIIGLQSHLMGLDTLGLNDVLAITGDPSKIGD
FPGATSVYDLTSFDLIRLIKQFNEGLSLSGKPLGKKTNFSVAAAFNPNVRHLDKAVKRLE
KKIDCGADYFVSQPVYSEQQLVDIHNETKHLKTPIYIGIMPLTSSRNAEFIHNEIPGIKL
SDSIREKMALAGEDKEKQKAEGLAIARSLLDTACELFNGIYLITPFLRSDLTAELTSYIQ
QKDEQRQNIYLH
>PK3-2_04389 hypothetical protein
MLQIKTIPAEDTYDIRHRILRPHQSIEQCKFEQDHAEGAFHLGAFYEGTLISIASFSPQQ
QPLLTESPAYRLRGMATLEEYRDQKAGSSLIKYAEQKLADKGVQAVWCNARHHVKGYYAK
LGWEELGEPFDIPGIGNHIIMYKTLGTSR
>PK3-2_04390 hypothetical protein
MDVADELIELHEEHVPGLLRLCRQAGWPDYGKQELTLLVRQGRFYGYQNVSGNIISCIGL
FLFGGLASIGLVIVDKDYKRLGLGRRMVHTCISQTTENTAIRLCATKEGLPLYEKAGFHM
AGSVRKYSCHSFHQIKKQEGLDAKLSPFKEQDFQELAAADLEAFGGDRSNLLQQLISTSE
ECVIARNNEGHLIGYGLSIRTPANLKFGPIITSSSDCAAQIINRLAAGKQGPMRIDIPAE
HTSFHDKLSEMGFHRDEEPPLMLYQKKMLPGQNGHLYALISQALG
>PK3-2_04391 Bacillibactin exporter
MESSKQNNGMTIVAIGSIPLILTLGNSMLIPILPKMKSELHLSQFQVSLVITVFSLIAAF
AIPIVGYLADRFSRKIIIIPCLILYGAGGLLAGFAAGFFDNAYPWVMAGRALQGIGAAGT
GPIAMALTGDLFKGAQESKVLGLVEASNGMGKVLSPIIGSLIALLVWYGAFFAFPVFCII
SIVLTWIFIKEKKKEKEPPPIGKYAKGLLSVFKHEGRWLFTAYLAGATCLFTLFGILFYL
SDVLEKTYDTDGVKKGLILAIPLLVMCVTSYTTGSKIGQKQSLMKKLIVLGLAFMTISYA
ALSFIENLVFFISVLVLSSIGSGLVLPCVNSFITGAVGKERRGFVTSLYGSVRFLGVAIG
PPIFGRLMQWSRPGMFLSIAGLTLVVGILVILLIHVNQNKEETKEKEEPKMAGNRLQPAE
ER
>PK3-2_04392 Putative isomerase YitF
MKIVQVETFPLLHRLEKPYGDANGFKRYRTCYLIRIVTDSGIDGWGECVDWLPALHVGFT
KRIIPYLLGKQADSRLPLVRTIQKWHQRAASAVSMALTEIAAKAADCSVCGLWGGRYREE
IPVYASFQSYSDHPQWISRSVSSVEAQLKKGFKQIKVKIGGTSFEEDVRHINALQHTAGS
SILMILDANQSYDTATAMKWERYFTEWVNISWLEEPLPFDQPQDYAMIRNRLSVPVAGGE
NMKGAAQFASLLSQRCLDIIQPDVMHANGIDEFRDCLQLARYFGVRASAHAYDGSLSRLY
ALFAQACLAPWSKMENVQIEPIEWDVMENPFTDLISLQPLKGKVHIPKGKGIGSEINMEI
VNRYKWDGSAY
>PK3-2_04393 hypothetical protein
METADKSFHKGANDLMAELLMKAKLTFMIVVGGVLQGLGMSLFLFPHDIPTGGAAGIAVL
LHYLFQIPHGFSVWAVNVSMLFTALKWLEMRTFTGTLASITVTSVSVLIFDAVFPDITSN
LWLDLASGAVLLGLGIGLLYKYKISNGGFGALALMISIYRGGNPGTILLIMNCIIFMVTA
SIIAWGIVIQALICQVISTRVIDFIYNIRLTSLPYLTPMYRHKK
>PK3-2_04394 Phosphosulfolactate synthase
MNDFSLELPVRTSKPRETGQTILIDNGYPLQFFKDVIAAASDYIDFVKFGWGTSLLTKDL
EEKISALKEHDIKFFFGGTLFEKYVSQKKVNEFHRYCTYFGCEYIEISNGTLPMTNKEKA
AYIADFSDEFLVLSEVGSKDAELSSRQSSEEWLEYIVEDMEAGAEKVITEARESGTGGIC
SSSGDVRFQIIDDIISSDIDITRLIFEAPNKTLQQGFIQRIGSNVNLANIPFHDAIALET
LRLGLRSDTFYL
>PK3-2_04395 putative 2-phosphosulfolactate phosphatase
MPITIYQGHHHSLAPADINIVIDVIRAFTVAHYAFIGGAKEILLAGTAEEAFALKDTYPD
YVLTGEEKGVGISGFDLDNSPKRMAKQEVGDKRLIQKTTNGVTATLGALNAKHLFVTGFS
NARTTAEHVKTLAAKDCVMNIVASHPSGDDDMACAEYIKGIIEGTNEVTAAEAIERIKRS
SVAEKFFDRRQPLFDPEDISYCTKELTGDFVMKVKQEREVPTIERVII
>PK3-2_04396 Phosphoadenosine phosphosulfate reductase
MNEQMITFDTWNDTLSKQIADQLIDELDVLKWAYRTYGEKIVYACSFGAEGMVLLDLISK
INKNAHIIFLDTGLHFQETYELIETVKERYPGLIIQLLEPELNLKEQETQYGGELWKHNP
NLCCQLRKIEPLKKHLSGMTAWISGLRREQSPTRKHIQYVNLDQKFKLIKICPLIHWTWN
DVWTYIRLHNLPYNKLHDQHYPSIGCEMCTLPSSDPNDERAGRWAGREKTECGLHQE
>PK3-2_04397 Sulfate adenylyltransferase
MNRNEPHGGVLINRCDPTCHFEGCTCEAELDQLALSDLELIAIGGYSPLTGFLGEKDYHS
VLKEMRLANGLPWSLPITLPVGEKTAKQLSAGDCVKLVKDGVTYGIITVTDIYQPDKTQE
ALSVFKTNDPAHPGVKKLLARPDYYIGGPITVSRLPDKSFEQFYAAPAETRAAFKKLGWK
TIVGFQTRNPVHRAHEYIQKTALETVDGLLLHPLVGETKSDDIPSDIRMESYQVLLDHYY
PKDRVMLSVFPAAMRYAGPREAIFHALVRKNYGCTHFIVGRDHAGVGSYYGTYDAQNIFQ
SFTEEELGIKPLFFEHSFYCRKCGNMGTSKTCPHSQRDHIHLSGTKVRELLRQGKKPPKE
FSRPEVANVLIKGLQQQPVAIQQNSGGLQ
>PK3-2_04398 putative adenylyl-sulfate kinase
MTHNPNIIWHTAAISKSDRQSLNGHKSCALWFTGLSGSGKSVLANAVDEKLYRMGIQSYV
LDGDNIRHGLNKDLGFQTEDRIENIRRIGEVAKLFVDSGQMILTAFISPFREDRDMVRAL
FPEGEFFEIYVKCPLHVCEQRDPKGLYQKARNGEIKHFTGIDSPYEPPLSPDFIIESDQT
SISDGADLIITELQSKGII
>PK3-2_04399 Arylesterase
MGHYIKTEEHVTLFVEDIGHGRPIIFLHGWPLNHKMFEYQMNELPKRGFRFIGVDLRGYG
QSDRPWEGYDYDTMADDVKAVIYTLQLEKAVLAGFSMGGAIAIRYMARHEGADIGKLILL
SAAAPAFTKRPGFPYGMRKQDIDDMIEQFQTDRPKTLADLGTQFFEKKVSPELRLWFLNL
MLEASSYGTIHSGIALRDEDLRKDLASIKVPTLILHGRKDKIAPFDFAKELKRGVKHSEL
VPFVNSGHGAFYEEKDKINRLIAQFAGS
>PK3-2_04400 hypothetical protein
MNKLAIQKPHIPENLQTADFHETVTQDDVISMHLFEDCTICGEDIDRLCVEKTLFRNVVF
IDVSFRHIELTDVIFEKCDLSNADFSGAVIHRTSVKQSKMVGMNLAESTLRNVLFEECHG
HFSSFSYSNMKQVRFDRCALLQSECSNTALQHTHFDGCELEGANFTGTSLQNMDISTCRF
EQLHVSLDKLKGCKIAPEHAIAFARSLGAVIV
>PK3-2_04401 HTH-type transcriptional regulator NorG
MSQWQPSRGSDLPLHRQIEQYMKDKILHGEWAVGTKIPSQRTLASMFQVNRSTVTAAIDE
LTSQGLLEGRSGGGTKVVNSTWSVLAAEPPLDWSDYVRSGIHHPNSSIIQEINQNEPKAD
IIRLGTGELSPDLLPADTMRRMFQKINPQALSLGYEQPKGNRQLREAVAEHLKGKQIHVS
PSAILIVSGALQALQLISIGLLKRGSVILTEKPSYLQSLHVFQSSGMRLRGLPMDEEGIK
AGLISSYRKQYGGQLLYTIPSFHNPTGTVMSEQRRKEIIIMSNKEQLPIIEDDAYGDLWF
EEKQPQPLKAMDQDGNILYLGTFSKTVSPGLRIGWLAGPEPVIERLADIKMQTDYGSSGL
SQWAAAEWLSRGYYEEHLTRVRMVLKQRRDAAIHFLKRYAGDIATWRIPAGGFYIWVTFH
NTLPVSRFFHEMLKQQVLVNPGSIYDGENRNSIRLSYSYASLADLETGIKAAAETARRLM
S
>PK3-2_04402 Arginine exporter protein ArgO
MSAIIHGFVLALGLILPLGAQNAFIFQQGAWQKHIWRALPAVISASVCDTLLIVLAVAGV
SVIVQQVPVFETVMMAGGFLFLLYMGWVTWNSRPNANQNEKNAFTAKKQAAFAAAVSLLN
PHAILDTIGVIGTSSLQYSGLEKWLFMTACITVSWFWFIFLVVAGRLFQTIDASGRLMLI
VNKCSALVMWAAAGYFGVSLFSN
>PK3-2_04403 hypothetical protein
MTDAKQFYDYHTWANKRIFNHIENLPEETAYQEVKSVFPSISDVLLHMCKADYIWLNVLS
GVAYQKIIDGVSKFEPAHGDMTAIKQHASELESQYHDFFSRQTDLEQTFSMQHPKLGTLE
STYAETILHVVNHGTYHRGNVTAMLRQLGHTGAPTDYVYYLYEKKESKG
>PK3-2_04404 scyllo-inositol 2-dehydrogenase (NAD(+))
MEHQVRCAVLGLGRLGYYHAKNLVTSVPGAKLVSVGDPLKGRAEQAAREFGIEKWSENPY
EMLEDPGIDAVIIVTPTSTHGDMIIKAAENGKQIFVEKPLTLSLEESKAVSEKVKETGVI
CQVGFMRRFDPAYADAKRRIDAGEIGKPIYYKGFTRDQGAPPAEFIKHSGGIFIDCSIHD
YDMARYLLGAEITSVSGHGRILNNPFMEQYGDVDQALTYIEFDSGAAGDVEASRTSPYGH
DIRAEVIGTEGSIFIGTLRNQHVTILTAKGSSYDIIPDFQTRFHEAYCLELEHFAKCVRN
GTAPIVTDVDATINLEVGIAATNSYRSGRPVQLDVNRAYTGL
>PK3-2_04405 HTH-type transcriptional regulator DegA
MNTTIYDVAKAAGVSITTVSRVINNTGRISEKTRQKVMNVMKEMAYTPNVHAAALTGKRT
NMIALVTPDISNPFYGELAKSIEERADELGFQMMICSTDYDPKKETKYFSVLKQKKVDGI
IFATGIENHDSMSALEEIASEQIPLAMISQDKALLPMDIVVMDDVRGGYEAAKHLLSLGH
TNIACIVGDGSTTGEKNRIKGFRQAMEEADVPIDKSLIVPTRFSLESGKEEAGKLLDRNA
PTAIFAFNDVLACAAIQAARIRGIKVPDDLSIIGFDNTILAEMAAPPLTTVAQPIKDMGR
SVIELLAEAIEGKRKTKQKIVLPPELVVRHSTSPLKPRAR
>PK3-2_04406 Arabinose operon regulatory protein
MPRILFTVPPFPVFIAAGEGVFKKGETHVKRVFSVFDLIYVKQGTLYITENEKAFSVEGG
EYILLSPGLEHYGTKGSDEATSYYWLHFDEHRYEFTAKGGSNWSELQQEKGSFEHPARYG
LALPRKGKVQRPQFMAQQFERLIDYSAENSDLPLRKQILFEELMLHLQKEAFQIPSAKER
VAWEAARYLQEHYKEKTTIKDLSLALHYNQDYVSRCMQQVLGVTPAQYTNRVRMTEAKRL
LSSTNDKMGVIAETVGMEDPTYFSKLFKQIEGISPIEYRKIVSRKVQ
>PK3-2_04407 putative FMN/FAD exporter YeeO
MKQAVFKSTALKKPADKSFSLFSLTWPIFIEVSLYMFMGNADTLMLSQYSDNSVAAVGVS
NQILNLIIVMFSFIATGTTVIISQFLGSRQKKEAMEIAYVSIGANFFISLAISAVVFFAA
VPLLHMMGLSNELMPDAKVFLQVVGGLSFIQALIMTFSAILKSYGYTKDTMFVTIGMNIL
NIAGNFVVIFGLFGFPVLGVAGVAISTSIARVIGLIAMIVIVNKRIQLKMSLKKVFHMHK
DHLRKLLKIGIPSAGEQLSYNLSQMIVTYFIAIMGAQALTTKVYTQNITMFILLFGTAIS
QGTQILIGRYIGGKQFDAAYERCMKSLYWAIGIAAATSVLMTIFSKDLIGIFTQSPDIIA
TASLLIAMTIILEPGRSFNVIIINSLRAAGDAKFPVYMAMISMWGIGLPLAYLFGIHLGF
GLAGVWISFIADEWVRGILMYRRWRSRIWIQKGMA
>PK3-2_04408 Putative phytoene/squalene synthase YisP
MKEIKEAYQQCGQIVGEYAPACFKALSYLPLKQRQAAWAVLSFCHTAASADEKVLPAFEA
EADHVYQRTNNGNHHLWKAFDHAYQTFTLDSEPFREFIAAQKEDTKPYDDLDELLMYAYQ
TGGAAGLMLLPILTRRKQDQLKQAAVSLGLAIQLVRFLSDLGTDQQKNRIPRQVMQQFGY
TEADLQKGTVNKAFTMTWEYIAFEAEAYLEECLDALPLFPKYSQKAVETAAHLYRAVLEK
IRTEQYNVFEQAQRSKANSV
>PK3-2_04409 putative protein YizA
MIKFFEYNWQVRDQWFTWCHQLTTEELLKNRVGGVENILYTLFHIIDVEYSWVRAIQGKE
DIVVQFADYHTLNKVKSLSNTFRTEIIDVLETHSDQIKDELVSVPWEKGVLYTRDEILHH
IIAHEIHHIGQLSVWARELKLSPVSANFIGRTLKPIHSY
>PK3-2_04410 Asparagine synthetase [glutamine-hydrolyzing] 3
MCGITGWVDFKKQLVQEKQTINRMTDTLSKRGPDDSNVWGEHHVLFGHKRLAVVDIEGGR
QPMACTYKGDTYTIIYNGELYNTEDLRKELRARGHQFERTSDTEVLLHSYIEWQEDCVDH
LNGIFAFAVWDEKRDLLFAARDRLGVKPFFYTEQGSSFLFGSEIKAILAHPEVKARVDRT
GLSEIFGLGPSRTPGTGVFKGIREVRPAHALTFSKDGLNIWRYWNVESETHTDSFDDTVA
NVRSLFQDAVTRQLVSDVPVCTFLSGGLDSSAITAIAAGHFEMEGKAPLHTYSIDYEEND
KFFQASAFQPNDDGPWIEKMTEAFGTTHHKCVISQKNLVDHLEEAVLVKDLPGMADVDSS
LLWFCREIKKDFVVSLSGECADEIFGGYPWFHMADVESGFPWMRSTEERIKLLSDSWQKK
LNLKEYVNAKYEETLAETPLLDGETGVDKARRQLFYLNMLWFMTNLLDRKDRMSMGASLE
VRVPFADHRLVEYVWNIPWEMKMHDNREKGILRKALDGILPDDILYRKKSPYPKTHHPEY
TKGVSEWLKTIRSQKDSVLHTLLDRKQLDQLLETEGSSFKVPWFGQLMKGPQLIAHLAQI
HTWFEAYRIDIDEG
>PK3-2_04411 hypothetical protein
MKRKQLLYKEEQKWEYGTILIEDGICLIENEEGDILLADSLHHGPIWIQHKGKWEQAGFQ
DQLVLTCGEENISLSGGERIRYEKSVKRPLMVLLDSLDDETFLAFLQHLHSFGLSVFDCV
FSYNKGVFSNTSEEQGVSFYHFSNDAAQCAVQHHYSHDGTGDRFEWTASNGKRSIMYSAV
QRRRK
>PK3-2_04412 Cell wall-associated protease
MKRRKFSSLVAAVLIIALIFSLFSPGTNAAAAGAIDQASALENGKEQTGAVKEPEQVKWY
KVTPGKTDIQKNSHMALTVKSDSVLNVSVYPSKEKALKDETFEMYRSYTAEDGKSEIIFP
YAWSGPYYVKVEYLGEEEPEDGGTAEAAAEAKYTIGYKGTKKQPSDLEEEEACPVEMSVD
QKKSGKSILDKLRAIRDEQLSQTAEGKELTSLYYKAAPFIVAKLALNKTARNEIYQDLVT
LKPMFEDVSENGVSSSYKITEKDQKAINRLYDTALQSVPSFLKEEIKKQAERLNIKQLQG
KTAGAILTENNIAAKSEVQTTKVIFKVKDKKSLSSVHNEMKGFSASAQSKKDISNVKKAK
KLFNNLYSFELPKDEKQNGTYTASAKRVKSAAATLSKMSNVEFAEPVQEYKSLANDIQYP
YQWPLKNTGENGGVKNADVKYEPASTLLSKRKLNDTLIAVVDTGVDSTLADLKGKVRTDL
GRNFVGRNNNAMDDQGHGTHVAGIIAAQSDNGYSMTGLNAKAKIIPVKVLDSTGSGDTEQ
IALGIKYAADKGAKVINLSLGGGYSRVLEFAMKYAADKNVLIAAASGNDGANSLSYPASS
KYVMSVGATNRMDMTADFSNYGKGLDISAPGSDIPSLVPNGNVTYMSGTSMATPYAAAAA
GLLFAQNPKLKRTEAEDILKKTADDISFESVDGEEEELYDDNGDLIDIPKTPGVDWHSGY
GRLNVMKAVSAADLKLKVNKLESTQTAVRGNAKEGTLIEVMSGKKKLGSAKAGKDGAFKV
NIPTQKQDQVLYVKAAKDDAKTSYKVVVVKGKPSGAPKVNAVKTKDTAVKGKANSKAMIR
VKNKSKKVIASAKADAKGTFTVKIKKQKAGTVLYVTAADTDKKESKDVKVVVEK
>PK3-2_04413 hypothetical protein
MTHLHITTWVVALILLFVSYSLYASGSAKGGKITHMILRLFYILIILTGAELFVRFANWN
GEYAGKMILGIITIGLMEMLLIRKKKEKSTGGLWIGFVIVLVLTVLLGLHLPIGFQLF
>PK3-2_04414 putative protein YisK
MKFATGELYNRMFVGLIIDDEKIMDLQKAEKKLFELETIPGSLIECIAEGDKFVAHARQL
AEWAKKPNDELGSFMYSLTDVKLHAPIPKPSKNIICIGKNYRDHAIEMGSEADIPEHPMV
FTKSPVTVTGHGDTVNNHEEVTSQLDYEGELAVVIGKSGTRISKEDAYDHVFGYTIVNDI
TARDLQKKHKQFFIGKSLDTTCPMGPVLVHKSSIQEPERLKVETRINGELRQSGSASDMI
FSIPELIETLSKGMTLEAGDIIATGTPSGVGKGFKPPKFLRSGDKIDITIDPIGTLSNQI
G
>PK3-2_04415 Inner spore coat protein H
MESVHLYFHREQLNRKGTVKGLLVTDRSVSPILLTQRDRAEKASYEISREPSLFGESTLF
LNAEQVDPSLMRRRLAYCFFDQIGVPAPLASYSFLTINGQPEGIYLNIKNQQLADRAGCR
VNIADPRVPLSVCKEESSAFLHEFLTLIRTAENDELAERIKMYLDVKQFFLCLIGSACTS
QGFYYACCPNESGRLHVTPMETRALAAPAKSDEDPLLTKGRTLAARLLSIPAFRSQYHTL
MKNVLNRSFTIERLSPFISDWHLDICQKADDDPFIKKSPLQFEKEQANILREIEERQDFL
QAHLARL
>PK3-2_04416 Aspartyl-phosphate phosphatase YisI
MNSKIEEMRIILIETAQKYGMNSEETIQCSQELDSLLNSRIKEEMIFAGYSESSRM
>PK3-2_04417 putative spore germination protein GerPA
MPAIVGAFKINAIGTSGVVHIGDCITISPQAQVRTFAGAGSFNTGDSLKVMNYQNATNVY
DNDAVDQPIVANA
>PK3-2_04418 putative spore germination protein GerPB
MNFYINQTIQINYLRLESISNSSILQIGSAGSIKSLSNLYNTGSYAEPAPEVSASGQPVQ
LQEPDTGSLVPLQPPGR
>PK3-2_04419 putative spore germination protein GerPC
MYDQSVSSYLQNLNSFVQQQALHIQQLERQLKEVQSEMNTMKQRPATTIERVEYKFDQLK
IERLDGTLNIGLNPSDPNSVQNFEVSQSTPEIGMMQQEESAQLMQQIRQNVDMYLTEEIP
DVLEQLENQYDSRLDDTNRHHIIEDVRKQMDSRIHYYMSHIKKEEHTPPAQYAEHIAEHV
KRDVIRAVEHFLEHIPSEMKGDEQS
>PK3-2_04420 putative spore germination protein GerPD
MIFTVINRSLEVGDIRMNGVSSSSVFHIGDTESIYLSSIFDTPPESLIIGPFAPIAPE
>PK3-2_04421 putative spore germination protein GerPE
MLKRISRIRVIKFNSLGIASVFQAGDTNEIDMSVKVFAVQRSLSTFYHNEGSFNRKEYQI
FEQQAVKPIPETGVESAFCHEVPVIHVRNIKIQGVSASSVFHAGASSIVRGDARLKHIRQ
IQSPRSQSPAKNI
>PK3-2_04422 putative spore germination protein GerPF
MPAIVGPIAINSISGGVVNFGDSFYLSPKSSSKSALGSGAGNTGDFLLLNNAVNATNYID
PDVNDQDMVGNG
>PK3-2_04423 hypothetical protein
MAKQTAGICELCGRSDVQLTEHHLTPKEEGGTFLPTAMLCIPCHKQIHALYTNQELAVRL
NGINELRSDPQLARFVKWIRKQPPEKLIKTKKSNERKKKT
>PK3-2_04424 Chromosome partition protein Smc
MKPIALTIKGLHSFREEQTIDFEGLSGAGVFGIFGPTGSGKSSILDAMTLALYGKVERAA
NNTHGILNHAEDTLSVSFTFALQTNHQISYKVERVFKRTDEMKVKTALCRFIEIKEEHTV
LADKASEVNKRVEELLGLTIDDFTRAVVLPQGKFAEFLSLKGAERRHMLQRLFNLEQYGD
RLVKKLRRQAQEANARKNEMLAEQSGLGEAGSEAVEQAEQALELAEARLEAMRKNRDQAK
ERFTEHQEIWNVQKEKAAYEEEKKRLEEEQPHVDSMQKRLVEAEKAAALKPYADRYAEAI
QHEEKAKKEQTLAQKDLADRTAFFHQKHEEYEAWRRHKSEKEPELLTEQEQLSRLQEIEI
KLSEAKREEEGKKAELQQKEEALQSVMNELEAVTDRLARGQNRQTELKQQLKSLQVTSDE
RKSCQQAAEMALRIRQTEEQITKEQKRSDALNLVLQKMNEEKSILVQKTEAEENNIIQAY
EAVQTVYHMVCETERSLTRMTEQAKKRQQTLHAQREKARVALLTKELAEKLTAGKPCPVC
GSTHHDSSASVHETYEFDSSLEDNIKQTDVLLTEAAALSQEILSAKITLEEQSARFIEQC
PFLQKIQQTPNIEAAASYESQPVLEAFDAAKIEWKRVKQDILSVKTRMAQMISVYQESLK
KADQLNEKIGFEKREADRIESIIAELQSSMDSRLKMFKEAFQDQSVNEAEKWQQAIEEKD
RAAEDCEKRIEKSIAFLAEHEAQKEKLRESGHQLEREKLELHYAAERIKSVIADCEHELG
DYAKGDSIQIKLRSVQQDLKLLKEKEQSLYEELQSAQMKLNQAKSRASASELTLQEAKDR
LGKAESDWLEHATSTRFTRTEEVERSLIPADELEKIKAGIDQFVDKLKQNAANLKRVEER
LAGRALSESEWSETVTALQEAEDAFGAAIEEKGAAAKALAVIREHHKRFNEIEHELKKWQ
THIDRLDKLQAVFKGNTFVEFLAEEQLESVARDASARLGMLTRQRYAIEVDSEGGFVMRD
DANGGVKRPVSSLSGGETFLTSLSLALALSAQIQLRGEYPLQFFFLDEGFGTLDQDLLDT
VVTALEKLQSDNLSVGVISHVQELRARLPKKLIVHPAEPSGRGTRVSLELM
>PK3-2_04425 Nuclease SbcCD subunit D
MRILHTADWHLGKTLEGRSRLSEQADVLDELNTIVKEERIDAVVMAGDAFDTVNPPALAE
QLFYESLSALSDRGKRPIVVIAGNHDNPDRLSAASPLTHEHGIYLIGYPTTEPLHIEVPS
AGELLAVGALAYPSEARLNEVLSDTFDEKLLRDHYDVKIRQAFEHMTSRFRKDAVKVAAS
HIYVAGGNQTDSERPIEVGGAYTVAAESLPADAAYVALGHLHRPQTIKRARTLARYSGSP
LAYSFSEAGYAKSVTIVDAKPGEEASWHEVLLSSGKPLVKWKAANGLSEVYGWLDEGKDQ
NAWIDLEIRVADQLSLEEIHRLRKAHPGFIHIKPVFEEQNKDRERIEVKHVSIEDRFKKF
YEKQTGGAVPDEEMVKLFLELASGVEEEDAK
>PK3-2_04426 ATP-dependent helicase/nuclease subunit A
MNIPKPADSTWTDDQWNAIVSTGQDILVAAAAGSGKTAVLVERMIRKITAEENPIDVDRL
LVVTFTNASAAEMKHRIADALEKELVKRPGSLHIRRQLSLLNRASISTLHSFCLQVLKKY
YYLIDLDPGFRIADQTEGELLGDEVLDELFEGEYAKGDKAFFELVDRYTTDRHDLDLQFL
VKQVYEYSRSHPNPEAWLESFVHLYDVSEKSAIEELPFYQYVKEDIAMVLNGAKEKLLRA
LELTKAPGGPAPRADNFLDDLAQIDELIQRQDDFSELYKRVPAVSFKRAKAVKGGEFDAA
LLDEATDLRNSAKKLIEKLKTDYFTRSPEQHLKSLADMKPVIETLVQLVISYGKRFEAAK
QEKSIIDFSDLEHYCLSILAAENGKGEREPSEAARFYQEQFHEVLVDEYQDTNLVQESIL
QLVTSGPEETGNLFMVGDVKQSIYRFRLAEPLLFLSKYKRFTESGEGTGRKIDLNKNFRS
RADILDSTNFLFKQLMGGKIGEVDYDEQAELKLGAAYPDNDETDTELLLIGSSEETDAGE
EAEELETVQFEAKAIAKEIRKLISSPFKVYDGKTKTHRNIQYRDIVILLRSMPWAPQIME
ELRAQGIPVYANLTSGYFEAVEVAVALSVLKVIDNPYQDIPLASVLRSPIVGADENELSL
IRLENTKAPYYEAMKDYLAAGDRNDELYQKLQTFYGHLQKWRSFSKNHSVSELIWEVYRD
TKYMDYVGGMPGGKQRQANLRVLYDRARQYEATAFRGLFRFLRFIERMQERGDDLGTARA
LSEQEDVVRLMTIHSSKGLEFPVVFAAGLGRNFNMMDLNKSYLLDKELGFGTKFIHPQLR
ISYPTLPLIAMKKKMRRELLSEELRVLYVALTRAKEKLFLIGSCKDHQKQLAKWQASASQ
TDWLLPEFDRYQAKTYLDFIGPALARHRDMETLAENSAAAHADISGHPARFAVRMIHSYD
LLDDDLEERMEEKSERLEAIRQGEPVPGSFAFDEKAREQLSWTYPHHVVTQIRTKQSVSE
IKRKREYEDEYSGRAPVKPADGSILYRRPAFMMKKGLTAAEKGTAMHTVMQHIPLTHVPT
IEEAEQTVQKLYEKELLTEEQKAAIDIEEIVQFFHTEIGGQLIGAKWKEREVPFSLALPA
KEIYPDAREAVEPLLVQGIIDCLYETEDGLYLLDYKSDRIEGKFQHGFEGAAPILMKRYE
TQIQLYTKAVEQIAKTKVKGCALYFFDGGHILTL
>PK3-2_04427 ATP-dependent helicase/deoxyribonuclease subunit B
MGAEFLVGRSGSGKTKLIIDSIQDELRRAPFGKPIIFLVPDQMTFLMEYELAKTPDMGGM
IRAQVFSFSRLAWRVLQHTGGMSRPFLTSTGVQMLLRKLIEEHKQEFKVYQKASDKSGFT
AQVERMLTEFKRYCLEPEDIRRMAESGTASEYRGERVLSEKLHDLSILYQQMEKSLADQY
LHSEDYLTLLAEHIPLSEDVKGAHIYVDGFYQFTPQEFRVLEQLMVHAEHITFSLTADKP
SYEREPHELELFRMTGKTYYRLHQKAKELNLDISYKELSGSERHLQTPELAHLEAQYEAR
PAIPYSEKQEAFTVMQAANRRAELEGIAREIHALVREKGYRYKDVAILARQPEDYKDMVK
EVFTDYEIPYFIDGKASMLNHPLIEFIRSSIDVLKGNWRYEAVFRCVKTELLFPLNEPKN
KVREQVDQLENYCIAYGIKGDRWTRGDRFHYRRFVSLDDDFAQTDQEIELENMLNDTRDW
IVPPLVQLQKRMKKAKTVQEKAEALYRYLEETDVPLKLDQERQRAEEEGRIIEAQQHQQA
WNAVIQLLEEFVEMMGEDEISLDLFQQMMEGGAESLTFSLIPPALDQVFVGNMDLSRIYG
TSCTFVLGANDGVLPARPDENGVLSDDDREWLKTIGVELSSGGRERLLDEHFLIYMAFSS
PSDRLYVSYPIADAEGKTLLPSIVIKRLEELFPQYKERLLTNEPEQVSDEEQLMYVVNKS
VAQSFAASQLRLWTREYDISDVWWSTYNVLMSGPDRLQSKKLFSSLFFRNEVKQLERSVS
RQLYGERIQGSVSRMETFNACPFSHFASHGLHLKERQFFKLEAPDIGQLFHSSLKLISDR
LREQKMDWRDLTKEQCELFSYDAVERLAPKLQKEILLSSNRHYYVKEKLQKIVTRVSGIL
SEHAKASGFVPIGLELGFGGKGPLPPLTFKLKNGCTMELVGRIDRVDKAESSKGLLLRIV
DYKSSDKGLDLAEVYYGLALQMLTYLDLSITHSEDWLGMRATPAGVLYFHIHDPMIQSNL
PLGLDEIEQEIFKKFKMKGLLLGDQEAVRLMDTTLQEGRSNIINAGLKKDGSLRSDSAAV
GEKEFELLTKHVRRTFQEAGEQITDGRVSIEPYKMKNKTPCTYCAFKSVCQFDESLEENE
YRPLKAEKDKTILEWIKKEADGNEHS
>PK3-2_04428 hypothetical protein
MYYSYYPYPVPYREDPVLIRNLKKAINGEFSAVQCYRKLAELASREDARKQIEEIRRDEM
RHLREFSTLYGAITGKHFMPKQTEECPDSFMRGLDAAFKDEQETVDFYLRAAEETSNLKA
KGIFTRAARDEQNHAVWFLYYLMER
>PK3-2_04429 HTH-type transcriptional regulator SgrR
MKLIEHYVELVKAGSAAYGQMNEMTLTEISDCLFCTERNAKLILHKLENKNWIIRESGAG
RGRKSKIAFLRQPEELLLQTAKEYTMAGKLHKAKELLQQYQSVFPGLQNEYDMWFSDVFG
FVTETCGDGEKDVLRLFITPEAVSSLDPCQIFLRSEGHFVKQIFDTLLTFDPAVQEPKPH
LVHGWEEDGKKRWRFFLRKGVFFHNGQPLTARDVAFTFQRFLTQADNPYKWLLYGVKQVL
ENSPYCVELILDKPNELLPYVLCDERLSILPAEEDGGINGTGPFRVNQHHSRMLVLEANE
RYFKGRPFLDRVEFVFSEQAEEINGFTIQEKQTCPDRQTVFDERHVQYLSLNLKKEGPLQ
HRSFRKALRLLISSERLVREAGGHRRTPVSSFLHPNPFDREGVSPFELLKQSGYEGETLV
LYTFSEADHREDAEWIQNVCAQHGIRLTLQFCDSADLRRREIVQMADIIHDSATFAQDSE
FGFLHLLLSENSFLCQHLSEKLTQICSGMTERIFSMPDRCSRIQMLHDIDRQLLQEFNAI
PLYQSVLQVTSSENVKGLMLDEEGWIDLYAVWLSK
>PK3-2_04430 Na(+), Li(+), K(+)/H(+) antiporter
MFTSFQSIKSRYTAPVWLRFFGEMLTSLTGAMMGPFMVLYLHEQLNGSVMIPMLIISLQP
FADICLTLIAGRVTDRLGRRTAILIALFLQSAAMTGFVFAEHAYAFAFLYVLNGIGRSLY
IPASRAQIAESTPESRRSEVFAVINAIYSAGLTAGPLLGMLLYKHNPVWIFALDAAALFI
FFLIAALKLPETKPIITADASAFPATFTIYRPVLLLLLLSLPISMLYAQTETTYRLFSKN
MFSDYLSALTIYSAAKALFSFVLQVPLVKGTEKLSMKTILLITYICYSLAAAGFACSTSL
TMLLVTAAVMTVGESIGLTHIQTFISKLAPPHLLGRFYAVYGLHWDISRSIGPLAGGLIL
TSIGGEVIFYALAVCLLAACLCLTYTIEKLEHKVIRKTNG
>PK3-2_04431 hypothetical protein
MLREKEEGFYIEERRKSPQRSMVYRNQCSRGFILSLTGISIGWMIGTLIVACCLAMIRPA
WLMMAPDQKGINRRWLALGQMILGIELGQKLNLSVLSVLKDHWFSVGVMLILSILLAMLS
GYVLWRFSKTDMMTSFVGTAPGGLSAMPSIAQEVGANTAIVSLVQMMRVLLVVLSIPFLV
ILIYTKHDGPASAAAETLSTATTDIRLTPVLWTAVLILAAWGACKAAKFLKFPAPWLLGS
MLGAALVHVGGSAVTGHDMTAWWPSQANHVSQVFLGATIGSKMYKSMFAGVTRIIIVGFV
SSVGLIAAMFVSAVIVSKLTGISLITSVLAFAPGGIAEMATTSVTLHADSTFVVAVQVIR
VILVIALLPPFYRLLHHLHGEKKDKERSISGSNA
>PK3-2_04432 HTH-type transcriptional repressor CytR
MPTIDEIAKLCNVSKTTVSRVLNNHPYVSKEKRDMILKAINELDYTPNYLARNFRRNKTQ
TIALSVPSIDHPFFAQLIKGVSHEALFKNYKVIVFQTFYDQQTELELLELLKHKEVDGII
LGTLENEWEKISPFLKYGPILLCNEYHHSADITIIGYNEFEAAYMGVVHLIERGHKKIGF
CFDTPYSEAQCQRKEGYLKALQDYNLQHRDEWIFGEMFNIEDGFRVFDKIKDLKDRPSAI
FTGNDQVAAGIIKQAIKNGFHVPEDLAVIGFDNHLICQVVTPTITTIDIPIIELGQQAVL
KIIESISGNASLNRRIIKLPTNLIIREST
>PK3-2_04433 3-oxo-glucose-6-phosphate:glutamate aminotransferase
MQKQVKVSGKSKENMLLLKHLKGDVQGKELVIEDSIVNERWRQVLKENTDIENDLFNYQK
NREISKVPFMPVDRLITNDEVDDILNTLTKVLPTGKFTSGSYLDQFEKVLSTYLHKRYVI
ATSSGTDAIMIGLLALGLNRGDEVIMPANSFSATENAVLALGGVPIYVDINPQTFCIDPH
KIEEAITPYTKFILPVHLYGKHSEMKHIRQIANRYKLKVIEDACQGIGLTDLGKYADITT
LSFNPYKNFGVCGKAGAIATDNEELAKKCIQFSYHGFEVNVKNKKVINFGFNSKMDNLQA
AIGLERIKYLSLNNFKRLFLADRYITQLAELQNKGLIELPELSEDHVWHLFPIKVRAEDR
TDIMTKLNEDFGVQTDIYYPILSHMQNTPLVQDKYTKLQLVHTEKAHSQVLHLPLYPSFT
LEEQDRVMEGLFNVIKQKAGV
>PK3-2_04434 Kanosamine-6-phosphate phosphatase
MLLSKKLEYKTLSKVEHPKYIVFCDFDETYFPHTIDEQKQQDIYELEDYLEQKSKDGELL
IGWVTGSSIESILDKMGRGKFRYFPHFIASDLGTEITYFSEHNFGQQDNEWNSRINEEFS
KEKIEILVKQLYENHNILLNPQTQLGKSRYKHNFYYQEQDEISDKKNLLVIEKICEEYGV
SVNINRCNPLAGDPEDSYDVDFIPMGTGKNEIVKFMLEKYNLNTEKAIAFGDSGNDVRML
QAVGNGYLLKNATQEAKNLHQLITDSEYSKGITNTLKKLIG
>PK3-2_04435 Glucose-6-phosphate 3-dehydrogenase
MKKIGIIGAGGIARAHATALSTIKIAELVGVYDINQQNAESFVKTFGGKTYENVDELIDV
SEGLIVASPNFCHKEHALQALAKHKHVLCEKPMAISLEEASIMKDTAERLDVRASMGFNY
RYLSYVNILKSLIINNELGNILSIKVHFKKNSALRRKKFTWRDDANSKKTSGSLGDLGIH
LIDMVWYLFESDFITESVRAKMNTNVKTKEDKQVLVDDYAEIYGQLKNKVFVNIITSKCS
VPEDCGFSIEVVGHKKEFKYHTNNPHVYKLIDGLNVVDCPVPQSLLNDPPNEFYGWADSF
RSELINWIESAQKEWIEIPSFNDGFRSQEVLEMFFEKDCDSQTMSALTVN
>PK3-2_04436 Glucose/mannose transporter GlcP
MLRGTYLFGYAFFFTVGIIHISTGSLTPFLLESFNKTTDDISVIIFFQFTGFLSGVLIAP
LMIKKYSHFRTLTLALTLMLAALSIFFLTKDWYYIVVMAFLLGYGAGTLETTVGSFVIAN
FESNAEKMSKLEVLFGLGALSFPLLINSFVDINNWHLPYYCIFTFLFVLLAGWLIFLSKN
RKYTKNNANQQVTLPNAGAFQYFIGDRKKSKQLGFFVFFAFLYAGIETNFANFLPSIMIN
QNNEQISLISVSFFWVGIIIGRILIGLVSRRLDFSKYLLFSCSCLIVLLIAFSYISNPIL
QLGGTFLIGLSIAGIFPIALTLASIIIQKYIDEVTSLFIASASFGGAIISFLIGWSLNQD
TILLTMGIFTTMAVILVGISVKIRRTKTENPISLENNASKTQ
>PK3-2_04437 hypothetical protein
MMKKIFKGDFLRDNPDKAMHLYYGLCLGIWLIYNLVTSGSPGLPLTILAGGNLIYLAILK
KKKET
>PK3-2_04438 HTH-type transcriptional regulator PchR
MNTDHTKHNLFELYAELIHQQEKWEGLIKAFLADELKKLDVEHGSKSQLSMTEIHVLSCI
GDNEPINVTSIAEKMNTTKATVSRISTKLLGAGFLHRTQLSDNKKEVYFRLTPAGKKLHG
LHKYYHQKVQQRFLSFFDRYTEEEILFAERLFRDLVTKWYPSSEEIEEGLHSIFK
>PK3-2_04439 12-dehydrotetracycline 5-monooxygenase/anhydrotetracycline 6-monooxygenase
MNVEAVIIGGGPVGFMLASELAMAGVKTCVIERLEKPVPHSKALTLHPRTLELLEMRGLL
ERFVSKGSKIPSGHFSMLDTRLDFSGLDTSCPYTLLLPQAKTEQLLEEHARSLGAEVFRG
AEALSVTQNGAEVQTIFKDRDGSVRTVTSQFAVGADGAGSTVRKQARIEFPGTDSTITAA
LADAALLSPPPSGVMSLCTKEGGVMIVPLSPNQYRIVVVSPYRTQTQKDVPVTEEELKAD
LIRICGTDFGLTESSWKSRFGNAARQAKRYRDGRIFLAGDAAHIHFPAGGQGLNVGLQDA
MNLGWKLAAAVKGTAPLWLLDSYHEERHPAAGGLLRNTEAQTKLIDFSQAGLHLRSMMSE
LLAFPEVNRYIAGQISALDVRYEADPDMPPHCLNGSRIPDMELNLPDGSSERLYSLLQNG
TFVLLSLIQEADDHSRIKGLRTVTASLAEPDGKLRGVHTILIRPDGHVAWAVDASAPDCA
DLIQTGLRRWLSVTSRV
>PK3-2_04440 Signal peptidase I V
MKKRFWFLAGVVSVVLAIQVKNAVFIDYKVEGVSMNPTFQEGNELLVNKFSHRFKTIHRF
DIVLFKGPDQKVLIKRVIGLPGESIKYKDDQLYVNGKHVAEPFLKHLKSVSAGSHVTGDF
TLKDVTGTRKVPKGQYFVVGDNRIYSFDSRHFGPIREKNIVGVISDAE
>PK3-2_04441 TVP38/TMEM64 family inner membrane protein YdjZ
MLEHFLSYLTQEHLTELFQSYRALGPLIAVLLPLIEAFLPFLPLIVFVVANTNSFGLWEG
FILSWAGSTAGSILVFLIVRQYGQRRLLGFIRSHPSVRKLMLWVERHGFGPMFLLLCFPF
TPSAAVNVVAGLSRIGTRPFILAAASGKLVMIFMISFIGYDLHALITQPIRTVIAVLVIL
VLWYVGKKVERYLHVRASQRERDGGRQ
>PK3-2_04442 hypothetical protein
MPKLQEEIYDFIERALFLPMAITILNRDLAGIDQSTLKLKQPYKQLISESLKIAQKDLME
VRKELRKRKIVIHEAERDEAFTLYVFVIDGYEEKHRYFNPRIREQVSELLTLYLFAPDKP
>PK3-2_04443 hypothetical protein
MKLIHVLAALPFIGILLGIPFANKVTPYVFGMPFILAYIVMWALLTSALMAVVYVLDNEN
KKEEAE
>PK3-2_04444 putative symporter YodF
MNAALIIIFGVLLLSIFLGIRAQKGKDMNLEQWTVGGRGFGTVFVFLLMAGEIYTTFTFL
GGSGWAYGKGGPAFYIIAYGCLAYILSYWLLPAVWTYAKQHKLMSQSDFFTKKYNSPLLG
VLVSLVGIAALIPYLVLQLKGLGLIVSETSYGKISPAAAIWIGAISITVYVMVSGIHGSA
WISVVKDIMILVVVLFLGIYLPIHYYGGFQDMFQQIETAKPGFLTLPETGQSTAWFSSTV
LLTALGFYMWPHTFSASYSAENPKVFRKNAIIMPLYQLVLLFVLFVGFAAILQVPGLKGA
DGDLSLLRLSLQTFDPWFVGIIGAAGLLTALVPGSMILMSASTLFAKNVYKVFAPRTTEQ
QVSALAKFLVPVIALISVYFTFKGGNTIVTLLLMGYSLVTQLFPALLFSLFKHNMVTKQG
AFCGIITGVGAVSYITLTETTIGTLFPALPQAAKDVNVGIVALLLNITVMAAVSFVTRKA
KSAAADQAA
>PK3-2_04445 hypothetical protein
MKKAAAVLLSLGLVFGFSYGAGHVAEAKTKVKVYKNCKELNKVYKGGVARTSKVKNKGGK
TKYKPYVSKALYDANKKRDRDKDLIACER
>PK3-2_04446 putative oxidoreductase YghA
MSDSNLSNPLTAFFHDEFPEQYQEPPGLQKNMKPVPDCGEKSYKGSGKLTGRKALVTGGD
SGIGRAAAIAYAREGADVAINYLPAEQPDAEEVKKLIEAEGRKAVLIPGI
>PK3-2_04447 putative oxidoreductase YghA
MSDESFCQDLVKQAHQELDGLDVLALVAGKQQAVEKIEDLPTEQIYKTFEVNVFSLYWVI
KAALPLLPKGASIITTTSVEGYNPSPMLLDYAATKNAIIGFTVGLGKQLASKGIRVNSVA
PGPIWTPLQISGGQPTENIPKFGQGTPPSPLNRAGQPAELADIYVFLASENSSYVTSQVY
GITGGIPTA
>PK3-2_04448 Competence transcription factor
MSQKTDAPLESYEVNGETIAVLPEEIDGKICSKIIEKDCVLYVSMKPLQIVDRSCRFFGS
SYAGRKAGTYEVTKISHKPPIMVDPSNQIFLFPTLSSTRPQCGWISHVHVKEFKPTEFDD
TEVTFSNGKTMELPISCNSFENQVYRTAWLRTKFQDRIEHRVPKRQEFMLYPKEERTKMI
YDFILRELGERY
>PK3-2_04449 hypothetical protein
MKEKKSYTELMKSRNTQKTKEFDVTMTDVYIQMVLDESLYKRRLAMLTDQINKALDEKDK
DAFLTLSKEYAALKQSE
>PK3-2_04450 General stress protein 39
MANQKKKTLPPQHQNQQPGFEYLMDPRPVFDKPKKAKKLEGKTAIITGGDSGIGRAVSVL
FAKEGANVAIVYFNEHQDAEETKQYVEKQGVKCLLIAGDVGDEAFCNDVVRQVSRAFPSI
DILVNNAAEQHVQPGIEKITSHQLIRTFQTNIFSMFYLTKAVLPHLKKGSSIINTASITA
YKGSKTLIDYSATKGAIVTFTRSLSQSLVQQGIRVNAVAPGPIWTPLIPASFAAKDVEVF
GSDVPMERPGQPVEVAPSYLYLASDDSTYVTGQTIHVNGGTIVNG
>PK3-2_04451 Cytochrome b6-f complex iron-sulfur subunit
MANQYFAKEAPETYWRTSTDLPSFPALQEDTECDVTIIGGGITGITTAYELTKRGFRVVL
IEANQVLNGTTAHTTAKITAQHDMIYDEFIRNFGLNHARLYYEANQNAIDYIKGIVDEHQ
IDCEWIEQDAYLYTAHENAVQKIRTEHEAYTKLGIERDLIKDLPIPVGSKLALVMKNQAQ
FHPLQYLKALLEQIVQKGGRIFEDTVALDIKKGERPEVITKTRHAIKSRFIICCSHFPFY
DGGGLYATRMYADRSYVLAVKPKIEYPEGMYLSIDKPSVALRYTLVDGEKLILFSGEGHK
TGQGKDMSTHYESLRKAAESTIGIKSIPYYWSTQDLVTIDKMPFIGPMSENEDNILVATG
FKKWGMTSSAVAATLLSDLMEKKDNPYESIFTPSRFHLNPGLQKVISYNADVAKHFIKGK
LEKPDVQFDEIAPGEGKAVTIKGKRAGAFRDETGCLHLVDTTCTHLGCEVEWNDGEHTWD
CPCHGSRFKPTGEVVEGPAIKPLKQIDLD
>PK3-2_04452 Heme-based aerotactic transducer HemAT
MLFKKDRKQETAYFSDSNGQKKNRIQLTNKHSDVKKQLKMVRLGDAELYVLEQLQPLIQE
NIVFIVDAFYKNLDHESSLMDIINDHSSVDRLKQTLKRHIQEMFAGVIDDEFIEKRNRIA
SIHLRIGLLPKWYMGAFQELLLSMINIYETSITNHQELLKAIKATTKILNLEQQLVLDAF
QSEYNQTRDEQEEKKNLLHQKIQETSGSIANLFSETSRSVQELVDKSEGISQASKAGTVT
SGTVEEKSIGGKKELENQQKQMNKIDTSLVQIEKEMVKLDEIAQQIEKIFGIVTGIAEQT
NLLSLNASIESARAGEHGKGFAVVANEVRKLSEDTKKTVSTVSELVNNTNTQINIVSKHI
KDVNGLVSESKEKMTQINRLFDEIVHSMKISKEQSGKIDVDLQAFLGGLQEVSRAVSHVA
ASVDSLVILTEE
>PK3-2_04453 putative biotin transporter BioY
MLRLIDMMHIAIFTALMAVLGFMPPLFLSFTPVPITLQTLGVMLAGSILKPKSAFLSQLV
FLLLVACGAPLLPGGRGGFGVFFGPSAGFLIAYPFASWLISLAASRLRKVTVLRLFFTHI
VFGIIFIYLLGIPVQAFMMHIDFSQAAFMSLAYVPGDLIKAAVSAFLAIKIAQALSLSDT
MFTKGG
>PK3-2_04454 putative acyl--CoA ligase YhfT
MTITHTYSATAETSPDRVAIHTESEQITYRDWARLVSQTANWLRSLPNMPNRVAILLPNS
PAFLQLFAGAAAAGCTAVPIDIRWSAEECKECLSISDADLVITSAFYKNKLIDSKTPVVL
LDHCMAAISEAAALPQLNIDPEHPFYMGFTSGSTGKPKAFTRSHRSWIESFACTETDFSI
SADDRVLIPGTLMSSHFLYGAVSTLFLGGTVCLLKKFSPAQTKEWLTLESISVLYTVPTM
TDALTRIEAFPDCPVKIISSGADWPAESKKKLANARPHLKLYDFYGTSELSFVTYSSPED
SKRKPHSAGRPFHNVQIEIRSAAGERCQPGEIGKIFVKSPMRFSGYVNGSAPVESGWMTV
DDMGCVDEEGYLYISGRENGMIVYGGLNIFPEEVERVLLSCPEVENAAVVGIPDEYWGEI
AVAVIHGNTNARKLKAWCKQTLASYKIPKKWVFAESLPETSSGKIARSRVKKWLEEGAV
>PK3-2_04455 Putative acetyl-CoA C-acetyltransferase YhfS
MNAVIVDAKRTIFGKQNGRLKPFLPEDLAAPIISCLSRKLEDQIIDEVILGNATSRGGNL
ARLSALQAGLPISVPGMTIDRQCGSGLEAVRYACTLIQAGAGTMYIAGGSESSSRSPFSE
RARFSPDSIGDPDMGIAAEYTAARYSISRSMQDDYALLSHQRSRSAHDEGFYREEIVPLG
DLETDEAFLKKRPIEAIISRAKPVFDTSSGTITAANSSGISDGAAALLVMEEEKAAALGL
KPVLRFIGSAASGINPNYPPAAPVDAIRKLFTTHDVTPEDIDLYEINEAFAVKICVCSQE
LGIPFSKINVRGGALALGHPYGASGAALVTRLFYEAKRRTDCHYAVAAIGSGGGIGLALL
FEILS
>PK3-2_04456 Phosphoserine phosphatase 1
MTAVCLVRHGETDWNLQQKCQGKTDIPLNATGEHQARETGEYVKDFSWDVIVTSPLKRAK
RTAEIINEFLHLPIVEMDDFKERDYGDAEGMLLEERTKRYPDKIYPNMEKLEDLTDRLMG
GLVKVNQMYPNKKVLIVAHGAAIHALLTEISGGDPELQSTRLVNACLSNIEFAEEKWRIK
DYNINSHLSGFIK
>PK3-2_04457 Putative ABC transporter substrate-binding lipoprotein YhfQ
MKKTLIILTVLLLSVLTAACSSSSGNQNSKENKVAITHDLGKTNVPENPKRVVVLELGFI
DTLLDLGITPVGVADDNKAKQLINKDVLNKIDGYTSVGTRSQPSMEKIASLKPDLIIADT
TRHKKVYNQLKKIAPTIALDNLNADYQDTIDASLTIAKAVGKEKEMEKKLTAHEEKLSET
KQKISANSQSVLLIGNTNDTIMARDENFFTSRLLTQVGYRYAISTSSNSESSNGGDSVNM
KMTLEQLLKTDPDVIILMTGKTDDIDADGKRPIEKNVLWKKLKAVKNGHEYHVDRAVWSL
RRSVDGANAILDELQKEMPADKK
>PK3-2_04458 Putative quinone oxidoreductase YhfP
MSTLYQALLAEKNADDVSVHVKTMSTEDLPKDGVLIKIAYSGINYKDGLAGKAGGNIVRE
YPLILGIDAAGTVVSSNDPRFAEGDEVIATSYELGVSRDGGLSEYASVPGDWLVPLPQNL
SLKEAMVYGTAGFTAALSVHRLEQNGLSPEKGSVLVTGATGGVGGIAVSMLNKRGYDVAA
STGNRDAVDYLKQLGASEVISREDVYDGTLKALSKQQWQGAVDPVGGKQLASLLSKIQYG
GAVAVSGLTGGGEVPATVYPFILRGVSLLGIDSVYCPMDVRAAVWERMSSDLKPDQLLTI
VDREVSLEEAPAALNDILQNRIQGRVIVKL
>PK3-2_04459 hypothetical protein
MYIRQANTSDIASIAPLFNQYREFYKQASDPQGAETFLKARLEHHESIILIAEENGEFIG
FTQLYPTFSSVSMQRIYILNDLFVAPHARTKGAGGQLLSAAKDFAAENGAKSLSLQTEHH
NRAARSLYEKNGYEEETAFIHYHLNVPAK
>PK3-2_04460 Subtilisin amylosacchariticus
MRSKKLWISLLFALTLIFTMAFSNMSAQAAGKSSTEKKYIVGFKQTMSAMSSAKKKDVIS
EKGGKVQKQFKYVNAATATLDEKAVKELKQDPSVAYVEEDHIAHEYAQSVPYGISQIKAP
ALHSQGYTGSNVKVAVIDSGIDSSHPDLNVRGGASFVPSETNPYQDGSSHGTHVAGTIAA
LNNSIGVLGVAPSASLYAVKVLDSTGSGQYSWIINGIEWAISNNMDVINMSLGGPSGSTA
LKTVVDKAVSSGIVVAAAAGNEGSSGSSSTVGYPAKYPSTIAVGAVNSSNQRASFSSAGS
ELDVMAPGVSIQSTLPGGTYGAYNGTSMATPHVAGAAALILSKHPTWTNTQVRDRLESTA
TYLGSSFYYGKGLINVQAAAQ
>PK3-2_04461 Protease HtpX
MRKWIAAAGLAYVLYGLFFYWYFFLSGDSAVPEAVKGTQADPASFMKPSELAVAEQYSNV
KNFLFFIGIPLDWFLFFVLLISGVSKKIKKWMEAAVPFRFLQIVGFVFVLSLITALVTLP
LDWIGYQVSLDYNISTQTAGSWAKDQVIDFWISFPIFTLCVLVFYWLIKRHEKKWWLYAW
LLTVPFSLFLFFIQPVIIDPLYNDFYPLKNKELESKILELAEEAKIPADHVYEVNMSEKT
NALNAYVTGIGANKRIVLWDTTLNKLDDSEILFIMGHEMGHYVMKHVYIGLAGYLLVSLA
GFYIIDKLYKRTVRFTRSMFHVEGRYDLAALPVLLLLVSVLSFAVTPFSNAVSRYQENQA
DQYGIELTENREAAVKTFQDLAVTGLSQVDPPVLVKIFRGSHPSIMERIQHAEIEEKAPE
HPASEQDADK
>PK3-2_04462 hypothetical protein
MKKIVAAIVVIGLVFIAFFYLYSRSGDVYQSVDADLITLSSSGQEDIEIEKRQHVKDMLD
IMNQGKQLKTKKTSTPDYEGTIKFHKDRYDSFRLWIDGSRQAVFLKDGTYYKLSKNDTKA
LLHIIQKEAKD
>PK3-2_04463 Long-chain-fatty-acid--CoA ligase
MNLVSKLEETASEKPDSIACRFKDHMMTYQELNEHIQRFADGLQEAGMEKGDHLALLLGN
SPDFIIAFFGALKAGIVVVPINPMYTPTEIGYMLTNGDVKAIVGVDQLLPLYESMHESLP
KVELVILCQTGAAEPEASDPEVRMKMTTFARILRPVPAAKQSPALVPDDTAVILYTSGTT
GKPKGAMLTHQNLYSNANDVAGYLGMDEKDNVVCALPMFHVFCLTVCMNAPLMSGATVLI
EPQFSPASVFQLVKLRQATIFAGVPTMYNYLFQHEDGKRDDFSSIRLCISGGAAMPVALL
TAFEEKFGVTILEGYGLSEASPVTCFNPFDRGRKPGSIGTSILHVENKVVDPLGRELPDH
QVGELIVKGPNVMKGYYKMPMETKHALKDGWLYTGDLARRDEDGYFYIVDRKKDMIIVGG
YNVYPREVEEVLYSHPDVKEAVVIGVPDAQSGEAVKGYVVPKRSGATEADIMEHCEQHLA
KYKRPAAITFLDDIPKNATGKMLRRALKDILPQ
>PK3-2_04464 putative sugar epimerase YhfK
MKVFLIGANGQIGQRLVSLFQDHPDHSVRAMVRKEEQKASLEAAGAEAVLANLEGSPEEI
AAAAKGCDAIIFTAGSGGSTGYDKTLLVDLDGAAKAVEAADIAGIKRFIMVSALQAHNRE
NWNESLKPYYVAKHYADKILEASGLTYTIIRPGGLRNEPGTGTVSAAADLERGSISREDV
AKTVIASLDETNTENRAFDLTEGDTPIAEALKKL
>PK3-2_04465 Lipoate-protein ligase LplJ
MLFIDNQNINDPRINLAIEEYCVKHLDPKQPYLLFYVNQPSIIIGKNQNTIEEINTKYVE
ENGIIVVRRLSGGGAVYHDLGNLNFSFITKDDGDSFHNFKKFTEPVIQALRQLGVEAELS
GRNDIVAGGRKISGNAQFATKGRIFSHGTLMFDSAIDHVVSALKVKKDKIESKGIKSIRS
RVANISEFLDDEMTTEEFRSHLLRHIFNTNDIQNVPEYKLTEKDWEVIHQISKERYQNWD
WNYGRSPKFNLNHSKRYPIGSIDLRLEVKKGKIEDCKIFGDFFGVGDVSEVQNLLVGKQY
ERSVIADVLEDVNLKHYFGNITKEDFLDLIY
>PK3-2_04466 putative protein
MKVTVIGCYGGFPAANEATSGYLFQSGDYSLLVDCGSAVLSKLFGHVPAEKLDAVILSHY
HHDHIADIGPLQFAKQVGSFLGKGEHTLPIYGHDADLEQFQKLTYKTHTKGIAYQPDQPL
TAGPFTITFLKTIHPVTCYAMRITDGSHTVVYTADSSYQDSFIPFSENADLLISECNFYA
DQDGTSAGHMNSLEAGRIAKEAGAGELLLTHLPHFGVHDNLRKEAKTVFNGKVNIATSGF
VWEG
>PK3-2_04467 Proton/sodium-glutamate symport protein
MKRIKFGLATQIFVGLILGVIAGVIWYGNPALPTYLQPIGDLFLRLIKMIVIPIVVSSLI
IGVAGAGNGKQVGKLGFRTILYFEIITTFAIILGLALANIFHPGTGVNIHEAQKTDISQY
VETEKEQSNKSVAETFLHIVPTNFFQSLVEGDLLAIIFFTVLFALGISAIGERGKPVLAF
FEGVSHSMFHVVNLVMKVAPFGVFALIGVTVSKFGLGSLLSLGKLVGLVYVALAFFLIVI
FGIVGKIAGISIFKFLAYMKDEILLAFSTSSSETVLPRIMEKMEKIGCPKGIVSFVIPIG
YTFNLDGSVLYQSIAALFLAQVYHIDLSIWQQITLVLVLMVTSKGMAAVPGTSFVVLLAT
LSTIGVPAEGLAFIAGVDRIMDMARTVVNLTGNALAAVVMSKWEGMFNPAKAEAVMSQSK
TDQNATISG
>PK3-2_04468 hypothetical protein
MICKLKSAYGWEGDDGLGEQLIQQILAGEKTATCAPKSLYSKDELSYVYQTAGQLVTVYD
KHDNPRCNIKVTDVFETTFGAPDMRLVKGEGNGDRIEEFQEDHRVAWAELIKNGDLELSE
DTVLVTELFALVQD
>PK3-2_04469 Putative aminopeptidase YsdC
MTSVRKTMELIKELVSIPSPTGNTYEVINYIESLLKEWKVETVRNHKGGLIATIPGRDTS
RHRMLTAHVDTLGAMVKEIKADGRLKIDLIGGFRYNSIEGEYCQIETASGKTYTGTILMH
QTSVHVYKDAGKAERNQENMEIRLDEPVHSRKDTEELGIGVGDFVSFDPRVEITSSGFIK
SRHLDDKASVALLLRLIHQIQTEDIELPYTTHFLISNNEEIGYGGNSNIPPETVEYLAVD
MGAIGDGQATDEYTVSICVKDASGPYHYQLRKHLVDLAEKHHIDYKLDIYPYYGSDASAA
IKAGHDIVHGLIGPGIDASHAFERTHKSSLRHTAKLLYYYVQSSMV
>PK3-2_04470 hypothetical protein
MVSQGAVVFMAVSGAIAFLLPIGLIIWFKRKYGASLKVFFIGALTFFVFAQLLEGGVHVY
VLQVNEMTKEAMRNPLWYGIYGCLMAGIFEECGRYIMMRLFLKRHHAWPDGLAFGTGHGG
LEAIMITGLSSISLIVYAFTINSGTFEQLLINDDMKQALLPIQEQLLHTPSYEWLLGGIE
RISAIAVQIGLSLVVLYAVKSRRPLFLLYSILLHALFNVPAVLYQKRIIEYVAAVEIIVA
LLAAVSVYWIIKAKRLFQ
>PK3-2_04471 3-oxoacyl-[acyl-carrier-protein] synthase 3 protein 2
MSKAKITAIGTYAPSSRLTNADLEKIVDTSDEWIVQRTGMRERRIADEQQFTSDLCIEAV
KDLKSRYEGTLDDVDMILVATTTSDYAFPSTACRVQNYFGWENTGALDINATCAGLTYGL
HLANGLITSGLHQKILVIAGETLSKVTDYTDRTTCVLFGDAAGALLVERDEETPGFLASV
QGTSGNAGDILYRAGLRNELNGVQLAGSGKMVQNGREVYKWAARTIPREFERLLQQAGLT
SGELDWFVPHSANLRMIESICEKTPFPIEKTLTSVEYYGNTSSVSIVLALDLAVKAGKLK
KDQTVMLFGFGGGLTYTGLLVKWGM
>PK3-2_04472 Chromosome partition protein Smc
MNTIRSQWKDIVTSKKLLIPIIAILFVPLIYSGVFLKAYWDPYGTVDQLPVVVVNQDKGA
TYEGEKLQIGDDLVKELKDNKNFDWHFSSDLDQSLKDLLNQKYYLVVEIPEDFSKNASTV
LDKNPKKLDLKYHTNAGSNYVGATIGEKAIDKLKASVSKEVTEQYTKVIFDNFKDIAKGL
SDASSGAKKIDDGTKDAKNGSAQLKENLAKLKESTATISDKTAQLADGAAQVTSGIQSLD
SSLGKFQDSSNQIYDNSNKLEAGSGKITGKLNELNAGLQKVQQGLPDLTNGLDQLNSKAQ
EGSEKAAKAEKLINALDLTQLETAVNNLEKSETAMKEFQKQLTDFENSLKNRDQAFKNLI
NSSDFLTAEQKSQLINSVEKQLPHVDAPDFDEILSGLPAADQLPDIATMKSSLEDVKAEV
AQLKAMPAATSKLYNGAKATQDAIDKLTAGSEKIHNASQQLTDGQNKLTAGIGEYNKQFA
KAKAGSEQLVTGSSQVSGGLLKLLDGSKQVQNGSSKLADGSASLDTGLGKLLDGTGQLSS
KLKDAADQTGDIDADDQTYGMFADPVKTNDDAIHSVPNYGTGLTPYILSMGLYVGGIMLT
VVFPLKEASGRPRNGFEWFFSKFNVMMLVGIIQSLIVATVLLLGIGLEVESTWRFYVFTI
ITSLAFLAMIQFLATTMGNPGRFIAVIILVLQLGASGGTFPLELLPNFYQVIHGALPMTY
SINGFRAVISNGDFGYMWQMAGVLIGIALVMILLSITYFTILSRKEETSEEQPAS
>PK3-2_04473 hypothetical protein
MSIDRKKLILEAATKSFTQFGYKATTMDLVAKLANVGKGTIYTFFKNKEELFDEIFTTLL
KEMKQKADEAMEPNLPFHENVHRALFAILEFRKTHQLTIKIFQENAEIGTMAVQDVIQKM
EQAILSYIKNKIEDGIESGAIKPCDPELTAFVMLKLYIALIFDWEKQHPPLDKETIAELL
ELYVVKGLSAN
>PK3-2_04474 Protoporphyrinogen oxidase
MSDGKKHVVIIGGGITGLAAAFYMEKEIKEKNLPLELTLVEASPRVGGKIQTVKKDGYII
ERGPDSFLERKKSAPQLVKDLGLEHLLVNNATGQSYVLVNRTLHPMPKGAVMGIPTKIAP
FVSTGLFSLSGKARAAMDFILPASKSKDDQSLGEFFRRRVGDEVVENLIEPLLSGIYAGD
IDKLSLMSTFPQFYQTEQKHRSLILGMKKTRPQGSGQQLTAKKQGQFQTLSTGLQTLVEE
IEKQLKLTKVYKGTKVTKISRGGTGYSLELDNGVTLDAESVIVTAPHKAAAGMLSELPAI
SHLKNMHSTSVANVALGFPEGAVQMEHEGTGFVISRNSDFAITACTWTNKKWPHAAPEGK
TLLRAYVGKAGDESIVDLSDNDIINIVLEDLKKVTNINGEPEMTCVTRWHESMPQYHVGH
KQRVKELREALASAYPGVYMTGASFEGVGIPDCIDQGKAAVTDALTYLFS
>PK3-2_04475 Ferrochelatase
MSRKKMGLLVMAYGTPYKEEDIERYYTHIRRGRKPEPEMLQDLKDRYEAIGGISPLAKIT
EEQAHNLEQHLNEIQDEITFKAYIGLKHIEPFIEDAVAEMHKDGITEAVSIVLAPHFSTF
SVQSYNKRAKEEAEKLGGLTITSVESWYDEPKFVTYWVDRVKETYASMPEDERENAMLIV
SAHSLPEKIKEFGDPYPDQLHESAKLIAEGAGVSEYAVGWQSEGNTPDPWLGPDVQDLTR
DLFEQKGYQAFVYVPVGFVADHLEVLYDNDYECKVVTDDIGASYYRPEMPNAKPEFIDAL
ATVVLKKLGR
>PK3-2_04476 Uroporphyrinogen decarboxylase
MSKRETFNETFLKAARGEKADHTPVWYMRQAGRSQPEYRKLKEKYGLFEITHQPELCAYV
TRLPVEQYGVDAAILYKDIMTPLPSIGVDVEIKNGIGPVIDQPIRSLADIEKLGRIDPEQ
DVPYVLETIKLLVNEQLNVPLIGFSGAPFTLASYMIEGGPSKNYNKTKAFMYSMPDAWNL
LMSKLADMIILYVKAQVKAGAKAIQIFDSWVGALNQADYRTYIKPVMNRIFSELAEENVP
LIMFGVGASHLASDWHDLPLDVVGLDWRLSIDEARSKGITKTVQGNLDPSILLAPWDVIE
KKTADILDQGMKSDNFIFNLGHGVFPDVSPEVLKKLTAFVHKYSQNKKMGQYS
>PK3-2_04477 Penicillin-binding protein 1F
MFKIKKKKLFIPIIILVLTAFLALIGYISIIFLGHYVIDEKKLILHASSKIVDQNGDEVA
SLYTENREPVSINEIPKQVREAFIAVEDKRFYEHHGIDVKSVGRAVYRDILAGGKVEGGS
TITQQLAKNIFLTHDKTFLRKTKEVIIAINLERDYSKDKLLEMYLNQLYFGHGVYGIQAA
SHYYFNKEAKDLTVSEGAVLAAIPKAPSTYSPVLHPDKSKERRDTILGMMNDQGYISAKE
AVSAQGRTLGLNVKKQSETPWFDSYIDLVIKEVEDKYSISGEQLLQGGYTIKVPLDSKLQ
KTAYQVMKQGSYYPGTDQNAEGSAVFINNKTGGVEAAVGGRDYTAKGYNRVTAVRQPGST
FKPLAVYGPAMQEKKFKPYSLLKDELQSYGDYTPKNYDSRYEGEVTMSDAITYSKNAPAV
WTLNEIGVETGKSYLKANGIDIPDEGLALALGGLEKGVSPLQLAGAFHTFAANGMYTEPY
FISSIIDEDGETLADHKEEEKRVFSKQTSWNMTRMLQQVVKKGTATSGTYHGDLAGKTGS
TTYTGVTGATKDAWFAGYTPKITGAVWMGYDKTDQNHYLKGGSAYSTRLFKDILTQAGET
GDVFTKPKNVKELESPIELEPVKTLKADYTFKAAGLFTIELNWDAQEDDRAVYRIYVNKD
GKETLLDSVEGKGSYEIPYANLFSGASYKVVPYNTQTKREGEGTDYVQPKLFSS
>PK3-2_04478 Heme-degrading monooxygenase HmoB
MKVYITYGTADFLKTIVKKHPSEHILLMQGQENAILIHETSGDTIFQAPHAYEVIDQVGE
MKHPGFAVLNNIAVTQEGRPLFENRFKNRAGKVENEPGFEAIRVLRPLDSDTYVILTLWE
TERAFQDWQQSDSYKEAHKKRGTSAGIDTTSIFSRPSYVTTYFAVE
>PK3-2_04479 hypothetical protein
MKHTCPVCGFKGLTEPPYDHEGNHSHEICPCCGFQFGFDDYEMRREAGSYLDPSESIAAY
RNNWLAGGAVIFSPDCCPPHQQKEQKVLQHVLTEQLKHINVHLSS
>PK3-2_04480 hypothetical protein
MEVGILPVHVLYVFFIGAIILFMLLRKDTTFISLFGIFMISLWASHSLSASVSSLFHSFI
YAAGELLPTIFIICFIVSMSDLLTKTGINEAMISPFASLVKGPVTAYWLIGGLMFAISLF
FWPSPGVALIGAVLLPAAARAGLPPIAAAMAMNLFGHGFALSGDFVIQAAPKLTADAAGI
PVGDVISASIPLVLIMGVTTTAAAFIMIQRERKKQLAPASFSPLLSGEQDTSLYLPKRLR
SLLAFLIPLVFLADIACMLLFNLQGNDATALIGGSAICILLTVHFLVYKQKGLEKITGYF
IDGFQFGFKVFGPVIPIAAFFYLGDSGYKSILGASLPEGSHGIVNDLGIALSHMMPMSKE
LAAAALTAAGAITGLDGSGFSGISLAGSIAKLFSSALPADPAVLTALGQISAIWVGGGTL
VPWALIPAAAICKVDPFELARKNFIPVAIGLSVTTIAAMFFL
>PK3-2_04481 N-acetyldiaminopimelate deacetylase
MSISTLQKEINKQLDSCFEEMVEIRRHFHMYPELSFQEEKTAAFIASYYESLGVPIRTNV
GGKGVLAYIEGSEPGPAVALRADFDALPIQDEKDVPYASKVPGVMHACGHDGHTAALLAV
GKVLHQNRHELKGTFVMIHQHAEEYYPGGAKPMIDDGCLENVDVIFGTHLWATEPLGTIL
CRPGAVMAAADRFTIKIHGKGGHGAHPHDTKDAVLIGSQIVSSLQHIVSRKVNPIQSAVI
STGSFIADNPFNVIADQAALIGTTRSFDDNVRIILEKEIEAVVKGVCSMHGAAYEYNYER
GYPAVVNHPAETSHLAGIAKNTEGVQQVIAGEPQMGGEDFAYYLQNVKGTFFFTGAAPEQ
PERVYSHHHPKFDINEKAMLTAAKVLAGAAITYHTL
>PK3-2_04482 hypothetical protein
MTDNQLLLQEALQWKMHFLRKDSMFERFSKRVQTKVNERIPEKIHTAVTESVKKMVEATM
AGSNIIAYKKDTSALSLSEKNELAKKTIASYQKVAAAEGVGTGAGGIFLGIADFPLLLSI
KMKCLFTLSSIYGFDVKDSEERMFLLLVFQLAFSSDDCRKSLFSVLDNWETEKKSIDWRV
FQQEYRDYIDVVKLFQLLPGVGAAVGGIANYKLLAQLGETARHVFHLRIGKETAGG
>PK3-2_04483 hypothetical protein
MNNMLDIWQSRLQEHIKETRMYMKYMLNDHLVIVLIFFLAGAASWYSKWIRDIPAHFPSF
WVMAVLFSLVLTSSYVRTLLKEADLVFLLPLEAKMGPYLKQAFVYSFVSQLFPLIALSLV
AMPLYFAVAPGASLVSYAAVFVQLLLLKAWNQVMEWRMTFQHDRSMKRMDVIIRFAANTL
VLYFVFQSVYMYALVVYVIMAALYLYMSSSAKRKSFKWESHIESELRRKQRFYRIANLFT
DVPHLRKQAKRRAYLDFLLRLVPFEQRKTFAYMFTRAFLRSSDYLGILVRLTVIFALIIM
YVSASPLIAGVLTVFTIFITGVQLLPLFGHFDHLALQELYPVKKETKLKSYFSLLKTALS
IQALLMSAASAYAAGITGFLYALIGSAVLIFVVLPSYMTTRLKKHGKL
>PK3-2_04484 ABC-type transporter ATP-binding protein EcsA
MSLLSVNDVTGGYTRNPVLKNVSFTLEPNQIVGLIGLNGAGKSTTIRHIIGLMDPQKGSI
ELNGKTFAEDPEGYRSQFTYIPETPVLYEELTLMEHLELTAMAYGLSKETMEKRLPPLLK
EFRMEKRLKWFPAHFSKGMKQKVMIMCAFLAEPALYIIDEPFLGLDPLAINALLERMNEA
KKGGASVLMSTHILATAERYCDSFIILHNGEVRARGTLSELREQFGMKDAALDDLYLELT
KEDAGHE
>PK3-2_04485 Protein hit
MHSAENCIFCKIIAGDIPSAKVYEDEHVLAFLDISQVTKGHTLVIPKTHIENVYEFTDEL
AKQYFHAVPKIARAIRDEFEPIGLNTLNNNGEKAGQSVFHYHMHIIPRYGKGDGFGAVWK
THADDYKPEDLQNISSSIAKRLASS
>PK3-2_04486 Phosphoserine aminotransferase
MMERTTNFNAGPAALPLEVLQRAQKEFIDFNESGMSVMELSHRSKEYEAVHQKAKSLLIE
LMGIPEDYDILFLQGGASLQFSMLPMNFLTPEKTAHFVMTGAWSEKALAETKLFGNTSVT
ATSEADHYSFIPEVDLTDVKDGAYLHITSNNTIFGTQWQEFPDSPIPLVADMSSDILSRT
IDVSKFDVIYGGAQKNLGPSGVTVVIMKKTWLQNENVNVPKILKYSTHVKADSLYNTPPT
FAIYMLSLVLEWLKENGGVEAAEQRNEQKAQVLYSCIDESNGFYKGHARTDSRSRMNVTF
TLRDDELTKTFVQKAKELKMVGLGGHRSVGGCRASIYNAVSLEDCEKLAAFMKKFQQENE
>PK3-2_04487 putative tryptophan transport protein
MKTKELVIMALFAAIGAALHSIIPPFLGGMKPDMMLIMMFMGILLFPRVQNVLVIGIVTG
IISALTTAFPAGQIPNIIDKPVSAFLFFFLFLLFRKSQKTGAAAVLTAIGTILSGIVFLS
SALLIVGLPGGFAALFAAVVLPAAVLNTIAVIIIYPIVQTILRRSSFMEAVK
>PK3-2_04488 hypothetical protein
MIVLSCITLAFASGAVYYIRLLSQAASYPPKKVIRQKALVCSTGTAFTLCLIFFTKLFV
>PK3-2_04489 hypothetical protein
MASGRSLLTGLFVGGIIGGAAVLLTAPSSGKQLREKMKTNYDSFEETIKRLKSDGLALKD
QLIKAAKESTDVIKDVSGELQTSIKKWQEEIKPHQQDLQKEIADIEEKIRQLEKTLQN
>PK3-2_04490 HTH-type transcriptional regulator Hpr
MNRVEPPYDVKEALVFTQKMAQLSKALWKSIEKDWQQWLKPYDLNINEHHILWIAYQLNG
ASISEIAKFGVMHVSTAFNFSKKLEERGYLQFSKRLNDKRNTYVQLTEEGTEVFWSLLEE
FDPTRNAVFKGSQPLYHLFGKFPEVAEMMCMIRHIYGDDFMEIFETSLTNIDNDFESVNG
KLKKKAKDSAADEPAEELEPVNS
>PK3-2_04491 putative protein YhaI
MDHRIERLEYYIQLLVKTVDMDRYPFYALLIDKGLSREEGEEVMRICVELSEELAAQKAQ
GFVTFDKLLALFAGQLNEKLDVHETIFALYEQGLYQELMEVFIGIMKHFD
>PK3-2_04492 hypothetical protein
MNCWKTINLMKDYGAVRIILTAVCFMILVFISTFLAFELLRPGTSLSDEYVPLFGGLLVV
ILFVHKVIHVLPIICKKRKIEKKFYILRMRTWKRIPKTTMLISLVSPFLLITPVLFYAAL
AFPNHAHYFCMISGIHAGYCLPDFLLALKLVRAPKACFIDQEADGLDILVEK
>PK3-2_04493 Foldase protein PrsA
MKKIAIAAITATSILALSACSSGDKEVIAKTDAGDVTKGELYTNMKKTAGASVLTQLVQE
KVLDKKYKVSDKEIDNKLKEYKTQLGDQYTALEEQYGKDYLKEQVKYELLTQKAAKDNIK
VTDADIKEYWEGLKGKIRASHILVADKKTAEEVEKKLKKGEKFEDLAKEYSTDTNSASQG
GELGWFAKEGQMDETFSKAAFKLKTGEVSDPVKTQYGYHIIKKTEERGKYDDMKKELKSE
VSEQKLSDNAAVQEAVQKVMKKADIEVKDKDLKDTFKTSSTSSSTSSSSNSSK
>PK3-2_04494 Sporulation protein YhaL
MLFFPWWVYLCIVGIIFSAYKLVAAAKEEEKVDQTFIEKEGQIYMERMEKERERRSSQQH
EEENPNHSIA
>PK3-2_04495 3'-5' exoribonuclease YhaM
MAKGIMLHEVGEQVDQYLLIKSSTKGIASNGKPFLTLMLQDQSGDIEAKLWDAKQSDEVT
YAPQTIVKVVGDVHHYRGRTQLKLRNIRPVSEHENVNIDDFLETAPIPKNEMMDTITQYI
FEMKNPNIQRITRFLVKKHEAEFMDYPAATKNHHEFVSGLAYHVVSMLNLAKSIADLYPS
LDRDLLYAGVILHDLGKVKELSGPVSTSYTVEGNLLGHISIMVTELSKAAEELQIDSEEV
LILQHLILSHHGKAEWGSPKPPMVKEAEILHYIDNLDAKMNMMDRALERVKPGEYTERVF
ALENRSFYKPTFHK
>PK3-2_04496 putative protein YhaN
MRIKSLHIYHYGKFSNRTFHFSASPVQLIYGLNEAGKTTMMSFIESMLFGFPKTKKYEPK
TGGVYGGVLEAEHPEYGVIKIERTKGTAEKLRVYTEKGQVKQEDFLKQLFQGTDRALYKA
IYSFDVFGLQEIHAFNRDKIGEFLLFSSLFGAEAVSKLDSRLTKESERLYKPNGRNPELN
QELDTLKKLAARLKQAEAEEAGYHQLLEEKRTLEARLAIAETELKEAAEHIRTIEGAIEL
KPQLHEKAALEQAMAQYPEQAGQFPADGLHQLEKYESHLHPKSAQLEALRVKKAELDKQL
QKLNPDQEILAKETLIQELSAAYHMYQSCGEQLAAIQAQLRQSSAQAAAGLEQLNKTDEN
ELLNMNTSYDYEWQLQQAVQQYVQARDRKRQLDETFELARQELEDAEKAVHAASSSILEN
SERKDKEAALKAYDEAQGQHLEQVKLREQLKFFERQQAKQKKTVIAAGMLFIVLFLLLQQ
WIPAISIGAALIVYGLASGKKTPSSRKSGEMRQPMTDISPAEAEAFREALWEDDRNKQHL
ITQRAVLQQKEAAYERVIQQFEQWEADMAPFFTQAERFMKELGFKEDPSFLLDAYSLMKD
VKKEVKKKHELTIEAGRLKKHRRTFEERVSKLYPANEGQNISISDALHTLRKNVEREKEI
EKQKKGIETDIHYTMEQLLELEQEIQYFQAQIEQLFAAAAVKDRNEFCAIADISLQLKDA
ENKLHHVNAQLQGGHPEELELADSNSLSELKNKQFVENERKERLTEEIQQLRSQIAMLLV
KQEQLEASGVVSDLKLQMEMQKERVKETAKQWASIQMIKQVIRNKLERHKKVELPRLLET
AGAFFRPLTDGSYRTIYFSDTDDSIMVMHCDGTVYHADELSQGTCEQLYTAIRFALAVTR
QDESRLPFQLDDSFVHFDQERLKRVLDVLYDLSEGGRQILYFTCHDHVKDAFQSSQIIHL
VS
>PK3-2_04497 putative metallophosphoesterase YhaO
MLTDLTFIHAADLHLDSPFYGISHLPEPIFARIKESTFASVRHMIDAAIRENVDFVLLAG
DLFDEANRSLKAQLFLKKQFERLRECGILVYVIFGNHDHLGGEWTPIEWPENVRIFSSAV
PEEKSFYKEGRRIASIYGFSYQARAVMENQAARYRRSTDAPFHIGMLHGTLSGSEGHDPY
CPFTHDDLVKSGMDYWALGHIHKRQVLSAEHPAVIYPGNTQARHMKETGDKGYYLVRVTN
GDISYEFQKAHDVLWEKAAVDVTEAKNMTALFQTVEDTFSKLRIKGSPVCVRLVLQGTAP
EWLLEAPKGTLDELLEAFQEQEAEEEHFIWPLSLDDETENEANVTNLDPFFGGLFADIDR
GDLTDVLEGLERHPVYRRHADRFSQEELQEIKEQAQIILKRQLKVLET
>PK3-2_04498 putative protein YhaP
MNRFWIMLSHTYKNKIMAKSFIISTVITVLLVLVVTNLESIISLFQGDDAKEKIAVVDET
NELYPIFSKQLKAVDTDGDLDVKQSKQTEAEVTKQVKDETLDGMLIIKRDEKGTISGTYK
ALTISDESTYQTLQQALTQTKTAVGTAELGVSQEEISSLYAPVTVGQEALKEGAKSEEEL
GQTVGLVYIMLFVIYFSVIMYASMIAMEVATEKSSRVMEILISSMPPIQQMFAKLVGIGL
VGITQLAVIITAGALSLKLNKTSETASSVGGFLNLTDVSTTTVIYAVIFFLLGYFLYATL
AAFLGSVVSRIEDVQQTITPMTLLVVAGFMIAMFGLNAPDAGFITVTSFIPFFTPMIMFL
RVGMLDIPFWQAAAGIGITLLTIVILAVIGARIYKGGVLIYGNSSAFKAIKQALRLAKN
>PK3-2_04499 Multidrug efflux system ATP-binding protein
MLKIDHVTKTFGDYKAVDGLDLDIPEQQMFGLLGANGAGKTTTFRMILGLLSITEGSISW
KGRPVNYSISSKIGYLPEERGLYPKMKVKDQLVYLARLKGMEKREAQKELGTWLERFNIT
DYENKKVEELSKGNQQKIQFISAVLHKPELLILDEPFSGLDPVNVELLKEAVISLKNSGV
SILFSSHRMEHVEELCEHLCILQKGKPVVQGRLKEIKRSFGKKNVTIHSDDDLRFLQSHE
GILQWKETAGGVKLQIANEDISQEIFAMLHGKGFIRKFELEEPSLHDIFIEKVGAVYE
>PK3-2_04500 hypothetical protein
MADYFLTAFDPSGKTLINERFEAENEEAAKMHGEDLLKEKELHSHTHRLVNAAGKLILFH
R
>PK3-2_04501 2,3-dehydroadipyl-CoA hydratase
MEFIQYECNGTVAEIILNRPEAHHALNEQMLSELKEAVEKAAASEALIVLLRGTGKGFSA
GGDIRMMTSEHDPDQFKQLMDTIEAVTLALYQMKKVTIAAIHGAAAGLGLSLALCADIVL
AEKNAVLAMNFIGIGLVPDGGGHYLLKKRIGEAKAKKLIWSGKKLSAAEAADMGLLDGTF
AGDPAQGARPFIETLLASPLLAMIETKAIFQSLQLEELKKVLSLERSAQEKMRKTKDHQE
GIRAFLEKREPKFQA
>PK3-2_04502 K(+)/H(+) antiporter modulator KhtS
MNKLLISFLLSLFMVYFPPSDVILPSQLEANTDSYVPMSSYPQETQAAKTPSPGSLYPAE
LTKEYSPLAQSVRHLSVKPLDEPLMNRLEKVCAVPVKYQSNYLRI
>PK3-2_04503 K(+)/H(+) antiporter subunit KhtT
MNIKENDLPGIGKKFEIETRSQEKMTIIIHDDGRREIYRFNDRDPDELLSNISLDDSEAR
QIAAILGGMVYKPQALESIEMAFSDLIIEWFKVEKGAKSIGSTLGELDVRQNYDVTVIAI
IKHSQEKLLNPGADSVIEENDTLVLSGERKHLKKLIHDFLSGEGV
>PK3-2_04504 K(+)/H(+) antiporter subunit KhtU
MDHLVFEVGTALVLVAIASVIANKIKFSIIPFLIVLGMLVGPHAPKIGIIDLTFIESSEI
IEFFGRMGVLFLLFYLGLEFSVGKLIKSGKSIAAGGTIYILINFSLGLLYGFITGFSFLE
VLVLAGVITISSSAIVAKVLVDLKRTANPETELILGIIMFEDIFLAVYLSVVSGLVLGDA
TSVGSALLSILIAFGYMVLFFIAARKLPPLLNKLLDIRSNEVFIIVIFAALFFIAGFSET
IHVAEAIGALLLGLVFSETEHSDRIEHLVVPFRDFFGAMFFFSFGLSIDPFSLGEAVWLA
LGAVMLTILGNFVAGMVAGRRAGLSHKASSNIGLTIVSRGEFSIIVANLGIAGGLSATLK
PFAALYVLILAILGPLLTKESKQIYRLLNKVFKWKPDVQPAKKQG
>PK3-2_04505 Oxygen-independent coproporphyrinogen-III oxidase-like protein HemZ
MQIKIEGIHDDRLHRPLQNIANLFYEECELVYGGEEPAEVVISLDCSQTAEHVTISGEVK
GAGIKEQHTKSFSPGMNEKEAFKQVKNTISYVYLNLLQAHTGITQKWGILTGIRPTKLLH
KKLQSGIPKEQAHAELKKDYLIHDEKIELMQEIVDRQLAAVPDLYQVKDEVSIYIGIPFC
PTKCAYCTFPAYAIQGQAGRVGSFLWGLHYEMQKIGEWLKEHDVKVTTIYFGGGTPTSIT
AEEMDLLYEEMVRSFPDVKNIREITVEAGRPDTITEEKLAVLNKYDIDRISINPQSYENE
TLKAIGRHHTVEETIEKYHLSRQHGMNNINMDLIIGLPGEGVEEFRHSLSETEKLMPESL
TVHTLSFKRASEMTRNKHKYKVAGREEVSQMMEDAVAWTKEHGYVPYYLYRQKNILGNLE
NVGYSLPGQESIYNIMIMEEVQTIIGIGCGAASKFIDRDTGKITHFANPKDPKSYNERFE
HYTDEKIKYLEQIFEKTTKQH
>PK3-2_04506 Stress response protein YhaX
MSKQLLALNIDGALLRSNGKIHQATKDAIEYVKKKGIYVTLVTNRHFRSAQKIAKSLKLD
AKLITHSGSYIAEKIDAPFFEKRISDDHTFNIVQVLESYQCNIRLLHEKYSIGNKKKVNS
NLLGKALIHPSDPIFYPVQFVESLSDLLMDEPVSAPVIEVYTEHDIQDDITETITKAFPA
VDVIRVNDEKLNIVPKGVSKEAGLALVASELGLTMDDVVAIGHQYDDLPMIELAGLGVAM
GNAAPEIKRKADWVTRSNDEQGVAYMMKEYFRMQQRKGFLDKFHMKRV
>PK3-2_04507 putative protein YhaZ
MVVNFWIETLDPERTFPYNINNKRKSGGQMADLKDIYNEELISRLIHHIKVSCPDFKQDR
FEEQLLQEDWPELALKERMRRITVSLYETLPKQYGEALAILQDAAPHFKGLSGILFPDYV
EQYGLAHWEESIKALAYFTQYSTSEFAVRPFLLLDQEKMMAQLLAWSEHENEHVRRLASE
GSRPRLPWGKSIPALKSDPSPILPILEKLMQDESLYVRKSVANNLNDISKTHPQLLKKVA
DRWYGTHPHTDWIIKHAYRTLLKKGDKQALALFGYENADSIQLHDFTCQSSRIPIGESLE
FSFSIHSDRDQKVRIEYAIDFVKARGQRHQKVFKITETNIRKNETKSYKKNHSFKDLTTR
KHYKGIHTLSVIINGEAKDSVDFEVC
>PK3-2_04508 hypothetical protein
MAVNFYDVAYDLENALRGSEEFTRLKNLYDEVNADESAKRMFENFRDVQLRLQQKQMAGE
EITQEEVTQAQKTVALVQQHEKISQLMEAEQRMSMLIGELNKIIMKPLEELYGSVEG
>PK3-2_04509 hypothetical protein
MGIAGTFIFMIVIGAVIGAVTNHLAIQMLFRPYKAYYLFGKRVPFTPGLIPRRRNELAKQ
MGLMVVNHLLTPEGIKKRLISDTAKTQALQIGEQLIQKLSLSEMTVKEALEKAGVKRPDE
AADAWISNWTDDKLNELFRQYEHQSLKELLPLEVQEKLEEKIPMISGYILSRSVSYFESD
EGKIRLGNMIDDFLKERGMLGSMVQMFLGNSSLADRVLPELLKFLRNEETNKLLSDLLKN
EWGKLREYTFNEADEKWNAKALIFSLKRSVLQTFSTAPFFDNTIGALTVRYESELTRQML
PALLDKLLEGVSANLESVLKRMRLEEIVKEQVDQFPVQRLEEMVLSISKKEFKMITYLGG
LLGGIIGAIQALFVTLF
>PK3-2_04510 hypothetical protein
MITLGFMSLSRQHEADYSAELAKRAPEFGIRFIRFTPFDISPDTLRVKASAYHSASSTWN
ETEMAIPDYIYDRCFYGKDSQSQKAKPIVEWLKKYPKTEFIGRGLPDKWTVFQDLQQHAV
INPYIPETTKVSRYEQIHSFLSKEKACILKPAFGAGGRGVILLELGKKNITATYHIGKDK
QTKTFSNQASFKTWCKKVLQHQYLLQPYLNIQDKEQYPCDIRLFMEKNESGEWNTVGKAV
RRGYKHGLLANLSGGSDALTFDSWFEDIPKKQQVVLLDDVFSITQSVPYYLDERYGPLFE
LGLDICLAKDGRIWILDINSKPGRKSILRVSPEQKEQLYTCPLKRCQYLFSEQSQKGVLP
RES
>PK3-2_04511 Endospore coat-associated protein YheD
MNHKRFLIGIDKTSENTLFLPSSLKRPGLLHAAFGTKVVRCHVSYRRHLEQTVLLSENLF
HELLLPHRSRADILIHDHTVHIGPLIGIFTAGFTASLERPFKDRSLFFSKLVTLHEQAGG
YCYVFGAHQINWEEGTIEGLLYRENGWEKKIVPLPNVVYDRLPNRKIEDSLLLQHTKKRL
IDEYQIPWFNKTFFNKWSVHQLLEKDPRTAPFLPKSELTPSVERIAELCDAYKKVYIKPA
NGALGTGIYQLAKTDDGLTVKHTNDAKTFSSIDYSDAAAFLAEFQKQHNPSDFLIQQGVD
LIKFQGKPADFRVHTNKNRKGKWTVTAIAVKISGENSITTHLSNGGSVKTLAEVYDNPAE
RIEVIKKLSAAALTASHVLHDHIEGFIGEIGFDFGIDQNGKVWMFEANSRPGRSIFSHPN
LHHVDSLTKRRSFEYASYLSEKAITSHDALWPS
>PK3-2_04512 hypothetical protein
MISHFSWKPLFQKEKLPGWRISFYYKGTHYEGIYHKSGEIEWGDLFPARADEPALTNEIH
ELMLFHIYD
>PK3-2_04513 Small, acid-soluble spore protein 1
MANQNSSNELLVPGAAQAIDQMKLEIASEFGVNLGADTTSRANGSVGGEITKRLVSFAQQ
QMGGRVQ
>PK3-2_04514 hypothetical protein
MAFIAFLNWELVQFVSVSMIHEYVSHRSVYLYRYSFPRCSN
>PK3-2_04515 hypothetical protein
MKIALFGASGRVGQAFIKQAAADEQFDIYALARSQPAELPLPKDRVVMGNARCREDVRRV
MKDAEIVISCLGTDGDDTLSAAMAHILAIMREEHIKRLITIGTAGILDSRYEPGKFRFET
NESKRRQTRAAKEHAKVYEMLKDSSLDWTIICPTYLPDGTATGVYRAERNVLPEGGTSIT
VGDTADFLYRELVTGEYVGYRAGLAY
>PK3-2_04516 putative multidrug resistance ABC transporter ATP-binding/permease protein YheH
MSFAYQDGEEVLKQISFTAQKGETVALVGHTGSGKSSILNLLFRFYDAQKGDVLIDGKSI
YNMSRQELRSHMGIVLQDPYLFSGTIGSNVSLDDERMTEEDIKKALRQVGAEPLLKKLPK
GINEPVIEKGSTLSSGERQLISFARALAFDPAILILDEATAHIDTETEAVIQKALDVVKQ
GRTTFVIAHRLSTIRNADQILVLDKGKIVERGNHEDLMAVKGQYYQMYELQKGQKHSIA
>PK3-2_04517 putative multidrug resistance ABC transporter ATP-binding/permease protein YheH
MKTGKTLWRYALLYRKLLIIAVLLLGVAVGAELTGPFIGKKMIDDHILGIEKTWYEAAEK
DENAVQFHGTSYVREDRMQEPVSQEKEAHIYQVGMAFYFVDQAVSFDGNRTVSDGKLTIT
NGDKSRTYAAEKLTKQELFQFYQPEIKGMVFLICLYGGLLVFSVFFQYGQHYLLQMSANR
IIQKMRQDVFSHIQKMPIRYFDNLPAGKVVARITNDTEAIRDLYVTVLSTFVTSGIYMIG
IFTALFLLDVKLAFVCLAIVPIIWLWSVIYRKYASYYNQKIRSINSDINAKMNESIQGMT
IIQAFRHQKETMKEFEELNESHFYFQNRMLNLNSLMSHNLVNVIRNLAFVCLIWHFGGAS
LNAAGIVSIGVLYAFVDYLNRLFQPITGIVNQFSKLELARVSAGRVFELLEEKIRKKRVN
RPRSARWGGLNFVMCHLPIKMVKKY
>PK3-2_04518 putative multidrug resistance ABC transporter ATP-binding/permease protein YheI
MFSVLKKLDWFFKAYWLRYTIAIVLLLGVNVIEMFPPKLLGNAIDDMKSGTYTAEGLLFY
IGIFFVLTAAVYIMSYFWMHQLFGGANVMEKILRTKLMGHLLAMSPPFYEKNRTGDLMAR
GTNDLQAVSLTTGFGILTLVDSTMFMMTIFLTMGFLISWKLTFAAIIPLPVMAIAISLYG
SKIHERFTEAQNAFGGLNDRVLESVSGVRVIRAYVQETNDVRRFNEMTADVYQKNMKVAF
IDSLFEPTVKLLVGASYLIGLGYGAFLVFRNELTLGELVSFNVYLGMMIWPMFAIGELIN
VMQRGNASLDRVNETLSYEPDVTDPEQPAELKEPGDIVFSHVSFTYPSSTSGNIQDISFS
VRKGQTVGIAGKTGSGKTTIIKQLLRQYPAGKGSITFSGVPIQKIPLDQLRGWIGYVPQD
HLLFSRSVKENILYGKQDASDEEVRQAIANAHFEKDLHMLPSGLETMVGEKGVALSGGQK
QRISIARALMANPEILILDDSLSAVDAKTEAAIISNIRENRKGKTTFILTHRLSAVEHAD
LILVMDDGVIAERGTHQELMANHGWYRKQYERQQLFTAEEGGAGA
>PK3-2_04519 Stress response protein NhaX
MFHADRIIVAFDGSENSKKALQTAIDLAKTVNAAITVAHSHDMKDNQTIIDPPRPAAGAS
YIGGGMTSVPDPLISDVAPPEPMIYEDRTEEVIAEARMMLNDQQTDGDIDILEGDPAESI
IEHANRISADMIVTGSRDQNKLKKLLFGSVSEKLSAKSDVPVLIVK
>PK3-2_04520 Na(+)/H(+) antiporter NhaC
MDSQKKLTFPLAVGLFIFMLGIIISCLFFFHTEPHIPLFLCVVMLSAAGLWFGFSWKDLE
KGIVEGIKNGVQPIIVLALIGILIGAWMYSGAIPSVTVYALSFIEPSHLLLTALFSCMII
STLVGSSLTTVSTIGVALIGVASAAGVPLEWTAGAVICGACFGDKMSPMSDTTNFAAGIG
EIPIFEHIRHMMGTTIPALLITVILFYFLGSSVSADAASTDDIQRVITGIKDAANVTPWA
LLSPILVVLLAIKRVSVIPVLTAGIISAGILTAIFVPDSSLQAFMAALQNGTMFNTDNEA
AAKIINRGGLQSMMGSVSLIMIAFALGGLMEKIGLISALLEGIMKGIRSKGQLIAATVCS
SIGINLATGEQYLSILIPGQSFKTLYDKQNIQRKFLSRSLEDGGTLINPLIPWGVSGAFM
ASALGVPVIDYIPFTFFLYISPILSILVGFIKK
>PK3-2_04521 D-alanine aminotransferase
MKVLVNGRLIERSEASIDLEDRGYQFGDGIYEVIRVYKGVLFGLREHAERFFRSAAEIGI
SLPFSIEDLEWDLQKLVQENAVGEGAVYIQTTRGVAPRKHQYEAGLEPQTTAYTFTVKKP
EQEQAYGVAAITDEDLRWLRCDIKSLNLLYNVMTKQKAYEAGAFEAILLRDGTVTEGTSS
NVYAVINGTVRTHPANRLILNGITRMNILGLIKKNEIELEEKPVSEEELRQAEEIFISST
TAEIIPVVTLDGESVGSGEPGPVTKQLQAAFQESIQQAASIS
>PK3-2_04522 Peptidoglycan-N-acetylglucosamine deacetylase
MRQTRGDASPSAVSLAFKFASLAVLCVLLLLMVILGYSNSSSKAKEVTVTTNGQLRNEKE
SLKLKNDSPDLLIKHLQTEQNMGDKTVYLTFDDGPSAYTNRLLNILKSADVKATFFMLSP
RMNEFKQAVKRADKEGHALGLHGVTHNNKLFYQTPTSPLKEMQEARDTLQDITGYKTDLV
RTPYGSKPSLTASQIRNLEKDGFVYWDWTIDSMDWKYRNPNYVTAVLQQLENMEHSHSSR
PYVILMHDLPATVNALPALINKLKEKGYSFGVLEDTMVPVHE
>PK3-2_04523 NAD-dependent protein deacetylase
MEAFINILNEAQRIVVLTGAGMSTESGIPDFRSDGGIWTEDASRMEAMSLDYFLSHPRLF
WPKFKELFQMKMSGSFEPNEGHLLLAELEKQGKQVDIFTQNIDGLHKKAGSRHVYELHGS
IQTAACPACGARYDLSHLLEREVPECTARRKDGELCGTVLKTDVVLFGDAVMHFDTLYEK
LDQADLLLVIGTSLEVAPARFVPEDASRIPGMKKVIINLEPTYCDSLFDMVIHHKIGEFS
RSLGIKK
>PK3-2_04524 hypothetical protein
MPDYLQQYFTLDKIIQIGISLAILLVFLILRKLFTRYFFQLLFNLTNRPKTEIFKQVVLA
FDKPARWFFVALGLFLAIRYSPFLDAQMPLISKIYRSLIVALLCWGLCNLTAASSFIFHK
VNQRFELDMDDILAPFLSKLLRFVIIALSVSVIAQEFNYDVNGFVAGLGLGGLAFALAAK
DTISNFFGGIIIITEKPFTIGDWVETSTVTGSVEDITFRSTRFRTAQGALVTVPNSTLSM
EAITNWTRMTKRQITFSIHVSYATPIENLERSIRSLRTMLLEHEGVDNETIMVNFDTFAD
SYYNLFFNFYTKTTVWAENLNIREDINYKIIEILGAEGVQFAYPGQMVVVKQKHESDPFQ
VNLNKEEKERA
>PK3-2_04525 hypothetical protein
MGKGRIRVEERIKAETDAEMQKATLLDQTQTKKSK
>PK3-2_04526 Glycerophosphodiester phosphodiesterase
MYTIAHRGASGYAPENTMAAFDLAAKMNADMIELDVQLTKDRQIVVIHDDRIDRTTNGSG
FVKDFTLEELQKLDAGSWYGSAFQGERIPTLEAVLKRYHKKIGFLIELKGHPSQIGIEEE
VGQLLGQFSFSINNIVQSFQFRSVQRFRELYPSIPTAVITRPNFGMLSRNQLKACQSIAN
YVNIKYTRLNRLMIASAHKNGLKVFAWTVKNQKIAAKLQAMGVDGIVTDYPDFIIKDGEH
EKI
>PK3-2_04527 Putative fluoride ion transporter CrcB
MKRYSAVFIGGALGACLRYGLNMWIHTDQFPKATWLENAAGSLLLGILTGFFMIRAKRPL
LSALLGTGFCGGFTTMSTFSKETVMLLQAQSSLAVLYMAVSLISGMVLALIGILAGRRIA
GIQQRKGLPE
>PK3-2_04528 Putative fluoride ion transporter CrcB
MMTLAGIFIAGGLGAMLRFWLGNVITAKTKGVSLPIGILTVNILGALGLGIFTGLHVTDA
SASLIIGTGFFGAFTTFSTFSVESVQLLLAKRVMASILYITLTLCGSLLAFWCGWTIAT
>PK3-2_04529 hypothetical protein
MDDIDSLILIGVLIALTAFFVASEFAIVRVRRSRIDQLITEGNKRAILAKRVITDLDEYL
SASQLGITLTSIGLGVLGEPAFERLLHPLFEPLGLPESVSHAVSFAVAYGLITFLHVVVG
ELAPKTVAIQKAEQLTLLIAGPLRLFYLLLFPFIWILNGAARLLCGMFGLKPASEHDGSH
SEEELRMLLSESLKNGEINPSEYKYVNKIFEFDNRIAKEIMIPRKEMAAVSTEMTMAEML
EVMLKEKYTRWPVTDGDKDSVIGLVNTKHLFSDLLFMTEEERMKMTIHPYVRPVIEVIET
IPVHDLLIKMQRERIHMAILSDEYGGTSGLVTTEDILEEIVGEIRDEFDEDEQPLIQQLG
DRHYVMDGKVRIDQVNSLLGASIQEDVDTIGGLILKENIDIETGESIRIGSYTIKVLKMD
GRLIKQIDIKEEAGNTTGTTAHHTLPMPEPVMLNSATLSEK
>PK3-2_04530 Aspartate aminotransferase
MKLAGLSREIEENLNKGSWIRKLFDEGARLKKEFGDDQVFDFSLGNPIIEPPEAFKRALI
EEAEKGNHGYIQNQGLPAAREKVAQFLASRFEAEFSAERVVMTVGAGGALNVALKSIVNP
GEEVIILAPYFAEYKLYIENYGGKAVSCPLTSKFEIDIEAVRQSITPKTKGLILNTPHNP
TGTVLSQKNIDDLGALLKEVEEKSGQTIYVLFDEPYSQLIYDAELANPFQSYHRVILASS
FSKDLGIAGERLGYIGLDSKMPDAGLLINAFVYCNRTLGFVNAPVMMQRAVARMDDLRVD
ASAYKERRDLIVGILKEAGFEFEMPKGGFFVFPKSPIEDEVAFCVHAAQKYKLLIVPSSG
FGMKGHFRLSFSVPIEQIKNSRDVFVSLYKDFA
>PK3-2_04531 hypothetical protein
MLLQSVSEFHNFQFPSKKNNKLVQDTVHILNYSHNYNVMVGRDIDGAETYRISELAALAG
VTKRTVDYYTNLGLLTPARSCSNYRYYDKHALKRLIFIVDCKKQRLALSDIKDRLENQFP
SSAKNHDEIGNLALEIDHMNQNISGILHRFERLEPEERDKLKSELTPEKLAVFQSFMLLL
S
>PK3-2_04532 hypothetical protein
MDIVNLILVAVLIALTAFFVASEFAIIRIRGSRIDQLIAEGHKAAIAVKKVTTHLDEYLS
ACQLGITLTSIGLGVLGESTIERLLHPLFVQMNVPSSLSHVISFIFAYAIITFLHVVVGE
LAPKTVAIQKAEAVSMLFAKPLIWFYRIMFPFIWLLNNSARLLTKAFGLESVSENELAHS
EEELRIILSESYKSGEINQSEFKYVNKIFEFDDRLAKEIMIPRTEIVSLPHDIKISEMMD
IIQIEKYTRYPVEEGDKDNIIGVINIKEVLTACISGEVSVDSTISQFVNPIIHVIESAPI
QDLLVKMQKERVHMAILSDEYGGTAGLVTVEDIIEEIVGEIRDEFDIDEINEIRKIGEGH
YILDGKVLIDQVNDLLGIHLENEEVDTIGGWFLTQKYDVEKDDSIIEEGCEFIINEIDGH
HVAYIEVKKLAVEELVEAGESKEA
>PK3-2_04533 ADP-L-glycero-D-manno-heptose-6-epimerase
MKVVVTGAAGKIGRWAVRTILEAGHDVTASDRLLREESASKKFIQADLRDYGQVCQLIMG
CDAVVHLGNIPTDVRNTSQAIFENNMLVNFNVLEACKDFKIPKLVWASSETVLGYPFVPK
ELSYLPVDEEHPTIVKSSYAMAKRLTEILSDMYSKLTKTQIVTLRFANIYEPDEYEKIPG
MHWNEQQKEIQKKNAWAYCDVRDAAHACLLAVEKNNLGNDVFHITAPDTIMKETSEDLVK
RFFPDVSLKRDIKGYETLMAIDKAKKVLGYEPRYTWRSVLNNDGSLKALPEDQLSLSKI
>PK3-2_04534 Glycine oxidase
MKKIIVVGAGILGASTAYQLAKMGAEVLIIDRKDKGQATHAAKGIICPWLSPRKNQAWYR
MAKAGAHFYPCFIEELRREGEKETGYAPVGALSIHPEKEKIEKIEKRVQERKQDAPEIGE
VSFLSEIKTVGMFPLLAERYHSIHISGAARVDGEMLRDALLRAAQRKGAVFLTGDAKLQY
HSKRVTGVTVGDECYSADKVIVCAGVWADQLLEPLGIRFKVSVQKAQIMYVQVPDANDMD
SWPAVMPPSKEYLLAYAVKRMAIGATREDDTEGHDVRITAGGLQELLNKGLEMAPGLTNS
IFQEARVGLRPFTPGDVPVIGPLHGWDGIIAANGLGSSGLTMGPYMGLQLAKLALNMDVD
INLEDYNIKKAAEDH
>PK3-2_04535 1-acyl-sn-glycerol-3-phosphate acyltransferase
MYKFCANALKVLLSLRGGVKVYNKENLPADSGFVIACTHSGWVDVITLGVGILPYQIHYM
AKKELFQNKWIGSFLKKIHAFPVDRENPGPSSIKTPIKLLKEGEIVGIFPSGTRTSEDVP
LKRGAVTIAQMGKAPLVPAAYQGPSSGKALFKKGKMKLIIGEPLHQADFAHLPSKERLAA
MTEALNNSIKELEKKLEQL
>PK3-2_04536 Aldo-keto reductase YhdN
MEYTSIADTGIKASRIGLGTWAIGGSMWGGTDEKTSIKTIRAALDQGITLIDTAPAYGFG
QSEEIVGKAIKEHGKRDQVILATKTALDWKNNQLFRHANRARIIEEVEDSLKRLQTDYID
LYQVHWPDPLVPIEETAEVMKELYDAGKIRAIGVSNFSVEQMDTFRAAAPLHTIQPPYNL
FEREIEENVLPYAKDKQITTLLYGSLCRGLLTGKMTEAYTFEGDDLRNHDPKFQKPRFKE
YLSAVNQLDELAKTRYGKSVIHLAVRWILDQPGADIALWGARKPEQVEAVSEITGWTLSR
EDQTDINTILEHTISDPVGPEFMAPPAREKI
>PK3-2_04537 ECF RNA polymerase sigma factor SigM
MTIDEIYQMYMNDVYRFLLSMTKDKHLAEDLLQETFMRAYIHIHSYDHSKVKPWLFQVAR
NAFIDYVRKHKKEVTISDDIIGSLFQNAVQSPAHQVEIKEVLTGYMSELPDNYREALTLY
YLKELNYKEASHIMNISEANFKSVLFRARQRLKALYNRGVNDE
>PK3-2_04538 putative anti-sigma-M factor YhdL
MNEEFKKRFDQYKNGKMSDQEMAAFEEELEKLEVYQELIDSELEDDSDWEVSISPEKQKA
ILAYGKRKSYLRISVLAVISTLMILPFCTLGSYLYYGMGGKHSTGNEFMETAAVTVALTM
PNVLVDTSGLKSQVKLFGMNTEFPLQKQIGTKTAAVGNERVEMFYNKVKAPSVNYYDLEV
HKTGHYFTHPSNASEQTTAKAEKTLKTLPEGTVSEVYLSYDRAYPTKEVYNKFKGYDVSF
LWNAIETEKNTNETAYTEPLGYPGKDSKFLAALNTKGKSNGDQFINALKFVSKHEKWAQV
ISKRKDLSIDNRLDYVEKNGVNVYGSVVTGPTKEIQRMLKNKSVKSANVGEVELWNW
>PK3-2_04539 putative anti-sigma-M factor YhdK
MELVRIFKEHNVFGWISVGTAVLSLLLLNLAIISNVTFYSYQMLPFAMAAVPFGVIELFI
KRGRTGPGLLGVILNLFVIICVYTIVSVDTNLQFGF
>PK3-2_04540 hypothetical protein
MIHMKQLTTKEEWAESYPVMSELRTGLDEETYLQRLEACVQKESYLLFALYEDTAIRALC
GALPRISIHKGEHLWIADLVTSAPYRSKGYGKMLLDFAADWAKKAGCGSVSLSSGLQRKD
AHRFYTDKMGFTIESYLFRKPLS
>PK3-2_04541 HTH-type transcriptional regulatory protein GabR
MDITPFLDKKGKTPLYEQLYAFFKQEISHARITKGTRLPSKRGLSCLLGVSTATIERAYE
QLTAEGYVKSKPKVGWFTAGVEADFPATPVHFQQSTQPVLHEENAPAIDFHLGNVDPAHF
PFNAWRKSMVKSLDRYSGSFHTSGDPQGEPELRQMIAHFVRLSRGVNCEPGQIIIGARTT
VLLQILCLALHPRTKIGFEEPGFHRSRRLFEANRMNVIPIRSDEEGVLPGELKRQNPYLV
YTTPSHQFPLGAIMTITRRQELLAWAKEANSFIIEDDYDGEFRYSGQPIPSLQGLDPNGR
VIYLGTFSKSLLPTLRLSYMILPPGLMEPVRKNAQLMKQTVSSHSQMALADFIENGEWQK
HLNRMRALYRKKHAVLLEAIRSELGNSVDILGKNSGLHILLRLLFPASEEEAIKAAGDSG
VTIYPVSSSYKGQPPFVSVLIGYGGLSEEDIRLGIKKLKTAWAPLISSN
>PK3-2_04542 hypothetical protein
MSEQKPVQWASKIGFVMAAAGSAIGLGAIWKFPYVAGTNGGGAFFLIFVLFTVLLGYPLL
VGEFIFGRRNQTNAIDAYKKEAPRSAWFLTGWVGVAACFLVLSFYSVIGGWILLYIVKTA
SGSLSGLTQAQYGALFASIIQNPVQTLAAQFVFMVLTVLVVARGVQKGIERVSAVMMPIL
FVLFILLVLRSLTLNGAMEGVKFLLVPQFGDLTPESILFALGQAFFTLTLGVSVMVTYSS
YLPKTQNVPRSAASIVGMNIIVTLLAGLAIFPAVFSFGFQPNEGPTLLFTVLPAVFEQLP
FGTLFFIGFLVAFLFAALTSAFSMVEIIVATIGKGDERKRKKLSWTSGLLIFLVGIPCCL
SYGVLSDMHIFGKTFFDVADFTVSNVLMPLGALLISLFIPLKIPKHELLAEMRNGSNAGK
AFFYTWFYLLRFIVPLAIIIVFLNLIGILSF
>PK3-2_04543 putative amino acid permease YhdG
MKGSVFRKKSIQDLLAATSGEKSLKRELGAFDLTLLGIGAIIGTGIFVLTGTGAVTAGPG
LTVSFVVAALACLFAALSYAEFASSVPVSGSVYTFTYATLGELLAFIIGWDLILEYMLAV
SAVSVGWSGYFQSFLSGLGIHLPVALTAAPGAVKGTFTVFNLPAFVIVMAITFLLYLGIK
ESKRVNNIMVILKVLVVLLFIAVAAVYVKPHNWQPFMPMGFGGVFSAAALVFFAFIGFDA
VSSAAEETRNPAKDLPKGIIFSLLVCTVLYVTVSAIMTGVIPFAQFAGVDHPVSLVLQSA
GQNWVAGIIDIGAVLGMTTVMLVMLYGQTRVMFAMSRDGLVPGSLSKVHPKHKTPYVATW
FFGTLSALLGSLVPLDELAKLVNIGTLSAFVLISVAVIVLRKKQPDLPRAFKCPGVPVIP
GLAILFCLFLILNLGWVTIVRFLVWLLIGLAIYFLYSRKHSKLNQ
>PK3-2_04544 General stress protein 39
MNPMDRQTEGQEPQHQDRQPGIESEMNPLPLSEDEDYQGSGKLKGKAAIITGGDSGIGRA
AAIAYAKEGTGVAILYLDEHSDAEETRKRIEEEHVRCLLIPGDVGDENHCEKAVQQTVDH
FGKLDILVNNAAEQHPQDSILNISTEQLEKTFRTNIFSMFHMTKKALPYLKEGSAIINTT
SITAYEGDTALIDYSSTKGAIVSFTRSMAMSLADKGIRVNAVAPGPIWTPLIPATFPEEK
VKRHGLDTPMGRAGQPVEHAGAYVLLASDESSYMTGQTIHVNGGRFIST
>PK3-2_04545 Citrate synthase 1
MVHYGLKGITCVETSISHIDGEKGRLIYRGHHAKDIALNHSFEEAAYLILFGKLPSPEEL
QTFEGKLAAERHLPEHIERLIQSLPNNMDDMSVLRTVVSAFGENVYTFHPKIEEAIRLIA
ITPSIIAYRKRWVRGEQAIAPSSQYGHVENYYYMLTGEQPSEAKKKALETYMILAMEHGM
NASTFSARVTLSTESDLVSAVTAALGTMKGPLHGGAPSAVTKMLEDIGEKENAEAYLKEK
LEKGERLMGFGHRVYKTKDPRAEALRQKAEEVAGNDRNLDLALHVEAEAIRLLEIYKPGR
KLYTNVEFYAAAVMKAIDFDDELFTPTFSASRMVGWCAHVLEQAENNMIFRPSAKYTGAI
PEEVLS
>PK3-2_04546 HTH-type transcriptional regulator CysL
MDFKWLHTFVTAAKYENFRKTADTLFLSQPTVTVHIKQLEKEISCKLFERKGRQIQLTDE
GRAYLPYALRLLDDYENSMAELHRVRQGYSQTLQLAVSPLIADTVLPSVMKRYTAMNTET
EMAVTIFESAEIASLIKAGEADIGLSCLKVQSSSLTCHCLYKDPVVLVAPPDQRFIEDKE
IDAKEVLEQYLLLTHNHPDYWDDLLRQVRVTFPFVRTMKVTQTHITKRFIKEGLGVSFLP
LSTVKRELAEKQMIRIPYQSVQMPYAGAYAIALYENKKEKKFLDFLSHFHF
>PK3-2_04547 putative peptidoglycan endopeptidase LytE
MKKQIITATTAVVLGSTLFAGAASAQSIKVKKGDTLWDLSRKYDTTISKIKSENSLRSDI
IYAGQTLSINGKSTSSKSSSSSSSSSTYKVKSGDSLWKISKKYGMTVSELKKLNGLKSDL
LRIGQVLKLKGSTSSKSSSSTKVSTSSTSTYKVKRGDSLSKIAKQYGTTVSKLKSLNGLK
SDVIYVNQVLKVKGTSSKTVSSSSSSSSSSKTSSATSLNVSKLVSDAKALIGTPYKWGGT
TTSGFDCSGFIWYVLNKQTSVGRTSTAGYWSSMKSISNPSVGDFVFFTTYKSGPSHMGIY
VGNNSFVHAGSDGVQISSLDNSYWKPRYLGAKRF
>PK3-2_04548 Alkaline phosphatase 4
MNLFQNMKTKLLPIAAVTVLTAGVFAGAELQQTEKASAKKQDKAEIRNVIVMIGDGMGTP
YINAYRSMKNNGEMPNNPRLTEFDRNLTGMMMTHPDDPDYNITDSAAAGTALATGVKTYN
NAIGVDKNRKKVKSVLEEAKQQGKSTGLVATSEINHATPAAYGAHNESRKNMNQIANSYI
DDKIKGKQKIDVLLGGGKSYFNRKDRNVTKEFKQAGYSYVTTKQALKKNKDQQVLGLFAD
GGLAKALDRDSKTPSLKDMTVSAIDRLNQNKKGFFLMVEGSQIDWAAHDNDTVGAMSEVK
DFEQAYKAAIDFAKKDKHTLVIANADHTTGGFTIGANGEKNWHAEPILAAKKTPEFMAKK
ISEGKPVKDVLTRYTNLTFTSEEIKTIQAAAQADKSKGAYKAIIKIFNTRSNSGWTSADH
TGEEVPVYAYGPGKEKFRGLINNTDQANIIFKILKTGK
>PK3-2_04549 hypothetical protein
MNAEEKKGLQRAIEEITEIAKGFGLDFYPMRYEICPAEIIYTFGAYGMPTRFSHWSFGKQ
FHKMKLHYDLGLSKIYELVINSDPCYAFLLDSNALIQNKLIVAHVLAHCDFFKNNCRFQN
TKRDMVESMAATAERIKHYEQVHGIKEVEAFLDAILSIQEHIDPSLVRPKLLWSVDDEEE
EFEEAATPYDDLWSLDEKKPKKQVKKSKKPFPPRPEKDILLFIEEHSRELEPWQRDILTM
MREEMLYFWPQLETKIMNEGWASYWHQRIIRELELTSDEAIEFAKLNAGVVQPSKTGINP
YYLGLKIFEDIEERYNNPTEEMKKMGVRPDSGREKMFEVREIESDISFIRNYLTKDLVMR
EDLYLFQKQGRDYKIIDKEWKSVRDQLVSMRVNGGFPYLTVNDGDYMKNNELYIKHWYEG
IELDLKYLEKVLPYLFQLWGRSVHIESVLEDKEVMFSYDGKGVHRRYL
>PK3-2_04550 hypothetical protein
MNVANVLSSYLSKLPNLIIALLVLLIGWAIAKIIEKAVYKGLRKTKFDDKLFAGKKPSRY
SSEKVISKVVYFIALIIVFILFFNILHLTTVASPFVSMLSAIAAAIPSVLKAGLILLLGW
AAASVLSFLVKKIGMKLNTSDKLRKWNLVSEGKDIHQAVNAASQIVFYLVLLVFLPGVLS
SLKISGISGPFTNMMESVLAFLPKLFAAALIVLIGWLVARLVRDIITNFLASIGTERFAA
RMGLSIYLKDTSLSAVIGTIAYVLILIPVVISALDQLDVAGISKPAVSMLNTILNMLPNI
IIAIVLVLAGMWAGKWVNTMVSGLLHRAGFDSVLGKMGMEAGTPAKLSLSQVVGMIAQII
VILLFTAEALQIVQLHFLVEIATGIIAYLPNVLVAVFILGIGLYAGELVRKVLASMIKGR
EFKSLAAIAKYTIIALAFFMALDQLGVAATIVNSAFIIVLSGFALAFGLSFGLGGKDFAS
RYLSAFERKMQNTEIDKNRKNQNPPNNM
>PK3-2_04551 HTH-type transcriptional repressor NsrR
MKLTNYTDYSLRVLIFLAAERPGELSNIKQIAETYSISKNHLMKVIYRLGQLGYVETIRG
RGGGIRLGMDPEDINIGEVVRKTEDDFNIVECFDVNKNLCVISPVCGLKHVLNEALMAYL
AVLDNYTLRDLVKNKEDIMKLLRMKE
>PK3-2_04552 Peptidoglycan endopeptidase LytF
MKKKLAAGLTASAIVSTTLAVTPAEAATIKVKSGDSLWKLAQNYNTSVAAITSANNLSTT
VLSIGQTLTIPGSNSGTSSTSSSTTKKSGSSVYTVKSGDSLWLIANEFKMTVQELKKLNG
LSSDMIRAGQKLKVSGTVSSSPSPSSSTKSSSNKSSSSSSSSGTYKVKLGDSLWKVANKV
SMSVAELKVLNNLKSDTIYVNQVLKTKSSGSDTSSKDTSSQSNKTAATTKYTVKSGDSLW
KIANNYNLTVQQIRNSNNLKSDMLYVGQVLKLTGKASSGTSSSPSSSSNAGSSTTTTYTV
KSGDSLWVIAQKFNVTAQQIREKNNLKTDVLQVGQKLAITGKASSSGSSSSGSSSTSSST
SAKINTMIAAAKAQLGVPYRWGGTTPNGFDCSGFMYYALNKVTSVSRLTAAGYWNTMKSV
SQPAVGDFVFFTTYKAGPSHVGIYLGNGEFINANDSGVVISNMNNSYWKQRYLGAKRFF
>PK3-2_04553 hypothetical protein
MKSLPYTIALLFCGMIIVSMAAKGQSADTNESVQKWEQLAWSKIQDEYKGASFSDYAYMG
RTEVNDQQTKDVFRVTVRQNKDIFSVRAEVYFHPVTNHMISINVFRL
>PK3-2_04554 hypothetical protein
MDYADYDKALYYTHRSQWDNLLILMVRTEDDLLSKRIEHFLHAYHFEQDYAVLEKMLYSL
LRYIDHATELTYEDQLALLT
>PK3-2_04555 FMN-dependent NADPH-azoreductase
MNMLVINGTPRKHGRTRIAASYISALYHTDLIDLSEFTLPIFNGEREQSELSQVQELKQR
VTKADAIVLLSPEYHSGMSGALKNALDFLSSEQFKYKPVALLAVAGGGKGGINALNNMRT
VMRGVYANVIPKQLVLDPVHIDVEIAAVTENIKDSVKELVEELGMFAKTGNPGV
>PK3-2_04556 Response regulator protein VraR
MKIVIADDHHVVRKGLRFFFATQDDIEVAGEAATGTEALRVIEETKPDLVLMDLSMPEMD
GIQAIRKAVQQFPGINIIVLTSYCDQEHVIPALQAGAKAYQLKDTEPEELVKTLRQVHAG
EYMMSSAIMPHVLTHMKNQHDPEKDKFYQLTRREKDVLNEIANGKSNKEIAAALFISEKT
VKTHVSNLLAKLEVADRTQAALFAVKYNLNGEITK
>PK3-2_04557 hypothetical protein
MSKTGMEKLKTLKTIAETLNQGHDVKATLDEVLKELLSLTNLQSGWIFLIEEDGSYTLAA
DAYLPPALIRKEKVLMCEGECYCLTKFNNGGLRRAANIMNCKRIESAEELHCFDTEGITH
HATVPLEDGDRRFGLLNVAAAGKTMFDEEELHLLESVAFQIGTAIQRMKLSEYKQKNALL
MERNRLAQELHDSVNQMLFSVSLTARAAKTLTKDENLQQMIDFIQNLSQDALAEMKALIW
QLRPGGLEKGLSEAIKSYGALIGLNVIFTQKGCPFLTDEQEHMLWRVVQEALNNIKKHAG
TDTAYVSLTAFSSQAELNIIDHGAGFRYEAHAGLPSLGIKGMKERAEKAGAEFVIESDLG
AGTKLSVRLPLTNQKGRTVQ
>PK3-2_04558 Phosphoglucomutase
MTWRKSYERWKQTEHLDPELKERLTELEGNEQALEDCFYKNLEFGTGGMRGEIGAGTNRM
NIYTVRKASAGFAAYISQQGEKAKKRGVVIAYDSRHKSPEFAMEAAKTLATQGIQTYVFD
ELRPTPELSFAVRQLNAYGGIVVTASHNPPEYNGYKVYGDDGGQLPPKEADIVIDQVNAI
ENELTITVDDEKALKEKGLIKIIGEDIDKVYTEKLTSISVHPELSKEVDVSVVFTPLHGT
ANKPVRRGLEALGYKNVTVVKEQELPDSDFSTVTSPNPEEHAAFEYAIKYGEEQNADILI
ATDPDADRLGIAVKNDQGKYTVLTGNQTGALLLHYLLSEKKKQGILPENGVVLKTIVTSE
IGRAVASSFGLDTIDTLTGFKFIGEKIKEYEASGQYTFQFGYEESYGYLIGAFARDKDAI
QAALLAVEVCAFYKKQGMSLYEALINLFNDYGFYREGLKSLTLKGKQGAEQIEAILASFR
QNPPQKMAGKQVVTAEDYAVSKRTLLKENKEEAIDLPKSNVLKYFLEDGSWFCLRPSGTE
PKVKFYFAVKGTSLVDSEKRLASLTDDVMKTVDDIVEATAK
>PK3-2_04559 Aerobic glycerol-3-phosphate dehydrogenase
MKHQFSSLERDRMLTDMTKKTYDLFIIGGGITGAGTALDAASRGMKVALSEMQDFAAGTS
SRSTKLVHGGLRYLKQFEVKMVAEVGKERAIVYENGPHVTTPEWMLLPFHKGGTFGSFTT
SIGLRVYDFLAGVKKSERRSMLSAKQTLQKEPLVKKDGLKGGGYYVEYRTDDARLTIEVM
KEAVKFGAEPVNYSKVKELLYEKGKAVGVLIEDMLTKKEYKVYAKKIVNATGPWVDQLRE
KDHSKNGKHLQHTKGIHLVFDQSVFPLKQAVYFDTPDGRMVFAIPREGKTYVGTTDTVYK
EALEHPRMTTEDRDYVIHSINYMFPELNITANDIESSWAGLRPLIHEEGKDPSEISRKDE
IWTSDSGLITIAGGKLTGYRKMAEHIVDLVRDRLKEEGEKDFGSCKTKNMPISGGHVGGS
KNLMSFVTAKTKEGIAAGLSEKDAKQLAIRYGSNVERVFSRVEALKEEAAKRHIPVHILA
EAEYSIEEEMTATPSDFFVRRTGRLFFDINWVKTYKDAVIDFMSERFQWDEQVKNKHTEN
LNKLLHDAVVPLEQ
>PK3-2_04560 Glycerol kinase
METYILSLDQGTTSSRAILFNKEGKIVHSAQKEFTQYFPHPGWVEHNANEIWGSVLAVIA
SVISESGISASQIAGIGITNQRETAVVWDKDTGKPVYNAIVWQSRQTSGICEKLREKGYN
DLFREKTGLLIDPYFSGTKVKWILDNVEGAREKAEKGELLFGTIDTWLIWKMSGGKAHVT
DYSNASRTLMFNIYDLKWDDELLDILDVPKSMLPEVKPSSHVYAETVDYHFFGKNIPIAG
AAGDQQSALFGQACFEEGMGKNTYGTGCFMLMNTGEKAIKSEHGLLTTIAWGIDGKVEYA
LEGSIFVAGSAIQWLRDGLRMFQDSALSESYAEKVDSTDGVYVVPAFVGLGTPYWDSDVR
GSVFGLTRGTTKEHFIRATLESLAYQTKDVLDAMEADSNISLKTLRVDGGAVKNNFLMQF
QGDLLDVPVERPEINETTALGAAYLAGIAVGFWKDRSEIANQWNLDKRFEPELEEEKRNE
LYKGWQKAVKAAMAFK
>PK3-2_04561 Glycerol uptake facilitator protein
MTAFWGEVIGTMLLIIFGAGVCAGVNLKKSLSFQSGWIVIVFGWGLGVAMAAYAVGGISG
AHLNPALTIALAFVGDFPWNEVPVYIAAQMIGAIIGAVIIYLHYLPHWKSTDDPAAKLGV
FSTGPSIPHTFGNVLSEVIGTFVLVLGILAIGANQFTEGLNPLIVGFLIVAIGISLGGTT
GYAINPARDLGPRIAHAFLPIPGKGSSNWKYAWVPVAGPILGGSFGGVFYNAAFKGQITS
SFWIVSVILVVVLLGLYIYTKSHSAKTLSNSKYM
>PK3-2_04562 Glycerol uptake operon antiterminator regulatory protein
MSFHNQPILPAIRNMKQFDEFLNSSFSYGVILDIHLGQLKGVIREAQKHGKNMMVHVDLI
QGIKHDEYGAEFICQDIKPAGIISTRSNVIAKAKQKKIYAIQRLFLLDTSAMEKSMEFVG
KHKPDFIEVLPGIVPSLIQEIKEKTGIPIFAGGFIRTEEDVEQALKAGAVAVTTSNTKLW
KKYENFLTENN
>PK3-2_04563 Taurine--pyruvate aminotransferase
MENIQQNQGLKQKDGQFVWHAMKGAHQADSLIAQKAEGAWVTDIDGRRYLDAMSGLWCVN
IGYGRKELAEAAYEQLKELPYYPLTQSHAPAIQLAEKLNEWLGGDYVIFFSNSGSEANET
AFKIARQYHLQNGDHSRYKFISRYRAYHGNTLGALSATGQAQRKYKYEPLSQGFLHAAPP
DVYRNPKDADTLESANEIDRIMTWELSETIAGVIMEPIITGGGILMPPDGYMKKVEDICR
RHGALLICDEVICGFGRTGEPFGFMHYGVKPDIITMAKGITSAYLPLSATAVKRDIFEAY
QGEAPYDRFRHVNTFGGSPAACALALKNLQIMEDEQLIQRSRDLGAALLSELQALREHPA
VGDVRGKGLLIGIELVKDQLTKEPADADKVNQVVAACKEKGLIIGKNGDTVAGYNNVVQL
APPFCLTEEDLSFIVKTVKDSFQMI
>PK3-2_04564 hypothetical protein
MNEFYRALTFVNKIFYEPNHLTINAIREEAQNSDYGAGMFQLNSKSVRFRVAKITPKKIG
QFVAFWEKDRNNKNQAFSYEKATDLLVINTFTSNNNFGQFVFPKEVLVKQNILKTTTVKG
KMAIRVYPRWEKPTSKQAIDTQKWQLAYFVEVNNTNSFPVQELLRLYSI
>PK3-2_04565 hypothetical protein
MSEKLDLTRFEKKMVIRNIEEKDIDKIIDLQKDCFPGMEPWKREHLISHLEHFPEGQFCA
EFEGEIIGSCSSLLINFDEYDDRHTWQDITDDGYITNHNPDGLNMYGIEVMVHPKYRRMK
IGHRLYEARKDLARRLNLKSIIIGGRIPNYHKYAEEMTARAYVEQVTRHQIYDPVLSFQL
MNGFTLMRLNPNYLPDDTASIKYATLMEWNNVDYLPQQTKRYYKSAFPVRICVIQYEMKK
IYSFEEFANQVEYYVDVASDARSDFAVFPEIFTTQLMSFLEERSPSLAVQRITEYTEDYI
SLFTDLAVKYNVNIIGGSHFVEEEGKIYNIAYLFRRDGTIEKQYKLHITPNERKWWGISA
GDQVRVFDTDCGKIAIQICYDIEFPELARIAADKGAKIIFTPFCTEDRQGYLRVRYCSQA
RAVENQIYTVISGTVGNLPQTENMDIQYAQSGIFAPSDFEFARDGIVGETNPNIEMVVIG
DVDLEILRRQRQNGTVRQLKDRRRDVYHIEYKK
>PK3-2_04566 Protein CbbY
MIKALIFDFDGLILDTETHEYEVLQEIFEEHGSVLPLSVWGKVIGTAAGFRPFEYLEEQI
GKKLNHEQLTTLRRERFAKRMETEKARPGVEAYLNAAKDLGLKVGLASSSDYKWVSGHLK
QIGLFDDFEVIQTADDVEEVKPNPELYLLAAKNLGVSPSECLAFEDSVNGSVAAKRAGMK
CVIVPNKVTGTLMFEDYDHRLESMAEMELALLLDHLNSQN
>PK3-2_04567 Inosine-5'-monophosphate dehydrogenase
MLTDRDIALRTTAQGRDGQTPVSEVMSTDLVSGNPNMSLEDASQLMAQHQIRRLPIVDQN
NLVGIVALGDLAVNQMSNESAGEALTNISHQNIH
>PK3-2_04568 hypothetical protein
MGSVKNTMTTQVATVSPNQTIQEAASLMKQHNVGAIPVVEQGV
>PK3-2_04569 hypothetical protein
MARKVIDVRIVNAATAEQESFIKELSMELIHDVFPLYFSELDIQRFKKKGVLSLNNHYYQ
GTLKEAFQIMACLQMIHIILTKPSLHSGLGDQAIFEKNSKMLNDFGIYFPFAFSDFQMKT
NKAFFGHRRLI
>PK3-2_04570 Ribosomal large subunit pseudouridine synthase D
MKQKGRGLELLINDKQDGQWLFAVLKTALKASKPVIQDWMSHHRIKVNHETVINNVIVKK
GDRVFIDLQESEESSLIPEYGELDILFEDNHMLIVNKPAGIATHPNEDGQTGTLANLIAY
HYQVNGETCKVRHVHRLDQDTSGAIVFAKHRLAHAILDQQLEKKTLKRTYTAIAEGKLKT
KKGTIDSPIGRDRSHPTRRRVSPGGQAAVTHFNVLAGNAKERLSLVELELETGRTHQIRV
HMASIGHPLTGDSLYGGGSKLINRQALHAKKVQAVHPITGELIIAEAPFPADIENLCRTY
FS
>PK3-2_04571 Sortase D
MKKVIPLIIIAAGLIITGYGGLQLIDTNMKTEQTLKEAKLAAEKPQKASGTKQSADQAKN
KASFKPETGQASGILEIPKINAELPIVEGTDADDLEKGVGHYKDSYYPDENGQIVLSGHR
DTVFRRTGELEKGDRLRILLSYGDFTYEIVKTKIVDKDDTSIITLQHEKEELILTTCYPF
SYVGNAPKRYIIYGKRVA
>PK3-2_04572 Endonuclease YhcR
MPLHQLPPSAILRLGEIPSGGKNADTEGKISTLPIQKETAESGSDHQLPDTSAGYYNFMV
IGAAVALSGTYLYVRRKRSASRT
>PK3-2_04573 Endonuclease YhcR
MRRILHIVLITVMMFLNVMYTCEAVKAAEPQQPISVDKAIEQKEGQALVEGYAIGQAVSP
QHYKLTSPFSNDYNVALADSKNETAPNRILPVQIPSAFRSHFGLQTNPLLLGKKITVQGQ
LENYFNTTGLKSVQSMNAADETKTPPAGQPVTINEARGRLNEEVTIKGVVTADQSAIGGG
KLSTFMQDGTGGINIYSSVPGQFPELKEGMDITVKGKITTYQGLTEIVPNTSGIKVNQPN
QSLPAPKLSTINELVNSSLGDLLEGRLVTLKAFVSSIPNSPAGGGYNVTIIDEDHLAMTL
RVMNETGVIDELDEGKWYKFTGVLSRYQSFQLLPRKSSDLKLLEEQPAPPSAEGEYEGIV
DRVVDGDTIHLKSPVLGTTKIRFVNVDTPETYHTPKNEADENQLKFGKKASDYLKTVLSP
GDKITVKVGSEAKDSYGRLLGQVITGSGSNVNLELVKNGYAPTYFIWPVDNKEDYQQFQA
AVAVAKKEQKGIWNEDDPLIEMPFEFRAREQGKGLTRYVGDSSNKTYVQPADWQQVAVEN
RIFFASASEAEIAGYKKRQTAPQENVPLRILSMNDLHGKIDQQYELDLDGNGTADGTFGR
MDYAAAYLKEKKAEKKNTLIVHAGDMIGGSSPVSSLLQDEPTVELMEDIGFDVGTVGNHE
FDEGTDELLRILKGGDHPNGTSGYDGQNFPLVCANCKMKSTGEPFLPAYDIINVEGIPVA
FIGVVTQSAAGMVMPDGIKNIEFTDEAAAVNEAAAELKKKGVKAIAVLAHMSAEQNGTAI
TGESADLANNTDSEIDVIFAAHNHKVVNGEVNGKLIVQAFEYGKAMGVVDVEIDKTTKDI
VKKSAEIVYVDQSKIEPDASAKGILKKYQTLAEPIISEVVGEAAVDMEGGYSNDGDTPLG
NLIADGMRAAMKTDFALMNGGGIRETLKKGPITWGDLYNIQPFGNVLTKLEIKGTDLREI
INAQISPVFGPDYSISGFTYTWDKETGKAVDMKLPNGTKIQPDAAYTLTVNNFMATATGA
KYQPIGLLGKNPVTGPEDLDATVEYVKSFNKPIAYTKEGRIKLAEASDIEDPVTEDPVTG
DDPGTERPV
>PK3-2_04574 hypothetical protein
MDQFNQQQSQMNKGIPGKPHKNHGGHEMFDMHEVLSGTLTVLDQFMMLRQFCKDQELLNI
LDRQHQFITSQYNLTAECFKTGSEPSQKTATYMMKEDNQTVYGMQPSQPKKPVQSMNDID
DSIISRQMLCAVKAQASMLTMASLEMTNPAVRRVLSAQIQQYVEMAFEIFLYQNKHGYYQ
VPQLDAQDMEQLRNSFAPAQGQMPPTQGGMGQQGLH
>PK3-2_04575 hypothetical protein
MDVVGFYSEREQLIGLLPEEKKKLLEGDEVAVYLYQRLLIHEYTHHAFHQKLKELEVDPD
EFPLWFHEGLSEWIANYELLIDPISFSVVPFDRLQTDQDWQEARTEYDTDVYLQSFYMIN
ELTEKYGKDIISEMIKETAKKGDFKKGFKSATKESLDQFEKDFKNTFEENRAALDSIYPM
PLLLMKSLLAHAALSWGHLPLCRSK
>PK3-2_04576 hypothetical protein
MRDGIGKRAASALFLCGVLVMLAVSSAIVSSTMYILSLPGQTSGITKEQVTKHMKKESFK
QADIYYTSKEKSLLPLTKETLEYAVRINQIMIGYSNQKPIDIIFFLTKNRWRLTPVYWM
>PK3-2_04577 putative spore germination lipoprotein YhcN
MIGKKQVLASMLLIPLLMTGCSMANQGEGRRDNLEPENVNYRNPVNDNGARNINDANDNR
DNVDNNVTDNVNNNDNGNNNDNNNRKLEVADDAADKITDMKEVKHANVIVAGNQAYVAVV
LTNGNKEVGKDLKKKISDKVRDTDKNMDNVYVSANPDFVDRMQGYGERIQNGDPIAGFFD
EFSETVQRVFPQAE
>PK3-2_04578 hypothetical protein
MLFNQRRGISPAALIIGSTMLIAALSPQIRQRISGFVTGQMKNRRNSENNMFDASNVGNM
VKQALGGGDNQDRSQNQSQRQNGRQHQHAGQQQTQHQHSQTQSRQTETAAKKRQPHYAEP
IQFEQSAMNVMDDNTMMEMLEDLEPGR
>PK3-2_04579 L-cystine uptake protein TcyP
METLLVVLHVFILFLLILGLFVMQKKHVSFSKRVFTALGLGIVFGFALQLIYGPTSNIVI
QTADWFNIAGGGYVKLLQMVVMPLVFISILGAFTKLKLTKNLGKISGLIIGILIATTAVA
AAVGIASALSFDLQAIQVDQGNTELSRGQELQQKSEDMTAKTLPQQIIELLPGNPFLDFT
GARPTSTIAVVIFAAFLGMAFLGVKHKQPEQAETFKKMVDAVYAIVMRVVTLILRLTPYG
VLAIMTKTIATSDIDSILKLGMFVVASYAALITMFIIHLLLLTLSGLNPIIYLKKALPVL
VFAFTSRSSAGALPLNIKTQRSMGVPEGIANFAGSFGLSIGQNGCAGIYPAMLAMMIAPT
IGQNPLDPVFIITVIAVVAISSFGVAGVGGGATFAALLVLSSLNMPVALAGLLISIEPLI
DMGRTALNVSGSMTSGLITSKVTKEIDSGVFNDQSRVIEAEEA
>PK3-2_04580 hypothetical protein
MLKELFVNLTILITFNYLFTHLFKERLVHKKDSISFQAVKGLACGLLGVILMVFGFSYQH
SIIDLRNIPIMIAALYGGWVSTAMALVMIAAGRMLITMNTSAIYSVIIICFAAIPSLIVS
GRKKVQLKHAFYLLIITNSLISISFYFFINLHSYELHLYFWIISIAGGMLSLYIIDHETN
AHLLFKQYKFQAHFDFLTGIYNRRKFEEITQALYQQAANTPNFQFALIYMDIDHFKTIND
QYGHHEGDQVLKELGSRLRQSIRNSDPAARIGGEEFAVLLPNCTLDKAVQIAERIRRTVS
DSPIRLTNGEELSVTISLGAAHYPNNKEHPESLPILADQMLYKAKETGRNKVCFSEKKNE
FNVRIHSSNLKDVS
>PK3-2_04581 Methionine-binding lipoprotein MetQ
MKKWLICSFVLVFLVSFTACSPSAEHETIKIGIAESDEAIWNYIANKAEGAGLDIQLVPF
SDYAESDIALANKEIDANALQTISYFQSFTQKYKRKLAPLGTTYITPMGLYSKRYDRIQD
IPRGAVVSVPDKAIDFGRALTVLQEAGLLTLKNGFNGTGSVDMIKDNPRHLKLKAVPQQD
AVSGADVFVMKPSEAKKAGLNPKEHTIKSGGQMCKEEVNLIVVRAEDQDREALRTILELY
HADDTAAFIEKEYRGDIVPAFLPMKRLSDWKNEFEH
>PK3-2_04582 Cold shock protein CspB
MLEGKVKWFNSEKGFGFIEVEGQDDVFVHFSAIQGEGFKTLEEGQAVSFEIVEGNRGPQA
ANVTKEA
>PK3-2_04583 hypothetical protein
MLNLIYNEWIKIFSRAGTWVMIGILALTMIGWAFLTNHFSSDEANPKWKQTLQAENAALK
KEMKEDPSLKDGYEETITVNNYRIKHNIPNDTGYTVWSYVTDSAGFTILTGLFTIIIAAG
IVANEFNWGTIKLLMIRPLNRFQILLSKYITVLLFGFLLLVILFMGSTLLGMLFFGTGGD
TAANVHLIYKDGHVIEQNMMGYLAKTYLSESVAALMIATMAFMLSAVFRNSSLAVGFSIF
LLVTGMTATAFIAAKFDWAKYILFANVNLMQYVEGTPLVEGMTMTFSIVMLVIYFIIFLL
LAFGIFMKRDIAN
>PK3-2_04584 Bacitracin transport ATP-binding protein BcrA
MKTVLELKNVTKNIRGRTIIDHLSFTIREGEVFGFLGPNGAGKTTTIRMMVGLMKLSKGD
VLICGQSITKEYAKAIKHIGAIVENPELYKFLSGYKNLQQYARMVKGVTKEKIDEVVELV
GLTDRIHDKVKTYSLGMRQRLGLAQCLLHDPKVLILDEPTNGLDPAGIREIRDHLKKLTR
ERGMAVIVSSHLLSEMELMCDRIAILQKGKLIDIQNVRDEITDENDTYFFQVDQPKEAAS
VLKEYDVVSKTNGIEVKLAKDEVPAAIELLVMQQIRIYEVKVMTKSLEDRFLEMTGEAKE
EVQHA
>PK3-2_04585 Multidrug efflux system ATP-binding protein
MEITLEHVSKKYGRHTAVNDVSITLSSGRIYGLIGPNGSGKSTTLKMMAGLLFPTSGFVK
VNEKPVTRDMVRQAAYLTELDMFYPHFTVKDMVNFYQTQFPDFQTEQAYKLLNEMQLDPN
KKIKKLSKGNRGRLKIVLALARRASVILLDEPFSGLDPMVRDSIVNSLVSYIDFEQQIVV
IATHEIDEIETLLDEVIILANGEKVEQRVVEEIREREGMSVLQWFKSKMEVC
>PK3-2_04586 HTH-type transcriptional repressor YtrA
MDNQFQSSKPIYLQIADQIFYRLVRKELLPGDKLPSVREMAIQTKVNPNTIQRTYSEMER
LGIVETRRGQGTFIAEKAEIVDELKDRLTREVLEGFVKQMKELGLTKEEMVEGIKTFTEG
G
>PK3-2_04587 hypothetical protein
MDSFLGLLKKDLKLSKIWLLAWICGIIFLLVTGHIIASHTKQPLVSFGFFVAVAFFLVFL
SPVFVFYHLHKEGKSQLWLYNPNGGFLLLSSKLAASLLYQFLIQLALTAYGIWIYHMFSV
KNLLEHHVDMTSTVVLLNVYGLISALYMSVTIVVFWTVFHSLKNWRGMRWAAMGLLAAVW
YFFDECIMSPLLESQKHFWPVTVYCNFDFNFHNVWRLELKPIHLSVLGFPIAIIITIILL
LMASKLLDRKVEV
>PK3-2_04588 hypothetical protein
MAIIIAIIAAVIVIAALITFNVRNASPGPEKQETTERIAPPEEENNEAQYPAEARAAEHT
PAVVNNDSPQEKRNTMGDDIYRQALQKFKHSDEDQAEEEVTEESDKMQDSSYRDALLSMK
NKKK
>PK3-2_04589 p-benzoquinone reductase
MKIYVVYDSEGEHTKVLAEAIAEGARENEAAEVLIDHVDQADIRKLKDMDAIIWGCPGHF
GTISSGLKAWIDRLGYLWAEGELINKVGAVFCTTATTHGGLEMTMHNLITPMFHQGMIVV
GLPGNVPENALYGSYYGAGVTCPVDSDELMSEEGIQLGRALGRRVSQVTGNLTSGQ
>PK3-2_04590 Putative multidrug resistance protein MdtD
MATGKENNAKSPMTLLFVLMAGLFLAILNQTLLNVAMPHLMTEFGVSATTIQWLTTGYML
VNGVLIPLSAFLITRFGQRSLFLVAMFCFTLGTLVCGIAPNFSTMLIGRLIQAVGGGILQ
PLVMTTILLIFPPESRGKGMGIFGLAMMFAPAVGPTLSGWIIEHYTWRIMFYGLVPVGAI
VIIVAFFIFKNLVEPQKIKLDTLGAILSIVGFASLLYGVSEAGSDGWSDPIVLSTVIIGV
IAIVAFVIQQLRHDDPMLDFRVFKYDIFSLSSVINIIITVALYTGMFLLPIYLQNLVGFT
ALQSGLLLLPGAIVMLIMSPISGILFDKFGPRPLAIIGLLVTVVTTYQYTQLTIDTPYTH
IMLIYSIRAFGMSLLMMPVMTAGMNQLPARLNSHGTAMSNTLRQISGSIGTSLITTIYTN
RTTFHYSQIADKTSTADPNFLHAFQNAVTNLMVNMNMSYDTAKTYVFSHLYKHASLDSNV
MGINDAFMWATIFCVFGLILALFLRDVRKDKARAEKKKQEELSLLPAPKEVKES
>PK3-2_04591 p-hydroxybenzoic acid efflux pump subunit AaeA
MNRGRLILTNIIGLIVVLAIIGGGAYYYYQSTNFVKTDEAKVAGDMAAITAPAAGKVSDW
DLEEGKTVKKGDTVAKIKGEQSVEVKSIMDGTIVKNEVKNGQTVQAGTTIAQTIDMDHLY
ITANIKETEIADIENGDKVDIVVDGDPDTTFDGTVEEIGYATNSTFDMLPSSNSSGNYTK
VTQKVPVKISISNPSSKVLPGMNATVKISE
>PK3-2_04592 hypothetical protein
MTESERALLTFEQLFDTSRAIYKKQKKILEIVLEPFDITVLQYLLMFKIHQSGSTPLSKL
AMSLDLKPASVTRMTDILYKRQLMNRYDSPDDRRIVMIQLTEEGEELLNNAAVNYAKMGA
SLYQKLDTSQLQYLRKLAGSLSKLAEGCSEKSGN
>PK3-2_04593 hypothetical protein
MSQNDSGHFLISEENWSLHRKGFDDQQRHQKKVQEAIKNNLPDLVTEESIIMSNGKDVVK
IPIRSLDEYKIRYNYDKNKHVGQGEGDSQVGDVVARDGSDKKQGPGKGQGAGDQAGEDYY
EAEVSLMDLEEALFKELELPNLQQKERDNIIHTDIEFNDIRKTGLTGNIDKKRTMMSAFK
RNAMSGKPSFYPIYPEDLKYKTWNDITKPESKAVVLAMMDTSGSMGVWEKYMARSFFFWM
TRFLRTKYETVEIEFIAHHTEAKVVSEEDFFSKGESGGTICSSVYRKSLELIDEKYNPAR
YNIYPFHFSDGDNLTSDNARCVKLVNDIMKKANLFCYGEVNQYNRHSTLMSAYKNVKDEK
FKYYILKQKSDVFQALKNFFRNEESGVSHQYS
>PK3-2_04594 hypothetical protein
MDILKKIEQYREEEQRLKWEGTFADYLEIIKENPMVAQSAHSRVFNMIKDSGIEEIDGRK
KYSFFDRELFGLEESLERLVEEYFHPAAKRLDVRKRILLLMGPVSGGKSTLVTMLKKGLE
AYTLTDNGAVYAIKGCPMHEDPLHLIPHHLREDFYREYGIRIEGSLSPLNVMRLEEEYGG
RIEDVRVERIFFSEDKRTGIGTFSPSDPKSQDIADLTGSIDFSTIAEYGSESDPRAYRFD
GELNKANRGMMEFQEMLKCDEKFLWHLLSLTQEGNFKAGRFALISADELIVAHTNETEYR
SFISNKKNEALHSRIIVMPVPYNLKVSEEERIYEKMIAESDVADVHIAPHTLKVAAMFSI
LTRLKEPKRSDIDLVKKMRLYDGESVEGYNSVDVEDMKKEYNDEGMSGIDPRYVINRISS
TIIRKNMESINSLDVLRSLKEGLDQHPSISSEDRERYLNFISAARKEYDDIAKKEVQKAF
VYSYEESAKTLMDNYLDNVEAYCNKNKLRDPLTGEEMNPDEKLMRSIEEQIGISENAKKA
FREEILIRISAYARKGKRFDYNSHERLREAIQKKLFADLKDVVKITTSTKTPDEQQLKKV
NEVVARLIDEHGYNSTSANELLKYVGSLLNR
>PK3-2_04595 hypothetical protein
METTKLGNLKLYGAGYAAGGAYHHVSIKGEGVVGEGLSAAGCRIFGTGLFLGKAETERLR
VFGESEFKSNLTSGRINIYGTMKVSGSLQFDRFNLKGLAEICGNMAGESCDVKGKLSVKG
DCETEMFHVTGCVDVSGLLNAGDVKLGLSHDVSYVREIGGTTITVKRRAGLFNRKKVKLI
ADLIEGDQVYLENTEAAVVRGKEVIIGPGCSIGTIEYKNKYECDQHSKIKETNNI
>PK3-2_04596 hypothetical protein
MDVMEKLVINGSGSSKGGTFQSVEINGSGTVAGDVECDTFSFNGTGKADGSVKAKAVTIS
GSGKIHGDVEAESIRIHGTGFIQGEASAKQLKIAGSSTFGGTVKADGIDISGKAVMEADC
ETETFQSEGKCKISGLLNADQVIIKLSAGESYVREIGCRHLQVTSRKGMLTLLRLMSQPV
LTAELIEGDVIELTNTKAKTVRGNTVKIGPDCQIETVEYSGDYTCDPSALVETCTKV
>PK3-2_04597 hypothetical protein
MRVEMLCFIFGLNNVTVLCYNVPIKGAGLMEEQLISKKELLERTSISYGQLYRWKRKNLI
PEEWFIRKSTFTGQETFFPREDILKRISMIQKMKENLSLDEMREMLSPKMKDVSMTADEL
LHKSLISKPALDVFSKGEGNPFFSSRDLLSLYVLEGLLQSGNVSLAEAKMAAEVLKQHDT
EEIKNQTELIVLRKLGITTCFIAAAADSILFESSVKVVERVDLIKASEELKTTYMQEGHQ
WM
>PK3-2_04598 tRNA (cytidine(34)-2'-O)-methyltransferase
MALHVVLYQPEIPANTGNIARTCAATNTTLHLIRPLGFSTDDKMLKRAGLDYWEFVNVVY
HDSLEELFEEYQKGQFFFITKFGQQPHTSFDYTDLDEDYFFVFGRETSGLPKDLIQNNMD
RCLRLPMTEHVRSLNLSNTAAILVYEALRQQNYRDLK
>PK3-2_04599 hypothetical protein
MSLKHILEQLAEERLSYLVNGHAMRQESEVGDLEVMERKKKLLEKRKVEIVKAKAKAVID
HVRVEDDGTTCVTYTIHYEYVCKEQEDSLYMEEHLEERRAFLYDHILISDQEIAKKPAGF
HEGTSIIDYSQEEREAFGRAFQYDRLGAVQYAEKYWNKRNPAYKNFSDNCTNFISQCLHA
GGAPMRGHPNRGSGWWMKQSSWSYSWTVAHSMKMYLSNSKAGMRAVRVKSAEELMPGDVI
CYDFEGDGRFNHTTIVVAKDKGNMPLVNAQSYDSRMRYWSYEDSTAYTPSIRYAFFHIVD
DTTKE
>PK3-2_04600 Epoxyqueuosine reductase
MNVYQLKEELIEYAKSIGVDKIGFTTADTFDSLKDRLILQESLGYLSGFEEPDIEKRVTP
KLLLPKAKSIVAIALAYPSRMKDAPRSTRTERRGIFCRASWGKDYHDVLREKLDLLEEFL
KSKHEDIRTKSMVDTGELSDRAVAERAGIGFSAKNCMITTPEYGSYVYLAEMITNIPFEP
DVPIEDMCGTCTKCLDACPTGALVNPGQLNAQRCISFLTQTKGFLPDEFRTKIGNRLYGC
DTCQTVCPLNKGKDFHLHPEMEPDPEIAKPLLKPLLTISNREFKEKFGHVSGSWRGKKPI
QRNAILALAHFKDASALPELTDLMHKDPRPVIRGTAAWAIGKIGDPAYANELEKALEKEK
DEEAKLEIEKGIDLLKASGMTKQGLS
>PK3-2_04601 hypothetical protein
MNIKIDSVITERAAGLLAAAVIYENIEVGSSPQMLKGRLRLFQESLFFDYADGGISDEPF
VKEWRELFKQLNPSFEGETTPMVDMLIPISKEQFMESKDSAHDTIDFFALKYSLPIMIYD
AGKLHEQVRISLGEKENILIFSDENGVFGDFKNSVNRYPVSNETKNMLQIIFFPPSIEKN
SAVKLLSSLTKMFEQIHGGAHTVHWLT
